MED-10~statin breast cancer surviv nationwid cohort studi finland abstract recent studi suggest statin establish drug group prevent cardiovascular mortal delay prevent breast cancer recurr effect disease specif mortal remain unclear evalu risk breast cancer death statin user population bas cohort breast cancer patient studi cohort includ newli diagnos breast cancer patient finland num num num case identifi finnish cancer registri inform statin diagnosi obtain nation prescript databas cox proport hazard regress method estim mortal statin user statin time depend variabl total num particip statin median follow up num year diagnosi rang num num year num particip die num num due breast cancer adjust age tumor characterist treatment select post diagnost pre diagnost statin lower risk breast cancer death hr num num ci num num hr num num ci num num risk decreas post diagnost statin affect healthi adher bias greater likelihood die cancer patient discontinu statin associ dose depend observ low dose short term dose time depend surviv benefit pre diagnost statin user suggest causal effect evalu clinic trial test statin effect surviv breast cancer patient
MED-14~statin diagnosi breast cancer surviv population bas cohort studi pubm ncbi abstract background preclin studi shown statin simvastatin prevent growth breast cancer cell line anim model investig statin breast cancer diagnosi reduc risk breast cancer specif all caus mortal larg cohort breast cancer patient method cohort num breast cancer patient newli diagnos num num identifi english cancer registri nation cancer data repositori cohort link uk clinic practic research datalink provid prescript record offic nation statist mortal data num identifi num death includ num death attribut breast cancer unadjust adjust hazard ratio hrs breast cancer specif all caus mortal statin user breast cancer diagnosi calcul time depend cox regress model sensit analys conduct multipl imput method propens score method case control approach result evid statin diagnosi breast cancer reduc mortal due breast cancer fulli adjust hr num num confid interv num num num num num associ mark simvastatin num num num num num num conclus larg population bas breast cancer cohort evid reduc mortal statin user breast cancer diagnosi associ weak magnitud attenu sensit analys
MED-118~alkylphenol human milk relat dietari habit central taiwan pubm ncbi abstract aim studi determin concentr num nonylphenol np num octylphenol op num human milk sampl examin relat factor includ mother demograph dietari habit women consum median amount cook oil signific higher op concentr num ng g consum num ng g num op concentr signific consumpt cook oil beta num num fish oil capsul beta num num adjust age bodi mass index bmi np concentr signific consumpt fish oil capsul beta num num process fish product beta num num food pattern cook oil process meat product factor analysi strong op concentr human milk num determin aid suggest food consumpt nurs mother order protect infant np op exposur num elsevi reserv
MED-301~methylmercuri potenti environment risk factor contribut epileptogenesi abstract epilepsi seizur disord common neurolog diseas human genet mutat ion channel receptor risk factor brain injuri link epileptogenesi major epilepsi case remain unknown gene environ interact thought play critic role etiolog epilepsi exposur environment chemic import risk factor methylmercuri mehg promin environment neurotoxic target primarili central nervous system cns patient anim acut chronic mehg poison display epilept seizur show increas suscept seizur suggest mehg exposur epileptogenesi mini review highlight effect mehg exposur development exposur suscept human anim seizur discuss potenti role low level mehg exposur epileptogenesi review propos preferenti effect mehg inhibitori gabaerg system lead disinhibit excitatori glutamaterg function potenti mechan mehg induc seizur suscept
MED-306~sensit continu perform test cpt age num year development methylmercuri exposur abstract hit reaction time latenc hrt continu perform test cpt measur speed visual inform process latenc involv neuropsycholog function depend time test initi orient learn habitu cognit process focus attent final sustain attent domin demand prenat methylmercuri exposur increas reaction time rt latenc examin associ methylmercuri exposur averag hrt age num year time interv test initi total num adolesc num birth cohort member complet cpt rt latenc record num minut visual target present num ms interv confound adjust regress coeffici show cpt rt outcom differ associ exposur biomark prenat methylmercuri exposur minut averag hrt weak methylmercuri beta se ten fold increas exposur num num strong num num minut interv num num strongest num num minut test initi num num pattern unchang simpl reaction time finger tap speed includ model covari postnat methylmercuri exposur affect outcom find suggest sustain attent neuropsycholog domain vulner development methylmercuri exposur indic probabl dysfunct frontal lobe cpt data measur neurotox test result analyz regard time test initi averag reaction time
MED-329~phosphat vascular toxin pubm ncbi abstract elev phosphat level advanc renal failur dysregul calcium parathyroid hormon vitamin level contribut complex chronic kidney disease miner bone diseas ckd mbd converg evid vitro clinic epidemiolog studi suggest increas vascular calcif mortal vessel expos high condit vitro develop apoptosi convert bone lik cell develop extens calcif clinic studi children dialysi show high increas vessel wall thick arteri stiff coronari calcif epidemiolog studi adult dialysi patient demonstr signific independ associ rais mortal import rais cardiovascular pre dialysi ckd subject normal renal function high binder effect reduc serum decreas link improv surviv rais serum trigger releas fibroblast growth factor num fgf num benefici effect increas excret earli ckd increas num fold dialysi independ cardiovascular risk factor fgf num co receptor klotho direct effect vasculatur lead calcif fascin disturb fgf num klotho rais prematur age data suggest high level advers vascular effect maintain serum level normal rang reduc cardiovascular risk mortal
MED-330~dietari phosphorus acut impair endotheli function abstract excess dietari phosphorus increas cardiovascular risk healthi individu patient chronic kidney diseas mechan risk complet understood determin postprandi hyperphosphatemia promot endotheli dysfunct investig acut effect phosphorus load endotheli function vitro vivo expos bovin aortic endotheli cell phosphorus load increas product reactiv oxygen speci depend phosphorus influx sodium depend phosphat transport decreas nitric oxid product inhibitori phosphoryl endotheli nitric oxid synthas phosphorus load inhibit endothelium depend vasodil rat aortic ring num healthi men altern serv meal num mg num mg phosphorus double blind crossov studi measur flow medi dilat brachial arteri num meal high dietari phosphorus load increas serum phosphorus num signific decreas flow medi dilat flow medi dilat correl invers serum phosphorus find suggest endotheli dysfunct mediat acut postprandi hyperphosphatemia contribut relationship serum phosphorus level risk cardiovascular morbid mortal
MED-332~public health impact dietari phosphorus excess bone cardiovascular health general popul pubm ncbi abstract review explor potenti advers impact increas phosphorus content american diet renal cardiovascular bone health general popul increas studi show phosphorus intak excess nutrient healthi popul signific disrupt hormon regul phosphat calcium vitamin contribut disord miner metabol vascular calcif impair kidney function bone loss larg epidemiolog studi suggest mild elev serum phosphat normal rang cardiovascular diseas cvd risk healthi popul evid kidney diseas studi link high dietari phosphorus intak mild serum phosphat natur studi design inaccuraci nutrient composit databas phosphorus essenti nutrient excess link tissu damag varieti mechan involv endocrin regul extracellular phosphat specif secret action fibroblast growth factor num parathyroid hormon disord regul hormon high dietari phosphorus key factor contribut renal failur cvd osteoporosi systemat underestim nation survey phosphorus intak continu increas result grow consumpt high process food restaur meal fast food conveni food increas cumul ingredi phosphorus food process merit studi shown potenti toxic phosphorus intak exceed nutrient
MED-334~differ total vitro digest phosphorus content plant food beverag pubm ncbi abstract object plant food grain product legum seed import sourc phosphorus current data content absorb food lack measur vitro digest dp content food reflect absorb object studi measur total phosphorus tp dp content select food compar amount tp dp proport dp tp food method tp dp content num food drink plant origin measur induct coupl plasma optic emiss spectrometri dp analysi sampl digest enzymat principl alimentari canal analys popular nation brand chosen analysi result highest amount tp num mg num found sesam seed hull lowest percentag dp num tp cola drink beer percentag dp tp num num num mg num cereal product highest tp content num mg num dp proport num present industri muffin sodium phosphat leaven agent legum averag dp content num mg num num tp conclus absorb differ substanti plant food high tp content legum poor sourc food phosphat addit proport dp high support previous conclus effect absorb addit copyright num nation kidney foundat publish elsevi reserv
MED-335~differ total vitro digest phosphorus content meat milk product pubm ncbi abstract object meat milk product import sourc dietari phosphorus protein addit common process chees meat product measur vitro digest phosphorus dp content food reflect absorb object studi measur total phosphorus tp dp content select meat milk product compar amount tp dp proport dp tp food method tp dp content num meat milk product measur induct coupl plasma optic emiss spectrometri icp o dp analysi sampl digest enzymat principl alimentari canal analys popular nation brand meat milk product chosen analysi result highest tp dp content found process hard chees lowest milk cottag chees tp dp content sausag cold cut lower chees chicken pork beef rainbow trout similar amount tp slight variat found dp content conclus food addit high content dp studi confirm cottag chees unenhanc meat choic process hard chees sausag cold cut chronic kidney diseas patient base lower p to protein ratio sodium content result support previous find absorb food anim origin legum copyright num nation kidney foundat publish elsevi reserv
MED-398~grapefruit wine glass metabol cardiovascular perspect abstract summari grapefruit popular tasti nutrit fruit enjoy global biomed evid num year shown consumpt grapefruit juic drug interact case fatal grapefruit induc drug interact uniqu cytochrom num enzym cyp num metabolis num common prescrib drug drug transport protein p glycoprotein organ cation transport protein express intestin involv extent grapefruit drug interact impact clinic set fulli determin case report recent emerg grapefruit virtu rich flavonoid content benefici manag degen diseas diabet cardiovascular disord potenti explos subject review
MED-557~dysmenorrhea pubm ncbi abstract dysmenorrhea lead recurr short term school absenc adolesc girl common problem women reproduct age risk factor dysmenorrhea includ nullipar heavi menstrual flow smoke depress empir therapi initi base typic histori pain mens negat physic examin nonsteroid anti inflammatori drug initi therapi choic patient presumpt primari dysmenorrhea oral contracept depo medroxyprogesteron acet consid pain relief insuffici prolonged cycl oral contracept intravagin oral contracept pill consid women desir hormon contracept evid benefit topic heat japanes herbal remedi toki shakuyaku san thiamin vitamin fish oil supplement low fat vegetarian diet acupressur dysmenorrhea remain uncontrol approach pelvic ultrasonographi perform referr laparoscopi consid rule secondari dysmenorrhea patient sever refractori primari dysmenorrhea addit safe altern women conceiv includ transcutan electr nerv stimul acupunctur nifedipin terbutalin danazol leuprolid consid rare hysterectomi effect surgic interrupt pelvic nerv pathway establish
MED-666~role surgeri treatment mastalgia pubm ncbi abstract breast pain common condit affect women stage reproduct life mastalgia resist treatment num cyclic num non cycl patient surgeri wide treat condit consid patient sever mastalgia resist medic aim studi audit efficaci surgeri sever treatment resist mastalgia assess patient satisfact surgeri retrospect review medic record patient mastalgia clinic univers hospit wale cardiff num postal questionnair distribut patient undergon surgeri result show num patient mastalgia clinic num num undergon surgeri surgeri includ num subcutan mastectomi implant num bilater num unilater num bilater simpl mastectomi num quadrantectomi num simpl mastectomi median durat symptom num year rang num year patient num pain free surgeri num develop capsular contractur num wound infect dehisc pain persist patient undergo quadrantectomi conclud surgeri mastalgia consid minor patient patient inform complic inher reconstruct surgeri warn num case pain improv
MED-691~ginger prevent nausea vomit review pubm ncbi abstract nausea vomit physiolog process experienc human stage life complex protect mechan symptom influenc emetogen respons stimuli symptom recur frequent signific reduc qualiti life detriment health exist antiemet agent ineffect stimuli expens possess side effect herbal medicin shown effect antiemet plant studi rhizom zingib officinal common ginger broad spectrum antiemet tradit system medicin num year preclin clinic studi shown ginger possess antiemet effect emetogen stimuli conflict report prevent chemotherapy induc nausea vomit motion sick prevent draw firm conclus current review time summar result attempt made address lacuna publish studi emphas aspect investig clinic futur
MED-692~effect safeti ginger pregnancy induc nausea vomit systemat review pubm ncbi abstract background ginger world therapeut agent centuri herb increas western societi common indic pregnancy induc nausea vomit pnv object examin evid safeti effect ginger pnv method randomis control trial rcts ginger pnv sourc cinahl cochran librari medlin trip methodolog qualiti rcts assess critic apprais skill programm casp tool result rcts met inclus criteria trial found oral administ ginger signific effect placebo reduc frequenc vomit intens nausea advers event general mild infrequ conclus evid suggest ginger safe effect treatment pnv remain uncertainti maximum safe dosag ginger durat treatment consequ over dosag potenti drug herb interact import area futur research copyright num australian colleg midwiv publish elsevi reserv
MED-702~efficaci safeti liraglutid pubm ncbi abstract aim review systemat analyz efficaci safeti liraglutid treatment diabet mellitus comparison mono combin therapi method pubm date embas year search conduct liraglutid search term phase iii clinic trial retriev databas resourc post drug fda websit evalu regard outcom efficaci safeti result phase iii clinic studi compar efficaci safeti liraglutid monotherapi combin liraglutid monotherapi dose num mg show signific superior reduct hba num compar monotherapi glimepirid glyburid liraglutid add on therapi glimepirid dose num mg reduct hba num greater combin therapi glimepirid rosiglitazon liraglutid add on therapi metformin fail show benefit combin metformin glimepirid tripl therapi liraglutid addit metformin glimepirid rosiglitazon result addit benefit hba num reduct common advers event gastrointestin disturb nausea vomit diarrhea constip clinic studi case pancreat case cancer report liraglutid arm case pancreat exenatid glimepirid arm case cancer metformin sitagliptin arm conclus liraglutid therapeut option improv glycem control patient type num diabet present lack evid durabl efficaci long term safeti limit util general treatment type num diabet time
MED-706~aqueous extract hibiscus sabdariffa calic modul product monocyt chemoattract protein num human pubm ncbi abstract diet supplement and or modul import strategi signific improv human health search plant addit sourc bioactiv phenol compound relev context aqueous extract hibiscus sabdariffa rich anthocyanin phenol compound includ hydroxycitr chlorogen acid extract shown effect protect cultur peripher blood mononuclear cell cellular death induc num num signific role product inflammatori cytokin vitro extract promot product il num il num decreas concentr mcp num supernat dose depend manner human ingest acut dose extract num toler decreas plasma mcp num concentr signific effect cytokin effect due concomit increas antioxid capac plasma mechan involv direct inhibit inflammatori and or metabol pathway respons mcp num product relev inflammatori chronic condit role mcp num establish benefici effect confirm patient hibiscus sabdariffa consid valuabl tradit herbal medicin treatment chronic inflammatori diseas advantag devoid calor potenti alcohol toxic copyright num elsevi gmbh reserv
MED-707~uricosur effect rosell hibiscus sabdariffa normal renal ston subject pubm ncbi abstract aim studi rosell hibiscus sabdariffa investig uricosur effect materi method human model subject histori renal stone non ren stone ns histori renal stone rs studi cup tea made num dri rosell calyc provid subject daili morn num day clot blood consecut num urin sampl collect subject time num baselin control num day num num tea drink period num day tea drink stop washout serum num urinari sampl analyz uric acid chemic composit relat urinari stone risk factor result analyz serum paramet normal rang similar group subject period vis vis urinari paramet baselin valu group similar tea trend increas oxal citrat group uric acid excret clearanc ns group rs group uric acid excret clearanc signific increas num fraction excret uric acid feua calcul valu increas ns sf group intak tea return baselin valu washout period observ data subject present individu conclus data demonstr uricosur effect rosell calyc chemic constitu rosell calyc identifi exert uricosur effect identifi
MED-708~inhibitori effect marinad hibiscus extract format heterocycl aromat amin sensori qualiti fri beef patti pubm ncbi abstract heterocycl aromat amin haa carcinogen compound found crust fri meat object examin possibl inhibit haa format fri beef patti marinad concentr hibiscus extract hibiscus sabdariffa num num num num num fri patti analyz num haa hplc analysi haa meiqx num num ng g phip num num ng g co mutagen norharman num num ng g harman num num ng g found low level concentr meiqx reduc num num appli marinad highest amount extract compar sunflow oil control marinad antioxid capac teac assay folin ciocalteu assay determin num num num num micromol trolox antioxid equival total phenol compound num num num microg g marinad sensori rank test marin fri patti signific num control sampl copyright num elsevi reserv
MED-709~testicular effect sub chron administr hibiscus sabdariffa calyx aqueous extract rat pubm ncbi abstract sub chron effect hibiscus sabdariffa hs calyx aqueous extract rat test investig view evalu pharmacolog basi hs calyx extract aphrodisiac test group receiv dose num num num g kg base ld num extract dissolv drink water control group equival volum water anim free access drink solut num week period exposur expir treatment period anim sacrif test excis weigh epididym sperm number record test process histolog examin result show signific num chang absolut relat testicular weight signific num decreas epididym sperm count num g kg group compar control num g kg dose group show distort tubul disrupt normal epitheli organ num g kg dose show hyperplasia testi thicken basement membran num g kg dose group hand show disintegr sperm cell result aqueous hs calyx extract induc testicular toxic rat
MED-711~effect hibiscus sabdariffa extract powder prevent treatment diet lipid profil patient metabol syndrom mesi pubm ncbi abstract insulin resist obes hypertens dyslipidemia strong metabol syndrom mesi consid revers clinic stage evolut coronari heart diseas diabet antihypertens hypolipidem properti aqueous hibiscus sabdariffa extract hse demonstr clinic trial vivo experi aim present studi evalu effect hibiscus sabdariffa extract powder hsep recogn prevent treatment diet lipid profil individu mesi nation cholesterol educ program adult treatment panel iii ncep atp iii criteria protocol follow up studi carri factori random design num prevent treatment compris diet num hsep num hsep prevent treatment diet mesi non mesi individu total daili dose num mg hsep oral administ capsul month prevent treatment diet select ncep atp iii recommend adjust individu total cholesterol ldl c hdl c vldl c triglycerid glucos urea creatinin ast alt level blood determin individu pre post treat mesi patient treat hsep signific reduc glucos total cholesterol level increas hdl c level improv tag hdl c ratio marker insulin resist t test num addit triglyceride low effect observ mesi patient treat hsep diet individu mesi treat hsep signific differ total cholesterol hdl c tag hdl c ratio found absolut differ treatment compar anova num addit document hypotens effect hibiscus sabdariffa suggest hsep individu dyslipidemia mesi
MED-712~chemoprevent properti molecular mechan bioactiv compound hibiscus sabdariffa linn pubm ncbi abstract hibiscus sabdariffa linn tradit chines rose tea effect folk medicin treatment hypertens inflammatori condit sabdariffa aqueous extract hse prepar dri flower sabdariffa rich phenol acid flavonoid anthocyanin review discuss chemoprevent properti mechan sabdariffa extract demonstr hse sabdariffa polyphenol rich extract hpe sabdariffa anthocyanin sabdariffa protocatechu acid pca exert biolog effect pca protect oxid damag induc tert butyl droperoxid t bhp rat primari hepatocyt rabbit fed cholesterol human experiment studi studi impli hse pursu atherosclerosi chemoprevent agent inhibit ldl oxid foam cell format smooth muscl cell migrat prolifer extract offer hepatoprotect influenc level lipid peroxid product liver marker enzym experiment hyperammonemia pca shown inhibit carcinogen action chemic tissu rat hpe demonstr cancer cell apoptosi leukemia gastric cancer recent studi investig protect effect hse hpe streptozotocin induc diabet nephropathi studi clear sabdariffa extract exhibit activ atherosclerosi liver diseas cancer diabet metabol syndrom result natur occur agent bioactiv compound sabdariffa develop potent chemoprevent agent natur healthi food
MED-713~effect water extract hibiscus sabdariffa linn malvacea rosell excret diclofenac formul pubm ncbi abstract effect beverag prepar dri calyx flower hibiscus sabdariffa excret diclofenac investig control studi healthi human volunt high pressur liquid chromatograph method analys num urin sampl collect administr diclofenac num ml equival num mg anthocyanin beverag administ daili num day unpair two tail t test analys signific differ observ amount diclofenac excret administr beverag reduct amount diclofenac excret wide variabl observ control water beverag hibiscus sabdariffa num increas counsel patient plant beverag drug
MED-714~prevent vitamin defici knowledg gap research vitamin nutrit public health pubm ncbi abstract north american institut medicin iom recent publish report dietari refer intak dri ca vitamin dri committee deliber underpin comprehens report vitamin nutrit date benefit huge expand knowledg base vitamin decad releas vitamin dri subject intens controversi larg due persist fundament knowledg gap vitamin identifi level exposur metabol storag status dose respons function benefici advers health effect safe effect applic intak recommend popul level sustain food bas approach present review overview approach iom committe revis dri vitamin collat number authorit sourc key knowledg gap vitamin nutrit public health perspect number research topic outlin data requir identifi map risk assess framework dri committe intend exhaust list basi organis prioritis research effort area vitamin offer perspect major area attent intend research nation polici maker public health communiti industri group relev stakehold includ fund institut
MED-716~vitamin d light solut health abstract evolut sunlight produc vitamin skin critic import health vitamin sunshin vitamin hormon produc skin ingest diet convert sequenti liver kidney biolog activ form num dihydroxyvitamin hormon interact receptor small intestin increas effici intestin calcium phosphat absorpt mainten skeleton life vitamin defici year life result flatten pelvi make difficult childbirth vitamin defici osteopenia osteoporosi increas risk fractur essenti tissu cell bodi vitamin receptor vitamin defici link increas risk preeclampsia requir cesarean section birth multipl sclerosi rheumatoid arthriti type diabet type ii diabet heart diseas dementia dead cancer infecti diseas sun exposur vitamin supplement num iu d adult num iu d children essenti maxim health
MED-717~fructos intak current level unit state gastrointestin distress normal adult pubm ncbi abstract object fructos intak increas unit state primarili result increas consumpt high fructos corn syrup fruit juic crystallin fructos purpos determin fructos amount common consum result malabsorpt and or symptom healthi person design fructos absorpt measur num hour breath hydrogen test symptom score rate subject respons gas borborygmus abdomin pain loos stool subjects set studi includ num normal free liv volunt medic center communiti perform gastrointestin specialti clinic intervent subject consum num num dose crystallin fructos water overnight fast separ test day main outcom measur peak breath hydrogen time peak area curv auc breath hydrogen gastrointestin symptom measur num hour period subject consum num num dose fructos statist analys differ breath hydrogen auc symptom score dose analyz pair test correl peak breath hydrogen auc symptom evalu result half num adult test show evid fructos malabsorpt num fructos greater show malabsorpt num fructos auc repres breath hydrogen respons signific greater num dose symptom score signific greater baselin dose score margin greater num num peak hydrogen level auc high correl signific relat symptom conclus fructos amount common consum result mild gastrointestin distress normal peopl addit studi warrant evalu respons fructose glucos mixtur high fructos corn syrup fructos food normal peopl gastrointestin dysfunct breath hydrogen peak occur num num minut high correl num minut breath hydrogen auc peak hydrogen measur consid shorten durat exam
MED-718~relat passag gas abdomin bloat colon gas product pubm ncbi abstract object determin relat gas passag abdomin bloat product gas colon design random double blind crossov studi gaseous symptom num week period set veteran affair medic center particip num healthi medic center employe intervent particip diet supplement placebo num lactulos nonabsorb sugar psyllium ferment fiber methylcellulos nonferment fiber measur particip poll gaseous symptom includ number gas passag impress increas rectal gas abdomin bloat examin breath hydrogen excret result particip pass gas num num time day sd placebo period signific increas gas passag num num time day subject impress increas rectal gas report lactulos fiber prepar breath hydrogen excret indic hydrogen product colon increas ingest fiber statist signific num increas feel abdomin bloat particip perceiv excess gas bowel report fiber prepar lactulos conclus physician distinguish excess gas excess gas product feel bloat unrel excess gas product treatment consist limit suppli ferment materi colon bacteria symptom bloat irrit bowel syndrom therapi direct
MED-719~flatulence  caus relat diet remedi pubm ncbi abstract addit caus embarrass uneas flatul link varieti symptom distress review describ origin intestin gas composit method develop analysi emphasi effect legum diet produc excess intestin gas role raffinose typ oligosaccharid alpha galactosid group suggest overcom problem present includ drug treatment enzym treatment food process plant breed emphasis remov raffinose oligosaccharid bean remov problem flatul anim man compound responsible  though assum polysaccharid polysaccharide deriv oligom form process cook have characteris
MED-720~effect oral alpha galactosidas intestin gas product gas rel symptom pubm ncbi abstract bloat abdomin distent flatul repres frequent complaint function disord pathophysiolog treatment larg unknown patient frequent associ symptom excess intestin gas reduct gas product repres effect strategi aim evalu effect alpha galactosidas administr random double blind placebo control protocol intestin gas product gas rel symptom challeng test meal healthi volunt healthi volunt ingest num num galu alpha galactosidas placebo test meal num cook bean breath hydrogen excret occurr bloat abdomin pain discomfort flatul diarrhea measur num hr administr num galu alpha galactosidas induc signific reduct breath hydrogen excret sever flatul reduct sever appar consid symptom num num galu induc signific reduct total symptom score alpha galactosidas reduc gas product meal rich ferment carbohydr patient gas rel symptom
MED-721~bismuth therapi gastrointestin diseas pubm ncbi abstract bismuth therapi shown efficaci major gastrointestin disord peptic ulcer diseas diarrhea peptic ulcer diseas effect num receptor antagonist cost offer lower rate relaps helicobact pylori implic bismuth act antimicrobi agent suppress organ elimin recent studi bismuth compound convent antibiot produc elimin organ histolog improv amelior symptom period longer year bismuth subsalicyl shown modest efficaci treat traveler diarrhea acut chronic diarrhea children effect prophylact traveler diarrhea epidem neurolog toxic report franc num prolong bismuth treatment bismuth subgal subnitr toxic rare bismuth subsalicyl colloid bismuth subcitr recent studi demonstr intestin absorpt bismuth num ingest dose sequestr heavi metal multipl tissu site occur convent dose num week period find inspir recommend treatment period bismuth contain compound longer num week num week bismuth fre interv
MED-722~understand excess intestin gas pubm ncbi abstract complaint excess gas patient common difficult imposs physician document review address pathophysiolog manag complaint sourc rout elimin excess eruct bloat distent addit common flatul problem summar includ excess flatus volum noxious flatus
MED-723~effect devic purport reduc flatus odor pubm ncbi abstract object varieti charcoal contain devic purport minim problem odorifer rectal gas evid support efficaci product virtual anecdot object evalu abil devic adsorb malodor sulfid gase hydrogen sulfid methylmercaptan instil anus method tube num ml nitrogen num ppm sulfid gase num num instil anus healthi volunt wore gas imperm mylar pantaloon garment num adsorb charcoal fraction sulfid gase remov determin concentr ratio sulfid gas num pantaloon space relat ratio instil gas result measur devic place show subject garment remov num num sulfid gase result obtain devic correct remov product adsorb virtual sulfid gase construct activ carbon fiber fabric pad worn insid underwear remov num sulfid gase cushion ineffect adsorb num gase conclus abil charcoal contain devic adsorb odorifer rectal gase limit incomplet exposur activ carbon gase made carbon fiber high effect pad effect remov num odor cushion ineffect
MED-724~flatulence  caus relat diet remedi pubm ncbi abstract addit caus embarrass uneas flatul link varieti symptom distress review describ origin intestin gas composit method develop analysi emphasi effect legum diet produc excess intestin gas role raffinose typ oligosaccharid alpha galactosid group suggest overcom problem present includ drug treatment enzym treatment food process plant breed emphasis remov raffinose oligosaccharid bean remov problem flatul anim man compound responsible  though assum polysaccharid polysaccharide deriv oligom form process cook have characteris
MED-726~associ alzheim diseas patholog abnorm lipid metabol hisayama studi pubm ncbi abstract object relationship lipid profil alzheim diseas ad patholog popul level unclear search evid ad rel patholog risk abnorm lipid metabol method studi includ brain specimen seri num autopsi perform num num resid hisayama town japan num men num women underw clinic examin num lipid profil total cholesterol tc triglycerid high dens lipoprotein cholesterol hdlc measur num low dens lipoprotein cholesterol ldlc calcul friedewald formula neurit plaqu nps assess consortium establish registri alzheimer diseas guidelin cerad neurofibrillari tangl nfts assess braak stage associ lipid profil ad patholog examin analysi covari logist regress analys result adjust tc ldlc tc hdlc ldlc hdlc non hdlc defin tc hdlc signific higher subject nps spars moder stage cerad num num compar subject nps multivari model includ apo num carrier confound factor subject highest quartil lipid profil signific higher risk nps compar subject lower respect quartil suggest threshold effect convers relationship lipid profil nfts conclus result studi suggest dyslipidemia increas risk plaque typ patholog
MED-727~illumin black box descript num patient visit num famili physician pubm ncbi abstract background content context famili practic outpati visit fulli leav aspect famili practic black box unseen policymak understood isol articl describ communiti famili practic physician patient outpati visit method practic famili physician northeast ohio invit particip multimethod studi content primari care practic research nurs direct observ consecut patient visit collect addit data medic record review patient physician questionnair bill data practic environ checklist ethnograph fieldnot result visit num patient num physician num practic observ outpati visit famili physician encompass wide varieti patient problem level complex averag patient paid num visit practic past year visit durat num minut fifty eight percent visit acut ill num chronic ill num care common time history tak plan treatment physic examin health educ feedback famili inform chat structur interact patient question conclus famili practic patient visit complex compet demand opportun address wide rang problem individu famili time stage health ill multimethod research practic set identifi enhanc compet opportun famili practic improv health patient
MED-728~barrier provid nutrit counsel cite physician survey primari care practition pubm ncbi abstract num pivot studi kushner attitud practic behavior barrier deliveri nutrit counsel primari care physician articl recogn nutrit dietari counsel key compon deliveri prevent servic primari care physician kushner call multifacet approach chang physician counsel practic prevail belief today chang healthi peopl num prevent task forc identifi physician address nutrit patient num object increas num proport offic visit includ order provid diet counsel patient diagnosi cardiovascular diseas diabet hypertens midcours review proport declin num num primari care physician continu provid nutrit counsel realm respons gap remain proport patient physician benefit nutrit counsel receiv primari care physician refer dietitian healthcar profession barrier cite recent year continu list kushner lack time compens lesser extent lack knowledg resourc num surgeon general vision healthi fit nation ladi obama let move campaign spotlight counsel adult children diet physic activ
MED-729~transfer spinal cord materi subsequ bovin carcass split pubm ncbi abstract slaughter process cattl carcass split central vertebr column result contamin half spinal cord materi method base real tim pcr assay measur saw medi tissu transfer carcass num tissu recov subsequ carcass swab split vertebr face carcass split approxim num mg spinal cord tissu control condit experiment abattoir num num tissu accumul split carcass total tissu recov num num origin carcass num num mg spinal cord tissu carcass commerci plant unit kingdom num num tissu recov depend saw wash procedur number carcass process carcass infect bovin spongiform encephalopathi enter slaughter line main risk subsequ carcass contamin tissu debri accumul split work highlight import effect clean design modif requir minim accumul spinal cord tissu debri risk cross contamin carcass
MED-730~clinic herd health farm manag antimicrobi resist campylobact coli finish pig farm switzerland pubm ncbi abstract world wid increas antimicrobi resist micro organ complic medic treatment infect human risk factor analysi preval antimicrobi resist campylobact coli num swiss pig finish farm novemb num faecal sampl farm collect floor pen hold finish pig short slaughter sampl pool cultur campylobact speci isol campylobact strain test resist select antimicrobi addit inform herd health manag aspect studi data qualiti histori antimicrobi farm poor non antimicrobi risk factor analys statist analys perform resist ciprofloxacin erythromycin streptomycin tetracyclin multipl resist defin resist antimicrobi risk factor outcomes  correct depend sampl herd level  wer analys generalis estimation equ model preval antimicrobi resist campylobact isol ciprofloxacin num erythromycin num streptomycin num tetracyclin num multipl resist num import risk factor contribut preval resist strain shorten tail lame skin lesion feed whey ad libitum feed multipl resist farm partial all in all out system num continuous flow system num compar strict all in all out animal flow presenc lame num ill thrift num scratch shoulder num herd increas odd multipl resist studi show finish farm maintain good herd health status optim farm manag preval antimicrobi resist favour
MED-731~rare case anthrax aris sourc pubm ncbi abstract anthrax acut bacteri infect caus bacillus anthraci human infect natur condit contact infect anim contamin anim product num human anthrax cutan num respiratori gastrointestin anthrax rare report num case anthrax mening rare complic form diseas report rare case anthrax gastrointestin oropharyng mening aris sourc patient singl famili admit clinic pictur ingest half cook meat sick sheep case emphas awar anthrax differenti diagnosi area diseas remain endem
MED-732~dissemin central nervous system tissu slaughter cattl irish abattoir pubm ncbi abstract spong sampl carcas meat personnel surfac involv stun slaughter dressing bon activ abattoir retail beef product sampl examin presenc central nervous system cns specif protein syntaxin num and or glial fibrillari acid protein gfap indic contamin cns tissu syntaxin num gfap detect spong sampl slaughter line chill room abattoir gfap detect sampl longissimus muscl striploin bone hall abattoir abattoir retail meat
MED-733~amyloid arthropathi chicken pubm ncbi abstract present paper present overview current knowledg amyloid arthropathi chicken cover pathogenesi amyloidosi general bird field case report studi perform assess amyloidogen agent compar enterococcus faecali anim model amyloid arthropathi present studi pathogenesi arthropath amyloidogen faecali infect brown layer review conclud descript patholog amyloid arthropathi biochem character chicken joint amyloid protein aa type investig serum amyloid saa gene involv local saa mrna express joint liver
MED-734~suscept domest duck ana platyrhyncho experiment infect toxoplasma gondii oocyst pubm ncbi abstract total num domest duck divid group duck group inocul os num num num num num num num oocyst toxoplasma gondii oocyst num strain avirul mice remain group control antibodi gondii detect duck indirect fluoresc antibodi test day num post inocul antibodi titr found rang num num depend infecti dose oocyst day num antibodi titr increas num num num day num num end experi antibodi titr decreas num duck remain duck continu increas duck bioassay mice reveal gondii breast leg muscl heart num num brain num num liver num num stomach num num infect duck show clinic sign result bioassay compar gallinac bird domest duck suscept gondii infect
MED-735~preval incid gastroduoden ulcer treatment vascular protect dose aspirin pubm ncbi abstract background aspirin valuabl prevent vascular event inform ulcer frequenc inform risk benefit decis individu patient aim determin ulcer preval incid popul repres aspirin therapi evalu risk predictor method patient aspirin num mg daili recruit countri exclus includ gastroprotect drug non steroid anti inflammatori drug measur point preval endoscop ulcer quantit dyspept symptom incid assess num month elig continu baselin ulcer reason gastroprotect result num patient ulcer preval num confid interv ci num num num dyspept symptom signific patient ulcer ulcer incid num patient num month num ci num num helicobact pylori infect increas risk duoden ulcer odd ratio num num ci num num age num ulcer stomach duodenum combin num num ci num num conclus gastroduoden ulcer found num patient low dos aspirin asymptomat discuss risks benefit patient risk factor includ older age pylori duoden ulcer
MED-736~diverticular diseas epidemiolog manag abstract diverticular diseas colon preval condit western societi lead reason outpati visit hospit previous consid diseas primarili affect elder increas incid individu younger num year age diverticular diseas frequent present uncompl diverticul cornerston manag antibiot therapi bowel rest segment coliti diverticula share common histopatholog featur inflammatori bowel diseas benefit treatment num aminosalicyl surgic manag requir patient recurr diverticul complic includ peridiverticular abscess perfor fistul diseas strictur and or obstruct sum la maladi diverticulair du lon est une des patholog les pr valent de la soci occidental des principal de consult ambulatoir hospitalis croyait qu ell touchait surtout les personn es mai son incid est en croissanc aupr des personn de moin de num la maladi diverticulair se manifest surtout sous form de diverticulit san complic la pierr angulair du traitement est antibioth rapi le repo intestin la colit segmentair associ aux diverticul partag des caract ristiqu histopathologiqu avec les maladi inflammatoir de intestin peut profit traitement aux num aminosalicyl une prise en charg chirurgical peut impos en pr senc de diverticulit current ou de une de ses complic compri abc ridiverticulair une perfor une fistulis des st nose ou des obstruct
MED-743~herbal medicin st john wort treatment depress systemat review pubm ncbi abstract object evalu herbal medicin st john wort treatment depress data sources search method computer bas search medlin cinahl ame alt health watch psych articl psych info current content databas cochran control trial regist cochran databas systemat review perform research contact bibliographi relev paper previous meta analysi hand search addit refer review method trial includ review prospect human trial assess herbal medicin st john wort treatment mild to moder depress util valid instrument assess particip elig clinic endpoint result trial identifi met elig requir studi investig saffron stigma investig saffron petal compar saffron stigma petal individu trial investig lavend echium rhodiola locat discuss result trial discuss saffron stigma found signific effect placebo equal efficaci fluoxetin imipramin saffron petal signific effect placebo found equal efficaci compar fluoxetin saffron stigma lavend found effect imipramin combin lavend imipramin signific effect imipramin compar placebo echium found signific decreas depress score week num week num rhodiola found signific improv depress symptom compar placebo conclus number herbal medicin show promis manag mild to moder depress
MED-744~therapi saffron goddess thera pubm ncbi abstract paper present interpret uniqu bronz age num bce aegean wall paint build xest num akrotiri thera crocus carturightianus activ principl saffron primari subject xest num line evid suggest fresco concern saffron heal num unusu degre visual attent crocus includ varieti method display stigma num paint depict line saffron product pluck bloom collect stigma num sheer number nineti medic indic saffron bronz age present xest num fresco portray divin heal phytotherapi saffron cultur commerci interconnect theran aegean world neighbor civil earli num millennium bce close network themat exchang evid akrotiri borrow medicin iconograph represent complex product line monument illustr goddess medicin saffron attribut earliest botan accur imag herbal medic theran innov
MED-745~double blind random placebo control trial gold standard golden calf pubm ncbi abstract double blind random control trial rct accept medicin object scientif methodolog ideal perform produc knowledg untaint bias valid rct rest theoret argument discrep rct rigor evid differ consid object measur bias overview histor recent develop discrep argument present articl examin possibl deviat truth result artifact introduc mask rct unbias method produc bias experi examin augment methodolog stringenc normal rct order render experi suscept subvers mind methodolog hypothet platinum standard judg gold standard conceal placebo control rct capabl generat mask bias potenti bias investig self select prefer consent briefli discuss potenti distort double blind rct object realist sens object softer disciplinari sens fact exist independ apparatus product
MED-746~evalu crocus sativus saffron male erectil dysfunct pilot studi pubm ncbi abstract studi effect crocus sativus saffron studi male erectil dysfunct ed twenti male patient ed ten day morn tablet num saffron patient underw nocturn penil tumesc npt test intern index erectil function questionnair iief num start treatment end ten day ten day saffron statist signific improv tip rigid tip tumesc base rigid base tumesc ilef num total score signific higher patient saffron treatment treatment num num treatment num num num saffron show posit effect sexual function increas number durat erectil event patient ed ten day
MED-748~medic practic social author pubm ncbi abstract question medic ethic treat difficult casuist problem difficult case illustr paradox advantag global moral theori argu opposit approach insepar question social histori social theori normat assess medic practic focus discuss question legitimaci social author exercis physician insuffici tradit defenc author liber societi voluntarist inform consent approach tradit attack strategi ideolog critiqu author institut bound role base argu refram broad adequ ethic problem medic practic
MED-749~current percept nutrit educ medic school pubm ncbi abstract histor physician perceiv qualiti nutrit train medic school inadequ literatur review suggest percept signific chang num school work creat clinic nutrit curricula medic school interest data suggest medic student percept import clinic nutrit decreas medic school recent data support import target nutrit therapi reduc morbid mortal number physician interest nutrit declin fewer hour nutrit train occur medic school solut improv train awar problem implement certif program student preceptor model cardiac life support train offer american heart associ
MED-751~dietari fat cholesterol risk cardiovascular diseas older adult health abc studi abstract background aim dietari fat cholesterol previous risk cardiovascular diseas cvd middl age popul older adult purpos studi determin associ dietari fat cholesterol egg cvd risk community dwel adult age num num health age bodi composit studi method result diet assess interviewer administ num item food frequenc questionnair num cvd event defin confirm myocardi infarct coronari death stroke relat rate cvd num year follow up estim cox proport hazard model follow up num incid case cvd signific associ dietari fat cvd risk dietari cholesterol hr num ci num num num upper lower tertil trend num egg consumpt hr num ci num num num num week num week trend num increas cvd risk subgroup analys dietari cholesterol egg consumpt increas cvd risk older adult type num diabet hr num ci num num num num num num upper lower tertile group conclus dietari cholesterol egg consumpt increas cvd risk older community dwel adult type num diabet research biolog mechan increas cvd risk higher dietari cholesterol frequent egg consumpt older adult diabet warrant
MED-752~phytoestrogen low dose combin inhibit mrna express activ aromatas human granulosa lut cell pubm ncbi abstract evid phytoestrogen inhibit aromatas enzym convert androgen oestrogen kinet studi cell fre prepar show inhibit aromatas competit bind enzym pauciti studi investig longer term effect phytoestrogen express steroidogen enzym studi test hypothesi phytoestrogen reduc aromatas activ down regul express experi carri primari cultur human granulosa lut gl cell expos phytoestrogen num aromatas activ measur abil cell convert testosteron estradiol num period aromatas mrna express mrna arom subsequ measur cell quantit real tim pcr compound investig flavon apigenin quercetin isoflavon genistein biochanin daidzein dose num microm num nm combin compound lower dose investig compound test dose depend reduc mrna arom compar control apigenin potent inhibitor signific inhibit mrna arom num microm num nm whilst flavonoid biochanin induc signific inhibit p or num higher dose low dose num nm mixtur compound ineffect combin isoflavon induc signific inhibit mrna arom aromatas activ parallel mrna arom result addit studi show reduct aromatas activ signific delay time compar reduct mrna arom studi compar action phytoestrogen singl low dos combin express activ aromatas human cell suggest chronic dietari exposur tissu accumul low dos mixtur phytoestrogen import consequ aromatas activ product oestrogen
MED-753~estrogen level nippl aspir fluid serum random soy trial abstract background base hypothes protect effect examin effect soy food estrogen nippl aspir fluid naf serum indic breast cancer risk method cross ov design random num women produc num naf high low soy diet num month high soy diet particip consum num soy serv soy milk tofu soy nut approxim num mg isoflavones day low soy diet maintain usual diet naf sampl obtain firstcyt aspir estradiol num estron sulfat num assess naf estron num serum high sensit radioimmunoassay mixed effect regress model account repeat measur left censor limit appli result num num lower high soy low soy diet num num pg ml num num ng ml reach signific num interact group diet signific effect soy treatment serum num num num num num num individu naf serum level num rs num num num rs num num correl num num naf serum strong rs num rs num num conclus soy food amount consum asian signific modifi estrogen level naf serum impact trend lower estrogen naf high soy diet counter concern advers effect soy food breast cancer risk
MED-754~effect dietari portfolio cholesterol low food num level intens dietari advic serum lipid hyperlipidemia pubm ncbi abstract context combin food recogn cholesterol low properti dietari portfolio proven high effect lower serum cholesterol metabol control condit object assess effect dietari portfolio administ num level intens percentag chang low dens lipoprotein cholesterol ldl c particip self select diet design set particip parallel design studi num particip hyperlipidemia num particip academ center canada quebec citi toronto winnipeg vancouv random june num februari num num num treatment num month intervent particip receiv dietari advic num month low satur fat therapeut diet control dietari portfolio counsel deliv frequenc emphas dietari incorpor plant sterol soy protein viscous fiber nut routin dietari portfolio involv num clinic visit num month intens dietari portfolio involv num clinic visit num month main outcom measur percentag chang serum ldl c result modifi intention to treat analysi num particip attrit rate signific treatment num intens dietari portfolio num routin dietari portfolio num control fisher exact test num ldl c reduct num mg dl num confid interv ci num mg dl num num ci num num num num mg dl num ci num num mg dl num intens dietari portfolio num num ci num num num num mg dl num ci num num mg dl num routin dietari portfolio num num ci num num num num mg dl num ci num num mg dl num control diet percentag ldl c reduct dietari portfolio signific control diet num num dietari portfolio intervent differ signific num particip random dietari portfolio intervent percentag reduct ldl c dietari portfolio dietari adher num num num conclus dietari portfolio compar low satur fat dietari advic result greater ldl c lower num month follow up trial registr clinicaltri gov identifi nct num
MED-756~diet rel telomer shorten chromosom stabil abstract recent evid highlight influenc micronutri mainten telomer length tl order explor diet rel telomer shorten physiolog relev accompani signific damag genom present studi tl assess termin restrict fragment trf analysi peripher blood lymphocyt num healthi subject detail inform dietari habit data compar incid nucleoplasm bridg npbs marker chromosom instabl relat telomer dysfunct visualis cytokinesis block micronucleus assay increas capabl detect slight impair telomer function incid npbs evalu cell expos vitro ionis radiat care control potenti confound factor influenc tl age htert genotyp smoke status data show higher consumpt veget relat signific higher tl num analysi associ micronutri tl highlight signific role antioxid intak beta caroten telomer mainten num diet rel telomer shorten result increas spontan radiation induc npbs distribut trfs analys slight preval radiation induc npbs num observ subject higher amount short trfs num kb relat incid short trfs posit associ age num unrel veget consumpt daili intak micronutri suggest degre telomer eros relat low dietari intak antioxid observ studi extens lead chromosom instabl
MED-757~turn back clock adopt healthi lifestyl middl age pubm ncbi abstract purpos determin frequenc adopt healthi lifestyl num fruit veget daili regular exercis bmi num num kg m num current smoke middle ag cohort determin subsequ rate cardiovascular diseas cvd mortal adopt healthi lifestyl method conduct cohort studi divers sampl adult age num atherosclerosi risk communiti survey outcom all caus mortal fatal non fat cardiovascular diseas result num particip num num num healthi lifestyl habit visit num num remaind newli adopt healthi lifestyl num year men african american individu lower socioeconom status histori hypertens diabet newli adopt healthi lifestyl num num year total mortal cardiovascular diseas event lower adopt num num chi num num num num chi num num compar individu adopt healthi lifestyl adjust adopt lower all caus mortal num num confid interv ci num num fewer cardiovascular diseas event num num ci num num num year conclus peopl newli adopt healthi lifestyl middle ag experi prompt benefit lower rate cardiovascular diseas mortal strategi encourag adopt healthi lifestyl implement peopl hypertens diabet low socioeconom status
MED-758~low risk lifestyl behavior all caus mortal find nation health nutrit examin survey iii mortal studi abstract object examin relationship num low risk behavior smoke healthi diet adequ physic activ moder alcohol consumpt mortal repres sampl peopl unit state method data num particip age num year older nation health nutrit examin survey iii mortal studi num num result number low risk behavior invers relat risk mortal compar particip low risk behavior num experienc reduc all caus mortal adjust hazard ratio ahr num num confid interv ci num num mortal malign neoplasm ahr num num ci num num major cardiovascular diseas ahr num num ci num num ahr num num ci num num rate advanc period repres equival risk number year chronolog age particip num high risk behavior compar num year all caus mortal num year malign neoplasm num year major cardiovascular diseas num year conclus low risk lifestyl factor exert power benefici effect mortal
MED-759~associ dietari dark green deep yellow veget fruit cervic intraepitheli neoplasia modif smoke pubm ncbi abstract smoke posit fruit veget intak negat cervic cancer common cancer women worldwid lower consumpt fruit reduc serum carotenoid observ smoker smoke effect risk cervic neoplasia modifi low intak fruit veget present studi examin combin effect tobacco smoke diet valid ffq serum carotenoid tocopherol level cervic intraepitheli neoplasia grade num cin num risk hospital bas case control studi conduct paulo brazil num num sampl compris num incid histolog confirm case cin num num control low intak num dark green deep yellow veget fruit tobacco smoke lesser effect cin num num num ci num num num smoker higher intak num num num ci num num num adjust confound joint exposur tobacco smoke low intak veget fruit greater num num ci num num num trend num num compar non smok higher intak adjust confound variabl human papillomavirus status similar result observ total fruit serum total caroten includ caroten tocopherol find suggest effect nutrit factor cin num modifi smoke
MED-760~high antioxid spice blend attenu postprandi insulin triglycerid respons increas plasma measur antioxid activ healthi overweight men abstract interest potenti dietari antioxid attenu vivo oxid stress character time plasma effect exist culinari spice demonstr potent vitro antioxid properti object studi examin ad num high antioxid spice blend num kj num kcal meal exert signific postprandi effect marker plasma antioxid status metabol healthi overweight men num consum control spice meal random crossov design num wk test session blood sampl prior meal num min interv num total num sampl mix linear model demonstr treatment time interact num insulin tg num num reduct postprandi level spice meal ad spice meal signific increas ferric reduc antioxid power postprandi increas spice meal num fold greater control meal num hydrophil oxygen radic absorb capac orac plasma increas spice num treatment differ glucos total thiol lipophil orac total orac incorpor spice diet normal postprandi insulin tg enhanc antioxid defens
MED-761~counsel practic internist pubm ncbi abstract object determin counsel practic group internist area smoke exercis alcohol seat belt determin associ physician person health habit counsel practic design random stratifi sampl member fellow american colleg physician num region select repres area unit state small proport women group oversampl set physician practic particip thousand hundr forty nin internist member fellow colleg return questionnair respons rate num defin general internist intervent questionnair obtain inform internist cigarett alcohol seat belt level physic activ data obtain indic counsel aggress counsel habit measur main result bivari logist regress analys compar tendenc internist subgroup indic counsel counsel generalist specialist counsel patient risk aggress counsel nineti percent respond counsel patient smoke num discuss seat belt num internist smoke cigarett num drank alcohol daili num extrem activ num seat belt time men internist habit alcohol person health practic substanti counsel patient nonsmok internist counsel smoker physic activ internist counsel exercis women internist physic activ counsel patient exercis alcohol conclus low level self report counsel internist suggest emphasi train skill associ person profession practic suggest medic school housestaff train program support health promot activ futur internist
MED-762~ethiopian field epidemiolog laboratori train program strengthen public health system build human resourc capac pubm ncbi abstract ethiopian field epidemiolog laboratori train program efeltp comprehens two year competency bas train servic program design build sustain public health expertis capac establish num program partnership ethiopian feder ministri health ethiopian health nutrit research institut addi ababa univers school public health ethiopian public health associ center diseas control prevent resid program spend num time undergo didact train num field work program field base establish moh region health bureaus investig diseas outbreak improv diseas surveil respond public health emerg health data make recommend undertak field epidemiolog relat activ set health polici resid num cohort program conduct num outbreak investig num nalys surveil data evalu num surveil system num ral poster present abstract accept num scientif confer submit num manuscript num publish efeltp provid valuabl opportun improv epidemiolog laboratori capac build ethiopia program young posit signific impact assist countri detect respond epidem address diseas major public health signific
MED-816~effect obes polycyst ovari syndrom systemat review meta analysi pubm ncbi abstract women polycyst ovari syndrom pcos overweight obes central obes effect excess weight outcom pcos inconsist review aim assess effect overweight obes central obes reproduct metabol psycholog featur pcos medlin embas cinahl cochran central regist control trial central psycinfo search studi report outcom bodi mass index categori bodi fat distribut data present differ risk ratio num confid interv review includ num elig studi overweight obes women pcos decreas sex hormone bind globulin shbg increas total testosteron free androgen index hirsut fast glucos fast insulin homeostat model assessment insulin resist index worsen lipid profil obes signific worsen metabol reproduct outcom measur hirsut compar normal weight women pcos overweight women differ total testosteron hirsut total cholesterol low dens lipoprotein cholesterol compar normal weight women differ shbg total testosteron compar obes women central obes higher fast insulin level result suggest prevent treatment obes import manag pcos num author obes review num intern associ studi obes
MED-818~role maca lepidium meyenii consumpt serum interleukin num level health status popul live peruvian central andes num altitud abstract lepidium meyenii maca plant grow num meter sea level central peruvian andes hypocotyl plant tradit consum nutrit medicin properti aim studi determin health status base health relat qualiti life hrql questionnair sf num serum level interleukin num il num subject maca consum cross sect studi design perform num subject junin num num subject maca consum num non consum sf num survey obtain summari measur health status stand chair sit sucsd test assess lower extrem function hemoglobin measur blood pressur sexual hormon level serum il num level score chronic mountain sick cms evalu testosterone estradiol ratio num il num num cms score lower health status score higher maca consum compar non consum num greater proport maca consum success complet sucsd test compar non consum num show signific associ lower valu serum il num num conclus consumpt maca low serum il num level turn health status score sf num survey low chronic mountain sick score
MED-819~effect metformin compar hypocalor diet serum c reactiv protein level insulin resist obes overweight women poli pubm ncbi abstract aim aim present studi investig efficaci metformin compar hypocalor diet c reactiv protein crp level marker insulin resist obes overweight women polycyst ovari syndrom pcos materi method forti women bodi mass index num pcos random alloc receiv metformin hypocalor diet assess treatment period num week high sensit crp hs crp marker insulin resist ir homeostasi model assessment ir quantit insulin sensit check index fast glucos insulin ratio evalu patient result total num subject complet trial patient metformin group patient diet group total num subject complet trial num subject metformin group num subject diet group serum concentr hs crp signific decreas metformin num num num num num diet group num num num num num signific differ hs crp decrement group decreas hs crp level signific correl waist circumfer diet group num num effect hypocalor diet num weight reduct marker insulin resist homeostasi model assessment ir fast glucos insulin ratio quantit insulin sensit check index metformin therapi num conclus weight reduct equal efficaci metformin decreas serum hs crp level signific effect improv insulin resist obes overweight pcos women num author journal obstetr gynaecolog research num japan societi obstetr gynecolog
MED-820~effect marjoram origanum majorana tea hormon profil women polycyst ovari syndrom randomis control pilot studi pubm ncbi abstract background tradit medicin marjoram herb origanum majorana local reput abil restor hormon balanc regul menstrual cycl pilot studi aim investig effect marjoram tea hormon profil women polycyst ovari syndrom pcos randomis double blind placebo control trial method twenty f patient assign receiv marjoram tea placebo tea daili num month intervent group num placebo group num hormon metabol paramet measur baselin intervent follicle stimul hormon luteinis hormon progesteron oestradiol total testosteron dehydroepiandrosterone sulph dhea fast insulin glucos homeostasi model assess insulin resist homa ir glucos insulin ratio result marjoram tea signific reduc dhea fast insulin level num sd num num mol num num num ml num comparison placebo group chang signific dhea num insulin num homa ir reduc signific intervent group num chang signific compar placebo group num conclus result obtain present studi show benefici effect marjoram tea hormon profil pcos women found improv insulin sensit reduc level adren androgen research confirm result investig activ compon mechan contribut potenti benefici effect marjoram herb num british dietet associ
MED-821~low glycem index vegan low calori weight loss diet women polycyst ovari syndrom random control feasibl studi pubm ncbi abstract aim random pilot assess feasibl dietari intervent women polycyst ovari syndrom pcos compar vegan low calori low cal diet overweight bodi mass index num num kg m num women pcos num age num num year num black experienc infertil recruit particip num month random weight loss studi deliv nutrit counsel e mail facebook bodi weight dietari intak assess num num month hypothes weight loss greater vegan group attrit high num num month num analys conduct intention to treat present median interquartil rang vegan particip lost signific weight num month num num num vegan num num num low cal num differ group num month num facebook group signific relat percent weight loss num num num month num vegan particip greater decreas energi num num kcal d fat intak num num num energi num month compar low cal particip num num kcal d num num num energi num preliminari result suggest engag social media adopt vegan diet effect promot short term weight loss women pcos larger trial address potenti high attrit rate confirm result copyright num elsevi reserv
MED-822~clinic biochem character women polycyst ovari syndrom north rhine westphalia pubm ncbi abstract polycyst ovari syndrom pcos defin combin oligoanovul hyperandrogen affect num women reproduct age insulin resist hyperinsulinemia play import role pathogenesi present character pcos cohort north rhine westphalia germani clinic featur famili histori endocrin metabol paramet prospect record num success patient patient evalu insulin resist beta cell funct oral glucos toler test patient data compar num age match control women pcos patient show signific higher bmi bodi fat mass androgen level impair glucos insulin metabol posit famili histori pcos diabet frequent pcos patient insulin resist num common metabol abnorm pcos patient obes num dyslipidemia num incid num metabol syndrom c reactiv protein cardiovascular risk factor frequent elev young pcos patient clinic characterist endocrin paramet german pcos cohort heterogen compar caucasian popul
MED-823~dietari composit treatment polycyst ovari syndrom systemat review inform evidence bas guidelin pubm ncbi abstract lifestyl manag recommend first lin treatment polycyst ovari syndrom pcos optim dietari composit unclear aim studi compar effect diet composit anthropometr reproduct metabol psycholog outcom pcos literatur search conduct australasian medic index cinahl embas medlin psycinfo ebm review recent search perform januari num inclus criteria women pcos anti obes medic weight loss mainten diet compar dietari composit studi assess risk bias total num articl retriev articl studi met priori select criteria num women includ meta analysi perform due clinic heterogen factor includ particip dietari intervent composit durat outcom subtl differ diet greater weight loss monounsatur fat enrich diet improv menstrual regular low glycem index diet increas free androgen index high carbohydr diet greater reduct insulin resist fibrinogen total high dens lipoprotein cholesterol low carbohydr low glycem index diet improv qualiti life low glycem index diet improv depress self esteem high protein diet weight loss improv present pcos dietari composit major studi weight loss target overweight women pcos reduc calor intak set adequ nutrit intak healthi food choic irrespect diet composit copyright num academi nutrit dietet publish elsevi reserv
MED-824~dietari intervent versus metformin improv reproduct outcom women polycyst ovari syndrom prospect compar studi pubm ncbi abstract object compar clinic result reproduct outcom obes women polycyst ovari syndrom pcos dietari intervent treatment metformin method forty six patient pcos studi prospect princ rash hospit irbid jordan januari num april num women random divid num group group num num prescrib num kcal day diet num protein num fat num carbohydr num gm fiber week group num num assign num mg metformin continu manner treatment continu num month clinic biochem data treatment reproduct outcom compar num group result signific differ num group term age bodi mass index bmi durat infertil group signific improv treatment menstrual cyclic num num versus num num signific reduct bmi num num versus num num lutein hormon level num num num num versus num num num num androgen testosteron androstenedion dehydroepiandrosteron sulfat concentr clinic biochem reproduct outcom includ menstrual cycl pattern ovul pregnanc rate similar group treatment conclus amelior hyperinsulinemia hyperandrogenemia dietari intervent metformin treatment improv signific clinic featur reproduct function overweight pcos women
MED-825~effect increas dietari protein to carbohydr ratio women polycyst ovari syndrom pubm ncbi abstract background evid suggest diet higher ratio protein carbohydr metabol advantag treatment polycyst ovari syndrom pcos object object studi compar effect high protein hp diet standard protein sp diet women pcos design control num mo trial conduct num pcos women women assign rank minim num diet calor restrict hp diet num energi protein num energi fat sp diet num energi protein num energi fat women receiv month dietari counsel baselin num num mo anthropometr measur perform blood sampl collect result women drop pregnanc num women drop reason num women complet studi hp diet produc greater weight loss num kg num ci num num kg bodi fat loss num kg num ci num num kg sp diet num mo waist circumfer reduc hp diet sp diet hp diet produc greater decreas glucos sp diet persist adjust weight differ testosteron sex hormone bind globulin blood lipid group num mo adjust weight led signific lower testosteron concentr sp diet group hp diet group conclus replac carbohydr protein ad libitum diet improv weight loss improv glucos metabol effect independ weight loss offer improv dietari treatment pcos women
MED-826~polycyst ovari syndrom posit statement european societi endocrinolog pubm ncbi abstract polycyst ovari syndrom pcos common ovarian disord androgen excess women justifi grow interest endocrinologist great effort made num decad defin syndrom presenc definit diagnosi pcos reflect phenotyp heterogen syndrom major criteria requir diagnosi turn identifi phenotyp combin criteria addit relev impact metabol issu specif insulin resist obes pathogenesi pcos suscept develop earlier expect glucos intoler state includ type num diabet support notion aspect consid defin pcos phenotyp plan potenti therapeut strategi affect subject paper offer critic endocrin european perspect debat definit pcos summaris major aspect relat aetiolog factor includ earli life event potenti involv develop disord diagnost tool pcos discuss emphasi laboratori evalu androgen potenti biomark ovarian metabol dysfunct paid specif attent role obes sleep disord neuropsycholog aspect pcos relev pathogenet aspect cardiovascular risk factor addit discuss target treatment choic base phenotyp individu patient final suggest potenti area translat clinic research futur specif emphasi hormon metabol aspect pcos num european societi endocrinolog
MED-827~dietari habit adolesc girl polycyst ovarian syndrom pubm ncbi abstract phenotyp polycyst ovarian syndrom pcos worsen weight gain increas ingest carbohydr sedentari lifestyl purpos studi assess dietari habit group adolesc girl pcos adolesc pcos recruit complet questionnair eat habit recal dietari diari calor macronutri intak calcul result compar group normal control thirty f women pcos num control includ girl pcos cereal breakfast num versus num result consum fibr control eat meal num versus num eat hour compar control compar bodi mass index girl pcos ate daili surplus calori averag num versus control negat calori intak num num amelior eat habit earli adolesc girl pcos improv futur metabol concern relat genet predisposit worsen unhealthi lifestyl
MED-828~maca meyenii improv sexual function systemat review abstract background maca lepidium meyenii andean plant brassica mustard famili prepar maca root report improv sexual function aim review assess clinic evid effect maca plant treatment sexual dysfunct method search num databas incept april num includ randomis clinic trial rcts type maca compar placebo treatment healthi peopl human patient sexual dysfunct risk bias studi assess cochran criteria statist pool data perform select studi data extract valid perform independ author discrep resolv discuss author result rcts met inclus criteria rcts suggest signific posit effect maca sexual dysfunct sexual desir healthi menopaus women healthi adult men rct fail show effect healthi cyclist rct assess effect maca patient erectil dysfunct intern index erectil dysfunct num show signific effect conclus result systemat review provid limit evid effect maca improv sexual function total number trial total sampl size averag methodolog qualiti primari studi limit draw firm conclus rigor studi warrant
MED-829~bodi fat composit distribut women polycyst ovari syndrom pubm ncbi abstract object aim present studi compar distribut accumul bodi fat women polycyst ovari syndrom pcos healthi control match age bodi mass index bmi investig associ androgen level insulin resist fat distribut materi method thirty on pcos women num age bmi match healthi control women evalu term subcutan adipos tissu thick determin skinfold calip bodi composit analyz bioelectr imped analysi blood sampl obtain determin follicle stimul hormon lutein hormon num eta estradiol num hydroxyprogesteron basal prolactin testosteron dehydroepiandrosteron sulfat sex hormone bind globulin shbg androstenedion insulin glucos level insulin sensit estim fast glucose insulin ratio free androgen index fai calcul num testosterone shbg differ analyz student test mann whitney test distribut data correl analysi perform bodi fat distribut paramet insulin resist androgen result fai signific higher patient pcos compar control group num fast insulin signific higher fast glucose insulin ratio signific lower pcos group control num num signific subcutan adipos tissu control pcos women tricep num subscapular region num waist to hip ratio pcos women signific higher control subject num conclus upper half type bodi fat distribut link pcos high free testosteron level insulin resist
MED-830~extract purif antioxid activ polysaccharid maca lepidium meyenii pubm ncbi abstract water solubl polysaccharid separ maca lepidium meyenii aqueous extract mae crude polysaccharid deprotein sevag method prepar process maca polysaccharid amylas glucoamylas effect remov starch maca polysaccharid lepidium meyenii polysaccharid lmps obtain chang concentr ethanol process polysaccharid precipit lmps compos rhamnos arabinos glucos galactos antioxid activ test reveal lmp num show good capabl scaveng hydroxyl free radic superoxid radic num mg ml scaveng rate num num result show maca polysaccharid high antioxid activ explor sourc bioactiv compound copyright num elsevi reserv
MED-831~dhea dhea pcos pubm ncbi abstract approxim num pcos women demonstr excess adren precursor androgen apa product primarili dhea marker apa general specif dhea synthesi role apa excess determin caus pcos unclear observ patient inherit apa excess patient num hydroxylas defici congenit classic non class adren hyperplasia demonstr apa excess result pcos lik phenotyp inherit defect enzym respons steroid biosynthesi defect cortisol metabol account small fraction women suffer hyperandrogen apa excess women pcos apa excess general exagger adren steroidogenesi respons acth stimul overt hypothalamic pituitary adren axi dysfunct general extra adren factor includ obes insulin glucos level ovarian secret play limit role increas apa product observ pcos substanti herit apa dhea found general popul women pcos hand snps discov date account small portion inherit trait paradox men elev level dhea protect cardiovascular risk women role dhea modul risk women pcos remain unknown summari exact apa excess pcos remain unclear reflect general inherit exagger androgen biosynthesi inherit natur copyright num elsevi reserv
MED-832~structur exercis train programm versus hypocalor hyperprot diet obes polycyst ovari syndrom patient anovulatori infertilit pubm ncbi abstract background lifestyl modif success employ treat obes overweight women polycyst ovari syndrom pcos aim current pilot studi compar efficaci reproduct function structur exercis train set programm diet programm obes pcos patient ii studi clinic hormon metabol effect elucid potenti mechan action method forti obes pcos patient anovulatori infertil underw set programm set group num hypocalor hyperprot diet diet group num clinic hormon metabol data assess baselin num num week follow up primari endpoint cumul pregnanc rate result group similar demograph anthropometr biochem paramet intervent signific improv menstrual cycl fertil note group differ group frequenc mens ovul rate signific num higher set group diet group increas cumul pregnanc rate signific bodi weight bodi mass index waist circumfer insulin resist index serum level sex hormone bind globulin androstenedion dehydroepiandrosteron sulphat chang signific num baselin signific num group conclus set diet intervent improv fertil obes pcos patient anovulatori infertil hypothes intervent improv insulin sensit pivot factor involv restor ovarian function potenti act mechan
MED-833~clinic metabol endocrin paramet respons metformin lifestyl intervent women polycyst ovari syndrom random pubm ncbi abstract aim studi evalu effect metformin addit diet exercis endocrin metabol disturb women polycyst ovari syndrom pcos prospect double blind random placebo pbo control trial thirti women insulin resist pcos receiv lifestyl modif num mg metformin placebo num month treatment bodi mass index waist hip ratio blood pressur hirsut menstrual pattern evalu serum concentr gonadotropin androgen progesteron glucos insulin lipid measur lifestyl intervent result similar weight menstrual cycle improv group signific reduct serum fast insulin homa index waist testosteron level observ metformin signific androstenedion dehydroepiandrosteron sulfat gonadotropin lipid level observ hirsut blood pressur find suggest metformin addit effect diet exercis improv paramet hyperandrogen insulin resist small decreas bodi weight trough lifestyl improv menstrual cycl insulin resist women pcos
MED-834~effect lifestyl intervent reproduct endocrin profil women polycyst ovarian syndrom systemat review meta analysi abstract polycyst ovarian syndrom pcos affect num num women reproduct age conduct systemat review meta analysi evalu expect benefit lifestyl exercis diet intervent reproduct endocrin profil women pcos potenti studi identifi systemat search pubm cinahl cochran control trial registri num april num systemat key concept pcos signific improv women receiv lifestyl intervent usual care follicle stimul hormon fsh level differ md num iu l num ci num num num sex hormone bind globulin shbg level md num nmol l num ci num num num total testosteron level md num nmol l num ci num num num androstenedion level md num ng dl num ci num num num free androgen index fai level md num num ci num num num ferriman gallwey fg score md num num ci num num num signific improv observ women receiv exercise alon intervent usual care fsh level md num iu l num ci num num num shbg level md num nmol l num ci num num num total testosteron level md num nmol l num ci num num num androstenedion level md num ng dl num ci num num num fg score md num num ci num num num analys suggest lifestyl diet exercis intervent improv level fsh shbg total testosteron androstenedion fai fg score women pcos
MED-835~reduc bioavail sex hormon comprehens chang diet diet androgen diana random trial pubm ncbi abstract high serum level testosteron estradiol bioavail increas western dietari habit import risk factor postmenopaus breast cancer hypothes ad libitum diet low anim fat refin carbohydr rich low glycemic index food monounsatur num polyunsatur fatti acid phytoestrogen favor modifi hormon profil postmenopaus women hundr postmenopaus women select num healthi volunt basi high serum testosteron level random dietari intervent control intervent includ intens dietari counsel special prepar group meal week num month serum level testosteron estradiol sex hormone bind globulin main outcom measur intervent group sex hormone bind globulin increas signific num num nmol lit compar control group num versus num num serum testosteron decreas num num ng ml num versus num control group num serum estradiol decreas chang signific dietari intervent group signific decreas bodi weight num kg versus num kg control group waist hip ratio total cholesterol fast glucos level area insulin curv oral glucos toler test radic modif diet design reduc insulin resist involv increas phytoestrogen intak decreas bioavail serum sex hormon hyperandrogen postmenopaus women addit studi determin effect reduc risk develop breast cancer
MED-836~optim diet women polycyst ovari syndrom pubm ncbi abstract optim diet prevent nutrient defici provid suffici nutrient energi human growth reproduct promot health longev reduc risk diet rel chronic diseas composit optim diet women polycyst ovari syndrom pcos diet assist short term weight manag symptom fertil specif target long term risk type num diabet cvd cancer insulin resist compensatori hyperinsulinaemia recognis key factor pathogenesi pcos clear reduc insulin level improv insulin sensit essenti part manag diet play signific role regul blood glucos insulin level research dietari manag pcos lack studi focus energi restrict dietari composit se balanc evid date diet low satur fat high fibr predomin low glycaemic index carbohydr food recommend pcos carri signific metabol risk research
MED-837~random trial effect type short term hypocalor diet weight loss women polycyst ovari syndrom pubm ncbi abstract object perform studi pilot experi investig short term effect diet vari composit weight loss primari outcom obes women polycyst ovari syndrom pcos seek fertil design random clinic trial set academ medic center patient thirty f obes women pcos intervent examin effect num month dietari intervent pcos phenotyp particip random energy restrict diet high protein hp num protein num carbohydr num fat high carbohydr hc num protein num carbohydr num fat fat content held constant diet main outcom measur primari chang bodi weight secondari biometr hormon lipid lipoprotein marker glucos homeostasi energi metabol result twenty six women complet studi hp num num kg hc num num kg diet result signific weight loss signific differ weight loss group differ diet varieti measur includ circul androgen measur glucos metabol leptin effect hypocalor diet se improv metabol reproduct abnorm group pcos women mark declin circul androgen num fast area curv auc insulin num num hour oral glucos toler test ogtt fast auc leptin level num high preval menstrual bleed trial num num patient conclus complet short term hypocalor diet signific weight loss signific improv reproduct metabol abnorm increas benefit high protein diet futur diet studi evalu ideal composit hypocalor diet women pcos requir larg studi popul requir multicent trial
MED-838~docosahexaeno acid cultur microalga inhibit cell growth induc apoptosi upregul bax bcl num ratio human breast carcinoma pubm ncbi abstract docosahexaeno acid dha omega num fatti acid compris num carbon num altern doubl bond hydrocarbon chain num omega num previous studi shown dha fish oil control growth develop cancer safeti issu rais repeat contamin toxin fish oil make longer clean safe sourc fatti acid investig cell growth inhibit dha cultur microalga crypthecodinium cohnii algal dha adha human breast carcinoma mcf num cell adha exhibit growth inhibit breast cancer cell dose depend num num control level num incub num num microm fatti acid dna flow cytometri show adha induc sub g num cell apoptot cell num num control level incub num mm fatti acid num num western blot studi show adha modul express proapoptot bax protein induc downregul anti apoptot bcl num express time depend caus increas bax bcl num ratio num num num num incub fatti acid result studi suggest dha cultur microalga effect control cancer cell growth downregul antiapoptot bcl num import step induc apoptosi
MED-839~omega num fatti acid nutrit medicin microalga oil vegetarian sourc epa dha pubm ncbi abstract long chain epa dha omega num fatti acid supplement co prev co therapeut current research suggest increas accumul long chain omega num health benefit natur medicin major diseas plant omega num sourc nutrit therapeut equival epa dha omega num fish oil healthi precursor ala bio convers epa ineffici product dha absent limit protect ala supplement flax oil pollut fish acquir high level epa dha predatori speci origin epa dha aquat ecosystem alga microalga produc high level epa dha organ produc dha rich microalga oil clinic trial dha rich oil compar efficaci fish oil protect cardiovascular risk factor lower plasma triglycerid oxid stress review discuss num omega num fatti acid nutrit medicin num omega num physiolog gene regul num protect mechan epa dha major diseas coronari heart diseas atherosclerosi cancer type num diabet num epa dha requir fish oil safeti num microalga epa dha rich oil recent clinic result
MED-840~efficaci home wash method control surfac microbi contamin fresh produc pubm ncbi abstract effort focus sanit fresh produc commerci level option consum purpos studi determin efficaci clean method reduc bacteri contamin fresh produc home set lettuc broccoli appl tomato inocul listeria innocua subject combin clean procedur soak num min tap water veggi wash solut num vinegar solut num lemon solut ii rins run tap water rins rub run tap water brush run tap water wipe wet dri paper towel presoak water rins signific reduc bacteria appl tomato lettuc broccoli wipe appl tomato wet dri paper towel show lower bacteri reduct compar soak rins procedur blossom end appl contamin surfac soak rins similar result observ flower section stem broccoli reduct innocua tomato appl num num log cfu g lettuc broccoli num num log cfu g subject wash procedur reduct surfac contamin lettuc soak lemon vinegar solut signific num lettuc soak cold tap water educ extens worker instruct consum rub brush fresh produc cold run tap water consumpt
MED-841~effect dietari soy intak breast cancer risk menopaus hormon receptor status pubm ncbi abstract background high soy consumpt lower breast cancer risk asian popul find epidemiolog studi inconsist object investig effect soy intak breast cancer risk korean women menopaus hormon receptor status method conduct case control studi num incid breast cancer patient num age match control histori malign neoplasm dietari consumpt soy product examin num item food frequenc questionnair result estim intak total soy isoflavon studi popul num day num mg day multivari logist regress model found signific invers associ soy intak breast cancer risk dose respons relationship odd ratio num confid interv ci highest lowest intak quartil num num num data stratifi menopaus status protect effect observ postmenopaus women num ci highest lowest intak quartil num num num associ soy breast cancer risk differ estrogen receptor er progesteron receptor pr status estim intak soy isoflavon show invers associ postmenopaus women er  pr tumor conclus find suggest high consumpt soy relat lower risk breast cancer effect soy intak vari depend factor
MED-842~high accumul subcellular distribut thallium green cabbag brassica oleracea var capitata pubm ncbi abstract accumul thallium tl brassicac crop wide uptak extent tl individu cultivar green cabbag distribut tl tissu green cabbag understood common cultivar green cabbag grown tl spike pot cultur trial studi uptak extent subcellular distribut tl result show trial cultivar concentr tl leav num num mg kg dw root stem signific differ cultivar num tl accumul leav reveal obvious subcellular fraction cell cytosol vacuol cell wall cell organell major num leaf tl found fraction cytosol vacuol serv major storag site major element ca mg specif subcellular fraction tl enabl green cabbag avoid tl damag vital organell green cabbag toler detoxifi tl studi demonstr green cabbag cultivar show good applic potenti phytoremedi tl contamin soil
MED-843~treatment vulvovagin candidiasi boric acid powder pubm ncbi abstract double blind comparison made num daili intravagin gelatin capsul num mg boric acid powder versus ident capsul num nystatin dilut volum cornstarch treatment vulvovagin candidiasi albican cure rate boric acid num num num day treatment num num day nystatin cure rate num num num day num num day speed allevi sign symptom similar drug untoward side effect cervic cytolog featur affect vitro studi found boric acid fungistat effect unrel ph blood boron analys absorpt vagina half lif num hour accept patient messi vagin cream self mad capsul boric acid powder inexpens num cent fourteen compar cost medic common prescrib
MED-844~antifung agent boric acid treat chronic mycot vulvovagin pubm ncbi abstract ninety two women chronic mycot vagin infect microscop examin vagin discharg prolong therapi antifung agent boric acid microscop pictur uniqu chronic mycot vagin observ repres cytolog reaction mucous membran chronic yeast infect diagnost tool prove extrem effect detect symptomat residu subclin mycot infect provid high predict measur probabl relaps ineffect convent antifung agent main reason chronic mycot infect contrast boric acid effect cure num patient previous fail respond common antifung agent treatment choic prophylaxi
MED-845~boric acid inhibit embryon histon deacetylas suggest mechan explain boric acid rel teratogen pubm ncbi abstract histon deacetylas hdac control gene express chang histon histon protein conform hdac inhibitor hdaci consid promis drug epigenet treatment cancer recent strict relationship histon hyperacetyl specif tissu mous embryo expos hdaci valproic acid trichostatin specif axial skeleton malform demonstr aim studi verifi boric acid ba induc rodent malform similar valproic acid trichostatin a rel act similar mechan hdac inhibit histon hyperacetyl pregnant mice treat intraperiton teratogen dose ba num mg kg day num gestat western blot analysi immunostain perform anti hyperacetyl histon num num antibodi embryo explant num num treatment reveal num hyperacetyl level somit hdac enzym assay perform embryon nuclear extract signific hdac inhibit activ compat mix type partial inhibit mechan evid ba kinet analys ba modifi substrat affin factor alpha num maximum veloc factor beta num work evid hdac inhibit ba suggest molecular mechan induct ba rel malform
MED-846~antifung mechan support boric acid therapi candida vagin pubm ncbi abstract background boric acid common cite treatment recurr resist yeast vagin data extent mechan antifung activ lack object aim studi vitro method understand spectrum mechan boric acid potenti treatment vagin infect method yeast bacteri isol test agar dilut determin intrins antimicrobi activ boric acid establish microbi physiolog method illumin mechan action boric acid candida albican result albican strain includ fluconazole resist strain inhibit concentr attain intravagin bacteria broth dilut mic num num mg l boric acid prove fungistat reflect decreas num generat prolong cultur num mg l fungicid organ acid yeast nitrogen broth yield lower ph equimolar boric acid sodium borat inhibitori cold anaerob incub protect yeast high boric acid concentr cell maintain integr num boric acid num degre num modest intrus propidium iodid occur loss plate count viabil preced uptak vital stain growth sub mic concentr boric acid decreas cellular ergosterol drug efflux pump cdr num protect candida cdr num express abrog boric acid boric acid interf develop biofilm hyphal transform conclus boric acid fungistat fungicid depend concentr temperatur inhibit oxid metabol key antifung mechan inhibit virul contribut therapeut efficaci vivo
MED-847~larg prospect investig meat intak relat mutagen risk renal cell carcinoma abstract background evid meat intak renal cell carcinoma rcc risk inconsist mutagen relat meat cook process variat rcc subtyp import object larg cohort prospect investig intak meat meat rel compound relat risk rcc clear cell papillari rcc histolog subtyp design studi particip num complet detail dietari assess link databas heme iron heterocycl amin hca polycycl aromat hydrocarbon pah nitrat nitrit concentr cook process meat num follow up identifi num case rcc num clear cell num papillari adenocarcinoma hrs num cis estim quintil multivari cox proport hazard regress result red meat intak num quintil num compar num quintil num num kcal median tendenc increas risk rcc hr num num ci num num p trend num num fold increas risk papillari rcc p trend num intak benzo pyren bap marker pah num amino num methyl num phenyl imidazo num b pyridin phip hca signific num num elev risk rcc num fold increas risk papillari rcc associ observ clear cell subtyp conclus red meat intak increas risk rcc mechan relat cook compound bap phip find rcc driven strong associ rarer papillari histolog variant studi regist clinicaltri gov nct num
MED-850~folat intak mthfr polymorph risk esophag gastric pancreat cancer meta analysi pubm ncbi abstract background aim increas evid suggest low folat intak impair folat metabol implic develop gastrointestin cancer conduct systemat review meta analysi epidemiolog studi evalu associ folat intak genet polymorph num methylenetetrahydrofol reductas mthfr central enzym folat metabol risk esophag gastric pancreat cancer method literatur search perform medlin studi publish march num study specif relat risk weight invers varianc obtain random effect summari estim result summari relat risk highest versus lowest categori dietari folat intak num num confid interv ci num num esophag squamous cell carcinoma num case control num num ci num num esophag adenocarcinoma num case control num num ci num num pancreat cancer num case control num cohort heterogen studi result dietari folat intak risk gastric cancer num case control num cohort inconsist studi mthfr num variant genotyp reduc enzym activ increas risk esophag squamous cell carcinoma gastric cardia adenocarcinoma noncardia gastric cancer gastric cancer subsit pancreat cancer num odd ratio num num estim statist signific studi mthfr num polymorph limit inconsist conclus find support hypothesi folat play role carcinogenesi esophagus stomach pancrea
MED-851~chemoprevent barrett oesophagus pubm ncbi abstract barrett oesophagus affect distal oesophagus metaplast columnar line epithelium replac stratifi squamous epithelium predispos cancer develop develop consequ chronic gastroesophag reflux gord barrett num fold increas risk oesophag adenocarcinoma num lack understand natur histori cell origin hamper research area accept limit test pathogenesi barrett oesophagus due lack univers accept anim model major question surround barrett oesophagus includ valid surveil strategi optim treatment import agent prevent progress cancer unaccept side effect main chemoprev agent show promis aspirin proton pump inhibitor ppis agent green tea berri antioxid diet suggest discuss evid strategi hope continu improv clinic trial infrastructur facilit test pharmacolog endoscop intervent barrett oesophagus copyright num elsevi reserv
MED-852~fiber intak risk oral pharyng esophag cancer pubm ncbi abstract relat type fiber oral pharyng esophag cancer investig data case control studi conduct num num itali case num hospit patient incid histolog confirm oral cancer num pharyng cancer num esophag cancer control num subject admit network hospit case acut nonneoplast diseas case control interview hospit stay valid food frequenc questionnair odd ratio comput age sex potenti confound factor includ alcohol tobacco consumpt energi intak highest lowest quintil intak oral pharyng esophag cancer combin num total englyst fiber num solubl fiber num cellulos num insolubl cellulos polysaccharid num total insolubl fiber num lignin invers relat similar veget fiber num fruit fiber num grain fiber num stronger oral pharyng cancer esophag cancer similar sex strata age educ alcohol tobacco consumpt total non alcohol energi intak studi fiber intak protect role oral pharyng esophag cancer
MED-853~hydrogen peroxid num exposur pubm ncbi abstract object present child develop gastric ulcer duoden eros ingest hydrogen peroxid num delin epidemiolog medic outcom toxic exposur agent manag poison control center method retrospect chart review exposur hydrogen peroxid num report long island region poison control center januari num april num conduct data extract includ age rout exposur amount agent symptom therapi medic outcom result num exposur hydrogen peroxid num num total exposur report num month exposur oral rout num occur children num year num asymptomat num exposur result benign outcom child present bloodi emesi develop multipl gastric ulcer duoden eros ingest hydrogen peroxid num oz conclus exposur hydrogen peroxid num benign sever gastric injuri occur small ingest children patient report persist vomit bloodi emesi requir medic evalu endoscopi evalu gastrointestin injuri
MED-854~cerebr air gas embol concentr hydrogen peroxid ingest pubm ncbi abstract introduct ingest small amount concentr hydrogen peroxid cerebr air gas embol cage hyperbar oxygen therapi hbot standard care treatment cage report case cage accident ingest num hydrogen peroxid treat hbot result revers clinic radiolog abnorm case report num year old male sip num hydrogen peroxid short time develop hematemesi left side hemiplegia confus left homonym hemianopsia initi laboratori studi chest x ray brain ct normal mri demonstr area restrict diffus num hyper intens multipl vascular territori consist ischemia due cage eighteen hour arriv patient underw hbot num atmospher absolut ata num minut num ata num minut clinic improv follow up mri month demonstr resolut hyper intens discuss search medlin num present reveal case cage ingest concentr hydrogen peroxid treat hbot case similar complet resolut symptom report case cage hydrogen peroxid undergo hbot patient report symptom resolut conclus ingest small amount concentr hydrogen peroxid result cerebr air gas embol hyperbar oxygen therapi benefit revers symptom prevent perman neurolog impair
MED-855~hydrogen peroxid poison pubm ncbi abstract hydrogen peroxid oxidis agent number household product includ general purpos disinfect chlorine fre bleach fabric stain remov contact len disinfect hair dye compon tooth whiten product industri princip hydrogen peroxid bleach agent manufactur paper pulp hydrogen peroxid employ medicin wound irrig sterilis ophthalm endoscop instrument hydrogen peroxid toxic main mechan corros damag oxygen gas format lipid peroxid concentr hydrogen peroxid caustic exposur result local tissu damag ingest concentr num hydrogen peroxid result generat substanti volum oxygen amount oxygen evolv exceed maximum solubl blood venous arteri gas embol occur mechan cns damag thought arteri gas embolis subsequ brain infarct rapid generat oxygen close bodi caviti mechan distens potenti ruptur hollow viscus secondari oxygen liber addit intravascular foam absorpt imped ventricular output produc complet loss cardiac output hydrogen peroxid exert direct cytotox effect lipid peroxid ingest hydrogen peroxid irrit gastrointestin tract nausea vomit haematemesi foam mouth foam obstruct respiratori tract result pulmonari aspir pain gastric distens belch caus liber larg volum oxygen stomach blister mucosa oropharyng burn common ingest concentr solut laryngospasm haemorrhag gastriti report sinus tachycardia lethargi confus coma convuls stridor sub epiglott narrow apnoea cyanosi cardiorespiratori arrest ensu minut ingest oxygen gas embol produc multipl cerebr infarct inhal exposur cough transient dyspnoea inhal high concentr solut hydrogen peroxid sever irrit inflamm mucous membran cough dyspnoea shock coma convuls ensu pulmonari oedema occur num hour post exposur sever toxic result hydrogen peroxid solut irrig wound close bodi caviti pressur oxygen gas embol result inflamm blister sever skin damag follow dermal contact ocular exposur num solut sting irrit lacrim blur vision sever injuri exposur concentr hydrogen peroxid solut num result ulcer perfor cornea gut decontamin ingest due rapid decomposit hydrogen peroxid catalas oxygen water gastric distens pain gastric tube pass releas gas earli aggress airway manag critic patient ingest concentr hydrogen peroxid respiratori failur arrest proxim death endoscopi consid persist vomit haematemesi signific oral burn sever abdomin pain dysphagia stridor corticosteroid high dosag recommend laryng pulmonari oedema superven unproven endotrach intub rare tracheostomi requir life threaten laryng oedema contamin skin wash copious amount water skin lesion treat thermal burn surgeri requir deep burn case eye exposur affect eye shod eye irrig immedi water num salin num minut instil local anaesthet reduc discomfort assist decontamin
MED-857~prospect studi dietari alpha linolen acid intak prostat cancer risk meta analysi pubm ncbi abstract individual bas studi investig relat dietari alpha linolen acid ala intak prostat cancer risk shown inconsist result carri meta analysi prospect studi examin associ systemat search studi publish decemb num log relat risk rrs weight invers varianc obtain pool estim num confid interv ci identifi prospect studi met inclus criteria report risk estim categori ala intak compar highest lowest ala intak categori pool rr num num ci num num associ heterogen report number case non cas categori ala intak found subject consum num g day ala compar subject consum num g day signific decreas risk prostat cancer rr num num ci num num diverg result part explain differ sampl size adjust highlight limit dietari ala assess prospect studi find support weak protect associ dietari ala intak prostat cancer risk research conclud question
MED-859~gamma irradi dose effect baby leaf spinach ascorb acid carotenoid folat alpha tocopherol phylloquinon concentr pubm ncbi abstract ioniz radiat fruit veget form gamma ray electron beam effect overcom quarantin barrier trade prolong shelf life void inform persist ioniz radiat effect vitamin profil individu food baby leaf spinach commerci cultivar flat leaf lazio crinkled leaf samish grown harvest surfac sanit industri practic baby leaf spinach cultivar packag air num atmospher repres industri practic expos cesium num gamma radi num num num num num kgi irradi leaf tissu assay vitamin num carotenoid lutein zeaxanthin neoxanthin violoxanthin beta caroten concentr atmospher irradi consist effect num versus air elev dihydroascorb acid level phytonutri vitamin num neoxanthin exhibit chang concentr increas dose irradi total ascorb acid vitamin free ascorb acid lutein zeaxanthin violaxanthin beta caroten signific reduc num kgi depend cultivar affect lesser dose num num kgi dihydroascorb acid affect compound indic stress due irradiation gener oxid radic increas increas irradi dose num kgi
MED-860~assess vitamin carotenoid concentr emerg food product edibl microgreen pubm ncbi abstract microgreen seedl edibl veget herb gain popular culinari trend past year small size microgreen provid surpris intens flavor vivid color crisp textur serv edibl garnish salad ingredi scientif data nutrit content microgreen present studi conduct determin concentr ascorb acid carotenoid phylloquinon tocopherol num commerci microgreen result show microgreen provid extrem vari amount vitamin carotenoid total ascorb acid content rang num num mg num fresh weight fw caroten lutein zeaxanthin violaxanthin concentr rang num num num num num num mg num fw phylloquinon level vari num num g g fw tocopherol tocopherol rang num num num num mg num fw num microgreen assay red cabbag cilantro garnet amaranth green daikon radish highest concentr ascorb acid carotenoid phylloquinon tocopherol comparison nutrit concentr matur leav usda nation nutrient databas microgreen cotyledon leav possess higher nutrit densiti phytonutri data provid scientif basi evalu nutrit valu microgreen contribut food composit databas data refer health agenc recommend consum choic fresh veget
MED-861~associ whole blood fatti acid dietari intak prostat cancer jamaica pubm ncbi abstract object investig associ whole blood fatti acid report intak fat risk prostat cancer pca design case control studi num men num year newli diagnos histolog confirm prostat cancer num cancer fre men attend urolog clinic whole blood fatti acid composit mol measur gas chromatographi diet assess food frequenc questionnair result high whole blood oleic acid composit tertil num tertil num num ci num num num moder palmit acid proport tertil num num ci num num tertil num num ci num num invers relat risk pca men high linolen acid proport increas likelihood pca tertil num tertil num num num num blood myrist stearic palmitol acid pca higher intak dietari mufa invers relat prostat cancer tertil num tertil num num ci num num princip sourc dietari mufa avocado intak dietari intak fat pca conclus whole blood dietari mufa reduc risk prostat cancer associ relat avocado intak high blood linolen acid direct relat prostat cancer associ warrant investig
MED-862~tradit live popul east africa serum num hydroxyvitamin concentr num nmol l pubm ncbi abstract cutan synthesi vitamin exposur uvb princip sourc vitamin human bodi current cloth habit reduc time spent outdoor put risk insufficiency rel diseas calcaem non calcaem function vitamin popul tradit lifestyl lifelong year round exposur tropic sunlight provid inform optim vitamin status evolutionari perspect measur sum serum num hydroxyvitamin num concentr thirty f pastor maasai num sd num year num male twenty f hadzab hunter gather num sd num year num male live tanzania skin type vi moder degre cloth spend major part day outdoor avoid direct exposur sunlight num concentr measur liquid chromatography ms m serum num concentr maasai hadzab num rang num num rang num nmol l concentr relat age sex bmi peopl tradit lifestyl live cradl mankind circul num concentr num nmol l concentr optim condit current western lifestyl uncertain target investig concomit appreci import factor ca homeostasi chang agricultur revolut
MED-863~penetr ocular injuri durian fruit pubm ncbi abstract durian inflict sever bodi injuri drop tree case report describ patient present facial penetr eye injuri ripe durian fruit drop face harvest fruit tree author emphas import facial eye protect devic durian fruit harvest season
MED-864~fatal fulmin hepat ganoderma lucidum lingzhi mushroom powder pubm ncbi abstract hepatotox effect relat ganoderma lucidum lingzhi mushroom powder patient hong kong num num author experienc case fatal fulmin hepat prepar patient therapeut agent tradit boil lingzhi toxic effect switch lingzhi powder form num month hepatotox episod occur patient toxic role lingzhi powder close monitor futur combin drug
MED-865~bitter melon extract impair prostat cancer cell cycl progress delay prostat intraepitheli neoplasia tramp model abstract prostat cancer remain lead cancer death american men earlier diagnosi increas surviv rate patient treatment advanc diseas limit hormon ablat techniqu palliat care method treatment prevent inhibit diseas progress hormon refractori state approach control prostat cancer prevent diet inhibit neoplast event reduc cancer risk centuri ayurveda recommend bitter melon momordica charantia function food prevent treat human health relat issu studi initi human prostat cancer cell pc num lncap vitro model assess efficaci bitter melon extract bme anti canc agent observ prostat cancer cell treat bme accumul phase cell cycl modul cyclin num cyclin num express treatment prostat cancer cell bme enhanc bax express induc poli adp ribos polymeras cleavag oral gavag bme dietari compound delay progress high grade prostat intraepitheli neoplasia pin tramp transgen adenocarcinoma mous prostat mice num prostat tissu bme f mice display num reduct pcna express result suggest time oral administr bme inhibit prostat cancer progress tramp mice interf cell cycl progress prolifer
MED-866~bitter melon momordica charantia review efficaci safeti pubm ncbi abstract pharmacolog clinic efficaci advers effect drug interact place therapi bitter melon bitter melon momordica charantia altern therapi primarili lower blood glucos level patient diabet mellitus compon bitter melon extract structur similar anim insulin antivir antineoplast activ report vitro clinic trial found bitter melon juic fruit dri powder moder hypoglycem effect studi small random double blind report advers effect bitter melon includ hypoglycem coma convuls children reduc fertil mice favism lik syndrom increas gamma glutamyltransferas alkalin phosphatas level anim headach bitter melon addit effect glucose low agent adequ power random placebo control trial proper assess safeti efficaci bitter melon routin recommend bitter melon hypoglycem effect data suffici recommend absenc care supervis monitor
MED-867~effect momordica charantia capsul prepar glycem control type num diabet mellitus studi pubm ncbi abstract background object momordica charantia local ampalaya wide advertis hypoglycem effect date larg clinic trial publish efficaci type prepar main object studi determin addit charantia capsul standard therapi decreas glycosyl hemoglobin hemoglobin num hba num level diabet patient poor sugar control studi design set random double blind placebo control trial conduct april septemb num outpati clinic philippin general hospit trial includ num patient num year newli diagnos poor control type num diabet num level num num top standard therapi patient random charantia capsul placebo treatment group receiv capsul charantia time day meal num month control group receiv placebo dose primari efficaci endpoint chang num level group secondari efficaci endpoint includ effect fast blood sugar serum cholesterol weight safeti endpoint includ effect serum creatinin hepat transaminas alanin aminotransferase alt aspart aminotransferase ast sodium potassium advers event result baselin characterist treatment control group similar differ chang num group num favor charantia num ci num num num signific effect fast blood sugar total cholesterol weight serum creatinin alt ast sodium potassium advers event general mild conclus random control trial shed light issu hypoglycem effect charantia investig target num declin num outset estim power num observ declin num achiev power num reason unabl make definit conclus effect charantia result studi estim sampl size bigger studi
MED-868~bitter melon momordica charantia extract suppress adrenocort cancer cell prolifer modul apoptot pathway steroid pubm ncbi abstract adrenocort carcinoma rare present extrem poor prognosi approach control cancer progress reduc cancer risk prevent diet bitter melon wide consum veget tradit medicin countri studi human mous adrenocort cancer cell vitro model assess efficaci bitter melon extract bme anticanc agent protein concentr bme extract measur bme treatment adrenocort cancer cell result signific dose depend decreas cell prolifer observ antiprolif effect adrenocort cancer cell treat extract blueberri zucchini acorn squash apoptosi adrenocort cancer cell accompani increas caspas num activ poli adp ribos polymeras cleavag bme treatment enhanc cellular tumor antigen num cyclin depend kinas inhibitor num call num cyclic amp depend transcript factor num level inhibit num s specif cyclin num num num mitogen activ protein kinas num call janus kinas express suggest addit mechan involv cell cycl regul cell surviv bme treatment decreas key protein involv steroidogenesi adrenocort cancer cell bme treatment decreas level phosphoryl cyclin depend kinas num requir part steroidogen factor num activ final observ bme treatment signific reduc level insulin lik growth factor num receptor downstream signal pathway evidenc lower level phosphoryl rac serine threonine protein kinas data illustr inhibitori effect bitter melon cell prolifer adrenocort cancer modul divers mechan
MED-869~yerba mate ilex paraguariensi consumpt higher bone miner densiti postmenopaus women pubm ncbi abstract yerba mate ilex paraguariensi tea consumpt higher argentina south american countri coffe tea camellia sinensi effect yerba mate bone health previous explor program osteoporosi prevent treatment postmenopaus women drank num yerba mate tea daili num year num identifi match age time menopaus equal number women drink yerba mate tea bone miner densiti bmd measur dual energi x ray absorptiometri dxa lumbar spine femor neck yerba mate drinker num higher lumbar spine bmd num g cm num versus num g cm num num num higher femor neck bmd num g cm num versus num g cm num num multipl regress analysi yerba mate drink factor bodi mass index show posit correl bmd lumbar spine num femor neck num result suggest protect effect chronic yerba mate consumpt bone copyright num elsevi reserv
MED-870~recent advanc ilex paraguariensi research minireview pubm ncbi abstract ilex paraguariensi dri minc leav made brew tea prepar sui generi manner larg popul south america evolv tea drunk guarani ethnic group beverag social ritualist role south american modern societi sourc caffein lieu parallel tea coffe therapeut agent alleg pharmacolog properti research biomed properti herb late start strong lag impress amount literatur green tea coffe past num year several fold increas literatur studi ilex paraguariensi properti show effect antioxid properti chemic model vivo lipoprotein studi vaso dil lipid reduct properti antimutagen effect controversi associ oropharyng cancer anti glyc effect weight reduct properti promis result human intervent studi surfac literatur offer develop area aim review provid concis summari research publish past year emphasi translat studi inflamm lipid metabol ilex paraguariensi reduc ldl cholesterol level human ilex paraguariensi dyslipoproteinemia effect synerg statin plasma antioxid capac express antioxid enzym posit modul intervent ilex paraguariensi human cohort review evid implic ilex paraguariensi heavi consumpt neoplasia show data inconclus contamin alkyl agent dri process leav avoid hand studi confirm antimutagen effect ilex paraguariensi model dna doubl break cell cultur model mice studi interest work emerg show signific effect weight reduct mice rat model mechan involv inhibit pancreat lipas activ ampk uncoupl electron transport intervent studi anim provid strong evid anti inflammatori effect ilex paraguariensi notabl protect cigarette induc lung inflamm act macrophag migrat inactiv matrix metalloproteinas research effect ilex paraguariensi health diseas confirm antioxid anti inflammatori antimutagen lipid low activ wait double blind random prospect clinic trial evid provid support benefici effect mate drink chronic diseas inflammatori compon lipid metabol disord copyright num elsevi ireland reserv
MED-872~mercuri exposur risk dental amalgam popul post num pubm ncbi abstract dental amalgam num metal mercuri hg weight hg vapour continu evolv in plac dental amalgam caus increas hg content increas amalgam load urin faec exhal breath saliva blood organ tissu includ kidney pituitari gland liver brain hg content increas matern amalgam load amniot fluid placenta cord blood meconium foetal tissu includ liver kidney brain colostrum breast milk base num num popul statist num million american carri grand total num billion restor teeth children young num month record restor teeth past dental practic recent data major restor compos dental amalgam employ recent population bas statist bodi weight frequenc dental restor tooth surfac recent research increment increas urinari hg concentr amalgam fil tooth surfac estim hg exposur amalgam fill determin num age group popul specif exposur scenario consid scenario increment reduc number tooth surfac assum restor amalgam base conserv scenario evalu estim num million american exceed hg dose refer exposur level rel num g m num establish environment protect agenc num million american exceed dose rel num g m num establish california environment protect agenc exposur estim consist previous estim present health canada num amount num num g day amalgam fil tooth surfac num num g day amalgam fil tooth depend age factor copyright num elsevi reserv
MED-873~apoptosi cell cycl arrest human colorect cancer cell line ht num induc vanillin pubm ncbi abstract background vanillin respons flavor smell vanilla wide flavor agent previous studi show vanillin enhanc repair mutat function anti mutagen role cancer diseas close relat mutat fulli elucid method studi investig cytolyt cytostat properti vanillin ht num human colorect cancer cell line method includ cell viabil assay acridin orang ao ethidium bromid eb doubl stain cell morpholog analysi cell cycl analysi annexin v propidium iodid apoptosi test num bromo num deoxyuridin brdu label cell prolifer assay result result show apoptosi induc vanillin ic num ht num nih num normal cell line num microg ml num microg ml concentr vanillin arrest cell cycl checkpoint num bromo num deoxyuridine label cell prolifer assay show num num arrest achiev lower concentr vanillin num microg ml cell cycl analysi flow cytomet show num arrest occur higher concentr vanillin num microg ml conclus cytolyt cytostat effect shown vanillin show colorect cancer prevent agent vivo studi carri confirm similar effect happen anim
MED-874~vanillin enhanc trail induc apoptosi cancer cell inhibit nf kappab activ pubm ncbi abstract background tumor necrosi factor rel apoptosis induc ligand trail promis anticanc agent select kill cancer cell effect normal cell trail resist wide found cancer cell previous report antimetatstat antiangiogen effect vanillin flavor agent vanilla evalu sensit effect vanillin trail resist human cervic cancer cell line hela materi method cell viabil treatment determin wst num cell count kit apoptosi demonstr detect caspas num activ cleavag poli adp ribos polymeras immunoblot analysi effect treatment trail signal pathway nuclear factor kappab fn kappab activ studi immunoblot analysi luciferas report assay result pretreat hela cell vanillin enhanc trail induc cell death apoptosi pathway vanillin pretreat inhibit trail induc phosphoryl num transcript activ nf kappab conclus vanillin sensit hela cell trail induc apoptosi inhibit nf kappab activ
MED-875~inhibit bacteri quorum sens vanilla extract pubm ncbi abstract aim purpos studi search quorum sens inhibitor analys inhibitori activ method result quorum sens inhibit monitor tn num mutant chromobacterium violaceum cv num vanilla bean vanilla planifolia andrew extract num v v aqueous methanol ad violaceum cv num cultur inhibitori activ measur quantifi violacein product spectrophotomet result reveal vanilla extract signific reduc violacein product concentration depend manner indic inhibit quorum sens conclus vanilla wide spice flavour inhibit bacteri quorum sens signific impact studi result suggest intak vanilla contain food materi promot human health inhibit quorum sens prevent bacteri pathogenesi studi requir isol specif substanc vanilla extract act quorum sens inhibitor
MED-876~adher mediterranean diet intak antioxid influenc spontan convers atrial fibril pubm ncbi abstract background aim mediterranean diet medd long lower incid cardiovascular diseas inform associ medd vitamin intak arrhythmia sought investig relationship adher medd antioxid intak spontan convers atrial fibril af method result group num subject includ case control studi num detect episod af nutrit paramet assess self administ food frequenc valid questionnair complet interviewer administ num day diet recal adher medd evalu mediterranean score intak antioxid food calcul adher med diet lower patient develop af compar control med score num num num num num median num num num rang num patient af num num num rang num estim intak total antioxid lower patient af num num num num mmol d num patient highest quartil mediterranean score higher probabl spontan convers atrial fibril num num ci num num high level antioxid intak increas probabl spontan convers arrhythmia num num ci num num num conclus patient atrial fibril lower adher medd lower antioxid intak compar control popul patient arrhythmia show higher med score probabl spontan convers atrial fibril copyright num elsevi reserv
MED-877~detriment effect energi drink consumpt platelet endotheli function pubm ncbi abstract background energi drink consumpt anecdot link sudden cardiac death recent myocardi infarct myocardi infarct strong platelet endotheli dysfunct test hypothesi energi drink consumpt alter platelet endotheli function method fifti healthi volunt num male age num num year particip studi platelet aggreg endotheli function test num hour consumpt num ml num sugar fre energi drink platelet function assess adenosin diphosphate induc num micromol l optic aggregometri platelet rich plasma endotheli function assess peripher arteri tonometri express reactiv hyperemia index rhi result compar baselin valu signific increas platelet aggreg energi drink consumpt chang observ control num num num num aggreg num similar rhi decreas energi drink consumpt num num num num rhi control num arteri pressur signific increas energi drink consumpt compar control num heart rate unaffect energi drink consumpt conclus energi drink consumpt acut increas platelet aggreg decreas endotheli function healthi young adult copyright num elsevi reserv
MED-878~acut effect coffe endotheli function healthi subject pubm ncbi abstract background object coffe wide consum beverag world effect cardiovascular system fulli understood coffe caffein antioxid influenc endotheli function investig object studi investig acut effect coffe endotheli function measur brachial arteri flow medi dilat fmd subjects method total num male num femal healthi non obes subject underw double blind crossov studi subject ingest cup caffein cc cup decaffein dc italian espresso coffe random order num num day interv result cc ingest fmd decreas progress signific mean num min num num num min num num num min num num anova analysi varianc num signific increas dc ingest num min num num num min num num num min num num num similar cc signific increas systol diastol blood pressur effect observ dc ingest blood glucos concentr remain unchang ingest cc dc insulin num min num num num min num num muu ml num c peptid num min num num num min num num ng ml num blood concentr decreas signific cc ingest conclus cc acut induc unfavor cardiovascular effect endotheli function fast state insulin secret reduc cc ingest futur studi determin cc detriment clinic relev effect unhealthi subject
MED-880~effect acut administr caffein vascular function pubm ncbi abstract caffein wide pharmacolog substanc world found common nonessenti groceri item coffe tea cocoa chocol effect caffein cardiovascular diseas includ hypertens remain controversi inform direct effect vascular function purpos studi determin effect caffein endotheli function human studi double blind random placebo activ drug studi forearm blood flow fbf respons acetylcholin ach endothelium depend vasodil sodium nitroprussid endothelium independ vasodil evalu healthi young men oral administr caffein num mg num placebo num fbf measur strain gaug plethysmograph caffein signific increas systol diastol blood pressur num num num num mm hg num alter heart rate baselin fbf caffein augment fbf respons ach num num num num ml min num ml tissu num sodium nitroprusside stimul vasodil alter caffein administr intra arteri infus monomethyl l arginin nitric oxid synthas inhibitor abolish caffeine induc augment fbf respons ach placebo group ach sodium nitroprusside stimul vasodil similar follow up period conclus find suggest acut administr caffein augment endothelium depend vasodil healthi young men increas nitric oxid product
MED-884~effect cook method veget oxal content pubm ncbi abstract approxim num kidney stone compos primarili calcium oxal hyperoxaluria primari risk factor disord type raw cook veget analyz oxal enzymat method high proport water solubl oxal test raw veget boil mark reduc solubl oxal content num effect steam num bake potato oxal loss assess oxal content cook water boil steam reveal approxim num recoveri oxal loss loss insolubl oxal cook vari great rang num num solubl sourc oxal absorb insolubl sourc employ cook method signific reduc solubl oxal effect strategi decreas oxaluria individu predispos develop kidney stone
MED-885~bioavail oxal acid spinach sugar beet fibr solut sodium oxal consum femal volunt pubm ncbi abstract oxal bioavail sugar beet fibr num spinach num solut sodium oxal num mg test women triplic num num latin squar arrang test substanc provid num mg oxal acid studi volunt consum control diet test substanc administ breakfast day initi num day control period oxal administ test period consist test day control day urin collect num hr period analys daili oxal oxal excret differ control day increas signific ingest sugar beet fibr volunt oxal excret greater num spinach sodium oxal solut diet sugar beet fibr control diet oxal bioavail sugar beet fibr num compar bioavail num num spinach oxal solut low bioavail oxal sugar beet fibr attribut high ratio miner calcium magnesium oxal complex fibr matrix loss solubl oxal process sugar beet
MED-886~effect hempse flaxse oil profil serum lipid serum total lipoprotein lipid concentr haemostat factor pubm ncbi abstract background hempse oil ho flaxse oil fo high amount essenti fatti acid fas linol acid la num num alpha linolen acid ala num num opposit ratio excess intak essenti fa interfer metabol metabol la ala compet enzym differ num num fa plant origin effect serum lipid profil aim studi compar effect ho fo profil serum lipid fast concentr serum total lipoprotein lipid plasma glucos insulin haemostat factor healthi human method fourteen healthi volunt particip studi randomis double blind crossov design volunt consum ho fo num ml day num week period separ num week washout period result ho period result higher proport la gamma linolen acid serum cholesteryl ester ce triglycerid tg compar fo period num fo period result higher proport ala serum ce tg compar ho period num proport arachidon acid ce lower fo period ho period num ho period result lower total to hdl cholesterol ratio compar fo period num signific differ found period measur valu fast serum total lipoprotein lipid plasma glucos insulin hemostat factor conclus effect ho fo profil serum lipid differ signific minor effect concentr fast serum total lipoprotein lipid signific concentr plasma glucos insulin haemostat factor
MED-887~storag elev phenol content antioxid activ suppress antiprolif pro apoptot properti colored flesh potato pubm ncbi abstract colored flesh potato excel sourc health benefit dietari polyphenol store num month consumpt studi investig effect simul commerci storag condit antioxid activ dpph abt phenol content fcr composit uplc m anticanc properti earli hct num advanc stage ht num human colon cancer cell line potato bioactiv compound extract potato clone differ flesh color white yellow purpl num day storag studi antioxid activ clone increas storag increas total phenol content observ purple flesh clone advanc purple flesh select num p pw greater level total phenol monomer anthocyanin antioxid activ divers anthocyanin composit compar purpl majesti purple flesh potato potent suppress prolifer elev apoptosi colon cancer cell compar white yellow flesh potato extract fresh store potato num g ml suppress cancer cell prolifer elev apoptosi compar solvent control anticanc effect pronounc fresh potato storag durat strong posit correl antioxid activ percentag viabl cancer cell negat correl apoptosi induct result suggest antioxid activ phenol content potato increas storag antiprolif pro apoptot activ suppress assess effect farm fork oper health benefit properti plant food critic quantit analyt techniqu conjunct vitro and or vivo biolog assay
MED-888~anti obes antioxid effect purpl sweet potato extract num num adipocyt vitro pubm ncbi abstract purpos current studi determin anti obes anti inflammatori effect extract purpl sweet potato psps num num adipocyt purpos differenti num num adipocyt treat psp extract concentr num num num g ml num hour measur size adipocyt secret leptin mrna protein express lipogen inflammatori lipolyt factor treatment psp extract psp extract diminish leptin secret indic growth fat droplet suppress extract suppress express mrnas lipogen inflammatori factor promot lipolyt action antioxid activ psp extract measur vitro method num diphenyl num picrylhydrazyl free radic scaveng activ ferric reduc abil potenti assay chelat activ transit metal ion studi show psp extract antilipogen anti inflammatori lipolyt effect adipocyt radic scaveng reduc activ
MED-890~diet cancer colon rectum case control studi china pubm ncbi abstract case control studi carri harbin citi assess role diet aetiolog colorect cancer total num incid case histolog confirm colorect cancer num colon cancer num rectal cancer equal number control non neoplast diseas interview hospit ward data averag frequenc consumpt amount consum singl food item obtain dietari histori questionnair odd ratio confid limit comput multipl regress risk status veget green veget chive celeri strong protect effect colorect cancer reduc consumpt meat egg bean product grain increas risk cancer rectum alcohol intak found import risk factor develop colon cancer male rectal cancer
MED-891~bisphenol food product canadian market pubm ncbi abstract method base solid phase extract derivat gas chromatography mass spectrometri analysi valid determin bisphenol bpa food product method analyz num food product bpa concentr bpa food product differ food type specif migrat limit num mg kg set european commiss direct bpa food food simul tuna product highest bpa concentr general maximum valu num num ng g bpa concentr condens soup product higher ready to serv soup product maximum valu num num ng g condens soup num num ng g ready to serv soup bpa concentr veget product low num product bpa concentr num ng g tomato past product lower bpa concentr pure tomato product maximum bpa concentr num num ng g tomato past product num num ng g pure tomato product
MED-892~habitu dietari sodium intak invers coronari flow reserv middle ag male twin abstract background evid link dietari sodium hypertens cardiovascular diseas cvd investig influenc cardiovascular function limit object examin relat habitu dietari sodium coronari flow reserv cfr measur coronari vasodil capac microvascular function hypothes increas sodium consumpt lower cfr design habitu daili sodium intak previous num mo measur num male middle ag twin num monozygot dizygot pair num unpair twin willett food frequ questionnair cfr measur positron emiss tomographi num ammonia quantit myocardi blood flow rest adenosin stress mixed effect regress analysi assess associ dietari sodium cfr result increas dietari sodium num mg d num lower cfr num ci num num adjust demograph lifestyl nutrit cvd risk factor num quintil sodium consumpt dietari sodium invers cfr p trend num top quintil num mg d num lower cfr bottom quintil num mg associ persist pair num mg d differ dietari sodium brother num differ cfr adjust potenti confound num conclus habitu dietari sodium invers cfr independ cvd risk factor share famili genet factor studi suggest potenti mechan advers effect dietari sodium cardiovascular system trial regist clinicaltri gov nct num
MED-894~ceylon cinnamon affect postprandi plasma glucos insulin subject impair glucos toler pubm ncbi abstract previous studi healthi subject shown intak num cinnamomum cassia reduc postprandi glucos intak num cassia reduc insulin respons affect postprandi glucos concentr coumarin damag liver present cassia cinnamomum zeylanicum aim present studi studi effect zeylanicum postprandi concentr plasma glucos insulin glycaem index gi insulinaem index gii subject impair glucos toler igt total ten subject igt assess crossov trial standard num oral glucos toler test ogtt administ placebo zeylanicum capsul finger prick capillari blood sampl glucos measur venous blood insulin measur num num num num num min start ogtt ingest num zeylanicum signific effect glucos level insulin respons gi gii ingest zeylanicum affect postprandi plasma glucos insulin level human subject feder institut risk assess europ suggest replac cassia zeylanicum aqueous extract cassia lower coumarin exposur posit effect cassia subject poor glycaem control lost
MED-895~asthma induc sulphur dioxid benzoat tartrazin orang drink pubm ncbi abstract num patient asthma thirti num gave histori exacerb occur ingest solut orang orang drink fourteen provoc test drink separ occas sulphur dioxid sodium benzoat tartrazin present orang drink react sulphur dioxid fall fev num sodium benzoat tartrazin react agent benzoat patient sensit sulphur dioxid sulphur dioxid sensit patient predomin young extrins asthma benzoat sensit patient predomin middle ag proport intrins asthma higher prior inhal sodium cromoglyc patient inhibit reaction substanc sulphur dioxid previous report exacerb asthma ingest food preserv preserv wide rang acid beverag food consid possibl causal patient suffer appar cryptogen asthma asthma due food allergi
MED-897~inhibit non haem iron absorpt man polyphenolic contain beverag pubm ncbi abstract effect polyphenol contain beverag fe absorpt bread meal estim adult human subject erythrocyt incorpor radio f test beverag polyphenol structur rich phenol acid chlorogen acid coffe monomer flavonoid herb tea camomil matricaria recutita vervain verbena officinali lime flower tilia cordata mill pennyroy mentha pulegium peppermint mentha piperita complex polyphenol polymer product black tea cocoa beverag potent inhibitor fe absorpt reduc absorpt dose depend fashion depend content total polyphenol compar water control meal beverag num mg total polyphenols serv reduc fe absorpt bread meal num beverag num mg total polyphenols serv reduc fe absorpt num inhibit black tea num peppermint tea num pennyroy num cocoa num vervain num lime flower num camomil num ident concentr total polyphenol black tea inhibitori cocoa inhibitori herb tea camomil vervain lime flower pennyroy equal inhibit peppermint tea ad milk coffe tea influenc inhibitori natur find demonstr herb tea black tea coffe coca potent inhibitor fe absorpt properti consid give dietari advic relat fe nutrit
MED-898~impact tea drink iron status uk review pubm ncbi abstract background aim review num evalu literatur impact tea drink iron status group uk popul num formul target evid base advic tea drink context iron nutrit group peopl method literatur search identifi num refer specif effect black tea iron absorpt iron nutrit recent review articl studi assess term methodog qualiti relev tea drink pattern uk popul result clear evid show tea drink limit absorpt nonhaem iron studi assess influenc tea drink indic iron status intervent studi conclus report review base num observ studi countri studi report signific negat correl tea drink blood indic iron status case anemia tea drinker compar nontea drinker studi review report addit relationship iron status indic factor dietari nondietari highlight complex influenc iron absorpt iron status conclus evid advis restrict tea drink healthi peopl risk iron defici group risk iron defici advic drink tea meal wait num eat drink tea
MED-899~milk induc pulmonari diseas infant heiner syndrom pubm ncbi abstract heiner syndrom hs food hypersensit pulmonari diseas affect primarili infant caus cow milk cm report publish due misdiagnosi review seri case diagnos num month age fed cm birth chronic respiratori symptom began age num month symptom form cough wheez hemoptysi nasal congest dyspnea recurr otiti media om recurr fever anorexia vomit colic diarrhea hematochezia failur thrive ftt radiolog evid pulmonari infiltr high titer precipit antibodi cm protein demonstr milk specif immunoglobulin ige posit pulmonari hemosiderosi ph confirm patient show iron laden macrophag ilm bronchoalveolar lavag bal gastric wash open lung biopsi addit find descend frequenc eosinophilia anemia elev level total igm ige iga milk elimin result remark improv symptom day clear pulmonari infiltr week parent consent milk challeng case develop recurr symptom num yr milk avoid patient milk challeng toler num month patient develop symptom serum milk precipitin pulmonari infiltr ilm hs suspect young children chronic pulmonari diseas obscur diagnosi support posit milk precipitin test improv trial milk elimin sever case complic ph suspect presenc anemia hemoptysi confirm demonstr ilm
MED-900~cow milk allergi thai children pubm ncbi abstract cow milk allergi cma nowaday common problem thai children review medic record patient cma depart pediatr king chulalongkom memori hospit past num year num num criteria diagnosi cma includ elimin cow milk formula result improv symptom recurr symptom reintroduct cow milk oral challeng accident ingest num children diagnosi cma num girl num boy averag age time diagnosi num month num day num year averag durat symptom diagnosi num month famili histori atop diseas found num patient mother report increas consumpt cow milk pregnanc common symptom respiratori num gastrointestin gi num skin manifest num common symptom includ failur thrive num anemia num delay speech due chronic serous otiti media num anaphylact shock num prick skin test cow milk extract posit num exclus breast f found num patient success treatment includ elimin cow milk milk product substitut soy formula num partial hydrolys formula phf num extens hydrolys formula ehf num amino acid formula num continu breast feed success num matern restrict cow milk milk product studi demonstr varieti clinic manifest cma thai children respiratori symptom overlook
MED-901~cow milk allergi recurr otiti media childhood pubm ncbi abstract determin cow milk allergi cma infanc recurr otiti media rom chronic ear infect conduct cohort studi enrol num milk allerg num control schoolchildren studi associ ear problem atop manifest higher proport children cma rom defin num acut otiti media episod age num year num num num undergon adenoidectomi tympanostomi compar control num num num true children develop respiratori atopi asthma and or allerg rhiniti atop dermat pose signific risk rom atop manifest enhanc risk secretori otiti media posit skin prick test food inhal allergen tend ear problem conclus found children cma infanc proper treat experienc signific rom risk associ concomit develop respiratori atopi
MED-902~toxic extract plant part moringa stenopetala hepg num cell vitro pubm ncbi abstract cytotox extract wide speci plant moringa stenopetala assess hepg num cell measur leakag lactat dehydrogenas ldh cell viabil function integr extract expos cell determin measur intracellular level atp glutathion gsh ethanol extract leav seed increas signific num ldh leakag dose time depend manner water extract leav ethanol extract root increas ldh leakag high signific num decreas hepg num viabil found incub cell highest concentr num microg ml ethanol leaf seed extract concentr num microg ml water extract leav increas num ethanol extract plant part decreas num atp level root seed extract signific effect atp level ethanol leaf extract decreas gsh level concentr num microg ml num ethanol extract seed num microg ml num microg ml num water extract leav alter gsh ldh level affect cell viabil suggest non tox consist veget data obtain studi ethanol extract leav seed moringa stenopetala show toxic substanc extract organ solvent form process extract solvent signific deplet atp gsh occur concentr extract caus leakag ldh investig plant order identifi constitu extract individu toxic effect vivo vitro warrant studi illustr util cell cultur screen plant extract potenti toxic copyright num john wiley son
MED-903~antiprolifer induct apoptosi moringa oleifera leaf extract human cancer cell pubm ncbi abstract medicin plant provid inexhaust sourc anticanc drug term varieti mechan action induct apoptosi key success plant product anticanc agent present studi design determin antiprolif apoptot event moringa oleifera leaf extract mle human tumor kb cell line model system kb cell cultur presenc leaf extract concentr num percentag cell viabil evalu mtt assay mle show dose depend inhibit cell prolifer kb cell antiprolif effect mle induct apoptosi morpholog dna fragment morpholog apoptot nuclei quantifi dapi propidium iodid stain degre dna fragment analyz agaros gel electrophoresi addit mle concentr found induc ros product suggest modul redox sensit mechan eventu hptlc analysi presenc phenol quercetin kaempferol find suggest leaf extract oleifera strong antiprolifer potent induct apoptosi oleifera leaf extract potenti cancer chemoprevent claim therapeut target cancer copyright num elsevi reserv
MED-904~systemat review meta analysi effect pasteur milk vitamin evid raw milk consumpt health rel pubm ncbi abstract pasteur milk ensur safeti human consumpt reduc number viabl pathogen bacteria public health benefit pasteur establish pro raw milk advoc organ continu promot raw milk nature perfect food advocaci group claim includ statement pasteur destroy import vitamin raw milk consumpt prevent treat allergi cancer lactos intoler systemat review meta analysi complet summar evid select claim forti studi assess effect pasteur vitamin level found qualit vitamin num decreas pasteur vitamin increas random effect meta analysi reveal signific effect pasteur vitamin num concentr standard differ smd num num confid interv ci num num num decreas concentr vitamin num smd num num ci num num num num smd num num ci num num num smd num num ci num num num folat smd num num ci num num num effect pasteur milk nutrit minim vitamin natur found low level milk import dietari sourc vitamin num impact heat treatment consid raw milk consumpt protect associ allergi develop studi relationship potenti confound farming rel factor raw milk consumpt cancer studi lactos intoler studi find interpret caution poor qualiti report methodolog includ studi
MED-905~inhibit angiotensin convertin enzym ace activ anthocyanin delphinidin cyanidin num o sambubiosid hibiscus sabdariffa pubm ncbi abstract ethnopharmacolog relev beverag hibiscus sabdariffa calyc wide mexico diuret treat gastrointestin disord liver diseas fever hypercholesterolemia hypertens work demonstr hibiscus sabdariffa extract reduc blood pressur human recent demonstr effect due angiotensin convert enzym ace inhibitor activ aim studi aim current studi isol character constitu respons ace activ aqueous extract hibiscus sabdariffa materi method bioassay guid fraction aqueous extract dri calyc hibiscus sabdariffa prepar reversed phas hplc vitro ace inhibit assay biolog monitor model isol isol compound character spectroscop method result anthocyanin delphinidin num o sambubiosid num cyanidin num o sambubiosid num isol bioassay guid purif compound show ic num valu num num microg ml similar obtain relat flavonoid glycosid kinet determin suggest compound inhibit enzym activ compet substrat activ site conclus competit ace inhibitor activ anthocyanin num num report time activ good agreement folk medicin hibiscus sabdariffa calyc antihypertens copyright num elsevi ireland reserv
MED-906~anaphylaxi annatto dye case report pubm ncbi abstract annatto dye orange yellow food color extract seed tree bixa orellana common chees snack food beverag cereal previous report advers reaction annatto dye includ urticaria angioedema present patient develop urticaria angioedema sever hypotens num minut ingest milk fiber cereal annatto dye subsequ skin test milk wheat corn negat patient strong posit skin test annatto dye control respons nondialyz fraction annatto dye sds page demonstr protein stain band rang num kd immunoblot demonstr patient ige specif band control show bind annatto dye contamin residu seed protein patient develop ige hypersensit annatto dye potenti rare anaphylaxi
MED-907~risk factor ischaem intracerebr haemorrhag stroke num countri interstrok studi case control studi pubm ncbi abstract background contribut risk factor burden stroke worldwid unknown countri low middl incom aim establish associ emerg risk factor stroke primari subtyp assess contribut risk factor burden stroke explor differ risk factor stroke myocardi infarct method undertook standardis case control studi num countri worldwid march num april num case patient acut stroke num day symptom onset num hospit admiss control histori stroke match case age sex particip complet structur questionnair physic examin provid blood urin sampl calcul odd ratio population attribut risk par associ stroke ischaem stroke intracerebr haemorrhag stroke select risk factor find num case num ischaem stroke num intracerebr haemorrhag stroke num control signific risk factor stroke histori hypertens num num ci num num par num num ci num num current smoke num num num num num num waist to hip ratio num num num highest lowest tertil num num num diet risk score num num num highest lowest tertil num num num regular physic activ num num num num num num diabet mellitus num num num num num num alcohol intak num num num num drink month bing drink num num num psychosoci stress num num num num num num depress num num num num num num cardiac num num num num num num ratio apolipoprotein num num num num highest lowest tertil num num num collect risk factor account num num ci num num par stroke altern definit hypertens histori hypertens blood pressur num mm hg combin par num num num stroke risk factor signific ischaem stroke hypertens smoke waist to hip ratio diet alcohol intak signific risk factor intracerebr haemorrhag stroke interpret find suggest ten risk factor num risk stroke target intervent reduc blood pressur smoke promot physic activ healthi diet substanti reduc burden stroke fund canadian institut health research heart stroke foundat canada canadian stroke network pfizer cardiovascular award merck astrazeneca boehring ingelheim copyright num elsevi reserv
MED-909~studi degrad kinet ascorb acid amla phyllanthus emblica cook pubm ncbi abstract kinet ascorb acid degrad amla phyllanthus emblica pure ascorb acid solut initi concentr present amla temperatur rang num degre steady st temperatur studi ascorb acid degrad first ord reaction kinet rate constant increas increas temperatur temperatur depend degrad adequ model arrhenius equat activ energi found num kcal mol amla num kcal mol pure vitamin solut degrad kinet ascorb acid evalu normal open pan cook pressure cook newli develop patent fuel effici ecocook unsteadi state heat process mathemat model develop steady st kinet paramet obtain predict loss ascorb acid time temperatur data unsteadi state heat process method result obtain ascorb acid degrad similar order magnitud method cook
MED-910~effect cook garlic allium sativum antiplatelet activ thiosulfin content pubm ncbi abstract raw form garlic prepar wide recogn antiplatelet agent contribut prevent cardiovascular diseas examin in vitro antiaggregatori activ ivaa human blood platelet induc extract garlic sampl previous heat form crush versus uncrush clove cook method intens concentr allicin pyruv predictor antiplatelet strength monitor oven h num degre immers boil water num min affect abil garlic inhibit platelet aggreg compar raw garlic heat num min complet suppress ivaa uncrush previous crush sampl sampl reduc signific antiplatelet activ prolong incub num min temperatur complet suppress ivaa microwav garlic effect platelet aggreg increas concentr garlic juic aggreg reaction posit ivaa dose respons crush uncrush microwav sampl addit raw garlic juic microwav uncrush garlic restor full complement antiplatelet activ complet lost garlic addit garlic induc ivaa allicin pyruv level result suggest num allicin thiosulfin respons ivaa respons num crush garlic moder cook reduc loss activ num partial loss antithrombot effect crushed cook garlic compens increas amount consum
MED-911~swim death naegleria fowleri infect recreat water pubm ncbi abstract naegleria fowleri free liv amoeba common found warm freshwat environ hot spring lake natur miner water resort spas frequent tourist fowleri etiolog agent primari amoeb meningoenceph pam acut fatal diseas central nervous system result death approxim day previous thought rare condit number report pam case increas year pam difficult diagnos clinic sign diseas similar bacteri mening key diagnosi physician awar clinic suspicion intent creat awar travel medicin practition tourism industri review focus present featur fowleri pam offer insight prevent treatment diseas copyright num elsevi reserv
MED-912~report prune liver function clinic trial pubm ncbi abstract prune folk remedi diseas includ hepat clinic trial design effect prune prunus domestica liver function num healthi volunt divid group random num num approx prune soak glass water num overnight subject test group drink prune juic eat fruit singl doubl dose prune earli morn daili num week subject control group glass water drink blood sampl week num week num chemic analysi signific reduct serum alanin transaminas num serum alkalin phosphatas num lower dose prune chang serum aspart transaminas bilirubin alter liver function prune clinic relev case prune prove benefici hepat diseas
MED-913~literatur review safeti assess genet modifi plant pubm ncbi abstract recent year notabl concern safeti genet modifi gm foods plant import complex area research demand rigor standard divers group includ consum environment government organ ngo suggest gm foods plant subject long term anim feed studi approv human consumpt num num review inform publish intern scientif journal note number refer human anim toxicological health risk studi gm foods plant limit main goal present review assess current state of the art potenti advers effects safeti assess gm plant human consumpt number citat found databas pubm scopus dramat increas num inform product potato cucumb pea tomato corn maiz rice soybean includ present review equilibrium number research group suggest basi studi number varieti gm product maiz soybean safe nutriti respect convent non gm plant rais concern observ note studi conduct biotechnolog compani respons commerci gm plant find suggest notabl advanc comparison lack studi publish recent year scientif journal compani recent inform critic review copyright num elsevi reserv
MED-914~studi safeti chines wild rice pubm ncbi abstract chines wild rice consum num year safeti food china establish grain higher amount protein ash crude fibr white rice level non nutrit miner element arsenic cadmium lead low eat pattern num peopl num yr show ill effect result acut toxic test mice fed diet num g kg chines wild rice correct abnorm reaction mice die bone marrow micronucleus sperm abnorm test conduct mice negat salmonella mutagen test result investig chines wild rice safe human consumpt
MED-915~heavi metal wild rice northern wisconsin pubm ncbi abstract wild rice grain sampl part world found elev concentr heavi metal rais concern potenti effect human health hypothes wild rice north centr wisconsin potenti elev concentr heavi metal exposur element atmospher water sediment addit studi heavi metal wild rice wisconsin perform baselin studi futur comparison wild rice plant collect area bayfield forest langlad oneida sawyer wood counti septemb num num divid plant part element analys root stem leav seed total num sampl num plant analyz local averag num sampl part depend element sampl clean soil wet digest analyz icp ag cd cr cu hg mg pb se zn root highest concentr ag cd cr hg pb se copper highest root seed zn highest seed magnesium highest leav seed baselin rang num element establish num confid interv median wild rice plant northern wisconsin normal level nutrit element cu mg zn seed silver cd hg cr se low concentr normal limit food plant arsenic pb elev pose problem human health pathway hg pb plant atmospher
MED-917~effect freez storag phenol ellagitannin flavonoid antioxid capac red raspberri pubm ncbi abstract scottish grown red raspberri rich sourc vitamin phenol notabl anthocyanin cyanidin num sophorosid cyanidin num num glucosylrutinosid cyanidin num glucosid ellagitannin sanguiin num lambertianin present trace level flavonol ellag acid hydroxycinnam antioxid capac fresh fruit level vitamin phenol affect freez fruit store num degre num day num degre num mimick rout fresh fruit harvest supermarket consumer tabl anthocyanin level unaffect vitamin level declin elligitannin increas effect antioxid capac fruit conclud fresh pick fresh commerci frozen raspberri similar level phytochem antioxid serv
MED-918~combin erythritol fructos increas gastrointestin symptom healthi adult pubm ncbi abstract consumpt larg amount dietari fructos induc gastrointestin intoler glucos enhanc fructos absorpt erythritol nonglycem sugar alcohol suggest erythritol absorb paracellular hypothes paracellular absorpt erythritol enhanc paracellular absorpt fructos healthi adult propos pathway addit glucos enhanc absorpt fructos thirty seven nondiabet healthi adult particip random double mask control crossov studi overnight fast particip consum beverag num fructos num glucos num fructos num erythritol equimolar concentr fructos num fructos breath hydrogen respons determin num hour postprandi gastrointestin intoler symptom number consist bowel movement record num hour postprandi breath hydrogen area curv auc fructos erythritol beverag num time auc fructos beverag num time auc fructos glucos beverag num compar fructos glucos beverag fructos frequenc wateri stool increas num gastrointestin toler worsen num particip consum fructos erythritol data suggest coingest equimolar concentr fructos erythritol increas carbohydr malabsorpt copyright num elsevi reserv
MED-919~evalu treatment prevent vitamin defici endocrin societi clinic practic guidelin pubm ncbi abstract object object provid guidelin clinician evalu treatment prevent vitamin defici emphasi care patient risk defici particip task forc compos chair addit expert methodologist task forc receiv corpor fund remuner consensus process consensus guid systemat review evid discuss confer call e mail communic draft prepar task forc review success endocrin society clinic guidelin subcommitte clinic affair core committe cosponsor associ post endocrin societi web site member review stage review task forc receiv written comment incorpor conclus vitamin defici common age group food vitamin task forc recommend supplement suggest daili intak toler upper limit level depend age clinic circumst task forc suggest measur serum num hydroxyvitamin level reliabl assay initi diagnost test patient risk defici treatment vitamin num vitamin num recommend defici patient present time suffici evid recommend screen individu risk defici prescrib vitamin attain noncalcem benefit cardiovascular protect
MED-920~vitamin treatment pulmonari tuberculosi pubm ncbi abstract vitamin treat tuberculosi pre antibiot era insight immunomodulatori properti num lpha num dihydroxy vitamin rekindl interest vitamin adjunct antitubercul therapi describ histor vitamin tuberculosi treatment discuss mechan modul host respons infect mycobacterium tuberculosi review clinic trial ten case seri vitamin treatment pulmonari tuberculosi
MED-921~wine bottl vitamin treatment prevent tuberculosi pubm ncbi abstract tuberculosi tb major mortal respons num num million death worldwid num global preval latent mycobacterium tuberculosi infect estim num carri num lifetim risk reactiv diseas emerg drug resist organ necessit develop agent enhanc respons antimicrobi therapi activ tb vitamin treat tb pre antibiot era activ metabolit num dihydoxyvitamin long enhanc immun respons mycobacteria vitro vitamin defici common patient activ tb clinic trial evalu role adjunct vitamin supplement treatment result studi conflict reflect variat studi baselin vitamin status particip dose regimen outcom measur vitamin defici recognis high preval peopl latent tuberculosi infect high low burden set wealth observ epidemiolog evid link vitamin defici increas risk reactiv diseas randomis control trial vitamin supplement prevent activ tb perform conduct trial research prioriti safeti low cost vitamin supplement potenti huge public health consequ posit result
MED-922~effect vegetarian diet select essenti nutrient children pubm ncbi abstract introduct vegetarian diet consid promot health reduc risk chronic diseas restrict exclus anim food result low intak essenti nutrient aim present studi assess intak serum status vitamin num folat vitamin concentr homocystein total antioxid status iron balanc polish vegetarian children materi method studi includ num children age num refer institut mother child dietari consult num vegetarian age num num year num omnivor age num num year dietari constitu analyz nutrit programm dietetyk num folat vitamin num determin chemiluminesc immunoassay total homocystein fluoresc polar immunoassay tas total antioxid status colorimetr method vitamin serum determin high pressur liquid chromatographi method hplc vitamin immunoenzymat assay elisa concentr iron ferritin transferrin total iron bind capac tibc serum determin commerci kit result vegetarian children daili intak vitamin num num recommend rang folat num vitamin num higher vitamin slight lower num three fold lower vitamin num refer serum concentr vitamin num pg ml folat num ng ml vitamin num mol l vitamin num mol l physiolog rang vitamin num g l half lowest limit refer vegetarian children comparison omnivor similar level homocystein num mol l num mol l vitamin num mol l num mol l observ lower num valu vitamin num mol l num mol l tas num mmol l num mmol l num found concentr iron marker physiolog rang conclus obtain result intak vitamin num folic acid vegetarian diet suffici maintain serum concentr homocystein iron rang observ omnivor children high consumpt vitamin low vitamin slight affect serum valu signific lower concentr serum vitamin vegetarian children comparison nonvegetarian reflect statist signific lower total antioxid status insuffici intak vitamin low serum concentr close monitor vegetarian children order prevent vitamin defici age depend supplement consid
MED-923~dexamethason facilit lipid accumul chicken skelet muscl pubm ncbi abstract effect glucocorticoid lipid metabol broiler chicken gallus gallus domesticus skelet muscl investig male arbor acr chicken num day subject dexamethason treatment num day found dexamethason retard bodi growth facilit lipid accumul pectorali major pm dexamethason increas express glucocorticoid receptor gr fatti acid transport protein num fatp num heart fatti acid bind protein h fabp long chain acyl coa dehydrogenas lcad mrna decreas express liver carnitin palmitoyltransferas num l cpt num adenosine monophosphate activ protein kinas ampk num lipoprotein lipas lpl mrna lpl activ decreas bicep femori bf level gr fatp num l cpt num mrna increas ampk thr num phosphoryl ctp num activ skelet muscl decreas dexamethason fed chicken dexamethason enhanc low dens lipoprotein receptor vldlr express ampk activ muscl impair express lpl l cpt num mrna lpl activ pm augment express gr lpl h fabp l cpt num lcad ampk num mrna bf adipos triglycerid lipas atgl protein express affect dexamethason conclus fast state dexamethasone induced retard fatti acid utilis involv augment intramyocellular lipid accumul glycolyt pm oxid bf muscl tissu fed state dexamethason promot transcript activ gene relat lipid uptak oxid muscl unmatch lipid uptak utilis suggest involv augment intramyocellular lipid accumul
MED-924~sever metabol alkalosi due bake soda ingest case report patient unsuspect antacid overdos pubm ncbi abstract oral ingest bake soda sodium bicarbon decad home remedi acid indigest excess bicarbon ingest place patient risk varieti metabol derang includ metabol alkalosi hypokalemia hypernatremia hypoxia clinic present high variabl includ seizur dysrhythmia cardiopulmonari arrest present case sever metabol alkalosi patient unsuspect antacid overdos present pathophysiolog antacid rel metabol alkalosi review
MED-925~bake soda potenti fatal home remedi pubm ncbi abstract present case six week old infant develop life threaten complic unintent sodium bicarbon intox bake soda mother home remedi babi burp review literatur misus bake soda patient note case report emphas warn bake soda product label recommend antacid poison high differenti diagnosi patient age present alter mental status status epilepticus
MED-926~sever metabol alkalosi emerg depart pubm ncbi abstract case sever metabol alkalosi ma result ingest bake soda sodium bicarbon present admiss emerg depart patient alert stabl initi examin remark carpoped spasm short patient sudden unexpect cardiopulmonari arrest resuscit administr sodium bicarbon arteri blood gas reveal ph num po num num mm hg pco num num mm hg admiss intens care unit patient ma correct iv num hydrochlor acid patient remain comatos result sever anox encephalopathi die week admiss report case sever ma result sudden cardiopulmonari arrest previous ambulatori patient
MED-927~evalu effect neptun krill oil clinic hyperlipidemia pubm ncbi abstract object assess effect krill oil blood lipid specif total cholesterol triglycerid low dens lipoprotein ldl high dens lipoprotein hdl method multi cent three month prospect random studi three month control follow up patient treat num num krill oil daili patient hyperlipidemia maintain healthi diet blood cholesterol level num num mg dl elig enrol trial sampl size num patient num patient group random assign group group receiv krill oil bodi mass index bmi depend daili dosag num daili patient group num num krill oil daili group fish oil num mg eicosapentaeno acid epa num mg docosahexaeno acid dha gram oil dose num daili group placebo microcrystallin cellulos krill oil studi neptun krill oil provid neptun technolog bioresourc laval quebec canada outcom measur primari paramet test baselin num day visit total blood cholesterol triglycerid ldl hdl glucos result krill oil num day bmi depend found effect reduct glucos total cholesterol triglycerid ldl hdl compar fish oil placebo conclus result present studi demonstr high level confid krill oil effect manag hyperlipidemia signific reduc total cholesterol ldl triglycerid increas hdl level lower equal dose krill oil signific effect fish oil reduct glucos triglycerid ldl level
MED-928~incorpor epa dha plasma phospholipid respons omega num fatti acid formul compar bioavail studi fish oil krill oil abstract background bioavail omega num fatti acid fa depend chemic form superior bioavail suggest phospholipid pl bound omega num fa krill oil ident dose chemic form compar method double blind crossov trial compar uptak epa dha formul deriv fish oil re esterifi triacylglycerid rtag ethyl est ee krill oil pl fa composit plasma pl proxi bioavail twelv healthi young men age num random num mg epa dha rtag ee krill oil fa level plasma pl analyz pre dos num num num num capsul ingest addit proport free epa dha appli supplement analyz result highest incorpor epa dha plasma pl provok krill oil auc num num num fish oil rtag auc num num num ee auc num num num due high standard deviat valu signific differ dha sum epa dha level treatment trend num observ differ epa bioavail statist pair wis group comparison reveal trend num rtag krill oil fa analysi supplement show krill oil sampl num total epa amount free epa num total dha amount free dha fish oil sampl free fa conclus studi larger sampl size carri longer period substanti find determin differ epa dha bioavail common chemic form lc num fa rtag ee krill oil unexpect high content free epa dha krill oil signific influenc avail epa dha krill oil investig depth futur trial
MED-930~organochlorin pesticid air wat exchang bioconcentr krill ross sea pubm ncbi abstract hexachlorobenzen hcb hexachlorocyclohexan hch concentr measur seawat air sampl confirm declin level compound antarct air water low alpha gamma hch ratio air begin sampl period suggest predomin fresh lindan enter antarct atmospher austral spring due current southern hemispher water air fugac ratio demonstr potenti hch gas deposit coastal antarct sea water air fugac ratio hcb impli volatil account observ decreas hcb surfac seawat hch concentr found krill sampl correl seawat concentr indic bioconcentr hchs seawat
MED-931~aqueous uptak subleth toxic p  dde non feed larval stage antarct krill euphausia superba pubm ncbi abstract studi evalu toxicolog sensit non feed larval stage key antarct speci antarct krill euphausia superba p  dichlorodiphenyl dichloroethylen p  dde exposur aqueous uptak clearanc rate num ml num preserv weight num determin p  dde antarct krill larva compar previous find small cold water crustacean time slower rate report amphipod inhabit warmer water natur variat larval physiolog influenc contamin uptak larval krill behaviour respons strong highlight import time measur ecotoxicolog test subleth narcosi immobl observ larval antarct krill p  dde bodi residu num mmol kg agreement find adult krill temper aquat speci find compar bodi residue bas toxic p  dde polar temper speci support tissu residu approach environment risk assess polar ecosystem copyright num elsevi reserv
MED-933~recurr monoarthr num year old boy occult coeliac diseas success stabl remiss gluten fre diet pubm ncbi abstract case occult coeliac diseas cd present recurr monoarthr boy age num year report case uniqu due associ occult untreat cd arthriti childhood peripher axial arthriti manifest occult cd adult patient interv arthriti cd num year case interv arthriti diagnosi cd num year boy asymptomat bowel diseas nutrit status normal diagnosi cd establish anti gliadin aga anti endomysium ema antibodi test confirm small bowel biopsi introduct gluten fre diet result persist remiss arthriti treatment cd associ arthriti base dietari therapi physician alert possibl occult cd child arthriti unclear origin
MED-934~preval urinari stone diseas vegetarian pubm ncbi abstract studi carri determin effect low anim protein diet vegetarian risk urinari stone diseas nation wid survey vegetarian uk show preval urinari stone format num predict group individu general popul match age sex social class vegetarian find support hypothesi diet low anim protein reduc risk urinari stone format
MED-936~effect vitamin supplement urinari oxal ph calcium stone form patient pubm ncbi abstract background contribut ascorb urinari oxal controversi present studi aim determin urinari oxal ph affect vitamin supplement calcium stone form patient method forty seven adult calcium stone form patient receiv num num num num vitamin supplement num day num healthi subject receiv num num hour urin sampl obtain vitamin calcium oxal magnesium citrat sodium potassium creatinin determin tiselius index calcium oxal crystal index spot fast morn urin sampl obtain determin urinari ph vitamin result fast urinari ph chang num num num num num num vitamin num num num num signific increas urinari oxal observ calcium stone form patient receiv num num num num num mg num hour num num num num num mg num hour vitamin healthi subject num num num num mg num hour signific increas tiselius index observ calcium stone form patient num num num num num num vitamin num num num num healthi subject num num num num ancillari analys spot urin obtain vitamin perform num control subject vessel ethylenediaminetetraacet acid edta differ urinari oxal num num num num mg l suggest vitro convers ascorb oxal occur conclus data suggest vitamin supplement increas urinari oxal excret risk calcium oxal crystal calcium stone form patient
MED-937~prospect double blind random placebo control studi effect saffron crocus sativus linn semen paramet semin plas pubm ncbi abstract male factor infertil multifactori disord affect signific percentag infertil coupl remain untreat recent year number infertil men sought herbal remedi effect treatment herbal remedi saffron recommend male infertil communiti effect saffron evalu compar placebo treatment idiopath male factor infertil studi includ num infertil men idiopath oligoasthenoteratozoospermia oat random saffron num mg day num group num similar regimen placebo num group num num week group compar semen paramet total semin plasma antioxid capac saffron administr result benefici effect end studi statist signific improv observ group studi semen paramet sperm densiti morpholog motil num end trial patient group num motil num num statist num num placebo group num normal sperm morpholog num num num num group num num num patient treat saffron placebo sperm densiti num num num num ml num saffron administr improv total semin plasma antioxid capac compar baselin num placebo subject num base pearson correl semen paramet correl signific treatment durat includ sperm densiti num num percent motil sperm num num percent sperm normal morpholog num num saffron statist signific improv semen paramet infertil men idiopath oat medic profession prescrib herbal remedi male infertil previous rigor scientif investig document safeti efficaci requir copyright num john wiley son
MED-938~studi cytotox apoptogen properti saffron extract human cancer cell line pubm ncbi abstract saffron dri stigma crocus sativus spice food color medicin plant millennia studi cytotox effect saffron extract evalu hepg num hela cell line role apoptosi ros explor malign non malign cell num cultur dmem medium incub concentr ethanol saffron extract cell viabil quantit mtt assay apoptot cell determin pi stain dna fragment flow cytometri sub g num peak ros measur dcf da flow cytometri analysi saffron decreas cell viabil malign cell concentr time depend manner ic num valu hela hepg num determin num num microg ml num saffron induc sub g num peak flow cytometri histogram treat cell compar control indic apoptot cell death involv saffron toxic toxic independ ros product conclud saffron cell death hela hepg num cell apoptosi program cell death play import role saffron consid promis chemotherapeut agent cancer treatment futur
MED-939~satier crocus sativus extract reduc snack increas satieti random placebo control studi mild overweight health pubm ncbi abstract snack uncontrol eat behavior predispos weight gain obes primarili affect femal popul frequent stress hypothes oral supplement satier inor plerin franc extract saffron stigma reduc snack enhanc satieti suggest mood improv effect contribut weight loss healthi mild overweight women num particip random placebo control double blind studi evalu efficaci satier supplement bodi weight num week period snack frequenc main secondari variabl assess daili self record episod subject nutrit diari day enrol subject consum num capsul satier num mg extract day num match placebo num calor intak left unrestrict studi baselin group homogen age bodi weight snack frequenc satier caus signific greater bodi weight reduct placebo num week num snack frequenc signific decreas satier group compar placebo group num anthropometr dimens vital sign remain unchang group subject withdraw attribut product effect report trial suggest good toler satier result satier consumpt produc reduct snack creat satiat effect contribut bodi weight loss combin adequ diet satier supplement subject engag weight loss program achiev object copyright num elsevi reserv
MED-940~open label random fixed dos crossov studi compar efficaci safeti sildenafil citrat saffron crocus sativus linn pubm ncbi abstract saffron crocus sativus linn perceiv public strong aphrodisiac herbal product studi address potenti benefici effect saffron erectil function ef men ed lack aim evalu efficaci safeti saffron administr ef men ed num week baselin assess num men ed age num num year random receiv on demand sildenafil num week num mg saffron daili num week vice versa separ num week washout period determin type ed penil color duplex doppler ultrasonographi intracavernos inject num microg prostaglandin num pudend nerv conduct test impair sensory evok potenti studi perform subject assess intern index erectil function iief questionnair sexual encount profil sep diari question patient partner version erectil dysfunct inventori treatment satisfact edit questionnair global efficaci question geq medic improv erect signific improv observ regard iief sexual function domain sep question edit score saffron administr baselin valu iief ef domain num num sildenafil placebo group num observ improv num individu iief question patient saffron treatment satisfact assess partner version edit found low saffron patient num num num patient respons geq num num sildenafil saffron num find support benefici effect saffron administr men ed
MED-941~topic vitamin treatment recalcitr common wart pubm ncbi abstract background common wart verruca vulgari benign epitheli prolifer human papillomavirus hpv infect salicyl acid cryotherapi frequent treatment common wart pain scar high failur recrudesc rate topic vitamin shown success treatment common wart prior inform studi case subject healthi physically act num femal num year histori common wart back hand wart resist treatment salicyl acid appl cider vinegar over the count blend essenti oil market treatment wart daili topic applic natur vitamin deriv fish liver oil num iu led replac wart normal skin smaller wart replac num day larg wart middl knuckl requir num month vitamin treatment resolv complet conclus retinoid investig control studi determin effect treat common wart broad rang benign cancer lesion induc hpvs
MED-942~esophag injuri appl cider vinegar tablet subsequ evalu product pubm ncbi abstract appl cider vinegar product advertis popular press internet treatment varieti condit advers event report author appl cider vinegar tablet product test ph compon acid content microbi growth variabl found brand tablet size ph compon acid content label claim doubt remain appl cider vinegar fact ingredi evalu product inconsist inaccuraci label recommend dosag unsubstanti health claim make easi question qualiti product
MED-943~embryotox effect pine needl pine needl extract pubm ncbi abstract heat stabl toxin present needl ponderosa pine found solubl methanol ethanol chloroform hexan num butanol embryotox effect fresh green pine needl chloroform methanol extract determin measur embryo resorpt pregnant mice autoclav needl extract num hour prior feed enhanc embryoresorpt effect num num result studi reveal embryo resorpt dose erd num heat stabl toxin num mous num gms fresh green pine needl num gms autoclav green pine needl addit embryocid effect feed toxin result signific weight loss adult mice
MED-944~nanomateri consum product challeng analyt problem pubm ncbi abstract product everyday life made assist nanotechnolog cosmet pharmaceut sunscreen powder food exampl end product nano s particl nps general ad improv product qualiti evalu correct benefit risk engin nanomateri legisl favor consumer protect hazard connect exposur level inform impli transvers studi number compet analyt point view identif quantif character nps food matric cosmet person care product pose signific challeng nps present low concentr level matric dispers complex incompat analyt instrument requir detect character paper focus analyt techniqu suitabl detect character quantif nps food cosmet product report recent applic character specif metal metal oxid nps import industri market sector character nps complet match complementari inform metric achiev valid procedur emerg research work produc standard materi set up methodolog determin number bas size distribut quantit date nps complex matric
MED-945~review efficaci green tea isoflavon alo vera supplement base randomis control trial pubm ncbi abstract assess evid health benefit common consum plant food supplement pfs green tea isoflavon alo vera base publish systemat review randomis control trial rcts whilst potenti benefit green tea report wide rang health area area metabol syndrom number rcts approach suffici judg efficaci isoflavon supplement wide rcts affect bone resorpt lower dose postmenopaus women undergo estrogen rel bone loss translat attenu bone loss higher dose isoflavon systemat review rcts conclud effect isoflavon hot flash postmenopaus women high variabl conclus drawn popular alo vera pfs evalu efficaci coadjuv therapi metabol digest patholog remain scarc constitut typic natur occur ingredi efficaci topic applic presuppos efficaci system applic toxic effect oral consumpt call caution util pfs num efficaci evalu pfs europ cover european union nutrit health claim legisl european food safeti author adopt approach reli rcts medicin effect accept base tradit general insuffici rcts claim made conclus result pfs obtain futur conduct studi homogen popul supplement optimis measur bioavail conduct larger rcts
MED-946~bulk agent antispasmod antidepress treatment irrit bowel syndrom pubm ncbi abstract background irrit bowel syndrom ib common chronic gastrointestin disord role pharmacotherapi ib limit focus symptom control object object systemat review evalu efficaci bulk agent antispasmod antidepress treatment irrit bowel syndrom search strategi comput assist structur search medlin embas cochran librari cinahl psychinfo conduct year num updat search april num identifi num studi consid inclus futur updat review select criteria random control trial compar bulk agent antispasmod antidepress placebo treatment patient irrit bowel syndrom age num year consid inclus studi publish full paper includ studi exclud basi languag primari outcom includ improv abdomin pain global assess symptom score data collect analysi author independ extract data select studi risk ratio rr standard differ smd num confid interv ci calcul proof practic analysi conduct includ sub group analys type bulk agent spasmolyt agent antidepress medic proof principl analysi studi adequ alloc conceal includ main result total num studi num patient includ review includ num studi bulk agent num patient num antispasmod num patient num antidepress num patient risk bias low item select bias unclear includ studi method random alloc conceal benefici effect bulk agent placebo found improv abdomin pain num studi num patient smd num num ci num num num global assess num studi num patient rr num num ci num num num symptom score num studi num patient smd num num ci num num num subgroup analys insolubl solubl fibr show statist signific benefit separ analysi studi adequ conceal alloc chang result benefici effect antispasmod placebo improv abdomin pain num antispasmod patient improv compar num placebo num studi num patient rr num num ci num num num nnt num global assess num antispasmod patient improv compar num placebo num studi num patient rr num num ci num num num nnt num symptom score num antispasmod patient improv compar num placebo num studi num patient rr num num ci num num num nnt num subgroup analys type antispasmod found statist signific benefit cimteropium dicyclomin peppermint oil pinaverium trimebutin separ analysi studi adequ alloc conceal found signific benefit improv abdomin pain benefici effect antidepress placebo improv abdomin pain num antidepress patient improv compar num placebo num studi num patient rr num num ci num num num nnt num global assess num antidepress patient improv compar num placebo num studi num patient rr num num ci num num num nnt num symptom score num antidepress patient improv compar num placebo num studi num patient rr num num ci num num num nnt num subgroup analys show statist signific benefit select serotonin releas inhibitor ssris improv global assess tricycl antidepress tcas improv abdomin pain symptom score separ analysi studi adequ alloc conceal found signific benefit improv symptom score global assess advers event assess outcom review author conclus evid bulk agent effect treat ib evid antispasmod effect treatment ib individu subgroup effect includ cimetropium dicyclomin peppermint oil pinaverium trimebutin good evid antidepress effect treatment ib subgroup analys ssris tcas unequivoc effect depend individu patient futur research rigor methodolog valid outcom measur
MED-947~alo versus silver sulfadiazin cream second degre burn random control studi pubm ncbi abstract purpos burn injuri high incid death disabl manag remain problemat cost conduct clinic studi evalu efficaci alo vera cream partial thick burn wound compar result silver sulfadiazin ssd method thirti patient similar type second degre burn site part bodi includ studi patient burn treat topic ssd treat alo cream random result rate re epitheli heal partial thick burn signific faster site treat alo site treat ssd num num num num day num site treat alo complet heal num day num day site treat ssd conclus result demonstr greater efficaci alo cream ssd cream treat second degre burn
MED-948~microbiolog examin veget seed sprout korea pubm ncbi abstract sprout veget seed food implic sourc outbreak salmonella escherichia coli num num infect profil microbiolog qualiti sprout seed sold retail shop seoul korea nineti sampl radish sprout mix sprout purchas depart store supermarket tradit market num sampl radish alfalfa turnip seed purchas onlin store analyz determin number total aerob bacteria tab mold yeast incid salmonella coli num num enterobact sakazakii signific higher number tab num log cfu g num log cfu g present mix sprout radish sprout num num cfu g popul tab sprout signific affect locat purchas radish seed tab popul num num log cfu g popul tab num num log cfu g popul num num log cfu g alfalfa turnip seed salmonella coli num num detect sprout seed sampl test sakazakii found seed num mix sprout sampl potenti pathogen bacterium
MED-949~efficaci herbal dietari supplement smooth move manag constip nurs home resid random double blind pla pubm ncbi abstract object investig efficaci cost effect herbal tea smooth move nurs home resid chronic constip design double blind placebo control num arm parallel group clinic trial set num bed nurs home allentown pennsylvania oper lehigh counti govern particip total num nurs home resid chronic constip intervent particip num random assign receiv smooth move num placebo num daili addit standard treatment chronic constip studi period num day measur primari efficaci paramet differ total number bowel movement secondari paramet includ differ averag number standard treatment dose dispens differ total medic cost result compar placebo intent treat itt analysi statist signific increas number bowel movement smooth move group smooth move group num compar placebo group num experienc averag num bowel movement num day studi period versus num day pre studi period num conclus smooth move herbal tea ad standard treatment regimen nurs home resid chronic constip increas averag number bowel movement compar addit placebo tea
MED-950~multivitamin supplement risk breast cancer meta analysi pubm ncbi abstract background associ consumpt multivitamin breast cancer inconsist epidemiolog studi object perform meta analysi cohort case control studi evalu multivitamin intak relationship breast cancer risk method publish literatur systemat search review medlin num juli num embas num juli num cochran central regist control trial cochran librari num issu num studi includ specif risk estim pool random effect model bias qualiti studi assess revman statist softwar version num grade method cochran collabor result num studi includ num subject analysi total durat multivitamin trial rang num num year frequenc current studi rang num num times week analys durat num year longer num year longer frequenc num times week report studi multivitamin signific risk breast cancer num recent swedish cohort studi conclud multivitamin increas risk breast cancer result meta analysi pool data num cohort studi num case control studi multivari relat risk odd ratio num num ci num num num num num ci num num num associ statist signific conclus multivitamin signific increas decreas risk breast cancer result highlight case control studi random control clinic trial examin relationship
MED-951~effect supplement vitamin miner develop prostat cancer systemat review meta analysi pubm ncbi abstract background vitamin supplement purpos alleg benefit vitamin prevent prostat cancer method conduct systemat review meta analysi topic pubm embas cochran databas search hand search refer key articl random control trial rcts cohort studi case control studi includ review assess effect supplement vitamin risk prostat cancer diseas sever death men prostat cancer result fourteen articl includ final assess individu studi show relationship ingest supplement vitamin miner incid sever prostat cancer smoker multivitamin supplement individu vitamin miner supplement affect occurr prostat cancer occurr advanced metastat prostat cancer death prostat cancer result studi combin meta analysi conduct sensit analys run meta analysi higher qualiti studi rcts associ found conclus convinc evid supplement multivitamin specif vitamin affect occurr sever prostat cancer high heterogen studi unidentifi subgroup benefit harm vitamin
MED-952~cannabi lung pubm ncbi abstract cannabi embed societi young wide perceiv safe increas concern potenti cannabi mental health effect domin cannabi research potenti advers respiratori effect receiv attent studi cannabi challeng subject confound concomit tobacco social factor studi refer review beset difficulti inher undertak epidemiolog research effect cannabi emerg concern chest physician suggest habitu smoke cannabi contribut develop chronic obstruct pulmonari diseas pneumothorax respiratori infect includ tuberculosi special attent risk lung cancer biolog plausibl preced epidemiolog
MED-953~effect acut consumpt fruit veget pur e bas drink vasodil oxid status pubm ncbi abstract epidemiolog studi diet rich fruit veget f v protect cvd pur ed f v product retain benefici compon includ flavonoid carotenoid vitamin dietari fibr present studi aim establish physiolog effect acut ingest f v pur e bas drink fvpd vasodil antioxid status phytochem bioavail cvd risk factor total twenty four subject age num year complet randomis single blind control crossov test meal studi subject consum num ml fvpd fruit flavour sugar match control low flavonoid diet num blood urin sampl collect studi day vascular reactiv assess num min interv laser doppler iontophoresi fvpd signific increas plasma vitamin num num total nitrate nitrit num num concentr signific time treatment effect vivo ldl oxid num num longer lag phase consum fvpd num juic consumpt antioxid capac plasma increas signific num num simultan increas plasma urinari phenol metabolit num num signific lower glucos insulin peak ingest fvpd compar control num num num num trend increas endothelium depend vasodil fvpd consumpt num num fvpd consumpt signific increas plasma vitamin total nitrate nitrit concentr trend increas endothelium depend vasodil pur ed f v product vehicl increas micronutri status plasma antioxid capac vivo generat contribut cvd risk reduct
MED-954~associ matern phthalat exposur cord sex hormon human infant pubm ncbi abstract specul matern phthalat exposur affect reproduct develop human newborn mechan await investig aim evalu associ matern phthalat exposur cord sex steroid hormon pregnant women newborn general popul total num matern infant pair recruit analyz level urinari phthalat metabolit sex steroid hormon determin liquid chromatography electrospray tandem mass spectrometri lc esi ms m radioimmunoassay ria signific correl found steroid hormon phthalat metabolit male newborn mmp margin signific correl num adjust matern age estradiol num level cord serum male newborn correl matern urinari phthalat metabolit femal newborn matern urinari level mono num ethylhexyl phthalat mehp mono num ethyl num hydroxyhexyl phthalat num h mehp negat correl free testosteron ft ft e num level cord serum pearson correl coeffici rang num num num addit gestat age adjust matern urinari level dehp negat correl free testosteron ft ft e num level cord serum suggest matern exposur phthalat affect sex steroid hormon status fetal newborn stage copyright num elsevi reserv
MED-955~compar assess human exposur phthalat ester hous dust china unit state pubm ncbi abstract volatil leach applic consum person care product phthalat ester ubiquit contamin indoor environ studi measur concentr profil num phthalat ester indoor dust sampl collect citi china num comparison analyz sampl collect albani york usa num result concentr dicyclohexyl phthalat dchp bis num ethylhexyl phthalat dehp profil phthalat ester vari signific countri concentr diethyl phthalat dep di n hexyl phthalat dnhp benzyl butyl phthalat bzbp num num time higher dust sampl collect albani chines citi contrast concentr di iso butyl phthalat dibp dust sampl albani num time lower chines citi estim daili intak di phthalat ester rout dust ingest dermal dust absorpt extent contribut indoor dust human exposur vari depend type phthalat ester contribut dust dehp exposur num num estim total dis china usa basi estim total dis phthalat extrapol urinari metabolit concentr contribut inhal dermal absorpt dietari intak total dis estim result dietari intak main sourc exposur dehp china dermal exposur major sourc dep studi elucid sourc human exposur phthalat general popul china
MED-956~emerg pollut wastewat review literatur pubm ncbi abstract num year articl report presenc compound call emerg compound wastewat aquat environ epa unit state environment protect agenc defin emerg pollut chemic regulatori status impact environ human health poor understood object work identifi data emerg pollut concentr wastewat influent effluent wastewat treatment plant wwtps determin perform sewag dispos collect num public databas sought data phthalat bisphenol pharmaceut includ drug human health disinfect gather concentr data chose num pharmaceut molecul phthalat bisphenol concentr measur influent rang num num liter remov rate rang num contrast media num psychostimul caffein molecul concentr influent highest molecul investig num liter remov rate num lead concentr effluent exceed num liter concentr ofloxacin lowest vari num num liter influent treatment plant num num liter effluent phthalat dehp wide quantifi author wastewat rate remov phthalat greater num studi compound remov rate antibiot num num bisphenol analges anti inflammatori beta block resist treatment num remov rate pharmaceut molecul collect data concentr high tetracyclin codein contrast product deserv research copyright num elsevi gmbh reserv
MED-957~final report safeti assess capsicum annuum extract capsicum annuum fruit extract capsicum annuum resin capsicum annuum fruit powd pubm ncbi abstract capsicum deriv ingredi function skin condit agents  miscellan extern analges flavor agent fragranc compon cosmet ingredi num cosmet product concentr high num cosmetic grad materi extract hexan ethanol veget oil full rang phytocompound found capsicum annuum capsicum frutescen plant aka red chile includ capsaicin aflatoxin n nitroso compound n nitrosodimethylamin n nitrosopyrrolidin detect contamin ultraviolet uv absorpt spectrum capsicum annuum fruit extract small peak approxim num nm gradual increas absorb begin approxim num nm capsicum paprika general recogn safe food drug administr food hexan chloroform ethyl acet extract capsicum frutescen fruit num mg kg result death mice short term inhal toxic studi rat differ found vehicl control num capsicum oleoresin solut num week feed studi red chilli capsicum annuum diet concentr num nontox group male mice num week feed studi rat intestin exfoli cytoplasm fatti vacuol centrilobular necrosi hepatocyt aggreg lymphocyt portal area num capsicum frutescen fruit num rat fed num g kg day num crude capsicum fruit extract num day exhibit signific gross patholog necropsi slight hyperemia liver redden gastric mucosa observ weanl rat fed basal diet supplement red pepper concentr num num week patholog larg intestin liver kidney destruct tast bud keratin eros gastrointestin gi tract note group fed num num red pepper result num num month extens studi show normal larg intestin kidney rabbit fed capsicum annuum powder num mg kg day num diet daili num month damag liver spleen note rabbit skin irrit test capsicum annuum fruit extract concentr rang num num produc irrit capsicum frutescen fruit extract induc concentration depend num num microg ml cytotox human buccal mucosa fibroblast cell line ethanol extract red chili mutagen salmonella typhimurium ta num ta num escherichia coli genotox assay gave similar pattern mix result adenocarcinoma abdomen observ num mice fed num mg red chili day num month tumor control anim neoplast liver intestin tumor observ rat fed red chili powder num mg kg day num num day intestin colon tumor rat fed red chili powder num dimethyl hydrazin tumor observ control studi rat red chile pepper diet dose decreas number tumor num dimethylhydrazin feed studi evalu effect red chili pepper incid stomach tumor produc n methyl n  nitro n nitrosoguanidin find red pepper promot effect capsicum frutescen fruit extract promot carcinogen effect methyl acetoxymethyl nitrosamin carcinogen benzen hexachlorid hepatocarcinogen inbr male femal balb c mice dose oral tongu applic clinic find includ symptom cough sneez runni nose chili factori worker human respiratori respons capsicum oleoresin spray includ burn throat wheez dri cough short breath gag gasp inabl breath speak rare cyanosi apnea respiratori arrest trade mixtur num num capsicum frutescen fruit extract induc slight erythema num num volunt patch test num capsicum frutescen fruit extract num repeated insult patch test num subject result clinic meaning irrit allerg contact dermat epidemiolog studi chili pepper consumpt strong risk factor gastric cancer popul high intak chili pepper studi find associ capsaicin function extern analges fragranc ingredi skin condit agent  miscellan cosmet product current capsaicin general recogn safe effect food drug administr fever blister cold sore treatment consid safe effect extern analges counterirrit ingest capsaicin rapid absorb stomach small intestin anim studi subcutan inject capsaicin rat result rise blood concentr reach maximum num highest tissu concentr kidney lowest liver vitro percutan absorpt capsaicin demonstr human rat mous rabbit pig skin enhanc skin permeat naproxen nonsteroid anti inflammatori agent presenc capsaicin demonstr pharmacolog physiolog studi demonstr capsaicin vanillyl moieti produc sensori effect activ ca num permeabl ion channel sensori neuron capsaicin activ vanilloid receptor num capsaicin induc stimul prostaglandin biosynthesi shown bull semin vesicl rheumatoid arthriti synoviocyt capsaicin inhibit protein synthesi vero kidney cell human neuroblastoma shsi num cell vitro inhibit growth coli pseudomona solanacearum bacillus subtili bacteri cultur saccharomyc cerevisia oral ld num valu low num mg kg rat num mg kg mice report capsaicin acut oral toxic studi hemorrhag gastric fundus observ anim die intraven intraperiton subcutan ld num valu lower subchron oral toxic studi mice capsaicin produc statist signific differ growth rate liver bodi weight increas capsaicin ocular irrit mice rat rabbit dose rel edema observ anim receiv capsaicin inject hindpaw rat applic ear mice guinea pig dinitrochlorobenzen contact dermat enhanc presenc capsaicin inject subcutan dermal applic inhibit sensit mice immun system effect observ neonat rat inject subcutan capsaicin capsaicin produc mix result typhimurium micronucleus sister chromatid exchang genotox assay posit result capsaicin report dna damag assay carcinogen cocarcinogen anticarcinogen antitumorigen tumor promot anti tumor promot effect capsaicin report anim studi signific reduct crown rump length day num rat inject subcutan capsaicin num mg kg gestat day num num num reproduct development toxic note pregnant mice dose subcutan capsaicin deplet substanc spinal cord peripher nerv pregnant femal fetus note clinic test nerv degener intracutan nerv fiber decreas pain sensat induc heat mechan stimuli evid subject inject intraderm capsaicin increas inspiratori flow report normal subject inhal nebul num num capsaicin result provoc predict test involv human subject capsaicin skin irrit studi suggest ingredi irrit low concentr genotox carcinogen tumor promot potenti capsaicin demonstr opposit effect skin irrit tumor promot effect capsaicin mediat interact vanilloid receptor mechan action observ tumor promot irrit skin panel consid potent tumor promot moder sever skin irrit limit capsaicin content signific reduc skin irrit potenti expect effect lessen concern relat tumor promot potenti capsaicin enhanc penetr anti inflammatori agent human skin panel recommend care exercis ingredi capsaicin cosmet product panel advis industri total polychlorin biphenyl pcb pesticid contamin limit num ppm num ppm specif residu agre limit impur arsenic num mg kg max heavi metal num max lead num mg kg max industri advis aflatoxin present ingredi panel adopt num ppb negat aflatoxin content ingredi deriv capsicum annuum capsicum frutescen plant speci product n nitroso compound form abstract truncat
MED-958~compar review thermographi breast cancer screen techniqu pubm ncbi abstract breast cancer frequent diagnos cancer women north america advanc treatment reduc mortal breast cancer remain lead cancer induc death establish tool screen breast cancer includ clinic breast exam mammogram ultrasound thermographi introduc screen tool num initi accept num studi found thermographi lag screen tool medic communiti lost interest diagnost approach review discuss screen tool focus brought thermographi singl tool excel predict combin incorpor thermographi boost sensit specif light technolog advanc matur thermograph industri addit research requir confirm potenti technolog provid effect non invas low risk adjunct tool earli detect breast cancer
MED-959~neurolog abnorm cobalamin defici higher cobalamin analogu valu hematolog abnorm pubm ncbi abstract serum cobalamin analogu level estim discrep cobalamin result radioassay pure intrins factor binder num patient low cobalamin level differ found low cobalamin level lower analogu level pregnant women num patient low cobalamin level primarili neurolog spinal cord neuropath cerebr combin symptom signific higher analogu level num patient primarili hematolog abnorm analogu level correl hemoglobin valu signific higher patient megaloblast bone marrow patient megaloblastosi analysi limit num patient pernici anemia yield similar find patient neurolog abnorm higher analogu level patient hematolog abnorm higher analogu level assay binder fail regist low cobalamin level num num patient low cobalamin level primarili neurolog abnorm compar num hematolog abnorm num num patient pernici anemia neurolog abnorm compar num abnorm differ patient hematolog disturb patient neurolog disturb invers relationship analogu level sever anemia suggest disproportion accumul analogu explain patient cobalamin defici display neurolog abnorm
MED-960~diagnost perform serum cobalamin test systemat review meta analysi pubm ncbi abstract aim serum cobalamin cbl vitamin num test routin order investig condit potenti amen cbl supplement studi aim systemat assess evid diagnost accuraci serum cbl test patient subgroup method medic databas search num novemb num studi includ compar serum cbl refer standard refer standard employ studi qualiti assess quada summari estim test perform determin bivari model hierarch summari receiv oper characterist curv hsroc result num identifi studi num includ studi rate poor quada criteria posit plr negat likelihood ratio nlr num num confid interv ci num num num num num studi employ methylmalon acid refer studi employ clinic refer standard plr num num num nlr num num num test perform vari clinic indic test method age conclus review limit qualiti evid base lack gold standard evid diagnosi condit amen cbl supplement basi serum cbl level consid reliabl approach investig suspect vitamin defici
MED-961~vitamin num potent vitamin num human pubm ncbi abstract background current unitag calciferol suggest equimolar quantiti vitamin num num num num biolog equival publish studi yield mix result object aim studi compar potenc num num design trial single blind random design num healthi adult calciferol dose num iu wk num wk princip outcom variabl area curv increment total num hydroxyvitamin num chang calciferol content sc fat result increment sd num area curv num wk num ng d ml num num treat group num num num sd steady st num increment show similar differ num ng ml num num num ng ml num num num subcutan fat content num rose num g kg num treat group num content rose num g kg num treat group total calciferol fat rose num ng kg num treat rose num g kg num treat group extrapol total bodi fat num storag amount num administ dose conclus num approxim num potent rais maintain serum num concentr produc num num fold greater storag vitamin equimolar num evid sequestr fat postul dose rang greater potenc lower cost num prefer treatment option correct vitamin defici
MED-962~treatment hypovitaminosi infant toddler abstract context hypovitaminosi rise young children implic skelet health object object studi compar safeti efficaci vitamin num daili vitamin num week vitamin num daili combin supplement calcium rais serum num hydroxyvitamin num lower pth concentr design num wk random control trial set studi conduct urban pediatr clinic boston subject forti healthi infant toddler hypovitaminosi num num ng ml particip studi intervent particip assign regimen num iu oral vitamin num daili num iu vitamin num week num iu vitamin num daili prescrib element calcium num mg kg infant receiv treatment num wk main outcom measur treatment serum measur num pth calcium alkalin phosphatas result treatment approxim tripl num concentr preplan comparison nonsignific daili vitamin num week vitamin num differ effect num daili num daili num num serum calcium chang small similar group signific differ pth suppress conclus short term vitamin num num iu daili vitamin num num iu week vitamin num num iu daili yield equival outcom treatment hypovitaminosi young children pediatr provid individu treatment regimen patient ensur complianc differ efficaci safeti note common treatment regimen
MED-963~comparison fatti acid cholesterol vitamin composit egg hen hous convent cage rang product facil pubm ncbi abstract public perceiv nutrit qualiti egg produc free rang superior egg produc cage studi compar nutrient content free rang cage produc shell egg examin effect laboratori product environ hen age flock num hy lin brown layer hatch simultan receiv care vaccin light feed regimen differ access rang nutrient content egg analyz cholesterol num fatti acid satur fat monounsatur fat polyunsatur fat caroten vitamin vitamin egg pool divid num laboratori analysi laboratori found signific effect content nutrient analysi cholesterol total fat content sampl vari num high num low num laboratori egg rang product environ total fat num monounsatur fat num polyunsatur fat num egg produc cage hen level num fatti acid higher num num rang egg num cage egg rang environ effect cholesterol num num mg num egg cage rang hen vitamin level affect husbandri hen expos lowest num wk age age hen influenc fat level egg cholesterol level highest num num wk age num mg num rang product influenc cholesterol level egg increas fat level egg produc rang
MED-965~endotheli dysfunct earli predictor atherosclerosi abstract abstract discoveri num nitric oxid fact elus endothelium deriv relax factor evid major cardiovascular signal molecul bioavail crucial determin atherosclerosi develop sustain high level harm circul stimuli cardiovascular risk factor diabet mellitus elicit respons endotheli cell sequenti endotheli cell activ endotheli dysfunct ed ed characteris reduc bioavail recognis earli revers precursor atherosclerosi pathogenesi ed multifactori oxid stress common cellular mechan ensu loss vaso act inflammatori haemostat redox homeostasi bodi vascular system role ed pathophysiolog link earli endotheli cell cardiovascular risk factor develop ischaem heart diseas import basic scientist clinician alik
MED-966~effect type exercis train detrain endothelium depend dilat patient recent myocardi infarct pubm ncbi abstract background coronari arteri diseas exercis train improv endotheli function relat effect type train purpos studi prospect evalu effect type endotheli function num patient recent acut myocardi infarct method result endotheli function evalu num week type num month detrain measur flow medi dilat von willebrand factor level baselin patient random num group group num aerob num group num resist train num group num resist aerob train num group num train num baselin flow medi dilat num num group num num num group num num num group num num num group num p ns flow medi dilat increas num num group num num num group num num num group num num versus baselin group increas group num lesser extent num num num versus train group von willebrand factor level decreas num num similar group num num remain unchang group num detrain return flow medi dilat baselin level num versus posttrain conclus patient recent acut myocardi infarct improv endotheli function independ type train effect disappear num month detrain
MED-967~dietari intak fruit veget improv microvascular function hypertens subject dose depend manner pubm ncbi abstract background observ evid consist link increas fruit veget consumpt reduc cardiovascular morbid direct trial evid support concept fruit veget consumpt improv vascular function studi assess dose depend effect fruit veget intervent arteri health subject hypertens method result num week run in period fruit veget intak limit num portion day particip random consum num num portion daili num week endothelium depend independ arteri vasodil respons assess venous occlus plethysmographi brachial circul intervent complianc monitor serial contemporan num day food record measur concentr circul dietari biomark total num volunt complet num week studi particip num num portions d group report consum averag num num num portion fruit veget serum concentr lutein beta cryptoxanthin increas group dose depend manner num portion increas report fruit veget consumpt num improv forearm blood flow respons intra arteri administr endothelium depend vasodil acetylcholin num associ increas fruit veget consumpt vasodil respons sodium nitroprussid endothelium independ vasodil conclus present studi illustr hypertens volunt increas fruit veget consumpt produc signific improv establish marker endotheli function cardiovascular prognosi
MED-969~spatial tempor dynam endothelium pubm ncbi abstract endothelium high metabol activ organ involv physiolog process includ control vasomotor tone barrier function leukocyt adhes traffick inflamm hemostasi endotheli cell phenotyp differenti regul space time endotheli cell heterogen import implic develop strategi basic research diagnost therapeut goal review mechan endotheli cell heterogen ii discuss bench to bedsid gap endotheli biomedicin iii revisit definit endotheli cell activ dysfunct iv propos goal diagnosi therapi final theme appli understand vascular bed specif hemostasi
MED-970~diet risk diverticular diseas oxford cohort european prospect investig cancer nutrit epic prospect studi british vegetarian non vegetarian abstract object examin associ vegetarian diet dietari fibr intak risk diverticular diseas design prospect cohort studi set epic oxford studi cohort health conscious particip recruit unit kingdom particip num num men women live england scotland num num report consum vegetarian diet main outcom measur diet group assess baselin intak dietari fibr estim num item valid food frequenc questionnair case diverticular diseas identifi linkag hospit record death certif hazard ratio num confid interv risk diverticular diseas diet group intak dietari fibr estim multivari cox proport hazard regress model result follow up time num year num case diverticular diseas num admiss hospit death adjust confound variabl vegetarian num lower risk relat risk num num confid interv num num diverticular diseas compar meat eater cumul probabl admiss hospit death diverticular diseas age num num meat eater num compar num vegetarian invers associ dietari fibr intak particip highest num g day women num g day men num lower risk num num num num trend compar lowest num g day women men mutual adjust vegetarian diet higher intak fibr signific lower risk diverticular diseas conclus consum vegetarian diet high intak dietari fibr lower risk admiss hospit death diverticular diseas
MED-972~symptomless diverticular diseas intak dietari fibr pubm ncbi abstract studi report preval symptomless diverticular diseas colon relat consumpt dietari fibr vegetarian non vegetarian vegetarian signific higher fibr intak num g day non vegetarian num g day diverticular diseas common non vegetarian num vegetarian num comparison subject diverticular diseas vegetarian non vegetarian group provid evid low intak cereal fibr presenc diverticular diseas
MED-973~high fiber diet pubm ncbi abstract recogn definit constitut high fiber diet intak dietari fiber popul intern vari wide num num day type food contribut fiber vari countri cereal contribut fiber leafi root veget predomin veget highest fiber content kcal popul fiber intak num veget contribut num total fiber intak rural uganda fiber hypothesi develop burkitt trowel veget contribut num fiber intak experiment diet simian diet develop mimic close human food diet consum simian ancestor great ape similar ugandan diet larg amount veget num fiber num kcal nutrit adequ diet bulki suitabl model general recommend dietari guidelin fat intak num energi fiber intak num g d recommend inconsist high fiber diet peopl consum num kcal low fiber choic fruit grain select dietari fiber intak rang num num fat num kcal omnivor diet select wholem bread fruit result fiber intak num g d num kcal vegetarian diet substitut modest amount peanut butter bean meat dietari fiber intak num g d desir promot unrefin food recommend dietari fiber intak minimum num num kcal
MED-974~complic diverticul abstract introduct knowledg treatment complic diverticul cd base outdat literatur report mortal rate num practic paramet recommend elect resect num episod diverticul reduc morbid mortal aim studi updat understand morbid mortal characterist outcom cd method hundr thirty seven patient hospit cd retrospect analyz characterist outcom determin chi squar fisher exact test result age patient num year seventi percent comorbid total num histori prior diverticul episod num present cd episod mortal rate num num perfor num anastomot leak num patient manag nonop total num perfor patient die histori diverticul steroid signific perfor rate mortal num num comorbid diabet collagen vascular diseas immun system compromis high death num num num morbid num older age gender steroid comorbid perfor signific morbid conclus today mortal cd exclud perfor reduc compar past data coupl fact major patient present cd episod call question current practic elect resect stratagem reduc mortal immunocompromis patient benefit earli resect prospect data redefin target group prophylact resect
MED-975~diverticular diseas colon western diseas shown due defici dietari fibr pubm ncbi abstract diverticular diseas colon diseas begin centuri commonest diseas colon western world found num num peopl num year age pathogenesi diseas involv excess segment explain aetiolog histor diseas clinic scene geograph distribut suggest due remov fibr carbohydr author treat num patient symptomat diverticular diseas high fibr diet result effect bran discuss
MED-976~preval diverticular diseas hiatus hernia pelvic phlebolith black white american pubm ncbi abstract phlebolith diverticular diseas hiatus hernia rarer develop countri econom develop communiti condit common black white american find suggest due environment genet defici intak dietari fibr common factor predispos condit
MED-977~constip low fib diet diverticulosi abstract background aim asymptomat diverticulosi common attribut constip secondari low fib diet evid mechan limit examin associ constip low dietari fiber intak risk asymptomat diverticulosi method perform cross section studi analyz data num individu diverticulosi num control particip underw colonoscopi assess diet physic activ bowel habit analysi limit analysi particip knowledg diverticular diseas reduc risk bias respons result constip increas risk diverticulosi particip frequent bowel movement bm num wk reduc odd diverticulosi compar regular num wk bm odd ratio num num confid interv ci num num report hard stool reduc odd num num ci num num associ diverticulosi strain num num ci num num incomplet bm num num ci num num found associ dietari fiber intak diverticulosi num num ci num num compar highest quartil lowest intak num versus num g day conclus cross sect colonoscopy bas studi constip low fib diet increas risk diverticulosi
MED-978~delay recrudesc case sigmoidocutan fistula due diverticul abstract colocutan fistula caus diverticul rare delay recrudesc case colocutan fistula uncommon report rare case japanes num year old male delay recrudesc sigmoidocutan fistula due diverticul colocutan fistula form drainag oper perfor sigmoid colon diverticulum num year treatment admit hospit lower abdomin pain diagnos recrudesc sigmoidocutan fistula abdomin comput tomographi gastrografin enema manag patient total parenter nutrit antibiot fistula format improv low anterior resect fistulectomi perform postop unev patient discharg report fistula skin caus diverticular diseas complet closur fistula conserv therapi case impli possibl recurr fistula conserv treatment effect case colocutan fistula due diverticul radic surgeri consid possibl recurr fistula
MED-979~giant multipl jejun diverticula present periton signific challeng disord abstract jejun diverticula uncommon acquir diseas silent asymptomat symptomat present chronic nonspecif symptom pain nausea malnutrit acut present gastrointestin hemorrhag periton obstruct major complic acut abdomen similar append cholecyst colon diverticul atyp symptom present num year old male report emerg pain abdomen diagnos periton laparotomi incident found giant multipl jejun diverticula ileal perfor jejun diverticula multipl non obstruct follow up num month patient jejuno il diverticulosi rare condit continu present formid challeng diagnosi treatment
MED-980~homocysteine low vitamin slow rate acceler brain atrophi mild cognit impair random control trial abstract background increas rate brain atrophi observ older subject suffer cognit declin homocystein risk factor brain atrophi cognit impair dementia plasma concentr homocystein lower dietari administr vitamin object determin supplement vitamin lower level plasma total homocystein slow rate brain atrophi subject mild cognit impair randomis control trial vitacog isrctn num method find single cent random double blind control trial high dos folic acid vitamin num num num individu num screen num mild cognit impair subset num volunt cranial mri scan start finish studi particip random assign group equal size treat folic acid num mg d vitamin num num mg d vitamin num mg d placebo treatment num month main outcom measur chang rate atrophi brain assess serial volumetr mri scan result total num particip num activ treatment group num receiv placebo complet mri section trial rate brain atrophi year num num ci num num activ treatment group num num num placebo group num treatment respons relat baselin homocystein level rate atrophi particip homocystein num mol l num lower activ treatment group num greater rate atrophi lower final cognit test score differ advers event treatment categori conclus signific acceler rate brain atrophi elder mild cognit impair slow treatment homocysteine low vitamin sixteen percent num mild cognit impair half develop alzheimer diseas acceler brain atrophi characterist subject mild cognit impair convert alzheimer diseas trial treatment delay develop alzheimer diseas trial registr controlled tri isrctn num
MED-981~plasma total homocystein status vegetarian compar omnivor systemat review meta analysi pubm ncbi abstract strong evid indic elev plasma total homocystein thci level major independ biomark and or contributor chronic condit cvd defici vitamin elev homocystein vegetarian group popul potenti greater risk vitamin defici omnivor systemat review meta analysi apprais rang studi compar homocystein vitamin level vegetarian omnivor search method employ identifi num entri screen set inclus exclus criteria elig cohort case studi eleven cross sect studi num num reveal compar concentr plasma thci serum vitamin omnivor lactovegetarian lacto ovovegetarian vegan identifi seventeen studi num particip studi report vegan concentr plasma thci serum vitamin differ omnivor present studi confirm invers relationship exist plasma thci serum vitamin conclud usual dietari sourc vitamin anim product choos omit restrict product destin vitamin defici present supplement fortif food unreli cyanocobalamin well design studi investig reliabl suitabl supplement normalis elev plasma thci high major vegetarian fill gap present nutrit scientif knowledg
MED-982~mechan homocystein neurotox neurodegen diseas special refer dementia pubm ncbi abstract mild moder hyperhomocysteinemia risk factor neurodegen diseas human studi suggest homocystein hci play role brain damag cognit memori declin numer studi recent year investig role hci brain damag hci folat vitamin num defici disturb methyl and or redox potenti promot calcium influx amyloid tau protein accumul apoptosi neuron death hci effect mediat activ n methyl d aspart receptor subtyp numer neurotox effect hci block folat glutam receptor antagonist antioxid review describ import mechan hci neurotox pharmacolog agent revers hci effect
MED-983~forecast global burden alzheimer diseas pubm ncbi abstract background goal forecast global burden alzheimer diseas evalu potenti impact intervent delay diseas onset progress method stochast multist model conjunct unit nation worldwid popul forecast data epidemiolog studi risk alzheimer diseas result num worldwid preval alzheimer diseas num million num preval quadrupl time num num person worldwid live diseas estim num preval case high level care equival nurs home intervent delay diseas onset progress modest num year num million fewer case diseas num entir declin attribut decreas person high level care conclus face loom global epidem alzheimer diseas world popul age modest advanc therapeut prevent strategi lead small delay onset progress alzheimer diseas signific reduc global burden diseas
MED-984~plasma concentr homocystein aminothiol compound relat food intak healthi human subject pubm ncbi abstract investig total free protein bound plasma homocystein cystein cysteinylglycin num subject age num breakfast num num protein dinner num approxim num protein twelv subject normal fast homocystein sd num num mumol l methionin concentr num num mumol l includ statist analys breakfast caus small signific increas plasma methionin num num nonsignific increas signific declin free homocystein total bound homocystein small dinner mark increas plasma methionin num num mumol l num num rapid mark increas free homocystein num num num dinner moder slow increas total num num num protein bound num num num homocystein meal cystein cysteinylglycin concentr relat homocystein parallel fluctuat free bound ratio thiol dietari plasma homocystein affect evalu vitamin defici state moder sever hyperhomocysteinemia concern risk assess cardiovascular diseas patient mild hyperhomocysteinemia synchron fluctuat free bound ratio plasma aminothiol compound biolog effect homocystein difficult separ effect due aminothiol compound
MED-985~hyperhomocysteinemia alzheim diseas ad risk factor ad marker abstract alzheim diseas ad common form neurodegen diseas vast major case ad sporad clear combin environment genet factor implic hypothesi homocystein hci risk factor ad initi prompt observ patient histolog confirm ad higher plasma level hci call hyperhomocysteinemia hhci age match control evid accumul implic hhci risk factor ad onset conflict result exist review summar report relationship hhci ad epidemiolog investig includ observ studi random control clinic trial examin recent vivo vitro studi potenti mechan hhci influenc ad develop final discuss reason exist conflict data provid suggest futur studi
MED-986~effect homocystein lower treatment cognit function systemat review meta analysi random control trial pubm ncbi abstract elev total plasma homocystein link develop cognit impair dementia life reliabl lower daili supplement vitamin num num folic acid perform systemat review meta analysi num english languag random placebo control trial homocystein lower b vitamin supplement individu cognit impair time studi entri standard score facilit comparison studi enabl complet meta analysi random trial addit stratifi analys folat status countri origin b vitamin supplement show improv cognit function individu smd num num ci num num smd num num ci num num signific cognit impair irrespect studi durat smd num num ci num num smd num ci num num studi size smd num num ci num num smd num num ci num num particip countri low folat status smd num num ci num num smd num num ci num num supplement vitamin num num folic acid combin improv cognit function individu exist cognit impair remain establish prolong treatment b vitamin reduc risk dementia life
MED-987~plasma homocystein risk factor dementia alzheimer diseas pubm ncbi abstract background cross sect studi elev plasma homocystein level poor cognit dementia studi newli diagnos dementia requir order establish elev homocystein level preced onset dementia result dementia rel nutrit vitamin defici method total num subject dementia num women num men age num year framingham studi constitut studi sampl examin relat plasma total homocystein level measur base line measur year earlier risk newli diagnos dementia follow up multivari proportional hazard regress adjust age sex apolipoprotein genotyp vascular risk factor homocystein plasma level folat vitamin num num result median follow up period year dementia develop num subject includ num diagnosi alzheimer diseas multivariable adjust relat risk dementia num num percent confid interv num num increas num sd log transform homocystein base line year earlier relat risk alzheimer diseas num num percent confid interv num num increas num sd base line num num percent confid interv num num increas num sd year base line plasma homocystein level greater num micromol liter risk alzheimer diseas doubl conclus increas plasma homocystein level strong independ risk factor develop dementia alzheimer diseas
MED-988~hypothesi hyperhomocysteinemia indic oxid stress pubm ncbi abstract elev plasma homocystein level increas risk atherosclerosi thrombosi varieti patholog birth defect alzheimer diseas dementia osteoporosi diabet renal diseas homocystein metabol catalyz number enzym requir b vitamin cofactor homocystein level respons folat status predict power plasma homocystein level risk factor atherothrombot order rais appeal hypothesi reduct homocystein level vitamin supplement result commensur reduct risk atherothrombot event clinic trial fail show signific benefit vitamin supplement cardiovascular event spite signific lower plasma homocystein level clear homocystein play causal role patholog marker mechan larg bodi data link hyperhomocysteinemia folat status oxid stress articl review data suggest homocystein promot cellular protein injuri oxid mechan marker presenc patholog oxid stress hyperhomocysteinemia common primari atherothrombot disord general popul marker system endotheli oxid stress major mediat disord publish elsevi
MED-990~associ elev homocystein cognit impair reduc white matter volum healthi adult pubm ncbi abstract object elev homocystein emerg risk factor cognit impair healthi elder person reduc brain volum white matter hyperintens occur healthi elder interrelationship studi report interrelationship dement healthi community dwel older adult singl east asian popul method hundr twenty eight right hand particip age num year evalu person medic condit neurolog diseas well control diabet mellitus hypertens exclud particip underw quantit magnet reson imag brain standard protocol neuropsycholog evalu plasma homocystein folat vitamin num marker cardiovascular risk blood pressur bodi mass index fast blood glucos lipid profil measur result elev homocystein reduc global cerebr volum larger ventricl reduc cerebr white matter volum lower cognit perform domain elev homocystein reduc white matter volum num num df num num lower speed process num num df num num control age gender educ associ homocystein lower speed process disappear control white matter volum elev homocystein white matter hyperintens volum hippocamp volum homocystein folat level correl effect white matter volum dissoci conclus dement healthi adult elev homocystein lower cognit score reduc cerebr white matter volum effect dissoci relat white matter hyperintens reduc folat level copyright num american associ geriatr psychiatri publish elsevi reserv
MED-991~preval cognit impair dementia unit state abstract background cognit impair dementia increas risk disabl increas health care cost progress dementia population bas preval estim condit unit state object estim preval cognit impair dementia unit state determin longitudin cognit mortal outcom design longitudin studi juli num march num set in hom assess cognit impair particip particip adam age demograph memori studi age num year older drawn nation repres hrs health retir studi num select individu num complet initi assess num select individu num complet num num month follow up assess measur assess includ neuropsycholog test neurolog examin clinic medic histori assign diagnosi normal cognit cognit impair dementia dementia nation preval rate estim population weight sampl result num estim num million peopl num unit state age num year older cognit impair dementia promin subtyp includ prodrom alzheim diseas num cerebrovascular diseas num particip complet follow up assess num cognit impair dementia progress dementia annual subtyp prodrom alzheim diseas stroke progress annual rate num num annual death rate num cognit impair dementia num cognit impair due medic condit limit num nondeceas target sampl complet initi assess popul sampl weight deriv adjust potenti bias due nonrespons attrit conclus cognit impair dementia preval unit state dementia subtyp vari preval outcom
MED-992~vegan diet bas lifestyl program rapid lower homocystein level pubm ncbi abstract background plasma homocystein level direct cardiac diseas risk current research rais concern comprehens lifestyl approach includ plant bas diet interact modul homocystein level method report observ homocystein level num self select subject particip vegan diet bas lifestyl program subject attend residenti lifestyl chang program lifestyl center america sulphur oklahoma fast plasma total homocystein measur enrol num week lifestyl intervent intervent includ vegan diet moder physic exercis stress manag spiritu enhanc session group support exclus tobacco alcohol caffein vitamin supplement reduc blood homocystein level provid result subject homocystein level fell num num micromol l sd num micromol l num micromol l sd num micromol l num subgroup analysi show homocystein decreas rang demograph diagnost categori conclus result suggest broad bas lifestyl intervent favor impact homocystein level analysi lifestyl center america program compon suggest factor addit vitamin intak involv observ homocystein lower
MED-993~associ dietari fiber intak folat status group femal adolesc pubm ncbi abstract main object studi assess associ dietari fiber intak folat status canadian femal adolesc assess dietari folat intak evalu preval biochem folat defici subject femal adolesc age num num recruit fast blood sampl collect dietari intak num food record record particip classifi lactoovovegetarian semivegetarian omnivor basi food consumpt pattern assess food frequ questionnair fourteen percent num num lactoovovegetarian semivegetarian omnivor dietari folat intak predict requir num num serum folat concentr indic defici low dietari folat intak serum folat concentr subject homocystein concentr indic defici suggest degre folat deplet produc function consequ import result suggest consumpt nonstarch polysaccharid signific serum folat concentr num num increas nonstarch polysaccharid intak num increas serum folat concentr expect summari propos increas nonstarch polysaccharid intak promot intestin biosynthesi folat provid complementari strategi enhanc folat nutritur human
MED-994~prevent alzheim disease rel gray matter atrophi b vitamin treatment abstract prevent atrophi key brain region relat cognit declin alzheim diseas ad approach modifi nongenet risk factor instanc lower elev plasma homocystein vitamin initi random control studi elder subject increas dementia risk mild cognit impair num petersen criteria show high dos b vitamin treatment folic acid num mg vitamin num mg vitamin num num mg slow shrinkag brain volum num demonstr b vitamin treatment reduc fold cerebr atrophi gray matter gm region specif vulner ad process includ medial tempor lobe placebo group higher homocystein level baselin faster gm atrophi deleteri effect larg prevent b vitamin treatment addit show benefici effect vitamin confin particip high homocystein median num mol l particip causal bayesian network analysi chain event vitamin lower homocystein direct lead decreas gm atrophi slow cognit declin result show b vitamin supplement slow atrophi specif brain region key compon ad process cognit declin b vitamin supplement trial focus elder subjet high homocystein level warrant progress dementia prevent
MED-995~human exposur pbdes associ pbde bodi burden food consumpt hous dust concentr pubm ncbi abstract studi design determin bodi burden polybromin diphenyl ether pbdes first tim mother greater boston massachusett area explor key rout exposur collect breast milk sampl num first tim mother num week birth sampl hous dust home subset particip vacuum common area data person characterist diet home furnitur electr devic gather particip questionnair breast milk dust sampl analyz pbdes gas chromatographi mass spectrometri pbde concentr log norm distribut breast milk dust found statist signific posit associ pbde concentr breast milk hous dust num num includ bde num report dietari habit consumpt dairi product num num meat num num due low detect rate draw conclus associ bde num milk dust result support hypothesi indoor environ diet play promin role adult human exposur pbdes
MED-996~concentr speciat polybromin diphenyl ether human amniot fluid abstract polybromin diphenyl ether pbdes persist organ chemic flame retard textil plastic consum product pbde accumul human note num studi investig pbdes gestat compart date identifi level amniot fluid present studi report congener specif bromin diphenyl ether bde concentr second trimest clinic amniot fluid sampl collect num fifteen women southeast michigan usa twenty on bde congen measur gc ms nci averag total pbde concentr num pg ml amniot fluid rang num num pg ml bde num bde num identifi sampl base median concentr domin congen bde num num num num repres num num num num total detect pbdes pbde concentr identifi amniot fluid sampl southeast michigan support investig fetal exposur pathway potenti impact perinat health
MED-998~polybromin diphenyl ether pbdes breast milk neuropsycholog develop infant abstract background increas interest potenti effect polybromin diphenyl ether pbdes children neuropsycholog develop small studi evalu effect object goal examin associ pbde concentr colostrum infant neuropsycholog develop assess influenc persist organ pollut pop associ method measur concentr pbdes pop colostrum sampl num women recruit spanish birth cohort test children mental psychomotor develop bayley scale infant develop num num month age analyz sum common pbde congen bdes num num num num congen separ result increas num bdes concentr show associ borderlin statist signific decreas mental develop score log ng g lipid num num ci num num bde num congen present highest concentr main congen respons associ num num ci num num evid associ psychomotor develop adjust pop bde num associ mental develop score slight weaker num num ci num num conclus find suggest associ increas pbde concentr colostrum wors infant mental develop bde num requir confirm larger studi associ causal due unmeasur bde num metabolit includ oh pbd hydroxyl pbdes toxic stabl cross placenta easili reach brain bde num
MED-999~polybromin diphenyl ether food human dietari exposur review recent scientif literatur pubm ncbi abstract polybromin diphenyl ether pbdes class bromin flame retard bfrs protect peopl fire reduc flammabl combust materi recent year pbdes widespread environment pollut bodi burden general popul increas number studi shown persist organ pollut dietari intak main rout human exposur pbdes recent scientif literatur level pbdes foodstuff human dietari exposur bfrs review note inform human total daili intak food consumpt basic limit number european countri usa china japan spite methodolog differ studi result show notabl coincid import contribut sum total pbdes congen bdes num num num compar high contribut fish seafood dairi product limit human health risk deriv dietari exposur pbdes issu direct relat human exposur pbdes diet investig copyright num elsevi reserv
MED-1000~neurobehavior function low level exposur bromin flame retard adolesc cross sect studi abstract background anim vitro studi demonstr neurotox potenti bromin flame retard group chemic household commerci product prevent fire report detriment neurobehavior effect rodent ten year ago human data spars method part biomonitor program environment health surveil flander belgium assess neurobehavior function neurobehavior evalu system nes num collect blood sampl group high school student cross sect data num adolesc num num year age analysi multipl regress model account potenti confound investig associ biomark intern exposur bromin flame retard serum level polybromin diphenyl ether pbde congen num num num hexabromocyclododecan hbcd tetrabromobisphenol tbbpa cognit perform addit investig associ bromin flame retard serum level ft num ft num tsh result two fold increas sum serum pbde decreas number tap preferred hand finger tap test num num ci num num num effect individu pbde congen motor speed consist serum level level quantif averag decreas ft num level num pg ml num ci num num num pbde num num pg ml num ci num num num pbde num compar concentr level quantif pbde num level level quantif averag increas tsh level num num ci num num num compar concentr level quantif observ effect pbde neurobehavior domain motor function hbcd tbbpa show consist associ perform neurobehavior test conclus studi studi largest investig neurobehavior effect bromin flame retard human consist experiment anim data pbde exposur motor function serum level thyroid hormon
MED-1002~polybromin diphenyl ether pbdes hydroxyl pbdes oh pbd measur thyroid function trimest pregnant women california abstract prenat exposur polybromin diphenyl ether pbdes disrupt thyroid function contribut advers neurodevelopment outcom conduct pilot studi explor relationship serum concentr lower bromin pbdes bde num num higher bromin pbdes bde num num hydroxyl pbde metabolit oh pbd measur thyroid function pregnant women concentr pbdes oh pbd thyroid stimul hormon tsh total thyroxin num free num measur serum sampl collect num num num trimest pregnant women california median concentr lower bromin pbdes oh pbd highest report date pregnant women median concentr bde num sum lower bromin pbdes pbde num num ng g lipid num ng g lipid num ng ml sum oh pbd oh pbd num observ posit associ weight sum chemic bind transthyretin ttr binder tsh level found posit associ tsh pbde num oh pbd num bde num bde num oh bd num num oh bd num invers associ bde num relationship free total num weak inconsist result pbde exposur elev pregnant women california suggest relationship thyroid function investig warrant character risk pbde exposur pregnanc
MED-1003~utero childhood polybromin diphenyl ether pbde exposur neurodevelop chamaco studi abstract background california children exposur polybromin diphenyl ether flame retard pbdes highest worldwid pbdes endocrin disruptor neurotoxic anim object investig relat utero child pbde exposur neurobehavior develop particip chamaco center health assess mother children salina california birth cohort method measur pbdes matern prenat child serum sampl examin associ pbde concentr children attent motor function cognit num num num year age num result matern prenat pbde concentr impair attent measur continu perform task num year matern report num num year age poorer fine motor coordin nondomin age point decrement verbal full scal iq num year pbde concentr children num year age signific margin concurr teacher report attent problem decrement process speed perceptu reason verbal comprehens full scal iq associ alter adjust birth weight gestat age matern thyroid hormon level conclus prenat childhood pbde exposur poorer attent fine motor coordin cognit chamaco cohort school ag children studi largest date contribut grow evid suggest pbdes advers impact child neurobehavior develop
MED-1004~diet contribut signific bodi burden pbdes general popul abstract background exposur popul polybromin diphenyl ether pbdes thought exposur dust diet work empir link bodi burden compound rout exposur object primari goal research evalu dietari contribut pbde bodi burden unit state link serum level food intak method dietari instrument num hr food recal num num year food frequenc questionnair ffq examin food intak particip num num nation health nutrit examin survey regress serum concentr pbdes bde congen num num num sum pbde diet variabl adjust age sex race ethn incom bodi mass index result pbde serum concentr vegetarian num num num num lower omnivor num num year ffq serum level pbde congen consumpt poultri fat low medium high intak correspond geometr pbde concentr num num num ng g lipid num observ similar trend red meat fat statist signific bde num bde num associ observ serum pbdes consumpt dairi fish result similar dietari instrument robust num conclus intak contamin poultri red meat contribut signific pbde bodi burden unit state
MED-1005~effect fibr antispasmod peppermint oil treatment irrit bowel syndrom systemat review meta analysi abstract object determin effect fibr antispasmod peppermint oil treatment irrit bowel syndrom design systemat review meta analysi randomis control trial data sourc medlin embas cochran control trial regist april num review method randomis control trial compar fibr antispasmod peppermint oil placebo treatment adult irrit bowel syndrom elig inclus minimum durat therapi consid week studi report global assess cure improv symptom cure improv abdomin pain treatment random effect model pool data symptom effect therapi compar placebo treatment report relat risk num confid interv symptom persist result num studi compar fibr placebo treatment num patient relat risk persist symptom num num confid interv num num effect limit ispaghula num num num twenti trial compar antispasmod placebo num patient num num num antispasmod studi otilonium trial num patient relat risk persist symptom num num num hyoscin trial num patient num num num show consist evid efficaci trial compar peppermint oil placebo num patient num num num conclus fibr antispasmod peppermint oil effect placebo treatment irrit bowel syndrom
MED-1006~treatment abdomin pain irrit bowel syndrom pubm ncbi abstract function abdomin pain context irrit bowel syndrom ib challeng problem primari care physician gastroenterologist pain specialist review evid current futur non pharmacolog pharmacolog treatment option target central nervous system gastrointestin tract cognit intervent cognit behavior therapi hypnotherapi demonstr excel result ib patient limit avail labor intens natur limit routin daili practic patient refractori first lin therapi tricycl antidepress tca select serotonin reuptak inhibitor effect obtain symptomat relief tcas shown improv abdomin pain meta analys diet low ferment carbohydr polyol fodmap effect subgroup patient reduc abdomin pain bloat improv stool pattern evid fiber limit isphagula benefici efficaci probiot difficult interpret strain quantiti studi antispasmod includ peppermint oil consid first lin treatment abdomin pain ib second lin therapi diarrhea predomin ib includ non absorb antibiot rifaximin num num antagonist alosetron ramosetron restrict rare risk ischem coliti laxative resist constipation predomin ib chloride secret stimul drug lubiproston linaclotid guanyl cyclas agonist direct analges effect reduc abdomin pain improv stool pattern
MED-1007~irrit bowel syndrom unit state preval symptom pattern impact pubm ncbi abstract background impact irrit bowel syndrom gastrointestin motil disord underestim poor quantifi clinician minor suffer aim determin preval symptom pattern impact irrit bowel syndrom method two phas communiti survey quota sampl random digit telephon dial screen interview identifi individu medic diagnos irrit bowel syndrom individu formal diagnos fulfil irrit bowel syndrom diagnost criteria man rome ii inform irrit bowel syndrom symptom general health status lifestyl impact symptom individu live collect in depth follow up interview data collect healthi control identifi screen interview result total preval irrit bowel syndrom num screen interview num medic diagnos num undiagnos meet irrit bowel syndrom criteria num abdomin pain discomfort common symptom prompt consult suffer num medic diagnos num undiagnos report altern constip diarrhoea previous diagnos gastrointestin disord occur suffer non suffer irrit bowel syndrom suffer day work num num day bed reduc activ greater extent non suffer conclus num irrit bowel syndrom suffer undiagnos irrit bowel syndrom substanti impact suffer well b health socioeconom consequ
MED-1008~peppermint oil mintoil treatment irrit bowel syndrom prospect doubl blind placebo control random trial pubm ncbi abstract introduct peppermint oil treat irrit bowel syndrom studi variabl result due presenc patient affect small intestin bacteri overgrowth lactos intoler celiac diseas symptom similar irrit bowel syndrom aim aim studi test effect enteric co peppermint oil patient irrit bowel syndrom small intestin bacteri overgrowth lactos intoler celiac diseas exclud method fifty seven patient irrit bowel syndrom rome ii criteria normal lactos lactulos breath test negat antibodi screen celiac diseas treat peppermint oil enteric co capsul day placebo num week doubl blind studi symptom assess therapi num num week therapi num num week end therapi num symptom evalu abdomin bloat abdomin pain discomfort diarrhoea constip feel incomplet evacu pain defec passag gas mucus urgenc defec symptom intens frequenc num num score total irrit bowel syndrom symptom score calcul sum averag intens frequenc score symptom result num patient peppermint oil group show num reduct basal num total irrit bowel syndrom symptom score compar num placebo group num peppermint oil num num compar num statist signific reduct total irrit bowel syndrom symptom score found num num num num num num num num num num compar num mean chang found placebo conclus num week treatment peppermint oil improv abdomin symptom patient irrit bowel syndrom
MED-1009~effect enteric co delayed releas peppermint oil irrit bowel syndrom pubm ncbi abstract herbal remedi peppermint report control symptom irrit bowel syndrom ib conduct random double blind placebo control studi num outpati ib subject capsul enteric co delayed releas peppermint oil colpermin placebo time daili num week visit patient fourth eighth week evalu symptom qualiti life number subject free abdomin pain discomfort chang num week num num week num colpermin group num num control num sever abdomin pain reduc signific colpermin group compar control colpermin signific improv qualiti life signific advers reaction colpermin effect safe therapeut agent patient ib suffer abdomin pain discomfort
MED-1010~treatment emerg sexual dysfunct relat antidepress meta analysi pubm ncbi abstract background sexual dysfunct sd import underestim advers effect antidepress drug patient fact direct question tend scarc report aim present meta analysi quantifi sd caus antidepress basi studi sexual function purpos investig direct inquiri specif questionnair method literatur search conduct medlin isi web knowledg refer select articl select studi perform patient previous sd enter cochran collabor review manag revman version num primari outcom measur rate total treatment emerg sd secondari outcom measur rate treatment emerg desir arous orgasm dysfunct result analys signific higher rate total specif treatment emerg sd specif phase dysfunct compar placebo drug decreas order impact sertralin venlafaxin citalopram paroxetin fluoxetin imipramin phenelzin duloxetin escitalopram fluvoxamin sd rang num num patient signific differ placebo found antidepress agomelatin amineptin bupropion moclobemid mirtazapin nefazodon discuss treatment emerg sd caus antidepress issu larg variat compound assumpt inclus open label studi differ scale assess sd reduc signific find treatment emerg sd frequent advers effect consid clinic activ choic prescrib drug
MED-1011~placebo decept random control trial irrit bowel syndrom abstract background placebo treatment signific influenc subject symptom wide believ respons placebo requir conceal decept test open label placebo non decept non conc administr superior no treat control match patient provid interact treatment irrit bowel syndrom ib method two group random control week trial august num april num conduct singl academ center involv num primarili femal num patient age num num ib diagnos rome iii criteria score num ib symptom sever scale ibs sss patient random open label placebo pill present placebo pill made inert substanc sugar pill shown clinic studi produc signific improv ib symptom mind bodi self heal process no treat control qualiti interact provid primari outcom ib global improv scale ibs gi secondari measur ib symptom sever scale ibs sss ib adequ relief ibs ar ib qualiti life ibs qol find open label placebo produc signific higher sd global improv score ibs gi num day midpoint num num num num num num day endpoint num num num num num signific result observ time point reduc symptom sever ibs sss num num adequ relief ibs ar num num trend favor open label placebo observ qualiti life ibs qol num day endpoint num conclus placebo administ decept effect treatment ib research warrant ib condit elucid physician benefit patient placebo consist inform consent trial registr clinicaltri gov nct num
MED-1012~peppermint oil treatment irrit bowel syndrom systemat review meta analysi pubm ncbi abstract goal aim studi assess efficaci safeti enteric co peppermint oil capsul compar placebo treatment activ irrit bowel syndrom ib background ib common disord encount clinic practic medic intervent limit focus symptom control studi random placebo control trial minimum treatment durat num week consid inclus cross ov studi provid outcom data cross ov includ literatur search upto februari num identifi applic randomized control trial studi qualiti evalu cochran risk bias tool outcom includ global improv ib symptom improv abdomin pain advers event outcom analyz intention to treat approach result studi evalu num patient identifi risk bias low factor assess peppermint oil found signific superior placebo global improv ib symptom num studi num patient relat risk num num confid interv num num improv abdomin pain num studi num patient relat risk num num confid interv num num peppermint oil patient signific experi advers event event mild transient natur common report advers event heartburn conclus peppermint oil safe effect short term treatment ib futur studi assess long term efficaci safeti peppermint oil efficaci relat ib treatment includ antidepress antispasmod drug
MED-1013~qualiti life patient irrit bowel syndrom pubm ncbi abstract underestim impact irrit bowel syndrom ib individual function qualiti life qol general health status young elder individu ib general found poorer general popul patient ib wors health rel qualiti life hrqol patient condit gastroesophag reflux diseas diabet end stag renal diseas disease specif instrument wide clinic trial measur qol patient ib treatment intervent data present clinic trial patient therapeut respons therapi ib improv hrqol major differ hrqol base ib subtyp constipation domin diarrhea domin sever bowel symptom ib impact hrqol patient wors bowel symptom greater diminish qol compar patient milder symptom evid hrqol patient ib affect sex psycholog condit care factor individu therapeut strategi optim long term outcom
MED-1014~medic manag irrit bowel syndrom pubm ncbi abstract background irrit bowel syndrom ib complex syndrom difficult manag present evid support medic treatment specif ib symptom discuss evidence bas manag ib medic includ dose regimen advers effect review progress research ib treatment summari evid support improv specif ib symptom treatment loperamid psyllium bran lubiproston linaclotid amitriptylin trimipramin desipramin citalopram fluoxetin paroxetin dicyclomin peppermint oil rifaximin ketotifen pregabalin gabapentin octreotid medic investig treatment ib key messag medic demonstr improv ib symptom rifaximin lubiproston linaclotid fiber supplement peppermint oil reliabl evid support treatment ib onset efficaci medic note earli num day initi efficaci medic assess prospect predefin period addit studi medic ongo defin place therapi expand therapeut option treatment ib promis medic ib includ varieti pharmacolog approach notabl dual opioid receptor agonist opioid antagonist jnj num num karger ag basel
MED-1015~treatment trial acupunctur ib patient abstract object compar effect true sham acupunctur reliev symptom ib method total num adult ib patient num femal averag age num yrs random assign num week true sham acupunctur num treatment num week run in sham acupunctur augment limit patient practition interact arm studi includ waitlist control group primari outcom ib global improv scale ibs gi rang num num secondari outcom includ ib symptom sever scale ibs sss adequ relief ibs ar ibs qual life ibs qol result statist signific differ acupunctur sham acupunctur ibs gi num num num group improv signific compar wait list control group num num num similar small differ statist signific favor acupunctur outcom ibs ar num num num ibs sss num num num ibs qol num num num elimin respond run in period substant chang result side effect general mild slight greater acupunctur group conclus studi find evid support superior acupunctur compar sham acupunctur treatment ib
MED-1016~linaclotid linzess irrit bowel syndrom constip chronic idiopath constip abstract linaclotid linzess irrit bowel syndrom constip chronic idiopath constip
MED-1017~complementari altern medicin irrit bowel syndrom integr view abstract irrit bowel syndrom ib common gastrointestin disord high incid general popul diagnosi ib base exclus intestin condit absenc inflammatori marker specif antigen current pharmacolog treatment approach focus reduc symptom sever limit qualiti life signific side effect led effect gap ib patient seek relief increas qualiti life complementari altern medicin cam higher degre symptom manag qualiti life ib patient past decad number import clinic trial shown specif herbal therapi peppermint oil iberogast hypnotherapi cognit behavior therapi acupunctur yoga present improv treatment outcom ib patient propos integr approach treat divers symptom ib combin benefit pharmacotherapi cam therapi provid ib patient treatment outcom achiev initi step direct consid increas number practition recommend cam therapi patient pharmacotherapi allevi symptom suffici
MED-1018~effect intens diabet treatment progress diabet retinopathi insulin depend diabet mellitus diabet control pubm ncbi abstract object determin magnitud decreas risk retinopathi progress observ intens treatment relationship baselin retinopathi sever durat follow up design random clinic trial num num year follow up set patient num num center enrol num patient insulin depend diabet mellitus age num num year includ num patient retinopathi durat diabet num num year primari prevent cohort num patient mild moder nonprolif diabet retinopathi durat diabet num num year secondari intervent cohort ninety f percent schedul examin complet intervent intens treatment consist administr insulin time day inject pump dose adjust base self blood glucos monitor goal normoglycemia convent treatment consist daili insulin inject outcom measur chang baselin follow up visit earli treatment diabet retinopathi studi retinopathi sever scale assess mask grade stereoscop color fundus photograph obtain num month result cumul num year rate retinopathi progress step consecut visit num convent treatment num intens treatment primari prevent cohort num num secondari intervent cohort num num month visit small advers effect intens treatment note earli worsen benefici effect increas magnitud time num year follow up risk progress time lower intens treatment convent treatment progress occur subsequ recoveri time intens treatment convent treatment treatment effect similar baselin retinopathi sever subgroup conclus result diabet control complic trial strong support recommend patient insulin depend diabet mellitus intens treatment aim level glycemia close nondiabet rang safe
MED-1019~diabet retinopathi pubm ncbi abstract diabet retinopathi common specif microvascular complic diabet remain lead prevent blind working ag peopl identifi peopl diabet increas risk life threaten system vascular complic includ stroke coronari heart diseas heart failur optimum control blood glucos blood pressur possibl blood lipid remain foundat reduct risk retinopathi develop progress time laser therapi effect preserv sight prolif retinopathi macular oedema abil revers visual loss poor vitrectomi surgeri occasion advanc retinopathi therapi intraocular inject steroid antivascular endotheli growth factor agent destruct retina older therapi patient respond poor convent therapi outlook futur treatment modal inhibit angiogen factor regen therapi topic therapi promis copyright num elsevi reserv
MED-1020~pan retin photocoagul prolif diabet retinopathi pattern scan laser versus argon laser pubm ncbi abstract purpos review diabet retinopathi lead visual impair working ag adult worldwid pan retin photocoagul prp provid effect treatment decreas risk sever vision loss patient prolif diabet retinopathi past decad pattern scan laser pascal develop minim side effect prp purpos review discuss differ tradit argon laser pascal recent find pascal achiev compar result convent argon prp treatment patient diabet retinopathi pascal deliveri system creat align array retin lesion shorter period pascal amor comfort profil compar argon laser summari pascal substitut convent argon laser prp clinic ophthalmologist mind adjust pascal set includ durat number size laser burn maintain regress elimin recurr neovascular patient prolif diabet retinopathi studi determin paramet optim safeti efficaci pascal
MED-1021~manag diabet retinopathi systemat review pubm ncbi abstract context diabet retinopathi dr lead blind working ag popul unit state intervent dr evid support uncertain object review evid primari secondari intervent manag dr includ diabet macular edema evid acquisit systemat review english languag articl retriev keyword search medlin num num embas cochran collabor associ research vision ophthalmolog databas nation institut health clinic trial databas manual search refer list select major review articl english languag random control trial rcts num month follow up meta analys includ delphi consensus criteria identifi well conduct studi evid synthesi forty four studi includ num meta analys met inclus criteria tight glycem blood pressur control reduc incid progress dr pan retin laser photocoagul reduc risk moder sever visual loss num patient sever nonprolif prolif retinopathi focal laser photocoagul reduc risk moder visual loss num num eye macular edema earli vitrectomi improv visual recoveri patient prolif retinopathi sever vitreous hemorrhag intravitr inject steroid consid eye persist loss vision convent treatment fail insuffici evid efficaci safeti lipid low therapi medic intervent antivascular endotheli growth factor incid progress dr conclus tight glycem blood pressur control remain cornerston primari prevent dr pan retin focal retin laser photocoagul reduc risk visual loss patient sever dr macular edema insuffici evid recommend routin treatment
MED-1023~optim manag cytomegalovirus retin patient aid abstract cytomegalovirus cmv retin common vision loss patient acquir immunodefici syndrom aid cmv retin afflict num num aid patient pre high activ antiretrovir therapi haart era vision loss due macula involv retin retin detach introduct haart signific decreas incid sever cmv retin optim treatment cmv retin requir evalu patient immun status accur classif retin lesion retin diagnos haart therapi start improv anti cmv therapi oral valganciclovir intraven ganciclovir foscarnet cidofovir administ select patient zone num retin receiv intravitr drug inject surgic implant sustained releas ganciclovir reservoir effect anti cmv therapi coupl haart signific decreas incid vision loss improv patient surviv immun recoveri uveiti retin detach import moder sever loss vision compar earli year aid epidem treatment emphasi post haart era chang short term control retin long term preserv vision develop countri face shortag health care profession inadequ suppli anti cmv anti hiv medic intravitr ganciclovir inject cost effect strategi treat cmv retin area
MED-1025~interpret function motil test defecographi abstract defecographi evalu real time morpholog rectum anal canal physiolog set inject thick barium past rectum subsequ evacu abil structur function evalu defecographi primarili perform work patient longstand constip unexplain anal rectal pain residu sensat defec suspect prolaps techniqu interpret examin outlin review
MED-1026~pressur varicos vein pubm ncbi abstract pressur superfici leg vein num patient varicos vein num normal control studi control rise pressur vein increas intra abdomin pressur patient varicos vein pressur rose signific squat sit prevent transmiss intra abdomin pressur leg vein conclud differ posit adopt defaec wide variat geograph distribut varicos vein
MED-1027~varicos vein deep vein thrombosi haemorrhoid epidemiolog suggest aetiolog abstract current concept aetiolog varicos vein deep vein thrombosi haemorrhoid examin light epidemiolog evid found suggest fundament disord faecal arrest result low residu diet
MED-1028~faecal retent common function bowel disord append haemorrhoids  with medic surgic therapi pubm ncbi abstract present studi explor faecal retent colon causat factor function bowel diseas append haemorrhoid faecal retent character colon transit time ctt radio opaqu marker ingest estim faecal load abdomin radiograph num num specif hypothes test patient num num healthi random control num questionnair complet patient cover abdomin anorect symptom priori group patient function bowel disord predomin women signific increas ctt faecal load compar control ctt signific posit correl segment total faecal load faecal load equal num num mirror presenc perman faecal reservoir clinic studi correl bowel symptom ctt colon faecal load abdomin bloat signific correl faecal load colon total faecal load ctt abdomin pain signific posit correl distal faecal load signific bloat phenomenon high faecal load normal ctt observ subset patient num prove faecal retent hidden constip ctt faecal load signific higher right sid compar left distal segment control group healthi person right sid faecal load signific greater left distal load ctt faecal load signific posit correl palpabl mass left iliac fossa meteor cluster analysi reveal ctt faecal load posit correl symptom factor consist bloat proctalgia infrequ defec solid faec hand ctt faecal load negat correl symptom factor compris frequent easi defec repetit incomplet solid liquid faec major patient heavi faecal load normal ctt repetit daili defec eas alter faecal consist flue lik episod co exist symptom factor abdomin pain meteor symptom palpabl iliac fossa mass tender factor seldom difficult defec epigastr discomfort halitosi patient seldom difficult defec solid faec experienc abdomin pain signific present palpabl mass iliac fossa tender meteor ctt signific prolong faecal load signific increas patient normal ctt increas faecal load patient abdomin pain signific correl faecal load bloat ctt faecal load shown time increas signific number colon redund colon length result signific increas bloat pain intervent bowel stimul regimen combin fibre rich diet fluid physic activ prokinet drug essenti prove abdomin symptom defec disord caus faecal retent prolong ctt ctt signific reduc faecal load bloat pain reduc signific defec easi solid faec day signific reduct incomplet repetit proctalgia flue lik episod signific reduc intervent signific reduc presenc tender palpabl mass fossa rectal constip patient normal ctt increas faecal load intervent signific chang ctt load bloat pain signific reduc defec improv knowledg faecal retent patient explain faecal retent occur infer present result constip irrit bowel belong diseas dimens faecal retent common factor measur ctt faecal load suggest guid posit function diagnosi bowel disord compar constel symptom thirty f patient underw surgeri refractori conserv treatment constip signific prolong ctt heavi faecal load respons aggrav abdomin defaecatori symptom oper patient present redund colon dolichocolon signific patient extrem high rate previous appendectomi twenty on patient underw hemicolectomi num patient subtot colectomi ileosigmoid anastomosi patient receiv stoma patient initi segment colectomi convert final subtot colectomi persist symptom subtot colectomi perform leakag rate colectomi num patient die follow up num year vast major patient abdomin pain bloat defec daili control qualiti life increas faecalith locat appendix occlus respons case acut append infrequ white popul effort trace origin faecalith faecal retent colon made case control studi num patient num random control ctt longer faecal load greater patient append compar control differ signific power calcul show patient reach statist signific paramet presenc faecalith gangren perfor appendix signific differ found ctt faecal load patient faecalith right sid faecal load signific higher left distal load haemorrhoid consequ constip defaecatori disord found patient function bowel disord present studi danish report oper cure diseas stapl haemorrhoidopexi num num patient major patient prolaps haemorrhoid durabl procedur confirm follow up num year normal anus oper time short post op pain low recoveri rapid incontin observ patient satisfact high signific correl normal anus prolaps cumul risk re oper greatest num year stapl haemorrhoidopexi patient persist haemorrhoid prolaps procedur repeat result good obtain rest patient shown statist model preoper sever haemorrhoid diseas postop result contribut signific predict outcom durabl oper frequent post op complic bleed requir surgic haemostasi complic occur anastomot leak high anastomosi result retro rectal retro intra periton mediastin gas patient recov conserv treatment surgic intervent stapl techniqu revolution surgic treatment prolaps haemorrhoid final common suspect diseas constant epidemiolog evid recogn constip diverticulosi ib increas risk colon cancer adenoma diseas exceed rare communiti exempt append haemorrhoid colon co morbid notabl patient function bowel disord higher rate previous appendectomi background popul addit patient previous appendectomi signific longer ctt compar patient data point involv faecal retent origin faecalith acut append faecal reservoir shown left colon segment patient control area bear highest incid adenomat polyp malign famili colorect cancer occur signific patient higher faecal load control malign num adenoma identifi increas faecal load colon delay transit increas bacteri count creat chronic inflamm colon mucosa risk factor cancer onset function bowel disord occur gradual transit primari function diseas specif organ diseas diet rich fibr regular physic activ therapeut prevent effect colorect diseas faecal retent
MED-1029~comparison strain defec posit result implic human health pubm ncbi abstract aim studi compar strain forc appli sit squat defec twenty eight appar healthi volunt age num year normal bowel function digit timer record net time sensat satisfactori empti defec altern posit sit standard s toilet seat num cm high sit lower toilet seat num cm high squat note subject impress intens defec effort consecut bowel movement record posit time sensat satisfactori bowel empti degre subject assess strain squat posit reduc sharpli volunt compar sit posit num conclus present studi confirm sensat satisfactori bowel empti sit defec postur necessit excess expuls effort compar squat postur
MED-1030~transient cerebr vascular resist valsalva maneuv man pubm ncbi abstract measur cerebr spinal fluid pressur arteri pressur intern carotid arteri blood flow obtain seri patient valsalva maneuv strain phase ii num reduct arteri pressur num decreas intern carotid flow control valu releas phase iv num increas arteri pressur produc num increas intern carotid arteri flow perfus pressur comput arteri pressur minus cerebr spinal fluid pressur intern carotid arteri blood flow calcul index cerebr vascular resist data modest signific decreas vascular resist occur phase ii iii return control level phase iv vascular resist rapid suffici magnitud maintain constant cerebr perfus valsalva maneuv
MED-1031~primari constip mechan pubm ncbi abstract primari simpl constip consequ habitu bowel elimin common toilet seat proport popul normal bowel movement frequenc difficulti empti bowel princip obstruct natur recto an angl associ sit postur defec natur defec postur human squat align recto an angl squat permit smooth bowel elimin prevent excess strain potenti result damag recto an region possibl colon organ evid habitu bowel elimin time day contribut final act rectal empti natur behavior empti bowel respons strong defec reflex allevi bowel empti recto anal inhibitori reflex
MED-1032~defec syncop symptom multipl etiolog pubm ncbi abstract knowledg previous clinic descript literatur patient defec syncop evalu num patient disord subgroup larger prospect studi syncop num women men age num year eleven patient episod experienc multipl episod fourteen patient recumb urg defec asleep diagnost evalu disclos patient gastrointestin tract problem cardiac diseas transient ischem attack addit patient mark orthostat hypotens identifi defec syncop found num patient medic problem note patient follow up year syncop recur ten patient major recurr unassoci defec patient die follow up period chronic diseas conclud defec syncop singl distinct clinic entiti multipl patholog abnorm associ physiolog sleep defec contribut syncop patient defec syncop undergo care evalu diagnosi ill caus syncop
MED-1033~bowel obsess syndrom patient chronic constip pubm ncbi abstract object bowel obsess syndrom bos psychosomat disord remain intersect somat psycholog domain adequ diagnos treat case report num year old man chronic constip present restrict diet compuls evacu social isol depress mood satisfi diagnosi bos cognit behavior therapi led complet remiss symptom result maintain num year follow up conclus bos frequent diagnos preval thought clinician awar exist order assess diagnos proper treat copyright num elsevi reserv
MED-1034~insight normal disord bowel habit bowel diari abstract background symptom questionnair provid snapshot bowel habit reflect day to day variat relationship bowel symptom stool form aim assess bowel habit daili diari women function bowel disord method community bas survey olmst counti mn women num random select subject interview gastroenterologist complet bowel symptom questionnair subject maintain bowel diari num wk result num subject questionnair reveal diarrhea num constip num num asymptomat subject report bowel symptom urgenc infrequ num time general hard loos stool urgenc soft form stool bristol form num preval subject diarrhea num constip num normal num stool form strain begin odd ratio num num confid interv ci num num end num num ci num num defec increas odd constip strain end defec num num ci num num increas stool frequenc num num ci num num incomplet evacu num num ci num num rectal urgenc num num ci num num increas odd diarrhea contrast variat stool frequenc form discrimin health diseas conclus bowel symptom occur associ part explain stool form disturb observ support role pathophysiolog mechan function bowel disord
MED-1035~trustworthi bowel histori comparison recal record inform abstract hundr fifti hospit outpati question bowel habit record diari booklet week recal record figur frequenc defec agre fair close num patient discrep bowel action week exagger differ norm day patient bad predict episod chang bowel frequenc find cast doubt popul survey bowel habit base sole questionnair suggest irrit bowel syndrom correct diagnos patient routin record bowel action
MED-1036~respons colon eat pubm ncbi abstract evid increas motor activ colon eat speci anim effect cephal origin greater part respons result arriv food stomach proxim intestin chemoreceptor stimul import mechanoreceptor stimul bring effect effect hormon neural polypeptid hormon releas proxim gut eat candid neural pathway parasympathet sympathet system respons exact natur chang colon motil produc unknown involv pacemak colon contract electr slow wave colon migrat spike burst colon excit colon musculatur colon mucos function
MED-1037~journey medic care diseas ancient egypt abstract ancient egypt greatest civil arisen cradl scientif enquiri social develop num millennia undoubt knowledg medicin vast underestim artefact surviv describ medic organ extent diseas afflict ancient populus studi evid papyri tomb bas relief write historian antiqu intens interest scienc human medicin born educ societi overcom superstit nomad ancestor
MED-1038~dietari fiber person factor determin stool output pubm ncbi abstract examin effect fiber stool output primari mediat variabl hypothes relationship fiber diseas total neutral deterg fiber dietari fiber sourc predict stool weight frequenc substanti individu differ stool output remain dietari factor control person measur predict stool weight frequenc independ diet account varianc stool output dietari fiber result suggest person factor predispos person low stool output individu benefit dietari fiber
MED-1039~bowel obsess syndrom patient ulcer coliti pubm ncbi abstract gastroenterologist face diagnost problem differenti acut symptom ulcer coliti function intestin disord bowel obsess syndrom bos ocd lik function syndrom character fear fecal incontin compuls behavior evacuation check spars case studi treatment bos antidepress publish studi success psychotherapi male patient ulcer coliti overlap function bowel symptom mark symptom bos clinic recognit bos clinician differenti diagnosi prevent unnecessari investig give patient treatment
MED-1040~assess normal bowel habit general adult popul popcol studi pubm ncbi abstract object defin normal stool habit import evalu diarrhoea constip common confound irrit bowel syndrom ib intak medic gastrointestin side effect consid earlier popul base studi defin normal hypothes exclus subject common confound understand normal bowel habit aim prospect studi bowel habit care studi random sampl general popul materi method hundr sixty eight random select subject num num year complet symptom diari week clinic evalu gastroenterologist colonoscopi laboratori investig exclud organ diseas result hundr twenty four subject organ gastrointestin abnorm ib relev medic num stool day week seventy seven percent stool normal num hard num loos consist urgenc report num strain num incomplet defec num exclus subject organ abnorm women signific symptom men term abdomin pain bloat constip urgenc feel incomplet evacu gender differ disappear exclud subject ib conclus studi confirm normal stool frequenc week day demonstr gender age differ term stool frequenc defecatori symptom abdomin bloat degre urgenc strain incomplet evacu consid normal
MED-1041~gastroenterolog ancient egypt pubm ncbi abstract physician ancient egypt devot care disord individu organ notabl specialti gastroenterolog subject matter occupi major portion surviv medic papyri diseas pharaon physician host gastroenterolog symptom extens array therapeut prescrib clinic account impress knowledg gastric anorect condit diseas mechan circul materia peccan absorb fece repres major medic symptom disord serv rational popular practic self purg enema
MED-1042~colon motil man featur normal subject patient chronic idiopath constip pubm ncbi abstract human colon unknown viscus motor activ recent year techniqu perfect understand colon motil prolong record period demonstr viscus contract circadian trend respons physiolog stimuli meal sleep featur high amplitud propuls contract part complex dynam defecatori process physiolog properti alter patient chronic idiopath constip review articl
MED-1045~colon cancer diet special refer intak fat fiber pubm ncbi abstract colon cancer rare past develop popul account num num death western popul evid suggest primari diet affect bowel milieu int rieur sophist popul higher concentr fecal bile acid sterol longer transit time favor product potenti carcinogen metabolit secular diet evid suggest etiolog import num fall intak fiber contain food effect bowel physiolog num decreas fiber increas fat intak respect capac rais concentr fecal bile acid sterol noxious substanc prophylaxi colon cancer recommend lower fat intak higher intak fiber contain food fiber ingest bran extrem adopt futur research western popul lower averag mortal rate seventh day adventist mormon rural finnish popul develop popul demand intens studi requir elucid respect role diet genet constitut concentr fecal bile acid transit time prone nonpron popul
MED-1046~cephal phase colon pressur respons food abstract cephal phase colon pressur respons food sought normal subject age num year num studi separ occas record intralumin pressur unprepar sigmoid colon gastric acid secret measur simultan continu aspir nasogastr tube num minut basal period num minut food relat cephal stimuli control stimulus random order record continu num minut cephal stimuli food discuss sight smell food tast smell food sight tast sight food smell tast modifi sham feed control stimulus discuss neutral topic colon pressur express studi segment activ index area curv mm hg min deriv fulli autom comput analysi gastric acid output express mmol num min food discuss signific num wilcoxon rank sum test increas colon pressur activ compar control basal activ smell food sight tast signific num increas colon pressur activ compar control basal period sham feed sight smell food tast signific num num increas colon pressur compar control basal activ increas colon activ sight food smell tast signific control basal activ num num food discuss strongest colon stimulus test food discuss sham feed signific num stimul gastric acid output control basal valu sight smell food tast signific num increas acid output basal smell food sight tast sight food smell tast signific num num increas acid output contrast effect colon pressur sham feed stimulus acid output increas colon pressur activ food discuss correl signific num num gastric acid output correl num num colon pressur activ gastric acid output control studi data show cephal phase colon respons food
MED-1047~develop concept dietari fiber human nutrit pubm ncbi abstract fundament studi laxat action wheat bran undertaken unit state earli decad num centuri walker south africa extend studi african black suggest cereal fiber protect metabol disord trowel uganda elabor concept regard rariti common noninfect diseas colon stream inquiri stem hypothesi cleav postul presenc refin sugar lesser extent white flour caus metabol diseas loss fiber caus colon disord burkitt collect massiv evid rariti append venous disord rural africa part asia num trowel propos physiolog definit fiber term residu plant food resist digest alimentari enzym man southgat propos chemic method analyz compon dietari fiber cellulos hemicellulos lignin
MED-1048~defec frequenc time stool form general popul prospect studi abstract rang bowel habit stool type communiti unknown question num men num women compris num random stratifi sampl east bristol popul record consecut defec includ stool form valid point scale rang hard round lump mushi questionnair respons agre moder record data common bowel habit daili minor practic sex regular num hour cycl appar num men num women num men num women regular thrice daili bowel habit peopl irregular bowel women defec daili num week stool constip end scale pass women men women child bear age bowel habit spectrum stool type shift constip irregular compar older women case sever slow transit constip discov young women age effect bowel habit stool type normal stool type defin evok symptom account num stool women num men defec occur earli morn earlier men women conclud convent normal bowel function enjoy half popul aspect human physiolog younger women disadvantag
MED-1049~bowel movement sixth vital sign pubm ncbi abstract bowel movement provid vital inform bodi function constip older adult problemat hear detail else bowel movement function nurs assess support treat attitud care patient pain
MED-1050~effect person lifestyl intervent health care provid patient clinic promot health experi pubm ncbi abstract object determin effect self experi multidisciplinari lifestyl intervent health care provid hcps patient clinic method random num primary car clinic serv num member match patient profil provid hcps intervent control hmo program person num hcps num patient evalu clinic measur rate cmr january septemb num israel result hcps intervent group demonstr person improv health initi attitud num baselin decreas salt intak num control hcp intervent group patient exhibit improv dietari pattern specif salt red meat num baselin fruit veget num control intak height lipid hba num cmr increas intervent group clinic num baselin increas referr angiographi test num control intervent group hcps salt pattern improv increas lipid cmr num num lower hcps bodi weight increas blood pressur num num lipid num num cmr conclus hcps person lifestyl direct correl clinic perform intervent promot health hcp s self experi valuabl halo patient clinic suggest adjunct strategi primari prevent copyright num elsevi reserv
MED-1051~physician advic influenc patient behavior evid prime effect pubm ncbi abstract object explor potenti prime effect physician advic patient respons behavior chang intervent design random control trial num month follow up set community bas group famili medicin clinic southeastern missouri particip adult patient num intervent print educ materi design encourag patient quit smoke eat fat increas physic activ main outcom measur recal rate educ materi smoke behavior dietari fat consumpt physic activ result patient receiv physician advic quit smoke eat fat exercis prior receiv intervent materi topic rememb materi show perceiv materi appli specif report quit smoke odd ratio num num confid interv ci num num quit num hour num num ci num num make diet num num ci num num physic activ num num ci num num conclus find support integr model diseas prevent physician advic catalyst chang support coordin system inform activ provid depth detail individu sustain behavior chang
MED-1053~physician disclosur healthi person behavior improv credibl abil motiv pubm ncbi abstract context studi shown physician healthi person habit discuss prevent patient knowledg publish inform test physician credibl patient motiv adopt healthier habit enhanc physician disclosur healthi behavior design health educ video improv diet exercis produc shown subject num num num num emori univers general medic clinic wait room atlanta ga video physician reveal addit half minut inform person healthi dietari exercis practic bike helmet appl visibl desk physician disclosur video video discuss person practic appl bike helmet includ control video result viewer physician disclosur video consid physician general healthier some what believ motiv viewer control video rate physician specif believ motiv exercis diet num conclus physician abil motiv patient adopt healthi habit enhanc convey healthi habit educ institut encourag health professionals in train practic demonstr healthi person lifestyl
MED-1054~global view develop communic diseas pubm ncbi abstract long time communic diseas ncds discuss burden develop world recent alarm data show revers trend dramat increas ncds develop world high popul transit countri true main mortal trigger diseas cvd cancer diabet num num ncd base death happen low middl incom countri develop multi factori base main trend global supermarket growth rapid urban increas sedentari lifestyl lead overweight obes promot ncds similar high blood pressur high cholesterol elev blood glucos high qualiti diet includ function food function ingredi accompani physic activ non smok polici promis factor primari secondari prevent ncds copyright num elsevi reserv
MED-1055~bush administr global sugar industri determin demolish num global strategi diet physic activ pubm ncbi abstract object world power nation state power sector food drink product manufactur industri determin demolish num world health organ global strategi diet physic activ health disassoci num who fao food agricultur organ expert report diet nutrit prevent chronic diseas background paper scientif basi strategi encourag repres nation state num world health assembl support strategi report strategi explicit quantifi respond express member state num world health assembl effect global strategi prevent control chronic diseas preval increas nutrient poor food low veget fruit high energy dens fatti sugari and or salti food drink physic inact diseas obes diabet cardiovascular diseas cancer site chief morbid mortal countri world method summari global strategi root scientif knowledg accumul half centuri reason global strategi expert report oppos current govern world sugar industri refer modern histor context summari trajectori global strategi draft made earli num summari weak strength potenti conclus num global strategi num who fao expert report perceiv current administr impedi trade intern polici general context current govern hostil unit nation system brake exercis power world domin nation policy mak world awar context current pressur put power nation state sector industri ideolog commerci interest challeng intern initi design improv public health leav legaci futur generat
MED-1056~global nutrit transit pandem obes develop countri abstract decad ago discuss impend global pandem obes thought heresi diet num began shift increas relianc process food increas home intak greater edibl oil sugar sweeten beverag reduc physic activ increas sedentari time began earli num low middl incom world recogn diabet hypertens obes began domin globe urban rural area sub saharan africa south asia poorest countri higher incom shown experienc rapid increas overweight obes status concurr rapid shift diet activ document array large scal programmat polici shift explor countri major health challeng face countri address prevent dietari challeng face
MED-1058~polit context world health organ sugar industri threaten scupper pubm ncbi abstract sugar associ repres sugar industri high critic report guidelin healthi eat suggest sugar account num percent healthi diet associ demand congress end fund world health organ withdraw guidelin associ big food industri group secretari health human servic influenc report withdrawn strong reject sugar lobby critic
MED-1060~death protein num num upregul modul apoptosi mediat endoplasm reticulum stress mitochondri dialog trigger lipotox rodent human cell apoptosi abstract environment factor diet rich satur fat contribut dysfunct death pancreat cell diabet endoplasm reticulum er stress elicit cell satur fatti acid show palmitate induc cell apoptosi mediat intrins mitochondri pathway microarray analysi identifi palmitate trigg er stress gene express signatur induct bh num protein death protein num dp num num upregul modul apoptosi puma knockdown protein reduc cytochrom releas caspas num activ apoptosi rat human cell dp num induct depend inositol requir enzym num ire num depend c jun nh num termin kinas pkr er kinas perk induc activ transcript factor atf num bind promot puma express perk atf num depend tribbl num trb num regul akt inhibit foxo num activ dp num mice protect high fat diet induc loss glucos toler twofold greater pancreat cell mass studi elucid crosstalk lipotox er stress mitochondri pathway apoptosi cell death diabet
MED-1061~satur fat intak insulin resist men coronari arteri diseas stanford coronari risk intervent project investig pubm ncbi abstract background determin associ diet plasma insulin concentr independ obes studi relat dietari composit calor intak obes plasma insulin concentr num nondiabet men age num year angiograph proven coronari arteri diseas method result adjust age intak satur fatti acid cholesterol posit correl num bodi mass index num num waist to hip circumfer ratio num num fast insulin num num carbohydr intak negat correl bodi mass index num waist to hip ratio num fast insulin num intak monounsatur fatti acid correl signific bodi mass index waist to hip circumfer ratio correl posit fast insulin num intak dietari calori negat correl bodi mass index num multivari analysi intak satur fatti acid signific relat elev fast insulin concentr independ bodi mass index conclus cross sect find nondiabet men coronari arteri diseas suggest increas consumpt satur fatti acid independ higher fast insulin concentr
MED-1062~fatti acid glucolipotox pathogenesi type num diabet pubm ncbi abstract preval type num diabet increas dramat result obes epidem pose major health socio econom burden type num diabet develop individu fail compens insulin resist increas pancreat insulin secret insulin defici result pancreat beta cel dysfunct death western diet rich satur fat obes insulin resist increas level circul nefa non esterifi free fatti acid addit contribut beta cel failur genet predispos individu nefa beta cel apoptosi contribut progress beta cel loss type num diabet molecular pathway regul involv nefa medi beta cel dysfunct apoptosi begin understood identifi er endoplasm reticulum stress molecular mechan implic nefa induc beta cel apoptosi er stress propos mechan link high fat diet induc obes insulin resist cellular stress respons common molecular pathway main type num diabet insulin resist beta cel loss understand molecular mechan contribut pancreat beta cel loss pave develop target approach prevent type num diabet
MED-1063~plasma fatti acid composit incid diabet middle ag adult atherosclerosi risk communiti aric studi pubm ncbi abstract background result epidemiolog studi conduct questionnair suggest dietari fat composit influenc diabet risk confirm find biomark warrant object prospect investig relat plasma cholesterol ester ce phospholipid pl fatti acid composit incid diabet mellitus design num adult age num plasma fatti acid composit quantifi gas liquid chromatographi express percentag total fatti acid incid diabet num identifi num follow up result adjust age sex baselin bodi mass index waist to hip ratio alcohol intak cigarett smoke physic activ educ parent histori diabet diabet incid signific posit proport total satur fatti acid plasma ce pl rate ratio incid diabet quintil satur fatti acid num num num num num num ce num num num num num num pl ce incid diabet posit proport palmit num palmitol num num dihomo gamma linolen num num acid invers proport linol acid num num pl incid diabet posit proport num stearic acid num conclus proport satur fatti acid composit plasma posit develop diabet find biomark suggest indirect dietari fat profil satur fat contribut etiolog diabet
MED-1066~dietari habit relat insulin resist postprandi lipemia nonalcohol steatohepat pubm ncbi abstract relat dietari habit insulin sensit postprandi triglycerid metabol evalu num patient nonalcohol steatohepat nash num age bodi mass index bmi gender match healthi control num day alimentari record underw standard oral glucos toler test ogtt insulin sensit index isi calcul ogtt oral fat load test perform num patient num control dietari intak nash patient richer satur fat num num num num total kcal num cholesterol num num num num mg d num poorer polyunsatur fat num num num num total fat num fiber num num num num g d num antioxid vitamin num num num num mg d num num num num num mg d num isi signific lower nash patient control postprandi total low densiti lipoprotein triglycerid num hour num hour triglycerid area curv increment triglycerid area curv higher nash compar control satur fat intak correl isi featur metabol syndrom postprandi rise triglycerid postprandi apolipoprotein apo num apob num respons nash flat strike dissoci triglycerid respons suggest defect apob secret conclus dietari habit promot steatohepat direct modul hepat triglycerid accumul antioxid activ indirect affect insulin sensit postprandi triglycerid metabol find provid rational specif alimentari intervent nonobes nondiabet normolipidem nash patient
MED-1067~differenti effect oleic palmit acid lipid accumul apoptosi cultur hepatocyt pubm ncbi abstract background aim studi shown monounsatur oleic acid toxic palmit acid prevent attenu palmit acid hepatocit toxic steatosi model vitro degre effect mediat steatosi extent unknown method evalu steatosi se hepatocyt apoptosi determin role oleic palmit acid abund fatti acid western diet triglycerid accumul apoptosi vitro model steatosi induc hepatocyt cell line hepg num huh num wrl num impact incub num oleic num num mm palmit acid num num mm combin molar ratio num num steatosi apoptosi insulin signal evalu result concurr ppargamma srebp num gene activ steatosi extent larger cell treat oleic palmit acid fatti acid increas pparalpha express cell apoptosi invers proport steatosi deposit palmit oleic acid impair insulin signal higher amount fat result incub fatti acid combin apoptosi rate impair insulin signal lower cell treat palmit acid indic protect effect oleic acid conclus oleic acid steatogen apoptot palmit acid hepatocityc cell cultur data provid biolog basi clinic find dietari pattern pathogenet model nonalcohol fatti liver diseas
MED-1068~molecular mechan role satur fatti acid progress non alcohol fatti liver diseas abstract steadi rise western obes rate close link signific increas multitud accompani health problem includ non alcohol fatti liver diseas nafld nafld sever rang simpl steatosi acut steatohepat molecular mechan control progress diseas poor understood recent literatur suggest elev free fatti acid ffas satur ffas play import role lipotox mechan experiment model nafld patient review highlight import cellular pathway involv hepat lipotox degre intrahepat lipid satur control cell fate respons elev ffa load relev cellular process causal link lipid induc apoptosi lipoapoptosi includ endoplasm reticulum er stress oxid stress mitochondri dysfunct jun n termin kinas jnk signal contrast increas triglycerid synthesi shown protect effect lipotox hallmark trait nafld develop nuanc understand molecular mechan nafld progress lead target effect therapeut increas preval diseas date proven pharmacolog treatment prevent revers
MED-1069~differenti effect monounsatur polyunsatur satur fat ingest glucose stimul insulin secret sensit clear pubm ncbi abstract aims hypothesi prolong elev plasma specif fatti acid exert differenti effect glucose stimul insulin secret gsis insulin sensit clearanc subject method examin effect oral ingest regular interv num emuls predomin monounsatur mufa polyunsatur pufa satur sfa fat water control gsis insulin sensit insulin clearanc overweight obes non diabet human studi conduct individu random order num week twenty four hour initi oral ingest subject underw num num mmol l hyperglycaem clamp assess gsis insulin sensit insulin clearanc result oral ingest fat emuls num plasma nefa elev approxim num num fold basal level ingest fat emuls result reduct insulin clearanc sfa ingest reduc insulin sensit pufa ingest absolut reduct gsis insulin secret fail compens insulin resist subject ingest sfa conclusions interpret oral ingest fat differ degre satur result effect insulin secret action pufa ingest result absolut reduct insulin secret sfa ingest induc insulin resist failur insulin secret compens insulin resist impli impair beta cell function sfa studi
MED-1070~long lifespan low turnov human islet beta cell estim mathemat model lipofuscin accumul pubm ncbi abstract aims hypothesi defect pancreat beta cell turnov implic pathogenesi type num diabet genet marker diabet decreas beta cell neogenesi contribut diabet longev turnov human beta cell unknown rodent num year half lif num day estim intracellular lipofuscin bodi lb accumul hallmark age neuron estim lifespan human beta cell measur beta cell lb accumul individu age num year method lb content determin electron microscop morphometri section beta cell human non diabet num type num diabet num non human primat num num year num mice age num week total cellular lb content estim three dimension num mathemat model result lb area proport signific correl age human non human primat proport human lb posit beta cell signific relat age appar differ type num diabet obes lb content low human insulinoma num alpha cell mous beta cell lb content mous num human num electron microscopi num mathemat model lb posit human beta cell repres age cell increas num year num year remain constant conclusions interpret human beta cell unlik young rodent long liv lb proport type num diabet obes suggest adapt chang occur adult human beta cell popul larg establish age num year
MED-1071~satur free fatti acid sodium palmitate induc lipoapoptosi target glycogen synthas kinas num activ human liver cell pubm ncbi abstract background elev serum satur fatti acid level hepatocyt lipoapoptosi featur nonalcohol fatti liver diseas nafld aim purpos studi investig satur fatti acid induct lipoapoptosi human liver cell mechan method human liver num hepg num cell treat sodium palmit satur fatti acid num lithium chlorid glycogen synthas kinas num gsk num inhibitor gsk num shrna transfect transmiss electron microscopi detect morpholog flow cytometri detect apoptosi colorimetr assay detect caspas num activ western blot analysi detect protein express result data show sodium palmit induc lipoapoptosi num hepg num cell western blot analysi show sodium palmit activ gsk num protein dephosphoryl gsk num ser num inhibit gsk num activ lithium chlorid treatment knockdown gsk num express shrna suppress sodium palmitate induc lipoapoptosi num hepg num cell molecular level inhibit gsk num express activ suppress sodium palmitate induc c jun n termin kinas jnk phosphoryl bax upregul gsk num inhibit affect endoplasm reticulum stress induc activ unfold protein respons conclus present data demonstr satur fatti acid sodium palmitate induc lipoapoptosi human liver num hepg num cell regul gsk num activ led jnk activ bax upregul find gsk num inhibit potenti therapeut target control nafld
MED-1072~relationship dietari satur fatti acid bodi habitus serum insulin concentr normat age studi pubm ncbi abstract purpos studi examin relationship bodi mass index abdomen hip ratio dietari intak fast postprandi insulin concentr num men age num normat age studi log transform fast insulin signific bodi mass index abdomen hip ratio total fat energi satur fatti acid energi correl coeffici rang num total fat num bodi mass index multivari model bodi mass index abdomen hip ratio satur fatti acid intak statist signific independ predictor fast postprandi insulin concentr age cigarett smoke physic activ adjust satur fatti acid percentag total energi decreas num num num decreas fast insulin num decreas postprandi insulin data suggest adipos abdomin obes diet high satur fatti acid independ predictor fast postprandi insulin concentr
MED-1097~mose maimonid mediev physician scholar pubm ncbi abstract mose maimonid num physician philosoph greatest jewish thinker middl age face life persecut exil tragedi maimonid overcam obstacl lead physician era clinician skill sought contin long day care patient maimonid wrote extens medicin philosophi medic work span topic clinic medicin reflect ration understand relationship mind bodi philosoph write guid perplex maimonid codifi jewish law revolution jewish review life achiev insight world remark num h centuri physician offer valuabl lesson physician today
MED-1098~intak dioxin relat compound food popul pubm ncbi abstract nationwid food sampl measur dioxin dibenzofuran coplanar mono ortho di ortho polychlorin biphenyl pcbs report studi twelv separ analys conduct num food sampl divid pool lot categori sampl purchas num supermarket atlanta ga binghamton ny chicago il louisvill ky san diego ca human milk collect estim nurs infant consumpt food categori highest world health organ dioxin toxic equival teq concentr farm grown freshwat fish fillet num pg g part trillion ppt wet weight categori lowest teq level simul vegandiet num ppt teq concentr ocean fish beef chicken pork sandwich meat egg chees ice cream human milk rang num num ppt wet weight dairi milk teq num ppt butter num ppt daili intak teq breast f infant year life estim num pg kg bodi weight children age num yr estim daili teq intak num pg kg bodi weight male femal age num yr estim teq intak num num pg kg bodi weight adult men women age num yr estim daili teq intak num num pg kg bodi weight estim daili intak teq declin age low num pg kg bodi weight age num yr older age num yr estim higher male femal adult dioxin dibenzofuran pcbs contribut num num dietari teq intak dde analyz pool food sampl
MED-1099~evid effect environment chemic endocrin system children pubm ncbi abstract pollut chemic widespread environ affect endocrin signal evidenc laboratori experi wildlif high exposur human common expos pollut chemic exposur general low clear effect endocrin function exposur difficult demonstr instanc data human exposur chemic agent endocrin outcom review includ age wean age puberti sex ratio birth strength evid discuss endocrin disrupt human pollut chemic remain larg undemonstr scienc sound potenti effect real
MED-1100~lower serum testosteron elev polychlorin biphenyl concentr nativ american men abstract background polychlorin biphenyl pcbs chlorin pesticid endocrin disruptor alter thyroid estrogen hormon system action androgen system object studi relationship serum concentr testosteron relat level pcbs chlorin pesticid adult nativ american mohawk popul method collect fast serum sampl num adult mohawk num men num women analyz sampl num pcb congen hexachlorobenzen hcb dichlorodiphenyldichloroethylen dde mirex testosteron cholesterol triglycerid associ testosteron tertil serum organochlorin level wet weight lipid adjust assess logist regress model control age bodi mass index bmi analyt lowest tertil consid refer male femal consid separ result testosteron concentr male invers correl total pcb concentr wet weight lipid adjust valu odd ratio testosteron concentr median num num confid interv ci num num total wet weight pcbs highest lowest tertil adjust age bmi total serum lipid pesticid lipid adjust total pcb concentr num num ci num num adjust analyt testosteron level signific invers relat concentr pcbs num num num pcbs num num num num num testosteron concentr femal lower male signific relat serum pcbs hcb dde mirex testosteron concentr men women conclus elev serum pcb level lower concentr serum testosteron nativ american men
MED-1101~exposur human fetal penil cell pcb mixtur transcriptom analysi point divers mode interfer extern genitali pubm ncbi abstract effect exert mixtur polychlorin biphenyl pcbs evalu human fetal corpora cavernosa cell model male extern genitalia develop mixtur featur congen group potenti share mode action dioxin lik dl mix num dioxin lik ndl mixtur featur congen defin estrogen mix num high persistent cytochrom num induc mix num congen concentr deriv human intern exposur data toxicogenom analysi reveal mixtur modul critic gene involv genitourinari develop display express profil dl mix num modul actin rel cell cel epithelial mesenchym communic morphogenet process mix num modul smooth muscl function gene mix num modul gene involv cell metabol steroid lipid synthesi growth data fetal exposur environment relev pcb level modul pattern genitourinari program ndl congen group specif mode action copyright num elsevi reserv
MED-1103~dietari acrylamid intak risk lymphat malign netherland cohort studi diet cancer abstract background acrylamid probabl human carcinogen present everyday food find presenc food num epidemiolog studi found suggest associ dietari acrylamid exposur risk cancer aim prospect studi investig time associ dietari acrylamid intak risk histolog subtyp lymphat malign method netherland cohort studi diet cancer includ num men women followed up septemb num number person year risk estim random sampl particip total cohort chosen baselin num acrylamid intak estim food frequenc questionnair combin acrylamid data dutch food hazard ratio hrs calcul acrylamid intak continu variabl categori quintil tertil men women separ never smok multivariable adjust cox proport hazard model result num year follow up num microscop confirm case lymphat malign multivariable adjust analysi multipl myeloma follicular lymphoma hrs men num num ci num num num num ci num num num acrylamide day increment never smok men hr multipl myeloma num num ci num num associ observ women conclus found indic acrylamid increas risk multipl myeloma follicular lymphoma men epidemiolog studi investig associ dietari acrylamid intak risk lymphat malign research observ associ warrant
MED-1104~multipl myeloma recent progress diagnosi treatment pubm ncbi abstract multipl myeloma mm intract hematolog diseas year recent basic clinic research advanc remark therapeut strategi establish introduct high dos melphalan autolog stem cel transplant avail molecular target agent immunomodulatori drug proteasom inhibitor dramat chang treatment strategi mm achiev high respons rate result extens surviv research develop multimod therapeut approach warrant cure diseas
MED-1105~case multipl myeloma present bullous dermatosi abstract multipl myeloma malign plasma cell prolif disord produc monoclon immunoglobulin protein skin involv develop bullous diseas rare featur multipl myeloma present num year old man longstand larg tens bullous erupt hypertroph scar bodi accompani recent weight loss fatiqu respons previous treatment includ oral glucocorticoid dapson histolog examin lesion reveal subepiderm bulla immunoflouresc stain observ detail labarotori examin multipl myeloma detect treatment multipl myeloma chemotherapi lesion regress patient longstand recurr unusu bullous erupt investig develop multipl myeloma
MED-1106~cancer british vegetarian updat analys num incid cancer cohort num meat eater num fish eater num vegetarian num vegan abstract background vegetarian diet affect risk cancer object object describ cancer incid vegetarian nonvegetarian larg sampl unit kingdom design pool analysi num prospect studi includ num british men women compris num meat eater num fish eater num vegetarian includ num vegan cancer incid nationwid cancer registri cancer risk vegetarian status estim multivari cox proport hazard model result averag follow up num num incid cancer num meat eater num num fish eater num num vegetarian num signific heterogen dietari group risk cancer stomach cancer rrs num cis compar meat eater num num num fish eater num num num vegetarian p heterogen num colorect cancer rrs num cis num num num fish eater num num num vegetarian p heterogen num cancer lymphat hematopoiet tissu rrs num cis num num num fish eater num num num vegetarian p heterogen num multipl myeloma rrs num cis num num num fish eater num num num vegetarian p heterogen num site combin rrs num cis num num num fish eater num num num vegetarian p heterogen num conclus british popul risk cancer lower fish eater vegetarian meat eater
MED-1107~myeloma precursor diseas multipl myeloma diagnost concept opportun earli intervent pubm ncbi abstract monoclon gammopathi undetermin signific mgus num year ago definit entiti evolv today num distinct clinic mgus subtyp defin non immunoglobulin igm igg iga mgus igm mgus light chain mgus clinic mgus subtyp character uniqu intermedi stage progress event strong evid multipl myeloma consist preced precursor state molecular level urgent understand mechan regul transform precursor full blown multipl myeloma futur knowledg clinician defin high risk low risk precursor patient tailor clinic manag provid insight individu patient diseas biolog turn target individu treatment strategi basi current clinic guidelin patient diagnos mgus smolder myeloma treat clinic trial futur reason high risk precursor patient candid earli treatment strategi review discuss insight recent studi propos futur direct relev clinic manag research studi num aacr
MED-1108~consumpt artifici sweeten sugar contain soda risk lymphoma leukemia men women abstract background safeti report artifici sweeten aspartam health rel concern remain object prospect evalu consumpt aspartam sugar contain soda risk hematopoet cancer design repeat assess diet nurs health studi nhs health profession follow up studi hpfs num identifi num non hodgkin lymphoma nhls num multipl myeloma num leukemia calcul incid rrs num cis cox proport hazard model result num cohort combin signific associ soda intak risk nhl multipl myeloma men num daili serv diet soda increas risk nhl rr num num ci num num multipl myeloma rr num num ci num num comparison men consum diet soda observ increas risk nhl multipl myeloma women observ unexpect elev risk nhl rr num num ci num num higher consumpt regular sugar sweeten soda men women contrast sex analyz separ limit power regular diet soda increas risk leukemia increas leukemia risk data men women combin rr consumpt num serv diet soda d num cohort pool num num ci num num conclus find preserv possibl detriment effect constitu diet soda aspartam select cancer inconsist sex effect occurr appar cancer risk individu consum regular soda permit rule chanc explan
MED-1109~risk factor multipl myeloma hospital bas case control studi northwest china pubm ncbi abstract background distinct racial ethn geograph distribut multipl myeloma mm suggest famili histori environment factor contribut develop method hospital bas case control studi consist num confirm mm case num individu match patient control sex age hospit carri num major hospit northwest china questionnair obtain inform demograph famili histori frequenc food item consum result base multivari analysi signific associ risk mm famili histori cancer degre relat observ num num ci num num fri food cured smok food black tea fish signific risk mm intak shallot garlic num num ci num num soy food num num ci num num green tea num num ci num num signific reduc risk mm contrast intak brine veget pickl signific increas risk num num ci num num multipl interact decreas risk mm found shallot garl soy food conclus studi northwest china found increas risk mm famili histori cancer diet character low consumpt garlic green tea soy food high consumpt pickl veget effect green tea reduc risk mm interest find confirm copyright num elsevi reserv
MED-1110~potenti role curcumin patient monoclon gammopathi undefin significance  it effect paraproteinemia urinari n te pubm ncbi abstract purpos determin effect curcumin plasma cell osteoclast patient mgus experiment design twenty six patient mgus recruit studi administ num grams day oral curcumin blood urin sampl collect visit initi therapi full blood count num microglobulin serum paraprotein immunoglobulin electrophoresi iepg epg determin patient visit serum calcium num hydroxyvitamin num bone specif alkalin phosphatas determin baselin urin morn second void sampl collect visit urinari n telopeptid type collagen result result show oral curcumin decreas paraprotein load select group paraprotein level num g l patient mgus fifti percent num num patient num num reduct paraprotein level curcumin therapi addit num patient curcumin num decreas urinari n telopeptid type collagen conclus due progress mgus multipl myeloma potenti role curcumin therapeut intervent mgus patient warrant investig
MED-1111~clinic trial observ monoclon gammopathi undetermin signific mgus consist preced multipl myeloma prospect studi abstract monoclon gammopathi undetermin signific mgus premalign plasma cel prolif disord life long risk progress multipl myeloma mm mm preced premalign asymptomat mgus stage num num healthi adult enrol nationwid population bas prospect prostat lung colorect ovarian plco cancer screen trial identifi num subject develop mm studi serial collect num prediagnost serum sampl obtain num num year prior mm diagnosi assay monoclon protein electrophoresis immunofix kappa lambda free light chain flcs determin longitudin preval mgus character pattern monoclon immunoglobulin abnorm prior mm diagnosi mgus present num num num num num num num num num num num num num num num num num num num num num num num num num year prior mm diagnosi approxim half studi popul m protein concentr involv flc ratio level show year increas prior mm diagnosi present studi asymptomat mgus stage consist preced mm molecular marker predict progress mm patient mgus
MED-1112~curcumin diferuloylmethan down regul constitut activ nuclear factor kappa ikappabalpha kinas human multipl myeloma pubm ncbi abstract central role transcript factor nuclear factor kappab nf kappab cell surviv prolifer human multipl myeloma mm explor possibl target mm treatment curcumin diferuloylmethan agent toxic human found nf kappab constitut activ human mm cell line examin curcumin chemoprevent agent down regul nf kappab cell line electrophoret mobil gel shift assay prevent nuclear retent num shown immunocytochemistri mm cell line show consitut activ ikappab kinas ikk ikappabalpha phosphoryl curcumin suppress constitut ikappabalpha phosphoryl inhibit ikk activ curcumin down regul express nf kappab regul gene product includ ikappabalpha bcl num bcl x cyclin num interleukin num led suppress prolifer arrest cell num phase cell cycl suppress nf kappab complex ikkgamma nf kappab essenti modulator bind domain peptid suppress prolifer mm cell curcumin activ caspas num caspas num induc polyadenosin num diphosphate ribos polymeras parp cleavag curcumin induc down regul nf kappab factor implic chemoresist induc chemosensit vincristin melphalan result curcumin down regul nf kappab human mm cell lead suppress prolifer induct apoptosi provid molecular basi treatment mm patient pharmacolog safe agent
MED-1113~monoclon gammopathi undetermin signific smolder multipl myeloma curcumin random double blind placebo control cross pubm ncbi abstract monoclon gammopathi undetermin signific mgus smolder multipl myeloma smm repres model studi multipl myeloma precursor diseas develop earli intervent strategi administ num dose curcumin perform randomis double blind placebo control cross ov studi open label extens studi num dose assess effect curcumin flc respons bone turnov patient mgus smm num patient num mgus num smm randomis group receiv num curcumin num placebo cross num month complet num arm patient option enter open label num dose extens studi blood urin sampl collect interv specif marker analys group valu express num sd data time interv group compar student pair t test num patient complet num cross ov studi num num extens studi curcumin therapi decreas free light chain ratio rflc reduc differ clonal nonclon light chain dflc involv free light chain iflc udpyd marker bone resorpt decreas curcumin arm increas placebo arm serum creatinin level tend diminish curcumin therapi find suggest curcumin potenti slow diseas process patient mgus smm copyright num wiley period
MED-1114~occup exposur meat risk lymphoma multicent case control studi europ pubm ncbi abstract studi suggest increas risk lymphoma worker expos meat conclus evid conduct multicent case control studi num czech republ franc germani ireland itali spain includ num case non hodgkin lymphoma num case hodgkin lymphoma num control collect detail inform occup histori assess exposur meat general type meat expert assess questionnair odd ratio non hodgkin lymphoma occup exposur meat num num confid interv ci num num exposur beef meat num num ci num num exposur chicken meat num num ci num num higher worker longer durat exposur increas risk worker expos beef meat appar diffus larg b cell lymphoma num num ci num num chronic lymphocyt leukemia num num ci num num multipl myeloma num num ci num num num type exposur chicken meat num num ci num num num num ci num num follicular lymphoma t cell lymphoma hodgkin lymphoma show increas risk occup exposur meat repres import risk factor lymphoma increas risk specif type non hodgkin lymphoma exclud num wiley liss
MED-1115~dispar preval pathogenesi progress monoclon gammopathi undetermin signific multipl myeloma black white abstract mark racial dispar incid monoclon gammopathi undetermin signific mgus multipl myeloma threefold increas risk black compar white increas risk african african american similar increas risk monoclon gammopathi black compar white note adjust socioeconom risk factor suggest genet predisposit higher risk multipl myeloma black result higher preval premalign mgus stage data suggest black higher progress rate mgus myeloma studi emerg suggest baselin cytogenet characterist progress differ race contrast increas risk note black studi suggest risk lower racial ethnic group notabl person japan mexico review literatur racial dispar preval pathogenesi progress mgus multipl myeloma black white discuss futur direct research inform manag condit posit influenc patient outcom
MED-1116~molecular mimicri hla dr allel rheumatoid arthriti proteus mirabili aetiolog basi autoimmun pubm ncbi abstract molecular mimicri patholog mechan propos explain associ microorgan autoimmun diseas review deal associ bacteria rheumat diseas special emphasi rheumatoid arthriti upper urinari tract infect proteus mirabili sever arthrit condit prospect trial involv anti proteus therapi carri
MED-1118~decreas anti proteus mirabili anti escherichia coli antibodi level rheumatoid arthriti patient treat fast year vegetarian diet abstract object measur proteus mirabili escherichia coli antibodi level patient rheumatoid arthriti ra treatment vegetarian diet method sera collect num ra patient part control clinic trial fast year vegetarian diet mirabili coli antibodi level measur indirect immunofluoresc techniqu enzym immunoassay result patient vegetarian diet signific reduct anti proteus titr time point studi compar baselin valu num signific chang titr observ patient omnivor diet decreas anti proteus titr greater patient respond vegetarian diet compar diet non respond omnivor total igg concentr level antibodi coli unchang patient group trial decreas baselin proteus antibodi level correl signific num decreas modifi stoke diseas activ index conclus decreas mirabili antibodi level diet respond correl decreas proteus antibodi level decreas diseas activ support suggest aetiopathogenet role mirabili ra
MED-1120~molecular mimicri autoimmun pathogenesi rheumat heart diseas pubm ncbi abstract molecular mimicri hallmark pathogenesi rheumat fever streptococc group carbohydr epitop n acetyl glucosamin a hel coiled coil streptococc protein structur mimic cardiac myosin human diseas rheumat carditi anim model immun streptococc protein cardiac myosin recent studi unravel potenti pathogen mechan immun respons group streptococcus attack rheumat valv lead chronic rheumat heart diseas t cell respons involv process evid hypothes molecular mimicri epitop spread review
MED-1121~rheumatoid arthriti autoimmun diseas trigger proteus urinari tract infect abstract rheumatoid arthriti ra chronic disabl polyarthrit diseas affect women middl age extens evid base result microbi immunolog molecular studi part world show strong link exist proteus mirabili microb ra propos sub clin proteus urinari tract infect main trigger factor presenc molecular mimicri cross react bacteria ra target tissu antigen assist perpetu diseas process product cytopath auto antibodi patient ra earli stage diseas benefit proteus anti bacteri measur involv antibiot vegetarian diet high intak water fruit juic cranberri juic addit employ treatment
MED-1122~evid patient rheumatoid arthriti asymptomat non signific proteus mirabili bacteriuria frequent healthi con pubm ncbi abstract object patient rheumatoid arthriti ra report sera rais level antibodi specif proteus mirabili aim studi verifi determin explan investig frequenc mirabili urinari tract infect ra patient match control method fresh void urin examin presenc number ident infect bacteria level antibodi blood urin igm iga igg class common serotyp mirabili antigen react determin enzyme link immunosorb assay elisa immunoblot result analysi urin num patient ra num age gender match healthi control show num control urin num ra patient infect commonest infect organ ra patient urin proteus mirabili occur frequent escherichia coli proteus mirabili found num infect urin ra patient detect pure growth insignific num ml number high improb find outcom differ age physic abil medic ra control patient group comparison antibodi level mirabili elisa show ra patient rais num num num level iga igg igm sera rais num num num level igg igm iga urin compar control group detect antibodi react mirabili antigen specif ra patient conclus result confirm ra patient rais level antibodi mirabili blood urin suggest aris ra patient asymptomat non signific mirabili bacteriuria frequent prolong control patient trigger ra condit
MED-1123~systemat literatur review econom implic pharmacoeconom issu rheumatoid arthriti pubm ncbi abstract object provid state art econom analys appli rheumatoid arthriti ra method systemat literatur review econom consequ pharmacoeconom issu ra perform result num valid articl examin review general financi impact ra substanti health car system societi worldwid differ exist nation economi direct indirect loss product cost contribut econom burden ra account estim impact societi diseas sever diseas activ age socioeconom status found relev predictor cost increas ra introduct biolog anti rheumat agent signific rais direct medic cost patient led mark improv reduc diseas activ joint damag product loss patient ra signific impact aspect qualiti life recent public health util score show ra diseas poorest qualiti life conclus ra repres clinic econom burden healthcar system attribut ra cost extens evalu decad issu expens therapi address frequent updat futur research provid health econom evid usual practic set econom impact therapeut approach pursu specif clinic target individu patient
MED-1124~uncook vegan diet shift profil human fecal microflora computer analysi direct stool sampl gas liquid chromatographi profil bacteri cellular fatti acid abstract effect uncook extrem vegan diet fecal microflora studi direct stool sampl gas liquid chromatographi glc bacteri cellular fatti acid quantit bacteri cultur classic microbiolog techniqu isol identif enumer bacteri speci eighteen volunt divid random group test group receiv uncook vegan diet num month convent diet mix western type month studi control group consum convent diet studi period stool sampl collect bacteri cellular fatti acid extract direct stool sampl measur glc computer analysi result fatti acid profil perform profil repres bacteri cellular fatti acid sampl reflect microflora detect differ similar bacteri flora individu sampl sampl group glc profil chang signific test group induct discontinu vegan diet control group time quantit bacteri cultur detect signific chang fecal bacteriolog group result suggest uncook extrem vegan diet alter fecal bacteri flora signific measur direct stool sampl glc bacteri fatti acid
MED-1125~rheumatoid arthriti caus proteus urinari tract infect pubm ncbi abstract genet molecular biolog studi rheumatoid arthriti ra sever arthrit disord affect approxim num popul develop countri caus upper urinari tract infect microb proteus mirabili elev level specif antibodi proteus bacteria report num countri pathogenet mechan involv stage trigger cross react autoantibodi evok proteus infect causat amino acid sequenc proteus esrral irret arginin doublet act peptidyl arginin deiminas explain earli anti citrullin protein antibodi patient ra ra patient treat earli anti proteus antibiot biolog agent avoid irrevers joint damag num apmi publish john wiley son
MED-1126~updat bioactiv plant lignan pubm ncbi abstract lignan class secondari plant metabolit produc oxid dimer phenylpropanoid unit molecular backbon consist phenylpropan num num unit lignan show enorm structur divers grow interest lignan synthet deriv due applic cancer chemotherapi pharmacolog effect review deal lignan possess anticanc antioxid antimicrobi anti inflammatori immunosuppress activ compris data report num peer review articl highlight recent report bioactiv lignan step develop potenti therapeut agent
MED-1127~rheumatoid arthriti caus proteus molecular mimicri theori karl popper pubm ncbi abstract rheumatoid arthriti crippl disabl joint diseas affect num million peopl occur predomin women smoker affect hla dr num individu carri share epitop amino acid eqrraa diseas investig method philosoph scienc karl popper suggest scientif research base bold conjectur critic refut popper sequenc generat fact chang alter origin problem fact explain theori molecular mimicri model found proteus bacteria possess amino acid sequenc esrral haemolysin resembl share epitop sequenc ureas resembl type xi collagen antibodi proteus bacteria found num countri rheumatoid arthriti caus upper urinari tract infect proteus bacteria anti proteus therapi assess manag diseas separ conjunct exist modal therapi
MED-1128~rheumatoid arthriti link proteus  th evid pubm ncbi abstract rheumatoid arthriti ra chronic inflammatori arthrit potenti disabl condit affect women middl age characterist clinic featur microbi agent implic causat ra extens literatur base result genet microbiolog molecular immunolog studi carri independ research group support role proteus mirabili bacteria etiopathogenesi ra diagnost marker criteria therapeut protocol form antibiot dietari measur suggest current treatment manag ra prospect longitudin studi antimicrobi measur patient ra requir establish therapeut benefit microbe diseas associ
MED-1129~rheumat fever sore throat autoimmun heart lesion pubm ncbi abstract molecular mimicri streptococci heart compon propos trigger factor lead autoimmun rheumat heart diseas rhd review present data cellular autoimmun respons focus interact hla class ii molecul streptococc peptid heart tissu protein t cell receptor tcr usag hla dr num num dq molecul relat develop valvular lesion sever rhd patient dr num num molecul involv recognit immunodomin num peptid patient cell infiltr rhd heart display oligoclon expans intralesion t cell clone present ident tcr bvbj avaj cdr num sequenc recogn antigen low homolog show intramolecular degener pattern antigen recognit peripher blood mononuclear cell rheumat fever rf patient produc proinflammatori cytokin intralesion mononuclear cell sever rhd patient produc predomin num type cytokin result illustr complex mechan lead heart tissu damag rf rhd patient copyright num karger ag basel
MED-1130~faecal flora rheumatoid arthriti fast one year vegetarian diet pubm ncbi abstract benefici effect num yr vegetarian diet ra recent demonstr clinic trial analys stool sampl num ra patient direct stool sampl gas liquid chromatographi bacteri cellular fatti acid base repeat clinic assess diseas improv indic construct patient time point intervent period patient diet group assign group high improv index group low improv index li signific alter intestin flora observ patient chang omnivor vegan diet signific differ period vegan lactovegetarian diet faecal flora patient li differ signific num num month diet find associ intestin flora diseas activ implic understand diet affect ra
MED-1131~faecal microbi flora diseas activ rheumatoid arthriti vegan diet pubm ncbi abstract clarifi role faecal flora diet induc decreas rheumatoid arthriti ra activ num ra patient random group test group receiv live food form uncook vegan diet rich lactobacilli control group continu ordinari omnivor diet base clinic assess intervent period diseas improv index construct patient index patient assign group high improv index group low improv index lo stool sampl collect patient intervent num month analys direct stool sampl gas liquid chromatographi bacteri cellular fatti acid method prove simpl sensit detect differ faecal microbi flora individu stool sampl group signific diet induc chang faecal flora num observ test group control group test group signific num differ detect lo categori num month pre test sampl conclud vegan diet faecal microbi flora ra patient faecal flora improv ra activ
MED-1133~preval kidney stone unit state abstract background nation repres assess kidney stone preval unit state occur num num yr hiatus nation health nutrit examin survey nhane reiniti data collect kidney stone histori object describ current preval stone diseas unit state identifi factor histori kidney stone design set particip cross sect analysi respons num num nhane num outcom measur statist analysi self report histori kidney stone percent preval calcul multivari model identifi factor histori kidney stone result limit preval kidney stone num num confid interv ci num num men preval stone num num ci num num compar num num ci num num women kidney stone common obes normal weight individu num num ci num num compar num num ci num num num black non hispan hispan individu report histori stone diseas white non hispan individu black non hispan odd ratio num num ci num num num hispan num num ci num num num obes diabet strong histori kidney stone multivari model cross sect survey design limit causal infer potenti risk factor kidney stone conclus kidney stone affect approxim num num peopl unit state data repres mark increas stone diseas compar nhane iii cohort black non hispan hispan individu diet lifestyl factor play import role chang epidemiolog kidney stone
MED-1134~effect low anim protein high fib diet urin composit calcium nephrolithiasi pubm ncbi abstract background purpos articl evalu impact low protein high fiber intak risk factor stone recurr idiopath calcium stone icsf method ninety six icsf random assign low anim protein diet num total energi high fib diet num g day usual diet control group patient recommend increas fluid intak daili urin composit analyz baselin month complianc dietari recommend check valid food frequenc questionnair complianc total anim protein intak assess num hour urea sulfat output nutrit intervent oral instruct written leaflet phone food assess carri research dietitian result baselin diet daili urin composit differ group month diet differ signific num hour output calcium oxal differ signific group adjust potenti confound age sex person famili histori calcium stone baselin valu num num icsf num ci num num assign low anim protein diet achiev reduct urin urea excret rate num mmol day exhibit signific decreas urinari calcium excret averag num mmol day signific correl urea calcium output observ patient hypercalciuria conclus result show icsf mark decreas anim protein intak hypercalciuria expect benefit dietari recommend
MED-1135~recurr calcium oxal stone vegetarian pubm ncbi abstract hypothesi incid calcium stone diseas relat consumpt anim protein examin male popul recurr idiopath stone consum anim protein normal subject singl stone anim protein intak intermedi normal men recurr stone high anim protein intak caus signific increas urinari excret calcium oxal uric acid num num main urinari risk factor calcium stone format relat probabl form stone calcul combin num main urinari risk factor mark increas high anim protein diet convers low anim protein intak vegetarian low excret calcium oxal uric acid low relat probabl form stone
MED-1136~effect high anim protein intak risk calcium stone form urinari tract pubm ncbi abstract num studi carri normal male subject determin short term effect increas dietari consumpt anim protein urinari risk factor stone form volum ph calcium oxal uric acid glycosaminoglycan num increas num g day anim protein diet signific increas urinari calcium num oxal num total urinari nitrogen increas averag num mmol day accompani increas dietari purin num mmol purin nitrogen day caus num increas excret uric acid num relat probabl form stone calcul combin risk factor mark increas num period high anim protein ingest
MED-1137~diet risk kidney stone oxford cohort european prospect investig cancer nutrit epic pubm ncbi abstract lifetim preval kidney stone num incid rate increas diet import determin kidney stone develop object investig associ diet kidney stone risk popul wide rang diet associ examin num particip oxford arm european prospect investig cancer nutrit data hospit episod statist england scottish morbid record cohort num particip attend hospit kidney stone episod cox proport hazard regress perform calcul hazard ratio hr num confid interv num ci compar high intak meat num g day hr estim moder meat eat num g day low meat eat num g day fish eat vegetarian num num ci num num num num ci num num num num ci num num num num ci num num high intak fresh fruit fibr wholegrain cereal magnesium lower risk kidney stone format high intak zinc higher risk conclus vegetarian lower risk develop kidney stone compar eat high meat diet inform import advis public prevent kidney stone format
MED-1138~anim protein risk kidney stone compar metabol studi anim protein sourc pubm ncbi abstract purpos compar effect num anim protein sourc urinari stone risk materi method total num healthi subject complet num phase random crossov metabol studi num week phase subject consum standard metabol diet beef chicken fish serum chemistri num hour urin sampl collect end phase compar mix model repeat measur analysi result serum urinari uric acid increas phase beef lower serum uric acid chicken fish num num num mg dl num fish higher urinari uric acid beef chicken num num num mg day num num signific differ phase note urinari ph sulfat calcium citrat oxal sodium satur index calcium oxal highest beef num differ attain signific compar chicken num num fish num num conclus consum anim protein increas serum urin uric acid healthi individu higher purin content fish compar beef chicken reflect higher num hour urinari uric acid reflect satur index stone form propens margin higher beef compar fish chicken stone advis limit intak anim protein includ fish copyright num american urolog associ educ research publish elsevi reserv
MED-1139~environment exposur pesticid cancer risk multipl human organ system pubm ncbi abstract grow evid associ long term exposur pesticid occup set elev rate chronic diseas includ type cancer data non occup exposur scarc draw conclus object studi investig putat associ environment pesticid exposur general popul cancer site discuss potenti carcinogen mechan pesticid develop cancer population bas case control studi conduct peopl resid num health district andalusia south spain estim risk cancer site health district categor area high low environment pesticid exposur base quantit criteria number hectar devot intens agricultur pesticid sale capita studi popul consist num cancer case num num age health district match control data collect computer hospit record minimum dataset num num preval rate risk cancer organ site signific higher district greater pesticid relat lower pesticid condit logist regress analys show popul live area high pesticid increas risk cancer site studi odd ratio num num hodgkin diseas non hodgkin lymphoma result studi support extend previous evid occup studi indic environment exposur pesticid risk factor type cancer level general popul copyright num elsevi ireland reserv
MED-1140~organ food buy safeti peac mind critic review literatur pubm ncbi abstract consum concern qualiti safeti convent food intensifi recent year primarili drive increas demand organ grown food perceiv healthier safer relev scientif evid scarc anecdot report abound urgent inform relat health benefit and or hazard food product origin general conclus remain tentat absenc adequ compar data organ fruit veget expect fewer agrochem residu convent grown altern signific differ question actual level contamin type food general accept limit leafi root tuber organ veget lower nitrat content compar convent dietari nitrat constitut threat human health matter debat hand differ identifi environment contamin cadmium heavi metal present food origin respect food hazard endogen plant toxin biolog pesticid pathogen microorgan evid extrem limit prevent general statement result mycotoxin contamin cereal crop variabl inconclus clear pictur emerg difficult weigh risk made clear organ automat equal safe addit studi area research warrant present state knowledg factor safeti aspect speak favor organ food
MED-1142~format dioxin exposur pesticid formul sunlight pubm ncbi abstract chlorin pesticid impur dibenzo p dioxin dibenzofuran pcdd fs precursor result manufactur process condit precursor format pcdd fs mediat ultraviolet light uv studi investig pcdd fs form pesticid expos natur sunlight formul pentachloronitrobenzen pcnb num num dichlorophenoxyacet acid num num expos sunlight quartz tube concentr num pcdd f congen monitor time format pcdd fs observ pcnb formul num maximum concentr num pcdd f kg num num formul num num pcdd f kg num teq increas num maximum concentr num kg num pcnb chang num formul assum similar yield observ present studi worst case scenario pcnb australia result format num teq annum num contribut primarili ocdd format warrant detail evalu contemporari releas pcdd fs environ pesticid congen profil includ ratio pcdds pcdfs df ratio suggest pesticid sourc pcdd fs sunlight exposur recogn base match sourc fingerprint establish manufactur impur provid preliminari insight format rout type precursor involv copyright num elsevi reserv
MED-1143~risk percept food choic exploratori analysi organ versus conventional produc buyer pubm ncbi abstract consum choic organ pesticid convent grown produc examin exploratori focus group discuss questionnair num suggest individu purchas organ grown produc substanti hazard convent altern pay signific premium obtain median num cost convent produc risk reduct impli increment pay high relat estim risk perceiv risk reduct larg organic produc consum conventional produc consum mitig ingestion rel risk contamin drink water automobil seatbelt
MED-1144~perceiv risk convent organ produc pesticid pathogen natur toxin pubm ncbi abstract public risk percept demand safer food import factor shape agricultur product practic unit state document food safeti concern attempt made elicit consum subject risk judgment rang food safeti hazard identifi factor predict perceiv food safeti risk studi num convent organ fresh produc buyer boston area survey perceiv food safeti risk survey result show consum perceiv high risk consumpt product convent grown produc compar public health hazard convent organ food buyer estim median annual fatal rate due pesticid residu convent grown food num million num million similar magnitud annual mortal risk motor vehicl accid unit state num survey respond perceiv reduct pesticid residu risk substitut organ grown produc convent grown produc num perceiv risk reduct due natur toxin microbi pathogen multipl regress analys factor consist predict higher risk percept includ feel distrust regulatori agenc safeti food suppli varieti factor found signific predictor specif categori food hazard suggest consum view food safeti risk dissimilar base studi find recommend futur agricultur polici risk communic effort util compar risk approach target rang food safeti hazard
MED-1146~estim cancer risk benefit potenti increas consumpt fruit veget pubm ncbi abstract current paper analysi potenti number cancer case prevent half popul increas fruit veget consumpt serv day number contrast upper bound estim concomit cancer case theoret attribut intak pesticid residu aris addit fruit veget consumpt cancer prevent estim deriv publish meta analysi nutrit epidemiolog studi cancer risk estim environment protect agenc epa method cancer potenc estim rodent bioassay pesticid residu sampl data depart agricultur usda result estim approxim num cancer case year prevent increas fruit veget consumpt num cancer case year caus ad pesticid consumpt estim signific uncertainti potenti residu confound fruit veget epidemiolog studi relianc rodent bioassay cancer risk overwhelm differ benefit risk estim confid consum concern cancer risk consum conventionally grown fruit veget copyright num elsevi reserv
MED-1147~cadmium organ convent pig product pubm ncbi abstract main sourc cadmium cd input soil phosphat fertil deposit air organ farm phosphat fertil long term result lower cd level present studi feed kidney liver manur growing finish pig rais convent organ farm microwave digest analyz cd graphit furnac atom absorpt spectrometri cd analyz soil water qualiti control program includ organ pig num rais outdoor fed organ feed convent pig num rais indoor convent feed cd level organ convent feed num microg kg num microg kg organ feed num potato protein contribut num cd content convent feed num beet fiber contribut num total cd content feed vitamin miner mixtur high level cd num microg kg organ num microg kg convent feed signific negat linear relationship cd concentr kidney kidney weight signific differ liver cd level organ convent pig sd num num spite lower level cd organ feed organ pig signific higher level kidney convent pig num num microg kg wet weight sd num num num microg kg wet weight num organ pig higher cd level manur indic higher cd exposur environ ingest soil differ feed composit bioavail cd feed compon explain kidney level cd
MED-1148~associ organ dietari choic pregnanc hypospadia offspr studi mother num boy oper hypospadia pubm ncbi abstract purpos etiolog hypospadia poor understood exposur pesticid consid risk factor find inconsist diet constitut signific exposur rout pesticid pesticid residu frequent report convent organ food product examin associ organ dietari choic pregnanc presenc hypospadia offspr materi method mother num boy oper hypospadia frequenc match geographi child birth year num mother healthi boy case control studi telephon interview conduct demograph lifestyl factor includ intak organ choic select food item milk dairi product egg fruit veget meat logist regress model construct dietari variabl odd ratio calcul control matern age bodi mass index alcohol consumpt result organ choic food item pregnanc hypospadia offspr frequent current consumpt high fat dairi product milk butter rare choos organ altern product pregnanc increas odd hypospadia adjust num num ci num num conclus larg case control studi boy oper hypospadia suggest associ hypospadia offspr mother choos organ altern high current intak nonorgan butter chees find due chemic contamin high fat dairi product general lifestyl health behavior relat choos organ altern explain find copyright num american urolog associ educ research publish elsevi reserv
MED-1149~profil organ food consum larg sampl french adult result nutrinet s cohort studi abstract background lifestyl dietari pattern nutrit status organ food consum rare interest sustain diet mark increas method consum attitud frequenc num organ product assess num adult particip nutrinet s cohort cluster analysi perform identifi behavior organ product consumpt socio demograph characterist food consumpt nutrient intak cluster provid cross sect associ overweight obes estim polytom logist regress result cluster identifi num cluster non consum reason differ occasion ocop num regular rcop num organ product consum rcop high educ physic activ cluster exhibit dietari pattern includ plant food sweet alcohol beverag process meat milk nutrient intak profil fatti acid miner vitamin fiber healthier close adher dietari guidelin multivari model account confound includ level adher nutrit guidelin compar interest organ product rcop particip show mark lower probabl overweight exclud obes num bodi mass index num obes bodi mass index num num num men num num women num ocop particip general show intermedi figur conclus regular consum organ product sizeabl group sampl exhibit specif socio demograph characterist healthi profil account studi analyz organ food intak health marker
MED-1150~organ grown food health benefit drosophila melanogast abstract organ food market fastest grow food sector unclear organ rais food nutrit superior convent grown food consum organ food bestow health benefit order evalu potenti health benefit organ food well character fruit fli drosophila melanogast model system fruit fli rais diet consist extract convent organ rais produc banana potato raisin soy bean fli subject varieti test design assess fli health fli rais diet made organ grown produc greater fertil longev food sourc greater activ greater stress resist addit observ suggest organ food bestow posit effect fli health data show drosophila conveni model system experiment test potenti health effect dietari compon system provid evid organ rais food provid anim tangibl benefit health
MED-1151~organ food consumpt incid cancer larg prospect studi women unit kingdom abstract background organ produc food convent produc food pesticid residu method examin hypothesi eat organ food reduc risk soft tissu sarcoma breast cancer non hodgkin lymphoma common cancer larg prospect studi num num middle ag uk women women report consumpt organ food cancer incid num year cox regress model estim adjust relat risk cancer incid report frequenc consumpt organ food result baselin num num women report usually alway eat organ food consumpt organ food reduct incid cancer num num case total rr usually alway num num confid interv ci num num soft tissu sarcoma rr num num ci num num breast cancer rr num num ci num num non hodgkin lymphoma rr num num ci num num conclus larg prospect studi decreas incid cancer consumpt organ food possibl non hodgkin lymphoma
MED-1152~pesticid exposur serum organochlorin residu testicular cancer patient healthi control pubm ncbi abstract incid testicular cancer tc increas worldwid decad reason increas remain unknown recent find suggest organochlorin pesticid op influenc develop tc hospital bas case control studi num case num control conduct determin environment exposur op risk tc measur serum concentr op includ p  dichlorodiphenyldichloroethylen p  dde isom hexachlorobenzen hcb particip signific associ observ tc household insecticid odd ratio num num ci num num adjust num num ci num num crude adjust tc signific higher serum concentr total op num num ci num num adjust num num ci num num case compar control find give addit support result previous research suggest environment exposur op implic pathogenesi tc
MED-1153~attent deficit hyperact disord urinari metabolit organophosph pesticid children num num year abstract context exposur organophosph op pesticid common compound neurotox properti studi examin risk children general popul object examin associ concentr urinari dialkyl phosphat dap metabolit op attent deficit hyperact disord adhd children age num num year particip method cross sect data nation health nutrit examin survey num num num children repres general popul structur interview parent ascertain adhd diagnost status base slight modifi criteria diagnost statist manual mental disorders iv result hundr nineteen children met diagnost criteria adhd children higher concentr urinari dap dimethyl alkylphosph dmap diagnos adhd num fold increas dmap concentr odd ratio num num confid interv ci num num adjust sex age race ethn poverty incom ratio fast durat urinari creatinin concentr common detect dmap metabolit dimethylthiophosph children level higher median detect concentr doubl odd adhd adjust num num ci num num compar non detect level conclus find support hypothesi op exposur level common children contribut adhd preval prospect studi establish associ causal
MED-1156~prospect studi organochlorin adipos tissu risk non hodgkin lymphoma abstract background exposur organochlorin examin potenti risk factor non hodgkin lymphoma nhl inconsist result relat limit statist power imprecis exposur measur object purpos examin associ organochlorin concentr prediagnost adipos tissu sampl risk nhl method conduct case cohort studi prospect danish cohort num person enrol num num cohort identifi num person diagnos nhl population bas nationwid danish cancer registri random select num subcohort person measur concentr num pesticid num polychlorin biphenyl pcb congen adipos tissu collect enrol associ num organochlorin nhl analyz cox regress model adjust bodi mass index result incid rate ratio confid interv cis interquartil rang increas concentr dichlorodiphenyltrichlorethan ddt cis nonachlor oxychlordan num num ci num num num num ci num num num num ci num num monoton dose respons trend ddt cis nonachlor base categor model relat risk estim higher men women contrast clear associ found nhl pcbs conclus found higher risk nhl associ higher adipos tissu level ddt cis nonachlor oxychlordan associ pcbs studi organochlorin nhl prediagnost adipos tissu sampl exposur assess environment health evid organochlorin contribut nhl risk
MED-1157~reduct pesticid residu produc rins pubm ncbi abstract num laboratori initi research program object examin effect rins produc tap water pesticid residu sampl obtain local market and or grown experiment farm approxim num produc retail sourc pesticid residu grow treat produc experiment farm advantag sampl pesticid residu pesticid appli normal field condit varieti food crop veget undergo natur weather prior harvest result sampl field incur field fortifi residu experiment design employ mimic close real world sampl crop treat harvest divid equal subsampl subsampl process unwash rins tap water extract analysi method multi residu method develop laboratori twelv pesticid includ studi fungicid captan chlorothalonil iprodion vinclozolin insecticid endosulfan permethrin methoxychlor malathion diazinon chlorpyrifo bifenthrin dde soil metabolit ddt statist analysi data wilcoxon signed rank test show rins remov residu twelv pesticid studi residu vinclozolin bifenthrin chlorpyrifo reduc rinsabl pesticid correl water solubl
MED-1158~behaviour organophosphorus organochlorin pesticid potato soak solut pubm ncbi abstract effici acid solut radish citric acid ascorb acid acet acid hydrogen peroxid neutral solut sodium chlorid alkalin solut sodium carbon tap water elimin organochlorin organophosphorus pesticid natur contamin potato examin result acid solut effect neutral alkalin solut elimin organochlorin compound investig radish solut elimin pesticid complet p  dde num loss citric ascorb acid solut hand organophosphorus pesticid pirimpho methyl malathion profenofo elimin acid neutral alkalin solut organochlorin percentag remov rang num num pirimpho methyl num num malathion num profenofo
MED-1160~effect dishwash liquid remov chlorothalonil chlorpyrifo residu cherri tomato pubm ncbi abstract wash practic remov pesticid residu fruit veget common kitchen dishwash liquid deterg chines market test enhanc remov chlorpyrifo chp chlorothalonil cht cherri tomato soak cherri tomato deterg solut critic micell concentr deterg deterg num mg num num mg num deterg higher solubil abil pesticid wash effect deterg appar solubl chp increas increas deterg concentr cht remain compar invari independ deterg concentr test rang appar solubl chp consist higher solut deterg compar cht due lower logkow cht readili wash cherri tomato chp term wash durat num min suffici remov pesticid cherri tomato distil water deterg solut effect remov pesticid increas increas deterg concentr num mg num num num num cht num chp remov multipl wash increas pesticid remov ad num acet acid lower ph increas wash temperatur favor pesticid remov num nacl produc shield effect substanti reduc effect deterg pesticid remov copyright num elsevi reserv
MED-1161~effect handl process pesticid residu food review abstract pesticid major input increas agricultur product crop pesticid residu left variabl extent food materi harvest control consum deleteri effect human health presenc pesticid residu major bottleneck intern trade food commod local pesticid food vari natur pesticid molecul type portion food materi environment factor food crop treat pesticid invari unpredict amount chemic imper find altern decontamin food wash water soak solut salt chemic chlorin chlorin dioxid hydrogen peroxid ozon acet acid hydroxi peracet acid iprodion deterg report high effect reduc level pesticid preparatori step peel trim remov residu outer portion thermal process treatment pasteur blanch boil cook steam canning scrambl found valuabl degrad pesticid depend type pesticid length treatment preserv techniqu dri dehydr concentr increas pesticid content fold due concentr effect techniqu refin ferment cure report affect pesticid level food vari extent mill bake wine make malt brew result lower pesticid residu level end product post harvest treatment cold storag found effect decontamin techniqu bring concentr pesticid mrl diminut effect depend initi concentr time harvest substrate food type pesticid diversifi inform literatur effect prepar process subsequ handl storag food pesticid residu compil articl
MED-1162~pesticid residu import organ suspect fruit veget pubm ncbi abstract consum frequent urg avoid import food specif fruit veget due health concern pesticid residu encourag choos organ fruit veget convent form studi demonstr organ fruit veget lower level pesticid residu convent fruit veget pesticid residu frequent detect organ fruit veget typic dietari consum exposur pesticid residu convent fruit veget health signific similar research demonstr import fruit veget pose greater risk pesticid residu domest fruit veget specif fruit veget singl high contamin pesticid avoid convent form
MED-1164~organophosphorus pesticid exposur urban suburban preschool children organ convent diet abstract assess organophosphorus op pesticid exposur diet biolog monitor seattl washington preschool children parent food diari num day urin collect distinguish organ convent food base label inform children classifi consum organ convent diet base analysi diari data residenti pesticid record home collect num hr urin sampl num children organ diet num children convent diet analyz op pesticid metabolit found signific higher median concentr total dimethyl alkylphosph metabolit total diethyl alkylphosph metabolit num num micro mol l num median total dimethyl metabolit concentr approxim time higher children convent diet children organ diet num num micro mol l num concentr differ factor num num micro mol l calcul dose estim urinari dimethyl metabolit agricultur pesticid data assum exposur singl pesticid dose estim suggest consumpt organ fruit veget juic reduc children exposur level environment protect agency current guidelin shift exposur rang uncertain risk rang neglig risk consumpt organ produc provid simpl parent reduc children exposur op pesticid
MED-1165~concentr polybromin diphenyl ether hexachlorobenzen polycycl aromat hydrocarbon foodstuff coo pubm ncbi abstract cooking induc level polybromin diphenyl ether pbdes hexachlorobenzen hcb num polycycl aromat hydrocarbon pah foodstuff investig food includ fish sardin hake tuna meat veal steak loin pork breast thigh chicken steak rib lamb string bean potato rice oliv oil food item raw cook fri grill roast boil sampl analyz variat concentr pbdes cook depend cook process specif food item highest hcb concentr found sardin lower cook sampl cook process enhanc hcb level hake scarc differ note tuna raw cook general term highest pah concentr found fri valu notabl fish hake highest total pah level correspond roast sampl result studi show general cook process limit reduc pbde hcb pah concentr food
MED-1166~prenat exposur organophosph pesticid iq num year old children abstract context organophosph op pesticid neurotox high dose studi examin chronic exposur lower level advers affect children cognit develop object examin associ prenat postnat exposur op pesticid cognit abil school ag children method conduct birth cohort studi center health assess mother children salina studi predomin latino farmwork famili agricultur communiti california assess exposur op pesticid measur dialkyl phosphat dap metabolit urin collect pregnanc children num month num num num year age administ wechsler intellig scale children num edit num children num year age analys adjust matern educ intellig home observ measur environ score languag cognit assess result urinari dap concentr measur half pregnanc similar relat cognit score averag concentr measur pregnanc analys averag matern dap concentr poorer score work memori process speed verbal comprehens perceptu reason full scal intellig quotient iq children highest quintil matern dap concentr averag deficit num iq point compar lowest quintil children urinari dap concentr consist cognit score conclus prenat postnat urinari dap concentr poorer intellectu develop num year old children matern urinari dap concentr present studi higher nonetheless rang level measur general popul
MED-1167~pesticid human chronic diseas evid mechan perspect pubm ncbi abstract wide pesticid world concern health impact rapid grow huge bodi evid relat exposur pesticid elev rate chronic diseas type cancer diabet neurodegen disord parkinson alzheim amyotroph sclerosi al birth defect reproduct disord circumstanti evid associ exposur pesticid chronic diseas respiratori problem asthma chronic obstruct pulmonari diseas copd cardiovascular diseas atherosclerosi coronari arteri diseas chronic nephropathi autoimmun diseas system lupus erythemat rheumatoid arthriti chronic fatigu syndrom age common featur chronic disord disturb cellular homeostasi induc pesticid primari action perturb ion channel enzym receptor mediat pathway main mechan review present highlight evid associ pesticide exposur incid chronic diseas introduc genet damag epigenet modif endocrin disrupt mitochondri dysfunct oxid stress endoplasm reticulum stress unfold protein respons upr impair ubiquitin proteasom system defect autophagi effect mechan action copyright num elsevi reserv
MED-1169~reduct urinari organophosph pesticid metabolit adult week long organ diet pubm ncbi abstract background convent food product common organophosph op pesticid negat health effect organ food deem healthier produc pesticid studi suggest organ food consumpt signific reduc op pesticid exposur children higher pesticid exposur adult due diet bodi weight behaviour effici metabol object prospect randomis crossov studi conduct determin organ food diet reduc organophosph exposur adult method thirteen particip random alloc consum diet num organ convent food num day cross altern diet urinari level dialkylphosph metabolit analys first morn void collect day num phase gc ms ms detect limit num num g l result total dap result organ phase num lower convent phase num sd num num sd num num total dimethyl dap num reduct num sd num num sd num num total diethyl dap level organ phase half convent phase num sd num num sd num wide variabl small sampl size meant differ statist signific conclus consumpt organ diet week signific reduc op pesticid exposur adult larger scale studi popul requir confirm find investig clinic relev copyright num elsevi reserv
MED-1170~parent occup exposur pesticid risk factor brain tumor children young adult systemat review meta analysi pubm ncbi abstract object examin potenti associ parent occup exposur pesticid occurr brain tumor children young adult method studi identifi medlin search num januari num refer list identifi public submit systemat review meta analysi relat risk estim extract num studi publish num num retriev studi involv farm agricultur job summari ratio estim sr calcul fix random effect meta analysi model separ analys conduct stratif studi design exposur paramet diseas definit geograph locat age diagnosi result statist signific associ observ parent potenti expos pesticid occup set occurr brain tumor offspr combin case control studi summari odd ratio sor num num num num cohort studi summari rate ratio srr num num ci num num signific increas risk prenat exposur window expos parent exposur defin pesticid occupational industri titl astrogli brain tumor combin case control studi north america cohort studi europ conclus meta analysi support associ parent occup exposur pesticid brain tumor children young adult add evid lead recommend minim parent occup exposur pesticid result interpret caution impact work rel factor pesticid exposur copyright num elsevi reserv
MED-1171~chemic exposur earli life neurodevelop children  an overview current epidemiolog evid pubm ncbi abstract number chemic shown demonstr neurotox effect human laboratori anim studi articl aim evalu impact exposur chemic includ organophosph organochlorin pesticid polychlorin biphenyl pcbs mercuri lead neurodevelop children review recent publish literatur answer question progress made epidemiolog neurodevelop children induc exposur chemic result present studi show exposur above ment chemic impair neurodevelop children neonat expos organophosph pesticid demonstr higher proport abnorm reflex young children attent problem exposur organochlorin pesticid children alert qualiti alert respons cost attent potenti attent measur major studi negat impact lead exposur level num g dl num g dl neurodevelop children result studi exposur pcbs mercuri effect neurodevelop inconsist suggest prenat exposur pcbs mercuri relat perform impair attent concentr problem present statist signific associ studi design prospect cohort exposur assess base biomark exposur covari confound affect endpoint present studi confound includ data analysi order recogn earli cognit motor languag outcom chemic exposur standard tool evalu neurodevelopment effect offer earli fair comprehens measur child develop neurotoxic cross placenta fetal brain exposur reduct exposur chemic implement
MED-1172~dietari intak contribut longitudin organophosphorus pesticid exposur urban suburban children abstract background widespread organophosphorus op pesticid led frequent exposur adult children exposur advers health effect children sourc pattern exposur studi object assess young urban suburban children longitudin exposur op pesticid children pesticid exposur studi cpes conduct greater seattl washington area studi design determin contribut dietari intak op pesticid exposur method twenty thre children num num year age consum convent diet recruit num year studi conduct num num children switch organ diet num consecut day summer fall sampl season measur specif urinari metabolit malathion chlorpyrifo op pesticid urin sampl collect daili period num num consecut day season result substitut organ fresh fruit veget convent food item median urinari metabolit concentr reduc nondetect close non detect level malathion chlorpyrifo end num day organ diet intervent period summer fall season observ season effect op urinari metabolit concentr season correspond consumpt fresh produc year conclus find studi demonstr dietari intak op pesticid repres major sourc exposur young children
MED-1173~choic organ food relat perceiv consequ human health environment friend behaviour pubm ncbi abstract design questionnair concern attitud behaviour organ food environment friend behaviour efb perceiv consequ organ food choic term human health environ anim welfar mail num random nation wid sampl num swedish citizen age num year num respond self report purchas organ food strong relat perceiv benefit human health perform efb refrain car drive good predictor purchas frequenc result egoist motiv predictor purchas organ food altruist motiv
MED-1174~organ diet signific lower children dietari exposur organophosphorus pesticid abstract studi design measur dietari organophosphorus pesticid exposur group num elementari school ag children urinari biomonitor substitut children convent diet organ food item num consecut day collect spot daili urin sampl first morn before bedtim void num day studi period found median urinari concentr specif metabolit malathion chlorpyrifo decreas nondetect level immedi introduct organ diet remain nondetect convent diet reintroduc median concentr organophosphorus pesticid metabolit lower organ diet consumpt day detect metabolit frequent show statist signific conclus demonstr organ diet dramat protect effect exposur organophosphorus pesticid common agricultur product conclud children expos organophosphorus pesticid exclus diet knowledg studi employ longitudin design dietari intervent assess children exposur pesticid persuas evid effect intervent
MED-1175~systemat review meta analysi childhood leukemia parent occup pesticid exposur abstract object conduct systemat review meta analysi childhood leukemia parent occup pesticid exposur data sourc search medlin num num electron databas yield num includ studi data extract author independ abstract data assess qualiti studi data synthesi random effect model obtain summari odd ratio num confid interv cis associ childhood leukemia patern occup pesticid exposur num num ci num num slight elev risk subgroup studi low total qu score num num ci num num ill defin exposur time window num num ci num num exposur inform collect offspr leukemia diagnosi num num ci num num childhood leukemia prenat matern occup pesticid exposur num num ci num num associ slight stronger studi high exposure measurement qu score num num ci num num higher confound control score num num ci num num farm rel exposur num num ci num num childhood leukemia risk elev prenat matern occup exposur insecticid num num ci num num herbicid num num ci num num conclus childhood leukemia prenat matern occup pesticid exposur analys studi combin subgroup associ patern occup pesticid exposur weaker consist research includ improv pesticid exposur indic continu follow up exist cohort genet suscept assess basic research childhood leukemia initi progress
MED-1176~neurodevelopment effect children exposur organophosph pesticid systemat review abstract studi investig neurodevelopment effect prenat earli childhood exposur organophosph op pesticid children collect evalu aim present articl synthes report evid decad op exposur neurodevelopment effect children data sourc pubm web scienc ebsco scivers scopus springerlink scielo doaj elig criteria consid studi assess exposur op pesticid neurodevelopment effect children birth num year age publish num num english spanish twenty seven articl met elig criteria studi rate evidenti high intermedi low base studi design number particip exposur measur neurodevelopment measur num studi evalu show negat effect pesticid neurobehavior develop posit dose respons relationship op exposur neurodevelopment outcom found num studi assess dose respons ten longitudin studi assess prenat exposur op cognit deficit relat work memori found children age num year behavior deficit relat attent toddler motor deficit abnorm reflex neonat meta analysi due measur exposur assess outcom eleven studi longitudin rate high num studi rate intermedi studi rate low evid neurolog deficit exposur op pesticid children grow studi review collect support hypothesi exposur op pesticid induc neurotox effect research understand effect exposur critic window develop
MED-1177~residenti exposur pesticid childhood leukaemia systemat review meta analysi pubm ncbi abstract object conduct systemat review publish studi associ residential household domest exposur pesticid childhood leukaemia provid quantit estim risk method public english search medlin num decemb num refer list identifi public extract relat risk rr estim perform independ num author predefin inclus criteria meta r ratio estim mrr calcul fix random effect model separ analys conduct stratif exposur time window residenti exposur locat biocid categori type leukaemia result rr estim extract num case control studi publish num num statist signific associ childhood leukaemia observ combin studi mrr num num ci num num exposur pregnanc posit childhood leukaemia strongest risk exposur pregnanc mrr num num ci num num stratif show greatest risk estim indoor exposur mrr num num ci num num exposur insecticid mrr num num ci num num acut non lymphocyt leukaemia anll mrr num num ci num num outdoor exposur exposur children herbicid pregnanc signific childhood leukaemia mrr num num ci num num mrr num num ci num num conclus find support assumpt residenti pesticid exposur contribut risk factor childhood leukaemia data scarc causal ascertain opportun prevent action includ educ measur decreas pesticid residenti purpos indoor insecticid pregnanc copyright num elsevi reserv
MED-1178~organ food safer healthier convent altern systemat review pubm ncbi abstract background health benefit organ food unclear purpos review evid compar health effect organ convent food data sourc medlin januari num num embas cab direct agricola toxnet cochran librari januari num num bibliographi retriev articl studi select english languag report comparison organ convent grown food popul consum food data extract num independ investig extract data method health outcom nutrient contamin level data synthesi num studi human num studi nutrient contamin level food met inclus criteria num human studi examin clinic outcom find signific differ popul food type allerg outcom eczema wheez atop sensit symptomat campylobact infect studi report signific lower urinari pesticid level children consum organ versus convent diet studi biomark nutrient level serum urin breast milk semen adult identifi clinic meaning differ estim differ nutrient contamin level food high heterogen estim phosphorus phosphorus level signific higher convent produc differ clinic signific risk contamin detect pesticid residu lower organ convent produc risk differ num ci num num differ risk exceed maximum limit small escherichia coli contamin risk differ organ convent produc bacteri contamin retail chicken pork common unrel farm method risk isol bacteria resist num antibiot higher convent organ chicken pork risk differ num ci num num limit studi heterogen limit number public bias present conclus publish literatur lack strong evid organ food signific nutriti convent food consumpt organ food reduc exposur pesticid residu antibiotic resist bacteria primari fund sourc
MED-1179~organ food health environment advantag disadvantag pubm ncbi abstract market organ food grown num billion num num billion num organ trade associ organ product sold specialti store convent supermarket organ product numer market claim term standard regul term health advantag organ diet convinc demonstr expos consum fewer pesticid human diseas organ farm demonstr environment impact convent approach current evid support meaning nutrit benefit deficit eat organ compar convent grown food well pow human studi direct demonstr health benefit diseas protect result consum organ diet studi demonstr detriment disease promot effect organ diet organ food regular command signific price premium well design farm studi demonstr cost competit yield compar convent farm techniqu pediatrician incorpor evid discuss health environment impact organ food organ farm continu encourag patient famili attain optim nutrit dietari varieti consist depart agriculture myplat recommend clinic report review health environment issu relat organ food product consumpt defin term organ review organ food label standard describ organ convent farm practic explor cost environment implic organ product techniqu examin evid nutrit qualiti product contamin convent produc organ food final report guidanc pediatrician assist advis patient organ convent produc food choic
MED-1180~antioxid level inhibit cancer cell prolifer vitro extract organ convent cultiv strawberri pubm ncbi abstract effect extract cultivar strawberri prolifer colon cancer cell ht num breast cancer cell mcf num investig correl level antioxid analyz addit effect organ cultiv compar convent cultiv content antioxid strawberri strawberri extract cancer cell prolifer investig ratio ascorb dehydroascorb signific higher organ cultiv strawberri strawberri extract decreas prolifer ht num cell mcf num cell dose depend inhibitori effect highest concentr extract rang num averag num inhibit compar control ht num cell num averag num mcf num cell extract organ grown strawberri higher antiprolif activ cell type highest concentr convent grown higher content secondari metabolit anticarcinogen properti organ grown strawberri ht num cell negat correl highest extract concentr content ascorb vitamin cancer cell prolifer mcf num cell high ratio ascorb dehydroascorb correl higher inhibit cell prolifer highest concentr signific effect ascorb cancer cell prolifer lie synergist action compound
MED-1181~higher antioxid lower cadmium concentr lower incid pesticid residu organ grown crop systemat literatur review meta analys abstract demand organ food partial driven consum percept nutriti scientif opinion divid signific nutrit differ organ non organ food recent review conclud differ present studi carri meta analys base num peer review public statist signific meaning differ composit organ non organ crops crop bas food import concentr rang antioxid polyphenol found substanti higher organ crops crop bas food phenol acid flavanon stilben flavon flavonol anthocyanin estim num ci num num ci num num ci num num ci num num ci num num ci num higher compound previous link reduc risk chronic diseas includ cvd neurodegen diseas cancer dietari intervent epidemiolog studi addit frequenc occurr pesticid residu found time higher convent crop signific higher concentr toxic metal cd signific differ detect miner vitamin compound evid higher antioxid concentr lower cd concentr link specif agronom practic non us miner fertilis prescrib organ farm system conclus organ crop averag higher concentr antioxid lower concentr cd lower incid pesticid residu non organ compar region product season
MED-1182~fruit soil qualiti organ convent strawberri agroecosystem abstract background sale organ food fastest grow market segment global food industri peopl buy organ food organ farm produc nutriti tast food healthier soil test signific differ fruit soil qualiti num pair commerci organ convent strawberri agroecosystem california methodology princip find multipl sampl time year evalu varieti strawberri miner element shelf life phytochem composit organolept properti analyz tradit soil properti soil dna microarray technolog found organ farm strawberri longer shelf life greater dri matter higher antioxid activ concentr ascorb acid phenol compound lower concentr phosphorus potassium varieti sensori panel judg organ strawberri sweeter flavor accept convent counterpart found organ farm soil total carbon nitrogen greater microbi biomass activ higher concentr micronutri organ farm soil exhibit greater number endem gene greater function gene abund divers biogeochem process nitrogen fixat pesticid degrad conclusions signific find show organ strawberri farm produc higher qualiti fruit higher qualiti soil greater microbi function capabl resili stress find justifi addit investig aim detect quantifi effect interact
MED-1184~antagonist effect sulfid butyr prolifer colon mucosa potenti role agent pathogenesi ulcerativ pubm ncbi abstract shown fece patient ulcer coliti uniform sulfat reduc bacteria sulfid produc bacteria interfer butyrate depend energi metabol cultur colonocyt involv pathogenesi ulcer coliti mucos biopsi sigmoid rectum num patient caner polyp inflammatori bowel diseas incub nacl sodium hydrogen sulfid num mmol l combin sodium hydrogen sulfid butyr num mmol l butyr mucos prolifer assess bromodeoxyuridin label cell s phase compar nacl sulfid increas label entir crypt signific num num effect due expans prolif zone upper crypt compart num increas prolifer num sulfide induc hyperprolifer revers sampl coincub sulfid butyr studi show sodium hydrogen sulfid induc mucos hyperprolifer data support role sulfid pathogenesi uc confirm role butyr regul colon prolifer treatment uc
MED-1185~sulfit sensit signific human health pubm ncbi abstract endogen sulfit generat consequ body normal process sulfur contain amino acid sulfit occur consequ ferment occur natur number food beverag food addit sulfit agent num approv unit state long ago num long experi easi understand substanc regard safe varieti preserv properti includ control microbi growth prevent brown spoilag bleach food estim num num popul sulfite sensit individu live unit state sulfit sensit occur asthmat adults  predomin women uncommon report preschool children advers reaction sulfit nonasthmat extrem rare asthmat steroid depend higher degre airway hyperreact greater risk experienc reaction sulfite contain food limit popul sulfit sensit reaction vari wide rang reaction sever major reaction mild manifest includ dermatolog respiratori gastrointestin sign symptom sever nonspecif sign symptom occur common broncho constrict common sensit respons asthmat precis mechan sensit respons complet elucid inhal sulfur dioxid num generat stomach ingest sulfite contain food beverag defici mitochondri enzym ige medi immun respons implic abstract truncat num word
MED-1186~resist starch lower fecal concentr ammonia phenol human pubm ncbi abstract investig effect resist starch rs marker colon protein metabol eleven subject particip random crossov studi consum high r num num g d chi sem low r num num g d diet num wk macronutri constant high r diet daili excret fecal nitrogen increas num num num num g d num excret fecal phenol fell num num num num mg d num fecal concentr ammonia decreas num num num num microgram g num phenol decreas num num num num microgram g num daili output urinari ammonia urea phenol total nitrogen chang signific ph decreas num num num num num high r period result suggest rs signific attenu accumul potenti harm byproduct protein ferment human colon
MED-1187~influenc dietari factor clinic ulcer coliti prospect cohort studi abstract background aim relaps ulcer coliti uc unknown dietari factor implic pathogenesi uc aim studi determin dietari factor increas risk relaps uc method prospect cohort studi perform uc patient remiss recruit district general hospit year determin effect habitu diet relaps relaps defin valid diseas activ index nutrient intak assess food frequenc questionnair categoris tertil adjust odd ratio relaps determin multivari logist regress control non dietari factor result total num patient recruit num complet studi fifti cent patient relaps consumpt meat odd ratio num num confid interv ci num num red process meat num num ci num num protein num num ci num num alcohol num num ci num num top tertil intak increas likelihood relaps compar bottom tertil intak high sulphur num num ci num num sulphat num num ci num num intak relaps offer explan observ increas likelihood relaps conclus potenti modifi dietari factor high meat alcohol beverag intak identifi increas likelihood relaps uc patient studi determin sulphur compound food mediat likelihood relaps reduc intak reduc relaps frequenc
MED-1188~inflammatori bowel diseas rural sub saharan africa rariti diagnosi patient attend mission hospit pubm ncbi abstract hundr eighteen missionari work num mission station hospit num sub saharan african countri provid inform medic practic preced year num detail collect total number patient admit year number case bloodi diarrhoea typhoid inflammatori bowel diseas num million outpati num inpati treat includ num case bloodi diarrhoea num typhoid twenty two case inflammatori bowel diseas report histolog support west africa num hospit access facil frequenc inflammatori bowel diseas sub saharan africa difficult limit access diagnost facil time reliabl estim incid preval crohn diseas ulcer coliti rural african popul made
MED-1190~high high density lipoprotein cholesterol african children adult popul free coronari heart disea abstract serum concentr high dens lipoprotein cholesterol proport constitut total serum cholesterol high children low suffer coronari heart diseas chd studi elder black african western transvaal show free chd hdl concentr measur birth group num num year old num num year num num year old show valu num num num num mmol l num num num mg num ml concentr constitu num num num total cholesterol valu fall youth age white rural south african black live diet high fibr low anim protein fat children activ adult remain activ high valu hdl repres popul activ frugal tradit diet free chd
MED-1192~blood pressur lower drug prevent cardiovascular diseas meta analysi num randomis trial context expect prospect epidemiolog studi abstract object determin quantit efficaci class blood pressur lower drug prevent coronari heart diseas chd stroke receiv treatment design meta analysi data sourc medlin num studi select randomis trial blood pressur lower drug record chd event stroke num trial studi differ blood pressur studi drug placebo control group receiv studi drug blood pressur differ trial num trial compar drug drug comparison trial trial randomis group fell categori result interpret context expect largest publish meta analysi cohort studi total num num peopl particip num num peopl defin mutual exclus categori particip histori vascular diseas histori chd histori stroke result blood pressur differ trial blocker special effect due blood pressur reduct prevent recurr chd event peopl histori chd risk reduct num confid interv num num compar num num trial drug extra effect limit year myocardi infarct risk reduct num compar num peopl chd recent infarct num blood pressur differ trial exclud chd event trial blocker peopl chd num reduct chd event num num num num reduct stroke blood pressur reduct num mm hg systol num mm hg diastol similar reduct num chd num stroke expect differ blood pressur cohort studi meta analysi indic benefit explain blood pressur reduct main class blood pressur lower drug thiazid blocker angiotensin convert enzym inhibitor angiotensin receptor blocker calcium channel blocker similar effect percentag point prevent chd event stroke calcium channel blocker greater prevent effect stroke relat risk num num confid interv num num percentag reduct chd event stroke similar peopl cardiovascular diseas blood pressur treatment num mm hg systol num mm hg diastol combin result studi meta analys blood pressur cohort studi trial determin blood pressur lower effect drug dose show peopl age num diastol blood pressur treatment num mm hg drug half standard dose combin reduc risk chd estim num stroke num drug standard dose half effect present meta analysi show drug calcium channel blocker non cardioselect blocker reduc incid heart failur num num calcium channel blocker num num conclus extra protect effect blocker short myocardi infarct minor addit effect calcium channel blocker prevent stroke class blood pressur lower drug similar effect reduc chd event stroke reduct blood pressur exclud materi pleiotrop effect proport reduct cardiovascular diseas event similar pretreat blood pressur presenc absenc exist cardiovascular diseas guidelin blood pressur lower drug simplifi drug offer peopl level blood pressur result import lower blood pressur age measur treat
MED-1193~effect lower ldl cholesterol statin therapi peopl low risk vascular diseas meta analysi individu data num randomis trial summari background statin reduc ldl cholesterol prevent vascular event net effect peopl low risk vascular event remain uncertain method meta analysi includ individu particip data num trial statin versus control num num ldl cholesterol differ num num mmol l median follow up num num year trial versus statin num num differ num num mmol l num num year major vascular event major coronari event non fat myocardi infarct coronari death stroke coronari revascularis particip separ categori baselin num year major vascular event risk control therapi statin low intens statin num num num num num num num num rate ratio rr num num mmol l ldl cholesterol reduct estim find reduct ldl cholesterol statin reduc risk major vascular event rr num num ci num num num num num num mmol l reduct larg irrespect age sex baselin ldl cholesterol previous vascular diseas vascular all caus mortal proport reduct major vascular event big lowest risk categori higher risk categori rr num num mmol l reduct lowest highest risk num num ci num num num num num ci num num num num num ci num num num num num ci num num num num num num ci num num num num trend num num reflect signific reduct lowest risk categori major coronari event rr num num ci num num num num num num num num ci num num num num num num coronari revascularis rr num num ci num num num num num num ci num num num num num num stroke reduct risk particip num year risk major vascular event lower num rr num num mmol l ldl cholesterol reduct num num ci num num num num num num similar higher risk categori trend num num particip histori vascular diseas statin reduc risk vascular rr num num mmol l ldl cholesterol reduct num num ci num num num num all caus mortal rr num num ci num num num num proport reduct similar baselin risk evid reduct ldl cholesterol statin increas cancer incid rr num num mmol l ldl cholesterol reduct num num ci num num num num cancer mortal rr num num ci num num num num non vascular mortal interpret individu num year risk major vascular event lower num num mmol l reduct ldl cholesterol produc absolut reduct major vascular event num num num year benefit great exceed hazard statin therapi present guidelin individu typic regard suitabl ldl lower statin therapi present report suggest guidelin reconsid fund british heart foundat uk medic research council cancer research uk european communiti biom programm australian nation health medic research council nation heart foundat australia
MED-1194~noncommunic diseas prevent lesson studi popul individu pubm ncbi abstract noncommunic diseas ncds main cancer cardiovascular diseas diabet chronic respiratori diseases  ar respons two third death worldwid low middle incom countri urgent polici strategi prevent ncds reduc major risk factor effect approach large scal ncd prevent includ comprehens tobacco alcohol control tax regul sale advertis reduc dietari salt unhealthi fat sugar regul well design public educ increas consumpt fresh fruit veget healthi fat grain lower price improv avail implement univers effect equit primary car system reduc ncd risk factor includ cardiometabol risk factor infect precursor ncds clinic intervent
MED-1195~antioxid status associ elev depress symptom adult nation health nutrit examin survey num num abstract examin relationship elev depress symptom antioxid status cross sect data nation health nutrit examin survey num num adult age num num year analyz depress symptom measur patient health questionnair score cutpoint num defin elev depress symptom serum antioxid status measur serum level carotenoid retinol free retinyl ester vitamin vitamin main analys consist multipl logist zero infl poisson regress model account sampl design complex final sampl consist num adult complet data higher total carotenoid serum level lower likelihood elev depress symptom reduct odd num sd increas exposur num women num dose respons relationship observ serum total carotenoid express quartil num num num mol l num num num mol l num num ci num num num p valu trend num signific associ found antioxid level carotenoid caroten men women combin lutein zeaxanthin women control dietari lutein zeaxanthin intak supplement independ invers associ elev depress symptom adult serum antioxid signific associ depress symptom independ total carotenoid covari conclus total carotenoid caroten lutein zeaxanthin serum reduc level depress symptom community dwel adult
MED-1196~dietari pattern depress symptom middl age abstract background studi diet depress focus primarili individu nutrient aim examin associ dietari pattern depress diet approach method analys carri data num particip num women age num year whitehal ii prospect cohort dietari pattern identifi food heavili load veget fruit fish process food heavili load sweeten dessert fri food process meat refin grain high fat dairi product self report depress assess num year center epidemiolog studi depress ces scale result adjust potenti confound particip highest tertil food pattern lower odd ces depress num num ci num num lowest tertil contrast high consumpt process food increas odd ces depress num num ci num num conclus middle ag particip process food dietari pattern risk factor ces depress num year food pattern protect
MED-1198~high dos ascorb acid increas intercours frequenc improv mood random control clinic trial pubm ncbi abstract background ascorb acid aa modul catecholaminerg activ decreas stress reactiv approach anxieti prolactin releas improv vascular function increas oxytocin releas process relev sexual behavior mood method random double blind placebo control num day trial sustained releas aa num healthi young adult num mg day ceteb placebo num healthi young adult subject partner record penile vagin intercours fsi noncoit partner sex masturb daili diari complet beck depress inventori trial result aa group report greater fsi hypothes sexual behavior frequenc effect promin subject cohabit sexual partner women aa placebo group experienc decreas beck depress score conclus aa increas fsi differenti benefit noncohabit suggest central activ disinhibit peripher mechan respons
MED-1199~tomato rich diet relat depress symptom elder popul age num year population bas cross sect analysi pubm ncbi abstract background enhanc oxid stress defect anti oxid defens relat pathogenesi depress symptom lycopen power antioxid carotenoid aim studi investig relationship veget includ tomatoes tomato product major sourc lycopen depress symptom community bas elder popul method analyz cross sect survey includ num community dwel elder japanes individu age num year older dietari intak assess valid self administ diet histori questionnair depress symptom evalu num item geriatr depress scale num cut off point num mild sever num sever anti depress agent result preval mild sever sever depress symptom num num adjust potenti confound factor odd ratio mild sever depress symptom increas level tomatoes tomato product num num num trend num similar relationship observ case sever depress symptom contrast relationship observ intak kind veget depress symptom limit cross sect studi make clinic diagnosi depress episod conclus studi demonstr tomato rich diet independ relat lower preval depress symptom result suggest tomato rich diet benefici effect prevent depress symptom studi confirm find copyright num elsevi reserv
MED-1200~antioxid potenti therapeut neuropsychiatr disord abstract oxid stress implic pathophysiolog neuropsychiatr disord schizophrenia bipolar disord major depress genet nongenet factor found increas cellular level reactiv oxygen speci capac antioxid defens mechan patient psychiatr disord factor trigger oxid cellular damag lipid protein dna lead abnorm neural growth differenti therapeut strategi supplement antioxid effect long term treatment manag neuropsychiatr disord antioxid pufa supplement treatment neuropsychiatr disord provid promis result time cautious antioxid excess antioxid danger interfer protect function reactiv oxygen speci present articl give overview potenti strategi outcom antioxid therapeut psychiatr disord
MED-1201~dietari folat risk depress finnish middle ag men prospect follow up studi pubm ncbi abstract background cross sect studi focus low blood folat level depress patient prospect studi publish associ dietari folat depress method studi associ dietari folat cobalamin receiv discharg diagnosi depress prospect follow up set cohort recruit num num end num consist num men age num num year eastern finland result intak folat cohort num microg day sd num median energy adjust folat intak higher risk discharg diagnosi depress rr num num ci num num follow up period folat intak median excess risk remain signific adjust current socioeconom status baselin hpl depress score energy adjust daili intak fibr vitamin total fat intak conclus low dietari intak folat risk factor sever depress nutrit role prevent depress
MED-1202~low folat risk factor depress meta analysi explor heterogen abstract low folat causat link depress research contradictori associ aris due chanc bias confound revers causal systemat review observ studi examin associ depress folat conduct num relev studi num num particip case control studi popul survey cohort studi examin risk depress presenc low folat found pool show signific relationship folat status depress odd ratio pool unadjust num num ci num num relationship remain adjust potenti confound pool adjust num num ci num num folat level lower depress accumul evid low folat status depress evid case control cross section studi cohort studi definit randomis control trial test therapeut benefit folat requir confirm refut causal relationship
MED-1203~folic acid supplement prevent mood disord young peopl famili risk randomis doubl blind placebo control trial pubm ncbi abstract background clinic mood disord clinic manifest teenag year earli twenti poor long term prognosi primari prevent disord great public health nutrit supplement feasibl intervent primari prevent epidemiolog studi link low folat status depress symptomatolog general popul method randomis doubl blind parallel group placebo control trial particip age num year increas famili risk mood disord randomis folic acid num mg daili ident placebo liquid maximum num month primari outcom data onset dsm iv mood disord collect num particip num group result incid mood disord folic acid placebo group num num non signific differ post hoc evid folic acid delay time onset mood disord particip unwel limit small sampl size rate onset mood disord lower expect conclus long term folic acid supplement toler high level adher evid reduc incid mood disord compar placebo copyright num elsevi reserv
MED-1204~cholesterol crystal mechan damag biolog membran propos mechan plaqu ruptur eros lead arteri thromb pubm ncbi abstract background plaqu ruptur and or eros lead cardiovascular event process understood morpholog characterist ruptur plaqu observ static histolog imag dynam plaqu ruptur elucid process plaqu ruptur investig transform cholesterol liquid solid crystal determin grow crystal capabl injur plaqu cap hypothesi hypothes cholesterol crystal spatial configur rapid caus forc expans sharp edg crystal damag plaqu cap method experi perform vitro cholesterol powder melt graduat cylind crystal room temperatur volum liquid solid state measur time thin biolog membran num microm put path grow crystal determin damag crystal result cholesterol crystal peak volum increas rapid num num min sharp tip crystal cut tore membran amount cholesterol peak level crystal growth correl direct num num amount cholesterol rate crystal growth num num conclus observ suggest crystal supersatur cholesterol atherosclerot plaqu induc cap ruptur and or eros insight develop therapeut strategi alter cholesterol crystal prevent acut cardiovascular event
MED-1205~effect cholesterol crystal plaqu intima arteri patient acut coronari cerebrovascular syndrom pubm ncbi abstract plaqu disrupt pd acut cardiovascular event cholesterol crystal ccs observ plaqu role pd unknown cholesterol expand crystal tear perfor fibrous tissu studi test hypothesi ccs damag plaqu intima trigger pd observ tissu prepar ethanol solvent dissolv ccs coronari arteri patient die acut coronari syndrom num non acut coronari syndrom num carotid plaqu patient num num neurolog symptom studi sampl examin ccs perfor intima light scan electron microscopi sem ethanol vacuum dehydr addit fresh unfix carotid plaqu examin num degre confoc microscopi crystal content sem score num num sem vacuum dehydr signific higher crystal content compar sem ethanol dehydr num num num num num enhanc detect cc perfor presenc ccs sem confoc microscopi similar suggest cc perfor occur vivo num degre patient acut coronari syndrom perfor ccs present patient acut coronari syndrom num plaqu strong associ ccs pd thrombus symptom num plaqu size num crystal content independ predictor thrombus symptom conclus avoid ethanol tissu prepar ccs perfor intima shown pd crystal content signific clinic event suggest cholesterol crystal role pd
MED-1207~cholesterol crystal pierc arteri plaqu intima trigger local system inflamm pubm ncbi abstract respons arteri wall injuri inflammatori process time integr develop atherosclerosi subsequ plaqu instabl injuri agent critic process receiv attent review model plaqu ruptur hypothes stage inflammatori activ stage cholesterol crystal induc cell injuri apoptosi intracellular cholesterol crystal induc foam cell apoptosi set vicious cycl signal macrophag result accumul extra cellular lipid local inflamm eventu lead format semi liquid lipid rich necrot core vulner plaqu stage ii cholesterol crystal induc arteri wall injuri satur lipid core prime crystal manifest clinic syndrom system inflamm respons cholesterol crystal trigger core expans lead intim injuri recent demonstr cholesterol crystal liquid solid state undergo volum expans tear plaqu cap observ cholesterol crystal perfor cap intim surfac made plaqu patient die acut coronari syndrom demonstr agent statin aspirin ethanol dissolv cholesterol crystal exert benefit direct mechan recent studi demonstr high sensit c reactiv protein reliabl marker select patient statin therapi reflect presenc intim injuri cholesterol crystal demonstr atherosclerot rabbit model propos cholesterol crystal explain part local system inflamm atherosclerosi copyright num nation lipid associ publish elsevi reserv
MED-1208~death row nutrit curious conclus meal pubm ncbi abstract grow macabr fascin meal offer window one true consumpt desir one futur discount close contrast popular anecdot individu case studi creat empir catalog actual meal final food request num individu execut unit state recent five year period content analys reveal key find num averag meal calor rich num calori proport averag num time daili recommend serv protein fat num frequent request calori dens meat num fri food num dessert num soft drink num num num request brand food beverag find respect consist model environment conting tempor discount consist studi food mediat feel stress distress peopl warn ill effect obes counterintuit engag unhealthi overconsumpt find suggest studi relat artifici mortal salienc campaign obes copyright num elsevi reserv
MED-1209~adher healthi lifestyl habit adult num pubm ncbi abstract background lifestyl choic cardiovascular diseas mortal purpos studi compar adher healthi lifestyl habit adult num num method analysi adher num healthi lifestyl trend num fruit vegetables day regular exercis num times month maintain healthi weight bodi mass index num num kg m num moder alcohol consumpt num drink day women num day men smoke nation health nutrit examin survey num compar result nation health nutrit examin survey num adult age num year result num year percent adult age num year bodi mass index num kg m num increas num num num physic activ num time month decreas num num num smoke rate chang num num eat num fruit veget day decreas num num num moder alcohol increas num num num adher num healthi habit num num num adher healthi lifestyl lower minor adher decreas non hispan white period individu histori hypertension diabetes cardiovascular diseas adher healthi lifestyl peopl condit conclus general adher healthi lifestyl pattern decreas num year decreas document num num healthi lifestyl habit find broad implic futur risk cardiovascular diseas adult
MED-1210~compar indic diet qualiti chronic diseas mortal risk postmenopaus women women health initi observ studi pubm ncbi abstract poor diet qualiti thought lead risk factor year life lost examin score num common diet qualiti indices th healthi eat index num hei altern healthi eat index num ahei altern mediterranean diet ame dietari approach stop hypertens dash are relat risk death cardiovascular diseas cvd cancer postmenopaus women prospect cohort studi includ num particip women health initi observ studi num complet food frequenc questionnair enrol cox proport hazard model fit person year time metric estim multivari hazard ratio num confid interv death increas quintil diet qualiti index score num year follow up num death occur includ num cvd num cancer indic adjust multipl covari diet qualiti assess hei ahei ame dash score statist signific num num lower all caus cvd mortal risk higher hei ame dash ahei score statist signific num num lower risk cancer death result suggest postmenopaus women consum diet line priori diet qualiti indic lower risk death chronic diseas publish oxford univers press behalf john hopkin bloomberg school public health num work written govern employe public domain
MED-1211~tempor region trend preval healthi lifestyl characterist unit state num num abstract object examin tempor region trend preval health lifestyl unit state method num num data behavior risk factor surveil system assess num healthi lifestyl characterist healthi weight smoke consum fruit veget engag physic activ concurr presenc num characterist defin healthi lifestyl logist regress assess tempor region trend result percentag individu smoke num increas healthi weight num decreas show strongest tempor num num chang fruit veget consumpt physic activ preval healthi lifestyl increas minim time vari modest region num percentag higher northeast num west num south num midwest num conclus larg increas overweight declin smoke net chang preval healthi lifestyl region differ preval healthi lifestyl unit state remain low
MED-1212~healthi lifestyl characterist adult unit state num pubm ncbi abstract background public health recommend clinic guidelin emphas import healthi lifestyl recent epidemiolog studi demonstr healthi lifestyl substanti health benefit object studi report preval healthi lifestyl characterist hlcs generat singl indic healthi lifestyl method nation data year num obtain behavior risk factor surveil system consist annual statewid random digit di household telephon survey defin num hlcs nonsmok healthi weight bodi mass index calcul weight kilogram divid squar height meter num num consum num fruit veget day regular physic activ num minut num time week num hlcs sum creat healthi lifestyl index rang num pattern num hlcs defin singl healthi lifestyl indic report preval hlc indic major demograph subgroup result data num adult preval num confid interv individu hlcs nonsmok num num num healthi weight num num num num fruit veget day num num num regular physic activ num num num preval healthi lifestyl indic num hlcs num num confid interv num num variat subgroup rang num num conclus data illustr healthi lifestyle defin combin num hlcs was undertaken adult unit state subgroup combin level remot consist clinic public health recommend
MED-1213~cardiovascular health behavior health factor num num project num abstract background american heart associ num strateg impact goal target num relat improv cardiovascular health num health behavior smoke diet physic activ bodi mass num health factor plasma glucos cholesterol blood pressur metric sought defin current trend forward project num cardiovascular health method result includ num cardiovascular diseas free adult age num year nation health nutrit examin survey num num subsequ num year cycl num num calcul popul preval poor intermedi ideal health behavior factor comput composit individual level cardiovascular health score num metric poor num point intermedi num point ideal num point total rang num num point preval current smoke hypercholesterolemia hypertens declin preval obes dysglycemia increas num physic activ level low diet qualiti score chang minim project num suggest obes impair fast glucose diabet mellitus increas affect num num men num num women population level cardiovascular health project improv num num current trend continu individual level cardiovascular health score project num men num num confid interv num num women num num confid interv num num fall level achiev num improv men num women num conclus american heart associ num target improv cardiovascular health num num reach current trend continu
MED-1215~clostridium difficil coliti unit state decad trend outcom risk factor colectomi mortal colectomi pubm ncbi abstract background clostridium difficil coliti cdc major health concern unit state earlier report demonstr rise incid studi analyz predictor total colectomi mortal colectomi limit small number studi design nationwid inpati sampl nis num num retrospect review cdc trend colectomi mortal rate patient hospit variabl lasso algorithm logist regress num fold cross valid build predict model colectomi requir mortal colectomi associ colectomi day mortal examin multivari logist regress analysi result estim num num discharg diagnosi cdc identifi decad colectomi requir num case num mortal num compar num num period num num period wit num increas rate cdc num increas rate colectomi lasso algorithm identifi predictor colectomi coagulopathi odd ratio num weight loss num teach hospit num fluid electrolyt disord num larg hospit num predictor mortal colectomi coagulopathi num age greater num year num acut renal failur num respiratori failur num sepsi num peripher vascular diseas num congest heart failur num surgeri num day admiss higher mortal rate num num ci num num num conclus clostridium difficil coliti increas increas total colectomi mortal rate colectomi remain elev progress colectomi mortal patient hospit factor knowledg risk factor risk stratif counsel copyright num american colleg surgeon publish elsevi reserv
MED-1216~clostridium difficil infect communiti zoonot diseas pubm ncbi abstract clostridium difficil infect cdis tradit elder hospit patient antibiot therapi communiti cdis requir visit general practition increas occur young healthi individu predispos factor difficil found commens pathogen intestin tract mammal bird reptil environ includ soil water difficil ubiquit base limit evid food product process meat fish veget difficil studi conduct europ report lower preval rate north america absolut count toxigen difficil environ food low exact infecti dose unknown date direct transmiss difficil anim food environ human proven similar pcr ribotyp found epidemiolog human cdi driven amplif anim sourc outbreak cdi report human communiti host factor increas vulner cdi import increas exposur difficil convers emerg difficil ribotyp num found high number piglet calv environ direct evid prove transmiss human circumstanti evid point zoonot potenti type futur emerg pcr ribotyp zoonot potenti consid num author clinic microbiolog infect num european societi clinic microbiolog infecti diseas
MED-1217~clostridium difficil potenti sourc foodborn diseas pubm ncbi abstract clostridium difficil recogn import human pathogen decad import agent anim diseas establish recent number report difficil food rise find vari studi north america preval contamin retail meat meat product rang num num european countri percentag difficil posit sampl lower num chapter summar current data associ difficil food difficulti isol organ discuss potenti difficil food transmit pathogen copyright num elsevi reserv
MED-1218~longitudin studi clostridium difficil methicillin resist staphylococcus aureus pig wean end pubm ncbi abstract recent increas community associ infect link methicillin resist staphylococcus aureus mrsa clostridium difficil establish pathogen recov retail pork unclear degre contamin acquir farm comparison acquir process address gap studi report carriag mrsa difficil pig birth end process difficil isol num num pig num day age preval declin sharpli num num market age num day mrsa preval peak num day age num num pig test posit declin num num num day age pig detect posit market age process facil difficil isol hold area singl carcass test posit pathogen preeviscer mrsa primarili isol nasal swab num carcass test posit postble increas num posit postscald tank carcass sampl postble test posit mrsa recoveri pathogen environment sampl difficil ribotyp num predomin longitudin portion studi account num isol recov pig difficil isol identifi ribotyp num recov slaughterhous mrsa spa type num num predomin pig farm sampl slaughterhous account num isol recov studi demonstr difficil mrsa acquir farm transfer process evid signific cross contamin carcass slaughterhous environ evid
MED-1219~divers sourc difficil infect identifi whole genom sequenc abstract background thought clostridium difficil infect transmit predomin health care set endem spread hamper identif precis sourc infect assess efficaci intervent method septemb num march num perform whole genom sequenc isol obtain symptomat patient difficil infect identifi health care set communiti oxfordshir unit kingdom compar single nucleotid variant snvs isol difficil evolut rate estim basi sampl obtain num patient num num snvs expect transmit isol obtain num day basi num predict interv identifi plausibl epidemiolog link genet relat case data hospit admiss communiti locat result num difficil case evalu num success sequenc comparison num sampl obtain april num march num obtain septemb num onward total num isol num num snvs num earlier case num isol num num snvs previous case reduct incid time similar group find suggest effect intervent target transit exposur diseas num patient num snvs consist transmiss num patient num close hospit contact patient num patient num hospit communiti contact patient distinct subtyp infect continu identifi studi suggest reservoir difficil conclus num year period num difficil case oxfordshir genet distinct previous case genet divers sourc addit symptomat patient play major part difficil transmiss fund clinic research collabor translat infect research initi
MED-1220~clostridium difficil infect human piglet health opportun pubm ncbi abstract clostridium difficil infecti diarrhoea human anim found diarrhoeal non diarrho pig hors cattl suggest potenti reservoir human insect num meat product canada usa suggest possibl albeit proven food born transmiss complet clear excess antimicrobi exposur drive establish difficil anim manner analog human infect organ normal flora anim gastrointestin tract pcr ribotyp num common ribotyp difficil found pig num studi usa cattl num ribotyp common ribotyp difficil found human infect europ human pig strain difficil genet ident europ confirm zoonosi exist rate community acquir difficil infect cdi increas world wide fact sit notion anim reservoir human infect problem requir resolut human health issu anim health issu factor common problem environment contamin success deal recent epidemiolog cdi requir health approach involv human health physician veterinarian environment scientist
MED-1221~clostridium difficil food anim histori measur reduc exposur pubm ncbi abstract articl summar chang epidemiolog clostridium difficil infect cdi human emerg presenc difficil food anim measur reduc human exposur import pathogen infrequ address cdis tradit assum restrict health car set recent molecular studi longer case anim food involv chang epidemiolog cdis human genom sequenc disprov person to person transmiss hospit zoonot foodborn transmiss confirm evid suscept peopl inadvert expos difficil food anim environ strain epidem clone present human common companion food anim raw meat poultri product veget ready to eat food includ salad order develop science bas prevent strategi critic understand difficil reach food human review contextu current understand cdis human anim food base inform propos list educ measur reduc exposur suscept peopl difficil enhanc educ effort behavior chang target medic non med personnel
MED-1223~cow milk consumpt insulin lik growth factor i human biolog life histori approach pubm ncbi abstract object assess life histori consequ cow milk consumpt stage earli life prenat adolesc regard linear growth age menarch role insulin lik growth factor igf i mediat relationship milk growth develop long term biolog outcom method unit state nation health nutrit examin survey nhane data num num review exist literatur result literatur support milk role enhanc growth earli life prior age num year support relationship middl childhood milk earli menarch acceler linear growth adolesc nhane data show posit relationship milk intak linear growth earli childhood adolesc middl childhood period slow growth igf i candid bioactiv molecul link milk consumpt rapid growth develop mechan exert effect unknown conclus routin milk consumpt evolutionarili dietari behavior potenti alter human life histori paramet vis vis linear growth turn negat long term biolog consequ copyright num wiley period
MED-1224~skim milk whey casein increas bodi weight whey casein increas plasma c peptid concentr overweight adolesc pubm ncbi abstract adult dietari protein induc weight loss dairi protein insulinotrop effect milk protein adolesc unclear object test milk milk protein reduc bodi weight waist circumfer homeostat model assess plasma insulin insulin secret estim plasma c peptid concentr overweight adolesc overweight adolesc num age num bmi num num kg m num sd random num l d skim milk whey casein water num wk milk drink num protein l random subgroup adolesc num studi num wk intervent began pretest control group effect milk bas test drink compar baselin wk num water group pretest control group diet physic activ regist outcom bmi for ag z score baz waist circumfer plasma insulin homeostat model assess plasma c peptid found chang baz pretest control water group greater num wk skim milk whey casein group compar baselin water pretest control group plasma c peptid concentr increas baselin wk num whey casein group increment greater pretest control num signific plasma c peptid skim milk water group data suggest high intak skim milk whey casein increas baz overweight adolesc whey casein increas insulin secret effect bodi weight primari secondari increas insulin secret remain elucid
MED-1226~milk intak total dairi consumpt associ earli menarch nhane num abstract background compon dairi product link earlier menarch methods find studi assess posit associ exist childhood milk consumpt age menarch likelihood earli menarch num yrs sampl data deriv nation health nutrit examin survey nhane num num sampl util num women age num num yrs num girl age num num yrs regress analysi weak negat relationship found frequenc milk consumpt num num yrs age menarch daili milk intak num num sometimes vari milk intak num num compar intak rarely nev cox regress yield greater risk earli menarch drank milk sometimes vari daili never rar hr num num hr num num num num yr cox regress total dairi kcal calcium protein daili milk intak past num day contribut earli menarch girl middl tertil milk intak margin lower risk earli menarch highest tertil hr num num lowest tertil dairi fat intak greater risk earli menarch highest hr num num hr num num lowest middl tertil lowest calcium intak lower risk earli menarch hr num num highest tertil relationship remain adjust overweight overweight height percentil increas risk earlier menarch black white reach menarch earli hr num num control overweight conclus evid greater milk intak increas risk earli menarch lower age menarch
MED-1227~breast feed delay introduct solid food protect subsequ obes pubm ncbi abstract correct methodolog flaw type ii error confound variabl nonblind previous studi relat infant feed obes conduct case control studi num patient num num year age attend adolesc clinic num similar age healthi children attend montreal high school subject classifi obes overweight nonobes base measur height weight tricep subscapular skinfold feed histori famili histori demograph data ascertain blind telephon interview analysi raw data reveal signific elev estim relat risk breast feed signific trend rate breast feed weight group magnitud protect effect rise slight increas durat breast feed delay introduct solid food provid addit benefit demograph clinic variabl prove confound signific protect effect breast feed persist control confound conclud breast feed protect obes attribut conflict result previous studi insuffici attent methodolog standard
MED-1229~milk food genet transfect system activ mtorc num signal postnat growth abstract milk recogn repres function activ nutrient system promot neonat growth mammal cell growth regul nutrient sensit kinas mechanist target rapamycin complex num mtorc num lack inform mechan mtorc num up regul milk consumpt review present milk materno neonat relay system function transfer preferenti amino acid increas plasma level glucose depend insulinotrop polypeptid gip glucagon lik peptid num glp num insulin growth hormon gh insulin lik growth factor num igf num mtorc num activ import milk exosom regular microrna num repres genet transfect system enhanc mtorc num driven metabol process human breast milk ideal food infant postnat growth species specif metabol program persist high milk signal adolesc adulthood continu cow milk consumpt promot mtorc num driven diseas civil
MED-1230~relationship fund sourc outcom obesity rel research pubm ncbi abstract studi examin relationship fund sourc outcom publish obesity rel research list fund project human nutrit research link food intak obes num drawn distinct sourc feder government semi publ generic commod promot checkoff program fluid milk dairi nation institut health nih princip investig fund project determin publish literatur individu locat ovid medlin pubm author search articl relat dairi obes includ financi sponsorship articl articl conclus classifi independ group co investig seventy nin relev articl includ studi num sponsor checkoff program num nih studi find consist evid checkoff fund project support obes prevent benefit dairi consumpt studi identifi research methodolog investig bias sourc sponsorship copyright num elsevi reserv
MED-1231~lower lifetim dietari fiber intak carotid arteri stiff amsterdam growth health longitudin studi pubm ncbi abstract background fiber intak lower cardiovascular diseas risk arteri stiff influenc lifetim fiber intak associ explain part cardioprotect effect attribut fiber intak object object investig lower intak fiber fiber rich food young life adolesc adulthood arteri stiff adulthood design longitudin cohort studi num particip dietari intak assess age num num num repeat measur median num arteri stiff estim num larg arteri ultrasonographi ascertain age num result adjust sex height total energi intak lifestyl variabl subject stiffer carotid arteri consum fiber g d num studi stiff carotid arteri defin basi highest compar lowest sex specif tertil distens complianc coeffici revers young elast modulus num num ci num num num num num num num num subject stiffer carotid arteri character lower lifetim consumpt fruit veget grains deleteri associ explain great extent relat low fiber intak conclus lower lifetim intak fiber young age carotid arteri stiff adulthood promot consumpt fiber rich food young offer prevent acceler arteri stiffen adulthood relat cardiovascular sequela
MED-1232~high dietari fiber intak prevent stroke popul level pubm ncbi abstract background aim research aim clarifi high dietari fiber intak impact incid risk stroke popul level method num unselect subject dietari fiber intak dfi detect num year population bas studi dietari variabl anagraph biometr blood pressur heart rate blood lipid glucos insulin uricaemia fibrinogenaemia erytrosediment rate diabet insulin resist smoke pulmonari diseas left ventricular hypertrophi covari result adjust cox model high dfi reduc risk stroke analysi base quintil fiber intak adjust confound hr incid stroke lower daili intak solubl fiber num insolubl fiber num multivari analys valu cut off dfi risk stroke lower intak cut off solubl hr num num num insolubl hr num num num fiber incid stroke lower num num num num conclus higher dietari dfi invers independ incid risk stroke general popul copyright num elsevi european societi clinic nutrit metabol reserv
MED-1233~dietari fiber intak risk stroke systemat review meta analysi pubm ncbi abstract background purpos fiber intak reduc stroke risk prospect studi meta analysi publish date method multipl electron databas search healthi particip studi report fiber intak incid hemorrhag ischem stroke publish januari num num result cohort studi unit state northern europ australia japan met inclus criteria total dietari fiber intak invers risk hemorrhag ischem stroke evid heterogen studi num relat risk num g day num num confid interv num num num num solubl fiber intak num g day stroke risk reduct evid low heterogen studi relat risk num num confid interv num num num num studi report stroke risk relat insolubl fiber fiber cereal fruit veget conclus greater dietari fiber intak signific lower risk stroke find support dietari recommend increas intak total dietari fiber pauciti data fiber food preclud conclus associ fiber type stroke futur studi focus fiber type examin risk ischem hemorrhag stroke separ
MED-1234~cardiovascular benefit dietari fiber pubm ncbi abstract relationship dietari fiber risk cardiovascular diseas cvd extens studi epidemiolog evid indic invers associ dietari fiber intak cvd risk associ found stronger cereal fiber fruit veget fiber studi found increas grain consumpt cvd risk reduct light evid recent dietari guidelin endors increas consumpt fiber rich grain regular consumpt dietari fiber fiber cereal sourc improv cvd health multipl mechan includ lipid reduct bodi weight regul improv glucos metabol blood pressur control reduct chronic inflamm futur research focus food sourc fiber includ type grain legum fruit veget nut resist starch relat cvd risk weight control explor biolog mechan cardioprotect effect fiber rich diet studi ethnic group popul vari sourc dietari fiber
MED-1236~pathogenesi type num diabet trace revers rout cure pubm ncbi abstract metabol abnorm type num diabet revers reproduc bariatr surgeri quantifi major pathophysiolog abnorm insulin secret insulin action surgeri sequenc event lead restor normal metabol defin liver fat level fall day normal hepat insulin sensit restor simultan plasma glucos level return normal insulin sensit muscl remain abnorm week month bariatr surgeri effect surgeri explic sole term energi restrict combin inform prospect observ immedi preced onset type num diabet clear pictur emerg insulin resist muscl caus inherit environment factor facilit develop fatti liver posit energi balanc establish increas insulin secret requir maintain plasma glucos level increas liver fat deposit fatti liver resist insulin suppress hepat glucos output rais plasma triacylglycerol exposur beta cell increas level fatti acid deriv circul local deposit triacylglycerol suppress glucose medi insulin secret revers initi eventu perman essenti time sequenc pathogenesi type num diabet evid muscl insulin resist determin rate fatti liver progress ectop fat deposit liver islet relat dynam defect hepat insulin resist beta cell dysfunct defect capabl dramat revers hypoenerget feed condit complet earli diabet worthwhil extent establish diseas
MED-1237~bant memori lectur num revers twin cycl type num diabet abstract wide accept type num diabet inevit life long irrevers progress beta cell damag restor normal glucos metabol day bariatr surgeri major peopl type num diabet disprov concept doubt revers diabet depend sudden profound decreas food intak relat direct surgic effect counterpoint studi demonstr normal glucos level normal beta cell function restor low calori diet magnet reson method appli measur intra organ fat result show time cours resolut hepat insulin sensit day rapid fall liver fat normalis fast glucos level return normal beta cell insulin secret week step fall pancrea fat observ pathophysiolog event revers type num diabet revers time event determin onset condit identifi twin cycl hypothesi postul chronic calori excess lead accumul liver fat eventu spill pancrea self reinforc cycl liver pancrea eventu metabol inhibit insulin secret meal onset hyperglycaemia clear type num diabet revers condit intra organ fat excess peopl suscept
MED-1238~relationship dietari fat glucos metabol pubm ncbi abstract relationship dietari fat glucos metabol recogn num year experiment anim high fat diet result impair glucos toler impair decreas basal insulin stimul glucos metabol impair insulin bind and or glucos transport relat fatti acid composit membran induc dietari fat modif human high fat diet independ fatti acid profil report result decreas insulin sensit satur fat relat monounsatur polyunsatur fat deleteri respect fat induc insulin insensit advers effect induc fat feed amelior omega num fatti acid epidemiolog data human suggest subject higher intak fat prone develop disturb glucos metabol type num diabet impair glucos toler subject lower intak fat inconsist data attribut cluster high intak dietari fat anim fat obes inact metabol studi suggest higher fat diet higher proport unsatur fat result measur glucos metabol high carbohydr diet area dietari fat glucos metabol fulli elucid
MED-1240~updat manag postop nausea vomit pubm ncbi abstract antiemet drug develop formul guidelin risk evalu controversi occur area postop nausea vomit ponv develop improv understand prevent treatment ponv postanesthesia care unit discharg home hospit ward antiemet drug research result introduct second gener num hydroxytryptamin num ht num receptor antagonist palonosetron neurokinin num nk num receptor antagonist aprepit data exist antiemet frontier nausea vomit research therapi area postdischarg nausea vomit patient discharg home phase ii ambulatori stepdown unit hospit ward antiemet drug select depend efficaci cost safeti eas dose safeti concern arisen side effect antiemet specif effect ecg prolong qtc interv butyrophenon first gener num ht num receptor antagonist class antiemet impact pharmocogenet antiemet drug metabol result efficaci correl genet makeup affect drug respons discuss ethic ponv research initi meta analysi ponv studi guid antiemet select ponv therapi clinic practition societi ambulatori anesthesia samba ponv consensus guidelin introduc updat
MED-1241~control breath peppermint aromatherapi postop nausea and or vomit symptom relief random control trial pubm ncbi abstract purpos scientif evid support aromatherapi postop nausea and or vomit ponv symptom studi evalu control breath peppermint aromatherapi ar control breath cb ponv relief design singl blind random control trial design method initi ponv complaint symptomat subject receiv cb num ar num intervent base random enrol treatment repeat num minut final assess occur num minut post initi treatment rescu medic offer persist symptom find elig subject ponv incid num num gender risk factor contribut ponv symptom num statist signific cb efficaci ar num versus num conclus cb initi delay altern prescrib antiemet data support peppermint ar conjunct cb ponv relief copyright num american societi perianesthesia nurs publish elsevi reserv
MED-1242~simplifi risk score predict postop nausea vomit conclus cross valid center pubm ncbi abstract background recent center independ develop risk score predict postop nausea vomit ponv studi investig num risk score valid center num risk score base logist regress coeffici simplifi loss discrimin power method adult patient center oulu finland num wuerzburg germani num receiv inhal anesthesia antiemet prophylaxi type surgeri ponv defin nausea vomit num surgeri risk score estim probabl ponv obtain fit logist regress model simplifi risk score construct base number risk factor found signific logist regress analys origin simplifi score cross valid combin data set creat estim potenti center effect construct final risk score discrimin power score assess area receiv oper characterist curv result risk score deriv center predict ponv center area curv num num simplif essenti weaken discrimin power area curv num num center effect detect combin data set odd ratio num num confid interv num num final score consist predictor femal gender histori motion sick ms ponv nonsmok postop opioid risk factor present incid ponv num num num conclus risk score deriv center prove valid simplifi signific loss discrimin power risk score broad applic predict ponv adult patient undergo inhal anesthesia type surgeri patient identifi predictor prophylact antiemet strategi consid
MED-1243~comparison inhal isopropyl alcohol promethazin treatment postop nausea vomit ponv patient identifi pubm ncbi abstract frequent patient identifi high risk postop nausea vomit ponv treat prophylact intraven iv ondansetron postop iv promethazin purpos studi determin aromat therapi num isopropyl alcohol ipa effect promethazin resolut breakthrough ponv symptom group high risk patient administ prophylact ondansetron subject enrol identifi high risk ponv administ general anesthesia prophylact antiemet num mg iv ondansetron random receiv ipa promethazin treatment breakthrough ponv demograph verbal numer rate scale vnrs score nausea time num reduct vnrs score antiemet incid ponv measur data num subject includ analysi differ demograph variabl baselin measur note group ipa group report faster time num reduct vnrs score decreas antiemet requir similar incid ponv note group base find recommend inhal num ipa option treatment ponv high risk patient receiv prophylact ondansetron
MED-1244~examin effect peppermint aromatherapi nausea women post c section pubm ncbi abstract purpos studi examin effect peppermint spirit postop nausea women schedul c section design pretest posttest research design group peppermint group inhal peppermint spirit placebo aromatherapi control group inhal inert placebo green color steril water standard antiemet therapi control group receiv standard antiemet intraven ondansetron promethazin suppositori method women random assign group admiss hospit nauseat nurs mother babi unit assess nausea baselin administ assign intervent reassess particip nausea num num minut initi intervent particip rate nausea num point nausea scale find thirty f particip nauseat post op particip intervent group similar level nausea baselin nausea level particip peppermint spirit group signific lower particip group num num minut initi intervent conclus peppermint spirit adjunct treatment postop nausea studi replic particip varieti aromatherapi treat nausea particip preoper diagnos
MED-1245~updat manag postop nausea vomit postdischarg nausea vomit ambulatori surgeri pubm ncbi abstract postop nausea vomit ponv continu common complaint surgeri occur num surgeri high num num high risk popul prophylaxi num hydroxytryptamin type num ht num receptor antagonist continu mainstay antiemet therapi newer approach neurokinin num antagonist longer act serotonin receptor antagonist multimod manag techniqu manag high risk patient gain promin relat problem postdischarg nausea vomit pdnv receiv increas attent health care provid issu ponv pdnv signific context ambulatori surgeri compris num combin num million ambulatori inpati surgeri visit unit state period ambulatori patient spend health care facil import prevent treat ponv pdnv swift effect copyright num publish elsevi
MED-1246~aromatherapi peppermint isopropyl alcohol placebo equal effect reliev postop nausea pubm ncbi abstract determin aromatherapi reduc postop nausea investig studi num ambulatori surgeri patient complain nausea pacu indic sever nausea num mm visual analogu scale vas subject receiv random aromatherapi isopropyl alcohol oil peppermint salin placebo vapor inhal deepli nose scent gauz pad held direct beneath patient nostril exhal slowli mouth num minut subject rate nausea vas nausea score decreas num num mm se aromatherapi num num mm num minut aromatherapi num num num mm num minut aromatherapi num num nausea score differ treatment time num patient requir convent intraven iv antiemet therapi pacu stay satisfact postop nausea manag num num mm independ treatment group aromatherapi effect reduc perceiv sever postop nausea fact salin placebo effect alcohol peppermint suggest benefici effect relat control breath pattern actual aroma inhal
MED-1247~antiemet activ volatil oil mentha spicata mentha piperita chemotherapy induc nausea vomit abstract background studi aim determin efficaci mentha spicata spicata mentha piperita piperita prevent chemotherapy induc nausea vomit cinv method randomis double blind clinic trial studi prior studi patient random assign group receiv spicata piperita statist analysi includ num test relat risk student t test fifti cours analys group met elig criteria treatment placebo group appli essenti oil spicata piperita placebo control group continu previous antiemet regimen patient guardian record number emet event intens nausea num chemotherapi advers effect occur time result signific reduct intens number emet event num spicata piperita treatment group num compar control advers effect report cost treatment reduc essenti oil conclus spicata piperita essenti oil safe effect antiemet treatment patient cost effect
MED-1248~patient attitud rectal drug administr pubm ncbi abstract hundr adult patient attend day case surgeri survey anonym questionnair order determin attitud rectal drug administr fifti patient analges drug diclofenac sodium administ rectal whilst anaesthesia prefer oral nineti patient thought drug administ rectum discuss strong feel rout administr suggest prescrib rectal diclofenac discuss patient pre op whilst happi suppositori young patient sensit prefer medic mouth
MED-1249~hypocholesterolem effect substitut soybean protein anim protein diet healthi young women pubm ncbi abstract effect dietari protein level plasma cholesterol young healthi normolipidem women investig separ studi feed convent diet mix protein plant protein diet anim protein diet replac soy protein meat analogu soy milk diet similar respect carbohydr fat sterol composit studi num day involv subject gave indic plasma cholesterol level lower plant protein diet studi incorpor number improv base experi num day cross ov design involv group subject studi plasma cholesterol level found signific lower plant protein diet
MED-1250~comparison effect diet beef protein plant protein blood lipid healthi young men pubm ncbi abstract effect plant anim protein blood lipid level investig healthi normolipidem men age num num yr subject fed plant anim protein diet cross ov design diet consum num day period protein common plant sourc made plant protein diet beef protein substitut num plant protein anim protein diet fast venous blood sampl collect begin studi num day interv num day studi serum analyz total cholesterol triglycerid plasma low dens high dens lipoprotein cholesterol determin statist signific differ serum total cholesterol plasma low dens lipoprotein cholesterol subject consum diet plasma high dens lipoprotein cholesterol level signific num elev end num day period anim protein diet consum num num mg dl compar period plant protein diet fed num num mg dl serum triglycerid valu signific num increas day num plant protein diet period num num mg dl compar time period anim protein diet consum num num mg dl result studi ingest diet num protein suppli beef protein hypercholesterolem effect healthi normolipidem young men
MED-1252~determin hypocholesterolem respons soy anim protein bas diet pubm ncbi abstract effect substitut soy anim protein mix diet determin young men mild elev plasma cholesterol num num mg dl diet low cholesterol num mg day num num energi protein num num fat polyunsatur satur fat ratio num protein num mix anim protein isol soy protein product made compar addit extract anim fat fresh egg yolk ad balanc cholesterol content diet protein grain veget ident menus contribut num dietari protein twenti num subject decreas plasma cholesterol end protocol subject classifi respond nonrespond function greater lesser reduct cholesterol group decreas plasma cholesterol num num respond anim soy group signific num num respond group higher initi plasma cholesterol valu nonrespond plasma high dens lipoprotein cholesterol decreas slight high dens lipoprotein cholesterol cholesterol ratio high dens lipoprotein cholesterol tot cholesterol remain constant individu hypocholesterolem effect similar anim soy protein num fat num experiment diet group signific decreas dietari cholesterol num
MED-1253~effect soy tofu meat lipoprotein concentr pubm ncbi abstract object investig effect replac lean meat soy product tofu serum lipoprotein concentr studi design random cross ov dietari intervent studi subject forty two free liv healthi male age num complet dietari intervent addit subject non compli exclud prior analysi intervent diet lean meat num g d compar num g d tofu isocalor isoprotein substitut diet period num month fat intak care control result seven day diet record show diet similar energi macronutri fibr total cholesterol differ num mmol l num ci num num num triglycerid differ num mmol l num ci num num num signific lower tofu diet lean meat diet hdl c signific lower tofu diet differ num mmol l num ci num num num ldl c hdl c ratio similar conclus effect hdl c small ldl c reduct differ studi fat control comparison soy textur protein soymilk casein suggest differenti effect protein compar soy influenc find practic replac meat tofu decreas satur fat increas polyunsatur fat enhanc small benefit due soy protein sponsor deakin univers contribut commonwealth depart veteran affair research grant european journal clinic nutrit num num
MED-1254~effect meat replac tofu chd risk factor includ copper induc ldl oxid pubm ncbi abstract object investig effect replac lean meat soy product tofu coronari heart diseas risk factor includ serum lipoprotein lipoprotein factor vii fibrinogen vitro suscept ldl oxid design random cross dietari intervent studi set free liv individu studi deakin univers subject forty f free liv healthi male age num num year complet dietari intervent subject non compli exclud prior analysi intervent diet num gram lean meat day compar diet num gram tofu day isocalor isoprotein substitut dietari period month durat result analysi seven day diet record show diet similar energi protein carbohydr total fat satur unsatur fat polyunsatur satur fat ratio alcohol fiber total cholesterol triglycerid signific lower vitro ldl oxid lag phase signific longer tofu diet compar meat diet hemostat factor factor vii fibrinogen lipoprotein signific affect tofu diet conclus increas ldl oxid lag phase expect decreas coronari heart diseas risk
MED-1256~meta analysi random control trial compar lipid effect beef versus poultri and or fish consumpt pubm ncbi abstract background limit consumpt red meat includ beef often suggest strategi reduc risk coronari heart diseas chd role beef consumpt specif play promot advers cardiovascular risk factor profil unclear object meta analysi random control clinic trial rcts conduct evalu effect beef independ red process meat compar poultri and or fish consumpt lipoprotein lipid method rcts publish num num consid inclus studi includ report fast lipoprotein lipid beef poultry fish consumpt subject free chronic diseas total num rcts identifi num studi involv num subject met prespecifi entri criteria includ analysi result relat baselin diet standard error mg dl beef versus poultry fish consumpt num num num num total cholesterol num num num num num low dens lipoprotein cholesterol num num num num num high dens lipoprotein cholesterol num num num num num mg dl triacylglycerol num conclus fast lipid profil signific beef consumpt compar poultri and or fish consumpt inclus lean beef diet increas varieti food choic improv long term adher dietari recommend lipid manag copyright num nation lipid associ publish elsevi reserv
MED-1257~protein coronari heart diseas role protein sourc pubm ncbi abstract meat protein increas risk heart diseas recent data shown meat protein weight gain num year num kg weight increas num meat day nurs health studi diet low red meat nut low fat dairi poultri fish num num lower risk chd compar diet high meat low carbohydr diet high anim protein num higher total mortal rate low carbohydr diet high veget protein num lower total mortal rate recent soy intervent assess american heart associ found small reduct ldl cholesterol dairi intak lower weight lower insulin resist metabol syndrom long term num month dairi intervent perform shown effect paramet
MED-1258~effect combin plant sterol soy protein viscous fiber almond treat hypercholesterolemia pubm ncbi abstract reduct low dens lipoprotein cholesterol ldl c result diet almond diet low satur fat high viscous fiber soy protein plant sterol combin intervent singl diet portfolio diet determin cholesterol reduct achiev similar magnitud report recent statin trial reduc cardiovascular event twenty f hyperlipidem subject consum portfolio diet num low satur fat high plant sterol num num kcal soy protein num num kcal viscous fiber num num kcal almond num num kcal low satur fat diet num base whole wheat cereal low fat dairi food fast blood blood pressur bodi weight obtain week num num phase ldl c reduc num num num low fat diet num num num portfolio diet reduc ratio ldl c high dens lipoprotein cholesterol hdl c signific num num num reduct ldl c ldl hdl c ratio signific lower portfolio diet control diet num num weight loss similar test control diet num kg num kg differ blood pressur hdl c serum triglycerid lipoprotein lp homocystein concentr diet combin number food food compon singl dietari portfolio lower ldl c similar statin increas potenti effect dietari therapi
MED-1259~consumpt blueberri high carbohydr low fat breakfast decreas postprandi serum marker oxid pubm ncbi abstract sought determin consumpt blueberri reduc postprandi oxid consum typic high carbohydr low fat breakfast particip num receiv treatment num week cross ov design treatment consist high blueberri dose num low blueberri dose num control ascorb acid sugar content match high blueberri dose serum oxygen radic absorb capac orac serum lipoprotein oxid lo serum ascorb urat glucos measur fast num num sampl consumpt serum orac signific higher num group control group num postprandi serum lo lag time show signific trend num blueberri dose serum ascorb urat glucos signific group knowledg report demonstr increas serum antioxid capac attribut fructos ascorb content blueberri summari practic consum quantiti blueberri num provid statist signific oxid protect vivo high carbohydr low fat breakfast test direct effect due phenol compound direct indirect major famili compound blueberri potenti bioactiv activ
MED-1261~catalyt dose fructos benefit glycaem control harm cardiometabol risk factor small meta analysi randomis control feed trial abstract contrari concern fructos advers metabol effect evid small catalyt dose num g meal fructos decreas glycaem respons high glycaem index meal human subject assess longer term effect catalyt dose fructos undertook meta analysi control feed trial search medlin embas cinahl cochran librari analys includ control feed trial num featur catalyt fructos dose num g d isoenerget exchang carbohydr data pool generic invers varianc method random effect model express differ md num ci heterogen assess statist quantifi num heyland methodolog qualiti score assess studi qualiti total feed trial num met elig criteria catalyt dose fructos signific reduc hba num md num num ci num num num num fast glucos md num num ci num num num num benefit absenc advers effect fast insulin bodi weight tag uric acid subgroup sensit analys show evid effect modif condit small number trial short durat limit strength conclus conclus small meta analysi show catalyt fructos dose num g d improv glycaem control advers effect bodi weight tag insulin uric acid larger longer num month trial catalyt fructos confirm result
MED-1262~effect fruit restrict glycem control patient type num diabet random trial abstract background medic nutrit therapi recogn import treatment option type num diabet guidelin recommend eat diet high intak fiber rich food includ fruit base posit effect fruit human health health profession concern fruit intak negat impact glycem control recommend restrict fruit intak found studi address import clinic question object investig advic reduc intak fruit patient type num diabet affect hba num bodyweight waist circumfer fruit intak method open random control trial parallel group primari outcom chang hba num num week intervent particip random intervent medic nutrit therapi advic consum piec fruit day high fruit medic nutrit therapi advic consum piec fruit day low fruit particip consult regist dietitian fruit intak self report num day fruit record dietari recal assess made intent treat principl result studi popul consist num men women newli diagnos type num diabet patient complet trial high fruit group increas fruit intak num gram ci num num low fruit group reduc intak num gram ci num num hba num decreas group differ group diff num ci num num num group reduc bodi weight waist circumfer differ group conclus recommend reduc fruit intak part standard medic nutrit therapi overweight patient newli diagnos type num diabet result eat fruit effect hba num weight loss waist circumfer recommend intak fruit restrict patient type num diabet trial registr http   www clinicaltri gov identifi nct num
MED-1265~synergist toxic environment neurotoxin methylmercuri n methylamino l alanin pubm ncbi abstract determin environment factor involv neurodegen diseas elus methylmercuri n methylamino l alanin bmaa implic role exposur primari cortic cultur compound independ induc concentration depend neurotox import concentr bmaa num caus toxic potenti methylmercuri num toxic addit concentr bmaa methylmercuri effect main cellular antioxid glutathion decreas glutathion level combin toxic methylmercuri bmaa attenu cell permeant form glutathion glutathion monoethyl ester result synergist toxic effect environment neurotoxin bmaa methylmercuri interact level glutathion deplet
MED-1266~cyanobacteria deriv toxin beta n methylamino l alanin amyotroph sclerosi abstract mount evid suggest environment factor play major role develop neurodegen diseas al amyotroph sclerosi non protein amino acid beta n methylamino l alanin bmaa high incid amyotroph sclerosis parkinson dementia complex als pdc guam implic potenti environment factor al alzheim diseas neurodegen diseas bmaa number toxic effect motor neuron includ direct agonist action nmda ampa receptor induct oxid stress deplet glutathion non protein amino acid strong possibl bmaa intraneuron protein misfold hallmark neurodegener anim model bmaa induc al lack substanti evid support link toxin al ramif discov environment trigger al enorm articl discuss histori ecolog pharmacolog clinic ramif ubiquit cyanobacteria deriv toxin
MED-1267~cover transfer cyanobacteri neurotoxin temper aquat ecosystem suggest pathway human exposur abstract methylamino l alanin bmaa neurotox nonprotein amino acid produc cyanobacteria propos causat agent devast neurodegen diseas island guam pacif ocean cyanobacteria widespread global hypothes bmaa occur bioaccumul ecosystem demonstr base recent develop extract hplc ms ms method long term monitor bmaa cyanobacteri popul temper aquat ecosystem baltic sea num num bmaa biosynthes cyanobacteri genera domin massiv surfac bloom water bodi bmaa found higher concentr organ higher trophic level direct indirect feed cyanobacteria zooplankton vertebr fish invertebr mussel oyster pelag benthic fish speci human consumpt includ highest bmaa level detect muscl brain bottom dwel fish discoveri regular biosynthesi neurotoxin bmaa larg temper aquat ecosystem combin transfer bioaccumul major food web end human consumpt alarm requir attent
MED-1268~link methylamino l alanin exposur sporad amyotroph sclerosi annapoli md pubm ncbi abstract amyotroph sclerosi al case occur sporad environment trigger implic includ beta methylamino l alanin bmaa cyanobacteria produc neurotoxin studi aim identifi environment risk factor common sporad al patient live annapoli maryland usa develop diseas short time close proxim questionnair identifi potenti risk factor al cohort patient common factor al patient frequent consumpt blue crab sampl blue crab patient local fish market test bmaa lc ms ms bmaa identifi chesapeak bay blue crab conclud presenc bmaa chesapeak bay food web lifetim consumpt blue crab contamin bmaa common risk factor sporad al patient copyright num elsevi reserv
MED-1271~dietari bmaa exposur amyotroph sclerosi cluster southern franc abstract background dietari exposur cyanotoxin bmaa suspect amyotroph sclerosi western pacif island europ north america toxin identifi marin environ amyotroph sclerosi cluster date dietari exposur object aim identifi cluster amyotroph sclerosi rault district coastal district southern franc search identifi area exist potenti dietari sourc bmaa method spatio tempor cluster analysi perform district incid amyotroph sclerosi case identifi num num expert center investig cluster area serial collect oyster mussel subsequ analyz blind bmaa concentr result found signific amyotroph sclerosi cluster num surround thau lagoon import area shellfish product consumpt french mediterranean coast bmaa identifi mussel num g g num g g oyster num g g num g g highest concentr bmaa measur summer highest picocyanobacteria abund record conclus ascertain direct link shellfish consumpt exist al cluster result add data potenti associ bmaa sporad amyotroph sclerosi sever neurodegen disord
MED-1272~cluster amyotroph sclerosi hampshir role toxic cyanobacteria bloom pubm ncbi abstract cyanobacteria produc neurotoxin includ beta methylamino l alanin bmaa amyotroph sclerosi al neurodegen diseas number al case diagnos resid enfield nh town encompass lake histori cyanobacteria algal bloom investig associ toxic cyanobacteri bloom hampshir develop al review record institut communiti databas obtain demograph inform patient diagnos al england identifi al patient live lake mascoma enfield nh incid sporad al num num time expect incid num num year suggest high incid al potenti cluster direct relat chronic exposur cyanobacteri neurotoxin bmaa rout toxin exposur includ inhal aerosol toxin consum fish ingest lake water investig includ analysi brain tissu cyanobacteri toxin test associ bmaa al
MED-1273~amyotroph sclerosi case control studi detect cluster small wisconsin communiti pubm ncbi abstract num num case amyotroph sclerosi al diagnos long term resid river wis probabl occur due chanc num investig potenti risk factor al conduct case control studi control subject match case patient age gender durat resid river physic trauma frequent consumpt fresh caught lake michigan fish famili histori cancer report case patient control subject find support previous studi propos role trauma al pathogenesi suggest causat role diet explor continu surveil epidemiolog investig al cluster subsequ retrospect analysi provid clue al
MED-1274~cyanobacteri neurotoxin n methylamino l alanin bmaa shark fin abstract shark threaten group marin speci popul declin global support grow demand shark fin soup shark bioaccumul toxin pose health risk consum shark product feed habit shark vari includ fish mammal crustacean plankton cyanobacteri neurotoxin n methylamino l alanin bmaa detect speci free liv marin cyanobacteria bioaccumul marin food web studi sampl fin clip speci shark south florida survey occurr bmaa hplc fd tripl quadrupol lc ms ms method bmaa detect fin speci examin concentr rang num num ng mg wet weight bmaa link neurodegen diseas result import relev human health suggest consumpt shark fin increas risk human exposur cyanobacteri neurotoxin bmaa
MED-1276~spatial cluster amyotroph sclerosi finland place birth place death pubm ncbi abstract previous evid spatial cluster amyotroph sclerosi inconclus studi identifi appar cluster base small number case result occur chanc process studi geograph locat time death basi cluster detect explor cluster point life cycl studi author examin num case amyotroph sclerosi distribut finland die june num decemb num spatial scan statist author examin signific cluster diseas time birth time death signific neighbor cluster identifi southeast south centr finland time death singl signific cluster identifi southeast finland time birth close match cluster identifi time death result base larg sampl case provid convinc evid spatial cluster condit result demonstr cluster analysi conduct stage case life cycl conclus potenti risk factor exist result
MED-1277~exposur cyanobacteria environment risk factor amyotroph sclerosi neurodegen diseas pubm ncbi abstract broad scientif consensus amyotroph sclerosi al caus gene environ interact mutat gene famili al fal discov num total popul al patient attent paid environment lifestyl factor trigger cascad motor neuron death lead syndrom al exposur chemic includ lead pesticid agricultur environ smoke sport trauma identifi increas risk al research quantifi relat role identifi risk factor al recent evid strengthen theori chronic environment exposur neurotox amino acid n methylamino l alanin bmaa produc cyanobacteria environment risk factor al describ method assess exposur cyanobacteria potenti bmaa epidemiolog questionnair direct indirect method estim cyanobacteri load ecosystem rigor epidemiolog studi determin risk exposur cyanobacteria combin genet analysi al case control reveal etiolog import gene environ interact genet vulner individu
MED-1278~amino methylaminopropion acid bmaa play role neurodegener abstract associ amino methylaminopropion acid bmaa elev incid amyotroph sclerosis parkinson diseas complex als pdc identifi island guam bmaa shown produc cyanobacteri order detect report varieti aquat terrestri environ worldwid suggest ubiquit vivo studi rat mice chick monkey shown neurodegen symptom ataxia convuls zebrafish research shown disrupt neural develop bmaa exposur vitro studi mice rat leech shown bmaa act predomin motor neuron observ increas generat reactiv oxygen speci ros ca num influx coupl disrupt mitochondri activ general neuron death main mode activ excitotox mechan current review pertain neurotox bmaa demonstr abil advers affect neural tissu implic potenti signific compound aetiolog neurodegen diseas potenti advers health effect exposur compound research understand mode toxic bmaa environment exposur limit essenti
MED-1279~spatial cluster amyotroph sclerosi potenti role bmaa pubm ncbi abstract amyotroph sclerosi al fatal neurodegen syndrom small proport case genet inherit develop al involv genet environment risk factor environment risk factor implic al includ heavi metal trauma pesticid electr injuri electromagnet radiat cyanobacterial deriv neurotoxin beta n methylamino l alanin bmaa investig environment risk number epidemiolog studi al conduct studi employ spatial analysi techniqu examin spatial cluster al guid research identifi environment exposur identifi geograph dispar distribut al case studi provid clear associ environment factor review literatur import studi spatial cluster al explor hypothes link neurotoxin bmaa al
MED-1280~divers taxa cyanobacteria produc n methylamino l alanin neurotox amino acid abstract cyanobacteria generat molecul hazard human health product cyanotoxin taxonom sporad member genera produc hepatotox microcystin product hepatotox nodularin limit singl genus product neurotoxin consid phylogenet unpredict report singl neurotoxin n methylamino l alanin produc group cyanobacteria includ cyanobacteri symbiont free liv cyanobacteria ubiqu cyanobacteria terrestri freshwat brackish marin environ suggest potenti wide spread human exposur
MED-1281~scan human proteom calmodulin bind protein abstract calcium ion ca num ubiquit messeng crucial regul wide varieti cellular process divers transient signal transduc ca num mediat intracellular ca num bind protein ca num sensor key obstacl studi ca num sens protein difficulti identifi numer downstream target interact respond ca num induc conform number ca num sensor eukaryot cell calmodulin cam widespread studi employ mrna display techniqu scan human proteom cam bind protein identifi character larg number previous uncharacter protein interact cam ca num depend manner interact identifi protein ca num cam confirm pull down assay coimmunoprecipit cam bind protein identifi belong protein famili dead h box protein ribosom protein proteasom num subunit deubiquitin enzym suggest involv ca num cam signal pathway select method identifi bind partner calcium sensor proteome wid scale
MED-1282~guam cyanobacteria bmaa hypothesi al neurodegen diseas pubm ncbi abstract excit neurogenet decad divert attent environment sporad al fifti year ago endem foci al frequenc hundr time rest world attract attent offer possibl find non endem al world research guam suggest al parkinson diseas dementia als pdc complex due neurotox non protein amino acid beta methylamino l alanin bmaa seed cycad cyca micronesica recent discoveri found bmaa produc symbiot cyanobacteria special root cycad concentr protein bound bmaa hundred fold greater free bmaa seed flour anim forag seed fli fox pig deer lead biomagnif food chain guam protein bound bmaa occur brain guamanian die als pdc averag concentr num microg g num mm control brain rekindl interest bmaa trigger guamanian als pdc intrigu find bmaa present brain tissu north american patient die alzheimer diseas averag concentr num microg g num mm suggest etiolog role bmaa non guamanian neurodegen diseas cyanobacteria ubiquit world human expos low amount cyanobacteri bmaa protein bound bmaa human brain reservoir chronic neurotox cyanobacteri bmaa major progress neurodegen diseas includ al worldwid montin al hplc method assay techniqu cox colleagu unabl reproduc find murch al mash colleagu origin techniqu murch al recent confirm presenc protein bound bmaa brain north american patient die al alzheimer diseas concentr num microg g brain non neurolog control huntington diseas hypothes individu develop neurodegener genet suscept inabl prevent bmaa accumul brain protein pattern neurodegener develop depend polygen background individu
MED-1283~current pathway epidemiolog research amyotroph sclerosi pubm ncbi abstract amyotroph sclerosi al rapid progress neurodegen diseas current status epidemiolog challeng studi studi design option discuss paper focus recent result large scal popul base prospect studi case control studi popul base registri risk factor neuropatholog find chronic traumat encephalomyelopathi identifi area interest futur research includ time trend incid preval al lifetim risk phenotyp descript al definit famili versus sporad al syndrom aspect al specif risk factor militari servic life style factor smoke statin presenc n methylamino l alanin bmaa excitotox amino acid deriv possibl produc cyanobacteria found terrestri aquat habitat emerg disappear endem al area pacif gene environ interact etiolog al move epidemiolog forward suggest well character cohort newli diagnos al patient identifi risk prognost factor store biolog materi futur studi build nation al registri resourc futur studi work multidisciplinari consortia address earli life etiolog al
MED-1284~num amino num methylamino propano acid bmaa cycad flour amyotroph sclerosi parkinsonism dementia guam pubm ncbi abstract conduct investig level neurotoxin num amino num methylamino propano acid bmaa cycad flour analysi num flour sampl process endosperm cyca circinali seed collect guam num total bmaa content remov process num sampl greater num total bmaa remov found signific region differ bmaa content flour prepar cycad seed collect villag guam test sampl prepar chamorro woman num year suggest wash procedur vari prepar prepar routin effici remov num total bmaa batch analysi flour sampl undergon num hour soak singl wash remov num total bmaa conclud process cycad flour prepar chamorro guam rota extrem low level bmaa order num weight valu sampl cycad flour dietari stapl eaten regular low level delay widespread neurofibrillari degener nerv cell observ amyotroph sclerosi parkinsonism dementia complex guam als pd
MED-1285~cycad neurotoxin consumpt fli fox als pdc diseas guam pubm ncbi abstract chamorro peopl guam afflict complex neurodegen diseas als pdc similar al ad pd higher rate popul world chamorro consumpt fli fox generat suffici high cumul dose plant neurotoxin result als pdc neuropatholog fli fox forag neurotox cycad seed
MED-1287~cyanobacteri bloom occurr neurotoxin beta n methylamino l alanin bmaa south florida aquat food web abstract recent studi demonstr cyanobacteria produc neurotoxin beta n methylamino l alanin bmaa biomagnifi terrestri food chain bmaa implic signific environment risk develop neurodegen diseas alzheim diseas parkinson diseas amyotroph sclerosi al examin bloom cyanobacteria south florida bmaa content resid anim includ speci human food wide rang bmaa concentr found rang assay detect limit approxim num g g concentr potenti long term human health hazard
MED-1288~biomagnif cycad neurotoxin fli fox implic als pdc guam pubm ncbi abstract beta methylamino l alanin bmaa occur higher level museum specimen guamanian fli fox cycad seed fli fox feed confirm hypothesi cycad neurotoxin biomagnifi guam ecosystem consumpt singl fli fox result equival bmaa dose obtain eat num num kg process cycad flour tradit feast fli fox relat preval neuropatholog diseas guam
MED-1289~mechan slow releas biomagnifi cyanobacteri neurotoxin neurodegen diseas guam abstract root symbiont cycad tree cyanobacteria genus nostoc produc methylamino l alanin bmaa neurotox nonprotein amino acid biomagnif bmaa guam ecosystem fit classic triangl increas concentr toxic compound food chain bmaa polar nonlipophil mechan biomagnif increas trophic level unclear report bmaa occur free amino acid guam ecosystem releas bound form acid hydrolysi remov free amino acid tissu sampl trophic level cyanobacteria root symbios cycad seed cycad flour fli fox eaten chamorro peopl brain tissu chamorro die amyotroph sclerosis parkinson dementia complex hydrolyz remain fraction found bmaa concentr increas num num fold bound form bmaa function endogen neurotox reservoir accumul transport trophic level subsequ releas digest protein metabol brain tissu endogen neurotox reservoir slowli releas free bmaa caus incipi recurr neurolog damag year decad explain observ long latenc period neurolog diseas onset chamorro peopl presenc bmaa brain tissu canadian patient die alzheimer diseas suggest exposur cyanobacteri neurotoxin occur guam
MED-1290~therapi al base cyanobacteria bmaa hypothesi pubm ncbi abstract cyanobacteria bmaa hypothesi al age rel neurodegen diseas remain proven earli treatment hypothesi correct paper review chronic bmaa neurotox prevent treat
MED-1291~mushroom tumor immun updat pubm ncbi abstract signific interest mushroom and or mushroom extract dietari supplement base theori enhanc immun function promot health extent select mushroom shown stimulatori action immun respons studi vitro widespread potenti health benefit surpris pauciti epidemiolog experiment studi address biolog activ mushroom oral administr anim human number studi address abil mushroom modul mononuclear cell activ phenotyp express cytokin cognat receptor number attempt determin antitumor activ mushroom studi import compon mushroom potenti signific biolog activ data temper possibl toxic level metal includ arsenic lead cadmium mercuri presenc radioact contamin num review present compar biolog respect immunolog antitumor activ mushroom extract highlight evidence bas research
MED-1292~immunobiolog mushroom pubm ncbi abstract enorm interest biolog activ mushroom innumer claim made mushroom benefici effect immun function subsequ implic inhibit tumor growth major observ anecdot lack standard remain data vitro vivo effect reflect potenti mushroom compound influenc human immun number effect benefici respons character base phenomenolog specul substanc respect tumor biolog neoplast lesion immunogen tumor antigen frequent antigen induc toler patient cancer exhibit suppress immun respons includ defect antigen present mushroom extract effect function result improv antigen present dendrit cell direct cytopath effect review attempt place data perspect focus dendrit cell popul abil mushroom extract modul immun present scientif basi mushroom mushroom extract treatment human patient signific potenti rigor research understand potenti mushroom human diseas focus clinic trial demonstr effect potenti toxic
MED-1293~immun plant effect mediat pubm ncbi abstract domain nutrit explor diet health linkag major area research outcom intervent led widespread accept function nutraceut food augment immun major concern dietari regimen immun system incred arrang specif organ cell enabl human carri defens undesir respons proper function essenti maintain bodi homeostasi array plant compon hold immunomodul properti inclus diet explor therapeut avenu enhanc immun diseas review intend highlight import garlic allium sativum green tea camellia sinensi ginger zingib officinal purpl coneflow echinacea black cumin nigella sativa licoric glycyrrhiza glabra astragalus st john wort hypericum perforatum natur immun booster plant bestow function ingredi provid protect menac mode action includ boost function immun system activ suppress immun special cell interf pathway eventu led improv immun respons defens system addit plant carri free radic scaveng anti inflammatori activ cancer insurg interact drug herbs botan investig recommend safe inform dissemin alli stakehold
MED-1294~immune modulatori effect dietari yeast beta num num d glucan abstract beta glucan heterogen group natur polysaccharid investig immunolog effect due low system avail oral prepar thought parenter appli beta glucan modul immun system vivo vitro investig reveal oral appli beta glucan exert effect receptor interact explain mode action detect effect depend sourc structur beta glucan meantim human clinic trial dietari insolubl yeast beta glucan perform result confirm previous find vivo studi result studi oral intak insolubl yeast beta glucan safe immun strengthen effect
MED-1295~natur modifi num num beta d glucan health promot diseas allevi pubm ncbi abstract number polysaccharid beta glycosid linkag widespread natur varieti sourc common structur num num beta d glucan backbon essenti attract attent year bioactiv medicin properti case function role mysteri establish insolubl chemic natur particul num num beta d glucan suitabl medic applic method chang modifi beta d glucan chemic structur transform solubl form publish beta d glucan bioactiv properti affect posit negat modif review examin beta glucan sourc natur health effect structure act relationship present current state beta d glucan solubil method discuss effect applic possibl futur
MED-1296~natur immunomodul stimul immun reaction true fals pubm ncbi abstract natur immunomodul popular popular bring over optimist claim mediocr effect purpos present studi direct compar eleven common immunomodul test cellular humor branch immun reaction found immunomodul test limit effect glucan consist activ molecul strong stimul reaction evalu data confirm lewi lung cancer model glucan resveratrol lower number metastas
MED-1298~increas interleukin num unchang insulin sensit num week num num beta glycan consumpt overweight human pubm ncbi abstract obesity induc insulin resist suggest system inflammatori condit activ innat immun system anim studi dietari fiber num num beta d glycan bdg potent effect immun activ increas antiinflammatori cytokin interleukin num il num reduc secret inflammatori factor hypothes bdg consumpt improv inflammatori marker insulin sensit overweight obes subject moder increas level c reactiv protein indic subclin inflamm screen num overweight obes subject moder increas c reactiv protein level num occas absenc sign acut infect twelv subject met inclus criteria investig random double blind placebo control crossov design num num week washout num week subject ingest capsul num num high purifi bdg num num placebo waxi maiz starch daili mainten normal diet particip correct intak capsul monitor num num day food record count provid capsul predefin outcom measur bdg induc pro antiinflammatori marker circul blood gene express adipos tissu peripher insulin sensit express bdg consumpt num week signific increas circul level adipos tissu messeng rna mrna express antiinflammatori cytokin il num overweight obes human insulin sensit circul level mrna express proinflammatori cytokin unaffect bdg treatment increas il num bdg consumpt contribut factor benefici effect dietari fiber intak
MED-1299~baker yeast beta glucan supplement reduc upper respiratori symptom improv mood state stress women pubm ncbi abstract object studi shown baker yeast beta num num d glucan extract saccharomyc cerevisia effect reduc incid cold flu symptom studi evalu effect specif beta glucan supplement wellmun upper respiratori tract symptom psycholog well b women moder level psycholog stress method healthi women num num year prescreen moder level psycholog stress self administ placebo num num mg wellmun num daili num week profil mood state pom psycholog survey assess mental phys energi level vigor well b global mood state quantit health percept log track upper respiratori symptom result subject wellmun group report fewer upper respiratori symptom compar placebo num num well b global mood state num num num num num superior mental phys energi level vigor num num num num num conclus data show daili dietari supplement wellmun reduc upper respiratori symptom improv mood state stress subject approach maintain immun protect daili stressor
MED-1300~yeast num num beta glucan maintain bodi defenc pathogen double blind random placebo control multicentr studi healthi subject abstract purpos effect brewer yeast num num beta d glucan consumpt number common cold episod healthi subject investig method placebo control double blind random multicentr clinic trial num healthi particip recur infect receiv num mg placebo num insolubl yeast num num beta d glucan prepar num day num week subject instruct document occur common cold episod diari rate ten predefin infect symptom infect period result symptom score subject examin investig episod visit num day cold episod result protocol popul supplement insolubl yeast num num beta glucan reduc number symptomat common cold infect num compar placebo num symptom score num lower beta glucan oppos placebo group num beta glucan signific reduc sleep difficulti caus cold episod compar placebo num efficaci yeast beta glucan rate placebo physician num particip num conclus present studi demonstr yeast beta glucan prepar increas bodi potenti defend invad pathogen
MED-1301~impact cereal grain consumpt develop sever non alcohol fatti liver diseas pubm ncbi abstract purpos evid dietari habit contribut presenc sever non alcohol fatti liver diseas nafld aim present studi explor associ consumpt grain develop sever nafld method seventy thre consecut nafld patient enrol addit num control match age sex bodi mass index num patient includ consumpt grain estim semi quantit food frequenc questionnair medic histori anthropometr indic bodi composit analysi physic activ data biochem inflammatori marker particip liver stiff measur transient elastographi perform num liver biopsi num patient result patient consumpt grain lower abdomin fat level num num lower level insulin resist index num num correl invers interleukin num level num num consumpt grain lower likelihood histolog steatohepat num num ci num num adjust sex energi intak associ weaker adjust abdomin fat interleukin num level case control analysi consumpt refin grain higher odd nafld num num ci num num adjust age sex energi intak abdomin fat level homa ir ldl adiponectin tnf conclus refin grain consumpt increas likelihood nafld whole grain consumpt favor affect clinic characterist patient nafld tend sever diseas
MED-1302~increas grain intak part prevent treatment nonalcohol fatti liver diseas abstract conjunct rise rate obes increas rate nonalcohol fatti liver diseas nafld nafld partial origin poor diet lack nutrit recommend patient suspect confirm diagnosi nafld eat healthi diet increas physic activ emphasis weight loss limit current literatur suggest opportun provid tailor dietari advic peopl diagnos risk nafld epidemiolog studi consist find associ grain intak reduc risk obes relat diseas work potenti grain prevent and or part treatment fatti liver diseas review examin potenti current evid grain impact nafld due nutrient phytochem composit switch consum refin grain grain consid part nutrit guidelin patient diagnos risk fatti liver diseas
MED-1303~avena sativa oat potenti neutraceut therapeut agent overview pubm ncbi abstract aim present review articl summar inform relat avail product chemic composit pharmacolog activ tradit avena sativa highlight potenti contribut human health oat cultiv worldwid form import dietari stapl peopl number countri varieti oat rich sourc protein number import miner lipid glucan mixed linkag polysaccharid form import part oat dietari fiber phytoconstitu avenanthramid indol alkaloid gramin flavonoid flavonolignan triterpenoid saponin sterol tocol tradit oat long consid stimul antispasmod antitumor diuret neuroton oat possess pharmacolog activ antioxid anti inflammatori wound heal immunomodulatori antidiabet anticholesterolaem wide spectrum biolog activ oat potenti therapeut agent
MED-1304~nonalcohol fatti liver diseas emerg threat obes diabet individu abstract nonalcohol fatti liver diseas nafld common liver diseas western world incid increas rapid nafld spectrum rang simpl steatosi benign hepat nonalcohol steatohepat nash progress cirrhosi obes insulin resist type num diabet mellitus dyslipidemia import risk factor nafld due heavi enrich metabol risk factor individu nafld signific higher risk cardiovascular diseas individu nafld higher incid type num diabet diagnosi nafld requir imag evid hepat steatosi absenc compet etiolog includ signific alcohol consumpt liver biopsi remain gold standard diagnos nash determin prognosi weight loss remain cornerston treatment weight loss num believ improv steatosi num weight loss improv steatohepat number pharmacolog therapi investig treat nash agent vitamin thiazolidinedion shown promis select patient subgroup
MED-1305~grain intak relat bodi weight epidemiolog evid clinic trial pubm ncbi abstract viewpoint aim num review scientif literatur relationship grain consumpt bodi weight regul num evalu potenti mechan grain intak reduc overweight num understand epidemiolog studi clinic trial provid diverg result topic prospect epidemiolog studi demonstr higher intak grain lower bmi bodi weight gain result clarifi grain consumpt simpli marker healthier lifestyl factor favor se lower bodi weight habitu grain consumpt lower bodi weight multipl mechan lower energi densiti grain base product lower glycem index ferment digest carbohydr satieti signal final modul intestin microflora contrast epidemiolog evid result clinic trial confirm grain low calori diet effect reduc bodi weight refin cereal diet result affect small sampl size short durat intervent intervent studi adequ methodolog clarifi question time grain consumpt recommend featur diet control bodi weight lower risk develop type num diabet cardiovascular diseas cancer copyright num elsevi reserv
MED-1307~bedsid ultrasound diagnosi nonalcohol fatti liver diseas abstract non alcohol fatti liver diseas nafld common liver diseas unit state american associ studi liver diseas guidelin defin nafld hepat steatosi detect histolog imag secondari abnorm hepat fat accumul imag modal recommend standard care screen diagnosi bedsid ultrasound evalu non invas method diagnos nafld presenc characterist sonograph find prior studi suggest characterist sonograph find nafld includ bright hepat echo increas hepatoren echogen vascular blur portal hepat vein subcutan tissu thick sonograph characterist shown aid bedsid clinician easili identifi potenti case nafld sonograph find attenu imag diffus echogen uniform heterogen liver thick subcutan depth enlarg liver fill entir field identifi clinician bedsid ultrasound access eas low sid effect profil ultrasound make bedsid ultrasound appeal imag modal detect hepat steatosi clinic risk factor steatosi involv greater num liver ultrasound reliabl diagnos nafld abil ultrasound detect moder hepat steatosi replac liver biopsi stage degre fibrosi purpos review examin diagnost accuraci util limit ultrasound diagnosi nafld potenti clinician routin practic
MED-1308~role grain bodi weight regul abstract grain wg rich diet purport varieti health benefit includ favor role bodi weight regul current dietari recommend advoc substitut wg refin grain rg benefici bioactiv compon intrins wg lost refin process epidemiolog studi consist demonstr higher intak wg rg lower bmi and or reduc risk obes recent clinic trial fail support role wg promot weight loss mainten biochem structur characterist wg shown modul appetit nutrient avail energi util capac wg food elicit effect vari type amount grain consum natur consumpt wg food differenti affect physiolog factor influenc bodi weight common practic process reconstitut wg ingredi food product mitig capac wg benefit bodi weight regul
MED-1309~oat prevent obes abdomin fat distribut improv liver function human pubm ncbi abstract obes great divers diseas includ non alcohol fatti liver diseas recent report suggest oat rich beta glucan metabolic regul liver protect effect anim model studi perform clinic trial confirm effect oat subject bmi num age num random divid control num oat treat num group placebo beta glucan contain oat cereal num week data show consumpt oat reduc bodi weight bmi bodi fat waist to hip ratio profil hepat function includ ast alt resourc evalu liver show decrement patient oat consumpt anatom observ ultrason imag analysi ingest oat toler advers effect trial conclus consumpt oat reduc obes abdomin fat improv lipid profil liver function daili supplement oat act adjuv therapi metabol disord
MED-1311~cetuximab preclin antitumor activ monotherapi combin base predict relat total activ epiderm growth facto pubm ncbi abstract erbitux cetuximab proven therapeut benefit clinic set molecular determin predict respons agent understood assess relationship basal total activ py num epiderm growth factor receptor egfr level tumor respons cetuximab monotherapi combination bas treatment human xenograft model cetuximab treatment num num mg mouse inject num effect delay growth geo num tumor minimum num day log cell kill valu num borderlin activ num widr xenograft cetuximab fail show signific antitumor activ ht num hct num lovo colo num lx num hcc num num model studi tumor detect variabl level egfr combin regimen cetuximab num mg mouse inject num num cisplatin num mg kg inject num num prove signific efficaci individu monotherapi cisplatin refractori cetuximab respons geo tumor model num therapeut enhanc observ cisplatin cetuximab weak respons num xenograft similar combin cpt num mg kg inject num num cetuximab num mg mouse inject num num fail show improv individu monotherapi cetuximab resistant weak respons ht num num widr model conclud preclin activ cetuximab monotherapi correl direct relat basal level total activ py num egfr tumor robust single ag activ cetuximab predictor agent potenti chemotherapy medi antitumor activ
MED-1312~inhibitori effect oatmeal extract oligom vasoact intestin peptide induc inflamm surviv human skin pubm ncbi abstract aim studi evalu antiinflammatori effect oatmeal extract oligom skin fragment stimul neuromedi vasoact intestin peptid vip skin fragment plastic surgeri maintain surviv condit num induc inflamm vip contact dermi cultur medium histolog analysi perform hematoxylin eosin stain slide edema evalu semiquantit score vasodil studi quantifi percentag dilat vessel score measur surfac morphometr imag analysi tnf alpha dosag made cultur supernat vasodil signific increas applic vip treatment oatmeal extract oligom surfac dilat vessel edema signific decreas compar vip treat skin treatment extract decreas tnf alpha
MED-1313~effect treatment colloid oatmeal lotion acneform erupt induc epiderm growth factor receptor multipl tyrosine kina pubm ncbi abstract current treatment modal epiderm growth factor egfr posit cancer recent includ antibodi small molecul tyrosine kinas inhibitor tki signific limit step agent dermatolog toxic frequent form acneiform erupt present manag modal toxic larg ineffect colloid oatmeal lotion demonstr multipl anti inflammatori properti effect arachidon acid cytosol phospholipas num tumour necrosi factor alpha pathway excel side effect profil treatment colloid oatmeal appli num patient rash induc cetuximab erlotinib panitumumab sorafenib num assess patient num complet respons num partial respons give respons rate num toxic treatment colloid oatmeal lotion effici control rash egfr multipl tki continu antineoplast treatment
MED-1314~manag skin reaction cancer patient receiv epiderm growth factor receptor target therapi pubm ncbi abstract epiderm growth factor receptor egfr inhibitor treatment solid tumour increas toler profil egfr inhibitor monoclon antibodi cetuximab tyrosin kinas inhibitor erlotinib characteris uniqu group skin reaction domin acneiform erupt xerosi eczema hair nail possibl skin toxic correl anti tumour activ offer potenti titrat dose case by cas basi skin effect constitut signific obstacl treatment complianc consist multi disciplinari manag strategi patient receiv recommend dosag target therapi erupt respond acn therapi xerosi control standard emolli present overview treatment option skin reaction today evalu treatment egfr inhibitor rel skin reaction improv futur evidence bas studi determin manag effect
MED-1315~primari acquir resist colorect cancer cell anti egfr antibodi converg mek erk pathway activ overcom pubm ncbi abstract purpos egfr independ activ ras raf mek mapk pathway resist mechan cetuximab experiment design evalu vitro vivo effect bay num select mek num inhibitor panel human colorect cancer cell line primari acquir resist cetuximab result colorect cancer cell line kras mutat lovo hct num hct num sw num sw num braf mutat ht num resist antiprolif effect cetuximab cell geo sw num high sensit treatment bay num determin dose depend growth inhibit cancer cell includ human colorect cancer cell acquir resist cetuximab geo cr sw num cr hct num cell combin treatment cetuximab bay num induc synergist antiprolif apoptot effect blockad mapk akt pathway cell primari acquir resist cetuximab synergist antiprolif effect confirm select mek num inhibitor selumetinib pimasertib combin cetuximab inhibit mek express sirna restor cetuximab sensit resist cell nude mice bear establish human hct num hct num sw num cr geo cr xenograft combin treatment cetuximab bay num caus signific tumor growth inhibit increas mice surviv conclus result suggest activ mek involv primari acquir resist cetuximab inhibit egfr mek strategi overcom anti egfr resist patient colorect cancer num american associ cancer research
MED-1316~colloid oatmeal histori chemistri clinic properti pubm ncbi abstract oatmeal centuri sooth agent reliev itch irrit xerot dermatos num readi colloid oatmeal produc fine grind oat boil extract colloid materi today colloid oatmeal dosag form powder bath shampoo shave gel moistur cream colloid oatmeal skin protect regul food drug administr fda over the count final monograph skin protect drug product issu june num prepar standard unit state pharmacopeia clinic properti colloid oatmeal deriv chemic polymorph high concentr starch beta glucan respons protect water hold function oat presenc type phenol confer antioxid anti inflammatori activ oat phenol strong ultraviolet absorb cleans activ oat due saponin function properti make colloid oatmeal cleanser moistur buffer sooth protect anti inflammatori agent
MED-1317~avenanthramid inhibit prolifer human colon cancer cell line vitro pubm ncbi abstract high intak grain food reduc risk colon cancer mechan protect elucid chronic inflamm cyclooxygenas num cox num express colon epithelium causal relat epitheli carcinogenesi prolifer tumor growth examin effect avenanthramid avn uniqu polyphenol oat anti inflammatori properti cox num express macrophag colon cancer cell line prolifer human colon cancer cell line found avns enrich extract oat avexo effect cox num express inhibit cox enzym activ prostaglandin num pge num product lipopolysaccharide stimul mous periton macrophag avn avexo avn c methyl form avn c ch num avn c signific inhibit cell prolifer cox num posit ht num caco num ls num cox num negat hct num human colon cancer cell line ch num avn c potent avn effect cox num express pge num product caco num ht num colon cancer cell result inhibitori effect avn colon cancer cell prolifer independ cox num express pge num product avn reduc colon cancer risk inhibit macrophag pge num product non cox rel antiprolif effect colon cancer cell interest avn effect cell viabil confluence induc differenti caco num cell display characterist normal colon epitheli cell result suggest consumpt oat oat bran reduc risk colon cancer high fiber content due avn attenu prolifer colon cancer cell
MED-1318~rice consumpt risk cardiovascular diseas morbid mortal japanes men women larg population bas pubm ncbi abstract background rice consumpt risk type num diabet relat cardiovascular diseas cvd limit object examin associ rice consumpt risk cvd incid mortal japanes popul design prospect studi num japanes men women age num rice consumpt determin updat num self administ food frequ questionnair num follow up incid num num cohort num num cohort ii mortal num num cohort num num cohort ii hrs num cis cvd incid mortal calcul quintil cumul averag rice consumpt result num follow up ascertain num incid case stroke num incid case ischem heart diseas ihd num death cvd rice consumpt risk incid stroke ihd multivari hr num ci highest compar lowest rice consumpt quintil num num num total stroke num num num ihd similar associ rice consumpt risk mortal cvd hr num ci mortal total cvd num num num interact sex effect modif bodi mass index endpoint conclus rice consumpt risk cvd morbid mortal num american societi nutrit
MED-1319~diet chronic degen diseas perspect china pubm ncbi abstract comprehens ecolog survey dietari life styl mortal characterist num counti rural china show diet substanti richer food plant origin compar diet consum industri western societi intak anim protein one tenth intak unit state energi percent total fat num energi dietari fiber num g d reflect substanti prefer food plant origin plasma cholesterol concentr approxim num num mmol l correspond dietari life styl princip hypothesi investig paper chronic degen diseas prevent aggreg effect nutrient nutrient intak amount common suppli food plant origin breadth consist evid hypothesi investig multipl intake biomarker diseas associ appropri adjust threshold plant food enrich minim fat intak diseas prevent occur find suggest small intak food anim origin signific increas plasma cholesterol concentr turn signific increas chronic degen diseas mortal rate
MED-1320~white rice brown rice risk type num diabet men women abstract context degre process nutrient content brown rice white rice effect risk type num diabet object prospect examin white rice brown rice consumpt relat type num diabet risk men women age num num yr design set health profession follow up studi num num nurs health studi num num ii num num particip prospect ascertain diet lifestyl practic diseas status num men num women cohort particip free diabet cardiovascular diseas cancer baselin intak white rice brown rice food nutrient assess baselin updat num num year result num num person year follow up document num incid case type num diabet multivari adjust age lifestyl dietari risk factor higher intak white rice higher risk type num diabet pool relat risk num confid interv type num diabet compar num servings week num serving month white rice num num num contrast high brown rice intak lower risk type num diabet pool multivari relat risk num confid interv num num num num servings week brown rice compar num serving month estim replac num grams day cook equival serving day intak white rice amount brown rice num confid interv num lower risk type num diabet replac grain group num confid interv num lower diabet risk conclus substitut grain includ brown rice white rice lower risk type num diabet data support recommend carbohydr intak grain refin grain facilit prevent type num diabet
MED-1321~phospholipid rice signific grain qualiti health benefit review pubm ncbi abstract phospholipid pls major class lipid rice grain pls minor nutrient compar starch protein nutrit function signific system review literatur class distribut variat pls rice relat rice end us qualiti human health method analyt profil phosphatidylcholin pc phosphatidylethanolamin pe phosphatidylinositol pi lyso form major pls rice deterior pc rice bran storag consid trigger degrad rice lipid rancid flavour paddi brown rice lyso form rice endosperm repres major starch lipid form inclus complex amylos affect physicochem properti digest starch cook eat qualiti dietari pls posit impact human diseas reduc side effect drug rice long consum stapl food asian countri rice pls signific health benefit popul rice pls influenc genet environment factor resolv interact futur exploit pl composit content boost rice eat qualiti health benefit consum identifi summaris method rice pl analysi discuss consequ variat report pl valu due inconsist method review enhanc understand natur import pls rice outlin potenti approach manipul pls improv qualiti rice grain cereal copyright num elsevi reserv
MED-1322~grain refin grain consumpt risk type num diabet systemat review dose respons meta analysi cohort studi pubm ncbi abstract studi suggest protect effect intak grain refin grain type num diabet risk dose respons relationship type grain type num diabet establish conduct systemat review meta analysi prospect studi grain intak type num diabet search pubm databas studi grain intak risk type num diabet june num num summari relat risk calcul random effect model sixteen cohort studi includ analys summari relat risk num serv day num num ci num num num num num grain num num ci num num num num num refin grain nonlinear associ observ grain nonlinear num refin grain nonlinear num invers associ observ subtyp grain includ grain bread grain cereal wheat bran brown rice result base studi white rice increas risk meta analysi suggest high grain intak refin grain reduc type num diabet risk posit associ intak white rice invers associ specif type grain type num diabet warrant investig result support public health recommend replac refin grain grain suggest serv grain day consum reduc type num diabet risk
MED-1323~low carbohydr diet score risk type num diabet men abstract background fat protein sourc influenc low carbohydr diet type num diabet num object object compar associ num low carbohydr diet score incid num design prospect cohort studi conduct particip health profession follow up studi free num cardiovascular diseas cancer baselin num num cumul averag num low carbohydr diet score high total protein fat high anim protein fat high veget protein fat calcul num food frequ questionnair incid num cox model result document num case num follow up adjust age smoke physic activ coffe intak alcohol intak famili histori num total energi intak bodi mass index score high anim protein fat increas risk num top compar bottom quintil hazard ratio hr num num ci num num trend num adjust red process meat attenu associ hr num num ci num num trend num high score veget protein fat signific risk num invers num men age num hr num num ci num num trend num interact num conclus score repres low carbohydr diet high anim protein fat posit risk num men low carbohydr diet obtain protein fat food red process meat
MED-1324~differenti effect protein fat ingest blood glucos respons high low glycemic index carbohydr noninsulin depend pubm ncbi abstract noninsulin depend diabet subject receiv meal num carbohydr potato spaghetti meal repeat addit num protein num protein num fat blood glucos insulin respons measur num test meal carbohydr blood glucos serum insulin increment higher potato meal addit protein increas insulin respons carbohydr slight reduc glycem respons mash potato num num addit fat reduc glycem respons mash potato num num chang blood glucos respons spaghetti num ns respons coingest protein fat reduc differ glycem respons carbohydr
MED-1326~preval diabet men women china pubm ncbi abstract background rapid chang lifestyl china concern diabet epidem conduct nation studi june num num estim preval diabet chines adult method nation repres sampl num adult num year age older num provinc municip particip studi overnight fast particip underw oral glucose toler test fast num hour glucos level measur identifi undiagnos diabet prediabet impair fast glucos impair glucos toler previous diagnos diabet determin basi self report result age standard preval total diabet includ previous diagnos diabet previous undiagnos diabet prediabet num num men num women num num men num women account num million adult diabet num million men num million women num million adult prediabet num million men num million women preval diabet increas increas age num num num person num num num num year age increas weight num num num num person body mass index weight kilogram divid squar height meter num num num num num num preval diabet higher urban resid rural resid num num preval isol impair glucos toler higher isol impair fast glucos num num men num num women conclus result diabet major public health problem china strategi aim prevent treatment diabet num massachusett medic societi
MED-1327~greater whole grain intak lower risk type num diabet cardiovascular diseas weight gain pubm ncbi abstract whole grain high fiber intak routin recommend prevent vascular diseas comprehens quantit assess data human aim studi systemat examin longitudin studi investig whole grain fiber intak relat risk type num diabet num cardiovascular diseas cvd weight gain metabol risk factor identifi num prospect cohort studi num randomized control trial rct num februari num search cumul index nurs alli health literatur cochran elsevi medic databas pubm studi characterist whole grain dietari fiber intak risk estim extract standard protocol random effect model found compar never rar consum grain consum num grain d num serving d num lower risk num rr num num ci num num num lower risk cvd rr num num ci num num consist weight gain num num num kg num rct weight differ post intervent circul concentr fast glucos total ldl cholesterol compar whole grain intervent group control signific lower concentr whole grain intervent differ fast glucos num mmol l num ci num num total cholesterol num mmol l num num ldl cholesterol num mmol l num num correct find meta analysi provid evid support benefici effect whole grain intak vascular diseas prevent potenti mechan respons grain effect metabol intermedi requir investig larg intervent trial
MED-1328~global region nation preval overweight obes children adult num systemat analysi global pubm ncbi abstract background num overweight obes estim num num million death num num year life lost num num disability adjust life year dali worldwid rise obes led widespread call regular monitor overweight obes preval popul compar up to d inform level trend essenti quantifi popul health effect prompt decis maker prioritis action estim global region nation preval overweight obes children adult num method systemat identifi survey report publish studi num includ data height weight physic measur self report mix effect linear regress correct bias self report obtain data preval obes overweight age sex countri year num spatiotempor gaussian process regress model estim preval num uncertainti interv ui find worldwid proport adult body mass index bmi num kg m num greater increas num num num num ui num num num num num num num men num num num num num num num num women preval increas substanti children adolesc develop countri num num num num boy num num num num girl overweight obes num preval overweight obes increas children adolesc develop countri num num num num num num num num num boy num num num num num num num num girl adult estim preval obes exceed num men tonga women kuwait kiribati feder state micronesia libya qatar tonga samoa num increas adult obes develop countri slow interpret establish health risk substanti increas preval obes major global health challeng obes increas nation success stori report past num year urgent global action leadership countri effect interven fund bill melinda gate foundat copyright num elsevi reserv
MED-1329~white rice bas food consumpt ischem stroke risk case control studi southern china pubm ncbi abstract white rice bas food high refin carbohydr wide consum china case control studi conduct investig associ white rice bas food consumpt risk ischem stroke southern chines popul inform diet lifestyl obtain num incid ischem stroke patient num hospital bas control logist regress analys perform assess effect rice bas food stroke risk week intak rice food signific higher case control increas consumpt cook rice conge rice noodl higher risk ischem stroke control confound factor adjust odd ratio num confid interv highest versus lowest intak level num num num num num num num num num signific dose respons relationship observ result provid evid posit associ habitu rice food consumpt risk ischem stroke chines adult copyright num nation stroke associ publish elsevi reserv
MED-1330~diabet preval determin adult china mainland num num systemat review pubm ncbi abstract aim systemat review trend diabet mellitus dm preval adult china num year identifi determin trend method systemat search conduct studi publish num num studi report dm preval includ met pre determin criteria preval estim report determin studi compar result twenty f manuscript report num studi select inclus review increas dm preval num num china past decad dm preval strong age higher urban resid compar rural popul studi found differ dm preval male femal find consist common report associ dm includ famili histori obes hypertens conclus period num identifi signific increas dm preval nation level import level govern develop effect strategi prevent manag rise diabet epidem import large scal studi diabet western central region china copyright num elsevi ireland reserv
MED-1331~dynam nutrit transit anim food sector china implic worri perspect pubm ncbi abstract diet physic activ occur simultan develop world diet shift includ larg increas energi densiti proport popul consum high fat diet anim product intak anim sourc food asf play major role diet shift articl document larg shift composit diet obes develop world note acceler china case studi evid speed process present descript rigor dynam longitudin analysi implic dietari obes pattern cardiovascular diseas great develop countri point preval obes greater undernutrit concern relat intak satur fat energi imbal consid agricultur sector current agricultur develop polici develop countri focus livestock promot potenti advers health consequ strategi linkag asf intak obes establish high asf intak heart diseas cancer potenti advers health effect link increas asf intak longer
MED-1332~incid type num diabet japan systemat review meta analysi abstract background definit incid type num diabet vari studi actual incid type num diabet japan unclear review definit incid type num diabet previous epidemiolog studi estim diabet incid rate japan method search relat literatur medlin embas ichushi databas septemb num review select studi evalu incid type num diabet japanes popul result num relev articl includ num studi num particip follow up period rang num num year studi initi num num random effect model pool incid rate diabet num num confid interv num num num person year observ high degre heterogen result num num num incid rate rang num num num person year studi base definit incid type num diabet self report num laboratori data num self report laboratori data compar studi defin diabet laboratori data num pool incid rate num num confid interv num num studi base self report tend show lower incid rate num pool incid rate num num confid interv num num interact num stratifi analys explain heterogen result conclus systemat review meta analysi presenc high degre heterogen suggest amount uncertainti incid type num diabet japan suggest laboratori data import accur estim incid type num diabet
MED-1333~insulin secret determin pancreat cancer risk pubm ncbi abstract epidemiolog confirm glucos intoler risk factor pancreat cancer associ account advers impact earli pancreat cancer beta cell function previous report risk pancreat cancer increas adult onset diabet streptozotocin diabet inhibit carcinogen medi induct pancreat cancer hamster reason interpret find insulin beta cell product act promot pancreat carcinogenesi view consist report human pancreat adenocarcinoma express insulin receptor stimul mitosi addit possibl high insulin level indirect promot pancreat carcinogenesi boost effect igf i activ hepat action intern ecolog epidemiolog pancreat cancer rate correl tight dietari intak anim product reflect fact vegan diet low diurnal insulin secret suggest evid macrobiot vegan diet low glycem index increas surviv time pancreat cancer type diet decreas postprandi insulin respons high protein diet mediterranean diet high oleic acid potenti pancreat cancer prevent huge increas age adjust pancreat cancer mortal japan african american centuri impli pancreat cancer substanti prevent low insulin respons diet coupl exercis train weight control smoke avoid commend great reason slash pancreat cancer mortal dramat copyright num harcourt publish
MED-1334~program polici option prevent obes china abstract num china preval overweight obes adult num percent num percent chines tradit diet replac western diet major declin phase activ increas sedentari activ main reason explain rapid increas overweight obes bring major econom health cost nutrit improv work manag approach releas num overweight obes prevention rel polici ad nation plan diseas prevent control guidelin prevent control overweight obes chines adult school ag children teenag overweight obes prevent control guidelin china promulg num num educ program implement select academ intervent research project domin focus reduc child obes promot healthier diet increas physic activ reduc sedentari time facilit famili school social cultur environ intervent sampl small address increas rate obes entir popul govern provis effect polici measur multisector cooper increas corpor social respons key curb trend overweight obes china
MED-1335~glycaem respons glucos rice peopl chines european ethnic pubm ncbi abstract aim diabet rate high china risk type num diabet increas high intak white rice stapl food chines peopl ethnic differ postprandi glycaemia report compar glycaem respons glucos rice varieti peopl european chines ethnic examin determin ethnic differ postprandi glycaemia method self identifi chines num european num healthi volunt attend occas studi ingest glucos jasmin basmati brown doongara parboil rice addit measur glycaem respons investig physic activ level extent chew rice salivari amylas activ determin measur explain differ postprandi glycaemia result glycaem respons measur increment area glucos curv num greater rice varieti num num greater glucos num chines compar european calcul glycaem index approxim num greater rice varieti basmati num num ethnic adjust risk ratio num num num num rice varieti import determin increment area glucos curv conclus glycaem respons ingest glucos rice varieti appreci greater chines compar european suggest review recommend dietari carbohydr rice popul high risk diabet num author diabet medicin num diabet uk
MED-1337~milk intak risk hip fractur men women meta analysi prospect cohort studi pubm ncbi abstract milk calcium phosphorus protein fortifi vitamin unit state ingredi improv bone health potenti benefit milk hip fractur prevent establish object studi assess associ milk intak risk hip fractur base meta analysi cohort studi middle ag older men women data sourc studi english non english public medlin ovid pubm embas search june num expert field refer list idea compar prospect cohort studi scale calcul relat risk rr hip fractur glass milk intak daili approxim num mg calcium glass milk pool analys base random effect model data extract independ observ result show women num studi num women num hip fractur associ total milk intak hip fractur risk pool rr glass milk day num num confid interv ci num num q test num men num studi num men num hip fractur pool rr daili glass milk num num ci num num conclus meta analysi cohort studi associ milk intak hip fractur risk women data men copyright num american societi bone miner research
MED-1338~milk intak risk mortal fractur women men cohort studi abstract object examin high milk consumpt mortal fractur women men design cohort studi set counti central sweden particip larg swedish cohort num num women num year baselin num num num men num year baselin num administ food frequenc questionnair women respond food frequenc questionnair num main outcom measur multivari surviv model appli determin associ milk consumpt time mortal fractur result follow up num year num num women die num num fractur num hip fractur male cohort follow up num year num num men die num fractur num hip fractur case women adjust mortal hazard ratio glass milk day compar glass day num num confid interv num num glass milk adjust hazard ratio mortal num num num women num num num men glass milk women reduct observ fractur risk higher milk consumpt fractur num num num hip fractur num num num adjust hazard ratio men num num num num num num subsampl addit cohort male femal posit associ milk intak urin num iso pgf num biomark oxid stress serum interleukin num main inflammatori biomark conclus high milk intak higher mortal cohort women cohort men higher fractur incid women observ studi design inher possibl residu confound revers causat phenomena cautious interpret result recommend
MED-1339~calcium supplement bone miner densiti femal childhood young adulthood random control trial pubm ncbi abstract background short term studi establish calcium influenc bone accret growth long term supplement influenc bone accret young adult object studi evalu long term effect calcium supplement bone accret femal childhood young adulthood design num random clinic trial recruit num femal pubert stage num option extend addit num dietari calcium intak particip num approxim num mg d calcium suppl person receiv addit approxim num mg d primari outcom variabl distal proxim radius bone miner densiti bmd total bodi bmd tbbmd metacarp cortic index result multivari analys primari outcom calcium supplement effect vari time follow up univari analys primari outcom signific larger supplement group placebo group year num endpoint year num endpoint effect vanish tbbmd distal radius bmd longitudin model tbbmd proxim radius bmd time menarch show high signific effect supplement pubert growth spurt diminish effect post hoc stratif compliance adjust total calcium intak final statur metacarp total cross sect area show calcium effect depend complianc bodi frame conclus calcium supplement signific influenc bone accret young femal pubert growth spurt young adulthood signific effect remain metacarp forearm tall person calcium requir growth skelet size result import primari prevent osteoporosi prevent bone fragil fractur growth
MED-1340~milk consumpt teenag year risk hip fractur older adult abstract import milk consumpt adolesc recommend promot peak bone mass reduc fractur risk life role hip fractur prevent establish high consumpt advers influenc risk increas height object determin milk consumpt teenag year influenc risk hip fractur older adult investig role attain height associ design prospect cohort studi num year follow up set unit state particip num caucasian postmenopaus women nurs health studi men age num older health profession follow up studi exposur frequenc consumpt milk food age num num attain height report baselin current diet weight smoke physic activ medic risk factor hip fractur report biennial questionnair main outcom measur cox proport hazard model calcul relat risk rr incid hip fractur low trauma event glass num fl oz num ml milk consum day teenag year result follow up num hip fractur identifi women num men control risk factor current milk consumpt addit glass milk day teenag year signific num higher risk hip fractur men rr num num ci num num associ attenu height ad model rr num num ci num num teenag milk consumpt hip fractur women rr num num ci num num glass day conclus relev greater milk consumpt teenag year lower risk hip fractur older adult posit associ observ men partial mediat attain height
MED-1341~skelet health adult patient classic galactosemia pubm ncbi abstract summari studi evalu bone health adult galactosemia associ bone miner densiti bmd nutrit biochem variabl explor calcium level predict hip spine bmd gonadotropin level invers spinal bmd women result afford insight manag strategi patient introduct bone loss complic galactosemia dietari restrict primari ovarian insuffici women disease rel alter bone metabol contribut studi examin relationship clinic factor bmd patient galactosemia method cross sect sampl includ num adult num women classic galactosemia age num num year bmd measur dual energi x ray absorptiometri correl age height weight fractur nutrit factor hormon status bone biomark result signific differ hip bmd women men num num g cm num num percentag subject bmd z num greater women men num num spine num num hip women report sustain fractur bivari analys yield correl bmi bmd z hip women num num spine men num num women weight correl bmd z num num hip c telopeptid num spine num hip num osteocalcin num spine num hip num invers correl bmd z final regress model higher gonadotropin level lower spinal bmd women num serum calcium signific predictor hip num spine num bmd sex conclus bone densiti adult galactosemia low indic potenti increas fractur risk etiolog multifactori
MED-1342~efficaci paroxetin placebo treat anxieti depress meta analysi chang hamilton rate scale abstract background previous meta analys publish unpublish trial antidepress provid modest benefit compar placebo treatment depress argu benefit clinic signific meta analys base trial submit initi fda approv medic limit aim treat depress time assess efficaci select serotonin reuptak inhibitor ssri treatment anxieti depress complet data set publish unpublish trial sponsor manufactur method find glaxosmithklin requir post result sponsor clinic trial onlin provid opportun assess efficaci ssri paroxetin complet data set trial conduct examin data placebo control double blind trial paroxetin includ chang score hamilton rate scale anxieti hrsa and or hamilton rate scale depress hrsd treatment anxieti num efficaci differ paroxetin placebo modest num independ baselin sever anxieti chang placebo tr individu replic num magnitud paroxetin respons efficaci superior treatment panic disord num general anxieti disord num publish trial show signific larger drug placebo differ unpublish trial num num depress trial num benefit paroxetin placebo consist previous meta analys antidepress efficaci num conclus empir evid paroxetin modest advantag placebo treatment anxieti depress treatment implic discuss
MED-1343~select public antidepress trial influenc appar efficaci pubm ncbi abstract background evidence bas medicin valuabl extent evid base complet unbias select public clinic trials  and outcom trials  can lead unrealist estim drug effect alter appar risk benefit ratio method obtain review food drug administr fda studi num antidepress agent involv num patient conduct systemat literatur search identifi match public trial report literatur compar publish outcom fda outcom compar effect size deriv publish report effect size deriv entir fda data set result num fda regist studi num account num studi particip publish studi publish studi outcom total num studi view fda posit result publish num studi view posit publish studi view fda negat question result num publish num studi publish opinion convey posit outcom num studi publish literatur num trial conduct posit contrast fda analysi show num posit separ meta analys fda journal data set show increas effect size rang num num individu drug num conclus determin bias observ result failur submit manuscript part author sponsor decis journal editor review publish select report clinic trial result advers consequ research studi particip health care profession patient copyright num massachusett medic societi
MED-1344~decept treatment case depress pubm ncbi abstract prescrib placebo patient clinic practic general medic council ambival issu american medic associ assert placebo administ patient inform potenti problem placebo involv decept case ethic tension aris patient autonomi physician requir open honest notion medic care primari concern paper examin case depress entri point understand complex prescript placebo recent import meta analys antidepress claim signific effect clinic set placebo antidepress numer advers side effect huge expens provoc research potenti ethic practic implic patient medic provid placebo prescrib place antidepress case depress highlight import issu medic ethic code hitherto overlook well b synonym realist oneself one circumst futur sever depress individu unduli pessimist world treatment depress individu deem success patient success attain posit illus indic psycholog health success psycholog treatment depress achiev limit unavoid role decept medicin
MED-1345~challeng receiv wisdom antidepress placebo effect abstract articl explor reaction articl challeng receiv wisdom publish cover extens media num articl question meta analysi antidepress clinic trial indic patient differ drug placebo clinic signific reaction rang denial effect antidepress small critic clinic trial analyz reaction explor counter
MED-1347~antidepress placebo respons pubm ncbi abstract aim evalu generat antidepress relat placebo respons method review meta analys respons antidepress medic respons placebo calcul result meta analys includ unpublish publish trial trial fail show signific advantag ssris inert placebo differ drug placebo clinic signific depress patient document obtain food drug administr fda reveal explicit decis inform public prescrib physician conclus incur drug risk exercis psychotherapi show benefit equal antidepress treatment choic depress individu
MED-1348~initi sever antidepress benefit meta analysi data submit food drug administr abstract background meta analys antidepress medic report modest benefit placebo treatment unpublish trial data includ benefit fall accept criteria clinic signific efficaci antidepress depend sever initi depress score purpos analysi establish relat baselin sever antidepress efficaci relev dataset publish unpublish clinic trial method find obtain data clinic trial submit food drug administr fda licens new gener antidepress full dataset meta analyt techniqu assess linear quadrat effect initi sever improv score drug placebo group drug placebo differ score drug placebo differ increas function initi sever rise virtual differ moder level initi depress small differ patient sever depress reach convent criteria clinic signific patient upper end sever depress categori meta regress analys relat baselin sever improv curvilinear drug group show strong negat linear compon placebo group conclus drug placebo differ antidepress efficaci increas function baselin sever small sever depress patient relationship initi sever antidepress efficaci attribut decreas respons placebo sever depress patient increas respons medic editor summari background feel miser occasion peopl depress sad feel month year interfer daili life depress medic ill caus imbal brain chemic regul mood affect peopl time life make feel hopeless worthless unmotiv suicid doctor measur sever depress hamilton rate scale depress hrsd num num item questionnair answer question score total score questionnair num sever depress mild depress treat psychotherapi talk therapi cognit behavior therapi peopl chang negat behav sever depress current treatment combin psychotherapi antidepress drug hypothes normal brain chemic affect mood antidepress includ tricycl monoamin oxidas select serotonin reuptak inhibitor ssris ssris newest antidepress includ fluoxetin venlafaxin nefazodon paroxetin studi food drug administr fda uk nation institut health clinic excel nice licens author approv ssris treatment depress doubt remain clinic efficaci antidepress approv patient undergo clinic trial compar abil improv hrsd score patient placebo dummi tablet drug individu trial inform drug effect addit inform gain combin result trial meta analysi statist method combin result studi previous publish meta analysi publish unpublish trial ssris submit fda licens drug margin clinic benefit averag ssris improv hrsd score patient num point placebo nice defin signific clinic benefit antidepress drug placebo differ improv hrsd score num point averag improv score obscur benefici effect group patient meta analysi paper research investig baselin sever depress affect antidepress efficaci research find research obtain data clinic trial submit fda licens fluoxetin venlafaxin nefazodon paroxetin meta analyt techniqu investig initi sever depress affect hrsd improv score drug placebo group trial confirm effect generat antidepress recommend criteria clinic signific show virtual differ improv score drug placebo patient moder depress small clinic insignific differ patient sever depress differ improv antidepress placebo reach clinic signific patient initi hrsd score num sever depress patient addit analys appar clinic effect antidepress sever depress patient reflect decreas respons placebo increas respons antidepress find find suggest compar placebo new gener antidepress produc clinic signific improv depress patient initi moder sever depress show signific effect sever depress patient find show effect patient due decreas respons placebo increas respons medic result research conclud reason prescrib new gener antidepress medic sever depress patient altern treatment ineffect addit find extrem depress patient respons placebo sever depress patient similar respons antidepress potenti import insight patient depress respond antidepress placebo investig addit inform access web site onlin version summari http   dx doi org num journal pmed num
MED-1349~antidepress placebo effect abstract antidepress suppos work fix chemic imbal specif lack serotonin brain suppos effect primari evid chemic imbal theori analys publish data unpublish data hidden drug compani reveal benefit due placebo effect antidepress increas serotonin level decreas effect serotonin show therapeut benefit small statist differ antidepress placebo enhanc placebo effect due fact patient doctor clinic trial success break blind serotonin theori close theori histori scienc prove wrong cure depress popular antidepress induc biolog vulner make peopl depress futur
MED-1350~pill ill patient report experi medic encount treatment depress abstract background start num broad bas patient movement began question doctor patern demand disclosur medic inform inform consent activ particip individu person health care scholar contribut downplay biomed approach favor patient ori perspect swedish non profit organ consum associ medicin health kilen offer possibl consum report percept experi medicin order strengthen consum health care sector methodolog paper qualit content analysi analyz num kilen consum report advers event antidepress medic order explor patient view mental ill health symptom doctor pati interact princip find kilen stori negat experi patient medic encount report intens emot outrag strong feel abus health care system report suggest doctor patient account natur problem patient seek patient sought problem tired sleepless person crisi sort treat doctor case quick diagnos depress prescrib antidepress treatment patient felt listen trust doctor compromis evid case doctor convinc part medic treatment threaten withdraw sick list conclus studi suggest dynam happen medic encount high affect medic domin patient ori perspect contribut question medic and or pharmaceutic depress
MED-1351~conflict interest psychiatri strategi cultiv literaci daili practic pubm ncbi abstract relationship psychiatri pharmaceut compani scrutini past decad concern grow financi tie psychiatrist pharmaceut industri unduli influenc profession judgment involv primari interest patient conflict interest threaten public trust psychiatri goal conflict interest polici protect integr profession judgment preserv public trust disclosur individu institut financi relationship critic limit step process identifi respond conflict interest conflict interest polici procedur strengthen engag psychiatrist research institut profession associ develop polici consensus standard research conflict interest provid stronger evid base polici design implement societi tradit grant medic profess autonomi continu case conflict interest concern grow stronger measur avoid undu regulatori burden psychiatrist play vital role design respons reason conflict interest polici reduc risk bias loss trust psychiatrist institut carri research educ clinic care practic guidelin develop recogn public concern conflict interest effect measur maintain public trust cultur chang practic psychiatri reactiv treatment seek mental ill proactiv advocaci patient num author psychiatri clinic neurosci num japanes societi psychiatri neurolog
MED-1352~primum nocer evolutionari analysi antidepress harm good abstract antidepress medic first lin treatment peopl meet current diagnost criteria major depress disord antidepress design perturb mechan regul neurotransmitt serotonin evolutionarili ancient biochem found plant anim fungi adapt process evolv regul serotonin includ emot develop neuron growth death platelet activ clot process attent electrolyt balanc reproduct principl evolutionari medicin disrupt evolv adapt degrad biolog function serotonin regul adapt process antidepress advers health effect instanc antidepress modest effect reduc depress symptom increas brain suscept futur episod discontinu contrari wide held belief psychiatri studi purport show antidepress promot neurogenesi flaw method distinguish neurogenesi neuron death fact antidepress neuron damag matur neuron revert immatur state explain antidepress neuron undergo apoptosi program death antidepress development problem advers effect sexual romant life increas risk hyponatremia low sodium blood plasma bleed stroke death elder review support conclus antidepress general harm good disrupt number adapt process regul serotonin specif condit warrant cancer recoveri stroke conclud alter inform consent practic greater caution prescript antidepress warrant
MED-1353~drug don work antidepress current futur pharmacolog manag depress abstract depress potenti life threaten disord affect million peopl globe huge burden individu societi cost num billion num world health organis cite lead global disabl num develop world project lead num serendipit discoveri antidepress revolution understand manag depress efficaci treatment depress long debat recent brought public limelight controversi public kirsch role placebo respons antidepress efficaci trial highlight whilst antidepress offer benefit short long term import problem persist intoler delay therapeut onset limit efficaci milder depress exist treatment resist depress
MED-1354~antidepress drug effect depress sever patient level meta analysi abstract context antidepress medic repres establish treatment major depress disord mdd evid specif pharmacolog effect relat pill placebo patient sever depress object estim relat benefit medic placebo wide rang initi symptom sever patient diagnos depress data sourc pubm psycinfo cochran librari databas search januari num march num refer meta analys review studi select random placebo control trial fda approv antidepress treatment major minor depress disord select studi includ author provid requisit origin data compris adult outpati includ medic placebo comparison num week exclud patient basi placebo washout period util hamilton rate scale depress data studi num patient includ data extract individu patient level data obtain studi author result medic placebo differ vari substanti function baselin sever patient hamilton score num cohen d type effect size differ medic placebo estim num standard definit small effect estim magnitud superior medic placebo increas increas baselin hamilton sever cross nice threshold clinic signific differ baselin score num conclus magnitud benefit antidepress medic compar placebo increas sever depress symptom minim nonexist averag patient mild moder symptom patient sever depress benefit medic placebo substanti
MED-1355~exercis treatment depress anxieti pubm ncbi abstract depress anxieti common psychiatr condit general medic set affect million individu unit state treatment depress anxieti multipl vari degre effect physic activ shown decreas symptom depress anxieti physic activ consist shown improv physic health life satisfact cognit function psycholog well b convers physic inact develop psycholog disord specif studi support exercis treatment depress exercis compar favor antidepress medic first lin treatment mild moder depress shown improv depress symptom adjunct medic extens studi exercis shown effect cost effici treatment altern varieti anxieti disord effect exercis shown reduc anxieti level achiev psychopharmaceut
MED-1356~associ physic activ mental disord adult unit state pubm ncbi abstract background object studi determin associ regular physic activ mental disord adult unit state method multipl logist regress analys compar preval mental disord report regular physic activ data nation comorbid survey num nation repres sampl adult age num unit state conclus slight one half adult report regular physic activ num regular physic activ signific decreas preval current major depress anxieti disord signific affect substanc psychot disord associ regular physic activ lower preval current major depress num num num panic attack num num num social phobia num num num specif phobia num num num agoraphobia num num num persist adjust differ sociodemograph characterist self report physic disord comorbid mental disord self report frequenc physic activ show dose respons relat current mental disord discuss data document negat associ regular physic activ depress anxieti disord adult popul futur research investig mechan associ longitudin data examin link physic activ incid recurr mental disord lifespan
MED-1357~effect exercis train older patient major depress pubm ncbi abstract background previous observ intervent studi suggest regular physic exercis reduc symptom depress extent exercis train reduc depress symptom older patient major depress disord mdd systemat evalu object assess effect aerob exercis program compar standard medic antidepress treatment mdd older patient conduct num week random control trial method hundr fifty six men women mdd age num year assign random program aerob exercis antidepress sertralin hydrochlorid combin exercis medic subject underw comprehens evalu depress includ presenc sever mdd diagnost statist manual mental disord fourth edit criteria hamilton rate scale depress ham d beck depress inventori bdi score treatment secondari outcom measur includ aerob capac life satisfact self esteem anxieti dysfunct cognit result num week treatment group differ statist ham d bdi score num adjust baselin level depress yield essenti ident result growth curv model reveal group exhibit statist clinic signific reduct ham d bdi score patient receiv medic exhibit fastest initi respons patient receiv combin therapi sever depress symptom initi show rapid respons initi sever depress symptom conclus exercis train program consid altern antidepress treatment depress older person antidepress facilit rapid initi therapeut respons exercis num week treatment exercis equal effect reduc depress patient mdd
MED-1358~acut effect exercis mood state pubm ncbi abstract paper document recent num literatur acut mood effect particip singl session exercis issu experiment design ecolog valid oper definit mood address result studi suggest clinic nonclin subject benefit acut singl bout exercis final mechan recommend futur research discuss
MED-1359~physic exercis intervent depress disord meta analysi systemat review pubm ncbi abstract previous meta analys investig effect exercis depress includ trial control condit categor placebo fact placebo intervent medit relax recogn antidepress effect medit mindfulness bas intervent depress reduct imposs separ effect physic exercis meditation rel part present studi determin efficaci exercis reduc symptom depress compar treatment placebo condit usual care clinic defin depress adult num retriev studi num pass inclus criteria num studi present suffici inform calcul effect size main result show signific larg effect favor exercis intervent effect size larger trial treatment placebo condit analyz effect size reduc moder level studi high methodolog qualiti includ analysi exercis recommend peopl mild moder depress motiv physic healthi engag program num john wiley son a publish john wiley son
MED-1360~exercis pharmacotherapi treatment major depress disord abstract object assess patient receiv aerob exercis train perform home supervis group set achiev reduct depress compar standard antidepress medic sertralin greater reduct depress compar placebo control method octob num novemb num perform prospect random control trial smile studi alloc conceal blind outcom assess tertiari care teach hospit total num adult num women num men diagnos major depress assign random condit supervis exercis group set home bas exercis antidepress medic sertralin num num mg daili placebo pill num week patient underw structur clinic interview depress complet hamilton depress rate scale ham d result num month treatment num particip achiev remiss defin longer meet criteria major depress disord mdd ham d score num patient receiv activ treatment tend higher remiss rate placebo control supervis exercis num home bas exercis num medic num placebo num num treatment group lower ham d score treatment score activ treatment group signific placebo group num conclus efficaci exercis patient general compar patient receiv antidepress medic tend placebo patient mdd placebo respons rate high suggest portion therapeut respons determin patient expect ongo symptom monitor attent nonspecif factor
MED-1362~adher mediterranean diet risk cancer systemat review meta analysi observ studi pubm ncbi abstract aim research studi meta analyz effect adher mediterranean diet md cancer risk cancer type literatur search perform electron databas medlin scopus embas januari num inclus criteria cohort case control studi studi specif risk ratio rrs pool random effect model cochran softwar packag review manag num twenty on cohort studi includ num num subject num case control studi num subject met object enclos meta analys highest adher md categori result signific risk reduct cancer mortality incid cohort rr num num ci num num num num num colorect cohort case control rr num num ci num num num num num prostat cohort case control rr num num ci num num num num num aerodigest cancer cohort case control rr num num ci num num num num num nonsignific observ breast cancer gastric cancer pancreat cancer egger regress test provid limit evid substanti public bias high adher md signific reduct risk cancer mortal num colorect cancer num prostat cancer num aerodigest cancer num num uicc
MED-1363~healthier mediterranean diet pubm ncbi abstract dietari guidelin promot good health base food nutrient dietari pattern predict chronic diseas risk epidemiolog studi sound nutrit recommend cardiovascular prevent base result larg random clinic trial hard end point main outcom evid obtain mediterranean diet predim prevenc con dieta mediterr nea trial lyon heart studi tradit mediterranean diet found oliv grow area crete greec southern itali late num major characterist includ high consumpt cereal legum nut veget fruit high fat consumpt provid oliv oil moder high fish consumpt poultri dairi product consum moder small amount low consumpt red meat meat product moder alcohol intak form red wine protect effect tradit mediterranean diet greater upgrad health effect dietari pattern chang common oliv oil extra virgin oliv oil increas consumpt nut fatti fish grain cereal reduc sodium intak maintain moder consumpt wine meal num elsevi reserv
MED-1365~bread consumpt num year adipos spanish subject high cardiovascular risk pubm ncbi abstract effect bread consumpt chang time anthropometr measur scarc studi analys num particip high risk cvd prevenc con dieta mediterr nea predim trial assess associ consumpt bread weight waist circumfer gain time dietari habit assess valid ffq baselin repeat year num year follow up multivari model adjust covari long term weight waist circumfer quartil chang energy adjust white whole grain bread consumpt calcul present result show num year particip highest quartil chang white bread intak gain num num kg lowest quartil trend num num num num cm lowest quartil trend num num signific dose respons relationship observ chang whole bread consumpt anthropometr measur gain weight num kg gain waist circumfer num cm follow up increas bread consumpt particip highest quartil white bread intak reduct num odd lose weight num kg reduct num odd lose waist circumfer num cm present result suggest reduc white bread whole grain bread consumpt mediterranean styl food pattern set lower gain weight abdomin fat
MED-1366~mediterranean diet public health person reflect pubm ncbi abstract concern diet public health problem began earli num napl observ low incid coronari heart diseas call good mediterranean diet heart diet vegetarian differ american northern european diet lower meat dairi product fruit dessert observ led subsequ research countri studi demonstr satur fat major dietari villain today healthi mediterranean diet chang coronari heart diseas longer confin medic textbook challeng persuad children parent eat mediterranean
MED-1371~adher mediterranean diet risk breast cancer european prospect investig cancer nutrit cohort studi pubm ncbi abstract epidemiolog evid suggest mediterranean diet md reduc risk breast cancer bc evid prospect studi remain scarc conflict investig associ adher md risk bc num women recruit num num ten european countri num year averag adher md estim adapt relat mediterranean diet arm score exclud alcohol cox proport hazard regress model adjust bc risk factor total num postmenopaus num premenopaus primari incid invas bc identifi num estrogen progesteron receptor posit er  pr num estrogen progesteron receptor negat er  pr arm invers risk bc postmenopaus women high low arm score hazard ratio hr num num confid interv ci num num ptrend num hr num num ci num num ptrend num associ pronounc er  pr tumor hr num num ci num num ptrend num arm score bc premenopaus women find show adher md exclud alcohol relat modest reduc risk bc postmenopaus women associ stronger receptor neg tumor result support potenti scope bc prevent dietari modif copyright num uicc
MED-1373~role virgin oliv oil compon modul endotheli function pubm ncbi abstract endothelium involv process relat develop atherosclerosi consid inflammatori diseas tradit risk factor atherosclerosi predispos endotheli dysfunct manifest increas express specif cytokin adhes molecul firm evid support benefici effect oliv oil genuin compon mediterranean diet effect oliv oil oleic acid rich dietari oil atherosclerosi plasma lipid role minor compon investig minor compon constitut num virgin oliv oil voo compos hydrocarbon polyphenol tocopherol sterol triterpenoid compon found trace low concentr non fatti acid constitu import studi compar monounsatur dietari oil report effect cardiovascular diseas compound demonstr antioxid anti inflammatori hypolipidem properti review summar current knowledg effect compound voo vascular dysfunct mechan modul endotheli activ mechan involv releas nitric oxid eicosanoid prostaglandin leukotrien adhes molecul case activ nuclear factor kappab reactiv oxygen speci
MED-1374~definit potenti health benefit mediterranean diet view expert world abstract mediterranean diet link number health benefit includ reduc mortal risk lower incid cardiovascular diseas definit mediterranean diet vari set score increas employ defin mediterranean diet adher epidemiolog studi compon mediterranean diet overlap healthi dietari pattern aspect uniqu mediterranean diet forum articl clinician research interest effect diet health describ constitut mediterranean diet geograph set studi health benefit dietari pattern
MED-1375~provegetarian food pattern reduct total mortal prevenc con dieta mediterr nea predim studi pubm ncbi abstract background vegetarian diet reduc mortal pure vegetarian diet easili embrac individu consum preferenti plant deriv food easili understood messag provegetarian food pattern fp emphas prefer plant deriv food reduc all caus mortal object object identifi associ priori defin provegetarian fp all caus mortal design num particip num women age num high cardiovascular risk median num valid num item semiquantit food frequ questionnair administ baselin year fruit veget nut cereal legum oliv oil potato posit weight ad anim fat egg fish dairi product meat meat product negat weight energy adjust quintil assign point build provegetarian fp rang num point death confirm review medic record nation death index result num death follow up period num cardiovascular num cancer num noncanc noncardiovascular higher baselin conform provegetarian fp lower mortal multivariable adjust hr num compar num point num num ci num num similar result found updat inform diet rr num num ci num num conclus omnivor subject high cardiovascular risk conform fp emphas plant deriv food reduc risk all caus mortal trial regist www controlled tri isrctn num num american societi nutrit
MED-1376~sociodemograph lifestyl statist oldest peopl num year live ikaria island ikaria studi abstract background place world peopl live longer activ past age num year share common behavior characterist place sardinia itali okinawa japan loma linda california nicoya peninsula costa rica blue zone recent report peopl ikaria island greec highest life expect world join blue zone aim work work evalu demograph lifestyl psycholog characterist num year peopl particip ikaria studi method num peopl age num men women ikaria island greec voluntarili enrol studi work num male num femal age num yrs studi num sampl socio demograph clinic psycholog lifestyl characterist assess standard questionnair procedur result larg proport ikaria study sampl age num percent peopl num higher european popul averag major oldest particip report daili physic activ healthi eat habit avoid smoke frequent social mid day nap extrem low rate depress conclus modifi risk factor physic activ diet smoke cessat mid day nap depict secret long liv find suggest interact environment behavior clinic characterist determin longev concept explor order understand factor relat import shape prolong life
MED-1377~higher diet qualiti decreas risk all caus cardiovascular diseas cancer mortal older adult abstract increas attent dietari research guidanc focus dietari pattern singl nutrient food group dietari compon consum combin correl collect bodi research topic hamper lack consist method examin relationship num indic healthi eat index num hei num altern healthi eat index num ahei num altern mediterranean diet ame dietari approach stop hypertens dash all caus cardiovascular diseas cvd cancer mortal nih aarp diet health studi num data num item food frequ questionnair calcul score adjust hrs num cis estim document num death includ num cvd num cancer specif death num follow up higher index score num num decreas risk all caus cvd cancer mortal specif compar highest lowest quintil score adjust hrs all caus mortal men hei num hr num num ci num num ahei num hr num num ci num num ame hr num num ci num num dash hr num num ci num num women hei num hr num num ci num num ahei num hr num num ci num num ame hr num num ci num num dash hr num num ci num num similar high adher index protect cvd cancer mortal examin separ find multipl score reflect core tenet healthi diet lower risk mortal outcom includ feder guidanc operation hei num harvard healthi eat plate captur ahei num mediterranean diet adapt american ame dash eat plan includ dash score
MED-1378~longev diet myth pragmat pubm ncbi abstract longev complex phenomenon environment behavior socio demograph dietari factor influenc physiolog pathway age life expect nutrit recogn import impact mortal morbid role extend life expect object extens scientif research paper review pathophysiolog mechan potenti link age diet scientif evid support anti ag effect tradit mediterranean diet specif food diet compon addit shown benefici effect co morbid typic elder popul epigenet effect diet age process calori restrict consumpt food red wine orang juic probiot prebiot attract scientif interest dark chocol red wine nut bean avocado promot anti ag food due anti oxid anti inflammatori properti final import moder relationship diet longev human health remain socio econom status individu healthi diet due higher cost close relat higher financi educ status copyright num elsevi ireland reserv
MED-1380~anatomi health effect mediterranean diet greek epic prospect cohort studi abstract object investig relat import individu compon mediterranean diet generat invers associ increas adher diet mortal design prospect cohort studi set greek segment european prospect investig cancer nutrit epic particip num num men women previous diagnos cancer coronari heart diseas diabet document surviv status june num complet inform nutrit variabl import covari enrol main outcom measur mortal result follow up num year num death occur num num particip mediterranean diet score num num num num particip score num control potenti confound higher adher mediterranean diet statist signific reduct total mortal adjust mortal ratio unit increas score num num confid interv num num contribut individu compon mediterranean diet associ moder ethanol consumpt num low consumpt meat meat product num high veget consumpt num high fruit nut consumpt num high monounsatur satur lipid ratio num high legum consumpt num contribut high cereal consumpt low dairi consumpt minim high fish seafood consumpt non signific increas mortal ratio conclus domin compon mediterranean diet score predictor lower mortal moder consumpt ethanol low consumpt meat meat product high consumpt veget fruit nut oliv oil legum minim contribut found cereal dairi product possibl heterogen categori food differenti health effect fish seafood intak low popul
MED-1381~nut consumpt vegetarian diet ischem heart diseas risk all caus mortal evid epidemiolog studi pubm ncbi abstract unexpect find nutrit epidemiolog past num nut consumpt protect ischem heart diseas ihd frequenc quantiti nut consumpt document higher vegetarian nonvegetarian popul nut constitut import part plant bas diet mediterranean asian diet larg prospect epidemiolog studi seventh day adventist california found frequenc nut consumpt substanti high signific invers associ risk myocardi infarct death ihd iowa women health studi document associ nut consumpt decreas risk ihd protect effect nut ihd found men women elder import nut similar associ vegetarian nonvegetarian protect effect nut consumpt ihd offset increas mortal frequenc nut consumpt found invers relat all caus mortal popul group white black elder nut consumpt offer protect ihd increas longev
MED-1383~mediterranean diet enzymat antioxid capac predim studi evid mechan antioxid tune pubm ncbi abstract background aim intak antioxidant rich food increas blood level enzymat antioxid capac neac neac account antioxid food synergist effect examin effect num year intervent mediterranean diet plasma neac assess relat baselin neac level method result hundr sixty four particip high cardiovascular risk random select predim prevenc con dieta mediterr nea studi larg num arm random clinic trial blood neac level measur baselin num year dietari intervent num mediterranean diet supplement virgin oliv oil med voo num mediterranean diet supplement nut med nut num control low fat diet plasma neac analyz frap ferric reduc antioxid potenti trap total radical trap antioxid paramet assay plasma frap level increas num year intervent med voo num mol l num ci num num med nut num mol l num num control low fat diet num mol l num num particip lowest quartil plasma frap baselin signific increas level intervent highest quartil decreas similar result occur trap level conclus studi show num year med diet intervent increas plasma tac level subject high risk cardiovascular diseas effect dietari supplement antioxid relat baselin level plasma neac num elsevi reserv
MED-1386~communic clinic research reduc cancer risk diet walnut case abstract inflamm mechan cancer initi progress implic etiolog condit affect cancer risk prognosi type num diabet cardiovascular diseas viscer obes emerg human evid primarili epidemiolog suggest walnut impact risk chronic diseas inflamm publish literatur document associ walnut consumpt reduc risk cancer mortal cancer diabet cardiovascular diseas context mediterranean diet encourag follow up human intervent trial elucid potenti cancer prevent effect walnut se human far reach posit effect plant bas diet includ walnut critic messag public translat nutrit research essenti facilit health consum dietari behavior paper explor translat applic human evid connect cancer biomark inflamm develop dietari guidanc public individu dietari advic strategi encourag dietari pattern reduc cancer risk explor
MED-1387~nut consumpt risk type num diabet cardiovascular diseas all caus mortal systemat review meta analysi pubm ncbi abstract background epidemiolog studi shown invers associ nut consumpt diabet cardiovascular diseas cvd all caus mortal result consist object assess relat nut intak incid type num diabet cvd all caus mortal design search pubm embas prospect cohort studi publish march num rrs num cis outcom interest random effect model pool risk estim studi result num report num prospect studi num type num diabet num cvd num ischem heart diseas ihd num stroke num mortal case rr increment serv day nut intak num num ci num num type num diabet adjust bodi mass index adjust associ attenu rr num num ci num num ns multivariable adjust model pool rrs num cis serv day nut consumpt num num num ihd num num num cvd num num num all caus mortal pool rrs num cis comparison extrem quantil nut intak num num num ns type num diabet num num num ihd num num num cvd num num num ns stroke num num num all caus mortal conclus meta analysi nut intak invers ihd cvd all caus mortal signific diabet stroke invers associ consumpt nut diabet attenu adjust bodi mass index find support recommend includ nut part healthi dietari pattern prevent chronic diseas num american societi nutrit
MED-1388~nut consumpt num all caus mortal mediterranean cohort sun project pubm ncbi abstract object aim studi assess associ nut consumpt all caus mortal num follow up spanish cohort method sun seguimiento universidad de navarra univers navarra follow up project prospect cohort studi form spanish univers graduat inform gather mail questionnair collect biennial num particip num baselin nut consumpt collect self report data valid num item semi quantit food frequenc questionnair inform mortal collect perman contact sun particip famili postal author nation death index associ baselin nut consumpt all caus mortal assess cox proport hazard model adjust potenti confound baselin nut consumpt categor analysi energy adjust quintil nut consumpt measur g d adjust total energi intak residu method analysi particip categor group pre establish categori nut consumpt servings d servings wk analys adjust potenti confound factor result particip consum nut num wk num lower risk all caus mortal consum nut adjust hazard ratio num num confid interv num num conclus nut consumpt signific reduc risk all caus mortal num follow up sun project copyright num elsevi reserv
MED-1389~mediterranean diet improv system lipid dna oxid damag metabol syndrom individu random control trial pubm ncbi abstract background aim metabol syndrom met non class featur increas system oxid biomark present high risk diabet cardiovascular diseas cvd adher mediterranean diet meddiet reduc risk met effect meddiet biomark oxid damag assess met individu investig effect meddiet system oxid biomark met individu method random control parallel clinic trial num femal met age num recruit larg trial predim studi test efficaci tradit meddiet primari prevent cvd particip assign low fat diet tradit meddiet meddiet virgin oliv oil meddiet nut meddiet group particip receiv nutrit educ free extra virgin oliv oil famili num l week free nut num g day diet ad libitum urin level num isoprostan num ip dna damag base num oxo num dihydro num deoxyguanosin num oxo dg evalu num year trial result num year urinari num ip decreas group decreas meddiet group reach borderlin signific versus control group urinari num oxo dg reduc group higher decreas meddiet group versus control num conclus meddiet reduc oxid damag lipid dna met individu data studi provid evid recommend tradit meddiet tool met manag regist clinic trial gov identifi nct num copyright num elsevi european societi clinic nutrit metabol reserv
MED-1390~oliv oil intak risk cardiovascular diseas mortal predim studi abstract background unknown individu high cardiovascular risk sustain benefit cardiovascular diseas increas oliv oil consumpt aim assess associ total oliv oil intak varieti extra virgin common oliv oil risk cardiovascular diseas mortal mediterranean popul high cardiovascular risk method includ num men women high cardiovascular risk age num num year prevenc con dieta mediterr nea predim studi multicent random control clinic trial particip random intervent mediterranean diet supplement nut extra virgin oliv oil control low fat diet present analysi conduct observ prospect cohort studi median follow up num year cardiovascular diseas stroke myocardi infarct cardiovascular death mortal ascertain medic record nation death index oliv oil consumpt evalu valid food frequenc questionnair multivari cox proport hazard general estim equat assess associ baselin year repeat measur oliv oil intak cardiovascular diseas mortal result follow up num cardiovascular event num death occur particip highest energy adjust tertil baselin total oliv oil extra virgin oliv oil consumpt num hr num num ci num num num hr num num ci num num cardiovascular diseas risk reduct compar refer higher baselin total oliv oil consumpt num hr num num ci num num reduc risk cardiovascular mortal num g d increas extra virgin oliv oil consumpt cardiovascular diseas mortal risk decreas num num signific associ found cancer all caus mortal associ cardiovascular event extra virgin oliv oil intak signific mediterranean diet intervent group control group conclus oliv oil consumpt specif extra virgin varieti reduc risk cardiovascular diseas mortal individu high cardiovascular risk trial registr studi regist controlled tri http   www controlled tri com isrctn num intern standard random control trial number isrctn num registr date num octob num
MED-1393~ultrasound assess carotid intima media thick plaqu mediterranean diet substudi predim trial pubm ncbi abstract object prevenc con dieta mediterr nea predim trial show mediterranean diet meddiet supplement extra virgin oliv oil num g d mix nut reduc incid cardiovascular event compar control low fat diet mechan cardiovascular protect afford meddiet remain uncov assess effect supplement meddiet intern carotid intima media thick ica imt plaqu height ultrasound featur predict futur cardiovascular event subject high cardiovascular risk approach result predim subcohort num plaqu height carotid imt num prespecifi segment ica bifurc common sonograph assess baselin intervent num year evalu num subject complet data multivari model ica imt progress control diet group num confid interv num mm num num mm regress meddiet nut group num mm num num mm num versus control similar result observ maximum ica imt control num mm num num mm meddiet nut num mm num num mm num maximum plaqu height control num mm num num mm meddiet nut num mm num num mm num ica imt plaqu meddiet extra virgin oliv oil conclus compar control diet consumpt meddiet supplement nut delay progress ica imt plaqu result contribut mechanist evid reduct cardiovascular event observ predim trial clinic trial registr url http   www controlled tri uniqu identifi isrctn num
MED-1394~primari prevent cardiovascular diseas mediterranean diet pubm ncbi abstract background observ cohort studi secondari prevent trial shown invers associ adher mediterranean diet cardiovascular risk conduct random trial diet pattern primari prevent cardiovascular event method multicent trial spain random assign particip high cardiovascular risk cardiovascular diseas enrol diet mediterranean diet supplement extra virgin oliv oil mediterranean diet supplement mix nut control diet advic reduc dietari fat particip receiv quarter individu group educ session depend group assign free provis extra virgin oliv oil mix nut small nonfood gift primari end point rate major cardiovascular event myocardi infarct stroke death cardiovascular basi result interim analysi trial stop median follow up num year result total num person enrol age rang num num year num women mediterranean diet group good adher intervent self report intak biomark analys primari end point event occur num particip multivariable adjust hazard ratio num num confid interv ci num num num num ci num num group assign mediterranean diet extra virgin oliv oil num event group assign mediterranean diet nut num event versus control group num event diet rel advers effect report conclus person high cardiovascular risk mediterranean diet supplement extra virgin oliv oil nut reduc incid major cardiovascular event fund spanish government instituto de salud carlo iii controlled tri number isrctn num
MED-1395~mediterranean alpha linolen acid rich diet secondari prevent coronari heart diseas pubm ncbi abstract prospect randomis single blind secondari prevent trial compar effect mediterranean alpha linolen acid rich diet usual post infarct prudent diet myocardi infarct patient random assign experiment num control group num patient num week randomis year num year experiment group consum signific lipid satur fat cholesterol linol acid oleic alpha linolen acid confirm measur plasma serum lipid blood pressur bodi mass index remain similar num group experiment group plasma level albumin vitamin vitamin increas granulocyt count decreas follow num month num cardiac death control num experiment group num non fat myocardi infarct control num experiment group risk ratio main endpoint combin num num ci num num num adjust prognost variabl mortal num control num experiment group adjust risk ratio num num ci num num num alpha linolen acid rich mediterranean diet effici present diet secondari prevent coronari event death
MED-1397~omega num fatti acid antioxid edibl wild plant pubm ncbi abstract human evolv diet balanc omega num omega num polyunsatur fatti acid pufa high antioxid edibl wild plant provid alpha linolen acid ala higher amount vitamin vitamin cultiv plant addit antioxid vitamin edibl wild plant rich phenol compound increas antioxid capac import systemat analyz total antioxid capac wild plant promot commerci develop develop countri diet western countri increas larger amount linol acid la promot cholesterol low effect recogn dietari la favor oxid modif low densiti lipoprotein ldl cholesterol increas platelet respons aggreg contrast ala intak inhibitori effect clot activ platelet respons thrombin regul arachidon acid aa metabol clinic studi ala contribut lower blood pressur prospect epidemiolog studi show ala invers relat risk coronari heart diseas men dietari amount la ratio la ala import metabol ala longer chain omega num pufa larg reserv la bodi fat found vegan diet omnivor western societi tend slow format long chain omega num fatti acid ala role ala human nutrit import term long term dietari intak advantag consumpt ala omega num fatti acid fish problem insuffici vitamin intak exist high intak ala plant sourc
MED-1398~mediterranean diet cardiovascular diseas histor perspect latest evid pubm ncbi abstract concept mediterranean diet lower incid cardiovascular diseas cvd propos num random control trial larg epidemiolog studi report associ lower cvd num num report intermedi final analys trial lyon diet heart studi num major epidemiolog studi greec show strong invers associ mediterranean score risk cardiovascular complic num report show non mediterranean popul gain benefit long term adhes mediterranean diet num predim trial show signific risk reduct low risk popul contrari pharmacolog approach cardiovascular prevent adopt mediterranean diet signific reduct cancer mortal term evidence bas medicin full adopt modern version mediterranean diet pattern consid effect approach prevent fatal nonfat cvd complic
MED-1399~mediterranean diet tradit risk factor rate cardiovascular complic myocardi infarct final report lyon di pubm ncbi abstract background lyon diet heart studi random secondari prevent trial aim test mediterranean typ diet reduc rate recurr myocardi infarct intermedi analysi show strike protect effect num month follow up report present result extend follow up num month patient deal relationship dietari pattern tradit risk factor recurr method result composit outcom cos combin cardiac death nonfat myocardi infarct num preced major secondari end point unstabl angina stroke heart failur pulmonari peripher embol num preced minor event requir hospit admiss num studi mediterranean diet group num reduc num event versus num prudent western typ diet group num num event versus num num num event versus num num adjust risk ratio rang num num tradit risk factor total cholesterol num mmol l increas risk num num systol blood pressur num mm hg increas risk num num leukocyt count adjust risk ratio rang num num count num num femal sex adjust risk ratio num num aspirin adjust risk ratio num num signific independ recurr conclus protect effect mediterranean dietari pattern maintain num year infarct confirm previous intermedi analys major tradit risk factor high blood cholesterol blood pressur shown independ joint predictor recurr indic mediterranean dietari pattern alter qualit usual relationship major risk factor recurr comprehens strategi decreas cardiovascular morbid mortal includ primarili cardioprotect diet pharmacolog aim reduc modifi risk factor trial combin num approach warrant
MED-1400~accru evid benefit adher mediterranean diet health updat systemat review meta analysi pubm ncbi abstract background mediterranean diet long report protect occurr health outcom object aim updat previous meta analysi publish cohort prospect studi investig effect adher mediterranean diet health status design conduct comprehens literatur search electron databas june num result updat review process show num prospect studi publish past num includ previous meta analysi num studi mortal num studi cardiovascular incid mortal num studi cancer incid mortal num studi neurodegen diseas recent studi includ num health outcom previous investig mild cognit impair stroke meta analysi studi random effect model conduct inclus recent studi show num point increas adher mediterranean diet signific reduct mortal relat risk rr num num ci num num cardiovascular incid mortal rr num num ci num num cancer incid mortal rr num num ci num num neurodegen diseas rr num num ci num num meta regress analysi show sampl size signific contributor model signific influenc estim associ mortal conclus updat meta analysi confirm larger number subject studi signific consist protect provid adher mediterranean diet relat occurr major chronic degen diseas
MED-1401~dietari iron intak bodi iron store risk coronari heart diseas meta analysi prospect cohort studi abstract link iron intak bodi iron store coronari heart diseas chd contenti debat epidemiolog evid inconsist aim quantit summar literatur associ dietari iron intake bodi iron store chd risk conduct meta analysi prospect cohort studi pubm find studi publish june num peer review journal embas hand search relev articl obtain addit articl pool rrs chd incid mortal num cis calcul random effect fixed effect model twenty on elig studi num cohort includ num particip averag num follow up includ heme iron found posit chd incid rr num num ci num num total iron invers rr num num ci num num heme iron total iron intak signific chd mortal transferrin satur serum iron invers relat chd incid rr num ci num num num num num num transferrin satur invers chd mortal rr num num ci num num conclus total iron intak serum iron concentr invers chd incid heme iron intak posit relat chd incid elev serum transferrin satur concentr invers chd incid mortal futur research establish causal relat elucid potenti mechan
MED-1402~mediterranean diet health status updat meta analysi propos literature bas adher score pubm ncbi abstract object updat previous meta analys cohort studi investig associ mediterranean diet health status util data cohort studi propos literature bas adher score mediterranean diet design conduct comprehens literatur search electron databas june num set cohort prospect studi investig adher mediterranean diet health outcom cut off valu food group comput adher score obtain subject updat search perform popul num num subject eighteen recent studi present previous meta analys result num point increas adher score mediterranean diet report determin num reduct mortal relat risk num num ci num num num num reduc risk cvd relat risk num num ci num num num num reduct neoplast diseas relat risk num num ci num num num util data cohort studi literatur propos literature bas adher score score rang num minim adher num maxim adher point includ categori consumpt food group compos mediterranean diet conclus mediterranean diet found healthi dietari pattern term morbid mortal data cohort studi propos literature bas adher score repres easi tool estim adher mediterranean diet individu level
MED-1403~heme iron intak risk new onset diabet mediterranean popul high risk cardiovascular diseas observ cohort analysi abstract background epidemiolog studi observ increas risk type num diabet mellitus num subject higher consumpt red process meat heme iron intak direct higher risk num healthi adult chines popul object present studi evalu associ heme iron intak incid num mediterranean popul high cardiovascular risk method assess subset particip predim trial observ cohort maximum year initi includ num non diabet subject num women age num num year high cardiovascular risk diet assess studi baselin valid semi quantit food frequenc questionnair result follow up period num diabet newli diagnos risk develop num assess baselin heme iron intak proport hazard model unadjust adjust energi final adjust dietari anthropometr socio demograph lifestyl variabl signific direct associ incid num found heme iron hazard ratio hr num num confid interv ci num num secondarili observ coffe hr num num ci num num alcohol beverag hr num num ci num num found reduc increas risk num conclus high dietari intak heme iron increas risk develop num mediterranean popul high cardiovascular risk trial registr identifi isrctn num
MED-1404~effect mediterranean diet develop type num diabet mellitus meta analysi num prospect studi num particip pubm ncbi abstract object purpos work meta analyz prospect studi evalu effect mediterranean diet develop type num diabet materials method pubm embas cochran central regist control trial databas search num novemb num english languag public alloc num origin research studi num clinic trial num prospect num cross sect identifi primari analys limit prospect studi clinic trial yield sampl num particip systemat review random effect meta analysi conduct result higher adher mediterranean diet num reduc risk develop type num diabet combin relat risk upper versus lowest centil num num ci num num subgroup analys base region health status particip number confound control show similar result limit includ variat mediterranean diet adher assess tool confound adjust durat follow number event diabet conclus present result major public health import consensus exist anti diabet diet mediterranean diet appropri adjust reflect local food avail individual constitut benefici nutrit choic primari prevent diabet copyright num elsevi reserv
MED-1405~polyphenol intak mortal risk re analysi predim trial abstract background polyphenol lower risk cardiovascular diseas cvd chronic diseas due antioxid anti inflammatori properti benefici effect blood pressur lipid insulin resist previous epidemiolog studi evalu relationship intak total polyphenol intak polyphenol subclass mortal aim evalu polyphenol intak all caus mortal subject high cardiovascular risk method data predim studi num particip parallel group random multicent control five year feed trial aim assess effect mediterranean diet primari prevent cardiovascular diseas polyphenol intak calcul match food consumpt data repeat food frequenc questionnair ffq phenol explor databas polyphenol content report food hazard ratio hr num confid interv ci polyphenol intak mortal estim time depend cox proport hazard model result averag num year follow up observ num death multivari adjust found num relat reduct all caus mortal compar highest versus lowest quintil total polyphenol intak hazard ratio hr num num ci num num trend num polyphenol subclass stilben lignan signific reduc all caus mortal hr num num ci num num trend num hr num num ci num num trend num signific associ appar rest flavonoid phenol acid conclus high risk subject report high polyphenol intak stilben lignan show reduc risk mortal compar lower intak result determin optim polyphenol intak specif food sourc polyphenol reduc risk all caus mortal clinic trial registr isrctn num
MED-1406~dietari magnesium intak invers mortal adult high cardiovascular diseas risk pubm ncbi abstract relat dietari magnesium intak cardiovascular diseas cvd mortal evalu prospect studi assess risk all caus mortal evalu mediterranean adult high cardiovascular risk aim studi assess associ magnesium intak cvd mortal risk mediterranean popul high cardiovascular risk high averag magnesium intak present studi includ num men women age num predim prevenc con dieta mediterr nea studi random clinic trial particip assign num num mediterranean diet supplement nut oliv oil control diet advic low fat diet mortal ascertain linkag nation death index medic record fit multivariable adjust cox regress assess associ baselin energy adjust tertil magnesium intak relat risk cvd mortal multivari analys general estim equat model assess associ year repeat measur magnesium intak mortal median follow up num num total death num cardiovascular death num cancer death num cardiovascular event occur energy adjust baselin magnesium intak invers cardiovascular cancer all caus mortal compar lower consum individu highest tertil magnesium intak num reduct mortal risk hr num num ci num num num dietari magnesium intak invers mortal risk mediterranean individu high risk cvd trial regist controlled tri isrctn num
MED-1407~mediterranean diet histori health abstract mediterranean tradit offer cousin rich color aroma memori support tast spirit live harmoni natur talk mediterranean diet proper generat lot confus reader coincid pizza identifi noodl meat sauc mixtur pseudo histor tradit folklor solv question basi diet combin balanc food satisfi qualit quantit individu sens preserv health substanc bodi perform normal vital function purpos work demonstr combin tast health goal absolut carri generous calor intak guarante good dish satisfact consum absolut novelti sound tradit mediterranean cuisin time wide varieti tasti gastronom choic invit color strong scent absolut line health
MED-1408~mediterranean diet stroke cognit impair depress meta analysi pubm ncbi abstract object meta analysi aim quantit synthes studi examin associ adher mediterranean diet risk stroke depress cognit impair parkinson diseas method potenti elig public provid effect estim relat risk rr associ mediterranean diet aforement outcom studi sought pubm octob num maxim adjust effect estim extract separ analys perform high moder adher result twenty two elig studi includ num cover stroke num cover depress num cover cognit impair num pertain parkinson diseas high adher mediterranean diet consist reduc risk stroke rr num num confid interv ci num num depress rr num num ci num num cognit impair rr num num ci num num moder adher similar reduc risk depress cognit impair protect trend stroke margin subgroup analys highlight protect action high adher term reduc risk ischem stroke mild cognit impair dementia alzheim diseas meta regress analysi protect effect mediterranean diet stroke prevent sizeabl male depress protect effect high adher independ age favor action moder adher fade advanc age interpret adher mediterranean diet contribut prevent seri brain diseas special age western societi num american neurolog associ
MED-1409~chang preval coronari heart diseas risk factor cardiovascular diseas men rural area crete num num pubm ncbi abstract studi compar preval coronari heart diseas chd risk factor rf cardiovascular diseas cvd cretan men rural area examin num num studi popul consist num men num num men num age group fifty f fifty nin year rural area men complet examin cardiovascular system rest electrocardiogram ecg systol bp sbp num mmhg found num subject num num num ns diastol bp num mmhg found num subject num oppos num num num total serum cholesterol tsch num mg dl approxim num mmol l found num subject num num num num heavi smoker num cigarettes daili num num compar num num ns num subject num light physic activ pa compar num num num num subject farmer num compar num num num preval chd num num compar num num num hypertens heart diseas found num subject num num num ns preval major cvd higher num num compar num num num conclus preval chd rf cvd higher num num cretan men age group higher preval relat dietari life styl place crete thirti year
MED-1410~diet num year death rate countri studi pubm ncbi abstract num cohort countri studi compris num men age num year healthi entri num die num year death rate differ cohort differ age blood pressur serum cholesterol smoke habit explain num varianc death rate num coronari heart diseas num cancer num stroke death rate differ unrel cohort differ relat bodi weight fat physic activ cohort differ averag diet death rate relat posit averag percentag dietari energi satur fatti acid negat dietari energi percentag monounsatur fatti acid unrel dietari energi percentag polyunsatur fatti acid protein carbohydr alcohol death rate negat relat ratio monounsatur satur fatti acid inclus ratio age blood pressur serum cholesterol smoke habit independ variabl account num varianc rate death num coronari heart diseas num cancer num stroke oleic acid account differ monounsatur cohort all caus coronari heart diseas death rate low cohort oliv oil main fat causal relationship claim characterist popul individu popul urg evalu risk
MED-1411~effect mediterranean diet metabol syndrom compon meta analysi num studi num individu pubm ncbi abstract object aim studi meta analyz epidemiolog studi clinic trial assess effect mediterranean diet metabol syndrom ms compon background mediterranean diet long low cardiovascular diseas risk adult popul method author conduct systemat review random effect meta analysi epidemiolog studi random control trial includ english languag public pubm embas web scienc cochran central regist control trial april num num origin research studi num clinic trial num prospect num cross sect num particip includ analysi result combin effect prospect studi clinic trial show adher mediterranean diet reduc risk ms log hazard ratio num num confid interv ci num num addit result clinic studi differ num ci reveal protect role mediterranean diet compon ms waist circumfer num cm num ci num num high dens lipoprotein cholesterol num mg dl num ci num num triglycerid num mg dl num ci num num systol num mm hg num ci num num diastol blood pressur num mm hg num ci num num glucos num mg dl num ci num num result epidemiolog studi confirm clinic trial conclus result public health import dietari pattern easili adopt popul group cultur cost effect serv primari secondari prevent ms individu compon copyright num american colleg cardiolog foundat publish elsevi reserv
MED-1412~faecal ph modif dietari south african black white schoolchildren pubm ncbi abstract faecal ph valu differ signific group rural south african black schoolchildren num num year ate tradit high fibr low fat diet urban dweller consum partial western diet signific lower group white schoolchildren feed studi num day durat faecal ph black children signific acid white bread replac maiz meal signific acid supplement num orang consum daili supplement consist skim milk butter sugar signific effect faecal ph white children institut ph faec signific acid supplement num orang bran crunchi consum daili
MED-1413~human gut microbiota diet matter pubm ncbi abstract human oro gastrointestin gi tract complex system consist oral caviti pharynx oesophagus stomach small intestin larg intestin rectum anus accessori digest organ constitut digest system function digest system break dietari constitu small molecul absorb subsequ distribut bodi digest carbohydr metabol indigen microbiota import influenc host physiolog nutrit immunolog process commens bacteria modul express host gene regul divers fundament physiolog function main extern factor affect composit microbi communiti general healthi adult includ major dietari antibiot therapi select bacteri group observ due control normal diet high protein diet high fat diet prebiot probiot polyphenol specif type quantiti non digest carbohydr human diet influenc metabol product form lower region gi tract bacteri popul detect faec interact dietari factor gut microbiota host metabol increas demonstr import maintain homeostasi health aim review summaris effect diet dietari intervent human gut microbiota import confound factor methodolog intrins human factor relat gut microbiota analys elucid
MED-1414~high colon ph promot colorect cancer pubm ncbi abstract evid suggest carcinogen co carcinogen respons develop colorect cancer bacteri degrad bile acid cholesterol propos high colon ph promot co carcinogen format substanc acidif colon dietari fibr bacteri digest short chain fatti acid milk lactose intoler individu prevent process
MED-1415~vegan vegetarian diet substanti alter human colon faecal microbiota pubm ncbi abstract background object consist num microbi cell intestin microbiota repres largest complex microbi communiti inhabit human bodi influenc regular diet microbiota wide unknown subjects method examin faecal sampl vegetarian num vegan num equal number control subject consum ordinari omnivor diet match age gender classic bacteriolog isol identif enumer main anaerob aerob bacteri genera comput absolut relat number compar group result total count bacteroid spp bifidobacterium spp escherichia coli enterobacteriacea spp signific lower num num num num vegan sampl control coli biovar klebsiella spp enterobact spp enterobacteriacea enterococcus spp lactobacillus spp citrobact spp clostridium spp subject vegetarian diet rank vegan control total microbi count differ group addit subject vegan vegetarian diet show signific num lower stool ph control stool ph count coli enterobacteriacea signific correl subgroup conclus maintain strict vegan vegetarian diet result signific shift microbiota total cell number remain unalt
MED-1416~faecal urobilinogen level ph stool popul group incid cancer colon role aetiolog abstract faecal urobilinogen level ph stool found higher subject popul group high risk develop cancer colon subject match age sex socioeconom status low risk popul group alkalin reaction colon content tumorigen effect direct action mucus mucous cell acid reaction hand protect differ depend pattern diet manner eat proper mastic food roughag cellulos veget fibr short chain fatti acid milk ferment milk product diet protect
MED-1417~diet microbiota microbi metabolit colon cancer risk rural african african american abstract background epidemiolog studi suggest case sporad colon cancer attribut diet recognit colon microbiota major influenc colon health suggest mediat colon carcinogenesi object examin hypothesi influenc diet colon cancer risk mediat microbiota metabolit measur differ colon microb metabolit african american high risk rural nativ african low risk colon cancer design fresh fecal sampl collect num healthi african american age num num num age sex match nativ african microbiom analyz num ribosom rna gene pyrosequenc quantit polymeras chain reaction major ferment butyrate produc bile acid deconjug bacteria fecal short chain fatti acid measur gas chromatographi bile acid liquid chromatographi mass spectrometri result microbi composit fundament predomin prevotella nativ african enterotyp num bacteroid african american enterotyp num total bacteria major butyrate produc group signific abund fecal sampl nativ african microbi gene encod secondari bile acid product abund african american encod methanogenesi hydrogen sulfid product higher nativ african fecal secondari bile acid concentr higher african american short chain fatti acid higher nativ african conclus result support hypothesi colon cancer risk influenc balanc microbi product health promot metabolit butyr potenti carcinogen metabolit secondari bile acid
MED-1418~hydrogen sulfid induc direct radical associ dna damag pubm ncbi abstract hydrogen sulfid num produc indigen sulfate reduc bacteria larg intestin repres environment insult colon epithelium clinic studi link presenc sulfate reduc bacteria num colon chronic disord ulcer coliti colorect cancer point evid circumstanti mechan remain undefin show previous sulfid concentr similar found human colon induc genom dna damag mammalian cell present studi address natur dna damag determin sulfid direct genotox genotox requir cellular metabol question sulfid genotox mediat free radic dna base oxid involv nake nuclei untreat chines hamster ovari cell treat sulfid dna damag induc concentr low num micromol l damag effect quench cotreat butylhydroxyanisol sulfid treatment increas number oxid base recogn formamidopyrimidin fapy  dna glycosylas result confirm genotox sulfid strong implic genotox mediat free radic observ highlight role sulfid environment insult predispos genet background lead genom instabl cumul mutat characterist colorect cancer
MED-1419~diet high fat meat low dietari fibr increas genotox potenti faecal water pubm ncbi abstract determin effect diet genotox human faecal water diet rich fat meat sugar poor veget free wholem product diet num consum healthi volunt period num day week end period volunt start consum diet enrich veget wholem product poor fat meat diet num period num day genotox effect faecal water obtain diet assess singl cell gel electrophoresi comet assay human colon adenocarcinoma cell line ht num clone num target fluoresc length tail comet imag reflect degre dna damag singl cell dna damag express ratio tail intens fluoresc tail total intens comet incub faecal water volunt consum diet num high diet num suscept cell incub faecal water dna damag caus addit hydrogen peroxid treatment show signific differ diet generat oxid pyrimidin purin base reveal differ pretreat type faecal water result diet high fat meat low dietari fibr increas genotox faecal water colon cell contribut enhanc risk colorect cancer
MED-1420~nutrit colon health critic role microbiota pubm ncbi abstract purpos review highlight mechan diet affect colon function diseas pattern recent find topic nutrient preferenti gut mucosa maintain structur function colon topic nutrient generat colon microbiota maintain mucos health import short chain fatti acid control prolifer differenti reduc colon cancer risk patient massiv loss small intestin short chain fatti acid product support surviv releas num kcal energy day human studi show microbiota synthes larg pool utiliz folat support surviv impoverish popul microbiota elabor toxic product food residu genotox hydrogen sulfid sulfur reduc bacteria respons high meat diet employ culture fre techniqu base num region dna reveal colon harbor num bacteri speci num strain evid suggest diet direct influenc divers microbiota provid link diet colon diseas colon cancer microbiota determin effici food absorpt risk obes summari investig focus small number bacteri speci character microbiota metabol expect provid key colon health diseas
MED-1421~contribut dietari protein sulfid product larg intestin vitro control feed studi human pubm ncbi abstract background hydrogen sulfid lumin act bacteri deriv cell poison implic ulcer coliti sulfid generat colon driven dietari compon sulfur contain amino acid saa inorgan sulfur sulfit object assess contribut saa meat sulfid product intestin bacteria model cultur system vitro vivo human feed studi design healthi men hous metabol suit fed sequenc num diet num meat intak rang num g d vegetarian diet num g d high meat diet fecal sulfid urinari sulfat measur sampl collect day num num diet period addit num num bovin serum albumin casein l ad batch cultur inocul fece num healthi volunt concentr sulfid ammonia lowry react substanc measur num result sem fecal sulfid concentr rang num num mmol kg num g d diet num num mmol kg num g d diet signific relat meat intak num sulfid format fecal batch cultur supplement bovin serum albumin casein correl protein digest measur disappear lowry react substanc ammonia conclus dietari protein meat import substrat sulfid generat bacteria human larg intestin
MED-1425~epidemiolog analysi crohn diseas japan increas dietari intak num polyunsatur fatti acid anim protein relat pubm ncbi abstract examin correl incid crohn diseas dietari chang homogen japanes popul incid daili intak dietari compon compar annual num num univari analysi show increas incid crohn diseas strong num correl increas dietari intak total fat num anim fat num num polyunsatur fatti acid num anim protein num milk protein num ratio num num fatti acid intak num correl intak total protein num num correl intak fish protein num num invers correl intak veget protein num num multivari analysi show increas intak anim protein strongest independ factor weaker factor increas ration num num polyunsatur fatti acid present studi associ report clinic studi suggest increas dietari intak anim protein num polyunsatur fatti acid num polyunsatur fatti acid contribut develop crohn diseas
MED-1426~influenc dietari protein supplement format bacteri metabolit colon abstract background evalu influenc increas dietari protein intak bacteri colon metabol healthi volunt method short chain fatti acid ammonia volatil organ compound faecal sampl phenol urin volunt measur week basal nutrient intak week diet supplement protein rich food fortimel nutricia zoeterm netherland pair test factor analysi statist analysi result total energi resist carbohydr intak remain unchang studi period percentag energi intak deliv dietari protein increas signific num num num supplement intak signific increas faecal ammonia num faecal valer acid num urinari p cresol num note supplementari protein intak total num volatil compound isol faecal sampl num increas signific dietari protein supplement chang volatil pattern metabolit shown factor analysi model made distinct dietari regimen volunt conclus increas dietari protein lead alter product format colon metabol reflect increas faecal ammonia faecal volatil substanc urinari p cresol
MED-1428~optim low dens lipoprotein num num mg dl lower physiolog normal pubm ncbi abstract normal low dens lipoprotein ldl cholesterol rang num num mg dl nativ hunter gather healthi human neonat free liv primat wild mammal develop atherosclerosi random trial data suggest atherosclerosi progress coronari heart diseas event minim ldl lower num mg dl major safeti concern surfac studi lower ldl rang num num mg dl current guidelin set target ldl num num mg dl lead substanti undertreat high risk individu
MED-1429~themat review seri pathogenesi atherosclerosi interpret histori cholesterol controversi part discoveri pubm ncbi abstract review seri steinberg num lipid res num num steinberg num lipid res num num steinberg num lipid res num num steinberg num lipid res num num trace gradual accumul evid evid kind support lipid hypothesi track histori anitschkow num classic work cholesterol f rabbit model breakthrough num coronari primari prevent trial larg random double blind primari intervent trial show decreas blood cholesterol cholestyramin signific reduc coronari heart diseas event point time decreas blood cholesterol level offici nation public health goal small fraction patient high risk cholesterol low treatment number import clinic question remain unansw final review seri trace earli studi led discoveri statin briefli review familiar large scal clinic trial demonstr safeti remark effect reduc coronari heart diseas morbid mortal
MED-1430~vegetarian diet cholesterol triglycerid level pubm ncbi abstract object compar level triglycerid tg total cholesterol tc low densiti lipoprotein ldl high densiti lipoprotein hdl vegetarian omnivor method blood sampl collect num individuals  both male females  separ diet group omnivor lacto ovo vegetarian lacto vegetarian restrict vegetarian vegan dose tc ldl hdl tg result signific differ report tc ldl tg level sampl higher level report omnivor decreas level vegetarian anim product restrict lowest level report vegan standard deviat tc num num mg dl group omnivor num num mg dl group vegan num ldl valu omnivor vegan num num mg dl num num mg dl num tg valu num num mg dl num num mg dl num hdl level differ report sampl hdl tc ratio signific higher vegan num conclus vegetarian diet lower level tg tc ldl compar diet omnivor
MED-1431~advanc glycat end product level diabet acceler cognit age abstract object studi report diabet increas risk cognit impair hypothes advanc glycat end product age underli associ age cross link product result reaction glucos protein associ peripher age concentr cognit age method prospect studi num elder dementia num diabet num normal glucos age num year mix model examin baselin age concentr measur urin pentosidin analyz tertil perform modifi mini ment state examin num digit symbol substitut test dsst baselin repeat num year incid cognit impair declin num sd test analyz logist regress result older adult high pentosidin level wors baselin dsst score num num score num test pronounc num year declin high mid pentosidin level compar lowest tertil num num num num point declin num dsst num num num point declin num incid cognit impair higher high mid pentosidin level lowest tertil num num num odd ratio num num confid interv num num dsst num num odd ratio num num confid interv num num interact pentosidin level diabet status cognit declin multivari adjust age sex race educ hypertens cardiovascular diseas estim glomerular filtrat rate diabet diminish result pattern remain similar conclus high peripher age level greater cognit declin older adult diabet
MED-1432~sirtuin promot mammalian longev critic review relev longev effect induc calori restrict abstract sirtuin sirt famili nicotinamid adenin dinucleotid nad depend deacetylas emerg key molecul regul age age rel diseas includ cancer metabol disord neurodegen diseas isoform sirt sirt num num identifi mammal sirt num num local nucleus regul transcript gene dna repair sirt num mitochondria regul mitochondri bioenerget initi studi yeast nematod fli strong connect sirt life prolong effect calori restrict cr robust experiment intervent longev rang organ subsequ studi report controversi find sirt role effect cr review describ function role mammalian sirt discuss relev mechan longev effect cr
MED-1433~dietari advanc glycat end product age abstract advanc glycat end product age heterogen complex group compound form reduc sugar react non enzymat amino acid protein macromolecul occur exogen food endogen human greater concentr found older adult higher age occur healthi older adult chronic diseas research progress quantifi age food peopl identifi mechan explain human tissu damag twenti year increas evid age implic develop chronic degen diseas age cardiovascular diseas alzheim diseas complic diabet mellitus result studi anim model human show restrict dietari age posit effect wound heal insulin resist cardiovascular diseas recent effect restrict age intak report increas lifespan anim model paper summar work publish food age vivo age relat age provid suggest futur research
MED-1434~protect effect mechan sirtuin nervous system abstract silent inform regul protein sirtuin sirt group histon deacetylas activ depend regul nicotinamid adenin dinucleotid nad suppress genome wid transcript upregul select set protein relat energi metabol pro surviv mechan play key role longev effect elicit calori restrict recent neuroprotect effect sirtuin report acut chronic neurolog diseas focus review summar latest progress protect effect sirtuin focus sirt num introduc distribut sirtuin brain express activ regul highlight protect effect common neurolog disord cerebr ischemia axon injuri alzheim diseas parkinson diseas amyotroph sclerosi multipl sclerosi final analyz mechan sirtuin medi neuroprotect center non histon substrat dna repair enzym protein kinas transcript factor coactiv collect inform compil serv comprehens refer action sirtuin nervous system date design experiment research expand sirtuin therapeut target futur
MED-1435~longitudin magnet reson imag studi older adult shrink brain pubm ncbi abstract age rel loss brain tissu infer cross sect neuroimag studi direct measur gray white matter longitudin studi lack quantifi longitudin magnet reson imag mri scan num nondement older adult age num year baselin baltimor longitudin studi age determin rate region distribut gray white matter tissu loss older adult imag baselin num year num year follow up found signific age gray num white num volum subgroup num healthi elder annual rate tissu loss num num num num num num cm num year total brain gray white volum ventricl increas num num cm num year num num num num cm num healthi frontal pariet compar tempor occipit lobar region show greater declin gray matter loss pronounc orbit inferior frontal cingul insular inferior pariet lesser extent mesial tempor region white matter widespread studi gray white matter volum demonstr signific longitudin tissu loss gray white matter healthi older adult data provid essenti inform rate region pattern age associ patholog evalu suggest slower rate brain atrophi individu remain medic cognit healthi
MED-1436~sirtuin cognit age alzheimer diseas pubm ncbi abstract purpos review sirtuin famili enzym high conserv evolut involv mechan promot healthi age longev review aim discuss recent advanc understand role sirtuin mammalian sirt num promot longev potenti molecular basi neuroprotect cognit age alzheimer diseas patholog recent find accumul increas oxid stress age shown decreas sirt num activ catabol tissu possibl direct inactiv reactiv oxygen sirt num overexpress prevent oxid stress induc apoptosi increas resist oxid stress regul foxo famili forkhead transcript factor addit resveratrol strong stimul sirt num deacetylas activ dose depend manner increas bind affin acetyl substrat nad recent sirt num shown affect amyloid product influenc adam num gene upregul sirt num induc notch pathway inhibit mtor signal summari recent studi reveal mechan pathway neuroprotect effect sirt num
MED-1437~crossroad lifespan calori restrict chromatin diseas meet sirtuin pubm ncbi abstract longev lifespan cancer cellular transform energi calori restrict diabetes  what tie divers hot topic biomed research emerg find suggest answer lie understand function recent discov famili protein sirtuin barcelona host scientif meet complet focus evolutionari conserv protein deacetylas bring expert biochemistri cellular biolog mice model drug target pathophysiolog molecul work summar establish sirtuin major player cellular homeostasi human diseas act rang biochem substrat physiolog process undoubt increas expand field stay growth
MED-1438~serum concentr inflammatori glycotoxin methylglyox increas cognit declin elder individu abstract background advanc glycat end product increas oxid stress inflamm neurotox serum level increas diabet age examin relationship serum methylglyox deriv smg cognit declin num non dement elder method tobit mix regress model assess associ baselin smg cognit declin mini mental state exam mmse time control sociodemograph factor age sex year educ cardiovascular risk factor diabet presenc apo num allel kidney function smg assess elisa result fulli adjust model show annual declin num mmse point unit increas baselin smg num signific unchang addit risk factor ad model interact smg diabet sex age kidney function apo num genotyp signific conclus higher level baselin smg faster rate cognit declin adjust sociodemograph clinic characterist relationship differ sex apo num genotyp diabet status suggest general subject cognit normal begin studi elev smg indic brain cell injuri initi clinic evid cognit compromis
MED-1439~brain volum longitudin magnet reson imag normal older peopl pubm ncbi abstract background purpos purpos studi investig longitudin age rel human brain volum stereolog method method sixty six older particip num men num women age sd num num year rang num year normal baselin follow up examin underw num mris magnet reson imag brain averag num year volum cerebrum defin cortex basal ganglia thalamus white matter ventricl cerebellum estim num mris unbias stereolog method cavalieri principl result annual decreas sd cerebr volum num num num averag volum ventricl mri increas num num year num averag volum cerebellum mri decreas num num year num averag cerebr volum signific men women initi mri mri percentag chang age rel cerebr volum decreas male femal brain initi mri mri ident conclus find show age rel atrophi cerebrum cerebellum age rel disproport enlarg ventricl normal older men women
MED-1440~sirt num decreas parallel accumul tau alzheim diseas abstract age metabolism rel disord risk factor alzheim diseas ad sirtuin increas lifespan regul cellular metabol compar concentr sirtuin num sirt num brain ad patient num control num western immunoblot situ hybrid report signific reduct sirt num mrna num protein num pariet cortex ad patient cerebellum analys cohort num subject confirm cortic sirt num decreas cortex ad patient individu mild cognit impair sirt num mrna translat protein correl negat durat symptom mrna num num protein num num accumul pair helic filament tau mrna num num protein num num weak insolubl amyloid num mrna num num protein num num signific relationship sirt num level global cognit score proxim death found num num num contrast cortic sirt num level remain unchang triple transgen anim model ad collect result loss sirt num close accumul tau cerebr cortex patient ad
MED-1441~scienc salsa antimicrobi properti salsa compon learn scientif methodolog abstract ethnic food cook practic incorpor spice food addit common spice cross cultur boundari multipl ethnic cuisin recent studi demonstr ingredi possess antimicrobi properti common food spoilag microorgan develop laboratori exercis promot scientif methodolog evalu effect salsa compon inhibit growth undesir microorgan tomato onion garlic cilantro jalap test antimicrobi properti repres fungus saccharomyc cerevisia common food spoilag bacteria staphylococcus aureus bacillus cereus escherichia coli compon ethanol extract modif kirby bau method antimicrobi sensit employ garlic demonstr greatest inhibitori effect organ test onion demonstr slight inhibit organ cilantro show inhibit bacteria effect fungus jalap slight inhibit coli aureus evidenc consist measur increas zone inhibit statist signific compar control initi exercis student opportun repeat exercis spice cinnamon clove nutmeg coriand student learn outcom evalu preliminari secondari survey focus definit scienc hypothesi process scienc student enjoy exercis met learn goal understand process methodolog scienc interdisciplinar inher scienc student learn evidenc increas number correct respons secondari survey comparison preliminari
MED-1442~genet analysi chemosensori trait human twin abstract explor genet influenc percept tast smell stimuli adult twin rate chemosensori aspect water sucros sodium chlorid citric acid ethanol quinin hydrochlorid phenylthiocarbamid ptc potassium chlorid calcium chlorid cinnamon androstenon galaxolid cilantro basil trait individu differ stabl time trait herit num num num subject genotyp num singl nucleotid polymorph gene relat tast smell result associ analys confirm previous genotyp phenotyp result ptc quinin androstenon associ detect rate basil bitter tast receptor gene tas num cilantro variant gene trpa num gnat num tas num flavor ethanol relat variat olfactori receptor gene num gene encod subunit epitheli sodium channel scnn num studi demonstr person to person differ tast smell percept simpl food drink partial account genet variat chemosensori pathway
MED-1443~anti inflammatori potenti lipolot coriand oil ultraviolet erythema test pubm ncbi abstract summari background coriand oil antimicrobi agent natur fragranc present studi investig anti inflammatori potenc coriand oil ultraviolet uv erythema test vivo method num volunt enrol monocentr random placebo control double blind studi test area back irradi num fold minim erythema dose uv b subsequ test area treat occlus num hour lipolot num num essenti coriand oil hydrocortison num betamethason valer num vehicl serv posit control vehicl place bo effect test substanc uv induc erythema measur photometr num hour addit skin toler test prepar assess non irradi skin result compar placebo lipolot num coriand oil signific reduc uv induc erythema effect hydrocortison skin toler coriand oil concentr excel conclus lipolot coriand oil display mild antiinflammatori effect studi concomit treatment inflammatori skin diseas
MED-1444~coriand coriandrum sativum potenti sourc high valu compon function food nutraceuticals  a review pubm ncbi abstract coriand coriandrum sativum herbal plant belong famili apicea valu culinari medicin part herb flavor agent and or tradit remedi treatment disord folk medicin system civil plant potenti sourc lipid rich petroselin acid essenti oil high linalool isol seed aerial part due presenc multitud bioactiv wide array pharmacolog activ ascrib part herb includ anti microbi anti oxid anti diabet anxiolyt anti epilept anti depress anti mutagen anti inflammatori anti dyslipidem anti hypertens neuro protect diuret interest coriand possess lead detoxifi potenti review focus medicin detail phytochemistri biolog activ valuabl herb explor potenti function food nutraceut industri copyright num john wiley son
MED-1445~effect low fat plant bas dietari intervent bodi weight metabol insulin sensit pubm ncbi abstract purpos studi investig effect low fat plant bas diet bodi weight metabol insulin sensit control exercis free liv individu subject method outpati set num overweight postmenopaus women random assign low fat vegan diet control diet base nation cholesterol educ program guidelin energi intak limit maintain exercis unchang dietari intak bodi weight composit rest metabol rate thermic effect food insulin sensit measur baselin num week result standard deviat intervention group bodi weight decreas num num kg compar num num kg control group num regress model predictor weight chang includ diet group energi intak thermic effect food rest metabol rate report energi expenditur signific effect found diet group num thermic effect food num rest metabol rate num index insulin sensit increas num num num num num intervent group differ group signific num conclus adopt low fat vegan diet signific weight loss overweight postmenopaus women absenc prescrib limit portion size energi intak
MED-1446~longitudin associ anim veget protein intak obes adult male unit state chicago western electr studi abstract literatur associ protein intak bodi weight inconsist relat long term protein intak obes studi aim determin associ protein intak obes cohort num employ white men age num num year chicago western electr studi num num diet assess burk comprehens diet histori method baselin examin height weight covari measur annual train interview general estim equat gee examin relat baselin total anim veget protein intak likelihood overweight obes sequenti annual examin dietari anim protein posit relat overweight obes year follow adjust potenti confound age educ cigarett smoke alcohol intak energi carbohydr satur fat intak histori diabet chronic diseas odd ratio num confid interv obes num num num trend num particip highest compar lowest quartil anim protein num num num trend num highest quartil veget protein intak statist signific posit associ anim protein intak obes higher quartil veget protein intak lower odd obes result anim veget protein relat differ occurr obes long run
MED-1447~nutrient intak geico multicent trial effect multicompon worksit intervent abstract background object assess effect macro micronutri intak nutrit intervent program corpor set unit state subjects method hundr ninety two individu overweight type num diabet recruit num site insur compani hundr seventy on particip complet baselin diet recal num particip complet dietari recal num week site random assign intervent group site control group site num week intervent site particip follow low fat vegan diet attend week group meet control site particip continu usual diet baselin num week particip complet num day diet recal between group differ nutrient intak assess analysi covari result compar control group intervention group particip signific reduc report intak total fat num satur num monounsatur fat num cholesterol num protein num calcium num increas intak carbohydr num fiber num caroten num vitamin num magnesium num potassium num conclus num week intervent program corpor set reduc intak total fat satur fat cholesterol increas intak protect nutrient fiber caroten vitamin magnesium potassium reduct calcium intak plan nutrient
MED-1448~cost obes workplac pubm ncbi abstract object quantifi capita aggreg medic expenditur lost product includ absente presente overweight grade ii iii obes employe method cross sect analysi num medic expenditur panel survey num nation health survey result men estim rang num overweight num grade iii obes men women estim rang num overweight num grade iii aggreg annual cost attribut obes full tim employe num billion individu bodi mass index num repres num obes popul respons num excess cost conclus success effort reduc preval obes bodi mass index num result signific save employ
MED-1449~workplac program generat save pubm ncbi abstract amid soar health spend grow interest workplac diseas prevent program improv health lower cost critic meta analysi literatur cost save program found medic cost fall num dollar spent program absente cost fall num dollar spent explor mechan work broader applic find return invest suggest wider adopt program prove benefici budget product health outcom
MED-1450~multicent random control trial plant bas nutrit program reduc bodi weight cardiovascular risk corpor set geico studi abstract background object determin effect low fat plant bas diet program anthropometr biochem measur multicent corpor set subjects method employe num site major compani bodi mass index num kg m num and or previous diagnosi type num diabet random follow low fat vegan diet week group support work cafeteria option make diet num week dietari intak bodi weight plasma lipid concentr blood pressur glycat hemoglobin hba num determin baselin num week result bodi weight fell num kg num kg intervent control group num total low dens lipoprotein ldl cholesterol fell num num mg dl intervent group num num mg dl control group num hba num fell num percentag point num percentag point intervent control group num studi complet bodi weight num kg num kg intervent control group num total ldl cholesterol fell num num mg dl intervent group num num mg dl control group num hba num level decreas num percentag point num percentag point intervent control group num conclus num week dietari intervent low fat plant bas diet corpor set improv bodi weight plasma lipid individu diabet glycem control
MED-1451~link workforc health safeti health bottom line track market perform compani nurtur cultur pubm ncbi abstract object test hypothesi comprehens effort reduc workforce health safeti risk company stock market perform method stock market perform corpor health achiev award winner track scenario simul past market perform result portfolio compani recogn award win approach health safeti workforc outperform market evid support build cultur health safeti competit advantag marketplac research identifi associ compani focus health safeti compani manag aspect busi equal conclus compani build cultur health focus well b safeti workforc yield greater investor
MED-1454~substitut dietari satur monounsatur fat impair insulin sensit healthi men women kanwu studi pubm ncbi abstract aims hypothesi amount qualiti fat diet import develop insulin resist relat metabol disord aim determin chang dietari fat qualiti alter insulin action human method kanwu studi includ num healthi subject chosen random receiv control isoenerget diet num month high proport satur safa diet monounsatur mufa diet fatti acid group assign random supplement fish oil num num fatti acids d placebo result insulin sensit signific impair satur fatti acid diet num num chang monounsatur fatti acid diet num ns num differ diet insulin secret affect addit num fatti acid influenc insulin sensit insulin secret favour effect substitut monounsatur fatti acid diet satur fatti acid diet insulin sensit total fat intak median num insulin sensit num lower num higher satur fatti acid diet monounsatur fatti acid diet num low densiti lipoprotein cholesterol ldl increas satur fatti acid diet num num decreas monounsatur fatti acid diet mufa num num lipoprotein lp increas monounsatur fatti acid diet num num conclusions interpret chang proport dietari fatti acid decreas satur fatti acid increas monounsatur fatti acid improv insulin sensit effect insulin secret benefici impact fat qualiti insulin sensit individu high fat intak num
MED-1455~lipotox effect dietari satur transfatti acid abstract ingest excess amount satur fatti acid sfas transfatti acid tfas consid risk factor cardiovascular diseas insulin resist dyslipidemia obes focus paper elucid influenc dietari sfa tfa intak promot lipotox liver cardiovascular endotheli gut microbiota system insulin resist endoplasm reticulum stress satur transfatti acid favor proinflammatori state lead insulin resist fatti acid involv inflammatori pathway contribut diseas progress chronic inflamm autoimmun allergi cancer atherosclerosi hypertens heart hypertrophi metabol degen diseas consequ lipotox occur target organ direct effect repres inflamm pathway indirect effect includ import alter gut microbiota endotoxemia interact pathway perpetu feedback process exacerb inflammatori state import lifestyl modif includ improv diet recommend strategi treatment diseas
MED-1456~vegan relationship insulin resist intramyocellular lipid pubm ncbi abstract object test hypothesi dietari factor vegan diet lead improv insulin sensit lower intramyocellular lipid imcl storag design case control studi set imperi colleg school medicin hammersmith hospit campus london uk subject total num vegan num omnivor particip studi vegan subject match match result shown num vegan num omnivor subject match gender age bodi mass index bmi intervent full anthropometri num day dietari assess physic activ level obtain insulin sensit beta cel function determin homeostat model assess homa imcl level determin vivo proton magnet reson spectroscopi total bodi fat content assess bioelectr imped result differ group sex age bmi waist measur percentag bodi fat activ level energi intak vegan signific lower systol blood pressur num mmhg ci num num num higher dietari intak carbohydr num ci num num num nonstarch polysaccharid num ci num num num polyunsatur fat num ci num num num signific lower glycaem index num ci num num num vegan lower fast plasma triacylglycerol num mmol l ci num num num glucos num mmol l ci num num num concentr signific differ homa homa num ci num num num imcl level signific lower soleus muscl num ci num num num conclus vegan food intak biochem profil expect cardioprotect lower imcl accumul beta cel protect
MED-1457~high fat diet coordin downregul gene requir mitochondri oxid phosphoryl skelet muscl pubm ncbi abstract obes type num diabet high fat diet hfd reduc mitochondri mass function hypothes hfd affect express gene involv mitochondri function biogenesi test hypothesi fed num insulin sensit male isoenerget hfd num day muscl biopsi intervent oligonucleotid microarray analysi reveal num gene differenti regul hfd bonferonni adjust num gene involv oxid phosphoryl oxpho decreas member mitochondri complex ndufb num ndufb num nduf num ndufv num sdhb complex ii mitochondri carrier protein slc num peroxisom proliferator activ receptor gamma coactiv num pgc num alpha pgc num eta mrna decreas num num num num separ experi fed num num mice hfd num week found oxpho pgc num mrnas downregul approxim num cytochrom pgc num lpha protein approxim num combin result suggest mechan hfd downregul gene oxpho mitochondri biogenesi mimic observ diabet insulin resist sustain result mitochondri dysfunct prediabetic insulin resist state
MED-1458~higher insulin sensit vegan higher mitochondri densiti pubm ncbi abstract background object vegan lower incid insulin resist ir associ diseas higher insulin sensit compar omnivor aim studi examin higher vegan relat marker mitochondri biogenesi intramyocellular lipid imcl content subjects method eleven vegan num match race age sex bodi mass index physic activ energi intak omnivor control enrol case control studi anthropometri bioimped bia ultrasound measur viscer subcutan fat layer paramet glucos lipid homeostasi hyperinsulinem euglycem clamp muscl biopsi perform citrat synthas cs activ mitochondri dna mtdna imcl content assess skelet muscl sampl result group compar anthropometr bia paramet physic activ protein energi intak vegan signific higher glucos dispos m valu vegan num num control num num mg kg min num confid interv num num num slight lower imcl content vegan num num num control num num num mg g muscl num confid interv num num num slight higher relat muscl mtdna amount vegan num num control num num num confid interv num num num signific differ found cs activ vegan num num control num num mol g min num confid interv num num num conclus vegan higher compar mitochondri densiti imcl content omnivor suggest decreas whole bodi glucos dispos preced muscl lipid accumul mitochondri dysfunct ir develop
MED-1459~integr mechan insulin resist common thread miss link abstract insulin resist complex metabol disord defi singl etiolog pathway accumul ectop lipid metabolit activ unfold protein respons upr pathway innat immun pathway implic pathogenesi insulin resist pathway close link fatti acid uptak lipogenesi energi expenditur impact ectop lipid deposit ultim accumul specif lipid metabolit diacylglycerol and or ceramid liver skelet muscl common pathway lead impair insulin signal insulin resist
MED-1460~mechan skelet muscl insulin resist induc fatti acid import mitochondri function abstract insulin resist condit develop syndrom obes type num diabet mellitus metabol syndrom factor link insulin resist syndrom precis defin evid suggest elev plasma free fatti acid ffa level play import role develop skelet muscl insulin resist accord vivo vitro exposur skelet muscl myocyt physiolog concentr satur fatti acid insulin resist condit mechan postul account fatti acids induc muscl insulin resist includ randl cycl oxid stress inflamm mitochondri dysfunct review experiment evid support involv proposit develop skelet muscl insulin resist induc satur fatti acid propos integr model place mitochondri dysfunct import common factor mechan
MED-1461~intramyocellular triglycerid content determin vivo insulin resist human num num nuclear magnet reson spectroscopi pubm ncbi abstract insulin resist predict factor clinic onset type num diabet suggest intramuscular triglycerid store primari pathogen factor develop test hypothesi num young lean offspr type num diabet parent model vivo insulin resist increas risk develop diabet num healthi subject match anthropomorph paramet life habit studi num euglycemic hyperinsulinem clamp assess bodi insulin sensit num local num nuclear magnet reson nmr spectroscopi soleus higher content fiber type insulin sensit tibiali anterior higher content fiber type iib insulin sensit muscl assess intramyocellular triglycerid content num nmr calf subcutan adipos tissu assess composit saturated unsatur carbon triglycerid fatti acid chain num dual x ray energi absorpt assess bodi composit offspr diabet parent notwithstand normal fat content distribut character insulin resist increas intramyocellular triglycerid content soleus num tibiali anterior num show normal content saturated unsatur carbon fatti acid chain subcutan adipocyt stepwis regress analysi select intramyocellular triglycerid soleus content plasma free fatti acid level main predictor bodi insulin sensit conclus num num nmr spectroscopi reveal intramyocellular abnorm lipid metabol bodi insulin resist subject high risk develop diabet tool noninvas monitor alter diabet prediabet state
MED-1463~role insulin pathogenesi free fatti acid induc insulin resist skelet muscl pubm ncbi abstract insulin resist pathophysiolog link obes type num diabet initi insulin resist critic prevent treatment type num diabet lipotox well known concept explan initi insulin resist prevail hypothes cellular molecular mechan lipotox inflamm oxid stress hyperinsulinemia er stress relat import hypothes event remain determin role hyperinsulinemia document literatur initi insulin resist review interact fatti acid beta cel synergi free fatti acid ffas insulin emphas role hyperinsulinemia articl present evid ffa induc insulin secret vitro vivo recent advanc molecular mechan ffa action beta cel role gpr num develop insulin resist negat feedback loop insulin receptor signal pathway negat feedback loop discuss detail focus ir num serin kinas articl substanti support role insulin earli stage ffa associ insulin resist hypothesi insulin role lipotox refer insulin hypothesi review hypothesi prevent increas beta cel respons glucos potenti approach earli intervent metabol syndrom
MED-1464~fast plasma free fatti acid risk type num diabet atherosclerosi risk communiti studi pubm ncbi abstract object evalu plasma level free fatti acid ffas independ incid type num diabet research design method case cohort design random select num incid case diabet num noncas num african american white men women atherosclerosi risk communiti studi age num year preval diabet baselin exam incid diabet ascertain exam num year follow up ffa level measur plasma sampl collect baselin exam result baselin ffa level invers height posit femal sex bmi waist circumfer waist to hip ratio heart rate plasma triglycerid inflamm score quantifi level system inflamm marker relat risk incid diabet fourth quartil ffas increas basic model adjust age sex race center hazard ratio num num ci num num model adjust baselin fast glucos insulin bmi waist circumfer triglycerid inflamm score num num num relat risk greater ffa level lowest normal weight highest obes formal test interact ffas bmi statist signific conclus individu higher fast level plasma ffas modest higher risk type num diabet cohort middle ag adult
MED-1465~effect intraven dietari lipid challeng intramyocellular lipid content relat insulin sensit human pubm ncbi abstract increas intramyocellular lipid imcl content quantifi num h magnet reson spectroscopi num h mrs reduc insulin sensit present unclear factor determin imcl format rapid imcl accumul induc studi impact hyperinsulinemia elev circul nonesterifi fatti acid nefa level imcl format insulin sensit evalu influenc high fat diet imcl storag infus protocol num healthi male subject underw num hyperinsulinemic euglycem glucos clamp concomit infus intralipid heparin imcl quantifi num h mrs soleus sol tibiali anterior ta muscl baselin hour imcl level start increas signific num reach maximum num num sol num num ta baselin num num parallel glucos infus rate gir decreas progress reach minimum num num baselin num time gir strong correl imcl ta num num sol muscl num num diet protocol num male subject ingest high fat low fat diet num day complet diet imcl level insulin sensit assess high fat diet imcl level increas signific ta muscl num num baselin num sol muscl num num baselin ns insulin sensit decreas num num baselin num signific insulin sensit imcl level low fat diet effect high fat diet show greater interindividu variat infus protocol data lipid infus protocol suggest function relationship imcl level insulin sensit similar effect induc high fat diet underlin physiolog relev observ
MED-1466~free fatti acid inhibit glucos util human skelet muscl pubm ncbi abstract rat muscl studi suggest competit free fatti acid ffa glucos oxid result glucos num phosphat accumul ffa decreas glucos num phosphat human skelet muscl indic direct inhibit glucos transport phosphoryl mechan redirect glucos muscl brain fast explain insulin resist high lipid diet obes
MED-1467~adipos insulin resist human role tissu cellular lipid depot pubm ncbi abstract human adipos long insulin resist increas cardiovascular risk abdomin adipos consid advers intra abdomin fat insulin resist possibl mediat greater lipolyt activ lower adiponectin level resist leptin increas inflammatori cytokin contribut clear liver lipid close import contributor insulin resist part consequ lipogen pathway insulin action up regul hyperinsulinemia unimpair signal intramyocellular triglycerid muscl insulin resist anomali includ higher intramyocellular triglycerid insulin sensit athlet women men issu explain culprit activ lipid moieti diacylglycerol ceramid speci depend lipid metabol partit triglycerid amount subcutan fat gluteofemor metabol protect illustr insulin resist dyslipidemia patient lipodystrophi studi suggest deep sc abdomin fat advers properti pericardi perivascular fat relat atheromat diseas insulin resist recent interest recogniz brown adipos tissu adult human augment hormon irisin exercis muscl brown adipos tissu metabol activ oxid fatti acid generat heat small variabl quantiti metabol import human usual live condit unclear understand specif role lipid depot approach control obes metabol sequela
MED-1468~dynam fat cell turnov human pubm ncbi abstract obes increas epidem manner countri constitut public health problem enhanc risk cardiovascular diseas metabol disord type num diabet owe increas obes life expect start decreas develop countri time recent histori factor determin fat mass adult human fulli understood increas lipid storag develop fat cell adipocyt thought import show adipocyt number major determin fat mass adult number fat cell stay constant adulthood lean obes individu mark weight loss indic number adipocyt set childhood adolesc establish dynam stabl popul adipocyt adult measur adipocyt turnov analys integr num deriv nuclear bomb test genom dna approxim num fat cell renew annual adult age level bodi mass index adipocyt death generat rate alter earli onset obes suggest tight regul fat cell number condit adulthood high turnov adipocyt establish therapeut target pharmacolog intervent obes
MED-1470~intramyocellular lipid concentr correl insulin sensit human num nmr spectroscopi studi pubm ncbi abstract recent muscl biopsi studi shown relat intramuscular lipid content insulin resist aim studi test relat human proton nuclear magnet reson num nmr spectroscopi techniqu enabl non invas rapid approxim num min determin intramyocellular lipid imcl content normal weight non diabet adult num age num num year bmi num num kg m num studi cross sect analysi insulin sensit assess num hyperinsulinaem approxim num pmol l euglycaem approxim num mmol l clamp test intramyocellular lipid concentr determin local num nmr spectroscopi soleus muscl simpl linear regress analysi show invers correl num num correct intramyocellular lipid content m valu num min clamp fast plasma non esterifi fatti acid concentr m valu num num intramyocellular lipid content relat bmi age fast plasma concentr triglycerid non esterifi fatti acid glucos insulin result show intramyocellular lipid concentr assess invas local num nmr spectroscopi good indic bodi insulin sensit non diabet non obes human
MED-1471~overnight lower free fatti acid acipimox improv insulin resist glucos toler obes diabet nondiabet subject pubm ncbi abstract obes common elev plasma free fatti acid ffa level insulin resist hyperinsulinemia import cardiovascular risk factor insulin resist hyperinsulinemia obes remain uncertain test hypothesi ffas link obes insulin resistance hyperinsulinemia lower chronic elev plasma ffa level improv insulin resistance hyperinsulinemia glucos toler obes nondiabet diabet subject acipimox num mg long act antilipolyt drug placebo overnight num num num num lean control subject num obes nondiabet subject num obes subject impair glucos toler num patient type num diabet euglycemic hyperinsulinem clamp oral glucos toler test num perform separ morn overnight acipimox placebo treatment obes studi group acipimox lower fast level plasma ffas num plasma insulin approxim num insulin stimul glucos uptak euglycemic hyperinsulinem clamp twofold higher acipimox placebo area glucos insulin curv oral glucos toler test approxim num lower acipimox administr placebo conclud lower elev plasma ffa level reduc insulin resistance hyperinsulinemia improv oral glucos toler lean obes nondiabet subject obes patient type num diabet
MED-1472~rapid impair skelet muscl glucos transport phosphoryl free fatti acid human pubm ncbi abstract initi effect free fatti acid ffas glucos transport phosphoryl studi healthi men presenc elev num num mmol l basal num num mmol l low num mmol l control plasma ffa concentr num group euglycemic hyperinsulinem clamp concentr glucos num phosphat num inorgan phosphat pi phosphocreatin adp ph calf muscl measur num min num min num nuclear magnet reson spectroscopi rate whole bodi glucos uptak increas similar num min declin approxim num presenc basal high ffas num num num num control num num micromol kg num min num num rise intramuscular num concentr blunt num min high ffa exposur num num control num num micromol l num num min num lower presenc high basal ffas num num num num control num num micromol l num intramuscular ph decreas num num num control increas num num num high ffa exposur pi rose approxim num mmol l num num min slowli decreas studi conclus lack initi peak earli declin muscl num concentr suggest physiolog concentr ffas primarili inhibit glucos transport phosphoryl preced reduct whole bodi glucos dispos num min human
MED-1473~mechan free fatti acid induc insulin resist human abstract examin mechan lipid insulin resist human skelet muscl glycogen glucos num phosphat concentr measur num min simultan num num nuclear magnet reson spectroscopi healthi subject presenc low num num mm sem control high num num mm lipid infus plasma free fatti acid level euglycem approxim num mm hyperinsulinem approxim num pm clamp condit num initi num clamp rate whole bodi glucos uptak affect lipid infus decreas continu approxim num control valu num num augment lipid oxid accompani approxim num reduct oxid glucos metabol start hour lipid infus num rate muscl glycogen synthesi similar num lipid control infus decreas approxim num control valu num num num num mumol  kg min num reduct muscl glycogen synthesi elev plasma free fatti acid preced fall muscl glucos num phosphat concentr start approxim num num num control num num mm num contrast origin postul mechan free fatti acid thought inhibit insulin stimul glucos uptak muscl initi inhibit pyruv dehydrogenas result demonstr free fatti acid induc insulin resist human initi inhibit glucos transport phosphoryl approxim num reduct rate muscl glycogen synthesi glucos oxid
MED-1474~free fatti acid skelet muscl insulin resist pubm ncbi abstract purpos review acut exposur fatti acid insulin resist muscl excess dietari lipid obes strong muscl insulin resist relev mechan fulli elucid examin latest evid lipid accumul muscl mechan lipid induc insulin resist recent find muscl lipid metabolit long chain fatti acid coenzym diacylglycerol ceramid impair insulin signal direct crosstalk inflammatori signal pathway insulin signal pathway mitochondri dysfunct oxid stress put forward major contributor develop mainten lipid induc insulin resist muscl anim model gene delet pathway fatti acid synthesi storag show increas metabol rate reduc intramuscular lipid storag improv insulin action challeng high lipid load summari studi genet dietari obes anim model genet modifi anim human obes type num diabet suggest plausibl mechan effect fatti acid lipid metabolit inflammatori pathway mitochondri dysfunct insulin action muscl mechan demonstr situat lipid accumul obes exist initi event lead muscl insulin resist direct effect fatti acid muscl secondari lipid accumul adipos tissu liver remain clarifi
MED-1475~effect overnight intraven lipid infus intramyocellular lipid content insulin sensit african american versus caucasian adolesc abstract object explain predisposit insulin resist african american aa adolesc studi aim num examin intramyocellular lipid content imcl insulin sensit intralipid il infus num determin increas imcl compar aa caucasian adolesc materi method thirteen aa num caucasian normal weight adolesc bmi num underw num hyperinsulinemic euglycem clamp occas random order overnight num hr infus num il num normal salin ns imcl quantifi num magnet reson spectroscopi tibiali anterior muscl il infus result il infus plasma tg glycerol ffa fat oxid increas signific race differ hepat insulin sensit decreas il infus differ group il infus signific increas imcl compar aa num ns num num il num num mmol kg wet weight caucasian num ns num num il num num mmol kg wet weight similar reduct num insulin sensit group num ns num num il num num mg kg min u ml aa num ns num num il num num mg kg min u ml caucasian adolesc conclus healthi adolesc acut elev plasma ffa il infus accompani signific increas imcl reduct insulin sensit race differenti find suggest aa normal weight adolesc suscept caucasian ffa induc imcl accumul insulin resist
MED-1476~neanderth cannib moula guerci ard che franc pubm ncbi abstract cave site moula guerci num meter modern rhone river occupi neanderth approxim num year ago excav num yield rich paleontolog paleobotan archaeolog assemblag includ part neanderth neanderth contemporari stone tool faunal remain tight control stratigraph spatial context infer neanderth cannib moula guerci base compar analysi hominid ungul bone spatial distribut modif stone tool skelet part represent
MED-1478~paleolith nutrit twenty f year pubm ncbi abstract quarter centuri pass public evolutionari discord hypothesi departur nutrit activ pattern hunter gather ancestor contribut great specif defin endem chronic diseas modern civil refin model chang respect anthropolog evid continu ancestr human diet preval evolut character lower level refin carbohydr sodium higher level fiber protein compar level fat primarili unsatur fat cholesterol physic activ level higher current level result higher energi throughput outset evid suggest testabl hypothes recommend ultim rest convent epidemiolog clinic laboratori studi studi multipli support aspect model extent respect offici recommend today target closer preval hunter gather compar recommend num year ago doubt rais necess low level protein fat cholesterol intak common offici recommend impress random control trial begun confirm hunter gather diet high risk group compar routin recommend diet research past quarter centuri proven interest heurist ultim valid model
MED-1479~paleolith prescript incorpor divers flexibl studi human diet evolut abstract evolutionari paradigm human health nutrit center evolutionari discord mismatch model human bodi reflect adapt establish paleolith era ill suit modern industri diet result rapid increas rate chronic metabol diseas model remain argu util explain evolut human dietari tendenc limit assumpt human diet mismatch evolv biolog impli instinctu genet determin root paleolith review current research indic human eat habit primarili learn behavior social physiolog mechan start utero extend life adapt strong genet reflect neolith paleolith adapt signific influenc human niche construct behavior incorpor broader understand evolv mechan human learn imprint eat habit reciproc effect habit physiolog provid tool structur nutrit intervent
MED-1482~hand hygien complianc health care worker chang patient contact precaut room icus pubm ncbi abstract background hand hygien complianc rate health care worker hcw rare exceed num contact precaut thought increas hcws hand hygien awar sought determin differ hand hygien complianc rate hcw patient contact precaut isol method hospital medic micu surgic sicu intens care unit train observ direct observ hand hygien type room contact precaut noncontact precaut type hcw nurs doctor result sicu similar complianc rate num num contact precaut room num num complianc noncontact precaut room num micu similar hand hygien complianc rate num num contact precaut room num num noncontact precaut room num hand hygien complianc rate stratifi hcw similar num micu nurs higher rate hand hygien complianc contact precaut room room noncontact precaut num num conclus complianc hand hygien hcws differ contact precaut room room noncontact precaut nurs micu publish mosbi
MED-1483~empir evalu larg treatment effect medic intervent pubm ncbi abstract context medic intervent modest effect occasion clinic trial find larg effect benefit harm object evalu frequenc featur larg effect medicin data sourc cochran databas systemat review cdsr num issu num studi select separ binary outcom cdsr forest plot comparison intervent publish trial subsequ trial trial nomin statist signific num larg effect odd ratio num sampl random num topic group in depth evalu data extract assess type treatment outcom trial larg effect examin large effect trial trial topic effect compar effect respect meta analys result num forest plot num review num num signific larg effect publish trial num num publish trial num num trial signific larg effect nomin signific larg effect typic small trial median number event num trial num subsequ trial topic larg effect topic address mortal num trial num subsequ trial num trial signific larg effect address laboratory defin efficaci num trial num subsequ num trial signific larg effect trial larg effect trial larg effect subsequ publish trial nineti percent num larg effect observ subsequ publish trial smaller meta analys includ trial median odd ratio decreas num num trial num num subsequ trial num num select topic num subsequ trial large effect trial meta analysi maintain larg effect num addit trial includ pertain mortality rel outcom cdsr num intervent larg benefici effect mortal num major concern qualiti evid trial extracorpor oxygen sever respiratori failur newborn conclus larg treatment effect emerg small studi addit trial perform effect size typic smaller well valid larg effect uncommon pertain nonfat outcom
MED-1484~estim health care associ infect death hospit num synopsi object purpos studi provid nation estim number healthcare associ infect hai death unit state hospit method singl sourc nation repres data hai author multi step approach data sourc main sourc data nation nosocomi infect surveil nnis system data num num conduct center diseas control prevent data nation hospit discharg survey num american hospit associ survey num supplement nnis data percentag patient hai death determin caus hai nnis data estim number death result num estim number hai hospit adjust includ feder facil approxim num million num hai newborn high risk nurseri num newborn well babi nurseri num adult children icus num num adult children icus estim death hai hospit num num pneumonia num bloodstream infect num urinari tract infect num surgic site infect num infect site conclus hai hospit signific morbid mortal unit state method estim number hai make exist data nation level
MED-1486~patient expect lipid low drug pubm ncbi abstract object object studi assess expect effect statin treatment popul aim examin factor includ histori concurr risk coronari heart diseas higher lower treatment belief method hundr twenty nin num swedish patient statin complet postal questionnair health life style cardiovascular risk factor expect treatment expect treatment benefit outcom measur result medic histori coronari heart diseas affect treatment expect patient high risk cardiovascular diseas report slight lower expect treatment effect num year perspect num shorter time perspect low satisfact explan purpos treatment poor perceiv control health negat view treatment benefit conclus rational appli physician prescrib statin relat patient expect factor relat patient physician relationship social situat perceiv control health affect patient belief practic implic associ patient poor satisfact treatment explan low belief treatment benefit emphas import patient physician communic suggest clinic tool develop order identifi patient poor belief treatment benefit tailor educ group reduc risk non compli subsequ reduc risk coronari heart diseas
MED-1487~patient expect screen prevent treatment abstract purpos inform decis accept health care intervent requir understand benefit studi assess particip estim benefit minimum accept benefit screen breast bowel cancer medic prevent hip fractur cardiovascular diseas method general practition questionnair regist patient age num num year patient agre particip studi estim number event fractur death prevent group num patient undergo intervent period num year minimum number event avoid intervent consid justifi proport particip overestim intervention benefit calcul univari multivari analys predictor respons perform result particip rate num patient invit particip studi num return complet questionnair particip overestim degre benefit confer intervent num particip overestim effect breast cancer screen num overestim effect bowel cancer screen num overestim effect hip fractur prevent medic num overestim effect prevent medic cardiovascular diseas estim minimum accept benefit conserv cardiovascular diseas mortal prevent respond minimum benefit greater intervent achiev lower level educ higher estim minimum accept benefit intervent conclus patient overestim risk reduct achiev num exampl screen prevent medic lower level educ higher minimum benefit justifi intervent tendenc overestim benefit affect patient decis intervent practition awar tendenc discuss intervent patient
MED-1488~benefit patient expect ad antihypertens drug abstract aim discov patient expect benefit addit drug treatment hypertens investig patient characterist predict treatment method anonym questionnair survey carri singl primari care group random sampl patient practic list stratifi age gender survey determin benefit requir decid receiv subsequ drug treat hypertens largest number treatment num year nnt num prevent myocardi infarct num smallest benefit persuad treatment demograph inform explain variabl enthusiasm treatment collect result particip requir higher benefit drug treatment expect nnt num treatment num num ci num num margin benefit demand addit treatment great nnt num num num ci num num nnt num num num ci num num addit factor influenc treatment gender differ nnt num men women num num ci num num difficulti make decis easi difficult num num ci num num year full time educ num num ci num num addit year educ slope nnt num increas number tablet disappear gender year educ difficulti reach decis account simultan conclus peopl greater expect benefit antihypertens drug treatment view addit subsequ drug lesser step start term benefit expect full understand risk benefit critic import spend longer full time educ expend effort make decis accept treatment discrep benefit expect demand research method determin patient expect inform individu patient decis
MED-1489~revers cad pubm ncbi abstract purpos plant bas nutrit achiev coronari arteri diseas cad arrest revers small studi skeptic approach succeed larger group patient purpos follow up studi defin degre adher outcom num consecut patient volunt receiv counsel convert usual diet plant bas nutrit method num consecut patient counsel plant bas nutrit patient establish cardiovascular diseas cvd interest transit plant bas nutrit adjunct usual cardiovascular care consid particip adher elimin dairi fish meat ad oil result num patient cvd num adher major cardiac event judg recurr diseas total stroke adher cardiovascular particip recurr event rate num signific report studi plant bas nutrit therapi thirteen num nonadher particip experienc advers event conclus volunt patient cvd respond intens counsel sustain plant bas nutrit num year experienc low rate subsequ cardiac event dietari approach treatment deserv wider test adher sustain broader popul plant bas nutrit potenti larg effect cvd epidem
MED-1490~prevent drug prevent studi patient expect benefit prevent drug pubm ncbi abstract object studi aim find threshold benefit hypothet cholesterol low drug subject prepar drug proxim target event myocardi infarct subject view drug affect threshold design studi num subject written questionnair interview group num subject discharg coronari care unit group num subject cardio protect drug recent histori myocardi infarct group num subject histori myocardi infarct cardio protect drug result median valu threshold benefit subject prevent drug num num absolut risk reduct group num num median valu expect averag prolong life num num month num subject drug offer num absolut risk reduct year subject view medicin drug general proxim target event predictor accept prevent drug eighti percent subject told numer benefit prevent drug start conclus major expect benefit prevent drug higher actual benefit provid current drug strategi tension patient chanc benefit prevent drug reduct uptak inform
MED-1491~flaxse fed pork num fatti acid enrich contribut dietari recommend pubm ncbi abstract potenti increas num fatti acid fa intak flaxse fed pork underestim restrict pure longissimus muscl combin muscl adipos tissu typic consum present fa content pig fed num num dietari flaxse num week measur loin picnic butt primal lean muscl epimysium seam fat ls ls num mm backfat lss num fa content enrich claim canada num mg num serv exceed primal feed num flaxse num fold control num enrich inclus adipos tissu num increas flaxse feed level combin adipos tissu inclus amplifi total long chain num fa num num num num num flaxseed f num fa enrich pork contribut substanti daili long chain num fa intak societi typic low seafood consumpt num
MED-1492~effect blood pressur reduct blood pressure low regimen major cardiovascular event baselin bloo pubm ncbi abstract background benefit reduc blood pressur establish remain uncertainti magnitud effect vari initi blood pressur level object compar risk reduct achiev blood pressure low regimen individu baselin blood pressur method thirty two random control trial includ comparison type treatment made comparison primari prespecifi analysi includ calcul summari estim effect random effect meta analysi major cardiovascular event group defin baselin sbp num num num num mmhg result num particip num primari outcom event observ evid differ proportion risk reduct achiev blood pressure low regimen group defin higher lower level baselin sbp trend num find broad consist comparison regimen dbp categori common blood pressur cut point conclus effect blood pressure low treatment depend substant start blood pressur level major patient trial contribut overview histori hypertens receiv background blood pressure low therapi find suggest addit blood pressur reduct hypertens patient meet initi blood pressur target produc benefit broad data support util blood pressure low regimen high risk patient hypertens
MED-1493~flaxse miracul defens critic maladi pubm ncbi abstract presenc omega num omega num rich oil alpha linol acid dietari fiber secoisolariciresinol diglucosid protein miner flaxse constitut strong basi util flaxse food prepar curat agent extens bodi literatur illustr flaxse gain signific posit domain nutrit scienc owe pivot role antioxid agent review discuss length numer health benefit flaxse typic focus prevent role cardiovascular diseas cancer diabet enhanc spatial memori massiv increas size popul special emphas develop countri urg explor altern dietari resourc meet dietari nutrit forthcom generat respect remark nutrit import review question enabl research engag nutrit scienc investig therapeut flaxse function compon dietari applic food product avail process food human cell line
MED-1494~potent antihypertens action dietari flaxse hypertens patient pubm ncbi abstract flaxse num fatti acid lignan fiber provid benefit patient cardiovascular diseas anim work identifi patient peripher arteri diseas benefit dietari supplement flaxse hypertens common peripher arteri diseas purpos studi examin effect daili ingest flaxse systol sbp diastol blood pressur dbp peripher arteri diseas patient prospect double blind placebo control random trial patient num total ingest varieti food num mill flaxse placebo day num month plasma level num fatti acid linolen acid enterolignan increas num num fold flaxseed f group increas signific placebo group patient bodi weight signific num group time sbp num mm hg lower dbp num mm hg lower flaxse group compar placebo num month patient enter trial sbp num mm hg baselin obtain signific reduct num mm hg sbp num mm hg dbp flaxse ingest antihypertens effect achiev select hypertens patient circul linolen acid level correl sbp dbp lignan level correl dbp summari flaxse induc potent antihypertens effect achiev dietari intervent
MED-1495~respons surfac methodolog predict qualiti characterist beef patti ad flaxse tomato past pubm ncbi abstract respons surfac methodolog studi effect flaxse flour fs tomato past tp addit num num num num beef patti qualiti characterist assess qualiti characterist color ph textur profil analysi tpa sensori analysi perform assess color juici firm general accept fs addit reduc valu decreas weight loss cook product num opposit effect observ tp ad num tpa paramet decreas percentag fs tp increas formul beef patti fs tp addit advers affect sensori characterist cook product num sensori characterist evalu accept score num fs tp ingredi beef patti prepar copyright num elsevi reserv
MED-1496~brain rust recent discoveri role oxid stress neurodegen diseas pubm ncbi abstract oxid stress os damag due excess reactiv oxygen speci ros common injuri cell organ preval neurodegen diseas increas age research involv ros os emerg work field text review recent publish articl role os review field focus center articl publish recent scientif journal directori support brazilian ministri educ offic coordin higher educ personnel improv cape search download review articl search engin term oxid stress neurodegen diseas nutrit num scientif collect biochem marker lack sensit specif diagnosi track respons therapi today os intim connect albeit low level ros protect brain deleteri mitochondria os calcium glucocorticoid inflamm trace metal insulin cell cycl protein aggreg hundr thousand gene occur interact gene environ explain os receiv attent year increas number scientif work antioxid intervent stop delay present intervent vitro vivo human continu contribut understand patholog
MED-1497~traumat brain injuri risk factor alzheimer diseas pubm ncbi abstract traumat brain injuri tbi constitut major global health socio econom problem neurobehavior sequela contribut long term disabl brain swell axon injuri hypoxia disrupt blood brain barrier function increas inflammatori respons oxid stress neurodegener lead cognit impair epidemiolog studi show num patient die tbi plaqu patholog featur alzheimer diseas ad tbi act import epigenet risk factor ad review focus ad relat gene express tbi relev progress diseas understand diagnos risk tbi patient develop ad design therapeut intervent copyright num elsevi reserv
MED-1498~modest propos longitudin studi dementia prevent apolog jonathan swift num pubm ncbi abstract studi document role risk protect factor late life dement ill alzheimer diseas systemat review agenc healthcar research qualiti nation institut age conclud qualiti evid low recommend public health made order gain evid efficaci lifestyl intervent propos modest propos studi num subject num year random assign group low high satur fat diet head injuri high low level mental activ physic activ inact smoke non smok propos studi accomplish modest propos illustr absenc definit evid restrict physician make reason recommend base evid
MED-1499~neuroprotect effect natur product alzheimer diseas pubm ncbi abstract natur gift mankind plethora flora bear fruit veget nut divers array bioactiv nutrient present natur product play pivot role prevent cure neurodegen diseas alzheimer diseas ad parkinson diseas neuron dysfunct accumul evid suggest natur occur phyto compound polyphenol antioxid found fruit veget herb nut potenti hinder neurodegener improv memori cognit function nut walnut demonstr neuroprotect effect ad molecular mechan curat effect reli action phytonutri distinct signal pathway protein fold neuroinflamm neuroprotect effect natur occur compound ad evalu review
MED-1500~fruit veget prevent cognit declin dementia systemat review cohort studi pubm ncbi abstract background regular consumpt fruit veget consid reduc risk dementia age associ cognit declin associ unsupport systemat review literatur method search medlin embas biosi aloi cochran librari publish databas bibliographi retriev articl cohort studi follow up num month longer includ report associ alzheimer diseas cognit declin regard frequenc fruit veget consumpt find studi total num particip met inclus criteria studi analyz fruit veget separ found higher consumpt veget fruit decreas risk dementia cognit declin associ found studi fruit veget consumpt analyt combin conclus increas intak veget lower risk dementia slower rate cognit declin older age evid associ valid high fruit consumpt lack
MED-1501~systemat review factor risk prevent cognit declin life pubm ncbi abstract background biolog behavior social environment factor contribut delay prevent cognit declin purpos summar evid putat risk protect factor cognit declin older adult effect intervent preserv cognit data sourc english languag public medlin hugepedia alzgen cochran databas systemat review num num octob num studi select observ studi num particip random control trial rcts num adult particip num year older drawn general popul num year includ relev good qual systemat review elig data extract inform studi design outcom qualiti extract research verifi rate qualiti evid assign grade grade recommend assess develop evalu criteria data synthesi num observ studi num rcts num systemat review review area nutrit factor medic factor medic social econom behavior factor toxic environment exposur genet factor suffici evid support associ cognit declin basi observ studi evid support benefit select nutrit factor cognit physic leisur activ limit current tobacco apolipoprotein epsilon num genotyp medic condit increas risk rct found small sustain benefit cognit train high qualiti evid small rct report physic exercis maintain cognit function limit categor definit exposur heterogen studi design priori assess associ specif exposur cognit declin review includ english languag studi priorit categor outcom exclud small studi conclus potenti benefici factor identifi evid risk protect factor cognit declin qualiti evid low primari fund sourc agenc healthcar research qualiti nation institut age offic medic applic research nation institut health
MED-1502~longer term impact western diet human cognit brain pubm ncbi abstract anim work decad generat convinc bodi evid western diet high satur fat refin carbohydr hfs diet damag brain system review examin evid human converg line evid neuropsycholog epidemiolog neuroimag data anim research organ princip examin evid dietari induc impair frontal limbic hippocamp system function learn memori cognit hedon evid role hfs diet attent deficit disord neurodegen condit examin human research data earli stage evid associ hfs diet impair cognit function base anim data grow understand hfs diet disrupt brain function suggest causal link run hfs diet impair brain function human hfs diet contribut develop neurodegen condit crown copyright num publish elsevi reserv
MED-1503~role lutein zeaxanthin cognit function elder pubm ncbi abstract epidemiolog studi suggest dietari lutein zeaxanthin benefit maintain cognit health carotenoid lutein zeaxanthin cross blood retina barrier form macular pigment mp eye preferenti accumul human brain lutein zeaxanthin macula nonhuman primat found signific correl concentr match brain tissu mp biomark lutein zeaxanthin primat brain tissu interest signific correl found mp densiti global cognit function healthi older adult examin relat cognit lutein zeaxanthin concentr brain tissu deced population bas studi centenarian found zeaxanthin concentr brain tissu signific relat antemortem measur global cognit function memori retent verbal fluenci dementia sever adjust age sex educ hypertens diabet univari analys lutein relat recal verbal fluenci strength associ attenu adjust covari lutein concentr brain signific lower individu mild cognit impair normal cognit function num mo double blind placebo control trial older women involv lutein supplement num mg d combin dha num mg d verbal fluenci score improv signific dha lutein combined treat group memori score rate learn improv signific combined treat group show trend effici learn observ idea lutein zeaxanthin influenc cognit function older adult warrant studi
MED-1504~risk factor prevent intervent alzheim diseas state scienc pubm ncbi abstract background numer studi investig risk factor alzheim diseas ad recent nation institut health state of the sci confer independ panel found insuffici evid support associ modifi factor risk cognit declin ad object present key find select factor ad risk led panel conclus data sourc evid report commiss agenc healthcar research qualiti includ english languag public medlin cochran databas systemat review num octob num expert present public discuss consid studi select studi inclus criteria evid report particip age num year older general popul develop countri minimum sampl size num cohort studi num random control trial num year exposur outcom assess well accept diagnost criteria ad data extract includ studi evalu elig data abstract qualiti evid factor summar low moder high data synthesi diabet mellitus hyperlipidemia midlif current tobacco increas risk ad mediterranean typ diet folic acid intak low moder alcohol intak cognit activ physic activ decreas risk qualiti evid low associ conclus insuffici evid exist draw firm conclus associ modifi factor risk ad
MED-1505~nutrit modul cognit function mental health pubm ncbi abstract import role diet cardiometabol health general recognis mental health understood lifestyl risk factor poor physic health risk factor mental ill includ poor diet reflect high level poor physic health peopl mental ill mediterranean food diet reduc risk chronic diseas research investig mental health benefit provid model pathway food compon provid mediterranean styl diet facilit healthi brain function review evid role select nutrients food compon antioxid omega num fatti acid vitamin brain modul cognit function mental health converg evid multipl pathway nutrient assist brain function draw studi investig isol work synergist action nutrient diet highlight human intervent studi investig benefit mediterranean styl diet mental cardiometabol health copyright num elsevi reserv
MED-1506~western diet consumpt cognit impair link hippocamp dysfunct obes abstract intak satur fat simpl carbohydr primari compon modern western diet link develop obes alzheimer diseas present paper summar research show western diet intak cognit impair specif emphasi learn memori function depend integr hippocampus paper consid evid satur fat simpl carbohydr intak correl neurobiolog hippocampus relat abil dietari compon impair cognit function final model propos western diet consumpt contribut develop excess food intak obes part interf type hippocampal depend memori inhibit critic abil anim refrain respond environment cue food ultim consum energi intak excess driven sole calor
MED-1507~curcumin ingest exercis train improv vascular endotheli function postmenopaus women pubm ncbi abstract vascular endotheli function declin age increas risk cardiovascular diseas lifestyl modif aerob exercis dietari adjust favor effect vascular age curcumin major compon turmer anti inflammatori anti oxid effect investig effect curcumin ingest aerob exercis train flow medi dilat indic endotheli function postmenopaus women total num postmenopaus women assign num group control exercis curcumin group curcumin group ingest curcumin oral num week exercis group underw moder aerob exercis train num week intervent flow medi dilat measur differ baselin flow medi dilat key depend variabl detect group flow medi dilat increas signific equal curcumin exercis group observ control group result curcumin ingest aerob exercis train increas flow medi dilat postmenopaus women suggest potenti improv age rel declin endotheli function copyright num elsevi reserv
MED-1508~leisur time spent sit relat total mortal prospect cohort adult abstract obes epidem attribut part reduc physic activ evid support reduc time spent sit activ improv metabol consequ obes analys conduct larg prospect studi adult enrol american cancer societi examin leisur time spent sit physic activ relat mortal time spent sit physic activ queri questionnair num men num women diseas free enrol author identifi num death men num death women num year follow up adjust smoke bodi mass index factor time spent sit num num hours day mortal women relat risk num num confid interv ci num num men relat risk num num ci num num relat risk sit num hours day physic activ num metabol equival met hours week combin num num ci num num women num num ci num num men compar time sit activ associ strongest cardiovascular diseas mortal time spent sit independ total mortal physic activ level public health messag includ physic activ reduc time spent sit
MED-1509~sedentari time adult associ diabet cardiovascular diseas death systemat review meta analysi pubm ncbi abstract aims hypothesi sedentari sit behaviour ubiquit modern societi conduct systemat review meta analysi examin associ sedentari time diabet cardiovascular diseas cardiovascular all caus mortal method medlin embas cochran librari databas search term relat sedentari time health outcom cross sect prospect studi includ rr hr num cis extract independ review data adjust baselin event rate pool random effect model bayesian predict effect interv calcul varianc outcom expect studi conduct futur result eighteen studi num prospect cross sect includ num particip fifteen studi moder high qualiti greatest sedentari time compar lowest num increas rr diabet rr num num credibl interv cri num num num increas rr cardiovascular event rr num num ci num num num increas risk cardiovascular mortal hr num num cri num num num increas risk all caus mortal hr num num cri num num predict effect interv signific diabet conclusions interpret sedentari time increas risk diabet cardiovascular diseas cardiovascular all caus mortal strength associ consist diabet
MED-1510~hemodynam respons prolong sit pubm ncbi abstract young men group underw num quiet sit preced num min recumb num min stand num walk young men group underw num min sit preced recumb determin effect prolong sit previous postur hemodynam respons measur imped plethysmographi group show calf blood pool decreas thigh blood flow sit comparison control group num sit hemodynam respons group similar sit num num num result increas calf venous pool num decreas calf bf num reduct gravit pool thigh increas pool calf increas diastol arteri pressur num num mmhg minor heart rate stroke volum cardiac output result show sit num hemodynam respons assess posit postur maintain previous main effect prolong sit pool calf compens increas peripher resist
MED-1511~sedentari time cardio metabol biomark adult nhane num num abstract aim prolong sedentari time ubiquit develop economi advers cardio metabol risk profil prematur mortal studi examin associ object assess sedentari time break interrupt sedentari time continu cardio metabol inflammatori risk biomark associ vari sex age and or race ethn method result cross sect analys num particip num year num num nation health nutrit examin survey nhane actigraph acceleromet deriv sedentari time num count minut cpm break sedentari time independ potenti confound includ moderate to vigor exercis detriment linear associ trend num sedentari time waist circumfer hdl cholesterol c reactiv protein triglycerid insulin homa  b homa observ independ potenti confound sedentari time break benefici waist circumfer c reactiv protein trend num limit evid meaning differ associ biomark age sex race ethn notabl sex differ associ sedentari time break hdl cholesterol race ethn differ associ sedentari time waist circumfer associ detriment non hispan white null mexican american benefici non hispan black conclus population repres find deleteri associ prolong sedentari time cardio metabol inflammatori biomark find suggest clinic communic prevent health messag reduc break sedentari time benefici cardiovascular diseas risk
MED-1512~effect endur exercis train curcumin intak central arteri hemodynam postmenopaus women pilot studi pubm ncbi abstract background lifestyl modif regular physic activ diet effect prevent age rel increas cardiovascular diseas risk potenti therapeut effect curcumin diferuloylmethan confirm diseas includ cancer alzheimer diseas effect curcumin test central arteri hemodynam aim pilot studi test hypothesi regular endur exercis combin daili curcumin ingest lower age rel increas left ventricular lv afterload greater extent monotherapi intervent postmenopaus women random double blind placebo control parallel manner method forty f women random assign intervent placebo ingest num curcumin ingest num exercis train placebo ingest num exercis train curcumin ingest num curcumin placebo pill num mg day administ num week aortic blood pressur bp augment index aix index lv afterload evalu puls wave analysi tonometr measur radial arteri pressur waveform result signific differ baselin hemodynam variabl group intervent brachial systol bp sbp signific decreas exercise train group num aortic sbp signific decreas combined treat exercis curcumin group num heart rate hr correct aortic aix signific decreas combined treat group conclus find suggest regular endur exercis combin daili curcumin ingest reduc lv afterload greater extent monotherapi intervent postmenopaus women
MED-1513~sit population health scienc sedentari behavior abstract adult meet physic activ guidelin sit prolong period compromis metabol health tv time objective measur studi show deleteri associ break sedentari time benefici sit time tv time time sit automobil increas prematur mortal risk evid prospect studi intervent trial population bas behavior studi requir
MED-1514~break sedentari time benefici associ metabol risk pubm ncbi abstract object total sedentari absenc whole bodi movement time obes abnorm glucos metabol metabol syndrom addit effect total sedentari time manner accumul import examin associ break object measur sedentari time biolog marker metabol risk research design method particip num age num year cross sect studi recruit num australian diabet obes lifestyl studi sedentari time measur acceleromet counts minut num num worn wake hour consecut day interrupt sedentari time counts min num consid break fast plasma glucos num plasma glucos serum triglycerid hdl cholesterol weight height waist circumfer rest blood pressur measur matlab deriv break variabl spss statist analysi result independ total sedentari time moderate to vigor intens activ time increas break sedentari time benefici waist circumfer standard beta num num ci num num num bmi beta num num num num triglycerid beta num num num num num plasma glucos beta num num num num conclus studi evid import avoid prolong uninterrupt period sedentari primarili sit time find suggest public health recommend break sedentari time complementari physic activ
MED-1515~postprandi lipaemia effect sit stand walk healthi normolipidaem human pubm ncbi abstract long period sedentari behaviour advers affect health irrespect physic activ level studi compar effect sit stand walk postprandi lipaemia healthi normolipidaem japanes men num particip age num num year sd complet num day trial random order num sit control num stand num walk day num sit trial particip rest day num stand trial particip stood num min period day num walk trial particip walk brisk num min approxim num maximum heart rate day num trial particip rest consum test meal breakfast lunch venous blood sampl collect morn afternoon day num fast state num num num postprandi day num day num area serum triacylglycerol concentr time curv num lower walk trial sit stand trial num factor anova num postprandi lipaemia reduc stand reduc low volum walk compar sit healthi normolipidaem japanes men georg thiem verlag kg stuttgart york
MED-1516~sit endotheli dysfunct role shear stress summari sedentari activ modifi life styl behavior key compon etiolog atherosclerot cardiovascular diseas acvd adult children spend half wake time sedentari pursuit sedentari activ shown result impair insulin sensit impair metabol function attenu endotheli function classic marker acvd sedentari activ defin sit activ behavior promot reduc muscular activ lower extrem decreas leg blood flow increas blood pool calf augment arteri pressur deform arteri segment result low shear stress ss ss activ distinct physiolog mechan propos protect acvd specif ss induc endothelium deriv nitric oxid mechan reduc bioavail nitric oxid creat pro oxid milieu result increas oxid stress suffici evid demonstr endotheli function attenu presenc oxid stress sedentari activ result low ss lower extrem result increas oxid stress impair endotheli function review sit model studi effect inact discuss physiolog mechan suggest futur direct
MED-1517~break prolong sit reduc postprandi glycemia healthi normal weight adult random crossov trial pubm ncbi abstract background sedentari behavior risk factor cardiometabol diseas regular interrupt sedentari behavior activ break lower risk object compar effect prolong sit continu physic activ combin prolong sit regular activ break postprandi metabol design seventi adult particip random crossov studi prolong sit intervent involv sit num physic activ intervent involv walk num min sit regular activity break intervent involv walk num min num num min particip consum meal replac beverag num num min result plasma increment area curv iauc insulin differ intervent num regular activ break lower valu num iu num num num ci num num iu num num num num compar prolong sit num iu num num num ci num num iu num num num num compar physic activ plasma glucos iauc differ intervent num regular activ break lower valu num mmol num num num ci num num mmol num num num num compar prolong sit num mmol num num num ci num num mmol num num num num compar physic activ plasma triglycerid iauc differ intervent num physic activ lower valu num mmol num num num ci num num mmol num num num num compar regular activ break conclus regular activ break effect continu physic activ decreas postprandi glycemia insulinemia healthi normal weight adult trial regist australian zealand clinic trial registri actrn num
MED-1518~treadmil desk num year prospect trial pubm ncbi abstract object sedentari weight gain obes treadmil desk combin stand desk treadmil employe work walk low speed design method hypothesi num year intervent treadmil desk increas employe daili physic activ summat activ minut decreas daili sedentari time activ employe num women num men sedentari job num num kg bmi num num kg m num num lean bmi num kg m num num overweight num bmi num kg m num num obes bmi num kg m num volunt tradit desk replac treadmil desk promot physic activ num year result daili physic activ acceleromet work perform bodi composit blood variabl measur baselin num num month treadmil desk intervent subject treadmil desk increas daili physic activ baselin num num activ unit au day num month num num au day num num month num num au day num access treadmil desk signific decreas daili sedentari time activ baselin num num min day num month num num min day num num month num num min day num group weight loss averag num num kg num weight loss obes subject num num kg num access treadmil desk increas daili physic activ compar tradit chair bas desk deploy alter perform num particip fat mass chang signific lost weight num lost num num kg num fat mass weight loss greatest peopl obes conclus access treadmil desk improv health offic worker affect work perform copyright num obes societi
MED-1519~improv perform cleric task administr peppermint odor pubm ncbi abstract previous research presenc odor enhanc task perform present studi investig peppermint odor type perform memor alphabet particip complet protocol twice  onc peppermint odor present analysi signific differ gross speed net speed accuraci type task odor improv perform alphabet improv signific odor condit type durat memor result suggest peppermint odor promot general arous attent particip stay focus task increas perform
MED-1520~effect peppermint exercis perform abstract background enhanc athlet perform great desir athlet coach research mint famous natur herb analges anti inflammatori antispasmod antioxid vasoconstrictor effect inhal mint aroma athlet investig signific effect exercis perform method twelv healthi male student day consum num ml bottl miner water num ml peppermint essenti oil ten day blood pressur heart rate spirometri paramet includ forc vital capac fvc peak expiratori flow rate pef peak inspiratori flow pif determin day supplement period particip underw treadmill bas exercis test metabol gas analysi ventil measur bruce protocol result fvc num num num num num pef num num num num num pif num num num num num signific chang ten day supplement exercis perform evalu time exhaust num num num num work num num num num kj power num num num num kw signific increas num addit result respiratori gas analysi exhibit signific differ vo num num num num num l min num vco num num num num num l min num conclus result experi support effect peppermint essenti oil exercis perform gas analysi spirometri paramet blood pressur respiratori rate young male student relax bronchial smooth muscl increas ventil brain oxygen concentr decreas blood lactat level plausibl explan
MED-1521~effect peppermint tea plasma testosteron follicle stimul hormon lutein hormon level testicular tissu rat pubm ncbi abstract object justifi effect mentha piperita labiata mentha spicata labiata herbal tea plasma total testosteron lutein hormon follicle stimul hormon level testicular histolog featur perform studi major complaint area men advers effect herb male reproduct function method experiment studi includ num male wistar albino rat bodi weight num num rat random group num rat control group commerci drink water experiment group num g l piperita tea num g l spicata tea num g l spicata tea result follicle stimul hormon lutein hormon level increas total testosteron level decreas experiment group compar control group differ statist signific johnsen testicular biopsi score signific statist experiment group control group seminifer tubular diamet experiment group greater control group differ statist signific effect piperita testicular tissu segment matur arrest seminifer tubul effect spicata extend matur arrest diffus germ cell aplasia relat dose conclus benefici effect piperita spicata digest awar toxic effect herb recommend fashion recommend dose
MED-1522~spearmint herbal tea signific anti androgen effect polycyst ovarian syndrom random control trial pubm ncbi abstract hirsut polycyst ovarian syndrom pcos consequ elev androgen level lead signific cosmet psycholog problem recent research turkey shown spearmint tea antiandrogen properti femal hirsut research undertaken assess reduct androgen level brought spearmint tea translat clinic improv degre hirsut studi centr num day random control trial forti volunt random spearmint tea day num month period compar placebo herbal tea num num day studi serum androgen hormon level gonadotrophin check degre hirsut clinic rate ferriman galwey score questionnair modifi dqli dermatolog qualiti life index assess improv level self report hirsut forti num patient complet studi free total testosteron level signific reduc num day period spearmint tea group num lh fsh increas num patient subject assess degre hirsut score modifi dqli signific reduc spearmint tea group num signific reduct object ferriman galwey rate hirsut trial group trial durat num clear signific alter relev hormon level clinic reduct self report degre hirsut object rate score demonstr confirm spearmint antiandrogen properti simpl fact translat clinic practic due relationship androgen hormon follicular hair growth cell turnov time simpli put studi durat long origin studi turkey fact num day long time hirsut resolv signific longer futur studi propos preliminari find encourag spearmint potenti natur treatment hirsut pcos num john wiley son
MED-1523~fatal case high dose peppermint oil ingest lesson learnt abstract peppermint oil easili constitu medicin fatal case due ingest toxic dose oral peppermint oil report patient comatos state shock manag mechan ventil ionotrop vital paramet reach normal num hour conscious num hour side effect peppermint oil consid mild case report warn ingest oral toxic dose peppermint oil danger
MED-1524~ambient scent enhanc nightlif experi abstract smoke prohibit restaur bar club undesir smell previous mask cigarett smoke notic open opportun improv danc club environ introduc pleasant ambient scent mask unwant odor compet club differenti field studi conduct danc club num num latin squar design pre post measur no scent control condit scent test orang seawat peppermint scent shown enhanc danc activ improv evalu evalu music mood visitor ad scent signific differ found scent
MED-1525~effect spearmint mentha spicata labiata tea androgen level women hirsut pubm ncbi abstract mentha spicata labiata spearmint mentha piperita labiata peppermint kind ill herbal medicin flavor industri spicata labiata grow anama plateau yenithornarbadem town isparta locat southwest part turkey town clinician thought consumpt tea steep spicata piperita caus diminish libido antiandrogen effect spearmint peppermint found previous rat decid observ effect herbal tea androgen level hirsut women twenty on femal hirsut patient num polycyst ovari syndrom num idiopath hirsut includ studi cup herbal tea steep spicata num day day follicular phase menstrual cycl treatment spearmint tea signific decreas free testosteron increas lutein hormon follicle stimul hormon estradiol signific decreas total testosteron dehydroepiandrostenedion sulphat level spearmint altern antiandrogen treatment mild hirsut studi test reliabl result avail spearmint drug hirsut copyright num john wiley son
MED-1526~effect inhal peppermint odor ethanol women athlet pubm ncbi abstract purpos studi determin inhal peppermint odor effect time run maximum heart rate mhr maximum oxygen consumpt vo num ax oxygen consumpt vo num minut ventil ve respiratori exchang ratio rer acut intens exercis num women soccer player chosen particip research random divid num group control inhal peppermint inhal mixtur peppermint ethanol order awar similar group subject bmi determin anova show signific differ num subject group ran treadmil bruce test heart rate time run vo num ax vo num ve rer measur gas analyz collect data anova num result show studi inhal fragrant odor signific effect time run mhr vo num ax vo num ve rer due intens durat train refer result present studi suggest inhal peppermint odor acut intens exercis signific effect pulmonari index physic perform tab num fig num ref num
MED-1527~vegetarian dietari pattern mortal adventist health studi num abstract import evid suggest vegetarian dietari pattern reduc mortal relationship establish object evalu associ vegetarian dietari pattern mortal design prospect cohort studi mortal analysi cox proport hazard regress control import demograph lifestyl confound set adventist health studi num ah num larg north american cohort particip total num seventh day adventist men women recruit num num analyt sampl num particip remain exclus exposur diet assess baselin quantit food frequenc questionnair categor num dietari pattern nonvegetarian semi vegetarian pesco vegetarian lacto ovo vegetarian vegan main outcom measur relationship vegetarian dietari pattern all caus cause specif mortal death num identifi nation death index result num death num particip follow up time num year mortal rate num num ci num num death num person year adjust hazard ratio hr all caus mortal vegetarian combin non vegetarian num num ci num num adjust hr all caus mortal vegan num num ci num num lacto ovo vegetarian num num ci num num pesco vegetarian num num ci num num semi vegetarian num num ci num num compar nonvegetarian signific associ vegetarian diet detect cardiovascular mortal noncardiovascular noncanc mortal renal mortal endocrin mortal associ men larger signific women conclus relev vegetarian diet lower all caus mortal reduct cause specif mortal result robust male favor associ consid care offer dietari guidanc
MED-1528~effect vegetarian diet non communic diseas pubm ncbi abstract vegetarian diet general includ plenti veget fruit rich phytochem antioxid fiber magnesium vitamin fe folic acid num polyunsatur fatti acid pufa low cholesterol total fat satur fatti acid sodium fe zinc vitamin num pufa mortal all caus ischem heart diseas circulatori cerebrovascular diseas signific lower vegetarian omnivor popul compar omnivor incid cancer type num diabet signific lower vegetarian vegetarian number increas risk factor non communic diseas increas plasma homocystein platelet volum platelet aggreg compar omnivor low intak vitamin num pufa base present data vegetarian care design diet specif focus increas intak vitamin num pufa reduc low mortal morbid non communic diseas num societi chemic industri
MED-1529~risk hospit death ischem heart diseas british vegetarian nonvegetarian result epic oxford cohort studi pubm ncbi abstract background previous prospect studi examin differ incid ischem heart diseas ihd risk vegetarian nonvegetarian object object examin associ vegetarian diet risk incid nonfat fatal ihd design total num men women live england scotland enrol european prospect investig cancer nutrit epic oxford studi num consum vegetarian diet baselin part analysi incid case ihd identifi linkag hospit record death certif serum lipid blood pressur measur num case match ihd case sex age ihd risk vegetarian status estim multivari cox proport hazard model result averag follow up num num ihd case num hospit admiss num death compar nonvegetarian vegetarian lower bmi kg m num num ci num num non hdl cholesterol concentr num num ci num num mmol l systol blood pressur num num ci num num mm hg vegetarian num lower risk hr num num ci num num ihd nonvegetarian slight attenu adjust bmi differ materi sex age bmi smoke presenc ihd risk factor conclus consum vegetarian diet lower ihd risk find mediat differ non hdl cholesterol systol blood pressur
MED-1530~cardiovascular diseas mortal cancer incid vegetarian meta analysi systemat review pubm ncbi abstract background prospect cohort studi examin mortal cancer incid vegetarian result inconclus aim object present meta analysi investig cardiovascular diseas mortal cancer incid vegetarian nonvegetarian method medlin embas web scienc databas search cohort studi publish incept septemb num studi includ relat risk rr num ci particip uk germani california usa netherland japan result studi total num particip includ analysi all caus mortal vegetarian num lower nonvegetarian rr num num ci num num mortal ischem heart diseas signific lower vegetarian nonvegetarian rr num num ci num num observ num lower mortal circulatori diseas rr num num ci num num num lower mortal cerebrovascular diseas rr num num ci num num vegetarian compar nonvegetarian vegetarian signific lower cancer incid nonvegetarian rr num num ci num num conclus result suggest vegetarian signific lower ischem heart diseas mortal num cancer incid num nonvegetarian copyright num karger ag basel
MED-1531~multicountri ecolog studi cancer incid rate num respect risk modifi factor abstract observ ecolog studi general determin presenc effect cancer risk modifi factor research general agre environment factor smoke alcohol consumpt poor diet lack physic activ low serum num hdyroxyvitamin level import cancer risk factor ecolog studi age adjust incid rate num cancer num countri num high qual data num respect dietari suppli factor includ capita gross domest product life expect lung cancer incid rate index smoke latitud index solar ultraviolet b dose factor found correl strong multipl type cancer lung cancer direct correl num type cancer energi deriv anim product direct correl num type cancer invers latitud direct correl type invers correl capita gross nation product type life expect sweeten direct correl cancer anim fat alcohol consumpt anim product correl cancer incid lag time num num year type cancer correl strong anim product consumpt tend correl weak latitud occur num cancer entir set countri regress result num high qual countri data set num countri set single countri ecolog studi invers correl cancer solar ultraviolet b dose result provid guidanc prevent cancer
MED-1532~trend mortal cancer breast colon prostat esophagus stomach east asia role nutrit transit pubm ncbi abstract substanti nutrit transit character increas intak energi anim fat red meat occur decad east asia studi systemat evalu tempor trend cancer incid mortal popul area sought investig question tremend public health implic data mortal rate cancer breast colon prostat esophagus stomach china num hong kong num japan num korea num singapor num obtain joinpoint regress investig trend mortal cancer remark increas mortal rate breast colon prostat cancer precipit decreas esophag stomach cancer observ select countri breast cancer hong kong studi period annual percentag increas breast cancer mortal num num confid interv num num period num korea mortal rate prostat cancer signific increas num num confid interv num num year num num japan cancer mortal lag num year incept nutrit transit western diet select countri region strike mortal rate breast colon prostat esophag stomach cancer east asia decad part attribut concurr nutrit transit
MED-1533~after school snack raisin lower cumul food intak young children pubm ncbi abstract snack import part children dietari intak role dri fruit energi intak children unknown effect ad libitum consumpt after school snack raisin grape potato chip chocol chip cooki appetit energi intak twenty six num num y old normal weight num num percentil children examin num separ weekday num wk children num num standard breakfast morn snack appl standard lunch school children random receiv num num ad libitum snack instruct eat comfort full appetit measur num num min snack consumpt children consum calori raisin grape cooki num weight raisin consum similar potato chip num lower compar grape cooki num raisin grape led lower cumul food intak breakfast morn snack lunch after school snack num cooki increas cumul food intak num compar snack grape lower appetit compar snack num express chang appetit kilocalori snack ad libitum consumpt raisin potenti after school snack achiev low snack intak prior dinner similar grape compar potato chip cooki children num num num institut food technologist
MED-1534~glucos insulin respons manufactur whole food snack pubm ncbi abstract determin realist snack ad sugar evok excess insulin respons num healthi subject consum snack meal similar fat total energi content snack base sugari manufactur product chocolate co candi bar cola drink crisp food raisin peanut banana peanut processed food snack plasma glucos level tend rise higher fall lower whole food snack area plasma insulin curv num greater manufactur snack raisin peanut snack banana peanut snack evok intermedi insulin respons subject patholog insulinaemia manufactur snack normal respons whole food snack find suggest food drink ad fiber deplet sugar stress overwhelm homeostat mechan suggest insulin respons food influenc physic state food
MED-1535~raisin compar snack effect glycemia blood pressur random control trial pubm ncbi abstract object compar effect raisin snack convent snack glycemia cardiovascular risk factor materi method num week random control trial compar num times a day consumpt raisin intak process snack glycemia cardiovascular risk factor men women random snack num raisin num outcom measur perform baselin num num week result fast plasma glucos level signific affect intak raisin snack subject post prandial glucos level signific reduc raisin intak num week raisin intak num mg dl num baselin num snack eat raisin signific decreas glycat hemoglobin hba num level num num signific greater level decreas snack intak num snack intak signific affect subject systol diastol blood pressur bp raisin intak reduct systol blood pressur sbp num num week num num mmhg statist signific num num raisin signific greater diastol blood pressur dbp num num week snack num bodi weight signific chang group conclus regular consumpt raisin reduc glycemia cardiovascular risk factor includ bp rate
MED-1538~premeal snack raisin decreas mealtim food intak grape young children pubm ncbi abstract effect premeal snack grape raisin mix almond raisin compar water control food intak fi examin num num year old normal weight num num percentil children children random receiv num num ad libitum experi num boy num girl fixed calori num kcal experi num boy num girl treatment ad libitum pizza meal num min appetit measur studi fi measur num min ad libitum consumpt experi num raisin reduc pizza intak num compar water num grape num mix snack num cumul energi intak kcal snack pizza lower water raisin grape mix snack num fixed calori num kcal snack experi num raisin reduc pizza intak compar water num num result cumul intak similar water grape mix snack result higher cumul intak num appetit lower calor ad libitum snack num fix amount grape mix snack num compar water conclus consumpt premeal snack raisin grape mix raisin almond reduc meal tim energi intak lead increas cumul energi intak children
MED-1540~vegetarian diet effect common chronic diseas abstract number studi evalu health vegetarian studi health effect food prefer avoid vegetarian purpos review critic evid health effect vegetarian diet seek explan result conflict convinc evid vegetarian lower rate coronari heart diseas larg explain low ldl cholesterol probabl lower rate hypertens diabet mellitus lower preval obes cancer rate moder lower live communiti life expect greater result specif cancer convinc requir studi evid risk colorect cancer lower vegetarian eat meat result british vegetarian present disagre explan probabl label vegetarian dietari categori broad understand serv divid vegetarian descript subtyp vegetarian diet health lower risk chronic diseas type vegetarian experi effect health
MED-1541~vegetarian diet reduc occurr diabet abstract propos hypothesi vegetarian diet reduc risk develop diabet find generat hypothesi popul num adult white seventh day adventist identifi num num year follow up risk diabet death adventist approxim one half risk white male adventist popul vegetarian substanti lower risk non vegetarian diabet contribut death male femal adventist popul preval self report diabet lower vegetarian non vegetarian associ observ diabet meat consumpt appar due confound under weight select dietari factor physic activ associ meat consumpt diabet stronger male femal
MED-1542~status cardiovascular health adult preval estim nation health nutrit examin survey nhane num abstract background american heart association num strateg impact goal defin concept cardiovascular cv health current preval estim status cv health adult age sex race ethn publish method result includ num adult num year num nation health nutrit examin survey particip stratifi young num year middl num year older age num year cv health behavior diet physic activ bodi mass index smoke cv health factor blood pressur total cholesterol fast blood glucos smoke defin poor intermedi ideal num adult exhibit ideal cv health num metric cv health behavior non smok preval rang num num ideal healthi diet score preval rang num num group preval ideal bmi rang num num ideal physic activ level rang num num higher young adult compar middl older age ideal total cholesterol rang num num blood pressur rang num num fast blood glucos rang num num lower older adult compar young middl age adult preval poor cv health factor lowest young age higher middl older age preval estim age sex consist race ethn group conclus preval estim cv health repres start point effect effort promot cv health prevent cv diseas monitor compar adult popul
MED-1543~patient rel diet exercis counsel provid lifestyl habit matter pubm ncbi abstract goal research evalu person health behavior physician train attend physician associ patient rel lifestyl counsel physician major teach hospit survey person lifestyl behavior perceiv confid frequenc counsel patient lifestyl behavior hundr eighty thre total respons receiv traine consum fast food consum fruit veget attend attend physician exercis num day week num minut week attend physician counsel patient healthi diet num num num regular exercis num num num compar traine traine attend confid abil chang patient behavior predictor confid counsel exercis includ provider exercis time num minut week overweight report adequ train counsel adequ train counsel predictor strong self efficaci counsel diet physician lack confid abil counsel patient lifestyl person behavior includ regular exercis train counsel techniqu improv patient counsel num wiley period
MED-1544~select level prevent pubm ncbi abstract articl outlin advantag disadvantag univers target intervent program advantag univers program absenc label stigmat inclus middl class make program run disadvantag unapp public politician greatest effect lowest risk target program potenti address problem earli potenti effici target accur disadvantag includ difficulti screen possibl label stigmat argument put reduc immens burden suffer child adolesc psychiatr disord optim mix univers target clinic program carri context civic communiti trade off strategi element combin chang knowledg accumul
MED-1545~physician smoke status attitud smoke cessat advic patient intern survey pubm ncbi abstract object smoke status physician impact interact patient smoke smoke opinion physician stop survey examin associ exist physician smoke status belief smoke cessat physician clinic interact patient relev smoke cessat percept barrier assist quit method general famili practition num countri survey telephon face to fac interview convenience sampl methodolog physician smoke status self report result num physician invit num particip survey num smoker signific fewer smoke non smok physician volunt smoke harm activ num num num non smok agre smoke cessat singl biggest step improv health num num num discuss smoke visit num num num non smok physician identifi willpow num num num lack interest num num num barrier quit smoke physician stress barrier num num num conclus smoke physician initi cessat intervent practic implic specif strategi encourag smoke physician quit motiv practition adopt systemat approach assist smoke cessat
MED-1546~low preval ideal cardiovascular health community bas popul heart strategi concentr risk evalu heart score studi abstract background cardiovascular health construct defin american heart associ aha part num impact goal definit applic construct community bas popul distribut compon race sex report method result aha construct cardiovascular health aha ideal health behavior index ideal health factor index evalu num particip age num year num black num femal community bas heart strategi concentr risk evalu studi num particip num met num compon aha definit ideal cardiovascular health num particip met num compon ideal cardiovascular health subgroup race sex age incom level thirty nin subject num compon ideal health behavior index num num compon ideal health factor index black signific fewer ideal cardiovascular health compon white num num num num num adjust sex age incom level black num lower odd num compon ideal cardiovascular health odd ratio num num confid interv ci num num num interact found race sex conclus preval ideal cardiovascular health extrem low middle ag community bas studi popul comprehens individu population bas intervent develop support attain aha num impact goal cardiovascular health
MED-1548~defin set nation goal cardiovascular health promot diseas reduct american heart association strateg impact pubm ncbi abstract document detail procedur recommend goal metric committe strateg plan task forc american heart associ develop num impact goal organ committe charg defin concept cardiovascular health determin metric monitor time ideal cardiovascular health concept support literatur defin presenc ideal health behavior nonsmok bodi mass index num kg m num physic activ goal level pursuit diet consist current guidelin recommend ideal health factor untreat total cholesterol num mg dl untreat blood pressur num num mm hg fast blood glucos num mg dl level children provid level span entir rang metric cardiovascular health status popul defin poor intermedi ideal metric monitor determin chang preval cardiovascular health status defin achiev impact goal addit committe recommend goal reduct cardiovascular diseas stroke mortal committe recommend impact goal num improv cardiovascular health american num reduc death cardiovascular diseas stroke num goal requir strateg direct american heart associ research clinic public health advocaci program cardiovascular health promot diseas prevent decad
MED-1549~physician health habit lifestyl counsel hypertens patient pubm ncbi abstract background seventh report joint nation committe prevent detect evalu treatment high blood pressur jnc vii recommend lifestyl intervent pharmacolog treatment patient high blood pressur object studi determin associ physician person habit attitud behavior jnc vii lifestyl modif guidelin method thousand primari care physician complet docstyl num voluntari web bas survey design provid insight physician attitud behavior health issu result respond averag age num year num male physician behavior num smoke week num ate num cup fruit and or veget num days week num exercis num days week specif type advic offer hypertens patient physician report recommend patient eat healthi diet num cut salt num attain maintain healthi weight num limit alcohol num physic activ num collect num made num lifestyl modif recommend nonsmok physician recommend lifestyl intervent hypertens patient exercis num day week recommend limit alcohol conclus probabl recommend num jnc vii intervent greater physician nonsmok exercis num day week
MED-1551~effect ingest meat plasma cholesterol vegetarian pubm ncbi abstract control trial num strict vegetarian studi prospect week two week control period usual vegetarian diet week num beef ad isocalor daili vegetarian diet week control diet plasma high dens lipoprotein cholesterol chang studi plasma total cholesterol rose signific num end meat eat period systol blood pressur bp increas signific meat eat num control valu diastol bp show major plasma renin activ prostaglandin level urinari kallikrein norepinephrin epinephrin excret normal limit chang notabl trial studi suggest advers effect consumpt beef plasma lipid bp level
MED-1552~dietari lipid blood cholesterol quantit meta analysi metabol ward studi abstract object determin quantit import dietari fatti acid dietari cholesterol blood concentr total low densiti lipoprotein high densiti lipoprotein cholesterol design meta analysi metabol ward studi solid food diet healthi volunt subject num dietari experi median durat num month num group individu result isocalor replac satur fat complex carbohydr num dietari calori result blood total cholesterol fall num se num mmol l low densiti lipoprotein cholesterol fall num num mmol l isocalor replac complex carbohydr polyunsatur fat num dietari calori result total cholesterol fall num num mmol l low densiti lipoprotein cholesterol fall num num mmol l similar replac carbohydr monounsatur fat produc signific effect total low densiti lipoprotein cholesterol avoid num mg day dietari cholesterol decreas blood total cholesterol num num mmol l low densiti lipoprotein cholesterol num num mmol l conclus typic british diet replac num satur fat fat avoid num dietari cholesterol reduc blood total cholesterol num mmol l num reduct low densiti lipoprotein cholesterol
MED-1553~develop action dietari guidanc messag dietari fat case studi pubm ncbi abstract consum concern nutrit awar eat health diet import good health knowledg translat health diet behavior motiv behavior chang effort understand consum attitud nutrit explor altern communic dietari advic languag meaning motiv behavior chang intern food inform council ific conduct qualit research consum focus group regist dietitian telephon interview num num result research present dietari fat case studi find ific research report dietari guidelin advisori committe assist committe develop meaning action ori dietari advic relat dietari fat inclus num dietari guidelin american motiv easi consum implement recommend moder fat intak dietari guidelin choos diet low satur fat cholesterol moder total fat consist communic recommend ific research moder fat messag empow suggest achiev dietari regimen reduc guilt worri food flexibl enjoy desir food promot common sens diet issu emerg ific research appli general nutrit communic consum nation nutrit recommend one on on counsel situat effect messag consum nutrit specif dietari fat address sourc discomfort dietari choic engend sens empower motiv provid clear inform propel action appeal make person choic
MED-1554~reduc modifi dietari fat prevent cardiovascular diseas pubm ncbi abstract background reduct modif dietari fat improv total cholesterol level varieti effect posit negat cardiovascular risk factor object aim systemat review assess effect reduct modif dietari fat total cardiovascular mortal cardiovascular morbid num month random clinic trial search strategi cochran librari medlin embas cab abstract cvrct registri relat cochran group trial regist search spring num sigl januari num trial expert field biographi includ num select criteria trial fulfil criteria num random control group num intent reduc modifi fat cholesterol intak exclud exclus omega num fat intervent num multi factori num healthi adult human num intervent month num mortal cardiovascular morbid data inclus decis duplic disagr resolv discuss parti data collect analysi rate data extract independ review meta analysi perform random effect methodolog meta regress funnel plot main result twenti studi includ num intervent arm num person year signific effect total mortal rate ratio num num ci num num trend protect form cardiovascular mortal rate ratio num num ci num num signific protect cardiovascular event rate ratio num num ci num num non signific sensit analysi trial particip involv num year show signific reduct rate cardiovascular event suggest protect total mortal degre protect cardiovascular event similar high low risk group statist signific reviewer conclus find suggest small potenti import reduct cardiovascular risk trial longer year lifestyl advic high risk cardiovascular diseas statin unavail ration lower risk popul group continu includ perman reduct dietari satur fat partial replac unsatur
MED-1555~diet serum cholesterol correl negat relationship pubm ncbi abstract confound result uncontrol condit epidemiolog observ made suffici undermin valid respect investig relationship diet serum cholesterol paper author show mathemat model refer empir data varianc suffici great effect correl coeffici close expect actual data cross sect studi cross sect design suitabl studi relationship
MED-1556~meta analysi prospect cohort studi evalu associ satur fat cardiovascular diseas abstract background reduct dietari satur fat general thought improv cardiovascular health object object meta analysi summar evid relat associ dietari satur fat risk coronari heart diseas chd stroke cardiovascular diseas cvd chd inclus stroke prospect epidemiolog studi design twenty on studi identifi search medlin embas databas secondari referenc qualifi inclus studi random effect model deriv composit relat risk estim chd stroke cvd result num num follow up num subject num develop chd stroke intak satur fat increas risk chd stroke cvd pool relat risk estim compar extrem quantil satur fat intak num num ci num num num chd num num ci num num num stroke num num ci num num num cvd age sex studi qualiti chang result conclus meta analysi prospect epidemiolog studi show signific evid conclud dietari satur fat increas risk chd cvd data elucid cvd risk influenc specif nutrient replac satur fat
MED-1557~intak fatti acid general popul worldwid meet dietari recommend prevent coronari heart diseas systemat review pubm ncbi abstract aim systemat review data countri popul intak total fat satur fatti acid sfa polyunsatur fatti acid pufa compar recommend food agricultur organ unit nations th world health organ fao who method data nation dietari survey popul studi publish num search medlin web scienc websit nation public health institut result fatti acid intak data num countri includ total fat intak rang num num percent energi intak sfa num num pufa num num intak met recommend total fat num sfa num pufa num num num countri sfa intak correl total fat intak num num pufa intak num num twenty seven countri provid data distribut fatti acid intak num num countri num popul sfa intak num num num countri major popul pufa intak num conclus countri fatti acid intak adult meet level recommend prevent chronic diseas relat sfa pufa intak show lower intak sfa popul accompani higher intak pufa recommend prevent coronari heart diseas
MED-1558~recommend dietari refer intak nutrit goal dietari guidelin fat fatti acid systemat review pubm ncbi abstract dietari fat effect health diseas attract interest research public health num bodi organ publish recommend fat intak paper set recommend analyz systemat review process examin dietari refer intak nutrit goal dietari guidelin fat fatti acid literatur search conduct relev literatur databas search suitabl grey literatur report document includ report inform recommend intak level dietari refer valu nutrit object dietari guidelin fat and or fatti acid and or cholesterol intak report background inform process produc recommend standard approach deriv nutrient recommend recommend vari countri level intak advis process set recommend recommend fat intak share similar figur total fat intak satur fat tran fat set includ recommend cholesterol intak recent document provid advic specif num fatti acid effort develop evid base nutrient recommend dietari guidelin contribut enhanc health gap research desir bodi concern remain transpar develop dietari recommend order achiev type evid select base recommend rank regular updat recommend plan
MED-1559~adher wcrf aicr guidelin cancer prevent lower mortal older femal cancer survivor abstract background num world cancer research fund american institut cancer research wcrf aicr guidelin encourag cancer survivor follow cancer prevent recommend evalu adher wcrf aicr guidelin cancer prevent lower mortal older femal cancer survivor method num num num particip iowa women health studi confirm cancer diagnosi num num complet num follow up questionnair adher score wcrf aicr guidelin bodi weight physic activ diet comput assign num num point recommend depend degre adher all caus num cancer specif num cardiovascular diseas cvd specif mortal num compar total adher score adher score compon recommend result women highest num num lowest num num adher score lower all caus mortal hr num num ci num num meet physic activ recommend lower all caus ptrend num cancer specif ptrend num cvd specif mortal ptrend num adher dietari recommend lower all caus mortal ptrend num adher bodi weight recommend higher all caus mortal ptrend num conclus adher wcrf aicr guidelin lower all caus mortal older femal cancer survivor adher physic activ recommend strongest associ lower all caus disease specif mortal impact older cancer survivor decreas risk death lead healthi lifestyl cancer diagnosi
MED-1560~ideal cardiovascular health invers incid cancer atherosclerosi risk communiti studi abstract background american heart associ aha defin concept ideal cardiovascular health promot num strateg impact goal examin adher ideal level aha cardiovascular health metric incid cancer atherosclerosi risk communiti aric studi num year follow up method result exclus miss data preval cancer num aric particip includ analysi baselin measur classifi particip aha cardiovascular health metric combin cancer incid exclud non melanoma skin cancer num captur cancer registri hospit surveil num incid cancer case occur follow up cox regress calcul hazard ratio incid cancer signific p trend num grade invers associ number ideal cardiovascular health metric baselin cancer incid particip meet goal num ideal health metric num popul num lower risk incid cancer meet goal num ideal health metric smoke remov sum ideal health metric associ attenu particip meet goal num health metric num lower cancer risk meet goal num ideal health metric p trend num conclus adher ideal health metric defin aha num goal lower cancer incid aha continu pursu partnership cancer advocaci group achiev reduct chronic diseas preval
MED-1563~combin effect healthi lifestyl behavior mortal systemat review meta analysi pubm ncbi abstract object lifestyl factor relat mortal impact singl factor current evid combin effect lifestyl behavior mortal systemat compil method search medlin embas global health februari num prospect studi select report combin effect lifestyl factor obes alcohol consumpt smoke diet physic activ effect size number combin lifestyl factor mortal compar group number healthi lifestyl factor meta analysi sensit analys conduct explor robust result result num studi num cohort met inclus criteria num includ meta analysi compris num peopl follow up num year relat risk decreas proportion higher number healthi lifestyl factor mortal combin healthi lifestyl factor reduct mortal risk num confid interv num num conclus adher healthi lifestyl lower risk mortal copyright num publish elsevi
MED-1564~adher wcrf aicr cancer prevent recommend risk post menopaus breast cancer abstract background num world cancer research fund wcrf american institut cancer research aicr releas recommend relat bodi fat physic activ diet aim prevent common cancer worldwid limit inform exist associ meet recommend risk specif cancer includ breast cancer method operation recommend relat bodi fat physic activ food promot weight gain plant food red process meat alcohol examin associ invas breast cancer incid num year follow up vitamin lifestyl vital studi cohort particip includ num post menopaus women age num num year baselin num num histori breast cancer breast cancer num track western washington surveil epidemiolog end result seer databas result breast cancer risk reduc num women met recommend compar met hr num num ci num num ptrend num analys sequenti remov individu recommend reduc risk suggest reduct due meet recommend relat bodi fat plant food alcohol hr meet meet recommend num num ci num num ptrend num conclus meet wcrf aicr cancer prevent recommend specif relat alcohol bodi fat plant food reduc post menopaus breast cancer incid impact increas adher wcrf aicr cancer prevent recommend substanti reduc post menopaus breast cancer risk women
MED-1565~adher world cancer research fund american institut cancer research guidelin risk death europ result europea pubm ncbi abstract background num world cancer research fund wcrf american institut cancer research aicr issu recommend diet physic activ weight manag cancer prevent basi comprehens collect evid object investig concord wcrf aicr recommend relat risk death design current studi includ num particip num european countri enrol european prospect investig cancer nutrit studi recruit num dietari anthropometr lifestyl inform collect wcrf aicr score incorpor num wcrf aicr recommend men bodi fat physic activ food drink promot weight gain plant food anim food alcohol drink score rang num num wcrf aicr recommend women breastfeed score rang num construct higher score greater concord wcrf aicr recommend associ wcrf aicr score risk total cause specif death estim cox regress analysi result median follow up time num num death identifi particip highest categori wcrf aicr score num point men num point women num lower hazard death num ci num num compar particip lowest categori wcrf aicr score num point men num point women signific invers associ observ countri wcrf aicr score signific lower hazard die cancer circulatori diseas respiratori diseas conclus result studi suggest wcrf aicr recommend signific increas longev
MED-1567~cancer incid danish seventh day adventist baptist pubm ncbi abstract introduct american seventh day adventist report lower cancer mortal incid general popul adventist consum tobacco alcohol pork adher lacto ovo vegetarian lifestyl baptist discourag excess alcohol tobacco studi investig incid cancer larg cohort danish adventist baptist compar general danish popul materi method num danish adventist baptist nationwid danish cancer registri inform case cancer num cancer incid cohort compar general danish popul standard incid ratio sir num confid interv cis within cohort comparison made cox model result lower cancer incid observ seventh day adventist men sir num ci num women num num result observ baptist low differ pronounc smoking rel cancer buccal caviti lung sir num num seventh day adventist men num num seventh day adventist women incid lifestyle rel cancer stomach rectum liver cervix decreas general sir lower men women adventist lower hazard rate baptist discuss find point benefit complianc public health recommend lifestyl popul chang cancer risk individu copyright num elsevi reserv
MED-1568~trp channel blame burn cold tropic fish meal abstract embo num num num doi num emboj num publish onlin juli num ciguatera common form food poison occur consumpt fish contamin ciguatoxin work vetter al num reveal key molecular player underli alter temperatur sensat ciguatera show ciguatoxin act sensori neuron express trpa num ion channel implic detect noxious cold
MED-1569~polymyos ciguatera toxin exposur pubm ncbi abstract biopsy prov polymyos subsequ develop patient sever poison ciguatera fish toxin ciguatera toxin mechan action repres toxin patient clinic cours unlikelihood coincid contract diseas suggest causal relationship prove relationship suggest mechan toxin predispos muscl inflamm
MED-1570~ciguatera recent advanc risk remain pubm ncbi abstract ciguatera import form human poison caus consumpt seafood diseas characteris gastrointestin neurolog cardiovascular disturb case sever toxic paralysi coma death occur immun toxin cumul symptom persist month year recur period epidemiolog ciguatera complex central import manag futur marin resourc ciguatera import medic entiti tropic subtrop pacif indian ocean region tropic caribbean reef fish increas export area world health problem diseas under report misdiagnos lipid solubl polyeth toxin ciguatoxin accumul muscl subtrop tropic marin finfish ciguatera ciguatoxin aris biotransform fish polar ciguatoxin gambiertoxin produc gambierdiscus toxicus marin dinoflagel live macroalga attach dead coral toxin metabolit concentr food chain carnivor fish prey smaller herbivor fish human expos end food chain num speci fish vector ciguatoxin general small number speci regular incrimin ciguatera ciguater fish tast smell normal detect toxin fish remain problem num precursor gambiertoxin ciguatoxin identifi toxicus herbivor carnivor fish toxin polar undergo oxid metabol pass food chain main pacif ciguatoxin p ctx num ciguatera level num microg kg flesh carnivor fish main caribbean ciguatoxin c ctx num polar num fold toxic p ctx num ciguatoxin activ sodium ion na channel caus cell membran excit instabl worldwid coral bleach document strong associ global warm bleach death coral natur environment factor earthquak hurrican man mad factor tourism dock construct sewag eutroph creat favour environ toxicus low level toxicus found tropic subtrop water presenc bloom number unpredict patchi genet strain produc ciguatoxin environment trigger increas toxin product unknown
MED-1571~ciguatera union island sw indian ocean epidemiolog clinic pattern pubm ncbi abstract hundr fifty nin ichtyosarcotox outbreak includ num peopl record island union sw indian ocean num num ciguatera outbreak repres num total case annual incid rate estim num num resid symptom caus ciguatera poison report pacif caribbean island addit symptom hallucinatori poison num patient serranida fish includ speci great commerci common incrimin account num outbreak
MED-1572~ciguatera fish poison southern california epidem abstract ciguatera fish poison result bioconcentr varieti toxin produc marin dinoflagel sign symptom vari wide present gastrointestin neurolog complaint begin short ingest fish toxin symptom persist month year case report unit state epidem common tropic subtrop coast involv ingest larg carnivor fish review literatur report epidem num case ciguatera fish poison present area hospit southern california success track depart health servic isol fish caught coast baja california mexico
MED-1573~ciguatera scombroid fish poison unit state pubm ncbi abstract background ciguatera scombroid fish poison common fish rel foodborn ill unit state exist surveil system underestim human health impact object studi aim describ exist data ciguatera scombroid fish poison outbreak poison control center report estim number ciguatera scombroid fish poison ill hospit death unit state method analyz outbreak data foodborn diseas outbreak surveil system fdoss num num poison control center call data nation poison data system npds num num report ciguatera scombroid fish poison statist model input adjust outbreak data undercount due underreport underdiagnosi generat estim underreport underdiagnosi multipli deriv poison control call data publish literatur result annual averag num ciguatera num scombroid fish poison outbreak involv total num num ill person report fdoss num npds report averag num exposur call ciguatoxin num exposur call scombroid fish poison annual num adjust undercount estim num num credibl interv cri num num ciguatera fish poison ill annual result num cri num hospit death num cri num estim num num cri num num scombroid fish poison ill result num cri num hospit num death conclus ciguatera scombroid fish poison affect american report surveil system addit data improv assess estim number ill caus seafood intox illumin public health problem effort includ educ reduc ciguatera scombroid fish poison
MED-1574~crohn disease associ adherent invas escherichia coli adhes enhanc exposur ubiquit dietari polysaccharid maltodextrin abstract crohn diseas cd intestin dysbiosi evidenc alter microbiom form thick biofilm epithelium addit adherent invas coli aiec strain frequent isol ileal lesion cd patient indic potenti role strain diseas pathogenesi composit characterist host microbiom influenc environment factor diet polysaccharid ad food emulsifi stabil bulk agent link bacteria associ intestin disord escal consumpt polysaccharid western diet parallel increas incid cd num centuri studi effect polysaccharid panel adhes cd associ aiec strain lf num analyz determin food addit promot disease associ bacteri phenotyp maltodextrin mdx polysaccharid deriv starch hydrolysi mark enhanc lf num specif biofilm format biofilm format multipl coli strain promot mdx mdx induc coli biofilm format independ polysaccharid chain length indic requir mdx metabol mdx exposur induc type pili express requir mdx enhanc biofilm format mdx increas bacteri adhes human intestin epitheli cell monolay mechan depend type num pili independ cellular receptor ceacam num suggest mechan epitheli cell adhes analysi mucosa associ bacteria individu cd show increas preval malx gene essenti mdx metabol uniqu ileum cd patient find demonstr ubiquit dietari compon mdx enhanc coli adhes suggest mechan western diet rich specif polysaccharid promot dysbiosi gut microb contribut diseas suscept
MED-1575~express distribut claudin num num lead discontinu tight junction barrier dysfunct activ crohn diseas abstract background epitheli barrier function impair crohn diseas aim defin cellular mechan special attent tight junction method biopsi specimen sigmoid colon patient mild moder activ inact crohn diseas studi uss chamber barrier function determin imped analysi conduct scan tight junction structur analys freez fractur electron microscopi tight junction protein investig immunohistochem confoc laser scan microscopi quantifi immunoblot epitheli apoptosi analys termin deoxynucleotidyl transferas mediat deoxyuridin triphosph nick end label num num diamidino num phenylindol stain result patient activ crohn diseas show impair intestin barrier function distinct reduct epitheli resist distribut conduct focal epitheli lesion microeros contribut barrier dysfunct freez fractur electron microscopi analysi show reduc discontinu tight junction strand occludin seal tight junction protein claudin num claudin num downregul redistribut tight junction pore form tight junction protein claudin num strong upregul constitut molecular basi tight junction claudin unchang claudin num num detect sigmoid colon claudin num num num claudin num upregul pronounc activ crohn diseas compar activ ulcer coliti induc tumour necrosi factor sourc impair barrier function epitheli apoptosi distinct increas activ crohn diseas sd num num num num control contrast barrier function tight junction protein apoptosi unaffect crohn diseas remiss conclus upregul pore form claudin num downregul redistribut seal claudin num num lead alter tight junction structur pronounc barrier dysfunct mild moder activ crohn diseas
MED-1576~dietari intak risk develop inflammatori bowel diseas systemat review literatur pubm ncbi abstract object incid inflammatori bowel diseas ibd increas dietari factor spread western diet high fat protein low fruit veget increas studi evalu associ diet ibd risk systemat review method perform systemat review guideline recommend methodolog evalu associ pre il intak nutrient fat carbohydr protein food group fruit veget meat risk subsequ ibd diagnosi elig studi identifi structur keyword search pubm googl scholar manual search result nineteen studi includ encompass num ibd patient num crohn diseas cd num ulcer coliti uc patient num control studi report posit associ high intak satur fat monounsatur fatti acid total polyunsatur fatti acid pufa total omega num fatti acid omega num fatti acid mono disaccharid meat increas subsequ cd risk studi report negat associ dietari fiber fruit subsequ cd risk high intak total fat total pufa omega num fatti acid meat increas risk uc high veget intak decreas risk uc conclus high dietari intak total fat pufa omega num fatti acid meat increas risk cd uc high fiber fruit intak decreas cd risk high veget intak decreas uc risk
MED-1577~treatment rel progress multifoc leukoencephalopathi current understand futur step abstract progress multifoc leukoencephalopathi pml rare demyelin disord brain caus ubiquit polyomavirus jc virus pml immunosuppress acquir immun defici syndrom common predispos disord recent pharmacolog agent demonstr increas risk pml therapi predispos peopl pml classifi categori therapi uniqu increas risk disord monoclon antibodi natalizumab efalizumab therapi increas risk individu risk pml due pre exist condit rituximab mycophenol mofetil therapi mechan action suggest potenti increas pml risk and or rare case pml observ unlik class therapeut agent uniqu increas risk pml greater preval disord latent interv time drug initi develop pml pml develop pharmacolog agent provid insight pathogenesi devast disord review focus risk pml multipl pharmacolog agent propos pathogenesi agent potenti risk mitig strategi
MED-1578~dietari clue pathogenesi crohn diseas pubm ncbi abstract crohn diseas complex inherit disord unknown pathogenesi environment genet microbi factor involv develop diseas remark featur diseas childhood effect respons exclus enter nutrit een therapi complet exclus normal diet requir success principl exclus een dietari intervent act remov dietari compon affect microbi composit decreas proinflammatori respons promot restitut epitheli barrier likewis termin vicious disease form cycl critic threshold reach multipl tradit nontradit dietari compon affect microbiom mucous layer intestin permeabl adher transloc pathobiont review epidemiolog data data anim model cell line propos model pathogenesi term bacteri penetr cycl dietari compon anim fat high sugar intak gliadin consumpt emulsifi maltodextrin low fib diet local acquir bacteri clearanc defect lead bacteri adhes penetr subsequ inflamm gut num karger ag basel
MED-1579~crohn diseas review treatment option current research pubm ncbi abstract crohn diseas autoimmun disord affect num million american etiolog crohn diseas complet understood research suggest genet link cure crohn diseas result government fund research conduct increas qualiti life afflict patient reduc chronic inflamm allevi growth impair pediatr patient number treatment option includ alpha num integrin inhibitor tnf alpha inhibitor research conduct altern treatment option understand cellular mechan induc apoptosi leukocyt requir clinic efficaci review seek chronicl current treatment option patient affect crohn diseas aid understand potenti cellular mechanist requir efficaci drug shed light potenti option futur treatment crown copyright num publish elsevi reserv
MED-1580~transloc crohn diseas escherichia coli m cell contrast effect solubl plant fibr emulsifi abstract background crohn diseas common develop nation typic diet low fibr high process food primari lesion overli peyer patch colon lymphoid follicl bacteri invas m cell occur assess effect solubl non starch polysaccharid nsp food emulsifi transloc escherichia coli m cell method assess effect solubl plant fibr food emulsifi transloc mucosa associ coli isol crohn diseas patient non crohn control m cell monolay generat co cultur caco num cl num raji cell human peyer patch mount uss chamber result coli transloc increas m cell compar parent caco num cl num monocultur num fold iqr num num crohn diseas coli num num fold iqr num num control isol num electron microscopi confirm coli m cell plantain broccoli nsp mark reduc coli transloc m cell num mg ml rang num num inhibit num appl leek nsp signific effect polysorb num num vol vol increas coli transloc caco num cl num monolay num fold num higher concentr increas transloc m cell similar coli transloc human peyer patch reduc num num solubl plantain nsp num mg ml increas num fold polysorb num num vol vol conclus transloc coli m cell reduc solubl plant fibr plantain broccoli increas emulsifi polysorb num effect occur relev concentr contribut impact dietari factor crohn diseas pathogenesi
MED-1581~cure crohn pubm ncbi abstract crohn diseas life long idiopath inflammatori diseas affect entir gastrointestin tract occasion extra intestin organ cd thought result complex interact environment factor gut microb genet background immun system host decad research pathogenet compon mucos immun led develop biolog agent therapeut strategi improv dramat treatment cd cure diseas treatment cd evolv method step integr research compon involv pathogenesi cd holist global approach aid unravel mysteri cd develop agent therapeut strategi target multipl pathogenet pathway stage diseas lead cure copyright num elsevi reserv
MED-1582~prospect studi long term intak dietari fiber risk crohn diseas ulcer coliti abstract background aim increas intak dietari fiber propos reduc risk inflammatori bowel diseas crohn diseas cd ulcer coliti uc prospect studi examin associ long term intak dietari fiber risk incid cd uc method collect analyz data num women num particip nurs health studi num num person i dietari inform prospect ascertain administr valid semi quantit food frequenc questionnair num self report cd uc confirm review medic record cox proport hazard model adjust potenti confound calcul hazard ratio hrs result confirm num incid case cd incid num num person i num case uc incid num num person i compar lowest quintil energy adjust cumul averag intak dietari fiber intak highest quintil median num g day num reduct risk cd multivari hr cd num num confid interv ci num num appar reduct greatest fiber deriv fruit fiber cereal grain legum modifi risk contrast total intak dietari fiber multivari hr num num ci num num intak fiber specif sourc signific risk uc conclus base data nurs health studi long term intak dietari fiber fruit lower risk cd uc studi determin mechan mediat associ
MED-1584~obstetr complic twin pregnanc pubm ncbi abstract advanc assist reproduct technolog increas proport matern older women contribut steep increas incid twin pregnanc num matern perinat complic higher twin singleton pregnanc signific proport perinat mortal morbid twin due high incid preterm deliveri ad complic twin to twin transfus syndrom ttts monochorion twin monochorion twin higher rate perinat mortal dichorion twin greatest risk fetal viabil num week gestat earli diagnosi twin chorion close fetal surveil monochorion twin prompt therapeut intervent tts reduc perinat mortal intrapartum manag hospit set anaesthet neonat facil critic assess mode deliveri led outcom ultrasonographi valuabl tool manag twin pregnanc chapter briefli summaris topic focus recent literatur
MED-1585~effect twin gestat matern morbid pubm ncbi abstract incid twin gestat increas import matern risk carri multipl compar singleton gestat increas risk mother antepartum intrapartum postpartum period pregnanc complic occur twin gestat includ preeclampsia hypertens disord antepartum hospit preterm labor abnorm bleed nutrit defici cesarean deliveri postpartum hemorrhag women carri twin benefit earli educ issu close matern monitor physic therapi session nutrit counsel pregnanc copyright num elsevi reserv
MED-1586~evidence bas care women multipl pregnanc pubm ncbi abstract women multipl pregnanc face greater risk infant women pregnant child pre pregn care focus avoid multipl pregnanc earli prenat care centr determin chorion screen fetal anomali care focus present predict manag preterm birth intrauterin growth restrict optim time mode birth focus current multicentr randomis control trial data trial care women multipl pregnanc limit area care requir better qu inform includ assist reproduct techniqu optim number embryo transfer care diagnosi chorion benefit specialis multipl pregnanc clinic better qu inform requir inform clinic practic women complic multipl pregnanc includ monoamniot twin pregnanc treatment twin to twin transfus syndrom care singl intrauterin fetal death
MED-1587~mechan twin vii effect diet hered human twin rate pubm ncbi abstract object evalu biochem effect diet hered rate monozygot dizygot twin studi design insulin lik growth factor igf found elev cow select demonstr increas twin rate effect agent influenc level igf women examin correl prior histori singleton versus twin birth effect diet consist exclud anim product elev igf content milk consid result vegan women exclud dairi product diet twin rate one fifth vegetarian omnivor conclus result report support propos igf model dizygot twin genotyp favor elev igf diet includ dairi product area growth hormon cattl enhanc chanc multipl pregnanc due ovarian stimul
MED-1588~reduc incid twin triplet pubm ncbi abstract multipl pregnanc rate remain high assist concept misconceiv assumpt transfer embryo maxim pregnanc rate matern morbid sevenfold greater multipl pregnanc singleton perinat mortal rate fourfold higher twin sixfold higher triplet cerebr palsi rate num num twin num triplet pregnanc multipl pregnanc consid advers outcom assist reproduct techniqu primari prevent multipl pregnanc solut overwhelm evid present chapter demonstr limit embryo transfer vitro fertil embryo signific reduc advers matern perinat outcom reduc incid high order multipl pregnanc reduc take home babi rate secondari prevent multifet pregnanc reduct effect accept patient develop blastocyst cultur singl embryo transfer embryo cryopreserv pre implant aneuploidi exclus improv pregnanc rate increas multipl pregnanc
MED-1592~occurr estrogen hormon biosolid anim manur mushroom compost pubm ncbi abstract presenc natur estrogen hormon trace concentr environ report research grow concern due advers effect ecosystem studi municip biosolid poultri manur pm cow manur cm spent mushroom compost smc analyz presenc estrogen hormon num estradiol num estradiol num dihydroequilin estron detect sampl biosolid manur concentr rang num num ng g dri solid num estradiol num estradiol estron detect smc concentr rang num num ng g dri solid desorpt experi simul laboratori deioniz water milli q aqueous phase examin presenc estrogen hormon determin desorpt potenti low desorpt num num estrogen hormon observ municip biosolid smc estim total estrogen contribut solid wast sourc report anim manur pm cm contribut signific load estrogen hormon natur environ
MED-1593~oestrogen level serum urin premenopaus women eat low high amount meat pubm ncbi abstract object base hypothesi high meat diet increas breast cancer risk hormon pathway present analysi compar oestrogen serum urin meat eat status design intervent repeat measur set random soya trial bean num bean num premenopaus healthi women subject bean num particip complet unannounc num dietari recal donat blood urin sampl num year bean num women provid recal sampl num month serum sampl analys oestron oestradiol ria oestrogen metabolit measur urin lc ms semi vegetarian includ women report consum num red meat poultri fish daili pescatarian report consum num meat poultri num fish daili women classifi non vegetarian appli mix model comput least squar vegetarian status adjust potenti confound result age num particip num num sd num num year serum num num pg ml num num num num pg ml num num level lower thirty seven semi vegetarian num non vegetarian sum urinari oestrogen metabolit num num pmol mg creatinin num num proport individu oestrogen pathway differ meat eat status restrict model sampl collect luteal phase strengthen associ conclus limit studi lower level serum oestrogen semi vegetarian non vegetarian confirm larger popul
MED-1594~occurr fate biodegrad estrogen sewag manur pubm ncbi abstract estrogen estron num alpha estradiol num lpha num eta estradiol num eta estriol num natur sex hormon produc human anim addit synthet estrogen num lpha ethinylestradiol ee num contracept purpos compound produc endocrin disrupt live organ nanogram per lit level human anim estrogen excret urin fece reach natur environ discharg sewag treatment plant stp manur dispos unit stps hormon remov depend type treatment process paramet hydraul sludg retent time hormon elimin rate vari num num stps anim import sourc estrogen environ anim produc high concentr hormon end manur typic spread land waste born anim hormon transfer pollut soil purpos review highlight signific health environ pollut estrogen critic review exist knowledg fate remov treatment process relev inform microbi degrad hormon metabol pathway includ
MED-1595~develop lc ms ms method quantifi sex hormon bovin milk influenc pregnanc level pubm ncbi abstract hormon work harmoni bodi status maintain avoid metabol disequilibrium subsequ ill report exogen steroid presenc environ food product influenc develop import ill human endogen steroid hormon food anim origin unavoid occur natur product presenc hormon food connect human health problem bovin milk quantiti hormon concern liquid chromatography tandem mass spectrometri lc ms ms method base hydroxylamin derivatis develop valid quantif sex hormon milk pregnenolon progesteron estron testosteron androstenedion dehydroepiandrosteron dhea method appli real raw milk sampl exist differ milk pregnant non pregn cow statist confirm base revis exist publish data conclud maximum daili intak hormon reach milk ingest dairi product import sourc hormon product anim origin consid intak calcul
MED-1596~oral contracept signific contributor estrogen drink water pubm ncbi abstract recent observ femin aquat anim rais concern estrogen compound water suppli potenti chemic reach drink water public percept frequent attribut femin oral contracept oc wastewat rais concern exposur oc drink water contribut recent rise human reproduct problem paper review literatur sourc estrogen surfac sourc drink water emphasi activ molecul oc includ discuss agricultur industri municip sourc outlin contribut estrogen chemic estrogen waterway estim risk exposur synthet estrogen drink water human health neglig paper recommend strategi understand potenti sourc estrogen compound environ possibl reduc level estrogen chemic water suppli
MED-1597~assess potenti exposur risk estrogen drink water abstract background detect estrogen environ rais concern recent year potenti affect wildlif human object compar exposur prescrib natur occur estrogen drink water exposur natur occur background level estrogen diet children adult independ deriv accept daili intak adi determin drink water intak larger smaller dietari intak adi method pharmaceut assess transport evalu phate model predict concentr estrogen potenti present drink water predict drink water concentr combin default water intak rate estim drink water exposur predict drink water intak compar dietari intak adi present comparison individu estrogen combin estrogen result analysi estim child exposur individu prescrib estrogen drink water num num time lower depend estrogen type exposur background level natur occur estrogen milk child exposur total estrogen drink water prescrib natur occur num time lower exposur milk adult margin exposur moe base total dietari exposur num time smaller children margin safeti moss adult exposur total prescrib estrogen drink water vari num num depend adi moss exposur total estrogen drink water num time lower moss prescrib estrogen depend adi moss young children rang num num total estrogen includ prescrib natur occur sourc drink water conclus consist larg moe moss strong suggest prescrib total estrogen potenti present drink water unit state caus advers effect resid includ sensit subpopul
MED-1598~cigarett smoke toxin deposit surfac implic human health abstract cigarett smoke remain signific health threat smoker nonsmok alik secondhand smoke shs intrins toxic direct inhal smoke recent threat discov thirdhand smoke ths accumul shs surfac age time progress toxic ths potenti health threat children spous smoker worker environ smoke goal studi investig effect ths liver lung skin heal behavior anim model expos ths condit mimic exposur human ths expos mice show alter multipl organ system excret level nnal tobacco specif carcinogen biomark similar found children expos shs ths liver ths lead increas lipid level non alcohol fatti liver diseas precursor cirrhosi cancer potenti contributor cardiovascular diseas lung ths stimul excess collagen product high level inflammatori cytokin suggest propens fibrosi implic inflammation induc diseas chronic obstruct pulmonari diseas asthma wound skin heal ths expos mice characterist poor heal surgic incis observ human smoker behavior test show ths expos mice hyperact data combin emerg behavior problem children expos shs ths suggest prolong exposur signific risk develop sever neurolog disord result provid basi studi toxic effect ths human inform potenti regulatori polici prevent involuntari exposur ths
MED-1599~exposur nitrosamin thirdhand tobacco smoke increas cancer risk non smok pubm ncbi abstract addit passiv inhal non smok children expos residu tobacco smoke gase particl deposit surfac dust thirdhand smoke ths potenti cancer risk pathway exposur high uncertain consid public health polici studi estim time potenti cancer risk age group non dietari ingest dermal exposur carcinogen n nitrosamin tobacco specif nitrosamin tsnas measur hous dust sampl high sensit select analyt approach determin presenc nicotin n nitrosamin tobacco specif nitrosamin forty six settl dust sampl home occupi smoker non smok observ hous dust composit estim cancer risk appli recent offici toxicolog inform calcul cancer risk exposur observ level tsnas earli life stage num num ear exceed upper bound risk recommend usepa num smoker num non smok home maximum risk exposur nitrosamin measur smoker occupi home excess cancer case thousand popul expos result present highlight potenti sever long term consequ ths exposur children give strong evid potenti health risk consid develop futur environment health polici copyright num elsevi reserv
MED-1600~celeri starter cultur advanc natural organ cure process unit state pubm ncbi abstract past num ear ongo develop cure process natur ingredi design meet consum demand regulatori requir natur organ process meat initi process util celeri concentr high nitrat content combin nitrate reduc starter cultur subsequ advanc includ celeri concentr nitrat convert nitrit supplier question develop reduc concentr preserv microbiolog safeti process meat addit advanc result wide varieti ingredi process design provid supplementari antimicrobi effect improv product safeti copyright num elsevi reserv
MED-1601~survey natur convent cure commerci frankfurt ham bacon physio chem characterist affect bacteri growth pubm ncbi abstract natur organ food regul preclud sodium nitrite nitr antimicrobi process meat product processor begun natur nitrate nitrit sourc celeri juice powd sea salt turbinado sugar manufactur natur organ product cure meat characterist sodium nitrit object studi compar physio chem characterist affect clostridium perfringen listeria monocytogen growth natur cure tradit cure commerci frankfurt ham bacon correl specif product characterist pathogen growth vari product pathogen water activ salt concentr product composit moistur protein fat common intrins factor correl pathogen growth product frequent correl trait relat cure reaction cure pigment residu nitrit nitrat signific correl perfringen growth ham product copyright num elsevi reserv
MED-1602~dietari intak nitrat nitrit risk renal cell carcinoma nih aarp diet health studi abstract background nitrat nitrit present food precursor n nitroso compound anim carcinogen potenti human carcinogen prospect investig associ nitrat nitrit intak dietari sourc risk renal cell carcinoma rcc clear cell papillari histolog subtyp nih aarp diet health studi method nitrat nitrit intak estim num item food frequenc questionnair follow up num year identifi num rcc case num clear cell num papillari cell num num particip cox proport hazard regress estim hazard ratio hrs num confid interv cis result individu highest quintil nitrit intak anim sourc compar lowest quintil increas risk total rcc clear cell subtyp hr num num ci num num hr num num ci num num nitrit process meat anim sourc increas clear cell adenocarcinoma risk hr num num ci num num hr num num ci num num found associ nitrit intak plant sourc nitrat intak conclus find suggest nitrit anim sourc increas risk rcc clear cell adenocarcinoma
MED-1603~thirdhand cigarett smoke experiment chamber evid surfac deposit nicotin nitrosamin polycycl aromat hydrocarbon pubm ncbi abstract background grow bodi evid show secondhand cigarett smoke undergo numer chemic releas air adsorb indoor surfac desorb back air undergo chemic age object test effect age concentr polycycl aromat hydrocarbon pah nicotin tobacco specif nitrosamin cigarett smoke method generat sidestream mainstream cigarett smoke smoke machin dilut condit filter air pass num num flow reactor air exchang rate match normal residenti air exchang rate test effect num min age concentr num pah nicotin cotinin tobacco specif nitrosamin measur sorption deposit nicotin cotinin tobacco specif nitrosamin materi flow reactor result observ mass loss num pah num nicotin num n nitrosonornicotin num num methylnitrosamino num num pyridyl num butanon nnk extract cotton cloth expos smoke yield nicotin nnk ratio nnk nicotin expos cloth num fold higher aerosol sampl conclus data suggest major pah nicotin cotinin tobacco specif nitrosamin releas smoke home public place deposit room surfac data give estim potenti accumul carcinogen thirdhand cigarett smoke exposur pah tobacco specif nitrosamin dermal absorpt inhal contamin dust contribut smoking attribut morbid mortal
MED-1604~crucifer veget consumpt risk renal cell carcinoma meta analysi pubm ncbi abstract previous cohort case control studi associ crucifer veget consumpt risk renal cell carcinoma illustr conflict result demonstr potenti associ meta analysi perform elig studi retriev computer search review refer summari relat risk rrs num confid interv ci highest lowest consumpt crucifer veget calcul heterogen public bias evalu stratifi analys perform cohort num case control studi includ signific decreas risk renal cell carcinoma observ crucifer veget consumpt group rr num num ci num num subgroup case control studi rr num num ci num num cohort studi rr num num ci num num heterogen public bias detect studi find support crucifer veget consumpt relat decreas risk renal cell carcinoma limit number studi well design prospect studi research conduct clarifi protect effect crucifer veget renal cell carcinoma potenti mechan
MED-1605~time regul carcinogen tobacco specif nitrosamin cigarett tobacco abstract famili smoke prevent tobacco control act food drug administr power regul tobacco product commentari call regul carcinogen tobacco specif nitrosamin num methylnitrosamino num num pyridyl num butanon nnk nitrosonornicotin nnn cigarett tobacco logic path cancer prevent nnk nnn power carcinogen laboratori anim evalu carcinogen human intern agenc research cancer nnk nnn present tobacco virtual market cigarett level cigarett smoke direct proport amount tobacco nnk metabolit nnal strong carcinogen present urin smoker non smok expos secondhand smoke highest level nnk nnn found product establish factor choic tobacco blend agricultur condit process method influenc level nnk nnn cigarett tobacco cigarett smoke time control factor produc cigarett num ppb nnk nnn tobacco result approxim num fold reduct carcinogen mainstream smoke popular cigarett sold unit state
MED-1606~intak fiber fiber rich plant food lower risk renal cell carcinoma larg cohort abstract background plant bas fiber rich diet high veget fruit grain recommend prevent cancer chronic condit renal cell carcinoma rcc obes hypertens diabet diet play role etiolog rcc direct and or indirect object larg prospect cohort men women comprehens investig dietari intak food sourc fiber relat rcc risk design particip nih aarp diet health studi num complet self administ questionnair demograph diet lifestyl medic histori num year follow up identifi num incid case rcc hrs num cis estim quintil multivari cox proport hazard regress result total dietari fiber intak signific num num lower risk rcc num highest quintil compar lowest p trend num intak legum grain crucifer veget num num reduc risk rcc convers refin grain intak posit rcc risk comparison quintil num quintil num hr num num ci num num p trend num invers associ fiber intak rcc consist particip smoke bodi mass index bmi kg m num report histori diabet hypertens conclus intak fiber fiber rich plant food signific lower risk rcc larg cohort trial regist clinicaltri gov nct num
MED-1607~long term dietari sodium potassium fluid intak explor potenti risk factor renal cell cancer netherland cohort studi diet cancer abstract background sodium potassium fluid intak relat hypertens establish risk factor renal cell cancer rcc independ risk factor rcc method netherland cohort studi nlcs case cohort design includ num num particip age num num year baselin diet lifestyl assess questionnair num year follow up num rcc case num subcohort member analys result sodium intak increas rcc risk p trend num fluid potassium intak high sodium low fluid intak rcc risk addit increas p interact num conclus sodium intak potenti risk factor rcc fluid consumpt low
MED-1609~high carbohydr high fib diet increas peripher insulin sensit healthi young adult pubm ncbi abstract examin extra alimentari effect high carbohydr high fib hcf diet insulin medi glucos dispos employ euglycem clamp hepat glucos output hgo employ num num glucos measur num healthi young individu num hcf diet diet lower fast concentr glucos num num num num mmol l num insulin num num num num pmol l num fast serum cholesterol decreas num num num num mmol l num young individu num num num num mmol l num elder individu fast serum triglycerid concentr basal hgo insulin suppress hgo unchang diet glucos dispos rate increas num num num num mumol kg num min num diet num hcf diet improv carbohydr economi enhanc peripher sensit insulin
MED-1610~pork beef chicken similar effect acut satieti hormon marker appetit pubm ncbi abstract effect meat contain breakfast meal pork beef chicken acut satieti appetit regulatori hormon compar within subject studi design thirti fast non smok pre menopaus women attend research centr test day consum meat contain meal match energi kj protein content palat differ found meat group energi intak macronutri profil food consum subsequ ad libitum buffet lunch rest day visual analogu scale vas rate hunger satieti num min period differ test meal consumpt test meal signific differ found pyy respons pork chicken meal num level cck ghrelin insulin glucos studi posit pork beef chicken equal effect satieti releas appetite rel intestin hormon insulin copyright num elsevi reserv
MED-1611~latest insight risk cancer diabet abstract grow bodi evid observ studi meta analys data suggest diabet mellitus increas risk cancer meta analys shown diabet increas risk total cancer site specif cancer breast endometrium bladder liver colorectum pancrea decreas risk prostat cancer insulin resist secondari hyperinsulinemia frequent propos hypothesi hyperglycemia promot carcinogenesi addit facet lifestyl includ obes smoke lack exercis treatment diabet affect risk cancer instanc metformin insulin sensit report potenti anticanc effect light explod global epidem diabet modest increas cancer risk translat substanti socioeconom burden current insight underscor clinic attent better design studi complex interact diabet cancer
MED-1612~effect protein ingest glucos insulin respons standard oral glucos load pubm ncbi abstract type ii diabet subject num protein num glucos num glucos num protein singl meal random sequenc plasma glucos insulin respons determin subsequ num plasma glucos area baselin glucos meal reduc num protein glucos protein glucos concentr remain stabl num declin insulin area glucos modest greater protein meal num num num microu h ml glucos protein insulin area greater glucos protein num num microu h ml amount protein num glucos insulin area respons essenti order subsequ subject num glucos num glucos num protein meal num random sequenc insulin area signific meal higher protein glucos glucos meal plasma glucos area num meal glucos protein meal plasma glucos area mark reduc num larg meal data protein glucos increas insulin secret reduc plasma glucos rise type ii diabet person
MED-1613~taiwanes vegetarian higher insulin sensit omnivor pubm ncbi abstract present studi design examin effect habitu consumpt taiwanes vegetarian diet hormon secret lipid glycaem control ninety eight healthi femal adult recruit hualien taiwan age num year forty nin buddhist lactovegetarian forty nin omnivor dietari intak measur blood level nutrient hormon analys vegetarian consum energi fat protein fibr omnivor compar omnivor vegetarian averag lower bmi smaller waist circumfer slight lower level thyroxin num vegetarian vegetarian omnivor show similar level triiodothyronin num free num thyroid stimul hormon num num ratio cortisol compar omnivor vegetarian signific lower level fast insulin median num num pmol l plasma glucos num se num num se num mmol l insulin resist calcul homeostasi model assess method signific lower vegetarian omnivor median num num beta cel function group bmi diet independ predictor insulin resist contribut num num variat insulin resist conclus taiwanes vegetarian lower glucos insulin level higher insulin sensit omnivor diet lower bmi partial respons high insulin sensit observ young taiwanes vegetarian
MED-1614~insulin sensit chines ovo lactovegetarian compar omnivor pubm ncbi abstract aim compar insulin sensit indic chines vegetarian omnivor method studi includ num healthi volunt vegetarian num omnivor num normal fast plasma glucos level particip complet insulin suppress test compar steady st plasma glucos sspg fast insulin homeostasi model assess insulin sensit homa ir homa beta cel function homa beta group test correl sspg year vegetarian diet result omnivor subject younger vegetarian num num num num year age num differ group sex blood pressur renal function test lipid profil omnivor higher serum uric acid level vegetarian num num num num mg dl num result indic omnivor vegetarian sspg mean num num num num mg dl num fast insulin num num num num microu ml num homa ir num num num num num homa num num num num num insulin secret index homa beta num num num num num found clear linear relat year vegetarian diet sspg num num conclus vegetarian insulin sensit omnivor counterpart degre insulin sensit correl year vegetarian diet
MED-1615~role diet exercis manag hyperinsulinemia atherosclerot risk factor pubm ncbi abstract hyperinsulinemia hypertens hypertriglyceridemia obes independ risk factor coronari arteri diseas found person studi investig effect intens num week dietari exercis program risk factor group divid diabet patient non insulin depend diabet mellitus niddm num insulin resist person num normal insulin equal num microu ml num normal group small statist signific decreas risk factor patient niddm greatest decreas insulin reduc num num num num microu ml blood pressur num num num num num num mm hg triglycerid num num num num mg dl bodi mass index num num num num kg m num signific weight loss group niddm result decreas bodi mass index num num patient initi overweight overweight end program num num obes bodi mass index greater num kg m num indic normal bodi weight requisit reduct normal risk factor insulin reduc num num num num microu ml insulin resist group num num subject achiev normal fast insulin num microu ml abstract truncat num word
MED-1616~very low carbohydr ketogen diet low fat diet long term weight loss meta analysi randomis control trial pubm ncbi abstract role very low carbohydr ketogen diet vlckd long term manag obes establish present meta analysi aim investig individu assign vlckd diet num carbohydrates d achiev long term bodi weight cardiovascular risk factor manag compar individu assign convent low fat diet lfd restricted energi diet num energi fat august num medlin central sciencedirect scopus lilac scielo clinicaltri gov grey literatur databas search date languag restrict randomis control trial assign adult vlckd lfd num month follow up primari outcom bodyweight secondari outcom tag hdl cholesterol hdl c ldl cholesterol ldl c systol diastol blood pressur glucos insulin hba num c reactiv protein level total thirteen studi met inclusion exclus criteria analysi outcom reveal signific result individu assign vlckd show decreas bodi weight weight differ num num ci num num num kg num patient tag weight differ num num ci num num num mmol l num patient diastol blood pressur weight differ num num ci num num num mmhg num patient increas hdl c weight differ num num ci num num num mmol l num patient ldl c weight differ num num ci num num num mmol l num patient individu assign vlckd achiev greater weight loss assign lfd longterm vlckd altern tool obes
MED-1617~effect num day daniel fast metabol cardiovascular diseas risk factor men women abstract background dietari modif calor restrict multipl effect relat improv metabol cardiovascular health mandat reduct kilocalori well toler individu limit long term applic plan daniel fast wide util fast base biblic book daniel involv num day ad libitum food intak period devoid anim product preserv inclus fruit veget grain legum nut seed purpos present studi determin efficaci daniel fast improv marker metabol cardiovascular diseas risk method num subject num men num women num num yrs rang num yrs complet num day period modifi food intak accord detail guidelin provid investig subject purchas prepar food initi screen subject week prepar fast time report lab pre intervent assess day num num day fast subject report lab post intervent assess day num visit subject report num hr fast state perform strenuous physic activ preced num hrs visit mental physic health sf num form rest heart rate blood pressur anthropometr variabl measur blood collect determin complet blood count metabol panel lipid panel insulin homa ir c reactiv protein crp subject self report complianc mood satieti relat fast record diet record maintain subject num day period immedi prior fast usual intak final num day fast result subject complianc fast num num sem num point scale subject mood satieti num num variabl signific num lower fast compar fast white blood cell count num num num num num num blood urea nitrogen num num num num mg dl num blood urea nitrogen creatinin num num num num protein num num num num dl num total cholesterol num num num num mg dl num ldl c num num num num mg dl num hdl c num num num num mg dl num sbp num num num num mmhg dbp num num num num mmhg insulin num num num num ml num num homa ir num num num num num crp num num num num mg num num lower clinic meaning albeit statist insignific extent signific differ note anthropometr variabl num expect multipl differ dietari intak note num includ reduct total kilocalori intak num num num num conclus num day period modifi dietari intak accord daniel fast num well toler men women num improv risk factor metabol cardiovascular diseas larger scale random studi inclus longer time period possibl slight modif food choic attempt maintain hdl cholesterol extend find
MED-1618~moder increas daili protein intak caus enhanc endogen insulin secret alter circul level urinari excret pubm ncbi abstract studi effect moder increas insulin secret produc increas daili protein intak dehydroepiandrosteron sulfat dhea balanc random crossov trial consist strict control dietari regimen perform healthi male volunt basic diet num protein d diet basic diet enrich num protein d num mmol l methionine d methionin specif nonprotein sourc endogen deriv sulfat control confound effect dhea due increas sulfat suppli end num day diet period blood num hour urin sampl collect fast plasma level testosteron cortisol insulin lik growth factor i igf i insulin urinari output total hot acid cleav testosteron conjug num lpha androstanediol glucuronid show signific respons dietari manipul endogen sulfat avail reflect renal sulfat output num hour approxim doubl diet plasma level num num num num num num micromol l urinari excret num num num num num num micromol d dhea remain unaffect clear increment num urinari c peptid excret diet num num nmol d versus diet num num num num nmol d result suggest moder strong diet induc increas daili insulin secret alter urinari plasma level dhea
MED-1619~evid insulin resist normal weight vegetarian case control studi pubm ncbi abstract background diet rich carbohydr low glycem index high fiber content flat post prandi rise blood glucos minim post prandi insulin secret mainten insulin sensit protect food commod prevent cardiovascular diseas insulin resist syndrom diabet crucial compon vegetarian diet aim studi insulin resist valu assess relat nutrit metabol abnorm predictor age rel diseas pronounc obes subject insulin resist valu normal weight subject nutrit habit correl age method fast concentr glucos insulin calcul valu insulin resist ir homa assess nutrit group appar healthi adult subject age rang num num year normal weight bodi mass index num num kg m num vegetarian group num long term lacto ovo vegetarian durat vegetarian num num year non vegetarian control group num subject general popul tradit western diet intak energi main nutrient fat saccharid protein similar group result glucos insulin concentr ir homa valu signific lower vegetarian glucos num num num num mmol l insulin num num num num mu l ir homa num num num num ir homa depend age signific subject western diet signific increas ir found age rang num year compar vegetarian continu age decad age independ low insulin resist valu vegetarian consequ effect diet prevent long term frequent consumpt protect food vegetarian signific higher consumpt grain product puls product oat barley conclus result age independ low valu insulin resist document benefici effect long term vegetarian nutrit prevent metabol syndrom diabet cardiovascular diseas
MED-1620~num day daniel fast krill oil supplement improv anthropometr paramet cardiometabol profil men women abstract background daniel fast vegan diet prohibit consumpt anim product refin food white flour preserv addit sweeten flavor caffein alcohol dietari plan num day demonstr improv blood pressur ldl c marker oxid stress shown lower hdl c krill oil supplement shown increas hdl c method investig effect daniel fast dietari plan krill oil supplement num g day placebo supplement coconut oil num g day num day subject studi num men num women heterogen respect bodi mass index bmi normal weight overweight obes blood lipid normolipidem hyperlipidem blood glucos normal fast glucos impair fast glucos type num diabet blood pressur normotens hypertens result krill oil supplement effect outcom measur num data krill oil group placebo group collaps analyz examin effect num day daniel fast signific reduct observ ldl c num num mg dl num num mg dl ldl hdl ratio num num num num fast blood glucos num num mg dl num num mg dl fast blood insulin num num u ml num num u ml homeostasi model assess insulin resist homa ir num num num num systol bp num num mm hg num num mm hg bodi weight num num kg num num kg num conclus daniel fast dietari plan improv varieti cardiometabol paramet wide rang individu num day improv unaffect krill oil supplement trial registr clinicaltri govnct num
MED-1621~coffe tea mortal pubm ncbi abstract conflict evid coffe risk coronari diseas coffe tea link major death widespread beverag limit prior studi concern persist cox model ten covari studi relat num person num subsequ death slight increas risk acut myocardi infarct heavier num cups d coffe user relat risk versus nondrink num num confid interv num num num increas risk mortal death relat risk cup coffe day num num confid interv num num relat risk cup tea day num num confid interv num num major adjust analys coffe relat lower risk liver cirrhosi death relat risk cup coffe day num num confid interv num num beverag relat lower risk suicid progress lower higher coffe intak relat risk cup coffe day num num confid interv num num conclud coffe tea relat mortal risk coffe increas coronari risk balanc unexplain lower risk condit notabl cirrhosi suicid
MED-1622~coffe caffein risk complet suicid result num prospect cohort american adult abstract object evalu associ coffe caffein consumpt suicid risk large scal cohort men women method access data num men enrol health profession follow up studi hpfs num num num women nurs health studi nhs num num num women nhs ii num num consumpt caffein coffe decaffein coffe assess year valid food frequ questionnair death suicid determin physician review death certif multivari adjust relat risk rrs estim cox proport hazard model cohort specif rrs pool random effect model result document num death suicid compar consum num cup week caffein coffe num oz num ml pool multivari rr num confid interv ci suicid num num num consum num num cups day num num num consum num cups day trend num pool multivari rr num ci suicid num num num increment num cups day caffein coffe num num num increment num mg day caffein conclus result larg cohort support associ caffein consumpt lower risk suicid
MED-1623~neurolog effect aspartam wide food addit abstract artifici sweeten aspartam l aspartyl l phenylalanyl methyl ester consum primarili beverag larg number american caus signific elev plasma brain phenylalanin level anecdot report suggest peopl suffer neurolog behavior reaction associ aspartam consumpt phenylalanin neurotox affect synthesi inhibitori monoamin neurotransmitt phenylalanin aspartam conceiv mediat neurolog effect mice aspartam dose elev plasma phenylalanin level tyrosin occur aspartam dose human frequenc seizur administr epileptogen drug pentylenetetrazol enhanc effect simul equimolar phenylalanin block concurr administr valin block phenylalanine entri brain aspartam potenti induct seizur inhal fluorothyl electroconvuls shock regul sale food addit modifi requir report advers reaction continu conduct mandat safeti research
MED-1624~direct indirect cellular effect aspartam brain pubm ncbi abstract artifici sweeten aspartam long contempl studi research peopl concern negat effect aspartam compos phenylalanin num aspart acid num methanol num phenylalanin play import role neurotransmitt regul aspart acid thought play role excitatori neurotransmitt central nervous system glutam asparagin glutamin form precursor aspart acid methanol form num broken product convert bodi format excret give rise formaldehyd diketopiperazin carcinogen number high toxic deriv previous report consumpt aspartam neurolog behaviour disturb sensit individu headach insomnia seizur neurolog effect encount accredit region brain concentr catecholamin includ norepinephrin epinephrin dopamin aim studi discuss direct indirect cellular effect aspartam brain propos excess aspartam ingest involv pathogenesi mental disord dsm iv tr num compromis learn emot function
MED-1625~sugar substitut health controversi perceiv benefit abstract sugar insepar part food consum sugar ideal teeth waistlin controversi suggest excess sugar play import role degen diseas artifici sweeten artifici sweeten product continu attract consum sugar substitut artifici sweeten food addit duplic effect sugar tast food energi benefit anim studi convinc proven artifici sweeten weight gain brain tumor bladder cancer health hazard kind health relat side effect includ carcinogen note human larg number studi carri substanc conclus rang safe condit unsaf dose scientist divid view issu artifici sweeten safeti scientif lay public support studi wide referenc oppos result de emphas dismiss review aim explor health controversi perceiv benefit sugar substitut
MED-1626~advers reaction aspartam double blind challeng patient vulner popul pubm ncbi abstract studi design ascertain individu mood disord vulner advers effect aspartam protocol requir recruit num patient unipolar depress similar number individu psychiatr histori project halt institut review board total num individu complet studi sever reaction group patient histori depress crossov design subject receiv aspartam num mg kg day placebo num day small signific differ aspartam placebo number sever symptom patient histori depress individu histori conclud individu mood disord sensit artifici sweeten popul discourag
MED-1627~sweeten beverag coffe tea depress risk older adult abstract sweeten beverag coffe tea consum non alcohol beverag import health consequ prospect evalu consumpt type beverag assess num num relat self report depress diagnosi num num particip nih aarp diet health studi odd ratio num confid interv ci deriv multivari logist regress num ci compar num cans cup day num num ci num num soft drink num num num fruit drink num num num coffe trend num null associ observ iced tea hot tea stratifi analys drinker primarili diet versus regular beverag num num num diet versus num num num regular soft drink num num num diet versus num num num regular fruit drink num num num diet versus num num num regular sweeten iced tea final compar nondrink drink coffe tea sweeten lower risk depress ad artifici sweeten sugar honey higher risk frequent consumpt sweeten beverag diet drink increas depress risk older adult coffe consumpt lower risk
MED-1628~heavi coffe drink risk suicid pubm ncbi abstract earlier research implic coffe drink protect factor suicid followed up num subject num year num suicid commit daili coffe drink j shape associ risk suicid cox model control potenti covari found heavi coffe drinker num cups day risk suicid num higher compar moder drinker
MED-1630~neurobehavior effect aspartam consumpt pubm ncbi abstract widespread artifici sweeten aspartam remain controversi food addit due mix evid neurobehavior effect healthi adult consum study prepar high aspartam diet num mg kg bodi weight day num day low aspartam diet num mg kg bodi weight day num day num week washout diet examin within subject differ cognit depress mood headach measur includ weight food consum aspartam mood depress scale cognit test work memori spatial orient consum high aspartam diet particip irrit mood exhibit depress perform wors spatial orient test aspartam consumpt influenc work memori higher intak level test maximum accept daili intak level num mg kg bodi weight day care warrant consum food product affect neurobehavior health num wiley period
MED-1631~coffe caffein risk depress women abstract background caffein world wide central nervous system stimul num consum form coffe studi analyz prospect relat coffe caffein consumpt depress risk scarc method total num women age num year free depress symptom baselin num prospect num caffein coffe consumpt caffein decaffein beverag obtain valid questionnair complet num num comput cumul averag consumpt num year latenc appli clinic depress defin report physician diagnos depress antidepress relat risk clinic depress estim cox proport hazard regress model result num year follow up num num num incid case depress identifi compar women consum caffein coffe frequent num cup wk multivari relat risk depress num num confid interv ci num num consum num num cups d num num ci num num trend num consum num cups d multivari relat risk depress num num ci num num trend num women highest num mg d lowest num mg d num caffein consumpt categori decaffein coffe depress risk conclus larg longitudin studi found depress risk decreas increas caffein coffe consumpt investig confirm find determin usual caffein coffe consumpt contribut depress prevent
MED-1634~cardiovascular diseas data standard europ pubm ncbi abstract esc creat inventori cardiovascular diseas registri task forc data standard
MED-1635~tea consumpt enhanc endothelial depend vasodil meta analysi abstract background tea consumpt lower risk cardiovascular diseas includ stroke direct effect tea compon vasculatur endothelium part explain associ object perform meta analysi control human intervent studi effect tea flow medi dilat fmd brachial arteri measur endotheli function suggest cardiovascular risk method human intervent studi identifi systemat search databas medlin embas chemic abstract biosi march num hand search relat articl studi select base predefin criteria intervent tea sole experiment variabl placebo control design miss data fmd outcom variabl random effect model calcul pool effect fmd due intak tea impact subject treatment characterist investig presenc heterogen result total num studi research group includ num relev studi arm absolut increas fmd tea placebo num arteri diamet num ci num num p valu num median daili dose num ml tea num num cup relat increas approxim num compar averag fmd num measur placebo baselin condit signific heterogen studi p valu num part explain cuff posit distal proxim area fmd measur indic public bias found conclus moder consumpt tea substanti enhanc endothelial depend vasodil provid mechanist explan reduc risk cardiovascular event stroke observ tea drinker
MED-1636~coffe consumpt serum lipid meta analysi random control clinic trial pubm ncbi abstract coffe drink increas serum cholesterol level studi medlin search english languag literatur publish prior decemb num bibliographi review consult expert perform identifi num publish trial coffe consumpt inform abstract independ review standard protocol random effect model treatment effect estim pool result individu trial weight result invers total varianc dose respons relat coffe consumpt total cholesterol ldl cholesterol identifi num increas serum lipid greater studi patient hyperlipidemia trial caffein boil coffe trial filter coffe demonstr increas serum cholesterol consumpt unfilt filter coffe increas serum level total ldl cholesterol
MED-1637~black tea increas coronari flow veloc reserv healthi male subject pubm ncbi abstract epidemiolog studi suggest tea consumpt decreas risk cardiovascular event clinic report examin effect tea consumpt coronari circul purpos studi evalu effect black tea coronari flow veloc reserv cfvr transthorac doppler echocardiographi ttde double blind crossov studi num healthi male volunt conduct compar effect black tea caffein coronari circul coronari flow veloc left anterior descend coronari arteri measur baselin hyperemia adenosin triphosph infus ttde determin cfvr cfvr ratio defin ratio cfvr beverag consumpt cfvr beverag consumpt data divid num group beverag type group black tea group caffein two way analysi varianc show signific group effect interact cfvr beverag consumpt num cfvr signific increas tea consumpt group num num num num num cfvr ratio group larger group num num num num num acut black tea consumpt improv coronari vessel function determin cfvr
MED-1638~caffein enhanc endotheli repair ampk depend mechan pubm ncbi abstract object migratori capac endotheli progenitor cell epc matur endotheli cell ec key prerequisit endotheli repair denud injuri endotheli damag method result demonstr caffein physiolog relev concentr num num micromol l induc migrat human epc matur ec patient coronari arteri diseas cad caffein coffe increas caffein serum concentr num micromol l num micromol l coincid signific increas migratori activ patient deriv epc decaffein coffe affect caffein serum level migratori capac epc treatment caffein num num day mouse model improv endotheli repair denud carotid arteri enhanc reendotheli caffein signific reduc ampk knockout mice compar wild typ anim transplant wild typ ampk bone marrow wild typ mice reveal differ caffein challeng reendotheli ec deplet mitochondri dna migrat challeng caffein suggest potenti role mitochondria caffeine depend migrat conclus result provid evid caffein enhanc endotheli cell migrat reendotheli part ampk depend mechan suggest benefici role caffein endotheli repair
MED-1639~impact acut caffein ingest endotheli function subject coronari arteri diseas pubm ncbi abstract coffe wide pharmacolog activ beverag impact cardiovascular system controversi explor effect acut caffein ingest brachial arteri flow medi dilat fmd subject coronari arteri diseas cad control patient cad prospect assess brachial arteri fmd num control num age gender match patient document stabl cad num separ morn num week num week overnight fast discontinu medic num hour absenc caffein num hour particip receiv capsul caffein num mg placebo hour drug ingest particip underw brachial arteri fmd nitroglycerin medi dilat ntg high resolut ultrasound expect patient cad diabet hypertens obes dyslipidem smoke control num comparison aspirin clopidogrel angiotensin convert enzym inhibitor blocker statin signific common patient cad control num comparison baselin fmd ntg signific lower patient cad compar control acut caffein ingest signific increas fmd patient cad num num num num control num num num num num comparison ntg patient cad num num num num control num num num num ns comparison signific decreas high sensit c reactiv protein patient cad num num num num mg l control num num num num mg l num comparison num group compar placebo conclus acut caffein ingest signific improv endotheli function assess brachial arteri fmd subject cad lower plasma marker inflamm copyright num elsevi reserv
MED-1640~effect coffe endotheli function healthi subject role caffein pubm ncbi abstract coffe wide pharmacolog activ beverag present studi design evalu acut effect coffe ingest endotheli function healthi individu potenti role caffein studi num healthi young adult num num year men regular non heavi coffe drinker endotheli perform estim endothelium depend fmd flow medi dilat brachial arteri num num num min ingest cup caffein coffe num mg caffein decaffein beverag num mg caffein separ session random single blind cross ov design differ baselin fmd valu session num compar num caffein decaffein coffe ns signific caffein coffe led declin fmd num num num num num baselin num num num min num advers effect focus num num num min num signific effect fmd found decaffein coffe session num num num num num ns composit effect type coffe consum time fmd signific num conclus coffe exert acut unfavour effect endotheli function healthi adult num intak effect attribut caffein decaffein coffe chang endotheli perform
MED-1641~caffein impair myocardi blood flow respons physic exercis patient coronari arteri diseas age match control abstract background caffein wide consum pharmacolog activ substanc acut effect myocardi blood flow wide unknown aim assess acut effect caffein dose cup coffe myocardi blood flow mbf coronari arteri diseas cad methodology princip find mbf measur num label num positron emiss tomographi pet rest supin bicycl exercis control num age num num year cad patient num age num num year region mbf assess segment subtend stenot remot coronari arteri measur repeat fifti minut oral caffein ingest num mg myocardi perfus reserv mpr calcul ratio mbf bicycl stress divid mbf rest rest mbf affect caffein group exercise induc mbf respons decreas signific caffein control num num num num num remot num num num num num stenot segment num num num num num caffein decreas mpr signific num control num baselin cad patient mpr decreas num num baselin remot num stenot segment num baselin conclus conclud caffein impair exercise induc hyperaem mbf respons patient cad greater degre age match control
MED-1642~dose depend effect decaffein coffe endotheli function healthi subject pubm ncbi abstract background object coffe antioxid substanc effect blunt caffein unfavor affect cardiovascular system studi design investig acut dose depend effect decaffein coffe dc endotheli function measur brachial arteri flow medi dilat fmd subjects method total num men num women healthi nonobes subject underw single blind crossov studi subject ingest cup decaffein italian espresso coffe random order num num day interv result hour ingest cup dc fmd increas mean num min num num num min num num num min num num num compar consumpt cup dc num min num num num min num num num min num num num num repeated measur analysi varianc num time treatment effect blood pressur differ group basal heart rate lower two cup group baselin num min conclus present studi demonstr signific acut favor dose depend effect decaffein espresso coffe endotheli function studi investig effect chronic dc respect caffein coffe subject cardiovascular diseas
MED-1643~glass red wine improv endotheli function pubm ncbi abstract aim examin acut effect red wine de alcohol red wine endotheli function method result high frequenc ultrasound measur blood flow percentag brachial arteri dilat reactiv hyperaemia induc forearm cuff occlus num healthi subject num year age cardiovascular risk factor subject drank num ml red wine alcohol num min random procedur brachial arteri dilat measur num num min subject finish drink subject studi time week studi cross ov design red wine alcohol rest brachial arteri diamet rest blood flow heart rate plasma ethanol increas signific de alcohol red wine paramet unchang flow medi dilat brachial arteri signific higher num drink de alcohol red wine num num drink red wine alcohol num num drink num num conclus ingest red wine alcohol brachial arteri dilat blood flow increas observ de alcohol red wine attribut ethanol haemodynam conceal effect flow medi brachial arteri dilat increas drink red wine alcohol flow medi dilat brachial arteri increas signific de alcohol red wine find support hypothesi antioxid qualiti red wine ethanol protect cardiovascular diseas copyright num european societi cardiolog
MED-1645~acut effect green tea consumpt endotheli function healthi individu pubm ncbi abstract background tea consumpt decreas cardiovascular risk flow medi dilat fmd brachial arteri relat coronari endotheli function independ predictor cardiovascular risk black tea benefici effect endotheli function effect green tea brachial arteri reactiv defin design method studi num healthi individu age num num year cardiovascular risk factor smoke num separ occas num green tea num mg caffein amount num tea hot water fmd brachial arteri measur intervent num num min afterward high sensit c reactiv protein interleukin num il num num il num total plasma antioxid capac total plasma oxid status stress measur baselin num min intervent result rest hyperem brachial arteri diamet chang tea caffein fmd increas signific tea num peak num min num chang signific caffein increas num peak num min p ns tea caffein effect high sensit c reactiv protein il num il num total plasma antioxid capac total plasma oxid status stress conclus green tea consumpt acut benefici effect endotheli function assess fmd brachial arteri healthi individu involv benefici effect tea cardiovascular risk
MED-1646~propos guidanc system beverag consumpt unit state pubm ncbi abstract beverag guidanc panel assembl provid guidanc relat health nutrit benefit risk beverag categori beverag panel initi author panel purpos attempt systemat review literatur beverag health provid guidanc consum addit purpos panel develop deeper dialog scientif communiti beverag consumpt pattern unit state great potenti chang pattern improv health past decad level overweight obes increas popul group unit state concurr increas daili intak num kcal age sex group occur approxim num increas calori consumpt calor sweeten beverag panel rank beverag lowest highest base calor nutrient content relat health benefit risk drink water rank prefer beverag fulfil daili water decreas tea coffe low fat num num skim nonfat milk soy beverag noncalor sweeten beverag beverag nutrit benefit fruit veget juic milk alcohol sport drink calor sweeten nutrient poor beverag panel recommend consumpt beverag calori preced consumpt beverag calori
MED-1647~short long term black tea consumpt revers endotheli dysfunct patient coronari arteri diseas pubm ncbi abstract background epidemiolog studi suggest tea consumpt decreas cardiovascular risk mechan benefit remain undefin endotheli dysfunct coronari arteri diseas increas oxid stress antioxid shown revers endotheli dysfunct tea antioxid flavonoid method result test hypothesi tea consumpt revers endotheli dysfunct random num patient proven coronari arteri diseas consum black tea water crossov design short term effect examin num hour consumpt num ml tea water long term effect examin consumpt num ml tea water daili num week vasomotor function brachial arteri examin baselin intervent vascular ultrasound fifti patient complet protocol technic suitabl ultrasound measur short long term tea consumpt improv endothelium depend flow medi dilat brachial arteri consumpt water effect num repeated measur anova tea consumpt effect endothelium independ nitroglycerin induc dilat equival oral dose caffein num mg short term effect flow medi dilat plasma flavonoid increas short long term tea consumpt conclus short long term black tea consumpt revers endotheli vasomotor dysfunct patient coronari arteri diseas find part explain associ tea intak decreas cardiovascular diseas event
MED-1648~coffe endotheli function battl caffein antioxid pubm ncbi abstract coffe larg consum adult western countri controversi exist impact cardiovascular system recent demonstr caffein decaffein espresso coffe acut effect endotheli function healthi subject measur flow medi dilat fmd brachial arteri studi measur anti oxid capac coffe substanc term free stabl radic num diphenyl num picryl hydrazyl num inhibit num dpph caffein coffe slight higher anti oxid capac decaffein espresso coffe num dpph num num num num num suggest unfavour effect observ caffein coffe ingest due caffein antioxid activ respons increas fmd observ decaffein coffe ingest clinic epidemiolog studi understand chronic effect coffe consumpt health
MED-1649~consumpt boil greek type coffe improv endotheli function ikaria studi pubm ncbi abstract object associ coffe consumpt cardiovascular diseas remain controversi endotheli function cardiovascular risk examin associ chronic coffe consumpt endothelium function elder inhabit island ikaria method analysi conduct num elder subject age num year ikaria studi endotheli function evalu ultrasound measur flow medi dilat fmd coffe consumpt evalu base food frequenc questionnair categor low num ml day moder num ml day high num ml day result subject includ studi num consum boil greek type coffe num low num moder num high daili coffe consumpt linear increas fmd coffe consumpt low num num moder num num high num num num subject consum boil greek type coffe signific higher fmd compar consum type coffe beverag num conclus chronic coffe consumpt improv endotheli function elder subject provid connect nutrit vascular health
MED-1650~tobacco obes epidem short abstract campaign promot healthi eat undermin ubiqu process energi dens food global strategi tackl rise preval obes
MED-1651~bodi weight status cardiovascular risk factor adult frequenc candi consumpt abstract background limit inform impact candi consumpt health purpos studi investig associ typic frequenc candi consumpt bodi weight status select cardiovascular risk factor adult unit state method data collect num num nation health nutrit examin survey nhane adult categor infrequ num eat occas eo  month moder num eo month num eo week frequent num eo week candi consum base combin frequenc chocol candi consumpt previous num month weight adipos status analyz logist regress model blood pressur lipid insulin sensit analyz linear regress model model adjust age sex race ethn addit covari potenti associ outcom statist weight yield result generaliz popul result frequenc candi consumpt risk obes overweight obes elev waist circumfer elev skinfold thick blood pressur low densiti lipoprotein ldl high densiti lipoprotein hdl cholesterol triglycerid insulin resist increas frequenc candi consumpt higher energi intak higher energi adjust intak carbohydr total sugar ad sugar total fat satur fatti acid monounsatur fatti acid num lower adjust intak protein cholesterol num conclus increas frequenc candi consumpt adult unit state object measur adipos select cardiovascular risk factor dietari differ cross sect studi design conclud candi consumpt obes untoward level cardiovascular risk marker lack associ frequenc candi consumpt cardiovascular risk factor due reduc intak candi overweight due diet health profession recommend addit import note analysi base frequenc candi consumpt amount candi consum longitudin studi confirm lack associ frequenc candi consumpt cardiovascular risk factor
MED-1655~archaeolog dig rice fruit diet revers ecg hypertens pubm ncbi abstract num young german refuge physician scientist duke univers durham north carolina began treat patient acceler malign hypertens radic diet consist white rice fruit strike favor result report rapid reduct blood pressur rapid improv renal failur papilledema congest heart failur manifest previous fatal ill treatment base theori kidney excretori metabol function remov sodium protein burden organ enabl regain normal abil perform import metabol function effect ordinari hypertens absenc dramat vasculopathi acceler form result dramat experienc physician suspect falsifi data result normal ecg hypertens paper review publish experi radic therapi controversi rise fame declin popular advent effect antihypertens drug featur ecg fatal diseas revers rice diet treatment difficult patient produc effect make equal superior current multi drug treatment hypertens poor import observ patient follow regim slowli guid gradual modif diet month transit toler low fat larg vegetarian diet lead normal activ life medic indic diseas state perman modifi copyright num elsevi reserv
MED-1656~preval low back pain children adolesc meta analysi abstract background low back pain lbp common children adolesc public health concern recent year increas research studi examin preval lbp popul studi exhibit great variabl preval rate report purpos research examin meta analyt investig preval rate lbp children adolesc method studi locat computer databas isi web knowledg medlin pedro ime lilac cinahl sourc search period extend april num includ meta analysi studi report preval rate point period lifetim preval lbp children and or adolesc num year independ research code moder variabl studi extract preval rate separ meta analys carri type preval order avoid depend problem meta analysi random effect model assum carri statist analys result total num articl fulfil select criteria point preval obtain num studi num num ci num num period preval num month obtain num studi num num ci num num period preval week obtain studi num num ci num num lifetim preval obtain num studi num num ci num num lifetim preval exhibit posit statist signific relationship age particip sampl public year studi conclus recent studi show higher preval rate oldest studi methodolog exhibit higher lifetim preval rate studi methodolog poor futur studi report inform definit lbp improv methodolog qualiti studi
MED-1657~preval stenot arteri suppli lumbar spine postmortem angiograph studi num subject abstract object studi preval arteri diseas arteri suppli lumbar spine relat vascular diseas chronic low back pain method pair lumbar arteri middl sacral arteri evalu num postmortem aortogram perform connect routin medicoleg necropsi subject rang num num year age inform low back pain histori close relat deceas interview week necropsi result twenti num men num women occlud arteri addit num num men num num women narrow arteri age men occlud narrow arteri num year women num year stenot orific part arteri middl sacral arteri affect fourth lumbar arteri number collater arteri increas occlud num narrow arteri num stenot lumbar middl sacral arteri found averag year earlier atherosclerosi coronari arteri subject occluded narrow arteri num time suffer chronic month longer low back pain time life find odd ratio adjust age sex num num confid interv num num num conclus studi show lumbar middl sacral arteri frequent obliter atheromat lesion adult life obliter arteri common subject histori chronic back pain
MED-1658~correl diffus lumbar intervertebr disk occlus lumbar arteri studi adult volunt pubm ncbi abstract purpos evalu correl diffus valu lumbar intervertebr disk lumbar arteri status degre disk degener materi method sagitt num weight imag lumbar spine obtain num asymptomat volunt age num year appar diffus coeffici adc num lumbar intervertebr disk determin two dimension time of flight magnet reson angiographi perform num lumbar arteri pair total arteri num degre disk degener status lumbar arteri evalu independ radiologist adc calcul perform basi averag signal intens select region interest lumbar disk associ adc valu disk disk degener status lumbar arteri level analyz analysi covari pairwis analysi group scheff post hoc multipl comparison perform statist softwar valu num consid signific result lumbar arteri status correl strong diffus valu intervertebr disk adc valu decreas higher degre arteri narrow correl disk degener diffus signific sever degener disk normal lumbar arteri status diffus valu found conclus impair flow lumbar arteri signific decreas diffus lumbar disk play import role disk degener
MED-1659~classif age rel lumbar intervertebr disc num volvo award basic scienc pubm ncbi abstract studi design histolog studi age rel human lumbar intervertebr disc conduct object investig comprehens age rel temporospati histolog human lumbar intervertebr disc develop practic reliabl classif system age rel histolog disc alter summari background data comprehens microscop analysi age rel disc conceptu morpholog framework classifi age rel disc refer basi sophist molecular biolog analys causat factor disc age prematur age degener method total num complet sagitt lumbar motion segment slice obtain num deceas individu fetal num year age analyz regard num histolog variabl intervertebr disc endplat addit num surgic specimen num region investig regard histolog variabl base semiquantit analys num histolog variabl assess classif system develop test term valid practic reliabl classif system appli cadaver surgic disc specimen includ develop classif system score assess addit independ rater result semiquantit analys provid clear histolog evid detriment effect diminish blood suppli endplat result tissu breakdown begin nucleus pulposus start life decad signific temporospati variat presenc abund histolog disc alter observ level region macroscop degener grade age group practic classif system age rel histolog disc alter develop result moder excel reliabl kappa valu num num depend histolog variabl applic classif system cadaver surgic specimen demonstr signific correl age num macroscop grade degener num substanti data scatter caution relianc tradit macroscop disc grade favor histology bas classif system refer standard conclus histolog disc alter reliabl grade base propos classif system provid morpholog framework sophist molecular biolog analys factor lead age rel disc diminish blood suppli intervertebr disc half life decad initi tissu breakdown
MED-1660~serum lipid relat sciatica finn pubm ncbi abstract object atherosclerosi arteri suppli lumbar region suggest mechan lead intervertebr disc degener sciatica studi examin serum lipid level pharmacolog treat hyperlipidemia sciatica method nation repres sampl num finn age num year interview examin sciatica assess physician preset criteria inform present purpos num sampl result preval sciatica num men num women men hyperlipidemia treatment sciatica total cholesterol high low tertil num num ci num num ldl cholesterol num num num triglycerid num num num adjust age bmi exercis smoke heavi physic work educ hdl sciatica men highest tertil total cholesterol triglycerid sciatica num num num comparison men cholesterol lowest tertil triglycerid lowest middl tertil similar analys women associ pharmacolog treat hyperlipidemia sciatica women num num num men num num num conclus independ bmi confound clinic assess sciatica men level atherogen serum lipid pharmacolog treat hyperlipidemia sciatica women find accord atherosclerosis sciatica hypothesi
MED-1661~lumbar disc degener correl age sex spine level num autopsi specimen pubm ncbi abstract data num publish report author correl macroscop disc degener grade age sex spine level num lumbar intervertebr disc num cadav age num year male disc degener femal disc age signific sixth seventh decad averag num num num num level disc show degener disc lumbar level macroscop find corrobor radiograph data epidemiolog studi calcul suggest higher mechan stress combin longer nutrit pathway respons earlier degener male disc
MED-1663~mr aortographi serum cholesterol level patient long term nonspecif lower back pain pubm ncbi abstract studi design cross sect analysi feed arteri lumbar spine cholesterol level patient long term nonspecif lower back pain object evalu occlus lumbar middl sacral arteri serum cholesterol level lower back pain and or disc degener summari background data atherosclerosi wall abdomin aorta develop ostia branch arteri bifurc obliter orific lumbar middl sacral arteri obstruct arteri ischemia lumbar spine result back symptom disc degener method mr aortographi cholesterol blood test perform num patient long term lower back pain specif find spinal nerv root compress regular lumbar mr imag patient rang num num year age age num year serum cholesterol low dens lipoprotein ldl cholesterol level measur assess symptom disabl nass low back outcom instrument result twenty nin num num men num num women show occlud lumbar and or middl sacral arteri preval occlud arteri num time subject age group finnish necropsi materi twenty thre num men num women signific disc degener disc degener occlud lumbar middl sacral arteri num patient occlud arteri signific disc degener complain sever symptom patient normal serum ldl cholesterol score higher neurogen symptom num complain sever pain num normal ldl cholesterol conclus studi lumbar middl sacral arteri occlud patient nonspecif long term lower back pain occlus arteri disc degener
MED-1664~degener intervertebr disc abstract intervertebr disc cartilagin structur resembl articular cartilag biochemistri morpholog show degen age earlier connect tissu bodi believ import clinic associ disc degener back pain current treatment predomin conserv common surgic case clear diagnosi therapi consid inadequ develop genet biolog approach diagnosi treatment futur
MED-1665~symptomat disc herniat serum lipid level abstract insuffici blood suppli intervertebr disc ivd propos play role causat factor ivd degener associ ivd diseas increas risk die ischaem heart diseas obes tobacco potenti risk factor degen ivd diseas high blood cholesterol triglycerid serum level risk factor atherosclerosi respons decreas blood suppli poor vascular ivd perform frequency match case control studi determin serum level patient symptomat herniat lumbar disc examin fast serum lipid level num subject oper institut group num includ num consecut patient num men num women age num year rang num num underw surgeri symptomat disc herniat group num control group includ num patient num men num women age num year rang num num underw arthroscop meniscectomi menisc tear period patient frequency match age num year gender patient group num sera extract blood sampl concentr total cholesterol tc triglycerid tg determin compar group patient symptomat herniat lumbar disc show statist signific higher triglycerid concentr num total cholesterol concentr num serum lipid level risk factor ivd patholog enhanc understand factor hold promis approach prevent manag ivd patholog
MED-1666~nutrit intervertebr disc pubm ncbi abstract studi design review literatur disc nutrit object summar inform disc nutrit relat disc degener summari background data disc avascular disc cell depend diffus blood vessel disc margin suppli nutrient essenti cellular activ viabil remov metabol wast lactic acid nutrient suppli fail due blood suppli sclerosi subchondr bone endplat calcif block transport blood suppli disc due cellular demand method review studi disc blood suppli solut transport studi solut transport anim human disc vitro theoret model studi examin factor affect disc nutrit result small nutrient oxygen glucos suppli disc cell virtual diffus convect transport aris load induc fluid movement disc virtual direct influenc transport nutrient steep concentr gradient oxygen glucos lactic acid disc oxygen glucos concentr lowest center nucleus lactic acid concentr greatest actual level concentr depend balanc diffus transport cellular demand fall critic level endplat calcifi nutrit demand increas conclus loss nutrient suppli lead cell death loss matrix product increas matrix degrad disc degener
MED-1667~non specif low back pain pubm ncbi abstract non specif low back pain major public health problem worldwid lifetim preval low back pain report high num preval chronic low back pain num num popul disabl low back pain mechan factor lift carri major pathogen role genet constitut import histori clinic examin includ diagnost guidelin clinic imag diagnosi restrict mechan action treatment unclear effect size treatment low patient prefer clinic evid account pain manag general self manag support recommend surgeri overtreat avoid copyright num elsevi reserv
MED-1668~review postcontrast mri studi diffus human lumbar disc pubm ncbi abstract diffus sourc nutrit intervertebr disc alter diffus consid final common pathway disc degener diffus remain poor understood due pauciti reliabl method studi diffus noninvas human vivo recent year postcontrast mri emerg power reliabl tool analyz diffus lumbar disc noninvas safe document process diffus tempor period num hour well design studi shown diffus slow process endplat main structur control process diffus contrast mri studi made identifi endplat break vivo futur techniqu appli studi influenc smoke mechan load disc abnorm postur atherosclerosi lumbar arteri diffus condit implic disc degener final common pathway alter diffus decreas nutrit review articl focus current knowledg methodolog factor influenc diffus properti disc futur applic promis techniqu num wiley liss
MED-1669~effect energy restrict diet low fructos diet versus moder natur fructos diet weight loss metabol syndrom param pubm ncbi abstract propos obes metabol syndrom excess intak product ad sugar fructos abil excess intak fructos induc metabol syndrom mount date studi address diet specif lower fructos total carbohydr reduc featur metabol syndrom total num patient random compar short term effect num energy restrict diets a low fructos diet moder natur fructos diet on weight loss metabol syndrom paramet patient random receiv num num cal diet sex age height natur fructos differ absorb compar fructos ad sugar random obes subject low fructos diet num g d moderate fructos diet natur fruit supplement num g d compar effect diet primari outcom weight loss num week follow up period blood pressur lipid profil serum glucos insulin resist uric acid solubl intercellular adhes molecul num qualiti life score includ secondari outcom hundr num num particip women age num num year bodi mass index num num kg m num intervent diet signific weight loss compar baselin weight loss higher moder natur fructos group num num kg low fructos group num num kg num compar baselin intervent diet signific improv secondari outcom reduct energi ad fructos intak repres import therapeut target reduc frequenc obes diabet weight loss achiev energy restrict moder natur fructos diet superior low fructos diet copyright num elsevi reserv
MED-1670~polyphenol phenol acid strawberri appl decreas glucos uptak transport human intestin caco num cell pubm ncbi abstract effect polyphenol phenol acid tannin ppts strawberri appl uptak apic basolater transport glucos investig caco num intestin cell monolay substanti inhibit uptak transport observ extract strawberri appl sodium contain glucos transport sglt num glut num activ sodium fre glut num activ condit show inhibit glut num greater sglt num extract analyz constitu ppts test quercetin num o rhamnosid ic num phloridzin ic num num caffeoylquin acid ic num contribut num num inhibitori activ appl extract pelargonidin num o glucosid ic num contribut num total inhibit strawberri extract strawberri extract inhibit transport non competit base kinet analysi inhibit cellular uptak mixed typ inhibit max appar result assay show ppts inhibit glucos transport intestin lumen cell glut num facilit exit basolater side copyright num wiley vch verlag gmbh kgaa weinheim
MED-1671~postprandi glucos insulin free fatti acid respons sucros consum blackcurr lingonberri healthi women pubm ncbi abstract background sucros induc high postprandi glucos insulin respons vitro studi suggest berri reduc digest absorpt sucros suppress postprandi glycemia evid human limit object investig effect sucros ingest blackcurr ribe nigrum lingonberri vaccinium vitis idaea postprandi glucos insulin free fatti acid respons design twenti healthi women particip random control crossov meal studi consum blackcurr lingonberri num serv pur es blackcurr lingonberri nectar num ml num ad sucros sucros num num ml water refer blood sampl collect num num num num min result comparison sucros ingest sucros berri result reduc glucos insulin concentr num min slower declin hour signific improv glycem profil berri prevent sucrose induc late postprandi hypoglycem respons compensatori free fatti acid rebound similar effect observ sucros consum berri nectar improv respons evid higher content carbohydr berri nectar meal natur sugar present berri conclus blackcurr lingonberri berri nectar optim postprandi metabol respons sucros respons consist delay digest sucros consequ slower absorpt glucos
MED-1672~sugar uric acid etiolog diabet obes abstract intak ad sugar tabl sugar sucros high fructos corn syrup increas dramat hundr year correl close rise obes metabol syndrom diabet fructos major compon ad sugar distinct sugar abil intracellular atp deplet nucleotid turnov generat uric acid articl revisit hypothesi uniqu aspect fructos metabol account fructos intak increas risk metabol syndrom recent studi show fructose induc uric acid generat mitochondri oxid stress stimul fat accumul independ excess calor intak studi challeng long stand dogma calori calori suggest metabol effect food matter energi content discoveri fructose medi generat uric acid causal role diabet obes insight pathogenesi therapi import diseas
MED-1673~dietari polyphenol decreas glucos uptak human intestin caco num cell pubm ncbi abstract effect class dietari polyphenol intestin glucos uptak investig polaris caco num intestin cell glucos uptak cell sodium depend condit inhibit flavonoid glycosid non glycosyl polyphenol aglycon phenol acid effect sodium fre condit aglycon non glycosyl polyphenol inhibit glucos uptak glycosid phenol acid ineffect data suggest aglycon inhibit facilit glucos uptak glycosid inhibit activ transport glucos non glycosyl dietari polyphenol exert effect steric hindranc epigallochatechingal epichatechingal epigallochatechin effect transport
MED-1674~fructos alcohol buzz abstract atkin diet tradit japanes diet common atkin diet low carbohydr high fat japanes diet high carbohydr low fat work promot weight loss common diet elimin monosaccharid fructos sucros tabl sugar synthet sister high fructos corn syrup consist num molecul glucos fructos glucos molecul polymer form starch high glycem index generat insulin respons sweet fructos found fruit generat insulin respons sweet fructos consumpt increas worldwid parallel obes chronic metabol diseas pandem sugar fructose contain mixtur vilifi nutritionist age sourc empti calori empti calori fructos unlik glucos hypercalor glycogen replet state intermediari metabolit fructos metabol overwhelm hepat mitochondri capac promot de novo lipogenesi lead hepat insulin resist drive chronic metabol diseas fructos promot reactiv oxygen speci format lead cellular dysfunct age promot brain reward system drive excess consumpt fructos exert detriment health effect calori mimic ethanol metabol cousin distinct fructos metabol central nervous system exert acut neuron depress experienc imbib ethanol metabol hedon analog argu fructos thought alcohol buzz
MED-1675~industri fruit fructos intak sever liver fibrosi genotyp num chronic hepat patient pubm ncbi abstract background aim unhealthi food intak specif fructos metabol alter sever liver fibrosi patient non alcohol fatti liver diseas cohort patient genotyp num chronic hepat num chc test associ fructos intak sever liver histolog method anthropometr metabol factor includ waist circumfer wc waist to hip ratio whr dorso cerv lipohypertrophi homa assess num consecut biopsy proven num chc patient food intak industri fruit fructos investig three day structur interview comput databas biopsi score experienc pathologist stage grade scheuer classif grade steatosi consid moderate sever num featur non alcohol steatohepat nash chc assess bedossa classif result daili intak total industri fruit fructos num num num num num num intak industri fruit fructos independ higher whr num hypercalor diet num chc patient sever liver fibrosi num report signific higher intak total num num num num g day num industri fructos num num num num num fruit fructos num num num num num multivari logist regress analysi show older age num num ci num num num sever necroinflammatori activ num num ci num num num moderate sever steatosi num num ci num num num industri fructos intak num num ci num num num independ link sever fibrosi associ found fructos intak liver necroinflammatori activ steatosi featur nash conclus daili intak industri fruit fructos risk factor metabol alter sever liver fibrosi patient num chc copyright num european associ studi liver publish elsevi reserv
MED-1676~berri reduc postprandi insulin respons wheat rye bread healthi women pubm ncbi abstract starch white wheat bread wb induc high postprandi glucos insulin respons rye bread rb glucos respons similar insulin respons lower vitro studi suggest polyphenol rich berri reduc digest absorpt starch suppress postprandi glycemia evid human limit investig effect berri consum wb rb postprandi glucos insulin respons healthi femal num particip num random control crossov num meal studi consum wb rb equal num starch num whole berri pur amount bread berri refer studi num wb serv strawberri bilberri lingonberri studi num raspberri cloudberri chokeberri studi num wb rb serv mixtur berri consist equal amount strawberri bilberri cranberri blackcurr strawberri bilberri lingonberri chokeberri consum wb berri mixtur consum wb rb signific reduc postprandi insulin respons strawberri num berri mixtur wb num rb num signific improv glycem profil bread result suggest wb consum berri insulin mainten normal slight improv postprandi glucos metabol lower insulin respons rb compar wb reduc berri
MED-1677~primari prevent stroke healthi lifestyl abstract background combin healthi lifestyl factor lower risk coronari heart diseas diabet total cardiovascular diseas impact multipl lifestyl factor risk stroke method result conduct prospect cohort studi num men health profession follow up studi num women nurs health studi diet lifestyl factor updat self report questionnair defin low risk lifestyl smoke bodi mass index num kg m num num minutes day moder activ consum alcohol modest men num num women num num alcohol day score top num healthi diet score document num stroke num ischem num hemorrhag women num stroke num ischem num hemorrhag men follow up women low risk factor relat risk num num ci num num total num num ci num num ischem stroke compar women factor men relat risk num num ci num num total num num ci num num ischem stroke comparison women num ci num total num ci num ischem stroke case attribut lack adher low risk lifestyl men num ci num total num ci num ischem stroke prevent conclus low risk lifestyl reduc risk multipl chronic diseas benefici prevent stroke ischem stroke
MED-1678~combin effect low risk dietari lifestyl behavior primari prevent myocardi infarct women pubm ncbi abstract background limit data benefit combin healthi dietari lifestyl behavior prevent myocardi infarct mi women method factor analysi identifi low risk behavior bas dietari pattern num postmenopaus women population bas prospect swedish mammographi cohort free diagnos cancer cardiovascular diseas diabet mellitus baselin septemb num defin num low risk lifestyl factor nonsmok waist hip ratio num percentil num physic activ num minut daili walk bicycl num hour week exercis result num year num person year follow up ascertain num case primari mi major identifi dietari pattern healthi alcohol signific decreas risk mi low risk diet high score healthi dietari pattern character high intak veget fruit grain fish legum combin moder alcohol consumpt num alcohol day num low risk lifestyl behavior num decreas risk num confid interv num num compar find women low risk diet lifestyl factor combin healthi behavior present num prevent num mis studi popul conclus mis women prevent consum healthi diet moder amount alcohol physic activ smoke maintain healthi weight
MED-1679~healthi lifestyl factor primari prevent coronari heart diseas men benefit user nonus lipid low pubm ncbi abstract background healthi lifestyl choic eat prudent diet exercis regular manag weight smoke substanti reduc coronari heart diseas chd risk improv lipid blood pressur risk factor burden chd avoid adher modifi lifestyl factor assess middle ag older men specif men medic hypertens hypercholesterolemia method result prospect monitor num men health profession follow up studi num num year age free diseas num lifestyl factor updat self report questionnair low risk defin num absenc smoke num bodi mass index num kg m num moderate to vigor activ num min d num moder alcohol consumpt num num g d num top num distribut healthi diet score num year document num incid case chd nonfat myocardi infarct fatal chd multivariate adjust cox proport hazard model men low risk num lifestyl factor lower risk chd relat risk num num confid interv ci num num compar men low risk lifestyl factor sixty two percent num ci num coronari event cohort prevent adher num healthi lifestyl practic men medic hypertens hypercholesterolemia num ci num coronari event prevent low risk lifestyl compar men make lifestyl follow up adopt num addit low risk lifestyl factor num ci num lower risk chd conclus major chd event men prevent adher healthi lifestyl practic medic hypertens hypercholesterolemia
MED-1680~effect potenti modifi risk factor myocardi infarct num countri interheart studi case control studi pubm ncbi abstract background num global burden cardiovascular diseas occur low incom middle incom countri knowledg import risk factor larg deriv develop countri effect factor risk coronari heart diseas region world unknown method establish standardis case control studi acut myocardi infarct num countri repres inhabit contin num case num control enrol relat smoke histori hypertens diabet waist hip ratio dietari pattern physic activ consumpt alcohol blood apolipoprotein apo psychosoci factor myocardi infarct report odd ratio num cis associ risk factor myocardi infarct popul attribut risk par calcul find smoke odd ratio num current par num current rais apob apoa num ratio num top lowest quintil par num top quintil lowest quintil histori hypertens num par num diabet num par num abdomin obes num top lowest tertil num middl lowest tertil par num top tertil lowest tertil psychosoci factor num par num daili consumpt fruit veget num par num lack daili consumpt regular alcohol consumpt num par num regular physic activ num par num signific relat acut myocardi infarct num risk factor num alcohol associ note men women young region world collect risk factor account num par men num women interpret abnorm lipid smoke hypertens diabet abdomin obes psychosoci factor consumpt fruit veget alcohol regular physic activ account risk myocardi infarct worldwid sex age region find suggest approach prevent base similar principl worldwid potenti prevent prematur case myocardi infarct
MED-1681~diet lifestyl risk type num diabet mellitus women pubm ncbi abstract background previous studi examin individu dietari lifestyl factor relat type num diabet combin effect factor larg unknown method num femal nurs num num women free diagnos cardiovascular diseas diabet cancer base line inform diet lifestyl updat period low risk group defin combin variabl bodymass index weight kilogram divid squar height meter num diet high cereal fiber polyunsatur fat low tran fat glycem load reflect effect diet blood glucos level engag moderate to vigor physic activ half hour day current smoke consumpt averag half drink alcohol beverag day result num year follow up document num case type num diabet overweight obes singl import predictor diabet lack exercis poor diet current smoke abstin alcohol signific increas risk diabet adjust body mass index compar rest cohort women low risk group num percent women relat risk diabet num num percent confid interv num num total num percent case diabet cohort num percent confid interv num num attribut habit form behavior conform low risk pattern conclus find support hypothesi vast major case type num diabet prevent adopt healthier lifestyl
MED-1682~supplement western diet golden kiwifruit actinidia chinensi var hort num effect biomark oxid damag antioxid protect abstract background health posit effect diet high fruit veget general replic supplement trial isol antioxid vitamin consequ emphasi chronic diseas prevent shift food food product method carri human intervent trial golden kiwifruit actinidia chinensi measur marker antioxid status dna stabil plasma lipid platelet aggreg hypothesi supplement normal diet kiwifruit effect biomark oxid status healthi volunt supplement normal diet golden kiwifruit day cross ov studi num num week plasma level vitamin carotenoid ferric reduc activ plasma frap measur malondialdehyd assess biomark lipid oxid effect dna damag circul lymphocyt estim comet assay enzym modif measur specif lesion modif estim dna repair result plasma vitamin increas supplement resist num induc dna damag purin oxid lymphocyt dna decreas signific kiwifruit day pyrimidin oxid decreas fruit day dna base excis nucleotid excis repair influenc kiwifruit consumpt malondialdehyd affect plasma triglycerid decreas blood platelet aggreg decreas kiwifruit supplement conclus golden kiwifruit consumpt strengthen resist endogen oxid damag
MED-1683~platelet atherogenesi platelet anti aggreg activ endotheli protect tomato solanum lycopersicum abstract recent year shown platelet involv arteri thrombot process play activ role inflammatori process atherogenesi begin interact platelet endotheli cell occur manner activ platelet unit intact endotheli cell platelet rest adher activ endothelium context inhibit platelet function adhesion aggreg contribut prevent atherothrombosi lead cardiovascular morbid achiev antiplatelet agent public health level level primari prevent healthi diet shown exert benefici effect element healthi diet consumpt tomato solanum lycopersicum stand effect platelet anti aggreg activ endotheli protect benefici cardiovascular health articl briefli discuss involv platelet atherogenesi mechan action provid tomato platelet anti aggreg activ endotheli protect
MED-1685~effect tomato extract human platelet aggreg vitro pubm ncbi abstract fruit test vitro anti platelet properti tomato highest activ grapefruit melon strawberri pear appl activ tomato extract num microl num juic inhibit adp collagen induc aggreg num inhibit arachidon acid induc platelet aggreg concomit thromboxan synthesi similar experiment condit anti platelet compon mw num da tomato water solubl heat stabl concentr yellow fluid seed activ fraction separ gel filtrat hplc aqueous fraction num xg supernat tomato anti platelet activ subject gel filtrat column chromatographi biogel num column activ fraction peak peak num peak num major peak subsequ peak num purifi hplc reversed phas column nmr mass spectroscopi studi peak num obtain peak num adenosin cytidin deamin peak num adenosin deaminas complet abolish anti platelet activ confirm presenc adenosin fraction comparison deamin peak num result partial loss inhibitori activ activ peak num remain unaffect result tomato anti platelet compound addit adenosin unlik aspirin tomato deriv compound inhibit thrombin induc platelet aggreg data tomato potent anti platelet compon consum tomato benefici prevent therapeut regim cardiovascular diseas
MED-1686~cardioprotect properti kiwifruit pubm ncbi abstract benefici effect consumpt fruit veget cardiovascular system report fruit veget compon affect cardiovascular system antioxid nonantioxid mechan action understood compound present fruit veget function individu concert protect lipoprotein vascular cell oxid mechan reduc plasma lipid level high blood pressur platelet hyperact emerg data kiwifruit benefici prevent cardiovascular diseas consumpt fruit day num day lower platelet hyperact plasma lipid blood pressur human volunt studi suggest kiwifruit provid dietari part prevent therapeut strategi favor modifi cardiovascular risk factor relev lower cardiovascular risk factor kiwifruit human health discuss copyright num elsevi reserv
MED-1687~inhibitori effect aqueous extract herb human platelet aggreg vitro pubm ncbi abstract effect aqueous extract herb human platelet aggreg vitro investig num herbs nutriceut investig camomil nettl alfalfa garlic onion exhibit signific anti platelet activ num inhibit aqueous extract alfalfa fresh nettl camomil inhibit adp induced platelet aggreg num num compar control num camomil alfalfa inhibit collagen induc platelet aggreg num num nettl inhibit collagen induc aggreg contrast nettl potent inhibitor num blood aggreg induc collagen alfalfa num camomil num compar control num herb inhibit arachidon acid thrombin induc platelet aggreg camomil alfalfa strong inhibit thromboxan num synthesi induc adp collagen nettl effect alfalfa nettl increas cgmp level platelet num num compar control num num nm num data camomil nettl alfalfa potent anti platelet properti inhibitori action mediat mechan
MED-1688~effect tomato extract platelet function double blind crossov studi healthi human pubm ncbi abstract background aqueous extract tomato display rang antiplatelet activ vitro previous show activ compon alter vivo platelet function person high respons adp agonist object object evalu suitabl tomato extract dietari supplement prevent platelet activ design random double blind placebo control crossov studi conduct num healthi human subject select normal platelet function baselin hemostat function measur num consumpt extract enrich control supplement result signific reduct vivo platelet aggreg induc adp collagen observ num supplement dose tomato extract equival num te num te tomato num micromol adp l num high dose num num low dose num num num micromol adp l num num num num num num mg collagen l num num num num num signific effect observ control supplement dose respons tomato extract found low level platelet stimul inhibit platelet function greatest subgroup highest plasma homocystein num c reactiv protein concentr num conclus function food dietari supplement tomato extract role primari prevent cardiovascular diseas reduc platelet activ contribut reduct thrombot event
MED-1689~effect tomato industri process phenol profil antiplatelet activ pubm ncbi abstract background regular consumpt fruit veget tomato shown benefici term reduc incid cardiovascular diseas industri process tomato tomato bas product includ thermal treatment effect tomato industri process antiaggregatori activ phenol profil method assess effect tomato by product extract platelet aggreg induc adp collagen trap num arachidon acid vitro antithrombot properti support vivo model thrombosi set antiplatelet compound select hplc analysi extract result natur compound chlorogen caffeic ferul p coumar acid identifi hplc tomato product inhibit platelet activ red tomato tomato product sauc ketchup juic by product extract inhibit platelet aggreg induc adenosin num diphosph collagen thrombin receptor activ peptid num arachidon acid extent pomac extract present antithrombot activ conclus process tomato higher content health benefit compound fresh pomac present antiplatelet activ final tomato product function ingredi ad antiplatelet activ process food
MED-1690~effect antiplatelet compon tomato extract platelet function vitro vivo time cours cannul studi healthi human pubm ncbi abstract background natur antithrombot agent influenc platelet function potenti interest primari prevent cardiovascular diseas previous report show tomato extract inhibit platelet aggreg vitro activ compon mode action efficaci vivo object object studi examin antiplatelet activ specif tomato compon vitro experiment establish vivo efficaci healthi human design mechan action antiplatelet compon isol tomato extract examin vitro num time cours studi carri cannul human subject num determin vivo efficaci supplement drink tomato extract onset durat antiplatelet effect result inhibit adp collagen thrombin arachidonate medi platelet aggreg tomato extract compon link inhibit glycoprotein iib iiia platelet secretori mechan found signific inhibit baselin platelet function num num optim adp concentr num num num suboptim adp concentr num num supplement dose tomato extract equival num tomato observ effect persist num coagul variabl affect conclus ingest tomato compon vitro antiplatelet activ signific affect vivo platelet function report cardioprotect effect tomato potenti link modul platelet function
MED-1691~diet thrombosi risk nutrient prevent thrombot diseas pubm ncbi abstract increas prothrombot state major risk factor develop heart attack stroke venous thromboembol platelet activ aggreg play import role determin prothrombot state pharmaceut agent aspirin heparin warfarin reduc prothrombot tendenc long term drug treatment produc varieti side effect includ bleed diet general recogn signific involv modifi individu risk develop thrombot diseas influenc treatment disord import dietari intervent proven effect lower serum lipid level essenti element pathogenesi cardiovascular diseas likewis dietari compon proven effect decreas platelet activ mechan contribut attenu futur risk thrombosi articl up to d review role nutrient nonnutri supplement platelet aggreg risk thrombosi thiem medic publish
MED-1693~tomato cardiovascular health pubm ncbi abstract diet believ play complex role develop cardiovascular diseas lead death western world tomato produc consum veget nationwid rich sourc lycopen beta caroten folat potassium vitamin flavonoid vitamin process tomato signific affect bioavail nutrient homogen heat treatment incorpor oil process tomato product lead increas lycopen bioavail process signific loss nutrient nutrient content affect varieti matur nutrient function individu concert protect lipoprotein vascular cell oxid wide accept theori genesi atherosclerosi hypothesi support vitro limit vivo epidemiolog studi associ reduc cardiovascular risk consumpt antioxidant rich food cardioprotect function provid nutrient tomato includ reduct low dens lipoprotein ldl cholesterol homocystein platelet aggreg blood pressur tomato includ nutrient theoret proven effect wide consum year round consid valuabl compon cardioprotect diet
MED-1695~effect kiwi fruit consumpt platelet aggreg plasma lipid healthi human volunt pubm ncbi abstract fruit veget thought benefici cardiovascular diseas benefici effect fruit veget explain antioxid compon nutrient function individu concert protect lipoprotein vascular cell oxid mechan reduc plasma lipid level ldl cholesterol triglycerid platelet aggreg respons kiwi fruit high amount vitamin vitamin polyphenol benefici cardiovascular diseas cardioprotect effect platelet involv atherosclerot diseas develop reduct platelet activ medic reduc incid sever diseas end evalu consum kiwi fruit modul platelet activ plasma lipid human volunt random cross ov studi report consum kiwi fruit day num day reduc platelet aggreg respons collagen adp num compar control num addit consumpt kiwi fruit lower blood triglycerid level num compar control num effect observ case cholesterol level data consum kiwi fruit benefici cardiovascular diseas
MED-1696~gender race diet affect platelet function test normal subject contribut high rate abnorm result summari assess sourc variabl platelet function test normal subject num healthi young adult test num num occas num week interv num method platelet aggreg agg platelet rich plasma prp bio data pap num aggregomet bd chrono log lumi aggregomet cl agg blood wb cl multipl platelet function analyz mp atp releas rel cl prp cl wb food medic exposur record prospect num week prior blood draw agg abnorm num num drug fre specimen cl prp num cl wb num bd prp num mp wb increas inclus rel num cl prp num cl wb epinephrin agg rel signific reduc male num ristocetin agg collagen thrombin rel signific reduc black num one third specimen drawn flavonoid rich food exposur aberr result compar num specimen exposur num prp test intra individu variat wb test gender race diet test system affect result platelet function test healthi subject suggest caution interpret result platelet function test patient
MED-1697~effect tomato industri process hybrid past pomac inhibit platelet function vitro vivo vivo abstract cardiovascular diseas cvd lead death worldwid healthi eat safeguard daili intak fruit veget context shown tomato solanum lycopersicum present antiplatelet activ present studi evalu vitro antiplatelet activ fresh hybrid tomato process hybrid apt num num bos num sun num ab num hmx num num num num past by product industri process pomac assess antiplatelet activ vivo bleed time rat ingest num num g kg pomac day studi vitro signific differ antiplatelet activ observ fresh tomato hybrid agro industri process affect antiplatelet activ past pomac likewis pomac intak num g kg day prolong bleed time reduc vivo platelet aggreg rat data obtain tomato compound caus antiplatelet activ regular consumpt tomato industri deriv part cvd prevent regimen
MED-1699~mediterranean diet cognit function dementia systemat review pubm ncbi abstract background adher mediterranean diet lower risk age rel diseas includ dementia narrat review publish systemat review synthes studi associ mediterranean diet adher cognit function dementia method conduct systemat review num electron databas includ medlin publish articl januari num refer list select journal content relev websit search studi select data extract qualiti assess perform independ review predefin criteria studi includ examin associ mediterranean diet adher score cognit function dementia result twelv elig paper num observ studi random control trial identifi describ uniqu cohort methodolog heterogen limit statist power studi consist pattern associ higher adher mediterranean diet cognit function lower rate cognit declin reduc risk alzheim diseas num studi result mild cognit impair inconsist conclus publish studi suggest greater adher mediterranean diet slower cognit declin lower risk develop alzheim diseas studi clarifi associ mild cognit impair vascular dementia long term random control trial promot mediterranean diet establish improv adher prevent delay onset alzheim diseas dementia
MED-1700~dietari fat type num year cognit chang community dwel older women abstract object relat dietari fat type cognit chang healthi community bas elder method num older particip women health studi relat intak major fatti acid fas satur sfa mono unsatur mufa total poly unsatur pufa trans unsatur late lif cognit trajectori serial cognit test conduct num year began num year post dietari assess primari outcom global cognit averag test general cognit verbal memori semant fluenci verbal memori averag test recal analys respons profil logist regress estim multivariable adjust differ cognit trajectori risk worst cognit chang worst num fat intak result higher sfa intak wors global cognit p linear trend num verbal memori p linear trend num trajectori higher risk worst cognit chang compar highest lowest sfa quintil multivariable adjust odd ratio num confid interv ci num num num global cognit num num num verbal memori contrast higher mufa intak relat global cognit p linear trend num verbal memori p linear trend num trajectori lower num ci worst cognit chang global cognit num num num verbal memori num num num total fat pufa tran fat intak cognit trajectori interpret higher sfa intak wors global cognit verbal memori trajectori higher mufa intak relat trajectori consumpt level major specif fat type total fat intak influenc cognit age
MED-1701~strawberri extract present antiplatelet activ inhibit inflammatori mediat atherosclerosi sp selectin scd num rant il num pubm ncbi abstract cardiovascular diseas prevent high prioriti develop countri healthi eat habit includ regular intak antithrombot diet fruit veget contribut prevent platelet function critic factor arteri thrombosi effect strawberri unclear aim studi systemat examin action strawberri prevent platelet activ thrombus format strawberri extract concentration depend num num mg ml inhibit platelet aggreg induc adp arachidon acid concentr strawberri inhibit platelet aggreg signific decreas sp selectin scd num rant il num level strawberri exert signific protect effect thromboembolic rel disord inhibit platelet aggreg suggest antithrombot activ anti inflammatori effect
MED-1702~mediterranean diet alzheim diseas mortal abstract background previous report mediterranean diet medi relat lower risk alzheim diseas ad medi subsequ ad outcom investig object examin associ medi mortal patient ad method total num community bas individu york diagnos ad prospect num year adher medi num num point scale higher score indic higher adher main predictor mortal cox model adjust period recruit age gender ethnic educ apo genotyp calor intak smoke bodi mass index result eighty f patient ad num die num num num num year follow up unadjust model higher adher medi lower mortal risk addit medi point hazard ratio num num ci num num num result remain signific control covari num num num num adjust model compar ad patient lowest medi adher fertil middl fertil lower mortal risk num num num num year longer surviv subject highest fertil lower risk num num num num year longer surviv trend num conclus adher mediterranean diet medi affect risk alzheim diseas ad subsequ diseas higher adher medi lower mortal ad gradual reduct mortal risk higher medi adher tertil suggest dose respons effect
MED-1703~project impact risk factor reduct alzheimer diseas preval abstract approxim num million individu alzheimer diseas ad worldwid preval expect tripl num year goal review summar evid potenti modifi ad risk factor diabet mid lif hypertens mid lif obes smoke depress low educ attain physic inact addit project impact risk factor reduct ad preval calcul popul attribut risk par percent case attribut factor number ad case potenti prevent num num risk factor reduct worldwid factor contribut half ad case global num million num million num num reduct risk factor potenti prevent num num million case worldwid num num case
MED-1704~alzheimer diseas incur prevent pubm ncbi abstract dramat rise incid cost alzheimer diseas ad requir research effort fund primarili direct find cure appli prevent measur curb disord cure ad signific cognit loss occur neuron network control perturb cognit abil dead irrevers damag replac technic reconstruct intellectu ident host prevent risk factor sporad ad realist stratagem treatment ideal begin cognit intact individu part mass screen effort prevent modifi risk factor ad cost effect reduc hospic hospit stay repeat doctor visit long term care present neurocognit neuroimag test partial success identifi person higher risk ad test pinpoint specif intervent attenu diseas progress previous propos carotid arteri ultrasound echocardiographi ankle brachail index cause abi mass screen test asymptomat person detect cardio cerebrovascular risk factor ad identifi intervent cause abi simpl perform cost effect non invas accur intend purpos addit detect cardio cerebrovasacular abnorm long express cognit deterior higher success rate earlier treatment evidence bas medicin recommend optim clinic decision mak evalu ad risk factor treatment
MED-1705~turn point alzheimer diseas pubm ncbi abstract archiv num research paper publish decad subject alzheimer diseas ad clinic progress made relat peopl sporad ad avoid review spotlight strateg step turn point dramat lower alzheim preval main strategi includ applic pillar prevent num earli identif ad vascular risk factor num earli detect ad vascular risk factor num earli intervent ad vascular risk factor base evidence bas medic decis num patient follow up assess modifi intervent tandem pillar prevent proactiv lifestyl consist healthi diet coupl physic mental activ appli part therapeut intervent persuad mount compel evid ad multifactori disord kindl vascular risk factor generat chronic brain hypoperfus cbh advanc age pathobiolog cascad biochem event presenc cbh lead oxid stress neurodegener involv multipl biofactor includ micronutri trace metal lipid pro oxid review special issu biofactor modul biofactor prevent control incipi ad num intern union biochemistri molecular biolog copyright num intern union biochemistri molecular biolog
MED-1706~glycem index physiolog mechan relat obes diabet cardiovascular diseas pubm ncbi abstract glycem index propos num altern system classifi carbohydrate contain food hundr scientif articl numer popular diet book publish topic clinic signific glycem index remain subject debat purpos review examin physiolog effect glycem index relev effect prevent treat obes diabet cardiovascular diseas
MED-1707~dietari sugar bodi weight reach crisi epidem obes diabet health damn pour sugar pubm ncbi abstract sugar sweeten drink health problem point narrat present provid opinion review data date reconsid consumpt dietari sugar base grow concern obes type num diabet counterpoint narrat contribut drs kahn sievenpip provid defens suggest dietari sugar culprit data nation health nutrit examin survey depart agricultur dietari survey commerci homescan data household purchas understand sugar fructos consumpt meta analys random clinic trial evalu outcom beverag fructos intak num food beverag ad sugar larg array form consumpt soft drink increas fivefold num meta analys suggest consumpt sugar sweeten beverag ssbs relat risk diabet metabol syndrom cardiovascular diseas drink num ounc ssbs day num month induc featur metabol syndrom fatti liver random control trial children adult num month num year shown lower intak soft drink reduc weight gain recent studi suggest gene ssb potenti relationship consumpt calorie sweeten beverag continu increas play role epidem obes metabol syndrom fatti liver diseas reduc intak soft drink weight gain
MED-1708~dietari sugar intak cardiovascular health scientif statement american heart associ pubm ncbi abstract high intak dietari sugar set worldwid pandem obes cardiovascular diseas heighten concern advers effect excess consumpt sugar num num usual intak ad sugar american num teaspoon day num calori day num num averag annual avail sugars ad sugar increas num ad num calori american averag daili energi intak soft drink sugar sweeten beverag primari sourc ad sugar american diet excess consumpt sugar link metabol abnorm advers health condit shortfal essenti nutrient trial data limit evid observ studi higher intak soft drink greater energi intak higher bodi weight lower intak essenti nutrient nation survey data excess consumpt ad sugar contribut overconsumpt discretionari calori american basi num dietari guidelin intak ad sugar great exceed discretionari calori energi view american heart associ recommend reduct intak ad sugar prudent upper limit intak half discretionari calori american women num calori day american men num calori day ad sugar
MED-1709~dietari sugar bodi weight reach crisi epidem obes diabet pox sugar overwrought pubm ncbi abstract preced point narrat drs bray popkin provid opinion review data suggest reconsid consumpt dietari sugar base grow concern obes type num diabet counterpoint narrat argu clear convinc evid dietari ad sugar uniqu detriment impact relat sourc calori develop obes diabet sugar pure high palat sourc energi properti contribut nutrit well b essenti food reduc energi consumpt ingest sugar good place start automat portend clinic benefit
MED-1710~energi fructos beverag sweeten sugar high fructos corn syrup pose health risk peopl abstract sugar intak unit state increas num fold american revolut health concern rais amount sugar current diet primarili beverag subject review num ad sugar sugar high fructos corn syrup found soft drink fruit drink intak soft drink increas num fold num num meta analys shown risk obes diabet cardiovascular diseas metabol syndrom relat consumpt beverag sweeten sugar high fructos corn syrup calor sweeten beverag intak relat risk nonalcohol fatti liver diseas men gout calor sweeten beverag contribut obes calor load intak beverag produc reduct intak food suggest beverag calori add on calori increas plasma triglycerid concentr sugar sweeten beverag attribut fructos glucos sugar random trial sugar contain soft drink versus low calori calorie fre beverag show sugar num fructos fructos increas triglycerid bodi weight viscer adipos tissu muscl fat liver fat fructos metabol primarili liver liver atp decreas rapid phosphat transfer fructos form make easi convert lipid precursor fructos intak enhanc lipogenesi product uric acid worsen blood lipid contribut obes diabet fatti liver gout fructos amount consum hazard health peopl
MED-1711~figitumumab combin carboplatin paclitaxel treatment na ve japanes patient advanc non smal cell lung cancer summari object insulin lik growth factor igf signal pathway implic pathogenesi numer tumor type includ non smal cell lung cancer nsclc figitumumab fulli human igg num monoclon antibodi igf num receptor igf num method phase open label dose escal studi clinicaltri gov nct num assess safeti toler figitumumab num num mg kg combin carboplatin area curv num mg min ml paclitaxel num mg m num japanes patient num chemotherapy na ve advanc nsclc treatment administ intraven day num num day cycl cycl pharmacokinet biomark antitumor activ evalu result figitumumab combin carboplatin paclitaxel toler dose num mg kg dose limit toxic observ dose level combin figitumumab plasma exposur increas approxim dose proport manner approxim num fold accumul repeat administr support num day regimen figitumumab administr serum total igf num igf bind protein num concentr increas figitumumab dose clear dose depend relationship demonstr num evalu patient experienc partial respons conclus figitumumab num mg kg combin carboplatin paclitaxel toler chemotherapy na ve japanes patient nsclc analysi biomark data develop figitumumab therapi
MED-1712~dietari restrict reduc insulin lik growth factor level modul apoptosi cell prolifer tumor progress num defici pubm ncbi abstract diet contribut one third cancer death western world factor diet influenc cancer elucid reduct calor intak dramat slow cancer progress rodent major contribut dietari effect cancer insulin lik growth factor igf i lower dietari restrict dr human rat igf i modul cell prolifer apoptosi tumorigenesi mechan protect effect dr depend reduct multifacet growth factor test hypothesi igf i restor dr ascertain lower igf i central slow bladder cancer progress dr heterozyg num defici mice receiv bladder carcinogen p cresidin induc preneoplasia confirm bladder urotheli preneoplasia mice divid group ad libitum num dr num dr igf i igf i dr serum igf i lower num dr complet restor igf i dr tr mice recombin igf i administ osmot minipump tumor progress decreas dr restor igf i serum level dr treat mice increas stage cancer igf i modul tumor progress independ bodi weight rate apoptosi preneoplast lesion num time higher dr treat mice compar igf dr ad libitum tr mice administr igf i dr treat mice stimul cell prolifer num fold hyperplast foci conclus dr lower igf i level favor apoptosi cell prolifer ultim slow tumor progress mechanist studi demonstr igf i supplement abrog protect effect dr neoplast progress
MED-1714~long term low protein low calori diet endur exercis modul metabol factor cancer risk pubm ncbi abstract background western diet obes sedentari lifestyl increas cancer risk mechan respons increas risk clear object hypothes long term low protein low calori intak endur exercis low concentr plasma growth factor hormon link increas risk cancer design plasma growth factor hormon evalu num sedentari subject eat low protein low calori diet num num sd age num num num endur runner match bodi mass index bmi kg m num num age sex match sedentari subject eat western diet result bmi lower low protein low calori diet num num runner num num group western diet num num num group plasma concentr insulin free sex hormon leptin c reactiv protein lower sex hormone bind globulin higher low protein low calori diet runner group sedentari western diet group num plasma insulin lik growth factor igf i concentr ratio igf i igf bind protein num lower low protein low calori diet group num num ng ml num num runner num num ng ml num num sedentari western num num ng ml num num diet group num conclus exercis train decreas adipos long term consumpt low protein low calori diet low plasma growth factor hormon link increas risk cancer low protein intak addit protect effect decreas circul igf i independ bodi fat mass
MED-1715~long term effect calori protein restrict serum igf num igfbp num concentr human summari reduc function mutat insulin igf i signal pathway increas maxim lifespan health span speci calori restrict cr decreas serum igf num concentr num protect cancer slow age rodent long term effect cr adequ nutrit circul igf num level human unknown report data long term cr studi num num year show sever cr malnutrit chang igf num igf num igfbp num ratio level human contrast total free igf num concentr signific lower moder protein restrict individu reduc protein intak averag num kg num bodi weight day num kg num bodi weight day num week volunt practic cr result reduct serum igf num num ng ml num num ng ml num find demonstr unlik rodent long term sever cr reduc serum igf num concentr igf num igfbp num ratio human addit data provid evid protein intak key determin circul igf num level human suggest reduc protein intak import compon anticanc anti ag dietari intervent
MED-1716~twenty first centuri cancer epidem caus obes involv insulin diabet insulin lik growth factor abstract obes reach epidem proport develop world progress obes diabet mellitus type num metabol syndrom recognis signific increas risk major human cancer acknowledg review molecular basi involv morbid high concentr endogen therapeut insulin insulin lik growth factor progress obes diabet final cancer epidemiolog biochem studi establish role insulin hyperinsulinaemia cancer risk progress insulin lik growth factor igf num igf num secret viscer mammari adipos tissu signific paracrin endocrin effect effect exacerb increas steroid hormon product structur studi elucid ligand insulin igf num igf num interact differ isoform insulin receptor type igf receptor explain protagonist contribut diabetes associ cancer inform treatment cancer aris obes individu diabet mellitus type num drug target insulin insulin lik growth factor signal transduct pathway clinic trial effect biomarker inform patient stratif implement
MED-1717~body mass index incid cancer systemat review meta analysi prospect observ studi pubm ncbi abstract background excess bodyweight express increas body mass index bmi risk common adult cancer systemat review meta analysi assess strength associ bmi site cancer investig differ associ sex ethnic group method electron search medlin embas num novemb num search report identifi prospect studi incid case num cancer type random effect meta analys meta regress study specif increment estim determin risk cancer num kg m num increas bmi find analys num dataset num articl includ num incid case men num kg m num increas bmi strong oesophag adenocarcinoma rr num num thyroid num num colon num num renal num num cancer women record strong associ num kg m num increas bmi endometri num num gallbladd num num oesophag adenocarcinoma num num renal num num cancer note weaker posit associ rr num increas bmi rectal cancer malign melanoma men postmenopaus breast pancreat thyroid colon cancer women leukaemia multipl myeloma non hodgkin lymphoma sex associ stronger men women colon num cancer associ general similar studi north america europ australia asia pacif region record stronger associ asia pacif popul increas bmi premenopaus num postmenopaus num breast cancer interpret increas bmi increas risk common common malign cancer type associ differ sex popul ethnic origin epidemiolog observ inform explor biolog mechan link obes cancer
MED-1718~obes major risk factor cancer abstract number cancer case caus obes estim num increas risk malign influenc diet weight chang bodi fat distribut physic activ report intern agenc research cancer world cancer research fund wcrf shown strongest evid exist associ obes cancer type endometri esophag adenocarcinoma colorect postmenopaus breast prostat renal common malign leukemia non hodgkin lymphoma multipl myeloma malign melanoma thyroid tumour develop method prevent treatment understand process link cancer obes main system identifi potenti produc cancer obes insulin insulin lik growth factor i sex steroid adipokin candid mechan propos chronic inflamm oxid stress crosstalk tumour cell surround adipocyt migrat adipos stromal cell obesity induc hypoxia share genet suscept function defeat immun function review major pathogen link obes suscept cancer
MED-1719~patient congenit defici igf i protect develop malign preliminari report pubm ncbi abstract object overexpress igf i occur tumor diagnos childhood osteosarcoma wilm tumor neuroblastoma adult breast ovari colon prostat cancer aim studi establish preval malign state congenit igf i defici subject survey num patient congenit igf i defici laron syndrom gh gene delet ghrh receptor defect igf i resist num second degre relat result igf i defici patient cancer num famili member histori malign conclus congenit igf i defici act protect factor develop cancer
MED-1720~insulin lik growth factor igf i igf bind protein num cancer risk systemat review meta regress analysi pubm ncbi abstract background insulin lik growth factor igf i main bind protein igfbp num modul cell growth surviv thought import tumour develop circul concentr igf i increas risk cancer igfbp num concentr decreas cancer risk method systemat review meta regress analysi case control studi includ studi nest cohort associ concentr igf i igfbp num prostat colorect premenopaus postmenopaus breast lung cancer study specif dose respons slope obtain relat natur log odd ratio exposur level blood concentr normalis percentil scale find identifi num elig studi num dataset includ num case num control high concentr igf i increas risk prostat cancer odd ratio compar num num percentil num num ci num num premenopaus breast cancer num num num high concentr igfbp num increas risk premenopaus breast cancer num num num associ larger assess plasma sampl serum sampl standard case control studi compar nest studi interpret circul concentr igf i igfbp num increas risk common cancer associ modest vari site laboratori method standardis epidemiolog observ major implic assess risk prevent cancer
MED-1721~cancer incid mortal relat bodi mass index million women studi cohort studi abstract object examin relat bodi mass index kg m num cancer incid mortal design prospect cohort studi particip num million uk women recruit million women studi age num num averag num year cancer incid num year cancer mortal main outcom measur relat risk incid mortal cancer num specif type cancer bodi mass index adjust age geograph region socioeconom status age birth pariti smoke status alcohol intak physic activ year menopaus hormon replac therapi result num num incid cancer num num death cancer occur follow up period increas bodi mass index increas incid endometri cancer trend relat risk num unit num num confid interv num num adenocarcinoma oesophagus num num num kidney cancer num num num leukaemia num num num multipl myeloma num num num pancreat cancer num num num non hodgkin lymphoma num num num ovarian cancer num num num cancer combin num num num breast cancer postmenopaus women num num num colorect cancer premenopaus women num num num general relat bodi mass index mortal similar incid colorect cancer malign melanoma breast cancer endometri cancer effect bodi mass index risk differ signific menopaus status conclus increas bodi mass index signific increas risk cancer num num specif type examin postmenopaus women uk num cancer num annual attribut overweight obes endometri cancer adenocarcinoma oesophagus bodi mass index repres major modifi risk factor half case postmenopaus women attribut overweight obes
MED-1722~insulin lik growth factor num childhood cancer risk abstract overexpress growth factor and or receptor common event malign mechan hallmark cancer uncontrol prolifer mount evid suggest igf num involv pathogenesi progress type human cancer colon breast prostat lung studi investig associ igf num level childhood cancer risk aim compar igf num serum level children de novo malign healthi children assess relationship cancer type stage metastasi diseas characterist studi carri num children num children de novo malign num healthi children match age gender control group patient subject routin work up cancer local standard estim serum level igf num carri group elisa result show children cancer signific higher level igf num healthi control age gender associ found igf num tumor type stage metastasi diseas characterist conclus igf num serum level import indic risk preval form childhood cancer identifi children highest risk cancer aid determ benefit prevent strategi small number children studi studi larger popul requir confirm result
MED-1723~associ diet serum insulin lik growth factor main bind protein num women meat eat vegetarian vegan pubm ncbi abstract lower rate cancer asian countri western countri part diet mechan unknown aim cross sect studi determin plant bas vegan diet lower circul level insulin lik growth factor igf i compar meat eat lacto ovo vegetarian diet num british women age num year serum igf i concentr num lower num vegan women compar num meat eat num vegetarian num concentr serum igf bind protein igfbp num igfbp num num higher vegan women compar meat eat vegetarian num num igfbp num igfbp num signific differ igfbp num c peptid sex hormone bind globulin concentr diet group intak protein rich essenti amino acid posit serum igf i pearson partial correl coeffici num num explain differ igf i concentr diet group data suggest plant bas diet lower circul level total igf i higher level igfbp num igfbp num
MED-1724~low fat whole food vegan diet strategi down regul igf i activ slow human age process pubm ncbi abstract amount evid consist proposit system igf i activ act pacesett age process reduct igf i activ common characterist rodent maxim lifespan increas wide rang genet dietari measur includ calor restrict lifespan breed dog strain rat tend invers proport matur weight igf i level link igf i age evolutionarili conserv worm fli lifespan increas reduction of funct mutat signal intermedi homolog mediat insulin igf i activ mammal fact increas igf i activ play key role induct sexual matur consist broader role for igf i age regul down regul igf i activ slow age human rang practic measur achiev hand includ low fat whole food vegan diet exercis train solubl fiber insulin sensit appetit suppress agent flax lignan oral estrogen tamoxifen decreas hepat synthesi igf i measur expect decreas risk common age rel diseas regimen combin approach suffici impact igf i activ achiev retard age process light fact igf i promot endotheli product nitric oxid especi import cerebrovascular health addit measur stroke prevention most notabl salt restriction may advis attempt down regul igf i activ pro longev strategi
MED-1725~integr assess multipl pesticid risk factor non hodgkin lymphoma men abstract method num nation cancer institut conduct case control studi nhl midwestern unit state pool data examin pesticid exposur farm risk factor nhl men larg sampl size num analysi num pesticid simultan control potenti confound pesticid model adjust estim base prespecifi varianc make stabl result report individu pesticid increas nhl incid includ organophosph insecticid coumapho diazinon fonofo insecticid chlordan dieldrin copper acetoarsenit herbicid atrazin glyphos sodium chlorat subanalysi potenti carcinogen pesticid suggest posit trend risk exposur increas number conclus multipl exposur import accur estim specif effect evalu realist exposur scenario
MED-1726~major pesticid toxic human cell declar activ principl abstract pesticid world mixtur call formul adjuv confidenti call inert manufactur compani declar activ principl test test toxic num pesticid compar activ principl formul human cell line hepg num hek num jeg num glyphos isoproturon fluroxypyr pirimicarb imidacloprid acetamiprid tebuconazol epoxiconazol prochloraz constitut activ principl num major herbicid num insecticid num fungicid measur mitochondri activ membran degrad caspas num activ fungicid toxic concentr num num time lower agricultur dilut herbicid insecticid similar profil cell type benign reput roundup toxic herbicid insecticid test import num formul num thousand time toxic activ principl result challeng relev accept daili intak pesticid norm calcul toxic activ principl chronic test pesticid reflect relev environment exposur ingredi mixtur test
MED-1728~epidemiolog studi glyphos cancer review pubm ncbi abstract unit state environment protect agenc regulatori agenc world regist glyphos broad spectrum herbicid multipl food non food crop glyphos wide consid regulatori author scientif bodi carcinogen potenti base primarili result carcinogen studi rat mice examin potenti cancer risk human review epidemiolog literatur evalu exposur glyphos causal cancer risk human review relev methodolog biomonitor studi glyphos cohort studi fourteen case control studi examin associ glyphos cancer outcom review found consist pattern posit associ indic causal relationship total cancer adult children site specif cancer exposur glyphos data biomonitor studi underscor import exposur assess epidemiolog studi studi incorpor durat frequenc pesticid type pesticid formul generic exposur assess lead exposur misclassif recommend exposur algorithm valid biomonitor data copyright num elsevi reserv
MED-1729~birth defect season concept sex children born pesticid applic live red river valley minnesota usa abstract previous demonstr frequenc birth defect children resid red river valley rrv minnesota usa signific higher major agricultur region state year num children born male pesticid applic highest risk present smaller cross sect studi num famili num children conduct num detail examin reproduct health outcom farm famili ascertain parent report birth defect present studi year life birth defect rate num birth num num total report birth defect confirm medic record inclus children identifi birth development disord num year life led rate num num num children num live birth concept spring result signific children birth defect found season num num twelv famili child birth defect num children forty two percent children famili recurr birth defect conceiv spring signific higher rate season famili kinship defin contribut first degre relat sibl similar birth defect consist mendelian inherit pattern remain famili follow mendelian inherit pattern sex ratio children birth defect born applic famili show male predomin num num specif pesticid class exposur categori exclus fungicid fungicid exposur categori normal femal birth signific exceed male birth num num similar proport male femal children birth defect signific lower num num num advers neurolog neurobehavior development effect cluster children born applic fumig phosphin odd ratio num confid interv ci num num herbicid glyphos yield num ci num num neurobehavior categori final studi point herbicid appli spring factor birth defect observ fungicid signific factor determin sex children famili rrv distinct class pesticid advers effect reproduct outcom biolog base confirmatori studi
MED-1730~epidemiolog studi glyphos non canc health outcom review pubm ncbi abstract unit state environment protect agenc epa regulatori agenc world regist glyphos broad spectrum herbicid multipl food non food crop examin potenti health risk human search review literatur evalu exposur glyphos causal non canc health risk human review biomonitor studi glyphos comprehens discuss issu relat exposur assess misclassif cohort case control cross sect studi glyphos non canc outcom evalu varieti endpoint includ non canc respiratori condit diabet myocardi infarct reproduct development outcom rheumatoid arthriti thyroid diseas parkinson diseas review found evid consist pattern posit associ indic causal relationship diseas exposur glyphos report associ weak signific num accur exposur measur crucial valid result recommend pesticide specif exposur algorithm develop valid copyright num elsevi reserv
MED-1731~glyphos herbicid formul potenti lethal ingest pubm ncbi abstract glyphos surfact herbicid glysh toxic uncommon poison report fatal involv suicid ingest herbicid death occur earli recognit natur poison aggress treatment death seri analys context review exist literatur tradit regard minim toxic death report suicid ingest sever glysh toxic refractori intens support care triad pulmonari oedema metabol acidosi hyperkalaemia portend poor outcom carbon phosphorus moieti glysh exhibit organophosph toxic clinic guid assess sever glysh toxic propos treatment modal discuss
MED-1732~glyphos induc human breast cancer cell growth estrogen receptor pubm ncbi abstract glyphos activ ingredi wide herbicid believ toxic pesticid recent studi show potenti advers health effect human endocrin disruptor studi focus effect pure glyphos estrogen receptor er mediat transcript activ express glyphos exert prolif effect human hormone depend breast cancer num cell hormone independ breast cancer mda mb num cell num num estrogen withdraw condit prolif concentr glyphos induc activ estrogen respons element ere transcript activ num fold control num kbluc cell activ inhibit estrogen antagonist ici num indic estrogen activ glyphos mediat er glyphos alter er express result low environment relev concentr glyphos possess estrogen activ glyphosate bas herbicid wide soybean cultiv result found addit estrogen effect glyphos genistein phytoestrogen soybean addit effect glyphos contamin soybean anim studi copyright num elsevi reserv
MED-1733~rhabdomyolysi intramuscular inject glyphosate surfact herbicid pubm ncbi abstract introduct glyphosate surfact herbicid glysh wide non select herbicid intox case ingest inhal skin exposur intramuscular inject glysh report present case glysh intox intramuscular inject case report num year old woman emerg depart complain pain swell left upper limb num perform intramuscular inject num ml glysh aspect left elbow num previous physic examin disclos pain swell left distal arm elbow forearm needl punctur ct scan reveal ill defin area heterogen high densiti mark swell subcutan tissu posterior aspect elbow discuss mechan toxic glysh complic surfact thought play import role glysh intox intramuscular glysh poison oral glysh intox care monitor acut rhabdomyolysi compart syndrom develop rapid contribut surfact compon glyphos formul
MED-1736~prepubert exposur commerci formul herbicid glyphos alter testosteron level testicular morpholog pubm ncbi abstract glyphos herbicid wide kill weed agricultur non agricultur landscap reproduct toxic relat inhibit star protein aromatas enzym vitro reduct testosteron estradiol synthesi studi vivo herbicid effect prepubert wistar rat reproduct develop perform moment evalu includ progress puberti bodi develop hormon product testosteron estradiol corticosteron morpholog testi result show herbicid num signific chang progress puberti dose depend manner num reduc testosteron product seminefer tubul morpholog decreas signific epithelium height num control num num microm num mg kg num num microm num mg kg num num microm num mg kg num num microm increas lumin diamet num control num num microm num mg kg num num microm num mg kg num num microm num mg kg num num microm num differ tubular diamet observ num relat control differ serum corticosteron estradiol level detect concentr testosteron serum lower treat group num control num num ng dl num mg kg num num ng dl num mg dl num num ng dl num mg kg num num ng dl result suggest commerci formul glyphos potent endocrin disruptor vivo caus disturb reproduct develop rat exposur perform puberti period
MED-1737~time dose depend effect roundup human embryon placent cell pubm ncbi abstract roundup major herbicid worldwid genet modifi plant design toler test toxic endocrin disrupt potenti roundup bioforc human embryon num placental deriv jeg num cell normal human placenta equin testi cell line proven suitabl estim hormon activ toxic pollut median lethal dose ld num roundup embryon cell num num serum fre medium decreas reach num compound num mm glyphos num presenc serum condit embryon cell num time sensit placent instanc roundup general agricultur num num mm glyphos effici activ ingredi glyphos suggest synergist effect provok adjuv present roundup demonstr serum fre cultur short term basi num reveal xenobiot impact visibl num day serum document lower non overt toxic dose num num microm glyphos num roundup aromatas disruptor direct inhibit temperature depend confirm tissu speci cell line placenta embryon kidney equin testicular human fresh placent extract glyphos act direct partial inactiv microsom aromatas independ acid dose depend manner cytotox potenti endocrine disrupt effect roundup amplifi time data suggest roundup exposur affect human reproduct fetal develop case contamin chemic mixtur formul underestim toxic hormon impact
MED-1738~development reproduct outcom human anim glyphos exposur critic analysi pubm ncbi abstract glyphos activ ingredi wide herbicid formul glyphos target shikim metabol pathway found plant anim relat safeti glyphos advers development reproduct problem alleg result exposur human anim assess development reproduct safeti glyphos analysi literatur conduct epidemiolog anim report studi mechan action relat development reproduct effect glyphos review evalu databas found consist effect glyphos exposur reproduct health develop offspr plausibl mechan action effect elucid toxic observ studi glyphosate bas formul data strong suggest effect due surfact present formul direct result glyphos exposur estim potenti human exposur concentr glyphos result work direct herbicid biomonitor data examin data demonstr extrem low human exposur result normal applic practic estim exposur concentr human num fold oral refer dose glyphos num mg kg d set environment protect agenc epa num conclus literatur show solid evid link glyphos exposur advers development reproduct effect environment realist exposur concentr
MED-1739~roundup disrupt male reproduct function trigger calcium medi cell death rat testi sertoli cell pubm ncbi abstract glyphos primari activ constitu commerci pesticid roundup present result show acut roundup exposur low dose num ppm num g l num min induc oxid stress activ multipl stress respons pathway lead sertoli cell death prepubert rat testi pesticid increas intracellular ca num concentr open l type voltage depend ca num channel endoplasm reticulum ip num ryanodin receptor lead ca num overload cell set oxid stress necrot cell death similar num min incub testi glyphos num ppm increas num ca num uptak event prevent antioxid trolox ascorb acid activ protein kinas phosphatidylinositol num kinas mitogen activ protein kinas erk num num apk play role elicit ca num influx cell death roundup decreas level reduc glutathion gsh increas amount thiobarbitur acid react speci tbar protein carbonyl exposur glyphosate roundup stimul activ glutathion peroxidas glutathion reductas glutathion s transferas glutamyltransferas catalas superoxid dismutas glucos num phosphat dehydrogenas support downregul gsh level glyphos endocrin disruptor affect male reproduct system molecular basi toxic remain clarifi propos roundup toxic implic ca num overload cell signal misregul stress respons endoplasm reticulum and or deplet antioxid defens contribut sertoli cell disrupt spermatogenesi impact male fertil copyright num elsevi reserv
MED-1740~pesticid roundup provok cell divis dysfunct level cdk num cyclin activ pubm ncbi abstract assess human health risk environment chemic studi effect cell cycl regul wide glyphosate contain pesticid roundup model system sea urchin embryon divis fertil studi univers cell cycl regul interfer transcript show num roundup num mm glyphos induc delay kinet cell cleavag sea urchin embryo delay depend concentr roundup delay cell cycl induc increas glyphos concentr num mm presenc subthreshold concentr roundup num glyphos ineffect indic synergi glyphos roundup formul product effect roundup lethal involv delay entri m phase cell cycl judg cytolog cdk num cyclin regul univers m phase cell cycl analyz cdk num cyclin activ divis earli develop roundup delay activ cdk num cyclin vivo roundup inhibit global protein synthet rate prevent accumul cyclin summari roundup affect cell cycl regul delay activ cdk num cyclin complex synerg effect glyphos formul product univers speci cdk num cyclin regul result question safeti glyphos roundup human health
MED-1741~differenti effect glyphos roundup human placent cell aromatas abstract roundup glyphosate bas herbicid worldwid includ genet modifi plant design toler residu enter food chain glyphos found contamin river agricultur worker glyphos pregnanc problem mechan action mammal question show glyphos toxic human placent jeg num cell num hr concentr lower found agricultur effect increas concentr time presenc roundup adjuv surpris roundup toxic activ ingredi test effect glyphos roundup lower nontox concentr aromatas enzym respons estrogen synthesi glyphosate bas herbicid disrupt aromatas activ mrna level interact activ site purifi enzym effect glyphos facilit roundup formul microsom cell cultur conclud endocrin toxic effect roundup glyphos observ mammal suggest presenc roundup adjuv enhanc glyphos bioavail and or bioaccumul
MED-1743~composit differ soybean market glyphos accumul roundup readi gm soybean pubm ncbi abstract articl describ nutrient element composit includ residu herbicid pesticid num soybean batch iowa usa soy sampl group categori genet modifi glyphosate toler soy gm soy ii unmodifi soy cultiv convent chemic cultiv regim iii unmodifi soy cultiv organ cultiv regim organ soybean show healthiest nutrit profil sugar glucos fructos sucros maltos signific total protein zinc fibr convent gm soy organ soybean total satur fat total omega num fatti acid convent gm soy gm soy high residu glyphos ampa num num mg kg convent organ soybean batch agrochem num nutrit element variabl characteris soy sampl discrimin gm convent organ soybean demonstr substanti non equival composit characterist ready to market soybean copyright num author publish elsevi reserv
MED-1744~properti genet engin develop nation risk pubm ncbi abstract eighti percent commerci genet engin seed ges design resist herbicid farmer chemic cut labor cost develop nation ges food shortag unemploy resist weed extinct nativ cultivar volunt drift nearbi ges patent reason paper argu patent polici paper survey ge technolog outlin john locke classic account properti argu current patent polici revis account lockean ethic constraint answer key object concret suggest implement ethic conclus
MED-1745~chemic composit glyphosate toler soybean num num grown europ remain equival convent soybean glycin max pubm ncbi abstract composit glyphosate toler roundup readi soybean num num compar convent soybean grown romania num part compar safeti assess program sampl collect replic field trial composit analys perform measur proxim moistur fat ash protein carbohydr calcul fiber amino acid fatti acid isoflavon raffinos stachyos phytic acid trypsin inhibitor lectin grain proxim fiber forag valu biochem compon assess roundup readi soybean num num similar convent control publish rang observ commerci soybean composit profil roundup readi soybean num num compar convent soybean varieti grown romania calcul num toler interv describ composit variabl popul tradit soybean varieti marketplac comparison histori safe soybean common compon anim feed human food lead conclus roundup readi soybean num num composit equival safe nutriti convent soybean varieti grown commerci
MED-1746~impact alter herbicid residu transgen herbicide resist crop standard set herbicid residu pubm ncbi abstract global area cover transgen genet modifi crop rapid increas introduct mid num crop render herbicid resist envisag modif impact profil level herbicid residu crop articl main categori herbicid resist includ resist acetolactate synthas inhibitor bromoxynil glufosin glyphos review topic consid molecular mechan herbicid resist natur level residu form impact residu definit maximum residu limit mrls defin codex alimentarius commiss nation author general conclus drawn natur level residu case by cas basi intern residu definit mrls lack herbicide crop combin harmonis recommend copyright num societi chemic industri
MED-1747~legaci public health syphili studi tuskege hiv aids rel belief heterosexu african american latino abstract knowledg public health syphili studi tuskege cite princip reason low particip rate racial ethn minor african american biomed research studi explor possibl data random digit dial telephon survey num african american num latino age num num year investig associ knowledg usph syphili studi tuskege endors hiv aid conspiraci theori respond drawn area low incom predomin race segreg citi household los angel result african american signific latino endors hiv aid conspiraci theori african american awar usph syphili studi tuskege sst num african american num latino report heard syphili studi tuskege awar syphili studi tuskege signific predictor endors hiv aid conspiraci theori result suggest factor import account low biomed behavior studi particip rate
MED-1748~complet gene pass food human blood abstract bloodstream consid environ separ world digest tract standard paradigm larg macromolecul consum food pass direct circulatori system digest protein dna thought degrad small constitu amino acid nucleic acid absorb complex activ process distribut part bodi circul system base analysi num human sampl independ studi report evid meal deriv dna fragment larg carri complet gene avoid degrad unknown mechan enter human circul system blood sampl relat concentr plant dna higher human dna plant dna concentr show surpris precis log norm distribut plasma sampl non plasma cord blood control sampl found free plant dna
MED-1749~matern fetal exposur pesticid genet modifi food eastern township quebec canada pubm ncbi abstract pesticid genet modifi food pagmf engin toler herbicid glyphos glyp gluphosin gluf insecticid bacteri toxin bacillus thuringiensi bt aim studi evalu correl matern fetal exposur determin exposur level glyp metabolit aminomethyl phosphor acid ampa gluf metabolit num methylphosphinicopropion acid num mppa cri num protein bt toxin eastern township quebec canada blood thirti pregnant women pw thirty nin nonpregn women npw studi serum glyp gluf detect npw detect pw serum num mppa cryab num toxin detect pw fetus npw studi reveal presenc circul pagmf women pregnanc pave field reproduct toxicolog includ nutrit utero placent toxic copyright num elsevi reserv
MED-1750~clinic agricultur evolutionari biolog myostatin compar review abstract discoveri myostatin introduct mighti mous decad ago spur basic appli research impact popular cultur myostatin nul genotyp produc doubl muscl mice livestock recent child field rapid growth surpris potenti benefit enhanc muscl growth clinic agricultur set recent studi suggest block myostatin inhibitori effect improv clinic treatment muscl growth disord compar studi suggest action part conserv neutral myostatin effect agricultur signific extrapol studi vertebr model fish mammal confus genom duplic event result product retent uniqu myostatin gene fish speci comparison suggest myostatin action limit skelet muscl se addit influenc tissu includ cardiac muscl adipocyt brain therapeut intervent clinic farm potenti altern side effect impact tissu addit presenc multipl activ diversifi myostatin gene fish speci uniqu opportun studi adapt molecular evolut provid insight myostatin nonmuscl action result compar studi gain visibl biomed field
MED-1751~commerci conspiraci theori pilot studi abstract categoris conspiraci theori present studi examin individu demograph predictor belief commerci conspiraci theori british sampl num women men result show peopl cynic sceptic regard advertis trick tactic organis bank alcohol drug tobacco compani belief sort identifi cluster label sneaki manipul change the rul suppression prevent high alpha scale suggest general belief commerci conspiraci regress suggest peopl religi left w pessimist self defin wealthi neurot open to experi believ commerci conspiraci individu differ variabl explain varianc belief implic find literatur conspiraci theori discuss limit studi discuss
MED-1752~regul skelet muscl mass mice tgf beta superfamili member pubm ncbi abstract transform growth factor beta tgf beta superfamili encompass larg group growth differenti factor play import role regul embryon develop maintain tissu homeostasi adult anim degener polymeras chain reaction identifi murin tgf beta famili member growth differenti factor num gdf num express specif develop adult skelet muscl earli stage embryogenesi gdf num express restrict myotom compart develop somit stage adult anim gdf num express muscl bodi determin biolog function gdf num disrupt gdf num gene gene target mice gdf num null anim signific larger wild typ anim show larg widespread increas skelet muscl mass individu muscl mutant anim weigh num time wild typ anim increas mass result combin muscl cell hyperplasia hypertrophi result suggest gdf num function specif negat regul skelet muscl growth
MED-1753~current state gmo govern readi gm anim pubm ncbi abstract histori gmo conflict debat gm anim futur depend respons regulatori landscap rang interest group nation region intern level focus eu usa articl examin form multi level respons increas role cultur valu contribut exist interest group consequ implic commerci green red gm anim biotechnolog copyright num publish elsevi
MED-1754~recurs furi conspiracist ideat blogospher respons research conspiracist ideat abstract conspiracist ideat repeat implic reject scientif proposit empir evid date spars recent studi involv visitor climat blog found conspiracist ideat reject climat scienc reject scientif proposit link lung cancer smoke hiv aid lewandowski al press log num articl analys respons climat blogospher public log num identifi trace hypothes emerg respons log num question valid paper conclus establish criteria identifi conspiracist ideat show hypothes exhibit conspiratori content counterfactu hypothes initi narrowli focus log num ultim grew scope includ actor author log num univers execut media organ australian govern pattern blogospher respons log num illustr role conspiracist ideat reject scienc altern scholar interpret advanc futur
MED-1755~occurr livestock associ methicillin resist staphylococcus aureus turkey broiler barn contamin air soil surfac vicin abstract emiss microorgan resist bacteria methicillin resist staphylococcus aureus mrsa poultri farm public interest occurr relev controversi discuss limit data issu studi investig occurr livestock associ la mrsa insid previous test mrsa posit poultri barn germani total turkey broiler fatten farm investig time longitudin studi fatten period sampl collect anim anim environ insid barn includ air barn surround ambient air boot swab ground surfac distanc barn cross sect studi carri insid barn turkey broiler farm fat period cross sect studi la mrsa detect air barn num num num sampl origin anim detect level num num broiler num num turkey farm longitudin studi la mrsa found ambient air turkey barn ground surfac downwind side num turkey broiler farm spa type isol observ insid barn transmiss mrsa poultri farm emiss airborn rout
MED-1757~longitudin studi contamin air soil surfac vicin pig barn livestock associ methicillin resist staphylococcus aureus abstract num year sampl num day sampl season pig floor air insid pig barn ambient air soil distanc commerci livestock associ methicillin resist staphylococcus aureus la mrsa posit pig barn north east germani la mrsa isol anim floor air sampl barn show rang airborn la mrsa num num cfu m num median num cfu m num downwind barn la mrsa detect low concentr num num cfu m num distanc num num upwind air sampl negat contrast la mrsa found soil surfac distanc num num downwind barn statist differ observ proport posit soil surfac sampl distanc upwind barn posit soil surfac sampl found sporad signific posit la mrsa sampl found summer season air soil sampl upwind downwind pig barn spa type confirm ident la mrsa type found insid barn result show regular airborn la mrsa transmiss deposit strong influenc wind direct season num posit pig barn boot sampl method suitabl character contamin vicin la mrsa posit pig barn airborn rout
MED-1759~livestock associ methicillin resist staphylococcus aureus respons human colon infect area itali high densiti pig farm abstract background livestock associ mrsa la mrsa belong st num lineag common pig anim emerg central northern europ risk factor mrsa farm worker strain belong st num respons human colon infect area high livestock farm aim studi investig occurr livestock associ methicillin resist staphylococcus aureus la mrsa human colon infect area lombardi region itali italian region highest densiti pig farm method period march april num nasal swab subject admiss local hospit serv area lombardi region devot agricultur farm period march num februari num mrsa strain community acquir infect cai observ hospit collect molecular character isol includ sccmec type spa type multilocus sequenc type mlst result num nasal swab examin num yield mrsa strain assign sequenc type st num spa num isol num num isol categor la mrsa num isol hospit origin strain posit panton valentin leukocidin gene twenti mrsa isol detect cai num skin soft tissu infect num infect mrsa isol otiti externa num st num pvl negat categor la mrsa isol assign num st num strain pvl posit communiti acquir ca mrsa belong clone frequent st num conclus area itali high densiti pig farm la mrsa colon popul rare produc infect typic ca mrsa common la mrsa cai
MED-1760~effect fast food brand young children tast prefer pubm ncbi abstract object examin effect cumul real world market brand exposur young children test influenc brand heavili market sourc tast prefer design experiment studi children tast num pair ident food beverag packag mcdonald match unbrand packag tast tast set preschool low incom children particip sixty thre children sd age num num year rang num num year main exposur brand fast food outcom measur summari total tast prefer score rang num unbrand sampl num prefer num mcdonald brand sampl test null hypothesi children express prefer result sd total tast prefer score food comparison num num median num interquartil rang num num signific greater num indic children prefer tast food drink thought mcdonald moder analysi found signific greater effect brand children televis set home children ate food mcdonald conclus brand food beverag influenc young children tast percept find consist recommend regul market young children suggest brand strategi improv young children eat behavior
MED-1761~market fast food impact fast food restaur children hospit pubm ncbi abstract object object studi num determin fast food restaur preval hospit pediatr resid num evalu hospit environ affect purchas percept fast food method survey pediatr resid program fast food restaur hospit determin preval fast food restaur hospit survey adult children pediatr outpati visit num hospit hospit on sit mcdonald restaur hospit mcdonald site mcdonald brand hospit on sit mcdonald brand sought determin attitud consumpt influenc purchas fast food mcdonald food result fifty nin num hospit pediatr resid fast food restaur total num outpati survey analyz fast food consumpt survey day common hospit respond num hospit num hospit num purchas mcdonald food hospit num hospit num hospit num mcdonald account num fast food consum hospit respond num bought food on sit mcdonald logist regress analysi hospit respond num time respond hospit purchas mcdonald food survey day visitor hospit hospit mcdonald support hospit financi respond hospit rate mcdonald food healthier respond hospit conclus fast food restaur fair common hospit sponsor pediatr resid program mcdonald restaur children hospit signific increas purchas mcdonald food outpati belief mcdonald corpor support hospit financi higher rate healthi mcdonald food
MED-1762~meat intak reproduct paramet young men abstract background unit state anabol sex steroid administ cattl growth promot concern reproduct consequ practic men eat beef investig meat consumpt semen qualiti paramet reproduct hormon level young men method semen sampl obtain num men age num year diet assess previous valid food frequenc questionnair linear regress analyz cross sect associ meat intak semen qualiti paramet reproduct hormon adjust potenti confound result invers relat process red meat intak total sperm count adjust relat differ total sperm count men increas quartil process meat intak num ref num confid interv num num num num num num num num million test trend num associ strongest men abstin time num day driven strong invers relat process red meat intak ejacul volum test trend num conclus popul young men process meat intak lower total sperm count distinguish associ due residu confound abstin time repres true biolog effect
MED-1763~sensit child sex steroid impact exogen estrogen pubm ncbi abstract current trend increas incid testi breast prostat cancer poor understood assum sex hormon play role disrupt sex hormon action believ involv increas occurr genit abnorm newborn boy precoci puberti girl articl recent literatur sex steroid level physiolog role childhood review conclud circul level estradiol prepubert children lower origin claim ii children extrem sensit estradiol respond increas growth and or breast develop serum level current detect limit iii threshold establish hormon effect children expos exogen steroid endocrin disruptor iv hormon level fetal prepubert develop sever effect adult life daili product rate sex steroid children estim food drug administr num risk assess high overestim revis lower threshold estrogen action establish caution avoid unnecessari exposur fetus children exogen sex steroid endocrin disruptor low level
MED-1764~lipid concentr semen qualiti life studi abstract declin sperm count rate num year parallel rise preval obes lipid level strong obes high lipid level hyperlipidemia play import role declin fertil addit environment lifestyl factor object popul base cohort studi evalu associ men serum lipid concentr semen qualiti paramet num male partner coupl desir pregnanc discontinu contracept particip provid prospect semen sampl num men provid semen sampl num men provid sampl approxim month linear mix effect model estim associ baselin lipid concentr semen qualiti paramet adjust age bodi mass index race found higher level serum total cholesterol free cholesterol phospholipid signific lower percentag sperm intact acrosom smaller sperm head area perimet result suggest lipid concentr affect semen paramet specif sperm head morpholog highlight import cholesterol lipid homeostasi male fecund
MED-1765~effect simvastatin pravastatin gonad function male hypercholesterolem patient pubm ncbi abstract inhibit cholesterol biosynthesi hydroxymethyl glutaryl coenzym hmg coa reductas inhibitor theori advers affect male gonad function cholesterol precursor steroid hormon object random double blind trial compar effect simvastatin pravastatin placebo gonad testosteron product spermatogenesi num week placebo lipid low diet run in period num male patient age num num year type iia iib hypercholesterolemia low dens lipoprotein ldl cholesterol num num mg dl normal basal level testosteron random assign treatment simvastatin num mg num simvastatin num mg num pravastatin num mg num placebo num daili num week treatment total cholesterol level decreas num num ldl cholesterol decreas num num num active treat group num comparison placebo num week statist signific differ placebo group active treat group chang baselin testosteron human chorion gonadotropin hcg stimul testosteron free testosteron index follicle stimul hormon fsh lutein hormon lh sex hormone bind globulin shbg statist signific differ week num week num chang baselin sperm concentr ejacul volum sperm motil activ treatment relat placebo simvastatin pravastatin toler summari found evid clinic meaning effect simvastatin pravastatin gonad testosteron product testosteron reserv multipl paramet semen qualiti
MED-1766~lipid testicular function pubm ncbi abstract studi num male patient primari hyperlipoproteinaemia control group num healthi men num infertil male treatment undertaken spermiogram semin biochem studi measur plasma hormon level lipid determin carri hyperlipoproteinaem patient show abnorm spermiogram valu lower control semen volum semin biochem determin normal major hormon profil show abnorm valu num lipid abnorm common azoosperm infertil men lipid level higher correl studi suggest high level and or tg poor semen qualiti higher fsh level result studi suggest high lipid level exert advers direct effect testicular level
MED-1768~milk respons male reproduct disord pubm ncbi abstract role environment compound estrogen activ develop male reproduct disord sourc great concern rout human exposur estrogen concern cow milk amount estrogen major sourc animal deriv estrogen human diet milk dairi product account num estrogen consum human consum milk obtain heifer half pregnanc estrogen level cow mark elev milk consum unlik consum num year ago modern genetically improv dairi cow holstein fed combin grass concentr grain protein mix by product lactat half pregnanc num day gestat hypothes milk respons part male reproduct disord copyright num harcourt publish
MED-1770~health impact anim oestrogen food pubm ncbi abstract oestrogen govern reproduct function vertebr present anim tissu theoret maximum daili intak tmdi oestradiol num eta consumpt cattl meat calcul num ng oestradiol contain growth promot agent tmdi increas factor num num ng oestradiol num eta assum singl dosag good anim husbandri observ pork poultri similar amount oestrogen untreat cattl concentr oestradiol num eta milk estim num pg ml scarc data egg report num pg g oestradiol num eta risk evalu oestrogen growth promot agent limit analyt uncertainti residu oestradiol num lpha import oestrogen conjug wide unknown perform mass spectrometri improv confirm oestrogen concentr food present potenti relev oestradiol acyl ester actual daili product rate oestradiol prepubert children role oestradiol metabolit cancer obscur presenc cytoplasm oestrogen receptor subtyp potenti oestradiol effect non reproduct function requir examin
MED-1771~observ human semen analysi pubm ncbi abstract semen analysi num unmarri medic student age group num year carri higher liquefact time ph motil lower sperm count abnorm form observ compar report valu liquefact time ph sperm count found signific non vegetarian vegetarian due differ dietari protein
MED-1773~dairi food intak relat semen qualiti reproduct hormon level physic activ young men abstract studi question increas consumpt dairi food lower semen qualiti summari answer found intak full fat dairi invers relat sperm motil morpholog associ driven primarili intak chees independ dietari pattern suggest environment estrogen respons putat secular declin sperm count dairi food larg amount estrogen studi suggest dairi contribut factor decreas semen qualiti find consist studi studi design size durat rochest young men studi num cross sect studi conduct num num univers rochest participants materi set method men age num num year includ analysi diet assess food frequenc questionnair linear regress analyz relat dairi intak convent semen qualiti paramet total sperm count sperm concentr progress motil morpholog ejacul volum adjust age abstin time race smoke status bodi mass index recruit period moderate to intens exercis tv watch total calori intak main result role chanc total dairi food intak invers relat sperm morpholog p trend num associ driven intak full fat dairi food adjust differ num confid interv normal sperm morpholog percent num num num men upper half lower half full fat dairi intak num equival contrast low fat dairi intak pronounc num num num num full fat dairi intak signific lower percent progress motil sperm num limit reason caution cross sect studi causal infer limit wider implic find research prove causal link high consumpt full fat dairi food detriment effect semen qualiti verifi find intak full fat dairi food consid attempt explain secular trend semen qualiti men children restrict intak studi funding compet interest european union seventh framework program environ development effect environ reproduct health deer grant num grant num type entrez nucleotid attr  text dk num term id num term text dk num dk num ruth kirschstein nation research servic award num dk num nation institut health author conflict interest declar
MED-1774~nation survey persist bioaccumul toxic pbt pollut unit state milk suppli pubm ncbi abstract studi measur num persist bioaccumul toxic pbt pollut milk suppli milk fat highest dietari sourc exposur pbts import understand level food nationwid sampl collect num dairi plant juli num januari num level chemic chlorobenzen pesticid halogen organ group determin detect limit sampl nation averag comput num chemic chemic group found detect limit nation averag cdd cdf pcb teq concentr num num pg l total num pg l level half valu found similar studi conduct num differ fact indic declin milk level assum exposur level nondairi pathway remain time period result decreas adult background dioxin exposur num pah detect nation averag rang num num ng l cadmium concentr rang num num ng l nation averag num ng l lead concentr consist higher cadmium rang num num ng l nation averag num ng l pah show strongest seasonal geograph differ higher level winter summer north south east west averag adult daili intak total milk fat ingest comput detect compound compar total intak pathway cdd cdf pcb teq num num pg day pah num num micro g day lead num num micro g day cadmium num num micro g day
MED-1775~comparison individu antioxid sperm semin plasma fertil infertil men pubm ncbi abstract object measur individu antioxid sperm semin plasma fertil infertil men determin antioxid reduc infertil men design semen sampl prepar discontinu percol gradient separ sperm semin plasma antioxid concentr assess sampl screen phorbol ester induc reactiv oxygen speci ros activ set depart obstetr gynaecolog clinic biochemistri queen univers belfast northern ireland patient fifty nin male patient attend infertil center num men wive ongo pregnanc ivf normozoosperm semen profil num infertil men normozoosperm num men asthenozoosperm semen profil main outcom measur ascorb urat sulphydryl group tocopherol carotenoid concentr measur sperm semin plasma fertil infertil men result semin plasma ascorb contribut urat thiol level ascorb ascorb level semin plasma asthenozoosperm individu ros signific reduc sperm thiol contribut ascorb fraction total conclus semin plasma ascorb urat thiol major antioxid present contrast sperm group major contributor sampl exhibit ros activ ascorb concentr semin plasma signific reduc
MED-1776~semen qualiti trend french region consist global chang environment exposur pubm ncbi abstract retrospect studi carri recent larg sampl men close general popul report signific strong declin sperm concentr morpholog franc num num studi trend region franc data obtain fivnat databas studi sampl compris male partner steril women tube absent block locat assist reproduct technolog center bayesian spatio tempor model parametr time trend adjust age model time trend region result show sperm concentr decreas region franc aquitain show highest decreas midi pyr es lowest averag period total motil region show slight increas bourgogn show steep signific decreas sperm morpholog decreas region decreas aquitain midi pyr es stronger compar trend conclus decreas sperm concentr morpholog shown french metropolitan territori level observ region franc consist global chang environment exposur endocrin disruptor hypothesi ubiquitari exposur chemic grow general popul franc num result support lifestyl hypothesi highest decreas lowest valu consist observ proxim region high agricultur dens popul
MED-1777~shed light controversi surround tempor declin human sperm count systemat review abstract systemat examin evid declin sperm count hypothesi increas exposur environment pollut respons declin search engin includ pubm medlin embas biosi cochran librari identifi epidemiolog studi publish num num conclud evid confirm worldwid declin sperm count scientif truth causat role endocrin disruptor tempor declin sperm product assumpt base meta analys retrospect studi well conduct research confirm find acknowledg difficult to control confound factor high variabl natur semen select criteria compar popul time period secular trend studi qualiti laboratori method count sperm appar geograph variat semen qualiti main issu complic interpret evid owe import subject uncertainti prevail continu monitor semen qualiti reproduct hormon xenobiot definit fecund
MED-1778~dairi intak semen qualiti men attend fertil clinic abstract object examin relationship dairi food intak semen paramet design longitudin studi set men attend academ medic center fertil clinic boston ma patient num men intervent main outcom measur total sperm count sperm concentr progress motil morpholog result low fat dairi intak posit relat sperm concentr progress motil averag men highest quartil intak num num servings day num confid interv ci num higher sperm concentr num num ci num num percentag unit higher sperm motil men lowest quartil intak num servings day associ primarili explain intak low fat milk result low fat milk num ci num higher sperm concentr num num ci num num percentag unit higher sperm motil chees intak lower sperm concentr smoker group men highest tertil intak num num servings day num num ci num num lower sperm concentr men lowest tertil chees intak num servings day conclus find suggest low fat dairi intak low fat milk relat higher sperm concentr progress motil chees intak lower sperm concentr past current smoker
MED-1779~reactiv oxygen species tot antioxid capac score measur oxid stress predict male infertil pubm ncbi abstract imbal reactiv oxygen speci ros product total antioxid capac tac semin fluid oxid stress correl male infertil composit ros tac score strong correl infertil ros tac measur ros tac ros tac score semen num patient num healthi control patient num varicocel varicocel prostat num vasectomi revers num idiopath infertil ros level higher infertil men varicocel prostat se num num vasectomi revers num num infertil group signific lower ros tac score control ros tac score identifi num patient signific ros identifi varicocel idiopath infertil num patient partner achiev pregnanc ros tac score num num similar control signific higher num patient remain infertil num num num ros tac score measur oxid stress superior ros tac discrimin fertil infertil men infertil men male factor idiopath diagnos signific lower ros tac score control men male factor diagnos eventu initi success pregnanc signific higher ros tac score fail
MED-1780~happen human fertil pubm ncbi abstract semen qualiti declin recent decad popul north western europ time coupl fertil increas hypothes suggest appar inconsist alongsid deterior spermatogenesi clear evid increas relat problem notabl testicular cancer sharpli rise trend condit start centuri ago  decad earlier thought evid environment origin definit genet compon relationship genet environ discuss context puzzl infertil inherit imposs evolutionari standpoint poor semen qualiti relat testicular cancer zygot develop cancer lik disrupt genet apparatus observ implic offspr health context human reproduct prone higher degre impair mammalian speci relat spermatogenesi coupl fertil earli pregnanc loss embryon aneuploidi femal male medi pathway implic unclear human specif origin evolutionary genet historico soci timescal import relat pathogenesi evid popular explan male reproduct system impair endocrin disrupt hypothesi explain main featur descript epidemiolog altern pathogenesi outlin exposur consid respons
MED-1781~high dietari intak satur fat reduc semen qualiti num young danish men general popul pubm ncbi abstract background satur fat intak cardiovascular diseas cancer risk newli publish studi found associ satur fat intak lower sperm concentr infertil men object object examin associ dietari fat intak semen qualiti num young danish men general popul design cross sect studi men recruit examin determin fit militari servic num num deliv semen sampl underw physic examin answer questionnair compris quantit food frequ questionnair assess food nutrient intak multipl linear regress analys perform semen variabl outcom dietari fat intak exposur variabl adjust confound result lower sperm concentr total sperm count men high intak satur fat found signific dose respons associ found men highest quartil satur fat intak num ci num num lower sperm concentr num ci num lower total sperm count men lowest quartil associ semen qualiti intak type fat found conclus find potenti great public interest diet past decad part explan recent report high frequenc subnorm human sperm count reduct satur fat intak benefici general reproduct health
MED-1782~antioxid reduc sperm dna fragment unexpect advers effect pubm ncbi abstract reactiv oxygen speci ros negat impact sperm dna lead format oxid product num oxo num dihydroxyguanosin compound fragment mutagen effect patient treatment oral antioxid vitamin standard practic male infertil attempt decreas format ros improv fertil studi dna fragment index degre sperm decondens measur sperm chromatin structur assay num day treatment antioxid vitamin zinc selenium antioxid treatment led decreas sperm dna fragment num num suggest part decay link ros led unexpect negat effect increas sperm decondens order magnitud num num open interchain disulphid bridg protamin explain aspect antioxid vitamin vitamin open cystin net interf patern gene activ preimplant develop observ explain discrep observ role antioxid treatment improv male fertil
MED-1783~semen qualiti relat antioxid intak healthi male popul abstract object assess relationship dietari antioxid intak semen qualiti young healthi male design cross sect studi set univers colleg campus rochest york area patient num university ag men intervent main outcom measur semen volum total sperm count concentr motil total motil count morpholog result progress motil num num ci num num percentag unit higher men highest quartil caroten intak compar men lowest quartil similar result observ lutein intak lycopen intak posit relat sperm morpholog adjust percentag num ci morpholog normal sperm increas quartil lycopen intak num num num num num num num num num num num num non linear relationship vitamin intak sperm concentr men quartil intak averag highest sperm concentr men top quartil intak lowest concentr conclus popul healthi young men carotenoid intak higher sperm motil case lycopen sperm morpholog data suggest dietari carotenoid posit impact semen qualiti
MED-1784~associ sperm qualiti oxid stress semin antioxid activ pubm ncbi abstract object determin semin antioxid capac oxid stress marker associ semen qualiti oxid stress consid major etiolog factor male infertil subject method semen sampl obtain num men categor basi sperm count motil morpholog semin oxid antioxid marker lipid peroxid lpo protein carbonyl pc superoxid dismutas sod catalas cat thiol ascorb acid determin result sperm count signific correl posit progress sperm motil normal morpholog sperm count normal morpholog show signific negat correl lpo pc sperm count progress motil show signific posit relationship sod sod cat thiol posit lpo pc negat elev sperm count conclus insuffici antioxid enzym increas oxid stress attribut risk declin semen qualiti protect role antioxid enzym oxid damag rule copyright num canadian societi clinic chemist publish elsevi reserv
MED-1785~walnut improv semen qualiti men consum western styl diet random control dietari intervent trial pubm ncbi abstract test hypothesi num whole shel walnuts day ad western styl diet healthi young men benefici affect semen qualiti random parallel two group dietari intervent trial single blind mask outcom assessor conduct num healthi men age num yr routin consum western styl diet primari outcom improv convent semen paramet sperm aneuploidi baselin num wk secondari endpoint includ blood serum sperm fatti acid fa profil sex hormon serum folat group consum walnut num experienc improv sperm vital motil morpholog chang group continu usual diet avoid tree nut num compar differ group baselin signific found vital num motil num morpholog normal form num serum fa profil improv walnut group increas omega num num omega num num control group plant sourc omega num alpha linolen acid ala increas num sperm aneuploidi invers correl sperm ala sex chromosom nullisomi spearman correl num num find demonstr walnut ad western styl diet improv sperm vital motil morpholog
MED-1786~good semen qualiti life expect cohort studi num men pubm ncbi abstract fertil status predict mortal studi examin effect semen qualiti subsequ mortal men refer copenhagen sperm analysi laboratori general practition urologist num num uniqu person identif number link danish central regist hold inform case cancer death number children danish popul men decemb num death censor whichev occur total mortal cause specif mortal cohort compar age standard danish men semen characterist num men azospermia refer infertil problem mortal decreas sperm concentr increas threshold num million ml percentag motil morpholog normal spermatozoa semen volum increas mortal decreas dose respons manner trend num decreas mortal men good semen qualiti due decreas wide rang diseas found men children decreas mortal attribut sole lifestyl and or social factor semen qualiti fundament biomark male health
MED-1787~evid decreas qualiti semen past num year abstract object investig semen qualiti chang past num year design review public semen qualiti men histori infertil select cumul index medicus current list num medlin silver platter databas num august num subject num men includ total num paper publish num num main outcom measur sperm densiti semin volum result linear regress data weight number men studi show signific decreas sperm count num num ml num num num ml num num semin volum num ml num ml num indic pronounc decreas sperm product express declin sperm densiti conclus genuin declin semen qualiti past num year male fertil extent correl sperm count result reflect reduct male fertil biolog signific emphasis concomit increas incid genitourinari abnorm testicular cancer possibl cryptorchid hypospadia suggest grow impact factor effect male gonad function
MED-1788~micronutri intak improv sperm dna qualiti older men pubm ncbi abstract object investig lifestyl factor increas dietari intak micronutri reduc risk sperm dna damag older men benefit younger men design cross sect studi design equal assign age group set nation laboratori univers patient nonclin group num year old nonsmok men num report fertil problem main outcom measur sperm dna damag measur alkalin neutral dna electrophoresi sperm comet assay result sociodemograph occup exposur medic reproduct histori lifestyl habit determin questionnair averag daili dietari supplement intak micronutri vitamin vitamin b caroten zinc folat determin num item modifi block food frequenc questionnair ffq men highest intak vitamin approxim num sperm dna damag alkalin sperm comet men lowest intak similar find vitamin folat zinc caroten older men num year highest vitamin intak approxim num sperm dna damag compar older men lowest intak similar find vitamin zinc older men highest intak micronutri show level sperm damag similar younger men younger men num year benefit higher intak micronutri survey conclus men higher dietari supplement intak micronutri produc sperm dna damag older men rais broader question lifestyl factor includ higher intak antioxid micronutri protect somat germ cell age associ genom damag copyright num publish elsevi
MED-1789~nonextract polyphenol major part dietari polyphenol studi spanish diet pubm ncbi abstract scope dietari polyphenol pp divid group extract polyphenol epp compound solubil aqueous organ solvent nonextract polyphenol nepp compound remain extract residu studi food polyphenol dietari intak address exclus epp object work determin actual amount pp includ nepp food diet method result hplc ms analys perform identifi epp methanol aceton extract nepp acid hydrolyz extract residu cereal fruit veget nut legum nepp content estim hydrolyz pp nonextract proanthocyanidin pa rang num mg num dri weight fruit num mg num cereal substanti higher content epp nepp intak day person spanish diet num mg higher epp intak num mg fruit veget num mg major contributor total pp intak num mg conclus extract polyphenol major part dietari polyphenol knowledg intak physiolog properti nepp understand potenti health effect dietari pp
MED-1790~reduc childhood obes elimin num fruit juic abstract healthi hunger fre kid act num present opportun chang nutrit qualiti food serv low incom childcar center includ head start center excess fruit juic consumpt increas risk obes recent scientif evid sucros consumpt fiber common present fruit juic metabol syndrom liver injuri obes increas risk obes preschool children recommend depart agricultur child adult food care program manag meal pattern childcar center head start promot elimin fruit juic favor fruit children
MED-1791~combin prebiot short long chain inulin typ fructan enhanc calcium absorpt bone miner young adolesc pubm ncbi abstract background short term studi adolesc general shown enhanc calcium absorpt inulin typ fructan prebiot result inconsist studi conduct determin effect persist long term object object assess effect calcium absorpt bone miner accret num wk num supplement inulin typ fructan design pubert adolesc random assign receiv num g d mix short long degre polymer inulin typ fructan product fructan group maltodextrin placebo control group bone miner content bone miner densiti measur random num calcium absorpt measur stabl isotop baselin num wk num supplement polymorph fok num vitamin receptor gene determin result calcium absorpt signific greater fructan group control group num wk differ num num num num differ num num num interact fok num genotyp present subject ff genotyp initi respons fructan num fructan group greater increment whole bodi bone miner content differ num num num whole bodi bone miner densiti differ num num g cm num num control group conclus daili consumpt combin prebiot short long chain inulin typ fructan signific increas calcium absorpt enhanc bone miner pubert growth effect dietari factor calcium absorpt modul genet factor includ specif vitamin receptor gene polymorph
MED-1792~intak appl clear appl juic contrast effect plasma lipid healthi volunt pubm ncbi abstract purpos fruit consumpt decreas risk cvd cohort studi endors health author part num day campaign glass fruit juic general count serv fruit protect affect common risk factor cvd method appl common consum fruit chosen comprehens num num week dietari crossov studi assess effect appl num g day appl pomac num g day clear cloudi appl juic num ml day supplement lipoprotein blood pressur group num healthi volunt result intervent signific affect serum total ldl cholesterol trend lower serum ldl concentr observ appl num pomac num cloudi juic num intak hand ldl cholesterol concentr increas num clear juic compar appl pomac effect hdl cholesterol tag weight waist to hip ratio blood pressur inflamm hs crp composit gut microbiota marker glucos metabol insulin igf num igfbp num conclus appl rich polyphenol pectin potenti bioactiv constitu constitu segreg differ process juic product clear juic free pectin cell wall compon conclud fibr compon cholesterol low effect appl healthi human clear appl juic suitabl surrog fruit nutrit recommend
MED-1793~concept health rel properti nonextract polyphenol miss dietari polyphenol pubm ncbi abstract research studi field dietari polyphenol phenol compound chemic approach focus exclus polyphenol extract plant food organ solvent appreci part polyphenol extract organ solvent biolog nutrit epidemiolog studi recent studi shown nonextract polyphenol nepp major part total dietari polyphenol exhibit signific biolog activ physiolog approach propos basi bioavail health rel properti polyphenol depend solubl intestin fluid solubl organ solvent paper clarifi concept nepp distinguish chemic physiolog approach point main qualit quantit differ stress literatur databas refer extract polyphenol greater attent nepp fill current gap field dietari polyphenol
MED-1794~dietari role non starch polysaccharid human nutrit review pubm ncbi abstract nonstarch polysaccharid nsps occur natur food physiochem biolog properti compound correspond dietari fiber nonstarch polysaccharid show physiolog effect small larg intestin import health implic human remark properti dietari nsps water dispers viscos effect bulk ferment short chain fatti acid scfas featur lead diminish risk diet relat diseas major problem western countri emerg develop countri greater affluenc condit includ coronari heart diseas colo rect cancer inflammatori bowel diseas breast cancer tumor format miner relat abnorm disord laxat insolubl nsps cellulos hemicellulos effect laxat solubl nsps mixed link glucan lower plasma cholesterol level normal blood glucos insulin level make kind polysaccharid part dietari plan treat cardiovascular diseas type num diabet major proport dietari nsps escap small intestin intact ferment scfas commens microflora present colon cecum promot normal laxat short chain fatti acid number health promot effect effect promot larg bowel function nsps ferment product promot growth specif benefici colon bacteria offer prebiot effect mode action nsps therapeut agent propos present review addit nsps base film coat packag wrap commerci interest compat type food product physiolog nutrit impact nsps mechan involv fulli understood recommend dose dietari nsps intak age group studi
MED-1795~fruit consumpt risk type num diabet result prospect longitudin cohort studi abstract object determin individu fruit differenti risk type num diabet design prospect longitudin cohort studi set health profession unit state particip num women nurs health studi num num women nurs health studi ii num num men health profession follow up studi num free major chronic diseas baselin studi main outcom measur incid case type num diabet identifi report confirm supplementari questionnair result num num person year follow up num particip develop type num diabet adjust person lifestyl dietari risk factor diabet pool hazard ratio type num diabet servings week total fruit consumpt num num confid interv num num mutual adjust individu fruit pool hazard ratio type num diabet servings week num num num blueberri num num num grape raisin num num num prune num num num appl pear num num num banana num num num grapefruit num num num peach plum apricot num num num orang num num num strawberri num num num cantaloup pool hazard ratio increment fruit juic consumpt num num num associ risk type num diabet differ signific individu fruit num cohort conclus find suggest presenc heterogen associ individu fruit consumpt risk type num diabet greater consumpt specif fruit blueberri grape appl signific lower risk type num diabet greater consumpt fruit juic higher risk
MED-1796~associ adenovirus num infect obes metabol marker human meta analysi observ studi abstract background studi shown adenovirus num ad num influenc risk obes human clarifi relationship ad num infect obes lead effect approach manag obes object studi conduct meta analysi confirm influenc ad num infect obes metabol marker methodology princip find search medlin cochran librari pertin articl includ refer publish num april num english languag report origin observ studi includ meta analysi data extract perform independ review weight differ wmds pool odd ratio num confid interv num cis calcul random effect model num potenti relev studi num cross sect studi num conform select criteria pool analysi show wmd bmi ad num infect compar non infect num num ci num num num sensit analysi restrict studi adult yield similar result num num ci num num num increas risk obes ad num infect signific num num ci num num num signific differ found relat total cholesterol num triglycerid num hdl num blood glucos num waist circumst num systol blood pressur num conclusion signific ad num infect risk obes weight gain abnorm metabol marker includ waist circumst suggest ad num infect accumul subcutan fat viscer fat relationship ad num obes assess studi includ well design prospect studi gain understand ad num play role etiolog human obes
MED-1797~compar genom analysi human genom reveal chicken gene fat bodi weight pubm ncbi abstract select meat typ chicken broiler rapid growth accompani excess fat deposit studi analys num candid gene obes obesity rel trait human found chicken orthologu blast search identifi singl nucleotid polymorph snps signific differ allel frequenc broiler layer candid gene adrenerg beta num receptor surfac adrb num melanocortin num receptor mc num leptin receptor lepr mckusick kaufman syndrom mkks milk fat globule egf factor num protein mfge num adenyl kinas num ak num examin associ fat and or bodi weight bird extrem phenotyp num backcross popul vari level abdomin fat weight cent afw bodi weight assess level gene express real tim pcr gene adrb num mfge num found signific associ afw adrb num gene found signific higher express liver lean chicken compar fat individu approach appli identif quantit gene num author anim genet num sticht intern foundat anim genet
MED-1798~adenovirus num infect obes pubm ncbi abstract import factor lead fat accumul children genet inherit endocrin alter behavioural environment addit experiment anim studi shown infect due pathogen lead overweight obes condit studi human found incid seroconvers signific frequent obes adult children normal subject result studi conclus case rais question answer review literatur role adenovirus num ad num wide studi infecti agent anim human potenti associ childhood obes evid suggest studi evalu associ presenc ad num antibodi obes simpli unrel verifi subject greater tendenc obes easili suscept ad num infect predisposit suffer persist viral infect easili lead develop obes demonstr ad num play role obes import investig vaccin infect antivir drug capabl inhibit diseas progress copyright num elsevi reserv
MED-1799~adipogen human adenovirus ad num induc commit differenti lipid accumul human adipose deriv stem cell abstract human adenovirus ad num causat correl link anim human obes ad num enhanc differenti rodent preadipocyt effect adipogenesi human unknown indirect assess role ad num induc adipogenesi human obes effect virus commit differenti lipid accumul investig vitro primari human adipose deriv stem strom cell hasc ad num infect hasc time dose depend manner presenc osteogen media ad num infect hasc show signific greater lipid accumul suggest commit adipocyt lineag absenc adipogen induc ad num signific increas hasc differenti time depend express gene adipogen cascad ccaat enhanc bind protein peroxisom proliferator activ receptor fatti acid bind protein consequenti increas lipid accumul time viral dose depend manner induct hasc adipocyt state ad num support increas express lipoprotein lipas accumul extracellular fraction hasc subject harbor ad num dna adipos tissu due natur infect signific greater abil differenti compar ad num dna neg counterpart offer proof concept ad num potenti induc adipogenesi hasc contribut adipos induc virus
MED-1800~adenovirus num obes children adult sweden determin rapid elisa abstract background experiment natur human adenovirus num adv num infect multipl anim speci result obes increas adipogenesi lipid accumul adipocyt presenc adv num antibodi detect serum neutral assay previous obes children adult live usa south korea itali associ adult obes detect belgium th netherland usa militari personnel adv num infect shown reduc blood lipid level increas glucos uptak adipos tissu skelet muscl biopsi associ improv glycem control non diabet individu princip find elisa num clinic well character individu includ num children num non diabet adult num anonym blood donor resid central sweden repres popul stockholm area studi presenc antibodi adv num serum preval adv num posit lean individu increas num num num num num num num parallel increas obes preval found adv num posit serolog pediatr obes sever obes femal compar lean overweight mild obes individu num num fold adv num posit increas case adv num posit common femal male antilipid pharmacolog treatment high blood triglycerid level insulin sensit measur lower homa ir show higher point estim adv num posit obes femal male statist signific num conclus elisa show adv num infect pediatr obes sever obes adult femal lower risk high blood lipid level non diabet swedish individu
MED-1801~modern organ broiler chicken sold human consumpt provid energi fat protein pubm ncbi abstract object num royal colleg physician british cardiac societi recommend eat fatti red meat poultri lean situat chang time strike increas fat content standard broiler chicken aim present studi report snapshot data fat chicken sold public design sampl obtain random num num uk supermarket farm shop footbal club amount chicken fat estim emulsif chloroform methanol extract set food sold supermarket farm england subject chicken sampl result fat energi exceed protein loss num fatti acid num num ratio found high num oppos recommend num tag level meat bird exceed proport phospholipid higher muscl function num fatti acid docosapentaeno acid dpa num num num excess dha num num num previous analys usual bird dha dpa conclus tradit poultri egg land bas sourc long chain num fatti acid dha synthes parent precursor green food chain view obes epidem chicken provid time fat energi compar protein illog type chicken husbandri review regard implic anim welfar human nutrit
MED-1802~longitudin bmi older adult meat consumpt differenti type meat consum pubm ncbi abstract hypothes role meat consumpt bodi weight modul contradictori prospect studi associ meat consumpt bmi chang limit assess associ meat consumpt chang bmi time num men women age num netherland cohort studi dietari intak estim baselin ffq bmi ascertain baselin self report height num weight num num analys base sex specif categori daili total fresh meat red meat beef pork minc meat chicken process meat fish consumpt baselin linear mix effect model adjust confound assess longitudin associ signific cross sect differ bmi quintil total meat intak observ p trend num sex associ total fresh meat consumpt prospect bmi chang observ men bmi chang highest lowest quintil num num kg m num women bmi chang num kg m num men highest intak beef experienc signific lower increas bmi num num lowest intak bmi chang num num kg m num signific higher increas bmi higher intak pork women bmi chang highest lowest quintil num kg m chicken sex bmi chang highest lowest categori men women num kg m result remain similar stratifi median baselin bmi age stratifi analys yield mix result differenti bmi chang effect observ subtyp meat total meat consumpt factor direct relat total meat intak strong weight chang num prospect follow up elder popul
MED-1803~framework identif infect contribut human obes pubm ncbi abstract declar obes global epidem obes manag strategi target behaviour compon disord margin effect comprehens understand causat factor obes provid effect manag approach microb causat correl link obes anim human infect contribut human obes prevent treatment strategi public health polici address subtyp disord ethic reason preclud experiment infect human candid microb unequivoc determin contribut obes altern inform adipogen human adenovirus ad num creat templat examin comprehens contribut specif candid microb human obes clinician awar infectobes obes infecti origin potenti import effect obes manag copyright num elsevi reserv
MED-1804~human adenovirus num childhood obes pubm ncbi abstract increas evid obes human infect human adenovirus num adv num infect experiment anim adv num demonstr virus obes human studi shown preval adv num infect num greater obes adult human correl obes demonstr contrast publish studi present studi total num children show increas preval adv num infect obes children num compar non obes children num explan appar robust correl adv num infect obes children adult clear data anim peopl suggest adv num contribut worldwid increas childhood obes research identifi preval consequ adv num infect peopl age group geograph locat
MED-1806~long term adipos glycem control past adenovirus infect abstract object ad num human adenovirus increas adipos improv glycem control anim model similar natur ad num infect cross sect greater adipos glycem control human studi compar longitudin observ indic adipos bmi bodi fat percentag glycem control fast glucos insulin ad num infect versus uninfect adult research design method baselin sera hispan men women num screen post hoc presenc ad num specif antibodi indic adipos glycem control baselin num year past baselin compar seroposit seroneg subject adjust age sex addit age sex indic glycem control adjust baselin bmi analyz nondiabet subject result seroposit subject num greater adipos baselin compar seroneg subject longitudin seroposit subject show greater adipos indic lower fast insulin level subgroup analys reveal ad num seroposit baselin glycem control lower fast insulin level time normal weight group bmi num kg m num longitudin greater adipos overweight bmi num num kg m num obes bmi num kg m num men statist differ seroposit seroneg individu modest light multipl test perform conclus studi strengthen plausibl human ad num increas adipos attenu deterior glycem control panopt studi rais possibl infect modul obes diabet risk comprehens understand under recogn factor effect combat metabol disord
MED-1807~intak total anim plant protein subsequ weight waist circumfer european men women diogen project pubm ncbi abstract background protein consid increas thermogenesi satieti macronutri benefici effect prevent weight gain weight mainten object object studi assess associ amount type dietari protein subsequ weight waist circumfer wc method num men women countri particip european prospect investig cancer nutrit epic num year associ intak protein subgroup protein anim plant sourc weight year wc cm year investig gender centre specif multipl regress analys adjust made baselin dietari factor baselin anthropometr demograph lifestyl factor follow up time random effect meta analys obtain pool estim centr result higher intak total protein protein anim sourc subsequ weight gain gender strongest women associ attribut protein red process meat poultri fish dairi sourc associ intak plant protein subsequ weight clear associ intak total protein subgroup wc present associ show heterogen centr pool estim consid justifi conclus high intak protein found lower weight waist gain observ studi contrast protein food item anim origin meat poultri posit long term weight gain clear associ waist
MED-1808~human adenovirus num antibodi status obes children pubm ncbi abstract background human adenovirus num ad num thought induc obes direct effect viral num rf num gene lipogen enzym host adipocyt ad num preval num obes adult preval report childhood obes object determin preval ad num infect obes korean children age num num rang num num year correl infect bmi z score obes measur method blood drawn annual school physic exam clinic visit ad num status determin serum neutral assay routin serum chemistri valu result total num subject posit num ad num negat num signific higher bmi z score num num num waist circumfer num num cm num found infect versus uninfect children cardiovascular risk factor signific conclus ad num infect common obes korean children correl high obes ad num play role obes type num diabet epidem children
MED-1810~transmiss adenovirus induc adipos chicken model pubm ncbi abstract background previous report human adenovirus ad num induc adipos paradox lower level serum cholesterol chol triglycerid tg anim object evalu transmiss ad num ad num induc adipos chicken model design experi num chicken hous cage cage inocul ad num durat presenc ad num dna blood chicken monitor experi num group chicken intranas inocul ad num infect donor i d media control donor c d blood drawn num i d c d group inocul wing vein recipi chicken infect receiv i r control receiv c r sacrific num week post inocul blood drawn bodi weight note viscer fat separ weigh result experi num ad num dna blood inocul chicken uninocul chicken cage mate num inocul viral dna persist num day blood experi num compar c d viscer total bodi fat signific greater chol signific lower i d i r tg signific lower i d ad num isol num num blood sampl i d inocul i r chicken ad num dna present blood adipos tissu i d i r skelet muscl anim select random test conclus experi num ad num infect transmit horizont infect chicken chicken share cage addit experi num demonstr blood born transmiss ad num induc adipos chicken transmiss ad num induc adipos chicken model rais concern possibl human investig
MED-1811~phase studi investig safeti pharmacokinet high bioavail curcumin theracurmin cancer patient pubm ncbi abstract background grow number preclin studi demonstr curcumin promis anticanc drug poor bioavail major obstacl clinic applic overcom problem develop form curcumin theracurmin report high plasma curcumin level safe achiev singl administr theracurmin healthi volunt studi aim evalu safeti repetit administr theracurmin cancer patient method pancreat biliari tract cancer patient fail standard chemotherapi elig studi base previous pharmacokinet studi select theracurmin num mg curcumin level num start dose dose safe escal level num num mg curcumin theracurmin oral administ day standard gemcitabine bas chemotherapi addit safeti pharmacokinet data nf activ cytokin level efficaci quality of lif score evalu result ten patient assign level num level num peak plasma curcumin level median theracurmin administr num ng ml rang num num ng ml level num num ng ml rang num num ng ml level num unexpect advers event observ num patient safe continu theracurmin administr num month conclus repetit system exposur high concentr curcumin achiev theracurmin increas incid advers event cancer patient receiv gemcitabine bas chemotherapi
MED-1812~dietari habit past medic histori relat fatal pancrea cancer risk adventist pubm ncbi abstract epidemiolog studi diet pancrea cancer includ ecolog comparison limit number prospect case control studi food and or nutrient suggest increas risk cancer includ total fat intak egg anim protein sugar meat coffe butter consumpt raw fruit veget consist decreas risk dietari habit medic histori variabl evalu prospect studi fatal pancrea cancer num california seventh day adventist num num forti death pancrea cancer occur follow up period compar white adventist experienc decreas risk pancrea cancer death standard mortal ratio smr num men num women statist signific suggest relationship increas meat egg coffe consumpt increas pancreat cancer risk variabl signific relat risk control cigarett smoke increas consumpt vegetarian protein product bean lentil pea dri fruit high signific protect relationship pancrea cancer risk prior histori diabet increas risk subsequ fatal pancrea cancer histori surgeri peptic duoden ulcer histori tonsillectomi slight nonsignific protect relationship histori allerg reaction find suggest protect relationship frequent consumpt veget fruit high protease inhibitor content import increas pancrea cancer risk attend frequent consumpt meat anim product previous report posit associ diabet abdomin surgeri pancrea cancer risk support data
MED-1813~phase ii trial curcumin patient advanc pancreat cancer pubm ncbi abstract purpos pancreat cancer lethal food drug administration approv therapi gemcitabin erlotinib produc object respons num patient evalu clinic biolog effect curcumin diferuloylmethan plant deriv dietari ingredi potent nuclear factor kappab nf kappab tumor inhibitori properti advanc pancreat cancer experiment design patient receiv num curcumin mouth daili diseas progress restag num month serum cytokin level interleukin il num il num il num il num receptor antagonist peripher blood mononuclear cell express nf kappab cyclooxygenas num monitor result twenty f patient enrol num evalu respons circul curcumin detect drug glucuronid sulfat conjug form albeit low steady st level suggest poor oral bioavail patient show clinic biolog activ ongo stabl diseas num month interest addit patient mark tumor regress num accompani signific increas num num fold serum cytokin level il num il num il num il num receptor antagonist toxic observ curcumin down regul express nf kappab cyclooxygenas num phosphoryl signal transduc activ transcript num peripher blood mononuclear cell patient baselin level higher found healthi volunt interpati variat plasma curcumin level drug level peak num num ng ml remain constant num week conclus oral curcumin toler limit absorpt biolog activ patient pancreat cancer
MED-1814~dietari pattern risk pancreat cancer larg population bas case control studi san francisco bay area abstract pancreat cancer high lethal identifi modifi risk factor substanti public health impact population bas case control studi num case num control princip compon analysi multivari uncondit logist regress model examin dietari pattern risk pancreat cancer adjust risk factor prudent dietari pattern character greater intak veget fruit fish poultri grain low fat dairi approxim num reduct pancreat cancer risk men num num ci num num p trend num women num num ci num num p trend num western dietari pattern character higher intak red process meat potato chip sugari beverag sweet high fat dairi egg refin grain num fold increas risk pancreat cancer men num ci num num p trend num risk women men upper quintil western diet lower quintil prudent diet num fold increas risk consist recommend chronic diseas consum diet rich plant bas food grain white meat reduc risk pancreat cancer
MED-1817~meat fish consumpt risk pancreat cancer result european prospect investig cancer nutrit pubm ncbi abstract pancreat cancer fourth common cancer death worldwid larg geograph variat impli contribut diet lifestyl etiolog examin associ meat fish consumpt risk pancreat cancer european prospect investig cancer nutrit epic total num epic particip num european countri recruit num num includ analysi num nonendocrin pancreat cancer case observ calibr relat risk rrs num confid interv cis comput multivariable adjust cox hazard regress model consumpt red meat rr num increas day num num ci num num process meat rr num increas day num num ci num num increas pancreat cancer risk poultri consumpt tend increas pancreat cancer risk rr num increas day num num ci num num associ fish consumpt rr num increas day num num ci num num result support conclus world cancer research fund red process meat consumpt possibl increas risk pancreat cancer posit associ poultri consumpt pancreat cancer chanc find contradict previous find copyright num uicc
MED-1818~nutrient bas dietari pattern pancreat cancer risk pubm ncbi abstract purpos data role combin food and or nutrient pancreat cancer risk add inform dietari pattern potenti pancreat cancer appli exploratori princip compon factor analysi num major nutrient deriv italian case control studi method case num incid pancreat cancer case control num frequency match control admit hospit non neoplast diseas dietari inform collect valid reproduc food frequenc questionnair multipl logist regress model adjust sociodemograph variabl major recogn risk factor pancreat cancer estim odd ratio pancreat cancer dietari pattern result identifi dietari patterns nam anim product unsatur fat vitamin fiber starch rich explain num total varianc nutrient intak popul pattern posit associ found anim product starch rich pattern highest versus lowest quartil num num confid interv ci num num num num ci num num invers associ emerg vitamin fiber pattern num num ci num num associ observ unsatur fat pattern num num ci num num conclus diet character high consumpt meat anim product refin cereal sugar posit pancreat cancer risk diet rich fruit veget invers copyright num elsevi reserv
MED-1819~potenti gemcitabin turmer forc pancreat cancer cell line pubm ncbi abstract gemcitabin line cancer drug wide treatment pancreat cancer therapeut effici signific limit resist pancreat cancer cell chemotherapeut drug investig cytotox effect turmer forc tf supercrit hydroethanol extract turmer combin gemcitabin pancreat carcinoma cell line bxpc num panc num tf high cytotox bxpc num panc num cell line ic num valu num num microg ml superior cytotox curcumin gemcitabin ic num cell line num microg ml num pancreat cancer cell resist gemcitabin concentr num microg ml comparison tf induc cell death num cell num microg ml combin gemcitabin tf synergist ic num level achiev pancreat cancer cell line lower concentr calcusyn analysi cytotox data show gemcitabin turmer forc combin strong synerg combin index ci valu num num bxpc num panc num line ic num level synergist effect due increas inhibitori effect combin nuclear factor kappab activ signal transduc activ transcript factor num express compar singl agent
MED-1820~gemcitabin erlotinib advanc pancreat cancer systemat review meta analysi abstract background studi aim comprehens summar evid efficaci safeti gemcitabin erlotinib treat advanc pancreat cancer methodology princip find pubm embas cochran librari abstract recent major confer systemat search identifi relev public studi conduct advanc pancreat cancer patient treat gemcitabin erlotinib comparison gemcitabin report object respons rate diseas control rate progression fre surviv time to progress surviv num year surviv rate and or advers event includ data object respons rate diseas control rate num year surviv rate advers event rate combin meta analyst softwar random effect model data progression fre surviv time to progress surviv summar descript sixteen studi num advanc pancreat cancer patient treat gemcitabin erlotinib includ report median progression fre surviv time to progress median surviv num year surviv rate object respons rate diseas control rate num num month num num month num num num num num weight num year surviv rate object respons rate diseas control rate base studi report robust result num num num studi relev data incid total sever advers event num num frequent report advers event leucopenia rash diarrhea vomit neutropenia thrombocytopenia anaemia stomat drug induc liver injuri fatigu fever compar gemcitabin progression fre surviv surviv gemcitabin erlotinib signific longer death interstiti lung disease lik syndrom relat treatment conclusions signific gemcitabin erlotinib repres option treatment advanc pancreat cancer mild clinic meaning addit efficaci compar gemcitabin safeti profil general accept care manag specif advers event
MED-1825~flax breast cancer systemat review pubm ncbi abstract background flax food dietari supplement common menopaus symptom flax lignan linolen acid fiber content compon possess phytogestrogen anti inflammatori hormon modul effect conduct systemat review flax efficaci improv menopaus symptom women live breast cancer potenti impact risk breast cancer incid recurr method search medlin embas cochran librari ame incept januari num human intervent observ data pertain flax breast cancer result num record includ total num studi num random control trial num uncontrol trial num biomark studi num observ studi nonsignific ns decreas hot flash symptomatolog flax ingest num g d flax num g d increas tumor apoptot index num decreas num express num cell prolifer ki num index ns newli diagnos breast cancer patient compar placebo uncontrol biomark studi suggest benefici effect hot flash cell prolifer atyp cytomorpholog mammograph densiti anti angiogen activ dose num ground flax num mg secoisolariciresinol diglycosid daili observ data suggest associ flax decreas risk primari breast cancer adjust odd ratio aor num num confid interv ci num num mental health aor num num ci num num lower mortal multivari hazard ratio num num ci num num breast cancer patient conclus current evid suggest flax decreas risk breast cancer flax demonstr antiprolif effect breast tissu women risk breast cancer protect primari breast cancer mortal risk reduc live breast cancer author num
MED-1826~consumpt flaxse rich sourc lignan reduc breast cancer risk pubm ncbi abstract purpos investig associ intak flaxseed th richest sourc dietari lignan class phytoestrogen and breast cancer risk method food frequenc questionnair measur consumpt flaxse flax bread num women breast cancer num healthi control women particip ontario women diet health studi num logist regress investig associ consumpt flaxse flax bread breast cancer risk confound establish suspect breast cancer risk factor dietari factor assess result flaxse flax bread consum week num control women num variabl assess identifi confound associ flaxse flax bread breast cancer risk consumpt flaxse signific reduct breast cancer risk odd ratio num num confid interv ci num num consumpt flax bread num num ci num num conclus canadian studi knowledg report associ flaxse breast cancer risk found flaxse intak reduct breast cancer risk dietari intak flaxse modifi find public health import respect breast cancer prevent
MED-1827~vitro anti metastat activ enterolacton mammalian lignan deriv flax lignan down regul matrix metalloproteinas pubm ncbi abstract background actin cytoskeleton involv actin bas cell adhes cell motil matrix metalloproteinas mmps mmp num mmp num mmp num mmp num respons cell invas breast cancer metastasi dietari intak lignan flax seed convert enterolacton el enterodiol human system show enterolacton signific anti metastat activ demonstr abil inhibit adhes invas migrat mcf num mda mb num cell line materi method migrat inhibit assay actin bas cell motil assay revers transcriptas polymeras chain reaction rt pcr mmp num mmp num mmp num mmp num gene perform mcf num mda mb num cell line result enterolacton inhibit actin bas cell motil evidenc confoc imag photo document cell migrat assay result support observ enterolacton vitro signific down regul metastasis rel metalloproteinas mmp num mmp num mmp num gene express signific alter mmp num gene express found conclus suggest anti metastat activ el attribut abil inhibit cell adhes cell invas cell motil el affect normal filopodia lamellipodia structur polymer actin filament lead edg inhibit actin bas cell adhes cell motil process involv multipl force gener mechan actin filament protrus traction deadhes tail retract down regul metastasis rel mmp num mmp num mmp num gene express el respons cell invas step metastasi
MED-1828~quantit determin lignan isoflavonoid plasma omnivor vegetarian women isotop dilut gas chromatography mass sp pubm ncbi abstract quantit method determin lignan isoflavonoid phytoestrogen plasma present ion exchang chromatographi diphenol separ fraction num biolog activ fraction free compound mono disulf num biolog inact fraction mono diglucuronid sulfoglucuronid hydrolysi fraction purifi solid phase extract ion exchang chromatographi loss complet procedur correct radioact estrogen conjug step ad deuter intern standard compound measur matairesinol enterodiol enterolacton daidzein o desmethylangolensin equol genistein final determin carri isotop dilut gas chromatography mass spectrometri select ion monitor mode gc ms sim diphenol measur concentr low num num nmol l result plasma analys compound num pre postmenopaus omnivor vegetarian women present time import find free sulf fraction low genistein num total num enterolacton enterodiol occur fraction good correl plasma urin valu found total concentr individu compound vari great subject pmol l mumol l vegetarian higher valu vegan subject highest total enterolacton concentr exceed num mumol l conclud high specif method assay num lignan num isoflavonoid plasma develop method futur studi lignan isoflavonoid metabol
MED-1829~estradiol tamoxifen flaxse alter il num il num level normal human breast tissu vivo pubm ncbi abstract introduct sex steroid exposur increas risk breast cancer unclear mechan diet modif breast cancer prevent strategi proinflammatori cytokin famili il num implic cancer progress il num endogen inhibitor proinflammatori il num il num object object studi elucid estrogen tamoxifen and or diet modif alter il num level normal human breast tissu design method microdialysi perform healthi women hormon exposur tamoxifen therapi diet modif breast cancer women surgeri breast tissu biopsi reduct mammoplasti cultur result show signific posit correl estradiol vivo level il num breast tissu abdomin sc fat il num exhibit signific negat correl estradiol breast tissu tamoxifen dietari addit num flaxse day result signific increas level il num breast result confirm vivo cultur breast biopsi immunohistochemistri biopsi reveal cellular content il num suggest secret level affect breast cancer patient intratumor level il num signific higher compar normal adjac breast tissu conclus il num control estrogen vivo attenu antiestrogen therapi diet modif increas il num breast cancer women strong suggest il num potenti therapeut target breast cancer treatment prevent
MED-1830~explor num common drug supplement cognit older adult abstract background conflict report lack evidence bas data effect medic cognit cognit normal older adult explor num common medic older adult longitudin cognit perform method longitudin observ cohort analysi data collect septemb num num maintain nation alzheim coordin center nacc uniform data set particip age num year older cognit normal num composit score construct num psychometr test score particip reflect chang psychometr composit score baselin clinic assess assess calcul general linear model test composit chang score differ particip report start stop continu num frequently us medic nacc sampl result averag time assess num year sd num medic show differ num particip group psychometr chang score assess medic improv psychometr perform naproxen calcium vitamin ferrous sulfat potassium chlorid flax sertralin medic declin psychometr perform bupropion oxybutynin furosemid conclus report common medic cognit perform older adult studi investig mechan effect
MED-1831~children daili exposur polychlorin biphenyl dietari supplement fish oil pubm ncbi abstract children omega num polyunsatur fatti acid pufa elicit suit health benefit includ enhanc cognit develop subsequ dietari supplement omega num pufa increas popular largest sourc benefici pufa supplement fish oil signific level contamin polychlorin biphenyl pcbs object studi evalu congener specif pcb concentr num over the count children dietari supplement fish oils powd assess potenti pcb exposur ingest product daili basi supplement analys pcbs concentr num num ng pcbs g supplement serv size suggest daili exposur valu rang num num ng pcbs day daili exposur children supplement signific lower previous report adult supplement explain part variabl amount fish oil pufa content serv size base studi factor fish oil purif method molecular distil trophic level fish speci make fish oil indic pcb level children supplement fish supplement decreas increas daili pcb exposur compar ingest fresh fish eat fish high omega num pufa low pcbs reduc pcb exposur compar daili supplement fish oil product studi
MED-1832~visual acuiti essenti docosahexaeno acid arachidon acid diet term infant pubm ncbi abstract dietari suppli docosahexaeno acid dha arachidon aid aa term infant evalu double mask random clinic trial effect supplement term infant formula dha num total fatti acid dha num aa num visual acuiti develop hundr healthi term infant enrol studi num exclus formula f birth random group num exclus breast f gold standard group infant evalu time point num mo life blood fatti acid composit growth sweep visual evok potenti vep acuiti forc choic preferenti acuiti supplement term infant formula dha dha aa num mo life yield clear differ total red blood cell rbc lipid composit supplement term infant formula dha dha aa yield sweep vep acuiti num num wk age num wk age acuiti develop reach plateau rbc lipid composit sweep vep acuiti supplement infant similar human milk f infant rbc lipid composit sweep vep acuiti unsuppl infant signific human milk f infant differ acuiti diet group subtl detect forc choic preferenti protocol infant diet group similar rate growth toler diet earli dietari intak preform dha aa optim develop brain eye human infant
MED-1833~cod liver oil intak incid asthma norwegian adults  th hunt studi pubm ncbi abstract background cod liver oil import sourc vitamin fat solubl compon vitamin num cod liver oil formula norway high concentr vitamin num num ml high vitamin status increas risk chronic diseas object investig associ cod liver oil intak asthma develop method nord tr ndelag health studi total num norwegian adult age num year num num current analysi base num subject free asthma complet inform cod liver oil intak baselin cod liver oil intak defin daili intak num month year prior baselin incid asthma report new onset asthma num year follow up result num subject num num consum cod liver oil daili num month past year cod liver oil intak signific incid asthma num num ci num num adjust age sex daili smoke physic activ educ socio econom status famili histori asthma bodi mass index bmi posit associ consist age num num year sex men women famili histori asthma yes no bmi subgroup num num kg m num conclus intak cod liver oil high vitamin content signific increas incid adult onset asthma
MED-1834~role latitud ultraviolet radiat exposur vitamin childhood asthma hayfev australian multicent studi pubm ncbi abstract observ increas allergi preval decreas distanc equat posit associ ambient ultraviolet radiat contribut grow interest role vitamin etiolog allergi aim studi describ latitudin variat preval childhood allergi australia evalu parallel individu associ ultraviolet radiat uvr vitamin d relat measur hayfev asthma condit particip population bas control part multicent case control studi age num yr resid studi region rang latitud num num data deriv self administ questionnair interview examin research offic biolog sampl latitud longitud coordin geocod particip residenti locat climat data link postcod current resid store serum analyz num hydroxyvitamin concentr silicon rubber cast skin object measur cumul actin damag invers latitud gradient asthma num decreas increas degre latitud pattern persist adjust averag daili temperatur associ uvr vitamin d relat measur childhood asthma greater time sun winter age num yr increas odd hayfev adjust odd ratio num num ci num num oral supplement cod liver oil childhood increas odd histori asthma hayfev num num num investig role earli vitamin supplement develop allergi warrant result suggest solar exposur childhood import allerg sensit plausibl explan includ biolog mechan exist observ num john wiley son a
MED-1836~longitudin manganese depend superoxid dismutas index manganes iron status women pubm ncbi abstract effect dietari factor manganese depend superoxid dismutas mnsod activ human studi longitudin evalu mnsod activ indic manganes iron status num women num supplement studi subject receiv treatment placebo num mg iron num mg manganes miner supplement daili manganes supplement result signific increas lymphocyt mnsod activ serum manganes concentr baselin valu urinari manganes excret indic iron status oral contracept stage menstrual cycl confound lymphocyt mnsod activ serum manganes monitor manganes status fat intak affect indic work demonstr lymphocyt mnsod activ serum manganes concentr monitor manganes exposur human
MED-1837~dietari manganes intak type lipid affect clinic neuropsycholog measur healthi young women pubm ncbi abstract manganes mn potenti toxic dietari fat type affect mn absorpt object current studi determin diet low high amount mn enrich satur unsatur fat affect measur neuropsycholog basic metabol function healthi young women fed num wk crossov design diet provid num num mg mn d half subject receiv num energi cocoa butter half receiv num energi corn oil meal num mn fed num wk subject underw whole bodi count num blood draw neuropsycholog test administ regular interv dietari period subject consum diet low mn compar high mn diet absorb signific higher percentag num mn signific longer biolog half lif absorb num mn manganes intak affect neurolog measur minim affect psycholog variabl data show effici mechan oper maintain mn homeostasi rang intak encount mix western diet dietari intak mn num num mg num wk result mn defici toxic sign healthi adult
MED-1838~aluminium element select herbal tea plant speci infus pubm ncbi abstract determin al cu fe mn ni zn ca mg induct coupl plasma optic emiss spectrometri icp o flame atom absorpt spectroscopi faa digest infus hibiscus sabdariffa petal rosa canina receptacl ginkgo biloba leav cymbopogon citratus leav alo vera leav panax ginseng root carri studi attent al heavi metal identif raw materi contamin transform infus predict eventu role human diet daili consumpt addit ion chromatographi ic speciat al leachat carri dri herb hibiscus ginkgo greatest content al fe mn ni zn mg vera highest amount ca highest valu cu observ ginseng infus topmost concentr al cu fe mn ni zn detect prepar hibiscus petal ca alo leav mg leav ginkgo daili consumpt exceed num hibiscus decoct identifi potenti dietet signific content element possibl top contributor food num num mg l mg infus num num mg l contributor attenu blood pressur high amount access mn num num mg l advers effect human total al num num mg l suggest num hibiscus infus consum day sensit individu includ pregnant women complet exclud diet children num month age children chronic renal failur copyright num elsevi reserv
MED-1839~gastrointestin absorpt aluminium singl dose aluminium antacid man pubm ncbi abstract ten subject normal renal function singl dose aluminium antacid num num tablet antacid tablet aluminium content num mg tablet num chew swallow water orang juic citric acid solut mark increas serum concentr aluminium antacid ingest citric acid num orang juic num antacid water slight signific increas serum aluminium concentr num num num tablet dose antacid signific increas num urinari excret aluminium estim absorpt aluminium num num time higher antacid orang juic citric acid water measur quantiti aluminium absorb singl oral dose antacid absorpt substanti enhanc concomit ingest citric acid
MED-1840~influenc tea drink manganes intak manganes status leucocyt express mnsod cytosol aminopeptidas pubm ncbi abstract object black tea high level manganes mn investig relationship dietari mn intak circul mn level leucocyt express mn depend enzym tea drinker non tea drinker design assess mn intak food frequenc questionnair fast blood plasma mn level quantit express peripher blood mononuclear cell mn depend superoxid dismutas mnsod cytosol aminopeptidase p cap p set subject total num tea drinker num black tea day num non tea drinker recruit staff student king colleg london circular email result dietari mn intak rang signific lower num tea drinker num mg day num num tea drinker num mg day num num mg day num depend mn level black tea blood plasma mn level express mnsod cap p differ group continu analysi blood mn level express mnsod correl invers paramet conclus tea drink major sourc dietari mn intak common exceed propos adequ intak valu num num mg mn day occas exceed upper limit num mg day dietari mn intak influenc marker mn status express mn depend enzym fast blood mn level leucocyt express mnsod investig marker mn status
MED-1841~dietari citric acid enhanc absorpt aluminum antacid pubm ncbi abstract ten healthi men ingest daili meal seven day experiment period citric acid lemon juic al num al num citric acid blood sampl dietari period analyz electrotherm digest nitric acid moder signific increas al concentr compar pretreat valu num sd num microgram al liter ingest citric acid al num sd num num sd num micrograms l ingest al num citric acid result pronounc high signific num increas al concentr num sd num microgram al l owe format absorpt al citr complex
MED-1842~effect sour tea hibiscus sabdariffa essenti hypertens pubm ncbi abstract high preval hypertens debilit end organ damag side effect chemic drug treatment conduct experiment studi evalu effect sour tea hibiscus sabdariffa essenti hypertens purpos num num patient moder essenti hypertens random assign experiment control group patient secondari hypertens consum drug exclud studi systol diastol blood pressur measur num day intervent experiment group num patient male num femal age num num year control group num patient male num femal age patient num num year statist find show num lower systol blood pressur num decreas diastol pressur experiment group num day begin treatment compar day differ systol blood pressur group signific differ diastol pressur group day stop treatment systol blood pressur elev num diastol pressur elev num experiment control group differ group signific studi prove public belief result vitro studi effect sour tea lower high blood pressur extens studi subject
MED-1843~aluminium over the count drug risk outweigh benefit pubm ncbi abstract earli num aluminium toxic implic pathogenesi clinic disord patient chronic renal failur involv bone renal osteomalacia brain tissu dialysi encephalopathi time toxic effect aluminium ingest consid major concern absorpt occur aluminium toxic investig countless epidemiolog clinic studi anim experi paper publish subject common acknowledg aluminium toxic induc infus aluminium contamin dialysi fluid parenter nutrit solut oral exposur result aluminium contain pharmaceut product aluminium bas phosphat binder antacid intak over the count antacid import sourc human aluminium exposur quantit point view aluminium act power neurolog toxic provok embryon fetal toxic effect anim human gestat exposur fact patient inform leaflet european antacid otc show substanti differ warn aluminium toxic advis patient receiv inform aluminium toxic patient inform leaflet regard increas absorpt concomit administr citrate contain beverag antacid pregnanc
MED-1844~determin total aluminum chromium copper iron manganes nickel fraction leach infus black tea green tea pubm ncbi abstract total aluminum chromium copper iron manganes nickel determin black tea green tea hibiscus sabdariffa ilex paraguariensi mate electrotherm atom absorpt spectrometri nitric perchlor acid digest case ground sampl commerci leafi materi prepar num subsampl run parallel infus analyz percentag element leach liquor evalu obtain result hibiscus mate lower level aluminum num num microg g num num microg g refer black tea num num microg g green tea num icro num microg g suggest mate drink good dietari sourc essenti micronutri manganes total content num num microg g num leach infus found infus hibiscus suppli greater amount iron num num microg g total num leach copper num num microg g total num leach compar infus found percentag element leach infus strong relat tannin content beverag correl coeffici num nickel lower tannin level leach observ
MED-1845~plasma level aluminium tea ingest healthi volunt pubm ncbi abstract num healthi volunt control aluminium al diet consum tea infus num ml num kg bodi weight milk lemon juic addit miner water three way crossov design concentr al determin diet miner water tea infus plasma sampl collect num hr consumpt tea water graphite furnac atom absorpt spectrophotometri induct coupl plasma emiss spectrometri consumpt num mg al tea milk lemon juic increas plasma al level compar consumpt approxim num mg al miner water result suggest short term drink tea contribut signific total bodi burden al
MED-1846~effect fruit juic fruit absorpt iron rice meal pubm ncbi abstract effect chemic composit fruit juic fruit absorpt iron rice oryza sativa meal measur num parous indian women erythrocyt util radioact fe method correct geometr fe absorpt juic vari num num variat correl close ascorb acid content juic rs num num ascorb acid organ acid respons promot effect citrus fruit juic fe absorpt fe absorpt laboratori orang juic num ml water num mg ascorb acid num mg citric acid signific num ml water num mg ascorb acid num num fe absorpt num ml orang juic num mg ascorb acid num ml water amount ascorb acid num num final fe absorpt laboratori lemon juic num ml orang juic num citric acid signific num ml orang juic num num correct geometr fe absorpt rice meal num fruit effect fe absorpt meal num num includ grape viti vinifera peach prunus persica appl malus sylvestri avocado pear persea americana fruit mild moder enhanc effect fe absorpt num num includ strawberri fragaria sp uncorrect valu plum prunus domestica rhubarb rheum rhaponticum banana musa cavendishii mango mangifera indica pear pyrus communi cantaloup cucumi melo pineappl anana comosus uncorrect valu guava psidium guajava pawpaw carica papaya mark increas fe absorpt num num close correl fe absorpt ascorb acid content fruit test rs num num weaker signific correl citric acid content rs num num reflect direct effect citric acid fe absorpt note fruit citric acid ascorb acid rs num num abstract truncat num word
MED-1847~gastro intestin avail aluminium tea pubm ncbi abstract vitro speciat aluminium al black tea infus ph num assess num num num da cut off ultrafilt effect ad human gastric juic ph num rais ph num studi num al tea infus pass num da ultrafilt percentag increas num addit gastric juic ph num reduc approxim num incub adjust ph num breakdown tea deriv polyphenol low molecular weight phenol vivo measur high resolut num nuclear magnet reson spectroscop analysi ileostomi effluent evid low molecular weight breakdown product polyphenol ingest tea effluent result suggest small proport al tea potenti absorpt small bowel mislead estim system al absorpt tea drink simpli total urinari aluminium excret previous
MED-1848~neurotox effect aluminium foundri worker alzheimer diseas pubm ncbi abstract background cross sect case control studi conduct northern itali num aluminium dust expos worker compar num unexpos control compani match age profession train econom status educ clinic featur find lead author suggest role inhal aluminium dust pre clin mild cognit disord prelud alzheimer diseas ad ad lik neurolog deterior method investig involv standardis occup medic histori attent exposur symptom assess neurotox metal serum aluminium al copper cu zinc zn s blood manganes mn b lead pb b iron fe b cognit function assess mini mental state examin mmse clock draw test cdt auditori evok event rel potenti erp p num detect earli sign mild cognit impair mci time requir solv mmse mmse tim cdt cdt time measur result signific higher intern dose al fe b found ex employe compar control group neuropsycholog test show signific differ latenc num mmse score mmse tim cdt score cdt time expos control popul num latenc found correl posit al mmse tim al signific effect test negat relationship observ intern al concentr mmse score cdt score posit relationship found intern al concentr mmse tim cdt time potenti confound age height weight blood pressur school year alcohol coffe consumpt smoke habit account conclus find suggest role aluminium earli neurotox effect detect pre clin stage num mmse mmse tim cdt time cdt score num micrograms l cut off level serum aluminium aluminium foundri worker concomit high blood level iron author rais question pre clin detect aluminium neurotox consequ earli treatment prevent retard onset ad ad lik patholog
MED-1849~aluminum involv progress alzheimer diseas pubm ncbi abstract neuroanatom specif alzheimer diseas ad progress provid clue ad etiopatholog magnet reson imag studi ad clinic progress confirm general conclus earlier studi ad neuropatholog progress neurofibrillari tangl patholog observ spread well defin sequenc corticocort corticosubcort connect preferenti affect cell type spare ident non ident twin studi consist shown ad mix environment genet etiopathogenesi decades long prodrom phase ad develop suggest slow progress accumul toxic infect agent time major environment candid review assess fit profil agent slowli accru suscept cell type ad vulner brain region toxic level age give rise ad neuropatholog rapid neuron lysi chronic aluminum neurotox match profil human routin ingest aluminum salt addit process food alum tr drink water physic properti aluminum ferric iron ion similar aluminum mechan evolv iron enter vulner neuron involv ad progress accumul neuron neurofibrillari damag genet compon ad etiopathogenesi appar involv suscept gene identifi increas aluminum absorpt ad syndrom patient higher normal plasma brain aluminum level review describ evid aluminum involv ad neuropatholog clinic progress sporad ad
MED-1850~urin level aluminum drink tea pubm ncbi abstract microwave assist acid digest procedur coupl graphit furnac atom absorpt method appli determin aluminum al urin verifi correl free form al tea infus urinari excret al signific urinari al excret found num urin volunt tea drink differ amount al excret urin consumpt oolong black tea long jin green tea uniqu al content speci signific find high level free al speci tea infus result signific chang urinari excret metal possibl owe transform ligand present food gastrointestin tract git assum big differ absorpt metal human bodi fraction consum al retain bodi excret bile fece consid
MED-1851~aluminum alzheimer diseas centuri controversi plausibl link pubm ncbi abstract brain high compartment organ suscept accumul metabol error alzheimer diseas ad preval neurodegen diseas elder character region specif neural aberr higher cognit function aluminum al abund neurotox metal earth wide bioavail human repeat shown accumul ad suscept neuron foci spite role al ad heavili disput base claim num bioavail al enter brain suffici amount damag num excess al effici excret bodi num al accumul neuron consequ neuron loss research reveal num small amount al produc neurotox criterion satisfi dietari al intak num al sequest transport mechan activ travers brain barrier num increment acquisit small amount al lifetim favor select accumul brain tissu num num experiment evid repeat demonstr chronic al intox reproduc neuropatholog hallmark ad misconcept al bioavail misl scientist signific al pathogenesi ad hypothesi al signific contribut ad built solid experiment evid dismiss step lessen human exposur al singl aggrav avoid factor relat ad
MED-1852~aluminium migrat beverag dent safe pubm ncbi abstract aluminium al migrat beer tea studi time analys al drink perform till sell bi date month aluminium migrat found increas num mg num beer num mg num tea studi includ dent aluminium migrat tea found sever al concentr dent tea increas num mg num month
MED-1853~eros potenti brew tea pubm ncbi abstract purpos measur ph titrat acid fluorid concentr eros potenti brew tea method bag tea purchas repres black green citrus fruiti floral tea flavor tulsi bigelow hyve tazo yogi brand brew num bag num ml boil water num minut ph titrat acid fluorid concentr measur measur repres tea flavor select investig eros potenti extract human molar random assign tea teeth paint fingernail polish expos num num mm window soak tea total num hour tea refresh num hour teeth section microtom photograph polar light microscop lesion depth erod surfac measur imag pro softwar differ physiochem properti lesion depth beverag investig one way anova post hoc tukey hsd test relationship lesion depth physiochem properti evalu pearson correl test result ph titrat acid fluorid concentr differ tea flavor num brand num lesion depth produc citrus tea num num microm greater produc fruiti tea num num microm tea produc greater depth black num num microm floral num num microm green num num microm tea num ph num num invers titrat acid num num posit lesion depth
MED-1857~periodont condit vegetarian clinic studi pubm ncbi abstract background object investig correl vegetarian diet periodont condit rare character small case number aim clinic studi investig influenc vegetarian diet periodont paramet sampl size subjects method total num patient num vegetarian num non vegetarian includ studi patient examin includ full mouth assess periodont dental condit addit questionnair hand patient oral hygien habit level educ statist analysi mann whitney test num analysi questionnair appli level signific num result periodont risk factor age gender smoke habit equal distribut group num femal num male num smoker group age num year vegetarian versus num year non vegetarian vegetarian signific lower probe pocket depth num bleed probe num periodont screen index num hygien index num mobil teeth num dental examin reveal signific miss teeth num decay num erod num teeth vegetarian vegetarian higher level educ num visit dentist signific frequent conclus vegetarian reveal periodont condit inflamm sign periodont damag dental home care consid vegetarian avoid meat nutrit character healthier life style
MED-1858~influenc drink pattern carbon beverag dental eros pubm ncbi abstract hard tissu dental diseas dental eros multifactori etiolog major dental eros origin extrins sourc result dietari intak acid beverag prevent propos minim damag dentit includ reduct consumpt causat beverag adopt specif method drink util straw cup articl present case involv clinic radiograph featur eros lesion chronic excess intak acid carbon beverag exampl embodi drink pattern influenc format eros lesion anatom locat dentit clinic radiograph evid present report caution nonspecif term cup versus straw suggest implement precis descript suggest method view extens damag inflict chronic excess intak carbon beverag prevent measur consid effect manag articl offer illustr exampl eros lesion long term excess intak carbon beverag influenc drink method  that straw posit labial vestibul versus cup  on anatom locat eros lesion demonstr clinic radiograph evid
MED-1859~rosell hibiscus sabdariffa soybean oil effect qualiti characterist pork patti studi respons surfac methodolog pubm ncbi abstract respons surfac methodolog investig effect interact process variabl rosell extract num num soybean oil num physicochem textur sensori properti cook pork patti found reduct thick ph valu decreas water hold capac reduct diamet valu increas amount rosell increas soybean oil addit increas water hold capac reduct thick valu patti hard depend rosell soybean oil ad linear effect negat num prefer color tender juici qualiti depend addit rosell soybean oil maximum qualiti score num observ num soybean oil num rosell extract ad result optim studi meat industri increas product yield patti optimum level ingredi rsm copyright num elsevi reserv
MED-1860~effect sour tea hibiscus sabdariffa hypertens patient type ii diabet pubm ncbi abstract compar antihypertens effect sour tea st hibiscus sabdariffa black tea bt infus diabet patient double blind random control trial carri sixti diabet patient mild hypertens antihypertens antihyperlipidaem medicin recruit studi patient random alloc st bt group instruct drink st bt infus time day num month blood pressur bp measur day num num studi systol bp sbp st group decreas num num mm hg begin studi num num mm hg num month p valu num measur chang num num num num mm hg p valu num bt group period intervent statist signific effect diastol bp dbp st bt group puls pressur pp patient st group decreas num num num num mm hg p valu num studi bt group increas num num num num mm hg p valu num conclus consum st infus posit effect bp type ii diabet patient mild hypertens studi support result similar studi antihypertens effect shown st
MED-1861~effect hibiscus sabdariffa treatment hypertens systemat review pubm ncbi abstract introduct hypertens common global health problem signific mortal morbid hibiscus sabdariffa plant countri consum hot cold drink addit folk medicin suggest treatment condit includ hypertens object object review examin evid effect safeti hibiscus treatment hypertens method search medic databas medlin embas cinahl cochran central regist control trial special regist cochran hypertens group general engin googl januari num includ random control trial examin hibiscus effect safeti treatment primari hypertens adult author independ select trial review extract data critic apprais includ studi result trial total num patient met inclus criteria studi compar hibiscus sabdariffa black tea studi compar captopril lisinopril studi found hibiscus greater blood pressur reduct tea ace inhibitor studi short term poor qualiti jadad score num meet intern standard conclus random control studi identifi review provid reliabl evid support recommend hibiscus sabdariffa treatment primari hypertens adult copyright num elsevi gmbh reserv
MED-1862~effect comprehens lifestyl modif diet weight physic fit blood pressur control num month result random trial pubm ncbi abstract background main num month result premier trial show comprehens behavior intervent program improv lifestyl behavior lower blood pressur object compar num month effect num multicompon behavior intervent versus advic hypertens status lifestyl blood pressur design multicent num arm random trial conduct januari num novemb num set num clinic center coordin center patient num adult volunt prehypertens stage num hypertens systol blood pressur num num mm hg diastol blood pressur num num mm hg intervent multicompon behavior intervent implement long establish recommend establish multicompon behavior intervent implement establish recommend dietari approach stop hypertens dash diet establish dash advic measur lifestyl variabl blood pressur status follow up blood pressur measur num month num result compar advic behavior intervent statist signific reduc weight fat intak sodium intak establish dash intervent statist signific increas fruit veget dairi fiber miner intak relat advic group odd ratio hypertens num month num num ci num num establish group num ci num num establish dash group reduct absolut blood pressur num month greater particip establish establish dash group advic group differ statist signific limit exclus criteria volunt natur cohort limit generaliz blood pressur well accept risk factor cardiovascular diseas author assess intervent effect clinic cardiovascular event limit time sampl size conclus num month person prehypertens stage num hypertens sustain multipl lifestyl modif improv control blood pressur reduc risk chronic diseas
MED-1863~vegetarian diet blood pressur meta analysi pubm ncbi abstract import previous studi suggest associ vegetarian diet lower blood pressur bp relationship establish object conduct systemat review meta analysi control clinic trial observ studi examin associ vegetarian diet bp data sourc medlin web scienc search articl publish english num octob num num novemb num studi select studi met inclus criteria num particip older num year num vegetarian diet exposur intervent num differ bp outcom num control trial observ studi design addit met exclus criteria num twin particip num multipl intervent num report categor bp data num relianc case seri case report data extract synthesi data collect includ studi design baselin characterist studi popul dietari data outcom data pool random effect model main outcom measur net differ systol diastol bp consumpt vegetarian diet assess result num studi identifi num clinic trial num observ studi met inclus criteria num control trial total num particip age num year consumpt vegetarian diet reduct systol bp num mm hg num ci num num num num num num heterogen diastol bp num mm hg num ci num num num num num num heterogen compar consumpt omnivor diet num observ studi total num particip age num year consumpt vegetarian diet lower systol bp num mm hg num ci num num num num num num heterogen diastol bp num mm hg num ci num num num num num num heterogen compar consumpt omnivor diet conclus relev consumpt vegetarian diet lower bp diet nonpharmacolog reduc bp
MED-1864~hibiscus sabdariffa treatment hypertens hyperlipidemia comprehens review anim human studi abstract effect hibiscus sabdariffa hs treatment risk factor cardiovascular diseas assess review comprehens approach interpret random clinic trial rct result context ethnomed phytochem pharmacolog safeti toxic inform hs decoct infus calyx occas leav num countri worldwid treatment hypertens hyperlipidemia report advers event side effect hs extract low degre toxic ld num rang num num mg kg day evid hepat renal toxic result hs extract consumpt advers hepat effect high dose evid hs act diuret case extract signific influenc electrolyt level anim studi consist shown consumpt hs extract reduc blood pressur dose depend manner rcts daili consumpt tea extract produc hs calyx signific lower systol blood pressur sbp diastol blood pressur dbp adult pre moder essenti hypertens type num diabet addit hs tea effect lower blood pressur common blood pressur medic captropril effect lisinopril total cholesterol low dens lipoprotein cholesterol ldl c triglycerid lower major normolipidem hypolipidem diabet anim model high dens lipoprotein cholesterol hdl c general affect consumpt hs extract half rcts show daili consumpt hs tea extract favor influenc lipid profil includ reduc total cholesterol ldl c triglycerid increas hdl c anthocyanin found abund hs calyx general consid phytochem respons antihypertens hypocholesterolem effect evid provid role polyphenol hibiscus acid number potenti mechan propos explain hypotens anticholesterol effect common explan antioxid effect anthocyanin inhibit ldl c oxid imped atherosclerosi import cardiovascular risk factor comprehens bodi evid suggest extract hs promis treatment hypertens hyperlipidemia high qualiti anim human studi inform actual therapeut practic provid recommend potenti widespread public health benefit
MED-1865~hibiscus sabdariffa tea tisan lower blood pressur prehypertens mild hypertens adult pubm ncbi abstract vitro studi show hibiscus sabdariffa ingredi found herbal tea blend beverag antioxid properti anim model extract calyc demonstr hypocholesterolem antihypertens properti object studi examin antihypertens effect sabdariffa tisan hibiscus tea consumpt human random double blind placebo control clinic trial conduct num pre mild hypertens adult age num blood pressur bp lower medic num ml servings d brew hibiscus tea placebo beverag num wk standard method measur bp baselin week interv num wk hibiscus tea lower systol bp sbp compar placebo num num num num mm hg num diastol bp lower chang differ placebo num num num num mm hg num chang arteri pressur borderlin signific compar placebo num num num num mm hg num particip higher sbp baselin show greater respons hibiscus treatment num sbp chang num effect observ regard age gender dietari supplement result suggest daili consumpt hibiscus tea amount readili incorpor diet lower bp pre mild hypertens adult prove effect compon dietari recommend peopl condit
MED-1866~hibiscus sabdariffa extract lower blood pressur improv endotheli function pubm ncbi abstract polyphenol hibiscus sabdariffa calic administ patient metabol syndrom num mg kg day num wk num spontan hypertens rat num num mg kg singl dose daili num wk num experiment group sabdariffa extract improv metabol display potent anti inflammatori antioxid activ signific reduc blood pressur human rat diuresi inhibit angiotensin i convert enzym found import mechan relat antioxid anti inflammatori endothelium depend effect explain benefici action notabl polyphenol induc favor endotheli respons consid manag metabol cardiovascular risk num author molecular nutrit food research publish wiley vch verlag gmbh kgaa weinheim
MED-1867~effect sour tea hibiscus sabdariffa lipid profil lipoprotein patient type ii diabet pubm ncbi abstract object increas evid intak sour tea hibiscus sabdariffa hypoglycem hypolipidem effect benefit patient suffer metabol disord diabet object present studi investig hypolipidem effect sour tea patient diabet compar black tea design sequenti random control clinic trial num patient diabet recruit random assign group sour tea st black tea bt instruct consum sour tea black tea time day num month outcom measur fast blood sampl begin end studi evalu lipid lipoprotein apoprotein result fifty thre num patient conclud studi st group high dens lipoprotein cholesterol hdlc increas signific num end studi apolipoprotein a num lipoprotein signific signific decreas total cholesterol low densiti lipoprotein cholesterol triglycerid apo b num group bt group hdlc show signific chang num end studi measur statist signific conclus result present studi show st signific effect blood lipid profil patient diabet
MED-1868~hibiscus sabdariffa extract inhibit obes fat accumul improv liver steatosi human pubm ncbi abstract obes great divers diseas includ non alcohol fatti liver diseas previous report suggest hibiscus sabdariffa extract hse metabolic regul liver protect potenti studi perform clinic trial confirm effect hse subject bmi num age num random divid control num hse treat num group num week data show consumpt hse reduc bodi weight bmi bodi fat waist to hip ratio serum free fatti acid ffa lower hse anatom reveal hse improv ill liver steatosi ingest hse toler advers effect trial alter found serum amylas lipas clinic effect attribut polyphenol hse composit analysi show branch chain amino acid obes high conclus consumpt hse reduc obes abdomin fat serum ffa improv liver steatosi hse act adjuv prevent obes non alcohol fatti liver
MED-1869~relationship dietari protein intak blood pressur result premier studi pubm ncbi abstract observ clinic studi suggest high protein intak protein plant sourc reduc blood pressur bp examin associ dietari protein bp analys data premier num month clinic trial num examin effect multi compon lifestyl modif bp examin associ protein intak bp independ relationship plant anim protein bp multivari linear regress analys perform cross sect longitudin data dietari plant protein invers systol diastol bp cross sect analys num month follow up num num fruit veget intak invers systol diastol bp cross sect num month num num longitudin analys high intak plant protein num month margin reduct systol diastol bp baselin num month num num independ chang bodi weight waist circumfer increas intak plant protein fruit veget signific lower risk hypertens num num month result studi plant protein benefici effect bp lower risk hypertens num month data conjunct research suggest increas intak plant protein prevent treat hypertens
MED-1871~effect toler standard extract hibiscus sabdariffa patient mild moder hypertens control pubm ncbi abstract order compar antihypertens effect toler standard extract hibiscus sabdariffa captopril control random clinic trial patient num num year diagnos hypertens antihypertens treatment num month includ experiment procedur consist administr infus prepar num dri calyx sabdariffa num water num mg anthocyanin content daili breakfast captopril num mg day num week outcom variabl toler therapeut effect diastol reduct num mm hg experiment group urinari electrolyt modif nineti subject includ num withdrew studi due non med reason analysi includ num num patient experiment control group result show sabdariffa decreas systol blood pressur bp num num mm hg anova num diastol bp num num mm hg anova num end studi signific differ bp detect treatment group anova num rate therapeut effect num num sabdariffa captopril chi num num whilst toler num treatment natriuret effect observ experiment treatment obtain data confirm sabdariffa extract standard num mg total anthocyanin captopril num mg day show signific differ relat hypotens effect antihypertens effect toler
MED-1872~effect comprehens lifestyl modif blood pressur control main result premier clinic trial pubm ncbi abstract context weight loss sodium reduct increas physic activ limit alcohol intak establish recommend reduc blood pressur bp dietari approach stop hypertens dash diet lower bp date trial evalu effect simultan implement lifestyl recommend object determin effect bp num multicompon behavior intervent design set particip random trial enrol num clinic center januari num june num num adult sd age num num year num women num african american above optim bp includ stage num hypertens num mm hg systol num mm hg diastol antihypertens medic intervent particip random num intervent group num establish behavior intervent implement establish recommend num establish dash implement dash diet num num advic comparison group num main outcom measur blood pressur measur hypertens status num month result behavior intervent signific reduc weight improv fit lower sodium intak establish dash intervent increas fruit veget dairi intak group gradient bp hypertens status evid subtract chang advic net reduct systol bp num mm hg num establish group num mm hg num establish dash group systol bp differ establish establish dash group num mm hg num compar baselin hypertens preval num preval num month num advic group num establish group num compar advic group num establish dash group num compar advic group num compar establish group preval optim bp num mm hg systol num mm hg diastol num advic group num establish group num compar advic group num establish dash group num compar advic group num compar establish group conclus individu above optim bp includ stage num hypertens make multipl lifestyl lower bp reduc cardiovascular diseas risk
MED-1873~dietari satur fat intak negat weight mainten premier particip pubm ncbi abstract research find composit macronutri intak bodi weight consist research examin impact subcompon macronutri satur fat plant protein bodi weight purpos report examin impact satur fat anim plant protein macronutri intak end intens intervent subsequ follow up bodi weight secondari observ data analysi data premier num month random clinic trial enrol total num particip particip complet group individu session design improv blood pressur bp control make lifestyl dietari intak assess num diet recal baselin num num month bodi weight physic fit monitor regular regress model examin impact anim plant protein macronutri intak subsequ bodi weight control potenti confound calorie contribut nutrient intak baselin subsequ weight num num month greater intak satur fat num month higher weight num month num greater intak plant protein num month margin lower absolut weight num month num conclud macronutri intak intervent subsequ bodi weight num num month lower satur fat intak achiev num month intervent predict lower bodi weight num month greater weight loss mainten
MED-1874~garden eden  pl base diet genet drive conserv cholesterol implic heart diseas num centuri pubm ncbi abstract plant food consumpt human evolut shape dietari requir contemporari human diet high dietari fiber veget protein plant sterol phytochem low satur trans fatti acid substrat cholesterol biosynthesi meet body cholesterol genet differ polymorph conserv evolut tend rais serum cholesterol level result modern man radic diet lifestyl middl age recommend medic lower cholesterol reduc risk cardiovascular diseas experiment introduct high intak viscous fiber veget protein plant sterol form myocen diet leafi veget fruit nut lower serum ldl cholesterol healthi volunt num equival generat statin standard cholesterol low medic supplement modern therapeut diet hyperlipidem subject compon oat barley psyllium viscous fiber soy almond veget protein plant sterol enrich margarin produc similar reduct ldl cholesterol myocene lik diet reduc major subject blood lipid concentr normal rang conclud reintroduct plant food compon present larg quantiti plant base diet eaten human evolut modern diet correct lipid abnorm contemporari eat pattern reduc pharmacolog intervent
MED-1876~consumpt grain reduc risk deterior glucos toler includ progress prediabet pubm ncbi abstract background high whole grain intak report reduc risk develop type num diabet num effect possibl subject genet effect modif confirm prospect studi investig impact prediabet object prospect population bas studi investig higher intak grain protect develop prediabet num test modul polymorph tcf num gene design examin num incid prediabet impair glucos toler impair fast glucos combin num relat intak grain baselin data num women num men age num result higher intak grain num compar num g d num lower risk deterior glucos toler prediabet num women men combin associ remain adjust age famili histori diabet bmi physic activ smoke educ blood pressur num num ci num num risk reduct signific men num num ci num num women associ signific prediabet se num num ci num num men num num ci num num intak grain correl invers insulin resist homa ir impact whole grain intak undetect men harbor diabetogen polymorph tcf num gene conclus higher intak grain decreas risk deterior glucos toler includ progress normal glucos toler prediabet mechan tie effect insulin sensit effect modif tcf num genet polymorph support
MED-1878~cross qualiti chasm health system num centuri pubm ncbi excerpt seri public institut medicine qualiti health care america project today health care provid research find technolog recent report rais doubt qualiti health care america cross qualiti chasm make urgent call fundament chang close qualiti gap book recommend sweep redesign american health care system overarch principl specif direct policymak health care leader clinician regul purchas comprehens volum committe offer set perform expect num centuri health care system set num rule guid patient clinician relationship suggest organ framework align incent inher payment account improv qualiti key step promot evidence bas practic strengthen clinic inform system analyz health care organ complex system cross qualiti chasm document qualiti gap identifi current practic imped qualiti care explor system approach implement chang copyright num nation academi scienc reserv
MED-1879~daili flaxse consumpt improv glycem control obes men women pre diabet random studi pubm ncbi abstract studi hypothesi fast glucos insulin fructosamin c reactiv protein interleukin num decreas adiponectin increas daili flaxse consumpt overweight obes individu pre diabet random cross ov studi overweight obes men postmenopaus women num pre diabet consum num num ground flaxse num week glucos insulin homeostat model assess homa ir normal percent linolen fatti acid ala signific treatment multipl analysi varianc num num num num pair test show glucos decreas num intervent compar num period num num num mg l sem num num num mg l num insulin decreas num intervent num num num num period num num num mu l num num num mu l num num num mu l homa ir decreas num period num num num num period num num num num num num num num num linolen fatti acid decreas num period num num num num period num num num num num num num num num fructosamin high sensit c reactiv protein adiponectin high sensit interleukin num signific differ flaxse intak decreas glucos insulin improv insulin sensit part habitu diet overweight obes individu pre diabet copyright num elsevi reserv
MED-1880~effect cook germin phenol composit biolog properti dark bean phaseolus vulgari pubm ncbi abstract legum bas diet countri hold high nutrit properti relat human health nowaday studi aim work studi influenc process boil germin phenol composit dark bean phaseolus vulgari tolosana effect antioxid neuroprotect anticanc abil phenol composit raw process dark bean analys hplc pad hplc esi m antioxid activ evalu orac astrocyt cultur num test neuroprotect effect anticanc activ evalu cell line renal adenocarcinoma tk num breast adenocarcinoma mcf num melanoma uacc num sulphorhodamin method qualit quantit differ phenol composit observ raw process dark bean influenc antioxid activ germin sampl show decreas antioxid capac assay extract decreas reactiv oxygen speci releas exhibit cytotox activ cancer cell line raw bean prove activ neuroprotect antitumor effect sampl rich phenol compound anthocyanin studi demonstr phenol composit dark bean relat cook process neuroprotect anticanc activ cook dark bean improv digest absorpt intestin level maintain protect abil oxid process cellular level copyright num elsevi reserv
MED-1881~lower intak veget legum cognit declin illiter elder chines num year cohort studi pubm ncbi abstract background studi cognit function influenti factor popul research design studi relationship dietari intak cognit function elder object conduct population bas prospect nest case control studi investig associ dietari habit declin cognit function year chines illiter elder design method studi part chines longitudin health longev studi clhls thousand hundr eleven illiter resid age num older investig socio demograph dietari habit data collect baselin cognit function illiter elder person assess chines revis mini mental state examin mmse r num num cognit declin defin mmse r score drop num follow up normal cognit function mmse r num baselin odd ratio calcul logist regress model result thousand hundr nineti elder includ current analysi bivari analysi cognit declin gender marit status financi status smoke drink alcohol drink tea eat fruit veget legum fish meat egg sugar multivari logist regress analysi found eat veget adjust num num confid interv ci num num consum legum aor num num ci num num invers cognit declin conclus lower intak veget legum cognit declin illiter elder chines dietari factor import prevent cognit declin
MED-1882~low dens lipoprotein high dens lipoprotein particl subclass predict coronari event favor chang gemfibrozil therapi pubm ncbi abstract background convent lipid risk factor gemfibrozil treatment partial explain reduct coronari heart diseas chd event experienc men veteran affair high dens lipoprotein intervent trial va hit examin measur low dens lipoprotein ldl high dens lipoprotein hdl particl subclass addit inform relat chd risk reduct method result prospect nest case control studi num men chd event nonfat myocardi infarct cardiac death num year median follow up num age match control nuclear magnet reson nmr spectroscopi quantifi level ldl hdl particl subclass particl size plasma obtain baselin num month treatment gemfibrozil placebo odd ratio num sd increment lipoprotein variabl calcul adjust logist regress model gemfibrozil treatment increas ldl size lower number ldl particl num rais number hdl particl num small hdl subclass particl num concentr ldl hdl particl achiev gemfibrozil signific independ predictor chd event total ldl hdl particl odd ratio predict chd benefit num num ci num num num num ci num num ldl hdl particl size chd event conclus effect gemfibrozil nmr measur ldl hdl particl subclass reflect convent lipoprotein cholesterol measur explain demonstr benefit therapi patient low hdl cholesterol
MED-1884~mainten ldl cholesterol hdl cholesterol ratio elder popul dietari cholesterol challeng pubm ncbi abstract previous evalu respons dietari cholesterol children young adult studi effect dietari cholesterol plasma lipid ldl atherogen evalu num elder subject num postmenopaus women num men num exclus criteria diabet heart diseas reductas inhibitor studi random crossov design subject assign consum equival num larg egg egg daili amount cholesterol fre fat fre egg substitut num mo period num wk washout period subject assign altern treatment concentr plasma cholesterol egg period vari subject subject evalu signific increas ldl cholesterol ldl c num hdl c num men women egg period result alter ldl c hdl c total cholesterol hdl c ratio addit ldl peak diamet increas egg period subject contrast measur paramet ldl oxid conjug dien format ldl lag time differ egg period conclud studi dietari cholesterol provid egg increas risk heart diseas healthi elder popul
MED-1885~rethink dietari cholesterol pubm ncbi abstract purpos review perceiv notion dietari cholesterol increas risk coronari heart diseas chd led dietari recommend num mg day healthi popul usa studi review recent evid challeng current dietari restrict cholesterol present benefici effect egg icon dietari cholesterol healthi individu recent find european countri australia canada zealand korea india upper limit cholesterol intak dietari guidelin exist epidemiolog data demonstr dietari cholesterol correl increas risk chd numer clinic studi shown dietari cholesterol challeng increas plasma ldl cholesterol individu sensit dietari cholesterol one quart popul hdl cholesterol rise result mainten ldl hdl cholesterol ratio key marker chd risk summari line evid current epidemiolog studi clinic intervent util type cholesterol challeng support notion recommend limit dietari cholesterol reconsid
MED-1886~lipoprotein particl profil nuclear magnet reson compar standard lipid apolipoprotein predict incid cardiovascular diseas women abstract background nuclear magnet reson nmr spectroscopi measur number size lipoprotein particl cholesterol triglycerid content clinic util uncertain method result baselin lipoprotein measur nmr num initi healthi women incid cardiovascular diseas cvd num num year adjust non lipid risk factor hazard ratio hrs num confid interv cis top bottom quintil nmr measur lipoprotein particl concentr particles l low dens lipoprotein ldlnmr num num num high dens lipoprotein hdlnmr num num num very low dens lipoprotein vldlnmr num num num ldlnmr hdlnmr ratio num num num similarly adjust result nmr measur lipoprotein particl size nanomet ldlnmr size num num num hdlnmr size num num num vldlnmr size num num num hazard ratio nmr measur compar superior standard lipid total cholesterol num num num ldl cholesterol num num num hdl cholesterol num num num triglycerid num num num non hdl cholesterol num num num total hdl cholesterol ratio num num num apolipoprotein num num num num num num num num num num ratio num num num essenti reclassif improv ad ldlnmr particl concentr apolipoprotein num model includ total hdl cholesterol ratio non lipid risk factor net reclassif index nri num num addit variabl result statist signific improv c index conclus prospect studi healthi women cvd risk predict lipoprotein profil evalu nmr compar superior standard lipid apolipoprotein
MED-1887~role advanc lipoprotein analysi practic pubm ncbi abstract practition advanc lipoprotein analysi goal predict risk individu lifestyl drug therapi cardiovascular prevent low dens lipoprotein ldl high dens lipoprotein hdl particl number size lipoprotein subfraction apolipoprotein lipoprotein met current standard biomark evalu remain determin test increment add cardiovascular risk predict tradit risk factor import determin treatment strategi guid target measur improv cardiovascular outcom drug therapi alter advanc lipoprotein analysi paramet specif niacin fenofibr shown addit reduc cardiovascular risk recent random trial high risk patient treat statin therapi find suggest advanc lipoprotein analysis guid strategi reduc cardiovascular event lead increas advers effect cost approach research establish role individu therapi cardiovascular prevent contrast larg bodi evid support focus ldl cholesterol reduct intensif statin therapi reduc cardiovascular risk copyright num american colleg cardiolog foundat publish elsevi reserv
MED-1888~intestin microbi metabol phosphatidylcholin cardiovascular risk abstract background recent studi anim shown mechanist link intestin microbi metabol cholin moieti dietari phosphatidylcholin lecithin coronari arteri diseas product proatherosclerot metabolit trimethylamine n oxid tmao investig relationship intestin microbiota depend metabol dietari phosphatidylcholin tmao level advers cardiovascular event human method quantifi plasma urinari level tmao plasma cholin betain level liquid chromatographi onlin tandem mass spectrometri phosphatidylcholin challeng ingest hard boil egg deuterium num label phosphatidylcholin healthi particip suppress intestin microbiota oral broad spectrum antibiot examin relationship fast plasma level tmao incid major advers cardiovascular event death myocardi infarct stroke num year follow up num patient undergo elect coronari angiographi result time depend increas level tmao num isotopologu cholin metabolit detect phosphatidylcholin challeng plasma level tmao mark suppress administr antibiot reappear withdraw antibiot increas plasma level tmao increas risk major advers cardiovascular event hazard ratio highest lowest tmao quartil num num confid interv num num num elev tmao level predict increas risk major advers cardiovascular event adjust tradit risk factor num lower risk subgroup conclus product tmao dietari phosphatidylcholin depend metabol intestin microbiota increas tmao level increas risk incid major advers cardiovascular event fund nation institut health
MED-1889~consumpt egg meal increas suscept human plasma low dens lipoprotein lipid peroxid pubm ncbi abstract consumpt egg long period shown result hypercholesterolemia general restrict reason present studi analyz effect egg consumpt num week lipoprotein atherogen consumpt num egg day meal num week result minor elev plasma glucos urea concentr plasma cholesterol concentr increas num num result increas plasma low dens lipoprotein ldl cholesterol level plasma triglycerid decreas num num signific alter plasma apolipoprotein a i num concentr plasma high dens lipoprotein hdl cholesterol decreas num num num reduct signific cholesterol efflux num num macrophag hdl deriv egg consumpt comparison hdl obtain baselin suscept plasma num mm num azobi num amidinopropan aaph ldl num microm copper ion lipid peroxid increas num num measur thiobarbitur acid reactiv substanc tbar assay num kinet analysi ldl oxid copper ion reveal num reduct lag time requir initi ldl oxid num week egg consumpt total plasma fatti acid concentr increas num num num num mg ml plasma antioxid vitamin carotenoid signific affect egg consumpt conclud egg consumpt addit hypercholesterolem effect increas plasma ldl oxidiz phenomenon shown enhanc progress atherosclerosi atherogen properti contribut acceler atherosclerosi preval popul high cholesterol intak
MED-1890~dietari cholesterol egg increas ratio total cholesterol high dens lipoprotein cholesterol human meta analysi pubm ncbi abstract background epidemiolog studi found effect egg consumpt risk coronari heart diseas advers effect egg ldl cholesterol offset favor effect hdl cholesterol object object review effect dietari cholesterol ratio total hdl cholesterol design studi identifi medlin biolog abstract search num june num review refer list addit includ data recent publish studi studi includ crossov parallel design control group experiment diet differ amount dietari cholesterol number egg fed num hdl cholesterol concentr report num studi identifi num studi involv num subject met criteria result addit num mg dietari cholesterol d increas ratio total hdl cholesterol num unit num ci num num total cholesterol concentr num mmol l num mg dl num ci num num mmol l num num mg dl hdl cholesterol concentr num mmol l num mg dl num ci num num mmol l num num mg dl conclus dietari cholesterol rais ratio total hdl cholesterol advers affect cholesterol profil advic limit cholesterol intak reduc consumpt egg cholesterol rich food valid
MED-1914~earli life stress telomer length investig connect mechan abstract advers experi earli life maltreat exert power negat effect health decad answer lie dna research suggest exposur stress acceler eros dna segment call telomer shorter telomer length correl chronolog age diseas morbid mortal telomer eros potenti mechan link childhood stress health problem life array mechanist methodolog basic biolog question address order translat telomer discoveri clinic applic monitor health predict diseas risk paper cover current state scienc lay research direct
MED-1915~work rel exhaust telomer length population bas studi abstract background psycholog stress suggest acceler rate biolog age investig work rel exhaust indic prolong work stress acceler biolog age shorter leukocyt telomer dna protein complex cap chromosom end cell method data repres sampl finnish working ag popul health num studi sampl consist num men women age num num work rel exhaust assess maslach burnout inventori general survey determin relat leukocyt telomer length quantit real tim polymeras chain reaction pcr base method result adjust age sex individu sever exhaust leukocyt telomer averag num relat unit shorter standard error num exhaust num associ exhaust relat telomer length remain signific addit adjust marit socioeconom status smoke bodi mass index morbid adjust differ num relat unit standard error num num conclus data suggest work rel exhaust relat acceler rate biolog age hypothesi await confirm prospect studi measur relat telomer length time
MED-1916~associ physic activ leisur time leukocyt telomer length pubm ncbi abstract background physic inact import risk factor aging rel diseas leukocyt telomer dynam telomer length age depend attrit rate ostens biolog indic human age test hypothesi physic activ level leisur time past num month leukocyt telomer length ltl normal healthi volunt method studi num white twin volunt compris num women num men questionnair physic activ level smoke status socioeconom status leukocyt telomer length deriv termin restrict fragment length adjust age potenti confound result leukocyt telomer length posit increas physic activ level leisur time num associ remain signific adjust age sex bodi mass index smoke socioeconom status physic activ work ltls activ subject num nucleotid longer activ subject num num kilobas num find confirm small group twin pair discord physic activ level averag ltl activ twin num nucleotid longer activ twin num conclus sedentari lifestyl addit smoke high bodi mass index low socioeconom status effect ltl acceler age process power messag clinician promot potenti antiag effect regular exercis
MED-1917~effect healthi lifestyl behavior associ leukocyt telomer length coronari arteri calcium pubm ncbi abstract telomer length indic biolog age shorter telomer coronari arteri calcium cac valid indic coronari atherosclerosi unclear healthi lifestyl behavior affect relat telomer length cac sampl subject age num num year previous diagnosi coronari heart diseas stroke diabet mellitus cancer num healthi lifestyl behavior greater fruit veget consumpt lower meat consumpt exercis healthi weight presenc social support examin determin attenu associ shorter telomer length presenc cac logist regress analys control age gender race ethn framingham risk score reveal relat shorter telomer presenc cac attenu presenc high social support low meat consumpt high fruit veget consumpt shorter telomer characterist signific longer telomer convers subject shorter telomer healthi lifestyl signific increas risk presenc cac low fruit veget consumpt odd ratio num num confid interv num num high meat consumpt odd ratio num num confid interv num num low social support odd ratio num num confid interv num num stratif gender yield similar result men women fruit veget consumpt attenu shorter telomer length cac relat conclus result present studi suggest involv healthi lifestyl behavior attenu associ shorter telomer length coronari atherosclerosi identifi cac num elsevi reserv
MED-1918~intens medit train immun cell telomeras activ psycholog mediat pubm ncbi abstract background telomeras activ predictor long term cellular viabil decreas chronic psycholog distress epel al num buddhist tradit claim medit decreas psycholog distress promot well b dalai lama cutler num investig effect num month medit retreat telomeras activ major contributor experi stress perceiv control decreas stress neurotic increas subject distress mediat model test perceiv control neurotic explain medit retreat effect telomeras activ addit investig qualiti develop medit practic increas mind purpos life account retreat rel stress rel variabl telomeras activ method retreat particip num medit num daili num month compar wait list control group num match age sex bodi mass index prior medit experi retreat particip receiv instruct concentr medit techniqu complementari practic cultiv benevol state mind wallac num psycholog measur assess pre post retreat peripher blood mononuclear cell sampl collect post retreat telomeras activ clear priori hypothes num tail signific criteria result telomeras activ signific greater retreat particip control end retreat num increas perceiv control decreas neurotic increas mind purpos life greater retreat group num mediat analys effect retreat telomeras mediat increas perceiv control decreas neurotic turn perceiv control neurotic partial mediat increas mind purpos life addit increas purpos life direct mediat telomeras group differ increas mind conclus studi link medit posit psycholog chang telomeras activ measur baselin telomeras activ data suggest increas perceiv control decreas negat affect contribut increas telomeras activ implic telomer length immun cell longev purpos life influenc medit practic direct affect perceiv control negat emot affect telomeras activ direct indirect copyright num elsevi reserv
MED-1919~human telomeras model show role ten domain advanc doubl helix polymer step abstract telomeras constitut group special ribonucleoprotein enzym remedi chromosom shrinkag result end repl problem defect telomer length regul diseas age cancer signific progress understand role telomeras complet structur human telomeras enzym bound telomer dna remain elus detail molecular mechan telomer elong unknown applic comput method distant homolog detect compar model molecular dock guid experiment data generat three dimension structur model partial telomeras elong complex compos essenti protein domain bound single strand telomer dna sequenc form heteroduplex templat region human rna subunit ter model structur mechan process telomeras offer insight elong conclud rna dna heteroduplex constrain telomeras ten domain repeat extens cycl ten domain control process move templat ahead base time translat rotat doubl helix rna region direct templat bind complementarili newli synthes telomer dna templat reus telomeras activ site reaction cycl structur model human telomeras enzym detail molecular mechan telomeras immedi import target ration drug design
MED-1920~ahead action health diabet design method clinic trial weight loss prevent cardiovascular diseas pubm ncbi abstract overweight obes major contributor type num diabet cardiovascular diseas cvd individu type num diabet overweight obes high risk cvd morbid mortal short term weight loss shown amelior obesity rel metabol abnorm cvd risk factor long term consequ intent weight loss overweight obes individu type num diabet adequ examin primari object ahead clinic trial assess long term effect num year intens weight loss program deliv num year overweight obes individu type num diabet approxim num male femal particip type num diabet num year age bodi mass index num kg m num random group intens lifestyl intervent design achiev maintain weight loss decreas calor intak increas physic activ program compar control condit diabet support educ primari studi outcom time incid major cvd event studi design provid num probabl detect num differ major cvd event rate group outcom includ compon cvd risk cost cost effect diabet control complic hospit intervent process qualiti life
MED-1921~intak small to medium chain satur fatti acid peripher leukocyt telomer length postmenopaus women abstract dietari factor includ dietari fat affect biolog age process reflect shorten telomer length tl affect level oxid stress inflammatori respons examin direct relat total type dietari fat fat rich food peripher leukocyt tl num appar healthi postmenopaus women particip women health initi intak total fat individu fatti acid fat rich food assess questionnair tl measur quantit polymeras chain reaction intak short to medium chain satur fatti acid smsfas aliphat tail num carbon invers tl compar particip quartil smsfa intak women highest quartil median num energi shorter tls num kb num ci num num kb women lowest quartil intak median num energi longer tls num kb num ci num num kb p trend num lauric acid individu smsfas invers tl num isoenerget substitut model substitut num energi smsfas energi sourc num bp longer tls num ci num bp intak nonskim milk butter whole milk chees major sourc smsfas invers tl signific associ found long chain satur fatti acid monounsatur fatti acid polyunsatur fatti acid conclus found higher intak smsfas smsfa rich food shorter peripher leukocyt tl postmenopaus women find suggest potenti role smsfas rate biolog age
MED-1922~stress telomer biolog lifespan perspect abstract past decad grow field telomer scienc open excit avenu understand cellular molecular substrat stress stress rel age process ver lifespan shorter telomer length advanc chronolog age increas diseas morbid mortal emerg studi suggest stress acceler eros telomer earli life possibl influenc initi newborn set telomer length review highlight recent empir evid link stress mental ill time lifespan telomer eros present find development program telomer biolog link prenat stress newborn adult telomer length present find link exposur childhood trauma mental disord telomer shorten review studi character relationship relat health risk behavior telomer shorten lifespan process buffer negat effect stress telomer understand mechan govern regul telomer biolog lifespan inform understand etiolog long term consequ stress mental ill age process divers popul set
MED-1923~loving kind medit practic longer telomer women pubm ncbi abstract short telomer length serv marker acceler age shorter telomer link chronic stress specif lifestyl behavior mitig effect stress longer telomer length previous research suggest link behavior focus well b volunt caregiv health longev examin relat telomer length group individu experienc loving kind medit lkm practic deriv buddhist tradit util focus unselfish kind warmth peopl control particip medit blood collect venipunctur genom dna extract peripher blood leukocyt quantit real time pcr measur relat telomer length rtl cawthon num fifteen lkm practition num control particip signific differ age gender race educ exposur trauma control group higher bodi mass index bmi lower rate past depress lkm practition longer rtl control trend level num women lkm practition signific longer rtl control num remain signific control bmi past depress limit small sampl size result offer intrigu possibl lkm practic women alter rtl biomark longev copyright num elsevi reserv
MED-1924~satur fatti acid metabol key link cell divis cancer senesc cellular organ age abstract cellular senesc vivo vitro phenomenon accompani physiolog includ cessat divis disturb organell structur function review literatur undertaken determin evid organ age cell senesc share common initi pathway vivo age cell lineag includ age lymphocyt show high express ink num num gene cell cultur telomer shorten past key length state arf ink gene system num num human num num mice switch activ num suppress cell divis num gene key tumor suppressor delet mutat cancer growth switch num fatti acid metabol down regul fatti acid synthas stearoyl coa delta num desaturas co suppress gene enhanc uptak extracellular fatti acid lead rais level cellular palmit induct apoptosi senesc senesc cell fatti acid composit cellular membran alter lead structur function organell mitochondria anim model acceler age exhibit repress stearoyl coa desaturas activ anti ag calori restrict stimul enzym system conclud age cell organ share common initi pathway cellular senesc protect cancer healthi longev enhanc factor activ suppress excess cell divis
MED-1926~habitu physic exercis benefici effect telomer length postmenopaus women pubm ncbi abstract object report women benefit mainten telomer length estrogen exercis favor influenc telomer length result inconsist durat type exercis cell type measur telomer length purpos studi investig relationship habitu physic exercis telomer length peripher blood mononuclear cell pbmcs postmenopaus women postmenopaus women chosen studi particip typic estrogen defici method experimental control cross sect studi includ num healthi nondiabet nonsmok postmenopaus women habitu exercis sedentari particip match age bodi mass index bodi weight height blood pressur waist hip circumfer measur mitochondri dna copi number telomer length pbmcs determin biochem test perform habitu physic exercis defin combin aerob resist exercis perform num minut session time week num month result age particip num num year particip habitu exercis group exercis time week averag num num month serum triglycerid level num fast insulin concentr num homeostasi model assess insulin resist num signific lower high dens lipoprotein cholesterol level num circul adiponectin num mitochondri dna copi number num telomer length num signific higher habitu exercis group sedentari group stepwis multipl regress analysi habitu exercis num num adiponectin level num num independ factor telomer length pbmcs postmenopaus women conclus habitu physic exercis greater telomer length postmenopaus women find suggest habitu physic exercis postmenopaus women reduc telomer attrit
MED-1928~telomer lifestyl cancer age abstract purpos review grow evid lifestyl factor affect health lifespan individu affect telomer length purpos review highlight import telomer human health age summar lifestyl factor affect health longev alter rate telomer shorten recent find recent studi telomer length affect lifestyl factor affect pace age onset age associ diseas summari telomer length shorten age progress shorten telomer lead senesc apoptosi oncogen transform somat cell affect health lifespan individu shorter telomer increas incid diseas poor surviv rate telomer shorten increas decreas specif lifestyl factor choic diet activ great potenti reduc rate telomer shorten prevent excess telomer attrit lead delay onset age associ diseas increas lifespan review highlight role telomer age describ lifestyl factor affect telomer human health age
MED-1929~pilot studi yogic medit famili dementia caregiv depress symptom effect mental health cognit telomeras activ abstract background studi examin effect daili yogic medit mental health cognit function immun cell telomeras activ famili dementia caregiv mild depress symptom method thirty nin famili dementia caregiv age num year sd num random practic kirtan kriya listen relax music num minut day week sever depress symptom mental cognit function assess baselin follow up telomeras activ peripher blood mononuclear cell pmbc examin peripher pbmc pre post intervent result medit group show signific lower level depress symptom greater improv mental health cognit function compar relax group medit group num show num improv hamilton depress rate scale num particip show num improv mental health composit summari score mcs sf num scale compar num num relax group pp num medit group show num improv telomeras activ compar num relax group num conclus pilot studi found daili medit practic famili dementia caregiv lead improv mental cognit function lower level depress symptom improv accompani increas telomeras activ suggest improv stress induc cellular age result confirm larger sampl
MED-1930~leukocyt telomer length relat food nutrient intak elder popul pubm ncbi abstract background object shorter leukocyt telomer length ltl chronic diseas studi assess associ dietari factor ltl object studi associ fat fruit veget ltl cross sect studi design hypothes intak fruit veget posit ltl intak fat satur fatti acid sfas negat ltl subjects method ltl measur quantit real tim polymeras chain reaction num men women age num year helsinki birth cohort studi assess diet valid semiquantit num item food frequ questionnair result general signific result total fat sfa intak num num invers ltl men adjust age energi intak women veget intak posit ltl num men consum butter fruit signific shorter telomer consum lowest amount butter highest amount fruit num found associ ltl bodi mass index waist hip ratio smoke physic activ educ attain conclus cross sect studi elder men women statist signific effect diet general support hypothesi fat veget intak ltl
MED-1931~acceler telomer eros declin immun function caregiv alzheim diseas patient abstract caregiv alzheim diseas patient endur chronic stress declin immun function assess psycholog immunolog caregiv compar depress symptom pbmc composit vitro activation induc prolifer cytokin product telomer length telomeras activ num individu num caregiv num age gender match control found depress symptom signific higher caregiv control num correspond caregiv signific lower cell prolifer higher product immune regulatori cytokin tnf il num control respons stimul vitro examin impact cellular replic lifespan found caregiv signific shorter telomer length pbmc control num num kb num similar shorten isol cell monocyt telomer attrit caregiv due increas shorter telomer possess cell subset pbmc final show basal telomeras activ pbmc cell signific higher caregiv control num point unsuccess attempt cell compens excess loss telomer caregiv find demonstr chronic stress alter cell function acceler immun cell age suggest excess telomer loss
MED-1932~exposur violenc childhood telomer eros num num year age longitudin studi abstract increas interest discov mechan mediat effect childhood stress late lif diseas morbid mortal previous studi suggest potenti mechan link stress cellular age diseas mortal human telomer eros examin telomer eros relat children exposur violenc salient early lif stressor long term consequ well b major public health social welfar problem prospective longitudin studi repeat telomer measur children experienc stress test hypothesi childhood violenc exposur acceler telomer eros age num age num year violenc assess exposur matern domest violenc frequent bulli victim physic maltreat adult particip num children num femal num violenc exposur recruit environmental risk longitudin twin studi nation repres num num birth cohort child relat telomer length measur simultan baselin follow up dna sampl quantit pcr method t s ratio ratio telomer repeat copi number single copi gene number compar counterpart children experienc kind violenc exposur show signific telomer eros age num baselin age num follow up measur adjust sex socioeconom status bodi mass index num num num find support mechan link cumul childhood stress telomer mainten observ young age potenti impact life long health
MED-1933~cover acceler telomer shorten respons life stress abstract numer studi demonstr link chronic stress indic poor health includ risk factor cardiovascular diseas poorer immun function exact mechan stress skin remain elus investig hypothesi stress impact health modul rate cellular age provid evid psycholog stress perceiv stress chronic stress signific higher oxid stress lower telomeras activ shorter telomer length determin cell senesc longev peripher blood mononuclear cell healthi premenopaus women women highest level perceiv stress telomer shorter averag equival decad addit age compar low stress women find implic understand cellular level stress promot earlier onset age rel diseas
MED-1934~independ combin effect dietari weight loss exercis leukocyt telomer length postmenopaus women abstract object investig effect num month dietari weight loss and or aerob exercis leukocyt telomer length postmenopaus women design method num overweight obes women num num random dietari weight loss num ii aerob exercis num iii diet exercis num iv control num diet intervent group bas program num weight loss goal exercis intervent num mins day num days week moderate to vigor aerob activ fast blood sampl baselin num month dna extract isol leukocyt telomer length measur quantitative polymeras chain reaction qpcr compar group intent to treat general estim equat result baselin telomer length invers age num num posit maxim oxygen uptak num num bmi bodi fat chang telomer length invers correl baselin telomer length num num signific differ leukocyt telomer length detect intervent group compar control magnitud weight loss telomer length num month conclus twelve month dietari weight loss exercis chang telomer length postmenopaus women
MED-1935~diet rel telomer shorten chromosom stabil abstract recent evid highlight influenc micronutri mainten telomer length tl order explor diet rel telomer shorten physiolog relev accompani signific damag genom present studi tl assess termin restrict fragment trf analysi peripher blood lymphocyt num healthi subject detail inform dietari habit data compar incid nucleoplasm bridg npbs marker chromosom instabl relat telomer dysfunct visualis cytokinesis block micronucleus assay increas capabl detect slight impair telomer function incid npbs evalu cell expos vitro ionis radiat care control potenti confound factor influenc tl age htert genotyp smoke status data show higher consumpt veget relat signific higher tl num analysi associ micronutri tl highlight signific role antioxid intak beta caroten telomer mainten num diet rel telomer shorten result increas spontan radiation induc npbs distribut trfs analys slight preval radiation induc npbs num observ subject higher amount short trfs num kb relat incid short trfs posit associ age num unrel veget consumpt daili intak micronutri suggest degre telomer eros relat low dietari intak antioxid observ studi extens lead chromosom instabl
MED-1936~physic exercis prevent cellular senesc circul leukocyt vessel wall pubm ncbi abstract background molecular mechan vasculoprotect effect physic exercis incomplet understood telomer eros central compon age telomere associ protein regul cellular senesc surviv studi examin effect exercis vascular telomer biolog endotheli apoptosi mice effect long term endur train telomer biolog human method result num bl num mice random voluntari run run wheel condit num week exercis upregul telomeras activ thorac aorta circul mononuclear cell compar sedentari control increas vascular express telomer repeat bind factor num ku num reduc express vascular apoptosi regul cell cycle checkpoint kinas num num num mice precondit voluntari run exhibit mark reduct lipopolysaccharide induc aortic endotheli apoptosi transgen mous studi show endotheli nitric oxid synthas telomeras revers transcriptas synerg confer endotheli stress resist physic activ test signific data human telomer biolog circul leukocyt young middle ag track field athlet analyz peripher blood leukocyt isol endur athlet show increas telomeras activ express telomere stabil protein downregul cell cycl inhibitor compar untrain individu long term endur train reduc leukocyt telomer eros compar untrain control conclus physic activ regul telomere stabil protein mice human protect stress induc vascular apoptosi
MED-1937~effect turmer alzheimer diseas behavior psycholog symptom dementia abstract describ patient alzheimer diseas ad behavior symptom improv remark result turmer treatment tradit indian medicin cognit declin behavior psycholog symptom dementia bpsd sever patient exhibit irrit agit anxieti apathi patient suffer urinari incontin prescrib turmer powder capsul start recov symptom advers reaction clinic symptom laboratori data num week treatment total score neuro psychiatr inventory brief questionnair decreas signific acuiti symptom burden caregiv case mini ment state examin mmse score point num num case signific chang mmse recogn famili num year treatment case turmer num year re exacerb bpsd present case suggest signific improv behavior symptom ad turmer treatment lead probabl benefit turmer individu ad bpsd
MED-1939~oral curcumin alzheimer diseas toler efficaci num week random doubl blind placebo control studi abstract introduct curcumin polyphenol compound deriv plant curcuma long lin demonstr antioxid anti inflammatori effect effect reduc beta amyloid aggreg reduc patholog transgen model alzheimer diseas ad promis candid treat human ad purpos current studi generat toler preliminari clinic biomark efficaci data curcumin person ad method perform num week random doubl blind placebo control studi curcumin num complex open label extens num week thirty six person mild to moder ad random receiv placebo num grams day num grams day oral curcumin num week week num num subject receiv curcumin continu dose subject previous receiv placebo random num ratio num grams day num grams day primari outcom measur incid advers event clinic laboratori test alzheimer diseas assess scale cognit subscal adas cog num week complet studi secondari outcom measur includ neuropsychiatr inventori npi alzheimer diseas cooper studi activ daili live adcs adl scale level num num plasma level num t tau p tau num num isoprostan cerebrospin fluid plasma level curcumin metabolit hour drug administr measur result age complet num num year mini ment status examin mmse score num subject withdrew placebo num worsen memori num subject withdrew curcumin group num due gastrointestin symptom curcumin num complex lower hematocrit increas glucos level clinic insignific differ treatment group clinic biomark efficaci measur level nativ curcumin measur plasma low num ng ml conclus curcumin general well toler subject curcumin withdrew due gastrointestin symptom unabl demonstr clinic biochem evid efficaci curcumin num complex ad num week placebo control trial preliminari data suggest limit bioavail compound trial registr clinicaltri gov identifi nct num
MED-1941~curcuminoid enhanc amyloid beta uptak macrophag alzheimer diseas patient pubm ncbi abstract treatment alzheimer diseas ad difficult due ignor pathogenesi ad patient defect phagocytosi amyloid beta num abeta vitro innat immun cell monocyte macrophag clearanc abeta plaqu num natur product curcuminoid enhanc brain clearanc abeta anim model treat macrophag ad patient num control curcuminoid vitro measur abeta uptak fluoresc confoc microscopi baselin intens abeta uptak ad macrophag signific lower comparison control macrophag involv surfac bind intracellular uptak treatment macrophag curcuminoid abeta uptak macrophag ad patient signific num num increas confoc microscopi ad macrophag respons curcuminoid show surfac bind untreat macrophag co loc phalloidin intracellular compart treatment immunomodul innat immun system curcuminoid safe approach immun clearanc amyloidosi ad brain
MED-1942~curri consumpt cognit function elder pubm ncbi abstract curcumin curri spice turmer shown possess potent antioxid antiinflammatori properti reduc beta amyloid plaqu burden experiment studi epidemiolog evid lack author investig associ usual curri consumpt level cognit function elder asian population bas cohort num nondement elder asian subject age num year num author compar mini ment state examin mmse score categori regular curri consumpt account sociodemograph health behavior correl mmse perform consum curri occasion signific mmse score subject rare consum curri author report tentat evid cognit perform curri consumpt nondement elder asian confirm futur studi
MED-1944~incid alzheimer diseas rural communiti india indo us studi pubm ncbi abstract object determin age specif incid rate ad rural population bas cohort ballabgarh india compar refer popul monongahela valley pennsylvania method num year prospect epidemiolog studi subject age num year util repeat cognit function abil screen standard clinic evalu diagnost statist manual mental disord num edit nation institut neurolog communic disord stroke alzheimer diseas relat disord associ criteria diagnosi clinic dementia rate scale stage dementia ad result incid rate num person year ad cdr num num num ci num num age num year num num ci num num age num year standard age distribut num census incid rate age num year num num person year substanti lower rate num num person year monongahela valley conclus ad incid rate report indian subcontin lowest report short durat follow up cultur factor potenti confound suggest caution interpret find
MED-1947~role curcumin idiopath inflammatori orbit pseudotumour pubm ncbi abstract present report describ time clinic efficaci curcumin activ constitu rhizom curcuma longa treatment patient suffer idiopath inflammatori orbit pseudotumour curcumin administ oral dose num mg num times day oral period num month patient period num year num month interv patient complet studi recov complet patient swell regress complet limit movement persist side effect note patient recurr suggest curcumin safe effect drug treatment idiopath inflammatori orbit pseudotumour copyright num john wiley son
MED-1948~curcumin neurodegen diseas abstract ten year curcumin report effect wide varieti diseas character anti carcinogen hepatoprotect thrombosuppress cardioprotect anti arthrit anti infecti properti recent studi perform vertebr invertebr model conduct determin curcumin neuroprotect efficaci curcumin pre clin trial neurodegen diseas creat excit due lack toxic low cost suggest curcumin worthi candid nutraceut intervent age common risk factor neurodegen diseas compound target age mechan prevent kind diseas potenti mechan explain general health benefit curcumin prevent aging associ cellular protein lead protein insolubl aggreg loss protein homeostasi age rel diseas recent curcumin found maintain protein homeostasi extend lifespan model invertebr caenorhabd elegan review evid anim model curcumin improv healthspan prevent delay onset neurodegen diseas
MED-1949~preterm birth risk factor adult cardiometabol diseas pubm ncbi abstract infant experi modern pre neonat care thirti age incid cardiometabol diseas low data cohort born preterm prior introduct modern care suggest increas risk type num diabet young adult cohort small preterm infant accumul evid increas risk factor cardiovascular diseas includ higher blood pressur lower lean bodi mass impair glucos regul atherogen lipid profil lifestyl adult born small preterm undertak non condit physic activ lower intak fruit milk product intervent reduc risk factor blood pressur low physic activ substanti potenti reduc lifetim diseas burden small preterm infant data warrant expert evalu level evid cardiometabol diseas individu born small preterm public health implic copyright num elsevi reserv
MED-1950~intak garlic dri fruit lower risk spontan preterm deliveri abstract studi found associ microbi infect pregnanc preterm deliveri ptd investig influenc food antimicrobi prebiot compon risk spontan ptd literatur search identifi microb spontan ptd subsequ num main food type allium dri fruit identifi antimicrobi compon affect microb spontan ptd dietari fiber recogn prebiot investig intak num women norwegian mother child cohort moba num underw spontan ptd num gestat week allium garlic onion leek spring onion num num ci num num num dri fruit raisin apricot prune fig date num num ci num num num decreas risk spontan ptd intak allium relat pronounc risk reduct earli spontan ptd gestat week num num num num ci num num strongest associ group garlic num num ci num num cook onion intak dri fruit show associ preterm prelabor ruptur membran pprom num num ci num num strongest associ group raisin num num ci num num strongest associ pprom allium group garlic num num ci num num conclus intak food antimicrobi prebiot compound import reduc risk spontan ptd garlic lower risk spontan ptd dri fruit raisin reduc risk pprom
MED-1951~late preterm birth review medic neuropsycholog childhood outcom pubm ncbi abstract late preterm lp birth num num num num week gestat account three fourth preterm birth make popul sizeabl public health concern immatur fetal develop lp deliveri increas risk mortal short term medic complic combin matern fetal neonat risk factor critic recent begun address lp birth disrupt impact brain develop exert advers effect neuropsycholog function childhood adolesc understudi earli data shown grade respons lp children function preterm children wors term children subtl intellectu neuropsycholog deficit lp children compar healthi children born term gestat age character neuropsycholog profil requir accomplish prospect longitudin studi moder lp birth result dispar medic psycholog outcom common methodolog combin particip singl research cohort assess risk outcom reconsid rapid grow lp outcom literatur reinforc critic principl fetal develop occur dynam matur continuum concept birth success gestat day improv outcom
MED-1952~grow extrem preterm birth lifespan mental health outcom pubm ncbi abstract grow interest long term mental health sequela extrem preterm birth paper review literatur relat mental health outcom lifespan studi conduct preschool year school age adolesc adulthood show continu outcom point increas risk inattent socio commun problem emot difficulti individu born extrem preterm behaviour neuroimag studi provid evid neurodevelopment origin mental health disord popul summaris contemporari evid highlight key methodolog carri interpret studi field copyright num elsevi reserv
MED-1953~antimicrobi properti allium sativum garlic pubm ncbi abstract garlic medicin properti thousand year investig mode action recent garlic wide spectrum action antibacteri antivir antifung antiprotozo benefici effect cardiovascular immun system resurg natur herbal altern brought medicin plant forefront pharmacolog investig drug discov review aim address histor garlic sulfur chemistri provid basi research antimicrobi properti
MED-1954~preterm birth behaviour problem infant preschool ag children review recent literatur pubm ncbi abstract behaviour problem children born preterm school age studi behaviour problem preterm born infant infanc preschool age fourteen cohort studi publish pubm psycinfo num num review focus type occurr comorbid stabil predict perinat social relat risk factor behaviour problem preterm born children infanc num preschool age num relat risk factor consid addit paper very preterm very low birthweight moderately preterm children age group show behaviour problem term born comparison children perinat social risk factor cognit perform control poor social interact skill poor behaviour emot self regul emot difficulti reduc attent common behaviour problem behaviour problem infanc predict behaviour problem includ follow up programm author development medicin child neurolog num mac keith press
MED-1955~matern dietari pattern preterm deliveri result larg prospect cohort studi abstract object examin associ exist matern dietari pattern risk preterm deliveri design prospect cohort studi set norway num num particip num num pregnant women singleton answer food frequenc questionnair miss inform pariti previous preterm deliveri pregnanc durat num num gestat week diabet enrol pregnanc main outcom measur hazard ratio preterm deliveri level adher distinct dietari pattern interpret prudent veget fruit oil water beverag grain cereal fibr rich bread western salti sweet snack white bread dessert process meat product tradit potato fish result adjust covari high score prudent pattern signific reduc risk preterm deliveri hazard ratio highest versus lowest num num confid interv num num prudent pattern signific lower risk late spontan preterm deliveri independ associ preterm deliveri found western pattern tradit pattern reduc risk preterm deliveri highest versus lowest hazard ratio num num num conclus studi show women adher prudent tradit dietari pattern pregnanc lower risk preterm deliveri compar women find establish causal support dietari advic pregnant women eat balanc diet includ veget fruit grain fish drink water result increas intak food prudent dietari pattern import total exclud process food fast food junk food snack
MED-1956~elev tcdd chicken egg farm rais catfish fed diet ball clay southern unit state mine pubm ncbi abstract food drug administr fda termin ball clay mine mississippi addit anim feed discov nanogram gram concentr num num tetrachlorodibenzo p dioxin num num tcdd fda collect chicken egg farm rais catfish affect area remain continent unit state assess level num num tcdd method quadrupol ion storag tandem in tim mass spectrometri qistm measur num num tcdd level num catfish fillet composit num tilapia fillet composit num chicken egg sampl num chicken feed catfish composit num egg sampl num num tcdd concentr signific num pg g wet weight fillet egg farm rais catfish expos feed ball clay num num tcdd concentr num pg g tcdd isom pattern ball clay differ tcdd isom pattern fli ash sampl chick edema factor tcdd pattern sampl refer toxic fat feed ingredi num
MED-1957~pcdd pcdf contamin catfish feed arkansa usa pubm ncbi abstract combin catfish feed sampl arkansa usa ingredi analyz pcdds pcdfs ingredi soybean meal high contamin pcdds toxic num num substitut congen num pg g dri weight num pg g lipid num num tetra cdd i teq soybean meal num pg g dri weight num pg g fat valu combin catfish feed concentr approxim num time lower congen pattern congen profil ratio sigma pcdds sigma pcdfs soybean meal uniqu awar environment sampl technic product similar characterist result natur format pcdds found soybean meal rule
MED-1958~congener specif level dioxin dibenzofuran food estim daili dioxin toxic equival intak abstract food meat milk fish sourc polychlorin dibenzo p dioxin pcdds dibenzofuran pcdfs dioxinlik compound general popul estim intak high toxic compound perform congener specif dioxin analys time food num dairi meat fish sampl supermarket upstat york num num tetrachlorodibenzo p dioxin tcdd dioxin toxic equival teq wet weight basi dairi product rang num num ppt meat teq rang num num ppt fish teq rang num num ppt previous human breast milk infant formula analys current preliminari food data estim rang dioxin intak american averag daili food intak teq adult weigh num kg estim num num pg kg bodi weight total num pg teq num american consumpt rate due high level pcdds pcdfs common found human breast milk american women women industri countri nurs infant consum averag num pg teq kg bodi weight day year life compar current epa virtual safe dose num pg tcdd kg bodi weight day num year lifetim base upper limit cancer risk num num num pg kg day european govern agenc
MED-1959~dioxin congen pattern commerci catfish unit state indic miner clay potenti sourc pubm ncbi abstract num depart agricultur usda conduct annual survey pesticid residu food agricultur market service pesticid data program pdp assess chemic residu domest market catfish product num catfish sampl collect num pdps subset num sampl analys num toxic polychlorin dibenzo p dioxin furan pcdd fs averag pattern individu pcdd f congen concentr catfish uniqu measur amount polychlorin dibenzofuran pcdfs pcdds present pattern domin domest produc catfish product import product china taiwan comparison pattern sourc pcdd fs show strong similar pattern pcdd fs found kaolin clay anti cak agent anim feed investig catfish feed sourc pcdd fs found catfish archiv catfish feed data food drug administr usfda databas examin num num feed sampl pcdd concentr num time higher pcdf concentr resembl pattern found catfish product clay mine south eastern unit state sourc pcdd fs domest market catfish product definit establish mine clay product feed consid sourc wide concentr rang pcdd fs found clay critic control point pcdd fs entranc food suppli
MED-1960~pcdd pcdf pcb farm rais catfish southeast unit states  concentr sourc cyp num induct pubm ncbi abstract catfish fillet catfish nugget feed sampl pond sediment analyz pcdd pcdf pcb farm rais catfish mississippi alabama arkansa signific level num num substitut pcdd pcdf addit larg number num num substitut congen present sampl catfish fillet catfish nugget high concentr dioxin lik pcb number non dioxin lik pcb teq base pcdd pcdf rang num num pg g lipid teq base pcb rang num num pg g lipid catfish sampl dioxin lik pcb contribut num total teq pcdd pcdf pcb catfish sampl major sourc pcdd pcdf pcb feed pond sediment immunoreact cyp num protein elev num fold pond rais catfish compar aquarium rais result studi suggest pcdd pcdf import pcb cyp num induct
MED-1961~reduc exposur dioxin relat compound food generat pubm ncbi abstract dioxin relat compound undesir unintend contamin food suppli dietari intak major rout exposur reduc dietari exposur dioxin vulner segment popul pregnant women infant young girl effect strategi reduc bodi burden futur generat exposur dioxin food minim select lower fat version meat poultri dairi product consum food includ fatti fish recommend amount congruent goal reduc dioxin intak exposur maintain good health
MED-1962~concentr distribut num num dibenzo p dioxins  furan chicken pubm ncbi abstract concentr num num cl substitut dibenzo p dioxins  furan pcdds pcdfs determin edibl tissu chicken fryer compar valu found abdomin fat valu present weight basi lipid adjust basi tissu mark differ concentr num num dibenzo p dioxin edibl tissu express weight basi lipid adjust concentr individu dioxin statist tissu valid lipid adjust concentr num num pcdds pcdfs abdomin fat determin presenc compound tissu
MED-1963~polychlorin dibenzo p dioxin polychlorin dibenzofuran pcdd pcdf food sampl collect southern mississippi usa pubm ncbi abstract num analyz num foodstuff sampl local supermarket southern mississippi usa pcdd pcdf num num cl num quantifi num sampl lipid basi level meat num num pg i teq g dairi product num num pg i teq g slight lower report industri countri level dairi sampl unit state europ compar differ contribut individu congen i teq milk sampl germani approxim num i teq due presenc num num num cl num mississippi sampl congen contribut num highest concentr pcdd pcdf studi detect farm rais catfish num num pg i teq g uniqu find addit num num substitut pcdd pcdf catfish sampl num num substitut congen unusu vertebr anim select elimin metabol num num substitut congen
MED-1966~effect dietari cholesterol serum cholesterol meta analysi review pubm ncbi abstract attempt estim effect dietari cholesterol serum cholesterol meta analysi previous includ baselin ad dietari cholesterol mathemat model report serum cholesterol num studi control diet suppli metabol kitchen provid num data point weight number subject nonlinear regress good fit data num num observ predict point equat num num chi num num chi chang serum cholesterol mmol l chi ad dietari cholesterol chi num baselin dietari cholesterol mg d reason hyperbol shape relationship chang serum cholesterol ad dietari cholesterol mechan individu respons dietari cholesterol import implic interpret prior studi public health issu discuss
MED-1968~effect increas amount dietari cholesterol postprandi lipemia lipoprotein human subject pubm ncbi abstract aim determin effect increas amount dietari cholesterol num mg postprandi plasma lipid respons lipoprotein normolipidem human subject ten subject fed test meal random order meal fat cholesterol fix amount lipid num num num num mg cholesterol fast post meal blood sampl obtain num larg small triglyceride rich lipoprotein trl low densiti ldl high densiti hdl lipoprotein isol compar no fat no cholesterol meal fat enrich meal rais num plasma triglycerid phospholipid free cholesterol lower cholesteryl ester postprandi meal num mg cholesterol general elicit compar postprandi plasma lipoprotein lipid respons meal provid num num mg cholesterol signific increas postprandi plasma phospholipid larg trl triglycerid decreas plasma esterifi cholesterol lipid composit larg trls concentr small trl lipid compon alter postprandi cholesterol intak hand ldl free cholesterol increas num ldl cholesteryl ester drop num num hdl cholesteryl ester drop num hdl phospholipid increas num ingest meal high enrich cholesterol blood insulin apoa i apob alter postprandi cholesterol intak data show ingest num mg cholesterol meal signific alter postprandi lipoprotein respons healthi subject
MED-1977~colon butcher livestock associ methicillin resist staphylococcus aureus pubm ncbi abstract report document colon swine europ north america recent china livestock associ methicillin resist staphylococcus aureus la mrsa contamin pig farmer veterinarian abattoir worker strain observ contamin level num retail pork report netherland canada limit data contamin rate worker handl raw meat investig rate mrsa contamin local butcher work wet market recent slaughter pig cut nasal swab collect num pork butcher market hong kong enrich brain heart infus broth num salt cultur mrsaselect isol confirm staphylococcus aureus suscept test perform presenc meca confirm sccmec spa type determin related investig pfge subject complet questionnair mrsa carriag risk factor seventeen sampl num yield mrsa num harbour sccmec ivb ten strain num cc num previous report local pig carcass strain healthcar sccmec type ii num cc num colon subject establish singl isol num cc num num cc num num cc num remain isol num cc num previous report buffalo num cc num report bovin milk butcher report recent hospit healthcar worker famili recent receiv antibiot skin infect report wound infect year expos meat num day carriag mrsa higher butcher general communiti strain healthcar origin high incid num cc num suggest cross contamin pork occur frequent wash hand touch raw pork advis num blackwel verlag gmbh
MED-1978~high dens livestock oper crop field applic manur risk community associ methicillin resist staphylococcus aureus infect pennsylvania usa abstract context num antibiot unit state sold livestock feed manur produc livestock antibiotic resist bacteria resist gene antibiot subsequ appli crop field put communiti member risk antibiotic resist infect object assess associ individu exposur swine dairy v industri agricultur risk methicillin resist staphylococcus aureus mrsa infect design set particip population bas nest case control studi geising primari care patient pennsylvania num num incid mrsa case identifi electron health record classifi community associ healthcare associ frequency match random select control patient skin soft tissu infect nutrient manag plan creat exposur variabl season crop field manur applic number livestock oper sub studi collect num isol patient stratifi locat diagnosi proxim livestock oper main outcom measur community associ mrsa healthcar associated mrsa skin soft tissu infect status histori mrsa compar control result num patient num community associ mrsa num healthcare associ mrsa num skin soft tissu infect case num control includ adjust mrsa risk factor highest quartil swine crop field exposur signific community associ mrsa healthcare associ mrsa skin soft tissu infect case status adjust odd ratio num num ci num num num num ci num num num num ci num num trend increas odd quartil outcom trend num similar weaker associ swine oper community associ mrsa skin soft tissu infect molecular test num isol identifi num uniqu spa type correspond cc num previous found swine conclus proxim swine manur applic crop field livestock oper mrsa skin soft tissu infect find contribut grow concern potenti public health impact high dens livestock product
MED-1979~pig pork methicillin resist staphylococcus aureus pork product chain pubm ncbi abstract methicillin resist staphylococcus aureus mrsa major global public health concern food safeti issu recurr report document pig herd import reservoir mrsa specif livestock associ sequenc type num high preval mrsa pig primari product facil frequent detect mrsa type pork pig meat product rais question mechan introduct transmiss mrsa pork product chain comprehens review current literatur worldwid presenc livestock associ mrsa step pork product chain reveal slaughter process play decis role mrsa transmiss farm fork superfici heat treatment scald flame slaughter process signific reduc burden mrsa carcass recontamin mrsa occur surfac treat machineri result fecal contamin eviscer increas human handl meat process optim process carcass decontamin avoid recontamin effect clean person hygien manag transmiss mrsa pig pork minim
MED-1980~rapid detect extended spectrum lactamase produc enterobacteriacea abstract enterobacteri strain produc clavulanic acid inhibit extended spectrum lactamas esbl increas report worldwid convent detect esbl product remain time consum num num esbl ndp nordmann dortet poirel test develop rapid identif esbl enterobacteriacea biochem test base vitro detect cephalosporin cefotaxim hydrolysi inhibit tazobactam addit esbl activ evidenc color chang red yellow ph indic red phenol due carboxyl acid format result cefotaxim hydrolysi revers addit tazobactam posit test esbl ndp test appli cultur strain num esbl produc num esbl nonproduc sensit specif num num sensit num excel detect ctx m produc esbl produc num remain suscept cefotaxim detect test evalu spike blood cultur show excel sensit specif num test rapid num cost effect implement health care facil adapt infect control purpos
MED-1981~antibiot resistance th global solut pubm ncbi abstract antibiot resist complex includ human behaviour level societi consequ affect world similar climat chang evid effort made describ facet antibiot resist intervent meet challeng coordin action larg absent polit level nation intern antibiot pave unpreced medic societ develop today indispens health system achiev modern medicin major surgeri organ transplant treatment preterm babi cancer chemotherapi today grant access effect treatment bacteri infect year face dire setback medic social econom real unpreced global coordin action immedi describ global situat antibiot resist major consequ identifi key area action urgent copyright num elsevi reserv
MED-1982~contamin hand methicillin resist staphylococcus aureus contact environment surfac contact skin pubm ncbi abstract studi num methicillin resist staphylococcus aureus mrsa carrier hand contamin equal contact common examin skin site common touch environment surfac patient room num num find suggest contamin surfac import sourc mrsa transmiss
MED-1983~transfer methicillin resist staphylococcus aureus retail pork product food contact surfac potenti consum exposur pubm ncbi abstract methicillin resist staphylococcus aureus mrsa pathogen develop resist beta lactam antibiot isol low popul number retail meat product object studi estim potenti transfer mrsa contamin retail pork product food contact surfac estim potenti human exposur mrsa contact contamin surfac pork loin bacon fresh pork sausag inocul four strain mix mrsa cultur rang popul approxim num num log vacuum packag store num week num simul normal packag distribut primari transfer determin place inocul product knife blade cut board human skin model pork skin num min secondari transfer determin place inocul product contact surfac remov place secondari contact surfac initi contact surfac pork skin model simul transfer human skin place contact contact surfac percentag transfer primari transfer inocul product cut board rang num num percentag transfer knife rang num num percentag transfer inocul product pork skin rang num num secondari transfer percentag rang num num product contact surfac statist analysi show signific differ amount transfer transfer surfac cell concentr
MED-1985~attain height lacto ovo vegetarian children adolesc pubm ncbi abstract relationship diet attain height studi children adolesc southern california diet pattern determin extens food frequenc questionnair num caucasian children num year attend state school num num seventh day adventist school num num major differ diet pattern state adventist school children meat consumpt adventist children split categori frequenc meat consumpt num week num week less num greater equal num num percent state school children consum meat daili vegetarian consum meat num week differ signific consumpt major food group fruit veget school diet subgroup num percentil nation center health statist age adjust regress analysi show averag adventist vegetarian children taller meat consum classmat num num cm boy girl result chang materi adjust food group adjust parent height socioeconom factor sub sampl num children result vegetarian children adolesc balanc diet grow tall children consum meat
MED-1986~long term morbid mortal overweight adolesc follow up harvard growth studi num num pubm ncbi abstract background overweight adult increas morbid mortal contrast long term effect overweight adolesc morbid mortal method studi relat overweight morbid mortal num lean overweight adolesc num num year particip harvard growth studi num num overweight adolesc defin body mass index occas greater num percentil subject age sex larg nation survey lean adolesc defin body mass index num num percentil subject aliv interview num obtain inform medic histori weight function capac risk factor die inform death obtain death certif result overweight adolesc subject increas risk mortal disease specif mortal men women relat risk men num num percent confid interv num num num mortal num num percent confid interv num num num mortal coronari heart diseas risk morbid coronari heart diseas atherosclerosi increas men women overweight adolesc risk colorect cancer gout increas men risk arthriti increas women overweight adolesc overweight adolesc power predictor risk overweight adulthood conclus overweight adolesc predict broad rang advers health effect independ adult weight num year follow up
MED-1987~manag type num diabet mellitus children adolesc pubm ncbi abstract object num decad preval childhood obes increas dramat north america usher varieti health problem includ type num diabet mellitus num previous typic life technic report describ detail procedur undertaken develop recommend accompani clinic practic guidelin manag type num diabet mellitus children adolesc in depth inform rational recommend studi make clinic practic guideline recommend method primari literatur search conduct relat treatment num children adolesc secondari literatur search conduct relat screen treatment num m s comorbid children adolesc inclus criteria prospect unanim agre member committe articl elig inclus address treatment primari search num num comorbid secondari search num publish num written english includ abstract primari research inquiri consid review articl consid includ primari data opinion research popul constitut children and or adolesc exist diagnosi num studi adult patient consid num studi popul younger num year retriev titl abstract articl review consult epidemiologist result thousand articl retriev consid search basi aforement criteria primari search num abstract identifi inclus num retain systemat review studi classifi grade studi num grade num grade num grade articl treatment num select inclus divid num major subcategori basi type treatment discuss num medic treatment num studi num nonmed treatment num studi num provid behavior num studi num social issu num studi secondari search addit num abstract relat comorbid identifi inclus num retain systemat review articl includ num systemat review literatur comorbid num adolesc num expert opinion present global recommend base evid num cohort studi report natur histori diseas comorbid num specif attent comorbid pattern specif ethnic group case control cohort clinic report adult literatur num report associ microalbuminuria retinopathi num case control num cohort num report preval nephropathi cohort num report peripher vascular diseas case seri num discuss retinopathi num case control num posit statement num address hyperlipidemia american heart associ posit statement cardiovascular risk american diabet associ consensus statement case seri breakdown grade recommend show grade studi num grade studi num grade studi num grade studi regard screen treatment recommend comorbid data children scarc literatur conflict therapeut recommend hypertens dyslipidemia retinopathi microalbuminuria depress summar expert guidelin document present detail guidelin refer provid committe independ assess support evid screen tool provid supplement inform
MED-1988~pediatrician role screen treatment bulli prediabet oral health pubm ncbi abstract purpos review review recent literatur import topic pediatr offic practic bulli screen prediabet state pediatr oral health recent find recent literatur show bulli behavior common children young kindergarten age strong associ bulli victim rang psychosomat depress symptom children intervent includ famili therapi school bas program effect bulli victim recent studi delin glucos insulin metabol recent work provid model practition screen prediabet state hope provid earlier opportun interven avoid morbid type num diabet mellitus recent literatur emphas continu gap dental healthcar patient risk recent studi emphas import role diet sealant prevent dental cari summari recent literatur emphas import role office bas pediatrician identifi patient involv bulli risk develop type num diabet mellitus poor dental health futur research delin problem provid refin primari prevent treatment guidelin
MED-1990~intens versus convent glucos control critic ill patient pubm ncbi abstract background optim target rang blood glucos critic ill patient remain unclear method num hour admiss intens care unit icu adult expect requir treatment icu num consecut day random assign undergo intens glucos control target blood glucos rang num num mg decilit num num mmol liter convent glucos control target num mg decilit num mmol liter defin primari end point death num day random result num patient underw random num assign undergo intens control num undergo convent control data regard primari outcom day num num num patient group similar characterist baselin total num patient num intensive control group num num conventional control group die odd ratio intens control num num confid interv num num num treatment effect differ signific oper surgic patient nonop medic patient odd ratio death intensive control group num num num sever hypoglycemia blood glucos level num mg decilit num mmol liter report num num patient num intensive control group num num num conventional control group num signific differ treatment group median number day icu num hospit num median number day mechan ventil num renal replac therapi num conclus larg intern random trial found intens glucos control increas mortal adult icu blood glucos target num mg decilit result lower mortal target num num mg decilit clinicaltri gov number nct num massachusett medic societi
MED-1991~plant food plant bas diet protect childhood obes pubm ncbi abstract object articl review epidemiolog literatur examin role plant food plant bas diet prevent childhood obes data suggest protect effect ready to eat cereal risk obes prospect studi studi fruit veget grain cereal high protein food includ bean legum soy fiber plant bas dietari pattern inconsist general null evid base limit studi fraught methodolog limit includ cross sect design inadequ adjust potenti confound lack report error stage growth genet influenc well design prospect studi lack evid show associ plant bas diet childhood obes diet encourag plant food highlight dietari guidelin american children meet current recommend plant food advic consum plant bas low energy dens diet sound ethic question aris high price diet unit state diet perceiv part world reduc burden childhood obes elimin health dispar prevent spread diseas globe requir polici intervent ensur plant food afford access children incom level awar sociocultur norm affect consumpt
MED-1992~prediabet high risk state develop diabet summari prediabet intermedi hyperglycaemia base glycaem paramet normal diabet threshold high risk state diabet annual convers rate num num similar proport convert back normoglycaemia preval prediabet increas worldwid project num million peopl prediabet num prediabet simultan presenc insulin resist cell dysfunct abnorm start glucos detect observ evid show associ prediabet earli form nephropathi chronic kidney diseas small fibr neuropathi diabet retinopathi increas risk macrovascular diseas multifactori risk score optim estim diabet risk non invas paramet blood bas metabol trait addit glycaem valu prediabet individu lifestyl modif cornerston diabet prevent evid num num relat risk reduct accumul data suggest potenti benefit pharmacotherapi
MED-1993~type num diabet mellitus children adolesc abstract type num diabet mellitus emerg clinic problem pediatr practic recent report increas preval type num diabet mellitus children adolesc world ethnic preval obes increas major young peopl diagnos type num diabet mellitus found specif ethnic subgroup african american hispan asian pacif island american indian clinician awar frequent mild asymptomat manifest type num diabet mellitus childhood screen meaning high risk group children adolesc obes relat type num diabet mellitus clinic featur insulin resist hypertens dyslipidemia polycyst ovarian syndrom acanthosi nigrican treatment choic lifestyl intervent pharmacolog treatment metformin drug dipeptidyl peptidas inhibitor glucagon peptid num mimet pipelin treatment youth type num diabet mellitus recent report high dropout medic care system adolesc type num diabet mellitus suggest manag children adolesc type num diabet mellitus requir remodel current healthcar practic
MED-1994~prediabet type num diabet youth emerg epidem diseas pubm ncbi abstract purpos review preval obes youth increas alarm children adolesc unit state problem fall disproportion african american hispan children metabol cardiovascular complic obes present childhood close link concomit insulin resistance hyperinsulinemia degre obes co morbid persist adulthood recent find progress normal glucos toler type num diabet mellitus involv intermedi stage prediabet impair glucos regul prediabet character peripher insulin resist impair glucos sensit first phas insulin secret hand overt type num diabet mellitus beta cel failur fulli manifest progress prediabet type num diabet mellitus youth character mark weight gain reduct insulin secret insulin resist summari revert obes lifestyl modif involv nutrit educ behavior modif exercis import step prevent progress diabet
MED-1996~childhood obes type num diabet mellitus pubm ncbi abstract recent major case diabet mellitus children adolesc immune medi type num diabet obes led dramat increas incid type num diabet num children adolesc past num decad obes strong insulin resist coupl relat insulin defici lead develop overt num children adolesc num experi microvascular macrovascular complic diseas younger age individu develop diabet adulthood includ atherosclerot cardiovascular diseas stroke myocardi infarct sudden death renal insuffici chronic renal failur limb threaten neuropathi vasculopathi retinopathi lead blind health care profession advis perform screen children risk num diagnos condit earli provid rigor manag diseas
MED-1997~vegetarian diet childhood obes prevent pubm ncbi abstract increas preval childhood overweight obes uniqu industri societi dramat increas occur urban area develop countri light consensus obes signific public health concern weight loss intervent unsuccess long term explor food pattern benefici primari prevent obes warrant focus articl review relat vegetarian diet obes relat childhood obes epidemiolog studi vegetarian diet lower bodi mass index bmi lower preval obes adult children meta analysi adult vegetarian diet studi estim reduc weight differ num kg men num kg women result num point lower bmi kg m num similar compar nonvegetarian vegetarian children leaner bmi differ greater adolesc studi explor risk overweight food group dietari pattern plant bas diet approach prevent obes children plant bas diet low energi densiti high complex carbohydr fiber water increas satieti rest energi expenditur plant bas dietari pattern encourag optim health environment benefit food polici warrant support social market messag reduc cultur econom forc make difficult promot plant bas dietari pattern
MED-1998~earli treatment type num diabet pubm ncbi abstract grow epidem type num diabet lead prematur morbid mortal worldwid due micro macrovascular complic diseas grow bodi evid suggest risk develop complic greater glucos level establish threshold diagnosis  increas parallel rise hyperglycemia individu glucos level prediabet rang increas risk earli intervent ideal abnorm glucos homeostasi detect great import minim burden diseas earli stage diseas asymptomat diagnos prediabet earli overt type num diabet challeng aim articl discuss challeng benefit earli intervention  with emphasi prevent trial show progress type num diabet delay address prediabetes  and exist evidence bas guidelin drawn optim standard care prediabet overt type num diabet stage copyright num publish elsevi
MED-1999~strategi prevent type num diabet updat clinician abstract diabet major grow public health challeng threaten overwhelm medic servic futur type num diabet confer signific morbid mortal notabl target organ damag eye kidney nerv heart magnitud cardiovascular risk diabet illustr posit coronari heart diseas risk equival complic relat neuropathi vast work concert vascular abnorm result clinic consequ foot ulcer increas understand natur histori disord generat potenti interven halt patholog progress overt diseas ensu point manag increas challeng concept prediabet formal diagnosi begun translat research set clinic practic continu updat guidelin vari nomenclatur emerg pharmacotherapi ever chang evid base clinician left uncertain practic identifi manag patient prediabet stage review aim summar epidemiolog data concept diseas pathogenesi guidelin recommend addit lifestyl pharmacolog surgic therapi target stop progress prediabet diabet antidiabet medic newer anti obes medic intervent bariatr procedur shown promis benefit diet therapeut lifestyl chang remain mainstay manag improv metabol profil individu glucos dysregul risk stratif tool identifi at risk individu coupl unselect popul level intervent hold promis futur practic
MED-2000~project year num burden diabet adult popul dynam model incid mortal prediabet preval abstract background peopl diabet suffer divers complic erod qualiti life diabet cost unit state num billion year num expect increas larg financi toll subsequ year accur project diabet burden essenti policymak plan futur health care cost method data prediabet diabet preval unit state forecast incid current census project mortal migrat author construct seri dynam model employ system differ equat project futur burden diabet adult three stat model partit popul diabet undiagnos diabet diagnos diabet four stat model divid state diabet high risk prediabet low risk normal glucos state five st model incorpor intervent design prevent delay diabet adult high risk result author project annual diagnos diabet incid case increas num case num num num num assum low incid high diabet mortal total diabet preval diagnos undiagnos case project increas num num num adult popul num recent increas diabet incid continu diabet mortal low preval increas num num middle ground scenario project preval num num num intervent reduc elimin increas diabet preval conclus project increas larg attribut age popul increas number member higher risk minor group popul peopl diabet live longer effect strategi undertaken moder impact factor nation diabet burden analysi suggest widespread implement effect prevent intervent focus high risk subgroup popul reduc elimin futur increas diabet preval
MED-2001~awar prediabetes  unit state num pubm ncbi abstract num approxim adult age num year estim num million person prediabet condit blood glucos hemoglobin num num level higher normal high classifi diabet person prediabet high risk develop type num diabet account num num case diabet year num person prediabet lose weight engag moder physic activ progress type num diabet averag num year follow up evidence bas lifestyl program encourag dietari moderate intens physic activ modest weight loss delay prevent type num diabet person prediabet identifi person prediabet inform increas risk type num diabet step encourag person prediabet make healthi lifestyl num approxim num person prediabet awar prediabet examin recent awar prediabet factor awar adult age num year cdc analyz data nation health nutrit examin survey nhane report describ result analysi num approxim num prediabet awar condit num estim awar prediabet num popul subgroup level health car access factor unit state person prediabet includ regular access health care benefit effort aim make awar risk develop type num diabet reduc risk make modest lifestyl effort increas awar
MED-2002~prevent type num diabet mellitus lifestyl subject impair glucos toler pubm ncbi abstract background type num diabet mellitus increas common primarili increas preval sedentari lifestyl obes type num diabet prevent intervent affect lifestyl subject high risk diseas method random assign num middle ag overweight subject num men num women age num year body mass index weight kilogram divid squar height meter num impair glucos toler intervent group control group subject intervent group receiv individu counsel aim reduc weight total intak fat intak satur fat increas intak fiber physic activ oral glucose toler test perform annual diagnosi diabet confirm test durat follow up num year result sd amount weight lost base line end year num num num kg intervent group num num kg control group net loss end year num num num kg intervent group num num kg control group num comparison group cumul incid diabet year num percent num percent confid interv num num percent intervent group num percent num percent confid interv num num percent control group trial risk diabet reduc num percent num intervent group reduct incid diabet direct lifestyl conclus type num diabet prevent lifestyl high risk subject
MED-2003~reduct incid type num diabet lifestyl intervent metformin abstract background type num diabet affect approxim num percent adult unit state risk factor elev plasma glucos concentr fast state oral glucos load over weight sedentari lifestyl potenti revers hypothes modifi factor lifestyle intervent program administr metformin prevent delay develop diabet method random assign num nondiabet person elev fast post load plasma glucos concentr placebo metformin num mg daili lifestyle modif program goal num percent weight loss num minut physic activ week age particip num year body mass index weight kilogram divid squar height meter num num percent women num percent member minor group result averag follow up num year incid diabet num num num case num person year placebo metformin lifestyl group lifestyl intervent reduc incid num percent num percent confid interv num num percent metformin num percent num percent confid interv num num percent compar placebo lifestyl intervent signific effect metformin prevent case diabet period year num person particip lifestyle intervent program num receiv metformin conclus lifestyl treatment metformin reduc incid diabet person high risk lifestyl intervent effect metformin
MED-2004~creat public awar state num diabet forecast pubm ncbi abstract incid preval diabet primarili type num diabet risen sharpli num project increas num num num affect num million peopl result medic societ cost half trillion dollar year prevent case diabet treat effect earli treatment make signific differ prevent major complic reduc prematur death cure diseas earli detect prediabet conjunct lifestyl reduc number peopl diabet dramat reduct diabet preval time requir signific lifestyl part societi purpos studi increas public awar sever region diabet trend provid detail forecast state metropolitan area num num model creat util latest nation diabet popul data project transform state metropolitan area forecast popul major subgroup forecast summar easy to understand paper state select metro area provid onlin easi public access research import data exist project futur preval potenti cost diabet state metro area level data key stakehold make inform decis diabet impact communiti resourc alloc
MED-2005~microvascular complic retinopathi nephropathi pubm ncbi abstract diabet retinopathi diabet nephropathi extract enorm toll patient diabet enorm burden health care system aggress control glycemia blood pressur coupl aggress laser photocoagul treatment microalbuminuria problem larg elimin futur specif intervent emerg interdict pathophysiolog process lead initi progress microvascular complic challeng primari care physician diabetologist attain excel glycem control aggress control blood pressur assur patient dilat fundus examin annual prefer ophthalmologist retin specialist regular screen microalbuminuria medic manag intervent occur reduc risk blind renal failur lessen burden diabet retinopathi nephropathi
MED-2006~identif peptid hormon amphipath helix class helic hydrophob moment algorithm pubm ncbi abstract eisenberg helic hydrophob moment mu greater algorithm appli analysi primari structur amphipath alpha hel peptid hormon optim method identifi peptid class determin quantit compar amphipath helic peptid hormon group peptid proven nonamphipath properti determin method distinguish respect maximum num residu mu greater amphipath helic control peptid num num num num num reflect amphipath potenti entir peptid percent num residu segment peptid mu greater plot mu greater result curv refer hm c hm c group high signific hm c method superior abil distinguish amphipath nonamphipath peptid potenti member structur class identifi approach molecular model portion prolactin inhibitori factor reveal strong amphipath alpha helix residu num computer bas method enabl rapid identif peptid amphipath alpha helix class
MED-2007~prevent diabet reduct major cardiovascular event studi subject prediabet meta analysi randomis control pubm ncbi abstract background impair glucos toler igt impair fast glucos ifg pre diabet state treatment prevent delay onset overt diabet potenti reduc major cardiovascular cv event sought determin intervent includ diet exercis pharmacolog therapi alter all caus cardiovascular relat mortal subject method perform meta analysi prospect randomis control trial rcts identifi medic literatur databas trial elig inclus report all caus mortal rate minimum recruit approxim num patient minimum follow up year intervent divid pharmacolog non pharmacolog result ten rcts enrol num patient met entri criteria trial ran averag num year diabet delay prevent intervent control risk ratio num num ci num num non drug approach num superior drug bas approach num diabet prevent num num num num num num num differ risk all caus mortal intervent versus control group num num num differ cv death num num num non signific trend reduct fatal non fat myocardi infarct num num num fatal non fat stroke borderlin reduc num num num intervent versus control conclus intervent success retard progress overt diabet result reduct all caus cardiovascular mortal myocardi infarct stroke
MED-2008~pulse bas diet effect reduc total ldl cholesterol older adult pubm ncbi abstract purpos determin effect pulse bas diet individu num year older reduc cvd risk factor total num particip randomis receiv pulse bas food serv daili bean chickpea pea lentil num g d dri weight regular diet num month washout num month cross ov diet num month anthropometr measur bodi composit biochem marker serum ldl cholesterol ldl c primari outcom lipid glucos insulin c reactiv protein assess diet phase total eighty seven particip thirti male fifty seven femal num num sd num num year bodi mass num sd num kg complet studi compar regular diet pulse bas diet decreas total cholesterol num num puls num num sd num num num num sd num num mmol l regular num num sd num num num num sd num num mmol l num num ldl c num num puls num num sd num num num num sd num num mmol l regular num num sd num num num num sd num num mmol l num num sub analysi individu high lipid level baselin twenti individu high cholesterol pulse bas diet reduc cholesterol num compar regular diet puls num num sd num num num num sd num num mmol l regular num num sd num num num num sd num num mmol l num num pulse bas diet effect reduc total cholesterol ldl c older adult reduc risk cvd
MED-2009~nutrit qualiti health benefit chickpea cicer arietinum review pubm ncbi abstract chickpea cicer arietinum import puls crop grown consum world afro asian countri good sourc carbohydr protein protein qualiti consid puls chickpea signific amount essenti amino acid sulphur contain amino acid complement ad cereal daili diet starch major storag carbohydr dietari fibr oligosaccharid simpl sugar glucos sucros lipid present low amount chickpea rich nutrit import unsatur fatti acid linol oleic acid sitosterol campesterol stigmasterol import sterol present chickpea oil ca mg present chickpea seed chickpea good sourc import vitamin riboflavin niacin thiamin folat vitamin precursor caroten puls chickpea seed anti nutrit factor reduc elimin cook techniqu chickpea potenti health benefit combin puls cereal benefici effect import human diseas cvd type num diabet digest diseas cancer chickpea import puls crop divers array potenti nutrit health benefit
MED-2010~nutrit qualiti legum role cardiometabol risk prevent review pubm ncbi abstract legum includ alfalfa clover lupin green bean pea peanut soybean dri bean broad bean dri pea chickpea lentil repres import compon human diet area world develop countri complement lack protein cereal root tuber region world legum seed protein suppli diet health benefit legum consumpt receiv rise interest research consumpt product extend worldwid european countri higher legum consumpt observ mediterranean capita daili consumpt num num northern europ daili consumpt num capita physiolog effect legum vari signific differ result polysaccharid composit quantiti varieti dietari fiber starch protein make up variabl phytochem content major legum phytochem bioactiv compound includ enzym inhibitor phytohemagglutinin lectin phytoestrogen oligosaccharid saponin phenol compound play metabol role human frequent consum food dietari intak phytochem provid health benefit protect numer diseas disord coronari heart diseas diabet high blood pressur inflamm synergist antagonist effect phytochem mixtur food legum interact compon diet mechan action remain challeng regard understand role phytochem health diseas mitig effect mechan action address understand role phytochem health diseas review overview nutrit qualiti legum potenti contribut cardiometabol risk prevent
MED-2011~exploratori studi relationship hypertens diet divers saba island abstract relationship diet divers hypertens examin cross sect exploratori studi num random select adult resid saba island netherland antill eastern caribbean basin blood pressur measur num year antihypertens medic identifi chronic hypertens num hour dietari recal semi quantit food frequenc interview ethnograph confirm techniqu calcul diet divers measur dietari pattern result suggest hypertens lack balanc food group daili diet imbal dietari cation sodium potassium calcium bivari analys found signific associ poor diversifi diet hypertens odd ratio num num percent confid interv ci num num dietari intak sodium potassium calcium examin found presenc hypertens bivari analys includ cation individu logist regress model includ diet divers diminish diet diversity hypertens associ multipl logist regress model potenti confound variabl individu enter control variabl bodi fat skin color age sex perceiv stress alcohol intak aerob activ socioeconom status alter result analysi presenc absenc individu food group lack legum daili diet diagnosi hypertens num num percent ci num num
MED-2013~celiac diseas wheat allergi gluten sensit gluten free fad pubm ncbi abstract gluten fre diet gfd gain popular general public health practition begin question real health benefit patient celiac diseas cd gfd consid medic nutrit therapi proven treatment result improv symptomatolog small bowel histolog wheat allergi benefit gfd patient restrict rye barley oat diet gluten sensit controversi subject patient cd wheat allergi vari degre symptomat improv gfd condit categori includ dermat herpetiformi dh irrit bowel syndrom ib neurolog diseas gluten sensit ataxia autism import patient healthcar practition understand differ condit respond gfd patient cd experi comorbid nutrit defici higher risk develop cancer autoimmun condit wheat allergi gluten sensit thought higher risk complic defin symptom biochem marker gluten sensit condit import area futur investig high qual large scal random trial prove true benefit gfd evolv field
MED-2014~characterist patient avoid wheat and or gluten absenc celiac diseas pubm ncbi abstract background gastrointestin symptom respond remov wheat and or gluten common patient avoid wheat and or gluten pwawg heterogen group predomin self diagnos prior present clinic evalu specif aim character pwawg tertiari care referr center compar patient celiac diseas cd subject nation health nutrit examin survey nhane method cross sect studi evalu patient gastroenterologist cd referr center baselin characterist laboratori valu medic comorbid compar cd patient present center subject enrol nhane result eighty four pwawg identifi compar num cd patient num nhane patient thirty two altern diagnos made num pwawg includ small intestin bacteri overgrowth fructose lactos intoler compar patient cd pwawg similar bodi mass index bmi num num num hemoglobin num num num compar male femal patient nhane bmi folat hemoglobin valu lower pwawg male femal pwawg lower preval hypertens conclus similar cd pwawg possibl due share hla haplotyp effect gluten fre diet altern diagnos common patient pwawg similar cardiovascular profil cd patient term lower bmi lower preval hypertens
MED-2016~econom burden gluten fre diet pubm ncbi abstract background coeliac diseas common autoimmun disord treatment lifelong adher gluten fre diet studi evalu econom burden adher gluten fre diet method market basket product identifi brand weight packag size regular wheat bas product gluten fre counterpart develop differ price purchas venu type store general groceri store upscal groceri store health food store internet bas groceri site region analys result avail gluten fre product vari venu regular groceri store carri num upscal market carri num health food store num compar num avail internet gluten fre product expens wheat bas counterpart num bread pasta expens wheat bas counterpart cost affect shop venu geograph locat conclus studi demonstr gluten fre food poor avail expens gluten contain counterpart impact find dietari complianc qualiti life address
MED-2018~spectrum gluten rel disord consensus nomenclatur classif abstract decad ago celiac diseas consid extrem rare europ complet health care profession num year key mileston move celiac diseas obscur popular spotlight worldwid observ interest phenomenon generat great confus health care profession number individu embrac gluten fre diet gfd higher project number celiac diseas patient fuel global market gluten fre product approach num billion global sale num trend support notion celiac diseas condit relat ingest gluten emerg health care concern review summar current knowledg main form gluten reaction allerg wheat allergi autoimmun celiac diseas dermat herpetiformi gluten ataxia possibl immune medi gluten sensit outlin pathogen clinic epidemiolog differ propos nomenclatur classif
MED-2019~effect wheat gluten hydrolys immun system healthi human subject pubm ncbi abstract healthi volunt divid test group num control group num test group consum num gram wheat gluten hydrolys num nk cell activ hematolog paramet measur assess perform control group receiv wheat gluten hydrolys test group nk cell activ increas signific num wheat gluten hydrolys intak advers effect observ group
MED-2020~effect wheat bran serum lipid influenc particl size wheat protein pubm ncbi abstract object wheat fiber protect cardiovascular diseas lack consist effect serum lipid determin report inconsist effect wheat bran result differ particl size high gluten content method studi conduct one month metabol diet num hyperlipidem subject consum bread provid addit num g d dietari fiber medium ultra fin wheat bran extra protein num energi wheat gluten two week ad libitum diet num predomin normolipidem subject consum breakfast cereal provid addit num g d dietari fiber coars mixtur ultra fin coars wheat bran chang gluten intak studi random crossov design control period subject ate low fib bread cereal ad gluten fast blood lipid measur day end phase result wheat bran effect total ldl hdl cholesterol irrespect particl size level gluten diet consumpt increas gluten metabol studi num num reduct serum triglycerid num normal gluten ad libitum studi conclus protect effect wheat fiber cardiovascular diseas explain effect wheat bran reduc serum cholesterol hyperlipidem subject displac carbohydr gluten high fib phase lower serum triglycerid
MED-2021~celiac diseas manag persist symptom patient gluten fre diet abstract aim investig patient refer center non respons celiac diseas nrcd establish continu symptom method assess patient refer center non respons celiac diseas num mo period individu investig establish eitiolog continu symptom patient clinic histori examin perform routin blood work includ tissu transglutaminas antibodi measur refer specialist gastroenterolog dietician identift laps diet sourc hidden gluten ingest repeat small intestin biopsi perform compar biopsi refer hospit colonoscopi lactulos hydrogen breath test pancreolauryl test comput tomographi scan abdomen undertaken symptom persist clinic progress minimum num year result hundr twelv consecut patient refer nrcd twelv found celiac diseas cd remain num patient num adequ adher strict gluten fre diet num found inadvert ingest gluten num admit non compli microscop coliti diagnos num small bowel bacteri overgrowth num refractori cd diagnos num diagnos intestin lymphoma num year num patient remain continu symptom die conclus individu nrcd remedi found num continu gluten ingest lead propos algorithm investig
MED-2022~grain human health pubm ncbi abstract epidemiolog studi find whole grain intak protect cancer cvd diabet obes recommend consum serv grain daili usual intak western countri serving d grain rich nutrient phytochem health benefit grain high concentr dietari fibr resist starch oligosaccharid grain rich antioxid includ trace miner phenol compound compound link diseas prevent protect compound grain includ phytat phyto oestrogen lignan plant stanol sterol vitamin miner publish whole grain feed studi report improv biomark whole grain consumpt weight loss blood lipid improv antioxid protect difficult separ protect properti grain dietari fibr compon diseas protect grain prospect epidemiolog studi exceed protect isol nutrient phytochem grain
MED-2024~cutting edg issu celiac diseas gluten intoler pubm ncbi abstract celiac diseas cd gluten depend immune medi diseas preval general popul estim num num large scal epidemiolog studi shown num case cd identifi basi clinic find laboratori test crucial identifi subject subtl atyp symptom correct choic clinic diagnost tool enabl accur diagnosi earli recognit silent cd case review consid relev aspect relat laboratori diagnosi cd extens gluten intoler combin test earli accur diagnosi diagnost role test detect antibodi neoepitop produc transglutaminase gliadin complex form non celiac gluten intoler gluten sensit signific measur cytokin cd
MED-2026~preval celiac diseas unit state pubm ncbi abstract object preval celiac diseas cd unit state unknown sought estim cd preval nationwid nation repres sampl method studi includ num person age num year older particip nation health nutrit examin survey num serum sampl particip test immunoglobulin iga tissu transglutaminas antibodi find abnorm iga endomysi antibodi inform prior diagnosi cd gluten fre diet gfd obtain direct interview cd defin double posit serolog serolog diagnos cd report diagnosi cd doctor health car profession gfd report clinic diagnosi cd result cd found num particip num unawar diagnosi median age num year interquartil rang num year num women num non hispan white preval cd unit state num num confid interv ci num num num num ci num num non hispan white num particip report gfd correspond preval num num ci num num conclus preval cd unit state num num num similar found european countri case undiagnos cd rare minor group affect num non hispan white person gfd diagnosi cd
MED-2027~character adult self diagnosi nonceliac gluten sensit pubm ncbi abstract background nonceliac gluten sensit ncgs occur patient celiac diseas gastrointestin symptom improv gluten fre diet gfd larg self report diagnosi common aim studi character patient ncgs materi method advertis direct adult believ ncgs particip clinic trial respond complet questionnair symptom diet celiac investig result num respond num complet survey age num year num women seventy two percent meet descript ncgs due inadequ exclus celiac diseas num uncontrol symptom gluten restrict num gfd num combin gfd self initi num respond respond prescrib altern health profession num dietitian num general practition num celiac investig perform num respond num respond duoden biopsi num inadequ gluten intak time endoscopi inadequ celiac investig common gfd initi num altern health profession num general practition num dietitian num num respond fulfil criteria ncgs knowledg adher gfd excel num identifi food intoler conclus num num respond self report ncgs fulfil criteria diagnosi initi gfd adequ exclus celiac diseas common num num respond symptom poor control gluten avoid num american societi parenter enter nutrit
MED-2028~reactiv dietari gluten insight differenti diagnosi gluten relat gastrointestin disord pubm ncbi abstract ingest dietari gluten trigger allerg autoimmun nonallerg nonautoimmun respons typic gluten relat allerg disord wheat allergi wa celiac diseas cd gluten relat autoimmun condit clinic express gluten relat nonallerg nonautoimmun respons nonceliac gluten sensit ncgs emerg condit framework unclear diagnosi suggest demonstr gluten depend patient symptom exclus wa cd review discuss current tool identifi patient suffer wa cd ncgs recent insight differenti diagnosi gluten relat gastrointestin disord
MED-2029~gluten contamin natur gluten fre flour starch canadian celiac diseas pubm ncbi abstract larg nation investig extent gluten cross contamin natur gluten fre ingredi flour starch sold canada perform sampl num purchas canadian citi internet period num analys gluten contamin result show num num num sampl contamin codex recommend maximum level gluten fre product num mg kg rang num mg kg ingredi label gluten fre contamin rang num mg kg number sampl lower num num pictur consist time approxim percentag sampl num mg kg initi set subsequ lot total composit contamin specif ingredi largest consist contamin higher fibr ingredi soy num mg kg millet num mg kg buckwheat num mg kg natur gluten fre flour starch test gluten fre label higher fibr ingredi constitut greatest probabl contamin gluten num mg kg
MED-2030~italian prospect multicent survey patient suspect non celiac gluten sensit abstract background non celiac gluten sensit ncgs undefin syndrom unsettl issu increas awar exist carri prospect survey ncgs italian center diagnosi gluten rel disord aim defin clinic pictur syndrom establish rough preval compar celiac diseas method novemb num octob num italian center num adult gastroenterolog num intern medicin num pediatr num allergi particip prospect survey questionnair order uniform accur collect clinic biochem instrument data result total num patient suspect ncgs identifi num year period female mal ratio num num age num year rang num num clinic pictur character combin gastrointestin abdomin pain bloat diarrhea and or constip nausea epigastr pain gastroesophag reflux aphthous stomat system manifest tired headach fibromyalgia lik joint muscl pain leg arm numb foggi mind dermat skin rash depress anxieti anemia larg major patient time laps gluten ingest symptom vari hour num day frequent disord irrit bowel syndrom num food intoler num ige medi allergi num autoimmun diseas detect num case famili histori num patient relat celiac diseas correl found ncgs posit hla dq num dq num igg anti gliadin antibodi detect num patient test proport patient underw duoden biopsi biopsi show normal intestin mucosa num mild increas intraepitheli lymphocyt num ratio suspect ncgs cd diagnos assess num particip center num num conclus prospect survey show ncgs strong correl femal gender adult age base result preval ncgs slight higher celiac diseas relat articl http   www biomedcentr num num
MED-2031~non celiac gluten sensit clinic relev recommend futur research pubm ncbi abstract background increas interest entiti non celiac gluten sensit ncgs recent year remain controversi topic pathogenesi understood celiac diseas contrast well studi condit increas recogn preval condit aris heighten immunolog respons gluten wheat allergi ige medi condit capabl caus varieti gastrointestin symptom number patient celiac diseas wheat allergi deriv benefit gluten fre diet increas substanti term ncgs describ condit increas preval recent year purpos review focus gastrointestin manifest ncgs discuss evid condit putat pathogenesi discuss area controversi area potenti futur research num john wiley son
MED-2032~non celiac wheat sensit diagnos double blind placebo control challeng explor clinic entiti pubm ncbi abstract object non celiac wheat sensit ws consid clinic entiti increas percentag general popul avoid gluten ingest real exist condit debat specif marker lack aim demonstr exist ws defin clinic serolog histolog marker method review clinic chart subject irrit bowel syndrom ib like present diagnos ws double blind placebo control dbpc challeng year num hundr celiac diseas cd patient fifti ib patient serv control result hundr seventy six patient ws diagnos dbpc challeng includ group show distinct clinic characterist identifi ws group num ws multipl food hypersensit group num group ws patient show higher frequenc anemia weight loss self report wheat intoler coexist atopi food allergi infanc ib control higher frequenc posit serum assay igg iga anti gliadin cytometr basophil activ vitro assay main histolog characterist ws patient eosinophil infiltr duoden colon mucosa patient ws character clinic featur similar found cd patient patient multipl food sensit character clinic featur similar found allerg patient conclus data confirm exist non celiac ws distinct clinic condit suggest exist distinct popul subject ws characterist similar cd characterist point food allergi
MED-2033~non celiac gluten sensit literatur review pubm ncbi abstract background signific percentag general popul report problem caus wheat and or gluten ingest celiac diseas cd wheat allergi wa test negat cd specif serolog histopatholog immunoglobulin ige mediat assay patient report gastrointestin nongastrointestin symptom report improv symptom gluten fre diet clinic condit non celiac gluten sensit ncgs aim attempt defin current pathogen clinic diagnost criteria diseas provid practic view evalu diagnos manag ncgs patient method review intern literatur pubm medlin search term wheat hyper sensit wheat allergi wheat intoler gluten hyper sensit gluten intoler discuss current knowledg ncgs result demonstr patient suffer ncgs heterogen group compos subgroup character pathogenesi clinic histori clinic ncgs diagnosi reach exclud cd wa recent evid show person histori food allergi infanc coexist atopi posit immunoglobulin igg antigliadin antibodi flow cytometr basophil activ test wheat duoden and or ileum colon intraepitheli lamina propria eosinophil count identifi ncgs patient conclus futur research aim identifi reliabl biomark ncgs diagnosi defin ncgs subgroup key teach point patient report gastrointestin nongastrointestin symptom agre improv symptom gluten fre diet ncgs diagnosi reach exclud celiac diseas wheat allergi patient suffer ncgs heterogen group compos subgroup character pathogenesi clinic histori clinic person histori food allergi infanc coexist atopi posit igg antigliadin antibodi aga flow cytometr basophil activ test wheat duoden and or ileum colon intraepitheli lamina propria eosinophil count identifi ncgs patient futur research aim identifi reliabl biomark ncgs diagnosi defin ncgs subgroup
MED-2034~nonceliac gluten sensit sens sensibl pubm ncbi abstract recent studi support exist condit nonceliac gluten sensit manifest intestin extraintestin symptom improv disappear gluten withdraw individu normal small bowel mucosa negat result serum antitransglutaminas antiendomysi antibodi test clinic concept debat preval nonceliac gluten sensit general popul suppos time higher celiac diseas lack unambigu definit nonceliac gluten sensit major pitfal primarili relat heterogen condit symptom presum caus mechan nonceliac gluten sensit etiolog heterogen syndrom manag option vari predomin concomit pathogen pathway
MED-2035~gluten sensit diarrhea evid celiac diseas pubm ncbi abstract adult femal patient suffer abdomin pain chronic diarrhea incapacit frequent nocturn dramat relief gluten fre diet return symptom gluten challeng previous nonspecif measur milk fre diet ineffect multipl jejun biopsi show minor signific cellular return normal gluten fre diet slight increas jejun cellular immunolog abnorm found gluten challeng steatorrhea biochem defect common celiac diseas found conclud patient gluten sensit diarrhea evid celiac diseas
MED-2036~sensitivity rel ill escal pandem allergi food intoler chemic sensit pubm ncbi abstract preval allergic rel diseas food intoler chemic sensit pediatr adult popul increas dramat decad escal rate morbid condit acquir allergi food intoler chemic hypersensit frequent direct sequela toxic induc loss toler tilt respons signific initi toxic exposur primari toxic insult individu sensit low level divers unrel trigger environ common encount chemic inhal food antigen sensit individu exposur assort incit stimuli precipit divers clinic and or immun sequela evidenc clinic symptom vari lymphocyt antibodi cytokin respons case recent recogn mechan diseas develop tilt result sensitivity rel ill sri involv organ system evok wide rang physic neuropsycholog manifest escal rate toxic exposur bioaccumul population at larg increas proport contemporari ill direct result tilt ensu sri avoid trigger preclud symptom desensit immunotherapi immun suppress amelior symptomatolog case resolut sri general occur gradual basi elimin bioaccumul toxic avoid initi advers environment exposur case medic histori evid diseas mechan emerg resist translat knowledg abound copyright num elsevi reserv
MED-2037~non celiac gluten sensit gluten grain pubm ncbi abstract celiac diseas immune medi inflammatori disord small intestin caus sensit dietari gluten relat protein genet predispos individu past year concept non celiac gluten sensit ncgs gain signific interest scientif communiti mass media number individu embrac gluten fre diet rapid grow condit character gastrointestin extraintestin symptom respond gluten withdraw evid celiac diseas wheat allergi symptom display signific overlap irrit bowel syndrom import factor condit remain elucid discrimin marker support diagnosi gluten sensit identifi pathogenesi remain obscur review current knowledg ncgs outlin potenti pathogen pathway gluten relat disord order gain clue pathophysiolog condit
MED-2038~absenc somat non coeliac gluten sensit pubm ncbi abstract object contrast coeliac diseas cd mechan non coeliac gluten sensit ncgs unclear aim studi measur presenc somat person trait anxieti depress health rel qualiti life ncgs individu compar cd patient healthi control compar respons gluten challeng ncgs cd patient materi method examin num cd patient num hla dq num ncgs patient cd gluten fre diet cd patient challeng oral num day gluten symptom registr perform challeng comparison group num healthi control includ patient healthi control complet questionnair anxieti depress neurotic lie hostil aggress alexithymia health locus control physic complaint health rel qualiti life result ncgs patient report abdomin num non abdomin num symptom gluten challeng cd patient signific differ cd ncgs patient person trait level somat qualiti life anxieti depress symptom somat level low cd ncgs group symptom increas gluten challeng relat person ncgs patient conclus ncgs patient exhibit tendenc general somat person qualiti life differ ncgs cd patient level healthi control ncgs patient report symptom cd patient gluten challeng
MED-2039~randomis clinic trial gluten depress subject non coeliac gluten sensit exploratori clinic studi pubm ncbi abstract background current evid suggest patient self report non coeliac gluten sensit ncgs retain gastrointestin symptom gluten fre diet gfd continu restrict gluten report feel aim investig notion major effect gluten ncgs mental state necessarili gastrointestin symptom method twenty two subject num year male irrit bowel syndrom coeliac diseas exclud symptomat control gfd undertook double blind cross ov studi particip random receiv dietari challeng num day minimum num day washout cross diet challeng gluten fre food supplement gluten num g day whey num g day supplement placebo end point includ mental state assess spielberg state trait person inventori stpi cortisol secret gastrointestin symptom result gluten ingest higher stpi state depress score compar placebo num num ci num num num whey num num ci num num num differ found stpi state indic stpi trait measur differ cortisol secret identifi challeng gastrointestin symptom induc similar dietari challeng conclus short term exposur gluten specif induc current feel depress effect indic emot disposit gluten specif induct gastrointestin symptom identifi find explain patient non coeliac gluten sensit feel gluten fre diet continu gastrointestin symptom num john wiley son
MED-2040~gluten gastrointestin symptom subject celiac diseas double blind random placebo control trial pubm ncbi abstract object increas prescript gluten fre diet gastrointestin symptom individu celiac diseas minim evid suggest gluten trigger aim studi determin gluten ingest induc symptom non celiac individu examin mechan method double blind random placebo control rechalleng trial undertaken patient irrit bowel syndrom celiac diseas exclud symptomat control gluten fre diet particip receiv gluten placebo form bread slice muffin day gluten fre diet num week symptom evalu visual analog scale marker intestin inflamm injuri immun activ monitor result total num patient age num year num men complet studi protocol num human leukocyt antigen hla dq num and or hla dq num adher diet supplement high num patient num gluten group num report symptom adequ control compar num num placebo num general estim equat visual analog scale patient signific wors gluten num week symptom num pain num bloat num satisfact stool consist num tired num anti gliadin antibodi induc signific fecal lactoferrin level celiac antibodi high sensit c reactiv protein intestin permeabl differ end point individu dq num dq num conclus non celiac gluten intoler exist clue mechan elucid
MED-2041~coeliac diseas pathophysiolog find implic therapi pubm ncbi abstract english german die liaki ist weltweit ein der ufigsten erkrankungen die aus einer kombin von umwelt gluten und genetischen human leukozyten antigen hla und nicht hla gen faktoren resultiert abh ngig von der geographischen lage wird die pr valenz der liaki auf etwa num num der bev lkerung gesch tzt die einzig behandlung die derzeit bei liaki verf gbar ist besteht einer glutenfreien di gfd die glutenhaltig getreid wie weizen roggen und gerst sowi ander lebensmittel mit nat rlichem oder zugesetztem gluten ausschli die complianceraten und die akzeptanz durch die patienten sind jedoch oft schlecht weiterhin kann die di selbst bei patienten die dies vollst ndig einhalten glicherweis nicht zu einer klinischen oder histologischen verbesserung hren daher ist es nicht verwunderlich dass studien zeigen dass liakie patienten sehr nichtdi tetischen alternativen interessiert sind die folgend bersicht konzentriert sich auf aktuell pathophysiologisch konzept der liaki bei denen jene signalweg herausgestellt werden die al glich neue nichtdi tetisch therapeutisch ansatzpunkt der behandlung der liaki dienen nnten coeliac diseas cd common diseas worldwid result combin environment gluten genet human leucocyt antigen hla non hla gene factor depend geograph locat preval cd estim approxim num num treatment cd gluten fre diet gfd exclud gluten contain cereal wheat rye barley foodstuff natur ad gluten adher rate patient accept poor fulli adher patient diet fail induc clinic histolog improv unsurpris studi show cd patient high interest non dietari altern review focus current pathophysiolog concept cd spotlight pathway serv non dietari therapeut target treatment cd
MED-2042~posit statement part immun function exercis pubm ncbi abstract ever grow volum peer review public speak recent rapid growth scope understand exercis immunolog num peer review public exercis immunolog num public search term exercis immun publish format intern societi exercis immunolog isei num isi web knowledg recognis epidemiolog distinct generic term physic activ specif categori exercis impli activ specif purpos improv physic condit competit extrem physic activ type implic immun system emot compon exercis larger effect date great major knowledg subject exercis studi
MED-2043~natur killer cell activ peripher blood high train untrain person pubm ncbi abstract natur killer nk cell activ concentr cd num cell nk cell cd num cell monocyt peripher blood measur high train race cyclist age sex match untrain control median nk cell activ num rang num num train num rang num num untrain num median cd num cell num rang num num train num num untrain num indomethacin vitro enhanc nk cell activ group signific differ nk cell activ train untrain exposur indomethacin vitro indomethacin enhanc nk cell activ num rang num num train num rang num num untrain num cd num cell num rang num num train num num num untrain num increas nk cell function demonstr high train person result resist infecti diseas
MED-2044~exercise rel improv immun influenc cancer prevent prognosi elder pubm ncbi abstract cancer incid increas advanc age num cancer num cancer death occur individu age num year older factor contribut immunosenesc canopi term describ age rel declin normal function immun system multipl age rel deficit innat adapt system play role increas incid cancer includ decreas nk cell function impair antigen uptak present monocyt dendrit cell increas inflammag declin number na ve t cell respond evolv tumor cell increas function exhaust senesc cell consensus habitu physic exercis offer protect type cancer evid link immunolog mechan exercis reduc cancer risk remain tentat multipl studi publish decad suggest exercis mitig deleteri effect age immun function increas anti canc immun potenti amelior effect exercis mechan includ evid physic activ stimul greater nk cell activ enhanc antigen present reduc inflamm prevent senesc cell accumul elder discuss role play immun system prevent control cancer age retard anti canc mechan propos pathway exercise induc alter immunosenesc decreas incid cancer improv prognosi cancer patient copyright num elsevi ireland reserv
MED-2045~age hepat virus hcv infect person unit state multipl cohort model hcv preval diseas progress pubm ncbi abstract background aim preval chronic hepat ch c remain high complic infect common goal project futur preval ch c complic method develop multicohort natur histori model overcom limit previous model predict diseas outcom benefit therapi result preval ch c peak num num million fibrosi progress invers relat age infect cirrhosi complic common age num year infect occur proport ch c cirrhosi project reach num num num num total number cirrhosi peak num million num higher current level num declin hepat decompens liver cancer continu increas num num year treatment infect patient num reduc risk cirrhosi decompens cancer liver rel death num num num num current respons rate antivir therapi conclus preval hepat cirrhosi complic continu increas decad affect older num year age current treatment pattern effect complic wider applic antivir treatment respons agent signific reduc impact diseas year
MED-2046~efficaci safeti chlorella supplement adult chronic hepat virus infect abstract aim evalu safeti efficaci chlorella num patient chronic infect hepat virus hcv genotyp num method eighteen adult chronic infect hcv genotyp num receiv daili oral supplement chlorella num wk rna level hcv aspart aminotransferas ast alanin aminotransferas alt level evalu treatment period pair test conduct compar variabl begin end studi side effect qualiti life aspect compar week num num studi period result major num patient signific decreas alt level week num week num evalu side effect show chlorella toler qualiti life assess show num particip report improv energi level num report improv percept general health num show decreas ast level statist signific patient exhibit improv alt ast level show tendenc decreas hcv viral load hcv rna level show decreas num patient ast alt ratio week num week num result statist signific conclus chlorella supplement toler patient chronic hcv signific decreas alt liver enzym level
MED-2047~physic activ immun function elder women pubm ncbi abstract relationship cardiorespiratori exercis immun function upper respiratori tract infect urti studi elder women util random control experiment design follow up num wk thirty two sedentari elder caucasian women num yr age met specif select criteria random walk calisthen group num complet studi twelv high condit elder women num yr age activ endur competit recruit baselin cross sect comparison intervent group exercis num min num wk num num wk walk group train num heart rate reserv calisthen group engag mild range of mot flexibl movement heart rate close rest level baselin high condit subject exhibit superior nk num num num num lytic unit num num num num num cpm num num pha num cell function differ circul level lymphocyt subpopul twelv week moder cardiorespiratori exercis improv vo num ax sedentari subject num result improv nk cell activ cell function incid urti lowest high condit group highest calisthen control group num wk studi walker intermedi posit chi squar num num conclus high condit elder women studi superior nk cell function compar sedentari counterpart abstract truncat num word
MED-2048~salivari secretori immunoglobulin secret increas num week ingest chlorella deriv multicompon supplement human random cross studi abstract background chlorella unicellular green alga grow fresh water high level protein vitamin miner dietari fiber studi report favor immun function rel effect biolog secret blood breast milk human ingest chlorella deriv multicompon supplement effect chlorella deriv supplement mucos immun function remain unclear purpos studi investig chlorella ingest increas salivari secretori immunoglobulin siga secret human blind random crossov studi design method fifteen men num placebo num chlorella tablet day num week separ num week washout period trial saliva sampl collect steril cotton ball chew overnight fast salivari siga concentr measur elisa result complianc rate placebo chlorella ingest num num num num differ observ salivari siga concentr placebo ingest num salivari siga concentr signific elev chlorella ingest compar baselin num trial period interact identifi saliva flow rate siga secret rate affect placebo ingest num signific increas num week chlorella ingest intak num conclus result suggest num week ingest chlorella deriv multicompon supplement increas salivari siga secret possibl improv mucos immun function human
MED-2049~benefici immunostimulatori effect short term chlorella supplement enhanc natur killer cell activ earli inflammatori respons random double blind placebo control trial abstract background vitro anim studi demonstr chlorella potent biolog respons modifi immun direct evid effect chlorella supplement immune inflamm respons healthi human method studi design num week random double blind placebo control trial num chlorella num placebo num form tablet cytotox activ natur killer nk cell serum concentr interferon interleukin num interleukin num measur result num week serum concentr interferon num interleukin num num signific increas interleukin num num tend increas chlorella group increment cytokin intervent signific bigger chlorella group placebo group addit nk cell activ signific increas chlorella group placebo group increment nk cell activ signific bigger chlorella group placebo group addit chang level nk cell activ posit correl serum interleukin num num num interferon num num signfic posit correl observ chang level serum cytokin interferon interleukin num num num interleukin num interleukin num num num interleukin num interferon num num conclus result suggest benefici immunostimulatori effect short term chlorella supplement enhanc nk cell activ produc interferon interleukin num interleukin num num cell induc cytokin healthi peopl
MED-2050~effect moder exercis train natur killer cell acut upper respiratori tract infect pubm ncbi abstract random control num wk exercis train studi num min sessions wk brisk walk num heart rate reserv group num mild obes sedentari women conduct investig relationship improv cardiorespiratori fit natur killer nk cell number activ acut upper respiratori tract infect uri symptomatolog studi conduct num exercis nonexercis group num baselin num num wk test session factori design data analyz repeat measur anova signific chang nk cell number occur result measur cd num leu num monoclon antibodi signific effect nk cell activ e t num initi num wk period num num num data daili log subject exercis group found signific fewer uri symptom days incid nonexercis group num num num num day num improv cardiorespiratori fit correl signific reduct uri symptom days incid num num chang nk cell activ baselin num wks num num summari moder elev nk cell activ num week reduc uri symptomatolog comparison random sedentari control group
MED-2051~econom evalu direct act antivir therapi chronic hepat pubm ncbi abstract num proteas inhibitor boceprevir telaprevir approv unit state european union treatment hepat infect remark effect newli approv therapi accompani addit side effect cost understand balanc cost effect critic make decis optim agent health care system constrain rise cost goal review facilit understand import cost effect analys guid polici decis newli approv drug futur therapi hepat
MED-2052~manag advers effect complic complet treatment hepat virus infect pubm ncbi abstract addit direct act antivir daa hepat virus hcv treatment regimen made treatment effect patient manag complex shepherd patient full hcv therapi requir motiv involv part patient physician physician inexperi lack confid guid patient challeng treatment primari reason earli discontinu therapi complic hcv treatment manag effici effect depress psychiatr disord hematolog abnorm includ daa ribavirin associ anemia peginterferon alfa associ neutropenia thrombocytopenia rash drug erupt includ telaprevir associ rash weight loss practic manag common complic offer articl summar present kenneth sherman md phd ias usa live continu medic educ held york june num
MED-2053~cow s milk fre diet therapeut option childhood chronic constip pubm ncbi abstract object report number children constip respond diet free cow s milk cm protein evid lack support immunoglobulin e medi mechan patient method perform open label crossov studi compar cm rice milk num children fulfil rome iii criteria chronic constip clinic physic immunolog paramet patient respond respond nr cm free diet compar result thirty f num children num improv cm free diet phase num develop constip cm reintroduc num children num develop constip cm challeng improv cm free diet phase group thirty four children num improv cm free diet phase nr group bowel movement week children signific increas compar nr children num num nr num num num seventy eight percent children development delay respond cm free diet num signific statist differ found nr children term fiber milk consumpt atop allerg histori full blood eosinophil count percentag lymphocyt popul immunoglobulin immunoglobulin ig subclass total ige serum specif immunoglobulin cm protein conclus clear associ cm consumpt constip found children analyt paramet demonstr immunoglobulin e medi immunolog mechan
MED-2054~preval symptom outcom constip infant toddler pubm ncbi abstract object determin preval constip children num year describ symptom constip review specif intervent effect studi design retrospect chart review result num children num year age num children constip preval rate constip year life num year life rate num function constip num children boy girl affect equal frequenc constip caus organ diseas num case num children function constip dietari corn syrup initi treatment suggest num children num children underw follow up examin constip resolv num children num children treat milk magnesia polyethylen glycol num electrolyt num children underw follow up examin constip resolv treatment num children conclus dietari corn syrup resolv constip num children laxat resolv constip num children milk magnesia polyethylen glycol effici safe infant toddler
MED-2055~intoler cow milk chronic constip children pubm ncbi abstract background chronic diarrhea common gastrointestin symptom intoler cow milk children basi prior open studi hypothes intoler cow milk sever perian lesion pain defec consequ constip young children method perform double blind crossov studi compar cow milk soy milk num children age rang num num month chronic constip defin bowel movement num num day refer pediatr gastroenterolog clinic previous treat laxat success num anal fissur perian erythema edema num day observ patient receiv cow milk soy milk week one week washout period feed revers respons defin bowel movement treatment period result forty four num children num percent respons receiv soy milk anal fissur pain defec resolv children receiv cow milk respons num children respons respons confirm double blind challeng cow milk children respons higher frequenc coexist rhiniti dermat bronchospasm respons num num children num num num anal fissur erythema edema base line num num num num num evid inflamm rectal mucosa biopsi num num num num num sign hypersensit specif ige antibodi cow s milk antigen num num num num num conclus young children chronic constip manifest intoler cow milk
MED-2056~cow milk allergi major contributor recurr perian dermat infant abstract background recurr perian inflamm great etiolog divers cow milk allergi cma aim assess magnitud subject method follow clinic studi carri num infant perian dermat num week histori recurr definit diagnosi made infant medic histori clinic examin investig includ stool analysi cultur stool ph reduc substanc perian swab cultur stain candida albican complet blood count quantit determin cow milk specif serum ige concentr patient cma confirm open withdrawal rechalleng procedur serum immunoglobulin cd marker gastrointestin endoscopi patient result perian dermat includ cma num bacteri dermat num moniliasi num enterobiasi num lactos intoler num predictor cma includ presenc bloodi and or mucoid stool atop manifest anal fissur recurr vomit conclus conclud cow milk allergi common recurr perian dermat mucoid bloodi stool anal fissur ulcer vomit atop manifest predict etiolog
MED-2057~role cow milk allergi pediatr chronic constip random clinic trial abstract object cow milk allergi present children function bowel symptom chronic constip aim studi investig role cow milk allergi chronic constip effect cow milk free diet cmfd treatment children method perform random clinic studi compar cmfd cow milk diet cmd group consist num patient age rang num year chronic function constip defin rome iii criteria subject refer pediatr gastroenterolog clinic previous treat laxat num month success num patient perform skin prick test case group receiv cmfd num week receiv cmd num extra week control group receiv cmd num week respons defin decreas sign symptom fulfil rome iii criteria num week cmfd back rome iii criteria num week cmd challeng find num week num patient case group respond comparison num num patient control group num case group num week challeng num num num respond develop constip rome iii criteria word frequenc cow milk allergi constip patient num patient posit skin prick test conclus children chronic constip manifest cow milk allergi present aspect investig therapeut attempt elimin diet advis children constip unrespons correct laxat treatment
MED-2058~cow milk consumpt constip anal fissur infant young children pubm ncbi abstract object examin daili cow milk consumpt durat breastfeed infant young children anal fissur constip method group num consecut children age num month num year evalu retrospect group compris children chronic constip anal fissur surgic exclud group ii compris normal children daili consumpt cow milk durat breastfeed clinic featur children investig result daili consumpt cow milk signific higher group num ml rang num ml group ii num ml rang num ml num group children breastf signific shorter period num month rang num month group ii num month rang num month num odd ratio factor children consum num ml cow milk day num children group num children group ii breastfeed num month num children group num children group ii calcul num num confid interv ci num num num num num ci num num num conclus infant young children chronic constip anal fissur consum larger amount cow milk children normal bowel habit addit shorter durat breastfeed earli bottl feed cow milk play role develop constip anal fissur infant young children
MED-2059~review articl chronic constip food hypersensitivity  an intrigu relationship pubm ncbi abstract background chronic constip common general popul studi shown children cow milk protein hypersensit chronic constip unrespons laxat treatment aim review literatur summar data point relationship refractori chronic constip food hypersensit discuss hypothesi pathogenesi constip due food hypersensit method search nation librari medicin perform match key word chronic constip food intoler allergi result thirty thre paper found num relat topic review data relationship constip food allergi subgroup paediatr patient idiopath constip unrespons laxat treatment studi adult demonstr resolut chronic constip hypoallergen diet patient conclus increas number report suggest relationship refractori chronic constip food allergi children similar data adult scarc confirm studi perform obtain firmer evid role allergi constip clarifi pathogenet mechan involv
MED-2060~cow milk protein intoler chronic constip children pubm ncbi abstract cow milk protein cmp allergi investig num children age rang num month num year chronic constip diagnosi constip made basi histori pain elimin hard stool num month reduc frequenc stool soil children evalu clinic paramet laboratori test total serum immunoglobulin ige specif ige radioallergosorb test rast cow milk alpha lactoalbumin beta lactoglobulin food group skin prick test milk alpha lactoalbumin beta lactoglobulin casein evalu children submit cmp free diet period num week patient num constip disappear cmp free diet reappear num challeng cow milk infant rectal biopsi reveal allerg coliti undergo challeng high serum level total ige observ children show clinic improv num posit skin test num detect specif ige num result suggest cmp allergi intoler consid chronic refractori constip children mechan requir investig
MED-2061~chronic constip symptom cow milk allergi pubm ncbi abstract twenty seven consecut infant age num month chronic idiopath constip studi investig relat constip cow milk protein allergi cmpa infant initi observ unrestrict diet number stool day record subsequ infant put diet free cow milk protein cmp period num month separ challeng cmp cmp free diet resolut symptom num patient consecut challeng constip reappear num num hour patient cmp free diet lead improv constip patient improv cmp free diet concomit symptom suspect cmpa medic histori cmpa found num num patient cure patient condit improv num addit num num cure patient result laboratori test specif ige igg anti beta lactoglobulin circul eosinophil posit time diagnosi indic hypersensit compar patient condit improv num endoscop histolog find time diagnosi show proctiti monocyt infiltr patient cure cmp free diet num month diet complet normal conclud constip infant allerg pathogenesi
MED-2062~oligo antigen diet treatment chronic anal fissur evid relationship food hypersensit anal fissur pubm ncbi abstract object patient chronic constip due food hypersensit fh elev anal sphincter rest pressur studi investig role fh anal fissur af aim evalu num effect diet cure af evalu num clinic effect double blind placebo control dbpc challeng cow milk protein wheat method hundr sixty on patient af random receiv true elimin diet sham elimin diet num week group receiv topic nifedipin lidocain sixti patient cure true elimin diet underw dbpc challeng cow milk wheat result end studi num true diet group num sham diet group show complet heal af num thirteen num patient af recurr num week cow milk dbpc challeng num patient af recurr wheat challeng end challeng anal sphincter rest pressur signific increas patient show af reappear num compar baselin valu patient react challeng signific higher number eosinophil lamina propria intraepitheli lymphocyt react challeng conclus oligo antigen diet combin medic treatment improv rate chronic af heal num patient receiv medic dietari treatment af recur dbpc food challeng
MED-2063~food intoler chronic constip manometri histolog studi pubm ncbi abstract background chronic constip children caus cow milk intoler cmi pathogenesi unknown aim evalu histolog manometri pattern patient food intolerance rel constip patient method thirty six consecut children chronic constip enrol underw elimin diet success double blind food challeng underw rectal biopsi anorect manometri result total num patient found suffer cmi multipl food intoler normal stool frequenc elimin diet constip recur food challeng patient food intoler show signific higher frequenc eros mucosa number intra epitheli lymphocyt eosinophil rectal mucous gel layer show food intoler patient signific lower thick mucus subject studi manometri show higher anal sphincter rest pressur lower critic volum food intoler patient suffer constip unrel food intoler histolog manometri abnorm disappear elimin diet conclus food intolerance rel constip character proctiti increas anal rest pressur reduc mucous gel layer consid contributori factor pathogenesi constip
MED-2064~anti prolif activ chemoprotect effect dna oxid damag fresh cook brassicacea pubm ncbi abstract epidemiolog evid show regular consumpt brassicacea reduc risk cancer heart diseas crucifer speci process eat real impact cook practic bioactiv properti fulli understood evalu effect common cook practic boil microwav steam biolog activ broccoli cauliflow brussel sprout anti prolif chemoprotect effect dna oxid damag fresh cook veget extract evalu num num dimethylthiazol num yl num num carboxymethoxyphenyl num num sulfophenyl num tetrazolium comet assay ht num human colon carcinoma cell fresh veget extract show highest anti prolif antioxid activ ht num cell broccoli cauliflow brussel sprout genotox activ detect sampl test cook method appli influenc anti prolif activ brassica extract alter antioxid activ present raw veget raw microwav boil broccoli steam veget extract concentr present protect antioxid action compar vitamin num mm data provid insight influenc domest treatment qualiti food support recent epidemiolog studi suggest consumpt crucifer veget cook relat reduc risk develop cancer
MED-2065~protect effect sulforaphan oxid stress recent advanc pubm ncbi abstract sulforaphan num isothiocyan num methylsulfinyl butan natur dietari isothiocyan produc enzymat action myrosinas glucopharanin num methylsulfinylbutyl glucosinol crucifer veget genus brassica broccoli brussel sprout cabbag studi compound increas anticarcinogen cytoprotect properti vivo experiment paradigm oxid stress focal cerebr ischemia brain inflamm intracerebr hemorrhag ischemia reperfus induc acut renal failur cisplatin induced nephrotox streptozotocin induc diabet carbon tetrachloride induc hepatotox cardiac ischemia reperfus protect effect observ vitro studi cell line human neuroblastoma sh si num renal epitheli proxim tubul llc pk num cell aortic smooth muscl num cell sulforaphan consid indirect antioxid compound induc cytoprotect protein includ antioxid enzym nrf num antioxid respons element pathway heme oxygenas num nad quinon oxidoreductas glutathione s transferas gamma glutamyl cystein ligas glutathion reductas cytoprotect protein induc sulforaphan conclus sulforaphan promis antioxid agent effect attenu oxid stress tissue cel damag vivo vitro experiment paradigm copyright num elsevi gmbh reserv
MED-2066~glucosinol brassica veget influenc food suppli chain intak bioavail human health pubm ncbi abstract glucosinol glss found brassica veget exampl sourc includ cabbag brussel sprout broccoli cauliflow root veget radish turnip number epidemiolog studi identifi invers associ consumpt veget risk colon rectal cancer anim studi shown enzym activ dna damag result consumpt brassica veget isothiocyan breakdown product bdp glss bodi mechanist studi begun identifi compound exert protect action relev studi protect effect human alimentari tract unproven vitro studi number specif isothiocyan suggest mechan basi chemoprotect effect concentr composit glss plant plant seed root leav vari great plant develop effect factor suppli chain brassica veget includ breed cultiv storag process intak bioavail glss extens discuss paper
MED-2067~sulforaphan promis molecul fight cancer pubm ncbi abstract number natur compound inhibitori effect tumorigenesi identifi diet studi document cancer prevent activ signific number isothiocyan itc major occur plant crucifer veget character itc sulforaphan sfn sfn receiv great deal attent abil simultan modul multipl cellular target involv cancer develop includ dna protect modul carcinogen metabol enzym block action mutagen ii inhibit cell prolifer induct apoptosi retard elimin clonal expans initi transform and or neoplast cell iii inhibit neoangiogenesi progress benign tumor malign tumor metastasi format sfn prevent delay revers preneoplast lesion act cancer cell therapeut agent account evid favor toxicolog profil sfn view conceptu promis agent cancer prevent and or therapi
MED-2068~isothiocyan concentr interconvers sulforaphan erucin human subject consumpt commerci frozen broccoli compa pubm ncbi abstract scope sulforaphan potent anticarcinogen isothiocyan deriv glucoraphanin wide consid respons protect effect broccoli consumpt broccoli typic purchas fresh frozen cook consumpt compar bioavail metabol sulforaphan portion light cook fresh frozen broccoli investig bioconvers sulforaphan erucin method result eighteen healthi volunt consum broccoli soup produc fresh frozen broccoli floret light cook sulforaphan thio conjug quantifi plasma urin sulforaphan bioavail tenfold higher soup made fresh compar frozen broccoli reduct shown due destruct myrosinas activ commerci blanching freez process sulforaphan plasma urin free form thio conjug form erucin n acetyl cystein conjug signific urinari metabolit shown human gut microflora produc sulforaphan erucin nitril glucoraphanin conclus short period blanch produc commerci frozen broccoli destroy myrosinas substanti reduc sulforaphan bioavail sulforaphan convert erucin excret urin shown human colon flora capabl convers num wiley vch verlag gmbh kgaa weinheim
MED-2069~sulforaphan protect len cell oxid stress implic cataract prevent pubm ncbi abstract purpos protect len oxid stress great import delay onset cataract isothiocyan sulforaphan sfn propos provid cytoprotect oxid stress test abil sfn perform role len cell establish abil delay onset cataract method human len epitheli cell line fhl num porcin len cultur system apotox glo triplex assay assess fhl num cell surviv cytotox apoptosi mts assay assess cell popul determin level dna strand break alkalin comet assay perform quantifi lactat dehydrogenas level medium evalu reflect cell damage death assess level gene express illumina whole genom ht num num beadchip protein express determin western blot immunocytochemistri result exposur num num fhl num cell caus reduct cell viabil increas cytotoxicity apoptosi effect signific inhibit num hour pretreat num sfn addit num sfn signific reduc num induc dna strand break appli cultur porcin lens sfn protect num induc opacif illumina whole genom ht num num beadchip microarray data reveal gene upregul num hour exposur num num sfn includ nqo num txnrd num pattern confirm protein level nrf num transloc nucleus respons num num sfn exposur conclus dietari compon sfn demonstr abil protect human len cell oxid stress potenti delay onset cataract
MED-2070~broccoli sprout rich sourc induc enzym protect chemic carcinogen abstract induct phase num detox enzym glutathion transferas epoxid hydrolas nad quinon reductas glucuronosyltransferas power strategi achiev protect carcinogenesi mutagenesi form toxic electrophil reactiv form oxygen consumpt larg quantiti fruit veget strike reduct risk develop varieti malign interest number edibl plant substanti quantiti compound regul mammalian enzym xenobiot metabol edibl plant belong famili crucifera genus brassica broccoli cauliflow substanti quantiti isothiocyan form glucosinol precursor sulforaphan num methylsulfinylbutyl isothiocyan potent induc phase num enzym unexpect num day old sprout cultivar crucif includ broccoli cauliflow num num time higher level glucoraphanin glucosinol sulforaphan matur plant glucosinol isothiocyan effici extract plant hydrolysi glucosinol myrosinas homogen mixtur equal volum dimethyl sulfoxid dimethylformamid acetonitril num extract num day old broccoli sprout glucoraphanin sulforaphan princip enzym induc high effect reduc incid multipl rate develop mammari tumor dimethylbenz anthracene tr rat notabl sprout broccoli cultivar neglig quantiti indol glucosinol predomin matur veget give rise degrad product indol num carbinol enhanc tumorigenesi small quantiti crucif sprout protect risk cancer effect larger quantiti matur veget varieti
MED-2071~potenti intensifi sulforaphan format cook broccoli brassica oleracea var italica mustard seed sinapi alba pubm ncbi abstract sulforaphan natur occur cancer chemoprevent hydrolysi product glucoraphanin main glucosinol broccoli hydrolysi requir myrosinas isoenzym present suffici activ process lead denatur reduc hydrolysi studi effect ad mustard seed resili isoform myrosinas process broccoli investig view intensifi format sulforaphan thermal inactiv myrosinas broccoli mustard seed studi thermal degrad broccoli glucoraphanin investig addit effect thermal process format sulforaphan sulforaphan nitril limit thermal degrad glucoraphanin num observ broccoli vacuum seal bag sous vide cook water bath num num num min boil broccoli water prevent format signific level sulforaphan due inactiv myrosinas addit powder mustard seed heat process broccoli signific increas format sulforaphan crown copyright num publish elsevi reserv
MED-2073~antiprolif effect fresh thermal process green red cultivar cur kale brassica oleracea convar acephala var sabellica pubm ncbi abstract brassica veget divers rang phytochem biolog properti antioxid anticanc activ knowledg biolog activ affect process lack green cultivar red cultivar cur kale evalu water methanol solubl phytochem process involv blanch freez storag boil in bag heat treatment kale cultivar process result signific decreas total phenol antioxid capac content distribut flavonol anthocyanin hydroxycinnam acid glucosinol vitamin interest red cur kale cultivar higher capac withstand thermal loss phytochem extract green red cur kale inhibit cell prolifer human colon cancer cell line caco num ht num hct num extract fresh plant materi signific stronger antiprolif effect extract process plant materi
MED-2074~modifi process handl frozen broccoli increas sulforaphan format pubm ncbi abstract frozen broccoli provid cheaper product longer shelf life prepar time fresh broccoli previous show commerci frozen broccoli product retain abil generat cancer prev agent sulforaphan hypothes hydrolyz enzym myrosinas destroy blanch part process frozen broccoli undergo studi carri determin overcom loss hydrolyz activ industri blanch aim inactiv peroxidas lipoxygenas play greater role product degrad frozen storag broccoli blanch num higher inactiv peroxidas lipoxygenas myrosinas blanch num inactiv num lipoxygenas activ num loss myrosinase depend sulforaphan format consid thaw frozen broccoli disrupt membran integr myrosinas glucoraphanin contact thaw frozen broccoli num support sulforaphan format exogen sourc myrosinas ad thermal stabil studi show broccoli root sourc myrosinas heat stabl broccoli floret daikon radish root support sulforaphan format heat num num min time temperatur compar greater microwav cook daikon radish num ad frozen broccoli thaw support sulforaphan format visual alter untreat broccoli num institut food technologist
MED-2075~multi target prevent cancer sulforaphan abstract isothiocyan found crucifer veget broccoli brussel sprout cauliflow cabbag epidemiolog studi suggest crucifer veget intak lower cancer risk includ colon prostat cancer sulforaphan sfn isothiocyan found crucifer veget high broccoli broccoli sprout sfn prove effect chemoprotect agent cell cultur carcinogen induc genet anim cancer model xenograft model cancer earli research focus block activ sfn phase num enzym induct inhibit enzym involv carcinogen activ grow interest mechan chemoprotect sfn recent studi suggest sfn offer protect tumor develop post initi phase mechan suppress effect sfn includ cell cycl arrest apoptosi induct interest human key factor determin efficaci sfn chemoprevent agent gain understand metabol distribut bioavail sfn factor alter paramet review discuss establish anti canc properti sfn emphasi chemoprevent mechan current status sfn human clinic trial includ chemistri metabol absorpt factor influenc sfn bioavail
MED-2076~favor effect berri consumpt platelet function blood pressur hdl cholesterol pubm ncbi abstract background berri rich sourc polyphenol bioactiv substanc vitamin previous studi consumpt polyphenol rich food cocoa tea red wine induc benefici pathway relat cardiovascular health consumpt berri similar effect unknown object aim investig effect berri consumpt hemostat function serum lipid blood pressur bp design middle ag unmed subject num cardiovascular risk factor consum moder amount berri control product num wk single blind random placebo control intervent trial result berri consumpt inhibit platelet function measur platelet function analyz collagen adp platelet activ num num berri control group num analysi covari ancova plasma biomark platelet activ coagul fibrinolysi chang intervent serum hdl cholesterol concentr increas signific num ancova berri control group num num total cholesterol triacylglycerol remain unchang systol bp decreas signific num ancova decreas occur subject high baselin bp num mm hg highest tertil num ancova polyphenol vitamin concentr plasma increas nutrit biomark folat tocopherol sodium potassium unaffect conclus consumpt moder amount berri result favor platelet function hdl cholesterol bp result regular consumpt berri play role prevent cardiovascular diseas
MED-2077~platelet dysfunct vascular patholog treat pubm ncbi abstract cardiovascular diseas lead morbid mortal industri countri process play role develop vascular diseas thrombosi primari event precipit stroke acut coronari syndrom blood platelet signific import medicin cell involv physiolog process haemostasi abil aggreg form clot respons activ addit dynam cell display activ extend thrombosi includ import role initi sustain vascular inflamm expans knowledg basic clinic research highlight critic posit platelet inflammatori diseas arthriti atherosclerosi platelet emerg import mediat inflamm provid import signal mediat phenotyp blood vascular cell import role platelet arteri thrombosi onset acut myocardi infarct atherosclerot plaqu ruptur make inhibit platelet aggreg critic step prevent thrombot event stroke heart attack peripher arteri thrombosi platelet inhibitor thrombosi prevent seek delic balanc inhibit platelet activ increas bleed risk aim review up dat knowledg platelet physiolog dysfunct patholog diabet mellitus hypercholesterolemia hypertens emphas link platelet inflammation rel atherosclerosi review evalu opportun offer platelet inhibitor effici allevi thrombot event copyright num elsevi reserv
MED-2078~dietari compon human platelet activ pubm ncbi abstract platelet hyperact import factor respons incid cardiovascular diseas nutrit non nutrit compound present diet affect platelet function recent discoveri anti platelet factor plant veget fruit dietari long term strategi favor modifi human blood platelet activ review summaris effect dietari compon human platelet function vitro vivo
MED-2079~one month strawberry rich anthocyanin supplement amelior cardiovascular risk oxid stress marker platelet activ human pubm ncbi abstract strawberri import fruit mediterranean diet high content essenti nutrient benefici phytochem exert benefici effect human health healthi volunt supplement daili num strawberri num month plasma lipid profil circul cellular marker antioxid status oxid stress platelet function evalu baselin num day strawberri consumpt num day end studi high concentr vitamin anthocyanin found fruit strawberri consumpt benefici influenc lipid profil signific reduc total cholesterol low dens lipoprotein cholesterol triglycerid level num num num num compar baselin period high dens lipoprotein cholesterol remain unchang strawberri supplement signific decreas serum malondialdehyd urinari num ohdg isoprostan level num num num num paramet return baselin valu washout period signific increas plasma total antioxid capac measur ferric reduc abil plasma oxygen radic absorb capac assay vitamin level num num num num observ strawberri consumpt spontan oxid hemolysi signific reduc num num num compar baselin point remain stabl washout period final strawberri intak signific decreas num number activ platelet compar baselin washout valu strawberri consumpt improv plasma lipid profil biomark antioxid status antihemolyt defens platelet function healthi subject encourag evalu popul higher cardiovascular diseas risk copyright num elsevi reserv
MED-2080~platelet atherosclerosi pubm ncbi abstract obvious function haemostasi thrombosi platelet consid essenti proinflammatori surround atherosclerosi allergi rheumatoid arthriti cancer atherosclerosi platelet facilit recruit inflammatori cell lesion site releas plethora inflammatori mediat enrich boost inflammatori milieu platelet interact endotheli cell circul leukocyt monocyt neutrophil dendrit cell t cell progenitor cell cross talk enforc leukocyt activ adhes transmigr platelet function innat host defens releas antimicrobi peptid express pattern recognit receptor sever sepsi platelet trigger format neutrophil extracellular trap net bind clear pathogen present antiplatelet therapi target key pathway platelet activ aggreg hold potenti modul platelet deriv immun function reduc cellular interact platelet immun compon reduc secret inflammatori protein milieu object review updat discuss current percept platelet immun constitu prospect therapeut target atherosclerot set
MED-2082~global region mortal num death num age group num num systemat analysi global burden diseas pubm ncbi abstract background reliabl time inform lead death popul chang crucial input health polici debat global burden diseas injuri risk factor studi num gbd num aim estim annual death world num region num num num uncertainti interv ui separ age sex method attempt identifi data death num countri num num vital registr verbal autopsi mortal surveil census survey hospit polic record mortuari assess data qualiti complet diagnost accuraci miss data stochast variat probabl death appli model strategi estim cause specif mortal trend depend strength data num special aggreg death ensembl model codem approach famili statist model test larg set model permut covari model ensembl develop compon model assess model perform rigor out of sampl test predict error valid num ui num low observ number death develop negat binomi model plausibl covari num death rare model higher level hierarchi gbd num alloc death compon proportion estim data databas select african trypanosomiasi congenit syphili whoop cough measl typhoid parathyroid leishmaniasi acut hepat hiv aid natur histori model base inform incid preval case fat separ estim fraction aetiolog diarrhoea lower respiratori infect mening disaggreg subcaus chronic kidney diseas matern disord cirrhosi liver cancer death due collect violenc natur disast mortal shock regress estim num ui captur paramet estim uncertainti uncertainti due model specif codem constrain cause specif fraction age sex group sum total mortal base draw uncertainti distribut find num num num million death global aggreg level communic matern neonat nutrit num num death worldwid num num num million num num num num million num decreas larg due decreas mortal diarrhoeal diseas num num num num million lower respiratori infect num num num num million neonat disord num num num num million measl num num num num million tetanus num num num num million death hiv aid increas num num million num num num million num reach peak num num million num malaria mortal rose estim num num num num num million death num tuberculosi kill num num million peopl num death non communic diseas rose num million num num account death num num million worldwid num million peopl die cancer num decad ago num num million num trachea bronchus lung cancer ischaem heart diseas stroke collect kill num num million peopl num death worldwid compar num num million death due diabet num fraction global death due injuri num num million death margin higher num num compar decad earlier num num driven num rise death worldwid due road traffic accid num num million num rise death fall ischaem heart diseas stroke chronic obstruct pulmonari diseas copd lower respiratori infect lung cancer hiv aid lead death num ischaem heart diseas lower respiratori infect stroke diarrhoeal diseas malaria hiv aid lead year life lost due prematur mortal ylls num similar estim num hiv aid preterm birth complic ylls lower respiratori infect diarrhoea decreas num num ischaem heart diseas stroke ylls increas num region variat lead death substanti communic matern neonat nutrit account num prematur mortal sub saharan africa num age standardis death rate key disord rose hiv aid alzheimer diseas diabet mellitus chronic kidney diseas diseas death rate fell past decad includ major vascular diseas copd form cancer liver cirrhosi matern disord condit notabl malaria prostat cancer injuri chang note interpret popul growth increas averag age world popul larg decreas age specif sex specif cause specif death rate combin drive broad shift communic matern neonat nutrit non communic diseas communic matern neonat nutrit remain domin ylls sub saharan africa overlaid general pattern epidemiolog transit mark region variat exist interperson violenc suicid liver cancer diabet cirrhosi chaga diseas african trypanosomiasi melanoma region heterogen highlight import sound epidemiolog assess death regular basi fund bill melinda gate foundat copyright num elsevi reserv
MED-2083~grape juic orang juic grapefruit juic inhibit human platelet aggreg pubm ncbi abstract coronari arteri diseas respons mortal morbid world platelet involv atherosclerot diseas develop reduct platelet activ medic reduc incid sever diseas red wine grape polyphenol compound includ flavonoid reduc platelet aggreg lower rate cardiovascular diseas citrus fruit class polyphenol share properti studi evalu commerci grape orang grapefruit juic daili reduc vivo platelet activ random cross ov design ten healthi human subject age num gender drank num num ml kg purpl grape juic orang juic grapefruit juic num platelet aggreg blood imped aggregometri chronolog model num baselin compar result consumpt juic drink purpl grape juic week reduc blood platelet aggreg respons num mg l collagen num num num num num ohm num orang juic grapefruit juic effect platelet aggreg purpl grape juic approxim time total polyphenol concentr citrus juic potent platelet inhibitor healthi subject citrus juic show effect platelet inhibitori effect flavonoid grape juic decreas risk coronari thrombosi myocardi infarct
MED-2085~antiplatelet anticoagul fibrinolyt activ vitro extract select fruit veget pubm ncbi abstract diet rich fruit veget decreas risk cardiovascular diseas inform antithrombot activ antiplatelet anticoagul fibrinolyt fruit veget scarc aim studi assess antithrombot activ extract fruit veget wide consum central chile studi includ sampl num fruit num veget repres local diet extract prepar sampl includ aqueous juic press solubl and or methanol solubl fraction extract evalu antiplatelet anticoagul fibrinolyt activ vitro final concentr num mg ml antiplatelet activ assess platelet aggreg inhibit anticoagul activ measur prothrombin time pt dilut prothrombin time dpt activ partial thromboplastin time aptt kaolin clot time kct thrombin time fibrinolyt effect determin euglobin clot lysi time fibrin plate method extract green bean tomato inhibit platelet aggreg induc adp arachidon acid concentration depend manner methanol extract grape prolong pt dpt final extract raspberri prolong aptt present fibrinolyt activ conclus screen includ varieti fruit veget found antiplatelet activ green bean tomato anticoagul activ grape raspberri fibrinolyt activ observ raspberri investig advanc knowledg activ compound fruit veget mechan action
MED-2086~medicalis tall girl discours analysi medic literatur synthet oestrogen reduc femal height pubm ncbi abstract endocrin research num increas extend sex hormon medic therapi unpreced femal ailment num therapeut sex hormon extend treatment tall girl ambigu definit tall girl arbitrari natur treatment decis divers therapeut regim highlight problemat natur medic practic linguist repertoir studi polit ideolog implic found pattern languag paper report discours analysi medic literatur treatment tall girl num num treatment peak linguist repertoir emerg institut author medicin determin abnorm tall statur femal clinic knowledg experi diagnosi medic risk tall statur women hormon cosmet therapi produc feminin tall girl relat mainten cultur represent social expect feminin evid psycholog harm tall statur women long term studi effect benefit decad clinician persuad patient tall statur requir therapeut intervent treatment tall girl high dose oestrogen view medicalis normal physic attribut advers relat social construct gender copyright num elsevi reserv
MED-2087~diethylstilboestrol  a long term legaci pubm ncbi abstract diethylstilboestrol des endocrin disrupt cancer rodent prescrib larg amount treat women gynaecolog problem daughter women subsequ develop rare cancer vagin clear cell adenocarcinoma genit abnorm found son decad livestock feed contamin food chain lead exposur general popul des epigenet effect anim evid occur man mechan carcinogenesi complex effect difficult prove due background dietari environment phyto xenooestrogen suggest endocrin disrupt des act obesogen human popul copyright num elsevi ireland reserv
MED-2088~arsenic speci poultri feather meal pubm ncbi abstract organoarsen drug wide product broiler chicken unit state feather chicken process meal product anim feed addit organ fertil research conduct date suggest arsenic drug specif roxarson poultri product result accumul arsenic keratin materi poultri feather feather meal product human food system set result human exposur arsenic presenc natur arsenic twelv sampl feather meal product state china examin arsenic toxic high species depend speciat analysi hplc icpm perform determin biolog relev detect arsenic arsenic detect sampl num kg num speciat analys reveal inorgan form arsenic domin repres num num total arsenic roxarson detect sampl num kg num feather meal product repres previous unrecogn sourc arsenic food system pose addit risk human result organ fertil anim wast manag copyright num elsevi reserv
MED-2089~genotox mouthwash product drosophila wing spot test pubm ncbi abstract studi genotox mouthwash product chlorexidin benzidamine hcl investig drosophila wing spot test make wing cell marker multipl wing hair mwh flare flr detect mitot recombin type mutat event induc mutat detect singl mosaic spot wing blade surviv adult show multipl wing hair flare phenotyp induc recombin lead mwh flr twin spot extent mwh singl spot record frequenc size spot quantit determin mutagen recombinogen effect trans heterozyg third instar larva treat concentr mouthwash product chlorexidin exposur concentr num num num g ml benzidamine hcl exposur concentr num num num mg ml addit observ mutat classifi size type mutat wing chlorexidin benzidamine hcl genotox term total mutat wing highest dose surviv rate fli experi signific lower control group mouthwash product show toxic effect drosophila melanogast larva copyright num elsevi reserv
MED-2090~endodont compound induc genet damag comprehens review pubm ncbi abstract genet damag play import role carcinogenesi purpos paper provid overview genotox potenti endodont compound dentistri formocresol paramonochlorophenol calcium hydroxid resin bas sealer phenol compound chlorhexidin miner trioxid aggreg compound capabl exert noxious activ genet materi action mechan discuss area warrant investig estim risk substanc respect genotox ad regulatori purpos improv oral health prevent oral carcinogenesi
MED-2091~comparison effect num tea num neem num chlorhexidin mouthwash oral health random control trial pubm ncbi abstract background aim studi evalu compar effect num tea num neem num chlorhexidin mouthwash oral health materi method random blind control trial num healthi human volunt age group num year carri subject random assign num group group num chlorhexidin glucon bench mark control group num neem group num tea num subject group plaqu accumul gingiv condit record plaqu index gingiv index oral hygien assess simplifi oral hygien index ohi salivari ph assess indikrom ph strip plaqu gingiv simplifi ohi score salivari ph record baselin immedi num st rins num week num week num week num week skip group result plaqu gingiv score reduc num week trial period experiment control group anti plaqu effect observ group highest group num neem tea show compar effect gingiva chlorhexidin num salivari ph rise sustain signific group compar group oral hygien improv appreci group group conclus effect num tea compar num neem num chlorhexidin mouth rins
MED-2092~cytotox mouthrins epitheli cell micronucleus test abstract object determin cytotox commerci mouthrins klorhex andorex tanflex buccal epitheli cell micronucleus mn test materi method num patient age num num undergon mouthrins applic analyz week exposur physiolog salin control group mn incid score buccal epitheli particip differ pre post treat week incid mn plaqu pi gingiv indic gi compar non parametr statist test result micronuclei incid increas klorhex tanflex andorex group exposur mouth rins num compar control group differ andorex control group num studi group mn incid signific increas num day treatment num gi score group decreas signific num pi score decreas klorhex group num conclus primari find support presenc cytotox effect mouthrins gingiv epitheli cell
MED-2093~chlorhexidin chx dentistri state art pubm ncbi abstract chlorhexidin chx common prescrib antisept agent dental field long last antibacteri activ broad spectrum action shown reduc plaqu gingiv inflamm bleed consid power adjuv mechan oral hygien brush floss case perform correct mouthwash gel aerosol spray disk chx consid safe compound minim transitori local system side effect data support period adjuv normal brush floss subject unabl maintain proper oral hygien due physic and or mental impair lack motiv decreas salivari rate chx altern mechan oral hygien procedur case contraind surgic procedur preoper rins procedur dental dam aim articl offer complet review literatur characterist applic problem chlorhexidin dental field
MED-2094~pilot studi role green tea oral health pubm ncbi abstract introduct increas number peopl world turn natur natur herbal product prophylax treatment diseas green tea activ chemic ingredi poss divers pharmacolog properti includ anti inflammatori anticariogen antioxid antibacteri effect aim assess protect properti green tea oral health method research measur streptococcus mutan count saliva plaqu salivari plaqu ph valu gingiv bleed index gbi above ment measur appli sampl consist num subject rins green tea num min short term studi mutan count saliva plaqu gbi measur experiment intervent studi carri el azhar univers dental clinic result result studi show statist signific differ subject pre post rins num green tea num min mutan count saliva plaqu salivari plaqu ph valu gbi conclus studi support effect local applic green tea antibacteri anticariogen materi decreas acid saliva plaqu cost effect cari prevent measur develop countri num john wiley son a
MED-2095~monitor buccal epitheli cell alkalin comet assay singl cell gel electrophoresi techniqu cytogenet evalu chlorhexidin pubm ncbi abstract year increas interest buccal epitheli cell cytogenet evalu materi present studi cell peripher lymphocyt cytogenet evalu chlorhexidin diglucon chx comet assay singl cell gel electrophoresi scge report techniqu detect dna strand break individu cell alkalin condit thirteen volunt request rins mouth num chx solut num day buccal epitheli cell peripher blood lymphocyt obtain particip baselin end experiment period hundr cell subject analys dna damag statist increas observ damag buccal blood cell chx applic grade damag buccal cell statist blood cell due minim absorpt chlorhexidin tissu low concentr free chlorhexidin oral caviti dna damag produc chlorhexidin lymphocyt lower buccal epitheli cell chlorhexidin accumul bodi frequenc dna damag transient detect dna damag chx indic earlier effect dna repair begin revers
MED-2096~emerg scienc dietari control prevent dental cari pubm ncbi abstract key environment factor involv cari incid ferment carbohydr high cost cari treatment research continu explor dietari control promis prevent method dietari chang demonstr reduc streptococcus mutan prevent role expect function food dietari habit alter author recent advanc understand cari patholog reveal dietari control valuabl method promot healthi dentit
MED-2097~nutrit intervent patient periodont diseas clinic immunolog microbiolog variabl num month pubm ncbi abstract role nutrit onset progress treatment periodont evalu present prospect clinic studi investig influenc nutrit intervent clinic microbiolog immunolog periodont variabl period num month patient metabol syndrom chronic periodont twenti femal subject metabol syndrom mild moder chronic periodont particip guid nutrit intervent programm examin assess num week num num month intervent clinic measur includ probe depth sil gingiv index quigley hein plaqu index gingiv crevicular fluid periodontopathogen level il num eta il num activ granulocyt elastas determin stimul saliva antioxid oxid variabl measur num month signific observ reduct clinic probe depth num num mm num reduct gingiv inflamm gingiv index num num num reduc concentr il num eta num num pg ml site num il num num num pg ml site num gingiv crevicular fluid bacteri count gingiv crevicular fluid oxid antioxid variabl saliva show signific salivari catalas show tendenc lower valu find patient metabol syndrom wholesom nutrit reduc inflammatori variabl periodont diseas promot periodont health
MED-2098~steam cook signific improv vitro bile acid bind collard green kale mustard green broccoli green bell pepper cabbag pubm ncbi abstract bile acid bind capac relat cholesterol low potenti food food fraction lower recircul bile acid result util cholesterol synthes bile acid reduc fat absorpt secondari bile acid increas risk cancer bile acid bind potenti relat lower risk heart diseas cancer previous report bile acid bind uncook veget veget consum cook cook influenc vitro bile acid bind veget investig mixtur bile acid secret human bile physiolog condit replic incub conduct treatment simul gastric intestin digest includ substrat bile acid mixtur num substrat bile acid mixtur cholestyramin cholesterol low bile acid bind drug posit control treatment cellulos negat control relat cholestyramin vitro bile acid bind dri matter basi collard green kale mustard green num broccoli num brussel sprout spinach num green bell pepper num cabbag num result point signific num health promot potenti collard green kale mustard green broccoli brussel sprout spinach green bell pepper cabbag bile acid bind dri matter basi steam cook signific improv vitro bile acid bind collard green kale mustard green broccoli green bell pepper cabbag compar previous observ bile acid bind valu veget raw uncook inclus steam cook collard green kale mustard green broccoli green bell pepper cabbag daili diet health promot veget emphas green leafi veget consum regular steam cook lower risk cardiovascular diseas cancer advanc human nutrit research improv public health
MED-2099~vitro bind capac dietari fiber mixtur toxic element cholesterol bile acid pubm ncbi abstract water solubl dietari fiber appl peel water insolubl dietari fiber wheat bran soybean se hull evalu bind capac toxic element pb hg cd lard cholesterol bile acid water solubl dietari fiber show higher bind capac toxic cation cholesterol sodium cholat lower bind capac lard compar water insolubl mixtur dietari fiber sampl appl peel wheat bran soybean se hull ratio num num w w signific increas bind capac water insolubl dietari fiber toxic cation cholesterol sodium cholat mixtur lower concentr pb num cd test solut level lower occur rice veget grown pollut soil test fiber show low bind capac toxic anion aso num num copyright num publish elsevi
MED-2100~cytolog abnorm nippl aspir breast fluid women sever constip pubm ncbi abstract relat epitheli dysplasia nippl aspir breast fluid frequenc bowel movement studi num white women signific posit associ dysplasia risk ratio num num confid interv num num women report sever constip fewer bowel movement week women report bowel movement daili women bowel movement daili day increas risk ratio cytolog abnorm breast epithelium sever constip relev studi diet breast diseas intestin flora report metabol bile salt oestrogen secret liver gastrointestin tract a process enhanc sever constip
MED-2101~breast gut connect origin chenodeoxychol acid breast cyst fluid pubm ncbi abstract notion breast gut connect modul microenviron breast tissu support find breast cyst fluid bile acid characterist found intestin establish gut circul steroid precursor sourc bile acid breast cyst fluid gave patient deuterium label chenodeoxychol acid num mg dose mouth start num day aspir breast cyst chenodeoxychol acid concentr sampl aspir cyst fluid rang num num mumol l serum concentr chenodeoxychol acid day num num mumol l label compound compris num num mumol l num num mumol l deuter chenodeoxychol acid concentr cyst fluid num num mumol l sampl patient num num mumol l patient num valu equival num serum concentr correct studi show intestin bile acid rapid gain access cyst fluid studi investig mechan govern exchang process mainten high cyst fluid plasma concentr gradient biolog half liv individu constitu
MED-2102~bile acid influenc growth oestrogen receptor oestrogen regul protein mcf num human breast cancer cell abstract effect major human serum bile acid glycochenodeoxychol acid gcdc unconjug chenodeoxychol acid cdc mcf num human breast cancer cell line studi vitro oestrogen bile acid depriv cultur condit gcdc increas growth breast cancer cell rang num microm concentr excess bile acid bind capac medium cell growth prevent contrast num microm cdc tend reduc cell growth oestrogen er progesteron pgr receptor ps num total cathepsin quantifi monoclon antibodi base immunoassay ten num microm gcdc num microm cdc down regul er protein accompani induct oestrogen regul protein pgr ps num possibl cathepsin includ increas secret protein cultur medium quantit similar observ num nm oestradiol bile acid effect er pgr due interfer assay procedur cell incub num microm gcdc num microm cdc higher pmolar concentr bile acid control studi suggest natur occur bile acid influenc growth steroid receptor function human breast cancer cell
MED-2103~plasma deoxychol acid concentr elev postmenopaus women newli diagnos breast cancer pubm ncbi abstract object high concentr plasma deoxychol acid dca found human breast cyst fluid hypothesis relat risk breast cancer aim pilot studi ascertain plasma bile acid concentr greater women breast cancer design case control studi compar postmenopaus women breast cancer healthi control conduct subject twenti caucasian postmenopaus breast cancer patient recruit time diagnosi num healthi control match age bodi mass index exclus criteria includ treatment breast cancer hormon replac therapi num month diabet mellitus histori liver gall bladder diseas abnorm liver function measur fast plasma bile acid concentr determin gas liquid chromatography mass spectrometri result plasma dca concentr num higher num patient breast cancer compar control conclus result support hypothesi dca involv aetiolog breast cancer
MED-2105~recent perspect relat fecal mutagen genotox diet abstract dna damag essenti compon genesi colon cancer gut microbi product food compon thought princip respons damag initi diseas progress modifi ame test comet assay develop measur mutagen genotox relev oncogenesi remain confirm relat import mutagen genotox compound present fecal water bacteria involv metabol dietari intervent studi provid clue risk oncogenesi high protein diet lead increas n nitroso compound fecal water greater dna damag measur comet assay dietari intervent non digest carbohydr probiot lead lower fecal genotox order make recommend general public develop understand genotox compound form colon accur ame comet assay diet affect genotox
MED-2106~bile acid carcinogen human gastrointestin cancer pubm ncbi abstract bile acid propos carcinogen num num basi work rodent model bile acid regard cancer promot carcinogen indirect evid obtain recent support view bile acid carcinogen human num report num num bile acid dna damag mechan indirect involv induct oxid stress product reactiv oxygen speci damag dna repeat dna damag increas mutat rate includ mutat rate tumor suppressor gene oncogen addit report num num bile acid increas concentr accompani high fat diet induc frequent apoptosi cell expos popul reduc apoptosi capabl tend surviv select prolifer bile acid dna damag select apoptosis resist cell lead increas mutat bile acid carcinogen human increas incid cancer laryngopharyng tract esophagus stomach pancrea small intestin ampulla vater colon high level bile acid larger number cell generat colon gastrointestin epithelia human compar rodent time induct select mutat lead cancer human rodent
MED-2107~metabol consequ slow colon transit pubm ncbi abstract intestin transit substanti influenc enterohepat circul bile acid steroid hormon colon ph short chain fatti acid concentr distal colon slow transit favor diseas process relat over effici enterohepat recircul lack short chain fatti acid distal colon includ gallston larg bowel cancer possibl breast cancer best docu influenc slow colon transit bile acid metabol slow colon transit increas deoxychol rais cholesterol satur bile make gallston format review examin evid slow colon transit import etiolog larg bowel breast cancer lack data pertain relationship colon transit diseas colon breast cancer slow colon transit prove signific factor etiolog diseas health popul benefit dietari lifestyl speed intestin transit
MED-2108~diet nutrit intak metabol popul high low risk colon cancer nutrient intak pubm ncbi abstract num day diari portion size weigh subject num recal obtain num set subject seventh day adventist lacto ovo vegetarian nonvegetarian general popul nonvegetarian match age num yr sex marit status educ type milk prefer index frequenc dairi egg product addit num unmatch person follow pure vegetarian dietari pattern meat fish fowl dairi egg product recruit studi ration dietari method present detail method result nutrient analysi num recal num day diari present num day nutrient intak group compar sex specif recommend daili supplement contribut nutrit supplement nutrient intak discuss group show adequ excess intak level calori protein fat num recal num day diari valu consid higher intak calori note nonvegetarian explain higher intak fat protein group vitamin level num day dairi estim adequ supplement calcium intak recommend level pure vegetarian femal iron intak low femal heme iron sourc improv intak level nonvegetarian femal comparison result prior report nutrient intak seventh day adventist present
MED-2109~extracorpor membran oxygen convent medic therapi neonat persist pulmonari hypertens newborn prospecti pubm ncbi abstract thirty nin newborn infant sever persist pulmonari hypertens respiratori failur met criteria num likelihood die enrol random trial extracorpor membran oxygen ecmo therapi compar convent medic therapi cmt phase num num babi cmt group die num num babi ecmo group surviv random halt fourth cmt death plan initi studi num babi treat ecmo phase ii num surviv treatment group cmt ecmo phase ecmo phase ii compar sever ill mechan ventil support surviv ecmo tr infant num num compar num num cmt group num
MED-2110~extracorpor membran oxygen newborn respiratori failur forty f case pubm ncbi abstract type newborn respiratori failur revers support treatment oxygen posit airway pressur damag lung newborn respiratori failur remain major morbid death infant prolong extracorpor membran oxygen ecmo life support lung rest ecmo num moribund newborn infant num surviv neonatologist refer patient unrespons maxim therapi atrium aortic arch cannul jugular vein carotid arteri heparin infus continu main activ clot time num num airway oxygen pressur reduc low level primari diagnos hyalin membran diseas num surviv num die meconium aspir num surviv num die persist fetal circul includ diaphragmat hernia num surviv num die sepsi num surviv num die growth develop brain lung function normal num num survivor ecmo decreas newborn respiratori failur mortal morbid rate phase trial control random studi underway result suggest ecmo effect older patient irrevers lung damag occur
MED-2111~updat num year experi arrest revers therapi coronari heart diseas overdu requiem palliat cardiolog pubm ncbi abstract coronari arteri diseas essenti nonexist cultur nutrit assur cholesterol level num mg dl patient advanc coronari arteri diseas abolish diseas progress plant bas diet cholesterol low medic achiev maintain total cholesterol num mg dl
MED-2112~evidence bas medicin bias physician nutrit pubm ncbi abstract medic student unit state taught nutrit dietet wors train bias studi show power dietari approach manag diseas current approach evidence bas medicin encourag physician ignor inform double blind random control trial human blind dietari intervent result physician bias drug treatment dietari intervent manag chronic diseas copyright num elsevi reserv
MED-2114~potenti role foxo num mtorc num pathogenesi western diet induc acn abstract acn adolesc develop countri epidem skin diseas link western diet wd intent viewpoint discuss impact wd mediat nutrient signal pathogenesi acn high glycaem load dairi protein consumpt increas insulin insulin lik growth factor num igf num signal ii superimpos elev igf num signal puberti cell nutrit status primarili sens forkhead box transcript factor num foxo num serine threonin kinas mammalian target rapamycin complex num mtorc num increas ii extrud foxo num cytoplasm nuclear foxo num suppress hepat igf num synthesi impair somat growth foxo num attenu androgen signal interact regulatori protein import sebac lipogenesi regul activ innat adapt immun antagon oxid stress import function rheostat mtorc num master regul cell growth prolifer metabol homoeostasi foxo num link nutrient avail mtorc num driven process increas protein lipid synthesi cell prolifer cell differenti includ hyperprolifer acroinfundibular keratinocyt sebac gland hyperplasia increas sebac lipogenesi insulin resist increas bodi mass index enhanc androgen tnf igf num signal due genet polymorph promot risk acn converg mtorc num activ enhanc nutrient signal wd deeper insight molecular interplay foxo num mtorc num mediat nutrient signal critic import understand impact wd promot epidem acn mtorc num driven diseas civil
MED-2115~diet supplement donkey milk upregul liver mitochondri uncoupl reduc energi effici improv antioxid antiinflam pubm ncbi abstract dietari pufa num famili play essenti role mainten energi balanc reduct bodi fat deposit upregul mitochondri uncoupl main sourc reactiv oxygen speci hypothes rat supplement raw donkey milk dm character low fat content higher num num ratio affect energi balanc lipid metabol prooxid status compar anim treat cow milk present studi effect drink raw dm num week energi balanc lipid metabol antiinflammatori antioxidant detoxifi defenc compar produc rat intak iso energet amount raw cow milk hypolipidem effect produc dm parallel enhanc mitochondri activity proton leakag increas activ express mitochondri marker carnitin palmitoyl transferas uncoupl protein num associ decreas energi effici reduc proinflammatori sign tnf lps level signific increas antioxid total thiol detoxifi enzym activ glutathione s transferas nadh quinon oxidoreductas dm treat anim benefici effect attribut part activ nuclear factor num erythroid rel factor num pathway num wiley vch verlag gmbh kgaa weinheim
MED-2116~turn acn on off mtorc num abstract past num year increas comprehens mechan acn exponenti start ethnolog work cordain acceler epidemiolog work adebamowo support clinic trial smith mann kwon dilandro interfac diet acn focus melnik present pair paper illustr dermatologist translat research western diet role dairi foxo num mtorc num interplay agonist antagonist therapeut present futur jigsaw puzzl
MED-2117~diet acn evid role nutrient signal acn pathogenesi pubm ncbi abstract recent evid underlin role western diet pathogenesi acn acn absent popul consum palaeolith diet low glycaem load consumpt milk dairi product random control studi present issu acta dermato venereologica provid evid benefici therapeut effect low glycaem load diet acn epidemiolog evid confirm milk consumpt acne promot acne aggrav effect recent progress understand nutrient sensit kinas mammalian target rapamycin complex num mtorc num view nutrient signal acn high glycaem load increas insulin igf num leucin signal due milk protein consumpt acn regard mtorc num driven diseas civil obes type num diabet cancer induc western diet earli dietari counsel teenag acn patient great opportun dermatolog improv acn reduc long term advers effect western diet mtorc num driven diseas civil
MED-2120~acn risk prostat cancer abstract recent studi prostatectomi specimen propionibacterium acn cultur inflamm culture neg specimen specimen posit bacteria lead author hypothes acnes medi inflamm contribut prostat carcinogenesi indirect explor associ acn prostat cancer investig sever acn measur tetracyclin year relat incid prostat cancer health profession follow up studi num follow up questionnair particip tetracyclin month time acn reason durat prostat cancer diagnos ascertain subsequ biennial questionnair confirm medic record review num num num case prostat cancer report num elig particip men tetracyclin year signific higher risk prostat cancer num case num person year men tetracyclin num case num person year multivariable adjust rr num num ci num num intrigu find view cautious small number expos case indirect assess sever acn complex etiolog acn limit acn infect addit biolog epidemiolog studi determin elucid role acn infect prostat carcinogenesi
MED-2121~dietari intervent acn abstract purpos paper highlight endocrin signal western diet fundament environment factor involv pathogenesi epidem acn western nutrit character high calori uptak high glycem load high fat meat intak increas consumpt insulin igf num level elev dairi protein metabol signal western diet sens nutrient sensit kinas mammalian target rapamycin complex num mtorc num integr signal cellular energi growth factor insulin igf num protein deriv signal predomin leucin provid high amount milk protein meat mtorc num activ srebp master transcript factor lipogenesi leucin stimul mtorc num srebp signal leucin direct convert sebocyt fatti acid sterol sebac lipid synthesi over activ mtorc num increas androgen hormon secret amplifi androgen driven mtorc num signal sebac follicl testosteron direct activ mtorc num futur research investig effect isotretinoin sebocyt mtorc num activ conceiv isotretinoin downregul mtorc num sebocyt upregul nuclear level foxo num role western diet acn fulli appreci stimulatori input maxim mtorc num activ glucos insulin igf num leucin adequ consid epidem acn recogn mtorc num driven diseas civil obes type num diabet cancer neurodegen diseas insight western diet medi mtorc num hyperact provid ration basi dietari intervent acn attenu mtorc num signal reduc num total energi intak num hyperglycem carbohydr num insulinotrop dairi protein num leucine rich meat dairi protein dietari oppos evolut industri food fast food distribut western countri attenu mtorc num signal increas consumpt veget fruit major compon vegan paleolith diet dermatologist bear tremend respons young acn patient advis modifi dietari habit order reduc activ stimuli mtorc num improv acn prevent harm expens march mtorc num relat chronic diseas life
MED-2122~metabol disord breast cancer risk unit state pubm ncbi abstract object clarifi hormon context breast cancer etiolog data larg population bas case control studi investig relationship breast cancer risk histori diabet mellitus disord estrogen stimul uterin fibroid endometriosi gallston disord androgen stimul acn hirsut polycyst ovari method breast cancer patient num num year identifi state wid tumor registri wisconsin massachusett hampshir control random select driver licens list age num medicar enrol file age num inform reproduct histori medic histori person habit obtain telephon interview total num case num control interview provid suitabl data result associ breast cancer risk report histori diabet mellitus endometriosi uterin fibroid gallston cholecystectomi disord androgen associ confer increas risk odd ratio histori acn num num ci num num hirsut num num ci num num polycyst ovari num num ci num num diabet mellitus diagnos age num confer odd ratio num num num num diabet diagnos age increas risk num num ci num num conclus androgen rel phenomena import etiolog breast cancer
MED-2123~milk food genet transfect system activ mtorc num signal postnat growth abstract milk recogn repres function activ nutrient system promot neonat growth mammal cell growth regul nutrient sensit kinas mechanist target rapamycin complex num mtorc num lack inform mechan mtorc num up regul milk consumpt review present milk materno neonat relay system function transfer preferenti amino acid increas plasma level glucose depend insulinotrop polypeptid gip glucagon lik peptid num glp num insulin growth hormon gh insulin lik growth factor num igf num mtorc num activ import milk exosom regular microrna num repres genet transfect system enhanc mtorc num driven metabol process human breast milk ideal food infant postnat growth species specif metabol program persist high milk signal adolesc adulthood continu cow milk consumpt promot mtorc num driven diseas civil
MED-2124~acn risk indic increas bodi mass index insulin resist pubm ncbi abstract acn repres visibl indic diseas over activ mtorc num signal unfavour metabol deviat road common western diseas civilis increas bodi mass index insulin resist exagger mtorc num signal western diet explain associ acn increas bodi mass index insulin resist earli onset menarch high glycaem load increas consumpt milk milk product stapl western diet aggrav mammalian target rapamycin complex num signal review literatur summaris present evid associ acn increas bodi mass index insulin resist western diet dietari intervent palaeolithic typ diet dermatologist chanc attenu patient increas mtorc num signal reduc glycaem load milk consumpt improv acn delay march mtorc num driven diseas civilis
MED-2126~excess leucine mtorc num signal cow milk bas infant formula miss link understand earli childhood obes abstract increas protein suppli feed cow milk bas infant formula comparison lower protein content human milk well recogn major risk factor childhood obes conclus biochem concept explain mechan formula induc childhood obes intent articl provid biochem link leucine medi signal mammalian milk protein adipogenesi earli adipogen program leucin identifi predomin signal transduc mammalian milk stimul nutrient sensit kinas mammalian target rapamycin complex num mtorc num leucin function maternal neonat relay mtorc num depend neonat cell prolifer insulin secret mtorc num target num play pivot role stimul mesenchym stem cell differenti adipocyt induc insulin resist critic concern infant formula provid higher amount leucin comparison human milk exagger leucine medi mtorc num num signal induc infant formula explain increas adipogenesi generat lifelong elev adipocyt number attenu mtorc num signal infant formula leucin restrict physiolog lower level human milk offer great chanc prevent childhood obes obesity rel metabol diseas
MED-2127~nutrient signal mtor cell growth abstract mammalian target rapamycin mtor conserv protein kinas involv multitud cellular process includ cell growth increas mtor activ observ multipl human cancer inhibit mtor proven efficaci numer clinic trial mtor compris complex term mtorc num mtorc num complex respond growth factor mtorc num control nutrient glucos amino acid discoveri mtor extens studi intric detail molecular mechan mtorc num regul paradox amino acid induc mtorc num activ arguabl essenti stimulus lead mtorc num activ understood review current knowledg nutrient depend regul mtorc num
MED-2128~sirolimus kaposi sarcoma renal transpl recipi pubm ncbi abstract background recipi organ transplant suscept kaposi sarcoma result treatment immunosuppress drug sirolimus rapamycin immunosuppress drug antitumor effect method stop cyclosporin therapi num kidney transpl recipi biopsy proven kaposi sarcoma began sirolimus therapi patient underw excision biopsi lesion biopsi normal skin time diagnosi biopsi perform site previous kaposi sarcoma lesion month sirolimus therapi begun examin biopsi specimen vascular endotheli growth factor vegf flk num kdr protein phosphoryl akt num kinas enzym signal pathway target sirolimus result month sirolimus therapi begun cutan kaposi sarcoma lesion disappear patient remiss confirm histolog patient month sirolimus therapi begun acut episod reject kidney graft function level flk num kdr phosphoryl akt num kinas increas kaposi sarcoma cell express vegf increas kaposi sarcoma cell normal skin cell kaposi sarcoma lesion conclus sirolimus inhibit progress dermal kaposi sarcoma kidney transpl recipi provid effect immunosuppress copyright num massachusett medic societi
MED-2129~amino acid sens mechan achill heel cancer pubm ncbi abstract act increas mass non divid cell divid cell seek provid materi daughter cell depend continu presenc extracellular nutrient order conserv mass amino acid nutrient insuffici protein synthesi activ monitor prokaryot eukaryot cell elicit cellular respons depend bulk nutrient suppli abund specif amino acid num author journal compil num feb
MED-2130~deconvolut mtor biolog abstract metazoan tor essenti protein function master regul cellular growth prolifer past decad explos inform critic master kinas rang composit tor protein complex abil act integr numer extracellular signal plethora inform rais numer question tor function prevail view mammalian tor mtor exist molecular complex mtorc num mtorc num larg defin presenc raptor rictor addit co factor identifi complex import mediat mtor signal incomplet elucid similar differ mtor function reflect tissu origin review present altern view mtor complex format function envis mtor regul signal propag reflect cell type basal state depend condit re interpret mtor biolog framework facilit design therapi effect inhibit central regul cell behavior
MED-2132~mtorc num signal don t pubm ncbi abstract mammalian target rapamycin mtor protein kinas play key role cellular regul form complex addit protein best understood mtor complex num mtorc num regul cellular function mtorc num subject intens studi question remain answer includ question actual mechan mtorc num signal stimul hormon growth factor involv small gtpase rheb amino acid involv gtpase protein control rheb mechan activ mtorc num remain incomplet understood year rapamycin interfer function mtorc num function mtorc num affect mtorc num regul divers cellular function mtorc num substrat case physiolog role poor incomplet understood case process clear regul mtorc num mtorc num mtorc num implic age unclear mechan account import mtorc num signal cellular function human diseas high prioriti gain insight control mtorc num signal mechan control cellular function anim physiolog
MED-2134~mtor cancer therapi pubm ncbi abstract protein regul mammalian target rapamycin mtor target mtor kinas overexpress mutat cancer rapamycin natur occur inhibitor mtor number recent develop rapamycin analog rapalog consist synthet deriv compound minor chemic modif parent structur inhibit growth cell line deriv multipl tumor type vitro tumor model vivo result clinic trial rapalog treatment subset type cancer sporad respons initi clinic trial base hypothesi general translat inhibit cancer cell begin understood owe complet understand dynam mtor regul function mtor tumor microenviron review summar preclin clinic data recent discoveri function mtor cancer growth regul
MED-2135~fisetin regul obes target mtorc num signal pubm ncbi abstract fisetin flavonol present veget fruit possess antioxid anti inflammatori properti studi demonstr fisetin prevent diet induc obes regul signal mammalian target rapamycin complex num mtorc num central mediat cellular growth cellular prolifer lipid biosynthesi evalu fisetin regul mtorc num signal investig phosphoryl kinas activ num kda ribosom protein num kinas num num mtorc num num num preadipocyt fisetin treatment preadipocyt reduc phosphoryl num mtorc num time concentration depend manner understand fisetin negat regul mtorc num signal analyz phosphoryl num mtor akt fisetin tr tsc num knockdown cell result suggest fisetin treatment inhibit mtorc num activ akt depend manner recent studi shown adipocyt differenti depend mtorc num activ fisetin treatment inhibit adipocyt differenti consist negat effect fisetin mtor inhibitori effect fisetin adipogenesi depend mtor activ suggest fisetin inhibit adipogenesi accumul intracellular triglycerid adipocyt differenti target mtorc num signal fisetin supplement mice fed high fat diet hfd signific attenu hfd induc increas bodi weight white adipos tissu observ fisetin effici suppress phosphoryl akt num mtorc num adipos tissu collect result suggest inhibit mtorc num signal fisetin prevent adipocyt differenti num num preadipocyt obes hfd fed mice fisetin phytochem agent attenu diet induc obes copyright num elsevi reserv
MED-2136~impact cow milk medi mtorc num signal initi progress prostat cancer abstract prostat cancer pca depend androgen receptor signal aberr pi num akt mtorc num pathway mediat excess sustain growth signal nutrient sensit kinas mtorc num upregul num advanc human pcas oncogen mtorc num signal activ key subset mrnas cooper distinct step pca initi progress epidemiolog evid point increas dairi protein consumpt major dietari risk factor develop pca mtorc num master regul protein synthesi lipid synthesi autophagi pathway coupl nutrient sens cell growth cancer review evid pca initi progress promot cow milk human milk stimul mtorc num signal mammalian milk present endocrin signal system activ mtorc num promot cell growth prolifer suppress autophagi natur milk medi mtorc num signal restrict postnat growth phase mammal persist consumpt cow milk protein human provid high insulinotrop branched chain amino acid bcaa provid milk fast hydrolys whey protein elev postprandi plasma insulin level increas hepat igf num plasma concentr casein deriv amino acid bcaa insulin igf num pivot activ signal mtorc num increas cow milk protein medi mtorc num signal constant exposur commerci cow milk estrogen deriv pregnant cow explain observ associ high dairi consumpt increas risk pca western societi well balanc mtorc num signal play import role prostat morphogenesi differenti exagger mtorc num signal high cow milk consumpt predomin critic growth phase prostat develop differenti exert long term advers effect prostat health attenu mtorc num signal contemporari paleolith diet restrict dairi protein intak mtorc num depend phase prostat develop differenti offer protect common dairy promot cancer men western societi
MED-2137~rapalog cancer prevent abstract common cancer age rel diseas slow age reduc delay carcinogenesi calori restrict cr studi anti ag intervent prevent cancer slow age process evid emerg cr deceler age deactiv mtor target rapamycin rapamycin rapalog suppress cellular senesc slow age postpon age rel diseas includ cancer time rapalog approv cancer treatment cancer prevent explain direct target cancer cell rapamycin prevent cancer indirect slow age process increas evid point scenario
MED-2138~calor restrict incid breast cancer pubm ncbi abstract context restrict calor intak effect extend lifespan reduc spontan tumor occurr experiment anim similar associ hold human appropri studi object determin calor restrict earli life reduc risk invas breast cancer design set particip retrospect cohort studi data swedish inpati registri swedish cancer registri swedish death registri swedish fertil registri particip num swedish women hospit anorexia nervosa prior age num year num num women exclud num diagnos cancer prior discharg hospit anorexia nervosa main outcom measur incid invas breast cancer result compar swedish general popul women hospit anorexia nervosa prior age num year num confid interv ci num num lower incid breast cancer nullipar women anorexia nervosa num ci num higher num lower lower incid parous women anorexia nervosa num ci num num lower incid conclus sever calor restrict human confer protect invas breast cancer low calor intak prior birth subsequ pregnanc pronounc reduct risk
MED-2139~prognost therapeut implic mtorc num rictor express human breast cancer pubm ncbi abstract mammalian target rapamycin mtor play key role regul cellular metabol growth prolifer form multi protein complex complex num mtorc num num mtorc num raptor rictor core protein mtorc num mtorc num studi examin relationship mtorc num rictor raptor mrna express human breast cancer correl mtorc num htert investig breast cancer tissu num normal tissu num analys revers transcript quantit pcr transcript level correl clinicopatholog data higher mtor express note breast cancer tissu num higher grade tumour grade num num num ductal tumour num wors surviv num rictor express signific higher background breast tissu compar tumour invers relat nottingham prognost index npi num num num tumour grade grade num num num num disease fre surviv num mrna express raptor higher tumour compar normal tissu express raptor higher tumour grade grade num num num high signific posit correl mtor htert num observ observ consist role mtorc num anti apoptosi pathway suggest select inhibitor mtorc num efficaci human breast cancer find support hypothesi mtorc num import upregul telomeras breast cancer
MED-2140~bean rice meal reduc postprandi glycem respons adult type num diabet cross ov studi abstract background world bean rice common consum meal type num diabet increas effect tradit diet pattern glycem respons studi fulli method evalu glycem respons bean rice tradit meal compar rice adult type num diabet seventeen men women type num diabet control metformin num diet exercis num age num num year particip random num num crossov trial white long grain rice control pinto beans ric black beans ric red kidney beans ric test meal match num gram carbohydr consum breakfast num hour fast capillari blood glucos concentr baselin num minut interv num minut postprandi collect manova repeat measur establish glucos differ treatment pair test identifi differ bean type rice control signific manova result postprandi net glucos valu signific lower bean ric treatment contrast rice control num num minut increment area curv valu signific lower pinto black bean ric meal compar rice kidney bean conclus pinto dark red kidney black bean rice attenu glycem respons compar rice promot tradit food provid non pharmaceut manag type num diabet improv dietari adher cultur group trial registr clinic trial number nct num
MED-2141~high intak grain bean pattern invers insulin resist healthi korean adult popul pubm ncbi abstract investig associ dietari pattern insulin resist num healthi korean adult num num korea nation health nutrit examin survey grain bean pattern lower preval insulin resist highest quintil num num ci num num trend num copyright num elsevi ireland reserv
MED-2143~antidiabet drug europ prior discoveri insulin pubm ncbi abstract therapeut agent treatment diabet mellitus insulin discov hundr plant shown extent antidiabet activ studi explor agent wide europ pre insulin era scientif literatur proprietari drug industri num num agent consid hypoglycem activ occasion recommend market larg extent medicin plant syzygium cumini syn jambolanum eugenia jambolana vaccinum myrtillus phaseolus sp common frequent agent opium opium alkaloid alkaloid quinin belladonna alkaloid salicyl alkalin substanc sodium bi carbon strong poison arsenic uranium salt syzygium jambolanum seed powder intens studi antidiabet agent plant origin
MED-2144~bean diabet phaseolus vulgari prepar antihyperglycem agent pubm ncbi abstract bean pod phaseolus vulgari wide tradit remedi diabet mellitus histor knowledg summar compar recent studi result report date half num centuri recent public show contradictori result phaseolus prepar consid choic phytopharmaceut treatment diabet lead structur research effect fair high dose aqueous extract fiber content alpha amylas inhibitori effect bean food compon prevent amelior type num diabet
MED-2145~effect non oil se puls glycaem control systemat review meta analysi randomis control experiment trial peopl wi pubm ncbi abstract aims hypothesi dietari non oil se puls chickpea bean pea lentil good sourc slowli digest carbohydr fibr veget protein valuabl lower glycaemic index gi diet assess evid dietari puls benefit glycaem control conduct systemat review meta analysi randomis control experiment trial investig effect puls part low gi high fibr diet marker glycaem control peopl diabet method search medlin embas cinahl cochran librari relev control trial num day independ review esfahani wong extract inform studi design particip treatment outcom data pool generic invers varianc method express standardis differ smd num cis heterogen assess chi num quantifi num meta regress model identifi independ predictor effect result total num trial num report includ puls num trial lower fast blood glucos fbg num num ci num num insulin num num ci num num puls low gi diet num trial lower glycosyl blood protein gp measur hba num fructosamin num num ci num num final puls high fibr diet num trial lower fbg num num ci num num gp num num ci num num inter studi heterogen high unexplain outcom benefit modifi predict diabet status puls type dose physic form durat follow up studi qualiti macronutri profil background diet feed control design conclusions interpret pool analys demonstr puls low gi high fibr diet improv marker longer term glycaem control human extent improv subject signific inter studi heterogen larg well design trial
MED-2146~antidiabet potenti common consum legum review pubm ncbi abstract decad lifestyl result drastic increas incid diabet world develop countri oral hypoglycem agent insulin form mainstay control diabet promin side effect fail signific alter diabet complic diet exercis program form part lifestyl modif proven great effect manag diseas dietari therapi show bright futur prevent treatment diabet legum owe high nutrit increas dietet formul treatment prevent diabet account antidiabet potenti background paper review glucos lipid low action possess common consum legum anim human studi conclud legum vari degre antidiabet potenti benefici decreas risk factor cardiovascular renal diseas
MED-2147~phaseolus bean impact glycaem respons chronic diseas risk human subject pubm ncbi abstract consumpt phaseolus vulgari bean speci pinto black navi kidney benefici prevent treatment chronic diseas condit promot increas glycaem stress hyperglycaemia hyperinsulinaemia includ diabet cvd cancer reduc individu eat bean present paper discuss influenc vulgari speci glycaem respons impact relationship risk develop diabet cvd cancer
MED-2148~regular consumpt puls num week reduc metabol syndrom risk factor overweight obes adult pubm ncbi abstract puls low energi densiti support inclus diet manag risk factor metabol syndrom metsyn aim present studi describ effect frequent consumpt cups week num week puls yellow pea chickpea navi bean lentil compar counsel reduc energi intak num kj d num kcal d risk factor metsyn group nineteen twenty on subject overweight obes bmi num num kg m num adult bodi weight waist circumfer blood pressur fast blood paramet num food intak measur week num num blood glucos insulin c peptid glucagon lik peptid num glp num ghrelin measur num oral glucos load week num num week num group report reduct energi intak waist circumfer systol blood pressur glycosyl hb hba num glucos auc homeostasi model insulin resist homa ir glucos load num num hdl fast c peptid insulin auc respons depend diet num num hdl c peptid increas num num num num puls group decreas num num num num energy restrict group insulin auc decreas femal male energy restrict diet num num num num puls diet decreas num num femal increas num num male num num conclus frequent consumpt puls ad libitum diet reduc risk factor metsyn effect equival instanc stronger counsel dietari energi reduct
MED-2149~legum intak invers metabol syndrom adult pubm ncbi abstract background studi associ legum intak metabol syndrom met spars object studi evalu associ legum intak met compon method studi conduct num subject num femal met case num age gender match healthi control anthropometr measur blood pressur fast blood glucos lipid profil evalu standard method dietari data collect food frequenc questionnair ffq legum intak determin met defin definit adult treatment panel iii result sd intak legum num num servings week case num num servings week control subject num adjust potenti confound decreas systol blood pressur fast blood glucos increas hdl cholesterol level observ increas quartil categori legum intak adjust life style food group subject highest quartil legum intak lower odd met compar lowest quartil odd ratio num num ci num num num associ weaken adjust bodi mass index bmi remain signific num num ci num num num conclus legum intak invers risk met compon
MED-2150~veget protein veget fat intak pre adolesc adolesc girl risk benign breast diseas young women abstract previous investig adolesc diet recal adulthood found lower risk benign breast diseas bbd higher intak veget fat nut high school investig veget protein fat deriv diet report pre adolesc adolesc subsequ risk bbd young women grow today studi includ num femal num num year num complet questionnair annual num num num num food frequenc questionnair num num obtain intak data varieti food begin num women num num year report diagnos bbd confirm breast biopsi num case logist regress estim associ intak veget protein fat biopsy confirm bbd individu food largest contributor protein fat cohort investig analys intak num num cohort youngest veget fat num num gm day num ci num num num invers bbd risk greatest sourc veget fat protein girl peanut butter peanut nut bean bean lentil soybean corn daili serv lower risk num serv day num ci num num num peanut butter nut age num year invers risk num analys intak age num year veget protein lower bbd risk num num gm day num ci num num num daili serv num year food lower risk num num ci num num num peanut butter nut num girl famili histori breast cancer signific lower risk consum food veget fat conclus consumpt veget protein fat peanut butter nut older girl reduc risk bbd young women
MED-2152~mechanist examin walnut prevent breast cancer pubm ncbi abstract walnut bioactiv molecul contribut benefici effect includ alpha linolen acid ala phytosterol studi extract walnut purifi compound postprandi serum examin effect breast cancer cell prolifer gene express extract deriv walnut oil decreas prolifer mcf num cell ala sitosterol gene express respons ala mous breast cancer cell line tm num molecul multipl cellular target peroxisom proliferator activ receptor ppar target gene liver receptor lxr farnesoid receptor fxr target gene affect transactiv assay walnut oil extract increas activ fxr greater extent test nuclear receptor examin separ walnut compon ala sitosterol efficaci activ fxr serum individu fed walnut compon appli mcf num cell correl bodi mass index breast cancer cell prolifer vitro data support effect walnut bioactiv constitu mammari epitheli cell multipl molecular target involv
MED-2153~nut consumpt risk pancreat cancer women abstract background increas nut intak reduc risk diabet mellitus risk factor pancreat cancer method prospect num num women nurs health studi examin associ nut consumpt pancreat cancer risk particip previous histori cancer exclud nut consumpt assess baselin updat num num year relat risk rrs num confid interv num cis estim cox proport hazard model result document num incid case pancreat cancer adjust age height smoke physic activ total energi intak women consum num num oz serv size nut num time week experienc signific lower risk pancreat cancer rr num num ci num num trend num compar larg abstain nut result appreci chang adjust bodi mass index bmi histori diabet mellitus rr num num ci num num trend num invers associ persist strata defin bmi physic activ smoke intak red meat fruit veget conclus frequent nut consumpt invers risk pancreat cancer larg prospect cohort women independ potenti risk factor pancreat cancer
MED-2154~obesity associ mechan hepatocarcinogenesi pubm ncbi abstract obes recogn key compon metabol syndrom cluster risk factor diabet cardiovascular morbid addit obes link higher frequenc cancer varieti tissu includ liver liver cancer occur hepatocellular carcinoma hcc complic cirrhosi due chronic viral infect toxic injuri remain lead cancer death world hcc increas diagnos individu obes relat disord metabol condit global preval coexist well establish risk factor hcc creat uniqu challeng liver chronic diseas organ obesity associ hcc recent attribut molecular mechan chronic inflamm due adipos tissu remodel pro inflammatori adipokin secret ectop lipid accumul lipotox alter gut microbiota disrupt senesc stellat cell insulin resist lead increas level insulin insulin lik growth factor mechan synerg occur chronic liver diseas result etiolog acceler develop hcc onset cirrhosi increas common interact oncogen pathway link obes chronic liver diseas explain hcc malign rise incid develop countri understand complex process improv strategi cancer prevent predict surveil publish elsevi
MED-2155~effect habitu coffe consumpt cardiometabol diseas cardiovascular health all caus mortal pubm ncbi abstract coffe water wide consum beverag unit state princip sourc caffein intak adult biolog effect coffe substanti limit action caffein coffe complex beverag hundr biolog activ compound health effect chronic coffe intak wide rang cardiovascular cv standpoint coffe consumpt reduc risk type num diabet mellitus hypertens condit cv risk obes depress advers affect lipid profil depend beverag prepar grow bodi data suggest habitu coffe consumpt neutral benefici risk varieti advers cv outcom includ coronari heart diseas congest heart failur arrhythmia stroke larg epidemiolog studi suggest regular coffe drinker reduc risk mortal cv all caus potenti benefit includ protect neurodegen diseas improv asthma control lower risk select gastrointestin diseas daili intak num num cup coffe safe neutral benefici effect studi health outcom data coffee health effect base observ data random control studi associ prove causat addit advantag regular coffe consumpt weigh potenti risk relat high caffein content includ anxieti insomnia tremul palpit bone loss possibl increas risk fractur copyright num american colleg cardiolog foundat publish elsevi reserv
MED-2156~effect coffe consumpt chronic hepat random control trial pubm ncbi abstract background coffe reduc risk hepatocellular carcinoma patient chronic hepat prospect trial aim assess mechan coffee rel protect effect method forti patient chronic hepat random group consum num cup coffee day num day remain coffe abstin day num group switch month result baselin aspart aminotransferas alanin aminotransferas lower patient drink num group num cups day group num num num num num num num u l num num hcv rna level signific higher group num num num num num num ui ml num coffe intak num hydroxydeoxyguanosin collagen level signific lower abstin num num num num hydroxydeoxyguanosin num deoxyguanosin num num num num num ng ml num telomer length signific higher patient coffe intak num num num num arbitrari unit num telomer length num hydroxydeoxyguanosin invers correl conclus chronic hepat coffe consumpt induc reduct oxid damag correl increas telomer length apoptosi lower collagen synthesi factor mediat protect exert coffe respect diseas progress copyright num editric gastroenterologica italiana publish elsevi reserv
MED-2157~hepatocellular carcinoma liver lesion pubm ncbi abstract patient cirrhosi greatest risk develop hepatocellular carcinoma hcc undergo semiannu surveil ultrasound alpha fetoprotein patient posit surveil test undergo contrast enhanc mri num phase ct diagnost evalu therapeut option patient tumor stage treatment decis individu account degre liver dysfunct patient perform status multidisciplinari approach care recommend optim communic treatment deliveri aim review provid up to d summari diagnosi manag hcc copyright num elsevi reserv
MED-2158~consumpt coffe reduc risk liver cancer meta analysi abstract background epidemiolog studi report inconsist result coffe consumpt risk liver cancer perform meta analysi publish case control cohort studi investig associ coffe consumpt liver cancer method search medlin embas isi web scienc cochran librari studi publish num perform meta analysi case control studi cohort studi result summari odd ratio high no almost drinker num num confid interv ci num num signific heterogen studi num num num num num num ci num num case control studi num num ci num num cohort studi num num ci num num male num num ci num num femal num num ci num num asian studi num num ci num num european studi num num ci num num adjust histori liver diseas num num ci num num adjust histori liver diseas conclus result meta analysi suggest invers associ coffe consumpt liver cancer small number studi prospect studi
MED-2159~dose gender depend interact coffe consumpt serum ggt activ alcohol consum pubm ncbi abstract aim coffe consumpt recent link decreas blood gamma glutamyltransferas ggt activ protect alcohol liver diseas explor relationship dose respons assess impact coffe alcohol intak serum ggt activ appar healthi men women vari level coffe alcohol consumpt method data coffe alcohol consumpt serum ggt activ collect num individu num men num women age num year rang num year particip larg nation cross sect health survey bodi mass index smoke index age covari analys result studi popul num report vari level coffe consumpt num abstain alcohol num moder drinker num heavi drinker num drinker men elev ggt induc heavi drink num g week found signific reduc coffe consumpt exceed num cup day similar trend observ women reach statist signific conclus coffe modul effect ethanol serum ggt activ dose gender depend manner observ implic studi hepatoprotect effect coffe alcohol consum
MED-2160~associ coffe intak liver cancer incid chronic liver diseas mortal male smoker abstract background coffe intak reduc risk liver cancer chronic liver diseas report previous studi includ prospect conduct asian popul hepat virus hbvs hepat virus hcvs domin risk factor prospect studi western popul lower hbv hcv preval spars prepar method affect coffe constitu unknown method affect diseas associ method evalu associ coffe intak incid liver cancer chronic liver diseas mortal num num finnish male smoker age num num alpha tocopherol beta caroten cancer prevent studi record coffe consumpt num year incid liver cancer chronic liver diseas mortal multivari relat risk rrs num confid interv cis estim cox proport hazard model result coffe intak invers incid liver cancer rr cup day num num ci num num p trend categori num mortal chronic liver diseas rr num num ci num num p trend num invers associ persist diabet hbv hcv negat case analys stratifi age bodi mass index alcohol smoke dose observ similar associ drink boil filter coffe conclus find suggest drink coffe benefit liver irrespect coffe boil filter
MED-2161~coffe reduc risk hepatocellular carcinoma updat meta analysi pubm ncbi abstract background aim coffe consumpt suggest reduc risk hepatocellular carcinoma hcc perform meta analysi epidemiolog studi provid updat inform coffe drink affect hcc risk method perform pubmed medlin search origin articl publish english num septemb num case control cohort studi coffe consumpt liver cancer hcc calcul summari relat risk rr low high consumpt coffe consumpt cut off point low high consumpt set num cup day num studi num cup day num studi result summari rr coffe consumpt consumpt num num studi compris total num hcc case num confid interv ci num num rrs num num case control studi num ci num num num num cohort studi num ci num num compar coffe consumpt summari rr num num ci num num low consumpt num num ci num num high consumpt summari rr num num ci num num increment num cup coffe day invers relationship coffe hcc risk consist subject sex alcohol drink histori hepat liver diseas conclus meta analysi risk hcc reduc num coffe consumpt consumpt invers associ part larg exist patient liver digest diseas reduc coffe intak coffe shown affect liver enzym develop cirrhosi protect liver carcinogenesi copyright num aga institut publish elsevi reserv
MED-2162~overweight obes mortal cancer prospect studi cohort adult pubm ncbi abstract background influenc excess bodi weight risk death cancer fulli character method prospect studi popul num adult num men num women free cancer enrol num num death cancer num year follow up examin relat men women body mass index num risk death cancer cancer individu site control risk factor multivari proportional hazard model calcul proport death cancer attribut overweight obes popul basi risk estim current studi nation estim preval overweight obes adult popul result heaviest member cohort body mass index weight kilogram divid squar height meter num death rate cancer combin num percent higher men num percent higher women rate men women normal weight men relat risk death num num percent confid interv num num women relat risk num num percent confid interv num num men women body mass index signific higher rate death due cancer esophagus colon rectum liver gallbladd pancrea kidney true death due non hodgkin lymphoma multipl myeloma signific trend increas risk higher body mass index valu observ death cancer stomach prostat men death cancer breast uterus cervix ovari women basi associ observ studi estim current pattern overweight obes unit state account num percent death cancer men num percent women conclus increas bodi weight increas death rate cancer combin cancer multipl specif site copyright num massachusett medic societi
MED-2163~trom heart studi distribut determin gamma glutamyltransferas free liv popul pubm ncbi abstract gamma glutamyltransferas ggt measur num men age num year num women age num year screen coronari risk factor distribut right skew median num num u l men women num men num women ggt greater equal num u l low level ggt match low mortal cirrhosi modest alcohol norway multipl regress analysi sex show strong posit associ bodi mass index alcohol unexpect negat associ coffe consumpt serum triglycerid time meal show weaker posit associ women oral contracept posit ggt
MED-2164~common common adult movement disord updat worldwid preval essenti tremor pubm ncbi abstract essenti tremor preval neurolog disord preval estim vari enorm make difficult establish preval precis num review worldwid preval population bas epidemiolog studi num deriv precis estim diseas preval num examin trend import differ studi identifi num population bas preval studi num countri meta analysi pool preval age num statist signific heterogen studi num num num addit descript analys crude preval age num preval increas mark age advanc age meta analysi preval age num year num addit descript analys median crude preval age num num studi age num year crude preval num studi report ethnic differ preval studi greater one third studi show gender differ demonstr higher preval men gender prefer interest clinic epidemiolog patholog associ parkinson diseas precis preval estim provid import form numer basi plan public health initi provid data background occurr diseas famili studi offer clue exist environment biolog factor mechanist import num movement disord societi
MED-2165~elev level harman norharman cerebrospin fluid parkinsonian patient pubm ncbi abstract death dopaminerg neuron parkinson diseas pd partial caus synthesi accumul endogen exogen toxin structur similar mptp beta carbolin norharman harman propos putat neurotoxin vivo easili form cyclize indoleamin aldehyd elucid role beta carbolin neurodegen disord harman norharman level cerebrospin fluid csf measur num patient pd compar age sex match control group num csf level norharman harman pd signific higher compar control result suggest role harman norharman n methyl carbolinium ion pathophysiolog process initi pd origin increas level beta carbolin remain unclear hand specul unknown metabol process induc increas synthesi harman norharman pd hand impact exogen sourc
MED-2166~blood harman num methyl num pyrido num b indol concentr essenti tremor repeat observ case control york abstract essenti tremor widespread late lif neurolog diseas genet environment factor play import etiolog role harman num methyl num pyrido num b indol potent tremor produc neurotoxin previous elev blood harman concentr demonstr case compar control observ cross sect assess subject time point repeat assay blood harman subject observ case control differ persist time point year unknown current goal re assess sampl case control determin blood harman concentr remain elev time point blood harman concentr quantifi well establish high perform liquid chromatographi method num case num control approxim num year elaps initi subsequ blood harman determin log blood harman concentr signific higher case control num num num ml num num num ml median case doubl control num num ml num num ml log blood harman concentr highest case famili histori blood harman concentr elev case compar control re assess time point year indic stabl associ environment toxin
MED-2167~explor relationship caffein intak essenti tremor pubm ncbi abstract background suggest environment factor essenti tremor studi carri evalu associ caffein intak method case control studi patient diagnos healthi control underw standard questionnair interview evalu exposur coffe tea intak multivari logist regress analysi carri evalu associ caffein intak environment factor risk result num subject includ num patient num control match age gender ethnic includ analysi univari analysi reveal caffein consumpt patient higher control group median num percentil rang num num mg year versus num num mg year num multivari logist regress analysi demonstr caffein longer signific factor num signific correl amount caffein intak diseas durat spearman num num total tremor score spearman num num patient conclus caffein consumpt risk studi popul studi investig signific gene environment interact
MED-2168~quantif neurotox beta carbolin harman barbecued gril meat sampl correl level pubm ncbi abstract harman heterocycl amin hcas potent neurotoxin link human diseas dietari exposur cook meat major sourc exogen exposur human knowledg harman concentr cook meat sampl limit goal num quantifi concentr harman type cook meat sampl num compar concentr well understood hcas num examin relationship harman concentr level thirti barbecued gril meat sampl num beef steak num hamburg num chicken analyz harman hcas num amino num methyl num phenylimidazo num b pyridin phip amino num dimethylimidazo num f quinoxalin meiqx num amino num num trimethylimidazo num f quinoxalin dimeiqx num amino num dimethylfuro num e imidazo num b pyridin ifp sd harman concentr num num ng g harman concentr highest chicken num num ng g lowest beef steak num num ng g harman concentr higher hcas signific correl phip concentr harman concentr meat sampl cook beef steak hamburg correl meat concentr greater phip harman evid harman detect nanogram gram quantiti cook meat chicken abund hcas correl meat harman concentr correl robust observ phip data improv estim human dietari exposur neurotoxin
MED-2169~relat exposur beta carbolin norharman harman food tobacco smoke pubm ncbi abstract norharman harman heterocycl beta carbolin num pyrido num b indol alkaloid biolog potenti toxicolog activ foodstuff environment sourc assess occurr distribut compound estim exposur level base detect amount numer sampl foodstuff cigarett smoke analys solid phas extract high perform liquid chromatography fluoresc level found beta carbolin high variabl low process foodstuff milk yoghurt uncook meat fish norharman harman detect limit high concentr ten ng num microg num level depend process condit well don cook meat fish highest amount norharman harman found brew coffe num microg num sauc soy sauc tabasco num microg num cook meat fish num ng num toast bread num ng num ferment alcohol beverag num mug num beta carbolin occur high amount mainstream cigarett smoke num ng cigarett import contributor daili exposur compound base result conclud daili exposur beta carbolin human ten hundr microgram cigarett smoke coffe season cook food alcohol beverag order major contributor foodstuff contribut minor amount norharman harman food tobacco smoke potenti contributor report endogen presenc beta carbolin human
MED-2170~dietari epidemiolog essenti tremor meat consumpt meat cook practic abstract background aim harman num methyl num pyrido num indol tremor produc neurotoxin blood harman concentr elev essenti tremor patient unclear reason potenti mechan includ increas dietari harman intak well cook meat genetic metabol factor test hypothesi meat consumpt level meat higher case control method detail data collect lawrenc livermor nation laboratori meat questionnair result total current meat consumpt greater men num num num num g day num women versus num num num num g day num adjust logist regress analysi male higher total current meat consumpt num num num addit g day meat odd increas num male case higher odd highest lowest quartil total current meat consumpt adjust num num meat level similar case control conclus studi evid dietari differ male case male control etiolog ramif result warrant addit investig copyright num karger ag basel
MED-2171~carbolin alkaloid essenti tremor explor environment determin preval neurolog diseas abstract essenti tremor preval neurolog diseas etiolog understood suscept genotyp undoubt underli case gene identifi environment factor contribut etiolog harman num methyl num pyrido num indol potent tremor produc carbolin alkaloid emerg literatur provid initi link neurotoxin report review literatur studi york demonstr higher blood harman level case control studi high level famili case replic studi popul york studi brain harman level undertaken small number studi explor biolog correl exposur harman patient studi mechan putat elev harman explor role increas dietari consumpt find weak evid increas exogen intak male case studi found initi evid elev harman due hereditarili reduc capac metabol harman harmin num methoxi num methyl num pyrido num indol studi harman associ intrigu addit studi establish definit toxic exposur etiolog import
MED-2172~quantif co mutagen beta carbolin norharman harman cigarett smoke condens cook food pubm ncbi abstract co mutagen beta carbolin norharman harman quantifi mainstream sidestream smoke condens japanes brand cigarett num kind cook food combin blue cotton treatment hplc norharman harman detect cigarett smoke condens sampl level mainstream smoke case num ng cigarett norharman num ng harman sidestream smoke num ng norharman num ng harman beta carbolin found present cook food sampl level num num ng norharman num num ng harman gram cook food observ concentr higher found mutagen carcinogen heterocycl amin hcas suggest human expos norharman harman daili life larger extent hcas
MED-2173~mptp industri chemic contamin illicit narcot stimul era research parkinson diseas abstract mptp num methyl num phenyl num num tetrahydropyridin select destruct dopaminerg neuron nigrostriat pathway human primat specif potent mice slight effect rat differ rate site metabol mptp activ toxic high polar metabolit mpp num methyl num phenylpyridin influenc speci specif rat type monoamin oxidas mao b mediat convers mptp mpp act enzymat barrier brain microvessel primat enzym present astrocyt import bioactiv mptp toxic metabolit mpp substrat catecholamin uptak site concentr neuron molecular mechan mpp toxic establish definit convers free radic uptak mitochondria inhibit mitochondri respiratori enzym lead calcium releas cell death suggest discoveri toxin anim model parkinson diseas stimul research environment factor contribut progress degen disord assess approach therapi
MED-2174~cancer blood concentr co mutagen harman essenti tremor abstract background blood concentr harman tremor produc neurotoxin elev essenti tremor harman co mutagen object compar preval cancer case control determin blood harman concentr elev case cancer method case control design result num num case num num control cancer adjust num num ci num num num specif cancer type colon cancer preval case control num num num log blood harman concentr higher case control num particip cancer num log blood harman concentr highest case cancer compar group num discuss link cancer high blood harman cancer deserv studi
MED-2175~blood harman correl cerebellar metabol essenti tremor pilot studi pubm ncbi abstract background proton magnet reson spectroscop imag num mrsi decreas cerebellar n acetylaspartate tot creatin naa tcr essenti tremor signifi cerebellar neuron dysfunct degener harman present human diet potent tremor produc neurotoxin blood harman concentr elev object assess patient blood harman concentr correl cerebellar naa tcr neuroimag measur neuron dysfunct degener method twelv patient underw num mrsi major neuroanatom structur interest cerebellar cortex secondari region central cerebellar white matter cerebellar vermi thalamus basal ganglia blood concentr harman neurotoxin lead assess result sd cerebellar naa tcr num num linear regress model adjust age gender log blood harman concentr predictor cerebellar naa tcr beta num num num num ml unit increas log blood harman concentr num unit decreas cerebellar naa tcr associ blood harman concentr brain naa tcr occur cerebellar cortex observ secondari brain region interest associ specif harman neurotoxin lead conclus studi addit support emerg link harman neurotoxin studi warrant address cerebellar harman concentr cerebellar patholog postmortem studi brain
MED-2176~exposur beta carbolin norharman harman pubm ncbi abstract aromat beta carbolin norharman harman implic number human diseas includ parkinson diseas tremor addict cancer shown compound normal bodi constitu form endogen extern sourc identifi summaris literatur data level norharman harman fri meat fish meat extract alcohol drink coffe brew sourc includ edibl medicin plant tobacco smoke identifi major sourc exposur level dietari sourc estim maximum num microg norharman kg bodi weight bw day num microg harman kg bw day exposur tobacco smoke depend smoke habit type cigarett estim num microg kg bw norharman num microg kg bw harman packag cigarett smoke studi toxicokinet inhal exposur lead rapid increas plasma level high bioavail norharman harman oral bioavail lower indic sublingu absorpt increas dietari uptak beta carbolin endogen format estim num ng kg bw day norharman num ng kg bw day harman rate increas high intak precursor biomark studi plasma level beta carbolin report elev level norharman harman diseas patient alcohol tobacco smoke consumpt beta carboline contain food cigarett smoke identifi major influenc dietari exposur contribut exposur
MED-2177~chronic parkinson human due product meperidine analog synthesi pubm ncbi abstract person develop mark parkinson illicit drug intraven analysi substanc inject patient reveal primarili num methyl num phenyl num num tetrahydropyridin mptp trace amount num methyl num phenyl num propionoxy piperidin mppp basi strike parkinsonian featur observ patient addit patholog data previous report case propos chemic select damag cell substantia nigra
MED-2178~blood harman blood lead sever hand tremor evid addit effect abstract background tremor widespread phenomenon human popul environment factor play etiolog role harman num methyl num pyrido num indol potent tremor produc carbolin alkaloid lead tremor produc neurotoxic effect harman lead respect tremor studi isol object test hypothesi tremor sever individu high blood concentr toxic method blood concentr harman lead quantifi num individu num essenti tremor case num control enrol environment epidemiolog studi total tremor score rang num num clinic measur tremor sever result total tremor score rang num num indic full spectrum tremor sever captur sampl blood harman concentr correl total tremor score num blood lead concentr num total tremor score lowest particip low blood harman lead concentr num num intermedi particip high concentr toxic num num highest particip high concentr toxic num num num conclus blood harman lead concentr separ correl total tremor score particip high blood concentr toxic highest tremor score suggest addit effect toxic tremor sever high popul preval tremor disord identifi environment determin import primari diseas prevent
MED-2179~cook frequenc enhanc surviv taiwanes elder pubm ncbi abstract object investig associ cook behaviour long term surviv elder taiwanes design cohort studi durat follow up interv date interview date death num decemb num censor survivor inform includ demograph socio econom status health behaviour cook frequenc physic function cognit function nutrit knowledg awar eat habit food nutrient intak data link death record cox proportional hazard model evalu cook frequenc death num num relat covari adjust set elder nutrit health survey taiwan num subject nation repres free liv elder peopl age num year num result num year follow up num particip die cook frequent younger women unmarri educ non drink alcohol non smok chew difficulti spous dinner companion normal cognit walk shop week ate meat veget high frequent cook num times week compar predict surviv hazard ratio hr num num ci num num num adjust physic function cognit function nutrit knowledg awar covari hr num num ci num num num women benefit cook frequent men decreas hr num num compar num year delay assess survivorship led similar find conclus cook behaviour favour predict survivorship high frequent cook favour women men
MED-2180~christma num research nutrit content supermarket readi meal recip televis chef unit kingdom cross section studi abstract object compar energi macronutri content main meal creat televis chef readi meal sold supermarket compar nutrit guidelin publish world health organ uk food standard agenc design cross section studi set supermarket largest share groceri market unit kingdom num sampl num main meal recip bestsel cookeri book uk televis chef num brand readi meal lead uk supermarket main outcom measur number meal nutrit content compli recommend proport nutrient classifi red amber green uk fsa traffic light system label food result recip readi meal fulli compli recommend readi meal compli recommend proport energi deriv carbohydr num num num sugar num num num fibr densiti num num num recip compli recommend sodium densiti num num num salt season assess distribut traffic light colour fsa food label recommend differ modal traffic light red recip num green readi meal num recip signific energi num kj num kj protein num num fat num num satur fat num num num signific fibr num num num portion readi meal conclus recip creat televis chef readi meal sold lead uk supermarket compli recommend recip healthi readi meal signific energi protein fat satur fat fibr portion readi meal
MED-2181~trend energi intak children eat locat food sourc num num abstract background impact locat food consumpt prepar daili energi intak children object examin trend daili energi intak children food eaten home away from hom sourc prepar combin categori eat locat food sourc subject analysi data num children age num num year num num nationwid food consumpt survey num num num num continu survey food intak individu num num nation health nutrit examin survey method nation repres weight percentag daili energi intak eat locat analyz trend num num comparison food sourc examin num num analys repeat num age group num num num num num year differ test conduct test result increas energi intak num kcal d children num num major increas calori eaten away from hom num kcal d percentag kcal d eaten away from hom increas num num num num increas observ num num sourc calori shift percentag calori fast food increas surpass intak school largest contributor food prepar away from hom age group food eaten away from hom percentag kcal d store increas largest sourc calori eaten away from hom fast food eaten home store bought food eaten away from hom increas signific conclus eat locat food sourc signific impact daili energi intak children food prepar away from hom includ fast food eaten home store prepar food eaten away from hom fuel increas total calori intak research altern data sourc verifi store bought food eaten away from hom increas store prepar
MED-2182~food cook skill health literatur review pubm ncbi abstract past centuri major shift north american food practic place literatur topic lack area research food cook practic current context present focus affect health contribut health inequ popul cook cook skill examin ambigu relat term cook research literatur food choic cook health relat econom factor lead health inequ popul import develop understand factor wider food system part food choic cook skill present gap research literatur examin area futur research present cook practic studi import understand human nutrit health relat cultur environment econom factor
MED-2183~impact cook home food prepar intervent adult outcom implic futur program abstract object cook program grow popular extens review examin impact studi review previous research cooking hom food prepar intervent diet health rel outcom adult identifi implic practic research design literatur review descript summat method main outcom measur dietari intak knowledge skil cook attitud self efficacy confid health outcom analysi articl evalu effect intervent includ cooking hom food prepar primari aim januari num decemb num identifi ovid medlin agricola web scienc databas studi group design outcom review valid establish code system result summar outcom categori result num studi identifi num includ control group non random random control trial evalu post intervent studi pre post intervent num post intervent num qualit quantit measur suggest posit influenc main outcom non rigor studi design vari studi popul non valid assess tool limit stronger conclus conclus implic well design studi rigor evalu long term impact cook behavior dietari intak obes health outcom
MED-2184~resist recess low incom adult mainten cook away from hom eat behavior time econom turbul abstract object examin effect state level unemploy rate recess num pattern home food prepar away from hom afh eat low incom minor popul method analyz pool cross sect data num num adult age num year older part american time studi multinomi logist regress model stratifi gender evalu associ state level unemploy poverti race ethn time spent cook log binomi regress assess respond afh consumpt pattern result high state level unemploy trivial increas respond cook pattern virtual chang afh eat pattern low incom racial ethn minor group disproportion affect recess conclus major econom downturn adult resist food rel behavior chang work understand reluct chang attribut time limit lack knowledg skill relat food prepar lack access fresh produc raw ingredi
MED-2185~microstructur vitro beta caroten bioaccess heat process orang flesh sweet potato pubm ncbi abstract orang flesh sweet potato ofsp identifi good sourc beta caroten beta caroten bioaccess affect process studi effect tradit heat process method microstructur vitro bioaccess beta caroten ofsp investig bioaccess determin simul vitro digest model membran filtrat separ micellar fraction bioaccess beta caroten process led decreas amount all trans beta caroten increas num cis beta caroten process ofsp signific higher num bioaccess beta caroten compar raw form bioaccess vari process treatment order raw bake steamed boil deep fri light microscopi show microstructur ofsp disrupt process method employ cell wall ofsp slough tradit heat process method appli find show heat process improv bioaccess beta caroten ofsp due disrupt tissu microstructur
MED-2188~stabil carotenoid total phenol vitro antioxid capac thermal process orange flesh sweet potato ipomoea batat pubm ncbi abstract intervent strategi biofortif orange flesh sweet potato rich sourc carotenoid combat vitamin defici develop brazil studi conduct evalu concentr individu carotenoid total phenol compound antioxid capac root biofortifi sweet potato cultivar raw process common heat treatment hplc folin ciocalteu dpph abt assay cultivar show high level carotenoid raw root predomin all tran caroten num num mg num num dw suggest high estim vitamin activ cnph num cultivar report carotenoid valu highest cultivar num total phenol compound vari cultivar heat treatment num num mg num dw case heat treatment result signific decreas carotenoid phenol compound content antioxid capac process flour present greatest loss major carotenoid phenol phenol compound show stabil carotenoid process signific correl carotenoid phenol compound antioxid capac
MED-2189~anticanc effect sweet potato protein human colorect cancer cell abstract aim investig effect protein purifi sweet potato storag root human colorect cancer cell line method num num dimethylthiazol num yl num diphenyltetrazolium bromid mtt assay hoechst num nuclear stain boyden transwel chamber method determin purifi sweet potato protein spp fresh sweet potato root affect prolifer migrat invas human colorect cancer sw num cell vitro inhibitori effect spp growth human colorect cancer hct num cell intraperiton xenograft nude mice spontan lung metastasi murin lewi lung carcinoma num cell subcutan transplant num bl num mice investig vivo result spp inhibit prolifer sw num cell dose depend manner ic num num mol l num num num mtt assay hoechst num nuclear stain reveal inhibit cell viabil induct apoptosi spp transwel assay disclos signific reduct migrat cells field num mol l spp num num num num num invad cells field ecmatrix num mol l spp compar control num num num num num intraperiton ip intragastr ig administr spp led signific suppress growth intraperiton inocul hct num cell nude mice num num num num num num control num treatment bloodi ascit addit disappear ip inject trypsin inhibitor notabl ig ip administr spp induc signific decreas spontan pulmonari metastat nodul format num bl num mice num num num num nodules lung num num nodules lung control num num treatment averag weight primari tumor nodul hind leg mice decreas num num g mice control num num g mice ip group num conclus spp exert signific antiprolif antimetastat effect human colorect cancer cell line vitro vivo
MED-2191~effect bake boil nutrit antioxid properti sweet potato ipomoea batata lam cultivar pubm ncbi abstract effect bake boil nutrit antioxid properti sweet potato cultivar beniazuma koganesengan kotobuki cultiv turkey investig sampl analyz proxim composit total phenol content ascorb acid caroten antirad activ free sugar dri matter protein starch content sweet potato signific chang treatment ash crude fiber content differ signific caroten content bake boil sweet potato lower fresh sweet potato total phenol ascorb acid content bake boil sweet potato higher fresh sampl general antirad activ sweet potato increas treatment sucros glucos fructos quantifi free sugar fresh sweet potato maltos determin treat sampl term analyz paramet explicit differ sweet potato cultivar
MED-2194~role anthocyanin enrich purple flesh sweet potato num colorect cancer prevent abstract scope anthocyanin natur pigment plant food cancer prevent content anthocyanin stapl food typic low mechan exert anti canc activ fulli defin method result select anthocyanin enrich purple flesh sweet potato clone num investig potenti anti canc effect vitro cell cultur vivo anim model addit high level total phenol antioxid capac num possess high content anthocyanin num mg g dri matter treatment human colon sw num cancer cell num anthocyanin extract num num peonidin num glucosid equival result dose depend decreas cell number due cytostat arrest cell cycl num phase cytotox dietari num num num signific suppress azoxymethane induc format aberr crypt foci colon cf num mice conjunct part lesser prolif pcna greater apoptot caspas num express colon mucos epitheli cell conclus observ coupl vitro vivo studi report suggest anthocyanin enrich sweet potato num protect colorect cancer induc cell cycl arrest anti prolif apoptot mechan
MED-2195~influenc deep fri veget oil acrylamid format sweet potato ipomoea batata lam chip pubm ncbi abstract object studi evalu precursor acrylamid format sweet potato sp ipomoea batata lam chip determin effect type veget oil vos palm olein coconut oil canola oil soya bean oil acrylamid format reduc sugar amino acid sp slice analyz acrylamid concentr sp chip measur sp chip fri lower degre unsatur oil lower acrylamid concentr num g kg fri higher degre unsatur oil higher acrylamid concentr num g kg sp root found acrylamid precursor num mg g glucos num mg g fructos num mg g free asparagin type vo condit fri signific influenc acrylamid format studi contribut lipid format acrylamid neglect num institut food technologist
MED-2200~diet gallbladd cancer case control studi pubm ncbi abstract cancer gallbladd rare fatal unusu geograph demograph distribut gallston obes suggest risk factor diet influenc factor carri present studi evalu role diet gallbladd carcinogenesi case control studi involv num newli diagnos case gallbladd cancer num case gallston carri dietari evalu carri dietari recal method base preset questionnair develop specif present studi mind common dietari habit prevail part world odd ratio num confid interv ci calcul dietari item signific reduct odd ratio consumpt radish num num ci num num green chilli num num ci num num sweet potato num num ci num num veget mango num num ci num num orang num num ci num num melon num num ci num num papaya num num num num fruit reduct odd consumpt crucifer veget bean onion turnip differ statist signific hand increas odd observ consumpt capsicum num beef num tea num red chilli num mutton num differ statist signific conclus result present studi show protect effect veget fruit gallbladd carcinogenesi red meat beef mutton found increas risk gallbladd cancer
MED-2201~metric afford nutrit veget provid nutrient cost pubm ncbi abstract measur food price gram calori make health veget expens measur afford nutrient content veget account studi base analys depart agricultur dataset aim identifi veget includ juic soup provid nutrient unit cost nutrient densiti measur nutrient rich food nrf index base nutrient encourag protein fiber vitamin calcium iron magnesium potassium nutrient limit satur fat ad sugar sodium food cost dollar calcul num num kcal serv nutrient content one way analys varianc post hoc test determin statist signific result show tomato juic tomato soup dark green leafi nonleafi veget deep yellow veget includ sweet potato highest nrf score highest nrf score dollar obtain sweet potato white potato tomato juic tomato soup carrot broccoli tomato sauc raw tomato potato chip eaten frequent veget afford nutrient rich measur afford nutrit foodservic health profession identifi veget provid highest nutrient densiti unit cost process veget includ soup juic contribut qualiti afford diet copyright num academi nutrit dietet publish elsevi reserv
MED-2202~sweet potato review past present futur role human nutrit pubm ncbi abstract object chapter review past present futur role sweet potato ipomoea batata lam human nutrit specif chapter describ role sweet potato human diet outlin biochem nutrit composit sweet potato emphasi beta caroten anthocyanin content highlight sweet potato util potenti value ad product human food system demonstr potenti sweet potato african context earli record sweet potato stapl food sourc indigen popul central south america ryukyu island africa caribbean maori peopl hawaiian papua guinean protein content sweet potato leav root rang num num num num sweet potato consid excel sourc natur health promot compound beta caroten anthocyanin function food market high concentr anthocyanin beta caroten sweet potato combin high stabil color extract make promis healthier altern synthet color agent food system starch flour process sweet potato creat econom employ activ farmer rural household add nutrit food system reposit sweet potato product potenti value ad product contribut substanti util benefit human food system multidisciplinari integr research develop activ aim improv product storag postharvest process technolog qualiti sweet potato potenti value ad product critic issu address global
MED-2203~effect sweet potato footbath acupressur intervent prevent constip hospit patient acut coronari syndro pubm ncbi abstract constip common health problem advers affect qualiti life prognosi hospit patient acut coronari syndrom ac purpos studi develop test sweet potato footbath acupressur massag sfa intervent safe treatment prevent constip increas satisfact bowel empti hospit patient ac studi prospect random control trial sampl num patient sfa group num usual care group num patient sfa group receiv sfa intervent combin usual care result show statist differ group term num incid constip num laxat enema num patient subject satisfact bowel empti hospit num sensat incomplet evacu anorect obstruction blockad sfa intervent effect econom practic usual care manag constip satisfact defec patient hospit ac
MED-2204~multipl biolog function sporamin relat stress toler sweet potato ipomoea batata lam pubm ncbi abstract initi investig natur protein tuber sweet potato ipomoea batata lam reveal globulin design ipomoein report jone gersdorff num ipomoein renam sporamin found major storag protein account num total protein tuber root date sporamin studi seri biochem molecular approach purif sporamin major fraction success complet num characterist protein diversif nucleotid sequenc gene famili protein structur biolog function storag defens inhibitori activ ros scaveng identifi past decad sporamin classifi kunitz typ trypsin inhibitor insect resist capabl examin transgen tobacco cauliflow plant indic multipl function protein evolv facilit growth develop sweet potato sporamin constitut express tuber root express stem leav protein express system respons wound abiot stress dual express pattern transcript level reveal complex regulatori mechan sporamin modul environment stress versatil function sporamin make storag protein good research model studi molecular evolut regulatori mechan physiolog function plant review summar discuss recent approach futur perspect agricultur biotechnolog copyright num elsevi reserv
MED-2205~anticanc effect sweet potato protein human colorect cancer cell abstract aim investig effect protein purifi sweet potato storag root human colorect cancer cell line method num num dimethylthiazol num yl num diphenyltetrazolium bromid mtt assay hoechst num nuclear stain boyden transwel chamber method determin purifi sweet potato protein spp fresh sweet potato root affect prolifer migrat invas human colorect cancer sw num cell vitro inhibitori effect spp growth human colorect cancer hct num cell intraperiton xenograft nude mice spontan lung metastasi murin lewi lung carcinoma num cell subcutan transplant num bl num mice investig vivo result spp inhibit prolifer sw num cell dose depend manner ic num num mol l num num num mtt assay hoechst num nuclear stain reveal inhibit cell viabil induct apoptosi spp transwel assay disclos signific reduct migrat cells field num mol l spp num num num num num invad cells field ecmatrix num mol l spp compar control num num num num num intraperiton ip intragastr ig administr spp led signific suppress growth intraperiton inocul hct num cell nude mice num num num num num num control num treatment bloodi ascit addit disappear ip inject trypsin inhibitor notabl ig ip administr spp induc signific decreas spontan pulmonari metastat nodul format num bl num mice num num num num nodules lung num num nodules lung control num num treatment averag weight primari tumor nodul hind leg mice decreas num num g mice control num num g mice ip group num conclus spp exert signific antiprolif antimetastat effect human colorect cancer cell line vitro vivo
MED-2206~consum accept vegetarian sweet potato product intend space mission pubm ncbi abstract sweet potato crop select nasa advanc life support program potenti long dur lunar mar mission articl present recip product made sweet potato determin consum accept product num num sweet potato dri weight basi product develop nutriti palat meal futur space explor sensori evalu appearance color aroma textur flavor tast accept studi conduct determin consum accept vegetarian product made sweet potato panelist nasa johnson space center houston tx product includ control ingredi anim origin sweet potato pie num point hedon scale num extrem num dislik extrem evalu num product compar similar commerci product control product test pancak waffl tortilla bread pie pound cake pasta veget patti doughnut pretzel product moder slight sweet potato veget patti dislik comparison sensori score sweet potato recip control accomplish student t test nutrit adequaci consum accept product recommend nasa advanc life support program inclus vegetarian menu plan design lunar mar space mission
MED-2207~growth inhibit induct apoptosi nb num promyelocyt leukemia cell trypsin inhibitor sweet potato storag root pubm ncbi abstract object studi investig antiprolif effect mechan trypsin inhibitor ti sweet potato ipomoea batata lam tainong num storag root nb num promyelocyt leukemia cell result show ti inhibit cellular growth nb num promyelocyt leukemia cell time depend dose depend manner treatment num induc mark inhibit cellular growth show ic num num num microg ml ti caus cell cycl arrest num phase determin flow cytometr analysi apoptosi shown dna ladder ti induc cell apoptosi involv num bcl num bax cytochrom protein nb num cell num bax protein accumul antiapoptot molecul bcl num decreas test cell time depend manner ti treatment ti induc substanti releas cytochrom mitochondria cytosol ti induc apoptosi nb num cell mitochondria depend pathway activ caspas num num result demonstr ti induc nb num cell apoptosi inhibit cell growth activ pathway caspas num num cascad
MED-2208~therapeut efficaci once daili oral administr kunitz typ proteas inhibitor bikunin mous model human cancer pubm ncbi abstract background bikunin kunitz typ proteas inhibitor specif inhibit tumor invas metastasi method author initi evalu therapeut efficaci once daili oral administr dose bikunin human ovarian carcinoma hra cell grow peritonea nude mice vivo studi femal num week old nude mice random num num group bikunin tr group num group receiv num num microg g bodi weight day bikunin num day gastrointestin gavag control group num receiv vehicl solut phosphate buff salin gastrointestin gavag day num abdomin caviti examin observ blind treatment result oral administr intact bikunin detect mous serum specimen num num hour declin num hour mice bikunin highest dose level num decreas tumor load highest uptak tumor obtain num bikunin num hour postadministr effect food intak bodi weight observ treat versus sham group current studi report potent activ once daili oral administr bikunin ovarian carcinoma author perform phase trial determin maximum toler dose mtd safeti once daili oral administr schedul indic local advanc uterin cervic carcinoma definit treatment escal dose num num mg kg day bikunin administ oral patient num day dose limit toxic mtd bikunin schedul defin author obtain preliminari data effect urokinase typ plasminogen activ express highest dose level conclus once daili oral administr bikunin found safe human exhibit sign biolog activ copyright num american cancer societi
MED-2209~relationship process method glycem indic ten sweet potato ipomoea batata cultivar common consum jamaica abstract studi investig effect tradit cook method glycem index gi glycem respons ten sweet potato ipomoea batata cultivar common eaten jamaica matur tuber cook roast bake fri boil immedi consum ten nondiabet test subject num male num femal age num num year gi vari num num num num tuber studi sampl prepar boil lowest gi num num num num process bake num num num num roast num num num num highest gi valu studi glycem index jamaican sweet potato vari signific method prepar lesser extent intravariet differ consumpt boil sweet potato minim postprandi blood glucos spike prove efficaci manag type num diabet mellitus
MED-2210~sporamin induc apoptosi human tongu carcinoma cell down regul akt gsk num signal pubm ncbi abstract investig effect sporamin major solubl protein kunitz typ trypsin inhibitori activ root tuber sweet potato cell prolifer apoptosi akt gsk num signal relat gene provid insight mechan inhibitori effect sporamin human tongu cancer line tca num studi sporamin inhibit cell prolifer induc apoptosi tca num cell concentration depend time depend manner consist bax up regul bcl num down regul sporamin tr cell akt gsk num signal down regul sporamin tr cell consist phosphoryl bad signific declin sporamin tr tca num cell result suggest antiprolif effect sporamin tca num cell result part induct apoptosi down regul akt gsk num pathway num author fundament clinic pharmacolog num soci fran ais de pharmacologi de rapeutiqu
MED-2211~epidemiolog alzheimer diseas form dementia china num systemat review analysi pubm ncbi abstract background china increas face challeng control grow burden non communic diseas assess epidemiolog alzheimer diseas form dementia china num num improv estim burden diseas analys time trend inform health polici decis relev china rapid age popul method systemat review search report alzheimer diseas dementia china publish chines english num num search china nation knowledg infrastructur wanfang pubm databas investig independ assess case definit alzheimer diseas dementia exclud studi intern accept case definit exclud review viewpoint studi numer estim studi mainland china poisson regress demograph data estim preval age group incid standardis mortal ratio dementia subtyp china num num find search return num report num met inclus criteria num assess preval num incid mortal total includ studi num particip num case alzheimer diseas record num peopl assess form dementia num vascular dementia frontotempor dementia lewi bodi dementia num preval form dementia num num ci num num num num year num num num num age num year num preval num num num num age num year num num num num age num year number peopl dementia china num num million num ci num num num num num million num num num num num num million num num num num period number peopl alzheimer diseas num num million num num num num num million num num num peopl num num num million num num num num incid dementia num num case num person year alzheimer diseas num num case num person year vascular dementia num num case num person year rare form dementia num num case num person year retriev mortal data num peopl dementia num healthi control num year median standardis mortal ratio num num iqr num num num interpret analysi suggest previous estim dementia burden base smaller dataset underestim burden dementia china burden dementia increas faster general assum intern health communiti rapid effect govern respons tackl dementia low incom middle incom countri fund nossal institut global health univers melbourn australia nation num five year major project china nation health medic research council australia china exchang fellowship import develop high calibr talent project beij municip institut bill melinda gate foundat copyright num elsevi reserv
MED-2212~dietari link alzheimer diseas num updat pubm ncbi abstract republ grant num paper provid epidemiolog evid link diet develop alzheimer diseas ad time review find hypothes light subsequ literatur main find dietari fat energi age high risk factor fish cereal risk reduct factor support recent epidemiolog studi diet contribut develop ad modul oxid stress inflamm link oxid stress aris seri num prostaglandin age dietari modif addit supplement design reduc free radic product inflamm provid signific measur reduct risk develop ad
MED-2213~incid dementia alzheim diseas num communiti yoruba resid ibadan nigeria african american resid indianapoli pubm ncbi abstract context alzheim diseas ad repres major increas public health problem popul identifi signific lower higher incid rate ad search risk factor genesi ad great enhanc object compar incid rate dementia ad num divers elder community dwel popul design indianapolis ibadan dementia project longitudin prospect population bas studi consist baselin survey num num subsequ follow up wave num year num num year num wave num stage design in hom screen interview full diagnost workup subsampl particip base screen perform set particip total num community dwel yoruba resid ibadan nigeria dementia num community dwel african american resid indianapoli ind dementia age num year older cohort num year num year main outcom measur incid case dementia ad num popul result age standard annual incid rate signific lower yoruba african american dementia yoruba num num confid interv ci num num african american num num ci num num ad yoruba num num ci num num african american num num ci num num conclus report incid rate differ dementia ad studi num popul nonindustri industri countri ident method group investig site explor popul differ identifi potenti modifi environment genet factor account site differ dementia ad
MED-2214~global preval dementia delphi consensus studi summari background num year descript alzheimer diseas disabl burdensom health condit worldwid delphi consensus method determin dementia preval world region method num intern expert provid systemat review publish studi dementia provid preval estim world region men women combin num year age band num num year age num year older popul estim project estim number peopl dementia num num estim incid rate preval remiss mortal find evid well plan repres epidemiolog survey scarc region estim num num million peopl dementia today num num million case dementia year case num number peopl affect doubl num year num num million num peopl dementia live develop countri num num rise num num rate increas uniform number develop countri forecast increas num num num num india china south asian western pacif neighbour interpret detail estim paper constitut basi policymak plan alloc health welfar resourc
MED-2215~incid dementia intak anim product preliminari find adventist health studi pubm ncbi abstract investig relationship anim product consumpt evid dementia cohort substudi enrol num california resid match age sex zip code num vegan num lacto ovo vegetarian num heavi meat eater num quartet design ensur wide rang dietari exposur includ num unmatch subject resid loma linda california area subject enrol adventist health studi match subject ate meat includ poultri fish dement vegetarian counterpart relat risk num num discrep widen relat risk num num past meat consumpt account signific differ incid dementia vegetarian versus meat eat unmatch subject obvious explan differ substudi power unmatch sub studi detect effect heavi meat consumpt unexpect limit trend delay onset dementia vegetarian substudi
MED-2216~trend diet alzheimer diseas nutrit transit japan develop countri pubm ncbi abstract background alzheimer diseas ad rate japan develop countri risen rapid recent year research factor western diet obes alcohol consumpt smoke risk ad object paper evalu dietari transit explain rise trend ad preval japan develop countri evalu factor method studi approach dietari explain ad trend japan develop countri approach involv compar trend ad japan nation dietari suppli factor alcohol consumpt lung cancer mortal rate num year preval data compar ad preval valu develop countri dietari suppli factor num year preval data result japan alcohol consumpt anim product meat rice suppli lung cancer rate correl high ad preval data strongest correl lag num year eight countri studi total energi anim fat correl high ad preval data lag num year mechan explain find includ increas obes countri increas cholesterol satur fat iron increas anim product meat suppli japan conclus evid ad rate continu rise non western countri time address major risk factor involv diet obes smoke
MED-2217~preval alzheimer diseas dementia rural india indo us studi pubm ncbi abstract object determin preval ad dementia rural elder hindi speak popul ballabgarh northern india design author perform communiti survey cohort num individu age num year older num illiter hindi cognit function screen instrument develop valid popul screen cohort total num subject num met oper criteria cognit function impair random sampl num unimpair control subject num underw standard clinic assess dementia diagnost statist manual mental disorders fourth edit diagnost criteria clinic dementia rate scale cdr nation institut neurolog communic disord stroke alzheimer diseas relat disord associ nincds adrda criteria probabl ad result found preval rate num num ci num num dementia cdr score num popul age num year older preval rate num num ci num num popul age num year older preval rate ad num num ci num num popul age num num num ci num num popul age num greater age signific higher preval ad dementia gender literaci preval conclus popul preval ad dementia low increas age gender literaci explan includ low life expect short surviv diseas low age specif incid potenti due differ distribut risk protect factor compar popul higher preval
MED-2218~preval dementia older japanese american men hawaii honolulu asia age studi pubm ncbi abstract object determin preval dementia subtyp japanese american men compar find rate report popul japan design set honolulu heart program prospect population bas studi cardiovascular diseas establish num preval estim comput case identifi num num examin cognit perform assess standard method instrument diagnost criteria particip subject num japanese american men num surviv cohort age num num year live communiti institut main outcom measur age specif age standard cohort preval estim comput dementia defin num set diagnost criteria num level sever preval level alzheim diseas vascular dementia estim result dementia preval diagnost statist manual mental disord edit revis rang num men age num num year num men age num num year age standard preval num preval estim cohort num dementia num alzheim diseas primari contribut num vascular dementia primari contribut num found num case alzheim disease vascular dementia ratio num case attribut primarili alzheim diseas vascular dementia conclus preval alzheim diseas older japanese american men hawaii higher japan similar european ancestri popul preval vascular dementia slight lower japan higher european ancestri popul cross nat research emphasi standard diagnost method
MED-2219~harm effect coca cola beverag num month intak rat test pubm ncbi abstract laboratori recent report num month exposur rat cola lik beverag induc sex hormon aim studi investig effect type coca cola intak composit num month oxid status test testosteron adult male rat fifti adult male wistar rat divid control group drink water group drink coca cola beverag regular coca cola coca cola caffeine fre coca cola light coca cola oxid carbonyl stress marker measur testicular tissu assess oxid status testicular plasma testosteron star express test marker steroidogenesi quantifi signific differ found group measur paramet conclus oxid carbonyl stress testicular tissu influenc drink type coca cola addit testosteron test plasma testicular star express compar group copyright num elsevi reserv
MED-2220~posit academi nutrit dietet total diet approach healthi eat pubm ncbi abstract posit academi nutrit dietet total diet pattern food eaten import focus healthi eat food fit pattern consum moder portion size combin physic activ academi strive communic healthi eat messag emphas balanc food beverag energi food meal public polici dietari pattern support total diet approach includ num dietari guidelin american dash dietari approach stop hypertens diet myplat let move nutrit fact label healthi peopl num dietari refer intak contrast total diet approach classif specif food good bad simplist foster unhealthi eat behavior altern approach situat eat practic dynam influenc factor includ tast food prefer weight concern physiolog time conveni environ abund food econom media market perceiv product safeti cultur attitudes belief increas effect nutrit educ promot food choic skill food nutrit practition util behavior theori evidence bas strategi focus varieti moder proport context healthi lifestyl target specif nutrient food reduc consum confus prevent unnecessari relianc supplement proactiv empow practic messag emphas total diet approach promot posit lifestyl copyright num academi nutrit dietet publish elsevi reserv
MED-2221~peril ignor histori big tobacco play dirti million die similar big food abstract context num tobacco industri paid publish frank statement cigarett smoker hundr newspap state public health industry concern promis varieti good faith decad deceit action cost million live hope food histori written differ articl highlight import lesson learn tobacco experi recommend action food industri method review analysi empir histor evid pertain tobacco food industri practic messag strategi influenc public opinion legisl regul litig conduct scienc find tobacco industri playbook script emphas person respons pay scientist deliv research instil doubt critic junk scienc found harm smoke make self regulatori pledg lobbi massiv resourc stifl govern action introduc safer product simultan manipul deni addict natur product market children script food industri similar tobacco industri script conclus food tobacco food industri differ tobacco compani import signific similar action industri respons concern product harm obes major global problem world afford repeat tobacco histori industri talk moral high ground occupi
MED-2222~effect cocoa chocol ingest brachial arteri flow medi dilat relev cardiovascular health diseas human pubm ncbi abstract prospect studi high intak dietari flavanol cocoa chocol reduc rate cardiovascular rel morbid mortal human numer mechan underli associ favor effect flavanol blood pressur platelet aggreg thrombosi inflamm vascular endothelium brachial arteri flow medi dilat fmd techniqu emerg robust method quantifi endotheli function human collect preponder evid fmd power surrog measur firm cardiovascular endpoint cardiovascular rel mortal human liter thousand studi util techniqu document group differ fmd assess effect intervent fmd numer studi acut chronic ingest cocoa chocol increas fmd human increas fmd cocoa chocol ingest dose depend greater increas fmd observ ingest larger quantiti mechan respons divers data suggest effect increas nitric oxid bioavail posit vascular effect cocoa chocol endothelium underli link mechanist reduct cardiovascular risk human copyright num elsevi reserv
MED-2223~evalu antirad activ cocoa chocol product relat lipid protein composit abstract chocol antioxid properti claim frequent parent natur sourc due industri artisan transform antioxid properti chocol cocoa adequ consum make food flavor tast properti studi investig antioxid capac total phenol content cocoa nib cocoa mass chocol bar percentag cocoa origin antioxid capac sampl measur assay num diphenyl num picryl hydrazyl radic dpph ferric reduc antioxid potenc frap test folin ciocalteu reagent assess total phenol content mass show higher antioxid power nib attribut fact nib present lipid part form cocoa butter influenc milk whey soy protein investig result show extra dark cocoa bar num cocoa chocol term total polyphenol content term antioxid capac dpph frap test addit bar organ dark chocol num dark tanzania num trinidad num product perform respect highlight antirad properti cocoa product higher antioxid supplement tablet
MED-2224~dark chocol improv coronari vasomot reduc platelet reactiv pubm ncbi abstract background dark chocol potent antioxid properti coronari atherosclerosi promot impair endotheli function increas platelet activ tradit risk factor high oxid stress reduc antioxid defens play crucial role pathogenesi atherosclerosi transplant heart flavonoid rich dark chocol hold potenti benefici impact graft atherosclerosi method result assess effect flavonoid rich dark chocol compar cocoa fre control chocol coronari vascular platelet function num heart transplant recipi double blind random studi coronari vasomot assess quantit coronari angiographi cold pressor test num hour ingest num dark num cocoa chocol control chocol hour ingest flavonoid rich dark chocol coronari arteri diamet increas signific num num num num mm num remain unchang control chocol endothelium depend coronari vasomot improv signific dark chocol num num versus num num placebo group num platelet adhes decreas num num num num num dark chocol group remain unchang control group conclus dark chocol induc coronari vasodil improv coronari vascular function decreas platelet adhes num hour consumpt benefici effect parallel signific reduct serum oxid stress posit correl serum epicatechin concentr
MED-2225~effect dark chocol renal tissu oxygen measur bold mri healthi volunt pubm ncbi abstract background cocoa rich flavonoid anti oxid properti increas bioavail nitric oxid adequ renal tissu oxygen crucial mainten renal function goal studi investig effect cocoa rich dark chocol dc renal tissu oxygen human compar flavonoid poor white chocol wc method ten healthi volunt preserv kidney function age sd num num year num women bmi num num kg m num underw blood oxygen level depend magnet reson imag bold mri num hour ingest num g kg dc num cocoa renal tissu oxygen determin measur num map num coron slice cover kidney num num num valu medulla cortex calcul low num indic high tissu oxygen particip underw bold mri num week num hour intak num g kg wc result medullari num lower dc intak compar baselin num num num num num num num cortic medullari num valu chang wc intak chang medullari num correl level circul epi catechin metabolit flavonoid num num independ plasma renin activ conclus studi suggest time increas renal medullari oxygen intak dark chocol link flavonoid induc renal perfus oxygen consumpt cocoa potenti renoprotect properti merit studi
MED-2226~effect sugar sweeten sugar fre cocoa endotheli function overweight adult pubm ncbi abstract background studi cocoa suggest array cardiovascular benefit effect daili intak sugar fre sugar sweeten cocoa beverag endotheli function ef establish method num adult bmi num kg m num particip random control crossov trial particip random assign treatment sequenc sugar fre cocoa beverag sugar sweeten cocoa beverag sugar sweeten cocoa fre placebo treatment administ daili num week num week washout period result cocoa ingest improv ef measur flow medi dilat fmd compar placebo sugar fre cocoa chang num num ci num num num num ci num num differ num num ci num num num sugar sweeten cocoa chang num num ci num num num num ci num num differ num num ci num num num magnitud improv fmd consumpt sugar fre versus sugar sweeten cocoa greater signific biomark cardiac risk chang appreci baselin bmi remain stabl studi conclus daili cocoa ingest improv ef independ biomark cardiac risk weight gain sugar fre prepar augment endotheli function copyright num elsevi ireland reserv
MED-2227~chocolate  guilti pleasur healthi supplement pubm ncbi abstract dark chocol cocoa product popular popul health benefit remain controversi observ kuna indian popul shown impress cardiovascular health benefit cocoa reason benefit robust popul addit mechan propos confer cocoa health benefit consensus reach cocoa physiolog role promot cardiovascular health flavanol theobromin contribut enhanc endotheli function subsequ improv contributor cardiovascular diseas cvd includ hypertens platelet aggreg adhes insulin resist hypercholesterolemia benefit cocoa alter stage growth develop product peopl healthi dark chocol provid pleasur role cvd risk reduct object review discuss associ cocoa decreas blood pressur improv cvd risk describ mechan potenti benefit highlight cocoa dietari supplement
MED-2228~effect chocol cocoa flavan num ol cardiovascular health systemat review meta analysi random trial pubm ncbi abstract background substanti interest chocol flavan num ol prevent cardiovascular diseas cvd object object systemat review effect chocol cocoa flavan num ol major cvd risk factor design search medlin embas cochran databas random control trial rcts chocol cocoa flavan num ol contact author addit data conduct duplic assess studi inclus data extract valid random effect meta analys result includ num acut short term chronic num wk rcts compris num particip insulin resist homa ir num num ci num num improv chocol cocoa due signific reduct serum insulin flow medi dilat fmd improv chronic num num ci num num acut num num ci num num intak effect homa ir fmd remain stabl sensit analys observ reduct diastol blood pressur bp num mm hg num ci num num mm hg arteri pressur num mm hg num ci num num mm hg margin signific effect ldl num mmol l num ci num num mmol l hdl num mmol l num ci num num mmol l cholesterol chocol cocoa improv fmd dose consum dose num mg epicatechin d result greater effect systol diastol bp grade grade recommend assess develop evalu tool assess qualiti evid strength recommend suggest low moderate qu evid benefici effect suggest negat effect strength evid lower due unclear report alloc conceal dropout miss data outcom heterogen biomark result studi conclus found consist acut chronic benefit chocol cocoa fmd previous unreport promis effect insulin homa ir larger longer dur independ fund trial requir confirm potenti cardiovascular benefit cocoa flavan num ol
MED-2229~broccoli sprout reduc oxid stress type num diabet random double blind clinic trial pubm ncbi abstract background object vitro anim studi report young broccoli sprout improv oxid stress status diabet condit object double blind placebo control random clinic trial investig effect broccoli sprout powder bsp oxid stress paramet type num diabet patient subjects method total num patient type num diabet random assign treatment group num week group receiv num g d bsp num g d bsp num placebo num serum total antioxid capac tac total oxid status tos oxid stress index osi malondialdehyd mda oxid low densiti lipoprotein ldl cholesterol measur baselin num week treatment result num patient group includ analysi num g d bsp num g d num placebo num num week consumpt bsp result signific decreas mda num treatment effect oxid low densiti lipoprotein cholesterol num treatment effect osi num treatment effect signific increas tac num treatment effect effect found tos conclus bsp favor effect oxid stress status type num diabet patient
MED-2231~potenti efficaci broccoli sprout uniqu supplement manag type num diabet complic pubm ncbi abstract function food nutraceut compon consid supplementari treatment type num diabet prevent long term complic young broccoli sprout function food bioactiv compound special sulforaphan hyperglycem oxid condit sulforaphan potenti activ nf e num relat factor num nrf num depend antioxid response sign pathway induc phase num enzym attenu oxid stress inactiv nuclear factor kappa b nf key modul inflammatori pathway interest sulforaphan induc peroxisom proliferator activ receptor contribut lipid metabol glucos homeostasi anim vitro model sulforaphan show antihypertens anticanc cardioprotect hypocholesterolem capac bactericid properti helicobact pylori supplement type num diabet high sulforaphan content broccoli sprout result increas total antioxid capac plasma decreas oxid stress index lipid peroxid serum triglycerid oxid low dens lipoprotein ldl ldl cholesterol ratio serum insulin insulin resist serum high sensit c reactiv protein sulforaphan prevent nephropathi diabetes induc fibrosi vascular complic potenti efficaci sulforaphan bioactiv compon young broccoli sprout make excel choic supplementari treatment type num diabet
MED-2232~target cancer stem cell sulforaphan dietari compon broccoli broccoli sprout pubm ncbi abstract studi support protect effect broccoli broccoli sprout cancer chemoprevent properti sulforaphan deriv princip glucosinol broccoli broccoli sprout extens studi recent research effect sulforaphan cancer stem cell cscs drawn lot interest cscs suggest respons initi maintain cancer contribut recurr drug resist number studi sulforaphan target cscs type cancer modul nf shh epithelial mesenchym transit wnt catenin pathway combin therapi sulforaphan chemotherapi preclin set shown promis result articl focus effect sulforaphan cscs self renew pathway give review recent human studi broccoli sprout prepar
MED-2233~physiolog biochem metabol germin broccoli seed sprout pubm ncbi abstract physiolog biochem metabol glucoraphanin sulforaphan content germin broccoli seed sprout investig studi sprout length root length fresh weight increas germin time dri weight vari num num mg sprout rapid increas respiratori rate sprout occur num num germin stay high level hplc analysi found glucoraphanin content increas earli stage num germin decreas low num mg g num reach highest num mg g num germin sulforaphan content decreas dramat day germin increas slowli reach high num mg g num declin
MED-2234~effect broccoli sprout insulin resist type num diabet patient random double blind clinic trial pubm ncbi abstract antioxid compon approach improv insulin resist ir main featur type num diabet complic aim studi investig effect broccoli sprout powder bsp high concentr sulphoraphan ir type num diabet patient eighty on patient random assign receiv num g d bsp num g d bsp num placebo num num week fast serum glucos insulin concentr glucos insulin ratio homoeostasi model assess ir homa ir index measur baselin num week treatment seventy two patient complet studi num includ analysi num week consumpt num g d bsp result signific decreas serum insulin concentr homa ir num treatment effect broccoli sprout improv ir type num diabet patient
MED-2235~bioavail inter convers sulforaphan erucin human subject consum broccoli sprout broccoli supplement cross ov studi design abstract broccoli consumpt reduc risk cancer broccoli supplement bioavail excret mercaptur acid pathway metabolit isothiocyan human consumpt broccoli supplement test import isothiocyan broccoli sulforaphan erucin employ cross ov studi design num subject consum num gram fresh broccoli sprout num month washout period num subject consum num pill broccoli supplement negat control isothiocyan consumpt addit subject consum alfalfa sprout phase placebo pill blood urin sampl collect num hour phase analyz sulforaphan erucin metabolit lc ms ms bioavail sulforaphan erucin dramat lower subject consum broccoli supplement compar fresh broccoli sprout peak plasma concentr urinari excret delay subject consum broccoli supplement gstp num polymorph affect metabol excret sulforaphan erucin sulforaphan erucin interconvert vivo interconvers consist subject variabl subject studi confirm consumpt broccoli supplement devoid myrosinas activ produc equival plasma concentr bioactiv isothiocyan metabolit compar broccoli sprout implic peopl consum recommend serv size num pill broccoli supplement equival dose isothiocyan
MED-2237~tobacco smoke chew alcohol drink lung cancer risk men southern india pubm ncbi abstract india lung cancer common lethal cancer tobacco smoke remain import etiolog factor object studi examin effect tobacco consumpt form includ smoke chew lung cancer risk men southern india compar effect bidi smoke cigarett smoke lung carcinogenesi evalu role indian alcohol beverag non indian alcohol beverag lung carcinogenesi conduct case control studi chennai trivandrum total num lung cancer case num control includ num cancer control num healthi control recruit effect cigarett bidi smoke chew alcohol drink risk lung cancer estim uncondit multivari logist regress appli general addit model gam locally weight running lin smoother loess find plausibl curv dose respons relationship result gam suggest plateau num year smoke num cigarette equival pack year cigarett bidi num num ci num num num num ci num num num year cigarette on bidi on smoke num num ci num num num num ci num num num weight cumul cigarette on bidi on consumpt lung cancer risk cigarett smoker drop quick quit smoke compar bidi smoker evid effect chew lung cancer risk clear evid effect alcohol drink never smok indian alcohol drink remain lung cancer risk limit power num num ci num num bidi smoke stronger carcinogen effect cigarett smoke differ hold matter aspect smoke consid copyright num wiley liss
MED-2238~sick individu sick popul pubm ncbi abstract rose depart epidemiolog london school hygien tropic medicin keppel street london wc num num uk sick individu sick popul intern journal epidemiolog num num num aetiolog confront distinct issu determin individu case determin incid rate exposur agent homogen popul case control cohort method fail detect identifi marker suscept strategi control high risk approach seek protect suscept individu popul approach seek control incid approach competit prior concern discov control incid
MED-2239~curcumin bas vagin cream vacurin select elimin appos human cervic cancer cell pubm ncbi abstract object human papillomavirus hpv infect remain lead mortal worldwid strategi screen vaccin prevent hpv associ cervic neoplasm consum immens healthcar cost spice compon curcumin potent anticanc antivir properti difficult har treatment due poor system bioavail project test possibl develop curcumin bas therapi cervic cancer method hpv cervic cancer cell line normal fibroblast test select potenc curcumin elimin hpv cell subsequ develop curcumin bas cervic cream test efficaci elimin appos hpv cell side effect vagin epithelium healthi mice result curcumin select elimin varieti hpv cervic cancer cell hela num siha sw num suppress transform antigen num dramat inhibit express pro canc protein epiderm growth factor receptor egfr concomit induc num addit vacurin uniform colloid solut curcumin clinic amphipath vagin cream elimin appos hela cell suppress express egfr mice daili intravagin applic vacurin week produc chang bodi weight mice sacrif vagin tract epithelium show vacurin evok advers effect conclus develop curcumin bas vagin cream effect erad hpv cancer cell affect non cancer tissu preclin data support approach treatment cervic hpv infect copyright num elsevi reserv
MED-2240~curcumin diferuloylmethan deliveri method review pubm ncbi abstract curcumin interact larg number extra intracellular target biphas dose depend manner control inflamm oxid stress cell surviv cell secret homeostasi prolifer mechan action general direct cell exhibit disord physiolog blatant mutation bas abnorm state optim prevent therapeut applic requir deliv quantiti curcumin lesion cellular target diseas condit anatom locat topic system site effici applic curcumin requir specif lesion ori deliveri method repres review copyright num intern union biochemistri molecular biolog
MED-2243~turmer curcumin topic agent cancer therapi pubm ncbi abstract ethanol extract turmer curcuma longa ointment curcumin activ ingredi found produc remark symptomat relief patient extern cancer lesion reduct smell note num case reduct itch case dri lesion observ num case small number patient num reduct lesion size pain patient effect continu month advers reaction notic num patient evalu
MED-2244~combin treatment curcumin quercetin adenoma famili adenomat polyposi pubm ncbi abstract background aim familialadenomat polyposi fap autosomal domin disord character develop hundr colorect adenoma eventu colorect cancer regress adenoma syndrom occur administr nonsteroid anti inflammatori drug cyclooxygenas num inhibitor compound side effect evalu efficaci combin diet deriv nonprescript supplement curcumin quercetin regress adenoma patient fap method fap patient prior colectomi num retain rectum num ileal anal pouch receiv curcumin num mg quercetin num mg oral num time day number size polyp assess baselin therapi wilcoxon signed rank test determin differ number size polyp treatment side effect medic complianc evalu result num patient decreas polyp number size baselin num month treatment curcumin quercetin percent decreas number size polyp baselin num num num num minim advers side effect laboratori abnorm note conclus combin curcumin quercetin reduc number size ileal rectal adenoma patient fap appreci toxic random control trial valid find
MED-2245~curcumin impair tumor suppressor num function colon cancer cell pubm ncbi abstract curcumin diferuloylmethan consid potenti chemoprevent agent human vitro inhibit transcript nf kappab activ lipoxygenas cyclooxygenas enzym facilit tumor progress vivo protect rodent model chemic carcinogenesi curcumin alpha beta unsatur keton reactiv chemic substitu respons repress nf kappab compound curcumin electrophil moieti inactiv tumor suppressor num report curcumin behav analog compound disrupt conform num protein requir serin phosphoryl bind dna transactiv num respons gene num mediat cell cycl arrest
MED-2246~pharmacodynam pharmacokinet studi oral curcuma extract patient colorect cancer pubm ncbi abstract curcuma spp extract dietari polyphenol curcumin prevent colon cancer rodent view spars inform pharmacodynam pharmacokinet curcumin human dose escal pilot studi standard curcuma extract proprietari capsul form perform dose num num mg day num mg curcumin fifteen patient advanc colorect cancer refractori standard chemotherapi receiv curcuma extract daili num month activ glutathion s transferas level dna adduct num form malondialdehyd product lipid peroxid prostaglandin biosynthesi measur patient blood cell oral curcuma extract toler dose limit toxic observ curcumin metabolit detect blood urin curcumin recov fece curcumin sulfat identifi fece patient ingest num mg curcuma extract num day accompani num decreas lymphocyt glutathion s transferas activ higher dose level effect observ leukocyt num level constant patient unaffect treatment radiolog stabl diseas demonstr patient num month treatment result suggest curcuma extract administ safe patient dose num daili equival num mg curcumin curcumin low oral bioavail human undergo intestin metabol larger clinic trial curcuma extract merit
MED-2247~carcinogenesi gi tract morpholog genet back pubm ncbi abstract genet alter colorect cancer progress determin separ distinct pathway genom instabl pathway chromosom instabl character allel loss aneuploidi pathway microsatellit instabl character abund subtl dna mutat diploidi gene caus chromosom instabl remain unknown microsatellit instabl caus inactiv dna mismatch repair gene predomin mlh num msh num microsatellit instabl present num colorect cancer diagnos analysi tumor dna paraffin block demonstr loss mismatch repair protein express cancer addit uniqu profil genet alter colorect cancer microsatellit instabl distinct patholog featur improv surviv final cancer patient hereditari non polyposi colorect cancer lynch syndrom microsatellit instabl due germlin mutat dna mismatch repair gene identif microsatellit instabl pathway enorm implic clinic investig manag colorect cancer patient
MED-2248~trace element status healthi subject switch mix lactovegetarian diet num mo pubm ncbi abstract consequ chang mix lactovegetarian diet num mo trace element concentr plasma hair urin fece studi num women num men diet shift intak zinc magnesium chang selenium decreas num month diet shift plasma hair concentr zinc copper selenium decreas magnesium increas concentr mercuri lead cadmium hair lower excret zinc copper magnesium urin selenium urin fece decreas small occur remain lactovegetarian diet period year trace element concentr revert baselin concentr copper valu similar baselin concentr data magnesium slight higher complex pattern observ zinc selenium conclud shift lactovegetarian diet trace element status
MED-2249~zinc multi miner supplement mitig pathogen impact cadmium exposur pubm ncbi abstract high level cadmium cd exposur long induc nephropathi sever osteoporosi fractur human recent epidemiolog reveal popul import industri exposur heavi metal high norm blood urin cd level correl increas risk vascular disord cancer diabet total mortal osteoporosi nephropathi disord expedit cd absorpt cd promot patholog rodent studi reason conclud cd import mediat risk factor disord human avoid tobacco smoke frequent ingest shellfish organ meat lessen human exposur cd chief dietari sourc cd plant deriv food green leafi veget grain tuber root veget typic recommend health support properti non smok vegan tend highest cd bodi burden fortun iron suffici ampl dietari intak calcium magnesium zinc imped absorpt dietari cd down regul intestin express miner transport direct compet cd access transport correct iron defici import control cd absorpt zinc supplement counteract toxic cd bodi induct metallothionein bind cd avid sulfhydryl group long remain sequest form cd innocu zinc supplement case recommend optim zinc status exert protect anti inflammatori antioxid immunosupport effect toxic cd mediat larg part oxid stress ingest spirulina lipoic acid melatonin n acetylcystein potenti mitig risk cd exposur suggest rodent studi cd prove major risk factor morbid mortal human practic strategi limit absorpt pathogen impact hand copyright num elsevi reserv
MED-2250~urinari cadmium num nation health nutrit examin survey nhane pubm ncbi abstract chronic low level cadmium cd exposur link kidney cardiovascular diseas fractur cancer diet smoke primari sourc exposur general popul analyz urinari cd nhane num determin level declin signific decad children teen adult nonsmok smoker factor influenc declin subpopul model log urinari cd variable threshold censor multipl regress model includ individual level covari age gender bmi incom race ethnicity countri origin educ survey period smoke hous home age water sourc filter diet supplement num calori fat protein micronutri cd contain food intak creatinin survey year variabl geometr urinari cd ng ml declin num subpopul regress show statist signific declin year teen adult covari signific cd subpopul creatinin age bmi race ethnicity origin educ smoker home serum cotinin num fat mg fe intak dietari supplement explain declin unidentifi time rel factor respons declin million american remain potenti risk advers outcom low level cd exposur
MED-2251~dietari cadmium exposur risk postmenopaus breast cancer population bas prospect cohort studi pubm ncbi abstract ubiquit food contamin cadmium featur estrogen mimet promot develop estrogen depend malign breast cancer prospect studi cadmium exposur breast cancer risk report examin associ dietari cadmium exposur baselin num risk estrogen receptor er defin er er breast cancer population bas prospect cohort num postmenopaus women averag num year follow up num incid case invas breast cancer ascertain num er num er adjust confound includ consumpt grain veget account num dietari exposur putat anticarcinogen phytochem dietari cadmium intak posit breast cancer tumor compar highest tertil lowest rate ratio rr num num confid interv ci num num trend num lean normal weight women statist signific associ observ tumor rr num num ci num num er tumor rr num num ci num num similar statist signific associ found er tumor rr num num ci num num risk breast cancer increas increas cadmium exposur similar tertil grain veget consumpt decreas increas consumpt grain veget tertil cadmium exposur interact num result suggest role dietari cadmium postmenopaus breast cancer develop
MED-2252~diet nutrient contribut factor influenc blood cadmium level pubm ncbi abstract studi suggest intak cd diet approxim equival smoke mutual metabol influenc cd nutrient report purpos studi evalu relationship blood cadmium concentr bcdc food consumpt nutrient intak ca fe zn vitamin vitamin tobacco smoke variabl age bodi mass index resid num adult live italian island sardinia sassari provinc specif hypothes offal consumpt contribut cd intak blood level bcdc quantifi graphit furnac atom absorpt spectrometri inform person data collect questionnair smoke signific contribut bcdc num nonsmok subject eat offal show signific higher bcdc num slight higher bcdcs observ nonsmok subject eat rice fish bread bcdc posit correl age subject num num offal daili intak nonsmok num num intak ca negat correl num num bcdc femal multipl linear regress analysi show smoke consumpt offal bodi mass index age import risk factor bcdc select popul copyright num elsevi reserv
MED-2253~effect meal meal time uptak lead gastrointestin tract human pubm ncbi abstract twenti adult ingest num lead acet num hour num fast retent measur num day whole bodi counter num whole bodi turnov rate suggest initi uptak greater balanc meal eaten num reduc lead uptak num influenc food num effect phytat ethylene diaminetetra acet edta caffein alcohol glucos liquid meal light snack test separ intermedi result effect meal larg due content calcium phosphat salt lead uptak reduc phytat plenti cereal increas factor milk uptak skim milk milk suggest factor fat comest low miner phytat content reduc lead uptak intermedi amount possibl stimul digest secret avid uptak lead fast larg reduct lead uptak meal likelihood variat gastric empti rate dietari habit major variat bodi burden lead popul
MED-2254~dietari cadmium intak belgian adult popul pubm ncbi abstract aim studi estim dietari cadmium cd intak belgian adult popul compar dietari cd exposur toler week intak twi recent establish european food safeti author efsa determin major food group contribut dietari cd exposur belgium food consumpt data deriv num belgian food consumpt survey num recal num particip cadmium concentr food item num gather control program belgian feder agenc safeti food chain period num dietari intak individu calcul consumpt data median cd concentr popul median num percentil dietari intak valu num num num kg bodi weight week percent belgian adult popul dietari cd intak recent twi num kg bodi weight establish efsa num cereal product potato contribut num cd intak
MED-2255~dietari cadmium intak risk cancer meta analysi abstract background diet major sourc cadmium intak non smok general popul recent studi determin cadmium exposur produc advers health effect lower exposur level previous predict conduct meta analysi combin analyz result previous studi investig associ dietari cadmium intak cancer risk method search pubm embas medlin databas case control cohort studi assess associ dietari cadmium intak cancer risk perform meta analysi elig studi summar data summari relat risk rrs num confid interv cis calcul random effect model result dietari cadmium intak show statist signific associ cancer risk rr num num ci num num highest lowest dietari cadmium group strong evid heterogen subgroup analys conduct studi design geograph locat cancer type subgroup analys posit associ dietari cadmium intak cancer risk observ studi western popul rr num num ci num num studi investig hormone rel cancer prostat breast endometri cancer conclus analysi found posit associ dietari cadmium intak cancer risk studi conduct western countri hormone rel cancer addit experiment epidemiolog studi requir verifi find
MED-2256~country specif correl europ model atmospher cadmium lead deposit concentr moss pubm ncbi abstract previous analys european scale shown cadmium lead concentr moss primarili determin total deposit metal analys current studi show spearman rank correl concentr moss deposit model european monitor evalu programm emep countri metal specif signific posit correl found particip countri num num num cd num correl signific negat countri moss sampl small number emep grid correl frequent improv data emep grid moss sampl site grid includ conclud spatial pattern tempor trend agre lead cadmium concentr moss model atmospher deposit copyright num elsevi reserv
MED-2257~associ cadmium exposur neurocognit test score cross sect studi adult abstract background low level environment cadmium exposur neurotox studi adult goal evalu associ neurocognit exam score biomark cumul cadmium exposur adult nation health nutrit examin survey nhane iii method nhane iii nation repres cross sect survey popul conduct num num analyz data subset particip age num num particip computer bas neurocognit evalu outcom measur simpl reaction time test srtt visual motor speed symbol digit substitut test sdst attention percept serial digit learn test sdlt trials to criterion sdlt total error scor sdlt test learn recall short term memori fit multivariable adjust model estim associ urinari cadmium concentr test score result num particip underw neurocognit screen num urinari cadmium level prior multivariable adjust higher urinari cadmium concentr wors perform num outcom multivariable adjust relationship signific age influenti variabl reduc associ magnitud never smok occup cadmium exposur relationship urinari cadmium sdst score attention percept signific num g l increas urinari cadmium correspond num num ci num num decrement perform conclus result suggest higher cumul cadmium exposur adult relat subt decreas perform task requir attent percept adult cadmium exposur primarili diet smoke work base cadmium exposur associ observ exposur level consid advers effect level common adult research potenti neurocognit effect cadmium exposur warrant cumul cadmium exposur mediat effect age smoke cognit adjust variabl result underestim associ cumul cadmium exposur prospect studi includ never smok non occup expos individu clarifi issu
MED-2258~environment cadmium breast cancer risk abstract breast cancer preval women cancer age adjust incid num num women cadmium ubiquit carcinogen pollut multipl biolog effect report breast cancer region case control studi examin associ breast cancer urinari cadmium ucd case control sampl women live long island li ny num breast cancer num region high rate breast cancer num num suffolk counti repres sampl women nhane num num breast cancer num multivari logist model sampl show signific trend increas odd breast cancer increas ucd quartil nhane num li num compar lowest quartil li women highest quartil increas risk breast cancer num num ci num num women highest quartil increas risk num num ci num num num num ci num num research warrant impact environment cadmium breast cancer risk specif popul identifi molecular mechan
MED-2259~cadmium intak system exposur postmenopaus women age match men smoke cigarett pubm ncbi abstract blood cadmium b cd concentr threefold higher smoker nonsmok basi phenomenon understood conduct detail multifacet studi cadmium exposur smoker group older smoker num num year num male nonsmok num num year num male subject cigarett machin smoke generat individu pair measur inhal cadmium i cd versus b cd i cd b cd evalu time month interv urin cadmium u cd analyz comparison smoker duplicate diet studi conduct kinet studi plasma cadmium versus b cd femal smoker b cd num ng cd ml num fold rang num num ng cd ml nonsmok lower b cd num ng cd ml num narrow rang num num ng cd ml rang male similar estim cadmium amount inhal daili subject smoke num cigarettes day num cd report ingest daili diet i cd amount low explain num fold elev b cd smoker assum greater cadmium absorpt lung gastrointestin tract cadmium accumul smoker lung provid ad cadmium final b cd linear relat i cd valu num smoker num higher b cd impli heterogen smoker circul cadmium concentr potenti cadmium toxic
MED-2260~faecal elimin lead cadmium subject mix lactovegetarian diet pubm ncbi abstract faecal elimin lead cadmium num subject chang mix diet lactovegetarian diet studi faecal weight increas signific chang vegetarian diet part increas water content larg inter individu variat faecal elimin lead cadmium mixed diet period rang num num median num microgram pb day rang num num median num microgram cd day vegetarian diet period rang num num median num microgram pb day rang num num median num microgram cd day tendenc increas faecal elimin lead cadmium chang vegetarian diet differ statist signific
MED-2261~cadmium zinc contain miner supplement pubm ncbi abstract zinc contain dietari supplement analyz zinc zn cadmium cd induct coupl plasma mass spectrometri icp m cadmium detect sampl amount cd num mg zn daili recommend dietari vari num fold num num microgram cd num mg zn supplement zn form glucon consist lowest amount cd cd non essenti potenti toxic element human concentr nutrit supplement minim possibl regul government establish standard
MED-2262~assess human exposur risk cadmium inhal seafood consumpt pubm ncbi abstract role cadmium cd bioaccess risk assess studi aim studi assess human health risk cd inhal seafood consumpt incorpor bioaccess relationship trophic cd bioaccess construct base experiment data estim cd concentr human urin blood daili intak seafood consumpt inhal base physiologically bas pharmacokinet pbpk model hill bas dose respons model assess human renal dysfunct peripher arteri diseas risk long term cd exposur show fish higher bioaccess num shellfish num human ingest result glomerular tubular damag gender smoker rang num num analysi show nonsmok num probabl peripher arteri diseas level exceed num num smoke popul num fold higher morbid risk peripher arteri diseas nonsmok studi conclud advers effect cd exposur exacerb high seafood consumpt coincid cigarett smoke work framework accur address risk dose depend cd hazard copyright num elsevi reserv
MED-2263~cadmium bioavail veget animal bas food assess vitro digestion caco num cell model pubm ncbi abstract background chronic dietari cadmium cd exposur result kidney dysfunct decreas bone miner densiti object determin compar bioavail cd veget animal bas food materi method caco num cell expos cd boil pig kidney ark shell kale raw kale mix boil pig kidney raw kale cdcl num vitro digest cellular cd uptak digest refer cdcl num solut measur atom absorpt spectrometri result cd bioavail animal bas food higher vegetable bas food addit raw kale exhibit inhibitori effect cd bioavail mix boil pig kidney cd kale increas absorb boil conclus cd bind molecular speci food compon veget animal bas food food combin cook process influenc uptak dietari cd relat bioavail factor account food matrix exposur assess estim prevent risk dietari cd
MED-2264~cadmium blood concentr relat nutrit pubm ncbi abstract cadmium toxic element ubiquit environ damag biolog system major sourc cadmium exposur food high cadmium content soil lead high cadmium concentr plant grain surfac layer germ oil non oil seed fruit veget food commod crucial compon vegetarian nutrit blood cadmium concentr measur non smok popul group vegetarian group num non vegetarian control group general popul tradit mix diet num signific higher blood cadmium content num num num num microg l measur vegetarian group healthi risk valu num microg l found num vegetarian non vegetarian highest cadmium concentr num num microg l measur vegan subgroup plant food num decreas increas anim food consumpt num num microg l lactovegetarian lactoovovegetarian subgroup ad dairi product egg num num num microg i semivegetarian subgroup previous subgroup ad white meat num risk vegetarian non risk vegetarian consum signific higher amount grain product grain sprout oil seed blood cadmium content direct influenc age num num grain product intak num num durat vegetarian num num oxid stress play major role chronic cadmium induc hepat renal toxic consequ cadmium injuri vegetarian signific higher plasma concentr natur antioxid suffici antioxid protect cadmium induc free radic format vegetarian inhibit harm effect greater cadmium intak plant food
MED-2265~physic activ increas bioavail flavanon dietari aronia citrus juic intak triathlet pubm ncbi abstract control triathlet volunt num num num ml num ml aronia citrus juic ac juic num urin sampl hydrolys determin flavanon concentr uplc qqq ms m flavanon metabolit group volunt glucuronid sulfat sulfo glucuronid total excret flavanon increas fivefold triathlet compar control volunt increas ninefold homoeriodictyol triathlet compar control volunt suggest overactiv microbiota metabol caus physic exercis differ bioavail detect men women controlboth group ac juic provid synergist effect health due increas bioavail flavanon avoid deleteri effect caus overdosag nutrit supplement copyright num elsevi reserv
MED-2266~over the count ibuprofen risk gastrointestin bleed complic systemat literatur review pubm ncbi abstract background exposur over the count otc ibuprofen otc non steroid anti inflammatori drug nsaid substanti literatur gastrointestin gi safeti nsaid therapi extens risk profil otc prescript dose seldom separ studi provid risk specif otc ibuprofen object conduct literatur review evalu risk gi bleed event relat otc ibuprofen method publish clinic trial observ studi meta analys otc ibuprofen defin num mg day state counter report endpoint incid rate proport gi bleed event gi bleeding rel hospit death identifi medlin num data studi summar result twenti studi observ ten clinic trial meta analysi report incid rate proport gi bleeding rel event otc otc specif dose ibuprofen includ frequenc gi rel hospit num patient otc compar dose incid rate otc compar dose rang num num num patient year incid gi bleeding rel event increas age concomit medic general statist signific ibuprofen dose respons relationship relat risk gi bleeding rel event rang num num user otc specif dose ibuprofen compar non us conclus studi report low incid gi bleed event otc ibuprofen publish studi specif investig otc ibuprofen identifi vari methodolog definit exposur outcom prevent direct comparison result studi method identifi research evalu risk gi bleed event patient otc specif ibuprofen
MED-2267~effect non steroid anti inflammatori drug prostaglandin permeabl human small intestin abstract intestin permeabl estim healthi subject ingest aspirin num num ibuprofen num mg indomethacin num mg midnight hour start num hromium label ethylenediaminetetraacet absorpt test intestin permeabl increas signific control level drug effect relat drug potenc inhibit cyclooxygenas intestin permeabl increas similar extent oral rectal administr indomethacin show effect system mediat prostaglandin num decreas intestin permeabl signific fail prevent indomethacin induc increas intestin permeabl studi show non steroid anti inflammatori drug disrupt intestin barrier function man suggest morpholog correl damag resid level intercellular junction
MED-2269~anti inflammatori activ natur dietari flavonoid pubm ncbi abstract past decad inflamm recogn major risk factor human diseas acut inflamm short term self limit it easi host defens return bodi homeostasi chronic inflammatori respons predispos patholog progress chronic ill character infiltr inflammatori cell excess product cytokin dysregul cellular signal loss barrier function target reduct chronic inflamm benefici strategi combat human diseas flavonoid wide present averag diet food fruit veget demonstr exhibit broad spectrum biolog activ human health includ anti inflammatori properti numer studi propos flavonoid act varieti mechan prevent attenu inflammatori respons serv cardioprotect neuroprotect chemoprevent agent review summar current knowledg mechan anti inflammatori activ flavonoid implic effect develop chronic inflammatori diseas journal royal societi chemistri num
MED-2270~gastrointestin safeti nsaid over the count analges pubm ncbi abstract non steroid anti inflammatori drug nsaid wide recognis advers damag gastrointestin tract aggrav pre exist diseas side effect upper gastrointestin tract assess studi type clinic connot short term num day demonstr dose depend damag prescrib nsaid damag proport acid drug cyclooxygenas num cox num select inhibitor pka num outcom bleed perfor studi helicobact pylori hp play role damag long term num month endoscopi studi patient show ulcer rate num num nsaid outcom exceed rare epidemiolog studi show associ nsaid intak event ibuprofen consist lower end toxic rank ketorolac azapropazon worst risk bleed increas advanc age presenc hp previous histori bleed anticoagul mega tri show cox num select agent halv bleed episod nsaid induc gastric bleed rare num num subject year seventi percent patient develop nsaid enteropathi intestin blood protein loss rare strictur over the count otc ibuprofen diclofenac symptomat gastrointestin side effect compar placebo ibuprofen shown remark toler otc dose number studi recent studi suggest otc nsaid fast stomach food common advoc num blackwel publish
MED-2271~watermelon juic potenti function drink sore muscl relief athlet pubm ncbi abstract l citrullin excel candid reduc muscl sore watermelon fruit rich amino acid studi investig potenti watermelon juic function drink athlet vitro studi intestin absorpt l citrullin caco num cell perform unpasteur nw pasteur num num watermelon juic pw control standard l citrullin l citrullin bioavail greater matrix watermelon heat treatment appli vivo experi maximum effort test cycloergomet athlet suppli num ml natur watermelon juic num l citrullin enrich watermelon juic num l citrullin num watermelon placebo watermelon juic reduc recoveri heart rate muscl sore num
MED-2272~consumpt cherri lower plasma urat healthi women pubm ncbi abstract assess physiolog effect cherri consumpt measur plasma urat antioxid inflammatori marker num healthi women consum bing sweet cherri women age num consum serv num cherri overnight fast blood urin sampl cherri dose num num num postdos plasma urat decreas num postdos sem num num micro mol l compar predos baselin num num micro mol l num urinari urat increas postdos peak excret num num micro mol mmol creatinin num postdos compar num num baselin num plasma c reactiv protein crp nitric oxid concentr decreas margin num postdos num plasma albumin tumor necrosi factor alpha unchang vitamin content cherri sole dehydroascorb acid postdos increas plasma ascorb acid dehydroascorb acid fruit bioavail vitamin decreas plasma urat cherri consumpt support reput anti gout efficaci cherri trend decreas inflammatori indic crp add vitro evid compound cherri inhibit inflammatori pathway
MED-2273~purine rich food intak recurr gout attack abstract object examin quantifi relat purin intak risk recurr gout attack gout patient method author conduct case crossov studi examin associ set putat risk factor recurr gout attack individu gout prospect recruit onlin num year particip inform experienc gout attack onset date gout attack clinic symptom sign medic includ antigout medic presenc potenti risk factor includ daili intak purine contain food item num day period prior gout attack exposur inform assess num day control period result studi includ num particip gout compar lowest quintil total purin intak num day period recurr gout attack num num num num increas quintil trend num num num num num increas quintil purin intak anim sourc trend num num num num num plant sourc num effect purin intak persist subgroup sex alcohol diuret allopurinol nsaid colchicin conclus studi find suggest acut purin intak increas risk recurr gout attack fivefold gout patient avoid reduc amount purine rich food intak anim origin reduc risk gout attack
MED-2274~cherri consumpt risk recurr gout attack abstract object studi relat cherri intak risk recurr gout attack individu gout method conduct case crossov studi examin associ set putat risk factor recurr gout attack individu gout prospect recruit onlin year particip inform experienc gout attack onset date gout attack symptom sign medic includ anti gout medic potenti risk factor includ daili intak cherri cherri extract num day period prior gout attack assess exposur inform num day control period estim risk recurr gout attack relat cherri intak condit logist regress result studi includ num individu gout cherri intak num day period num lower risk gout attack compar intak multivari odd ratio num num ci num num cherri extract intak show similar invers associ multivari num num ci num num effect cherri intak persist subgroup sex obes status purin intak alcohol diuret anti gout medic cherri intak combin allopurinol risk gout attack num lower period exposur num num ci num num conclus find suggest cherri intak lower risk gout attack
MED-2276~sweet bing cherri lower circul concentr marker chronic inflammatori diseas healthi human pubm ncbi abstract limit number studi demonstr modul inflamm alter consumpt sweet cherri proteom approach determin effect dietari cherri target gene express purpos determin caus cherri consumpt plasma concentr multipl biomark chronic inflammatori diseas healthi human modest elev c reactiv protein crp rang num mg l num mg l normal num mg l eighteen men women num supplement diet bing sweet cherri num g d num fast blood sampl start consum cherri studi num initi cherri supplement num num discontinu num num biomark assess cherri consumpt num alter concentr num chang num num detect limit cherri consumpt decreas num plasma concentr extracellular newli identifi ligand receptor advanc glycat end product num crp num ferritin num plasminogen activ inhibitor num num endothelin num num epiderm growth factor num il num num increas il num receptor antagonist num compar valu studi num ferritin concentr continu decreas num num signific lower num num particip studi healthi clinic patholog end point measur result present studi demonstr cherri consumpt select reduc biomark inflammatori diseas
MED-2278~anti inflammatori anti oxid effect cherri freund adjuvant induc arthriti rat pubm ncbi abstract object investig anti inflammatori anti oxid effect anthocyanin cherri freund adjuvant induc arthriti aia rat method arthriti induc intraderm inject num ml complet freund adjuv cfa hind footpad male spragu dawley sd rat anthocyanin num num mg kg bodi weight administ oral treat rat num day inject tumour necrosi factor alpha tnfalpha serum prostaglandin num pge num paw assay radioimmunoassay ria anti oxid effect assay measur total anti oxid capac t aoc superoxid dismutas sod malondialdehyd mda serum result anthocyanin num mg kg signific decreas level tnfalpha serum pge num paw simultan improv anti oxid status aia found dosag t aoc potent activ sod increas level mda serum decreas anthocyanin num num mg kg effect inflammatori factor anti oxid capac aia conclus anthocyanin potenti anti inflammatori anti oxid effect aia
MED-2279~role cyclooxygenas gastric mucos protect pubm ncbi abstract cox num cox num cyclooxygenas enzym respons prostanoid product cox num express inflammatori cell fibroblast gastric mucosa product growth factor includ hepatocyt growth factor hgf vascular endotheli growth factor vegf play key role tissu repair process aspirin induc acetyl cox num produc num epi lipoxina num anti inflammatori mediat thought protect gastric mucosa aspirin induc injuri recent pge synthas identifi convert cox num metabolit pge num mpge synthas mpges num shown induc coloc cox num fibroblast macrophag infiltr gastric ulcer bed cpges mpges num found express normal gastric mucosa chang express level gastriti gastric ulcer tissu final review discuss role enzym pathophysiolog gastric mucosa biologc signific inhibit
MED-2280~cyclooxygenas inhibitori antioxid cyanidin glycosid cherri berri pubm ncbi abstract anthocyanin tart cherri prunus cerasus rosacea cv balaton montmor sweet cherri prunus avium rosacea bilberri vaccinum myrtillus ericacea blackberri rubus sp rosacea blueberri var jersey vaccinium corymbosum ericacea cranberri var earli black vaccinium macrocarpon ait ericacea elderberri sambucus canadensi caprifoliacea raspberri rubus idaeus rosacea strawberri var honeoy fragaria ananassa duch rosacea investig cyclooxygenas inhibitori antioxid activ presenc level cyanidin num glucosylrutinosid num cyanidin num rutinosid num determin fruit hplc antioxid activ anthocyanin cherri compar commerci antioxid tert butylhydroquinon butyl hydroxytoluen butyl hydroxyanisol superior vitamin test concentr num microg ml anthocyanin raspberri sweet cherri demonstr num num cyclooxygenase i cyclooxygenase ii inhibitori activ assay num microg ml cyclooxygenas inhibitori activ anthocyanin fruit compar ibuprofen naproxen num microm concentr anthocyanin num num present cherri raspberri yield pure anthocyanin num num num balaton montmor tart cherri sweet cherri raspberri num num num num num num mg fresh blackberri strawberri anthocyanin num yield num num mg num anthocyanin num num found bilberri blueberri cranberri elderberri
MED-2281~epidemiolog nonsteroid anti inflammatori drug associ gastrointestin injuri pubm ncbi abstract nonaspirin nonsteroid anti inflammatori drug nsaid frequent drug countri major nsaid increas age primarili symptom osteoarthr chronic musculoskelet condit population bas studi shown day num elder peopl num year current recent nsaid prescript num month period alberta canada num elder peopl prescrib nsaid tennesse usa num elder peopl receiv nsaid prescript annual num nsaid prescript num year nsaid wide varieti side effect clinic import side effect upper gastrointestin tract dyspepsia peptic ulcer hemorrhag perfor lead death patient gastrointestin side effect common common nsaid associ side effect epigastr pain indigest gastrointestin side effect frequent reason withdraw nsaid co treat drug population bas studi peopl age num year agent prevent peptic ulcer reliev dyspepsia common regular nsaid user num non nsaid user num alberta canada estim nsaid account num prescript anti ulc drug peopl age num year studi shown nsaid increas risk peptic ulcer complic num fold popul estim num peptic ulcer complic due nsaid unit state estim num hospit num death year elder nsaid factor increas risk peptic ulcer diseas includ older age histori peptic ulcer diseas gastrointestin hemorrhag dyspepsia and or previous nsaid intoler measur poor health
MED-2282~mortal upper gastrointestin bleed perfor effect time nsaid abstract background peopl suffer upper gastrointestin bleed perfor die mortal rate estim num studi publish num systemat survey recent data treatment reduc mortal estim mortal explain patient risk therapi nsaid method systemat review studi publish num num num studi architectur accept report case die upper gastrointestin bleed perfor analys conduct separ case prescrib nsaid aspirin result inform num case num publish num num die mortal rate case fell signific num num confid interv num num pre num studi num num num publish num num patient nsaid aspirin mortal increas num num num num num num num num conclus upper gastrointestin bleed perfor carri finit risk death differ studi architectur popul characterist risk factor definit mortal report outcom impos limit interpret effect size data publish num suggest mortal patient suffer upper gastrointestin bleed perfor fallen num num remain higher num num expos nsaid aspirin
MED-2284~cox num inhibitor stori greed decept death pubm ncbi abstract num drug manufactur introduc class nsaid call cox num inhibitor coxib drug avid promot direct consum bestsel start arthriti suffer eager medic eas joint pain risk caus gastrointestin pain bleed side effect year introduct doctor wrote num million prescript celecoxib celebrex rofecoxib vioxx celebrex sixth best sel drug sale num billion debut num vioxx sale num billion num coxib increas risk heart attack stroke price usa obscen manufactur face possibl complicit toothless bloodless fda maneuv fleec patient reflect attitud thought belong tobacco industri fortun safe activ altern exist
MED-2285~process tart cherri products  compar phytochem content vitro antioxid capac vitro anti inflammatori activ pubm ncbi abstract process fruit veget affect phytochem nutrient content tart cherri commerci promot possess antioxid anti inflammatori activ process affect phytochem content affect relat health benefit current studi compar vitro antioxid capac anti inflammatori cyclooxygenas activ process tart cherri prunus cerasus products cherri juic concentr individu quick frozen cherri cherri dri cherri cherri product analyz total anthocyanin proanthocyanidin content profil serv basi total anthocyanin highest frozen cherri total proanthocyanidin highest juic concentr total phenol highest juic concentr juic concentr highest oxygen radic absorb capac orac peroxynitrit radic avert capac norac dri cherri highest hydroxyl radic avert capac horac superoxid radic avert capac sorac process tart cherri product compar favor dept agriculture report orac fresh process fruit inhibit vitro inflammatori cox num activ greatest juic concentr summari process tart cherri product possess antioxid anti inflammatori activ process differenti affect phytochem content vitro bioactiv serv basi juic concentr superior tart cherri product num institut food technologist
MED-2287~role cyclooxygenas isoform gastric mucos defenc pubm ncbi abstract complex system interact mediat exist gastric mucosa strengthen resist injuri system prostaglandin play import role prostaglandin biosynthesi catalys enzym cyclooxygenas cox exist isoform cox num cox num initi concept develop cox num function housekeep enzym cox num yield prostaglandin involv pathophysiolog reaction inflamm gastrointestin tract mainten mucos integr attribut exclus cox num contribut cox num ulcerogen effect non steroid anti inflammatori drug nsaid believ consequ inhibit cox num recent find cox num cox num concert contribut gastric mucos defenc normal rat gastric mucosa specif inhibit cox num elicit mucos lesion near maxim suppress gastric prostaglandin format select cox num inhibitor ulcerogen ad cox num inhibitor sever gastric damag develop contrast normal gastric mucosa requir simultan inhibit cox num cox num breakdown mucos resist acid challeng rat stomach inhibit cox num result dose depend injuri increas addit inhibit cox num enzym activ prevent acid induc up regul cox num express dexamethason cox num inhibitor damag normal acid challeng gastric mucosa nitric oxid format suppress affer nerv defunction specif inhibit cox num induc sever gastric damag ischemia reperfus gastric arteri up regul cox num cox num mrna cox num inhibitor dexamethason augment ischemia reperfusion induc gastric damag four fold effect abolish concurr administr num dimethyl pg num select inhibit cox num effect cox num inhibitor antagon protect effect mild irrit intragastr pepton perfus rat stomach protect induc chronic administr endotoxin mediat cox num final import function cox num acceler ulcer heal cox num up regul chronic gastric ulcer inhibitor cox num impair heal ulcer extent non select nsaid observ show cox isoenzym essenti factor mucos defenc specif contribut physiolog pathophysiolog situat
MED-2288~current protein intak america analysi nation health nutrit examin survey num pubm ncbi abstract recent year interest benefit high protein diet studi determin current usual intak protein america recent data nation health nutrit examin survey num usual protein intak american age num year estim usual protein intak calcul gram day gram kilogram ideal bodi weight percentag calori basi protein intak averag num num g d young children increas high approxim num num g d adult age num decreas approxim num num g d elder percentag male popul consum estim averag requir low estim num adolesc femal num num older adult women report consum protein level estim averag requir median intak protein percentag calori basi rang num children age num num men age num num percentil protein intak approach highest accept macronutri distribut rang num age sex group highest num percentil protein intak num calori men age num demonstr benefit higher protein intak weight manag sarcopenia physiolog function effort undertaken ensur american consum recommend amount protein num calori expect mypyramid food pattern
MED-2290~nutrient profil vegetarian vegetarian dietari pattern abstract background differ nutrient profil vegetarian vegetarian dietari pattern reflect nutrit differ contribut develop diseas object compar nutrient intak dietari pattern character consumpt exclus meat dairi product design cross sect studi num subject age num year adventist health studi num data collect num num particip complet num item valid semi quantit food frequenc questionnair dietari pattern compar vegetarian semi vegetarian pesco vegetarian lacto ovo vegetarian strict vegetarian ancova analyz differ nutrient intak dietari pattern adjust age sex race bmi relev demograph data report compar dietari pattern chi squar test anova result nutrient intak vari signific dietari pattern vegetarian lowest intak plant protein fiber caroten mg vegetarian dietari pattern highest intak satur tran arachidon docosahexaeno fatti acid lower tail nutrient distribut strict vegetarian suggest inadequ intak portion subject energi intak similar dietari pattern close num kcal d semi vegetarian intak num kcal d bmi highest non vegetarian standard deviat sd num num lowest strict vegetarian num num conclus nutrient profil vari mark dietari pattern defin meat dairi intak differ interest etiolog obes chronic diseas
MED-2291~viscous versus nonvisc solubl fiber supplement mechan evid fiber specif health benefit pubm ncbi abstract purpos review focus health benefit viscous versus nonvisc solubl fiber symptom occur increas fiber consumpt avoid symptom improv adher high fib diet data sourc review scientif literatur evidence bas guidelin resourc conclus general fiber good specif health benefit specif fiber characterist health benefit fiber direct correl viscos solubl fiber hydrat gel form reduct viscos fiber attenu health benefit nonvisc fiber exhibit health benefit implic practic increas viscos chyme viscous solubl fiber shown clinic lower cholesterol cardiovascular health improv glycem control type num diabet normal stool form constip soften hard stool diarrhea firm loose liquid stool improv object clinic measur metabol syndrom glycem control lipoprotein profil bodi mass index weight loss blood pressur num author journal compil num american academi nurs practition
MED-2292~diverticular diseas eat fiber pubm ncbi abstract industri nation diverticular diseas affect num individu num year age symptom rang mild gastrointestin disturb incapacit pain diverticular diseas relat increas affluenc chang diet current theori hold diverticular disease origin low fib diet explain incid highest acceler prosper countri intak fiber decreas intak mill grain refin sugar increas time patient develop symptom frequent complaint diverticulosi cramp left low quadrant bloat constip soil diverticula perfor gut wall pericol tissu small larg abscess accompani bleed form fistul occur penetr bladder treatment address symptom requir hospit symptomat period patient low fib bland diet acut episod high symptomat period resolv chronic diseas manag patient gradual increas dietari fiber num num gram daili dietari fiber form bulk stimul psyllium
MED-2293~dietari fiber futur direct integr definit find inform nutrit research communic abstract codex alimentarius definit dietari fiber includ nondigest carbohydr polym degre polymer num dietari fiber proviso show health benefit global definit accept authorit bodi offer chanc intern harmon research food composit tabl food label nonaccept highlight problem develop definit vari region definit requir research communiti agre physiolog effect substanti scientif agreement fiber effect laxat gut health attenu blood lipid blood glucos insulin promot ferment larg bowel definit necessit delin research protocol prove benefit isol synthes fiber eman evidence bas review fair weigh epidemiolog data ad fiber reflect food composit databas includ well control random control trial util anim studi determin mechan agreement studi variabl type subject type baselin diet fit question investig final definit establish type fiber address sever fiber consumpt gap exist world recogn combin fiber rich fortifi food increas fiber intak consum stay energi level
MED-2294~comparison nutrit qualiti vegan vegetarian semi vegetarian pesco vegetarian omnivor diet abstract number studi compar nutrit qualiti restrict diet limit data vegan subject lack aim present studi compar qualiti contribut compon vegan vegetarian semi vegetarian pesco vegetarian omnivor diet dietari intak estim cross sect onlin survey num item food frequenc questionnair ffq healthi eat index num hei num mediterranean diet score mds calcul indic diet qualiti analysi diet questionnair ffq num particip classifi vegan num vegetarian num semi vegetarian num pesco vegetarian num omnivor num restrict diet vegan diet lowest total energi intak fat intak profil lowest protein highest dietari fiber intak contrast omnivor diet calcium intak lowest vegan nation dietari recommend vegan diet receiv highest index valu omnivor lowest hei num mds typic aspect vegan diet high fruit veget intak low sodium intak low intak satur fat contribut substanti total score independ index system score prudent diet vegetarian semi vegetarian pesco vegetarian differ function index system term nutrient qualiti omnivor
MED-2295~trend dietari fiber intak unit state num pubm ncbi abstract background intak dietari fiber recommend year part guidelin american heart associ institut medicin group recommend adequ intak dietari fiber adult num num g day num num kcal day object determin averag daili intak dietari fiber adult past decad specif document progress nation goal design cross sect weight data nation health nutrit examin survey adult age num year older participants set data collect noninstitution adult age num year older nation repres complex multistag probability bas survey peopl live unit state conduct nation center health statist main outcom measur daili dietari fiber intak member popul base num year group continu survey num num result daili dietari fiber intak num num g day num intak num g day num intak num g day num intak num g day num intak num g day particip obes bodi mass index num consist report lower fiber intak individu normal weight overweight num num g day num num g day num mexican american signific higher intak num non hispan white num num g day num mexican american intak increas time num g day num non hispan black fiber intak num g day baselin increas modest num g day num conclus daili fiber intak general progress nation goal past decad differ health social factor addit clinic practic public health strategi copyright num academi nutrit dietet publish elsevi reserv
MED-2296~vegan lifestyl behavior explor congruenc health rel belief assess health indic pubm ncbi abstract studi aim investig health belief major motiv diet lifestyl behavior num vegan unit state determin congruenc select health nutrit outcom respons data administ questionnair analyz statist analys determin common factor influenc diet choic number vegan practic lifestyl behavior bodi mass index preval self report chronic diseas diagnos nutrient intak analyz assess dietari refer intak health report reason diet choic num health belief anim welfar religious oth motiv categori low percentag chronic diseas diagnos report num num signific differ health behavior indic vegan motiv categori product fat content choic entir studi popul health rel vegan motiv coincid regular exercis num normal bmi num minim alcohol smoke practic frequent consum veget nut grain healthi choic meal type cook method low fat product consumpt adequ intak protect nutrient compar refer valu incongru found num intak adequaci vitamin observ excess sodium copyright num elsevi reserv
MED-2297~prescrib exercis prevent therapi abstract energi expenditur num kcal num kj week equival walk num hour num day week signific health benefit health benefit achiev structur nonstructur physic activ accumul day short num minut bout day week articl outlin evalu cardiovascular musculoskelet fit method evalu physic activ level current recommend exercis includ intens type time frequenc resourc patient physician interest learn evalu physic activ fit level prescript exercis
MED-2298~guid exercis prescript pubm ncbi abstract exercis fundament compon good health american colleg sport medicin exercis medicin recommend treat exercis vital sign assess prescrib physic activ medic visit meet recommend goal physic activ result signific reduct all caus mortal physician improv health prescrib exercis copyright num elsevi reserv
MED-2299~health practic mortal japan combin effect smoke drink walk bodi mass index miyagi cohort studi pubm ncbi abstract background evid limit associ combin multipl health practic mortal method num num men women miyagi prefectur rural northern japan num year age complet self administ questionnair lifestyl score calcul ad number high risk practic smoke consum num alcohol d walk num hr d bodi mass index num num cox regress estim relat risk rr mortal lifestyl score adjust age educ marit status past histori diseas dietari variabl num year follow up num subject die result observ linear increas risk death increas number high risk practic compar men high risk practic multivari rrs men num num practic num num num num trend num rrs women num num num num trend num unit increas number high risk practic correspond num num year older men women conclus prospect cohort studi middle ag men women rural japan larger number high risk practic linear increas risk all caus mortal
MED-2300~exercis longev pubm ncbi abstract age natur complex physiolog process influenc factor modifi number older individu continu increas import develop intervent easili implement contribut success age addit healthi diet psychosoci well b benefit regular exercis mortal prevent control chronic diseas affect life expect qualiti life establish summar benefit regular exercis longev present current knowledg potenti mechan outlin main recommend exercis partial revers effect age process physiolog function preserv function reserv elder numer studi shown maintain minimum quantiti qualiti exercis decreas risk death prevent develop cancer lower risk osteoporosi increas longev train program includ exercis aim improv cardiorespiratori fit muscl function flexibl balanc benefit physic activ direct link notion train volum intens research requir elder order develop precis recommend bear mind main aim foster long term adher physic activ grow popul copyright num elsevi ireland reserv
MED-2301~compar effect exercis drug intervent mortal outcom metaepidemiolog studi abstract object determin compar effect exercis versus drug intervent mortal outcom design metaepidemiolog studi elig criteria meta analys randomis control trial mortal outcom compar effect exercis drug intervent control placebo usual care data sourc medlin cochran databas systemat review num main outcom measur mortal data synthesi combin studi level death outcom exercis drug trial random effect network meta analysi result includ num exercis num drug meta analys incorpor addit recent exercis trial review collect includ num randomis control trial num num particip condit evid effect exercis mortal outcom secondari prevent coronari heart diseas rehabilit stroke treatment heart failur prevent diabet num num particip randomis physic activ intervent num trial statist detect differ evid exercis drug intervent secondari prevent coronari heart diseas prediabet physic activ intervent effect drug treatment patient stroke odd ratio exercis anticoagul num num credibl interv num num exercis antiplatelet num num num diuret effect exercis heart failur exercis diuret num num num inconsist direct indirect comparison signific conclus limit quantiti exist randomis trial evid exercis intervent suggest exercis drug intervent potenti similar term mortal benefit secondari prevent coronari heart diseas rehabilit stroke treatment heart failur prevent diabet
MED-2303~balanc life styl genom research diseas prevent pubm ncbi abstract genet environment factor includ diet life styl contribut cardiovascular diseas cancer major mortal line evid environment factor import enthusiast expect benefit genet research diseas prevent potenti distort research prioriti spend health integr genet inform epidemiolog studi clarifi causal relat life styl genet factor risk diseas balanc approach provid data make inform choic effect prevent diseas
MED-2304~combin impact health behaviour mortal men women epic norfolk prospect popul studi abstract background overwhelm evid behaviour factor influenc health combin impact general popul document aim quantifi potenti combin impact health behaviour mortal men women live general communiti method find examin prospect relationship lifestyl mortal prospect popul studi num men women age num num cardiovascular diseas cancer baselin survey num num live general communiti unit kingdom num particip score point health behaviour current non smok physic inact moder alcohol intak num num unit week plasma vitamin num mmol l indic fruit veget intak serv day total score rang averag num follow up age sex bodi mass social class adjust relat risk num confid interv all caus mortal num death men women compar health behaviour num num num num num num num num num num num num num trend relationship consist subgroup stratifi sex age bodi mass index social class exclud death num trend strongest cardiovascular mortal risk compar health behaviour equival num younger chronolog age conclus health behaviour combin predict num fold differ total mortal men women estim impact equival num chronolog age abstract editor summari background day research show aspect lifestyl physic activ diet alcohol consumpt affect health longev person street inform confus healthi diet common theme benefit eat plenti fruit veget detail differ studi physic activ improv health gentl daili walk suffici simpli step stone exercis make real differ situat alcohol consumpt equal confus small amount alcohol appar improv health larg amount harm result hard public health offici find effect encourag behavior scientif evid suggest influenc health popul studi factor hinder offici attempt provid healthi lifestyl advic public overwhelm evid individu behavior factor influenc health inform combin impact combin small differ lifestyl shown mark effect health popul easier persuad peopl make behavior improv health simpl easi achiev studi form part european prospect investig cancer nutrit epic research examin relationship lifestyl risk die health behavior score base simpli defin behavior smoke physic activ alcohol drink fruit veget intak research find num num num men women age num num live norfolk uk cancer cardiovascular diseas heart circul problem complet health lifestyl questionnair health examin blood vitamin level measur part epic norfolk studi health behavior score num num calcul particip give point healthi behavior current non smok physic inact physic inact defin sedentari job recreat exercis moder alcohol intak num num unit week unit alcohol half pint beer glass wine shot spirit blood vitamin level consist fruit veget intak serv day death particip record num factor affect likelihood die age peopl health behavior score num time die cardiovascular diseas score num peopl score num die find find combin simpli defin health behavior predict num fold differ risk die averag period num year middle ag older peopl show risk death cardiovascular diseas decreas number posit health behavior increas final calcul person health score num risk die person health score num num year older find confirm popul extend analysi combin health behavior affect qualiti life risk death strong suggest modest achiev lifestyl mark effect health popul arm inform public health offici posit encourag behavior improv health middle ag older peopl addit inform access web site onlin version summari http   dx doi org num journal pmed num
MED-2305~healthi live reveng find european prospect investig cancer nutrition potsdam studi pubm ncbi abstract background object describ reduct relat risk develop major chronic diseas cardiovascular diseas diabet cancer num healthi lifestyl factor german adult method data num german particip age num num year european prospect investig cancer nutrition potsdam studi end point includ confirm incid type num diabet mellitus myocardi infarct stroke cancer num factor smoke bodi mass index lower num calcul weight kilogram divid height meter squar perform num h wk physic activ adher healthi dietari principl high intak fruit veget whole grain bread low meat consumpt num factor healthi num point unhealthi num point sum form index rang num num result follow up num year num particip develop new onset diabet num myocardi infarct num stroke num cancer num fewer num particip healthi factor num num healthi factor approxim num num factor adjust age sex educ status occup status hazard ratio develop chronic diseas decreas progress number healthi factor increas particip num factor baselin num confid interv ci num num lower risk develop chronic diseas diabet num ci num num myocardi infarct num ci num num stroke num ci num num cancer num ci num num particip healthi factor conclus adher num simpl healthi lifestyl factor strong impact prevent chronic diseas
MED-2306~healthi lifestyl behavior all caus mortal adult unit state pubm ncbi abstract object examin link fundament healthi lifestyl behavior smoke healthi diet adequ physic activ all caus mortal nation sampl adult unit state method data num particip age num year nation health nutrit examin survey num num result follow up num year num death occur compar counterpart risk all caus mortal reduc num confid interv ci num num adult nonsmok num ci num adult physic activ num ci num adult consum healthi diet compar particip healthi behavior risk decreas progress number healthi behavior increas adjust hazard ratio num confid interv num num num num num num num num num num num healthi behavior conclus adult smoke consum healthi diet engag suffici physic activ substanti reduc risk earli death publish elsevi
MED-2308~spend veget fruit consumpt reduc all caus mortal older adult abstract background studi evalu linkag food cost mortal older adult studi consid hypothesi greater food expenditur general nutriti plant animal deriv food decreas mortal older adult method studi num num elder nutrit health survey taiwan cohort num collect num hr dietari recal data num particip num men num women age num older month nation food price num hr recal studi present estim daili expenditur veget fruit animal deriv grain food categori particip link nation death registri result num origin particip num die num follow up period num food categori fourth expenditur quintil veget fruit highest surviv rate adjust co vari higher num veget higher fruit num food expenditur refer num signific predict reduc mortal hr num num ci num num hr num num ci num num risk decreas num num nt num num increas daili expenditur animal deriv grain food spend predict mortal conclus greater achiev veget fruit afford improv food secur longev older adult
MED-2309~bridg gap life expect aborigin taiwan pubm ncbi abstract background similar general popul taiwan health aborigin steadili improv num year gap remain wide male infus substanti medic resourc object studi quantifi contribut major death gap life expect propos initi bridg health gap aborigin general popul method studi includ resid slight num num aborigin township taiwan gap life expect aborigin general popul analys decompos gap major death analysi quantifi contribut death gap life expect popul result mortal aborigin township approxim num higher respect male femal general popul past num year mortal infecti diseas cirrhosi liver accid suicid substanti higher general popul gap life expect birth male num year num increas num year num gap femal remain stabl num year num year num year differ life expect male differenti mortal diseas digest system due cirrhosi liver accid motor vehicl non motor vehicl accid infecti parasit diseas contribut half num gap life expect femal primarili prevent death account num life expect gap conclus base find studi suggest futur focus area primari prevent order reduc incid infecti parasit diseas liver cirrhosi accid
MED-2310~fruit veget intak physic activ mortal older community dwel women abstract object examin relationship fruit veget intak physic activ all caus mortal older women design cox proport hazard model examin independ addit relationship physic activ carotenoid all caus mortal addit model test physic activ carotenoid conjoint relat mortal model adjust age educ race ethnic set baltimor maryland particip hundr thirteen women age num num particip women health age studi measur total serum carotenoid marker fruit veget intak physic activ measur baselin physic activ measur kilocalori expenditur result num year follow up num num particip die measur continu physic activ improv surviv hr num num ci num num num activ women surviv physic activ women hr num num ci num num num continu measur carotenoid improv surviv hr num num ci num num num women highest tertil total carotenoid surviv lowest hr num num ci num num num examin model continu measur physic activ hr num num ci num num num carotenoid hr num num ci num num num predict surviv follow up conclus combin low total serum carotenoid low physic activ modifi risk factor strong predict earlier mortal find provid preliminari support higher fruit veget intak exercis improv surviv
MED-2311~fruit veget consumpt all caus mortal dose respons analysi pubm ncbi abstract background associ fruit veget fv consumpt mortal seldom investig larg cohort studi find studi inconsist object object examin dose respons relat fv consumpt mortal term time rate larg prospect cohort swedish men women design fv consumpt assess self administr questionnair population bas cohort num particip num men num women age num perform dose respons analysi evalu num surviv percentil differ pds laplac regress estim hrs cox regress result num follow up num death num men num women occur cohort comparison num serv fv d lower consumpt progress shorter surviv higher mortal rate consum fv live num shorter pd num mo num ci num mo num higher mortal rate hr num num ci num num consum num serv fv d fruit veget separ show consum fruit live num mo shorter pd num mo num ci num mo ate num fruit d particip consum num vegetables d live num mo longer consum veget pd num mo num ci num mo conclus fv consumpt num servings d progress shorter surviv higher mortal rate swedish mammographi cohort cohort swedish men regist clinicaltri gov nct num nct num
MED-2313~random control trial anti inflammatori effect curcumin patient chronic sulphur mustard induc cutan complic pubm ncbi abstract background chronic cutan complic pruritus frequent complaint sulphur mustard sm expos patient present trial investig impact curcumin serum inflammatori biomark associ pruritus sever qualiti life qol method random double blind trial num male iranian veteran age num suffer chronic sm induc prurit skin lesion patient random assign curcumin num g d num placebo num week serum concentr interleukin num il num num il num high sensit c reactiv protein hs crp calcitonin gene rel peptid cgrp measur baselin end trial assess pruritus sever perform pruritus score qol dermatolog life qualiti index dlqi result serum il num hs crp signific reduc group magnitud reduct greater curcumin group num serum cgrp decreas curcumin group num signific chang observ serum il num signific correl cgrp il num num dlqi il num num curcumin group curcumin group serum il num concentr found signific predictor dlqi score num independ variabl predict pruritus score conclus curcumin supplement effect mitig inflamm patient suffer chronic sm induc cutan complic anti inflammatori effect account observ pruritus allevi qol improv phytochem
MED-2315~promiscu drug compar select drug promiscu virtu abstract background word select describ drug abil affect cell popul prefer part current state art search therapeut agent properti select mode action thought high degre desir grow activ area research select general worthi properti drug drug high select dramat effect singl agent target molecular driv involv pathogenesi diseas chronic myeloid leukemia cml cml specif chromosom abnorm philadelphia chromosom result singl gene produc abnorm protein discuss burgeon understand cellular mechan control etiolog pathogenes diseas understand enabl motiv develop drug induc specif action select cell popul target treatment drug target distinct molecular target involv pathologic pathogenet process signal transduct pathway develop case diseas involv multipl abnorm diseas dysfunct protein out of bal likewis drug strong target protein share similar activ domain protein drug target pleiotrop cytokin protein multi physiolog function multipl normal cellular pathway simultan influenc long term experi drug suppos design singl target unavoid involv function effect uncov fact molecular target medic flawless summari contend ideal drug efficaci base inhibit singl target rebalanc protein event contribut etiolog pathogenes progress diseas effect promiscu drug ideal minimum drug concentr side effect minim corollari argument grow fervor research select drug imprud total respons expens screen techniqu discov medic financi ineffici
MED-2322~exot spice modern drug pubm ncbi abstract global demand afford therapeut concern side effect common drug refocus interest eastern tradit medicin india china
MED-2323~plant phenol drug lead miss pubm ncbi abstract low molecular weight phenol plant origin undoubt semiochem easili classifi typic allelochem straightforward benefit releas select survey class secondari metabolit share high chemic reactiv intrins biocompat affin varieti molecular target gain evolut suitabl prospect lead compound medicin chemistri high unexplor plant phenol perceiv natur product librari privileg scaffold evidenc exampl endogen phenol phytochem aryl hydroxyl group phenol synthet drug postul applic bio chemo informat tool librari pull drug candid valid admet compat suitabl short survey structur divers repres plant phenol focus compound obvious dietari signific rich record pharmacolog studi grow phytochem dietari supplement slow progress clinic trial drug registr observ categori natur product wast resourc transform renew materi high tech high product aim improv human healthcar deplor reform sustain attempt answer question popular plant phenol establish health benefit recogn molecular pharmacolog catechin curcumin resveratrol quercetin glycosid genistein silymarin difficulti attain regist drug ind level
MED-2324~role hormesi life extens dietari restrict pubm ncbi abstract level food restrict result life extens retard age rodent enhanc abil cope intens stressor level dietari restrict dr lead modest increas daili peak concentr plasma free corticosteron strong point dr low intens stressor find suggest hormesi play role life extend anti ag action dr evid possibl consid conclud hormesi import role
MED-2325~longev allostat load dietari restrict pubm ncbi abstract restrict food intak num ad libitum unit weight energi content basi extend lifespan wide varieti speci prevent delay age rel diseas review briefli summar data delin mortal trajectori speci popul maintain restrict diet provid insight effect nutrient depriv distinct compon age process discuss number import studi address question lack calori and or specif nutrient determin longev respons dietari restrict final review evid hormesi proxim mechan underpin impact dietari restrict lifespan aggreg demograph data suggest dietari restrict slow age rel progress accumul cellular damag enhanc abil organ cope irrevers injuri restrict essenti nutrient calori affect life expect speci specif fashion hormesi evolutionari conserv stress respons routin provid protect wide varieti hazard respons low level stress contribut benefici health effect dietari restrict copyright num elsevi reserv
MED-2326~methionin methyl group donor synthesi mycobacterium avium envelop lipid inhibit dl ethionin d norleucin dl n pubm ncbi abstract radioact num methyl methionin rapid incorpor surfac lipid mycobacterium avium transmethyl reaction effici inhibit dl ethionin d norleucin dl norleucin structur outerlay avium envelop profound alter bacteria treat dl norleucin
MED-2327~xenohormesi mechan chemoprevent effect dietari phytochem pubm ncbi abstract wide varieti phytochem present diet includ fruit veget spice shown possess broad rang health benefici properti cytoprotect restor effect dietari phytochem result modul distinct cellular signal transduct pathway dietari phytochem synthes secondari metabolit function toxin phytoalexin protect plant insect damag organ stress low dose consum human mammal toxic plant deriv chemic mild stressor activ adapt cellular respons signal confer stress resist health benefit phenomenon refer xenohormesi review highlight xenohormesi mechan chemoprevent effect dietari chemoprevent phytochem special focus nuclear transcript factor erythroid num nf e num relat factor num nrf num key player num york academi scienc
MED-2328~treat age progress dietari restrict mimet abstract decad biogerontologist labor understand biolog basi age process studi gene signal pathway regul year breakthrough direct treatment slow age mimick effect dietari restrict
MED-2330~hormesi defin abstract hormesi term toxicologist refer biphas dose respons environment agent character low dose stimul benefici effect high dose inhibitori toxic effect field biolog medicin hormesi defin adapt respons cell organ moder intermitt stress exampl includ ischem precondit exercis dietari energi restrict exposur low dose phytochem recent find elucid cellular signal pathway molecular mechan mediat hormet respons typic involv enzym kinas deacetylas transcript factor nrf num nf result cell increas product cytoprotect restor protein includ growth factor phase num antioxid enzym protein chaperon understand hormesi mechan cellular molecular level lead approach prevent treatment diseas
MED-2331~xenohormesi sens chemic cue speci abstract plant molecul interact modul key regul mammalian physiolog benefici health propos heterotroph anim fungi sens chemic cue synthes plant autotroph respons stress cue provid advanc warn deterior environment condit heterotroph prepar advers condit favor
MED-2332~complex heat stress respons plant pubm ncbi abstract plant evolv varieti respons elev temperatur minim damag ensur protect cellular homeostasi inform structur function heat stress protein molecular chaperon time transcriptom analysi arabidopsi reveal involv factor classic heat stress respons gene thermotoler recent report suggest plant hormon reactiv oxygen speci contribut heat stress signal addit increas number mutant alter thermotoler extend understand complex heat stress respons plant
MED-2333~share signal potenti phylogenet espionag plant anim pubm ncbi abstract recent studi understand plant anim signal respons mechan develop independ recent biochem molecular work produc grow list element involv respons biotic abiot stimuli similar kingdom interest exampl includ prostaglandin octadecanoid medi respons wound steroid bas signal system pathogen recognit mechan similar repres evolutionari converg ancestr plant anim ecolog evolutionari implic overlap includ exist pathogen diseas plant anim abil herbivor manipul plant respons usurp microbi mechan gene herbivor anim plant evolut plant defens exploit share signal anim medicin plant human compar studi signal respons mechan plant anim microb insight ecolog evolut interact kingdom
MED-2335~xenohormesi health benefit eon plant stress respons evolut abstract xenohormesi biolog principl explain environment stress plant produc bioactiv compound confer stress resist surviv benefit anim consum anim piggyback product plant sophist stress respons evolv result stationari lifestyl factor elicit plant stress respons judici employ maxim yield health promot plant compound xenohormet plant compound ingest improv longev fit activ animal cellular stress respons appli drug discoveri drug product nutrit enhanc diet
MED-2336~non specif protein modif phytochem induc heat shock respons self defens abstract accumul evid show phytochem provid benefici effect human health recent number mechanist studi reveal direct interact phytochem function protein play signific role exhibit bioactiv bind select biolog molecul consid lower due small simpl structur studi found zerumbon bioactiv sesquiterpen bind numer protein select similar heat denatur protein zerumbone modifi protein recogn heat shock protein num constitut molecular chaperon lead heat shock factor num depend heat shock protein induct hepa num num mous hepatoma cell oral administr phytochem up regul heat shock protein express liver sprague dawley rat interest pretreat zerumbon confer thermoresist phenotyp hepa num num cell nematod caenorhabd elegan import note phytochem higher hydrophob electrophil includ phenethyl isothiocyan curcumin mark induc heat shock protein test nutrient result suggest non specif protein modif xenobiot phytochem mild proteostress induc heat shock respons lead potenti protein qualiti control system consid bioactiv xenohormesi adapt mechan xenobiot chemic stress heat shock respons phytochem fundament mechan bioactiv
MED-2337~manag childhood urticaria current knowledg practic recommend pubm ncbi abstract urticaria defin presenc wheal and or angio edema common condit children prompt parent consult physician success manag paediatric specif featur account identif elicit trigger pharmacolog therapi review systemat discuss current best avail evid spontan acut chronic urticaria physic urticaria type children potenti infect food drug hypersensit autoreact autoimmun condit elicit stimuli consid practic recommend specif diagnost approach second gener antihistamin mainstay pharmacolog treatment aim relief symptom requir dose adjust pae diatr therapeut intervent discuss addit unmet highlight aim promot research paediatr popul ultim aim effect manag childhood urticaria
MED-2338~anisaki simplex hypersensit chronic urticaria endem area pubm ncbi abstract background chronic urticaria cu affect num general popul anisaki simplex hypersensit frequent area raw fish consum simplex allergi repres relev acut urticaria assess associ cu simplex sensit area marin fish frequent eaten method histori cu sought num adult allergi center bari cu patient num control underw skin prick test commerci extract simplex reactor recommend num month raw fish fre diet regimen respond num month result num subject num met criteria cu num num sensit simplex signific differ patient age num num year num num num patient hypersensit simplex regular consum marin fish control popul cu preval simplex sensit num num num month diet regimen led disappear urticaria num case num versus num num subject chang dietari habit num nonrespond sensit house dust mite num respond followed up num month cu relaps num reintroduc raw fish versus num diet num conclus area raw marin fish frequent eaten simplex hypersensit frequent cu copyright num karger ag basel
MED-2339~anisaki simplex allergi eat chicken meat pubm ncbi abstract background allerg reaction food produc contamin induc sensit anisaki simplex seafood infest allerg symptom urticaria angioedema anaphylaxi asthma follow eat handl affect fish seafood princip sourc human infect parasit found allerg symptom num patient previous diagnos simplex sensit ate chicken meat chicken feed high proport fishmeal possibl contamin nematod object aim studi determin parasit protein present chicken meat respons symptom report subject method carri vivo test prick bronchial challeng double blind placebo control challeng meat chicken num patient perform immunoblot sera num patient control order detect simplex sensit investig presenc simplex protein sera chicken fed fishmeal sera chicken fed cereal exclud sensit chicken nematod serolog method result num patient present posit prick challeng simplex serum chicken fed fishmeal antigen blot patient num num num num recogn band num kd obtain pool fish shellfish simplex larva detect observ sera chicken fed cereal conclus provid evid base vivo vitro test subject high sensit simplex detect presenc anisaki speci allergen chicken meat
MED-2340~allerg cross react cat pig serum albumin studi protein dna level pubm ncbi abstract observ patient allerg cat dander pork devoid allergi prospect screen patient allerg cat sensit pork collect sera num young patient found specif ige cat dander pork undertook studi detect cross react allergen defin molecular characterist evalu clinic relev immunoblot techniqu cat porcin serum albumin found joint recogn molecul find analyz specif anti albumin ige titrat cross inhibit experi cat serum albumin cdna obtain cat liver amino acid sequenc deduc compar porcin human serum albumin sequenc inhibit experi show spectrum ige reactiv cat serum albumin complet ige reactiv porcin serum albumin suggest sensit cat primari event cohort cat allerg person frequenc sensit cat serum albumin found lie num num sensit porcin albumin found lie num num num person experi allerg symptom relat pork consumpt sensit cat serum albumin consid marker cross sensit porcin serum albumin mammalian serum albumin
MED-2341~beef pork milk allergi cross reactiv pet allergi pubm ncbi abstract object purpos studi examin milk allerg patient determin concomit reactiv milk beef pork cat dog dander common inhal allergen method num patient select immuno cap result increas ig level milk pork beef patient test johnson grass short ragwe cat dog dander farina result pearson test reveal strong correl beef pork beef milk pork milk ig count consecut num num num num num num num cat allerg patient allerg beef pork meat milk correl pork dog dander ig count signific num num num correl detect milk meat pet grass weed dust allergi discuss conclus patient pet allergi screen meat milk allergi milk allerg patient avoid cow pork meat
MED-2344~fish shellfish allergi children review persist food allergi pubm ncbi abstract increas consumpt fish shellfish result frequent report advers reaction seafood emphas specif diagnosi treatment condit explor reason persist allergi review discuss interest find area fish shellfish allergi allergen import potenti cross react allergen identifi fish famili shellfish arachnid insect diagnost approach requir prick to prick test crude extract raw cook form seafood screen seafood sensit food challeng food challeng feasibl allergen specif immunotherapi import mutat allergen seafood protein develop purpos persist allergi seafood protein resist rigor treatment cook extrem ph document addit ige antibodi individu persist allergi direct epitop patient transient allergi topic import area technolog develop signific impact provid accur method diagnos inform patient seafood allergi childhood num john wiley son a publish blackwel publish
MED-2345~anisakiasi underestim infect effect intestin permeabl anisaki simplex sensit patient pubm ncbi abstract anisaki simplex parasit present uncook contamin saltwat fish invad human gut clinic situat recogn gastrointestin diseas vari asymptomat episod vomit diarrhea classifi advers reaction food character wide spectrum allerg reaction rhiniti conjunct anaphylaxi caus hypotens and or shock intestin epithelium major defens system extern molecul repres open gate toxin allergen protect function compromis previous data demonstr strict relationship alter intestin permeabl worsen clinic manifest patient advers reaction food articl evalu sensit simplex patient refer clinic symptom allergi subject underw common alimentari skin prick test food allergen ani num simplex allergen ad addit simplex sensit subject determin enrol studi time num num month consum raw fish fre diet time num hundr forti subject screen num posit skin prick test num num posit ani num increas evidenc simplex sensit subject wors clinic symptom reced num month elimin raw seafood data demonstr alimentari habit eat raw fish repres high risk integr intestin mucosa suggest patholog situat constitut ideal under estim open gate molecul predispos import patholog
MED-2346~anisaki simplex obscur infecti worm induc immun hypersensit abstract summari infect human nematod worm parasit anisaki simplex num associ consumpt raw undercook fish num realiz ingest dead worm food fish sever hypersensit reaction preval infect outcom food prepar previous consid safe allerg symptom aris infect parasit gastroallerg anisakiasi true anaphylact reaction occur exposur allergen dead worm food born airborn skin contact rout review discuss simplex pathogenesi human cover immun hypersensit reaction context live infect term exposur allergen rout num year studi concentr simplex antigen character innat adapt immun respons parasit molecular character anisaki allergen isol encod cdnas activ field research provid improv diagnost tool addit tool enhanc understand pathogenesi controversi aspect simplex allergi discuss potenti relev parasit product allergen proteinas proteinas inhibitor activ basophil eosinophil mast cell induct simplex rel immun hypersensit state induc exposur parasit dead aliv
MED-2347~evidence bas evalu manag chronic urticaria children pubm ncbi abstract urticaria affect num popul time live subset children urticaria develop chronic condit great affect qualiti life numer trigger propos chronic urticaria cu children rang infect allergen medic physic factor autoimmun diseas exact etiolog identifi larg subset case design chronic idiopath urticaria clinic complex cu confus literatur topic develop conceptu framework base cumul evid assist categor clinic evalu treatment cu children num wiley period
MED-2348~galactos num galactos delay anaphylaxi angioedema urticaria children abstract background object histori comprehens test children present recurr symptom consist allerg reaction elud diagnosi recent research identifi idiopath allerg reaction immunoglobulin ige antibodi specif carbohydr galactos num galactos gal delay urticaria anaphylaxi occur num num hour eat beef pork lamb sought determin ige antibodi gal present sera pediatr patient report idiopath anaphylaxi urticaria method patient age num num enrol institut review board approv protocol univers virginia privat practic allergi offic lynchburg va sera obtain analyz immunocap total ige specif ige gal beef pork cat epithelium dander fel num dog dander milk result forty f pediatr patient identifi clinic histori support delay anaphylaxi urticaria mammalian meat ige antibodi specif gal addit case histori tick bite past year itch persist conclus form anaphylaxi urticaria occur num num hour eat mammalian meat uncommon children area identif case straightforward diagnosi confirm specif test consid children live area lone star tick common
MED-2349~updat childhood urticaria angioedema pubm ncbi abstract purpos review present review serv address urticaria acut chronic differenti diagnosi urticari syndrom pediatr popul updat reader progress pathophysiolog diagnosi treatment urticaria recent find acut chronic urticaria repres syndrom caus varieti trigger recent literatur continu describ subtyp urticaria differenti respons therapi recent associ highlight fulli evalu patient allerg infecti trigger urticaria import distinguish idiopath urticaria relat condit anaphylaxi system condit autoimmun urticaria antihistamin remain cornerston therapi urticaria subtyp respond therapi omalizumab chronic urticaria signific impact patient qualiti life summari urticaria common condit understand distinct urticaria subtyp differenti respons target therapi continu increas due myriad trigger urticaria care individu patient assess exclud potenti etiolog prior diagnosi idiopath urticaria
MED-2350~analysi food allerg anaphylact event nation electron injuri surveil system pubm ncbi abstract background nation electron injuri surveil system neiss captur nation repres probabl sampl hospit emerg depart ed unit state object emerg depart data neiss analyz assess magnitud sever advers event attribut food allergi method emerg depart event describ food rel allerg symptomatolog identifi num particip ed august num septemb num result extrapol neiss event data predict total num hospit ed visit num visit anaphylaxi num hospit caus food allergi unit state num month studi period median age num year num visit involv children num year shellfish frequent implic food person num year children num year experienc event egg fruit peanut tree nut report death review medic record found num patient receiv epinephrin criteria establish num anaphylaxi symposium num anaphylact event ed diagnosi anaphylaxi conclus analysi neiss data tool assess magnitud sever food allerg event criteria bas review medic record suggest underdiagnosi anaphylact event ed
MED-2351~specif stimul grave diseas thyrocyt natur anti g antibodi normal autolog serum pubm ncbi abstract anti g natur ab abund produc human interact specif carbohydr epitop gal alpha num gal beta num glcnac r term alpha galactosyl epitop epitop express larg amount thyrocyt nonprim mammal human previous found bind anti g alpha galactosyl epitop porcin thyrocyt result stimulatori effect similar exert thyroid stimul hormon thyrotropin present studi test hypothesi anti g contribut grave diseas gd pathogenesi stimul thyrocyt patient autoimmun disord anti g bind stimulatori effect assess primari thyrocyt cultur anti g specif bound gd thyrocyt induc increas camp synthesi num uptak dna synthesi cell stimulatori effect autolog sera gd thyrocyt great reduc specif deplet anti g sera bind stimulatori effect anti g observ normal human thyrocyt thyrocyt thyrotox patient lack thyroid stimul ig thyrotropin bind inhibit ig vitro stimulatori effect anti g gd thyrocyt suggest natur ab contribut vivo continu stimul thyrocyt gd patient possibl anti g stimul gd thyrocyt interact aberr express alpha galactosyl epitop thyroid stimul hormon receptor discuss
MED-2352~anaphylaxi pork kidney relat ige antibodi specif galactose alpha num galactos pubm ncbi abstract background carbohydrate specif ige antibodi present nonprim mammalian protein incrimin recent delay meat anaphylaxi aim studi explor anaphylaxi mammalian kidney galactos num galactos gal specif ige method fourteen patient anaphylaxi pork beef kidney underw prick test meat kidney patient underw skin test erbitux cetuximab ige antibodi gal swine urin protein beef pork meat serum albumin protein cat rfel num measur immunocap gal level estim meat kidney elisa inhibit assay cross react gal pork kidney studi immunocap inhibit assay result num patient num present anaphylact shock reaction occur num exposur num patient risk factor observ num case alcohol main cofactor patient underw oral challeng pork kidney anaphylaxi occur ingest small quantiti num prick test kidney posit num patient test patient show posit skin test erbitux patient test posit ige gal level rang num num ku l ige bind gal inhibit raw pork kidney extract num rang num show high amount gal determin conclus pork beef kidney anaphylaxi relat gal ige peculiar sever due elev content gal epitop kidney num john wiley son a
MED-2353~anti g abund human natur antibodi multipl pathogenes clinic benefit summari anti g abund natur antibodi human constitut num immunoglobulin anti g natur produc ape world monkey ligand anti g carbohydr antigen call gal epitop structur gal num gal num glcnac r gal epitop present major carbohydr antigen non prim mammal prosimian world monkey anti g contribut immunolog pathogenes anti g ige produc individu allergi meat therapeut monoclon antibodi cetuximab present gal epitop aberr express gal epitop antigen mimick human result autoimmun process grave diseas gal epitop produc trypanosoma cruzi interact anti g induc autoimmun inflammatori reaction chaga diseas anti g igm igg mediat reject xenograft express gal epitop abund anti g exploit clinic increas immunogen microbi vaccin influenza vaccin present gal epitop target effect uptak antigen pres cell tumour lesion convert vaccin autolog tumour associ antigen intra tumor inject gal glycolipid insert tumour cell membran anti g bind gal epitop tumour cell target uptak antigen pres cell acceler wound heal achiev applic gal nanoparticl bind anti g activ complement recruit activ macrophag induc tissu regener therapi signific regener intern injur tissu ischaem myocardium injur nerv
MED-2354~uniqu natur human igg antibodi anti alpha galactosyl specif abstract natur anti alpha galactosyl igg antibodi anti g found present high titer serum normal individu studi antibodi isol affin chromatographi melibiose sepharos column reactiv antibodi assess interact alpha galactosyl residu rabbit erythrocyt rabrbc specif determin inhibit experi carbohydr anti g interact alpha galactosyl residu possibl glycolipid human rbc hurbc remov membran protein treatment pronas addit anti g bind specif normal patholog senesc hurbc suggest physiolog role natur antibodi age rbc ubiquit presenc anti g high titer life impli constant antigen stimul addit theoret interest antibodi studi anti g reactiv bear immunodiagnost signific decreas antibodi titer found reflect humor immunodefici disord
MED-2355~delay anaphylaxi red meat patient ige specif galactos alpha num galactos alpha g abstract anaphylaxi sever allerg reaction rapid progress fatal instanc trigger allergen establish etiolog anaphylaxi pivot long term risk manag recent work identifi ige antibodi ab respons mammalian oligosaccharid epitop galactose alpha num galactos alpha g distinct form anaphylaxi num onset anaphylaxi exposur intraven cetuximab num delay onset anaphylaxi num num ingest mammalian food product beef pork result studi strong suggest tick bite signific ige ab respons alpha g southern eastern central unit state patient ige ab alpha g continu emerg increas case involv children ige ab respons cross react cat dog pose risk asthma impair diagnost test situat
MED-2356~relev tick bite product ige antibodi mammalian oligosaccharid galactos num galactos abstract background num report form delay anaphylaxi red meat relat serum ige antibodi oligosaccharid galactose alpha num galactos alpha g patient toler meat year previous implic exposur adult life stimul product ige antibodi object investig ige antibodi respons focus evid relat tick bite common region reaction occur method serum assay carri biotinyl protein extract bound streptavidin immunocap result prospect studi ige antibodi subject tick bite show increas ige alpha g twenty fold greater evid includ strong correl histori tick bite ige alpha g num num num ii evid ige antibodi common area tick amblyomma americanum common iii signific correl ige antibodi alpha g ige antibodi protein deriv americanum rs num num conclus result present provid evid tick bite possibl ige specif alpha g area unit state number subject sensit titer ige antibodi alpha g strike report respons ectoparasit give rise import form food allergi
MED-2357~evid human specif mechan diet antibody medi inflamm carcinoma progress abstract patient cancer circul heterophil antibodi agglutin anim red cell recognit mammalian cell surfac sialic acid n glycolylneuramin acid neu num long consid oncofet antigen human human genet defici neu num product metabol accumul neu num dietari sourc red meat milk product mice human lik defect show altern pathway neu num synthesi normal human express anti neu num antibodi show human tumor accumul neu num coval attach multipl class glycan paradox human tumor neu num accumul face circul anti neu num antibodi hypothes due facilit tumor progress result low grad chronic inflamm murin tumor express human lik level neu num show acceler growth syngen mice human lik neu num defici coincid induct anti neu num antibodi increas infiltr inflammatori cell transfer polyclon monospecif syngen mous anti neu num serum enhanc growth transplant syngen tumor bear human lik level neu num tumor show evid antibodi deposit enhanc angiogenesi chronic inflamm effect suppress cyclooxygenas num inhibitor drug type reduc human carcinoma risk final affinity purifi human anti neu num antibodi acceler growth neu num c contain tumor neu num c defici mice data suggest human propens develop diet rel carcinoma contribut local chronic inflamm result interact metabolically accumul dietari neu num circul anti neu num antibodi
MED-2359~anti g titer healthi adult inflammatori bowel diseas patient pubm ncbi abstract introduct alpha g glycoconjug present cell membran mammal bacteria human display anti g antibodi ab high titer provok commens gut flora present studi sought determin longitudin alpha g specif ab titer isotyp num week healthi adult subject hypothes inflammatori bowel diseas ibd patient display increas anti g titer materi method drew serum healthi proband num week num week obtain plasma sampl patient suffer crohn diseas num ulcer coliti num measur anti g ab isotyp total immunoglobulin ig content enzyme link immunosorb assay techniqu statist evalu longitudin titer calcul confid interv slope random intercept model compar varianc proband group comparison perform pair student t test pearson correl result alpha g specif igg igm igd iga titer remain unvari narrow rang longitudin observ proband display alpha g specif ige ab crohn diseas patient show high increas alpha gal specif iga titer compar control subject num conclus ige alpha gal specif ab isotyp remain constant longer time period healthi subject signific titer repres increas antigen exposur specif anti alpha g respons crohn diseas patient display increas anti g iga titer compar healthi control reflect chronic impair mucos gut barrier patient cohort copyright num elsevi reserv
MED-2360~stari master diseas lone star tick vector lyme lik ill pubm ncbi abstract lyme lik ill southern tick associ rash ill stari master diseas vector lone star tick amblyomma americanum lyme lik ill lesion similar erythema migran rash lyme diseas tend lymphocyt dermal infiltr borrelia lonestari causat agent agent lyme lik ill cultur research fulli understand newli recogn zoonosi clinician encourag increas knowledg awar lyme diseas mimic
MED-2361~southern tick associ rash ill stari north stari tick bite long island york pubm ncbi abstract common clinic manifest lyme diseas characterist rash erythema migran em num em lik erupt report missouri southeastern state em lik erupt unknown etiolog bite lone star tick amblyomma americanum rash call stari southern tick associ rash ill lone star tick found lyme disease endem area england mid atlant region unit state stari report northeast mid atlant region report child connecticut visit long island york develop rash thought em patient fail respond antibiot treat lyme diseas investig ensu diagnosi stari establish
MED-2362~distribut gal alpha num num al beta num num lcnac residu secret mammalian glycoprotein thyroglobulin fibrinogen immunoglobulin pubm ncbi abstract studi express gal alpha num num al beta num num lcnac residu mammalian glycoconjug interest num circul igg antibodi man natur anti g antibodi interact specif carbohydr residu recent studi found gal alpha num num al beta num num lcnac residu abund red cell nucleat cell nonprim mammal prosimian world monkey express diminish world monkey ape human present work analyz express residu secret mammalian glycoprotein purpos develop radioimmunoassay ria enabl quantif gal alpha num num al beta num num lcnac residu secret glycoprotein purifi biotinyl anti g antibodi ria bovin thyroglobulin enrich gal alpha num num al beta num num lcnac residu serv solid phas antigen studi report time evolutionari pattern gal alpha num num al beta num num lcnac residu distribut vivo secret glycoprotein similar observ membran cell line red cell thyroglobulin fibrinogen igg molecul nonprim mammal world monkey express vari amount gal alpha num num al beta num num lcnac residu rang num num residu molecul residu present glycoprotein human world monkey origin abstract truncat num word
MED-2363~pattern anti carbohydr antibodi respons present patient advanc atherosclerosi pubm ncbi abstract previous shown antibodi pool present normal human serum bind cytokin receptor vitro interfer assay captur cytokin receptor show antibodi pool natur antibodi term anti g bind alpha galactosyl carbohydr epitop alpha g predomin obstacl xenotransplant report high level igd anti alpha g volunt addit igg num iga igm immunoglobulin isotyp alpha g previous determin anti g interfer assay depend captur cytokin receptor measur level anti carbohydr antibodi cohort patient advanc atherosclerosi previous measur level activ tgf beta assay isotyp carbohydr combin larg signific differ level anti carbohydr antibodi patient atherosclerosi control adjust age sex blood group result similar previous data obtain activ tgf beta discount possibl anti g contribut previous data adjust risk factor cardiovascular diseas anti carbohydr antibodi signific patient control anti carbohydr antibodi repres class risk factor presenc advanc atherosclerosi larger studi requir confirm hypothesi
MED-2364~natur human anti g alpha num gal antibodi react human mucin peptid pubm ncbi abstract recent demonstr antibodi gal alpha num gal gal alpha num gal bind lectin ib num bind synthet peptid dahweswl similar recognit carbohydr peptid structur report anti g alpha num gal antibodi ib num lectin react peptid encod mucin gene muc num num sequenc rich serin threonin prolin activ demonstr num abil mucin deriv peptid block reaction anti g alpha num gal antibodi ib num lectin gal alpha num gal pig endotheli cell line reaction specif occur random peptid sequenc mucin peptid num fact anti mucin num antibodi react gal alpha num gal express transfect cos cell gal alpha num gal muc num cdna encod pig alpha num alactosyltransferas num ib num lectin anti g alpha num gal antibodi react mucin num found surfac human breast cancer cell natur occur anti g alpha num gal antibodi found human serum react muc num peptid express larg amount surfac tumour cell normal cell find interest serv explain previous report find human cell time express gal alpha num gal express artefact reaction due phenomenon anti g alpha num gal antibodi react mucin peptid
MED-2365~associ tick bite reaction red meat allergi human pubm ncbi abstract twenty f patient live tick endem region sydney south wale develop red meat allergi experienc larg local reaction tick bite repres potenti cross react arthropod food protein mja num num
MED-2366~role alpha num num galactosyl epitop natur anti g antibodi oncogenesi pubm ncbi abstract glycoconjug antibodi vital compon host tumor interact review concentr oncolog implic research alpha gal triad alpha num num galactosyl epitop alpha gal enzym respons construct alpha num galactosyl transferas alpha num gt antibodi anti g alpha gal epitop previous assum absent human tissu demonstr human cancer cell line senesc red blood cell grave diseas thyrocyt alpha g presenc neoplast line correl increas metastat format anim model mechan human respons neoantigen complex natur anti g antibodi exist high titer normal sera predict immunolog recognit cell express alpha gal epitop hypothes vari pathogen contribut metastasis associ phenomena de novo express alpha gal unmask desialyl alpha gal sporad express human tissu remain unknown galactosyl transferas produc epitop constitut express anim undergon signific mutat genom level human patholog re express presum requir permiss cellular level detail alter prerequisit comprehens metastat phenotyp context possibl therapeut strategi affect alpha gal express discuss
MED-2367~natur develop memori cell xenoreact swine antigen human peripher blood lymphocyt pubm ncbi abstract natur develop xenospecif ab well docu barrier xenograft transplant human analog xenoreact cell immun develop enzyme link immunospot assay determin frequenc cytokin profil xenoreact pbls panel human volunt naiv cell produc il num short term cultur ifn gamma product approach measur memori immun respons stimul human pbls purifi lymphocyt stimul cell inbr swine reveal high frequenc ifn gamma produc num fold fewer il num produc contrast lymphocyt obtain neonat umbil cord blood swine specif il num produc ifn gamma produc expect find naiv phenotyp pbls adult histori abstent pork consumpt respond swine cell signific lower frequenc ifn gamma produc pbls adult unrestrict diet suggest pork consumpt result prime swine specif cell immun find provid evid natur occur xenospecif cell immun human detect strength memori respons suggest present formid barrier transplant swine organ
MED-2368~proteom metabolom immunom microparticl deriv human atherosclerot plaqu pubm ncbi abstract background microparticl mps procoagul activ present human atherosclerosi detail inform composit method result obtain insight role mps atherogenesi mp protein identifi tandem mass spectrometri metabolit profil determin high resolut nuclear magnet reson spectroscopi antibodi reactiv assess combinatori antigen librari plaqu mps express surfac antigen consist leukocyt origin includ major histocompat complex class ii induc dose depend stimulatori effect t cell prolifer notabl taurin abund free organ acid human neutrophil scaveng myeloperoxidase catalyz free radic high enrich plaqu mps fluoresc label protein mp surfac suggest immunoglobulin trap insid confirm flow cytometri analysi permeabil nonpermeabil plaqu mps colabel cd num igg establish num igg mps cd num indic macrophag origin screen antigen librari reveal immunolog profil antibodi mps similar found plaqu differ profound antibodi plasma unexpect show strong reaction oligosaccharid antigen blood group antigen conclus studi evid immunoglobulin present mps deriv plaqu macrophag portfolio plaqu antibodi circul antibodi plasma anticarbohydr antibodi retain human atherosclerot lesion
MED-2369~delay anaphylaxi angioedema urticaria consumpt red meat patient ige antibodi specif galactos num galactos abstract background carbohydr moieti frequent encount food elicit ige respons clinic signific unclear recent work shown ige antibodi galactos num galactos gal carbohydr common express nonprim mammalian protein capabl elicit fatal reaction object sought determin ige antibodi gal present sera patient report anaphylaxi urticaria eat beef pork lamb method detail histori patient present univers virginia allergi clinic skin prick test spts intraderm skin test serum ige antibodi analysi perform common indoor outdoor food allergen result twenty four patient ige antibodi gal identifi patient similar histori anaphylaxi urticaria num num hour ingest meat report fewer episod avoid diet spts mammalian meat produc wheal num mm intraderm fresh food spts provid larger consist wheal respons cap rast test reveal specif ige antibodi beef pork lamb cow milk cat dog turkey chicken fish absorpt experi pattern sensit explain ige antibodi specif gal conclus report sever food allergi relat ige antibodi carbohydr epitop gal patient experi delay symptom anaphylaxi angioedema urticaria eat beef pork lamb
MED-2370~themat review seri pathogenesi atherosclerosi interpret histori cholesterol controversi part iii mechanist defi pubm ncbi abstract instal seri point absenc explicit detail plausibl hypothesi link hypercholesterolemia event arteri wall import reason continu skeptic failur treat elev blood cholesterol level rapid advanc understand lipoprotein metabol num num applic modern cellular biolog num provid context modern consensus pathogenet mechan atherogenesi
MED-2371~daili egg consumpt hyperlipidem adult effect endotheli function cardiovascular risk abstract background limit consumpt egg high cholesterol general recommend reduc risk cardiovascular diseas recent evid suggest dietari cholesterol limit influenc serum cholesterol cardiac risk object assess effect egg consumpt endotheli function serum lipid hyperlipidem adult method random placebo control crossov trial num hyperlipidem adult num women num men averag age num num year weight num num kilogram total cholesterol num num mg dl acut phase particip random assign sequenc singl dose medium hardboil egg sausage chees breakfast sandwich sustain phase particip random assign sequenc medium hardboil egg num cup egg substitut daili week treatment assign separ four week washout period outcom measur interest endotheli function measur flow mediat dilat fmd lipid panel result singl dose egg consumpt effect endotheli function compar sausage chees num num num num num daili consumpt egg substitut num week signific improv endotheli function compar egg num num num num num lower serum total cholesterol num num num num mg dl num ldl num num num num mg dl num studi result posit negat express term chang relat baselin conclus egg consumpt found non detriment endotheli function serum lipid hyperlipidem adult egg substitut consumpt benefici
MED-2372~egg consumpt endotheli function random control crossov trial pubm ncbi abstract background egg cholesterol content reduct egg consumpt general recommend reduc risk cardiovascular diseas recent evid accumul suggest dietari cholesterol relev cardiovascular risk dietari satur fat random control crossov trial conduct determin effect egg ingest endotheli function reliabl index cardiovascular risk method forty nin healthi adult age num year num femal underw baselin brachial arteri reactiv studi bar assign egg oat daili num week random sequenc num week washout bar end treatment phase measur flow medi vasodil fmd brachial arteri high frequ ultrasound result fmd stabl egg oat group between treat differ signific egg num oatmeal num num week egg ingest effect total cholesterol baselin num mg dl post treat num ldl baselin num mg dl post treat num contrast num week oat lower total cholesterol num mg dl num ldl num mg dl num differ bodi mass index bmi triglycerid hdl sbp level egg oat treatment assign conclus short term egg consumpt advers affect endotheli function healthi adult support view dietari cholesterol detriment cardiovascular health previous thought
MED-2374~egg consumpt risk cardiovascular diseas diabet meta analysi pubm ncbi abstract object assess dose respons relationship egg consumpt risk cardiovascular diseas cvd diabet method systemat search medlin databas decemb num fix random effect model pool relat risk rrs num confid interv cis subgroup analys perform explor potenti sourc heterogen weight linear regress model estim dose respons relationship result fourteen studi involv num subject includ pool rrs risk cvd cvd separ diabet patient diabet highest lowest egg intak num num ci num num num num ci num num num num ci num num num week increment egg intak rrs risk cvd cvd separ diabet patient diabet num num ci num num num num ci num num num num ci num num subgroup analys show popul western countri increas cvd usa rr num num ci num num num num ci num num num subgroup differ conclus studi suggest dose respons posit associ egg consumpt risk cvd diabet copyright num elsevi ireland reserv
MED-2376~brachial arteri flow medi dilat predict long term cardiovascular event subject heart diseas pubm ncbi abstract endotheli dysfunct consid import prognost factor atherosclerosi determin long term associ brachial arteri flow medi dilat fmd advers cardiovascular cv event healthi subject prospect assess brachial fmd num consecut healthi subject appar heart diseas num men num age num num year overnight fast discontinu medic num hour fmd assess high resolut linear array ultrasound subject divid num group fmd num num num num num median fmd compar cv risk factor lipoprotein fast glucos c reactiv protein concomit medic framingham num year risk score clinic follow up num num year composit cv event all caus mortal nonfat myocardi infarct hospit heart failur angina pectori stroke coronari arteri bypass graft percutan coronari intervent signific common subject fmd num num num num num univari analysi demonstr median fmd signific predict cv event odd ratio num num ci num num num multivari analysi control tradit cv risk factor demonstr median fmd independ predictor long term cv advers event odd ratio num num ci num num num conclus brachial arteri median fmd independ predict long term advers cv event healthi subject appar heart diseas addit deriv tradit risk factor assess copyright num elsevi reserv
MED-2378~effect diet high walnut flax oil hemodynam respons stress vascular endotheli function abstract background polyunsatur fatti acid pufa benefici effect cardiovascular risk mechan incomplet understood previous articl show signific reduct low dens lipoprotein cholesterol marker inflamm increas intak alpha linolen acid ala walnut flax object examin effect ala cardiovascular respons acut stress flow medi dilat fmd brachial arteri blood concentr endothelin num arginine vasopressin avp design random crossov studi design cardiovascular respons acut stress assess num hypercholesterolem subject subset underw fmd test num particip fed averag american diet aad num experiment diet vari amount ala linol acid la aad provid num energi pufa num la num ala la diet satur fat reduc pufa walnut walnut oil provid num energi num la num ala ala diet walnut walnut oil flax oil provid num energi pufa num la num ala result ala la diet signific reduc diastol blood pressur num num mm hg total peripher resist num effect evid rest stress main effect diet num fmd increas num diet addit ala avp increas num endothelin num unchang conclus result suggest mechan cardioprotect effect walnut flax work identifi bioactiv respons effect
MED-2379~effect walnut endotheli function overweight adult viscer obes random control crossov trial abstract object metabol syndrom precursor diabet cardiovascular diseas cvd walnut ingest shown reduc cvd risk indic diabet random control crossov trial perform investig effect daili walnut consumpt endotheli function biomark cardiac risk popul overweight individu viscer adipos method forty six overweight adult averag age num year num women num men elev waist circumfer num addit sign metabol syndrom random assign num week sequenc walnut enrich ad libitum diet ad libitum diet walnut separ num week washout period primari outcom measur chang flow medi vasodil fmd brachial arteri secondari measur includ serum lipid panel fast glucos insulin homeostasi model assess insulin resist valu blood pressur anthropometr measur result fmd improv signific baselin subject consum walnut enrich diet compar control diet num num versus num num num benefici trend systol blood pressur reduct mainten baselin anthropometr valu observ measur unalt conclus daili ingest num walnut improv endotheli function overweight adult viscer adipos addit walnut diet lead weight gain studi potenti role walnut intak diabet cvd prevent warrant
MED-2380~nut hypertens endotheli function pubm ncbi abstract background aim high blood pressur bp consid major risk factor cardiovascular diseas lifestyl factor diet play key role prevent control high bp import elucid dietari compon exert benefici effect bp modul endotheli function ef mechan paper review role nutrient food nut dietari pattern bp control data synthesi nut low sodium signific amount mono polyunsatur fatti acid fiber miner magnesium potassium calcium antioxid suggest potenti protect food hypertens limit evid prospect studi clinic trial suggest nut consumpt benefici effect bp ef bp secondari outcom nut feed trial studi ambulatori bp monitor standard bp measur conclus clinic trial ideal ambulatori bp monitor establish potenti protect effect nut consumpt hypertens vascular reactiv copyright num elsevi reserv
MED-2381~systemat review effect nut blood lipid profil human pubm ncbi abstract invers associ nut consumpt risk marker coronari heart diseas lipid spark interest scientif lay communiti object studi conduct systemat review investig effect nut lipid profil medlin web scienc databas search start databas august num supplement cross check refer list relev public human intervent trial object investig independ effect nut lipid concentr includ literatur search num public screen num studi includ paper receiv rate base methodolog public formal statist analysi perform due larg differ studi design dietari intervent trial result num almond num g d num peanut num g d num pecan nut num g d num walnut num g d studi show decreas total cholesterol num num ldl cholesterol num num compar subject consum control diet consumpt macadamia nut num g d produc convinc result conclus consumpt approxim num approxim num num serv nut num times wk part heart healthi diet total fat content high mono and or polyunsatur fatti acid approxim num energi signific decreas total cholesterol ldl cholesterol normo hyperlipidem individu
MED-2382~preval self report peanut tree nut sesam allergi num year follow up pubm ncbi abstract background allergi peanut tree nut tns lead fatal allerg reaction unit state preval increas object sought determin preval self report peanut tn sesam allergi num compar result compar survey conduct num num method nationwid cross sect random telephon survey peanut tn allergi conduct previous questionnair addit question sesam result total num household num subject survey particip rate num num num num num peanut allergi tn allergi report num subject num ci num num compar num num num num adult preval num num ci num num signific prior survey preval peanut tn allergi children younger num year num num ci num num compar num num num num num num preval peanut allergi children num num num ci num num compar num num signific num num num preval childhood tn allergi increas signific survey wave num num num num num num sesam allergi report num num ci num num conclus caution requir compar survey peanut allergi tn allergi continu report num popul num million subject increas report children past decad sesam allergi report common copyright num american academi allergi asthma immunolog publish mosbi reserv
MED-2383~role nut optim diet time critic apprais pubm ncbi abstract decad nut attract attent research potenti benefit cardiovascular prevent discuss aspect assum benefici effect nut weigh potenti harm epidemiolog observ control intervent trial consist suggest nut consumpt improv serum lipid profil decreas cardiovascular risk nut energi dens food impact energi balanc bodi weight consid claim ad nut habitu diet increas calori intak bodi fat accumul evid biolog plausibl potenti risk frequent occurr allerg reaction consumpt nut discuss copyright num elsevi reserv
MED-2384~hazelnut enrich diet improv cardiovascular risk biomark lipid low effect hypercholesterolem subject pubm ncbi abstract background tree nut almond walnut pistachio shown possess cardioprotect effect inform effect hazelnut consumpt cardiovascular risk marker method antiatherogen effect hazelnut consumpt hypercholesterolem subject investig twenty on hypercholesterolem volunt num men num women recruit doubl control sandwich model intervent studi singl group isoenerget diet period control diet num week hazelnut enrich diet num week hazelnut contribut num num total daili energi intak control diet period ii num week cardiovascular risk biomark endotheli function flow medi dilat fmd techniqu low dens lipoprotein ldl oxid product inflammatori marker high sensit c reactiv protein hs crp solubl intercellular adhes molecul num solubl vascular cell adhes molecul num svcam num lipid lipoprotein level monitor result consumpt hazelnut enrich diet signific improv fmd num total cholesterol num triacylglycerol num ldl cholesterol num high dens lipoprotein cholesterol num compar control diet oxidized ldl hs crp svcam num level signific lower group ingest hazelnut enrich diet compar control diet ii modest correl svcam num fmd svcam num hs crp observ num num num num conclus hazelnut enrich diet exert antiatherogen effect improv endotheli function prevent ldl oxid inflammatori marker addit lipid lipoprotein low effect benefici effect revers num week hazelnut fre diet hazelnut incorpor daili diet chang total calor intak sustain health benefit copyright num nation lipid associ reserv
MED-2385~concentr mercuri hair diseas peopl japan pubm ncbi abstract purpos investig estim total hair mercuri diseas peopl includ patient mercuri poison minamata diseas hair sampl collect num diseas volunt tokyo surround area oct num june num total mercuri concentr hair ordinari diseas peopl atop dermat asthma dementia cerebr infarct osteoporosi hypertens diabet num ppm num ppm valu higher healthi peopl age group uptak rout metabol mechan high hair mercuri concentr diseas peopl clear
MED-2386~methylmercuri exposur incid diabet men women prospect cohort abstract object emerg vitro anim evid suggest methylmercuri increas type num diabet evid exist human aim prospect determin associ mercuri exposur assess biomark measur incid diabet research design method neutron activ analysi measur toenail mercuri object biomark methylmercuri exposur num adult free diabet baselin separ prospect cohort incid diabet identifi biennial questionnair confirm valid supplementari questionnair symptom diagnost test medic therapi associ mercuri exposur incid diabet assess cox proport hazard result sd follow up num num year num case diabet diagnos num percentil toenail mercuri num g g men num g g women exposur num fold num fold higher environment protect agenc refer dose multivari analys toenail mercuri concentr higher incid diabet women men cohort combin compar highest lowest quintil exposur hazard ratio num ci incid diabet num num num women num num num men num num num combin cohort find similar extrem categori decil mercuri compar analys stratifi fish omega num consumpt bmi age conclus find separ larg prospect cohort support advers effect methylmercuri develop diabet men women usual level exposur popul
MED-2388~simultan exposur non diabet high level dioxin mercuri increas risk insulin resist pubm ncbi abstract insulin resist defect function pancreat cell occur year develop type num diabet investig clarifi integr effect moderate to high exposur dioxin mercuri pancreat endocrin function cross sect studi investig num non diabet resid desert pentachlorophenol chloralkali factori metabol syndrom relat factor measur examin associ serum dioxin blood mercuri investig associ insulin resist homa ir num percentil defect pancreat cell function homa cell num percentil serum dioxin blood mercuri adjust confound factor found insulin resist increas serum dioxin num num blood mercuri num num particip higher serum dioxin blood mercuri signific increas risk insulin resist trend num joint highest tertil serum dioxin blood mercuri elev homa ir num time odd joint lowest tertil aor num num ci num num hypothes simultan exposur dioxin mercuri heighten risk insulin resist individu exposur copyright num elsevi reserv
MED-2389~persist organ pollut type num diabet prospect analysi nurs health studi meta analysi abstract background prospect data persist organ pollut pop risk type num diabet num limit result individu pop consist studi object prospect examin plasma pop concentr relat incid num summar exist evid meta analysi method plasma polychlorin biphenyl pcbs dichlorodiphenyltrichloroethan ddt dichlorodiphenyldichloroethylen dde hexachlorobenzen hcb concentr measur num women free diabet blood draw num num particip case control studi nurs health studi identifi num incid num case num june num conduct literatur search pubm embas decemb num identifi prospect studi pop relat diabet fixed effect model summar result result multivari adjust plasma hcb concentr posit incid num pool odd ratio num num ci num num ptrend num compar extrem tertil pop signific diabet pool result publish prospect studi includ num diabet case total found hcb total pcbs diabet pool num num ci num num num num pheterogen num num num ci num num num num pheterogen num hcb total pcbs conclus find support associ pop exposur risk num
MED-2391~perfluorin compound polychlorin biphenyl organochlorin pesticid contamin composit food sampl dalla texa usa abstract object object articl extend previous studi persist organ pollut pop contamin food measur perfluorin compound pfcs organochlorin pesticid polychlorin biphenyl pcbs composit food sampl studi part larger studi report articl report level polybromin diphenyl ether hexabromocyclododecan bromin flame retard composit food schecter al num polybromin diphenyl ether pbdes hexabromocyclodecan hbcd composit food sampl environ health perspect num num method studi measur concentr num organochlorin pesticid num pcbs num pfcs composit sampl num type food num individu food sampl purchas supermarket dalla texa usa num dietari intak chemic calcul averag american result contamin vari great chemic food type highest level pesticid contamin dichlorodiphenyltrichloroethan ddt metabolit dichlorodiphenyldichloroethylen rang num ng g wet weight ww milk yogurt num ng g ww catfish fillet found pcb congen num num num num primarili fish highest level salmon pcb num num ng g ww pcb num num ng g ww pfcs detect perfluorooctano acid pfoa num num sampl rang num ng g potato num ng g oliv oil term dietari intak ddt ddt metabolit endosulfan aldrin pcbs pfoa consum highest level conclus product ban found pop food mixtur chemic consum american public vari level suggest expand test food chemic contamin
MED-2394~molecular epidemiolog evid diabetogen effect dioxin exposur air forc veteran vietnam war abstract background outcom posit dioxin exposur human type num diabet object studi conduct order find molecular biolog evid diabetogen action dioxin adipos sampl vietnam veteran method obtain num adipos tissu sampl vietnam veteran expos dioxin oper ranch hand comparison veteran serv southeast asia record dioxin exposur conduct quantit reverse transcrib polymeras chain reaction studi select marker mrnas sampl result found sensit reliabl molecular indic dioxin induc diabet ratio mrna glucos transport num glut num nuclear transcript factor kappa nf marker inflamm ratio show signific correl serum dioxin residu fast glucos ranch hand group surpris comparison group low level dioxin compar general public correl comparison group signific risk factor obes famili histori diabet conclus result show glut num nf ratio reliabl marker diabetogen action dioxin low exposur level higher found general public impli address current exposur level
MED-2395~strong dose respons relat serum concentr persist organ pollut diabet result nation health pubm ncbi abstract object low level exposur persist organ pollut pop recent focus link risk diabet research design method cross sect associ serum concentr pop diabet preval investig num adult particip nation health nutrit examin survey num pop num num num hexachlorobiphenyl num num num num heptachlorodibenzo p dioxin num num num num octachlorodibenzo p dioxin oxychlordan p  dichlorodiphenyltrichloroethan trans nonachlor select detect num particip result compar subject serum concentr limit detect adjust age sex race ethnic poverti incom ratio bmi waist circumfer diabet preval strong posit lipid adjust serum concentr pop particip classifi sum categori number pop adjust odd ratio num num num num num trend num associ consist stratifi analys stronger younger particip mexican american obes individu conclus strike dose respons relat serum concentr select pop preval diabet strong grade associ offer compel challeng futur epidemiolog toxicolog research
MED-2396~role persist organ pollut worldwid epidem type num diabet mellitus connect farm atlant salm pubm ncbi abstract rate type num diabet mellitus num unit state worldwid rise alarm rate decad diseas view primarili attribut unhealthi lifestyl habit great deal emphasi encourag increas exercis dietari habit weight loss recent studi reveal presenc persist organ pollut pop confer greater risk develop diseas establish lifestyl risk factor fact evid suggest hypothesi obes signific risk factor adipos tissu high amount pop chlorin pesticid polychlorin biphenyl strong link develop metabol syndrom insulin resist num addit review evid associ pop condit articl explor contribut farm atlant salmon signific common dietari sourc pop blood sugar dysregul condit
MED-2397~organochlorin exposur incid diabet cohort great lake sport fish consum abstract background studi demonstr ubiquit human exposur persist organ pollut pop diphenyldichloroethen dde polychlorin biphenyl pcbs evid pop exposur preval diabet studi establish causal cross sect studi design assess tempor exposur diseas associ prospect studi lack object studi design determin pop bodi burden relat incid diabet cohort great lake sport fish consum method cohort establish earli num num test serum dde pcb congen assess diabet diagnosi demograph fish consumpt associ diabet exposur examin prospect particip diabet num num num annual percent dde pcb num num num examin diabet status result dde exposur incid diabet incid diabet mono ortho pcb num total pcbs year sport fish consumpt annual percent chang dde pcb num differ signific diabet status conclus studi demonstr associ dde exposur incid diabet find associ dde incid diabet lack effect diabet annual percent chang pop support hypothesi associ pop diabet attribut revers causal addit studi address biolog pathway dde affect glucos homeostasi
MED-2398~role dietari num polyunsatur fatti acid type num diabet review epidemiolog clinic studi pubm ncbi abstract worldwid increas preval type num diabet mellitus num pose immens public health hazard lead varieti complic cardiovascular diseas nephropathi neuropathi diet key compon healthi human lifestyl play import role prevent manag num complic dietari num polyunsatur fatti acid pufa favour function anti inflammatori effect improv endotheli function control blood pressur reduc hypertriglyceridemia insulin insensit epidemiolog studi lower preval num found popul consum larg amount seafood product rich num pufa evid relat fish intak dietari num pufa risk num controversi paper aim review epidemiolog clinic studi role dietari num pufa num limit studi potenti research subject discuss copyright num elsevi ireland reserv
MED-2400~short long term morbid mortal popul expos dioxin seveso accid pubm ncbi abstract earli effect num num tetrachlorodibenzo para dioxin tcdd exposur popul involv seveso itali incid num examin numer studi chloracn effect link suffici certainti dioxin exposur long term consequ investig mortal cancer incid studi mortal morbid find num year period accid show increas risk lymphoemopoiet neoplasm digest system cancer rectum male biliari tract femal respiratori system cancer lung male incid analys thyroid gland pleura cancer suggest increas soft tissu sarcoma show increas largest expos exposur sub cohort hypothes associ non canc effect dioxin exposur corrobor find seveso popul case cardiovascular effect possibl link chemic exposur stress disast experi endocrin effect diabet femal reproduct effect exposur men tcdd link lower male femal sex ratio offspr result seveso studi point gender effect accord anim model notwithstand acknowledg studi limit lack individu exposur marker short latenc small popul size cancer type result previous experiment epidemiolog studi mechanist knowledg dioxin toxic support hypothes observ excess dioxin exposur mortal cancer incid follow up seveso cohort continu
MED-2402~fish intak risk total cause specif mortal num population bas cohort studi num men women abstract propos protect effect fish intak risk cardiovascular diseas epidemiolog evid fish intak mortal inconsist investig associ fish intak assess valid food frequenc questionnair risk total cause specif mortal num prospect cohort studi num chines men women num num vital status date death ascertain annual linkag shanghai vital statist registri databas biennial home visit cox regress calcul hazard ratio num confid interv exclud year observ analysi includ num death women num death men fish intak invers risk total ischem stroke diabet mortal hazard ratio highest quintil intak compar lowest num num confid interv ci num num num num ci num num num num ci num num associ cancer ischem heart diseas mortal observ analys suggest invers associ total ischem stroke diabet mortal primarili relat consumpt saltwat fish intak long chain num fatti acid find support postul health benefit fish consumpt
MED-2404~increas rate hospit diabet residenti proxim hazard wast site abstract background epidemiolog studi suggest associ environment exposur persist organ pollut pop diabet object aim studi test hypothesi residenti proxim pop contamin wast site result increas rate hospit diabet method determin number hospit patient num num year age diagnos diabet york state exclus york citi year num num descript statist negat binomi regress compar diabet hospit rate individu resid zip code abut hazard wast site pop pop site zip code hazard wast site wast pop site zip code identifi hazard wast site clean site result compar hospit rate diabet clean site rate ratio diabet discharg peopl resid pop site site adjust potenti confound num num confid interv ci num num num num ci num num subset pop site hudson river higher incom smoke diet exercis rate ratio num num ci num num compar clean site conclus control major confound found statist signific increas rate hospit diabet popul resid zip code toxic wast site
MED-2405~environment contamin risk factor develop diabet pubm ncbi abstract contribut exposur persist organ pollut pop incid diabet receiv attent recent number report emerg elev diabet person occup expos dioxin unit state air forc personnel vietnam spray agent orang dioxin contamin elev rate diabet lead govern compens diabet veteran recent studi popul expos polychlorin biphenyl pcbs chlorin pesticid found dose depend elev risk diabet elev risk diabet relat level pop demonstr group nation health nutrit examin survey nhane random sampl citizen strong associ studi suggest possibl exposur pop diabet strike observ obes person elev pop elev risk diabet suggest pop obes se respons associ specif mechan pop induc great number varieti gene includ alter insulin action diabet danger diseas increas frequenc world studi possibl exposur pop contribut etiolog diabet critic
MED-2406~fish marin omega num polyunsatur fatti acid consumpt incid type num diabet systemat review meta analysi abstract object examin associ fish marin long chain omega num polyunsatur fatti acid lc num pufa consumpt incid type num diabet num prospect cohort studi method meta analyt procedur estim relat risk rr random effect fix effect generic invers varianc model public bias studi heterogen assess egger test num statist result found signific associ intak fish seafood pool rr num num num ci num num num particip marin lc num pufa pool rr num num num ci num num num particip num risk signific studi heterogen observ fish seafood marin lc num pufa studi num subgroup analysi reveal obvious sourc high heterogen found signific protect effect oili fish intak num risk pool rr num num num ci num num dose respons analysi suggest num day intak oili fish reduc num risk num conclus found signific effect fish seafood marin lc num pufa intak risk num signific effect oili fish intak risk num
MED-2407~public health concern exposur persist organ pollut risk metabol diseas abstract background persist organ pollut pop hazard chemic omnipres food chain intern regul ensur public health initi potenc affect reproduct promot cancer recent studi highlight unexpect implic pop develop metabol diseas type num diabet obes base knowledg articl aim stimul discuss evalu effect current pop legisl protect human risk metabol diseas regul pop anim food product european union eu address special focus marin food repres major sourc pop exposur human discuss mount scientif evid show current pop risk assess regul effect protect human metabol disord regulatori control pop dietari product high public health prioriti summari general popul expos suffici pop term concentr divers induc metabol disord situat attract greatest attent public health government author
MED-2409~marin num polyunsatur fatti acid invers risk type num diabet asian systemat review meta analysi abstract background prospect cohort studi relat associ num polyunsatur fatti acid pufa risk type num diabet num inconsist differ tissu num pufa composit subject num inconsist cohort case control studi conduct systemat review meta analysi prospect cohort studi examin associ fish num pufa intak num risk differ tissu num pufa composit subject num investig base cohort case control studi method find pubm embas cochran librari china nation knowledg infrastructur cnki chines vip databas januari num identifi relev studi refer list retriev studi review author independ extract data random effect model pool summari relat risk rr twenty four studi includ num num patient num particip identifi cohort studi summari rr num highest lowest categori total fish marin num pufa alpha linolen acid intak num num ci num num num num ci num num num num ci num num subgroup analys summari rr highest lowest categori num fish marin num pufa intak num num ci num num num num ci num num asian popul num num ci num num num num ci num num western popul asian subject num signific lower tissu composit num num num smd num num ci num num total num pufa smd num num ci num num compar num conclus systemat review meta analysi evid marin num pufa benefici effect prevent num asian popul
MED-2410~fish consumpt insulin sensit beta cel function insulin resist atherosclerosi studi ira abstract background aim previous research associ fish consumpt incid type num diabet inconclus addit studi investig fish consumpt relat metabol abnorm diabet examin associ fish consumpt measur insulin sensit beta cel function multi ethn popul method result examin cross sect associ fish consumpt measur insulin sensit secret num non diabet particip insulin resist atherosclerosi studi ira fish consumpt categor num num portions week measur valid food frequenc questionnair insulin sensit si acut insulin respons air determin frequent sampl intraven glucos toler test higher fish consumpt independ lower si adjust air num num num num compar num num portions week fish consumpt posit intact split proinsulin c peptid ratio associ confound ethnic multivariable adjust num num num intact proinsulin c peptid ratio num num num split proinsulin c peptid ratio observ signific posit associ fish consumpt fast blood glucos multivariable adjust num num num num found associ fish consumpt si multivariable adjust num num num fast insulin multivariable adjust num num num conclus fish consumpt measur insulin sensit multi ethn ira cohort higher fish consumpt pancreat beta cel dysfunct
MED-2411~omega num fatti acid incid type num diabet systemat review meta analysi abstract relationship omega num polyunsatur fatti acid num pufa seafood eicosapentaeno acid epa docosahexaeno acid dha plant alpha linolen acid ala sourc risk type num diabet mellitus dm remain unclear systemat search multipl literatur databas june num identifi prospect studi examin relat dietari num pufa dietari fish and or seafood circul num pufa biomark incid dm data independ extract duplic num investig includ multivariate adjust relat risk rr estim num cis general least squar trend estim assess dose respons relationship pool summari estim calcul fixed effect random effect model num identifi abstract num studi met inclus criteria includ num separ cohort compris num individu num case incid dm consumpt fish and or seafood signific dm num studi rr num num num ci num num consumpt epa dha num cohort rr num g d num num ci num num circul level epa dha biomark num cohort rr num total fatti acid num num ci num num dietari ala num studi rr num g d num num ci num num circul ala biomark level num studi rr num total fatti acid num num ci num num num non signific trend lower risk dm substanti heterogen num observ studi fish seafood epa dha dm moder heterogen num dietari biomark ala dm unadjust meta regress studi locat asia north america europ bmi durat follow up modifi associ fish seafood epa dha consumpt dm risk p interact num limit statist power determin independ effect sourc heterogen due high collinear pool find support major harm benefit fish seafood epa dha develop dm suggest ala modest lower risk reason potenti heterogen effect includ true biolog heterogen public bias chanc deserv investig
MED-2412~fish oil supplement type num diabet quantit systemat review pubm ncbi abstract object determin effect fish oil supplement lipid level glycem control patient type num diabet research design method comprehens search medlin embas lilac cochran clinic trial registri bibliographi relev paper expert input updat septemb num undertaken random placebo control trial includ fish oil supplement intervent subject type num diabet investig perform data extract qualiti score independ discrep resolv consensus eighteen trial includ num subject num week includ dose fish oil rang num num g day outcom studi glycem control lipid level result meta analysi pool data demonstr statist signific effect fish oil lower triglycerid num mmol l num ci num num rais ldl cholesterol num mmol l num num statist signific effect observ fast glucos hba num total cholesterol hdl cholesterol triglyceride low effect elev ldl cholesterol mark trial recruit hypertriglyceridem subject higher dose fish oil heterogen observ explain recruit subject baselin hypertriglyceridemia studi conclus fish oil supplement type num diabet lower triglycerid rais ldl cholesterol statist signific effect glycem control trial hard clinic end point
MED-2413~associ fish num fatti acid intak risk type num diabet meta analysi prospect studi pubm ncbi abstract result observ studi associ fish num fatti acid consumpt type num diabet mellitus num risk conflict meta analysi perform investig associ cohort studi comprehens search conduct identifi cohort studi associ fish and or num fatti acid intak num risk highest lowest categor analys fix random effect model select base homogen test studi linear non linear dose respons relationship assess univari bivari random effect meta regress restrict maximum likelihood estim highest lowest categor analys pool relat risk rr num intak fish num fatti acid num num ci num num num num num ci num num num linear dose respons relationship pool rr increment time num week fish intak times month num num g d num fatti acid intak num num ci num num num num num ci num num num signific non linear dose respons associ fish num fatti acid intak num risk observ present evid observ studi suggest intak fish num fatti acid weak posit num risk studi confirm result
MED-2414~review epidemiolog studi dietari acrylamid intak risk cancer pubm ncbi abstract conjectur associ dietari acrylamid intak cancer evalu num epidemiolog studi examin major cancer site critic review epidemiolog studi estim dietari acrylamid exposur cancer substanti greater acrylamid exposur occur tobacco smoke dietari exposur present result separ smoker adjust statist smoke status extens examin publish literatur found consist credibl evid dietari acrylamid increas risk type cancer human nonsmok collect evid suggest high level dietari acrylamid intak risk factor breast endometri ovarian cancer generat interest conjectur hormon mechan acrylamid absenc posit associ smoke ovarian endometri cancer suggest associ cancer lower sporad dietari acrylamid intak conclus epidemiolog studi dietari acrylamid intak fail demonstr increas risk cancer fact sporad slight increas decreas risk ratio report dozen paper examin review strong suggest pattern expect find true null associ seri trial continu epidemiolog investig acrylamid cancer risk misguid research prioriti
MED-2416~chronic intak potato chip human increas product reactiv oxygen radic leukocyt increas plasma c reactiv protein pubm ncbi abstract background high concentr acrylamid common ingest food product french fri potato chip cereal constitut potenti risk human health object object pilot studi investig connect chronic ingest acrylamide contain potato chip oxid stress inflamm design fourteen healthi volunt age num num women num smoker num cigarettes d num potato chip num microg correct acrylamid daili num wk result increas acrylamide hemoglobin adduct blood found studi subject num pmol num num hemoglobin rang num num nonsmok num pmol num num hemoglobin rang num num smoker concurr signific increas num oxid ldl high sensit interleukin num high sensit c reactiv protein gamma glutamyltransferas concentr observ smoker nonsmok signific increas reactiv oxygen radic product monocyt lymphocyt granulocyt increas cd num express macrophag num found intak potato chip twenty eight day discontinu experi variabl studi decreas extent shown acrylamid increas product reactiv oxygen speci isol human monocyte macrophag vitro decreas cellular glutathion concentr conclus find chronic ingest acrylamide contain product induc proinflammatori state risk factor progress atherosclerosi
MED-2417~empir deriv dietari pattern risk postmenopaus breast cancer larg prospect cohort studi pubm ncbi abstract background inconsist associ report diet breast cancer object prospect examin associ dietari pattern postmenopaus breast cancer risk us wid cohort studi design data analyz num women complet self administ num item block food frequ questionnair breast cancer detect demonstr project num num women develop breast cancer dietari pattern defin princip compon factor analysi cox proport hazard regress assess breast cancer risk result major dietari pattern emerg vegetable fish poultry fruit beef pork starch tradit southern vegetable fish poultry fruit pattern higher educ pattern similar nutrient intak tradit southern pattern adjust confound signific associ vegetable fish poultry fruit beef pork starch pattern breast cancer tradit southern pattern nonsignific reduc breast cancer risk case situ invas signific invas breast cancer relat hazard num num ci num num trend num diet reduc risk women famili histori breast cancer num underweight normal weight bodi mass index kg m num num num tumor posit estrogen receptor num progesteron receptor num food tradit southern pattern reduc breast cancer risk legum low mayonnaise salad dress intak possibl cabbag conclus tradit southern diet compon reduc risk invas breast cancer postmenopaus women
MED-2418~consumpt deep fri food risk prostat cancera abstract background evid suggest high heat cook method increas risk prostat cancer pca addit oil fat deep fri concern specif investig relat pca potenti mechan includ format potenti carcinogen agent aldehyd acrolein heterocycl amin polycycl aromat hydrocarbon acrylamid method estim odd ratio num confid interv ci associ tertil intak deep fri food food frequenc questionnair french fri fri chicken fri fish doughnut snack chip pca risk adjust potenti confound num case num control addit examin associ aggress pca defin regional dist stage elev gleason score prostat specif antigen level result compar num week posit associ pca risk intak num week french fri num num ci num num fri chicken num num ci num num fri fish num num ci num num doughnut num num ci num num associ snack chip num num ci num num estim slight stronger aggress diseas num num ci num num fri fish conclus regular consumpt select deep fri food increas pca risk risk specif deep fri food repres risk regular intak food expos high heat and or aspect western lifestyl fast food consumpt remain determin
MED-2420~acrylamid food review scienc futur pubm ncbi abstract acrylamid occur food common consum diet worldwid form reaction reduc sugar glucos fructos amino acid asparagin maillard reaction occur heat process food primarili deriv plant origin potato cereal product num num major epidemiolog studi potenti relationship acrylamid consumpt type cancer increas risk type warrant studi effort reduc format acrylamid food product result success common approach work food reduct food result major toxicolog studi aqueous intak acrylamid rat mice process releas status current knowledg area review
MED-2421~birth weight head circumfer prenat exposur acrylamid matern diet european prospect mother child studi newgeneri abstract background acrylamid common dietari exposur cross human placenta classifi probabl human carcinogen development toxic observ rodent object examin associ prenat exposur acrylamid birth outcom prospect european mother child studi method hemoglobin hb adduct acrylamid metabolit glycidamid measur cord blood reflect cumul exposur month pregnanc num singleton pregnant women recruit denmark england greec norway spain num num matern diet estim food frequ questionnair result acrylamid glycidamid hb adduct statist signific reduct birth weight head circumfer estim differ birth weight infant highest versus lowest quartil acrylamid hb adduct level adjust gestat age countri num num ci num num differ head circumfer num cm num ci num num find similar infant nonsmok consist countri remain adjust factor reduc birth weight matern consumpt food rich acrylamid fri potato cord blood acrylamid adduct level reduc birth weight conclus dietari exposur acrylamid reduc birth weight head circumfer consumpt specif food pregnanc higher acrylamid exposur utero confirm find suggest dietari intak acrylamid reduc pregnant women
MED-2422~statist regress model estim acrylamid concentr french fri excess lifetim cancer risk assess pubm ncbi abstract human exposur acrylamid aa consumpt french fri food recogn potenti health concern statist non linear regress model base influenti factor cook temperatur time estim aa concentr french fri num predict model num suggest develop model signific valid base french fri intak survey data conduct studi fri temperature tim scheme produc tasti visual appeal french fri mont carlo simul result show aa concentr higher num ppb estim cancer risk adolesc age num year taichung citi higher target excess lifetim cancer risk elcr account limit life span order reduc cancer risk aa intak aa level french fri reduc epidemiolog observ valid mathemat model serv basi investig elcr includ life stage behavior popul group copyright num elsevi reserv
MED-2423~dietari pattern breast cancer risk women pubm ncbi abstract object breast cancer common type cancer women worldwid studi examin role singl nutrient food group breast cancer pathogenesi fewer investig address role dietari pattern main object identifi relationship major dietari pattern breast cancer risk iranian women design hospital bas case control studi set shohada teach hospit tehran iran subject num femal patient age num year breast cancer num femal hospit control includ present studi dietari intak assess valid reliabl semi quantit ffq consist num food item result dietari pattern identifi explain num num dietari variat studi popul healthi food pattern character consumpt veget fruit low fat dairi product legum oliv veget oil fish condiment organ meat poultri pickl soya grain unhealthi food pattern character consumpt soft drink sugar tea coffe french fri potato chip salt sweet dessert hydrogen fat nut industri juic refin grain red process meat compar lowest tertil women highest tertil healthi dietari pattern score num decreas risk breast cancer num num ci num num num women highest tertil unhealthi dietari pattern signific increas breast cancer risk num num ci num num num conclus healthi dietari pattern negat breast cancer risk unhealthi dietari pattern increas risk iranian women
MED-2424~preschool diet adult risk breast cancer pubm ncbi abstract event puberti affect adult risk breast cancer examin diet preschool age affect woman risk breast cancer life conduct case control studi includ num women breast cancer num control free breast cancer select particip nurs health studi nurs health studi ii inform childhood diet nurs age num year obtain mother particip num item food frequ questionnair increas risk breast cancer observ woman frequent consum french fri preschool age addit serv french fri week odd ratio breast cancer adjust adult life breast cancer risk factor num num confid interv ci num num consumpt milk slight decreas risk breast cancer covariate adjust addit glass milk day num num ci num num intak nutrient calcul relat risk breast cancer risk studi data suggest associ diet puberti subsequ risk breast cancer differenti recal preschool diet mother case control consid explan observ associ studi evalu associ preschool diet breast cancer reproduc prospect data subject recal bias copyright num wiley liss
MED-2426~pre diagnost acrylamid exposur surviv breast cancer postmenopaus danish women pubm ncbi abstract acrylamid probabl human carcinogen industri contact tobacco smoke food process high temperatur main rout exposur anim studi oral intak acrylamid relat cancer develop indic increas cancer occurr endocrin relat tumor human epidemiolog studi dietari exposur acrylamid suggest relat higher risk endocrin relat tumor estrogen sensit breast cancer aim present studi evalu pre diagnost acrylamid exposur measur acrylamid glycidamid hemoglobin adduct aa hb ga hb mortal breast cancer case num postmenopaus women includ danish cohort num num develop breast cancer num num die num aa hb ga hb concentr measur blood sampl relat mortal cox proport hazard model estim num pmol g globin higher level non smok higher concentr ga hb higher hazard rate breast cancer specif mortal hr num ci num num num hazard rate women diagnos estrogen receptor posit tumor hr num ci num num num aa hb tendenc similar statist signific estrogen receptor posit tumor hr num ci num num num conclus present studi pre diagnost exposur acrylamid relat mortal breast cancer patient concern endocrin relat type breast cancer copyright num elsevi ireland reserv
MED-2427~elev level cholesterol rich lipid raft cancer cell correl apoptosi sensit induc cholesterol deplet agent abstract lipid rafts caveola membran platform signal molecul regul cellular function includ cell surviv understand role raft tumor progress therapeut investig effect raft disrupt cell viabil compar raft level human cancer cell line versus normal counterpart report cholesterol deplet methyl cyclodextrin caus anoikis lik apoptosi num cell involv decreas raft level bcl xl down regul caspas num activ akt inactiv epiderm growth factor receptor activ cholesterol replet replenish raft cell surfac restor akt activ cell viabil breast cancer prostat cancer cell line lipid raft sensit cholesterol depletion induc cell death normal counterpart result cancer cell increas level raft suggest potenti raft modul agent anti canc drug
MED-2428~women statin women health advocaci perspect pubm ncbi abstract paper base longer report benefit safeti modal inform represent regard women statin situat histor context women health movement advoc unbias medic research prescrib women base goal full disclosur inform consent evidence bas medicin gender bas analysi evid base prescrib statin women primari prevent weak canadian data suggest half prescript women safeti meta analys disaggreg women femal vulner statin induc muscl problem women centr concern breast canc miscarriag birth defect under research trial publish non cardiac advers event data factor suggest standard full disclosur inform consent evidence bas prescrib gender bas analysi met women proceed caution
MED-2429~statin risk breast cancer meta analysi observ studi pubm ncbi abstract emerg evid suggest statin decreas risk cancer evid breast cancer conflict examin associ statin risk breast cancer conduct detail meta analysi observ studi publish subject pubm databas bibliographi retriev articl search epidemiolog studi publish januari num investig relationship statin breast cancer meta analysi studi evalu public bias heterogen combin relat risk rr num confid interv ci calcul random effect model dersimonian laird method subgroup analys sensit analysi cumul meta analysi perform total num cohort num case control studi involv num million particip includ num breast cancer case contribut analysi found evid public bias evid heterogen studi statin long term statin signific affect breast cancer risk rr num num ci num num rr num num ci num num analysi stratifi subgroup evid studi design substanti influenc effect estim sensit analysi confirm stabil result cumul meta analysi show chang trend report risk breast cancer posit negat statin user num num meta analysi find support hypothesi statin protect effect breast cancer random clinic trial observ studi confirm associ biolog mechan futur
MED-2430~beta sitosterol enhanc tamoxifen effect breast cancer cell affect ceramid metabol pubm ncbi abstract object studi investig effect dietari phytosterol beta sitosterol sit antiestrogen drug tamoxifen tam cell growth ceramid cer metabol mcf num mda mb num human breast cancer cell mcf num mda mb num cell line studi model estrogen receptor posit estrogen receptor negat breast cancer cell growth cell line determin sulforhodamin assay inhibit treatment num microm sit mcf num cell growth inhibit treatment num microm tam combin sit tam inhibit growth cell line signific mda mb num cell cer proapoptot signal cer level increas mcf num mda mb num cell individu treatment sit tam combin treatment rais cellular cer content sit tam rais cer level sit potent activ de novo cer synthesi mcf num mda mb num cell stimul serin palmitoyltransferas activ tam promot cer accumul cell type inhibit cer glycosyl result suggest combin regimen dietari sit tam chemotherapi benefici manag breast cancer patient
MED-2431~long term statin risk ductal lobular breast cancer women num year age abstract background mechanist studi larg support chemoprevent potenti statin result epidemiolog studi investig statin breast cancer risk inconsist lack abil evalu long term statin materi method util data population bas case control studi breast cancer conduct seattle puget sound region investig relationship long term statin breast cancer risk num invas ductal carcinoma idc num invas lobular carcinoma ilc case num year age diagnos num num compar num control women particip interview in person data hypercholesterolemia episod lipid lower medic collect structur questionnair assess relationship statin idc ilc risk polytom logist regress result current user statin num year longer num fold increas risk idc num confid interv ci num num num fold increas risk ilc num ci num num compar user statin women diagnos hypercholesterolemia current user statin num year longer doubl risk idc odd ratio num num ci num num ilc num num ci num num compar user conclus contemporari population bas case control studi long term statin increas risk idc ilc impact addit studi similar high frequenc statin durat confirm find
MED-2432~garden eden  pl base diet genet drive conserv cholesterol implic heart diseas num centuri pubm ncbi abstract plant food consumpt human evolut shape dietari requir contemporari human diet high dietari fiber veget protein plant sterol phytochem low satur trans fatti acid substrat cholesterol biosynthesi meet body cholesterol genet differ polymorph conserv evolut tend rais serum cholesterol level result modern man radic diet lifestyl middl age recommend medic lower cholesterol reduc risk cardiovascular diseas experiment introduct high intak viscous fiber veget protein plant sterol form myocen diet leafi veget fruit nut lower serum ldl cholesterol healthi volunt num equival generat statin standard cholesterol low medic supplement modern therapeut diet hyperlipidem subject compon oat barley psyllium viscous fiber soy almond veget protein plant sterol enrich margarin produc similar reduct ldl cholesterol myocene lik diet reduc major subject blood lipid concentr normal rang conclud reintroduct plant food compon present larg quantiti plant base diet eaten human evolut modern diet correct lipid abnorm contemporari eat pattern reduc pharmacolog intervent
MED-2434~high acat num express estrogen receptor negat basal lik breast cancer cell ldl induc prolifer pubm ncbi abstract specif role dietari fat breast cancer progress unclear low fat diet decreas recurr estrogen receptor alpha negat er breast cancer er basal lik mda mb num mda mb num breast cancer cell line greater number cytoplasm lipid droplet compar lumin er mcf num cell studi lipid storag function cell triacylglycerol cholesteryl ester ce concentr higher er cell abil synthes ce distinguish type breast cancer cell higher baselin oleic acid ldl stimul ce concentr found er compar er cell differ correspond greater mrna protein level acyl coa cholesterol acyltransferas num acat num higher acat activ higher caveolin num protein level greater ldl uptak lower de novo cholesterol synthesi er cell human ldl stimul prolifer er mda mb num cell effect prolifer er mcf num cell function signific find demonstr observ acat inhibitor cp num reduc prolifer breast cancer cell specif reduc ldl induc prolifer er cell studi show greater abil store util exogen cholesterol confer prolif advantag basal lik er breast cancer cell differ lipid uptak storag capabl partial explain differenti effect low fat diet human breast cancer recurr
MED-2435~chemoprevent breast cancer dietari compound pubm ncbi abstract breast cancer lead cancer rel death women unit state countri effect toxic therapeut prevent strategi cancer breast cancer natur product test hope identifi potent molecul anticanc agent phytochem dietari compound treatment ill histori due safeti low toxic general avail activ phytochem clinic trial preclin clinic studi daili consumpt dietari phytochem reduc risk cancer phytochem inhibit delay revers carcinogenesi induc detoxifi antioxid enzym regul inflammatory prolif signal pathway induc apoptosi review articl describ potenti natur cancer prevent compound mechanist discuss interact key cellular signal transduct pathway contribut suppress breast cancer cell growth
MED-2436~content low densiti lipoprotein receptor breast cancer tissu relat surviv patient abstract content low densiti lipoprotein ldl receptor tissu primari breast cancer determin prognost inform compar variabl establish prognost import frozen tumour specimen select tissu num patient num die studi ldl receptor content show invers correl surviv time analysi multivari statist method show presenc axillari metastasi content receptor oestrogen ldl diamet tumour dna pattern prognost regard patient surviv improv method predict surviv time patient breast cancer choic treatment individu patient
MED-2437~diet breast cancer understand risk benefit pubm ncbi abstract background breast cancer common diagnos cancer women unit state extens research complet evalu relationship dietari factor breast cancer risk surviv breast cancer summari report clinic infer materi method review summar current epidemiolog clinic trial evid relat diet breast cancer incid recurr surviv mortal review includ emerg epidemiolog studi assess risk breast cancer subtyp summari previous ongo dietari intervent trial design modifi breast cancer risk result literatur suggest low fat high fib diet weak protect breast cancer total energi intak alcohol posit fiber weak protect possibl modul estrogen fruit veget intak risk obes risk factor postmenopaus diseas adult weight gain avoid reduc risk survivor diet greatest potenti influenc mortal breast cancer specif event conclus diet modest breast cancer risk associ pronounc postmenopaus diseas healthi choic diagnosi treatment support longev reduc risk recurr diseas
MED-2438~associ dietari lignan phytoestrogen rich food fiber intak postmenopaus breast cancer risk german case control st pubm ncbi abstract phytoestrogen structur similar estrogen affect breast cancer risk mimick estrogenic antiestrogen properti western societi grain possibl soy food rich sourc phytoestrogen population bas case control studi german postmenopaus women evalu associ phytoestrogen rich food dietari lignan breast cancer risk dietari data collect num case num control valid food frequ questionnair includ addit question phytoestrogen rich food associ assess condit logist regress analys adjust relev risk confound factor polytom logist regress analysi perform evalu associ estrogen receptor er status high low consumpt soybean sunflow pumpkin seed signific reduc breast cancer risk compar consumpt num num ci num num num num ci num num observ associ differenti er status statist signific associ found dietari intak plant lignan fiber calcul enterolignan result provid evid reduc postmenopaus breast cancer risk increas consumpt sunflow pumpkin seed soybean
MED-2439~plant sterol anticanc nutrient evid role breast cancer abstract factor involv etiolog cancer establish diet signific impact risk diseas recent specif food compon identifi uniqu benefici mitig risk specif cancer subtyp plant sterol effect blood cholesterol level research potenti role mitig cancer risk remain infanc outlin review cholesterol modul action plant sterol overlap anti canc action breast cancer common malign affect women remain effect adjuv therapi diseas plant sterol play distinct role
MED-2440~total cholesterol cancer risk larg prospect studi korea abstract purpos clarifi relationship total cholesterol cancer remain unclear method prospect examin associ total cholesterol site specif all canc incid num num korean adult enrol nation health insur corpor underw standard biennial medic examin num num observ num year cancer diagnosi death result follow up num men num women diagnos primari cancer compar level num mg dl high total cholesterol num mg dl posit prostat cancer hazard ratio hr num num ci num num trend num colon cancer hr num num ci num num trend num men breast cancer women hr num num ci num num trend num higher total cholesterol lower incid liver cancer men hr num num ci num num trend num women hr num num ci num num trend num stomach cancer men hr num num ci num num trend num women hr num num ci num num trend num men lung cancer hr num num ci num num trend num result liver cancer slight attenu addit adjust liver enzym level hepat surfac antigen status men hr num trend num women hr num trend num exclus num year follow up men hr num trend num women hr num trend num total cholesterol invers all canc incid men hr num num ci num num trend num women hr num num ci num num trend num associ attenu exclud incid liver cancer men hr num trend num women hr num trend num conclus larg prospect studi found total cholesterol risk cancer relationship differ mark cancer site
MED-2441~vegetarian diet amelior symptom atop dermat reduct number peripher eosinophil pge num synthesi monoci pubm ncbi abstract patient atop dermat dissatisfi convent treatment base topic steroid experienc tradit remedi altern therapi therapi evalu scientif clinic specialist studi design assess vegetarian diet effect atop dermat identifi mechan remedi analys immunolog paramet open tri studi carri twenti patient atop dermat improv dermat evalu scorad index serolog immunolog paramet monitor two month treatment sever dermat strike inhibit assess scorad index serolog paramet includ ldh num activ number peripher eosinophil sharp reduct eosinophil neutrophil observ prior improv skin inflamm addit pge num product peripher blood mononuclear cell reduc treatment contrast serum ige level chang period studi open tri suggest treatment treatment adult patient sever atop dermat
MED-2442~double blind control crossov studi cyclosporin adult sever refractori atop dermat pubm ncbi abstract patient remain sever affect atop dermat adult life treatment system steroid azathioprin photochemotherapi num patient part double blind placebo control crossov studi assess efficaci safeti cyclosporin num mg kg day adult sever refractori atop dermat treatment week group num receiv placebo cyclosporin num receiv cyclosporin placebo diseas activ extent diseas sleep itch topic steroid advers event assess week extent activ dermat signific improv num subject measur diseas num patient receiv cyclosporin report advers event compar num placebo patient requir withdraw studi cyclosporin therapi led increas serum urea creatinin bilirubin concentr rise bilirubin signific num result confirm cyclosporin safe effect short term treatment sever refractori atop dermat
MED-2444~side effect profil cyclosporin patient treat psoriasi pubm ncbi abstract review side effect cyclosporin cya patient sever psoriasi renal dysfunct hypertens discuss paraesthesia hypertrichosi gingiv hyperplasia gastrointestin disord occur general transient mild to moder sever rare requir discontinu cya infect problem expect immunosuppress drug risk tumour develop squamous cell carcinoma skin malign develop exclus patient previous treat puva and or methotrex lymphoprolif disord regress spontan discontinu drug isol case solid tumour cya rel rais serum creatinin import indic renal dysfunct laboratori abnorm includ hypomagnesaemia hyperkalaemia increas uric acid liver function test fluctuat serum cholesterol triglycerid level clinic relev laboratori monitor patient psoriasi treat cya essenti
MED-2445~dietari polyphenol prevent treatment allerg diseas pubm ncbi abstract allerg disord encompass skin food respiratori allergi sensit harmless allergen result immun system bias predomin t helper type num respons re exposur allergen lead robust secret allergy rel mediat eventu trigger symptom understand disord enabl search therapeut approach modul sensit process impact allerg mediat manag allerg symptom polyphenol class compound found food plant sourc investig anti allerg effect diseas model human clinic trial anti inflammatori profil impact recruit immun cell skin prevent develop secondari infect disrupt skin barrier interact polyphenol protein modul process allerg sensit direct effect allerg effector cell mast cell inhibit mediat releas result allevi symptom addit endogen anti oxid abil limit extent cellular injuri free radic allerg insult polyphenol hold promis anti allergi agent capabl influenc multipl biolog pathway immun cell function allerg immun respons deserv investig object current review summar key find progress made studi polyphenol anti allerg ingredi special emphasi review highlight key physiolog cellular signal pathway implic mechan action polyphenol context allerg disord manifest num blackwel publish
MED-2446~dietari antioxid intak allerg sensit allerg diseas young children pubm ncbi abstract background allerg diseas risen preval recent decad aetiolog remain unclear result chang lifestyl and or environ reduct antioxid intak consequ reduc intak fresh fruit veget suggest object investig dietari antioxid intak age num relat atopi num num year age children unselect birth cohort method children birth parent complet valid respiratori questionnair children skin prick test num num year age serum ige level measur age num age num antioxid intak assess semi quantit food frequenc questionnair ffq nutrient analysi program comput nutrient intak frequenc count food high antioxid vitamin assess result hundr sixty on children complet respiratori ffq beta caroten intak reduc risk allerg sensit age num num num num num num num num addit beta caroten intak negat total ige level num vitamin intak increas risk allerg sensit num num num age num associ antioxid intak wheez eczema conclus increas beta caroten intak reduc risk allerg sensit lower ige level num num year old children dietari antioxid play role develop allerg sensit
MED-2448~clinic efficaci appl polyphenol treat cedar pollinosi pubm ncbi abstract double blind compar studi conduct cedar pollinosi patient order evalu treatment efficaci appl polyphenol ap ap administ num mg daili num week start num week prior cedar pollen dispers pollinosi symptom studi evalu classif guidelin allerg rhiniti diagnosi treatment result show sneez score signific lower ap group placebo group earli period pollen dispers main dispers period addit advers reaction induc ap studi result suggest ap allevi symptom cedar pollinosi
MED-2449~evalu clinic efficaci tomato extract perenni allerg rhiniti pubm ncbi abstract background recent common food daili life found anti allerg effect report tomato extract te possibl inhibit histamin releas mous ear swel respons report te reliev symptom japanes cedar pollinosi method evalu anti allerg effect te perform random double blind placebo control studi num patient perenni allerg rhiniti par oral administr te num mg day placebo num week result found sneez score signific decreas te group end trial compar begin num decreas tendenc rhinorrhea nasal obstruct te group patient qualiti life signific improv te group num week treatment num placebo group signific improv total symptom score combin sneez rhinorrhea nasal obstruct observ oral administr te num week num safeti te treatment confirm laboratori test inspect general condit conclus te expect safe improv nasal symptom par
MED-2450~protect effect fruit veget mediterranean diet asthma allergi children crete abstract background atopi uncommon children live rural crete wheez rhiniti rare studi undertaken examin discrep attribut high consumpt fresh fruit veget adher tradit mediterranean diet method cross section survey perform num children age num num year rural crete parent complet questionnair child respiratori allerg symptom num item food frequenc questionnair adher mediterranean diet measur scale num dietari item children underw skin prick test num common aeroallergen result num children ate fresh fruit num veget day intak grape orang appl fresh tomato main local product crete associ atopi protect wheez rhiniti high consumpt nut found invers wheez num num ci num num margarin increas risk wheez num num ci num num allerg rhiniti num num ci num num high level adher mediterranean diet protect allerg rhiniti num num ci num num modest protect observ wheez atopi conclus result studi suggest benefici effect common consum fruit veget nut high adher tradit mediterranean diet childhood symptom asthma rhiniti diet explain relat lack allerg symptom popul
MED-2451~diet lung function lung function declin cohort num middl age men abstract background prospect cohort studi num welshmen age num live caerphilli num investig associ diet lung function method baselin phase year follow phase ii forc expiratori volum fev num measur mcdermott spiromet dietari data obtain semi quantit food frequenc questionnair result good lung function high maximum fev num age height high intak vitamin vitamin caroten citrus fruit appl frequent consumpt fruit juices squash lung function invers magnesium intak evid associ fatti fish adjust confound includ bodi mass index smoke histori social class exercis total energi intak associ vitamin appl persist lung function estim num ml num confid interv ci num num higher vitamin intak standard deviat sd num ml higher num ci num num eat appl week compar non consum declin lung function phase signific chang intak appl vitamin associ high averag appl consumpt slow declin lung function lost signific adjust confound conclus strong posit associ lung function number appl eaten week cross section consist protect effect hard fruit soft citrus fruit recent suggest effect revers support longitudin analysi
MED-2452~prospect studi diet adult onset asthma pubm ncbi abstract role diet pathophysiolog asthma mediat alter immun antioxid activ consequ effect airway inflamm evalu associ dietari factor assess semiquantit food frequenc questionnair incid asthma num yr period num women num num yr age women highest quintil vitamin intak diet supplement risk num num confid interv ci num num compar women lowest quintil relationship attenu contribut nut major sourc vitamin data allergen remov relat risk num num num trend num posit associ found vitamin supplement explain women high risk asthma initi vitamin supplement prior diagnosi nonsignific invers associ caroten intak note clear relat asthma demonstr intak linol acid omega num fatti acid data suggest antioxid supplement intak fat adulthood import determin asthma vitamin diet modest protect effect
MED-2453~effect fresh fruit consumpt lung function wheez children abstract background fresh fruit consumpt vitamin intak improv lung function adult due enhanc lung growth reduct lung function declin protect bronchospasm unclear method cross section school base survey num children age num num town england wale main outcom measur forc expiratori volum fev num standardis bodi size sex exposur assess food frequenc questionnair parent measur plasma level vitamin subsampl num children result fev num posit frequenc fresh fruit consumpt adjust confound variabl includ social class passiv smoke ate fresh fruit estim fev num num ml num lower ate item day num ci num num ml associ fev num fruit consumpt stronger subject wheez non wheez num differ trend wheez relat fresh fruit consumpt frequenc consumpt salad green veget fev num relationship weaker fresh fruit plasma vitamin level unrel fev num num num wheez weak relat fresh fruit consumpt num num conclus fresh fruit consumpt benefici effect lung function children work confirm effect restrict subject wheez identifi specif nutrient involv
MED-2455~bronchial reactiv dietari antioxid abstract background postul dietari antioxid influenc express allerg diseas asthma test hypothesi case control studi perform nest cross section studi random sampl adult investig relationship allerg diseas dietari antioxid method studi perform rural general practic grampian scotland valid dietari questionnair measur food intak case defin peopl season allergic typ symptom bronchial hyperreact confirm methacholin challeng control allerg symptom bronchial reactiv result case season symptom differ control respect presenc atopi increas risk symptom lowest intak zinc lowest intak vitamin manganes fivefold increas risk bronchial reactiv decreas intak magnesium signific increas risk hyperreact conclus studi evid diet modulatori effect bronchial reactiv consist hypothesi observ reduct antioxid intak british diet num year factor increas preval asthma period
MED-2456~diet asthma allerg rhinoconjunct atop eczema symptom preval ecolog analysi intern studi asthma pubm ncbi abstract studi suggest increas preval symptom asthma rhiniti eczema dietari factor present paper global analysi preval rate wheez allerg rhinoconjunct atop eczema perform relat diet defin nation food intak data analys base intern studi asthma allergi childhood isaac data num num yr children symptom wheez allerg rhinoconjunct atop eczema symptom preval regress capita food intak adjust gross nation product account econom develop dietari data base num food agricultur organis unit nation data num num countri part isaac phase num num year age group show consist pattern decreas symptom wheez current sever allerg rhinoconjunct atop eczema increas capita consumpt calori cereal rice protein cereal nut starch veget veget nutrient video questionnair data num yr isaac data num yr show similar pattern food consist invers relationship preval rate condit intak starch cereal veget find generalis averag daili consumpt food increas specul import decreas symptom preval achiev
MED-2458~manipul antioxid intak asthma random control trial pubm ncbi abstract background antioxidant rich diet reduc asthma preval epidemiolog studi previous show short term manipul antioxid defens lead asthma outcom object object investig effect high antioxid diet compar low antioxid diet lycopen supplement asthma design asthmat adult num random assign high antioxid diet num serv veget num serv fruit daili num low antioxid diet num serv veget num serv fruit daili num num commenc parallel random control supplement trial subject consum high antioxid diet receiv placebo subject consum low antioxid diet receiv placebo tomato extract num mg lycopene d intervent continu week num exacerb occur result num subject consum low antioxid diet lower percentag predict forc expiratori volum num percentag predict forc vital capac consum high antioxid diet subject low antioxid diet group increas plasma c reactiv protein week num end trial time exacerb greater high antioxid low antioxid diet group low antioxid diet group num num ci num num num time exacerb subject low antioxid diet group differ airway system inflamm clinic outcom observ group consum tomato extract consum placebo conclus modifi dietari intak carotenoid alter clinic asthma outcom improv evid increas fruit veget intak suggest whole food intervent effect trial regist http   www actr org au actrn num
MED-2459~effect dietari pattern measur lipid peroxid result random clinic trial pubm ncbi abstract background free radical medi oxid damag lipid thought import process pathogenesi atherosclerosi previous studi demonstr benefici impact antioxid vitamin supplement lipid peroxid effect dietari pattern lipid peroxid unknown method result num week run in period random trial num healthi individu fed control diet low fruit veget dairi product num calori fat particip random consum num week num control diet num diet rich fruit veget similar control diet num combin diet rich fruit veget low fat dairi product reduc fat serum oxygen radical absorb capac malondialdehyd vitro measur lipid peroxid breath ethan vivo measur lipid peroxid measur end run in intervent period run in intervent num ci chang oxygen radical absorb capac u ml num num control diet num num fruit veget diet num compar control num num combin diet num compar control median interquartil rang chang ethan num num num control diet num num num fruit veget diet num compar control num num num combin diet num compar control chang malondialdehyd differ diet conclus studi demonstr modif diet favor affect serum antioxid capac protect lipid peroxid
MED-2460~airway circul level carotenoid asthma healthi control pubm ncbi abstract background elev oxid stress impair antioxid defenc increas recognis featur asthma carotenoid potent dietari antioxid protect asthma reduc oxid damag object studi aim characteris circul airway level carotenoid asthma compar healthi control relat dietari intak studi aim test airway lycopen defenc improv oral supplement method induc sputum peripher blood sampl collect subject asthma num healthi control num dietari carotenoid intak estim num hour recal method analys modifi version foodwork num nutrient calcul softwar group healthi control num supplement num mg day lycopen num week carotenoid beta caroten lycopen alpha caroten beta cryptoxanthin lutein zeaxanthin measur hplc result similar dietari intak blood level total carotenoid lycopen lutein beta cryptoxanthin alpha caroten beta caroten signific lower asthma control differ plasma sputum carotenoid level induc sputum carotenoid level signific lower plasma blood level correl strong plasma level num num increas plasma sputum lycopen level supplement airway lycopen level correl plasma level num num conclus blood plasma sputum carotenoid level defici asthma plasma carotenoid level reflect airway carotenoid level plasma level improv oral supplement reflect airway
MED-2461~associ diet respiratori symptom asthma schoolchildren taipei taiwan pubm ncbi abstract studi aim evalu associ diet respiratori symptom asthma schoolchildren taipei taiwan in class interview survey elicit experi asthma respiratori symptom consumpt frequenc major food categori num grader respiratori symptom survey includ persist cough chest tight wheez cold wheez cold dyspnea associ wheez exercise induc cough wheez result show consumpt sweeten beverag strongest associ respiratori symptom posit respiratori symptom num adjust odd ratio aor rang num num confid interv ci num num exercise induc cough num num ci num num wheez cold egg consumpt num num respiratori symptom consumpt seafood soy product fruit negat respiratori symptom num consumpt seafood negat physician diagnos asthma consumpt sweeten beverag egg posit suspect asthma num conclus studi suggest diet respiratori symptom schoolchildren taipei consumpt sweeten beverag egg increas risk respiratori symptom asthma consumpt soy product fruit reduc risk respiratori symptom
MED-2464~low veget intak allerg asthma moderate to sever airway hyperrespons pubm ncbi abstract background recent decad children diet qualiti chang asthma preval increas remain unclear event object examin children total compon diet qualiti asthma airway hyperrespons ahr proxi asthma sever method food frequenc questionnair adapt nurs health studi supplement food nutrient garner interest late relat asthma administ data diet qualiti score total compon base youth healthi eat index yhei adapt develop asthma assess perform pediatr allergist classifi atop status allerg asthma num posit skin prick test common allergen num mm compar negat control versus non allerg asthma negat skin prick test ahr assess cockcroft techniqu particip includ num boy num asthma num girl num asthma involv num manitoba prospect cohort studi nest case control studi logist regress examin associ diet qualiti asthma multinomi logist regress examin associ diet qualiti ahr result hundr seventi children num boy num num year asthma ahr preval num num fulli adjust model high veget intak protect allerg asthma num num ci num num num moderate sever ahr num num num num conclus veget intak invers allerg asthma moderate sever ahr copyright num wiley period
MED-2468~preval risk factor self report asthma adult indian popul cross sect survey abstract background method estim preval self report asthma adult indian examin risk factor influenc diseas preval analysi base num women num men age num num year includ india nation famili health survey num num multipl logist regress analysi estim preval odd ratio asthma adjust risk factor result preval self report asthma num num ci num num men num num ci num num women higher rate rural urban area mark geograph differ adjust asthma risk factor women num time asthma men daily week consumpt milk milk product green leafi veget fruit lower asthma risk consumpt chicken meat lower bodi mass index bmi num kg m num num num ci num num higher bmi num kg m num num num ci num num current tobacco smoke num num ci num num alcohol num num ci num num increas asthma risk conclus wide region variat preval asthma india find bmi associ asthma risk factor weak account small proport case sum context thode nous avon estim la pr valenc auto rapport de asthm chez les indien adult examin plusieur facteur de risqu influen ant la pr valenc de la maladi analys repos sur num femm num homm de num num inclus dan la troisi enqu te national des famill en ind num num utili analys de gression logistiqu multipl pour estim les odd ratio de pr valenc pour asthm apr ajust pour diver facteur de risqu sultat la pr valenc auto rapport de asthm est de num ic num num num parmi les homm de num ic num num num parmi les femm les taux tant lev dan les zone rural dan les zone urbain les diff renc ographiqu tant marqu es apr ajust pour les facteur de risqu asthm connus les femm sont num foi suscept de souffrir de asthm les homm la consomm quotidienn ou hebdomadair de lait produit laitier de gume feuill vert de fruit est en associ avec risqu faibl asthm alor la consomm de poulet ou de viand index de mass corporell bmi bas num kg m num num ic num num num ainsi qu bmi lev num kg m num num ic num num num le fait de fumer du tabac actuel num ic num num num utilis de alcool moment quelconqu num ic num num num sont en associ avec risqu accru asthm la pr valenc de asthm en ind vari largement selon les gion toutefoi des observ sur le bmi associ de asthm avec les facteur de risqu est relativ faibl ne rend compt une petit proport des cas seulement resumen marco de referencia todo se calcul la prevalencia de asma autorreferida en los adulto en la india se evaluaron vario factor de riesgo influyen sobr la prevalencia de la enfermedad el estudio se bas en las num mujer los num hombr de num num os de edad participaron en la tercera encuesta nacion sobr la salud de la familia en la india entr el num el num mediant lisi de regresi log stica multifactori se calcul la prevalencia de asma el cocient de posibilidad de padecerla al corregir diverso factor de riesgo resultado la prevalencia de asma autorreferida fue num en los hombr intervalo de confianza ic del num num num num en las mujer ic num num num se observaron tasa alta en las zona rural en las zona urbana se presentaron diferencia geogr fica tras corregir en funci de alguno factor de riesgo de padec asma conocido las mujer presentaron una probabilidad num vece superior los hombr de sufrir la enfermedad el consumo diario seman de lech producto cteo hortaliza de hoja verd fruta se asoci con menor riesgo de asma el consumo de carn de pollo de res bajo ndice de masa corpor num kg m num num ic num num num igual alto ndice de masa corpor num kg m num num ic num num num el tabaquismo actual num ic num num num el consumo de alcohol en alg momento de la vida num ic num num num se asociaron con mayor riesgo de padec la enfermedad conclusi existen amplia variacion geogr fica en la prevalencia de asma en la india sin embargo con la excepci del ndice de masa corpor la mayor part de las asociacion del asma con los factor de riesgo fueron bile explican solo una pequ proporci de los caso
MED-2469~anthroposoph lifestyl intestin microflora infanc pubm ncbi abstract intestin flora consid impact develop immun system anthroposoph lifestyl diet compris veget spontan ferment lactobacilli restrict antibiot anti pyret vaccin typic aim studi assess gut flora infant relat lifestyl characterist anthroposophi sixty nin children num year age anthroposoph lifestyl num infant similar age tradit lifestyl clinic examin questionnair repli assess fecal sampl analyz bacteri enumer bacteri type biochem fingerprint measur microflora associ characterist mac number colony form unit cfu g fece signific higher enterococci lactic acid bacteria children expos antibiot num num num num num num num num num num number enterococci signific higher breastf vegetarian infant num divers simpson divers index lactobacilli determin biochem fingerprint higher infant born home born hospit num mac relat specif lifestyl featur infant anthroposoph lifestyl higher proport acet acid lower proport propion acid stool compar control children conclus lifestyl factor relat anthroposoph life influenc composit gut flora infant differ contribut lower preval atop diseas previous observ children anthroposoph famili
MED-2471~popul level environment factor asthma rhinoconjunct eczema review ecolog analys isaac phase abstract intern studi asthma allergi childhood isaac phase show larg worldwid variat preval symptom asthma rhinoconjunct eczema num num fold countri ecolog analys undertaken isaac phase data explor factor contribut variat summaris review isaac phase preval symptom past num month asthma rhinoconjunct eczema estim studi num children age num num year num centr num countri num children age num year num centr num countri ecolog analys undertaken symptom preval gross nation product capita gnp food intak immunis rate tuberculosi notif climat factor tobacco consumpt pollen antibiot sale paracetamol sale outdoor air pollut symptom preval condit posit gnp tran fatti acid paracetamol women smoke invers food plant origin pollen immunis tuberculosi notif air pollut men smoke magnitud associ small consist direct condit mix associ climat antibiot sale symptom preval potenti causal associ warrant investig factor prevent develop condit absenc posit correl popul level import polici viewpoint focus posit risk factor intervent base small associ potenti larg public health benefit
MED-2472~vegan regimen reduc medic treatment bronchial asthma pubm ncbi abstract thirty f patient suffer bronchial asthma averag num yr receiv long term medic num includ cortison subject therapi vegan food num yr case medic withdrawn drastic reduc signific decreas asthma symptom twenty four patient num fulfil treatment num report improv num month num num yr signific improv number clinic variabl vital capac forc expiratori volum sec physic work capac signific chang biochem indic haptoglobin igm ige cholesterol triglycerid blood select patient fear side effect medic interest altern health care replac convent medic regimen
MED-2474~intern studi asthma allergi childhood isaac phase global synthesi pubm ncbi abstract isaac phase synthesi summaris inform main find studi region tabl figur relat preval sever current symptom asthma rhinoconjunct eczema main region world larg number survey children num num larg number centr num countri num particip isaac phase make studi comprehens survey diseas undertaken global preval current asthma rhinoconjunct eczema num year age group num num num num year age group preval current asthma rhinoconjunct eczema num num num studi show wide variabl preval sever asthma rhinoconjunct eczema occur region countri centr countri centr citi studi definit establish preval diseas high non afflu centr low socioeconom condit larg variabl suggest crucial role local environ characterist determin differ preval place isaac phase provid larg bodi epidemiolog inform asthma rhinoconjunct eczema childhood contrast environ expect yield clue aetiolog condit reason mark global variabl copyright num seicap publish elsevi espana reserv
MED-2475~effect exclus dietari egg milk manag asthmat children pilot studi pubm ncbi abstract current understand exclus diet manag asthma children limit controversi aim studi examin effect exclud egg milk occurr symptom children asthma involv num children age num year clinic diagnos mild moder diseas investig singl blind prospect parent option volunt join experi group avoid egg milk product week control group consum customari food thirteen children recruit experiment group control group train paediatrician begin end studi period assess children seven day assess food intak made immedi period dietari intervent group blood sampl child determin food specif antibodi children peak expiratori flow rate pefr measur base recommend nutrient intak rni percentag energi intak children experiment group signific lower num experiment group eight week studi period compar baselin valu serum anti ovalbumin igg anti beta lactoglobulin igg concentr statist signific reduc num experiment group contrast valu anti ovalbumin igg control group signific increas anti beta lactoglobulin igg practic unchang total ige valu unchang group studi period pefr children experiment group perform test signific increas chang note children control group test result suggest short time period week egg milk fre diet reduc atop symptom improv lung function asthmat children
MED-2476~diet infect wheezi ill lesson adult pubm ncbi abstract increas asthma atop diseas record countri societi prosper investig explan reduct childhood infect chang diet cohort peopl num origin select random sampl primari school children investig relev famili size common childhood infecti diseas develop eczema hay fever asthma membership larg famili reduc risk hay fever eczema asthma explain infect child suffer infect child greater likelihood asthma measl gave modest measur protect investig dietari factor separ studi shown risk bronchial hyper react increas seven fold lowest intak vitamin lowest intak satur fat gave num fold protect shown risk adult onset wheezi ill increas five fold lowest intak vitamin doubl lowest intak vitamin result support direct measur vitamin triglycerid plasma propos diet pregnant women reflect observ popul result birth cohort children predispos atopi asthma direct test studi diet nutrit status larg cohort pregnant women follow offspr forward current research
MED-2479~intestin microflora allerg estonian swedish num year old children pubm ncbi abstract background preval allerg diseas increas past num year allerg diseas common children socialist countri central eastern europ compar western europ suggest reduc microbi stimul infanc earli childhood result slower postnat matur immun system develop optim balanc num num immun aim test hypothesi allerg diseas children differ intestin microflora countri low estonia high sweden preval allergi method prospect studi develop allergi relat environment factor num estonian num swedish num year old children select nonallerg num confirm diagnosi allergi num verifi typic histori posit skin prick test egg cow milk weigh sampl faec serial dilut num num grown anaerob condit count genera speci calcul child addit relat amount microb express proport total count result allerg children estonia sweden colon lactobacilli num compar nonallerg children countri contrast allerg children harbour higher count aerob micro organ num coliform num staphylococcus aureus num proport aerob bacteria intestin flora higher allerg children num opposit true anaerob num similar allerg children proport coliform higher num bacteroid lower num nonallerg children conclus differ indigen intestin flora affect develop prime immun system earli childhood similar shown rodent role intestin microflora relat develop infant immun consequ allerg diseas life requir studi readili intervent primari prevent allergi administr probiot bacteria
MED-2482~random placebo control trial lactobacillus asthmat children allerg rhiniti pubm ncbi abstract previous studi suggest probiot administr therapeut and or prevent effect atop dermat infant role allerg airway diseas remain controversi determin daili supplement specif lactobacillus gasseri num num week improv clinic symptom immunoregulatori school children suffer asthma allerg rhiniti ar conduct random double blind placebo control studi school children age num year asthma ar elig studi subject receiv gasseri num num placebo num daili num month pulmonari function test perform clinic sever asthma ar evalu attend physician studi period diari card record day nighttim peak expiratori flow rate pefr symptom asthma ar score patient measur outcom treatment immunolog paramet total ige cytokin product peripher blood mononuclear cell pbmcs determin probiot treatment result show pulmonari function pefr increas signific clinic symptom score asthma ar decreas probiotic tr patient compar control signific reduct tnf ifn il num il num product pbmcs probiot treatment conclus probiot supplement clinic benefit school children suffer allerg airway diseas asthma ar
MED-2484~burden childhood asthma abstract paediatr asthma major clinic concern worldwid repres huge burden famili societi account larg number lost school day depriv child academ achiev social interact childhood asthma place strain healthcar resourc result doctor hospit visit cost treatment preval asthma vari worldwid possibl exposur respiratori infect indoor outdoor pollut diet risk factor predispos children develop asthma atop diseas includ incid sever wheez atopi matern smoke number fever episod paper discuss burden preval risk factor paediatr asthma
MED-2488~food price blood cholesterol pubm ncbi abstract cardiovascular diseas cvd cost american billion dollar year high cholesterol level close relat dietari habit major contributor cvd articl studi food price relat cholesterol level tax subsidi food effect lower cholesterol level cvd cost find price veget process food milk grain signific blood cholesterol level analyz cost benefit govern intervent find subsidi veget grain effici reduc cvd expenditur publish elsevi
MED-2489~agricultur polici food public health abstract histor view agricultur system evolv contribut obes diseas
MED-2490~arsenic organ food brown rice syrup abstract background rice major sourc inorgan arsenic asi sub popul rice product ingredi prepar food rice base organ brown rice syrup obr sweeten organ food product altern high fructos corn syrup hypothes obr introduc product object determin concentr speciat commerci brown rice syrup product obr includ toddler formula cereal energi bar high energi food endur athlet method induct coupl plasma mass spectrometri icp m ion chromatographi coupl icp m determin total astot concentr speciat product purchas internet store hanov hampshir area discuss found obr high concentr asi dimethyl arsen dma organ toddler milk formula obr primari ingredi astot concentr time environment protect agenc safe drink water limit cereal bar high energi food obr higher concentr equival product obr asi main speci food product test studi conclus regul applic food find suggest obr product evalu introduc signific concentr asi individu diet conclud urgent regulatori limit food
MED-2491~arsenic lead juic appl citrus apple bas pubm ncbi abstract exposur limit arsenic lead drink water long establish environment protect agenc regul presenc contamin bottl water effect california num compar exposur limit regul juic beverag arsenic lead studi articl num appl juic cider num apple contain juic grape citrus juic analyz arsenic lead arsenic detect juic lead detect num juic analyz twelv sampl num demonstr arsenic level drink water exposur limit num part billion juic lead drink water exposur limit expand drink water limit includ juic frequent consum beverag protect consum regular test juic inform consum risk pose specif juic brand
MED-2492~roxarson inorgan arsenic arsenic speci chicken base market basket sampl abstract background inorgan arsenic ia cancer possibl advers health outcom arsenic bas drug permit poultri product contribut chicken consumpt ia intak unknown object sought character arsenic speci profil chicken meat estim bladder lung cancer risk consum chicken produc arsenic bas drug method convent antibiotic fre organ chicken sampl collect groceri store num metropolitan area decemb num june num test num raw num cook chicken sampl total arsenic determin arsenic speci num raw num cook sampl total arsenic num g kg dri weight result geometr gm total arsenic cook chicken meat sampl num g kg num ci num num num cook sampl speciat ia concentr higher convent sampl gm num g kg num ci num num antibiotic fre gm num g kg num ci num num organ gm num g kg num ci num num sampl roxarson detect num num convent sampl num num antibiotic fre sampl num organ sampl ia concentr roxarsone posit sampl gm num g kg num ci num num signific higher roxarsone neg sampl gm num g kg num ci num num cook increas ia decreas roxarson concentr estim consum convent chicken ingest addit num g day ia num serv compar consum organ chicken assum lifetim exposur propos cancer slope factor num milligram kilogram bodi weight day increas arsenic exposur result num addit lifetim bladder lung cancer case num expos person conclus convent chicken meat higher ia concentr convent antibiotic fre organ chicken meat sampl cessat arsenic drug reduc exposur burden arsenic rel diseas chicken consum
MED-2493~environment toxic develop immun system miss link global battl infecti diseas abstract compel evid development exposur chemic environ contribut diseas life anim model support concept reproduct metabol neurodegen diseas contrast data development exposur impact suscept immun system function alter life surpris scant immun system form integr network detect destroy invad pathogen cancer cell bodi line defens consequ early lif exposur reduc immun function profound review summar data pollut cigarett smoke dioxin lik compound consist support idea development exposur critic impact immun system find suggest exposur common chemic daili environ repres overlook contributor fact infecti diseas remain top death worldwid
MED-2494~cancer non canc health effect food contamin exposur children adult california risk assess abstract background absenc current cumul dietari exposur assess analysi conduct estim exposur multipl dietari contamin children vulner toxic exposur adult method estim exposur multipl food contamin base dietari data preschool ag children num num year num school ag children num num year num parent young children num older adult num compar exposur estim eleven toxic compound acrylamid arsenic lead mercuri chlorpyrifo permethrin endosulfan dieldrin chlordan dde dioxin base self report food frequenc data age group determin cancer non canc benchmark level exceed chemic level food deriv public databas includ total diet studi result cancer benchmark level exceed children num arsenic dieldrin dde dioxin non canc benchmark exceed num preschool ag children acrylamid num preschool ag children mercuri preschool ag children signific higher estim intak num num compound compar school ag children num num base self report dietari data greatest exposur pesticid food includ analysi tomato peach appl pepper grape lettuc broccoli strawberri spinach dairi pear green bean celeri conclus dietari strategi reduc exposur toxic compound cancer non canc benchmark exceed children vari compound strategi includ consum organ produc dairi select fruit veget reduc pesticid intak consum anim food meat dairi fish reduc intak persist organ pollut metal consum lower quantiti chip cereal cracker process carbohydr food reduc acrylamid intak
MED-2495~prenat exposur polychlorin biphenyl dioxin matern diet immunosuppress effect persist int pubm ncbi abstract investig prenat exposur matern diet toxic polychlorin biphenyl pcbs dioxin develop immune rel diseas childhood children particip bramat sub cohort norwegian mother child cohort studi moba year life annual questionnair num year num num ear num blood paramet examin year age num matern intak toxic calcul valid food frequenc questionnair moba matern exposur pcbs dioxin found increas risk wheez frequent upper respiratori tract infect matern exposur pcbs dioxin found reduc antibodi respons measl vaccin associ found prenat exposur immunophenotyp data allerg sensit vaccine induc antibodi respons measl result suggest prenat dietari exposur pcbs dioxin increas risk wheez suscept infecti diseas earli childhood copyright num elsevi reserv
MED-2496~fish intak breastfeed time serum concentr organochlorin swedish popul pubm ncbi abstract persist organ pollut pop exert harm effect cognit endocrin immun function bioaccumul environ human tissu aim studi investig bodi burden pop adult popul num associ diet lifestyl factor swedish nation survey serum concentr polychlorin biphenyl pcbs pesticid hexachlorobenzen hcb hexachlorocyclohexan hch chlordan compound dichlorodiphenyldichloroethylen dde determin liquid liquid extract silica column cleanup gas chromatographi high resolut mass spectrometri diet assess num day food record complementari dietari lifestyl factor questionnair fish intak addit assess plasma fatti acid composit cluster compound reveal pcbs separ cluster includ low chlorin pcb num num high chlorin mono di ortho pcbs suggest similar dissimilar exposur sourc possibl toxicokinet men num num higher level pcb num chlordan compound compar women part explain elimin pop women report histori breastfeed proport long chain num fatti acid plasma posit correl pollut num pcb num num pcb num num pcb num num hcb num hch num chlordan compound num p  dde num individu consum fatti baltic fish num time month num higher serum level pcb num compar non consum level pcb num age residenti build conclud population distribut approach survey dietari habit lifestyl factor pop bodi burden made identifi person characterist pop bodi burden sweden copyright num elsevi reserv
MED-2497~prenat exposur polychlorin biphenyl dioxin increas risk wheez infect infant pubm ncbi abstract birth cohort bramat num sub cohort norwegian mother child cohort studi moba conduct norwegian institut public health establish studi prenat exposur toxic matern diet affect immunolog health outcom children report environment pollut polychlorin biphenyl pcbs dioxin acrylamid generat food heat treatment frequenc common infect eczema itchi period num day dri cough chest tight wheez call wheez children year life assess questionnair data num prenat dietari exposur toxic estim valid food frequenc questionnair moba prenat exposur pcbs dioxin found increas risk wheez exanthema subitum increas frequenc upper respiratori tract infect found associ prenat exposur acrylamid health outcom investig result suggest prenat dietari exposur dioxin pcbs increas risk wheez infecti diseas year life copyright num elsevi reserv
MED-2498~dietari restrict growth factor age yeast human abstract dietari restrict dr reduc growth factor signal elev resist oxid stress reduc macromolecular damag increas lifespan model organ rodent dr decreas growth factor signal reduc incid tumor slow cognit declin age dr reduc cancer cardiovascular diseas mortal monkey reduc metabol trait diabet cardiovascular diseas cancer human neoplasia diabet rare human loss function mutat growth hormon receptor dr reduc growth factor signal slow age similar evolutionarili conserv mechan review conserv anti ag pathway model organ discuss link diseas prevent mammal negat side effect hinder intervent intend extend healthi lifespan human
MED-2501~amino acid sens regul mtorc num pubm ncbi abstract amino acid play fundament role cell build block protein metabol precursor adapt limit period protein starvat multipl adapt mechan evolv includ rapid cessat protein synthesi increas amino acid biosynthesi transport autophagi discuss amino acid limit sens sens transmit mtorc num regul protein synthesi autophagi copyright num elsevi reserv
MED-2502~macronutri balanc lifespan abstract dietari restrict dr malnutrit wide regard univers mechan prolong lifespan general believ benefit dr aris eat fewer calori term calor restrict cr argu calori key determin relationship diet longev balanc protein non protein energi ingest ratio affect lifespan total energi intak metabol immun likelihood develop obes metabol disord mechan link macronutri balanc lifespan nexus tor ampk signal pathway emerg central coordin
MED-2504~nutrient control torc num cell cycl regul pubm ncbi abstract establish target rapamycin tor protein kinas pivot role control cell function includ protein synthesi cell growth cell prolifer implic numer human diseas mammalian tor complex num mtorc num signal activ hormon growth factor stimul intracellular amino acid recent research provid import insight poor understood mechan amino acid activ mtorc num signal show protein kinas map num rag gtpase import role mtorc num control num transit cell cycl data show torc num control num progress yeast mammal albeit contrast
MED-2505~ten year life matter choic pubm ncbi abstract background relat risk estim suggest effect implement behavior common advoc prevent medicin increas life expect direct evid object test hypothesi choic diet exercis smoke influenc life expect method total num california seventh day adventist num elig enrol cohort num num mail questionnair provid dietari exposur inform studi baselin mortal subject ascertain match state death tape nation death index result california adventist higher life expect age num year white californian num year num confid interv num num year men num year num confid interv num num year women give highest life expect formal popul common observ combin diet exercis bodi mass index past smoke habit hormon replac therapi women account differ num year life expect adventist comparison life expect factor high risk compar low risk valu show independ effect vari num num year variabl effect variabl assess medium high risk level conclus choic diet exercis cigarett smoke bodi weight hormon replac therapi combin chang life expect year longev experi adventist demonstr benefici effect optim behavior
MED-2506~calor restrict tradit okinawan diet healthi age diet world longest liv peopl potenti impact mor pubm ncbi abstract long term calor restrict cr robust reduc age rel diseas extend life span multipl speci effect human unknown low calor intak long life expect high preval centenarian okinawa argument support cr hypothesi human long term epidemiolog analysi conduct tradit dietari pattern energi balanc potenti cr phenotyp specif cohort okinawan purport calor restrict diet cohort subsequ mortal experi rigor studi investig decad archiv popul data elder cohort okinawan age num evid cr analys includ tradit diet composit energi intak energi expenditur anthropometri plasma dhea mortal age rel diseas current surviv pattern find includ low calor intak negat energi balanc younger age weight gain age life long low bmi high plasma dhea level older age low risk mortal age rel diseas surviv pattern consist extend maximum life span studi lend epidemiolog support phenotyp benefit cr human consist well known literatur anim regard cr phenotyp healthi age
MED-2507~mtorc num activ determin cancer risk  ration cancer prevent effect adiponectin metformin rapamycin low protein pubm ncbi abstract increas plasma level adiponectin metformin therapi diabet rapamycin administr transplant patient lifelong consumpt low protein plant bas diet link decreas risk cancer benefit mediat part down regul activ mtorc num complex key regul protein translat boost effect avail translat initi eif num mtorc num activ promot translat number weak mrnas code protein up regul cancer promot cellular prolifer invas angiogenesi abet cancer promot chemoresist oppos apoptosi measur inhibit eif num activ direct indirect util cancer prevent treatment cancer eif num drive malign eif num overexpress cancer strategi target eif num directly  som assess clinically  may broadest efficaci regard weak mrnas code protein promot malign behavior chemoresist regul transcript nf kappab and or stat num activ high proport cancer regimen concurr target eif num nf kappab stat num suppress protein transcript translat level potenti achiev mark reduct express copyright num elsevi reserv
MED-2509~amino acid sens dietary restriction medi longev role signal transduc kinas gcn num tor abstract dr dietari restrict reduc food intak malnutrit extend longev improv metabol fit increas stress resist wide rang organ dr refer calori restrict impli reduc energi intak respons widespread evolutionarili conserv benefit recent data dietari amino acid restrict key mediat dr benefit fruitfli imbal essenti amino acid intak thought underli longev benefit dr mammal reduc dietari protein essenti amino acid intak extend longev improv metabol fit increas stress resist present paper review evolutionarili conserv signal transduct pathway respons sens amino acid level eif num eukaryot initi factor num kinas gcn num general amino acid control non derepress num sens absenc amino acid virtu direct bind uncharg cognat trnas presenc amino acid leucin permit activ master growth regul kinas tor target rapamycin signal transduct pathway react amino acid depriv inhibit general protein translat time increas translat specif mrnas involv restor homoeostasi pathway contribut regul longev metabol fit stress resist
MED-2510~compar meta analyt insight life extens dietari restrict pubm ncbi abstract dietari restrict dr extend lifespan wide rang speci univers effect quantit examin report comprehens compar meta analysi dr studi speci dr signific increas lifespan effect modul factor general dr effect extend lifespan male non model organ surpris proport protein intak import life extens dr degre calor restrict show reduct age depend age independ mortal rate drive life extens dr well studi laboratori model speci yeast nematod worm fruit fli rodent result suggest converg adapt laboratori condit explain observ dr longev relationship evolutionari conserv altern explan num author age cell num blackwel publish ltd anatom societi great britain ireland
MED-2511~okinawan diet health implic low calori nutrient dens antioxidant rich dietari pattern low glycem load pubm ncbi abstract resid okinawa southernmost prefectur japan long averag life expect high number centenarian accompani low risk age associ diseas longev advantag okinawa thought relat healthi lifestyl tradit diet low calori nutrit dens regard phytonutri form antioxid flavonoid research suggest diet reduc risk chronic diseas similar tradit okinawan diet veget fruit heavi phytonutri antioxid rich reduc meat refin grain satur fat sugar salt full fat dairi product characterist diet okinawa share healthi dietari pattern tradit mediterranean diet modern dash dietari approach stop hypertens diet featur low level satur fat high antioxid intak low glycem load diet contribut decreas risk cardiovascular diseas cancer chronic diseas multipl mechan includ reduc oxid stress comparison nutrient profil dietari pattern show tradit okinawan diet lowest fat intak term satur fat highest carbohydr intak high intak antioxidant rich calorie poor orange yellow root veget sweet potato green leafi veget deeper analys individu compon okinawan diet reveal tradit food herb spice consum regular basi label function food explor potenti health enhanc properti
MED-2512~extend healthi age nutrient sensit pathway centenarian popul abstract age challeng live organ human longev complex phenotyp increas life expect maintain long term health function well b age essenti goal increas understand age work advantag analyz phenotyp centenarian exampl success age healthi age involv interact gene environ lifestyl factor diet evalu specif gene environ interact relat longev import focus attent modifi lifestyl factor diet nutrit achiev extens health span understand human longev assist design strategi extend durat optim human health articl briefli discuss relev topic age longev focus dietari pattern centenarian nutrient sens pathway pivot role regul life span final discuss potenti role nrf num system pro ag signal emphas phytohormet activ
MED-2513~insight benefici effect calor dietari restrict healthi prolong life abstract year evid pour remark effect calor restrict cr conspicu bedfellow age cancer anim model establish reduc calori intak increas life span lower risk age relat diseas cancer cancer cell believ depend glycolysi energi requir normal cell easili target alter energy metabol pathway hallmark cr inhibit growth transplant tumor cr shown inhibit develop spontan radiat chemic induc tumor question potenti anti tumor effect cr human part answer resist cohort women suffer anorexia earli life breast cancer human research benefici effect cr earli stage valid complet mechan anti tumor effect cr clear plausibl involv nutrient sens pathway igf num pathway propos anti ag action overrul fact cancer cell line mutant protein involv igf num pathway fail respond cr addit cr decreas level growth factor anabol hormon inflammatori cytokin oxid marker deregul cancer review discuss anti tumor effect cr describ experi vitro tumor model vivo mous model tumor induc radiat chemic exposur express oncogen delet tumor suppress gene discuss propos mechan cr anti tumor action argu necess gene express studi cancer versus normal cell cr
MED-2514~human lifespan rapid increas solv longev riddl revealed slow ag hypothesi abstract healthi life span rapid increas human age postpon recent exclaim natur find perplex dub longev riddl explain current increas longev discuss genet variant hyper act mtor mtarget rapamycin increas surviv earli life expens acceler age word robust fast age slow ag individu die prematur past recent fast ag individu manag surviv age progress civil num year ago slow ag individu surviv age emerg healthi centenarian discuss slow age manifest postpon healthi age rate deterior independ age entertain hypothet rapamycin era futur human longev
MED-2517~mtor key modul age age rel diseas abstract expert biolog age pharmacolog intervent slow age matter lead target intervent nutrient respons pathway defin mechanist target rapamycin mtor inhibit pathway extend lifespan model organ confer protect grow list age rel patholog character inhibitor pathway clinic approv develop advers side effect preclud healthi individu drug target mtor pathway day wide slow age reduc age rel patholog human
MED-2518~age program abstract age program age continu development growth driven genet pathway mtor iron misunderstood sort program age contrast age purposeless quasi program figur shadow actual program brightest flame cast darkest shadow georg martin
MED-2519~calor restrict human potenti pitfal health concern pubm ncbi abstract date intervent consist shown slow rate age increas maximum lifespan short liv speci life long calori restrict unclear long term calori restrict longer live speci primat human similar effect human studi investig short term calori restrict weight loss program suggest benefici outcom paramet cardiovascular diseas studi long term calori restrict perform self select group human subject show similar effect studi investig qualiti life potenti pitfal long term calori restrict human physiolog psycholog effect calor restrict occur anim impact human life differ calori restrict plethora health benefit mammal reduct age rel diseas cancer magic cr intervent human present number health concern applic impact life experiment anim human potenti pitfal side effect address literatur focus review
MED-2520~tor driven age speed car brake pubm ncbi abstract articl discuss tradit analog age organ rust albeit self repair car mislead true analog speed car enter low spe zone damag slow car brake driver age rust occur simpl analog turn gerontolog upsid articl discuss origin age overactiv mtor target rapamycin pathway age age damag organ damag damag age link age age rel diseas slow age versus age toler suppress age rapamycin
MED-2521~rapamycin ay num antifung antibiot taxonomi produc streptomycet isol activ principl pubm ncbi abstract streptomycet isol easter island soil sampl found inhibit candida albican microsporum gypseum trichophyton granulosum antibiotic produc microorgan character identifi streptomyc hygroscopicus antifung principl extract organ solvent mycelium isol crystallin form rapamycin rapamycin activ candida albican minimum inhibitori concentr ten strain rang num num mug ml appar activ microsporum gypseum trichophyton granulosum lower instabl cultur media prolong incub requir fungi activ observ gram posit gram neg bacteria acut toxic mice low
MED-2522~blood type diet lack support evid systemat review pubm ncbi abstract background diet base abo blood group system promot past decad claim improv health decreas risk diseas knowledg evid support effect blood type diet previous assess scientif literatur object current systemat review publish studi present data relat blood type diet identifi critic apprais grade recommend assess develop evalu grade approach design systemat search perform answer question human group blood type adher specif diet improv health and or decreas risk diseas compar nonadher diet cochran librari medlin embas systemat search sensit search strategi result sixteen articl identifi total num screen refer articl consid elig select criteria identifi articl studi variat ldl cholesterol respons mns blood type low fat diet studi direct answer current question studi show health effect abo blood type diet identifi conclus evid exist valid purport health benefit blood type diet valid claim studi requir compar health outcom particip adher blood type diet experiment group particip continu standard diet control group blood type popul
MED-2523~abo genotyp blood typ diet cardiometabol risk factor abstract background blood typ diet advis individu eat abo blood group improv health decreas risk chronic diseas cardiovascular diseas associ blood type bas dietari pattern health outcom examin object studi determin associ blood typ diet biomark cardiometabol health individual abo genotyp modifi associ method subject num particip toronto nutrigenom health studi dietari intak assess one month num item food frequenc questionnair diet score calcul determin relat adher blood typ diet abo blood group determin genotyp rs num rs num abo gene ancova age sex ethnic energi intak covari compar cardiometabol biomark tertil blood typ diet score result adher type a diet lower bmi waist circumfer blood pressur serum cholesterol triglycerid insulin homa ir homa beta num adher type ab diet lower level biomark num bmi waist circumfer adher type o diet lower triglycerid num match blood typ diet blood group chang effect size associ signific associ found type b diet conclus adher blood typ diet favor effect cardiometabol risk factor associ independ individual abo genotyp find support blood typ diet hypothesi
MED-2524~medic nutrit therapi hypercholesterolemia posit affect patient satisfact qualiti life outcom pubm ncbi abstract heart healthi diet lower cholesterol level assum difficult burdensom negat impact qualiti life qol purpos studi evalu impact medic nutrit therapi mnt versus usual care uc hypercholesterolemia patient satisfact qol nineti ambulatori care patient num men num women age num num random assign receiv mnt dietitian nation cholesterol educ program bas protocol uc physician patient receiv mnt report differ qol relat tast enjoy food compar uc patient mnt group report initi improv qol relat conveni cost low fat diet compar uc group mnt group report signific improv perceiv qol relat self car compar uc group mnt patient satisfi interact visit knowledg abil manag cholesterol eat habit time spent exercis life general mnt patient report negat impact relat low fat diet regard feel restrict diet interfer lifestyl activ difficulti plan purchas prepar meal eat home contrari popular belief appar reduct improv measur qol patient satisfact mnt hypercholesterolemia
MED-2525~global survey physician percept cholesterol manag heart studi pubm ncbi abstract aim guidelin cardiovascular diseas cvd prevent cite high level low dens lipoprotein cholesterol ldl c major risk factor recommend ldl c goal risk group lifestyl advis first lin treatment patient high cholesterol statin recommend high risk patient heart studi investig current practic diagnosi treatment high cholesterol attitud manag condit method physician random select num countri complet confidenti semi structur questionnair result num physician agre particip num respond physician rate cvd lead death physician num perceiv cancer fear ill patient physician num believ smoke greatest cvd risk factor num thought high cholesterol greatest risk physician num guidelin set cholesterol goal primarili nation guidelin num nation cholesterol educ program adult treatment panel iii guidelin num num patient reach maintain cholesterol goal num physician believ suffici number patient achiev goal num feel frustrat effect treat patient cvd conclus result discrep guidelin recommend clinic practic physician risk cvd import achiev healthi cholesterol level cvd prevent wide endors improv communic import cholesterol lower investig initi improv goal achiev physician
MED-2526~diet lifestyl etiolog coronari arteri diseas cornel china studi pubm ncbi abstract investig collect analyz mortal data num diseas includ num cancer num counti num villag rural mainland china blood urin food sampl detail dietari data collect num adult villag analyz varieti nutrit viral hormon toxic chemic factor rural china fat intak half unit state fiber intak num time higher anim protein intak low num intak serum total cholesterol num mg dl rural china versus num mg dl adult age num year unit state coronari arteri diseas mortal num fold greater men num fold greater women chines counterpart combin coronari arteri diseas mortal rate gender rural china invers frequenc intak green veget plasma erythrocyt monounsatur fatti acid posit combin index salt intak urinari sodium plasma apolipoprotein apolipoprotein turn posit anim protein intak frequenc meat intak invers plant protein legum light color veget intak rate diseas correl dietari factor evid threshold benefit accru increas proport plant bas food diet
MED-2527~cross analysi dietari prescript adher num hypercholesterolaem patient pubm ncbi abstract background major issu control serum cholesterol dietet intervent improv patient adher aim explor question barrier motiv cholesterol low diet adher method survey french general practition dietet practic patient hypercholesterolaemia patient attitud approach result analys num doctor person questionnair num patient self survey questionnair patient reason compli prescrib diet includ satisfactori food habit num unwilling suffer nutrit depriv num difficulti concili diet famili life num cholesterol low drug num general good understand patient doctor recommend discrep respect declar doctor larg thought patient explan diet lower cholesterol avoid drug num patient declar kind inform discrep observ barrier motiv patient adher dietet rule difficult compli num patient rememb eat fish num final physician patient display lack confid lipid low diet effici conclus improv patient educ percept risk increas involv dietician motiv explor order improv adher copyright num elsevi masson sas reserv
MED-2528~improv hostil depress relat dietari chang cholesterol lower famili heart studi pubm ncbi abstract object describ negat emot particip cholesterol low studi design cohort studi quantit evalu negat emot relat diet plasma cholesterol level num year dietari intervent program aim reduc plasma cholesterol level set community dwel famili famili heart studi portland oregon particip hundr forty nin men num women num famili age num year measur negat emot includ depress aggress hostil measur hopkin symptom checklist scl num result improv emot state note entir sampl consum low fat high complex carbohydr diet end studi show signific greater improv depress num differ improv num point aggress hostil num differ improv num point reduct plasma cholesterol level num differ improv num compar ate high fat american diet conclus particip cholesterol low program worsen emot state contrari improv diet reduct depress aggress hostil lower plasma cholesterol level
MED-2529~effect very high fib veget fruit nut diet serum lipid colon function pubm ncbi abstract test effect feed diet high fiber fruit veget level fed origin inspir dietari fiber hypothesi relat colon cancer heart diseas prevent eaten earli human evolut ten healthi volunt num metabol diet num week durat diet high veget fruit nut very high fib num num kcal starch bas cereal legum earli agricultur diet low fat contemporari therapeut diet diet intend weight maintain intak num kcal d compar starch bas low fat diet high fib veget diet result largest reduct low dens lipoprotein ldl cholesterol num num num greatest fecal bile acid output num num g d num fecal bulk num num g d num fecal short chain fatti acid output num num mmol d num due increas fecal bulk actual concentr fecal bile acid lowest veget diet num mg g wet weight num maximum lipid reduct occur num week urinari mevalon acid excret increas num high veget diet reflect larg fecal steroid loss conclud high veget fiber intak reduc risk factor cardiovascular diseas possibl colon cancer veget fruit fiber warrant detail investig copyright num saunder compani
MED-2530~pathophysiolog coronari arteri diseas pubm ncbi abstract understand coronari arteri diseas risk atherosclerot process chang great recent year angiograph appar coronari arteri plaqu major myocardi infarct mi unstabl soft plaqu angiograph prone ruptur result infarct import vascular reactiv result diet cholesterol level reveal patient coronari arteri diseas risk infarct occur patient normal total cholesterol level at risk patient identifi ratio total to high dens lipoprotein hdl cholesterol level ratio triglycerid hdl cholesterol level import simpl step assess patient risk practic outlin primari prevent trial demonstr coronari arteri diseas risk lower dramat diet drug therapi
MED-2544~suppress colon cancer dietari phytic acid pubm ncbi abstract larg differ exist human popul frequenc colon cancer epidemiolog evid differ strong influenc countri resid negat correl found fiber content diet frequenc colon cancer prompt hypothesi high fib diet protect reanalysi dietari data equal strong support hypothesi protect element phytic acid inositol hexaphosph heat acid st substanc present high concentr food item includ cereal grain nut seed phytic acid form chelat metal suppress damag iron catalyz redox reaction colon bacteria shown produc oxygen radic appreci amount dietari phytic acid suppress oxid damag intestin epithelium neighbor cell rapid accumul data anim model dietari supplement phytic acid provid substanti protect experiment induc colon cancer investig yield addit support hypothesi purpos amplif dietari phytic acid content repres simpl method reduc risk colon carcinogenesi
MED-2546~inositol hexaphosph ip num inhibit key event cancer metastasi ii effect integrin focal adhes pubm ncbi abstract background shown inositol hexaphosph ip num natur compound potent anti canc agent inhibit cancer cell adhes extracellular matrix ecm protein lead inhibit cell migrat invas cell adhes ecm mediat specif cell surfac integrin transduc intracellular signal interact activ protein recruit focal adhes hypothes ip num decreas cell adhes suppress integrin receptor subsequ signal pathway materi method analyz integrin express high invas estrogen receptor neg human breast cancer mda mb num cell expos ip num flow cytometri express focal adhes protein investig immunocytochemistri western blot result ip num treatment caus signific num decreas express integrin heterodim alpha num beta num collagen receptor alpha num beta num fibronectin receptor alpha beta num vitronectin receptor flow cytometri show alpha num subunit down regul num express alpha num alpha beta num beta num subunit affect ip num treatment express integrin cell surfac assess dramat num decreas express alpha num beta num ip num treat cell num indic decreas cell surfac express heterodim effect inositol hexasulf num analogu ip num control immunocytochemistri show lack cluster paxillin tyrosine phosphoryl protein ip num treat cell discontinu scatter cell peripheri pattern dens local control cell consist observ focal adhes kinas fak autophosphoryl tyrosin num residu suppress albeit modest ip num treatment suggest down regul integrin medi signal pathway conclus result studi ip num induc inhibit cancer cell adhes migrat invas mediat modul integrin dimer cell surfac express integrin associ signal pathway
MED-2559~effect ip num human neutrophil cytokin product cell morpholog pubm ncbi abstract inositol hexaphosph ip num anti canc properti recent extracellular function observ ip num includ enhanc superoxid product phagocytosi neutrophil presenc microbi stimuli studi investig inflammatori function ip num adher neutrophil effect ip num releas il num tumour necrosi factor tnf alpha il num neutrophil attach plastic laminin num hour respons stimul lipopolysaccharid n formyl met leu ph fmlp investig increas il num secret stimul cell occur presenc ip num incub cell attach laminin ip num num bm effect cell morpholog presenc num num fmlp alter cell shape direct effect ip num cell function trigger sustain assembl f actin exposur neutrophil low level ip num modul select neutrophil function
MED-2568~ip num anti canc agent pubm ncbi abstract inositol hexaphosph insp num ip num ubiquit num microm num mm concentr ip num lower phosphoryl form ip num inositol mammalian cell import regul vital cellular function signal transduct cell prolifer differenti strike anti canc action ip num demonstr vivo vitro base hypothes exogen administ ip num intern dephosphoryl ip num inhibit cell growth addit evid enhanc anti canc effect ip num decreas cellular prolifer ip num differenti malign cell result revers normal phenotyp data strong point involv signal transduct pathway cell cycl regulatori gene differenti gene oncogen tumor suppressor gene bring observ anti neoplast action ip num
MED-2570~vitro investig potenti health benefit australian grown faba bean vicia faba chemoprev capac inhibitori pubm ncbi abstract function properti includ antioxid chemoprev capac inhibitori effect angiotensin convert enzym ace glucosidas pancreat lipas australian grown faba bean genotyp nura rossa tf ic a num investig array vitro assay chromatogram on lin post column derivatis assay coupl hplc reveal exist activ phenol hump colour genotyp lack white colour breed line tf ic a num roast reduc phenol content diminish antioxid activ num measur reagent bas assay diphenylpicrylhydrazyl num azino bi num ethylbenzthiazolin num sulphon acid oxygen radic absorb capac genotyp cell culture bas antioxid activ assay cellular antioxid activ show increas activ colour genotyp roast faba bean extract demonstr cellular protect abil induc dna damag assess raw num cell inhibit prolifer human cancer cell line bl num ag hep num ht num evalu effect faba bean extract non transform human cell ccd num neglig flow cytometr analys show faba bean extract success induc apoptosi hl num acut promyelocyt leukaemia cell faba bean extract exhibit ace glucosidas pancreat lipas inhibitori activ extract nura buff colour rossa red colour compar tf ic a num white colour lowest phenol content exhibit antioxid enzym inhibit activ result import promot utilis faba bean human diet health benefit
MED-2571~efficaci ip num inositol treatment breast cancer patient receiv chemotherapi prospect random pilot clinic studi abstract background prospect random pilot clinic studi conduct evalu benefici effect inositol hexaphosph ip num inositol breast cancer patient treat adjuv therapi patient method patient invas ductal breast cancer polychemotherapi monitor period num fourteen patient stage ductal invas breast cancer involv studi divid random group group subject ip num inositol group placebo group patient laboratori paramet monitor treatment finish patient fill questionnair qlq num qlq br num determin qualiti life result patient receiv chemotherapi ip num inositol cytopenia drop leukocyt platelet count red blood cell count tumor marker unalt group patient ip num inositol signific qualiti life num function status num perform daili activ conclus ip num inositol adjunct therapi valuabl amelior side effect preserv qualiti life patient treat chemotherapi
MED-2572~tradit non western diet pubm ncbi abstract tradit cultur balanc health balanc lifestyl core belief diseas modern civil rare indigen peopl pattern ill western civil rapid develop diseas expos western food lifestyl food medicin interwoven cultur special function food prevent diseas food time food medicin food cultiv cook method maxim communiti health well b method pass generat cook process util enhanc miner nutrient bioavail articl focus research observ food tradit indigen peopl diseas pattern specif food environment factor affect peopl eat tradit food
MED-2573~anti angiogen activ inositol hexaphosph ip num pubm ncbi abstract signific anticanc activ natur occur carbohydr inositol hexaphosph ip num report numer cancer model tumor requir angiogenesi growth metastasi hypothes ip num reduc tumor growth inhibit angiogenesi angiogenesi depend interact endotheli tumor cell investig effect ip num ip num inhibit prolifer induc differenti endotheli cell vitro growth bovin aortic endotheli cell baec evalu mtt prolifer assay inhibit dose depend manner ic num num mm combin ip num vasostatin calreticulin fragment anti angiogen activ synergist superior growth inhibit compound ip num inhibit human umbil vein endotheli cell huvec tube format vitro capillari differenti reconstitut extracellular matrix matrigel disrupt pre form tube ip num signific reduc basic fibroblast growth factor bfgf induc vessel format num vivo matrigel plug assay exposur hepg num human hepatoma cell line ip num num result dose depend decreas mrna level vascular endotheli growth factor vegf assess rt pcr ip num treatment hepg num cell num signific reduc vegf protein level condit medium concentration depend manner num ip num inhibitori effect induc angiogenesi
MED-2574~protect cancer dietari ip num inositol pubm ncbi abstract inositol hexaphosph ip num natur occur polyphosphoryl carbohydr abund present plant sourc high fib diet cereal legum addit found plant ip num mammalian cell smaller amount import regul vital cellular function signal transduct cell prolifer differenti long time ip num recogn natur antioxid recent ip num receiv attent role cancer prevent control experiment tumor growth progress metastasi addit ip num possess signific benefit human health abil enhanc immun system prevent patholog calcif kidney stone format lower elev serum cholesterol reduc patholog platelet activ review show efficaci discuss molecular mechan govern action dietari agent exogen administ ip num rapid cell dephosphoryl lower inositol phosphat affect signal transduct pathway result cell cycl arrest strike anticanc action ip num demonstr experiment model addit reduc cell prolifer ip num induc differenti malign cell enhanc immun antioxid properti contribut tumor cell destruct preliminari studi human show ip num inositol precursor molecul ip num enhanc anticanc effect convent chemotherapi control cancer metastas improv qualiti life abund present regular diet effici absorb gastrointestin tract safe ip num inositol hold great promis strategi cancer prevent therapi evid justifi initi full scal clinic trial human
MED-2575~effect inositol hexaphosph express select metalloproteinas tissu inhibitor il num stimul colon cancer cell abstract introduct matrix metalloproteinas mmps repeat shown play activ role extracellular matrix degrad tumor invas metastasi tissu inhibitor mmps timp well known abil inhibit mmp activ inhibit malign progress inositol hexaphosph ip num phytic acid recogn prevent therapeut effect cancer includ colon vitro studi ip num demonstr inhibit cancer cell adhes migrat present studi effect ip num express mmp timp gene evalu unstimul il num stimul colon cancer cell line caco num materi method real tim qrt pcr valid transcript level select mmp timp gene caco num cell treatment num ng ml il num num mm ip num num num result stimul cell il num result overexpress mmp timp mrnas signific decreas mmp num mmp num mmp num timp num basal express achiev ip num ip num effici downregul mmp num mmp num timp num gene transcript stimul il num num cultur num il num induc mmp num mrna express signific reduc ip num conclus proinflammatori cytokin il num upregul mmp timp mrnas express colon cancer epitheli cell caco num ip num num mm influenc constitut express mmp timp gene downregul il num stimul transcript gene ip num exert anti metastat activ modul mmp timp gene express prevent cancer cell migrat invas
MED-2577~diet colorect cancer case control studi greec pubm ncbi abstract case control studi probe role diet incid colorect cancer undertaken athen greec popul character ethnic homogen substanti heterogen respect dietari habit case seri consist num consecut patient histolog confirm colorect cancer admit larg hospit athen num month period control seri consist orthopaed patient admit hospit time period individu match index case age sex dietari histori frequenc consumpt month week num food item obtain interview case report signific frequent consumpt veget beet spinach lettuc cabbag independ signific frequent consumpt meat notabl lamb beef extrem high veget low meat diet versus high meat low veget diet risk ratio num exist suffici size direct explain substanti part intern variat incid colorect cancer signific associ found beer alcohol beverag signific interact note respect age sex anatom local colon rectum
MED-2578~dietari suppress colon cancer fiber phytat pubm ncbi abstract incid colon cancer differ wide human popul suggest dietari fiber content utmost import invers relat occurr colon cancer high fib diet correl low frequenc colon cancer suggest involv addit dietari constitu inositol hexaphosph phytic acid abund plant seed compon present fiber rich diet author found phytic acid potent inhibitor iron medi generat hazard oxid hydroxyl radic author propos inhibit intracolon hydroxyl radic generat chelat reactiv iron phytic acid explain suppress colon carcinogenesi inflammatori bowel diseas diet rich phytic acid
MED-2579~prostat cancer inositol hexaphosph efficaci mechan pubm ncbi abstract extens scientif data suggest potenti role dietari non dietari phytochem prevent control prostat cancer pca growth progress pca diseas elder male popul slower rate growth progress compar cancer candid diseas prevent intervent pca growth progress involv aberr mitogen surviv signal deregul cell cycl progress accompani gradual accumul genet epigenet period year mechan includ overexpress growth surviv angiogen factor receptor loss decreas tumor suppressor num retinoblastoma cyclin depend kinas inhibitor implic pca growth progress phytochem target molecular event promis role pca prevent and or therapi inositol hexaphosph ip num major constitu cereal legum nut oil seed soybean oral over the count dietary nutri supplement recognis offer health benefit toxic vitro anticanc efficaci ip num observ human mous rat prostat cancer cell complet studi show oral feed ip num inhibit human pca xenograft growth nude mice toxic recent complet pilot studi observ similar prevent effect ip num prostat tumorigenesi tramp model mechanist studi ip num target mitogen surviv signal cell cycl progress pca cell ip num shown target molecular event angiogenesi ip num pleiotrop molecular target efficaci pca suitabl candid agent prevent intervent malign human
MED-2580~high dri bean intak reduc risk advanc colorect adenoma recurr particip polyp prevent trial abstract adequ fruit veget intak suggest protect colorect cancer colorect adenoma recent prospect studi report associ examin associ fruit veget adenomat polyp recurr polyp prevent trial ppt ppt low fat high fib high fruit veget dietari intervent trial adenoma recurr differ rate adenoma recurr particip intervent control arm trial analysi entir ppt trial base cohort multipl logist regress analysi estim odd ratio advanc nonadvanc adenoma recurr quartil baselin chang baselin minus num fruit veget intak adjust age total energyy intak nonsteroid anti inflammatori drug bmi gender signific associ nonadvanc adenoma recurr chang fruit veget consumpt highest quartil chang dri bean intak greatest increas compar lowest signific reduc advanc adenoma recurr num num ci num num trend num median highest quartil chang dri bean intak num higher baselin intak ppt trial base cohort evid dri bean invers advanc adenoma recurr
MED-2581~colorect cancer diet asian population  a case control studi singapor chines pubm ncbi abstract hospital bas case control studi diet colorect cancer conduct chines singapor constitut num popul total num case num control includ histori usual dietari intak year prior interview quantit food frequenc questionnair daili intak nutrient select food item comput stratifi tertil control rang assess risk low medium high intak categori effect adjust analysi age sex chines dialect group occup cancer colon rectum combin signific observ protect effect high crucifer veget intak num num predispos effect high meat veget consumpt ratio num num similar result observ colon cancer rectal cancer num case signific num protect effect observ high intak protein num fibr num beta caroten num crucifer veget num total veget num assess multipl logist regress test trend assess risk extrem highest lowest quintil control rang factor consist signific crucifer veget intak meat veget ratio high relat risk note associ low coffe consumpt num num trend consist trend note fat fibr intak non dietari variabl investig histori cholecystectomi increas risk cancer combin num num colon cancer num num studi asian popul countri southern eastern asia newli undergo industri rapid econom chang reflect chang cancer pattern suggest protect effect dietari constitu notabl crucifer veget import hitherto stress carcinogen potenti fat protein
MED-2582~nonstarch polysaccharid consumpt scandinavian popul pubm ncbi abstract nonstarch polysaccharid nsp intak measur repres sampl num men age num num urban num rural scandinavian popul exhibit num fold differ incid larg bowel cancer intak measur chemic analysi complet duplic portion food eaten day individu nsp intak show rural urban gradient num num g day rural finland num num g day rural denmark versus num num g day urban finland num num g day urban denmark nsp intak calcul food tabl weigh food record num day day duplic collect made intak num num g day higher method direct chemic analysi publish tabl valu outdat inaccur result improv method measur nsp food individu variat day day nsp intak averag nsp intak intak compon sugar invers relat colon cancer incid geograph comparison show relationship individu level diet cancer risk prospect studi requir detail accur method assess nsp consumpt
MED-2583~effect inositol hexaphosph ip num human normal leukaem haematopoiet cell pubm ncbi abstract inositol hexaphosph ip num natur polyphosphoryl carbohydr report signific vivo vitro anticanc activ numer tumour colon prostat breast liver rhabdomyosarcoma confirm activ haematolog malign character mechan ip num action analys effect human leukaem cell line fresh chronic myelogen leukaemia cml progenitor cell combin cellular molecular approach ip num dose depend cytotox effect evalu cell line accumul num phase cell line test molecular level cdna microarray analysi ip num exposur show extens downmodul gene involv transcript cell cycl regul coher upregul cell cycl inhibitor ip num treatment fresh leukaem sampl bone marrow cd num cml progenitor cell signific inhibit granulocyte macrophag colony form unit cfu gm format num comparison normal bone marrow specimen affect differenti effect hl num cell observ result confirm antiprolif activ ip num suggest specif antitumour effect chronic myeloid leukaemia activ gene modul
MED-2584~dietari risk factor colon cancer low risk popul pubm ncbi abstract num year prospect studi author examin relat diet incid colon cancer num non hispan white cohort member adventist health studi california num baselin document report histori cancer risk colon cancer determin proport hazard regress adjust age covari author found posit associ total meat intak risk ratio rr num time week meat intak num num confid interv ci num num trend num subject favor specif type meat posit associ red meat intak rr num time week red meat intak num num ci num num trend num white meat intak rr num time week white meat intak num num ci num num trend num invers associ legum intak rr num times week num time week num num ci num num trend num observ men posit associ bodi mass index observ relat rr tertil iii num kg m num tertil num kg m num num num ci num num trend num complex relat identifi subject exhibit high red meat intak low legum intak high bodi mass experienc threefold elev risk relat pattern base variabl pattern putat risk factor contribut increas insulin resist high bodi mass high red meat intak glycem load low legum intak synerg causal implic hyperinsulinem exposur colon carcinogenesi find cohort identifi red meat intak white meat intak import dietari risk factor colon cancer rais possibl risk due red meat intak reflect complex etiolog
MED-2585~cancer inhibit inositol hexaphosph ip num inositol laboratori clinic pubm ncbi abstract inositol hexaphosph ip num natur occur polyphosphoryl carbohydr present substanti amount plant mammalian cell recent recogn possess multipl biolog function strike anticanc effect ip num demonstr experiment model inositol natur constitu possess moder anticanc activ consist anticanc result obtain combin ip num inositol addit reduc cell prolifer ip num increas differenti malign cell result revers normal phenotyp exogen administ ip num rapid cell dephosphoryl lower phosph inositol phosphat interfer signal transduct pathway cell cycl arrest enhanc immun antioxid properti contribut tumor cell destruct molecular mechan anticanc action fulli understood abund present regular diet effici absorb gastrointestin tract safe ip num hold great promis strategi prevent treatment cancer ip num inositol enhanc anticanc effect convent chemotherapi control cancer metastas improv qualiti life shown pilot clinic trial data strong argu ip num inositol strategi cancer prevent treatment effect safeti ip num inositol therapeut dose determin phase phase ii clinic trial human
MED-2586~systemat review meta analysi clinic trial effect low carbohydr diet cardiovascular risk factor pubm ncbi abstract systemat review meta analysi carri studi effect low carbohydr diet lcd weight loss cardiovascular risk factor search perform pubm cochran central regist control trial scopus databas total num report num clinic investig identifi meet pre specifi criteria meta analysi carri data obtain num obes patient show lcd signific decreas bodi weight num kg num ci num num bodi mass index num kg num ci num num abdomin circumfer num cm num ci num num systol blood pressur num mm hg num ci num num diastol blood pressur num mm hg num ci num num plasma triglycerid num mg dl num ci num num fast plasma glucos num mg dl num ci num num glycat haemoglobin num num ci num num plasma insulin num micro iu ml num ci num num plasma c reactiv protein increas high dens lipoprotein cholesterol num mg dl num ci num num low dens lipoprotein cholesterol creatinin chang signific limit data exist plasma uric acid lcd shown favour effect bodi weight major cardiovascular risk factor effect long term health unknown num author obes review num intern associ studi obes
MED-2587~effect high protein diet coronari blood flow pubm ncbi abstract recent research demonstr success simultan treatment multipl risk factor includ cholesterol triglycerid homocystein lipoprotein lp fibrinogen antioxid endotheli dysfunct inflamm infect dietari factor lead regress coronari arteri diseas recoveri viabl myocardium preliminari work reveal number individu enrol origin studi popular high protein diet effort lose weight increas number individu high protein diet inform effect diet coronari arteri diseas coronari blood flow twenty six peopl studi num year myocardi perfus imag mpi echocardiographi echo serial blood work evalu extent region coronari blood flow region wall motion abnorm independ variabl import develop progress coronari arteri diseas treatment base homocystein lp c reactiv protein c rp triglycerid total cholesterol high dens lipoprotein cholesterol low dens lipoprotein cholesterol low dens lipoprotein cholesterol fibrinogen level variabl independ treat previous report mpi echo perform begin end studi individu num peopl treatment group tg studi modifi dietari intak instruct ten addit individu elect dietari regimen consist high protein high protein group hpg diet believ improv health patient tg demonstr reduct independ variabl studi regress extent sever coronari arteri diseas cad quantit measur mpi recoveri viabl myocardium num myocardi segment patient document mpi echo evalu individu hpg show worsen independ variabl notabl fibrinogen lp c rp increas averag num num progress extent sever cad document vascular territori cumul progress num differ progress extens diseas hpg regress diseas tg statist num signific patient recommend treatment independ variabl regress extent sever coronari arteri diseas cad improv myocardi wall motion function prescrib medic dietari guidelin individu receiv medic treatment high protein diet show worsen independ risk factor addit progress cad result suggest high protein diet precipit progress cai increas lipid deposit inflammatori coagul pathway
MED-2588~low carbohydr diet all caus mortal systemat review meta analysi observ studi abstract object low carbohydr diet combin high protein diet gain widespread popular control weight addit weight loss favor short term effect risk factor cardiovascular diseas cvd object elucid long term effect mortal cvd incid data sourc medlin embas isi web scienc cochran librari clinicaltri gov relev articl publish septemb num cohort studi year follow up period includ review method identifi articl systemat review pertin data select meta analysi pool risk ratio rrs num confid interv cis all caus mortal cvd mortal cvd incid calcul random effect model inverse vari weight result includ num studi systemat review meta analysi pertin data num peopl num cohort studi low carbohydr score num num case death all caus report risk all caus mortal high low carbohydr score signific elev pool rr num ci num num num total num num case cvd death num subject num cohort studi num num incid cvd case num peopl num cohort studi report risk cvd mortal incid statist increas pool rrs num cis num num num num num num analys low carbohydrate high protein score yield similar result conclus low carbohydr diet signific higher risk all caus mortal signific risk cvd mortal incid analysi base limit observ studi large scal trial complex interact low carbohydr diet long term outcom
MED-2589~treat hyperlipidemia elder pubm ncbi abstract background determin effect dietari modif hyperlipidem medic elder sixty f year age patient signific investig date knowledg elev cholesterol tc triglycerid tg level increas risk coronari arteri diseas cad method twenty seven individu treatment group longitudin examin effect diet hyperlipidem medic tc tg level group num num receiv dietari drug therapi group num num receiv dietari counsel concomit hyperlipidem medic subject group num num underw dietari instruct month hyperlipidem medic eighteen month result subject group num demonstr statist increas tc num studi patient group num num num num demonstr statist improv tc reduct dietari counsel effect tc blunt group num dietari counsel discontinu reduct tg level signific num patient group num conclus elder individu signific reduc tc tg level dietari modif minim improv addit hyperlipidem medic
MED-2590~revers heart diseas millennium  th fleme unifi theori pubm ncbi abstract nineteen peopl prior histori document heart diseas studi num month determin effect treatment base immunolog unifi theori vascular diseas subject underw myocardi perfus imag quantifi extent sever coronari arteri diseas assess wall motion abnorm eject fraction nuclear echocardiograph method test repeat end studi treatment consist dietari treatment cholesterol triglycerid homocystein lipoprotein fibrinogen c reactiv protein infect patient dietari recommend demonstr statist reduc diseas major coronari arteri individu high protein diet demonstr statist greater level diseas
MED-2591~negat effect low carbohydr high protein high fat diet small peripher arteri reactiv patient increas cardiovascular pubm ncbi abstract low carbohydr diet increas popular weight loss improv metabol marker type num diabet mellitus num metabol syndrom ms net effect arteri wall function remain unclear object evalu relat dietari macronutri composit small arteri reactiv hyperaemia index sarhi marker small arteri endotheli function cohort patient increas cardiovascular cv risk present cross sect studi includ num patient diet evalu num food intak regist reduc low carbohydr diet score lcds physic examin demograph biochem anthropometri paramet record sarhi measur patient individu lowest lcds quartil num carbohydr num protein num fat higher sarhi valu top quartil num carbohydr num protein num fat num sd num num sd num num result strong patient ms num num sd num num num sd num num num num num sd num num num sd num num multivari analysi demonstr individu highest lcds quartil signific negat coeffici sarhi independ confound num num ci num num num find suggest dietari pattern characteris low amount carbohydr high amount protein fat poorer small arteri vascular reactiv patient increas cv risk
MED-2592~effect pistachio bodi weight chines subject metabol syndrom abstract background studi shown pistachio improv blood lipid profil subject moder hypercholesterolemia reduc risk cardiovascular diseas wide perceiv view eat nut lead bodi weight gain due high fat content purpos investig impact dosag pistachio bodi weight blood pressur blood lipid blood glucos insulin subject metabol syndrom method nineti subject metabol syndrom consist num intern diabet feder metabol syndrom standard diabet enrol endocrinolog outpati clinic beij subject receiv dietari counsel guidelin american heart associ step diet num week run in subject random consum recommend daili serv num pistachio rsg higher daili serv num pistachio hsg pistachio dcg num week result subject group match baselin bmi dcg num num rsg num num hsg num num kg m num signific bodi weight bmi group studi chang baselin time point group entir studi signific differ waist to hip ratio group chang baselin group dcg num num rsg num num hsg num num signific differ detect group triglycerid fast glucos num hour postprandi glucos num gram glucos challeng exploratori analys demonstr glucos valu num num gm glucos challeng signific lower week num compar baselin valu hsg group num num mmol l num similar trend note rsg group num num mmol l num signific chang dcg group num num mmol l num end studi serum triglycerid level signific lower compar baselin rsg group num num mmol l num signific observ hsg dcg group conclus concern pistachio nut consumpt promot weight gain daili ingest num num pistachio num week lead weight gain increas waist to hip ratio chines subject metabol syndrom addit pistachio consumpt improv risk factor metabol syndrom
MED-2593~frequenc nut consumpt mortal risk predim nutrit intervent trial abstract background prospect studi non mediterranean popul consist relat increas nut consumpt lower coronari heart diseas mortal small protect effect all caus cancer mortal suggest examin associ frequenc nut consumpt mortal individu high cardiovascular risk spain mediterranean countri high averag nut intak person method evalu num men women age num num year random num num intervent mediterranean diet supplement nut oliv oil control diet predim prevenc con dieta mediterr nea studi nut consumpt assess baselin mortal ascertain medic record linkag nation death index multivariable adjust cox regress multivari analys general estim equat model assess associ year repeat measur nut consumpt mortal result median follow up num year num total death num cardiovascular death num cancer death occur nut consumpt signific reduc risk all caus mortal trend num compar non consum subject consum nut num servings week num cohort num lower mortal risk hazard ratio hr num num ci num num similar protect effect cardiovascular cancer mortal observ particip alloc mediterranean diet nut group consum nut num servings week baselin lowest total mortal risk hr num num ci num num conclus increas frequenc nut consumpt signific reduc risk mortal mediterranean popul high cardiovascular risk relat commentari http   www biomedcentr num num trial registr clinicaltri gov intern standard random control trial number isrctn num registr date num octob num
MED-2594~nut intak adipos meta analysi clinic trial pubm ncbi abstract background epidemiolog studi shown invers associ frequenc nut consumpt bodi mass index bmi risk obes clinic trial evalu nut consumpt adipos scarc inconclus object perform systemat review meta analysi publish random nut feed trial estim effect nut consumpt adipos measur design medlin cochran central regist control trial databas search relev clinic trial nut intak provid outcom bodi weight bmi kg m num waist circumfer measur publish decemb num languag restrict investig independ select review elig studi weight differ wmd nut control diet estim random effect meta analysi num cis result thirty thre clinic trial met inclus criteria pool result nonsignific effect bodi weight wmd num kg num ci num num kg num num bmi wmd num kg m num ci num num kg m num num num waist circumfer wmd num cm num ci num num cm num num diet includ nut compar control diet find remark robust sensit analysi public bias shown conclus compar control diet diet enrich nut increas bodi weight bodi mass index waist circumfer control clinic trial
MED-2595~health benefit nut consumpt special refer bodi weight control pubm ncbi abstract nut integr part mediterranean food pattern incorpor regular diet human believ provid health benefit recent recognit nut heart healthi food food drug administr major boost posit imag nut nut consumpt health benefit antioxid hypocholesterolem cardioprotect anticanc anti inflammatori antidiabet benefit function properti nut possess health benefit consumpt hamper lack adequ inform benefit addit nut energy dens food high fat content misconcept consum increas consumpt lead unwant gain bodi weight risk develop overweight obes nonetheless epidemiolog studi short term control feed trial support theori inclus nut typic diet induc weight gain expect increas total calor intak address mispercept nut bodi weight gain present review focus relat nut consumpt bodi weight gain context health benefit nut copyright num elsevi reserv
MED-2596~associ nut consumpt total cause specif mortal abstract background increas nut consumpt reduc risk major chronic diseas includ cardiovascular diseas type num diabet mellitus associ nut consumpt mortal remain unclear method examin associ nut consumpt subsequ total cause specif mortal num women nurs health studi num num num men health profession follow up studi num num particip histori cancer heart diseas stroke exclud nut consumpt assess baselin updat num num year result num num person year follow up num women num men die nut consumpt invers total mortal women men adjust suspect risk factor pool multivari hazard ratio death particip ate nut compar num num confid interv ci num num consumpt nut week num num ci num num week num num ci num num time week num num ci num num time week num num ci num num time week num trend signific invers associ observ nut consumpt death due cancer heart diseas respiratori diseas conclus larg independ cohort nurs health profession frequenc nut consumpt invers total cause specif mortal independ predictor death fund nation institut health intern tree nut council nutrit research educ foundat
MED-2597~nut nut abstract begin num increas evid support benefici effect nut consumpt health analysi spanish predim trial publish bmc medicin expand knowledg studi show individu eat nut time week die cardiovascular diseas cancer non consum studi add import find previous epidemiolog studi provid protect effect prematur mortal intervent group nut consumpt increas num year follow up intervent group addit oliv oil consumpt control group nut consumpt decreas follow up group question remain answer quantiti nut consum health benefit mechan action type nut favor relat research http   www biomedcentr num num
MED-2598~apoptosi induc death receptor pubm ncbi abstract death receptor belong tnf receptor famili characteris intracellular death domain serv recruit adapt protein tradd fadd cystein proteas caspas num activ caspas num aggreg receptor lead apoptosi trigger death receptor mediat bind specif ligand tnf famili homotrimer type num membran protein display receptor bind site modul activ death receptor status ligand membrane bound solubl critic activ fas trail receptor cleavag membrane bound fasl solubl form sfasl affect abil bind fas drastic decreas cytotox activ convers cross link epitope tag sfasl anti tag antibodi mimic membrane bound ligand result num fold increas cytotox suggest fas molecul aggreg effici signal apoptosi death receptor regul decoy receptor cytotox ligand trail interact receptor trail r num num death domain trail r num anchor membran glycolipid act domin negat inhibitor trail medi apoptosi overexpress trail sensit cell intracellular protein interact apoptot pathway potenti modul death receptor flip resembl caspas num structur lack proteas activ interact fadd caspas num inhibit apoptot signal death receptor time activ signal pathway lead nf kappa activ
MED-2599~curcumin sensit tumor necrosi factor rel apoptosis induc ligand trail induc apoptosi reactiv oxygen species medi upr pubm ncbi abstract curcumin exhibit anti inflammatori antitumor activ function mechan elucid numer studi shown curcumin induc apoptosi cancer cell present studi show subtox concentr curcumin sensit human renal cancer cell tumor necrosi factor rel apoptosi induc ligand trail mediat apoptosi apoptosi induc combin curcumin trail interrupt bcl num overexpress found treatment curcumin signific induc death receptor num dr num express mrna protein level accompani generat reactiv oxygen speci ros pretreat n acetylcystin ectop express peroxiredoxin ii antioxid protein dramat inhibit apoptosi induc curcumin trail combin block curcumin medi dr num upregul present studi demonstr curcumin enhanc trail induc apoptosi ros medi dr num upregul
MED-2601~curcumin induc apoptosi human non smal cell lung cancer nci h num cell er stress caspas cascad mitochondria depend pat pubm ncbi abstract report curcumin inhibit type cancer cell vitro vivo mechan curcumin inhibit cell growth induc apoptosi human non smal cell lung cancer cell nci h num remain unclear studi nci h num cell treat curcumin determin anticanc activ concentr curcumin durat nci h num cell subsequ cell morpholog viabil cell cycl mrna protein express determin curcumin induc apoptot morpholog nci h num cell dose depend manner curcumin treatment bax bad up regul bcl num bcl x xiap down regul addit reactiv oxygen speci ros intracellular ca num endoplasm reticulum er stress increas nci h num cell exposur curcumin signal led loss mitochondri membran potenti delta psi culmin caspas num activ curcumin induc apoptosi stimul fas caspas num extrins pathway er stress protein growth arrest dna damage induc gene num gadd num glucose regul protein num grp num activ nci h num cell apoptot cell death induc curcumin signific revers pretreat ros scaveng caspas num inhibitor nci h num cell tend arrest num cell cycl stage curcumin treatment down regul cyclin depend kinas num cdk num involv summari curcumin exert anticanc effect lung cancer nci h num cell apoptosi cell cycl arrest
MED-2602~curcumin induc apoptosi human melanoma cell fas receptor caspas num pathway independ num pubm ncbi abstract studi investig molecular pathway target curcumin apoptosi human melanoma cell line found curcumin caus cell death melanoma cell line wild typ mutant num demonstr curcumin induc apoptosi dose time depend found curcumin induc num suggest curcumin activ apoptosi pathway data show curcumin activ caspas num num caspas num support rational apoptosi occur membrane medi mechan caspas num broad bas caspas inhibitor caspas num specif inhibitor suppress curcumin induc cell death support hypothesi curcumin induc activ death receptor pathway show curcumin induc fas receptor aggreg fasl independ manner low temperatur incub previous shown inhibit receptor aggreg prevent curcumin induc cell death demonstr express domin negat fadd signific inhibit curcumin induc cell death addit result curcumin block nf kappab cell surviv pathway suppress apoptot inhibitor xiap melanoma cell mutant num strong resist convent chemotherapi curcumin overcom chemoresist cell provid potenti avenu treatment
MED-2603~fadd regul life death pubm ncbi abstract fas associ protein death domain fadd key adaptor protein transmit apoptot signal mediat main death receptor drs essenti instrument cell death fadd implic prolifer cell cycl progress tumor develop inflamm innat immun autophagi recent function fadd shown independ drs fadd function dictat protein local phosphoryl state fadd crucial uniqu control essenti cellular process full understand network dictat ultim function fadd provid paradigm multifacet protein copyright num elsevi reserv
MED-2604~curcumin cancer cell curri kill tumor cell select abstract cancer hyperprolif disord treat chemotherapeut agent toxic tumor cell normal cell agent produc major side effect addit agent high expens afford agent cancer prevent tradit medicin general free deleteri side effect inexpens curcumin compon turmer curcuma longa agent safe afford efficaci curcumin kill tumor cell focus review show curcumin modul growth tumor cell regul multipl cell signal pathway includ cell prolifer pathway cyclin num c myc cell surviv pathway bcl num bcl xl cflip xiap c iap num caspas activ pathway caspas num num tumor suppressor pathway num num death receptor pathway dr num dr num mitochondri pathway protein kinas pathway jnk akt ampk curcumin select kill tumor cell normal cell detail
MED-2605~curcumin induc apoptosi human colon cancer colo num cell product ros ca num activ caspas num pubm ncbi abstract curcumin diferuloylmethan yellow pigment turmer curcuma longa inhibit prolifer cancer cell arrest phase cell cycl induc apoptosi tumor cell curcumin induc apoptosi involv activ caspas num mitochondria medi pathway cancer cell tissu origin present studi induct apoptosi cytotox curcumin colon cancer colo num cell investig flow cytometri result demonstr curcumin induc cytotox apoptosi dose time deped curcumin induc product reactiv oxygen speci ros ca num decreas level mitochondria membran potenti induc caspas num activ curcumin promot express bax cytochrom num num inhibit express bcl num observ suggest curcumin therapeut potenti colon cancer patient
MED-2606~effect turmer urinari mutagen smoker pubm ncbi abstract curcumin activ principl turmer act anti oxid anti mutagen anti carcinogen experiment anim present studi anti mutagen effect turmer assess num chronic smoker observ turmer dose num g day num day signific reduc urinari excret mutagen smoker contrast non smok serv control chang urinari excret mutagen num day turmer signific effect serum aspart aminotransferas alanin aminotransferas blood glucos creatinin lipid profil result dietari turmer effect anti mutagen chemoprevent
MED-2607~perspect curcumin cancer prevent abstract numer natur compound extens investig potenti cancer prevent decad curcumin curcuma longa high promis natur compound potenti chemoprevent multipl cancer curcumin modul multipl molecular pathway involv lengthi carcinogenesi process exert chemoprevent effect mechan promot apoptosi inhibit surviv signal scaveng reactiv oxid speci ros reduc inflammatori cancer microenviron curcumin fulfil characterist ideal chemoprevent agent low toxic afford easi access clinic applic curcumin compromis poor bioavail review potenti curcumin cancer prevent molecular target action mechan final suggest specif recommend improv efficaci bioavail clinic applic
MED-2608~vitro antimutagen curcumin environment mutagen pubm ncbi abstract effect curcumin yellow pigment spice turmer curcuma longa mutagen environment mutagen investig salmonella microsom test aroclor num induc rat liv homogen num mix salmonella typhimurium strain ta num presenc num mix curcumin inhibit mutagen bidi cigarett smoke condens tobacco masheri extract benzo a pyrn dimethyl benzo a anthracen dose depend manner curcumin influenc mutagen num mix sodium azid monoacetylhydrazin streptozocin strain ta num num nitrophenylenediamin strain ta num observ curcumin alter metabol activ detoxif mutagen
MED-2616~signific azo reduct mutagenesi carcinogenesi azo dye pubm ncbi abstract azo dye wide textil print cosmet drug food process industri extens laboratori biolog stain ph indic extent relat degre industri intestin cancer common high industri countri connect exist increas number cancer case azo dye azo dye reduc aromat amin intestin microflora mutagen number azo dye review paper includ trypan blue ponceau num pinceau num methyl red methyl yellow methyl orang lithol red orang orang ii num phenylazo naphthylamin sudan sudan iv acid alizarin violet fast garnet gbc allura red ponceau sx sunset yellow tartrazin citrus red num orang yellow ab carmoisin mercuri orang ponceau versatint blue phenylazophenol evan blue degrad aromat amin signific azo reduct mutagenesi carcinogenesi azo dye discuss
MED-2617~teratolog evalu fd c red num collabor government industri studi ii fda studi pubm ncbi abstract recent studi indic embryoleth teratogen fd c red num ad hoc committe conven food drug administr question committe suggest collabor studi laboratori food drug administr fda industri bio test laboratori ibt nation center toxicolog research nctr red num num mg kg bodi weight gavag day num num num gestat fd c red num dose level water bottl control util fda osborne mendel strain rat ibt charl river nctr strain signific increas skelet viscer abnorm signific increas resorpt osborne mendel strain charl river strain ibt show signific increas litter resorpt dam num mg kg num day gestat nctr studi charl river strain show increas paramet dose level addit show signific increas percentag resorpt litter conclud inher variat absenc increas abnorm indic embryotox reason doubt effect biolog signific reproduc
MED-2618~toxicolog food dye pubm ncbi abstract background food dye synthes origin coal tar petroleum long controversi safeti concern dye ban advers effect laboratori anim inadequ test conclus review find us approv dye rais health concern vari degre red num cancer anim evid dye carcinogen dye red num yellow num yellow num found contamin benzidin carcinogen dye blue num red num yellow num yellow num hypersensit reaction numer microbiolog rodent studi yellow num posit genotox toxic test dye citrus red num orang suggest safeti concern citrus red num low level florida orang orang year inadequaci test evid carcinogen genotox hypersensit coupl fact dye improv safeti nutrit qualiti food dye remov food suppli replac safer color recommend regulatori author requir independ toxic test exercis greater caution continu approv dye futur approv well test safe dye
MED-2619~genotox mutagen effect erythrosin xanthen food dye hepg num cell pubm ncbi abstract erythrosin erb xanthen food drug administr approv dye food drug cosmet util permit erb inhibitor enzym protein protein interact toxic pituitari spermatogenesi process genotox mutagen erb inconclus literatur studi aim analyz genotox dye alkalin comet assay investig evalu erb mutagen cytokinesi block micronucleus cytom cbmn cyt assay hepg num cell cell chosen produc phase phase ii enzym mimic vivo metabol cell treat concentr num num ml num erb result show genotox highest concentr mutagen concentr micronuclei result clastogen aneugen process comet assay consid sensit detect dna singl strain break suggest aneugen respons observ damag erb approv food cosmet pharmaceut industri care damag dna structur copyright num elsevi reserv
MED-2627~human exposur endocrin disrupt carcinogen risk assess pubm ncbi abstract human exposur endocrin disrupt ed widespread consid pose grow threat human health recent advanc molecular genet research understand mechan blastic cell transform led effort improv cancer risk assess popul expos famili xenobiot risk assess low dose extrapol cancer incid data experiment anim epidemiolog studi larg base model assum linear correl low dose exist evid show weak ed risk assess poor exposur data ecolog studi frequent rough estim deriv contamin item local food basket survey polyhalogen hydrocarbon treat exampl grow sens urgenc develop biolog base dose respons model cancer risk integr emerg data molecular biolog epidemiolog provid realist data risk assessor public public health manag environment issu administr
MED-2643~endocrine disrupt chemic disord mechan action abstract incid and or preval health problem endocrine disrupt increas chemic endocrine disrupt properti includ bisphenol organochlorin polybromin flame retard perfluorin substanc alkylphenol phthalat pesticid polycycl aromat hydrocarbon alkylphenol solvent household product includ clean product air freshen hair dye cosmet sunscreen metal shown endocrine disrupt properti observ suggest endocrin disruptor contribut cancer diabet obes metabol syndrom infertil list paper overview present mechan contribut endocrin disrupt endocrin disruptor act classic nuclear receptor estrogen rel receptor membrane bound estrogen receptor interact target cytosol result activ src ras erk pathway modul nitric oxid addit metabol endogen hormon cross talk genom nongenom pathway cross talk estrogen receptor bind receptor interfer feedback regul neuroendocrin cell dna methyl histon modif genom instabl interfer spindl figur play role found effect receptor activ differ function ligand
MED-2644~p nonyl phenol estrogen xenobiot releas modifi polystyren abstract alkylphenol wide plastic addit surfact report identif alkylphenol nonylphenol estrogen substanc releas plastic centrifug tube compound extract methanol purifi flash chromatographi reverse phas high perform liquid chromatographi identifi gas chromatography mass spectrometri nonylphenol induc cell prolifer progesteron receptor human estrogen sensit mcf num breast tumor cell nonylphenol trigger mitot activ rat endometrium result confirm reliabl mcf num cell prolifer bioassay estrogen properti alkylphenol specif nonylphenol plasticwar chemic experiment diagnost test lead spurious result compound alkylphenol polyethoxyl potenti harm expos human environ larg
MED-2645~reduct peni size plasma testosteron concentr juvenil allig live contamin environ pubm ncbi abstract develop male reproduct duct extern genitalia vertebr depend elev androgen concentr embryon develop period postnat growth observ popul juvenil allig live lake apopka exhibit signific smaller peni size num averag decreas lower plasma concentr testosteron num lower concentr compar anim similar size lake woodruff addit smaller phalli relationship exist plasma testosteron concentr penil size male lake apopka posit relationship exist male lake woodruff allig lake apopka elev concentr antiandrogen ddt breakdown product p  dde store fat suggest number hypothes explain modif phenotyp juvenil male live lake apopka modif phenotyp includ smaller peni size lower plasma androgen concentr lack respons peni plasma androgen present
MED-2646~fast food asthma rhinoconjunct eczema global find intern studi asthma allergi childhood isaa pubm ncbi abstract background food increas decreas risk develop asthma rhinoconjunct eczema explor impact intak type food diseas phase intern studi asthma allergi childhood method written questionnair symptom preval asthma rhinoconjunct eczema type frequenc food intak past num month complet num year old adolesc parents guardian num year old children preval estim logist regress adjust confound random mix effect model result adolesc children potenti protect effect sever asthma consumpt fruit num time week num num ci num num num num ci num num increas risk sever asthma adolesc children consumpt fast food num time week num num ci num num num num ci num num increas risk sever rhinoconjunct sever eczema similar pattern age observ region analys consist gender affluenc categori current symptom condit conclus associ fast food symptom preval asthma rhinoconjunct eczema causal find major public health signific owe rise consumpt fast food global
MED-2647~dietari exposur xenoestrogen zealand pubm ncbi abstract continu evid feminis effect xenoestrogen rang wildlif speci increas assess human health risk estrogen mimic estim exposur zealand male femal young men rang natur occur synthet xenoestrogen found food estrogen compound act interact estrogen receptor includ theoret plasma estrogen activ level deriv estrogen exposur estim estrogen potenc data theoret plasma level compar publish data specif xenoestrogen surpris close agreement xenoestrogen dietari intak equal attribut natur occur synthet xenoestrogen relat contribut male isoflavon genistein daidzein num bisphenol num smaller contribut alkyl phenol num flavonoid phloretin kaempferol num suggest dietari xenoestrogen pharmacolog effect zealand male postmenopaus women signific pre menopaus women
MED-2648~comparison short term estrogen test identif hormone disrupt chemic abstract aim studi compar result obtain short term assay estrogenlik action chemic conduct num laboratori countri twenti chemic select repres direct act estrogen compound estrogen metabolit estrogen antagonist cytotox agent includ test panel num eta   estradiol posit control ethanol solvent control test compound code distribut test method includ direct bind estrogen receptor er prolifer mcf num cell transient report gene express mcf num cell report gene express yeast strain stabli transfect human er estrogen respons report gene vitellogenin product juvenil rainbow trout num eta estradiol num lpha ethynyl estradiol diethylstilbestrol induc strong estrogen respons test system colchicin caus cytotox bisphenol induc estrogen respons assay result obtain remain test compounds  tamoxifen ici num testosteron bisphenol dimethacryl num n octylphenol num n nonylphenol nonylphenol dodecylethoxyl butylbenzylphthal dibutylphthal methoxychlor p  ddt p  dde endosulfan chlomequat chlorid ethanol  vari assay result demonstr care standard obtain reason degre reproduc similar method vari sensit estrogen compound short term test screen purpos method valid addit interlaboratori interassay comparison document reliabl method
MED-2649~dietari meat fat intak preval rhinoconjunct pregnant japanes women baselin data kyushu okinawa matern child health studi abstract background dietari fat exert numer complex effect proinflammatori immunolog pathway epidemiolog studi examin relationship intak fatti acid and or food high fat allerg rhiniti provid conflict find current cross sect studi investig relationship japan method studi subject num pregnant women definit rhinoconjunct base criteria intern studi asthma allergi childhood inform dietari factor collect valid self administ diet histori questionnair adjust made age gestat region resid number older sibl number children smoke secondhand smoke exposur home work famili histori asthma atop eczema allerg rhiniti household incom educ bodi mass index result preval rhinoconjunct past num month num higher meat intak signific increas preval rhinoconjunct adjust odd ratio extrem quartil num num confid interv num num trend num measur associ found fish intak rhinoconjunct intak total fat satur fatti acid monounsatur fatti acid num polyunsatur fatti acid linolen acid eicosapentaeno acid docosahexaeno acid num polyunsatur fatti acid linol acid arachidon acid cholesterol ratio num num polyunsatur fatti acid intak evid relat preval rhinoconjunct conclus current result suggest meat intak posit preval rhinoconjunct young adult japanes women
MED-2650~inadvert exposur xenoestrogen pubm ncbi abstract num year constant report environment chemic hormone lik effect wildlif endocrin disruptor exogen substanc advers health effect intact organ progeni secondari endocrin function endocrin disruptor wide divers chemic structur oestrogen properti oestrogen xenobiot xenoestrogen substanc phytoestrogen mycoestrogen diet environ oestrogen activ substanc weaker oestradiol chemic endocrin disrupt potenti continu discov inadvert form exposur constant identifi increas concern cumul effect studi num num character oestrogen number industri compound pesticid p ddt kepon methoxychlor phenol deriv polychlorin biphenyl pcbs num year environment chemic ad list xenoestrogen includ pesticid toxaphen dieldrin endosulphan compound food industri antioxid t butylhydroxyanisol plastic benzylbutylphthal num oh alkylphenol substanc dental restor bisphenol a relev newli discov endocrin disruptor human health start emerg studi investig effect human point direct associ exposur substanc hormone disrupt activ disord endocrin organ incid disord greater area exposur agent activ high closer scrutini requir determin newli discov endocrin disrupt chemic contribut oestrogen pesticid exposur human xenoestrogen
MED-2651~alkylphenol human milk relat dietari habit central taiwan pubm ncbi abstract aim studi determin concentr num nonylphenol np num octylphenol op num human milk sampl examin relat factor includ mother demograph dietari habit women consum median amount cook oil signific higher op concentr num ng g consum num ng g num op concentr signific consumpt cook oil beta num num fish oil capsul beta num num adjust age bodi mass index bmi np concentr signific consumpt fish oil capsul beta num num process fish product beta num num food pattern cook oil process meat product factor analysi strong op concentr human milk num determin aid suggest food consumpt nurs mother order protect infant np op exposur num elsevi reserv
MED-2652~xeno estrogen compound precipit pubm ncbi abstract exposur chemic lead hormon disrupt effect present attent focus so cal xeno estrogen synthet compound interact hormon receptor caus number reaction eventu lead effect relat reproduct develop current studi initi investig presenc number compound precipit follow up previous studi pesticid concentr air precipit determin rainwat sampl collect num locat netherland week period sampl analys bisphenol a alkylphenol alkylphenol ethoxyl phthalat flame retard synthet musk compound result presenc compound precipit concentr rang low ng num rang flame retard thousand ng num phthalat bisphenol a found num sampl concentr num ng num alkylphenol alkylphenol ethoxyl found virtual locat concentr num ng num individu compound phthalat abund xeno estrogen precipit sampl found sampl di isodecyl phthalat found surpris high concentr num ng num polybromin flame retard found low ng num rang general num sampl notic find hexabromocyclododecan replac polybromint diphenyl ether locat concentr num ng num final expect synthet musk compound detect sampl true polycycl musk hhcb ahtn nitro musk found locat krige techniqu calcul precipit concentr actual sampl locat produc contour plot number compound plot show locat emiss sourc number compound bisphenol a nonylphenol ethoxyl phthalat ahtn contrari result hhcb phthalat diffus emiss pattern result consum product compound
MED-2653~nonylphenol octylphenol human breast milk pubm ncbi abstract human milk import form nourish newborn children consumpt strong recommend health author import advantag decad great number investig shown occurr environment contamin human milk lipophil properti studi investig presenc nonylphenol octylphenol op nonylphenol monoethoxyl np num octylphenol ethoxyl opeo op num op num human breast milk italian women np contamin found highest level concentr num ng ml order magnitud higher op num ng ml op num num ng ml op num num ng ml group studi posit correl fish consumpt level np milk observ accord evid seafood repres import sourc exposur group contamin itali basi concentr found breast milk sampl maximum np daili intak num microg kg day calcul close toler daili intak tdi num microg kg bodi weight bw propos danish institut safeti toxicolog case op tdi intak order magnitud lower noael num mg kg day deriv generat studi rat
MED-2654~endocrin disrupt nonylphenol ubiquit food pubm ncbi abstract num nonylphenol nps common product biodegrad wide group nonion surfact nonylphenol ethoxyl npes compound persist toxic estrogen activ worldwid scientif public discuss potenti consequ human long term dietari exposur endocrin disrupt numer determin nps environment sampl systemat report exist relat concentr nps food analyz nps num foodstuff commerci germani result nps ubiquit food concentr nps fresh weight basi vari num num microg kg fat content foodstuff base data german food consumpt rate analys nps food daili intak adult calcul num microg day nps infant exclus fed breast milk infant formula daili intak num microg day num microg day nps estim
MED-2655~associ dietari soy genistein intak lung function asthma control post hoc analysi patient enrol prospect multicentr clinic trial abstract background broad dietari pattern link asthma relat contribut specif nutrient unclear soy genistein import anti inflammatori biolog effect benefici asthma posit associ previous report soy genistein intak lung function asthma exacerb aim conduct post hoc analysi patient inadequ control asthma enrol prospect multicentr clinic trial replic associ method total num studi particip includ analysi dietari soy genistein intak measur block soy food screener level soy genistein intak intak moder intak high intak compar baselin lung function pre bronchodil forc expiratori volum num fev num asthma control proport particip episod poor asthma control epac annualis rate epac num month follow up period result particip genistein intak lower baselin fev num moder high intak num num num num epac common genistein intak moder high intak num num num num find remain signific adjust patient demograph bodi mass index conclus patient asthma consumpt diet moder high amount soy genistein lung function asthma control
MED-2656~effect intestin microflora environ develop asthma allergi pubm ncbi abstract aim previous research allerg diseas includ asthma identifi potenti risk factor environ major risk factor identifi past num year focus direct protect factor enhanc develop toler allergen previous encount earli life lost modern affluent societi role childhood infect discuss studi conclus recent epidemiolog studi experiment research suggest microbi environ exposur microbi product infanc modifi immun respons enhanc develop toler ubiquit allergen intestin microflora play role respect major extern drive forc matur immun system birth anim experi shown prerequisit normal develop oral toler recent studi shown differ composit microflora healthi allerg infant countri high low preval allergi healthi allerg infant countri differ appar week life preced clinic symptom live microorgan benefici health long tradit safeti document recent prospect intervent studi modifi gut flora birth yield encourag result suggest mode primari prevent allergi futur
MED-2657~increas preval japanes cedar pollinosi meta regress analysi pubm ncbi abstract background japanes cedar pollinosi caus pollen japanes cedar tree cryptomeria japonica commonest season allerg diseas japan number epidemiolog survey report japanes cedar pollinosi assess systemat quantit confirm increas preval japanes cedar pollinosi relat factor conduct meta regress analysi population bas survey japan method search data population bas survey serolog method test particip weight regress logit transform preval sensit rate evalu effect year survey age degre urban analyz relationship preval sensit rate result thirty eight report num subgroup preval num subgroup sensit rate select literatur publish year num num japanes cedar pollen sensit rate found signific correl year survey age degre urban adjust num num coeffici correl preval sensit rate reveal statist signific correl pearson num num conclus preval japanes cedar pollinosi adolesc predict num metropolitan area num general popul urban area year num deriv estim sensit rate relationship sensit rate preval preval japanes cedar pollinosi increas num fold num num preval differ age degre urban copyright num karger ag basel
MED-2658~alkylphenols  potenti modul allerg respons pubm ncbi abstract preval allerg diseas increas recent decad allerg diseas asthma complex diseas strong gene environ interact epidemiolog studi identifi varieti risk factor develop allerg diseas endocrine disrupt chemic edc play import role trigger exacerb diseas num nonylphenol np num octylphenol op two major alkylphenols  hav recogn common toxic xenobiot endocrin disrupt due low solubl high hydrophob low estrogen activ tend accumul human bodi advers effect allerg diseas recent evid support import alkylphenol vitro allerg respons review focus effect alkylphenol key cell type context allerg inflamm copyright num publish elsevi
MED-2659~european ban surfact trigger transatlant debat pubm ncbi abstract european regul research disagre risk common class surfact
MED-2660~trend nutrit intak serum cholesterol level num year tanushimaru japanes men pubm ncbi abstract background rapid socioeconom develop japan begin countri studi num brought remark lifestyl dietari pattern investig relationship time trend nutrient intak serum cholesterol level japanes cohort countri studi tanushimaru typic farm town kyushu island method subject total num num num num num num num subject men age num year eat pattern evalu num hour dietari recal num num food frequenc questionnair num measur serum cholesterol level health examin result total daili energi intak decreas num kcal num num kcal num carbohydr intak percentag total daili energi intak decreas mark num num num num contrast larg increas period protein intak num num fat intak num num proport dramat chang protein fat intak serum cholesterol level show larg increas num mg dl num mg dl conclus spite big dietari western diet incid coronari arteri diseas rural japanes area remain low care surveil futur remark increas intak fat satur fatti acid
MED-2661~alkylphenol alkylphenol ethoxyl contamin crustacean fish adriat sea itali pubm ncbi abstract paper present result investig occurr alkylphenol ap ethoxyl ape num edibl marin speci adriat sea estim intak italian popul crustacean nephrop norvegicus norway lobster squilla manti spottail manti shrimp fish speci engrauli enchrascicolus anchovi scomber scombrus atlant mackerel merluccius merluccius european hake mullus barbatus red mullet solea vulgari common sole lophius piscatorius angler analyz content nonylphenol np octylphenol op octylphenol polyethoxyl ope compound found analys sampl np detect highest concentr num num num ng num fresh weight fw crustacean fish op found respect level num num num num ng num fw crustacean fish ope determin respect concentr num num num num ng num fw speci result previous studi num edibl mollusc estim respect daili intak np op ope num num num microg day num italian adult live adriat coast relat np op intak lower dose toxic effect laboratori anim num mg kg num bw rat data exposur sourc chemic similar biolog characterist
MED-2662~effect xenoestrogen environment pollut prolifer human breast cancer cell line mcf num pubm ncbi abstract human breast cancer cell line mcf num develop vitro screen assay detect xenoestrogen environment pollut mcf num cell cultur dmem num fetal bovin serum fbs estrogen respons defin increas frequenc prolifer mcf num cell measur thymidin analog bromodeoxyuridin flow cytometri di num ethylhexyl phthalat dehp num n nonylphenol num n np model chemic prolifer rate s phase cell num exposur concentr num eta estradiol model compound compar posit negat control num nm num eta estradiol num ethanol dehp num n np increas frequenc prolifer mcf num cell dose depend manner lowest concentr signific increas prolifer mcf num cell num microm dehp num microm num n np result show assay accur quick perform prove valuabl tool screen potenti estrogen mimick environment pollut
MED-2663~berri thought provok idea potenti role plant polyphenol treatment age rel cognit disord pubm ncbi abstract today ten million elder individu worldwid suffer dementia pathogenesi dementia complex incomplet understood extent consequ system vascular patholog metabol syndrom individu compon induc proinflammatori state damag blood vessel condit chronic inflamm damag vasculatur brain direct neurotox associ establish metabol syndrom constitu dementia relationship observ dietari factor constitu mediterranean diet metabol syndrom similar associ note dietari factor dementia fruit juic extract investig treatment cognit impair blueberri strawberri blackberri grape plum juic extract success test cognit impair rodent publish trial benefit grape blueberri juic treatment small number cognit impair person recent benefit fruit product thought result polyphenol content grape polyphenol found grape resveratrol studi human grape blueberri pterostilben found improv cognit rodent design futur human trial poor bioavail product initi experiment therapi long onset symptom limit knowledg form juic powder individu polyphenol treatment
MED-2664~plant food brain age critic apprais pubm ncbi abstract num centuri human age biggest challeng societi world declin human fit typic hallmark age process cardiovascular system brain suffer signific life long impact stressor reactiv oxygen nitrogen speci oxytosi oxid stress induc cell death identifi play major role develop onset chronic diseas food plant origin rich antioxid numer vivo data suggest diet rich fruit veget support mainten anim human health benefici effect extend central nervous system due presenc blood brain barrier tight control influx metabolit nutrient earlier studi impact antioxid vitamin alpha tocopherol ascorb acid brain health interest recent focus move assess potenti unsatur fatti acid secondari plant metabolit polyphenol act neuroprotect experiment evid suggest polyphenol plant deriv bioactiv affect anim human brain function direct lower oxid stress load modul signal transduct pathway
MED-2665~dietari intak berri flavonoid relat cognit declin abstract object berri high flavonoid anthocyanidin improv cognit experiment studi prospect evalu greater long term intak berri flavonoid slower rate cognit declin older women method begin num semi quantit food frequenc questionnair administ year nurs health studi particip num num began measur cognit function num particip age num year follow up assess conduct two year interv ascertain long term diet averag dietari variabl num initi cognit interview multivariable adjust mix linear regress estim differ slope cognit declin long term berri flavonoid intak result greater intak blueberri strawberri slower rate cognit declin global score averag cognit test blueberri p trend num differ num num ci num num compar extrem categori intak strawberri p trend num differ num num ci num num compar extrem categori intak adjust multipl potenti confound effect estim equival find approxim num num year age cohort indic berri intak delay cognit age num year addit support evid greater intak anthocyanidin total flavonoid slower rate cognit declin p trend num num global score interpret higher intak flavonoid berri reduc rate cognit declin older adult
MED-2667~revers age rel declin neuron signal transduct cognit motor behavior deficit blueberri spinach strawberri pubm ncbi abstract ampl research age rel neuronal behavior decrement result oxid stress amelior antioxid previous studi shown rat dietari supplement fruit veget extract high antioxid activ num month begin num month age retard age rel declin neuron cognit function present studi show supplement strawberri spinach blueberri num num num gm dri aqueous extract kilogram diet fed num week num month old fischer num rat effect revers age rel deficit neuron behavior paramet includ oxotremorin enhanc evok releas dopamin striatal slice carbachol stimul gtpase activ striatal ca num buffer striatal synaptosom motor behavior perform rod walk accelerod task morri water maze perform find suggest addit benefici effect cancer heart diseas phytochem present antioxidant rich food benefici revers neuron behavior age
MED-2668~concord grape juic supplement neurocognit function human age pubm ncbi abstract polyphenol compound found berri fruit flavonoid health benefit includ improv cognit neuron function age concord grape juic polyphenol includ anthocyanin flavanol previous research shown improv number human health condit grape juic supplement current studi older adult subject mild cognit impair consum concord grape juic placebo num week administ assess memori function brain activ pre postintervent particip consum grape juic show reduc semant interfer memori task greater activ anterior posterior region hemispher observ function magnet reson imag grape juic treat subject find provid evid concord grape juic enhanc neurocognit function older adult mild memori declin
MED-2669~concord grape juic supplement improv memori function older adult mild cognit impair pubm ncbi abstract concord grape juic polyphenol compound antioxid anti inflammatori properti influenc neuron signal concord grape juic supplement shown reduc inflamm blood pressur vascular patholog individu cvd consumpt flavonoid contain food reduc risk dementia addit preliminari anim data improv memori motor function grape juic supplement suggest potenti cognit benefit age human initi investig neurocognit effect enrol twelv older adult memori declin dementia randomis placebo control double blind trial concord grape juic supplement num week observ signific improv measur verbal learn non signific enhanc verbal spatial recal appreci effect intervent depress symptom effect weight waist circumfer small increas fast insulin observ consum grape juic preliminari find suggest supplement concord grape juic enhanc cognit function older adult earli memori declin establish basi comprehens investig evalu potenti benefit assess mechan action
MED-2670~blueberri neuron age pubm ncbi abstract popul peopl unit state age num year continu increas incid age rel patholog includ decreas cognit motor function case sever deficit memori motor function hospit and or custodi care outcom found reduc age rel decrement neuron function health care cost continu rise exponenti evid accumul consumpt blueberri strategi forestal revers age rel neuron deficit subsequ behavior manifest order increas healthi age research suggest polyphenol compound found blueberri exert benefici effect abil lower oxid stress inflamm direct alter signal involv neuron communic intervent turn protect age rel deficit cognit motor function appropri depart agricultur figur promin discoveri effort usda research work depart num year copyright num karger ag basel
MED-2671~microbiolog fresh restructur lamb meat review pubm ncbi abstract microbiolog meat subject great concern food scienc public health recent year articl devot microbiolog beef pork poultri meat written microbiolog lamb meat restructur lamb meat articl present data microbiolog shelf lif fresh lamb meat restructur meat product restructur lamb meat product bacteriolog restructur meat product import foodborn pathogen salmonella escherichia coli num num listeria monocytogen meat lamb meat potenti sodium potassium lactat control foodborn pathogen meat restructur lamb meat review articl interest meat scientist food scientist public health microbiologist concern safeti meat general lamb meat
MED-2672~effect ad connect tissu sensori mechan properti restructur beef steak pubm ncbi abstract quantifi objection level connect tissu restructur beef product made num num num ad tendon num num ad epimysium gristl peri endomysium control initi tender residu connect tissu ct textur ot evalu sensori panel panelist advers score ct ot num num num tendon ct ot num epimysium gristl ct ot score correl hydroxyprolin content lee kram peak shear forc uncook steak ad tendon gristl epimysium peri endomysium accept product made raw materi free tendon limit amount epimysium copyright num publish elsevi
MED-2673~determin microbi transglutaminas meat meat product pubm ncbi abstract transglutaminas enzym cross link piec meat fish meat product result product optic impress intact chunk meat usag transglutaminas food addit permit countri utilis declar ensur transpar consum paper describ orthogon analyt method suit detect technolog relev transglutaminas concentr num mg pure enzym num kg product meat meat product mass spectrometry bas approach reli previous digest achromobact lyticus proteas lc ms ms separ detect suffici select obtain monitor peptid orthogon complementari independ elisa bas approach reli commerci bacteri transglutaminase specif antibodi combin sandwich elisa method test analys num sampl obtain market
MED-2674~num guardian genom policeman oncogen pubm ncbi abstract process malign transform univers entail genet damag oncogen signal stress signal num genet pathway base distinguish job num guardian genom consist sens react dna damag atm atr chk num chk num kinas policeman oncogen correspond consist respond oncogen signal num stabil protein arf contrari expect recent genet evid mice respons num dna damag impact cancer protect contrast arf depend activ num critic num mediat tumor suppress discuss mechanist implic observ relev cancer therapi
MED-2675~comparison cytotox mutagen potenti liquid smoke food flavour cigarett smoke condens wood smoke condens pubm ncbi abstract product pyrolysi cytotox mutagen relationship type materi pyrolys toxic result pyrolysi product poor understood object studi evalu compar cytotox mutagen type common pyrolysi product cytotox mutagen product assess neutral red uptak ame mutagen assay biolog activ liquid smoke food flavour lsf compar pyrolysis deriv materi cigarett smoke condens csc wood smoke condens wsc result mixtur exhibit concentration depend cytotox respons csc wsc cytotox lsfs cytotox brand csc mutagen salmonella strain lsfs wsc mutagen ta num lsfs posit ta num pyrolysis deriv materi evalu studi show differ pattern magnitud cytotox mutagen result cytotox mutagen complex mixtur deriv pyrolysi product affect type materi pyrolys and or method prepar mixtur cytotox potenti commerci smoke flavour greater cigarett smoke condens food flavour mutagen salmonella strain
MED-2676~mutagen test salmonella typhimurium assay phenol compound phenol fraction obtain smokehous smoke condens pubm ncbi abstract smokehous smoke flavour meat product investig mutagen activ salmonella typhimurium assay chiefli concern fraction free polycycl aromat hydrocarbon phenol compound respons preserv aromat properti smoke abund occur phenol compound phenol cresol num dimethylphenol brenzcatechin syringol eugenol vanillin guaiacol gave negat result test mutagen concentr num micrograms pl num mix strain typhimurium phenol investig varieti test condit induct revert observ smokehous smoke condens fraction major phenol fraction gave negat result test concentr strain typhimurium slight increas number revert case presenc phenol fraction small amount mutagen impur natur investig exclud result support develop non hazard smoke aroma prepar base phenol compon smokehous smoke
MED-2677~biolog clue potent dna damag activ food flavor abstract popul differ age rel diseas cancer stem differ diet character dna strand break activ select foods beverag flavor constitu chemic num cell cellular assay sensit break substanc test posit includ refer chemic quinacrin peak respons num etoposid num flavonoid egcg num curcumin num apigenin num quercetin num beverag chamomil num green num black tea num coffe num num liquid smoke num num damag occur dietari concentr etoposid num g ml produc respons similar num dilut liquid smoke num dilut coffe num dilut tea pyrogallol rel chemic tannin present dietari sourc individu produc strong activ pyrogallol num num methoxycatechol num gallic acid num num num benzenetriol num structure act relationship high activ depend specif orient hydroxyl benzen ring respons accompani cellular signal characterist dna break num phosphoryl break direct detect comet assay cellular toxicolog effect food flavor guid epidemiolog experiment studi potenti diseas risk dna strand break chemic diet
MED-2678~polycycl aromat hydrocarbon smoke food product commerci liquid smoke flavour pubm ncbi abstract smoke food includ turkey pork chicken beef fish product screen presenc carcinogen non carcinogen polycycl aromat hydrocarbon pah eighteen commerci liquid smoke flavour season analys total pah concentr smoke meat product rang num micrograms kg cook ham sampl num micrograms kg grill pork chop fish product rang num micrograms kg smoke shrimp num micrograms kg smoke salmon total concentr carcinogen pah benzo a anthracen benzo b fluoranthen benzo a pyren dibenzo a h anthracen indeno num num d pyren rang non detect meat product num micrograms kg grill pork chop num micrograms kg trout num micrograms kg salmon liquid smoke flavour season total pah concentr rang num num micrograms kg carcinogen pah rang num num micrograms kg
MED-2679~commerci hickory smok flavour human lymphoblast mutagen induc lung adenoma newborn mice pubm ncbi abstract commerci aqueous wood smok flavour induc signific increas num thioguanin resist mutat frequenc tk num human lymphoblast num microlit flavouring ml cell suspens correspond num micrograms ml dissolv solid determin fulli dri aqueous flavour vacuum desicc ahh num human lymphoblast cytochrom num monooxygenas system mutat induc num microliter ml num microliters ml dissolv solid flavour induc num azaguanin resist mutat salmonella typhimurium concentr num microliter ml higher concentr flavour toxic bacteria flavour induc lung adenoma tumour newborn mice inject ip total dose num microlit num wk period toxic kidney colon rectum observ mice num wk age
MED-2693~food frequ questionnair base estim total antioxid capac risk non hodgkin lymphoma abstract antioxid primarili fruit veget hypothes protect non hodgkin lymphoma nhl oxygen radic absorb capac orac assay measur total antioxid capac individu food account synerg estim food frequ questionnair ffq test hypothesi higher intak antioxid nutrient food supplement ffq base orac valu lower risk nhl clinic bas studi num incid case num frequency match control diet assess num item ffq logist regress estim odd ratio num confid interv adjust age sex resid total energi dietari intak tocopherol num p trend num caroten num p trend num lutein zeaxanthin num p trend num zinc num p trend num chromium num p trend num invers nhl risk inclus supplement impact associ total veget num p trend num green leafi num p trend num crucifer num p trend num veget invers nhl risk nhl risk invers hydrophil orac num p trend num lipophil orac num p trend num simultan adjust antioxid total veget associ lipophil orac remain signific strike heterogen result common nhl subtyp higher antioxid intak estim ffq orac lipophil compon lower nhl risk account antioxid nutrient veget intak support potenti summari measur total antioxid intak
MED-2694~patholog aspect lipid peroxid pubm ncbi abstract lipid peroxid lpo product accumul human tissu major tissular cellular dysfunct play major role age age rel oxid stress rel diseas current evid implic lpo patholog process discuss review data literatur review provid evalu role lpo pathophysiolog age classic oxid stress link diseas neurodegen diseas diabet atherosclerosi main cardiovascular complic strike evid implic lpo foetal vascular dysfunct occur pre eclampsia renal liver diseas role consequ cancer develop address
MED-2695~total antioxid capac diet risk myocardi infarct prospect cohort women pubm ncbi abstract background previous studi investig effect dietari antioxid relat myocardi infarct total antioxid capac diet account antioxid synergist effect aim studi examin total antioxid capac diet antioxidant contain food incid myocardi infarct middle ag elder women method population bas prospect swedish mammographi cohort num year old women num cardiovascular disease fre baselin women complet food frequ questionnair dietari total antioxid capac calcul oxygen radic absorb capac valu inform myocardi infarct identifi swedish hospit discharg death registri hazard ratio hr num confid interv ci calcul cox proport hazard model result follow up septemb num decemb num identifi num incid case myocardi infarct num person year multivariable adjust analysi hr women compar highest quintil dietari total antioxid capac lowest num num ci num num trend num serv fruit veget grain nonsignific invers myocardi infarct conclus data suggest dietari total antioxid capac base fruit veget coffe grain import prevent myocardi infarct copyright num elsevi reserv
MED-2696~dietari total antioxid capac gastric cancer risk european prospect investig cancer nutrit studi pubm ncbi abstract high intak dietari antioxid compound hypothes strategi reduc gastric cancer gc develop investig effect dietari total antioxid capac tac relat gc european prospect investig cancer epic studi includ num center num european countri total num subject num men age num year recruit larg num num ferric reduc antioxid potenti frap total radical trap antioxid paramet trap measur reduc chain break antioxid capac measur dietari tac plant food dietari antioxid intak reduct risk gc frap adjust hr num num ci num num trap adjust hr num num ci num num highest lowest quintil associ observ cardia noncardia cancer clear effect observ smoker signific reduct gc risk quintil intak assay highest lowest quintil adjust hr num num ci num num trend num frap adjust hr num num ci num num trend num trap nonsmok smoker associ frap intak statist signific highest lowest quintil adjust hr num num ci num num num associ observ trap dietari antioxid capac intak sourc plant food reduct risk gc copyright num uicc
MED-2697~impair endotheli function meal rich cook fat pubm ncbi abstract object purpos studi test hypothesi intak cook fat impair endotheli function background diet high level lipid oxid product acceler atherogenesi effect endotheli function unknown method flow medi endothelium depend dilat glyceryl trinitrate induc endothelium independ dilat brachial arteri investig num men subject arteri studi num test meal num meal fat num rich cook fat deep fri fast food restaur num meal fat num rich unus cook fat num low fat meal fat num ad fat result endothelium depend dilat decreas fast postprandi studi fat meal num num num num num signific chang unus fat meal num num num num low fat meal num num num num signific differ endothelium independ dilat meal plasma free fatti acid concentr chang signific meal level postprandi hypertriglyceridemia chang endotheli function conclus ingest meal rich fat previous deep fri commerci fast food restaur result impair arteri endotheli function find suggest intak degrad product heat fat contribut endotheli dysfunct
MED-2698~total antioxid capac diet risk stroke population bas prospect cohort women pubm ncbi abstract background purpos consumpt antioxidant rich food reduc risk stroke inhibit oxid stress inflamm total antioxid capac tac account antioxid synergist effect examin associ dietari tac stroke incid cardiovascular diseas cvd free women women cvd histori baselin method studi includ women num cvd free num cvd histori baselin age num num year swedish mammographi cohort diet assess food frequenc questionnair dietari tac calcul oxygen radic absorb capac valu stroke case ascertain linkag swedish hospit discharg registri result follow up septemb num decemb num identifi num stroke case num cerebr infarct num hemorrhag stroke num unspecifi stroke cvd free women num stroke case num cerebr infarct num hemorrhag stroke num unspecifi stroke women cvd histori multivari hazard ratio total stroke compar highest lowest quintil dietari tac num num ci num num trend num cvd free women women cvd histori hazard ratio highest versus lowest quartil tac num num ci num num trend num total stroke num num ci num num trend num hemorrhag stroke conclus find suggest dietari tac invers total stroke cvd free women hemorrhag stroke women cvd histori
MED-2699~free radic theori age revisit cell signal disrupt theori age abstract signific free radic theori age provid theoret framework enorm amount work lead signific advanc understand age turn centuri theori receiv abund support observ field compar physiolog molecular biolog recent advanc work laboratori support theori instanc show overexpress antioxid enzym result increas life span lab shown case increas oxid stress increas longev discoveri free radic molecular damag cell serv signal led propos act modul physiolog process instanc reactiv oxygen speci ros stimul physiolog adapt physic exercis critic issu critic blow free radic theori age epidemiolog studi show antioxid supplement lower incid age associ diseas case increas risk death recent molecular evid shown increas generat ros case increas longev futur direct gerontologist interest free radic biolog crossroad insight requir clarifi role ros process age hurdl doubt high intellectu practic promis studi magnitud feel effort generous reward antioxid redox signal num num
MED-2700~effect blood remov oxid shelf life broiler breast meat pubm ncbi abstract blood compon hemoglobin power promot lipid oxid decreas shelf life meat product studi examin slaughter techniqu determin effect ph num color l a b valu num lipid oxid residu hemoglobin concentr num sensori evalu num num postmortem pm broiler breast fillet treatment includ num num slaughter bled num stun bled num electr stun es bled num num stun bled num es decapit bird convent process analys perform num pm residu hemoglobin sampl frozen num degre analys num mo signific differ ph valu num pm treatment valu signific higher indic lighter fillet es decapit bird compar darker fillet num stun bled bird num slaughter bled bird signific higher valu indic red color compar es bled decapit bird signific differ residu hemoglobin content broiler breast muscl compar treatment num slaughter bled signific num greater tba react substanc tbar raw cook num cook num pm es bled bird lowest tbar compar remain treatment consum panel detect increas aroma chicken meati warmed ov aroma flavor chicken meati warmed ov flavor bled sampl num pm num pm signific differ aroma flavor slaughter bleed method affect color sensori properti broiler breast fillet es decapit method favor result sensori qualiti
MED-2702~antioxid supplement prevent gastrointestin cancer systemat review meta analysi pubm ncbi abstract background oxid stress cancer aim establish antioxid supplement reduc incid gastrointestin cancer mortal method cochran collabor methodolog review randomis trial compar antioxid supplement placebo prevent gastrointestin cancer search electron databas refer list februari num outcom measur incid gastrointestin cancer mortal advers effect outcom analys fixed effect random effect model meta analys report relat risk num cis find identifi num randomis trial num trial qualiti general high heterogen result low moder fixed effect relat risk num num ci num num random effect meta analys num num num show signific effect supplement beta caroten vitamin selenium combin versus placebo oesophag gastric colorect pancreat liver cancer incid high qual trial num fixed effect model show antioxid signific increas mortal num num num unlik random effect meta analysi num num num low qual trial show signific effect antioxid supplement mortal differ mortal estim high qual low qual trial signific num num test interact beta caroten vitamin num num num beta caroten vitamin num num num signific increas mortal beta caroten tend increas mortal num num num trial unclear inadequ methodolog selenium show signific benefici effect incid gastrointestin cancer interpret find evid antioxid supplement prevent gastrointestin cancer contrari increas mortal potenti prevent effect selenium studi adequ randomis trial
MED-2703~atherosclerosi oxid stress end road antioxid vitamin treatment pubm ncbi abstract extens experiment data reveal central role oxid stress atherogenesi suggest potenti role antioxid treatment cardiovascular diseas cvd num experiment data translat clinic benefit antioxid vitamin trial fail reduc cardiovascular morbid mortal num recent clinic trial suggest mono therapi antioxid vitamin vitamin fact detriment num result disappoint outcom antioxid vitamin trial author question util antioxid treatment cvd suppos central role oxid stress atherogenesi num investig sustain benefici effect lipid lower anti hypertens treatment part due antioxid properti addit specif pharmacolog properti num oxid stress play pivot role atherogenesi clinic promis antioxid vitamin fail translat clinic benefit increas evid suggest rigor clinic trial design effect divulg antioxid util multifacet antioxid approach atherosclerosi yield clinic reward articl review evid role oxid stress atherosclerosi analyz result larg anti oxid trial suggest investig true role antioxid treatment clinic set
MED-2704~oxid process meat meat product qualiti implic pubm ncbi abstract lipid peroxid instanc free radic chain reaction term initi propag branch termin process regard lipid peroxid import question concern sourc primari catalyst initi peroxid situ muscl food cell injur muscl food slaughter lipid peroxid favor trace num num num indic lipid peroxid form stabil muscl food product depend tone peroxid involv metal ion process cytosol prooxid antioxid tone affect oxid lipid peroxid primari mechan qualiti deterior food meat product qualiti manifest deterior flavor color textur nutrit product toxic compound copyright num publish elsevi
MED-2705~stomach bioreactor dietari lipid peroxid gastric fluid effect plant deriv antioxid pubm ncbi abstract atherosclerosi result part process occur food consumpt involv oxid lipid chylomicron investig reaction occur acid ph stomach acceler generat lipid hydroperoxid co oxid dietari constitu abil dietari polyphenol invert catalysi pro oxid antioxid examin acid ph gastric fluid amplifi lipid peroxid catalyz metmyoglobin iron ion metmyoglobin catalyz peroxid edibl oil result num fold increas hydroperoxid concentr incub heat muscl tissu simul gastric fluid num enhanc hydroperoxid accumul num fold num microm presenc catechin red wine polyphenol metmyoglobin catalyz breakdown hydroperoxid total prevent lipid peroxid beta caroten cooxid suggest human gastric fluid excel medium enhanc oxid lipid dietari constitu result potenti harm effect oxid fat intak presenc endogen catalyst found food major benefit includ meal plant dietari antioxid
MED-2706~advers effect aromatherapi systemat review case report case seri pubm ncbi abstract aim systemat review aim critic evalu evid advers effect aromatherapi method electron databas search identifi relev case report case seri result forti primari report met inclus criteria total num patient experienc advers effect aromatherapi advers effect rang mild sever includ fatal common advers effect dermat lavend peppermint tea tree oil ylang ylang common essenti oil respons advers effect conclus aromatherapi potenti advers effect frequenc remain unknown lack suffici convinc evid effect aromatherapi combin potenti advers effect question modal condit
MED-2707~ambient odor orang dental offic reduc anxieti improv mood femal patient pubm ncbi abstract essenti oil remedi long time cultur world scientif proof applic scarc includ num patient age num num wait dental treatment studi particip assign control group num men num women odor group num men num women ambient odor orang diffus wait room electr dispens odor group control group odor air assess self report demograph cognit variabl trait state anxieti current pain mood alert calm studi report exposur ambient odor orang relax effect specif compar control women expos orang odor lower level state anxieti posit mood higher level calm data support previous notion sedat properti natur essenti oil orang citrus sinensi
MED-2708~inhal aromatherapi radiotherapi result placebo control double blind random trial pubm ncbi abstract purpos determin inhal aromatherapi radiotherapi reduc anxieti patient method hundr thirteen patient undergo radiotherapi random assign receiv carrier oil fraction oil carrier oil pure essenti oil lavend bergamot cedarwood administ inhal concurr radiat treatment patient underw assess hospit anxieti depress scale somat psycholog health report sphere baselin treatment complet result signific differ depress sphere score random assign group anxieti score signific lower treatment complet carrier oil group compar fragrant arm num conclus aromatherapi administ studi benefici
MED-2709~cardiac tamponad caus acupunctur review literatur pubm ncbi abstract systemat review aim summar report case cardiac tamponad acupunctur electron databas file search report cardiac tamponad acupunctur restrict time languag impos data extract independ review predefin criteria found total num case num patient complic fatal instanc doubt causal conclud cardiac tamponad fatal complic acupunctur theoret avoid acupuncturist train minim risk copyright num elsevi ireland reserv
MED-2710~aromatherapi fact fiction scientif analysi olfactori effect mood physiolog behavior pubm ncbi abstract systemat review scientif experiment address olfactori effect mood physiolog behavior undertaken review num studi meet stringent empir criteria analyz detail found credibl evid odor affect mood physiolog behavior exist explain effect pharmacolog psycholog mechan explor psycholog interpret data found comprehens methodolog problem depend measur stimuli led inconsist data discuss mediat variabl cultur experi sex differ person
MED-2711~accident bullous phototox reaction bergamot aromatherapi oil pubm ncbi abstract oil bergamot extract rind bergamot orang citrus aurantium ssp bergamia pleasant refresh scent year ago wide ingredi cosmet restrict ban countri advers effect recent oil bergamot prepar gain renew popular aromatherapi oil bergamot possess photosensit melanogen properti presenc furocoumarin primarili bergapten num methoxypsoralen num mop num mop potenti phototox photomutagen increas applic recent report phototox reaction bergamot aromatherapi oil describ patient local dissemin bullous phototox skin reaction develop num num hour exposur bergamot aromatherapi oil subsequ ultraviolet exposur patient case num histori direct contact aromatherapi oil develop bullous skin lesion exposur aerosol evapor aromatherapi oil sauna subsequ uva radiat tan salon report highlight potenti health hazard relat increas psoralen contain aromatherapi oil
MED-2712~systemat review anxiolyt effect aromatherapi peopl anxieti symptom pubm ncbi abstract purpos review studi num num aromatherapi peopl anxieti anxieti symptom examin clinic effect method review conduct electron databas extract journal articl evalu anxiolyt effect aromatherapi peopl anxieti symptom result result base num random control trial examin anxiolyt effect aromatherapi peopl anxieti symptom studi posit effect quell anxieti advers event report conclus recommend aromatherapi appli complementari therapi peopl anxieti symptom studi qualiti methodolog conduct identifi clinic effect biolog mechan
MED-2713~effect sweet orang aroma experiment anxieti human pubm ncbi abstract object object studi evalu potenti anxiolyt effect sweet orang citrus sinensi aroma healthi volunt submit anxiogen situat design forti num male volunt alloc group inhal sweet orang essenti oil test aroma num num num drop tea tree essenti oil control aroma num drop water nonaromat control num drop immedi inhal volunt submit model anxieti video monitor version stroop color word test scwt outcom measur psycholog paramet state anxieti subject tension tranquil sedat physiolog paramet heart rate gastrocnemius electromyogram evalu inhal period scwt result unlik control group individu expos test aroma num num drop present lack signific alter num state anxieti subject tension tranquil level anxiogen situat reveal anxiolyt activ sweet orang essenti oil physiolog alter test prevent treatment group previous observ diazepam conclus studi find clinic relev aromatherapi anxieti disord present result acut anxiolyt activ sweet orang aroma give scientif support tranquil aromatherapist
MED-2714~aromatherapi systemat review abstract aromatherapi increas popular clear indic systemat review literatur aromatherapi order discov clinic indic recommend computeris literatur search perform retriev randomis control trial aromatherapi databas medlin embas british nurs index ciscom ame methodolog qualiti trial assess jadad score trial evalu independ author data extract pre defin standardis fashion twelv trial locat independ replic relat relax effect aromatherapi combin massag studi suggest aromatherapi massag mild transient anxiolyt effect base critic assess studi relat relax effect aromatherapi strong consid treatment anxieti hypothesi effect indic support find rigor clinic trial
MED-2715~physic activ energi expenditur declin num match energi expenditur wild mammal pubm ncbi abstract object obes result protract energi imbal compris excess energi intak lower physic activ remain disput design physic activ energi expenditur evalu daili energi expenditur dee measur doubli label water examin trend time data includ subject europ maastricht netherland north america extend back num data compar measur world measur made wild terrestri mammal result physic activ expenditur europ residu regress dee basal energi expenditur bee slight signific increas num trend time physic activ level pal dee be residu varianc dee mass sex age account index physic activ expenditur signific increas time north america dee individu europ north america signific individu measur world wild terrestri mammal dee depend bodi mass ambient temperatur predict dee num kg mammal live num degre num mj day num ci num num mj day signific measur dee modern human num num mj day conclus physic activ expenditur declin period obes rate increas dramat daili energi expenditur modern man line energi expenditur wild mammal decreas expenditur fuell obes epidem
MED-2716~myth presumpt fact obes abstract background belief obes persist absenc support scientif evid presumpt persist contradict evid myth promulg unsupport belief yield poor inform polici decis inaccur clinic public health recommend unproduct alloc research resourc divert attent evidence bas inform method internet search popular media scientif literatur identifi review classifi obesity rel myth presumpt examin fact support evid emphasi practic implic public health polici clinic recommend result identifi obesity rel myth effect small sustain increas energi intak expenditur establish realist goal weight loss rapid weight loss weight loss readi physical educ class breast feed energi expend sexual activ identifi presumpt purport effect regular eat breakfast earli childhood experi eat fruit veget weight cycl snack built human mad environ final identifi evidence support fact relev formul sound public health polici clinic recommend conclus fals scientif unsupport belief obes pervas scientif literatur popular press fund nation institut health
MED-2717~role exercis treatment obes pubm ncbi abstract unit state midst signific public health problem relat obes inact epidem far rang consequ workforc children show sign slow futur signific research perform effect exercis reduct bodi weight result studi exercis small effect body weight reduct independ calor restrict combin dietari restrict exercis synergist effect enhanc weight loss effect diet addit exercis shown signific benefici effect cardiovascular metabol risk factor independ actual weight loss lose small amount weight signific benefici effect paramet genet factor relat obes found posit modifi person incorpor physic activ lifestyl sit time independ risk factor develop metabol risk factor person spend time sit watch televis wors metabol profil achiev recommend amount physic activ week move day exercis essenti prevent weight gain life span amount requir prevent weight gain closer amount exercis recommend current physic activ guidelin american www health gov paguidelin physiatrist prepar specialist address complex multidimension problem obes inact copyright num american academi physic medicin rehabilit publish elsevi reserv
MED-2718~energi balanc obes abstract paper describ interplay energi intak energi expenditur bodi energi store illustr understand energi balanc develop strategi reduc obes reduc obes requir modifi energi intak energi expenditur simpli focus food restrict effect reduc obes human physiolog bias achiev energi balanc high energi flux high level energi intak expenditur previous environ high energi flux achiev high level physic activ today sedentari environ increas achiev weight gain match energi intak high level energi expenditur feasibl strategi peopl maintain healthi weight restrict food intak meet low level energi expenditur energi balanc point view success prevent excess weight gain treat obes energi balanc system show stronger opposit weight loss weight gain larg behavior produc maintain reduct bodi weight small behavior suffici prevent excess weight gain conclus concept energi balanc combin understand bodi achiev balanc framework develop strategi reduc obes rate
MED-2719~individu lose weight exercis intervent defin dose energi balanc analysi summari weight loss result exercis intervent lower predict modest weight loss aris increas energi intak physiolog reduct rest energi expenditur increas lean tissu decreas non exercis activ lower expect weight loss aris weak invalid assumpt predict model investig systemat review studi monitor complianc exercis prescript measur exercise induc chang bodi composit chang bodi energi store calcul determin deficit total daili energi intak energi expenditur inform combin measur critic evalu explan low exercise induc weight loss conclud small magnitud weight loss observ major evalu exercis intervent primarili due low dose prescrib exercis energi expenditur compound concomit increas calor intak
MED-2720~potenti effect physic activ base menu label calori content select fast food meal pubm ncbi abstract studi examin effect physic activ base label calori content meal select sampl fast food menu web bas survey particip random assign menus differ label scheme num menu nutrit inform num menu calori inform num menu calori inform minut walk burn calori num menu calori inform mile walk burn calori signific differ number calori order base menu type num averag num calori order menu nutrit inform num calori order menu calori inform num calori order menu calori inform minut walk burn calori num calori order menu calori inform number mile walk burn calori menu calori number mile walk burn calori effect influenc select lower calori meal num compar menu nutrit inform provid major particip num report prefer physic activ base menu label label calori inform nutrit inform label effect real lif scenario remain test copyright num elsevi reserv
MED-2721~increas food energi suppli suffici explain epidem obes pubm ncbi abstract background major driver obes epidem debat polici import population wid prevent obes object object determin relat contribut increas energi intak reduc physic activ obes epidem design predict weight estim energi intak children adult num num increas food energi suppli adjust wastag assum proport energi intak apport children adult insert equat relat energi intak bodi weight deriv doubli label water studi weight increas predict equat compar weight increas measur repres survey period result children measur weight gain num kg predict weight gain increas energi intak ident num kg adult measur weight gain num kg predict weight gain higher num kg conclus increas energi intak suffici explain weight gain popul revers increas energi intak approxim num kj d num kcal d adult num kj d num kcal d children revers bodi weight num altern larg compensatori increas physic activ num min walking d combin achiev outcom popul approach reduc obes emphas reduct driver increas energi intak
MED-2722~preval physic activ obes counti num num road map action abstract background obes physic inact chronic condit increas medic care cost prematur death method behavior risk factor surveil system brfss state bas random digit telephon survey cover major unit state counti nation health nutrit examin survey nhane nation repres sampl civilian noninstitution popul num million adult age num year older particip brfss num num num adult age num older particip nhane num num calcul bodi mass index bmi self report weight height brfss adjust self report bias nhane calcul self report physic activ physic activ physic activ meet recommend level self report data brfss valid small area estim method generat estim obes physic activ preval counti annual num num result result show increas preval suffici physic activ num num level general higher men women increas greater women men counti kentucki florida georgia california report largest gain increas level activ match increas obes counti time period low correl level physic activ obes counti num num control poverti unemploy number doctor num popul percent rural baselin level obes num percentag point increas physic activ preval obes preval num percentag point lower conclus studi show increas physic activ small impact obes preval counti level rise physic activ level posit independ impact health american reduc burden cardiovascular diseas diabet reduct calor intak curb obes epidem burden
MED-2723~health econom burden project obes trend usa uk pubm ncbi abstract rise preval obes worldwid health concern excess weight gain popul forecast increas burden diseas notabl cardiovascular diseas diabet cancer report simul model project probabl health econom consequ decad continu rise obes age populations  th usa uk trend project num million obes adult usa num million obes adult uk num accru addit num num million case diabet num num num million case heart diseas stroke num num addit case cancer num million quality adjust life year forgon usa uk combin combin medic cost treatment prevent diseas estim increas num billion year usa num num billion year uk num effect polici promot healthier weight econom benefit copyright num elsevi reserv
MED-2724~heart rate rate pressur product oxygen uptak sexual activ pubm ncbi abstract heart rate rate pressur product vo num measur ten healthi men sexual activ coitus husband top coitus wife top noncoit stimul husband wife self stimul husband foreplay generat slight statist signific increas rest baselin cardiac metabol variabl stimul orgasm averag effort modest short span maximum exercis valu occur span orgasm return quick baselin level noncoit activ requir lower expenditur coital posit man on top coitus rate highest larg variat subject activ discourag general equival activ comparison flight stair repres sexual activ
MED-2725~conflict interest approv addit food determin general recogn safe balanc pubm ncbi abstract import food drug administr fda guidanc food manufactur determin addit food general recogn safe gras manufactur requir notifi fda gras determin instanc notifi agenc individu compani select make determin financi conflict interest object determin extent individu select manufactur make gras determin conflict interest oblig ensur addit safe financi relationship compani design conflict interest criteria develop committe institut medicin analyz num gras notif voluntarili submit fda num num main outcom measur number gras notic submit fda frequenc type relationship decis maker addit manufactur frequenc particip gras panel individu number gras safeti determin identifi fda submit agenc result num gras notif num safeti assess made employe addit manufactur num employe consult firm select manufactur num expert panel select consult firm manufactur stand expert panel select parti made safeti assess num panel made gras determin averag num member maximum num ten individu serv num panel num individu serv num panel num num num individu frequent servic member num panel num conclus relev num num financi conflict interest ubiquit determin addit food gras lack independ review gras determin rais concern integr process ensur safeti food suppli instanc manufactur notifi fda determin fda address concern
MED-2726~profit pandem prevent harm effect tobacco alcohol ultra process food drink industri pubm ncbi abstract num high level meet non communic diseas ncds call multisector action includ privat sector industri sale promot tobacco alcohol ultra process food drink unhealthi commod transnat corpor major driver global epidem ncds role industri ncd prevent control emphasis rise sale unhealthi commod low incom middle incom countri common strategi transnat corpor undermin ncd prevent control assess effect self regul public priv partnership public regul model interact industri conclud unhealthi commod industri role format nation intern ncd polici common relianc industri self regul public priv partnership evid effect safeti public regul market intervent evidence bas mechan prevent harm caus unhealthi commod industri copyright num elsevi reserv
MED-2736~character campylobact spp transfer natur contamin chicken leg cook chicken slice cut board pubm ncbi abstract campylobact repres lead gastroenter europ campylobacteriosi due jejuni coli poultri meat main sourc contamin cross contamin consumer kitchen import rout exposur aim studi examin transfer campylobact natur contamin raw poultri product cook chicken product cut board determin characterist involv isol studi show transfer occur num assay jejuni coli speci transfer transfer link specif isol transfer separ trial correl found transfer adhes inert surfac num isol present moder high adhes abil test isol abil adher invad caco num cell present high variabl isol result highlight occurr campylobact cross contamin cut board kitchen provid interest data consid risk assess studi copyright num elsevi reserv
MED-2738~trend consum safe handl consumpt food risk percept num num pubm ncbi abstract survey result measur safeti consum food handl riski food consumpt practic publish num year evalu trend imposs design publish studi compar food safeti survey compar method interview adult telephon num num num food handl cross contamin prevent riski consumpt practic eat raw undercook food anim perceiv risk foodborn ill sampl size rang num num respons analyz descript indic measur meat chicken egg cross contamin fish cross contamin riski consumpt risk percept analyz general linear model extent media coverag food safeti issu examin found substanti improv food handl consumpt practic increas perceiv risk foodborn ill num num indic stabl declin num num num num safe food handl practic indic increas signific risk percept chang safe consumpt declin women safer food handl consumpt practic men oldest youngest respond highest educ safe food handl behavior safeti practic survey year consist chang number media stori food safeti period survey find suggest increas media attent food safeti issu rais awar food safeti hazard increas vigil food handl consum
MED-2740~foodnet estim burden ill caus nontyphoid salmonella infect unit state pubm ncbi abstract determin burden salmonella infect unit state foodborn diseas activ surveil network foodnet investig conduct population bas activ surveil culture confirm salmonella infect num foodnet laboratori addit clinic microbiolog foodnet laboratori survey determin practic isol salmonella telephon interview conduct resid foodnet site determin proport person diarrheal ill sought medic care proport submit stool specimen bacteri cultur model estim num million nontyphoid salmonella infect unit state result num physician offic visit year num includ culture confirm infect confirm cultur estim salmonella infect result num hospit num death annual estim salmonellosi present major ongo burden public health
MED-2741~overcrowd stress decreas macrophag activ increas salmonella enteritidi invas broiler chicken pubm ncbi abstract overcrowd stress realiti poultri industri chicken expos long term stress situat present reduct welfar immunosuppress design experi analys effect overcrowd stress num birds m num perform paramet serum corticosteron level relat weight bursa fabricius plasma iga igg level intestin integr macrophag activ experiment salmonella enteritidi invas result studi overcrowd stress decreas perform paramet induc enter decreas macrophag activ relat bursa weight broiler chicken chicken similar stress infect salmonella enteritidi increas feed convers decreas plasma igg level stress salmonella infect bird observ moder enter duodenum chicken stress infect salmonella overcrowd stress decreas macrophag phagocytosi intens increas salmonella enteritidi count liver bird challeng pathogen bacterium overcrowd stress hypothalamic pituitary adren axi increas corticosteron enter influenc qualiti intestin immun barrier integr small intestin effect pathogen bacteria migrat intestin mucosa result inflammatori infiltr decreas nutrient absorpt data strengthen hypothesi control welfar chicken avoid stress overcrowd poultri product relev factor mainten intestin integr perform decreas suscept salmonella infect
MED-2742~consum knowledg foodborn microbi hazard food handl practic pubm ncbi abstract nation telephon survey conduct num random select resid spoke english num year resid household kitchen facil respond interview recognit foodborn pathogen food risk transmit infect knowledg safe food handl food handl practic one third respond prepar meal report unsaf food hygien practic wash hand precaut prevent cross contamin raw meat unsaf practic report men adult num num year age occasion food prepar women person num year older frequent food prepar respond identifi food vehicl salmonella spp report wash hand clean cut board prepar raw meat poultri result rais concern consum food handl practic influenc food safeti train food handl experi age food handl practic studi awar food vehicl salmonella spp knowledg etiolog foodborn diseas promot safe food handl understand factor safe food handl assist develop effect safe food instruct program
MED-2743~outbreak salmonella heidelberg infect link singl poultri produc num state num pubm ncbi abstract june num oregon health author washington state depart health note increas number salmonella enterica serotyp heidelberg clinic isol share ident pulsed field gel electrophoresi pfge pattern num pattern link chicken foster farm washington state depart health preliminari num interview infect person exposur foster farm chicken august num cdc s pulsenet detect cluster num salmonella heidelberg clinic isol match outbreak pattern report summar investig cdc state local health depart depart agriculture food safeti inspect servic usda fsi food drug administr fda reinforc import safe food handl prevent ill total num case num state identifi includ num patient hospit multifacet investig standard epidemiolog laboratori data patient shopper card purchas inform pfge data retail meat compon nation antimicrobi resist monitor system narm tool outbreak investig link outbreak strain chicken foster farm
MED-2744~homicid rate person age num year unit state num pubm ncbi abstract homicid disproportion affect person age num year unit state consist rank top lead death age group result approxim num death estim num billion lost product medic cost num investig trend homicid person age num year period num cdc analyz nation vital statist system data death caus homicid person age group examin trend sex age race ethn mechan injuri report describ result analysi homicid rate vari substanti studi period sharp rise num num declin slow num period num rate declin group declin signific slower male compar femal black compar hispan person racial ethn group mechan injuri declin firearm homicid num num signific slower nonfirearm homicid homicid rate person age num year num num num lowest num year studi period primari prevent strategi remain critic group increas risk homicid
MED-2745~initi contamin chicken part salmonella retail cross contamin cook chicken salmonella raw chicken pubm ncbi abstract current studi undertaken acquir data contamin chicken part salmonella retail acquir data cross contamin cook chicken salmonella raw chicken meal prepar raw chicken num obtain local retail store cut wing breast skin bone thigh drumstick data cross contamin obtain cut steril cook chicken breast board knife cut raw chicken board knife latex glove food handler rins wash cut steril cook chicken breast provid worst cas scenario cross contamin standard curv concentr salmonella bacteria num ml buffer pepton water num incub chicken part function initi log number salmonella bacteria inocul chicken part develop enumer salmonella bacteria standard curv affect type chicken part differ num isol salmonella examin salmonella bacteria enumer natur contamin chicken part standard curv develop serotyp salmonella isol origin sampl preval contamin num num num incid cross contamin num num num posit chicken part thigh chicken num num cfu salmonella enterica serotyp kentucki wing thigh cook breast portion chicken num num cfu serotyp num num result poultri industri provid consum studi area chicken low preval low number salmonella bacteria retail low incid low level cross contamin cook chicken salmonella raw chicken meal prepar worst cas scenario
MED-2746~campylobact transfer natur contamin chicken thigh cut board invers relat initi load pubm ncbi abstract food prepar kitchen cross contamin campylobact contact raw product skin poultri measur percent transfer rate natur contamin poultri leg purchas supermarket transfer campylobact skin num meat num high dens polyethylen cut board surfac quantit assess contact time num num min percent transfer rate defin ratio number campylobact cell count cut board surfac initi number campylobact natur present skin sum campylobact cell skin board qualit transfer occur num num confid interv num num natur contamin leg studi reach num num confid interv num num subpopul leg contact surfac num min percent transfer rate vari num num num num observ signific kruskall w test num invers relat initi count poultri skin studi quantit data describ evolut proport campylobact organ transfer natur contamin poultri kitchen condit emphas linear relationship initi load campylobact skin percent transfer rate work confirm model transfer function initi load campylobact leg skin weight poultri piec durat contact skin surfac
MED-2747~attribut foodborn ill hospit death food commod outbreak data unit state num num abstract year num million foodborn ill estim caus major pathogen acquir unit state prevent ill challeng resourc limit link individu ill food rare outbreak develop method attribut ill food commod data outbreak simpl complex food data outbreak associ ill num num estim annual foodborn ill hospit death attribut num food commod attribut num ill produc found death attribut poultri commod extent estim reflect commod caus foodborn ill effort prevent contamin produc poultri method incorpor data sourc improv attribut estim commod agent
MED-2748~persist human norovirus reconstitut pesticides  pesticid applic sourc virus fresh produc chain pubm ncbi abstract consumpt fresh produc frequent outbreak human norovirus hnov diseas prevent contamin fresh produc hnov knowledg introduct sourc virus water implement effici prevent measur contamin water reconstitut pesticid relev sourc infecti hnov determin initi level virus contamin persist virus reconstitut pesticid studi persist hnov gi num hnov gii num murin norovirus mnv num cultur norovirus pesticid num num virus concentr determin revers transcriptas pcr infect mnv num determin endpoint dilut maximum likelihood estim mnv num found remain infecti test pesticid highest concentr appli practic presenc insecticid vertimec mnv num infect decreas rapid num log num unit reduct timepoint num concentr nov gi num rna decreas num log num unit reduct detect pcr fragment hnov gii num remain stabl assum similar persist infecti mnv num hnov conclud water hnov dilut pesticid import sourc infecti hnov fresh produc chain applic pesticid chemic hazard microbiolog hazard public health inclus antivir substanc reconstitut pesticid reduc virolog health risk pose applic pesticid copyright num elsevi reserv
MED-2749~epidemiolog foodborn norovirus outbreak unit state num num abstract norovirus lead foodborn ill unit state guid intervent analyz num foodborn diseas outbreak norovirus suspect confirm report foodborn diseas outbreak surveil system center diseas control prevent num num averag num foodborn norovirus outbreak report annual result estim num ill num health care provid visit num hospit num death num outbreak attribut singl commod leafi veget num fruits nut num mollusk num implic common infect food handler sourc num outbreak contribut num outbreak food contamin prepar servic mollusk occasion produc contamin product process intervent reduc frequenc foodborn norovirus outbreak focus food worker product produc shellfish
MED-2750~lack benefit dietari advic men angina result control trial pubm ncbi abstract object mortal men angina reduc dietari advic design random control factori trial set male patient general practition south wale subject total num men num age angina intervent subject random alloc group num advis eat portion oili fish week fish oil capsul daili num advis eat fruit veget oat num type advic num specif dietari advic mortal ascertain num result complianc fish advic fruit advic all caus mortal reduc form advic effect attribut fruit advic risk cardiac death higher subject advis oili fish advis adjust hazard ratio num num confid interv num num num greater sudden cardiac death num num ci num num num excess risk larg locat subgroup fish oil capsul evid due interact medic conclus advic eat fruit poor compli detect effect mortal men advis eat oili fish suppli fish oil capsul higher risk cardiac death result unexplain aris risk compens effect patient doctor behaviour
MED-2751~global fishmeal fish oil suppli input output market pubm ncbi abstract recent data fishmeal fish oil suppli present identifi key produc countri raw materi sourc distinguish fish by product convers raw materi marin ingredi discuss global volum present summari main countri marin ingredi recent year fishmeal fish oil market segment present global mass balanc input output deriv calcul input to output ratio fish in fish fifo main aquacultur product type made current area focus industri includ demonstr sustain practic strateg marin ingredi greater fisheri land anim by product veget substitut sourc essenti omega num fat notabl long chain polyunsatur fatti acid eicosapentaeno epa docosahexaeno dha acid implic drawn futur suppli prospect fishmeal fish oil futur role aquacultur agricultur human health num fisheri societi british isl
MED-2752~associ omega num fatti acid supplement risk major cardiovascular diseas event systemat review meta analysi pubm ncbi abstract context controversi exist associ omega num polyunsatur fatti acid pufa major cardiovascular end point object assess role omega num supplement major cardiovascular outcom data sourc medlin embas cochran central regist control trial august num studi select random clinic trial evalu effect omega num all caus mortal cardiac death sudden death myocardi infarct stroke data extract descript quantit inform extract absolut relat risk rr estim synthes random effect model heterogen assess statist num subgroup analys perform presenc blind prevent set patient implant cardioverter defibril meta regress analys perform omega num dose statist signific threshold num assum adjust multipl comparison data synthesi num citat retriev num studi num patient includ report num death num cardiac death num sudden death num myocardi infarct num stroke statist signific associ observ all caus mortal rr num num ci num num risk reduct num num ci num num cardiac death rr num num ci num num num num ci num num sudden death rr num num ci num num num num ci num num myocardi infarct rr num num ci num num num num ci num num stroke rr num num ci num num num num ci num num supplement studi consid conclus omega num pufa supplement lower risk all caus mortal cardiac death sudden death myocardi infarct stroke base relat absolut measur associ
MED-2753~secondari prevent chd uk men diet reinfarct trial sequel pubm ncbi abstract diet reinfarct trial dart involv num men age num year recov myocardi infarct random alloc receiv advic receiv advic dietari factor increas fatti fish intak reduct fat intak increas polyunsatur fat satur fat increas intak cereal fibr complianc satisfactori fish fibr advic fat advic men fish advic num lower num year all caus mortal form advic signific effect diet angina random trial dart num involv num men age num year stabl angina num year advic eat oili fish fish oil affect all caus mortal signific increas sudden cardiac death num effect larg confin subgroup fish oil capsul advic eat fruit veget effect poor complianc outcom dart num conflict dart studi explan consid nutrit intervent equal accept tailor individu intend distinct group rais risk chd assum nutrit intervent nutrit supplement necessarili effect food deriv
MED-2754~efficaci omega num fatti acid supplement eicosapentaeno acid docosahexaeno acid secondari prevent cardiovascular diseas pubm ncbi abstract background previous random double blind placebo control trial report efficaci omega num fatti acid supplement secondari prevent cardiovascular diseas cvd evid remain inconclus meta analysi investig efficaci eicosapentaeno acid docosahexaeno acid secondari prevent cvd method search pubm embas cochran librari april num independ review select elig random control trial result num articl retriev num random double blind placebo control trial involv num patient histori cvd includ final analys supplement omega num fatti acid reduc risk cardiovascular event relat risk num num ci num num all caus mortal sudden cardiac death myocardi infarct congest heart failur transient ischem attack stroke small reduct cardiovascular death relat risk num num ci num num disappear exclud studi major methodolog problem signific prevent effect observ subgroup analys countri locat inland coastal geograph area histori cvd concomit medic type placebo materi trial methodolog qualiti trial durat treatment dosag eicosapentaeno acid docosahexaeno acid fish oil supplement treatment conclus meta analysi show insuffici evid secondari prevent effect omega num fatti acid supplement cardiovascular event patient histori cardiovascular diseas
MED-2755~effect fat fish fibr intak death myocardi reinfarct diet reinfarct trial dart pubm ncbi abstract randomis control trial factori design examin effect dietari intervent secondari prevent myocardi infarct mi num men recov mi alloc receiv receiv advic dietari factor reduct fat intak increas ratio polyunsatur satur fat increas fatti fish intak increas cereal fibr intak advic fat differ mortal produc small reduct num serum cholesterol subject advis eat fatti fish num reduct num year all caus mortal compar advis effect signific alter adjust ten potenti confound factor subject fibr advic slight higher mortal subject signific num year incid reinfarct death ischaem heart diseas signific affect dietari regimen modest intak fatti fish portion week reduc mortal men recov mi
MED-2756~fish consumpt omega num fatti acid environment contamin relat low grad inflamm earli atherosclerosi pubm ncbi abstract background fish consumpt omega num polyunsatur fatti acid pufa intak shown protect cardiovascular diseas cvd fish environment contamin dibenzo p dioxin dibenzofuran pcdd fs polychlorin biphenyl pcbs methylmercuri mehg advers effect cardiovascular health object aim elucid associ fish consumpt omega num pufa environment contamin low grad inflamm earli atherosclerosi tradit cvd risk factor method health num survey particip num repres general finnish popul fishermen studi particip num repres popul high fish consumpt high exposur environment contamin model adjust geometr test linear trend calcul cvd risk factor tertil fish consumpt serum omega num pufa addit fishermen studi tertil serum pcdd f pcb blood mehg result serum triglycerid decreas omega num pufa tertil sex studi insulin resist c reactiv protein tumour necrosi factor interleukin num decreas omega num pufa tertil health num survey particip fishermen studi men insulin resist arteri stiff stiff index tend increas rr estim carotid arteri plaqu tend decreas tertil pcdd f pcb mehg conclus previous establish hypotriglyceridem anti inflammatori effect omega num pufa studi hypothesis favour effect insulin sensit arteri elast suggest counteract high exposur environment contamin effect plaqu preval harm copyright num elsevi reserv
MED-2757~multivitamin multiminer supplement mortal meta analysi random control trial pubm ncbi abstract background multivitamin common supplement develop world recent epidemiolog find suggest multivitamin increas risk mortal object aim determin multivitamin multiminer treatment primari secondari prevent increas risk mortal independ live adult design perform meta analysi random control trial multipl electron databas systemat search march octob num random control primari secondari prevent trial consid inclus elig trial investig daili multivitamin multiminer supplement num cohort institution termin ill tertiari prevent exclud number death sampl size studi arm extract independ num research twenty on articl includ analysi generat total pool sampl num peopl num death trial pool meta analysi outcom express rrs num cis result averag age pool sampl num averag durat supplement num mo studi effect multivitamin multiminer treatment all caus mortal rr num num ci num num observ trend reduc risk all caus mortal primari prevent trial rr num num ci num num multivitamin multiminer treatment effect mortal due vascular rr num num ci num num cancer rr num num ci num num statist evid heterogen public bias observ conclus multivitamin multiminer treatment effect mortal risk
MED-2758~multivitamin prevent cardiovascular diseas men physician health studi ii random control trial abstract context multivitamin aim prevent vitamin miner defici percept multivitamin prevent cardiovascular diseas cvd observ studi examin regular multivitamin inconsist cvd long term clinic trial multivitamin object determin long term multivitamin supplement decreas risk major cardiovascular event men design physician health studi ii random double blind placebo control trial common daili multivitamin began num continu treatment follow up june num set particip total num male physician initi age num year sd age num num year includ num men histori cvd random enrol intervent daili multivitamin centrum silver main outcom measur primari cardiovascular outcom composit endpoint major cardiovascular event includ nonfat myocardi infarct mi nonfat stroke fatal cvd secondari outcom includ mi stroke individu result median interquartil rang follow up num num num year num confirm major cardiovascular event compar placebo signific effect daili multivitamin major cardiovascular event activ placebo multivitamin group num num event num person year hazard ratio hr num num confid interv ci num num num daili multivitamin effect total mi activ placebo multivitamin group num num event num person year hr num num ci num num num total stroke activ placebo multivitamin group num num event num person year hr num num ci num num num cardiovascular mortal activ placebo multivitamin group num num event num person year hr num num ci num num num daili multivitamin signific total mortal hr num num ci num num num effect daili multivitamin major cardiovascular event differ men baselin histori cvd interact num conclus daili multivitamin reduc major cardiovascular event mi stroke cvd mortal decad treatment follow up
MED-2759~vomit multivitamin potenti drug interact pubm ncbi abstract commerci weight loss program client base compos num women experienc sporad complaint nausea vomit chang multivitamin supplier retrospect observ studi design determin relat advers event report signific investig potenti mechan occurr group subject concurr receiv oral contracept hormon replac therapi incid nausea vomit rash total complaint num month chang multivitamin formul compar complaint num month chang num month multivitamin chang num complaint nausea vomit num complaint rash num total complaint group num patient num month chang multivitamin num complaint nausea vomit complaint rash num total complaint num patient differ detect chi squar test signific event studi nausea vomit num rash num total complaint num alter multivitamin ad citrus bioflavanoid includ origin formula citrus bioflavanoid decreas clearanc exogen estrogen inhibit cytochrom num enzym system elev estrogen level account increas incid nausea vomit experi demonstr ad dietari herbal supplement multivitamin advers interact prescript drug
MED-2760~multivitamin prevent cancer men physician health studi ii random control trial abstract context multivitamin prepar common dietari supplement one third adult limit observ studi provid evid associ multivitamin total site specif cancer incid mortal object determin long term multivitamin supplement decreas risk total site specif cancer event men design physician health studi ii random double blind placebo control trial common multivitamin began num treatment follow up june num set particip total num male physician initi age num year sd age num num year includ num men histori cancer random enrol intervent daili multivitamin centrum silver main outcom measur primari outcom total cancer exclud non melanoma skin cancer prostat colorect site specif cancer secondari endpoint includ report result median interquartil rang follow up num num num year num men confirm cancer includ num case prostat cancer num case colorect cancer compar placebo men daili multivitamin statist signific reduct incid total cancer activ placebo multivitamin group num num event num person year hazard ratio hr num num confid interv ci num num num signific effect daili multivitamin prostat cancer hr num num ci num num num colorect cancer hr num num ci num num num site specif cancer lower risk cancer mortal reach statist signific hr num num ci num num num daili multivitamin reduct total cancer num men baselin histori cancer hr num num ci num num num differ signific num men initi free cancer hr num num ci num num num interact num conclus larg prevent trial male physician daili multivitamin supplement modest signific reduc risk total cancer
MED-2761~multivitamin cross sect studi physician health studi pubm ncbi abstract purpos aim studi examin preval self report multivitamin physician health studi phs cohort associ lifestyl clinic dietari factor improv understand multivitamin method num middle ag older men inform lifestyl clinic factor collect baselin enrol questionnair supplement dietari factor assess food frequ questionnair categori multivitamin consid num supplement num multivitamin num multivitamin individu vitamin miner supplement num supplement logist regress calcul multivari odd ratio num confid interv multivitamin supplement lifestyl clinic dietari factor result num men report current multivitamin men older current smoker aspirin num num multivitamin men histori hypercholesterolemia num multivitamin num num greater likelihood multivitamin observ men consum fruit veget grain tea similar associ observ likelihood multivitamin supplement men higher physic activ histori cancer hypertens higher consumpt nut lower consumpt red meat coffe multivitamin supplement num conclus self report multivitamin lifestyl clinic dietari factor indic healthi behavior result provid import inform interpret recent find phs ii trial result observ studi multivitamin chronic diseas
MED-2762~vitamin miner supplement primari prevent cardiovascular diseas cancer updat systemat evid review pubm ncbi abstract background vitamin miner supplement common prevent chronic diseas purpos systemat review evid benefit harm vitamin miner supplement community dwel nutrient suffici adult primari prevent cardiovascular diseas cvd cancer data sourc medlin embas cochran central regist control trial cochran databas systemat review databas abstract review effect search januari num num januari num manual search refer list gray literatur studi select investig independ select review fair good qual trial benefit fair good qual trial observ studi harm data extract dual qualiti assess data abstract data synthesi larg trial num report lower cancer incid men multivitamin num year pool unadjust relat risk num num ci num num studi includ women show effect group high qual studi num num singl pair nutrient vitamin folic acid selenium calcium scant heterogen show clear evid benefit harm vitamin caroten prevent cvd cancer caroten increas lung cancer risk smoker limit analysi includ primari prevent studi adult nutrit defici studi conduct older individu includ supplement dose set upper toler limit durat studi num year conclus limit evid support benefit vitamin miner supplement prevent cancer cvd trial found small borderline signific benefit multivitamin supplement cancer men effect cvd primari fund sourc agenc healthcar research qualiti
MED-2763~face faceless public health what public pubm ncbi abstract compel statist show elimin num heart diseas stroke num diabet num cancer basic lifestyl fail motiv public make fail motiv polici maker make healthi choic easiest choic dr katz suggest fail focus statist passion implor tap people passion connect statist human stori
MED-2765~current nutrit inform pubm ncbi abstract prevent delay occurr chronic diseas scientif bodi cardiolog oncolog disciplin made recommend daili dietari intak macro micronutri studi assess knowledg random popul num individu compris member public health care worker univers graduat student health club attende segment popul expect greater understand abil implement dietari recommend found num particip unawar recommend calcium salt vitamin fiber fiber content high fiber cereal approxim num particip unawar recommend fat intak calcul fat content food product half studi popul vitamin pill daili subject awar correct unit measur vitamin iu num gave respons exceed recommend daili intak major studi popul unawar dietari recommend prevent cardiovascular event cancer subgroup studi popul expect inform recommend higher educ health care profession display satisfactori level knowledg compound problem adher recommend guidelin label food product mislead recommend dietari intak inform food product content transmit public form readi applic purchas consum food
MED-2769~milk intak earli life risk advanc prostat cancer abstract author investig early lif resid area iceland mark distinct differ milk intak risk prostat cancer population bas cohort num men born num num linkag cancer mortal regist men prostat cancer diagnosi mortal studi entri wave num num num num num subgroup num particip report milk intak earli mid current life follow up period num year num men diagnos prostat cancer includ num advanc diseas stage num higher prostat cancer death compar early lif resid capit area rural resid num year life margin increas risk advanc prostat cancer hazard ratio num num confid interv ci num num men born num hazard ratio num num ci num num daili milk consumpt adolesc daili midlif num fold risk advanc prostat cancer num ci num num data suggest frequent milk intak adolesc increas risk advanc prostat cancer
MED-2770~experi japan clue etiolog breast ovarian cancer relationship death malign dietari prac pubm ncbi abstract breast ovarian cancer rare japan compar develop countri death rate increas japan dramat lifestyl occur world war ii past num year num age standard death rate breast ovarian cancer increas num num fold respect intak milk meat egg increas num num fold increas annual death rate breast ovarian cancer due lifestyl increas consumpt animal deriv food occur num food milk dairi product receiv attent amount estrogen
MED-2771~milk consumpt risk factor prostat cancer western countri evid cohort studi pubm ncbi abstract previous found posit associ milk consumpt prostat cancer risk meta analysi analyz publish case control studi present studi meta analysi conduct estim summari relat risk rr consumpt milk dairi product prostat cancer cohort studi publish num found num relev articl num independ studi analysi summari rr num num confid interv num num compar highest lowest quantil consumpt summari rrs studi stratif show posit associ dose respons relationship identifi combin studi partit consumpt quintil evalu effect limit dairi classif prostat cancer stage public bias present studi find previous studi suggest consumpt milk dairi product increas risk prostat cancer biolog plausibl milk amount fat hormon calcium prostat cancer risk
MED-2772~milk consumpt risk factor prostat cancer meta analysi case control studi pubm ncbi abstract prostat cancer common cancer men unit state milk consumpt consid risk factor epidemiolog studi result inconsist meta analysi method conduct estim combin odd ratio milk consumpt prostat cancer case control studi publish num num commerci softwar comprehens meta analysi combin num num confid interv num num num publish case control studi combin vari studi stratif addit evalu risk factor milk prostat cancer conclus found posit associ milk consumpt prostat cancer mechan includ fat calcium hormon factor investig copyright num lawrenc erlbaum associ
MED-2773~experi japan clue etiolog testicular prostat cancer pubm ncbi abstract japan dramat lifestyl occur world war num examin experi japan clue etiolog trend mortal rate testicular prostat cancer num num relat dietari practic male popul born num peak death testicular cancer thirti forti born num peak twenti death rate prostat cancer increas num fold linear war intak milk meat egg increas num num fold war connect develop growth testicular prostat cancer japan attent paid milk increas consumpt countri recent occurr milk amount estrogen satur fat
MED-2774~milk stimul growth prostat cancer cell cultur pubm ncbi abstract concern express fact cow milk estrogen stimul growth hormone sensit tumor studi organ cow milk commerci substitut digest vitro test effect growth cultur prostat breast cancer cell cow milk stimul growth lncap prostat cancer cell num separ experi produc averag increas growth rate num contrast almond milk suppress growth cell num cow milk almond milk affect growth mcf num breast cancer cell aspc num pancreat cancer cell signific soy milk increas growth rate breast cancer cell data prostat breast cancer patient caution promot effect commerci dairi product substitut
MED-2775~incid mortal testicular prostat cancer relat world dietari practic pubm ncbi abstract incid mortal rate testicular prostat cancer num countri correl dietari practic countri cancer rate num provid intern agenc research cancer iarc food suppli data num provid food agricultur organ fao food item examin chees close correl incid testicular cancer age num anim fat milk correl coeffici highest num calcul chees consum period num matern prepubert consumpt stepwise multiple regress analysi reveal milk chees num made signific contribut incid testicular cancer standard regress coeffici num prostat cancer milk num close correl num incid meat coffe stepwise multiple regress analysi identifi milk chees factor contribut incid prostat cancer num food close correl mortal rate prostat cancer milk num coffe chees anim fat stepwise multiple regress analysi reveal milk chees factor contribut mortal prostat cancer num result studi suggest role milk dairi product develop growth testicular prostat cancer close correl chees testicular cancer milk prostat cancer suggest mechanist studi undertaken develop male genit organ cancer copyright num wiley liss
MED-2777~associ gout nephrolithiasi nation health nutrit examin survey iii num pubm ncbi abstract background gout inflammatori arthriti report afflict num million men women unit state previous report suggest associ gout kidney stone diseas studi adjust import potenti confound obes presenc hypertens knowledg publish studi examin independ associ gout kidney stone diseas method nation probabl sampl popul determin independ associ report gout histori kidney stone diseas result men women num year older num num million report previous passag kidney stone num num million report diagnosi gout physician num individu report passag kidney stone occas histori gout convers preval previous kidney stone subject report gout num age adjust model gout increas odd ratio previous kidney stone num num confid interv ci num num adjust sex race bodi mass index presenc hypertens previous kidney stone individu gout decreas num num ci num num conclus show independ associ kidney stone diseas gout strong suggest share common pathophysiolog mechan identif mechan lead improv prevent strategi condit copyright num nation kidney foundat
MED-2780~total solubl oxal content indian spice pubm ncbi abstract spice cinnamon clove cardamom garlic ginger cumin coriand turmer world flavour colour ingredi indian food previous studi shown spice variabl amount total oxal report solubl oxal content studi total solubl insolubl oxal content ten spice common indian cuisin measur total oxal content rang num nutmeg num green cardamom mg num dm solubl oxal content rang num nutmeg num green cardamom mg num dm percentag solubl oxal content spice rang num num total oxal content suggest spice present risk peopl liabl kidney stone format spice suppli signific amount solubl oxal moder
MED-2781~effect curcumin dosag human gall bladder pubm ncbi abstract previous studi demonstr curcumin activ compound curcuma xanthorrhiza domestica produc posit cholekinet effect num mg amount curcumin capabl contract gall bladder num observ time num aim current studi defin dosag curcumin capabl produc num contract gall bladder determin linear relationship doubl curcumin dosag doubl gall bladder contract randomis single blind three phas crossover design examin carri num healthi volunt ultrasonographi carri serial measur gall bladder volum data obtain analys analysi varianc anova fast volum gall bladder similar num num num ml num mg curcumin num num ml num mg num num ml num mg percentag decreas gall bladder volum num administr num num mg num num num num num num signific num basi present find dosag cucumin capabl produc num contract bladder num mg studi show linear relationship doubl curcumin dosag doubl gall bladder contract
MED-2782~curcumin mainten therapi ulcer coliti random multicent double blind placebo control trial pubm ncbi abstract background aim curcumin biolog activ phytochem substanc present turmer pharmacolog action benefit patient ulcer coliti uc aim trial assess efficaci curcumin mainten therapi patient quiescent ulcer coliti uc method eighty nin patient quiescent uc recruit random double blind multicent trial curcumin prevent relaps forty f patient receiv curcumin num breakfast num meal sulfasalazin sz mesalamin num patient receiv placebo sz mesalamin num month clinic activ index cai endoscop index ei determin entri num month cai conclus num month trial end num month follow up result patient protocol violat num patient receiv curcumin num relaps num month therapi num num num patient num placebo group relaps num recurr rate evalu basi intent treat show signific differ curcumin placebo num curcumin improv cai num ei num suppress morbid uc num month follow up patient group sz mesalamin addit patient curcumin group num patient placebo group relaps conclus curcumin promis safe medic maintain remiss patient quiescent uc studi curcumin strengthen find
MED-2783~multitarget turmer golden spice kitchen clinic pubm ncbi abstract publish curcumin obtain turmer compar turmer turmer golden spice obtain rhizom plant curcuma longa give color tast food prepar ancient time tradit spice ayurveda folk medicin treatment ailment gynecolog problem gastric problem hepat disord infecti diseas blood disord modern scienc provid scientif basi turmer disord chemic constitu isol spice includ polyphenol sesquiterpen diterpen triterpenoid sterol alkaloid curcumin constitut num turmer most studi compon activ turmer mimick curcumin activ curcumin independ cell bas studi demonstr potenti turmer antimicrobi insecticid larvicid antimutagen radioprotector anticanc agent numer anim studi shown potenti spice proinflammatori diseas cancer neurodegen diseas depress diabet obes atherosclerosi molecular level spice shown modul numer cell sign pathway clinic trial turmer shown efficaci numer human ailment includ lupus nephriti cancer diabet irrit bowel syndrom acn fibrosi spice origin common kitchen exhibit activ clinic review discuss chemic constitu turmer biolog activ molecular target potenti clinic num wiley vch verlag gmbh kgaa weinheim
MED-2785~mitochondri nuclear dna damag induc curcumin human hepatoma num cell pubm ncbi abstract curcumin extens spice pigment anticarcinogen effect link antioxid properti studi suggest natur compound possess pro antioxid effect studi found curcumin induc dna damag mitochondri nuclear genom human hepatoma num cell quantit polymeras chain reaction immunocytochemistri stain num hydroxydeoxyguanosin demonstr curcumin induc dose depend damag mitochondri nuclear genom mitochondri damag extens nuclear dna fragment evid comet assay mechan elev level reactiv oxygen speci lipid peroxid generat curcumin lack dna damag low dose suggest low level curcumin induc dna damag play antioxid role carcinogenesi high dose found curcumin impos oxid stress damag dna data reinforc hypothesi curcumin play conflict dual role carcinogenesi extens mitochondri dna damag initi event trigger curcumin induc cell death
MED-2786~therapeut potenti turmer alzheimer diseas curcumin curcuminoid pubm ncbi abstract alzheimer diseas ad common form dementia limit choic modern therapeut drug limit success multipl side effect addit high cost newer altern treatment option explor effect safer therapeut target address ad turmer possess multipl medicin includ treatment ad curcuminoid mixtur curcumin demethoxycurcumin bisdemethoxycurcumin vital constitu turmer general believ curcumin import constitu curcuminoid mixtur contribut pharmacolog profil parent curcuminoid mixtur turmer care literatur studi reveal constitu curcuminoid mixtur contribut signific effect curcuminoid ad emphas review compon curcuminoid mixtur play distinct role make curcuminoid mixtur ad curcuminoid mixtur repres turmer medicin curcumin progress understand diseas etiolog demand multiple site target therapi curcuminoid mixtur compon merit make mixtur promis combat challeng diseas copyright num john wiley son
MED-2787~effect curcumin placebo human gall bladd function ultrasound studi pubm ncbi abstract background extract medicin plant curcumin tradit believ posit contract effect human gall bladd aim compar effect num mg curcumin placebo gall bladd volum healthi volunt method random doubl blind crossov design studi carri num healthi volunt male femal ultrasonographi examin carri serial measur gall bladd volum data obtain analys pair student t test result fast gall bladd volum num num ml curcumin num num ml placebo similar num gall bladd volum reduc period curcumin administr percentag gall bladd volum reduct num num num num num mg curcumin administr num num num num num num num num statist signific compar placebo conclus basi present find curcumin induc contract human gall bladd
MED-2788~clinic util curcumin extract pubm ncbi abstract turmer root medicin china india thousand year activ compon thought curcuminoid primarili curcumin common worldwid standard extract articl review pharmacolog curcuminoid efficaci potenti advers effect dosag standard preclin studi point mechan action predomin anti inflammatori antineoplast earli human clinic trial suggest benefici effect dyspepsia peptic ulcer inflammatori bowel diseas rheumatoid arthriti osteoarthr uveiti orbit pseudotumor pancreat cancer curcumin well toler common side effect nausea diarrhea theoret interact exist due purport effect metabol enzym transport protein clinic report support meaning interact nonetheless caution chemotherapi agent advis late phas clinic trial confirm benefici effect
MED-2790~clinic review formul vasa adhatoda vasica tamaka shwasa asthma abstract vasa adhatoda vasica linn easili drug season easi avail drug gain popular physician pharmaceut reason kalpana vasa found ayurvedika text dosag form vasa kvatha avaleha sneha sandhana treatment shwasa roga number research studi perform formul vasa effect shwasa roga review studi carri vasa extract vasa avaleha prepar svarasa kvatha vasa ghrita vasarishta vasakasava shwasa roga formul found review vasa ghana vasa ghrita num vasa avaleha shown good result tamaka shwasa
MED-2791~bioavail curcumin problem promis pubm ncbi abstract curcumin polyphenol compound deriv dietari spice turmer possess divers pharmacolog effect includ anti inflammatori antioxid antiprolif antiangiogen activ phase clinic trial shown curcumin safe high dose num g day human exhibit poor bioavail major reason contribut low plasma tissu level curcumin due poor absorpt rapid metabol rapid system elimin improv bioavail curcumin numer approach undertaken approach involv adjuv piperin interfer glucuronid liposom curcumin curcumin nanoparticl fourth curcumin phospholipid complex structur analogu curcumin ef num report rapid absorpt peak plasma half lif lower bioavail therapeut efficaci curcumin human diseas includ cancer cardiovascular diseas diabet arthriti neurolog diseas crohn diseas document enhanc bioavail curcumin futur bring promis natur product forefront therapeut agent treatment human diseas
MED-2792~cholesterol oxid indian ghee unexplain high risk atherosclerosi indian immigr popul pubm ncbi abstract popul immigr london west indi indian subcontin higher expect morbid mortal atherosclerosi show common accept major risk factor studi investig hypothesi ghee clarifi butter product prize indian cook cholesterol oxid import sourc dietari exposur cholesterol oxid explan high atherosclerosi risk substanti amount cholesterol oxid found ghee num sterol fresh butter thin lay high performance liquid chromatographi dietari exposur cholesterol oxid ghee offer logic explan high frequenc atherosclerot complic indian popul
MED-2793~biochem basi enhanc drug bioavail piperin evid piperin potent inhibitor drug metabol pubm ncbi abstract piperin major activ compon black long pepper report enhanc drug bioavail present studi aim understand interact piperin enzymat drug biotransform reaction hepat tissu vitro vivo piperin inhibit arylhydrocarbon hydroxyl ethylmorphine n demethyl num ethoxycoumarin o deethyl num hydroxy benzo pyren glucuronid rat postmitochondri supernat vitro dose depend manner piperin inhibit reaction postmitochondri supernat num methylcholanthren phenobarbital tr rat similar control inhibit piperin arylhydrocarbon hydroxylas ahh num methylcholanthrene tr rat compar observ num benzoflavon piperin caus noncompetit inhibit hepat microsom ahh untreat num methylcholanthrene tr rat ki num microm close appar km ahh observ control similar kinet inhibit ethylmorphine n demethylas control rat liver microsom exhibit noncompetit inhibit appar km num mm ki num microm studi demonstr piperin nonspecif inhibitor drug metabol show discrimin cytochrom num form oral administr piperin rat strong inhibit hepat ahh udp glucuronyltransferas activ maxim inhibit ahh observ num hr restor normal num hr pretreat piperin prolong hexobarbit sleep time zoxazolamin paralysi time mice half dose skf num result demonstr piperin potent inhibitor drug metabol
MED-2794~dietari turmer potenti reduc risk cancer pubm ncbi abstract turmer plant rhizom dri ground cook spice medicin thousand year curcumin phytochem turmer golden color respons therapeut effect turmer recent year curcumin studi effect chronic diseas diabet alzheimer cancer research investig turmeric curcumin cancer therapi epidemiolog inform effect turmer consumpt limit avail pharmacolog intervent area world turmer diet allevi diseas burden prevent provid overview turmer consumpt part world cancer rate region biochem mechan turmer act practic recommend base inform
MED-2797~osteoarthr inflammatori diseas osteoarthr osteoarthrosi pubm ncbi abstract osteoarthr oa long consid wear tear diseas lead loss cartilag oa consid sole consequ process lead increas pressur joint fragil cartilag matrix progress molecular biolog num profound modifi paradigm discoveri solubl mediat cytokin prostaglandin increas product matrix metalloproteinas chondrocyt led step inflammatori theori decad synov accept critic featur oa studi open condit driver oa process recent experiment data shown subchondr bone substanti role oa process mechan damper sourc inflammatori mediat implic oa pain process degrad deep layer cartilag initi consid cartilag driven oa complex diseas inflammatori mediat releas cartilag bone synovium low grad inflamm induc metabol syndrom innat immun inflammag recent argument favor inflammatori theori oa highlight review copyright num osteoarthr research societi intern publish elsevi reserv
MED-2799~synovi tissu inflamm earli late osteoarthr abstract object compar select immunohistolog featur inflamm synovi tissu patient earli late osteoarthr oa method synovi tissu sampl obtain num patient knee pain normal radiograph arthroscop manifest oa earli oa num patient oa undergo knee joint arthroplasti late oa convent immunohistochem techniqu measur microscop manifest inflamm inflammatori cell infiltr blood vessel format angiogen factor nf activ express tumour necrosi factor tnf interleukin num il num presenc cyclo oxygenas cox num cox num quantifi fibroblast lik synoviocyt fls isol earli late oa tissu sampl compar vitro product prostaglandin num pge num result synovi tissu patient earli oa demonstr signific greater cd num num cd num num cell infiltr blood vessel format num vascular endotheli growth factor num intercellular adhes molecul num express num number cell produc tnf il num signific greater earli oa num manifest inflamm earli oa increas express nf num num rela num subunit increas cox num express num cytokine induc pge num product cultur fls similar group conclus increas mononuclear cell infiltr overexpress mediat inflamm earli oa compar late oa isol fls function similar group consist microenvironment differ synovi tissu phase oa observ import therapeut implic patient earli evolut oa
MED-2800~curcumin paradigm therapeut opportun treatment osteoarthr curcumin osteoarthr manag abstract manag osteoarthr repres real challeng complex multi factori diseas evolv decad requir allevi symptom pain joint function preserv articular structur side effect nutraceut good candid manag oa due safeti profil potenti efficaci part treatment guidelin publish recommend curcumin yellow pigment isol rhizom curcuma longa common turmer curcumin high pleiotrop molecul excel safeti profil strong molecular evid publish potenc target multipl inflammatori diseas natur occur curcumin achiev optimum therapeut outcom due low solubl poor bioavail curcumin present great potenti treat oa categor preclin evid efficaci review aim gather inform document potenti efficaci curcumin base result obtain vitro model cartilag osteoarthr diseas
MED-2801~curcumin obes pubm ncbi abstract turmer long recogn anti inflammatori health promot properti curcumin princip anti inflammatori health compon turmer compris num turmer prepar experiment evid support activ curcumin promot weight loss reduc incid obesity rel diseas discoveri obes character chronic low grad metabol inflamm phytochem curcumin anti inflammatori activ intens investig recent scientif research reveal curcumin direct interact white adipos tissu suppress chronic inflamm adipos tissu curcumin inhibit macrophag infiltr nuclear factor nf activ induc inflammatori agent curcumin reduc express potent proinflammatori adipokin tumor necrosi factor tnf monocyt chemoattract protein num mcp num plasminogen activ inhibitor type num pai num induc express adiponectin princip anti inflammatori agent secret adipocyt curcumin effect inhibit adipocyt differenti promot antioxid activ divers mechan curcumin reduc obes curtail advers health effect obes copyright num intern union biochemistri molecular biolog
MED-2802~efficaci safeti curcuma domestica extract patient knee osteoarthr pubm ncbi abstract object object studi determin efficaci safeti curcuma domestica extract pain reduct function improv patient knee osteoarthr studi design set design set random control studi univers hospit bangkok thailand method one hundr num patient primari knee osteoarthr oa pain score num random receiv ibuprofen num mg day domestica extract num day num week main outcom improv pain level walk pain stair function knee assess time spent num walk flight stair advers event record result fifty two num num patient random domestica extract ibuprofen group baselin characterist patient group score aforement outcom week num num num signific improv compar baselin valu group differ paramet patient receiv ibuprofen domestica extract pain stair num signific differ advers event group found num versus num num domestica extract ibuprofen group conclus domestica extract similar efficaci safe ibuprofen treatment knee oa
MED-2803~dietari polyphenol mechan osteoarthr pubm ncbi abstract osteoarthr condit caus part injuri loss cartilag structur function imbal inflammatori anti inflammatori pathway primarili affect articular cartilag subchondr bone synovi joint result joint failur lead pain weight bear includ walk stand cure osteoarthr difficult restor cartilag destroy goal treatment reliev pain maintain improv joint mobil increas strength joint minim disabl effect diseas recent studi shown associ dietari polyphenol prevent osteoarthritis rel musculoskelet inflamm review discuss effect common consum polyphenol includ curcumin epigallocatechin gallat green tea extract resveratrol nobiletin citrus fruit pomegran genistein soy protein osteoarthr emphasi molecular antiosteoarthrit mechan copyright num elsevi reserv
MED-2804~epidemiolog oa abstract osteoarthr oa common form arthriti lead disabl typic defin epidemiolog studi basi radiograph find symptom incid preval rise relat age popul increas obes risk factor oa includ number person level factor age sex obes genet joint specif factor reflect abnorm load joint number methodolog challeng exist studi oa hamper abil identifi pertin relationship
MED-2805~pathobiolog obes osteoarthr integr biomechan inflamm abstract obes signific risk factor develop osteoarthr weight bear non weight bear joint pathogenesi obesity associ osteoarthr complet understood recent studi pro inflammatori metabol factor contribut increas osteoarthr risk adipos tissu infrapatellar fat local sourc pro inflammatori mediat increas obes shown increas cartilag degrad cell tissu cultur model adipokin leptin critic mediat obesity associ osteoarthr synergist action inflammatori cytokin biomechan factor increas risk osteoarthr activ cellular inflamm promot oxid stress type biomechan stimul physiolog cyclic load inhibit inflamm protect cartilag degrad high percentag obes individu knee osteoarthr sedentari suggest lack physic activ increas suscept inflamm comprehens approach understand obes alter daili biomechan exposur joint tissu provid insight protect damag effect biomechan factor inflamm osteoarthr
MED-2807~efficaci safeti meriva curcumin phosphatidylcholin complex extend administr osteoarthr patient pubm ncbi abstract previous three month studi meriva proprietari curcumin phosphatidylcholin phytosom complex decreas joint pain improv joint function observ num osteoarthr oa patient oa chronic condit requir prolong treatment long term efficaci safeti meriva investig longer month studi involv num oa patient clinic end point western ontario mcmaster univers womac score karnofski perform scale index treadmil walk perform complement evalu seri inflammatori marker interleukin il num eta il num solubl cd num ligand scd num solubl vascular cell adhes molecul svcam num erythrocyt sediment rate esr repres ambiti attempt date evalu clinic efficaci safeti curcumin anti inflammatori agent signific improv clinic biochem end point observ meriva compar control group coupl excel toler suggest meriva worth long term complementari manag osteoarthr
MED-2808~death design curcumin sensit drug resist tumour pubm ncbi abstract chemotherapi remain core anticanc treatment tremend stride made develop target anticanc therapi emerg resist chemotherapeut drug major obstacl success manag resist tumour profound investig in depth molecular mechan drug resist essenti translat effect therapi flip switch drug resist suscept mechanist resist phenomena explain overexpress drug efflux pump ii enhanc drug detoxif iii rapid dna repair effici iv defect apoptosi regul activ cell surviv signal advers effect multidrug resist safe multi target anticanc drug instig phytochem curcumin yellow pigment spice turmer pleotrop activ perform structur literatur review pubm medlin search secondari review cite public identifi studi role curcumin conquer drug resist cancer review describ curcumin sensit cancer cell regul multipl multidrug resist pathway employ drug multipl target curcumin cancer cell regain forgotten apoptosi modul drug target interact level restrain surviv pathway protein overexpress find altern carri forward process sensit resist tumour addit review dissect role curcumin target major culprit drug resist cancer stem cell csc circumv resist review strong suggest curcumin promis chemosensit agent uniqu properti curcumin exploit success manag resist tumour
MED-2809~therapeut role curcumin lesson learn clinic trial abstract extens research past half centuri shown curcumin diferuloylmethan compon golden spice turmer curcuma longa modul multipl cell signal pathway extens clinic trial past quarter centuri address pharmacokinet safeti efficaci nutraceut numer diseas human promis effect observ patient pro inflammatori diseas includ cancer cardiovascular diseas arthriti uveiti ulcer proctiti crohn diseas ulcer coliti irrit bowel diseas tropic pancreat peptic ulcer gastric ulcer idiopath orbit inflammatori pseudotumor oral lichen planus gastric inflamm vitiligo psoriasi acut coronari syndrom atherosclerosi diabet diabet nephropathi diabet microangiopathi lupus nephriti renal condit acquir immunodefici syndrom thalassemia biliari dyskinesia dejerine sotta diseas cholecyst chronic bacteri prostat curcumin shown protect hepat condit chronic arsenic exposur alcohol intox dose escal studi safeti curcumin dose high num g day num month curcumin pleiotrop activ eman abil modul numer signal molecul pro inflammatori cytokin apoptot protein nf cyclooxygenas num lox stat num c reactiv protein prostaglandin num prostate specif antigen adhes molecul phosphorylas kinas transform growth factor triglycerid num creatinin ho num ast alt human particip clinic trial curcumin combin agent formul curcumin includ nanoparticl liposom encapsul emuls capsul tablet powder examin review discuss detail human diseas effect curcumin investig
MED-2810~curcumin curecumin kitchen clinic pubm ncbi abstract turmer curcuma longa indian spice ayurveda treatment inflammatori diseas refer cultur activ principl call curcumin diferuloylmethan yellow pigment present turmer curri powder shown exhibit numer activ extens research half centuri reveal import function curcumin bind varieti protein inhibit activ kinas modul activ transcript factor curcumin regul express inflammatori enzym cytokin adhes molecul cell surviv protein curcumin downregul cyclin num cyclin mdm num upregul num num num preclin cell cultur anim studi suggest curcumin potenti antiprolif anti invas antiangiogen agent mediat chemoresist radioresist chemoprevent agent therapeut agent wound heal diabet alzheim diseas parkinson diseas cardiovascular diseas pulmonari diseas arthriti pilot phase clinic trial shown curcumin safe consum daili dose num num month clinic trial suggest potenti therapeut role curcumin diseas famili adenomat polyposi inflammatori bowel diseas ulcer coliti colon cancer pancreat cancer hypercholesteremia atherosclerosi pancreat psoriasi chronic anterior uveiti arthriti curcumin spice releg kitchen shelf move clinic prove curecumin
MED-2811~curcumin activ compon turmer prevent treatment ulcer coliti preclin clinic observ pubm ncbi abstract inflammatori bowel diseas ibd compris ulcer coliti uc crohn diseas cd major ailment affect small larg bowel clinic ibd treat num amninosalicyl antibiot steroid immunomodul long term usag agent undu side effect compromis therapeut advantag agent effect accept toxic human preclin studi experiment anim shown curcumin activ principl indian spice turmer curcuma longa linn effect prevent amelior uc inflamm decad increas interest role curcumin ibd studi experiment model ibd shown effect mediat inhibitori effect scaveng free radic increas antioxid influenc multipl signal pathway kinas mapk erk inhibit myeloperoxidas cox num cox num lox tnf ifn ino inhibit transcript factor nf clinic studi shown co administr curcumin convent drug effect well toler treat safe medic maintain remiss prevent relaps improv clinic activ index larg random control clinic investig requir fulli understand potenti oral curcumin treat ibd
MED-2812~molecular mechan curcumin action gene express pubm ncbi abstract curcumin deriv tropic plant curcuma longa long histori dietari agent food preserv tradit asian medicin centuri treat biliari disord anorexia cough diabet wound hepat disord rheumat sinus prevent therapeut properti curcumin antioxid anti inflammatori anticanc properti extens research decad attempt identifi molecular mechan curcumin action curcumin modul numer molecular target alter gene express signal pathway direct interact curcumin regul express inflammatori cytokin tnf il num growth factor vegf egf fgf growth factor receptor egfr num ar enzym cox num lox mmp num mapk mtor akt adhes molecul elam num icam num vcam num apoptosi relat protein bcl num caspas dr fas cell cycl protein cyclin num curcumin modul activ transcript factor nf ap num stat signal pathway base abil affect multipl target curcumin potenti prevent treatment diseas includ cancer arthriti allergi atherosclerosi age neurodegen diseas hepat disord obes diabet psoriasi autoimmun diseas review summar molecular mechan modul gene express curcumin copyright num intern union biochemistri molecular biolog
MED-2813~curcumin back root pubm ncbi abstract turmer deriv root plant curcuma longa treatment inflammatori diseas ayurveda tradit chines medicin thousand year activ compon turmer respons activ curcumin identifi centuri ago modern scienc reveal curcumin mediat effect modul import molecular target includ transcript factor nf kappab ap num egr num beta catenin ppar gamma enzym cox num lox ino hemeoxygenas num cell cycl protein cyclin num num cytokin tnf il num il num chemokin receptor egfr num cell surfac adhes molecul modul express target curcumin treat cancer arthriti diabet crohn diseas cardiovascular diseas osteoporosi alzheimer diseas psoriasi patholog interest num gingerol natur analog curcumin deriv root ginger zingib officinali exhibit biolog activ profil similar curcumin efficaci pharmacolog safeti cost effect curcuminoid prompt back root
MED-2814~curcumin cancer pubm ncbi abstract curcumin diferuloylmethan activ constitu turmer well describ phytochem ancient time treatment diseas dysregul cell signal pathway gradual alter regulatori protein root cancer curcumin modul regulatori protein molecular mechan research studi provid in depth analysi multipl target curcumin induc protect effect cancer includ gastrointestin genitourinari gynecolog hematolog pulmonari thymic brain breast bone molecular mechan action curcumin treat type cancer remain investig multifacet role dietari agent mediat inhibit cell signal pathway multipl level curcumin abil inhibit carcinogen modul cell cycl bind direct indirect molecular target includ transcript factor nf kb stat num catenin ap num growth factor egf pdgf vegf enzym cox num ino mmps kinas cyclin num cdks akt pkc ampk inflammatori cytokin tnf mcp il num il num upregul proapoptot bax bad bak downregul antiapoptot protein bcl num bcl xl varieti anim model human studi proven curcumin safe toler high dose studi elabor current understand chemoprevent effect curcumin multipl molecular pathway highlight therapeut treatment prevent wide rang cancer copyright num intern union biochemistri molecular biolog
MED-2815~curcumin compon turmer farm pharmaci pubm ncbi abstract curcumin activ polyphenol golden spice turmer high pleiotrop molecul potenti modul biolog activ number signal molecul tradit polyphenol asian countri treat human ailment acn psoriasi dermat rash recent studi curcumin target newli identifi signal pathway includ microrna cancer stem cell autophagi extens research preclin clinic studi delin molecular basi pharmaceut polyphenol cancer pulmonari diseas neurolog diseas liver diseas metabol diseas autoimmun diseas cardiovascular diseas numer chronic diseas multipl studi safeti efficaci curcumin numer anim includ rodent monkey hors rabbit cat provid solid basi evalu safeti efficaci human date num human clinic trial curcumin includ num patient complet num clinic trial underway curcumin supplement countri includ unit state india japan korea thailand china turkey south africa nepal pakistan review provid evid pharmaceut curcumin diseas copyright num intern union biochemistri molecular biolog
MED-2816~plant deriv health effect turmer curcuminoid pubm ncbi abstract plant numer polyphenol shown reduc inflamm increas resist diseas exampl polyphenol isothiocyan cabbag broccoli epigallocatechin green tee capsaicin chili pepper chalon rutin naringenin appl resveratrol red wine fresh peanut curcumin curcuminoid turmer diseas maintain sustain discreet obvious increas system inflamm studi suggest effect treatment improv combin restrict intak proinflammatori molecul advanc glycat end product age advanc lipoperoxid end product ale rich suppli antiinflammatori molecul plant polyphenol polyphenol bulk experiment document belong curcuminoid famili main ingredi curcumin review summar present knowledg turmericderiv ingredi proven strong antioxid inhibitor cyclooxigenas num cox num lipoxygenas lox nuclear factor kappa nf kappab age plethora clinic effect report experiment diseas clinic studi human suggest suppli polyphenol curcuminoid complement pharmaceut treatment prebiot treatment condit proven therapy resist crohn long stay patient intens care unit condit cancer liver cirrhosi chronic renal diseas chronic obstruct lung diseas diabet alzheimer diseas
MED-2817~curcumin inflammatori diseas pubm ncbi abstract curcumin diferuloylmethan yellow color agent extract turmer remedi treatment prevent inflammatori diseas acut chronic inflamm major factor progress obes type ii diabet arthriti pancreat cardiovascular neurodegen metabol diseas type cancer turmer long histori ayurved medicin treatment inflammatori disord recent studi efficaci therapeut applic turmer suggest activ ingredi tumer curcumin compel evid shown curcumin abil inhibit inflammatori cell prolifer invas angiogenesi multipl molecular target mechan action curcumin safe non tox mediat anti inflammatori effect down regul inflammatori transcript factor cytokin redox status protein kinas enzym promot inflamm addit curcumin induc apoptosi mitochondri receptor medi pathway activ caspas cascad current studi anti inflammatori effect curcumin evalu relat chronic inflammatori diseas base pharmacolog data obtain vitro vivo research clinic trial opportun exist translat curcumin clinic prevent inflammatori diseas futur copyright num intern union biochemistri molecular biolog
MED-2818~curcumin stori pubm ncbi abstract curcumin polyphenol deriv herbal remedi dietari spice turmer possess divers anti inflammatori anti canc properti oral topic administr curcumin potent antioxid capac neutral acid ph mechan action includ inhibit cell signal pathway multipl level effect cellular enzym cyclooxygenas glutathion s transferas immuno modul effect angiogenesi cell cel adhes curcumin abil affect gene transcript induc apoptosi preclin model relev cancer chemoprevent chemotherapi patient curcumin low system bioavail oral dose limit access suffici concentr pharmacolog effect tissu attain biolog activ level gastrointestin tract demonstr anim human suffici data exist advoc phase ii clinic evalu oral curcumin patient invas malign pre invas lesion gastrointestin tract colon rectum
MED-2819~biolog action curcumin articular chondrocyt pubm ncbi abstract object curcumin diferuloylmethan princip biochem compon spice turmer shown possess potent anti catabol anti inflammatori antioxid properti articl aim provid summari action curcumin articular chondrocyt literatur text min tool highlight potenti benefit drawback chemoprevent agent treat osteoarthr oa explor recent literatur molecular mechan curcumin mediat alter gene express mediat activ protein num ap num nuclear factor kappa nf kappab signal chondrocyt osteoblast synovi fibroblast method computer aid search pubmed medlin databas aid text min tool interrog resnet mammalian databas num result recent work shown curcumin protect human chondrocyt catabol action interleukin num beta il num eta includ matrix metalloproteinas mmp num up regul inhibit collagen type ii down regul beta num integrin express curcumin block il num eta induc proteoglycan degrad ap num nf kappab signal chondrocyt apoptosi activ caspas num conclus data publish vitro vivo studi suggest curcumin benefici complementari treatment oa human companion anim initi extens clinic trial basic research requir improv solubl absorpt bioavail gain addit inform safeti efficaci speci obstacl overcom curcumin structur relat biochem safer suitabl nutraceut altern non steroid anti inflammatori drug treatment oa copyright num osteoarthr research societi intern reserv
MED-2820~turmer curcuma longa inhibit inflammatori nuclear factor nf nf b regul gene product induc death receptor lead suppress prolifer induc chemosensit suppress osteoclastogenesi abstract scope incid cancer signific lower region turmer heavili consum lower cancer incid due turmer investig examin effect tumor cell prolifer pro inflammatori transcript factor nf stat num gene product method result cell prolifer cell cytotox measur mtt method nf activ emsa protein express western blot analysi ros generat fac analysi osteoclastogenesi trap assay turmer inhibit nf activ down regul nf b regul gene product link surviv bcl num cflip xiap ciap num prolifer cyclin num c myc metastasi cxcr num cancer cell spice suppress activ stat num induc death receptor dr num dr num turmer enhanc product ros suppress growth tumor cell line turmer sensit tumor cell chemotherapeut agent capecitabin taxol turmer found potent pure curcumin cell growth inhibit turmer inhibit nf activ induc rankl correl suppress osteoclastogenesi conclus result turmer effect block prolifer tumor cell suppress nf stat num pathway
MED-2821~turmer curcumin remedi gastroprotect action abstract purpos review summar pertin literatur publish present era antiulcerogen properti curcumin patholog respons ulcer effector helicobact pylori infect chronic ingest non steroid anti inflammatori drug exogen substanc gastrointestin problem caus etiolog observ alter physiolog paramet reactiv oxygen speci nitric oxid synthas lipid peroxid secret excess gastric acid gastrointestin ulcer result due imbal aggress defens factor num case gastric ulcer caus primarili due non steroid anti inflammatori categori drug num pylori num intak spici fast food number antiulc drug cytoprotect drug side effect limit recent year widespread search launch identifi antiulc drug synthet natur resourc indian dietari deriv curcumin yellow pigment found rhizom curcuma longa wide treatment diseas epidemiolog suggest curcumin reduc risk inflammatori disord cancer ulcer biolog effect attribut anti inflammatori antioxid activ report literatur curcumin prevent gastrointestinal induc ulcer recommend drug ulcer treatment
MED-2822~random pilot studi assess efficaci safeti curcumin patient activ rheumatoid arthriti pubm ncbi abstract curcumin possess potent antiinflammatori antiarthrit properti pilot clinic studi evalu safeti effect curcumin combin diclofenac sodium patient activ rheumatoid arthriti ra forty f patient diagnos ra random group patient receiv curcumin num mg diclofenac sodium num mg combin primari endpoint reduct diseas activ score das num secondari endpoint includ american colleg rheumatolog acr criteria reduct tender swell joint score patient treatment group show statist signific das score interest curcumin group show highest percentag improv das acr score acr num num score signific patient diclofenac sodium group import curcumin treatment found safe relat advers event studi evid safeti superior curcumin treatment patient activ ra highlight futur large scal trial valid find patient ra arthrit condit copyright num john wiley son
MED-2823~curcumin cell death process challeng cam age rel patholog abstract curcumin yellow pigment rhizoma curcuma longa wide studi phytochem varieti biolog activ anti inflammatori anti oxid review discuss biolog mechan clinic effect curcumin treatment cancer therapi neurodegen diseas alzheimer diseas attent cell death process induc curcumin oxid stress inflamm major determin age process argu curcumin general effect slow rate age final effect curcumin xenohormet activ sort stress respons mammalian cell
MED-2824~curcumin cancer old ag diseas age old solut pubm ncbi abstract cancer primarili diseas age life style play major role develop cancer recogn plant bas formul treat cancer centuri current treatment involv poison mustard gas chemotherapi radiat target therapi tradit plant deriv medicin safe activ principl mediat effect cancer illustr curcumin deriv turmer centuri treat wide varieti inflammatori condit curcumin diferuloylmethan deriv indian spice turmer popular call curri powder shown interfer multipl cell signal pathway includ cell cycl cyclin num cyclin apoptosi activ caspas down regul antiapoptot gene product prolifer num egfr ap num surviv pi num akt pathway invas mmp num adhes molecul angiogenesi vegf metastasi cxcr num inflamm nf kappab tnf il num il num cox num num lox activ curcumin report leukemia lymphoma gastrointestin cancer genitourinari cancer breast cancer ovarian cancer head neck squamous cell carcinoma lung cancer melanoma neurolog cancer sarcoma reflect abil affect multipl target old ag diseas cancer requir age old treatment
MED-2825~curcumin fre turmer exhibit anti inflammatori anticanc activ identif compon turmer pubm ncbi abstract turmer dri powder deriv rhizom curcuma longa centuri part world link numer biolog activ includ antioxid anti inflammatori anticanc antigrowth anti arthrit anti atherosclerot antidepress anti ag antidiabet antimicrobi wound heal memory enhanc activ compon turmer curcumin extens studi num citat past decad recent research identifi numer chemic entiti turmer curcumin unclear activ ascrib turmer due curcumin compound turmer manifest activ uniqu addit synergist curcumin studi turmer oil present turmer enhanc bioavail curcumin studi past decad curcumin fre turmer cft compon possess numer biolog activ includ anti inflammatori anticanc antidiabet activ elemen deriv turmer approv china treatment cancer current review focus anticanc anti inflammatori activ exhibit cft individu compon turmer includ turmerin turmeron elemen furanodien curdion bisacuron cyclocurcumin calebin germacron num wiley vch verlag gmbh kgaa weinheim
MED-2826~divers effect low dose supplement lipid curcumin healthi middl age peopl abstract background curcumin extract turmer propos produc health benefit date human intervent studi focus peopl exist health problem high dose poor absorb curcumin purpos current studi check healthi peopl low dose lipid curcumin extract alter wellness rel measur method present studi conduct healthi middl age peopl num num year low dose curcumin num mg day lipid form expect good absorpt subject curcumin num placebo num num wk blood saliva sampl num week analyz varieti blood saliva measur relev health promot result curcumin placebo produc statist signific lower plasma triglycerid valu lower salivari amylas level rais salivari radic scaveng capac rais plasma catalas activ lower plasma beta amyloid protein concentr lower plasma sicam read increas plasma myeloperoxidas increas c reactiv protein level increas plasma nitric oxid decreas plasma alanin amino transferas activ conclus collect result demonstr low dose curcumin lipid prepar produc varieti potenti health promot effect healthi middl age peopl
MED-2827~soy protein allevi osteoarthr symptom pubm ncbi abstract altern complementari therapeut approach wide array herbal nutrit physic manipul popular reliev symptom osteoarthr oa present studi evalu efficaci soy protein sp supplement reliev pain discomfort oa hundr thirty f free liv individu num men num women diagnos oa self report chronic knee joint pain attribut injuri rheumatoid arthriti recruit double blind placebo control parallel design studi studi particip assign random consum num supplement sp milk bas protein mp daili num month pain knee rang motion physic activ evalu prior start treatment month serum level glycoprotein num ykl num marker cartilag degrad insulin lik growth factor i igf i growth factor cartilag synthesi assess baselin end studi sp improv oa associ symptom rang motion factor pain qualiti life comparison mp benefici effect due effect sp men women biochem marker cartilag metabol support efficaci sp men signific increas serum level igf i signific decreas serum level ykl num compar mp studi provid evid benefici effect sp manag oa examin verifi long term effect sp improv symptom oa men warrant
MED-2830~bioavail herb spice human determin vivo inflammatori suppress dna strand break pubm ncbi abstract object aim work determin bioavail herb spice human consumpt measur abil protect lymphocyt oxid injuri examin impact inflammatori biomark activ thp num cell method ten num subject num group consum defin amount herb spice num day blood drawn subject consumpt num hour final herb spice capsul subject serum extract herb spice analyz antioxid capac oxygen radic absorb capac orac analysi num diphenyl num picrylhydrzyl dpph subject peripher blood mononuclear cell pbmcs medium num autolog serum incub hydrogen peroxid induc dna strand break subject serum treat activ thp num cell determin relat quantiti num inflammatori cytokin tumor necrosi factor tnf interleukin num il num il num mrnas result herb spice protect pbmcs dna strand break paprika rosemari ginger heat treat turmer sage cumin paprika protect cell normal apoptot process num cytokin mrnas studi tnf il num il num tnf sensit respond oxid ldl treat macrophag clove ginger rosemari turmer signific reduc oxid ldl induc express tnf serum consum ginger reduc inflammatori biomark ginger rosemari turmer show protect capac oxid protect inflamm measur conclus dna strand break inflammatori biomark good function measur food bioavail
MED-2831~curcumin oral bioavail blocker tnf pro inflammatori biomark abstract tnfs major mediat inflamm inflammation rel diseas unit state food drug administr fda approv blocker cytokin tnf treatment osteoarthr inflammatori bowel diseas psoriasi ankylosi drug includ chimer tnf antibodi infliximab human tnf antibodi humira solubl tnf receptor ii enbrel total cumul market num billion year expens num num person year drug inject advers effect black label warn fda current report describ altern curcumin diferuloylmethan compon turmer curcuma longa inexpens oral bioavail high safe human block tnf action product vitro model anim model human addit provid evid curcumin activ diseas tnf blocker mechan curcumin inhibit product cell signal pathway activ cytokin discuss health car cost safeti major issu today golden spice provid solut link articl articl part theme section emerg therapeut aspect oncolog view articl section visit http   dx doi org num bph num issu num
MED-2843~major congenit malform women gestat diabet mellitus systemat review meta analysi pubm ncbi abstract background risk major congenit malform mcm increas women pregest diabet mellitus pgdm risk increas gestat diabet mellitus gdm debat aim studi perform systemat review meta analysi major congenit malform women gestat diabet versus refer popul method conduct medlin search num januari num num decemb num origin studi report data major congenit malform women gestat diabet refer group inform pregest diabet collect investig consid studi inclus extract data discrep solv consensus meta analysi tool summar result moos prisma guidelin result case control num cohort studi select num retriev abstract higher risk major congenit malform observ offspr women gestat diabet relat risk rr odd ratio num confid interv ci rr num num num cohort studi num num num case control studi risk major congenit malform higher offspr women pgdm refer group rr num num num cohort studi num num num singl case control studi provid inform conclus slight higher risk major congenit malform women gestat diabet refer group contribut women overt hyperglycemia factor ascertain risk lower women pregest diabet copyright num john wiley son
MED-2844~prospect studi prepregn dietari iron intak risk gestat diabet mellitus abstract object import identifi modifi factor lower gestat diabet mellitus gdm risk dietari iron interest iron strong prooxid high bodi iron level damag pancreat cell function impair glucos metabol current studi determin prepregn dietari supplement iron intak risk gdm research design method prospect studi conduct num women report singleton pregnanc num num nurs health studi ii total num incid gdm case report pool logist regress estim relat risk rr gdm quintil iron intak control dietari nondietari risk factor result dietari heme iron intak posit signific gdm risk adjust age bmi risk factor rrs num cis increas quintil heme iron num refer num num num num num num num num num num num num linear trend num multivari adjust rr gdm num mg day increas intak num num num signific associ observ total dietari nonhem supplement iron intak gdm risk conclus find suggest higher prepregn intak dietari heme iron increas gdm risk
MED-2845~iron intak risk type num diabet women prospect cohort studi pubm ncbi abstract object epidemiolog studi suggest high bodi iron store insulin resist type num diabet aim studi evalu associ dietari intak iron risk type num diabet research design method conduct prospect cohort studi nurs health studi num healthi women age num year num num dietari data collect num year data medic histori lifestyl factor updat biennial result num year follow up document num incid case type num diabet found associ total dietari supplement nonhem iron risk type num diabet heme iron intak deriv anim product posit risk relat risk rrs increas quintil cumul intak num num num ci num num num num num num num num num num num trend num control age bmi nondietari dietari risk factor addit model heme iron categori multivari rr compar women consum num mg day intak num mg day num num num associ heme iron risk diabet signific overweight lean women conclus larg cohort studi suggest higher heme iron intak signific increas risk type num diabet
MED-2846~hospit base studi preval gestat diabet mellitus urban popul india pubm ncbi abstract object cross sect institutional bas studi undertaken preval gestat diabet mellitus gdm indian pregnant women subject method num pregnant women screen evid diabet previous diabet underw num num hour oral glucos toler test ogtt chi squar test statist associ variabl gdm result conclus result studi bad obstetr histori obes patient high calori diet vegetarian diet physic activ high prone develop gdm
MED-2847~type num diabet mellitus gestat diabet systemat review meta analysi pubm ncbi abstract background women gestat diabet increas risk develop type num diabet risk time onset fulli quantifi comprehens systemat review meta analysi assess strength associ condit effect factor modifi risk method identifi cohort studi women develop type num diabet gestat diabet jan num jan num embas medlin num relev report hand search select num studi includ num women num type num diabet event calcul pool unadjust relat risk rrs num cis studi random effect model subgroup analys number case type num diabet ethnic origin durat follow up matern age body mass index diagnost criteria find women gestat diabet increas risk develop type num diabet compar normoglycaem pregnanc rr num num ci num num largest studi num women num case type num diabet largest rr num num ci num num rrs general consist subgroup assess interpret increas awar magnitud time risk type num diabet gestat diabet patient clinician provid opportun test dietari lifestyl pharmacolog intervent prevent delay onset type num diabet affect women fund
MED-2848~aetiolog type num diabet epidemiolog perspect pubm ncbi abstract type num diabet increas rapid part western world evid scandinavia low concord rate insulin depend diabet mellitus monozygot twin genet risk factor suffici diseas occur strongest genet risk marker locat hla region chromosom num dna specif differ popul risk gene chromosom human genom suggest complex interact gene environ diseas pathogenesi diseas propos autoimmun natur environment risk factor initi autoimmun acceler ongo beta cel destruct risk factor disclos epidemiolog studi acceler pathogenet process cold environ high growth rate infect stress life event risk factor initi autoimmun process includ earli exposur cow milk protein nitrosamin earli foetal event blood group incompat foetal viral infect conclus population bas epidemiolog studi confirm propos aetiolog model arisen experiment research epidemiolog studi introduc import find reveal complex aetiolog diseas advanc understand closer ultim goal primari prevent
MED-2849~risk gestat diabet mellitus relat matern egg cholesterol intak abstract higher egg cholesterol intak increas risk type num diabet mellitus associ gestat diabet mellitus gdm evalu author assess associ prospect cohort studi num num num particip case control studi num num case num control food frequenc questionnair assess matern diet multivari model deriv relat risk num confid interv compar egg consumpt adjust relat risk gdm num num num num num consumpt num num num num num eggs week trend num women high egg consumpt num week num fold increas risk compar women lower consumpt num confid interv ci num num relat risk highest quartil cholesterol intak num mg day versus lowest num mg day num num ci num num case control studi adjust odd ratio consum num eggs week versus num eggs week num num ci num num odd gdm increas increas cholesterol intak trend num conclus high egg cholesterol intak pregnanc increas risk gdm
MED-2850~prospect studi prepregn dietari fat intak risk gestat diabet abstract background fatti acid play vital role glucos homeostasi studi habitu dietari fat intak gestat diabet mellitus gdm risk limit provid conflict find object determin total amount type sourc prepregn dietari fat relat risk gdm design prospect studi conduct num women report singleton pregnanc num num nurs health studi ii women num incid gdm case report adjust rr gdm estim quintil total fat specif fat sourc fat intak pool logist regress result higher anim fat cholesterol intak signific increas gdm risk increas quintil anim fat rrs num cis gdm num refer num num num num num num num num num num num num p trend num rrs num cis dietari cholesterol num refer num num num num num num num num num num num num p trend num substitut num energi anim fat equal percentag energi carbohydr signific increas risk gdm rr num ci num num num num signific associ observ dietari polyunsatur fat monounsatur fat tran fat intak gdm risk conclus higher prepregn intak anim fat cholesterol elev gdm risk
MED-2851~gestat diabet mellitus relat matern dietari heme iron nonhem iron intak abstract object higher heme iron intak increas type num diabet risk previous studi evalu gestat diabet mellitus gdm risk relat heme iron intak pregnanc investig associ matern preconcept earli pregnanc heme nonhem iron intak subsequ gdm risk research design method conduct prospect cohort studi num pregnant women food frequenc questionnair assess matern diet multivari general linear regress model deriv estim relat risk rrs num cis result approxim num cohort develop gdm num heme iron intak posit signific gdm risk ptrend num adjust confound women report highest heme iron intak level num num mg day experienc num fold increas gdm risk num ci num num fulli adjust model note num mg day increas heme iron num increas gdm risk rr num num ci num num nonhem iron invers statist signific gdm risk rrs num num num num quartil nonhem iron intak ptrend num conclus high level dietari heme iron intak preconcept earli pregnanc period increas gdm risk associ gdm risk dietari nonhem iron intak clear confirm find futur studi warrant
MED-2852~prospect studi dietari pattern meat intak risk gestat diabet mellitus pubm ncbi abstract aims hypothesi aim studi prospect examin dietari pattern relat risk gestat diabet mellitus gdm method prospect cohort studi includ num women free cardiovascular diseas cancer type num diabet histori gdm subject complet valid semi quantit food frequenc questionnair num report singleton pregnanc num num nurs health studi ii major dietari pattern prudent western identifi factor analysi prudent pattern characteris high intak fruit green leafi veget poultri fish western pattern characteris high intak red meat process meat refin grain product sweet french fri pizza result document num incid case gdm adjust age pariti pre pregn bmi covari relat risk rr gdm compar highest lowest quintil western pattern score num num ci num num trend num rr compar lowest highest quintil prudent pattern score num num ci num num trend num rr increment serving day num num ci num num red meat num num ci num num process meat conclusions interpret find suggest pre pregn dietari pattern affect women risk develop gdm diet high red process meat signific elev risk
MED-2853~gestat diabet pregnanc outcom systemat review world health organ intern associ diabet pregnanc studi group iadpsg diagnost criteria abstract background criteria base num num ogtt diagnosi gestat diabet gdm recommend year world health organ recent recommend intern associ diabet pregnanc studi group iadpsg generat hapo studi base pregnanc outcom aim systemat review evid associ gdm criteria advers outcom method search relev studi medlin embas lilac cochran librari cinhal who afro librari imsear emcat imemr wprim includ cohort studi permit evalu gdm diagnos iadpsg criteria advers matern perinat outcom untreat women studi univers applic num ogtt includ relat risk rrs num confid interv ci obtain studi combin studi result random effect model inconsist studi defin inconsist index num num result data extract studi total num women greater risk advers outcom observ diagnost criteria criteria consist associ macrosomia rr num num ci num num num larg gestat age rr num num ci num num num perinat mortal rr num num ci num num num preeclampsia rr num num ci num num num cesarean deliveri rr num num ci num num num data iadpsg criteria associ inconsist studi num num magnitud rrs num cis num num num num larg gestat age num num num num preeclampsia num num num num cesarean deliveri exclud hapo ebdg studi minim alter associ rrs iadpsg criteria reduc exclud hapo conclus iadpsg criteria gdm identifi women small increas risk advers pregnanc outcom associ similar magnitud criteria high inconsist iadpsg criteria full evalu set hapo requir addit studi
MED-2882~blueberri anthocyanin protect age light induc damag retin pigment epitheli cell pubm ncbi abstract retin pigment epithelium rpe cell vital retin health suscept injuri age exposur excess light includ uv num nm visibl num nm radiat evalu protect effect blueberri anthocyanin rpe cell vitro cell model replic senesc light induc damag establish present studi purif fraction blueberri anthocyanin extract bae yield total anthocyanin content num num sd num num studi replic senesc rpe cell induc repeat passag cell fourth passag tenth passag cultur rpe cell began enter replic senesc exhibit reduc cell prolifer increas number galactosidase posit cell rpe cell maintain high cell viabil num num low num num percentag galactosidase posit cell treat num num g ml bae contrast exposur num sd num lx light num nm num rpe cell posit control light exposur bae treatment exhibit prematur senesc low num num cell viabil increas num num vascular endotheli growth factor vegf releas compar negat control cell subject light irradi bae exposur correspond bae benefici rpe cell protect cell light induc damag suppress age apoptosi down regul over express vegf normal level result demonstr bae efficaci senesc light induc damag rpe cell
MED-2884~num wk egg intervent increas serum zeaxanthin macular pigment optic densiti women pubm ncbi abstract carotenoid found egg yolk lutein zeaxanthin accumul macular retina reduc photostress increas serum lutein zeaxanthin observ previous egg intervent studi measur macular carotenoid object project determin increas consumpt egg increas retin lutein zeaxanthin macular pigment twenty four femal num num assign pill treatment pill num num egg treatment num wk individu pill treatment consum num sugar fil capsule d individu egg treatment consum num eggs wk num microg egg num num microg egg num lutein zeaxanthin yolk serum cholesterol serum carotenoid macular pigment od mpod measur baselin num num wk intervent serum cholesterol concentr chang egg treatment group total cholesterol num triglycerid num increas pill group serum zeaxanthin serum lutein increas egg num num egg num num group likewis mpod increas egg num num egg num num group aggreg concentr carotenoid num egg yolk modest relat sourc spinach bioavail retina high increas egg consumpt num eggs wk effect method increas mpod
MED-2885~ultraviolet phototox retina pubm ncbi abstract object overview ultraviolet uv phototox consid interact uva short wavelength vis light retina retin pigment epithelium method damag mechan uv retin phototox illustr literatur survey present experiment result result depend wavelength exposur durat light interact tissu general mechan thermal mechan photochem anterior structur eye absorb uv compon optic radiat spectrum portion uva band num nm penetr retina natur sourc sun emit energet uv photon long durat typic result energi confin retina produc thermal mechan damag capabl induc photochem damag photochem damag retina proceed type num direct reaction involv proton electron transfer type num reaction involv reactiv oxygen speci mechan common drug antibiot nonsteroid anti inflammatori drug psychotherapeut agent herbal medicin act photosensit promot retin uv damag excit uva visibl light suffici retin penetr conclus anterior portion eye suscept uv damag retina risk longer uv wavelength propag ocular media phototox counteract reduc dietari intak antioxid protect phytonutri
MED-2886~goji berri effect macular characterist plasma antioxid level pubm ncbi abstract purpos goji berri lycium barbarum purport benefit vision high antioxid zeaxanthin content effect demonstr high qual human studi purpos studi evalu effect daili supplement proprietari milk bas formul goji berri lacto wolfberri lwb macular characterist plasma zeaxanthin antioxid capac level elder subject method double mask random placebo control trial healthi elder subject rang num num year receiv num g d lwb num placebo num num day subject underw direct ophthalm examin assess pigment soft drusen count macula blood draw measur plasma zeaxanthin level total antioxid capac result placebo group demonstr hypopigment soft drusen accumul macula lwb group remain stabl plasma zeaxanthin level antioxid capac increas signific lwb group num num chang placebo group product rel advers event report group conclus daili dietari supplement goji berri num day increas plasma zeaxanthin antioxid level protect hypopigment soft drusen accumul macula elder subject mechan action unclear lack relationship chang plasma zeaxanthin chang macular characterist
MED-2888~fast plasma zeaxanthin respons fructus barbarum wolfberri kei tze food bas human supplement trial pubm ncbi abstract age rel macular degener amd common disord irrevers loss central vision increas intak food zeaxanthin effect prevent amd macula accumul zeaxanthin lutein oxygen carotenoid antioxid blue light absorb properti lycium barbarum small red berri fructus lycii wolfberri west kei tze gou qi zi asia wolfberri rich zeaxanthin dipalmit valu chines cultur good vision aim studi single blind placebo control human intervent trial parallel design provid data fast plasma zeaxanthin concentr result dietari supplement wolfberri fast blood collect healthi consent subject fourteen subject num g d wolfberri estim num mg zeaxanthin num repeat fast blood collect day num age sex match control num wolfberri respons group compar mann whitney test supplement plasma zeaxanthin increas num fold valu day num num num sem num num sem num micromol l num supplement group num sem num num sem num micromol l num control group human supplement trial show zeaxanthin wolfberri bioavail intak modest daili amount mark increas fast plasma zeaxanthin level data support studi dietari strategi maintain macular pigment densiti
MED-2889~cataract self def reaction protect retina oxid damag pubm ncbi abstract age rel macular degener amd lead blind develop countri cataract extract common surgic procedur develop countri lutein zeaxanthin retin carotenoid power retin anti oxid absorb harm blue light deplet l z induc develop len opacification cataract cataract reduc retin oxid stress os reduct probabl develop amd oxid stress retin level common pathway develop amd cataract amd cataract independ process cataract self defens reaction retina reduc os retin damag restor anti oxid capabl retina increas intak l z reduc likelihood amd cataract extract opaqu len elev retin os increas rate amd copyright num elsevi reserv
MED-2890~nearwork induc transient myopia nitm perman myopia  i link pubm ncbi abstract myopia worldwid public health problem understand incomplet prevent therapeut aspect remain controversi nearwork primari environment base factor aetiolog perman myopia pm nearwork induc transient myopia nitm contributori compon relationship pm nitm suggest connect remain indirect elus base recent converg evid clinic laboratori model studi five fold argument advanc link pm nitm
MED-2891~variat product choic frequent purchas herb caveat emptor pubm ncbi abstract background patient report herb physician accur describ ingredi recommend dosag product herb differ purpos studi describ variat label inform product num common purchas herb method product num herb survey conveni sampl num retail store larg metropolitan area herb greatest sale dollar num echinacea st john wort ginkgo biloba garlic palmetto ginseng goldens alo siberian ginseng valerian result herb larg rang label ingredi recommend daili dose rdd product strength direct compar ingredi variabl num product num consist benchmark ingredi rdd num ingredi num consist label inform insuffici price rdd signific predictor consist benchmark store type conclus person self med herb ingest ingredi substanti recommend benchmark quantiti content higher price label rdd predictor consist benchmark studi demonstr health provid consum close examin label ingredi similar herbal product
MED-2892~effect bilberri nutrit supplement night visual acuiti contrast sensit pubm ncbi abstract purpos purpos studi investig effect bilberri night visual acuiti va night contrast sensit cs method studi util double blind placebo control crossov design subject young male good vision receiv placebo receiv activ capsul week activ capsul num mg bilberri extract num percent anthocyanosid placebo capsul inact ingredi subject ingest activ placebo capsul time daili num day three week treatment period one month washout period employ effect bilberri night vision dissip three week treatment period subject receiv placebo activ capsul receiv activ capsul placebo night va night cs test three month experi result differ night va measur period examin averag night va night va measur activ placebo treatment addit differ night cs measur period examin averag night cs night cs measur activ placebo treatment conclus current studi fail find effect bilberri night va night cs high dose bilberri signific durat current studi cast doubt proposit bilberri supplement form dose recommend effect treatment improv night vision popul
MED-2893~lutein zeaxanthin intak risk age rel macular degener systemat review meta analysi pubm ncbi abstract lutein zeaxanthin thought decreas incid age rel macular degener amd find inconsist conduct systemat literatur review meta analysi evalu relationship dietari intak lutein zeaxanthin amd risk relev studi identifi search databas april num refer list articl retriev expert contact literatur search data extract studi qualiti assess perform independ review result pool quantit meta analysi method potenti sourc heterogen public bias estim search yield longitudin cohort studi pool relat risk rr earli amd compar highest lowest categori lutein zeaxanthin intak num num ci num num num dietari intak carotenoid signific relat reduct risk late amd rr num num ci num num num statist signific invers associ observ lutein zeaxanthin intak neovascular amd risk rr num num ci num num num result essenti consist subgroup stratifi particip characterist find present meta analysi dietari lutein zeaxanthin signific reduc risk earli amd increas intak carotenoid protect late amd addit studi confirm relationship
MED-2894~two year random placebo control studi black currant anthocyanin visual field glaucoma pubm ncbi abstract aim examin influenc black currant anthocyanin bcac diseas progress open angl glaucoma oag random placebo control double mask trial made num patient oag treat antiglaucoma drop method bcac num mg day num placebo num oral administ daili num month period system blood pressur puls rate intraocular pressur iop ocular blood circul laser speckl flowgraphi humphrey visual field deviat md measur num month period result main outcom measur evalu differ group md deterior eye md trial baselin num month statist signific differ observ treatment group chang baselin md num month therapi num unpair test administr bcac ocular blood flow num month observ period increas comparison placebo tr patient signific observ system ocular condit includ iop num month period conclus result suggest oral administr bcac safe promis supplement patient oag addit antiglaucoma medic copyright num karger ag basel
MED-2895~dietari modif human macular pigment densiti pubm ncbi abstract purpos retin carotenoid lutein zeaxanthin form macular pigment mp prevent neovascular age rel macular degener purpos studi determin mp densiti retina rais increas dietari intak food method macular pigment measur psychophys num subject serum concentr beta caroten measur high perform liquid chromatographi eleven subject modifi usual daili diet ad num spinach num mg num mg num mg beta caroten ten ad num corn num mg num mg subject corn dietari modif num week result subject fed spinach spinach corn type respons dietari modif identifi retin respond increas serum num sd num mp densiti num sd num retin nonrespond show substanti increas serum num mp densiti num serum retin nonrespond show serum beta caroten chang mp densiti subject corn serum chang num subject serum increas num mp densiti increas num conclus increas mp densiti obtain num week dietari modif subject mp densiti increas dietari modif remain elev month resum unmodifi diet augment mp experiment clinic investig feasibl person
MED-2896~antioxid intak primari open angl glaucoma prospect studi pubm ncbi abstract relat dietari antioxid intak primari open angl glaucoma risk examin particip age num year nurs health studi num health profession follow up studi num biennial num num num period receiv eye examin dietari intak measur repeat num nurs health studi num health profession follow up studi valid food frequenc questionnair author analyz num self report glaucoma case confirm medic chart review primari open angl glaucoma visual field loss author cox proport hazard model cohort specif multivari analys result pool random effect model pool multivari rate ratio primari open angl glaucoma compar highest versus lowest quintil cumul updat intak num num confid interv ci num num alpha caroten num num ci num num beta caroten num num ci num num beta cryptoxanthin num num ci num num lycopen num num ci num num lutein zeaxanthin num num ci num num vitamin num num ci num num vitamin num num ci num num vitamin conclus author observ strong associ antioxid consumpt risk primari open angl glaucoma
MED-2898~macular pigment risk age rel macular degener subject northern european popul pubm ncbi abstract purpos age advanc diseas fellow eye import risk factor age rel macular degener amd studi author investig relationship variabl optic densiti macular pigment mp group subject northern european popul method optic densiti mp measur psychophys num subject rang age num num year healthi macula num healthi eye high risk amd advanc diseas fellow eye eye group match control eye basi variabl believ optic densiti mp iri color gender smoke habit age len densiti result age rel declin optic densiti macular pigment volunt ocular diseas eye num num num left eye num num num healthi eye predispos amd signific mp healthi eye risk wilcoxon sign rank test num conclus import risk factor amd relat absenc mp find consist hypothesi supplement lutein zeaxanthin delay avert modifi diseas
MED-2899~iri color macular pigment optic densiti pubm ncbi abstract present studi design assess relationship iri color macular pigment optic densiti melanin carotenoid respons iri color macular pigment composit protect retina similar mechan higher concentr reduc incid retin degener evalu relationship num subject examin variabl measur iri color macular pigment optic densiti mp plasma concentr lutein zeaxanthin beta caroten dietari intak lutein zeaxanthin beta caroten total fat intak iri color determin assess classifi blue gray group green hazel group ii brown black group iii mp densiti measur psychophys measur foveal parafov sensit light num num nm method heterochromat flicker photometri plasma carotenoid concentr measur reverse phas high perform liquid chromatographi dietari intak determin detail food frequ questionnair similar diet blood concentr carotenoid signific differ macular pigment densiti num found color iris group num mp num group ii num mp num group iii num mp num covari iri color mp past epidemiolog studi adequ determin independ effect factor relationship mp iri color result factor evolut share tendenc accumul melanin carotenoid due similar environment pressur light oxygen and or mp deplet due tendenc eye light iris transmit light eye dark iris caus increas oxid stress
MED-2900~associ consumpt fruits veget decreas risk glaucoma older african american women studi osteoporot fractur abstract purpos explor associ consumpt fruit veget presenc glaucoma older african american women design cross sect studi method disc photograph suprathreshold visual field obtain num african american particip studi osteoporot fractur mask train reader grade disc glaucoma specialist review photo visual field block food frequenc questionnair assess food consumpt relationship select fruit vegetable nutri consumpt glaucoma evalu logist regress model adjust potenti confound result exclud women miss food frequenc questionnair disc data num african american women num total african american cohort includ glaucoma diagnos eye num subject num women ate num servings day fruits fruit juic num odd ratio num num confid interv ci num num glaucoma women ate serving day women consum num servings week fresh orang num num ci num num peach num num ci num num decreas odd glaucoma compar consum serving week veget num serving week compar num serving month collard greens kal decreas odd glaucoma num num num ci num num protect trend glaucoma consum fruit fruit juic num fresh orang num fresh peach num collard greens kal num higher consumpt carrot num spinach num show associ individu nutrient intak food sourc found protect trend higher intak vitamin num vitamin num caroten num close statist signific trend caroten num folat num lutein zeaxanthin num conclus higher intak fruit veget high vitamin carotenoid decreas likelihood glaucoma older african american women random control trial determin intak specif nutrient risk glaucoma
MED-2901~associ glaucoma preval supplement oxid calcium iron abstract purpos investig relationship supplementari consumpt oxid calcium iron preval glaucoma method cross sect studi includ num particip nation health nutrit examin survey nhane num num num year age report presenc absenc glaucoma particip interview dietari supplement antacid preced num day period data pertain supplementari intak calcium iron aggreg divid quintil inform presenc absenc glaucoma demograph comorbid health rel behavior obtain interview result particip consum num mg d supplementari calcium num mg d supplementari iron signific higher odd diagnos glaucoma consum supplementari calcium iron adjust potenti confound odd ratio num num confid interv ci num num calcium num num ci num num iron concurr consumpt calcium iron level greater odd diagnos glaucoma num num ci num num clear dose respons relationship quintil supplementari calcium iron intak glaucoma preval found conclus result suggest threshold intak iron calcium increas risk develop glaucoma prospect longitudin studi assess oxid intak risk factor develop progress glaucoma
MED-2904~dose respons relationship prenat mercuri exposur iq integr analysi epidemiolog data abstract background prenat exposur mercuri advers childhood neurolog outcom epidemiolog studi dose respons inform relationship estim benefit reduc mercuri exposur object estim dose respons relationship matern mercuri bodi burden subsequ childhood decrement intellig quotient iq bayesian hierarch model integr data epidemiolog studi method input model consist dose respons coeffici studi conduct faro island zealand seychell island iq coeffici previous work studi coeffici faro island studi estim iq subtest test cognition achiev includ hierarch model obtain accur estim study to studi end point end point variabl result find central estim num iq point num confid interv num num part million increas matern hair mercuri similar estim faro island seychell studi lower magnitud estim zealand studi sensit analys produc similar result iq coeffici central estim rang num num conclus iq end point estim neurodevelopment effect fulli repres cognit deficit mercuri exposur repres deficit relat attent motor skill integr iq coeffici robust descript dose respons relationship prenat mercuri exposur cognit function result singl studi
MED-2905~associ matern long chain polyunsatur fatti acid methyl mercuri infant develop seychell child develop nutrit studi abstract fish consumpt gestat provid fetus long chain polyunsatur fatti acid lcpufa nutrient essenti growth develop brain fish consumpt expos fetus neurotoxic methyl mercuri mehg studi associ fetal exposur earli child develop seychell child develop nutrit studi scdns specif examin priori model num num lcpufa measur matern serum test hypothesi lcpufa famili adjust prenat mehg exposur reveal associ child develop assess bsid ii age num num month num children complet outcom covari data analysi num month pdi posit total num lcpufa negat ratio num num lcpufa associ stronger model adjust prenat mehg exposur secondari model suggest mehg effect num month vari ratio num num lcpufa signific associ lcpufa measur pdi num month signific advers associ prenat mehg num month pdi lcpufa measur includ regress analysi bsid ii mental development index mdi exposur variabl data support potenti import child develop prenat avail num lcpufa present fish lcpufa diet benefici effect lcpufa obscur determin advers effect prenat mehg exposur longitudin observ studi
MED-2906~speciat methyl ethyl mercuri hair breastf infant acut expos thimerosal contain vaccin pubm ncbi abstract background chemic form mercuri occur natur human milk controversi aspect earli post nat exposur organ mercuri ethylmercuri ethg thimerosal contain vaccin tcv countri exclus breastf infant expos fish deriv methylmercuri mehg matern diet ethg tcv aim studi evalu analyt method ethyl methyl mercuri hair sampl breastf infant receiv recommend schedul tcv method hair infant num month expos tcv hepat dtap analys method coupl isotherm gas chromatographi cold vapor atom fluoresc spectrometri mehg speciat ethg biolog matric result num sampl infant hair sampl show variabl amount mehg num num ng g precis reliabl concentr ethg num num ng g found num num sampl statist signific invers associ num num found hair ethg concentr time elaps tcv shot conclus analyt method prove sensit quantifi ethg babi hair acut exposur thimeros vaccin shot provid mass hair num organic mercuri exposur earli life speciat quantifi babi hair open opportun clinic forens studi copyright num elsevi reserv
MED-2907~fish eat perspect influenc fish consumpt choic abstract background divers perspect influenc fish consumpt choic object summar issu fish consumpt choic toxicolog nutrit ecolog econom point view identifi area overlap disagr viewpoint review effect previous fish consumpt advisori method review publish scientif literatur public health guidelin advisori relat fish consumpt focus advisori target popul conclus appli group similar fish consumpt pattern discuss combin matter relat fish consumpt fish consumpt pattern optim domain fish rich sourc protein nutrient contamin methylmercuri toxic higher fish intak lead greater toxic exposur stock wild fish adequ meet nutrient demand grow world popul fish consumpt choic broad econom impact fish industri guidanc account ecolog econom impact fish consumpt choic conclus relat lack inform integr health ecolog econom impact fish choic clear simpl guidanc effect desir comprehens advic develop describ multipl impact fish consumpt addit polici fisheri manag inter vent ensur long term avail fish import sourc human nutrit
MED-2910~sensit continu perform test cpt age num year development methylmercuri exposur abstract hit reaction time latenc hrt continu perform test cpt measur speed visual inform process latenc involv neuropsycholog function depend time test initi orient learn habitu cognit process focus attent final sustain attent domin demand prenat methylmercuri exposur increas reaction time rt latenc examin associ methylmercuri exposur averag hrt age num year time interv test initi total num adolesc num birth cohort member complet cpt rt latenc record num minut visual target present num ms interv confound adjust regress coeffici show cpt rt outcom differ associ exposur biomark prenat methylmercuri exposur minut averag hrt weak methylmercuri beta se ten fold increas exposur num num strong num num minut interv num num strongest num num minut test initi num num pattern unchang simpl reaction time finger tap speed includ model covari postnat methylmercuri exposur affect outcom find suggest sustain attent neuropsycholog domain vulner development methylmercuri exposur indic probabl dysfunct frontal lobe cpt data measur neurotox test result analyz regard time test initi averag reaction time
MED-2913~elimin half liv polychlorin biphenyl congen children abstract elimin kinet polychlorin biphenyl pcbs human difficult assess observ studi pcb exposur complet abolish communiti high dietari pcb exposur whale blubber examin group children increas bodi burden breast feed follow up age num year num year num subject num num year num subject calcul perform structur equat model adjust bodi weight dietari blubber intak main sourc postnat exposur result background exposur appar elimin half liv unexpect long base result cohort member subject exposur median highest quartil show half liv num year cb num num num year cb num cb num num num year cb num cb num cb num num year cb num cb num longest half liv correspond elimin parent pcb sole daili fat excret rate num shorter half liv assum metabol break down
MED-2917~nutrient contamin human milk mother macrobiot omnivor diet pubm ncbi abstract effect altern dietari habit prolong lactat nutrient contamin concentr human milk studi studi sampl consist mother macrobiot diet diari product meat num month postpartum num num month postpartum num mother omnivor diet num month postpartum num protein zinc concentr breast milk macrobiot mother decreas stage lactat adjust stage lactat milk macrobiot mother calcium magnesium satur fatti acid num num polyunsatur fatti acid observ tendenc lower protein fat higher lactos concentr macrobiot group statist signific concentr vitamin num hcb polychlorin biphenyl pcb num pcb num pcb num pcb num lower macrobiot group adjust confound variabl meat fish consumpt dairi product contribut vitamin num concentr meat diari product strong contribut breast milk concentr dieldrin pcbs fish pcb num smoke ddt dieldrin find suggest breast milk contamin reduc abstin smoke moder intak anim product risk nutrit defici rule complet avoid meat fish diari product quantit research effect reduc consumpt anim product smoke breast milk contamin warrant
MED-2921~evid human health effect low level methylmercuri exposur abstract background methylmercuri mehg neuro toxic emerg evid advers effect neuro log bodi system common low level exposur impact mehg exposur vari individu suscept confound bene fici nutrient fish mehg global relev synthesi literatur low level mehg exposur limit object undertook synthesi current knowledg human health effect low level mehg exposur provid basi futur research effort risk assess exposur remedi polici worldwid data sourc extract review publish literatur origin human epidemio log research articl report direct biomark mercuri exposur focus high qual studi specif low mercuri exposur exclud case seri studi popul unusu high fish consumpt seychell marin mammal consumpt faro island circumpolar indigen popul consumpt high contamin fish gold min region amazon data synthesi recent evid rais possibl effect low level mehg exposur fetal growth suscept subgroup infant growth num year life low level effect mehg neuro log outcom differ age sex time exposur clear pattern observ cardio vascular diseas cvd risk popul specif cvd end point studi evalu immunolog effect mehg result inconsist conclus studi target identifi potenti mechan low level mehg effect character individu suscept sexual dimorph non linear dose respons guid futur prevent polici regulatori effort surround mehg exposur
MED-2922~berri fruit cancer prevent current status futur prospect pubm ncbi abstract overwhelm evid suggest edibl small soft flesh berri fruit benefici effect type human cancer anticanc potenti berri relat part multitud bioactiv phytochem color fruit includ polyphenol flavonoid proanthocyanidin ellagitannin gallotannin phenol acid stilbenoid lignan triterpenoid studi show anticanc effect berri bioactiv partial mediat abil counteract reduc repair damag result oxid stress inflamm addit berri bioactiv regul carcinogen xenobiot metabol enzym transcript growth factor inflammatori cytokin subcellular signal pathway cancer cell prolifer apoptosi tumor angiogenesi berri phytochem potenti sensit tumor cell chemotherapeut agent inhibit pathway lead treatment resist berri fruit consumpt provid protect therapy associ toxic wide varieti berri fruit consum worldwid paper focus common consum north america blackberri black raspberri blueberri cranberri red raspberri strawberri addit larg bodi studi singl purifi berri bioactiv paper focus studi berri se berri extract purifi fraction juic freeze dri powder potenti mechan anticanc action bioavail berri phenol gap knowledg recommend futur berri research briefli discuss
MED-2923~death receptor ligand tumor pubm ncbi abstract activ apoptosi death receptor tight regul event death pathway open interfer part solubl membrane bound decoy receptor aggreg state death induc ligand crucial factor molecul recombin drug tumor tumor sensit ligand determin net abund death receptor versus decoy receptor balanc intracellular apoptot antiapoptot mechan vivo elimin tumor cell effector arm lymphocyt natur killer cell macrophag dendrit cell depend function activ lymphoid cell genet properti tumor cell death receptor ligand double edg sword express cytotox lymphocyt natur killer cell monocyt dendrit cell induc apoptosi tumor cell express tumor cell induc apoptosi killer cell vivo result influenc number infiltr cell state activ cytokin repertoir tumor microenviron abil tumor produc solubl factor inhibit cytolyt function
MED-2924~recent trend advanc berri health benefit research pubm ncbi abstract recent advanc made scientif understand berri promot human health prevent chronic ill cancer heart diseas neurodegen diseas cancer rapid overtak heart diseas number killer diseas develop countri phenomenon coupl grow age popul concomit age rel diseas surpris consum turn food medicin properti promis dietari intervent diseas prevent health mainten fruit berri color emerg champion substanti research data support abil posit affect multipl diseas state essenti dietari compon found berri vitamin miner fiber berri numer bioactiv provid health benefit extend basic nutrit berri bioactiv encompass wide divers phytochem phytonutri rang fat soluble lipophil water soluble hydrophil compound recent research laboratori globe provid insight biolog effect mechan action result eat berri cluster paper includ repres cross section topic discuss num intern berri health benefit symposium paper provid valuabl insight recent research trend advanc made evalu health benefit result consumpt berri deriv product
MED-2925~immunomodulatori effect standard lycium barbarum fruit juic chines older healthi human subject pubm ncbi abstract lycium barbarum tradit combin herb medicin properti systemat modern clinic evalu singl herb report examin systemat effect barbarum immun function general well b safeti test effect standard barbarum fruit juic gochi freelif intern phoenix az usa num ml day equival num fresh fruit amount tradit placebo num day random double blind placebo control clinic studi num older healthi adult num year gochi group show statist signific increas number lymphocyt level interleukin num immunoglobulin compar pre intervent placebo group number cd num cd num natur killer cell level interleukin num immunoglobulin signific alter placebo group show signific immun measur gochi group show signific increas general feel well b fatigu sleep show tendenc increas short term memori focus pre post intervent placebo group show signific posit measur advers reaction abnorm symptom bodi weight blood pressur puls visual acuiti urin stool blood biochemistri group conclus daili consumpt gochi signific increas immunolog respons subject feel general well b advers reaction
MED-2926~vitro investig potenti immunomodulatori anti canc activ black pepper piper nigrum cardamom elettaria cardamom pubm ncbi abstract immunomodulatori effect herb extens studi research relat immunomodulatori effect spice scarc potenti immunomodulatori effect black pepper cardamom investig data show black pepper cardamom aqueous extract signific enhanc splenocyt prolifer dose depend synergist fashion enzyme link immunosorb assay experi reveal black pepper cardamom signific enhanc suppress helper num cytokin releas splenocyt convers num cytokin releas splenocyt signific suppress enhanc black pepper cardamom experiment evid suggest black pepper cardamom extract exert pro inflammatori anti inflammatori role consist nitric oxid product macrophag signific augment reduc black pepper cardamom remark evid black pepper cardamom extract signific enhanc cytotox activ natur killer cell indic potenti anti canc effect find strong suggest black pepper cardamom exert immunomodulatori role antitumor activ manifest natur agent promot mainten healthi immun system anticip black pepper cardamom constitu potenti therapeut tool regul inflammatori respons prevent attenu carcinogenesi
MED-2928~ash num anniversari review human natur killer cell abstract natur killer nk cell discov num year ago nk cell larg granular lymphocyt belong innat immun system unlik lymphocyt adapt antigen specif immun system nk cell rearrang t cell receptor immunoglobulin gene germlin configur past num decad substanti gain understand nk cell lend import insight function purpos normal immun surveil recent discoveri nk cell receptor biolog fuel translat research led remark result treat human malign
MED-2938~homocystein circul vascular cell adhes molecul carotid atherosclerosi postmenopaus vegetarian women omnivor pubm ncbi abstract adopt vegetarian diet healthi lifestyl popular cardiovascular effect long term vegetarian explor present studi aim compar presenc sever carotid atherosclerosi ca blood level vitamin num homocystein hci solubl vascular cell adhes molecul num svcam num num healthi postmenopaus vegetarian num age match omnivor carotid atherosclerosi measur ultrasound found signific differ group fast blood glucos low dens lipoprotein cholesterol vitamin num signific lower hci svcam num higher vegetarian compar omnivor multivari regress analysi show level vitamin num negat level hci vegetarian hci level signific svcam num level univari analysi adjust covari identifi age vegetarian determin svcam num level multipl linear regress analysi identifi age systol blood pressur vegetarian determin common carotid arteri imt conclus signific differ ca appar healthi postmenopaus vegetarian omnivor find elev hci vegetarian import prevent vitamin num defici
MED-2939~arteri function carotid brachial arteri postmenopaus vegetarian abstract background vegetarian lower risk cardiovascular diseas studi arteri function vegetarian limit method studi investig arteri function vegetarian compar num healthi postmenopaus vegetarian num age match omnivor arteri function common carotid arteri assess carotid duplex puls dynam method measur brachial arteri distens bad complianc bac resist bar fast blood level glucos lipid lipoprotein high sensit c reactiv protein homocystein vitamin num measur result vegetarian signific lower serum cholesterol high dens low dens lipoprotein glucos compar omnivor lower vitamin num higher homocystein level serum level lipoprotein high sensit c reactiv protein group signific differ carotid beta stiff index bac bad group adjust covari bar signific lower vegetarian omnivor multipl linear regress analysi reveal age puls pressur import determin carotid beta stiff index bad vegetarian arteri elast conclus appar healthi postmenopaus vegetarian signific term carotid beta stiff index bac bad signific decreas bar omnivor prevent vitamin num defici benefici cardiovascular health vegetarian
MED-2940~radiat chest ct scan examin pubm ncbi abstract past num decad total number ct scan perform grown exponenti num num million ct scan perform unit state ct scan studi chest compris larg portion ct scan perform today technolog transform manag common chest diseas includ pulmonari embol coronari arteri diseas number studi perform year increas grow fraction popul expos low dos ioniz radiat ct scan data extrapol atom bomb survivor popul expos low dos ioniz radiat suggest ct scan associ radiat increas individual lifetim risk develop cancer find incontrovert topic recent attract attent scientif communiti general public increas import physician understand cancer risk ct scan capabl engag product dialogu patient articl review current literatur public health debat surround ct scan cancer risk quantifi radiat dose specif studi describ effort reduc population wid ct scan associ radiat exposur ct scan examin chest includ ct scan pulmonari coronari angiographi high resolut ct scan low dos lung cancer screen tripl rule out ct scan specif consid
MED-2941~common carotid intima media thick predict all caus cardiovascular mortal elder community dwel peopl longitudin investig longev age hokkaido counti lilac studi abstract cohort studi examin associ carotid intima media thick imt risk stroke myocardi infarct appar healthi person investig predict imt cardiovascular mortal elder community dwel peopl predict provid age mmse assess multivari cox model carotid imt plaqu evalu bilater ultrasonographi num peopl older num year num men num women averag age num year lilac studi start juli num consult repeat year follow up end novemb num follow up span num day num subject num men women die death attribut cardiovascular imyocardi infarct men women stroke men women age mmse adjust relat risk rr num confid interv num ci develop all caus mortal assess num mm increas left imt rr predict num num num similar increas imt rr num num num cardiovascular mortal rr valu num num num num num num carotid imt assess ultrasonographi posit increas risk all caus cardiovascular death elder community dwel peopl
MED-2942~impact vegan diet num status healthi omnivor five year prospect studi pubm ncbi abstract background long term prospect studi assess impact vegan diet vitamin num num status vegan num supplement irregular refus adopt unnatur product num fortifi food altern aim estim long term effect vegan diet serum num concentr healthi omnivor adult compar influenc natur product consumpt num fortifi food materi method year prospect studi carri compris num omnivor healthi adult subject move strict vegan diet num year ten volunt vegan diet base natur product remain ten subject consum food fortifi num subject serum vitamin num concentr determin num num num month implement diet result signific decreas num serum num concentr studi group note num month vegan diet observ fact limit subgroup consum exclus natur product num conclus transit omnivor vegan diet risk vitamin num defici num fortifi product constitut valuabl altern vegan refus vitamin supplement
MED-2943~long term low calori low protein vegan diet endur exercis low cardiometabol risk pubm ncbi abstract background western diet typic larg amount energy dens process food sedentari lifestyl increas cardiometabol risk evalu long term effect consum low calori low protein vegan diet perform regular endur exercis cardiometabol risk factor method cross sect studi cardiometabol risk factor evalu num sedentari subject low calori low protein raw vegan diet num num year age num num yrs num bodi mass index bmi match endur runner consum western diet num age gender match sedentari subject consum western diet result bmi lower low calori low protein vegan diet num num kg m num endur runner num num kg m num group sedentari western diet group num num kg m num num plasma concentr lipid lipoprotein glucos insulin c reactiv protein blood pressur bp carotid arteri intima media thick lower low calori low protein vegan diet runner group western diet group num systol diastol bp lower low calori low protein vegan diet group num num num num mm hg bmi match endur runner num num num num mmhg western diet group num num num num mm hg num bp valu direct sodium intak invers potassium fiber intak conclus long term consumpt low calori low protein vegan diet regular endur exercis train low cardiometabol risk data suggest specif compon low calori low protein vegan diet provid addit benefici effect blood pressur
MED-2944~systemat review incid sudden cardiac death unit state abstract consist current data describ true incid sca and or scd highlight recent sudden cardiac arrest thought leadership allianc scatla tank meet nation expert broad represent key stakehold includ thought leader repres american colleg cardiolog american heart associ heart rhythm societi evalu true magnitud public health problem perform systemat literatur search medlin mesh head death sudden term sudden cardiac death sudden cardiac arrest cardiac arrest cardiac death sudden death arrhythm death studi select criteria includ peer review public primari data estim scd incid web scienc cite refer search evalu impact primari estim medic literatur determin number time primari sourc cite estim annual incid scd vari wide num num num includ studi estim part due data sourc data age rang num num definit scd case ascertain criteria method estimation extrapol sourc case ascertain true incid sca and or scd remain unclear wide rang estim bad date reliabl estim scd incid import improv risk stratif prevent futur effort establish uniform definit sca scd prospect precis captur case sca scd popul
MED-2945~chines lacto vegetarian diet exert favor effect metabol paramet intima media thick cardiovascular risk healthi men pubm ncbi abstract background investig chines lacto vegetarian diet protect effect metabol cardiovascular diseas cvd method hundr sixty nin healthi chines lacto vegetarian num healthi omnivor men age num year enrol anthropometr index lipid profil insulin sensit pancreat cell function intima media thick imt carotid arteri assess compar cardiovascular risk point probabl develop cvd num year particip age num year calcul result compar omnivor lacto vegetarian remark lower bodi mass index systol diastol blood pressur serum level triglycerid total cholesterol low dens lipoprotein cholesterol apolipoprotein glutamyl transferas serum creatinin uric acid fast blood glucos lower total cholesterol high dens lipoprotein cholesterol ratio vegetarian higher homeostasi model assess cell function insulin secret index thinner carotid imt omnivor result correspond lower cardiovascular risk point probabl develop cvd num year vegetarian num year conclus healthi chines men lacto vegetarian diet exert protect effect blood pressur lipid profil metabol paramet result signific lower carotid imt lower cvd risk found vegetarian reflect benefici effect chines lacto vegetarian diet
MED-2946~vitamin num supplement improv arteri function vegetarian subnorm vitamin num status pubm ncbi abstract object vegetarian vascular healthi subnorm vitamin num status impair arteri endotheli function increas intima media thick aim studi impact vitamin num supplement marker vegetarian design double blind placebo control randomis crossov studi set communiti dwell vegetarian particip fifti healthi vegetarian vegetarian diet num year recruit intervent vitamin num g day ident placebo num week num week placebo washout crossov num open label vitamin num addit num week num measur flow medi dilat brachial arteri fmd intima media thick imt carotid arteri measur ultrasound result age subject num num year num male thirty f subject num serum num level num pmol l vitamin num supplement signific increas serum vitamin num level num lower plasma homocystein num vitamin num supplement placebo signific improv brachial fmd num num num num num carotid imt num num mm num num mm num found improv fmd num num num imt num num mm num num week open label vitamin num signific blood pressur lipid profil multivari analysi num num num homocystein relat fmd num num num conclus vitamin num supplement improv arteri function vegetarian subnorm vitamin num level propos strategi atherosclerosi prevent
MED-2947~radiat dose contemporari cardiothorac multidetector ct protocol anthropomorph femal phantom implic cancer induct pubm ncbi abstract purpos measur prospect direct organ dose effect dose ed adult cardiac pulmonari comput tomograph ct angiographi current clinic protocol num detector ct anthropomorph femal phantom estim lifetim attribut risk breast lung cancer incid basi measur ed organ dose materi method cardiac pulmonari num detector ct angiographi perform current clinic protocol evalu pulmonari vein electrocardiograph ecg gate num section num mm collim num kvp num ma num tube rotat nativ coronari arteri ecg gate num section num mm num kvp maximum current num ma minimum num ma num tube rotat pulmonari embolus num section num mm num kvp num ma num tube rotat absorb organ dose measur anthropomorph femal phantom metal oxid semiconductor field effect transistor detector ed calcul measur organ dose dose length product result ed current adult cardiac pulmonari num detector ct angiographi protocol num num msv skin breast esophagus heart highest record absorb organ dose relat risk breast cancer incid girl women num num singl examin relat risk lung cancer incid men women num num singl examin conclus ed organ dose num detector ct higher previous report adult cardiac pulmonari ct angiographi protocol risk breast lung cancer induct studi greatest younger patient popul rsna num
MED-2951~total antioxid content num food beverag spice herb supplement worldwid abstract background plant bas diet protect chronic oxid stress rel diseas dietari plant variabl chemic famili amount antioxid hypothes plant antioxid contribut benefici health effect dietari plant object develop comprehens food databas consist total antioxid content typic food dietari item tradit medicin plant herb spice dietari supplement databas intend wide rang nutrit research vitro cell anim studi clinic trial nutrit epidemiolog studi method procur sampl countri worldwid assay sampl total antioxid content modifi version frap assay result sampl inform countri origin product and or brand regist individu food sampl constitut antioxid food tabl result result demonstr thousand fold differ antioxid content food spice herb supplement includ antioxid rich product studi high berri fruit nut chocol veget product thereof constitut common food beverag high antioxid valu conclus databas knowledg comprehens antioxid food databas publish show plant bas food introduc signific antioxid human diet non plant food larg variat observ compar food sampl studi emphas import comprehens databas combin detail system food registr clinic epidemiolog studi present antioxid databas essenti research tool elucid potenti health effect phytochem antioxid diet
MED-2966~plasma antioxid capac meal measur abil food alter vivo antioxid status pubm ncbi abstract object determin num consumpt meal fruit berri increas plasma hydrophil lipophil antioxid capac aoc measur oxygen radic absorb capac orac fl num includ macronutri meal alter postprandi aoc num preliminari recommend develop antioxid intak method plasma aoc consumpt singl meal berries fruit blueberri dri plum dri plum juic grape cherri kiwifruit strawberri studi num clinic trial num subject experi studi blueberri grape addit macronutri carbohydr fat protein includ control treatment meal blood sampl collect meal analyz aoc result consumpt dri plum dri plum juic alter l aoc area curv auc consumpt blueberri num studi mix grape powder num studi num num studi num num studi num mmole trolox equival te aoc increas hydrophil aoc auc l aoc increas meal blueberri num mmole te aoc studi num consumpt num cherri num mmol te aoc increas plasma l aoc h aoc aoc control group addit macronutri studi num num ad decreas postprandi baselin aoc measur conclus demonstr consumpt berri fruit blueberri mix grape kiwifruit increas plasma aoc postprandi state consumpt energi sourc macronutri antioxid declin plasma aoc long term clinic studi necessarili translat increas plasma aoc potenti decreas risk chronic degen diseas preliminari estim antioxid base energi intak develop consumpt high antioxid food meal recommend order prevent period postprandi oxid stress
MED-2967~atherogenesi postprandi phenomenon pubm ncbi abstract hypothesi plasma chylomicron person ingest cholesterol rich diet atherogen evalu evid present human experiment anim chylomicron remnant low dens lipoprotein arteri cell person famili hyperlipoproteinemia atherogenesi occur postprandi period research direct contribut evalu chylomicron remnant risk factor atherogenesi discuss lipoprotein studi administr test meal fat cholesterol urgent
MED-2968~postprandi plasma lipid hydroperoxid link diet atherosclerosi pubm ncbi abstract increas evid implic dietari sourc plasma lipid peroxid elev postprandi state phenomenon contribut factor correl found postprandi hyperlipidemia increas risk cardiovascular diseas newli develop method measur lipid hydroperoxid direct plasma pilot studi perform reveal lipid hydroperoxid elev fatti meal lipid hydroperoxid increas num meal return basal level usual postprandi hyperlipidemia mark suppress postprandi hydroperoxid found meal consum wine suggest hydroperoxid form absorb digest process
MED-2969~orang juic fructos intak induc oxid inflammatori respons pubm ncbi abstract object previous shown num kcal glucos intak induc signific increas reactiv oxygen speci ros generat nuclear factor kappab nf kappab bind circul mononuclear cell healthi normal subject hypothes intak num calori orang juic fructos major carbohydr orang juic induc signific smaller respons glucos research design method group subject normal weight subject num cal drink glucos num fructos num orang juic water sweeten saccharin control group drink blood sampl collect result signific increas ros generat mononuclear cell num num num polymorph nuclear cell num num num nf kappab bind mononuclear cell num num num baselin num glucos intak absent fructos orang juic water intak signific lower ros generat nf kappab bind orang juic fructos water compar glucos num incub mononuclear cell vitro num mmol l flavonoid hesperetin naringenin reduc ros generat num num num num num fructos ascorb acid chang conclus calor intak form orang juic fructos induc oxid inflammatori stress possibl due flavonoid content repres potenti safe energi sourc
MED-2970~postprandi metabol event fruit deriv phenol review scienc pubm ncbi abstract increas evid postprandi state import contribut factor chronic diseas role fruit phenol compound protect health lower diseas risk action mitig fed stat metabol oxid stressor interest topic present paper main question pose role plant food specif fruit rich complex simpl phenol compound postprandi metabol manag evid support consum fruit meal practic strategi preserv health lower risk diseas review overview postprandi literatur specif effect fruit inher phenol compound human subject postprandi lipaemia glycaemia insulinaemia event oxid stress inflamm identifi well control human trial postprandi paradigm num trial wine wine compon remain berri notwithstand research collect data suggest consum phenolic rich fruit increas antioxid capac blood consum high fat carbohydr pro oxid pro inflammatori meal counterbal negat effect content avail fat carbohydr western diet regular consumpt phenolic rich food conjunct meal prudent strategi maintain oxid balanc health
MED-2971~glucos challeng stimul reactiv oxygen speci ros generat leucocyt pubm ncbi abstract diabet mellitus increas ros generat oxid injuri obes elucid relationship nutrit ros generat investig effect glucos challeng ros generat leucocyt num hox protein key protein enzym nadph oxidas alpha tocopherol level blood sampl drawn num normal subject prior num num ingest num glucos ros generat polymorphonuclear leucocyt pmnl mononuclear cell mnc increas peak num num num num basal num level num hox mnc homogen increas signific num num glucos intak alpha tocopherol level decreas signific num num num conclud glucos intak stimul ros generat num hox nadph oxidas increas oxid load fall alpha tocopherol concentr
MED-2972~strawberri modul ldl oxid postprandi lipemia respons high fat meal overweight hyperlipidem men women pubm ncbi abstract background elev level lipid total cholesterol tc low dens lipoprotein cholesterol ldl triglycerid tg wide recogn risk factor cardiovascular diseas cvd oxid ldl oxldl emerg risk factor consid relev oxid stress endotheli dysfunct implic progress cvd consumpt diet rich polyphenol cardioprotect impact oxid stress protect ldl oxid object studi design test abil strawberri phenol compound mitig postprandi effect high fat meal oxldl investig effect phenol compound lipid metabol method twenty four hyperlipidem men women num women num men age num sd num year recruit particip random single blind placebo control num wk crossov trial num day run in period subject consum activ strawberri beverag str num freeze dri fruit placebo pbo beverag match energi macronutri composit num week random num week crossov point subject receiv str pbo high fat challeng meal hfm tc ldl high dens lipoprotein cholesterol tg oxldl measur defin interv num hfm challeng fast concentr blood variabl num num week compar assess chronic intak str pbo result hfm run in period tg oxldl lower str pbo num num num hfm respons num week str versus pbo result decreas lipid level sex treatment interact oxldl num num conclus present result support role strawberri mitig fed stat oxid stressor contribut atherogenesi
MED-2973~egg consumpt risk type num diabet mellitus case control studi pubm ncbi abstract object type num diabet mellitus involv interact suscept genet background environment factor includ high calorif diet import identifi modifi risk factor reduc risk type num diabet mellitus aim present studi determin associ egg consumpt risk type num diabet mellitus design specif design questionnair collect inform risk factor type num diabet mellitus odd ratio num confid interv type num diabet mellitus calcul condit logist regress set case control studi lithuanian out pati clinic perform num subject total num case newli confirm diagnosi type num diabet mellitus num control free diseas result variabl bmi famili histori diabet cigarett smoke educ morn exercis plasma tag level retain multivari logist regress model confound inclus chang odd ratio num exposur categori adjust confound twofold increas risk type num diabet mellitus determin individu consum num num eggs week num num ci num num num threefold increas risk diseas determin individu consum num eggs week num num ci num num num compar eat num egg week conclus data support relationship egg consumpt increas risk type num diabet mellitus
MED-2975~egg consumpt risk diabet adult jiangsu china pubm ncbi abstract background egg consumpt elev plasma level cholesterol triglycerid risk cardiovascular diseas popul epidemiolog studi egg consumpt risk diabet extrem spars chines popul method data household survey year num num adult age num nation repres sampl jiangsu provinc china dietari inform assess valid food frequenc questionnair num weigh food record fast blood specimen collect result adjust age total calori intak educ smoke famili histori diabet sedentari activ egg consumpt signific posit diabet risk women odd ratio num ci diabet egg consumpt num wk num wk num total sampl num num num num num trend num num ci women num num num num num trend num addit adjust bodi mass index attenu associ remain signific similar statist signific associ men addit plasma triglycerid total cholesterol level signific higher women consum num eggs wk consum egg conclus egg consumpt posit risk diabet chines women copyright num elsevi reserv
MED-2976~egg consumpt risk type num diabet older adult abstract background type num diabet num remain import public health issu unit state limit inconsist data associ egg consumpt fast glucos incid diabet object assess associ egg intak incid diabet older adult design prospect studi num men women cardiovascular health studi num num assess egg consumpt picture sort food questionnair ascertain incid num annual inform hypoglycem agent plasma glucos cox proport hazard model estim adjust relat risk result follow up num num case num occur crude incid rate num num num num num num num person year peopl report egg consumpt num egg mo num num eggs mo num num eggs wk daili multivariable adjust model associ egg consumpt increas risk num sex secondari analysi dietari cholesterol incid diabet trend num addit egg consumpt clinic meaning differ fast glucos fast insulin measur insulin resist small absolut analyt differ signific conclus cohort older adult limit egg intak associ egg consumpt dietari cholesterol increas risk incid num
MED-2977~egg consumpt risk type num diabet men women abstract object limit inconsist find report relat dietari cholesterol egg consumpt fast glucos previous studi examin associ egg consumpt type num diabet project sought examin relat egg intak risk type num diabet larg prospect cohort research design method prospect studi data complet random trial num men physician health studi num num num women women health studi num num egg consumpt ascertain questionnair cox proport hazard model estim relat risk type num diabet result follow up num year men num year women num men num women develop type num diabet compar egg consumpt multivari adjust hazard ratio type num diabet num num ci num num num num num num num num num num num num num num consumpt num num num num num eggs week men trend num multivari hazard ratio women num num num num num num num num num num num num num num num trend num conclus data suggest high level egg consumpt daili increas risk type num diabet men women confirm find popul warrant
MED-2978~high intak protein process meat associ increas incid type num diabet pubm ncbi abstract diet high protein shown posit effect short term weight reduct glycaem control understand dietari macronutri composit relat long term risk type num diabet limit aim present studi examin intak macronutri fibr protein sourc relat incid type num diabet total num individu age num year population bas malm diet cancer cohort includ dietari data collect modifi diet histori method includ registr cook meal num year follow up num incid type num diabet case identifi high protein intak increas risk type num diabet hazard ratio hr num highest compar lowest quintil num ci num num trend num protein consumpt increas num energi expens carbohydr hr num num ci num num fat hr num num ci num num increas diabet risk observ intak highest quintil process meat hr num num ci num num trend num egg hr num num ci num num trend num increas risk intak fibre rich bread cereal invers type num diabet hr num num ci num num trend num conclus result present larg population bas prospect studi high protein intak increas risk type num diabet replac protein carbohydr favour fibre rich bread cereal chosen carbohydr sourc
MED-2979~neuroprotect effect natur iron chelat phytic acid cell cultur model parkinson diseas pubm ncbi abstract disrupt iron metabol excess iron accumul report brain parkinson diseas pd patient excess iron induc oxid stress subsequ caus degrad nigral dopaminerg neuron pd determin protect effect natur occur iron chelat phytic acid ip num num methyl num phenylpyridinium mpp induc cell death immort rat mesencephalic dopaminerg cell cell death induc mpp normal iron excess condit cytotox measur thiazolyl blue tetrazolium bromid mtt assay trypan blue stain apoptot cell death measur caspas num activ dna fragment hoechst nuclear stain compar mpp treatment ip num micromol l increas cell viabil num num decreas cell death num num threefold increas caspas num activ num twofold increas dna fragment num mpp treatment decreas num num num num ip num cell surviv increas num num num num num num micromol l ip num iron excess condit num num num protect observ caspas num activ num num micromol l ip num iron excess condit similar num reduct num dna fragment found num micromol l ip num addit hoechst nuclear stain result confirm protect effect ip num apoptosi similar protect observ differenti cell collect result demonstr signific neuroprotect effect phytat cell cultur model pd
MED-2980~inositol hexakisphosph inhibit osteoclastogenesi raw num cell human primari osteoclast abstract background inoxitol hexakisphosph ip num found import role biominer direct effect inhibit miner osteoblast vitro impair extracellular matrix product express alkalin phosphatas ip num propos exhibit similar effect bisphosphon bone resorpt direct effect osteoclast ocl present unknown methodology princip find aim present studi investig effect ip num raw num monocyte macrophag mous cell line human primari osteoclast hand show ip num decreas osteoclastogenesi raw num cell induc rankl affect cell prolifer cell viabil number trap posit cell mrna level osteoclast marker trap calcitonin receptor cathepsin mmp num decreas ip num rankl treat cell contrari give ip num matur osteoclast rankl treatment signific increas bone resorpt activ trap mrna level found hand show num ip num inhibit osteoclastogenesi human peripher blood mononuclear cell pbmnc resorpt activ undifferenti matur osteoclast conclusions signific result demonstr ip num inhibit osteoclastogenesi human pbmnc raw num cell line ip num repres type select inhibitor osteoclast prove treatment osteoporosi
MED-2982~surgic manag bisphosphonate rel osteonecrosi jaw oncolog patient challeng problem pubm ncbi abstract aim bisphosphonate rel osteonecrosi jaw bronj oral complic support cancer therapi method treatment unclear purpos articl analyz type treatment outcom larg patient cohort bronj patient method total num patient suffer bronj site studi patient treat intraven bisphosphon oncolog diseas descript analysi relev patient data perform emphasi surgic outcom result mandibl affect num patient patient previous invas dental procedur durat bisphosphon treatment num month total num patient treat surgic includ sequestrectomi mandibular resect soft tissu reconstruct achiev local closur myofasci flap mylohyoid muscl vascular fasciocutan flap patient boni reconstruct perform conclus surgic treatment bronj remain challeng limit evid oncolog patient bronj candid vascular bone reconstruct
MED-2983~ascorb acid prevent dose depend inhibitori effect polyphenol phytat nonheme iron absorpt pubm ncbi abstract effect maize bran phytat polyphenol tannic acid iron absorpt white bread meal test num subject phytat content vari ad concentr phytate fre ordinari maiz bran iron absorpt decreas progress maiz bran increas amount phytat phosphor phytat num num mg inhibitori effect overcom num mg ascorb acid inhibitori effect tannic acid num num mg dose depend studi suggest greater equal num mg ascorb acid requir overcom inhibitori effect iron absorpt meal greater num mg tannic acid find predict bioavail iron diet due account relat content diet major promot inhibitor iron absorpt
MED-2984~algorithm assess intestin iron avail dietari survey abstract nutrit epidemiolog assum nutrient absorpt proport nutrient intak nutrient includ non haem fe assumpt hold depend nutrient ingest non haem fe avail absorpt vari great fe intak examin associ fe health impact valid find previous algorithm adjust fe intak dietari factor affect absorpt found underestim fe absorpt present studi perform poor independ dietari data design algorithm adjust fe intak effect ascorb acid meat fish poultri phytat polyphenol ca incorpor absorpt data test meal current understand fe absorpt creat robust univers fe algorithm potenti larg cohort algorithm aim predict fe absorpt fe gut measur greater epidemiolog research fe fe absorpt gastrointestin tract account enhanc inhibit effect dietari modifi algorithm success estim averag fe avail test meal data construct algorithm unlik algorithm test provid plausibl predict appli independ dietari data futur research evalu extent algorithm epidemiolog research relat fe health outcom
MED-2985~phytat myo inositol hexaphosph risk factor osteoporosi pubm ncbi abstract risk factor play role develop osteoporosi phytat natur occur compound ingest signific amount diet rich grain aim studi evalu phytat consumpt risk factor osteoporosi group num volunt subject bone miner densiti determin dual radiolog absorptiometri calcaneus group num subject valid result obtain group bone miner densiti determin lumbar column neck femur subject individu interview select osteoporosi risk factor dietari inform relat phytat consumpt acquir questionnair conduct occas num num month perform one way analysi varianc student test determin statist differ group bone miner densiti increas increas phytat consumpt multivari linear regress analysi bodi weight low phytat consumpt risk factor greatest influenc bone miner densiti phytat consumpt protect effect osteoporosi suggest low phytat consumpt consid osteoporosi risk factor
MED-2986~effect phytic acid absorpt distribut endogen excret zinc rat pubm ncbi abstract zinc metabol male rat studi combin nutrit balanc method analysi num kinet rat group num fed zinc adequ diet num ppm zn num basal num phytic acid ad sodium phytat fourth ord exponenti function time cours num plasma compartment model develop plasma zinc exchang rapid zinc liver kidney zinc test skelet muscl bone total bodi zinc content num mg num live bodi weight measur chemic num time higher estim exchang zinc bodi whole bodi retent num higher endogen fecal zinc excret lower rat fed phytat fed basal diet respons phytat reflect homeostat adjust decreas absorpt zinc respect valu appar absorpt true absorpt zinc num num zinc intak rat fed phytat num num zinc intak rat fed basal diet grain matur seed constitut major portion diet phytat zinc molar ratio approach num studi phytic acid occur natur food affect zinc metabol extent sodium phytat determin studi
MED-2987~protect effect myo inositol hexaphosph phytat bone mass loss postmenopaus women pubm ncbi abstract introduct object paper evalu relationship urinari concentr insp num bone mass loss risk fractur postmenopaus women materi method total num postmenopaus women includ studi num low num num intermedi num num num high num urinari phytat concentr densitometri valu neck measur enrol num month lumbar spine femor neck num year risk fractur calcul tool frax result individu low insp num level signific greater bone mass loss lumbar spine num num num num high phytat level signific greater percentag women low high insp num level show num bone mass loss lumbar spine num num num year fractur probabl signific higher low phyt group compar high phyt group hip num num num num major osteoporot fractur num num num num discuss conclud high urinari phytat concentr correl reduc bone mass loss lumbar spine num month reduc num year probabl hip major osteoporot fractur indic increas phytat consumpt prevent develop osteoporosi
MED-2988~role phytic acid legum antinutri benefici function pubm ncbi abstract review describ present state knowledg phytic acid phytat present legum seed antinutrit effect phytic acid primarili relat strong chelat reactiv phosphat group abil complex protein miner subject investig chemic nutrit viewpoint hydrolysi phytat inositol phosphat phosphor acid occur result phytas nonenzymat cleavag enzym capabl hydrolys phytat wide distribut micro organ plant anim phytas act stepwis manner catalys hydrolysi phytic acid reduc elimin chelat abil phytat dephosphoryl hexa penta phosph form essenti high degre phosphoryl bind miner method decreas inhibitori effect phytic acid miner absorpt cook germin ferment soak autolysi inositol hexaphosph receiv increas attent owe role cancer prevent and or therapi hypocholesterolaem effect
MED-2989~phytat level bone paramet retrospect pilot clinic trial pubm ncbi abstract studi evalu relationship phytat urinari level bone characterist larg popul postmenopaus women studi popul consist num postmenopaus women particip descript cross sect studi urin sampl collect subject determin phytat level volunt divid group phytat urinari concentr low high level bone miner densiti determin lumbar spine femor neck group low high phytat urinari level urinari level phytat link dietari phytat consumpt bone miner densiti valu signific higher lumbar spine femor neck women consum high level phytat women low urinari phytat concentr higher urinari level phytat correl higher bone miner densiti lumbar spine femor neck postmenopaus women find demonstr potenti phytat treatment bone relat diseas mechan action similar bisphosphon
MED-2990~bisphosphonate associ osteonecrosi jaw report task forc american societi bone miner research pubm ncbi abstract onj increas suspect potenti complic bisphosphon therapi recent year asbmr leadership appoint multidisciplinari task forc address key question relat case definit epidemiolog risk factor diagnost imag clinic manag futur area research relat disord report summar find recommend task forc introduct increas recognit bisphosphon osteonecrosi jaw onj led leadership american societi bone miner research asbmr appoint task forc address number key question relat disord materi method multidisciplinari expert group review pertin publish data bisphosphonate associ onj food drug administr drug advers event report review result conclus case definit develop subsequ studi report condit task forc defin onj presenc expos bone maxillofaci region heal num wk identif health care provid base review publish unpublish data risk onj oral bisphosphon therapi osteoporosi low estim num num num num patient treat year task forc recogn inform incid onj rapid evolv true incid higher risk onj patient cancer treat high dose intraven bisphosphon higher rang num num patient depend durat therapi futur improv diagnost imag modal optic coher tomographi mri combin contrast agent manipul imag plane identifi patient preclin earli stage diseas manag larg support research agenda aim fill gap knowledg disord outlin
MED-2991~autopsi chicken nugget read chicken pubm ncbi abstract purpos determin content chicken nugget num nation food chain background chicken nugget major compon american diet sought determin current composit high process food method random select nugget num nation fast food chain fix formalin section stain microscop analysi result striat muscl chicken meat predomin compon nugget fat present equal greater quantiti epithelium bone nerv connect tissu conclus chicken nugget fat misnom copyright num elsevi reserv
MED-2992~toxic carcinogen studi num methylimidazol num rat num num mice abstract num methylimidazol num manufactur pharmaceut photograph chemic dye pigment clean agricultur chemic rubber identifi by product ferment food detect mainstream side stream tobacco smoke num studi high potenti human exposur group num male num femal num rat fed diet num num num ppm num male num num num num ppm num femal num week base food consumpt calcul averag daili dose approxim num num mg num i kg bodi weight male num num mg num i kg femal surviv expos group male femal similar control group bodi weight male num num ppm group femal num num ppm group control group studi feed consumpt num ppm femal control clonic seizur excit hyperact impair gait observ primarili num num ppm femal incid mononuclear cell leukemia num ppm femal signific greater control incid hepat histiocytosi chronic inflamm focal fatti chang signific increas expos group male femal rat incid hepatocellular eosinophil mix cell foci signific increas num ppm male num ppm femal group num male num femal num num mice fed diet num num num ppm num num week base food consumpt calcul averag daili dose approxim num num mg num i kg bodi weight male femal surviv expos group male femal similar control group bodi weight male femal num ppm group num num ppm femal control group feed consumpt expos group male femal mice similar control incid alveolar bronchiolar adenoma expos group femal alveolar bronchiolar carcinoma num ppm male alveolar bronchiolar adenoma carcinoma combin num ppm male num num ppm femal signific greater control group incid alveolar epitheli hyperplasia signific increas num ppm femal num carcinogen induc alveolar bronchiolar adenoma carcinoma male femal mice num induc mononuclear cell leukemia femal rat
MED-2993~num methylimidazol tumor prevent activ rat pubm ncbi abstract num methylimidazol num mei found wide array food product nation toxicolog program ntp recent conduct two year feed cancer bioassay num mei num num mice num rat rat ntp found equivoc evid carcinogen activ femal base increas incid mononuclear cell leukemia evid carcinogen activ male dose rel statist signific decreas multipl tumor observ male femal rat expos num mei ntp bioassay num mei num fold decreas incid mammari tumor high dose femal ntp note briefli decreas tumor includ mammari tumor greater attribut bodi weight present paper detail evalu evid num mei exhibit tumor prevent activ rat base result ntp bioassay reduc bodi weight offer partial explan reduct tumor primari decreas tumor incid indic num mei possess abil prevent tumor format copyright num elsevi reserv
MED-2994~carcinogen regul caramel color pubm ncbi abstract num num methylimidazol present contamin caramel color manufactur ammonia catalyst contamin shown induc cancer anim present caramel color amount exceed feder guidelin california requir warn notic product lead consumpt num microgram day food drug administr bar excess contamin caramel color food
MED-2997~etiolog signific relat diseas abstract diseas pattern emerg show diseas relat valuabl pointer common articl trace principl interpret diseas relationship illustr common condit western civil common postul remov fiber diet
MED-2999~western diseas emerg relat diet pubm ncbi abstract commonest diseas econom develop communiti characterist modern western cultur evid present suggest repres failur adapt dramat diet emerg modern western cultur dietari aim allevi prevent diseas discuss recommend
MED-3000~red meat consumpt cancer reason suspect involv bovin infecti factor colorect cancer pubm ncbi abstract increas risk colorect cancer consist report long tim consumpt cook process red meat frequent attribut chemic carcinogen aris cook process meat long tim fish poultri consumpt appar increas risk similar higher concentr chemic carcinogen record prepar consumpt geograph epidemiolog colorect cancer correspond region high rate beef consumpt countri virtual absenc beef diet india prefer lamb goat meat consum arab countri reveal low rate colorect cancer china pork consumpt long tradit intermedi colorect cancer rate japan korea larg scale beef pork import start world war ii korean war steep rise colorect cancer incid note num japan num korea consumpt undercook beef shabu shabu korean yukho japanes yukk popular countri data compat interpret specif beef factor suspect thermoresist potenti oncogen bovin virus polyoma papilloma possibl single strand dna virus contamin beef prepar lead latent infect colorect tract preced concomit subsequ exposur chemic carcinogen aris cook procedur result increas risk colorect cancer synergist infect copyright num uicc
MED-3001~system health challeng western diseas pubm ncbi abstract decad concept western diseas establish medicin approach group diseas search cure achiev success argu medicin accept failur strategi place major emphasi prevent key object chang climat opinion prevent general popul chief activ wide rang public educ campaign persuad peopl live healthier lifestyl medicin requir restructur order carri work medic educ reform medic student receiv train part integr approach govern industri medic research play major role govern taxat subsidi area food tobacco shift consumpt pattern healthier product govern tighten law tobacco sale advertis support health educ improv food label industri made respons health popul public educ alter demand govern action medic research chang emphasi studi detail mechan diseas complex research studi role lifestyl factor simpl research
MED-3012~fish consumpt child bear age quantit risk benefit analysi neurodevelop pubm ncbi abstract fish ingredi num docosahexaeno acid num num dha stimul brain develop hand methylmercuri mehg fish disturb develop central nervous system context iq score children consid aggreg measur utero brain develop determin effect dha exposur prenat neurodevelop matern dha intak pregnanc compar epidemiolog observ effect iq score children mehg matern intak convert accumul matern bodi matern bodi burden compar epidemiolog observ relationship iq score mehg dha content num fish speci net effect compound iq score quantifi fish speci advers effect mehg iq score exceed benefici effect dha case long liv predat negat effect num point iq score found result studi food intervent aim benefici effect fish consumpt focus fish speci high dha content avoid fish speci high mehg content copyright num elsevi reserv
MED-3013~reduc stagger cost environment diseas children estim num billion num pubm ncbi abstract num analysi document num billion annual cost environment mediat diseas children import feder polici implement prevent exposur toxic chemic updat expand previous analysi found cost lead poison prenat methylmercuri exposur childhood cancer asthma intellectu disabl autism attent deficit hyperact disord num billion num prevent increas cost effort institut premarket test chemic conduct toxic test chemic reduc lead bas paint hazard curb mercuri emiss coal fir power plant
MED-3019~evid human health effect low level methylmercuri exposur abstract background methylmercuri mehg neuro toxic emerg evid advers effect neuro log bodi system common low level exposur impact mehg exposur vari individu suscept confound bene fici nutrient fish mehg global relev synthesi literatur low level mehg exposur limit object undertook synthesi current knowledg human health effect low level mehg exposur provid basi futur research effort risk assess exposur remedi polici worldwid data sourc extract review publish literatur origin human epidemio log research articl report direct biomark mercuri exposur focus high qual studi specif low mercuri exposur exclud case seri studi popul unusu high fish consumpt seychell marin mammal consumpt faro island circumpolar indigen popul consumpt high contamin fish gold min region amazon data synthesi recent evid rais possibl effect low level mehg exposur fetal growth suscept subgroup infant growth num year life low level effect mehg neuro log outcom differ age sex time exposur clear pattern observ cardio vascular diseas cvd risk popul specif cvd end point studi evalu immunolog effect mehg result inconsist conclus studi target identifi potenti mechan low level mehg effect character individu suscept sexual dimorph non linear dose respons guid futur prevent polici regulatori effort surround mehg exposur
MED-3020~analysi autopsi brain tissu infant prenat expos methymercuri pubm ncbi abstract brain num neonat autopsi seychell examin histolog analyz mercuri level brain region sampl frontal occipit cortex tempor cortex hippocampus basal ganglia thalamus cerebellum pon medulla tissu block histolog mercuri analysi oppos face provid correl find similar studi perform num refer neonat brain rochest york clear cut development abnorm found brain exhibit low grad non specif destruct total mercuri level organ form elev seychell specimen correl demonstr mercuri level degre type histolog chang variabl total mercuri anatom region num seychell case region individu brain valu total mercuri num ppb statist analysi mercuri level region demonstr higher valu deep subcort nuclei brain stem cerebellum phylogenet older part brain total mercuri concentr region pair area brain pair valu plot entir group brain high correl obtain brain pair suggest strong concentration depend relationship mercuri intak brain content analysi mercuri level separ dissect block grey white matter num specimen reveal signific differ grey white comparison human development studi experiment development studi anim toxic demonstr total mercuri brain level num ppb studi found evid toxic rang mercuri level num ppb submicroscop subcellular alter subtl disturb unfold brain architecton exclud method report studi threshold effect mehg fetal brain essenti approxim half mercuri resid glial element white matter reinforc focus attent glia neuron develop
MED-3021~hair to blood ratio biolog half lif mercuri experiment studi methylmercuri exposur fish consumpt human pubm ncbi abstract hair to blood ratio biolog half lif methylmercuri one compart model differ past recent studi reevalu num healthi volunt expos methylmercuri provision toler week intak num g kg bodi weight week adult fish consumpt num week num week washout period cessat exposur blood collect num num week hair cut num week total mercuri t hg concentr analyz blood hair t hg level blood hair chang time num concentr increas num ng g week num num ng g week num blood num num g g hair hair to blood ratio adjust time lag blood hair num num entir period half liv t hg calcul raw data num num day blood num num day hair half liv recalcul subtract background level raw data num num num num day conclus hair to blood ratio methylmercuri base past studi underestim light recent studi crude half lif prefer recalcul practic uncertainti background level half lif approxim convent
MED-3022~face methylmercuri poison pubm ncbi abstract methylmercuri mm potent neurotox agent role pollut environ document vast amount studi past decad final provid insight aspect effect exposur mm ingest poison fish inadvert misus grain treat poison fungicid major epidem occur japan fetal minamata diseas iraq pakistan guatemala ghana sporad incid occur unit state canada effect antidot counteract effect mm central nervous system inform document provid hope effect therapi acut case
MED-3023~relationship prenat exposur low level mercuri size newborn cerebellum pubm ncbi abstract exposur methylmercuri stage central nervous system develop induc alter result sever congenit abnorm total mercuri level matern hair pregnanc correl blood level methylmercuri total mercuri level fetal brain prospect studi conduct total num childbear women live coastal region term normal pregnanc includ newborn evalu ultrasonographi mother newborn divid group hair mercuri level examin group high bodi level mercuri num g g control group low bodi level mercuri num g g neurosonograph examin conduct newborn dimens cerebellum sagital medi plane measur maximum height width start roof fourth chamber major mother hair mercuri level lower num g g num num g g sd num rang num num g g signific differ group width cerebellum mann whitney test num num comparison relat length cerebellum show statist signific smaller cerebellum newborn mother hair mercuri level higher num g g mann whitney test num num result lead conclus prenat exposur low level methylmercuri influenc fetal brain develop detect decreas size newborn cerebellum clinic point view question relat influenc prenat low level methylmercuri exposur fetal neurodevelop remain open object direct research perform detail neuropshycholog test children age num month test presenc subtl neurolog neuropsycholog deficit copyright num elsevi reserv
MED-3024~dietari lipid modul methylmercuri toxic atlant salmon pubm ncbi abstract experi aim studi molecular toxic methylmercuri mehg liver brain white muscl atlant salmon fed diet base fish oil fo high dietari num num ratio compar altern diet base veget oil vo low dietari num num ratio juvenil salmon fed decontamin diet fo vo diet enrich num mg hg kg ad mehg month dietari lipid composit affect fatti acid composit tissu liver white muscl num day exposur liver accumul time mehg brain white muscl vitamin content heme oxygenas tubulin alpha tuba cpt num transcript level show signific effect mehg exposur liver tbar tocopherol tocopherol transcript level thioredoxin heme oxygenas tuba pparb num num num show effect dietari lipid composit liver tissu effect dietari lipid observ brain tissu mt a hif num bcl x tuba interact effect mehg exposur dietari lipid composit observ tissu data suggest dietari fat modul effect mehg toxic atlant salmon copyright num elsevi reserv
MED-3025~abnorm neuron migrat derang cerebr cortic organ diffus white matter astrocytosi human fetal brain major effect pubm ncbi abstract detail clinic neuropatholog studi made fullterm newborn human infant expos methylmercuri utero result matern ingest methylmercury contamin bread earli phase pregnanc high level mercuri detect region brain autopsi studi brain reveal disturb develop case consist essenti incomplet abnorm migrat neuron cerebellar cerebr cortic derang cortic organ cerebrum numer heterotop neuron isol group white matter cerebrum cerebellum laminar cortic pattern laminar cortic pattern cerebrum disturb region shown irregular group derang align cortic promin white matter cerebrum cerebellum diffus gemistocyt astrocytosi accompani accumul mercuri grain cytoplasm find high degre vulner human fetal brain matern intox methylmercuri major effect relat faulti develop destruct focal neuron damag observ mercuri intoxicaiton adult children expos postnat
MED-3026~dose respons relationship prenat mercuri exposur iq integr analysi epidemiolog data abstract background prenat exposur mercuri advers childhood neurolog outcom epidemiolog studi dose respons inform relationship estim benefit reduc mercuri exposur object estim dose respons relationship matern mercuri bodi burden subsequ childhood decrement intellig quotient iq bayesian hierarch model integr data epidemiolog studi method input model consist dose respons coeffici studi conduct faro island zealand seychell island iq coeffici previous work studi coeffici faro island studi estim iq subtest test cognition achiev includ hierarch model obtain accur estim study to studi end point end point variabl result find central estim num iq point num confid interv num num part million increas matern hair mercuri similar estim faro island seychell studi lower magnitud estim zealand studi sensit analys produc similar result iq coeffici central estim rang num num conclus iq end point estim neurodevelopment effect fulli repres cognit deficit mercuri exposur repres deficit relat attent motor skill integr iq coeffici robust descript dose respons relationship prenat mercuri exposur cognit function result singl studi
MED-3027~marin food pollut risk factor hypoinsulinemia type num diabet abstract background persist environment chemic suspect caus increas risk type num diabet mellitus diseas common age num concern examin cross sect studi elder subject popul elev contamin exposur seafood speci high food chain method clinic examin num faroes resid age num year num elig popul includ fast plasma concentr glucos insulin glycosyl hemoglobin lifetim exposur persist environment chemic pilot whale tradit food estim dietari questionnair analysi blood sampl polychlorin biphenyl pcbs relat food contamin result septuagenarian type num diabet impair fast glycemia tend higher pcb concentr higher past intak tradit food childhood adolesc non diabet subject fast insulin concentr decreas num ci num num doubl pcb concentr adjust sex bodi mass index age num convers fast glucos concentr increas num num num doubl pcb similar associ subject impair fast glycemia adjust current bodi mass index lipid metabol paramet attenu associ conclus impair insulin secret constitut import part type num diabet pathogenesi exposur persist lipophil food contamin
MED-3028~fish consumpt dietari long chain num fatti acid risk type num diabet abstract object evid associ fish consumpt dietari long chain num fatti acid risk type num diabet inconsist perform systemat review meta analysi prospect evid research design method studi identifi search pubm embas databas num decemb num review refer list retriev articl prospect studi includ report relat risk rr estim num cis associ fish consumpt and or dietari long chain num fatti acid incid type num diabet dose respons random effect model combin study specif rrs potenti sourc heterogen explor prespecifi stratif result sixteen studi involv num particip num diabet case includ statist heterogen summari estim part explain geograph differ serv week increment fish consumpt rrs num cis type num diabet num num num num num num num num num combin european asian australian studi num day increment long chain num fatti acid summari estim num num num num num num num num num conclus result meta analysi differ geograph region observ associ fish consumpt dietari intak long chain num fatti acid risk type num diabet heterogen result relationship warrant investig current public health recommend fish consumpt upheld unchang
MED-3029~fish eat perspect influenc fish consumpt choic abstract background divers perspect influenc fish consumpt choic object summar issu fish consumpt choic toxicolog nutrit ecolog econom point view identifi area overlap disagr viewpoint review effect previous fish consumpt advisori method review publish scientif literatur public health guidelin advisori relat fish consumpt focus advisori target popul conclus appli group similar fish consumpt pattern discuss combin matter relat fish consumpt fish consumpt pattern optim domain fish rich sourc protein nutrient contamin methylmercuri toxic higher fish intak lead greater toxic exposur stock wild fish adequ meet nutrient demand grow world popul fish consumpt choic broad econom impact fish industri guidanc account ecolog econom impact fish consumpt choic conclus relat lack inform integr health ecolog econom impact fish choic clear simpl guidanc effect desir comprehens advic develop describ multipl impact fish consumpt addit polici fisheri manag inter vent ensur long term avail fish import sourc human nutrit
MED-3030~nation advisori serv local consum assess mercuri econom import north carolina fish pubm ncbi abstract consumpt marin fish benefit lean protein omega num fatti acid essenti nutrient risk main sourc mercuri hg exposur human mercuri potent neurotoxin sourc fish advisori nationwid toxic widespread natur hg unknown local hg contamin reflect nation region level base inform consum potenti fish consumpt risk object studi examin hg level common consum marin speci harvest local north carolina coast compar result publish region monterey bay aquarium seafood watch list nation environment protect agenc epa food drug administr fda hg averag action level guidelin found signific differ hg concentr collect speci identifi correl hg concentr fish length trophic level collect mahi mahi triggerfish epa fish tissu action level num ppm wahoo grouper exceed epa action level fda action level num ppm king mackerel highest hg concentr target speci exceed epa fda action level local result consist calcul averag epa fda databas speci find consist monterey bay aquarium seafood watch list southeast region recommend base hg level conflict recommend provid base sustain find region nation averag reflect local hg contamin suggest local data accur assess consum risk
MED-3031~quantit synthesi mercuri commerci seafood implic exposur unit state abstract background mercuri hg toxic metal present public health risk fish consumpt major sourc uncertainti evalu harm exposur inadequ knowledg hg concentr commerci import seafood object examin pattern variabl knowledg gap hg common commerci seafood item unit state compar seafood hg concentr databas exposur estim consumpt advic method develop databas hg concentr fish shellfish common market aggreg data govern monitor program scientif literatur calcul grand individu seafood item base report individu studi weight sampl size compar databas result feder program human health criteria food drug administr hg monitor program fda mp environment protect agenc epa result hg concentr seafood item high variabl studi span num num order magnitud farm fish general lower grand hg concentr wild counterpart wild seafood num num fold higher concentr depend seafood item farm fish understudi specif seafood item seafood import asia south america final found larg discrep hg concentr estim databas fda mp estim seafood item examin conclus high variabl hg common seafood item ramif public health formul consumpt guidelin exposur risk analys deriv smaller data set reflect collect inform seafood hg concentr
MED-3032~associ matern long chain polyunsatur fatti acid methyl mercuri infant develop seychell child develop nutrit studi abstract fish consumpt gestat provid fetus long chain polyunsatur fatti acid lcpufa nutrient essenti growth develop brain fish consumpt expos fetus neurotoxic methyl mercuri mehg studi associ fetal exposur earli child develop seychell child develop nutrit studi scdns specif examin priori model num num lcpufa measur matern serum test hypothesi lcpufa famili adjust prenat mehg exposur reveal associ child develop assess bsid ii age num num month num children complet outcom covari data analysi num month pdi posit total num lcpufa negat ratio num num lcpufa associ stronger model adjust prenat mehg exposur secondari model suggest mehg effect num month vari ratio num num lcpufa signific associ lcpufa measur pdi num month signific advers associ prenat mehg num month pdi lcpufa measur includ regress analysi bsid ii mental development index mdi exposur variabl data support potenti import child develop prenat avail num lcpufa present fish lcpufa diet benefici effect lcpufa obscur determin advers effect prenat mehg exposur longitudin observ studi
MED-3033~smoke lung cancer risk american japanes men intern case control studi pubm ncbi abstract rate lung cancer american men great exceed japanes men decad higher smoke preval japanes men relat risk lung cancer cigarett smoke lower japanes men american men risk vari amount durat smoke estim smoking specif relat risk lung cancer men multicentr case control studi carri york citi washington dc nagoya japan num num total num case num age match control interview unit state hospit num case num hospit control japanes hospit num japanes age match healthi control random select elector roll odd ratio lung cancer current unit state smoker relat nonsmok num num confid interv ci num num num time higher num current smoker japanes relat hospit control num ci num num time higher japanes relat communiti control num num ci num num substanti differ number year smoke averag daili number cigarett smoke unit state japanes case unit state japanes control american case began smoke averag num year earlier japanes case risk lung cancer cigarett smoke substanti higher unit state japanes male consist population bas statist smoke preval lung cancer incid explan differ risk includ toxic cigarett formul american manufactur cigarett evidenc higher concentr tobacco specif nitrosamin tobacco mainstream smoke wider activ charcoal filter japanes american cigarett document differ genet suscept lifestyl factor smoke
MED-3034~awar knowledg methylmercuri fish unit state pubm ncbi abstract num state great lake region concern mercuri contamin lake river issu local fish consumpt advisori num food drug administr fda advis pregnant women nurs mother young children women pregnant consum shark swordfish king mackerel tilefish recommend women exceed num ounc fish week num fda reissu advic joint environment protect agenc epa modifi slight provid inform consumpt tuna detail consumpt recreat caught fish studi examin consum awar joint fda epa advisori state advisori repres data examin awar knowledg mercuri problem fish pool nation repres num num food safeti survey fss sampl size num num num num result increas consum awar mercuri problem fish num num num num num regress model found year parent children num year age awar mercuri fish knowledg inform nation advisori mercuri fish num adult num num women childbear age age num awar knowledg inform women women age group larger gain awar knowledg male counterpart time particip race educ incom region fish prepar experi foodborn ill past year risk percept safeti food signific predictor awar knowledg copyright num elsevi reserv
MED-3035~function mri approach development methylmercuri polychlorin biphenyl neurotox abstract prenat earli childhood exposur methylmercuri mehg polychlorin biphenyl pcbs deficit cognit sensori motor function measur neurobehavior test main object pilot studi determin function magnet reson imag fmri effect visual brain function alter relat neurobehavior subject high prenat exposur neurotoxic mehg pcbs twelv adolesc boy faroes birth cohort assembl num num recruit base prenat exposur mehg pcb underw fmri scan behavior task age num year subject high mix exposur mehg pcbs compar low mix exposur fmri photic stimul motor task boy low mix exposur show pattern fmri activ visual motor task typic normal control subject high exposur show activ area brain wider pattern activ low mix exposur group brain activ pattern observ associ increas exposur mehg pcbs meaning regard neurotox substanc methodolog potenti util visual structur neural system determin exposure induc neurobehavior dysfunct
MED-3038~effect naltrexon food intak subject appetit eat evid opioid involv appet effect pubm ncbi abstract effect num mg naltrexon eat subject appetit assess double blind placebo control studi num male volunt appetit monitor disguis digit balanc connect micro comput constant monitor amount food remain automat interrupt feed num num consum appetit rate made half subject ate pasta chees sauc remaind pasta tomato sauc subject ate signific food num mg naltrexon placebo condit initi familiaris day naltrexon reduc rate pleasant food reduc eat rate best fit quadrat function describ rate hunger relat intak meal naltrexon abolish posit linear compon reflect initi stimul appetit alter intercept negat quadrat function mood rate suggest naltrexon mild sedat effect mood explain effect naltrexon appetit data suggest specif role opioid stimul appetit palat
MED-3044~cue induc cocain crave neuroanatom specif drug user drug stimuli pubm ncbi abstract object cocaine rel cue hypothes perpetu drug abus induc crave respons prompt drug seek behavior mechan neuroanatomi specif neuroanatomi fulli understood method address issu experienc cocain user num comparison subject num underw function magnet reson imag view separ film portray num individu smoke crack cocain num outdoor natur scene num explicit sexual content candid crave site identifi show signific activ cocain user view cocain film site requir show signific greater activ contrast comparison subject view cocain film popul specif cocain user view natur film content specif result brain region satisfi criteria larg left includ frontal lobe medial middl frontal gyri bilater inferior frontal gyrus pariet lobe bilater inferior pariet lobul insula limbic lobe anterior posterior cingul gyrus num region identifi putat crave site anterior cingul inferior pariet lobul caudate later dorsal nucleus show signific greater activ cocain film sex film cocain user suggest cocain cue activ similar neuroanatom substrat natur evoc stimuli cocain user final contrari effect cocain film cocain user show smaller respons comparison subject sex film conclus data suggest cocain crave dedic uniqu neuroanatom circuitri uniqu cocain user abil learn drug rel cue produc brain activ compar nondrug evoc stimuli healthi comparison subject
MED-3046~brain activ reward process smoker nonsmok positron emiss tomographi studi pubm ncbi abstract tobacco smoke frequent form substanc abus studi shown addict action nicotin mediat mesolimb dopamin system system implic reward process order understand relationship nicotin addict reward human investig differ smoker nonsmok activ brain region involv process reward inform num positron emiss tomographi pet measur region cerebr blood flow rcbf healthi smoker nonsmok perform prelearn pattern recognit task compar condit involv nonmonetari reinforc monetari reward baselin condit nonsens feedback present monetari reward found activ frontal orbitofront cortex occipit cortex cingul gyrus cerebellum midbrain group addit monetari reward activ typic dopaminerg region striatum nonsmok smoker found similar pattern activ nonmonetari reinforc nonsmok activ found smoker cerebellum pattern activ suggest brain smoker react reward nonsmok differ involv region dopaminerg system includ striatum principl observ interpret consequ tobacco primit condit brain led peopl smoke support relat nonimag studi interpret differ consequ tobacco smoke short term effect smoke prior experi exclud
MED-3050~frequent ice cream consumpt reduc striatal respons receipt ice cream base milkshak abstract background weight gain lead reduc reward region respons energy dens food receipt consumpt energy dens diet compar isocalor low energy dens diet lead reduc dopamin receptor phasic dopamin signal palat food receipt decreas repeat intak food collect suggest frequent intak energy dens food reduc striatal respons receipt food object test hypothesi frequent ice cream consumpt reduc activ reward rel brain region striatum respons receipt ice cream base milkshak examin influenc adipos tissu specif relat design healthy weight adolesc num underw fmri receipt milkshak receipt tasteless solut percentag bodi fat report food intak food crave assess result milkshak receipt robust activ striatal region frequent ice cream consumpt reduc respons milkshak receipt reward rel brain region percentag bodi fat total energi intak percentag energi fat sugar intak energy dens food relat neural respons milkshak receipt conclus result provid evid frequent consumpt ice cream independ bodi fat relat reduct reward region respons human parallel toler observ drug addict data impli intak energy dens food result attenu reward region respons specif food suggest sensori aspect eat reward learn drive specif
MED-3051~function mri human hypothalam respons glucos ingest pubm ncbi abstract hypothalamus intim involv regul food intak integr multipl neural hormon signal hypothalam nuclei glucose sensit neuron play crucial role energi homeostasi function magnet reson imag fmri studi glucos consumpt effect neuron activ level hypothalamus matter investig extens instanc dose depend hypothalam respons glucos ingest address measur effect glucos load neuron activ level human hypothalamus fmri overnight fast hypothalamus num normal weight men scan continu num min num min subject ingest water glucos solut num num glucos observ prolong decreas fmri signal hypothalamus start short subject began drink glucos solut num min observ respons dose depend larger glucos load result larger signal decreas effect pronounc upper anterior hypothalamus upper posterior hypothalamus signal decreas similar glucos load effect found lower hypothalamus suggest relat observ hypothalam respons blood insulin concentr
MED-3052~obes addict neurobiolog overlap pubm ncbi abstract drug addict obes share properti defin disord salienc specif type reward food drug exagger relat expens reward drug food power reinforc effect part mediat abrupt dopamin increas brain reward centr abrupt dopamin increas vulner individu overrid brain homeostat control mechan parallel generat interest understand share vulner addict obes predict engend heat debat specif brain imag studi begin uncov common featur condit delin overlap brain circuit dysfunct underli observ deficit combin result suggest obes drug addict individu suffer impair dopaminerg pathway regul neuron system reward sensit incent motiv condit self control stress reactiv interocept awar parallel studi delin differ centr key role peripher signal involv homeostat control exert food intak focus share neurobiolog substrat obes addict num author obes review num intern associ studi obes
MED-3053~fat intak modul cerebr blood flow homeostat gustatori brain area human pubm ncbi abstract background hypothalamus central homeostat control region brain high influenc nutrient glucos fat prolong homeostat effect glucos ingest character studi stimul fat investig percept process homeostat process gustatori cortex includ part insular cortex crucial process food item object aim studi investig effect high compar low fat meal hypothalamus insular cortex design eleven healthi men particip single blind function mri studi high low fat meal num measur day cerebr blood flow cbf measur num num min intak high low fat yogurt hunger rate blood sampl cbf measur result high fat yogurt induc pronounc decreas cbf hypothalamus cbf chang correl posit insulin chang insular activ increas num min low fat condit cbf chang region correl posit high fat condit conclus decreas hypothalam activ interact insular cortex elicit fat contribut effici energi homeostasi fat modul homeostat gustatori brain region interact trial regist clinicaltri gov nct num
MED-3054~food addict exist phenomenolog discuss base psychiatr classif substance rel disord addict pubm ncbi abstract relationship substanc abus behavior addict controversi medic establish form addict pertain substanc disord preliminari diagnost statist manual mental disord dsm suggest replac previous categori substance rel disord addict relat disord time diagnosi behavior addict past psychiatrist psychologist reluct systemat delin classifi term behavior addict broad overlap chemic behavior addict includ phenomenolog therapeut genet neurobiolog aspect interest point hormon leptin pronounc effect reward system suggest indirect link chemic addict leptin defici individu classifi fulfil criteria food addict overview review psycholog find chemic substance bas subsequ behavior addict analyz overlap discuss diagnost valid food addict theori chemic and or behavior base copyright num karger gmbh freiburg
MED-3055~food drug reward overlap circuit human obes addict pubm ncbi abstract drug addict obes defin disord salienc type reward drug food abnorm enhanc relat expens model consist fact drug food power reinforc effects part mediat dopamin increas limbic system that circumst vulner individu overwhelm brain homeostat control mechan parallel generat signific interest understand share vulner trajectori addict obes brain imag discoveri start uncov common featur condit delin overlap brain circuit dysfunct explain stereotyp relat behavior deficit human subject result suggest obes drug addict individu suffer impair dopaminerg pathway regul neuron system reward sensit incent motiv condit memory learn impuls control behaviour inhibit stress reactiv interocept awar integr find predomin deriv positron emiss tomographi shed light role dopamin drug addict obes propos updat work model identifi treatment strategi benefit condit
MED-3056~opioid system food intak homeostat hedon mechan pubm ncbi abstract opioid import reward process lead addict behavior self administr opioid drug abus includ nicotin alcohol opioid involv broad distribut neural network regul eat behavior affect homeostat hedon mechan sens opioid implic modul high palat food opioid antagonist attenu addict drug appetit palat food crave palat food consid form opioid rel addict main famili opioid receptor receptor strong implic reward administr select agonist nacc rodent induc feed satiat anim administr antagonist reduc food intak pharmacolog studi suggest role opioid receptor preliminari data transgen knockout model suggest mice lack receptor resist high fat diet induc obes copyright num karger gmbh freiburg
MED-3057~brain pet imag obes food addict current evid hypothesi pubm ncbi abstract ongo epidem obes main health concern present time obes individu share similar loss control compuls behavior observ drug addict subject suggest obes involv food addict review contribut provid positron emiss tomographi current understand cerebr control obes food intak human studi shown multipl area brain involv reward properti food prefront orbitofront somatosensori cortic insula thalamus hypothalamus amygdala review summar current evid support concept region involv somatosensori respons food sight tast smell activ palat food hyperrespons obes individu ii area control execut drive overreact anticip pleasur cue exposur iii involv cognit control inhibitori behavior resist percept reward food exposur obes subject featur stimul reason ingest high palat energy rich food region similar involv drug abus game addict individu direct resembl oversimplif heterogen studi preval exclus sensit group limit coher interpret find work requir comprehens tackl multifacet phenotyp obes identifi role food depend pathophysiolog copyright num karger gmbh freiburg
MED-3058~implic addict research understand treatment obes pubm ncbi abstract recent research similar obes addict disord phenomenolog neurobiolog level neuroendocrin imag studi suggest close link homeostat regul appetit hand motiv reward expect addit find neuropsycholog studi addit demonstr alter cognit function obes addict disord possibl contribut lack control resist consumpt review recent find overlap neurobiolog phenomenolog pathway summar impact regard treatment approach obes discuss num author addict biolog num societi studi addict
MED-3059~brain function magnet reson imag respons glucos fructos infus human pubm ncbi abstract aim anim intracerebroventricular glucos fructos oppos effect appetit weight regul human function brain magnet reson imag fmri studi glucos ingest infus demonstr suppress hypothalam signal studi compar effect glucos fructos sought determin brain respons differ glucos fructos human independ ingest process method healthi normal weight subject underw blood oxygen level depend bold fmri measur intraven iv glucos num mg kg fructos num mg kg salin administ num min random double blind crossov studi blood sampl num min baselin period infus num min total glucos fructos lactat insulin level result signific brain bold signal detect respons iv salin bold signal cortic control area increas glucos infus num increas plasma glucos insulin level contrast bold signal decreas cortic control area fructos infus num increas plasma fructos lactat glucos fructos infus signific alter bold signal hypothalamus conclus normal weight human cortic respons assess bold fmri infus glucos opposit fructos differenti brain respons sugar metabolit provid insight neurolog basi dysregul food intak high dietari fructos intak num blackwel publish
MED-3060~neural correl food addict abstract context research implic addict process develop mainten obes parallel neural function obes substanc depend found studi examin neural correl addictive lik eat behavior object test hypothesi elev food addict score similar pattern neural activ substanc depend design between subject fmri studi particip forty eight healthi adolesc femal rang lean obes recruit healthi weight mainten trial main outcom measur relat elev food addict score blood oxygen level depend fmri activ respons receipt anticip receipt palat food chocol milkshak result food addict score num correl greater activ anterior cingul cortex acc medial orbitofront cortex ofc amygdala respons anticip receipt food num false discoveri rate fdr correct multipl comparison small volum particip higher num versus lower num food addict score show greater activ dorsolater prefront cortex dlpfc caudat respons anticip receipt food activ ofc respons receipt food pfdr num conclus similar pattern neural activ implic addictive lik eat behavior substanc depend elev activ reward circuitri respons food cue reduc activ inhibitori region respons food intak
MED-3085~preval phosphorus food addit top sell food groceri store abstract object determin preval phosphorus contain food addit sell process groceri product compar phosphorus content subset top sell food phosphorus addit design label num sell brand groceri product northeast ohio review phosphorus addit top num sell product phosphorus addit food categori match similar product phosphorus addit analyz phosphorus content day sampl meal consist food phosphorus addit creat daili phosphorus price differenti comput set northeast ohio main outcom measur presenc phosphorus contain food addit phosphorus content result num sell groceri item phosphorus addit addit common prepar frozen food num dri food mix num packag meat num bread bake good num soup num yogurt num categori phosphorus addit food averag num mg phosphorus num gm match non addit food num sampl meal compris phosphorus additive contain food num mg phosphorus day compar meal consist additive fre food phosphorus additive fre meal cost averag num day conclus phosphorus addit common sell process groceri contribut signific phosphorus content phosphorus addit food cost phosphorus additive fre food result person chronic kidney diseas purchas popular low cost groceri unknow increas intak high bioavail phosphorus
MED-3086~effect polyphosph addit campylobact surviv process chicken exud abstract campylobact spp respons larg number bacteri food poison case worldwid sensit oxygen nutrit fastidi campylobact spp surviv food process environ reach consum suffici number diseas investig campylobact persist process chicken exud chicken produc consum sale collect steril type exud chicken product collect enhanc marinad ad chicken process nonenhanc addit ad process exud enhanc chicken product examin studi mixtur polyphosph exud sampl inocul campylobact jejuni campylobact coli strain incub rang environment condit viabl bacteria present result cultur enumer incub num microaerob environ exud enhanc chicken product result increas surviv jejuni coli compar nonenhanc exud rang num num log cfu ml relev food storag condit num normal atmospher exud enhanc chicken product demonstr improv campylobact surviv compar nonenhanc exud polyphosph present enhanc exud determin larg respons improv surviv observ type exud compar polyphosph enhanc chicken qualiti aid sustain number campylobact bacteria increas opportun diseas cross contamin improp cook poultri
MED-3087~preval public health signific aluminum residu milk dairi product pubm ncbi abstract sixti random sampl bulk farm milk market milk local manufactur process chees milk powder collect analyz aluminum al concentr graphit furnac atom absorpt spectrometri gfaa result compar provision accept permiss limit papl maximum estim dietari intak medi al examin sampl calcul addit experiment studi conduct determin leach al cookwar milk boil obtain result show al concentr examin bulk farm milk sampl found neglig contrast market milk reveal higher concentr num examin sampl papl result reveal signific differ al concentr al level process chees wrap al foil signific higher found sampl pack glass signific differ al concentr num examin milk powder sampl exceed papl num num mg kg medi al bulk farm milk control market milk market milk boil al cookwar market milk boil stainless steel cookwar process chees wrap al foil process chees pack glass milk powder calcul num num num num num num num ptdi result experiment studi show mark signific differ al concentr market milk control group boil al cookwar boil stainless steel cookwar practic applic result present studi al level milk al dairi product pack al foil permiss limit suggest health hazard milk construct stainless steel prevent entranc tap water milk process chees pack glass wrap al foil leach al increas signific percent storag boil milk stainless steel glass refriger
MED-3088~hidden sourc phosphorus typic american diet matter nephrolog pubm ncbi abstract elev serum phosphorus major prevent etiolog factor increas cardiovascular morbid mortal dialysi patient import determin serum phosphorus dietari intak miner make dietari restrict phosphorus cornerston prevent treatment hyperphosphatemia averag daili dietari intak phosphorus num mg male num mg femal general food high protein high phosphorus figur chang phosphat ad larg number process food includ meat chees dress beverag bakeri product result depend food choic addit increas phosphorus intak num g day nutrient composit tabl includ phosphorus addit result underestim dietari intak phosphorus patient goal convey understand phosphorus content current american diet equip nephrologist attempt control hyperphosphatemia
MED-3089~phosphorus food addit accuraci nutrient databas implic renal patient abstract object phosphorus addit increas ad food product sought determin potenti impact addit focus chicken product method purchas varieti chicken product prepar packag direct perform laboratori analys determin actual phosphorus content esha food processor sql softwar determin expect phosphorus content product result num chicken product num phosphorus addit list ingredi categori chicken product addit actual phosphorus content greater content expect nutrient databas actual phosphorus content exceed expect phosphorus content averag num mg num bread breast strip great deal variat categori differ actual expect phosphorus content rang num num mg num breast patti num serv addit product averag num mg phosphorus half total daili recommend intak dialysi patient conclus phosphorus addit signific increas amount phosphorus chicken product nutrient databas reflect higher phosphorus content variat similar product make imposs patient dietitian accur estim phosphorus content recommend dialysi patient limit intak addit product phosphorus content food product includ nutrit fact label
MED-3090~phosphat addit food health risk abstract background hyperphosphatemia identifi past decad strong predictor mortal advanc chronic kidney diseas ckd studi patient stage ckd num annual mortal num reveal num death group attribut elev serum phosphat concentr recent high norm serum phosphat concentr found independ predictor cardiovascular event mortal general popul phosphat addit food matter concern potenti impact health underappreci method review pertin literatur retriev select search pubm eu databas www zusatzstoffe onlin de www codexalimentarius de search term phosphat addit hyperphosphatemia result lower content natur phosphat organ ester food type phosphat incomplet absorb restrict intak lead protein malnutrit hand inorgan phosphat food addit effect absorb measur elev serum phosphat concentr patient advanc ckd food ad phosphat tend eaten person lower end socioeconom scale consum process fast food main pathophysiolog effect phosphat vascular damag endotheli dysfunct vascular calcif qualiti phosphat diet requir attent quantiti phosphat consum patient advanc renal failur exceed num mg day guidelin conclus prospect control trial unavail view high preval ckd potenti harm caus phosphat addit food public inform ad phosphat damag health call label content ad phosphat food
MED-3091~lack awar futur medic profession risk consum hidden phosphate contain process food drink abstract phosphat toxic import determin mortal patient chronic kidney diseas ckd undergo hemodialysi treatment ckd patient advis low phosphate contain diet addit prescrib phosphate low drug patient seek guidanc physician nurs dietari option conduct survey determin level awar high phosphat content commerci process food drink medic nurs student hirosaki univers school medicin japan survey num medic nurs student averag age num num year random select provid list question aim evalu awar food drink artifici ad phosphat ingredi num student awar presenc sugar commerci soda drink num awar presenc phosphat phosphor acid similar num student awar presenc phosphat commerci process food hamburg pizza survey student num unawar harm effect unrestrict consumpt phosphate contain food drink num survey student consum fast food week num drink num num soda drinks week realiz potenti long term risk consum excess phosphate contain food drink num survey particip consid reduc phosphat intak minim consumpt commerci process fast food item soda drink num student show interest obtain inform negat health effect consum excess amount phosphat survey emphas educ initi rais awar health risk pose excess consumpt phosphat addit
MED-3092~extra phosph load food addit common eaten food real insidi danger renal patient pubm ncbi abstract background restrict dietari phosphorus major aspect patient care renal diseas restrict dietari phosphorus control phosphat balanc conserv therapi dialysi treatment extra amount phosphorus consum result phosphate contain food addit real challeng patient renal diseas dietician repres hidden phosphat load object studi measur phosphorus content food common protein sourc compris includ list phosphat addit method determin dri matter nitrogen total solubl phosphat ion carri num sampl food cook ham roast breast turkey roast breast chicken num declar phosphat addit num similar item addit result total phosphorus num num mg num num num mg num num solubl phosphorus num num mg num num num mg num num content higher product addit food addit differ detect num group dri matter num num num num num num total nitrogen num num num num num num phosphorus intak gram protein greater food phosphorus addit num num mg g num num mg g num conclus result show food phosphat addit phosphorus content num higher sampl addit creat special concern extra amount phosphorus complet absorb intestin tract hidden phosphat worsen phosphat balanc control increas phosphat binder relat cost inform educ program essenti make patient renal diseas awar exist food phosphat addit fact highlight nation intern author devot attent food label report amount natur ad phosphorus copyright num nation kidney foundat publish elsevi reserv
MED-3093~dietari phosphorus restrict dialysi patient potenti impact process meat poultri fish product protein sourc pubm ncbi abstract background dietari intak phosphorus deriv larg protein sourc critic determin phosphorus balanc patient chronic kidney diseas inform phosphorus content prepar food general unavail believ contribut signific phosphorus burden patient chronic kidney diseas design analysi dietari compon set measur phosphorus content num food product includ num refriger frozen precook meat poultri fish item general nation brand outcom measur report phosphorus content food measur phosphorus associ analyt communiti offici method num protein associ analyt communiti offici method num result found ratio phosphorus protein content item rang num num mg phosphorus num protein ratio num food product label list phosphorus addit num mg g compar num mg g num item list phosphorus phosphorus content num precook food product wide dietari databas limit result extrapol product manufactur alter phosphorus content food time protein content direct measur food conclus report phosphorus content food manufactur result improv dietari phosphorus control risk protein malnutrit
MED-3094~descript sensori analysi broiler breast fillet marin phosphat salt acid solut pubm ncbi abstract sensori attribut fulli age broiler breast fillet marin num nacl solut num sodium tripolyphosph num num citric acid num num acet acid num num citric acid num phosphat solut num num acet acid solut num phosphat num studi num nacl num solut addit control oven cook sampl num degre oven num degre intern temperatur evalu num member train descript analysi sensori panel rate intens num flavor textur attribut num point line scale data analyz general linear model sas procedur determin signific differ num individu sensori attribut due marinad treatment sensori attribut score low intens rang num num brothi vinegar residu particl individu attribut rate signific num due treatment multivari analys sensori attribut form num dimens explain num variat data low intens valu textur attribut negat consequ due phosphat salt acid fulli age fillet
MED-3095~effect polyphosph addit ph process chicken exud surviv campylobact pubm ncbi abstract campylobact spp nutrit fastidi organ sensit normal atmospher oxygen level lack homologu common cold shock gene glanc bacteria ill equip persist food product process storag condit surviv number suffici largest number foodborn bacteri diseas annual mechan propos play role campylobact surviv addit polyphosphate contain marinad poultri process campylobact jejuni campylobact coli strain incub chicken exud collect poultri treat marinad demonstr surviv advantag num num log cfu ml strain incub chicken exud untreat bird polyphosph constitut larg portion commerci poultri marinad shown account major observ influenc marinad campylobact surviv food grade polyphosph disodium pyrophosph tetrasodium pyrophosph pentasodium triphosph sodium polyphosph monosodium phosphat trisodium phosphat util compar surviv campylobact strain chicken exud signific differ observ regard campylobact surviv polyphosph determin addit polyphosph chicken exud increas ph exud sodiat polyphosph increas ph greater degre sodiat polyphosph confirm chang ph mediat polyphosph respons observ increas campylobact surviv
MED-3096~origin articl phosphorus potassium content enhanc meat poultri product implic patient receiv dialysi abstract background object uncook meat poultri product common enhanc food processor phosphat salt addit potassium phosphorus food recogn quantifi design set particip measur measur phosphorus potassium protein content num uncook meat poultri product phosphorus associ analyt communiti aoac offici method num potassium aoac offici method num protein aoac offici method num result product report addit averag phosphate protein ratio num higher addit free product content rang num higher potassium content food addit vari wide addit free product num mg num num product addit num mg num maximum num mg num food phosphat potassium addit report addit unquantifi label num enhanc product list addit result appli product composit food addit food processor chang time conclus uncook meat poultri product enhanc addit increas phosphorus potassium content three fold modif discern inspect food label
MED-3098~camel urin inhibit cytochrom num num gene express ahr depend mechan hepa num num cell line pubm ncbi abstract aim studi drink camel urin tradit treat numer case cancer exact mechan investig examin abil camel urin virgin lactat pregnant sourc modul well known cancer activ enzym cytochrom num num cyp num murin hepatoma hepa num num cell line materi method effect camel urin compar bovin urin cyp num mrna determin real tim polymeras chain reaction cyp num protein catalyt activ level determin western blot analysi num ethoxyresorufin substrat role aryl hydrocarbon receptor ahr depend mechan determin electrophoret mobil shift assay emsa ahr depend luciferas report gene result type camel bovin urin differenti inhibit induct cyp num gene express tcdd potent cyp num induc carcinogen chemic import virgin camel urin show highest degre inhibit activ level lactat pregnant camel urin shown virgin camel urin signific inhibit tcdd mediat induct cyp num mrna protein express level mechanist abil virgin camel urin inhibit cyp num strong correl abil inhibit ahr depend luciferas activ dna bind determin emsa suggest ahr depend mechan involv conclus present work evid camel urin bovin inhibit tcdd mediat toxic effect inhibit express cyp num transcript post transcript level ahr depend mechan copyright num elsevi ireland reserv
MED-3099~aryl hydrocarbon receptor xenobiot ligand fundament trigger cardiovascular diseas pubm ncbi abstract review reconsid major cardiovascular diseas tobacco smoke activ aryl hydrocarbon receptor ahr dioxin receptor aryl hydrocarbon tar fraction tobacco organ cardiovascular domain concept shed light well known albeit controversi epidemiolog concept mediterranean diet french paradox review discoveri resveratrol natur ahr antagonist interest prevent treatment cardiovascular diseas
MED-3100~flavon flavonol dietari level inhibit transform aryl hydrocarbon receptor induc dioxin pubm ncbi abstract dioxin invad bodi diet produc toxic transform aryl hydrocarbon receptor ahr inhibitor transform protect toxic ideal part diet examin flavonoid ubiquit express plant food candid found subclass flavon flavonol suppress antagonist transform ahr induc num nm num num tetrachlorodibenzo p dioxin exhibit agonist effect transform ahr antagonist ic num valu rang num num microm close physiolog level human
MED-3102~updat dietari ligand ahr pubm ncbi abstract background halogen aromat hydrocarbon includ dioxin non halogen polycycl aromat hydrocarbon ligand aryl hydrocarbon receptor ahr stimul transform exposur environment contamin occur diet recent articl demonstr food factor regul ahr transform express downstream drug metabol enzym object explain action food factor ahr transform mechan fulli understood method review introduc recent articl demonstr molecular mechan food factor regul ahr transform downstream drug metabol enzym results conclus role classic ligand includ dioxin agonist receptor document food factor act antagonist basic suppress ahr transform mechan fate metabol food factor import understand mechan
MED-3103~intraepitheli lymphocyt serv protect abstract mucos immun system constant expos wide rang commens potenti pathogen microbi speci chronic exposur foreign organ make generat immun respons critic maintain balanc elimin harm pathogen peac coexist commens prevent autoimmun intestin intraepitheli lymphocyt provid line defens extens barrier world understand role immun critic
MED-3105~start begin perspect biolog mucos cell pubm ncbi abstract gastrointestin tract central organ uptak fluid nutrient time form main protect barrier steril environ bodi world mammal intestin evolv harbor vast load commens bacteria import function host discrimin host defens system nonself prevent invas pathogen equival respons dietari colon bacteria lead devast consequ organ dilemma impos gut environ contribut signific evolutionari drive led sophist mechan diversif immun system protect maintain integr mucos barrier immens expans special immun system mirror phylogeni ontogeni organ regul adapt intraepitheli lymphocyt iel key player uniqu intestin defens mechan evolv mammal
MED-3106~aryl hydrocarbon receptor inflammatori bowel diseas link environ diseas pathogenesi pubm ncbi abstract purpos review aryl hydrocarbon receptor ahr transcript factor activ larg number environment agent modul activ immun nonimmun cell gut repres import link environ immun perturb underli pathogenesi inflammatori bowel diseas review summar current knowledg role ahr regul intestin immun homeostasi inflamm recent find activ ahr dietari ligand mainten expans innat immun cell gut intraepitheli lymphocyt iel interleukin il num produc lymphoid cell ilc num ahr defici mice lack iel reduc number ilc num cell suscept bacteri infect experiment coliti anim model ahr activ inhibit proinflammatori cytokin synthesi attenu coliti pathway involv il num analysi ahr human gut reveal intestin cell natur killer cell isol crohn diseas patient express low level ahr respond ahr ligand downregul inflammatori cytokin upregul il num summari find explain environment factor regul mucos immun respons
MED-3107~iel enforc law order court intestin epithelium pubm ncbi abstract intestin intraepitheli lymphocyt iel cell dispers singl cell epitheli cell layer surround intestin lumen iel strateg locat interfac antigen rich world steril core bodi intestin higher vertebr evolv harbor numer commens bacteria carri import function host defens immun effect protect invas pathogen similar immun reaction food deriv antigen harmless colon bacteria result unnecessari damag immun respons result uniqu dilemma impos gut environ multipl subset iel differenti display characterist activ rest immun cell common featur iel heterogen regard phenotyp ontogeni function review discuss subtyp iel highlight distinct pathway led uniqu differenti high special effector memori cell provid effect immun protect strict regul fashion preserv integr vital function intestin mucos epithelium
MED-3108~epitheli barrier biolog good fenc make good neighbour abstract extern surfac bodi skin gastrointestin mucos membran import line defenc prevent invas microorgan product mucos immun cell intraepitheli lymphocyt involv maintain integr epitheli barrier contribut toler commens organ occupi site immun respons harm organ product composit microbiota influenc immun cell extern environment factor antibiot diet increas appreci microbiota affect system immun respons addit local immun failur control occup microorgan result disrupt delic homeostasi benefici harm microorgan contribut inflammatori patholog review discuss current understand impact immun cell diet microbiota
MED-3109~ahr eat link diet immun pubm ncbi abstract aryl hydrocarbon receptor ahr respons toxic effect environment pollut dioxin normal physiolog function li al num show specif dietari compound present crucifer veget act ahr promot intestin immun function reveal ahr critic link diet immun copyright num elsevi reserv
MED-3110~aryl hydrocarbon receptor ahr activ pharmaceut select ahr modul mda mb num bt num breast cancer cell abstract leflunomid flutamid nimodipin mexiletin sulindac tranilast num hydroxytamoxifen omeprazol pharmaceut previous character aryl hydrocarbon receptor ahr agonist cell line anim model studi ahr act pharmaceut investig high aggress aryl hydrocarbon ah respons bt num mda mb num breast cancer cell line effect ahr protein cyp num protein mrna cyp num mrna cell migrat determin num num tetrachlorodibenzo p dioxin tcdd posit control ahr agonist activ pharmaceut depend structur respons cell context compound induc ahr medi respons bt num cell ah respons mda mb num cell effect ahr act pharmaceut high variabl num hydroxytamoxifen mexiletin tranilast induc cyp num mda mb num cell combin tcdd mexiletin potent ahr antagonist tranilast partial antagonist num hydroxytamoxifen exhibit ahr antagonist activ omeprazol lesser extent sulindac leflunomid full partial ahr agonist breast cancer cell line data ahr act pharmaceut select ahr modul applic drug target ahr confirm studi relev cell context
MED-3111~light dark side intestin intraepitheli lymphocyt abstract intraepitheli lymphocyt iel resid epithelium intestin form main branch immun system iel locat critic interfac core bodi environ balanc protect immun abil safeguard integr epitheli barrier failur compromis homeostasi organ review address uniqu develop function intestin iel achiev balanc
MED-3112~biolog function aryl hydrocarbon receptor report intern interdisciplinari confer pubm ncbi abstract aryl hydrocarbon receptor ahr ligand activ transcript factor present cell ahr link environment chemic stimuli adapt respons detoxif cellular homoeostasi immun respons role ahr physiolog genet function discov report recent meet sseldorf meet highlight ahr research move focus toxic effect dioxin environment pollut biolog role instanc recent discov ahr respons element retrotransposon contribut function structur genom excit report concern plant deriv compound diet fulli function immun system gut human brain tumour ahr system gain growth advantag aspect cover neurotoxicolog circadian rhythm breadth adapt innat immun system hematopoiet stem cell dendrit cell cell mast cell final meet dealt discoveri xenobiot natur ligand translat medicin cancer biolog ahr
MED-3113~emerg lifestyl medicin structur approach manag chronic diseas pubm ncbi abstract chronic diseas lifestyle bas aetiolog make signific proport primari care consult manag fall demand public clinic health modifi clinic approach base concept lifestyl medicin fill gap ad behaviour motiv environment skill convent medic practic multidisciplinari set lifestyl medicin offer potenti cost effect benefit begin realis
MED-3123~dietcomplyf studi prospect cohort studi breast cancer surviv phytoestrogen consumpt pubm ncbi abstract dietcomplyf multi centr prospect studi design investig associ phytoestrogen natur occur plant compound oestrogen properti diet lifestyl factor breast cancer recurr surviv num women grade i iii breast cancer recruit num month post diagnosi num uk hospit detail inform clinico patholog diet lifestyl qualiti life collect annual num year biolog sampl collect resourc subsequ evalu characterist patient associ pre diagnosi intak phytoestrogen isoflavon lignan assess epic norfolk uk num question food frequenc questionnair breast cancer risk factor ii prognost factor num women complet data covari phytoestrogen interest isoflavon intak higher patient younger diagnosi non smok breast f supplement lignan intak higher patient higher age diagnosi ex smok breast f supplement lower bmi diagnosi lower age menarch nullipar signific associ pre diagnosi phytoestrogen intak factor improv breast cancer prognosi observ potenti explor relationship phytoestrogen breast cancer recurr surviv establish evid improv dietari lifestyl advic offer patient breast cancer diagnosi dietcomplyf data discuss copyright num elsevi ireland reserv
MED-3127~studi soy isoflavon consumpt risk breast cancer surviv pubm ncbi abstract aim isoflavon soy food part larger class flayonoid compound demonstr potent dietari anti canc agent effect soy intak surviv ovarian cancer conflict aim explor soy intak relat risk death breast cancer method prospect studi conduct total num patient includ studi breast cancer recruit januari num januari num januari num univari cox regress analysi assess associ soy intak surviv result educ level menopaus status er pr status tnm stage signific differ surviv breast cancer highest soy isoflavon decreas death risk breast cancer num num ci num num higher consumpt soy protein present trend decreas breast cancer risk highest consumpt signific reduc cancer risk compar lowest consumpt num num ci num num conclus present studi suggest soy intak signific reduc death risk breast cancer chines popul larg sampl studi warrant confirm invers associ soy consumpt breast cancer surviv menopaus status
MED-3129~brca num methyl sporad breast cancer brca lik show basal phenotyp absenc er express pubm ncbi abstract brca num mutat hereditari breast cancer recent studi subgroup sporad breast cancer reduct brca num mrna level protein express mechan reduc mrna protein express fulli elucid studi aim assess brca num protein express role brca num promot methyl sporad breast cancer north indian popul correl prognost factor molecular profil breast cancer brca num protein express normal num tumour cell num case reduc num tumour cell num case absent mark reduc num tumour cell num num case case negat brca num protein frequent posit basal marker num versus num er neg num versus num brca num posit tumour methyl brca num promot region num case num num case show brca num methyl absent case reduc case brca num protein express brca num protein neg tumour frequent basal marker posit er neg highlight brcaness sporad breast cancer loss brca num protein express promot hypermethyl similar hereditari breast cancer brca num mutat loss brca num sporad breast cancer suggest therapeut target brca num pathway hereditari breast cancer parp inhibitor therapeut target sporad breast tumour
MED-3130~soy phytoestrogen decreas dna methyl brca num brca num oncosuppressor gene breast cancer pubm ncbi abstract soy phytoestrogen postul exert protect effect breast cancer attend mechan epigenet underpin remain elus investig putat effect dna methyl natur occur isoflavon genistein daidzein studi brca num brca num oncosuppressor gene breast cancer cell line mcf num mda mb num mcf num demethyl agent num azacytidin methyl budesonid treatment control dna methyl brca num brca num investig methyl dna immunoprecipit coupl pcr parallel protein express determin western blot immunohistochemistri confoc microscopi result suggest treatment num genistein num daidzein revers dna hypermethyl restor express oncosuppressor gene brca num brca num azacitydin enhanc reexpress gene budesonid opposit effect knowledg observ requir replic provid evid potenti epigenet mechan genistein daidzein contribut regul brca num brca num futur studi warrant demethyl effect genistein daidzein global focus select candid gene
MED-3132~legum promot counsel e mail survey dietitian pubm ncbi abstract dietitian current practic counsel client legum low fat high fibr diet exploratori e mail questionnair member dietitian canada assess dietitian prefer legum dietitian practic opinion client attitud prefer resourc counsellor num high person legum num num serving week frequent recommend legum counsel legum prefer respond client peanut kidney bean split pea chickpea lentil respond recommend bean product num tofu num legum groceri product recommend common client issu identifi flatul num agre lack familiar num knowledg prepar num dietitian satisfi current resourc support practic respond provid primarili clinic counsel servic request resourc recip num pamphlet num food demonstr num internet site num client level research confirm import issu identifi develop test strategi legum promot counsel
MED-3135~cpg island tumor suppressor promot methyl non brca associ earli mammari carcinogenesi abstract background num breast cancer result brca num mutat methyl silenc tumor suppressor gene sporad breast cancer role famili breast cancer method cpg island promot methyl test initi random periareolar fine needl aspir sampl num asymptomat women high risk breast cancer promot methyl target includ rarb num num esr num ink num arf brca num pra prb rassf num hin num crbp num result frequenc cpg island promot methyl event increas age num specif methyl event age contrast cpg island methyl rarb num num ink num arf num hin num num pra num frequenc methyl event num abnorm masood cytolog associ promot methyl famili breast cancer test num unaffect premenopaus women cohort underw brca num mutat test women brca num mutat low frequenc cpg island promot methyl num num women num methyl event women mutat show high frequenc promot methyl event num num women num methyl event num women brca num mutat show methyl hin num num num women show cpg island methyl rarb num ink num arf prb promot conclus evid cpg island methyl tumor suppressor gene promot non brca num famili breast cancer
MED-3136~influenc frequent long term bean consumpt colon function ferment pubm ncbi abstract object studi determin influenc frequent long term consumpt legum seed colon function group subject studied  on group habitu consum legum seed part normal diet group infrequ consum legum differ group detect fecal output frequenc intestin transit time vfa excret fecal ph num day studi period subject consum usual diet num red kidney bean daili addit bean diet group provid signific dietari fiber produc greater fecal output higher concentr vfa fece fecal output determin independ parameters  dietari fiber intak vfa excret bean provid physiolog sourc dietari fiber favor influenc colon function
MED-3137~american meet feder dietari recommend abstract longstand goal dietari surveil estim proport popul intak target recommend level intak statist method assess align food intak recommend lack purpos studi demonstr nation cancer institut method estim distribut usual intak food determin proport popul meet feder dietari recommend data obtain num num nhane num person age num older quantiti food report num recal translat amount food group mypyramid equival databas usual dietari intak distribut model account sequenc effect weekend weekday effect sex age poverti incom ratio race ethn major popul meet recommend nutrient rich food group total grain meat bean concomit overconsumpt energi solid fat ad sugar alcohol beverag empti calori ubiquit num person age num num sex ag group intak empti calori exceed discretionari calori conclus entir popul consum diet par recommend find add piec disturb pictur emerg nation diet crisi
MED-3138~percept flatul bean consumpt adult num feed studi abstract background consum avoid eat bean legum consumpt excess intestin gas flatul increas bodi research num dietari guidelin american support benefit plant bas diet legum specif reduct chronic diseas risk purpos current research investig percept increas flatul gastrointestin discomfort particip consum cup bean daili num num week method particip studi test effect bean heart diseas biomark complet week questionnair assess gastrointestin discomfort issu increas flatul stool bloat studi num num random crossov trial particip consum cup pinto bean black ey pea carrot control num studi num random num week phase studi num particip ate cup bake bean carrot control num random num week phase studi num parallel arm trial num subject receiv cup pinto bean num consum control soup num week frequenc perceiv flatul stool characterist bloat primari outcom measur chi squar distribut examin presenc absenc symptom demograph characterist determin differ gender age bodi mass index bmi bean type result num report increas flatul eat pinto bake bean week trial num flatul increas black ey pea small percentag num report increas flatul studi control diet flatulence produc compon conclus people concern excess flatul eat bean exagger public health nutritionist address potenti gastrointestin discomfort increas fiber intak bean client import recogn individu variat respons bean type
MED-3139~soy food intak diagnosi breast cancer surviv in depth analysi combin evid cohort studi chines women abstract background soy isoflavon antiestrogen anticanc properti possess estrogen lik properti rais concern soy food consumpt breast cancer survivor object prospect evalu associ postdiagnosi soy food consumpt breast cancer outcom chines women data breast cancer pool project design analysi includ num breast cancer survivor diagnosi invas breast cancer num num num cohort num chines cohort soy isoflavon intak mg d measur valid food frequ questionnair hrs num cis estim delayed entri cox regress model adjust sociodemograph clinic lifestyl factor result follow up num identifi num total death num breast cancer num recurr larg differ soy isoflavon intak countri isoflavon consumpt invers recurr chines women data analyz separ countri combin heterogen observ pool analysi consumpt num mg isoflavones d nonsignific reduc risk all caus hr num num ci num num breast cancer specif hr num num ci num num mortal statist signific reduc risk recurr hr num num ci num num conclus larg studi combin data chines women postdiagnosi soy food consumpt num mg isoflavones d nonsignific reduc risk breast cancer specif mortal statist signific reduc risk recurr studi includ breast cancer pool project women healthi eat live studi regist clinicaltri gov nct num
MED-3140~legum import dietari predictor surviv older peopl ethnic pubm ncbi abstract identifi protect dietari predictor long liv elder peopl num food habit life fhill studi undertaken cohort japan sweden greec australia num num baselin data food intak collect num particip age num year base altern cox proport hazard model adjust age enrol num year interv gender smoke legum food group show num reduct mortal hazard ratio num increas daili intak control ethnic rr num num ci num num rr num num ci num num food group found consist signific predict surviv fhill cohort
MED-3141~bean fre diet increas risk all caus mortal taiwanes women role metabol syndrom pubm ncbi abstract object evalu associ chronic diseas risk mortal consequ bean fre diet taiwanes adult regard gender design sub sampl nation health interview survey nhis num agre physic examin subsequ year group part taiwanes survey hyperglycaemia hyperlipidaemia hypertens twshhh num set individu record link eventu death file num num subject end num total num men num women track death registri num num year follow up result num person year averag follow up num num year num all caus death identifi general linear model show bean favour metabol syndrom fast glucos men women bean favour waist circumfer hba num cumul logist regress model effect bean fre diet metabol syndrom score taiwanese modifi nation cholesterol educ program adult treatment panel iii ncep tw gave adjust odd ratio num num men num num women cox regress model bean fre diet show increas hazard ratio all caus mortal women num num ci num num num men num num ci num num num conclus bean fre diet play role develop metabol syndrom gender signific predictor all caus mortal taiwanes women men
MED-3142~posit effect soy isoflavon food surviv breast cancer patient china pubm ncbi abstract aim soy food major sourc isoflavon believ play import role genesi breast cancer progress conduct prospect studi evalu associ soy isoflavon food consumpt breast cancer prognosi method prospect studi perform januari num januari num china train interview conduct face to fac interview structur questionnair collect inform dietari habit potenti confound factor relat risk hazard ratio hr num ci calcul cox regress model signific predictor cancer diagnosi endpoint studi event result median follow num month rang num month total num breast cancer relat death record studi risk invers high intak soy isoflavon averag intak soy isoflavon num mg day mortal breast cancer reduc num found decreas breast cancer death high soy protein intak hr num ci num num num stratifi analysi refer er status demonstr prognosi er posit breast cancer high intak soy isoflavon hr num num num conclus studi show soy food intak longer surviv low recurr breast cancer patient cohort studi larger sampl size long term follow up
MED-3143~gastrointestin symptom num volunt ingest snack food olestra triglycerid num week random placebo control trial pubm ncbi abstract background olestra nonabsorb energy fre fat substitut absorb digest symptom consum larg amount object compar frequenc impact gastrointestin symptom adult children freeli consum snack olestra regular snack home design num week double blind random parallel placebo control trial set general communiti particip num volunt num num year age intervent household receiv ident packag label olestra corn potato chip packag olestra regular chip control measur gastrointestin symptom impact daili activ report daili record result gastrointestin symptom report num num num person olestra group num num num control differ num percentag point num ci num num percentag point num general group differ signific proport particip report individu gastrointestin symptom control report nausea num compar num differ num percentag point ci num num percentag point num differ group number day symptom report particip olestra group num symptom day frequent bowel movement control num symptom day compar num symptom day differ num symptom day ci num num symptom day num group differ impact symptom daili activ conclus clinic meaning bothersom gastrointestin effect unregul consumpt olestra corn potato chip home
MED-3144~optim lc ms ms analysi morphin codein poppi seed evalu fate food process basi risk analysi pubm ncbi abstract opiat alkaloid present poppi seed intend food recent rais major concern effici method routin analysi morphin codein liquid chromatographi combin tandem mass spectrometri tripl quadrupol instrument lc ms ms develop optim sampl prepar found cold extract num unground poppi seed num ml methanol num acet acid num min shaken num rpm fate morphin food process studi experi led signific reduct morphin codein poppi cake num morphin recov poppi bun highest temperatur num degre num origin morphin content found ground poppi seed show signific lower recoveri untreat seed morphin elimin food process account current discuss maximum limit poppi seed
MED-3145~morphin level urin subsequ poppi seed consumpt pubm ncbi abstract urin morphin level consumpt poppi seed measur separ trial maximum level approxim num micrograms ml found ria emit st gc methodolog posit immunoassay result num post ingest lot seed sourc assay morphin found rang num mg kg differenti poppi seed eater opiat user identif minor alkaloid constitu poppi seed analys opiat urin respect num o acetylmorphin level approxim num micrograms ml total opiat gc ms method choic analysi
MED-3146~poppi seed food opiat drug testing  wher today pubm ncbi abstract seed opium poppi plant legal sold wide consum food due contamin harvest seed morphin opiat alkaloid object studi review toxicolog poppi seed food influenc opiat drug test computer assist literatur review result num identifi refer normal poppi seed consumpt general regard safe food process morphin content reduc num possibl false posit opiat drug test poppi food ingest exist unambigu marker differenti poppi food ingest heroin pharmaceut morphin problem heroin assist mainten program basic requir substitut program patient abstin drug includ addit illicit heroin lack forens ingest trial detect factor influenc morphin content biolog matric consumpt studi control loss food process initi morphin dosag overestim larg reduct morphin content past year rais question valid poppi seed defenc threshold food lead posit drug test certainti unavail research prove morphin content today food pose possibl influenc drug test futur trial processing rel morphin loss
MED-3148~sympathet nervous system activ rest metabol rate vegetarian pubm ncbi abstract examin rest metabol rate rmr sympathet nervous system activ young male vegetarian num nonvegetarian num subject character rmr indirect calorimetri norepinephrin kinet infus tritiat norepinephrin energi macronutri intak num day food diari bodi composit underwat weigh vegetarian report greater relat intak carbohydr num num num num num lower relat intak fat num num num num num nonvegetarian differ observ daili energi intak bodi composit maxim aerob capac vo num ax group vegetarian exhibit num higher absolut rmr num num num num kcal min num higher plasma concentr norepinephrin num num num num pg ml num greater norepinephrin rate num num num num micrograms min num nonvegetarian statist control differ relat amount carbohydr fat diet norepinephrin concentr signific differ adjust rmr vegetarian nonvegetarian note result suggest higher rmr observ young male vegetarian partial mediat differ dietari macronutri composit increas sympathet nervous system activ
MED-3149~therapeut diet adher accept pubm ncbi abstract health condit treat part therapeut diet success intervent depend accept patient accept therapeut diet factor influenc larg neglect nutrit research work definit accept propos examin summari provid data accept common diet regimen medic condit goal suggest improv success therapeut diet propos work definit accept refer user judgment advantag disadvantag therapeut diet in relat palat cost effect eat behaviour health that influenc likelihood adher low calori reduced fat omnivor vegetarian vegan low carbohydr diet achiev accept major user studi year term attrit adher rate result questionnair assess eat behaviour longer studi fewer suggest vegetarian vegan reduced fat diet accept sustain nutrient intak studi length publish low calori low carbohydr diet long term studi adher accept therapeut diet warrant
MED-3150~circul leucocyt lymphocyt subtyp increas respons exercis children asthma abstract background exercis alter health children benefici reduc long term risk atherosclerosi advers exercis induc asthma mechan link exercis health rest part abil exercis increas circul immun cell effect exercis reflect natur occur pattern physic activ children immun cell respons object determin num num min bout exercis increas circul inflammatori cell healthi children num effect exercis greater children histori asthma method children mild moder persist asthma age match control num group age num year perform num min bout cycl ergomet exercis spirometri perform baselin exercis blood drawn exercis leucocyt quantifi key lymphocyt cell surfac marker assess flow cytometri result exercis decreas spirometri children asthma increas num type leucocyt lymphocyt control sd num cell children asthma num cell eosinophil control num cell children asthma num cell degre group similar exercis increas helper cell control num cell children asthma num cell lymphocyt subtyp test contrast basophil num cell cd num cd num ra lymphocyt num cell increas control increas cell type found children asthma conclus exercis increas circul inflammatori cell children asthma control circul inflammatori cell increas children asthma greater degre control fact basophil helper lymphocyt memori transit cell increas children asthma increas control exercis children adolesc robust mobilis circul immun cell
MED-3151~baker yeast glucan supplement increas monocyt cytokin post exercis implic infect risk pubm ncbi abstract strenuous aerob exercis weaken immun system nutrit supplement propos boost post exercis immun effect purpos present studi evalu num supplement defin sourc baker yeast glucan bg wellmun wgp minimis post exercis immunosuppress recreat activ men women num complet num trial condit cross ov design num washout period placebo rice flour baker yeast bg num mg d num num glucan deriv saccharomyc cerevisia bout cycl num num min hot num num humid num num relat humid environ blood collect baselin supplement pre pre post post num num post exercis total subset monocyt concentr measur four colour flow cytometri plasma cytokin level lipopolysaccharid lps stimul cytokin product measur separ multiplex assay total cd num pro inflammatori monocyt concentr cd num cd num signific greater post num num num bg supplement bg supplement boost lps stimul product il num il num il num interferon ifn pre post num num plasma il num il num ifn concentr greater num bg supplement num supplement bg increas potenti blood leucocyt product il num il num il num ifn key find present studi demonstr bg potenti alter immun strenuous exercis session
MED-3153~effect beta num num glucan upper respiratori tract infect symptom mood state marathon athlet abstract placebo control double blind studi design evalu effect commerci dietari supplement upper respiratori tract symptom urti mood state seventy f marathon runner num men num women rang age num year age num num self administ placebo num mg num mg beta num num glucan commerci wellmun wgp daili num week post marathon trial period num carlsbad marathon subject fill profil mood state pom assess questionnair style health log measur health status urti symptom num num week treatment administr num week studi subject treatment group num mg num mg beta glucan day report signific fewer urti symptom health decreas confus fatigu tension anger increas vigor base pom survey compar placebo beta glucan prevent urti symptom improv health mood competit marathon key point
MED-3154~infect risk link exercis workload pubm ncbi abstract anecdot survey epidemiolog data suggest endur athlet increas risk upper respiratori tract infect urti period heavi train num num wk period race event major athlet particip endur race event experi ill greater public health import consist find reduct urti risk report fit enthusiast athlet engag regular exercis train avoid overreaching overtrain natur infect risk link acut chronic exercise induc alter immun attempt measur associ unsuccess grow evid hour subsequ heavi exert compon innat adapt immun system exhibit suppress function immun respons heavi exert transient research mechan immun respons prolong intens endur exercis meaning clinic applic drawn attempt made chemic nutrit indomethacin glutamin vitamin carbohydr supplement attenu immun intens exercis lower risk infect consist relationship nutrit intervent exercis immunolog alter urti risk establish
MED-3155~aerob fit lower proport senesc blood t cell man pubm ncbi abstract senesc t cell accumul age lower na ve t cell repertoir increas host infect risk respons influenc lifestyl factor examin associ aerob fit vo num ax age rel accumul senesc t cell blood lymphocyt num healthi male num yr analyz klrg num cd num cd num cd num cd num surfac express cd num cd num t cell num color flow cytometri advanc age yr posit proport senesc klrg num cd num klrg num cd num cd num num num cd num num num t cell invers na ve klrg num cd num cd num num cd num num t cell vo num ax invers senesc cd num num cd num num strike age longer proport senesc na ve t cell adjust vo num ax associ vo num ax t cell subset withstood adjust age bmi percentag bodi fat rank particip age adjust vo num ax reveal highest tertil num na ve cd num t cell num num senesc cd num cd num t cell compar lowest tertil vo num ax latent cytomegalovirus cmv epstein barr virus ebv herp simplex virus num hsv num infect indic moder associ vo num ax confound persist viral infect studi show aerob fit lower age rel accumul senesc t cell highlight benefici effect maintain physic activ lifestyl age immun system copyright num elsevi reserv
MED-3156~short term blackcurr extract consumpt modul exercise induc oxid stress lipopolysaccharide stimul inflammatori respons pubm ncbi abstract exercise induc oxid stress instrument achiev health benefit regular exercis inappropri fruit deriv product common appli prophalyt antioxid counteract posit effect exercis human exercis cellular model found num blackcurr supplement suppress exercise induc oxid stress plasma carbonyl num num num num nmol mg protein placebo blackcurr num preincub thp num cell anthocyanin rich blackcurr extract inhibit lps stimul cytokin secret tnf alpha num num num num pg ml control extract num il num num num num pg ml control extract num nf kappab activ addit antioxid anti inflammatori properti found postexercis plasma collect blackcurr supplement enhanc differenti tempor lps stimul inflammatori respons thp num cell result earli suppress tnf alpha num num num num pg ml placebo blackcurr num il num num num num pg ml placebo blackcurr num secret num oxid stress cell model found preincub thp num cell hydrogen peroxid num num prior extract exposur caus greater suppress lps stimul cytokin secret num evid cell simultan incub num num extract summari find support concept consumpt blackcurr anthocyanin allevi oxid stress amount time complement abil exercis enhanc immun respons potenti pathogen
MED-3157~effect vitamin supplement physic perform pubm ncbi abstract vitamin essenti compon diet reduc advers effect exercise induc reactiv oxygen speci includ muscl damag immun dysfunct fatigu reactiv oxygen speci mediat benefici train adapt vitamin attenu total num studi vitamin dose num num impair sport perform substanti studi possibl reduc mitochondri biogenesi studi demonstr impair statist signific dose num num vitamin consum serv fruit veget suffici reduc oxid stress provid health benefit impair train adapt
MED-3158~inhibit xanthin oxidas flavonoid pubm ncbi abstract dietari flavonoid evalu vitro inhibitori effect xanthin oxidas implic oxid injuri tissu ischemia reperfus xanthin oxidas activ determin direct measur uric acid format hplc structure act relationship reveal planar flavon flavonol num hydroxyl group chrysin luteolin kaempferol quercetin myricetin isorhamnetin inhibit xanthin oxidas activ low concentr ic num valu num num microm mixed typ mode nonplanar flavonoid isoflavon anthocyanidin inhibitori result suggest flavonoid suppress vivo format activ oxygen speci urat xanthin oxidas
MED-3161~effect lemon verbena supplement muscular damag marker proinflammatori cytokin releas neutrophil oxid stress chronic pubm ncbi abstract intens exercis direct relat muscular damag oxid stress due excess reactiv oxygen speci ros plasma white blood cell exercise deriv ros essenti regul cellular adapt exercis studi antioxid supplement provid controversi result purpos studi determin effect moder antioxid supplement lemon verbena extract healthi male volunt num min run eccentr exercis protocol num day antioxid enzym activ oxid stress marker measur neutrophil inflammatori cytokin muscular damag determin blood serum sampl intens run exercis num day induc antioxid respons neutrophil train male increas antioxid enzym catalas glutathion peroxidas glutathion reductas supplement moder level antioxid lemon verbena extract block cellular adapt respons reduc exercise induc oxid damag protein lipid neutrophil decreas myeloperoxidas activ lemon verbena supplement maintain decreas level serum transaminas activ indic protect muscular tissu exercis induc decreas interleukin num interleukin num level num day measur basal condit inhibit antioxid supplement moder antioxid supplement lemon verbena extract protect neutrophil oxid damag decreas sign muscular damag chronic run exercis block cellular adapt exercis
MED-3163~antioxid prevent health promot effect physic exercis human abstract exercis promot longev amelior type num diabet mellitus insulin resist exercis increas mitochondri format harm reactiv oxygen speci ros antioxid wide supplement affect health promot effect exercis unknown evalu effect combin vitamin num mg day vitamin num iu day insulin sensit measur glucos infus rate gir hyperinsulinem euglycem clamp previous untrain num pretrain num healthi young men num week intervent physic exercis gir determin muscl biopsi gene express analys plasma sampl obtain compar baselin potenti influenc vitamin exercis effect exercis increas paramet insulin sensit gir plasma adiponectin absenc antioxid previous untrain num pretrain num individu parallel increas express ros sensit transcript regul insulin sensit ros defens capac peroxisome proliferator activ receptor gamma ppar ppar coactiv pgc num pgc num absenc antioxid num molecular mediat endogen ros defens superoxid dismutas num num glutathion peroxidas induc exercis effect block antioxid supplement consist concept mitohormesi exercise induc oxid stress amelior insulin resist adapt respons promot endogen antioxid defens capac supplement antioxid preclud health promot effect exercis human
MED-3164~nutrit limit exercise induc immunodepress pubm ncbi abstract prolong exercis heavi train depress immun cell function maintain immun function athlet eat well balanc diet suffici meet energi carbohydr protein micronutri requir consum carbohydr prolong strenuous exercis attenu rise stress hormon limit degre exercise induc immun depress recent evid suggest antioxid vitamin supplement reduc exercis stress impair leukocyt function research evalu effect antioxid dietari immunostimul probiot echinacea exercise induc immun impair
MED-3165~free radic skin muscl damag agent signal adapt pubm ncbi abstract current literatur biolog effect antioxid nutrient concentr potenti role inhibit prevent tissu damag induc free radic speci produc metabol recent find antioxid subtl role regul gene express induc oxid free radic speci increas evid free radic act signal cell adapt varieti cell type natur mechan free radic speci influenc gene express subject current research process import tissu regular expos vari amount oxid stress part normal physiolog function exampl tissu includ skin expos light skelet muscl subject repeat bout exercis
MED-3166~effect acut pre exercis dark chocol consumpt plasma antioxid status oxid stress immunoendocrin respons prolong pubm ncbi abstract purpos acut antioxid supplement modul oxid stress immun perturb typic occur prolong exercis aim present studi examin effect acut consum dark chocol high polyphenol content plasma antioxid capac marker oxid stress immunoendocrin respons prolong exercis method fourteen healthi men cycl num num maxim oxygen uptak num consum num dark chocol dc isomacronutri control bar cc bl randomised counterbalanc design result dc enhanc pre exercis antioxid status num reduc trend num num post exercis plasma free isoprostan compar cc isoprostan increas post exercis cc bl dc trial plasma insulin concentr signific higher pre exercis num num post exercis num dc compar cc trial mainten plasma glucos concentr dc trial num anova trial time interact num decreas post exercis trial signific higher num post exercis num dc trial trial differ tempor respons trial time interact num hypothalamic pituitary adren axi stress hormon plasma interleukin num magnitud leukocytosi neutrophilia neutrophil function conclus acut dc consumpt affect insulin glucos antioxid status oxid stress respons minim effect immunoendocrin respons prolong exercis
MED-3168~flavonoid glycosid isol uniqu legum plant extract inhibitor xanthin oxidas abstract legum polyphenol compound present gain lot interest due benefici health implic dietari polyphenol compound flavonoid exert antioxid properti potent inhibitor xanthin oxidas xo activ xo main contributor free radic exercis involv pathogenesi diseas vascular disord cancer gout order discov natur dietari xo inhibitor polyphenol fraction pure compound isol legum plant extract test effect xo activ fraction isol vicia faba lotus eduli plant extract potent inhibitor xo ic num valu rang num num g ml num num g ml pure polyphenol compound inhibit xo ki valu rang num num ten compound competit inhibitori model competit inhibitor find flavonoid isol legum plant extract natur xo inhibitor mode action investig order examin potenti drug design diseas relat overwhelm xo action
MED-3169~calcifi neurocysticercosi patient primari headach pubm ncbi abstract background anecdot report singl case control epidemiolog survey suggest associ helminth diseas neurocysticercosi primari headach present studi undertaken determin neurocysticercosi common patient primari headach neurolog disord method determin preval neurocysticercosi cohort patient primari headach institut num year period control peopl cohort major categori neurolog disord includ cerebrovascular diseas degen disord cns head trauma primari brain tumor evalu differ preval neurocysticercosi patient control result forty eight num patient primari headach num num control neurocysticercosi num num num calcifi parenchym brain cysticerci frequent patient primari headach cerebrovascular diseas num num num degen disord cns num num num head trauma num num num signific differ subset control primari brain tumor num num condit neurocysticercosi conclus relationship calcifi neurocysticercosi primari headach disord period remodel cysticercot calcif liber antigen brain parenchyma contribut occurr headach patient
MED-3170~cognit qualiti life neurocysticercosi longitudin studi abstract background studi focus cognit morbid neurocysticercosi ncc common parasit infect central nervous system longitudin assess cognit status qualiti life qol patient incid symptomat ncc case match control methodology princip find set studi sabog hospit cysticercosi unit depart transmiss diseas nation institut neurolog scienc lima peru design longitudin studi onset ncc case control particip includ total num patient recent diagnos ncc num healthi neighborhood control num recent diagnos epilepsi control standard neuropsycholog batteri perform baselin num month ncc case control brain mri perform patient ncc baselin num month neuropsycholog result compar ncc case control time point baselin patient ncc lower score attent task num compar epilepsi control signific differ compar healthi control month receiv anti parasit treatment ncc group signific improv task involv psychomotor speed num qol baselin suggest impair mental function social function ncc epilepsi group compar healthi control qol gain social function num note num month patient ncc conclusions signific newli diagnos patient ncc sampl mild cognit deficit mark decreas qualiti life baselin compar control improv found cognit status qualiti life patient ncc treatment author summari neurocysticercosi ncc common parasit infect central nervous system cognit frequent report diseas studi studi team recruit group onset ncc case match set healthi neighborhood control onset epilepsi control lima peru studi neuropsycholog batteri administ baselin num month group brain mri studi obtain ncc case baselin num month newli diagnos patient ncc mild cognit deficit mark decreas qualiti life baselin compar control improv found cognit status qualiti life patient ncc treatment studi assess cognit status qualiti life longitudin patient ncc data import clinic morbid outcom
MED-3171~freez infest pork muscl kill cysticerci pubm ncbi abstract method cultur cysticerci success evagin growth scolex metacestod taenia solium studi surviv cysticerci subject low temperatur refriger pork muscl infest cysticerci temperatur num degre affect parasit surviv cultur convers freez meat prevent surviv cyst practic procedur kill cysticerci storag pork muscl day num degre day num degre day num degre simpl measur prevent frequent parasitosi man central nervous system
MED-3172~neurocysticercosi oncogenesi pubm ncbi abstract recent studi suggest neurocysticercosi risk factor human cancer pathogenet mechan explain oncogen effect cysticerci includ parasite induc modul host immun respons loss regulatori mechan implic immunolog surveil cancer transfer genet materi parasit host caus dna damag malign transform host cell chronic inflamm liber nitric oxid inhibit tumor suppressor gene research confirm potenti role cysticercosi develop cancer studi determin presenc cysticercot factor respons transfer genet materi potenti mutat tumor suppressor gene prolifer astrocyt surround cysticercot lesion addit complex interact immun state host variabl cytokin releas presenc inflammatori cell releas nitric oxid dna damag impair tumor suppress mechan investig
MED-3173~natur mood food action polyphenol psychiatr cognit disord abstract object polyphenol natur compound found plant bas food possess special properti battl oxid stress stimul activ molecul aid synapt plastic process cognit function unlik tradit treatment polyphenol affect broad rang mechan brain assist mainten cognit mental health recoveri neurodegen diseas examin molecular basi link food intak brain function present excit possibl diet viabl method battl cognit psychiatr disord method discuss molecular system link polyphenol gut brain introduc publish human anim studi demonstr effect polyphenol consumpt brain plastic cognit result influenc cellular energi metabol modul signal pathway molecul involv brain plastic dietari factor recogn effect bodili system emerg affect brain conclus consumpt diet enrich polyphenol present potenti dietari manipul non invas natur inexpens therapeut support healthi brain
MED-3174~impact neurocysticercosi california review hospit case abstract assess burden neurocysticercosi ncc california examin statewid hospit discharg data num num case hospit ncc identifi incid num num case latino num slight male femal men num women num averag age num year major case hospit southern california num hospit los angel counti num men women sever diseas includ hydrocephalus num num num result longer hospit num day num num num cost charg num thousand men num woman num num death record num total ncc relat hospit charg exceed num million estim hospit cost exceed num million neurocysticercosi appreci diseas exact econom burden california author summari neurocysticercosi ncc consid major neglect infect poverti unit state mortal studi indic california bear highest burden diseas ncc report diseas california studi diseas larg under report contribut lack inform diseas distribut burden manuscript review distribut ncc hospit california demograph hospit total hospital rel charg num studi reveal major person hospit ncc california receiv medic servic southern california hospit primarili counti los angel compar women hospit diseas men longer cost hospit sever symptom hydrocephalus diagnosi suggest extraparenchym infect reason differ ncc sever gender clear due delay seek medic care languag barrier intens hospit care manag case sizabl ncc hospit charg underscor econom burden diseas present california
MED-3175~neurocysticercosi pregnanc headach pubm ncbi abstract infect pork tapeworm taenia solium affect approxim num million peopl worldwid import potenti devast form infest neurocysticercosi occur parasit invad central nervous system signific increas number case unit state due immigr endem area case studi pregnant woman num week gestat exemplifi consequ infect pregnanc discuss evidence bas approach diagnosi treatment erad prevent diseas num awhonn
MED-3176~dementia revers patient neurocysticercosi abstract method nineti consecut patient untreat ncc underw cognit assess mini ment state examin neurobehavior cognit status examin iqcod classifi dementia dsm iv criteria imag cerebrospin fluid examin data record cognit measur repeat month treatment albendazol steroid result initi evalu num num patient classifi dementia dementia older age lower educ level increas number parasit lesion brain frontal tempor pariet lobe month num patient dementia group continu full dementia disord num longer fulfil dsm iv criteria dementia patient show mild cognit declin conclus result studi suggest dementia occur frequent patient untreat ncc revers case
MED-3177~neurocysticercosi enigmat diseas pubm ncbi abstract neurocysticercosi ncc infect central nervous system cns caus metacestod larval form parasit taenia sp factor contribut endem natur cysticercosi inflammatori process occur tissu surround parasit and or distal result mechan disproportion number cyst discrep lead difficulti proper diagnosi peopl low endem region region lack laboratori resourc cns cysticerci basic form isol cyst cysticercus cellulosae cc racemos cyst cysticercus racemosus cr mening parenchym ventricular mix locat clinic manifest base fundament syndrom occur isol epilepsi intracrani hypertens asymptomat symptomat fatal acut sub acut chronic pictur remiss exacerb cerebrospin fluid csf normal patient viabl cysticerci patient begin exhibit classic syndrom ncc csf show routin analys paramet comput tomographi ct magnet reson imag mri non invas diagnos lead fals negat treatment high controversi issu characteris individualis therapi session drug common praziquantel pzq albendazol abz choic anti inflammatori drug includ steroid dextrochlorpheniramin dcp hydrocephalus common secondari effect ncc surgic case hydrocephalus submit ventricle periton shunt vps immedi cysticid treatment surgic extirp cyst lead absenc surround inflammatori process progress ncc simpl complic remiss treatment exhibit symptom disappear long period time persist death unknown neglect controversi aspect ncc impair fourth ventricl syndrom presenc chronic brain oedema psychic complaint addit lack detect glucos csf re infect discuss
MED-3178~clinic manifest diagnosi treatment neurocysticercosi pubm ncbi abstract neurocysticercosi ncc frequent parasit diseas human brain modern imag studi ct mri defin diagnosi character diseas studi therapeut approach case individu aid antihelmint steroid symptomat medicin surgeri therapeut measur larg depend peculiar combin number locat biolog stage lesion degre inflammatori respons parasit typic clinic pictur ncc epilepsi frequent manifest parenchym ncc hydrocephalus frequent manifest mening ncc erad cysticercosi attain goal public educ sanitari improv endem area
MED-3179~cognit impair dementia neurocysticercosi cross sect control studi pubm ncbi abstract object neurocysticercosi ncyst frequent cns parasit diseas worldwid affect num million peopl clinic find cognit impair dementia remain poor character control studi conduct investig frequenc clinic profil cognit impair dementia sampl patient ncyst comparison cognit healthi control hc patient cryptogen epilepsi ce method forti treatment na patient ncyst age num num year fulfil absolut criteria definit activ ncyst mri submit comprehens cognit function evalu compar num hc num patient ce similar age educ level seizur frequenc result patient ncyst display signific impair execut function verbal nonverb memori construct praxi verbal fluenci compar hc num dementia diagnos num patient ncyst dsm iv criteria compar patient ce patient ncyst present alter work episod verbal memori execut function verbal fluenci construct praxi visual spati orient correl emerg cognit score number local type ncyst lesion mri conclus cognit impair ubiquit sampl patient activ neurocysticercosi ncyst antiepilept drug seizur frequenc account featur dementia present signific proport patient data broaden knowledg clinic present ncyst impact world public health
MED-3180~aneurysm neurocysticercosi casual causal relationship case report review literatur abstract case suggest inflammatori aneurysm patient neurocysticercosi report case num year old woman present subarachnoid haemorrhag middl cerebr arteri bifurc aneurysm casual relationship neurocysticercosi surgeri viabl cysticercus sign inflamm thicken leptomening found distal posit aneurysm postop patient receiv albendazol dextrochlorpheniramin subsequ year patient asymptomat drug prevent convuls arteri hypertens relationship ncc presenc cerebr aneurysm discuss
MED-3181~psychiatr manifest neurocysticercosi studi num patient neurolog clinic brazil abstract object determin frequenc featur psychiatr morbid cross section num outpati neurocysticercosi method diagnosi neurocysticercosi establish ct mri csf analysi psychiatr diagnos made present state examin schedul affect disord schizophrenia lifetim version cognit state assess mini mental state examin strub black mental status examin result sign psychiatr diseas cognit declin found num num case depress frequent psychiatr diagnosi num num patient psychot activ diseas intracrani hypertens higher psychiatr morbid previous histori mood disord strong relat current depress variabl number type brain lesion sever neuropsycholog deficit epilepsi steroid correl mental disturb sampl conclus psychiatr abnorm depress syndrom frequent patient neurocysticercosi regard rare dementia mild cognit impair preval neuropsycholog featur patient neurocysticercosi extent organ mechan relat brain lesion underli mental unclear similar sex distribut patient depress mention correl provid evid part play organ factor syndrom
MED-3182~review case human cysticercosi canada pubm ncbi abstract object review human cysticercosi canada estim magnitud diseas describ pattern diseas express countri method medlin manual search case report case seri patient cysticercosi diagnos canada abstract data includ year diagnosi citizenship status clinic manifest form cysticercosi find total num articl report num patient found forti num patient diagnos past decad case ontario num quebec num immigr account num num case citizenship inform neurocysticercosi observ num patient isol compromis striat muscl remain seizur primari sole manifest diseas num patient parenchym brain cysticerci viabl cyst calcif patient posit taenia egg case household contact patient investig taeniasi conclus increas number patient cysticercosi report canada past decad suggest preval parasit diseas rise case occur immigr patient acquir diseas canada
MED-3193~num cholin num fdg pet ct assess bone involv patient multipl myeloma abstract background multipl myeloma mm cell neoplasm caus lytic osteopen bone abnorm bodi skelet survey wbss magnet reson mr num fdg pet ct imag techniqu routin evalu bone involv mm patient aim mm bone lesion present low num fdg uptak aim studi assess ad limit num cholin num fdg pet ct patient affect mm method ten patient affect mm underw standard num cholin pet ct num fdg pet ct week result scan compar term number site suvmax lesion result patient num negat concord num cholin num fdg pet ct scan patient num posit num cholin num fdg pet ct scan identifi number site bone lesion remain patient num posit num cholin num fdg pet ct scan exam identifi number lesion cholin show suvmax num fdg show suvmax num num num cholin pet ct scan detect num bone lesion num fdg pet ct scan detect num bone lesion differ signific num conclus preliminari data num cholin pet ct sensit num fdg pet ct detect boni myelomat lesion data confirm larger seri patient num cholin consid function imag associ mri mm bone stage
MED-3197~beef optim lean diet studi effect lipid lipoprotein apolipoprotein abstract background step diet lean beef compar lean white meat decreas ldl cholesterol knowledg studi evalu low satur fatti acid sfa num calori diet lean beef object studi effect ldl cholesterol cholesterol low diet vari amount lean beef dietari approach stop hypertens dash num beef d beef optim lean diet bold num beef d beef optim lean diet addit protein bold num beef d compar healthi american diet design thirty six hypercholesterolem particip ldl cholesterol concentr num mmol l random assign consum num diet num total fat num sfa num protein num beef d dash num total fat num sfa num protein num beef d bold num total fat num sfa num protein num beef d bold num total fat num sfa num protein num beef d num wk result decreas total cholesterol tc ldl cholesterol concentr num consumpt dash num num num num mmol l bold num num num num mmol l bold num num num num mmol l diet compar consumpt num num num num mmol l apolipoprotein a i c iii c iii bound apolipoprotein num particl decreas bold bold diet compar greater decreas apolipoprotein consumpt bold diet consumpt num ldl cholesterol tc decreas consumpt dash bold bold diet baselin c reactiv protein crp concentr num mg l ldl cholesterol tc decreas baselin crp concentr num mg l bold bold diet conclus low sfa heart healthi dietari pattern lean beef elicit favor effect cardiovascular diseas cvd lipid lipoprotein risk factor compar elicit dash dietari pattern result conjunct benefici effect apolipoprotein cvd risk factor consumpt bold bold diet greater bold diet provid support includ lean beef heart healthi dietari pattern trial regist clinicaltri gov nct num
MED-3198~chees intak larg amount lower ldl cholesterol concentr compar butter intak equal fat content pubm ncbi abstract background high content satur fatti acid chees increas plasma total ldl cholesterol concentr compar equival intak fat butter effect due high calcium content chees result higher excret fecal fat object object compar effect diet equal fat content rich hard chees butter habitu diet blood pressur fast serum blood lipid c reactiv protein glucos insulin examin fecal fat excret differ consumpt chees butter design studi random dietari intervent consist num wk crossov period num run in period subject consum habitu diet studi includ num men women replac part habitu dietari fat intak num energi chees butter result num wk chees intervent result lower serum total ldl hdl cholesterol concentr higher glucos concentr butter intervent chees intak increas serum total ldl cholesterol concentr compar run in period total fat satur fat intak lower fecal fat excret differ chees butter period conclus chees lower ldl cholesterol compar butter intak equal fat content increas ldl cholesterol compar habitu diet trial regist clinicaltri gov nct num
MED-3199~potenti risk result fruit vegetable drug interact effect drug metabol enzym drug transport pubm ncbi abstract establish complex mixtur phytochem fruit veget benefici human health increas appar phytochem influenc pharmacolog activ drug modifi absorpt characterist interact drug transport drug metabol enzym system effect occur intestin liver high concentr phytochem occur alter cytochrom num enzym activ influenc fate drug subject extens first pass metabol numer studi nutrient drug interact publish systemat review meta analys studi general effect nutrient drug interact drug bioavail public highlight unintend consequ combin nutrient drug phytochem shown pharmacokinet interact drug present review limit common consum fruit veget signific benefici effect nutrient compon folk medicin discuss phytochemistri pharmacokinet interact fruit veget grapefruit orang tangerin grape cranberri pomegran mango guava black raspberri black mulberri appl broccoli cauliflow watercress spinach tomato carrot avocado conclud knowledg potenti risk nutrient drug interact limit effort elucid potenti risk result food drug interact intensifi order prevent undesir harm clinic consequ num institut food technologist
MED-3200~prospect studi grapefruit intak risk breast cancer postmenopaus women multiethn cohort studi abstract vitro vivo studi shown cytochrom num num cyp num involv metabol oestrogen evid grapefruit inhibitor cyp num increas plasma oestrogen concentr establish oestrogen breast cancer risk plausibl regular intak grapefruit increas woman risk breast cancer investig associ grapefruit intak breast cancer risk hawaii los angel multiethn cohort studi prospect cohort includ num num postmenopaus women racial ethn group total num incid breast cancer case analysi grapefruit intak signific increas risk breast cancer relat risk num num confid interv num num subject highest categori intak one quart grapefruit day compar non consum ptrend num increas risk similar magnitud user oestrogen therapi user oestrogen progestin therapi user hormon therapi grapefruit intak increas risk breast cancer postmenopaus women
MED-3201~effect grapefruit grapefruit juic water preload energi balanc weight loss bodi composit cardiometabol risk free liv obes adult abstract background reduc dietari energi densiti proven effect strategi reduc energi intak promot weight control effect robust low energi dens preload consum meal discuss continu optim form preload purpos present studi compar effect solid grapefruit liquid grapefruit juic water preload consum prior breakfast lunch dinner context calor restrict method eighty f obes adult bmi num num random assign num grapefruit gf grapefruit juic gfj water preload num week complet num week calor restrict phase preload match weight calori water content energi densiti week measur includ blood pressur weight anthropometri num hour dietari intak rest energi expenditur bodi composit physic perform cardiometabol risk biomark assess result total amount gram food consum chang time preload combin calor restrict averag dietari energi densiti total energi intak decreas num baselin valu subject experienc num weight loss signific decreas percentag bodi trunk android gynoid fat waist circumfer num cm differ statist signific group amount direct chang serum hdl cholesterol level gf num gfj num preload group signific greater water preload group num conclus data incorpor consumpt low energi dens dietari preload calor restrict diet high effect weight loss strategi form preload differenti effect energi balanc weight loss bodi composit notabl subject gf gfj preload group experienc signific greater benefit lipid profil trial registr clinicaltri gov nct num
MED-3202~inhibitori effect grapefruit juic bitter princip naringenin cyp num depend metabol caffein man abstract num effect grapefruit juic naringenin activ human cytochrom num isoform cyp num evalu caffein probe substrat num vitro naringin potent competit inhibitor caffein num demethyl human liver microsom ki num microm num vivo grapefruit juic num day num num num naringin glycon form naringenin decreas oral clearanc caffein num ci num num prolong half lif num ci num num num conclud grapefruit juic naringenin inhibit cyp num activ man small effect caffein clearanc vivo suggest general ingest grapefruit juic clinic signific inhibit metabol drug substrat cypia num
MED-3203~red grapefruit posit influenc serum triglycerid level patient suffer coronari atherosclerosi studi vitro human pubm ncbi abstract content bioactiv compound red blond grapefruit influenc human suffer hypertriglyceridemia studi found red grapefruit higher content bioactiv compound higher antioxid potenti blond grapefruit determin oxygen radic scaveng capac num diphenyl num picrylhydrazyl carotenoid bleach folin ciocalteu assay fifty seven hyperlipidem patient age num year coronari bypass surgeri recruit institute pool volunt random divid equal number num group experiment red blond group control group cg num consecut day investig diet patient red blond dietari group daili supplement equal weight fresh red blond grapefruit trial serum lipid level fraction serum antioxid activ determin found serum lipid level patient red blond group versus cg treatment decreas total cholesterol num versus num mmol l num num versus num mmol l num low dens lipoprotein cholesterol num versus num mmol l num num versus num mmol l num triglycerid num versus num mmol l num num versus num mmol l num serum lipid level patient cg found conclus fresh red grapefruit higher quantiti bioactiv compound signific higher antioxid potenti blond grapefruit diet supplement fresh red grapefruit posit influenc serum lipid level fraction serum triglycerid serum antioxid activ addit fresh red grapefruit general accept diet benefici hyperlipidem hypertriglyceridem patient suffer coronari atherosclerosi
MED-3204~manag grapefruit drug interact pubm ncbi abstract grapefruit healthi addit well balanc diet fruit shown affect metabol medic increas risk toxic advers effect characterist oral medic interact grapefruit includ extens metabol intestin cytochrom num num system low bioavail narrow therapeut index promin medic interact grapefruit includ statin antiarrhythm agent immunosuppress agent calcium channel blocker equal effect altern drug class potenti interact grapefruit altern drug substitut patient experi risk grapefruit drug interact patient choos exclud grapefruit diet consum fruit includ type citrus avoid interact
MED-3205~prospect studi associ grapefruit intak risk breast cancer european prospect investig cancer pubm ncbi abstract grapefruit inhibit cytochrom num num affect estrogen metabol european prospect investig cancer nutrit epic examin relationship grapefruit intak risk breast cancer serum sex hormon level num women inform dietari intak grapefruit reproduct lifestyl risk factor median num year num incid breast cancer identifi fifty nin percent women report eat grapefruit num ate num g day cox proport hazard model estim hazard ratio hr breast cancer grapefruit intak adjust studi centr reproduct factor bodi mass index energi intak alcohol intak grapefruit intak relat risk breast cancer compar women ate grapefruit women highest intak num g day hr num num ci num num linear trend num relationship grapefruit intak breast cancer risk premenopaus women postmenopaus women postmenopaus women categor hormon replac therapi num associ grapefruit intak estradiol estron postmenopaus women studi found evid associ grapefruit intak risk breast cancer
MED-3206~effect grapefruit weight insulin resist relationship metabol syndrom pubm ncbi abstract studi effect grapefruit grapefruit product bodi weight metabol syndrom num obes patient random placebo capsul num ounc num ml appl juic grapefruit capsul num ounc num ml appl juic num ounc num ml grapefruit juic placebo capsul half fresh grapefruit placebo capsul time day meal metabol syndrom paramet measur begin end num week num week fresh grapefruit group lost num kg grapefruit juic group lost num kg grapefruit capsul group lost num kg placebo group lost num kg fresh grapefruit group lost signific weight placebo group num secondari analysi metabol syndrom treatment group demonstr signific greater weight loss grapefruit grapefruit capsul grapefruit juic group compar placebo num signific reduct num hour post glucos insulin level grapefruit group compar placebo half fresh grapefruit eaten meal signific weight loss metabol syndrom patient effect grapefruit product insulin resist improv fresh grapefruit mechan weight loss unknown reason includ grapefruit weight reduct diet
MED-3207~grapefruit wine glass metabol cardiovascular perspect abstract summari grapefruit popular tasti nutrit fruit enjoy global biomed evid num year shown consumpt grapefruit juic drug interact case fatal grapefruit induc drug interact uniqu cytochrom num enzym cyp num metabolis num common prescrib drug drug transport protein p glycoprotein organ cation transport protein express intestin involv extent grapefruit drug interact impact clinic set fulli determin case report recent emerg grapefruit virtu rich flavonoid content benefici manag degen diseas diabet cardiovascular disord potenti explos subject review
MED-3208~low energy dens diet ad fruit reduc weight energi intak women pubm ncbi abstract studi evalu effect ad fruit oat diet free liv women energi consumpt bodi weight fruit oat cooki amount fiber total calori approxim num kcal differ energi densiti analyz data clinic trial conduct primari care unit rio de janeiro brazil forty nin women age rang num num year bodi mass index bmi num kg m num random chosen add appl num kcal g energi densiti pear num kcal g energi densiti oat cooki num kcal g energi densiti usual diet num week fiber composit similar approxim num statist analysi repeat measur dietari composit bodi weight analyz mix model procedur result show signific decreas energi densiti follow up num kcal g num num kcal g num appl pear compar oat group energi intak decreas signific num num kcal day appl pear group show small increas num oat group appl pear num weight reduct num kg appl num pear group weight unchang num num oat group result suggest energi densiti fruit independ fiber amount reduc energi consumpt bodi weight time
MED-3209~grapefruit juic influenc ethinylestradiol bioavail pubm ncbi abstract effect grapefruit juic bioavail num alpha ethinylestradiol ee num singl oral administr num microgram ee num investig pharmacokinet ee num studi open random cross ov studi num healthi volunt administ drug herbal tea grapefruit juic naringin num mg ml contrast herbal tea grapefruit juic increas peak plasma concentr cmax signific num rang num num num increas area plasma concentration tim curv num num hour auc num num rang num num num studi show grapefruit juic increas bioavail amount ee num explan grapefruit juic inhibit metabol degrad ee num increas bioavail ee num grapefruit juic administr clinic import investig long term studi
MED-3210~effect daili consumpt grapefruit bodi weight lipid blood pressur healthi overweight adult pubm ncbi abstract folklor suggest consum grapefruit promot weight control spars data exist support hypothesi evid health promot effect regard blood pressur control modul circul lipid aim random control trial prospect evalu role grapefruit reduc bodi weight blood pressur promot improv lipid profil overweight adult num num week washout diet low bioactive rich fruit veget particip random control diet num daili grapefruit num amount half fresh rio r grapefruit meal num daili num week differ group weight blood pressur lipid demonstr grapefruit consumpt modest weight loss num num kg num signific reduct waist circumfer num num cm num signific reduct systol blood pressur num num mm hg num compar baselin valu improv observ circul lipid consum grapefruit total cholesterol low dens lipoprotein signific decreas num mg dl num num mg dl num compar baselin valu studi suggest consumpt grapefruit daili num week signific decreas bodi weight lipid blood pressur compar control condit improv blood pressur lipid demonstr intervent group suggest grapefruit evalu context obes cardiovascular diseas prevent copyright num elsevi reserv
MED-3215~excess dietari protein advers affect bone pubm ncbi abstract averag american diet high protein low fruit veget generat larg amount acid sulfat phosphat kidney respond dietari acid challeng net acid excret ammonium titrat acid excret concurr skeleton suppli buffer activ resorpt bone calciuria direct relat net acid excret food protein differ great potenti acid load acidogen effect diet high acid ash protein excess calcium loss acidogen content addit exogen buffer chemic salt fruit veget high protein diet result acid urin reduct net acid excret reduc ammonium titrat acid excret decreas calciuria bone resorpt halt bone accret occur alkali buffer chemic salt dietari fruit veget high potassium revers acid induc obligatori urinari calcium loss conclud excess dietari protein food high potenti renal acid load advers affect bone buffer consumpt alkali rich food supplement
MED-3216~low protein intak impact calcium bone homeostasi human pubm ncbi abstract increas dietari protein result increas urinari calcium num research sourc addit urinari calcium remain unclear calcium balanc studi found effect dietari protein intestin calcium absorpt assum skeleton sourc calcium hypothesi high endogen acid load generat protein rich diet increas bone resorpt skelet fractur definit nutrit intervent studi show detriment effect high protein diet skeleton hypothesi remain unproven recent studi laboratori demonstr dietari protein affect intestin calcium absorpt conduct seri short term nutrit intervent trial healthi adult dietari protein adjust low medium high highest protein diet result hypercalciuria chang serum parathyroid hormon surpris num low protein diet induc secondari hyperparathyroid persist num wk secondari hyperparathyroid induc low protein diet attribut reduct intestin calcium absorpt assess dual stabl calcium isotop long term consequ low protein induc calcium metabol detriment skelet health recent epidemiolog studi demonstr reduc bone densiti increas rate bone loss individu habitu consum low protein diet studi determin low protein intak direct affect rate bone resorpt bone format
MED-3217~age system acid bas equilibrium analysi publish data pubm ncbi abstract investig system acid bas equilibrium age normal adult human review publish articl report acid bas composit arteri arteri venous capillari blood age identifi healthi subject extract calcul blood hydrogen ion concentr plasma bicarbon concentr hco num blood pco num age comput total num age group distribut num year interv age num num year linear regress analysi found increas age signific increas steady st blood num reduct steady st plasma hco num num indic progress worsen low level metabol acidosi blood pco num decreas age num expect respiratori adapt metabol acidosi age rel increas metabol acidosi reflect part normal declin renal function increas age role age rel metabol acidosi pathogenesi degen diseas age warrant
MED-3220~alkalin diet favor lean tissu mass older adult abstract background maintain muscl mass age import prevent fall fractur metabol acidosi promot muscl wast net acid load diet rich net acid produc protein cereal grain relat content net alkali produc fruit veget contribut reduct lean tissu mass older adult object aim determin associ num urinari potassium index fruit veget content diet percentag lean bodi mass lbm chang lbm older subject design subject num men women num particip num trial compar calcium vitamin placebo potassium measur num urin collect baselin lbm defin total bodi nonfat nonbon tissu weight weight num measur dual energi x ray absorptiometri baselin num physic activ height weight assess baselin num result baselin urinari potassium excret num num mmol d urinari potassium mmol d signific posit lbm baselin num num adjust sex weight nitrogen excret num chang lbm num studi lbm increas num num conclus higher intak food rich potassium fruit veget favor preserv muscl mass older men women
MED-3221~effect urin ph chang dietari intervent uric acid clearanc mechan ph depend excret urinari uric acid abstract background find report previous paper alkal urin facilit uric acid excret contradictori expect occur food materi alkal urin fewer purin bodi acidif uric acid alkalin urin excret acid urin make clear compon uric acid excret mechan respons unexpect find simultan collect data concentr creatinin uric acid serum urin order calcul uric acid creatinin clearanc method framework japanes govern health promot program made recip consist protein rich vegetable fruit food materi load acid diet compos protein vegetable fruit rich food materi alkalin diet crossov studi limit healthi femal student medic problem regular physic examin provid univers enrol consecut num day studi test whole day collect urin total volum ph organ acid creatinin uric acid titrat acid cation na k ca num mg num nh num anion cl num po num estim acid base balanc measur earli morn breakfast num num num experiment day sampl num ml blood estim creatinin uric acid concentr serum result discuss urin ph reach steadi state num day switch ordinari daili diet regimen amount acid generat num organ acid gut alkali linear relat excret acid titrat acid nh num hco num indic urin generat metabol degrad food materi uric acid excret urin ph retain linear relationship report previous factor calcul clearanc uric acid creatinin identifi conspicu differ acid alkalin diet uric acid concentr serum urin uric acid serum higher acid group alkalin group uric acid urin acid group lower alkalin group uric acid acid urin serum reflect reduct clearanc observ consid uric acid reabsorb activ acid urin alkalin urin conclus conclud alkal urin eat nutrit well design alkalin prone food effect remov uric acid bodi
MED-3226~hypercalciuria high dietari protein intak due acid load abstract context object dietari intak anim protein increas urinari calcium nephrolithiasi risk test hypothesi acid load impos dietari protein hypercalciuria design set short term crossov metabol studi alkali salt provid high protein diet hpd neutral acid load impart dietari protein particip intervent eleven healthi volunt evalu end phase consum metabol diet fix calcium sodium content phase num num consist control diet cd phase num num consist eucalor hpd num g d anim protein ad cd hpd phase num num subject ingest num meq daili potassium citrat kcitrat alkalin salt potassium chlorid kcl control neutral salt result kcitrat complet neutral acid load impart hpd base urin ph net acid excret increas urinari citrat urinari calcium increas hpd phase compar cd signific hpd kcl hpd kcitrat phase num num num num mg d num increas urinari satur respect calcium oxal uric acid hpd abrog kcitrat conclus studi suggest short term mechan acid load account hypercalciuria induc hpd benefici effect kcitrat nephrolithiasi risk hpd correct declin urin ph citrat
MED-3227~impact dietari protein calcium absorpt kinet measur bone turnov women pubm ncbi abstract high protein diet induc hypercalciuria human sourc addit urinari calcium remain unclear hypothesi high endogen acid load high protein diet partial buffer bone lead increas skelet resorpt hypercalciuria dual stabl calcium isotop quantifi effect high protein diet calcium kinet women studi consist num wk lead in well balanc diet num experiment diet moder num g kg high num g kg protein thirteen healthi women receiv level protein random order intestin calcium absorpt increas high protein diet comparison moder num num num num num sem urinari calcium num num num num mmol d num sem high protein diet caus signific reduct fraction urinari calcium bone origin nonsignific trend reduct rate bone turnov protein induc effect net bone balanc data direct demonstr short term high protein diet detriment bone
MED-3228~dietari protein bone health harmon conflict theori pubm ncbi abstract precis understand role dietari protein bone health evas decad research dietari acid load harm bone sulfur contain amino acid metabol provid acid load protein elev urin calcium loss recent clinic studi meta analysi effect modest benefit higher protein intak contradictori explain exist two fac relationship protein bone simultan posit negat pathway opposit negat effect dietari acid load protein exert posit effect relat improv calcium absorpt increas insulin lik growth factor num improv lean bodi mass turn improv bone strength putat mechan pathway review limit histor literatur suggest measur counter futur identifi posit negat pathway consid tandem protein offer modest benefit bone presenc adequ dietari calcium acid neutr fruit veget num intern life scienc institut
MED-3229~protein intak calcium balanc health consequ pubm ncbi abstract high protein hp diet exert hypercalciur effect constant level calcium intak effect depend natur dietari protein lower urinari ph consist observ subject consum hp diet combin effect suspect dietari environ favor deminer skeleton increas calcium excret due hp diet link impair calcium balanc contrast data hp intak induc increas intestin calcium absorpt clinic data support hypothesi detriment effect hp diet bone health context inadequ calcium suppli addit hp intak promot bone growth retard bone loss low protein diet higher risk hip fractur increas acid calcium excret due hp diet accus constitut favor environ kidney stone renal diseas healthi subject damag effect hp diet kidney found observ intervent studi hp diet deleteri patient preexist metabol renal dysfunct hp diet lead calcium bone loss role protein complex depend dietari factor presenc nutrient diet
MED-3230~estim net acid excret invers correl urin ph vegan lacto ovo vegetarian omnivor pubm ncbi abstract object diet affect urin ph acid bas balanc excess acid alkalin ash eaa estim net acid excret nae calcul estim effect diet urin ph study goal determin free liv vegan lacto ovo vegetarian omnivor increas acid urin assess abil eaa estim nae calcul predict urin ph design studi cross sect design set particip studi assess urin sampl num vegan num lacto ovo vegetarian num healthi omnivor women boston metropolitan area num day food record dietari group analyz eaa content estim nae correl measur urin ph calcul result sd urin ph num num vegan num num lacto ovo vegetarian num num omnivor analysi varianc num calcul eaa valu signific group estim nae valu signific num num meq day vegan num num meq day lacto ovo vegetarian num num meq day omnivor analysi varianc num averag deattenu correl urin ph eaa num num estim nae urin ph regress equat ph num num nae num num conclus habitu diet estim nae calcul probabl rank urin ph dietari group determin acid bas status individu eaa calcul predict urin ph
MED-3231~alkalin diet evid alkalin ph diet benefit health abstract review role alkalin diet health pubm search articl ph potenti renal acid load bone health muscl growth hormon back pain vitamin chemotherapi book written lay literatur alkalin diet review evalu light publish medic literatur alkalin diet reduc morbid mortal chronic diseas studi warrant area medicin
MED-3232~dietari acid load lower bone miner densiti men low intak dietari calcium abstract high dietari acid load dal detriment bone miner densiti bmd object studi num evalu cross sect relat dal bmd num determin calcium intak modifi associ men num women num num includ nation health nutrit examin survey num num nutrient intak num num recal calcul net endogen acid product neap potenti renal acid load pral meq d pral calcul dietari calcium praldiet diet supplement calcium praltot test linear trend adjust bmd hip lumbar spine perform energi adjust neap pral quartil modif calcium intak dietari total num mg d assess interact term age num num women associ neap bmd praldiet posit proxim femur bmd trend num associ observ praltot bmd site p rang num num men signific associ observ bmd neap pral interact praldiet calcium intak observ proxim femur bmd num invers associ praldiet proxim femur bmd detect men num mg d dietari calcium num associ num mg d num signific interact praltot observ conclus supplement calcium consid associ dal bmd adult men low dietari calcium show invers relat pral proxim femur women interact observ studi highlight import calcium intak counteract advers effect dal bone health research determin relat dal chang bmd low calcium intak
MED-3233~diet high meat protein potenti renal acid load increas fraction calcium absorpt urinari calcium excret affect pubm ncbi abstract object studi determin effect high protein high potenti renal acid load pral diet calcium ca absorpt retent marker bone metabol random crossov design num postmenopaus women consum num diet num low protein low pral lplp total protein num g d pral num meq d num high protein high pral hphp total protein num g d pral num meq d num wk separ num wk break ca absorpt measur bodi scintil count radio label num ca compar lplp diet hphp diet increas particip serum igf i concentr num decreas serum intact pth concentr num increas fraction num ca absorpt pool sd num num num num urinari ca excret num num num mg d num net differ amount ca absorb excret urin differ num diet period num num num mg d dietari treatment affect marker bone metabol summari diet high protein pral increas fraction absorpt dietari ca partial compens increas urinari ca postmenopaus women increas igf i decreas pth concentr serum chang biomark bone resorpt format high protein diet advers effect bone health
MED-3235~alkalin diet favor lean tissu mass older adult abstract background maintain muscl mass age import prevent fall fractur metabol acidosi promot muscl wast net acid load diet rich net acid produc protein cereal grain relat content net alkali produc fruit veget contribut reduct lean tissu mass older adult object aim determin associ num urinari potassium index fruit veget content diet percentag lean bodi mass lbm chang lbm older subject design subject num men women num particip num trial compar calcium vitamin placebo potassium measur num urin collect baselin lbm defin total bodi nonfat nonbon tissu weight weight num measur dual energi x ray absorptiometri baselin num physic activ height weight assess baselin num result baselin urinari potassium excret num num mmol d urinari potassium mmol d signific posit lbm baselin num num adjust sex weight nitrogen excret num chang lbm num studi lbm increas num num conclus higher intak food rich potassium fruit veget favor preserv muscl mass older men women
MED-3236~nutrient base estim acid bas balanc vegetarian non vegetarian pubm ncbi abstract object present studi estim acid bas balanc food intak vegetarian non vegetarian object evalu addit input specif food item exist potenti renal acid load pral list comparison dietari pattern thirti vegetarian age num num year match sex age bmi num non vegetarian base num day food diari acid bas status food intak estim pral method pral valu estim standard tabl yield alkalin load num num meq d vegetarian compar acid load num num meq d nonvegetarian num pral valu estim extend tabl yield alkalin load num num meq d vegetarian compar acid load num num meq d non vegetarian num find studi vegetarian food intak produc alkalin outcom compar non vegetarian diet standard pral tabl suffici discrimin diet
MED-3237~diet induc metabol acidosi pubm ncbi abstract modern western typ diet defici fruit veget excess anim product generat accumul non metaboliz anion lifespan state overlook metabol acidosi magnitud increas progress age due physiolog declin kidney function respons state diet deriv metabol acidosi kidney implement compens mechan aim restor acid bas balanc remov non metaboliz anion conserv citrat enhanc kidney ammoniagenesi urinari excret ammonium ion adapt process lower urin ph induc extens chang urin composit includ hypocitraturia hypercalciuria nitrogen phosphat wast low urin ph predispos uric acid stone format hypocitraturia hypercalciuria risk factor calcium stone diseas mild degre metabol acidosi induc skelet muscl resist insulin action dietari acid load import variabl predict metabol abnorm cardiovascular risk general popul overweight obes person patient popul includ diabet chronic kidney failur high dietari acid load result diabet system hypertens increas cardiovascular risk result recent observ studi confirm associ insulin resist metabol acidosi marker includ low serum bicarbon high serum anion gap hypocitraturia low urin ph copyright num elsevi european societi clinic nutrit metabol reserv
MED-3238~veget intak reduc breast cancer recurr tamoxifen user secondari analysi women healthi eat pubm ncbi abstract protect effect veget risk breast cancer recurr uncertain sought evalu associ breast cancer recurr veget intak includ analys stratifi tamoxifen experiment evid anti carcinogen activ phytochem crucifer veget combin tamoxifen led specif evalu class veget assess associ veget intak breast cancer recurr veget intak repeat num dietari recal examin secondari analysi num breast cancer survivor enrol women healthi eat live whel studi time enrol women averag num month post diagnosi hazard recurr control relev signific clinic demograph variabl veget intak assess separ women tamoxifen whel particip report baselin intak se num num num num servings day total crucifer veget baselin veget intak highest compar lowest tertil lower adjust hazard ratio hr recurr num num ci num num women tamoxifen hrs num num ci num num total veget num num ci num num crucifer veget intak hazard women tamoxifen report crucifer veget intak median highest tertil total veget intak hr num num ci num num secondari analysi num breast cancer survivor suggest baselin veget intak reduct risk breast cancer recurr event tamoxifen associ explor possibl veget intak simpli surrog health promot behavior rule
MED-3241~signific dietari intak supplement breast cancer diagnosi uk multicentr studi pubm ncbi abstract diagnosi cancer motiv survivor alter lifestyl habit healthcar provid awar patient make order deriv pertin recommend studi report pre post diagnost lifestyl behaviour semi quantit food frequenc questionnair ffqs complet approxim num year diagnosi evalu dietari intak supplement diagnosi cohort num breast cancer patient particip uk prospect dietcomplyf studi intak fruit veget wholegrain lean sourc protein increas signific post diagnosi num convers diagnosi consumpt high fat high sugar product red meat coffe alcohol drink refin grain signific decreas num post diagnost diet accompani intak macronutri number vitamin miner supplement high preval num pre diagnosi increas num diagnosi num fish oil multivitamin miner primros oil proport user signific increas num diagnosi percentag women oestrogen botan supplement obss small doubl num diagnosi num british women particip dietcomplyf studi report signific dietari intak supplement breast cancer diagnosi find contribut understand femal cancer survivor dietari behaviour crucial develop implement recommend
MED-3242~macronutri intak risk urotheli cell carcinoma european prospect investig cancer nutrit pubm ncbi abstract previous studi suggest dietari factor import develop bladder cancer examin macronutri intak relat risk urotheli cell carcinoma num men women european prospect investig cancer nutrit associ examin cox regress stratifi sex age recruit centr adjust smoke status durat bodi mass index total energi intak averag num year follow up num case urotheli cell carcinoma identifi measur error num increas consumpt energi intak anim protein num higher risk num confid interv ci num trend num num increas energi plant protein intak num lower risk num ci num trend num dietari intak fat carbohydr fibr calcium risk find suggest anim and or plant protein affect risk urotheli cell carcinoma examin associ studi copyright num uicc
MED-3243~dietari intervent recurr prostat cancer definit primari treatment result random pilot trial pubm ncbi abstract object evid shown diet affect incid progress prostat cancer object studi determin men situat make chang diet emphas plant bas food fish examin effect qualiti life qol prostate specif antigen psa veloc method total num men partner random assign attend seri num dietari cook class integr mind practic support make chang wait list control group assess made dietari intak qol psa baselin intervent num week num month intervent result intervent group show signific reduct consumpt satur fat increas consumpt veget protein accompani reduct anim protein includ dairi product show increas qol signific chang found rate psa increas group psa doubl time intervent group substanti longer num month follow up visit control conclus men increas psa level primari treatment make chang prostate healthi diet accompani increas qol signific differ found log psa slope group psa doubl time increas substanti intervent group compar control futur trial examin effect prostate healthi diet larger sampl men longer period
MED-3244~measur dietari chang prostat cancer dietari program incorpor mind train abstract diet repres modifi prostat cancer cap risk factor vegetable bas prostate healthi diet major chang men ratio animal veget protein a v ratio evalu comprehens dietari chang self sustain complet num week dietari cook class integr mind train mt thirty six men recur cap random intervent wait list control assess baselin month month num men random intervent num complet requir nineteen random control num complet requir compar control signific post intervent num month decreas a v ratio intervent group num self maintain num month post intervent num assess a v ratio correl lycopen fiber satur fat dietari cholesterol dietari compon link clinic relev outcom cap chang a v ratio signific correl fiber satur fat dietari cholesterol intak particip report regular mt practic signific correl mt practic initi mainten chang a v ratio pilot result provid encourag evid feasibl dietari program includ mt support dietari chang men recurr cap invit studi explor role mt support initi dietari mainten time
MED-3245~veget fruit intak diagnosi risk prostat cancer progress abstract crucifer veget tomato sauc legum reduc risk incid advanc prostat cancer vitro anim studi suggest food inhibit progress prostat cancer limit data men prospect examin intak total veget specif crucifer veget tomato sauc legum diagnosi reduc risk prostat cancer progress num men diagnos non metastat prostat cancer particip cancer prostat strateg urolog research endeavor unit state prostat cancer registri secondari analysi examin veget sub group total fruit subgroup fruit particip diagnos primarili community bas clinic num num assess veget fruit intak semi quantit food frequenc questionnair ascertain prostat cancer outcom urologist report medic record observ num event progress num biochem recurr num secondari treatment due recurr bone metastas prostat cancer death num person yr men fourth quartil post diagnost crucifer veget intak statist signific num decreas risk prostat cancer progress compar men lowest quartil hazard ratio hr num num confid interv ci num num p trend num veget fruit group statist signific risk prostat cancer progress conclus crucifer veget intak diagnosi reduc risk prostat cancer progress
MED-3247~evid report efficaci safeti mitoxantron novantron treatment multipl sclerosi abstract object chemotherapeut agent mitoxantron approv multipl sclerosi ms num review evid origin report therapeut technolog assess subcommitte num conclud mitoxantron reduc clinic attack rate mri activ diseas progress subsequ report decreas systol function heart failur leukemia prompt food drug administr institut black box warn num review undertaken examin literatur efficaci safeti mitoxantron patient ms initi report method relev articl obtain review medic literatur strength evid grade american academi neurolog evid classif scheme result accumul class iii iv evid suggest increas incid systol dysfunct therapy rel acut leukemia tral mitoxantron therapi systol dysfunct occur num patient ms treat mitoxantron congest heart failur occur num leukemia occur num number harm num systol dysfunct num tral efficaci evid chang recommend previous report conclus risk systol dysfunct leukemia patient treat mitoxantron higher suggest time previous report comprehens postmarket surveil data lack glossari
MED-3248~retin arteri correl cerebr small vessel diseas pubm ncbi abstract object examin relat retin arteri diseas cerebr small vessel diseas svd method prospect cohort patient symptomat atherosclerot diseas author perform retin photograph brain mri ophthalmologist awar mr result independ assess retin arteri narrow cross sclerosi tortuos standard score list observ independ assess white matter lesion wml lacunar infarct mr imag lesion consid abnorm ophthalmologist mr rater agre cerebr svd defin presenc wml lacunar infarct result num patient retin photograph brain mri perform num patient mr sign svd num retin vascular abnorm num patient svd num retin patholog num type retin vascular patholog occur frequent patient svd retin arteri narrow sclerosi differ signific num normotens patient presenc retin vascular chang correl sign svd num conclus patholog retin arteri parallel small cerebr arteri wml lacun hypertens normotens patient
MED-3249~effect low satur fat diet earli late case multipl sclerosi pubm ncbi abstract num multipl sclerosi patient low fat diet num year categori neurolog disabl minimum moder sever patient adher prescrib diet equal num fat day show signific deterior lower death rate consum fat prescrib greater num fat day greatest benefit minimum disabl start trial group die non m diseas exclud analysi num surviv remain physic activ
MED-3250~improv endothelium depend coronari vasodil singl ldl apheresi patient hypercholesterolemia pubm ncbi abstract purpos studi determin singl ldl apheresi improv impair endothelium depend dilat coronari arteri patient hypercholesterolemia hypercholesterolemia impair endotheli function human studi cholesterol low drug endotheli function coronari arteri improv reduct serum ldl cholesterol num num month intern diamet left coronari arteri coronari blood flow measur intracoronari doppler wir measur quantit angiographi immedi singl ldl apheresi popul num patient famili hypercholesterolemia endothelium depend vasodil assess intracoronari infus acetylcholin num num microg min endothelium independ vasodil assess intracoronari bolus infus isosorbid dinitr num mg papaverin num mg singl num hour ldl apheresi reduc serum ldl cholesterol averag num num ldl apheresi coronari arteri diamet coronari blood flow respons infus num microg min acetylcholin increas signific compar pre apheresi valu num num num num num num num num num num ldl apheresi signific chang respons paramet infus isosorbid dinitr papaverin endotheli function epicardi coronari arteri coronari microvasculatur improv hypercholesterolem patient singl ldl apheresi procedur mark reduc serum level ldl cholesterol copyright num wiley liss
MED-3251~associ interferon beta progress disabl patient relapsing remit multipl sclerosi pubm ncbi abstract context interferon beta wide prescrib treat multipl sclerosi ms relationship disabl progress establish object investig associ interferon beta exposur disabl progress patient relapsing remit ms design set patient retrospect cohort studi base prospect collect data num british columbia canada patient relapsing remit ms treat interferon beta num compar untreat contemporari num histor num cohort main outcom measur main outcom measur time interferon beta treatment elig baselin confirm sustain score num requir cane walk num confirm num day measur improv expand disabl status scale edss rang num higher score indic higher disabl multivari cox regress model interferon beta treatment includ time vari covari assess hazard diseas progress interferon beta treatment analys includ propens score adjust address confound indic result median activ follow up time edss measur interferon beta tr cohort num year interquartil rang iqr num num year contemporari control cohort num year iqr num num year histor control cohort num year iqr num num year observ outcom rate reach sustain edss score num num num num num cohort adjust potenti baselin confound sex age diseas durat edss score exposur interferon beta statist signific differ hazard reach edss score num contemporari control cohort hazard ratio num num ci num num num histor control cohort hazard ratio num num ci num num num consid adjust comorbid socioeconom status chang interpret propens score adjust substanti chang result conclus patient relapsing remit ms administr interferon beta reduct progress disabl
MED-3252~molecular basi nutrit intervent multipl sclerosi narrat review pubm ncbi abstract common accept nutrit environment factor involv pathogenesi multipl sclerosi ms role complementari ms treatment unclear larg disregard present ms therapi diet due lack inform effect nutrit diseas overcom distrust dietari control ms encourag nutrit intervent diseas assess natur role bioactiv dietari molecul target establish dietari control influenc cell metabol improv ms patient aim review provid rational nutrit intervent ms evalu molecular level effect dietari molecul inflammatori autoimmun process involv diseas present data reveal healthi dietari molecul pleiotrop role chang cell metabol anabol catabol down regul inflamm interact enzym nuclear receptor transcript factor control gut dysbiosi combin hypo calor low fat diet specif vitamin oligoel dietari integr includ fish oil polyphenol slow down progress diseas amelior ms patient copyright num elsevi reserv
MED-3253~pathobiolog determin atherosclerosi youth risk score earli advanc atherosclerosi pubm ncbi abstract object atherosclerosi begin childhood progress adolesc young adulthood pathobiolog determin atherosclerosi youth studi previous report risk score estim probabl advanc atherosclerot lesion young individu age num num year coronari heart diseas risk factor gender age serum lipoprotein concentr smoke hypertens obes hyperglycemia studi investig relat risk score earli atherosclerot lesion method measur atherosclerot lesion left anterior descend coronari arteri coronari arteri abdomin aorta coronari heart diseas risk factor person num num year age die result extern autopsi forens laboratori result risk score comput modifi risk factor preval microscop demonstr lesion atherosclerosi american heart associ grade num left anterior descend coronari arteri extent earliest detect gross lesion fatti streak coronari arteri abdomin aorta risk score comput modifi risk factor preval lesion higher degre microscop sever intermedi advanc left anterior descend coronari arteri extent lesion higher degre sever intermedi rais lesion coronari arteri abdomin aorta conclus risk score calcul tradit coronari heart diseas risk factor identifi individu young person high probabl advanc atherosclerot lesion earlier atherosclerot lesion includ earliest anatom demonstr atherosclerot lesion result support lifestyl modif youth prevent develop initi lesion subsequ progress advanc lesion prevent delay coronari heart diseas
MED-3254~relat serum lipoprotein level systol blood pressur earli atherosclerosi bogalusa heart studi pubm ncbi abstract assess relat risk factor cardiovascular diseas earli atherosclerot lesion aorta coronari arteri num person age death num year aortic involv fatti streak greater black white num num percent num aortic fatti streak strong relat antemortem level total low dens lipoprotein cholesterol num num associ independ race sex age invers correl ratio high dens lipoprotein cholesterol low dens very low dens lipoprotein cholesterol num num coronary arteri fatti streak correl very low dens lipoprotein cholesterol num num systol blood pressur level tend higher subject coronary arteri fibrous plaqu num mm hg compar num num result document import risk factor level earli anatom aorta coronari arteri progress fatti streak fibrous plaqu uncertain data suggest ration approach prevent cardiovascular diseas begin earli life
MED-3255~endotheli function healthi num year old children dietari intervent onset infanc special turku coronari risk factor inter pubm ncbi abstract background earli childhood introduct nutrit habit aim atherosclerosi prevent reduc children serum total cholesterol concentr effect vascular endotheli function unknown method result num num random healthi num month old infant num intervent low saturated fat diet control unrestrict diet group age num year endothelium depend flow medi endothelium independ nitrate medi vasodilatori respons brachial arteri measur high resolut ultrasound num intervent num control children effect intervent endotheli function signific boy num girl num maximum endothelium depend dilat respons mean   sd num num num num intervent boy control boy num num num num intervent girl control girl intervent effect nitrate medi dilat differ endotheli function boy remain signific adjust current serum total ldl cholesterol nonsignific adjust cholesterol measur num year age adjust num ci num num versus num ci num num num conclus low saturated fat diet introduc infanc maintain decad life enhanc endotheli function boy effect explain part diet induc reduct serum cholesterol concentr
MED-3270~protein methionin content mda lysin adduct invers relat maximum life span heart mammal pubm ncbi abstract age affect organ basic mechan expect conserv speci oxid protein propos basic mechan link oxygen radic basic age process oxid damag protein involv age long liv anim age slowli show lower level marker kind damag short liv possibl investig studi steady st level marker kind protein damage  oxid glutam aminoadip semialdehyd mix glyco lipoxid carboxymethyl carboxyethyllysin lipoxid malondialdehydelysin amino acid composition  wer measur heart mammalian speci rang maximum life span mlsp num num year oxid marker direct correl mlsp speci mix glyco lipoxid marker correl mlsp lipoxid marker malondialdehydelysin invers correl mlsp num num num amino acid composit analysi reveal methionin amino acid strong correl mlsp correl negat num num num trait contribut lower steady st level oxid methionin residu cellular protein result reinforc notion high longev homeotherm vertebr achiev part constitut decreas sensit tissu protein lipid oxid damag obtain modifi constitu structur compon protein lipid select sensit oxid modif
MED-3271~dietari methionin restrict increas effect chemotherapi treatment advanc cancer pubm ncbi abstract metastat tumor origin prostat lung gastrointestin tract respond poor convent chemotherapi treatment strategi advanc cancer desper dietari restrict essenti amino acid methionin offer promis strategi combin chemotherapi treatment numer vitro anim studi demonstr effect dietari methionin restrict inhibit growth eventu caus death cancer cell contrast normal host tissu resist methionin restrict preclin observ led phase clinic trial dietari methionin restrict adult advanc cancer preliminari find trial dietari methionin restrict safe feasibl treatment patient advanc cancer addit trial yield preliminari evid antitumor activ patient hormone independ prostat cancer experienc num reduct serum prostate specif antigen psa num week diet patient renal cell cancer experienc object radiograph respons possibl methionin restrict act synergist cancer treatment chemotherapi explor find date support investig dietari methionin restrict treatment strategi advanc cancer
MED-3272~colorect cancer screen odour materi canin scent detect abstract object earli detect earli treatment vital import success treatment cancer develop screen method econom non invas faecal occult blood test fobt earli detect colorect cancer crc studi undertaken canin scent detect determin odour materi effect tool crc screen design exhal breath wateri stool sampl obtain patient crc healthi control prior colonoscopi test group consist sampl patient crc control sampl volunt cancer sampl random separ box labrador retriev special train scent detect cancer handler cooper test dog smell standard breath sampl patient crc smell sampl station sat front station cancer scent detect result num num group breath wateri stool sampl test patient crc control sensit canin scent detect breath sampl compar convent diagnosi colonoscopi num specif num sensit canin scent detect stool sampl num specif num accuraci canin scent detect high earli cancer canin scent detect confound current smoke benign colorect diseas inflammatori diseas conclus studi show specif cancer scent exist cancer specif chemic compound circul bodi odour materi effect tool crc screen futur studi design identifi cancer specif volatil organ compound import develop method earli detect crc
MED-3273~low methionin content vegan diet make methionin restrict feasibl life extens strategi pubm ncbi abstract recent studi confirm dietari methionin restrict increas maxim lifespan rat mice achiev age retard effect similar calor restrict includ suppress mitochondri superoxid generat voluntari calor restrict gain popular pro longev strategi human feasibl achiev moder methionin restrict light fact vegan diet tend low amino acid plant protein deriv legum nut tend lower methionin anim protein total protein content vegan diet function calori content lower omnivor diet plant protein lower bioavail anim protein whole food vegan diet moder bean soy intak includ ampl amount fruit wine beer low methionin suppli abund nutrit health assum concurr num supplement low fat vegan diet coupl exercis train expect promot longev decreas system level insulin free igf i effect amplifi methionin restrict clear igf i down regul sole basi impact low methionin diet longev rodent
MED-3274~olfactori detect human bladder cancer dog proof principl studi abstract object determin dog train identifi peopl bladder cancer basi urin odour success expect chanc design experiment proof principl studi dog train discrimin urin patient bladder cancer urin diseas healthi control evalu test requir select bladder cancer urin sampl control particip num male femal patient age rang num year present recurr transit cell carcinoma bladder num sampl train num formal test num male femal control diseas healthi age rang num year num sampl train num test main outcom measur proport success dog achiev evalu compar expect num num result group dog correct select urin patient bladder cancer num num occas gave success rate num confid interv num num assumpt normal num num bootstrap method compar num expect chanc multivari analysi suggest dog capac recognis characterist bladder cancer odour independ chemic aspect urin detect urinalysi conclus dog train distinguish patient bladder cancer basi urin odour success expect chanc suggest tumour relat volatil compound present urin impart characterist odour signatur distinct secondari effect tumour bleed inflamm infect
MED-3275~effect replac methionin homocystin surviv malign normal adult mammalian cell cultur abstract tissu cultur normal adult malign mammalian cell homocystin substitut methionin medium rich folic acid cyanocobalamin normal adult cell thrive high malign cell type speci includ man die
MED-3276~review methionin depend role methionin restrict cancer growth control life span extens pubm ncbi abstract methionin essenti amino acid key role mammalian metabol protein synthesi methyl dna polyamin synthesi restrict methionin import strategi cancer growth control cancer exhibit depend methionin surviv prolifer methionin depend cancer due combin delet polymorph alter express gene methionin de novo salvag pathway cancer cell defect unabl regener methionin pathway defect metabol folat contribut methionin depend phenotyp cancer select kill methionin depend cancer cell co cultur normal cell demonstr cultur media defici methionin anim studi util methionin restrict diet report inhibit cancer growth extens healthi life span human vegan diet low methionin prove nutrit strategi cancer growth control develop methioninas deplet circul level methionin strategi limit cancer growth applic nutrit methionin restrict methioninas combin chemotherapeut regimen current focus clinic studi copyright num elsevi reserv
MED-3277~express biochem defect methionin depend fresh patient tumor primari histocultur pubm ncbi abstract methionin depend metabol defect occur human tumor cell line normal unestablish cell strain methionine depend tumor cell line unabl prolifer arrest late s g num phase cell cycl methionin replac precursor homocystein cultur medium met hci medium methionin depend occur fresh patient tumor cell line order determin methionin depend occur fresh patient tumor methionin depend occur fresh patient tumor cell line advantag techniqu sponge gel support histocultur grow tumor direct surgeri measur nuclear dna content imag analysi determin cell cycl posit met hci compar met hci medium num human patient tumor human tumor cell line found methionin depend cell count posit control found mark reduct cell num compar total cell cell cycl met hci medium respect num total cell ratio met hci medium late cell cycl arrest marker methionin depend histocultur patient tumor found num human tumor num includ tumor colon breast ovari prostat melanoma methionin depend base cell cycl analysi data fresh human tumor methionin depend frequent occur cancer patient popul implic potenti therapi base methionin depend discuss
MED-3278~sniffer dog part bimod bionic research approach develop lung cancer screen abstract lung cancer lc continu repres heavi burden health care system worldwid epidemiolog studi predict role increas futur patient prognosi strong tumour stage earli detect diseas screen test exist suggest electron sensor devic common refer electron nose applic identifi cancer specif volatil organ compound breath patient repres promis screen technolog decad research bring forward clinic applic devic propos research approach involv special train sniffer dog research strategi make abil identifi lc breath sampl patient
MED-3279~chitin synthesi degrad target pesticid action pubm ncbi abstract pesticid destabil perturb inhibit crucial biochem physiolog target relat metabol growth develop nervous communic behavior pestifer organ chitin eukaryot extracellular aminosugar biopolym massiv produc fungal system invertebr notabl arthropod integr support compon fungal cell wall insect cuticl nematod egg shell chitin consid select target pesticid action elabor process chitin format deposit polymer event cell membran compart chemic interfer actinomycetes deriv nucleosid peptid fungicid polyoxin insecticid benzoylaryl urea reach commerci pesticid status polyoxin structurally rel antibiot nikkomycin strong competit inhibitor polymer enzym chitin synthas exact biochem lesion inflict benzoylaryl urea elus post polymer event transloc chitin chain cell membran suggest hydrolyt degrad chitin polym essenti hyphal growth branch septum format fungal system normal molt arthropod recent insect chitinas activ strong specif suppress allosamidin actimomycetes deriv metabolit part defens mechan plant invas pathogen induc chitinas chitin chitosan oligom act elicitor induc enhanc level chitinas plant lectin bind n acetyl d glucosamin strong interfer fungal insect chitin synthas plant lectin similar properti involv plant pathogen interact inter alia suppress fungal invas
MED-3280~methionin depend cancer treatment pubm ncbi abstract convent chemotherapi show limit notabl patient advanc cancer therapeut strategi identifi metabol abnorm cancer cell offer opportun human cancer cell line primari tumor absolut requir methionin essenti amino acid contrast normal cell resist exogen methionin restrict biochem mechan methionin depend studi extens fundament mechan remain unclear number investig attempt exploit methionin depend tumor therapeut effect vivo reduc vivo methionin plasma tumour dietari pharmacolog treatment methionine fre diet methionine depriv total parenter nutrit regress varieti anim tumour altern methionin deplet achiev methioninas enzym specif degrad methionin inhibit tumour growth preclin model potenti toxic qualiti life problem prolong methionin restrict diet methioninas suitabl clinic methionin restrict find greater applic associ chemotherapeut agent preclin studi demonstr synergi methionin restrict cytotox chemotherapi drug experiment result accumul decad suggest methionin restrict addit cancer therapeut strategi notabl associ chemotherapi
MED-3281~target methionin auxotrophi cancer discoveri explor pubm ncbi abstract introduct amino acid auxotrophi metabol defect render cancer incap surviv amino acid deplet condit exploit explor therapeut cancer earli clinic data asparagin arginine deplet drug demonstr low toxic efficaci melanoma hepatocellular carcinoma acut lymphoblast leukemia methionin auxotrophi nich explor target cancer area cover review explor discoveri methionin auxotrophi vitro vivo patient data target cancer methionin deplet end small discuss bioengin pegyl red blood cell encapsul mechan decreas immunogen methionine deplet drug hope provid platform futur pharmacolog toxicolog cytotox studi methionin deplet therapi drug expert opinion methionin auxotrophi viabl target extens research address normal versus cancer cell toxic conduct research conduct molecular mechan methionin deplet therapi final method develop decreas immunogen methionine deplet drug current issu protein therapeut
MED-3282~generat gaseous sulfur contain compound tumour tissu suppress gas diffus antitumour treatment pubm ncbi abstract background aim mechan cancer cell growth metastasi understood viewpoint chemic reaction tumour glycolyt metabol mark acceler cancer cell caus accumul glucos reduc sugar methionin amino acid non enzymat react form carcinogen substanc specul reaction produc gaseous sulfur contain compound tumour tissu aim studi clarifi product tumour investig effect tumour prolifer method product form reaction glucos methionin metabolit analys vitro gas chromatographi flatus sampl patient colon cancer exhal air sampl patient lung cancer analys near edg x ray fine adsorpt structur spectroscopi compar healthi individu tumour prolifer rate mice ht num human colon cancer cell implant compar mice cancer cell surround sodium hyaluron gel prevent diffus gaseous materi healthi cell result gaseous sulfur contain compound methanethiol hydrogen sulfid produc glucos react methionin metabolit homocystein cystein near edg x ray fine adsorpt structur spectroscopi show concentr sulfur contain compound sampl flatus patient colon cancer sampl exhal air patient lung cancer signific higher healthi individu anim experi show prevent diffus sulfur contain compound pronounc antitumour effect conclus gaseous sulfur contain compound main product tumour prevent diffus compound reduc tumour prolifer rate suggest possibl approach cancer treatment
MED-3283~lower methionin ingest respons decreas rodent mitochondri oxid stress protein dietari restrict pubm ncbi abstract inform long liv mammal low rate reactiv oxygen speci ros generat oxid damag mitochondria hand studi consist shown dietari restrict dr rodent decreas mitochondri ros mtros product oxid damag mitochondri dna protein observ protein restrict decreas mtros generat oxid stress rat liver carbohydr lipid restrict chang paramet interest protein restrict increas maximum longev rodent lower extent dr practic intervent human dr carbohydr lipid restrict chang rodent longev found isocalor methionin restrict decreas mtros generat oxid stress rodent tissu manipul increas maximum longev rat mice addit excess dietari methionin increas mtros generat rat liver studi suggest reduc intak dietari methionin respons decreas mitochondri ros generat ensu oxid damag occur dr part increas maximum longev induc dietari manipul addit intak protein methionin western human popul higher decreas level recommend great potenti lower tissu oxid stress increas healthi life span human avoid undesir effect dr diet
MED-3288~outbreak progress inflammatori neuropathi exposur aerosol porcin neural tissu pubm ncbi abstract fall num minnesota depart health notifi num case unexplain neurolog ill link pork process plant qualiti pork processor austin mn cluster worker experienc similar symptom includ fatigu pain numb tingl extrem weak symptom sensori motor patient evid polyradiculoneuropathi sign nerv root irrit epidemiolog investig reveal common case exposur pork brain extract procedur involv compress air relat case remain asymptomat cultur pathogen negat etiolog syndrom infecti clinic syndrom akin chronic inflammatori demyelin polyneuropathi laboratori test corrobor clinic find reveal inflamm peripher nerv nerv root case featur clinic distinct chronic inflammatori demyelin polyneuropathi laboratori test reveal immunoglobulin immunostain pattern suggest observ inflamm result num unidentifi antigen syndrom ultim dub progress inflammatori neuropathi theoriz autoimmun reaction aerosol porcin neural tissu investigation outset num case progress inflammatori neuropathi identifi minnesota pork process plant num similar case indiana plant num case nebraskan plant plant case identifi stop compress air remov pork brain case stabil improv requir immunosuppress analges treatment studi progress inflammatori neuropathi ongo detail investig highlight epidemiolog principl identif outbreak research attempt uncov uniqu pathophysiolog potenti etiolog ill mt sinai med num num num mount sinai school medicin
MED-3292~restrict zoonot perv transmiss human apobec num abstract human apobec num protein innat anti vir factor domin inhibit replic endogen exogen retrovirus prospect purpos har anti vir defens investig long term co cultur experi show porcin endogen retrovirus perv transmiss pig human cell reduc undetect level express human apobec num virus produc pig kidney cell inhibit occur deamination independ mechan particl product virus immort integr human genom dna perv inhibit requir dna cytosin deaminas activ apobec num correspond apobec num attribut hypermut detect contrast over express sole endogen apobec num protein pig fail interfer signific perv transmiss data constitut proof of principl demonstr apobec num protein fortifi innat anti vir defens cell prevent zoonot transmiss endogen retrovirus studi suggest human apobec num transgen pig provid safer perv less xenotransplant resourc analog cross speci apobec num depend restrict strategi thwart endogen exogen retrovirus infect
MED-3294~emerg re emerg swine virus pubm ncbi abstract past decad number virus emerg global swine popul porcin reproduct respiratori syndrom virus prrsv porcin circovirus type num pcv num econom import diseas pig porcin torqu teno virus ttv torqu teno sus virus ttsuv porcin bocavirus pbov relat parvovirus porcin kobuvirus porcin torovirus ptov porcin lymphotrop herpesvirus plhv subclin swine herd emerg swine virus swine hepat virus swine hev porcin endogen retrovirus perv porcin sapovirus porcin sav limit clinic implic swine health pose potenti public health concern human due zoonot swine hev potenti zoonot porcin sav xenozoonot perv plhv risk emerg virus nipah virus bungowannah virus menangl virus diseas pig pose import zoonot threat human articl focus emerg re emerg swine virus limit uncertain clinic econom impact pig health transmiss epidemiolog pathogen potenti virus discuss addit econom import emerg virus prrsv pcv num briefli discuss identifi import knowledg gap num blackwel verlag gmbh
MED-3295~cancer noncanc mortal american seafood worker abstract background studi investig mortal seafood worker worldwid studi conduct unit state object studi investig mortal american seafood worker method studi popul deriv num state consist num subject work seafood process plant num num standard mortal ratio smrs proport mortal ratio pmrs estim general popul comparison result num cohort born num total num death record num deced femal num white smrs stomach cancer disord thyroid gland cohort num num confid interv ci num num num num ci num num smrs breast cancer occlusion stenosi pre cerebral cerebr arteri cohort num num ci num num num num ci num num smr ischem heart diseas white femal num num ci num num conclus cohort excess death stomach cancer disord thyroid gland deficit death breast cancer stroke ischem heart diseas signific find unknown num cohort deceas cohort uniqu import follow up shed light mortal pattern occup group
MED-3302~cluster immune medi polyradiculoneuropathi swine abattoir worker expos aerosol porcin brain indiana unit state pubm ncbi abstract novemb num neuropathi immune medi polyradiculoneuropathi ip identifi worker minnesota swine abattoir uniqu compress air techniqu remov porcin brain epidemiolog investig abattoir indiana process launch evalu worker self report neurolog ill compat ip nest case control studi perform identifi case risk factor confirm probabl ip case detect ip case num year latino origin num femal onset date rang april num decemb num hospit ip case plant similar clinic present exposur risk detect minnesota swine abattoir similar brain extract method discontinu process
MED-3305~non occup malign pleural mesothelioma due asbesto non asbesto fibr pubm ncbi abstract background aim occurr malign pleural mesothelioma mpm report popul group document profession exposur asbesto fibr live geograph area paper review exist data relat occup mpm includ occurr provinc catania sicili itali method electron search literatur relat occup mpm perform includ year num result occup mpm subject live area contamin varieti asbesto asbesto fibr document number epidemiolog studi includ case seri case control studi cohort studi addit observ famili cluster mpm suggest genet factor play role pathogenesi malign epidemiolog evid suggest mpm occur result interact environment carcinogen genet factor virus infect conclus genet predisposit non occup exposur low dose asbesto asbestos lik fibr concur develop malign mesothelioma addit epidemiolog laboratori studi understand relationship environment exposur individu suscept malign
MED-3306~farm grow farm haematolog cancer mortal pubm ncbi abstract object occup farmer increas risk haematolog cancer adult studi aim examin farm exposur childhood contribut risk parent occup farm proxi grow farm method zealand death record num person age num extract num num usual occup occup parent code num uncondit logist regress analys includ num haematolog cancer death case num death control farm grow farm adjust year birth age death socio econom status ori ethnic immigr status sex result grow livestock farm posit haematolog cancer num num ci num num poultri farm num num ci num num grow crop farm num num ci num num crop farm adulthood increas haematolog cancer risk num num ci num num livestock farm num num ci num num beef cattl farm num num ci num num result chang appreci control group death conclus result suggest role earli life biolog exposur develop haematolog cancer
MED-3307~mortal worker employ pig abattoir process plant pubm ncbi abstract object worker slaughterhous process plant handl pig pork butchers meatcutt studi health risk employ spite fact potenti expos oncogen non oncogen transmiss agent chemic carcinogen work report updat mortal num worker employ abattoir process plant exclus handl pig pork product method standard mortal ratio smrs estim cohort subgroup defin race sex general popul mortal rate comparison studi subject januari num decemb num time num die result mortal signific increas cohort statist signific excess death observ colon lung cancer entir cohort smr num num ci num num smr num num ci num num signific smrs cohort observ senil pre senil psychot condit smr num num ci num num pneumonia smr num num ci num num observ excess subarachnoid hemorrhag white smr num num ci num num suggest excess death ischem heart diseas elev smr confin men statist signific conclus studi confirm excess occurr lung colon cancer stroke previous report occup group find excess risk senil pre senil psychot condit pneumonia excess colon cancer specif pig pork worker evid larger studi worker abattoir process plant handl cattl sheep caution exercis interpret find occur chanc result examin larg number death multipl studi subgroup moment signific find remain unknown confirm larger studi adequ statist power studi account occup non occup confound factor copyright num publish elsevi
MED-3308~wave asbestos rel diseas secondari asbesto case report industri pubm ncbi abstract occup health survey conduct workshop asbesto cement show initi atmospher asbesto level rang num num fibr millilitr air radiolog suggest asbestos rel pleural diseas found num worker num num num borderlin featur asbestosi survey confirm uncontrol hazard asbesto continu industri public awar danger asbesto regul num
MED-3309~restrict zoonot perv transmiss human apobec num abstract human apobec num protein innat anti vir factor domin inhibit replic endogen exogen retrovirus prospect purpos har anti vir defens investig long term co cultur experi show porcin endogen retrovirus perv transmiss pig human cell reduc undetect level express human apobec num virus produc pig kidney cell inhibit occur deamination independ mechan particl product virus immort integr human genom dna perv inhibit requir dna cytosin deaminas activ apobec num correspond apobec num attribut hypermut detect contrast over express sole endogen apobec num protein pig fail interfer signific perv transmiss data constitut proof of principl demonstr apobec num protein fortifi innat anti vir defens cell prevent zoonot transmiss endogen retrovirus studi suggest human apobec num transgen pig provid safer perv less xenotransplant resourc analog cross speci apobec num depend restrict strategi thwart endogen exogen retrovirus infect
MED-3310~type hypersensit pneumon salami brusher diseas pubm ncbi abstract observ consecut case hypersensit pneumon subject work salami factori worker clean white mould grow salami surfac manual wire brush patient femal age num num year smoker patient acut clinic present fever dyspnoea dri cough oxygen desatur present emerg depart suspect diagnosi communiti acquir pneumonia latenc develop respiratori symptom num day pulmonari function test demonstr reduct diffus capac dlco num patient num num predict skin prick test posit penicillium spp num case cladosporium aspergillus spp num specif igg antibodi penicillium spp posit num subject num posit aspergillus fumigatus prevail radiolog pattern ground glass patient acut clinic onset centrilobular patient subacut onset patient advis avoid exposur antigen follow up visit includ pulmonari function test dlco measur conduct month hrct perform month subject complet radiolog clinic resolut chang work patient treat oral steroid sever dyspnoea progress reduct dlco gain complet radiolog clinic stabil month
MED-3311~cancer mortal worker employ cattl pig sheep slaughter process plant pubm ncbi abstract object studi mortal separ cohort worker abattoir num meat process plant num belong meatcutt union expos virus cancer food anim chemic carcinogen work method standard mortal ratio smrs proport mortal ratio pmrs estim cohort subgroup defin race sex general popul mortal rate comparison studi subject januari num decemb num time num die result excess death cancer base tongu esophagus lung skin bone bladder lymphoid leukemia benign tumor thyroid endocrin gland possibl hodgkin diseas observ abattoir meat process worker signific lower smrs record cancer thymus mediastinum pleura breast cancer non hodgkin lymphoma conclus studi confirm excess occurr cancer worker abattoir meat process plant butcher meatcutt previous report cohort similar cohort worldwid larg nest case control studi examin specif occup non occup exposur respons excess suffici evid step protect worker carcinogen exposur workplac implic general popul expos virus copyright num elsevi reserv
MED-3312~synerg alcohol diabet viral hepat risk hepatocellular carcinoma black white pubm ncbi abstract background heavi alcohol consumpt viral hepat diabet risk factor hepatocellular carcinoma hcc author knowledg inform interact effect patient risk hcc spars method population bas case control studi hcc conduct num studi involv num hcc case num age gender race match control subject hispan non hispan white black los angel counti california lifestyl risk factor ascertain in person interview infect hepat hcv virus determin serolog marker result fourteen hcc case control subject test posit hepat surfac antigen seroposit antibodi hcv odd ratio num confid interv num ci num hcc seroposit antibodi hepat core antigen relat num num ci num num heavi alcohol consumpt cigarett smoke found independ statist signific threefold increas risk hcc adjust hepat serolog subject histori diabet num num ci num num hcc compar nondiabet subject synergist interact hcc risk observ heavi alcohol consumpt diabet num num ci num num heavi alcohol consumpt viral hepat num num ci num num diabet viral hepat num num ci num num conclus heavi alcohol consumpt diabet viral hepat found exert independ synergist effect risk hcc black white copyright num american cancer societi
MED-3313~occup toxicolog asbestos rel malign pubm ncbi abstract introduct asbesto ban western countri relat malign clinic concern long latenc review identifi address controversi occup clinic aspect asbestos rel malign method paper publish english num num retriev pubm total num origin articl identifi num includ assess exposur retrospect assess exposur perform questionnair job exposur matric care collect medic histori crucial inform manufactur process specif job obtain addit fiber asbesto bodi count lung tissu broncho alveolar lavag sputum techniqu interlaboratori variabl hamper interpret report measur screen malign effect low dos chest ct screen expos worker debat biomark consid screen individu risk lung cancer mesothelioma reliabl signatur miss attribut lung cancer exposur correl lung cancer high rang asbestosi occur unresolv question presenc fibrosi requir attribut lung cancer asbesto etiolog lung cancer difficult defin case low level asbesto exposur concurr smoke habit mesothelioma diagnosi malign mesothelioma difficult procedur sampl fixat process immunohistochem probe conclus assess exposur crucial requir accur medic occup histori quantit analysi asbesto bodi burden perform digest lung tissu count asbesto bodi light microscopi and or uncoat fiber transmiss electron microscopi benefit screen asbestos rel malign equivoc attribut lung cancer asbesto exposur difficult clinic set assess asbesto bodi burden fact virtual patient tobacco smoker smoker premis asbestosi causal link lung cancer asbesto assess lung fibrosi asbesto bodi burden
MED-3314~occup risk lymphoma multicentr prospect cohort studi epic pubm ncbi abstract object evid suggest occup relat exposur increas risk malign lymphoma farm print paper industri wood process meat handl process weld shoe leather manufactur teach profess categori implic previous studi relationship occup malign lymphoma investig larg european prospect studi method investig occup risk lymphoma european prospect investig cancer nutrit epic follow up time num subject num year sd num year analysi base num num newli diagnos case non hodgkin lymphoma nhl hodgkin lymphoma hl identifi epic subcohort occup data data num occup collect standardis questionnair cox proport hazard model explor associ occup risk malign lymphoma result occup posit malign nhl adjust studi centr age sex socioeconom status ses smoke alcohol butcher hr num num ci num num includ multipl myeloma plasmacytoma hr num num ci num num exclud multipl myeloma plasmacytoma car repair worker hr num num ci num num includ multipl myeloma plasmacytoma hr num num ci num num exclud multipl myeloma plasmacytoma hl gasolin station occup hr num num ci num num conclus find current studi higher risk nhl car repair worker butcher higher risk hl gasolin station worker suggest role occup relat exposur solvent zoonot virus risk factor malign lymphoma
MED-3315~pilot case cohort studi liver pancreat cancer poultri worker pubm ncbi abstract purpos test hypothesi exposur poultri oncogen virus wide occur occup poultri worker general popul increas risk death liver pancreat cancer identifi risk factor method pilot case cohort studi cancer combin cohort num high expos poultri worker num control subject conduct risk assess logist regress odd ratio proport hazard risk ratio result occup find record pancreatic liv cancer slaughter poultri num num confid interv ci num num num num ci num num catch live chicken num num ci num num num num ci num num kill type anim food num num ci num num num num ci num num work pig rais farm num num ci num num pancreat cancer non occup find liver cancer receiv immun yellow fever vaccin num num ci num num vaccin typhoid vaccin num num ci num num studi confirm previous report risk factor diseas conclus studi preliminari evid exposur poultri oncogen virus possibl occurr liver pancreat cancer case control studi nest occup cohort high expos subject suffici statist power provid effici valid method investigating confirm find copyright num elsevi reserv
MED-3316~outbreak neurolog autoimmun polyradiculoneuropathi worker expos aerosolis porcin neural tissu descript studi pubm ncbi abstract background novemb num num subacut neurolog syndrom affect worker swine abattoir minnesota indiana occup exposur aerosolis porcin brain aim describ pathogen immunolog characterist ill method patient abattoir present refer mayo clinic rochest mn usa neurolog symptom includ record detail exposur aerosolis brain tissu comprehens neurolog laboratori neuroimag electrophysiolog patholog autoimmun serolog assess healthi control recruit communiti worker plant minnesota find num patient identifi num minnesota indiana shortest durat exposur symptom onset num week infecti agent trigger diseas identifi patient develop polyradiculoneuropathi sensori predomin pain patient initi cns manifest transvers myeliti meningoenceph nerv conduct studi localis abnorm proxim distal nerv segment quantit sensori autonom test reveal involv larg small sensori fibr sweat fibr mri show promin abnorm root ganglia nerv biopsi identifi mild demyelin axon degener perivascular inflamm protein concentr high csf num num patient sera patient num num unaffect workplac control num communiti control distinct neural react igg num patient sera igg specif myelin basic protein seroposit correl direct exposur risk patient control num patient requir immunomodulatori therapi improv spontan lost follow up exposur stop interpret neurolog disord autoimmun origin relat occup exposur multipl aerosolis porcin brain tissu antigen pattern nerv involv suggest vulner nerv root termin blood nerv barrier permeabl fund mayo clinic foundat minnesota depart health center diseas control prevent copyright num elsevi reserv
MED-3317~auto immun polyradiculoneuropathi igg biomark worker expos aerosol porcin brain pubm ncbi abstract twenty four patient expos aerosol porcin brain tissu work plac environ abattoir develop syndrom immune medi polyradiculoneuropathi central nervous system manifest transvers myeliti meningoenceph asept mening patient characterist electrophysiolog find distal proxim conduct slow prolong distal f wave latenc region blood nerv barrier permeabl patient serum igg immunofluoresc pattern nerv patholog show mild segment demyelin axon degener inflammatori patient meaning improv symptom electrophysiolog find immun therapi remov exposur aerosol brain tissu postul outbreak auto immun polyradiculoneuropathi trigger occup exposur multipl aerosol porcin neural tissu antigen result neural damag blood nerv barrier robust num peripher nerv societi
MED-3318~cigarett smoke pancreat cancer pool analysi pancreat cancer cohort consortium abstract smoke establish risk factor pancreat cancer detail examin associ smoke intens smoke durat cumul smoke dose pancreat cancer limit author analyz pool data intern pancreat cancer cohort consortium nest case control studi num case num control odd ratio num confid interv calcul uncondit logist regress smoke intens effect examin excess odd ratio model linear pack year exponenti cigarett smoke day squar compar smoker current smoker signific elev risk odd ratio num num confid interv ci num num risk increas signific greater intens num cigarettes day num num ci num num durat num year num num ci num num cumul smoke dose num pack year num num ci num num risk num year smoke cessat similar smoker estim excess odd ratio pack year declin increas intens suggest greater risk total exposur deliv lower intens longer durat higher intens shorter durat find declin risk smoke cessat suggest smoke late stag effect pancreat carcinogenesi
MED-3319~epidemiolog investig immune medi polyradiculoneuropathi abattoir worker expos porcin brain abstract background octob num cluster patient experienc polyradiculoneuropathi identifi pork abattoir plant patient work primari carcass process area warm room major process sever head head tabl investig initi determin risk factor ill method result symptom report patient unlik previous occup ill case control studi conduct plant case defin evid symptom peripher neuropathi compat electrodiagnost test pork abattoir worker control group random select non il warm room worker num non il head tabl worker num consent case control interview blood throat swab collect num largest pork abattoir survey identifi addit case fifteen case identifi plant ill onset occur num novemb num median age num year rang num num year case warm room control work head tabl adjust odd ratio aor num num confid interv ci num num remov brain remov muscl back head aor num num ci num num work num num feet brain remov oper aor num num ci num num associ remain compar head tabl case head tabl control worker remov brain compress air liquefi brain generat aerosol droplet expos nearbi worker addit case identifi abattoir techniqu abattoir techniqu stop brain remov case report num month follow case compar control higher median interferon gamma ifn level num pg ml num pg ml num discuss polyradiculoneuropathi remov porcin brain compress air autoimmun mechan support higher level ifn case control consist immun mediat ill occur associ neural tissu exposur abattoir compress air remov brain avoid procedur aerosol cns tissu outbreak highlight potenti respiratori mucos exposur immune medi ill occup set
MED-3320~industri hygien assess reticuloendotheliosi virus exposur poultri industri pubm ncbi abstract object reticuloendotheliosi virus rev group retrovirus avian leukosis sarcoma virus alsv natur infect cancer chicken recent found alsv antibodi level job task poultri industri object studi examin similar associ found rev antibodi level examin correl rev alsv antibodi level method relat risk estim compar rev antibodi level num poultri worker num control expect antibodi level predict associ employ general linear model correl coeffici measur alsv rev antibodi level result rev antibodi level signific higher poultri worker control subject gender employ condit employ durat relat risk signific higher job categori signific correl observ rev alsv antibodi level strong poultri worker weak control subject conclus antibodi level valid identifi job task high risk exposur rev workplac practic implic recommend protect job task import situat exposur multipl pathogen workplac analysi antibodi level pathogen suffici repres exposur correl pathogen suggest exposur assess hold true pathogen similar rout transmiss
MED-3321~occup exposur assess antibodi level exposur avian leukosis sarcoma virus poultri industri pubm ncbi abstract avian leukosis sarcoma virus alsv infect cancer chicken poultri worker expos alsv infecti agent workplac studi examin industri hygien assess antibodi level poultri worker identifi riski job task higher exposur risk infecti agent alsv compar alsv antibodi level poultri worker control subject occup demograph factor examin associ exposur risk poultri worker found antibodi level signific higher poultri worker control subject job categori age signific antibodi level worker job task identifi signific higher antibodi level compar impli recommend made protect worker job find studi measur antibodi level worker industri hygien assess exposur infecti agent
MED-3348~appeal vaniti potenti improv motiv fruit veget consumpt abstract fruit veget consumpt inadequ adult unit state contribut prevent morbid mortal effect dietari intervent strategi recent intervent advertis consequ behavior success modifi sun exposur habit tobacco approach facilit dietari improv consumpt carotenoid rich fruit veget posit affect skin color influenc percept health attract promot effect motiv target audienc increas consumpt import food group approach repres direct field potenti suitabl cost effect population level dissemin visual media
MED-3350~effect dietari sodium restrict tast respons sodium chlorid longitudin studi pubm ncbi abstract normotens adult low sodium weight loss control diet record prefer perceiv salti sodium chlorid nacl ad cream soup interv num yr reduct sodium intak excret accompani shift prefer salt prefer concentr ad libitum salt declin num onset num nacl week num hedon score high concentr nacl decreas signific score low concentr increas num mo sodium restrict nacl prefer readjust lower level ad libitum addit nacl similar num num wk hedon variat observ control na restrict group weight loss group show increas mid rang nacl level mechan prefer includ physiolog behavior context effect provid insight mainten low sodium diet treatment prevent hypertens
MED-3351~color red reduc snack food soft drink intak pubm ncbi abstract base evid color red elicit avoid motiv context mehta zhu num studi investig effect color red snack food soft drink consumpt line hypothesi particip drank red label cup blue label cup studi num ate snack food red plate blue white plate studi num result suggest red function subtl stop signal work focus awar reduc incident food drink intak copyright num elsevi reserv
MED-3352~free fatti acid effect tast stimuli human present symposium tast fat discoveri role fat sensor pubm ncbi abstract popular low reduced fat food increas consum seek decreas energi consumpt fat replac fat reduc product maintain sensori properti ingredi larg formul replic nongustatori properti fat food achiev moder success increas evid fat activ tast system uniqu evok respons influenc product accept work support tast compon fat prompt question fat constitut addit primari basic tast qualiti review briefli summar evid focus human studi effect stimuli receptor physiolog due oral fat exposur discuss studi suggest fatti acid taster nontast verifi implic target product develop num institut food technologist
MED-3353~skin blood perfus oxygen colour affect perceiv human health abstract skin blood perfus oxygen depend cardiovascular hormon circulatori health human socio sexu signal physiolog domin reproduct status primat particip manipul colour calibr facial photograph empirically measur oxygen deoxygen blood colour axe separ simultan optimis healthi particip increas skin blood colour oxygen basal level optimis healthi show skin blood perfus oxygen influenc perceiv health import mate choic
MED-3354~lip colour affect perceiv sex typic attract human face pubm ncbi abstract lumin contrast facial featur facial skin greater women men women make up enhanc contrast black and whit photograph increas lumin contrast enhanc feminin attract women face reduc masculin attract men face caucasian contrast lip facial skin red red lip consid attract women geograph tempor divers cultur possibl mimic vasodil sexual arous investig effect lip lumin colour contrast attract sex typic masculinity feminin human face caucasian sampl particip manipul colour lip colour calibr face photograph cielab light  dark red  green yellow  blu axe enhanc appar attract sex typic particip increas red contrast enhanc feminin attract femal face reduc red contrast enhanc masculin men face lip blueness reduc femal male face increas light contrast enhanc attract sex effect percept sex typic associ lip colour contrast attract women face attribut associ oxygen blood perfus indic oestrogen level sexual arous cardiac respiratori health
MED-3355~recent fat intak modul fat tast sensit lean overweight subject pubm ncbi abstract object evalu effect high fat low fat diet tast sensit oleic acid num lean overweight obes ow ob subject design random cross ov dietari intervent involv consumpt high fat num fat low fat num fat diet consum num week period subject total num lean age num num year bodi mass index bmi num num kg num num ow ob age num num year bmi num num kg num subject particip studi measur tast threshold num fat percept hedon rate regular rf lowered fat lf food consumpt high low fat diet result consumpt low fat diet increas tast sensit num lean ow ob subject num increas subject abil perceiv small differ fat content custard num consumpt high fat diet signific decreas tast sensit num lean subject num chang sensit ow ob person num hedon rate rf lf food differ diet conclus alter fat content diet modul tast sensit num lean subject increas num week period fat restrict attenu high fat diet failur high fat diet alter fatti acid tast threshold ow ob subject suggest individu adapt high fat exposur differ habitu fat consumpt data suggest excess dietari fat attenu nutrient sens epithelia respons oral caviti diet weight status
MED-3356~desir eat high low fat food low fat dietari intervent pubm ncbi abstract object studi examin desir eat high fat low fat food obes treatment program hypothes examin num prefer low fat food increas time num prefer high fat food decreas time design single group prospect examin desir eat num food categor fat content num week treatment program set univers clinic memphi tennesse particip num obes weight num lbs women age num year particip obes treatment program intervent num week cognitive behavior program obes variabl measur desir eat num food vari fat content particip ate food analysi analysi varianc multipl regress pair test result result program prefer low fat food increas prefer high fat food decreas mirror consumpt low fat high fat food conclus implic behavior econom perspect reinforc low fat food increas low fat dietari intervent reinforc properti high fat food declin desir low fat food hold advantag high fat food term weight mainten
MED-3358~oral sensit oleic acid fat intak bodi mass index pubm ncbi abstract background aim tast sensit fatti acid influenc food ingest regul fat intak bodi weight status fatti acid detect homolog receptor mouth gastrointestin gi tract attenu sensit greater fat intak bmi studi aim extend observ surround fatti acid tast specif type food consum dietari behaviour fatti acid tast sensit method num subject num femal bmi num num kg m age num num yrs num male bmi num num kg m age num num yrs screen oral sensit oleic acid num mm triplic sensori evalu classifi hypersensit num correct identif hyposensit num fat tast percept sensory match custard made num num oil recent diet num day diet record food habit behaviour food habit behaviour questionnair establish result num num subject classifi hyposensit oleic acid subject differ classifi hypersensit hyposensit subject consum signific energi fat satur fat fatti food butter meat dairi greater bmi percept small fat content custard num compar hypersensit subject conclus inabl perceiv low concentr fatti acid food greater consumpt fatti food specif butter meat dairi increas bmi num elsevi european societi clinic nutrit metabol reserv
MED-3359~eat within subject increas fruit veget consumpt confer benefici skin color abstract background fruit veget consumpt ingest carotenoid found human skin color yellow recent cross sect studi carotenoid bas color contribut benefici health human held sexual select cue condit speci methodolog princip find investig effect fruit veget consumpt skin color longitudin determin magnitud durat diet chang requir chang skin color percept diet skin color record baselin week group num individu makeup self tan agent and or recent intens uv exposur six week fruit veget consumpt signific correl skin red yellow period diet link skin reflect signific spectral absorpt carotenoid melanin psychophys method investig minimum color chang requir confer percept healthier attract skin color modest dietari requir enhanc appar health num portion day attract num portion conclus increas fruit veget consumpt confer measur percept benefici effect caucasian skin week effect potenti motiv tool dietari intervent
MED-3369~hide veget reduc energi densiti effect strategi increas children veget intak reduc energi intak abstract background strategi increas children intak varieti veget includ veget object investig incorpor pur ed veget entr es reduc energi densiti ed kcal g affect veget energi intak num preschool children design crossov studi num num y old children num serv meal snack num d wk num wk condit entr es breakfast lunch dinner snack reduc ed increas proport pur ed veget condit num ed standard num ed tripl veget content num ed quadrupl veget content entr es serv unmanipul side dish snack children instruct eat result daili veget intak increas signific num num num ed condit num num num ed condit compar standard condit num consumpt veget entr es affect consumpt veget side dish children ate similar weight food condit daili energi intak decreas num kcal num num num ed condit num children rate manipul food similar ed amount conclus incorpor substanti amount pur ed veget reduc ed food effect strategi increas daili veget intak decreas energi intak young children trial regist clinicaltri gov nct num
MED-3370~serv style raw snack veget children pubm ncbi abstract primari aim studi investig serv style snack veget appeal children focus size shape secondari aim investig children particip fruit veget subscript servic school design hundr thirti children age num year snack meal compris combin carrot cucumb red pepper meal present serv style size small ordinari shape whole chunk slice stick figur star children particip veget subscript servic answer specif question serv design includ choic stimuli detail present style shape influenti children prefer veget cut figur differ observ slice stick size matter whole chunk ordinari size prefer children express high particip veget subscript servic conclus cut veget shape children easi parent produc alik children interest receiv serv school copyright num elsevi reserv
MED-3371~hidden veget effect strategi reduc energi intak increas veget intak adult abstract background overconsumpt energy dens food lead excess energi intak substitut low energy dens veget food higher energi densiti decreas energi intak difficult implement individu dislik tast veget object investig incorpor pur ed veget decreas energi densiti entr es multipl meal reduc daili energi intak increas daili veget intak design crossov studi num men num women ate ad libitum breakfast lunch dinner laboratori week num wk condit entr es meal vari energi densiti standard version num condit reduc version num num condit covert incorpor num num time amount pur ed veget entr es accompani unmanipul side dish particip rate hunger full meal result subject consum consist weight food condit energi densiti daili energi intak signific decreas num num kcal num condit num num num kcal num condit num daili veget consumpt signific increas num num veget num condit num num veget num condit num decreas energi intak rate hunger full signific differ condit entr es rate similar palat condit conclus larg amount pur ed veget incorpor food decreas energi densiti strategi lead substanti reduct energi intak increas veget intak trial regist clinicaltri gov nct num
MED-3372~associ parent style parent feed practic child characterist young children fruit veget consumpt pubm ncbi abstract purpos studi investig role parent child characterist explain children fruit veget intak num parent preschool age num year num school belgium fland complet questionnair includ parent child fruit veget food frequenc questionnair general parent style lax overreact posit interact specif food parent practic child cent parent cent feed practic children characterist children shyness emot stubborn activ sociabl negat reaction food multipl linear regress analys num signific posit associ children fruit veget intak parent intak negat associ children negat reaction food general parent style dimens child person characterist explain differ children fruit veget intak child cent feed practic posit relat children fruit veget intak parent cent feed practic negat relat children veget intak order increas children fruit veget consumpt parent guid improv diet child cent parent practic strategi decreas negat reaction food copyright num elsevi reserv
MED-3373~influenc social involv neighborhood aesthet communiti garden particip fruit veget consumpt abstract object consid relationship urban adult population fruit veget consumpt select social psycholog process benefici aesthet experi garden particip method conduct population bas survey repres num resid num block group denver colorado num num multilevel statist model evalu survey data result neighborhood aesthet social involv communiti garden particip signific fruit veget intak communiti garden consum fruit veget num time day compar home garden num time day nongarden num time day num communiti garden met nation recommend consum fruit veget num time day compar num home garden num nongarden conclus studi result shed light neighborhood process affect food rel behavior insight potenti communiti garden affect behavior qualiti intrins communiti garden make uniqu intervent narrow divid peopl place food grown increas local opportun eat
MED-3374~attract sustain increas veget intak school pubm ncbi abstract object studi determin select attract sustain scalabl increas select veget school lunchroom method studi num pair attract carrot elementari school num measur select consumpt week compar control studi num track food sale veget elementari school num systemat attract two month period studi conduct york num result studi num found elementari student ate percentag carrot attract x ray vision carrot un nam generic food day studi num found elementari school student num persist choos hot veget dish num fun attract discuss attract effect persist increas healthi food consumpt elementari school scalabl underscor success studi num implement execut neglig cost high school student volunt copyright num elsevi reserv
MED-3375~classroom cupcak celebr observ food offer consum pubm ncbi abstract object describ food beverag type offer consum classroom celebr elementari school low incom urban communiti addit report student intak fresh fruit provid alongsid parti food method observ held num classroom celebr food beverag item measur count celebr consumpt data record aggreg entir classroom adjust intak student result major item offer low nutri energy dens food calor intak celebr rang num num cal fruit provid num num classroom celebr result intak num full serv student conclus implic calor intak low nutri energy dens food beverag offer classroom celebr contribut num daili calor fresh fruit reason addit parti food tabl copyright num societi nutrit educ behavior publish elsevi reserv
MED-3376~split smaller item size cooki lead decreas energi intak children pubm ncbi abstract object examin influenc alter size snack food small larg cooki short term energi intak method sixth grad num particip between subject experiment design particip offer gram weight cooki afternoon tea school half particip food cut num make small item size food intak number cooki gram weight energi intak examin anova result decreas item size food led decreas num gram weight intak num kcal appetit rate subject food characterist moder effect conclus implic reduc item size food prove dietari prevent strategi base decreas consumpt aim counter obesity promot eat behavior favor easi avail larg food portion copyright num societi nutrit educ behavior publish elsevi reserv
MED-3377~offer dip promot intak moderately lik raw veget preschool genet sensit bitter pubm ncbi abstract background evidence bas strategi promot veget consumpt children limit object determin effect provid palat dip repeat exposur raw veget preschool intak particip hundr fifty two predomin hispan preschool ag children studi head start classroom num design between subject quasiexperiment design moderately lik raw veget broccoli offer week afternoon snack num week classroom random receiv broccoli condit differ provis dip bitter tast sensit assess num n propylthiouracil intervent broccoli provid condit regular salad dress dip light reduc energy fat version dress dip mix regular dress sauc plain dress main outcom measur broccoli intak num week exposur broccoli exposur statist analys descript statist generat multilevel model repeat measur test effect condit bitter sensit broccoli intak exposur pre post exposur adjust classroom effect potenti covari result major hispan preschool num show sensit bitter tast num n propylthiouracil children broccoli increas exposur vari dip condit bitter sensit bitter sensit children ate num broccoli dress serv plain num effect vari base regular light dress provid dip sauc dip promot broccoli intak bitter insensit children conclus provid dip regular light sauc increas raw broccoli intak bitter sensit hispan preschool find suggest offer low fat dip promot veget intak children sensit bitter tast
MED-3378~brain cancer environment lead exposur evid implement nation petrol lead phase out program plpop taiwa pubm ncbi abstract background object num petrol lead phase out program plpop launch taiwan abat environment lead emiss present studi intend examin high petrol lead emiss area plea result increas incid rate brain cancer base nation data bank method nation brain cancer incid data obtain taiwan nation cancer registri age standard incid rate calcul base num world standard popul gasolin consumpt data obtain bureau energi differ trend test age standard incid rate brain cancer high median low small plea analyz result signific increas found small high plea age standard incid rate brain cancer confound account age standard incid rate brain cancer high correl median high plea refer small plea conclus adjust number relev confound conclud high plea result increas incid rate brain cancer result high lead exposur copyright num elsevi reserv
MED-3379~urban rise fall air lead pb latent surg retreat societ violenc pubm ncbi abstract evalu air pb emiss latent aggrav assault behavior scale citi accomplish regress annual feder bureau investig aggrav assault rate record rise fall annual vehicl pb emiss chicago illinoi indianapoli indiana minneapoli minnesota san diego california atlanta georgia orlean louisiana thing held equal num increas tonnag air pb releas num year prior rais present period aggrav assault rate num num ci num num model explain num variat aggrav assault citi examin case orlean num tempor variat aggrav assault rate explain annual rise fall air pb total num metric ton releas popul orlean num year earlier metric ton pb releas num year prior latent increas num num ci num num num aggrav assault num report vehicl consum fuel pb addit contribut larger quantiti pb dust general recogn find predict prevent children lead exposur lead dust realiz numer societ benefit decad futur includ lower rate aggrav assault copyright num elsevi reserv
MED-3380~artifici food dye attent deficit hyperact disord pubm ncbi abstract attent deficit hyperact disord adhd common behavior disord children symptom adhd includ hyperact low frustrat toler impuls inattent biolog pathway lead adhd delin number genet environment risk factor disord recogn earli num research conduct dr benjamin feingold found hyperact children diet free artifici food addit dye symptom hyperact reduc clinic studi support find rigor empir studi conduct num year posit result research role food addit contribut adhd wane recent year interest area reviv respons recent research public petit decemb num british govern request food manufactur remov artifici food dye product strictur posit effect behavior remov food dye panacea adhd multifacet disord biolog environment underpin num intern life scienc institut
MED-3381~synthet food color neurobehavior hazard view environment health research abstract background proposit synthet food color induc advers behavior effect children enunci num feingold child hyperact york random hous num assert elev sensit food addit sign hyperact observ children evid suggest unknown proport children respond synthet food color food drug administr fda interpret evid inconclus studi publish num mccann al food addit hyperact behaviour num year old num year old children communiti randomis double blind placebo control trial lancet num num drew renew attent hypothesi studi size scope led fda review evid hold public hear seek advic food advisori committe prepar hear fda review evid conclud warrant agenc action object commentari examin basi fda posit element review led decis food advisori committe reason environment health issu discuss fda review confin essenc clinic diagnosi hyperact charg committe broader environment question behavior effect general popul fail recogn signific vulner subpopul misinterpret effect size criterion risk fda respons benefit adopt viewpoint perspect common environment health research time food color debat offer lesson environment health research narrow focus singl outcom criterion mislead
MED-3382~dietari sensit adhd symptom thirty f year research pubm ncbi abstract artifici food color afc establish main attention deficit hyperact disord adhd accumul evid suggest subgroup show signific symptom improv consum afc fre diet react adhd typ symptom challeng afc children suspect sensit num num react challeng num mg afc oligoantigen diet studi suggest children addit sensit afc sensit common nonsalicyl food milk chocol soy egg wheat corn legum salicylate contain grape tomato orang studi found cosensit rule recent num larg studi demonstr behavior sensit afc benzoat children adhd trial elimin diet children respond satisfactorili convent treatment parent pursu dietari investig
MED-3383~effect physic activ attent deficit hyperact disord symptom evid pubm ncbi abstract evid support benefici effect physic activ pa cognit perform suggest effect larg children limit research explor pa manag behavior symptom improv cognit perform children attent deficit hyperact disord adhd etiolog adhd putat mechan effect pa cognit perform suggest pa import popul object purpos paper review literatur potenti pa adhd symptom manag regard behavior cognit symptom method literatur review publish unpublish research specif examin effect pa cognit and or behavior symptom adhd addit potenti mechan address result albeit limit current research general support potenti acut chronic pa mitig adhd symptom conclus general support extant literatur challeng face children adhd futur research explor potenti pa popul advoc copyright num elsevi reserv
MED-3384~trend outpati prescript drug util children num pubm ncbi abstract object describ trend outpati prescript drug util children major area pediatr therapeut year num num method larg prescript databas im vector nation total patient tracker examin nation drug util pattern pediatr popul age num year num num result num total num million prescript dispens pediatr popul num lower num prescript dispens adult popul increas num time analysi pediatr drug util trend top num therapeut area num compar num show decreas system antibiot num allergi num pain num depress num cough cold expector num prescript asthma num attention deficit hyperact disord num contracept num prescript increas num amoxicillin frequent dispens prescript infant age num month children age num year methylphenid top prescript dispens adolesc age num year off label identifi lansoprazol num prescript dispens num infant num year conclus pattern pediatr drug util observ num num includ decreas antibiot increas attention deficit hyperact disord medic examin time articl overview pediatr outpati drug util set stage in depth analys
MED-3385~popcorn work lung caus corpor regulatori neglig avoid tragedi pubm ncbi abstract diacetyl contain butter flavor identifi outbreak bronchiol obliteran bo lung diseas popcorn pl worker litig document show outbreak predict prevent industri trade organ awar bo case worker butter flavor popcorn manufactur plant fail implement industri hygien improv activ hid pertin warn inform due weak organ mandat regulatori bodi organ niosh osha fda general recogn safe gras system epa fail detect prevent outbreak highlight system food product regul includ corpor act respons stronger regul activ enforc restructur gras system crimin penalti corpor profession hide inform relev worker protect
MED-3386~bronchiol obliteran organ pneumonia boop thorac radiotherapi breast carcinoma abstract common complic thorac radiotherapi includ esophag radiat pneumon import awar uncommon post radiotherapi complic bronchiol obliteran organ pneumonia boop report patient carcinoma breast develop interstiti lung diseas consist boop boop respond treatment corticosteroid prognosi general good long term administr corticosteroid relaps occur taper steroid report guidelin evalu treatment patient pulmonari infiltr radiotherapi
MED-3387~bronchiol obliteran consum exposur butter flavor microwav popcorn case seri pubm ncbi abstract respiratori exposur diacetyl diacetyl contain flavor butter flavor microwav popcorn bfmp lung diseas includ bronchiol obliteran bo flavor popcorn manufactur worker publish report lung diseas bfmp consum present case seri bfmp consum biopsy confirm bo review data relat consum exposur estim case exposur compar diacetyl contain flavoring expos manufactur worker lung diseas consum case exposur level compar caus diseas worker unabl identifi exposur diseas suspect bo case bfmp pose signific respiratori risk consum manufactur substitut diacetyl alpha diketon pose similar risk simpl consum practic cool popcorn bag elimin risk sever lung diseas
MED-3391~safeti sildenafil citrat review num double blind placebo control trial postmarket safeti databas abstract aim review special safeti topic sildenafil document toler num num mg dose age men erectil dysfunct ed method data collat num double blind placebo control dbpc trial num men conduct manufactur manufactur postmarket safeti databas num patient dbpc data stratifi dose start dose age num num year special safeti topic includ cardiovascular risk priapism non arterit anterior ischaem optic neuropathi naion impair renal hepat function drug interact nitrat cytochrom num inhibitor ed therapi blocker incorrect result sildenafil toler dose num num mg men ed age num year age num year analys databas reveal causal link sildenafil cardiovascular event safeti risk relat cardiovascular event priapism naion hear loss drug interact small number men moder impair renal function hepat function treat sildenafil dbpc trial safeti profil similar men impair renal hepat function overdos sildenafil rare ed popul safeti issu emerg trend advers reaction identifi conjunct overdos depend abus misus conclus collat review confirm general good toler establish safeti profil sildenafil num num mg men ed reveal safeti issu
MED-3394~risk factor mortal nurs health studi compet risk analysi abstract studi examin multipl risk factor mortal formal compar associ specif death author compet risk surviv analysi evalu associ lifestyl dietari factor all caus cause specif mortal num particip nurs health studi num death num num num cardiovascular diseas num smoking rel cancer num cancer relat smoke num age bodi mass index age num year weight chang height current smoke pack year smoke glycem load cholesterol intak systol blood pressur blood pressur medic diabet parent myocardi infarct age num year time menopaus direct relat all caus mortal invers associ physic activ intak nut polyunsatur fat cereal fiber moder alcohol consumpt decreas mortal model incorpor differ associ risk factor specif death signific fit compar model risk factor common associ futur model identifi individu increas risk mortal
MED-3395~mediterranean diet reduct prematur mortal middle ag adult pubm ncbi abstract larg prospect studi support invers associ adher mediterranean diet lower mortal includ older adult clear invers associ present younger individu lower mortal risk aim assess associ adher mediterranean diet total mortal middle ag adult seguimiento universidad de navarra sun project num spanish univers graduat num age num num num femal initi free cardiovascular diseas cancer diabet valid ffq assess dietari habit adher mediterranean diet categor num group mediterranean diet score low num point moder num point high num point outcom variabl total mortal cox proport hazard model estim hr num ci adjust estim sex age year univers educ bmi smoke physic activ televis watch histori depress baselin hypertens hypercholesterolemia observ num death num person year follow up fulli adjust hr moder high adher num num ci num num num num num ci num num num num point increment mediterranean diet score hr death num num ci num num num high educ middle ag adult adher tradit mediterranean diet reduc risk death
MED-3396~oral sildenafil citrat viagra erectil dysfunct systemat review meta analysi harm pubm ncbi abstract object summar compar evid harm sildenafil placebo tr men erectil dysfunct ed systemat review meta analysi method random placebo control trial rcts identifi electron search medlin embas psycinfo scopus cochran central rate advers event ae common report ae withdraw advers event advers event ascertain compar sildenafil placebo group result men ed stratifi clinic condit statist heterogen explor meta analys base random effect model perform result total num rcts includ sildenafil tr men higher risk all caus ae rr num num ci num num headach flush dyspepsia visual disturb compar placebo tr men magnitud excess risk greater fix flexible dos trial rate advers event withdraw advers event differ sildenafil placebo group higher dose sildenafil correspond greater risk ae increas risk harm observ clinic defin specif group patient conclus lack rcts report long term num month harm data short term trial men ed random sildenafil increas risk all caus ae headach flush dyspepsia visual disturb explor mode dose optim sildenafil warrant
MED-3397~phosphodiesteras type num inhibitor vision threaten advers event critic analysi review literatur pubm ncbi abstract introduct phosphodiesteras type num pde num inhibitor line drug treatment erectil dysfunct sildenafil viagra tadalafil ciali vardenafil levitra class drug inhibit pde num transient visual symptom chang color percept increas light sensit well known advers effect drug occur num sildenafil user vision threaten ocular complic nonarterit ischem optic neuropathi cilio retin arteri occlus rare report pde num inhibitor user aim highlight analyz recent publish case literatur ocular complic pde num inhibitor method search peer review english literatur conduct medlin databas search cumul index nurs alli health literatur cochran librari global health md consult causal assess report advers drug reaction analyz appli world health organ probabl scale criteria util nation registri drug induc ocular side effect main outcom measur scientif object find pde num inhibitor vision threaten ocular complic result case report pde num inhibitor associ ocular complic identifi januari num februari num case report includ case anterior posterior nonarterit ischem optic neuropathi central retin vein occlus cilio retin arteri occlus acut angl closur glaucoma optic atrophi sildenafil conclus lack conclus evid direct cause effect relationship pde num inhibitor vision threaten ocular event men pde num inhibitor suffer vision threaten complic frequenc general popul minor visual advers effect occur num user transient revers num intern societi sexual medicin
MED-3398~total cholesterol high densiti lipoprotein cholesterol import predictor erectil dysfunct pubm ncbi abstract erectil dysfunct frequent patient manifest arteriosclerot diseas independ contribut serum cholesterol predict erectil dysfunct unclear aim studi examin relat serum cholesterol erectil dysfunct medic histori physic examin blood test obtain cooper clinic dalla texa num men age num year num year erectil dysfunct visit clinic visit num num men num month clinic visit num month erectil dysfunct report num men num follow up mmol lit increas total cholesterol num time risk erectil dysfunct num confid interv num num mmol lit increas high densiti lipoprotein cholesterol num time risk num confid interv num num men high densiti lipoprotein cholesterol measur num mmol lit num mg dl num time risk num confid interv num num men num mmol lit num mg dl men total cholesterol num mmol lit num mg dl num time risk num confid interv num num men num mmol lit num mg dl differ remain essenti unchang adjust potenti confound author conclud high level total cholesterol low level high densiti lipoprotein cholesterol import risk factor erectil dysfunct
MED-3399~pistachio diet improv erectil function paramet serum lipid profil patient erectil dysfunct pubm ncbi abstract investig effect antep pistachio intern index erectil function iief score penil color doppler ultrasound pcdu paramet serum lipid level patient ed total num marri male patient ed num month includ prospect studi patient put num pistachio nut diet num week iief pcdu evalu pistachio diet addit plasma total cholesterol tc low dens lipoprotein ldl high dens lipoprotein hdl triglycerid measur dietari modif subject iief num score num num diet num num diet num similar increas domain iief observ diet num peak systol veloc valu pistachio diet num num num num cm num num pistachio diet tc ldl level decreas signific hdl level increas num num num demonstr pistachio diet improv iief score pcdu paramet side effect patient ed lipid paramet show statist signific improv diet
MED-3407~princeton iii consensus recommend manag erectil dysfunct cardiovascular diseas abstract princeton consensus expert panel confer multispecialti collabor tradit dedic optim sexual function preserv cardiovascular health princeton consensus met novemb num num num primari object object focus evalu manag cardiovascular risk men erectil dysfunct ed cardiovascular diseas cvd emphasi identif men ed requir addit cardiolog work up object focus reevalu modif previous recommend evalu cardiac risk sexual activ men cvd panel recommend build develop princeton consensus confer emphas exercis abil stress test ensur man cardiovascular health consist physic demand sexual activ prescrib treatment ed highlight link ed cvd asymptomat benefit cardiovascular risk reduct
MED-3417~correl penil duplex find stress electrocardiographi men erectil dysfunct pubm ncbi abstract aim work assess associ vasculogen erectil dysfunct ed coronari arteri diseas men age num studi includ num patient num age vasculogen ed num month durat dynam duplex studi intracavernos inject bimix solut num mg papaverin num mg phentolamin mesyl carri color ultrasound machin patient underw stress ecg test carri motor driven treadmil bruce protocol total num patient diagnos posit ischem heart diseas ihd peak systol veloc psv psv num cm s patient diagnos negat ihd psv num cm s statist signific differ observ patient posit ihd patient negat ihd psv num sensit psv num cm s predict ihd num specif num posit predict abnorm stress ecg predict psv num cm s num conclus psv cavernos arteri reliabl measur predict ihd patient vasculogen ed patient psv num cm s refer cardiolog assess carri real risk silent ihd
MED-3420~erectil dysfunct mortal abstract introduct erectil dysfunct ed cardiovascular diseas cvd share pathophysiolog mechan co occur ed earli warn increas cvd mortal aim sought examin associ ed all caus cause specif mortal method prospect population bas studi num men num elig age num num year ed measur self report subject num year hazard ratio hr calcul cox proport hazard regress model main outcom measur mortal due cvd malign neoplasm result num men num surviv end num complet ed age data num men die num complet data adjust age bodi mass index alcohol consumpt physic activ cigarett smoke self assess health self report heart diseas hypertens diabet ed hrs num num confid interv ci num num all caus mortal num num ci num num cvd mortal hr cvd mortal ed compar magnitud hrs convent cvd risk factor conclus find demonstr ed signific increas all caus mortal primarili associ cvd mortal
MED-3421~male sexual cardiovascular risk cohort studi patient erectil dysfunct pubm ncbi abstract introduct penil blood flow pbf recommend addit diagnost test identifi erectil dysfunct ed patient risk latent cardiovascular diseas studi assess associ pbf relat compon sexual function incid major cardiovascular event mace aim aim studi investig sever ed pbf factor relat couple relationship predict incid mace method consecut seri num patient studi clinic biochem instrument penil flow color doppler ultrasound paramet evalu main outcom measur inform mace obtain citi florenc registri offic result follow up num num year num mace num fatal observ cox regress analysi adjust age chronic diseas score show sever ed predict mace hazard ratio hr num num confid interv num num num addit lower pbf evalu flaccid dynam prostaglandin num stimul condit increas risk mace hr num num num num num num flaccid num cm second dynam num cm second peak systol veloc num report high sexual interest partner low sexual interest patient prove protect effect mace conclus investig male sexual pbf sexual desir provid insight present cardiovascular status prospect risk
MED-3422~mediterranean diet improv sexual function women metabol syndrom pubm ncbi abstract present studi test effect mediterranean styl diet sexual function women metabol syndrom women identifi databas subject particip control trial evalu effect lifestyl includ diagnosi femal sexual dysfunct fsd diagnosi metabol syndrom complet follow up studi trial intervent focus dietari fifty nin women met inclusion exclus criteria num assign mediterranean styl diet num control diet num year women mediterranean diet consum fruit veget nut grain oliv oil compar women control diet femal sexual function index fsfi improv intervent group basal num num post treat num num num remain stabl control group c reactiv protein crp level signific reduc intervent group num singl sexual domain desir arous lubric orgasm satisfact pain signific amelior dietari treatment suggest femal sexual find benefit lifestyl mediterranean styl diet effect amelior sexual function women metabol syndrom
MED-3423~adher mediterranean diet sexual function women type num diabet pubm ncbi abstract introduct report studi assess relat diet sexual function women diabet aim present studi explor relat consumpt mediterranean typ diet sexual function popul type num diabet women method patient type num diabet enrol diagnosi type num diabet month num year age num year bodi mass index bmi num higher hba num num higher treatment diet oral drug diabet patient invit complet food frequ questionnair self report measur sexual function total num num num women complet questionnair analyz present studi main outcom measur adher mediterranean diet assess num point scale incorpor salient characterist diet rang score num higher score indic greater adher femal sexual function index fsfi assess key dimens femal sexual function result diabet women highest score num lower bmi waist circumfer waist to hip ratio lower preval depress obes metabol syndrom higher level physic activ glucos lipid profil diabet women score num point scale proport sexual activ women show signific increas tertil adher mediterranean diet num num num base fsfi cutoff score femal sexual dysfunct fsd num women highest score adher lower preval sexual dysfunct compar women lower tertil num num num higher middl lower tertil num associ remain signific adjust potenti confound conclus women type num diabet greater adher mediterranean diet lower preval fsd
MED-3424~subclin endotheli dysfunct low grad inflamm play role develop erectil dysfunct young men low risk pubm ncbi abstract purpos studi investig pathogenesi erectil dysfunct ed young men low risk coronari heart diseas well known aetiolog conduct studi num patient ed age num enrol num age match normal control subject patient ed signific higher level systol blood pressur sbp total cholesterol triglycerid high sensit c reactiv protein hs crp greater carotid intima media thick cimt framingham risk score frs control group valu respect normal rang brachial arteri flow mediat vasodil fmd valu signific lower ed patient correl posit sever ed num num signific factor studi multivari logist regress model fmd sbp hs crp frs remain statist signific receiver oper characterist roc analysi demonstr fmd high abil predict ed young male low frs area curv auc num num cutoff fmd num sensit num specif num diagnosi ed frs hs crp proven predictor ed auc num num auc num num result studi valid subclin endotheli dysfunct low grad inflamm pathogenesi ed well known aetiolog young patient complain ed screen cardiovascular risk factor subclin atherosclerosi measur fmd hs crp frs improv abil predict treat ed subclin cardiovascular diseas earli young male num author intern journal androlog num european academi androlog
MED-3425~heart diseas risk factor predict erectil dysfunct num year rancho bernardo studi pubm ncbi abstract object examin common coronari heart diseas chd risk factor measur mid lif predict erectil dysfunct ed num year background retrospect cross sect studi suggest ed classic chd risk factor prospect studi studi associ method prospect studi community dwel men age num num year classic chd risk factor age smoke hypertens diabet hypercholesterolemia hypertriglyceridemia obes assess num num num averag follow up num year surviv male particip complet intern index erectil function iief num stratif ed group result sixty eight percent surviv men return num complet iief num questionnair respond favor level heart diseas risk factor baselin non respond baselin averag age num ed studi particip num year follow up averag age num year age bodi mass index cholesterol triglycerid signific increas risk ed cigarett smoke margin common severe complet ed compar ed blood pressur fast blood glucos signific ed due select mortal conclus improv chd risk factor mid lif decreas risk ed chd erectil dysfunct includ outcom clinic trial lipid low agent lifestyl modif
MED-3426~subclin coronari arteri atherosclerosi patient erectil dysfunct pubm ncbi abstract object purpos studi assess preval extent coronari arteri atherosclerosi asymptomat patient vascular erectil dysfunct ed background associ ed ischem heart diseas suggest unknown repres marker subclin coronari atherosclerosi method studi num consecut patient vascular ed evalu penil doppler num control subject histori coronari arteri diseas measur tradit coronari risk factor circul level c reactiv protein crp endotheli function ultrasound brachial arteri coronari arteri calcif multi slic comput tomographi result patient control group similar age race coronari risk score patient ed signific higher high sensit c reactiv protein level num num mg l num flow medi dilat brachial arteri impair patient ed control num num num coronari arteri calcif frequent individu ed control subject num multipl logist regress analysi show patient ed odd ratio num calcium score num percentil compar control conclus coronari atherosclerosi sever patient vascular ed ed predict presenc extent subclin atherosclerosi independ tradit risk factor cardiovascular diseas ed consid addit earli warn sign coronari atherosclerosi
MED-3427~link erectil cardiovascular health canari coal mine pubm ncbi abstract lifestyl nutrit increas recogn central factor influenc vascular nitric oxid product erectil function review underscor import princip mediat influenc cardiovascular health erectil function erectil dysfunct ed smoke excess alcohol intak physic inact abdomin obes diabet hypertens decreas antioxid defens reduc product lifestyl choic physic exercis improv nutrit weight control adequ intak supplement omega num fatti acid antioxid calcium folic acid replac testosteron defici improv vascular erectil function respons phosphodiesteras num inhibitor increas vascular product frequent penile specif exercis improv local endotheli product excess intak vitamin calcium l arginin l citrullin impart signific cardiovascular risk intervent discuss lower blood pressur prevent hypertens angiotensin ii receptor blocker improv erectil function reduc oxid stress men age num year men diabet hypertens erectil dysfunct critic warn sign exist impend cardiovascular diseas risk death antiarrhythm effect omega num fatti acid crucial men greatest risk sudden death conclus understand complex factor influenc erectil vascular health physician patient prevent vascular diseas improv erectil function motiv men improv lifestyl habit cardiovascular health copyright num elsevi reserv
MED-3428~erectil dysfunct preval time onset associ risk factor num consecut patient acut chest pain angiograph pubm ncbi abstract object aim studi assess erectil dysfunct preval time onset associ risk factor patient acut chest pain angiograph document coronari arteri diseas method num consecut patient acut chest pain angiograph document coronari arteri diseas assess semi structur interview investig medic sexual histori intern index erectil function instrument result patient age num num year rang num year durat symptom sign myocardi ischaemia prior enrol studi num month rang num coronari angiographi show num num vessel diseas num num num num patient preval ed patient num num erectil dysfunct score mild mild moder moder sever num num num num patient signific differ patient ed num ed num clinic angiograph characterist concern num patient co exist ed cad ed symptom report clinic evid prior cad symptom num num patient time interv onset ed cad num month rang num signific differ term risk factor distribut clinic angiograph characterist patient onset ed cad diagnosi interest patient type diabet ed develop sexual dysfunct cad onset num conclus studi suggest signific proport patient angiograph document coronari arteri diseas erectil dysfunct condit evid prior angina symptom num case futur studi includ control group patient coronari arteri diseas normal erectil function requir order verifi erectil dysfunct consid real predictor ischem heart diseas
MED-3429~lifestyle dietari recommend erectil dysfunct femal sexual dysfunct pubm ncbi abstract sexual problem diffus gender epidemiolog evid support role lifestyl factor erectil dysfunct limit data suggest treatment risk factor improv erectil dysfunct result spars associ lifestyl factor femal sexual dysfunct conclus influenc healthi behavior femal sexual dysfunct made studi perform specif effect sexual dysfunct men women adopt measur promot healthier life increas well b reduc burden sexual dysfunct copyright num elsevi reserv
MED-3430~effect lifestyl modif cardiovascular risk factor reduct erectil dysfunct systemat review meta analysi pubm ncbi abstract background erectil dysfunct ed share similar modifi risk factor coronari arteri diseas cad lifestyl modif target cad risk factor lead improv ed conduct systemat review meta analysi random control trial evalu effect lifestyl intervent pharmacotherapi cardiovascular cv risk factor sever ed method comprehens search multipl electron databas august num conduct predefin criteria includ random control clinic trial follow up num week lifestyl modif intervent pharmacotherapi cv risk factor reduct studi select num independ review main outcom measur studi weight differ intern index erectil dysfunct iief num score num confid interv cis random effect model result total num particip num clinic trial num countri identifi lifestyl modif pharmacotherapi cv risk factor statist signific improv sexual function iief num score weight differ num num ci num num trial statin intervent num exclud remain num trial lifestyl modif intervent num demonstr statist signific improv sexual function weight differ num num ci num num conclus result studi strengthen evid lifestyl modif pharmacotherapi cv risk factor effect improv sexual function men ed
MED-3431~population bas longitudin studi erectil dysfunct futur coronari arteri diseas abstract object assess associ erectil dysfunct ed long term risk coronari arteri diseas cad role age modifi associ particip method januari num decemb num biennial screen random sampl num community dwel men regular sexual partner cad presenc ed incid densiti cad calcul age stratif adjust potenti confound time depend cox proport hazard model result preval ed num men age num num year num men age num num year num men age num num year num men age num year older cad incid densiti num person year men ed age group num num year num num year num num year num num year men ed incid densiti cad age group num num year num num year num num year num num year conclus ed cad differ manifest common vascular patholog ed occur younger man mark increas risk futur cardiac event older men ed prognost import young men ed ideal candid cardiovascular risk factor screen medic intervent
MED-3432~mediterranean diet improv erectil function subject metabol syndrom pubm ncbi abstract men metabol syndrom demonstr increas preval erectil dysfunct ed present studi test effect mediterranean styl diet ed men metabol syndrom men identifi databas subject particip control trial evalu effect lifestyl includ diagnosi ed diagnosi metabol syndrom complet follow up studi trial intervent focus dietari sixty f men metabol syndrom met inclusion exclus criteria num assign mediterranean styl diet num control diet num year men mediterranean diet consum fruit veget nut grain oliv oil compar men control diet endotheli function score inflammatori marker c reactiv protein improv intervent group remain stabl control group num men intervent group control group num report iief score num higher mediterranean styl diet rich grain fruit veget legum walnut oliv oil effect se reduc preval ed men metabol syndrom
MED-3433~erectil dysfunct risk cardiovascular diseas meta analysi prospect cohort studi pubm ncbi abstract object goal evalu associ erectil dysfunct ed risk cardiovascular diseas cvd all caus mortal conduct meta analysi prospect cohort studi background observ studi suggest associ ed incid cvd ed independ risk factor cvd remain controversi method pubm databas search januari num identifi studi met pre stat inclus criteria refer list retriev articl review author independ extract inform design studi characterist studi particip exposur outcom assess control potenti confound factor fix random effect model calcul combin risk estim result twelv prospect cohort studi involv num particip includ meta analysi combin relat risk men ed compar refer group num num confid interv ci num num cvd num num ci num num coronari heart diseas num num ci num num stroke num num ci num num all caus mortal sensit analysi restrict studi control convent cardiovascular risk factor yield similar result evid public bias observ conclus meta analysi prospect cohort studi suggest ed signific increas risk cvd coronari heart diseas stroke all caus mortal increas independ convent cardiovascular risk factor copyright num american colleg cardiolog foundat publish elsevi reserv
MED-3434~dietari factor mediterranean diet erectil dysfunct pubm ncbi abstract introduct epidemiolog evid support role lifestyl factor pathogenesi erectil dysfunct ed limit data suggest dietari improv ed aim provid updat clinic evid role dietari factor ed method systemat literatur search perform medlin databas embas scopus mesh term keyword erectil dysfunct diet dietari pattern mediterranean diet lifestyl main outcom measur examin data relat erectil dysfunct dietari factor relationship impact dietari treatment result studi assess role effect diet ed dietari pattern high fruit veget nut grain fish low red process meat refin grain repres subject ed mediterranean diet propos healthi dietari pattern base evid greater adher diet lower all caus disease specif surviv type num diabet men highest adher mediterranean diet lowest preval ed sexual activ clinic trial mediterranean diet effect control diet amelior ed restor absent ed peopl obes metabol syndrom conclus adopt mediterranean diet improv erectil dysfunct
MED-3435~increas risk stroke men erectil dysfunct nationwid population bas studi pubm ncbi abstract introduct previous cross sect studi suggest erectil dysfunct ed repres independ risk factor futur cardiovascular event studi attempt examin associ ed subsequ stroke aim aim studi estim risk stroke num year follow up period ambulatori care visit treatment ed nationwid population bas data retrospect case control cohort design taiwan method studi data sourc longitudin health insur databas studi cohort compris num patient receiv princip diagnosi ed num num num random select subject comparison cohort patient num individu track num year index ambulatori care visit identifi diagnos episod stroke main outcom measur stratifi cox proport hazard regress perform compar num year stroke fre surviv rate cohort result sampl patient num num develop stroke num year follow up period num individu num patient ed studi cohort num individu num patient comparison cohort comparison cohort log rank test patient ed signific lower num year stroke fre surviv rate comparison cohort num adjust patient month incom geograph locat hypertens diabet coronari heart diseas peripher vascular diseas atrial fibril hyperlipidemia patient ed stroke num year follow up period patient comparison cohort hazard ratio num num confid interv num num num conclus result suggest ed surrog marker futur stroke men num intern societi sexual medicin
MED-3436~save life clinic visit erectil dysfunct modifi cardiovascular risk factor pubm ncbi abstract erectil dysfunct ed earli marker system atherosclerosi predictor coronari arteri diseas cardiac event aim paper convey import address cardiovascular risk factor patient ed inform urologist physician special cardiolog carri basic cardiovascular evalu includ histori physic examin object data review evid pathophysiolog link ed cardiovascular diseas describ carri basic cardiovascular evalu present data literatur show lifestyl modif medic therapi posit effect mortal numer cardiovascular end point ed suggest refer ed patient internist cardiologist provid identifi treat cardiovascular risk factor benefit patient ed save patient life
MED-3437~penil doppler ultrasound patient erectil dysfunct ed role peak systol veloc measur flaccid state predict ar pubm ncbi abstract introduct penil peak systol veloc psv measur flaccid state penil color doppler ultrasound pcdu examin question substanti evid aim assess valid psv measur flaccid state pcdu patient consult erectil dysfunct ed method consecut seri num age num num year male patient studi main outcom measur patient underw pcdu perform flaccid state dynam prostaglandin num stimul condit subset num subject uncompl type num diabet underw diagnost test silent coronari heart diseas adenosin stress myocardi perfus scintigraphi spect subject penil arteri flow simultan assess pcdu system adenosin administr result flaccid psv show signific num num correl dynam psv receiv oper characterist roc curv analysi demonstr threshold num cm second chosen flaccid psv predict dynam psv num num cm second accuraci num num subset patient underw spect impair coronari flow reserv icfr occur case num threshold num cm second chosen psv spect predict icfr accuraci num area roc curv num num num adjust confound anxieti symptom relat dynam psv adj num num flaccid psv conclus result show flow cavernos arteri routin evalu pcdu flaccid state perform pcdu flaccid state identifi subject patholog dynam psv accuraci higher num preliminari data suggest examin identifi diabet subject icfr accuraci num
MED-3438~arteri size hypothesi macrovascular link erectil dysfunct coronari arteri diseas pubm ncbi abstract erectil dysfunct ed defin inabl achiev maintain erect satisfactori sexual perform evid accumul ed vascular disord common risk factor atherosclerosi frequent found associ ed ed frequent report vascular syndrom coronari arteri diseas cad hypertens cerebrovascular diseas peripher arteri diseas diabet mellitus final similar earli impair endothelium depend vasodilat late obstruct vascular report ed vascular syndrom recent propos pathophysiolog mechan explain link ed cad call arteri size hypothesi system natur atherosclerosi major vascular bed affect extent symptom rare evid time differ rate occurr symptom propos caus size arteri suppli vascular bed larger vessel toler amount plaqu compar smaller hypothesi penil arteri smaller diamet coronari arteri patient ed seldom concomit symptom cad patient cad frequent complain ed clinic evid support hypothesi
MED-3439~erectil dysfunct coronari diseas evalu link pubm ncbi abstract erectil dysfunct ed common affect num men num year age so cal num num num num men num year age predomin vascular condit preced cardiovascular event num year ed consequ acut coronari syndrom increas cardiovascular all caus mortal earli identif offer window opportun cardiovascular risk reduct ed devast impact couple relationship treatment success maintain qualiti life middl age elder ed queri part ongo health care worker patient relationship earli detect prevent earli death copyright num elsevi ireland reserv
MED-3440~cardiovascular mortal men erectil dysfunct increas risk inevit pubm ncbi abstract introduct unclear men erectil dysfunct ed ultim die cardiovascular cv aim studi examin death men ed risk cv death method base statutori death registr hospit morbid data risk cv death men ed linked data studi assess cv mortal risk refer male popul main outcom measur death cv proport death age specif rate mortal rate ratio mrr standard mortal rate ratio smrr adjust hazard ratio hr result cv mortal num compar refer popul risk cv death higher men ed smrr num num confid interv ci num num risk cv mortal higher men cv diseas prior ed adjust hr num num ci num num histori hospit admiss cv event adjust hr num num ci num num compar respect histori mrr signific increas num year age group mrr num num ci num num median time interv manifest ed cv death num year greater proport death oncolog cv num num occur num year manifest ed conclus risk cv mortal greater men ed men die oncolog cv higher proport oncolog death occur sooner subsequ manifest ed num intern societi sexual medicin
MED-3441~marin edibl alga diseas prevent pubm ncbi abstract modern lifestyl feed habit settl world noncommunic diseas ncds evolv major disabl develop develop countri concomit effect grow interest natur healthi food increas awar risk factor determin diseas chapter describ nutrit fact seawe food ancient time china japan egypt india comment potenti util marin alga function food concept descript metabol syndrom basi comprehens seawe dread ill time high blood pressur cancer copyright num elsevi reserv
MED-3442~case control studi seawe consumpt risk breast cancer pubm ncbi abstract gim porphyra sp miyeok undaria pinnatifida seawe consum korean investig associ intak gim miyeok risk breast cancer case control studi case num women age num year histolog confirm breast cancer control visit hospit match case age sd num year menopaus status food intak estim quantit ffq num item includ gim miyeok condit logist regress analysi obtain num ci averag intak consumpt frequenc gim case lower control daili intak gim invers risk breast cancer num num quintil num num ci num num trend num adjust potenti confound stratif analysi perform menopaus status premenopaus women num num quintil num num ci num num trend num postmenopaus women num num quintil num num ci num num trend num show similar invers associ gim intak risk breast cancer adjust potenti confound dietari factor miyeok consumpt signific associ breast cancer result suggest high intak gim decreas risk breast cancer
MED-3443~dietari seawe revers metabol syndrom pubm ncbi abstract incid metabol syndrom increas worldwid notabl asian countri seawe common consum num men age num num yr num women averag age num num yr symptom metabol syndrom recruit quito ecuador random double blind placebo control trial subject assign group num placebo num num g d seawe undaria pinnatifida group num num g d seawe num num g d seawe blood pressur weight waist circumfer inflamm biomark lipid measur month repeat measur analysi varianc tukey multipl comparison test statist analysi group num systol blood pressur decreas num mmhg month num g d seawe num ci num num mmhg num primarili subject high norm baselin blood pressur waist circumfer chang women particip num cm decreas group num treatment placebo num ci num num cm num group num women decreas num cm num g d num ci num num cm num num cm decreas num num g d seawe num ci num num num observ consumpt num num g d seawe typic peopl japan low metabol syndrom preval
MED-3444~iodin thyroid cancer risk women multiethn popul bay area thyroid cancer studi pubm ncbi abstract research relationship iodin exposur thyroid cancer risk limit find inconclus studi fish shellfish consumpt proxi measur iodin exposur present studi extend research quantifi dietari iodin exposur incorpor biomark long term num year exposur toenail clip studi conduct multiethn popul wide variat thyroid cancer incid rate substanti divers exposur women age num resid san francisco bay area diagnos thyroid cancer num num num asian women compar women select general popul random digit dial interview conduct languag num case num control establish risk factor thyroid cancer found increas risk popul radiat head neck odd ratio num num confid interv ci num num histori goiter nodul num num ci num num famili histori prolif thyroid diseas num num ci num num contrari hypothesi increas dietari iodin relat multivitamin pill reduc risk papillari thyroid cancer risk reduct observ low risk women women establish risk factor note num num ci num num high risk women slight elev risk num num ci num num associ risk observ group biomark exposur evalu addit ethnic differ risk observ author conclud iodin exposur weak effect risk papillari thyroid cancer
MED-3445~epidemiolog studi thyroid cancer hawaii pubm ncbi abstract population bas case control interview studi design test hypothesi dietari iodin consumpt goitrogen veget increas risk thyroid cancer total num histolog confirm case num percent femal num match control ethnic group hawaii analysi women intak seafood shellfish harm ha ferment fish sauc dietari iodin increas risk cancer consumpt goitrogen primarili crucifer veget decreas risk non dietari risk factor includ miscarriag pregnanc fertil drug famili histori thyroid diseas obes work farm labor odd ratio combin effect high iodin intak first pregn miscarriag num num percent confid interv ci num num high iodin intak fertil drug num num percent ci num num men posit associ found obes work farm labor past histori benign thyroid diseas studi identifi dietari non dietari risk factor thyroid cancer fulli explain high incid rate filipino women hawaii
MED-3446~dietari seawe modifi estrogen phytoestrogen metabol healthi postmenopaus women pubm ncbi abstract seawe soy food consum daili japan breast cancer rate postmenopaus women signific lower west mechan includ differ diet soy consumpt estrogen metabol fifteen healthi postmenopaus women particip double blind trial seawe supplement soy challeng particip random num wk num g d seawe alaria placebo maltodextrin wk num particip consum daili soy protein isol num mg isoflavones kg bodi weight num wk washout period particip cross altern supplement schedul invers correl seawe dose mg kg bodi weight serum estradiol num seaweed placebo num dose num num num correct linear rang weight soy supplement increas urinari daidzein glycitein genistein o desmethylangolensin num decreas matairesinol enterolacton num soy seawe soy seasoy increas urinari excret num hydroxyestrogen num ohe num ratio num ohe num lpha hydroxyestron num lphaoh num num num equol excretor soy increas urinari equol excret num combin seasoy increas equol excret num num equol produc num increas num ratio num seasoy seawe favor alter estrogen phytoestrogen metabol includ modul colon bacteria
MED-3447~seawe prevent breast cancer pubm ncbi abstract investig chemoprevent effect seawe breast cancer studi relationship iodin breast cancer found earlier seawe wakam show suppress effect prolifer dmba dimethylbenz anthracen induc rat mammari tumor possibl apoptosi induct present studi powder mekabu distil water left stand num num degre filter supernat mekabu solut show extrem strong suppress effect rat mammari carcinogenesi daili drink water toxic vitro mekabu solut strong induc apoptosi num kind human breast cancer cell effect stronger chemotherapeut agent wide treat human breast cancer apoptosi induct observ normal human mammari cell japan mekabu wide consum safe inexpens food result suggest mekabu potenti chemoprevent human breast cancer
MED-3448~seawe consumpt risk thyroid cancer women japan public health center bas prospect studi pubm ncbi abstract iodin suspect risk factor thyroid cancer seawe account num japanes people iodin intak examin associ seawe consumpt risk thyroid cancer japanes women women particip japan public health center bas prospect studi num age num year num year num thyroid cancer case includ num papillari carcinoma case identifi seawe consumpt assess food frequ questionnair divid categori num days week refer num days week daili cox proport hazard model appli estim hazard ratio hrs num confid interv cis seawe consumpt increas risk papillari carcinoma hr daili consumpt compar num days week num num ci num num trend num stratif menopaus status increas risk observ postmenopaus women papillari carcinoma hr daili consumpt compar num days week num num ci num num trend num premenopaus women hr num num ci num num trend num studi identifi posit associ seawe consumpt risk thyroid cancer papillari carcinoma postmenopaus women
MED-3449~antigenotox activ watercress extract vitro mammalian system comet assay pubm ncbi abstract watercress crucifera integr part mediterranean diet nutrit food treatment diseas oxid dna damag play crucial role chronic aging rel diseas consid import carcinogen factor aim work determin impact watercress extract cell viabil potenti antigenotox properti induc oxid damag comet assay peripher blood cell vitro model aqueous extract leav prepar juic processor centrifug filter preserv num concentr aqueous extract num num mg ml assay differ found cell viabil control treat group time signific antigenotox effect observ concentr express damag index num num min num num num min percentag reduct damag similar num num result suggest consumpt watercress diet power tool improv health qualiti life copyright num john wiley son
MED-3450~exercise induc oxid stress myth realiti physiolog relev pubm ncbi abstract assay popular marker exercise induc oxid stress experi methodolog flaw suffici credibl evid suggest exercis accompani increas generat free radic result measur degre oxid modif molecul mechan respons unclear common assumpt increas mitochondri oxygen consumpt lead se increas reactiv oxygen speci ros product support vitro vivo data specif contribut system xanthin oxidas inflamm haem protein auto oxid poor characteris demonstr ros capac contribut develop muscl fatigu situ lack convinc direct evid ros impair exercis perform vivo human remain unclear exercise induc oxid modif signific induc harm oxid damag integr part redox regul clear ros play import role numer physiolog process rest detail physiolog function ros exercis remain elucid
MED-3451~vegetarian diet reduc exercise induc oxid stress review literatur pubm ncbi abstract oxid stress natur physiolog process describ imbal free radic product abil antioxid defenc system bodi neutral free radic free radic benefici promot wound heal contribut healthi immun respons free radic detriment impact interfer regul apoptosi play role promot cancer condit cardiovascular diseas antioxid molecul reduc damag oxid stress counteract free radic regular exercis vital compon healthi lifestyl increas oxid stress typic vegetarian diet compris wide rang antioxidant rich food plausibl consumpt food result enhanc antioxid system capabl reduc exercise induc oxid stress addit relationship vegetarian diet lower risk cardiovascular diseas cancer establish review explor current evid link exercis vegetarian antioxid oxid stress
MED-3452~foster antioxid defenc up regul antioxid gene antioxid supplement pubm ncbi abstract vitamin tradit consid food compon requir normal diet prevent defici newer concept function vitamin nutrit simpli prevent defici symptom concept consid vitamin larg dose import function prevent defici linus paul instrument put forward concept vitamin high intak vitamin vitamin antioxid consid healthi human popul true special situat instanc prevent alzheimer diseas progress recent epidemiolog evid support claim antioxid vitamin increas well b prolong life span fact vitamin supplement detriment reduc life span concept put forward nutrient up regul endogen antioxid defenc true case phytoestrogen bind oestrogen receptor eventu up regul express antioxid gene review discuss pros con antioxid vitamin supplement possibl ingest nutrient effect increas antioxid defenc up regul activ antioxid enzym present cell
MED-3453~supplement vitamin n acetyl cystein increas oxid stress human acut muscl injuri induc eccentr exercis pubm ncbi abstract investig determin wide over the count water solubl antioxid vitamin n acetyl cystein nac act pro oxid human inflammatori condit induc acute phas inflammatori respons eccentr arm muscl injuri inflamm character edema swell pain increas plasma inflammatori indic myeloperoxidas interleukin num immedi injuri subject consum placebo vitamin num mg kg bodi weight nac num mg kg bodi weight num result muscl injuri caus increas level serum bleomycin detect iron amount iron higher vitamin nac group concentr lactat dehydrogenas ldh creatin kinas ck myoglobin signific elev num num postinjuri return baselin level day num addit ldh ck activ elev greater extent vitamin nac group level marker oxid stress lipid hydroperoxid num iso prostaglandin num lpha num iso pgf num lpha antioxid enzym activ elev post injuri subject receiv vitamin nac higher level lipid hydroperoxid num iso pgf num lpha num exercis acut human inflammatori model strong suggest vitamin nac supplement immedi post injuri transient increas tissu damag oxid stress
MED-3454~endur exercis result dna damag detect comet assay pubm ncbi abstract determin num week supplement antioxid allevi exercise induc dna damag studi num runner num km ultramarathon subject random assign group num placebo pl num antioxid ao num mg vitamin num iu rrr alpha tocopheryl acet comet assay assess dna damag circul leukocyt select time point pre mid num postrac daili num day postrac subject complet race run time num num energi expenditur num num kcal women num num num kcal men num percentag dna damag increas midrac num return baselin num postrac indic exercis bout induc nonpersist dna damag gender treatment time interact num day postrac women ao num dna damag women pl num contrast statist signific differ treatment group men time point endur exercis result dna damag shown comet assay ao enhanc recoveri women men
MED-3455~exercise induc lipid peroxid implic deoxyribonucl acid damag system free radic generat pubm ncbi abstract exercise induc deoxyribonucl acid dna damag increas free radic lack evid examin parallel studi test hypothesi high intens exercis abil produc free radic capabl caus dna damag twelv appar healthi male subject age num num year statur num num cm bodi mass num num kg vo num ax num num ml kg min perform num min consecut increment stage num num vo num ax aerob exercis num min period separ stage blood drawn bout exercis determin vivo free radic dna damag protein carbonyl lipid hydroperoxid looh concentr rang lipid solubl antioxid lipid deriv oxygen cent free radic hyperfin coupl constant nitrogen num gauss hydrogen num increas result acut moder high intens exercis num dna damag increas num system observ looh lipid solubl antioxid exercis num observ chang protein carbonyl concentr num find identifi lipid deriv free radic speci contributor peripher mononuclear cell dna damag human exercis model damag occur presenc lipid oxid absenc chang protein carbonyl concentr signific find relev term immun function age process patholog carcinogenesi copyright num wiley liss
MED-3456~acut chronic watercress supplement attenu exercise induc peripher mononuclear cell dna damag lipid peroxid pubm ncbi abstract pharmacolog antioxid vitamin previous investig prophylact effect exercise induc oxid stress larg dose requir lead state pro oxid oxid damag watercress array nutrit compound caroten tocopherol increas protect exercise induc oxid stress present randomis control investig design test hypothesi acut consumpt num exercis chronic num week consumpt watercress supplement attenu exercise induc oxid stress total ten appar healthi male subject age num sd num year statur num sd num cm bodi mass num sd num kg recruit complet num week chronic watercress intervent period num week control ingest experi cross order compet single dos acut phase control ingest blood sampl baselin pre supplement rest pre exercis exercis subject complet increment exercis test volit exhaust chronic acut watercress supplement control main find show exercise induc increas dna damag lipid peroxid acut chronic control supplement phase num supplement acut chronic watercress attenu dna damag lipid peroxid decreas accumul exhaust exercis num control mark increas main lipid solubl antioxid tocopherol tocopherol xanthophyl observ watercress supplement num control experiment phase find suggest short long term watercress ingest potenti antioxid effect exercise induc dna damag lipid peroxid
MED-3457~oxid dna damag human peripher leukocyt induc massiv aerob exercis pubm ncbi abstract reactiv oxygen speci produc vigor exercis permeat cell nuclei induc oxid dna damag support evid lack num km marathon race model massiv aerob exercis demonstr signific degre unrepair dna base oxid peripher immunocompet cell concurr increas urinari excret num hydroxi num deoxyguanosin singl cell gel electrophoresi incorpor lesion specif endonucleas reveal oxid pyrimidin endonucleas iii sensit site contribut postexercis nucleotid oxid oxid dna damag correl signific plasma level creatinin kinas lipid peroxid metabolit num week race phenomenon mechan immun dysfunct exhaust exercis
MED-3458~physic activ induc dna damag pubm ncbi abstract singl cell gel electrophoresi scg assay comet assay sensit techniqu detect presenc dna strand break alkali labil damag individu cell techniqu studi peripher blood cell volunt physic activ test subject run treadmil check blood pressur ecg lactat concentr creatin kinas activ blood time run multipl step test volunt ran long increas speed test run num min fix individu speed defin ensur aerob metabol test white blood cell subject show increas dna migrat scg assay effect num end exercis reach maximum num num dna migrat decreas control level distribut dna migrat cell demonstr major white blood cell exhibit increas dna migrat effect due small fraction damag cell blood sampl blood cultur set studi effect frequenc sister chromatid exchang sce indic genotox effect signific increas sce cultur exercis aerob metabol effect dna migrat abstract truncat num word
MED-3459~whole bodi vibrat prevent treatment delayed onset muscl sore abstract context numer recoveri strategi attempt minim symptom delayed onset muscl sore dom whole bodi vibrat wbv suggest viabl warm up athlet scientif evid support protect effect wbv train wbvt muscl damag lack object investig acut effect wbvt appli eccentr exercis prevent dom design random control trial set univers laboratori patient particip total num healthi untrain volunt random assign wbvt num control num group intervent volunt perform num set num maxim isokinet num eccentr contract dominant limb knee extensor dynamomet wbvt group train appli vibratori platform num hz num mm peak peak num knee flexion num eccentr exercis vibrat appli control group main outcom measur muscl sore thigh circumfer pressur pain threshold record baselin num num num num day postexercis maxim voluntari isometr isokinet knee extensor strength assess baselin immedi exercis num num num day postexercis serum creatin kinas measur baselin num num day postexercis result wbvt group show reduct dom symptom form maxim isometr isokinet voluntari strength loss lower creatin kinas level pressur pain threshold muscl sore num compar control group effect thigh circumfer evid num conclus administ eccentr exercis wbvt reduc dom muscl function improv investig undertaken ascertain effect wbvt attenu dom athlet
MED-3460~massag therapi attenu inflammatori signal exercise induc muscl damag pubm ncbi abstract massag therapi common physic rehabilit skelet muscl amelior pain promot recoveri injuri evid massag reliev pain injur muscl massag affect cellular function remain unknown assess effect massag administ massag therapi treatment separ quadricep num young male particip exercise induc muscl damag muscl biopsi acquir quadricep vastus laterali baselin immedi num min massag treatment num hour period recoveri found massag activ mechanotransduct signal pathway focal adhes kinas fak extracellular signal regul kinas num erk num potenti mitochondri biogenesi signal nuclear peroxisom proliferator activ receptor coactiv num pgc num mitig rise nuclear factor nf num nuclear accumul caus exercise induc muscl trauma effect muscl metabolit glycogen lactat massag attenu product inflammatori cytokin tumor necrosi factor tnf interleukin num il num reduc heat shock protein num hsp num phosphoryl mitig cellular stress result myofib injuri summari administ skelet muscl acut damag exercis massag therapi clinic benefici reduc inflamm promot mitochondri biogenesi
MED-3461~acut inflamm mechan delay onset muscl sore pubm ncbi abstract document anim human research unaccustom eccentr muscl action suffici intens and or durat disrupt connect and or contractil tissu human sensat delay onset muscl sore dom late num propos sensat sore acut inflammatori respons subsequ research fail substanti theori present articl suggest result research dom reflect event typic acut inflamm similar event includ cardin symptom pain swell loss function evid cellular infiltr macrophag biochem marker increas lysosom activ increas circul level acut phase protein histolog initi num final section paper theoret sequenc event propos base research involv acut inflamm dom
MED-3462~muscl sore delayed onset muscl sore pubm ncbi abstract delayed onset muscl sore differ chronolog present condit share qualiti pain elicit reliev activ vari degre function deficit singl mechan muscl sore culmin num mechan develop pathway dom begin microtrauma muscl surround connect tissu microtrauma inflammatori process subsequ shift fluid electrolyt progress event muscl spasm present exacerb condit multitud modal manag symptom sore dom outcom modal divers modal judici nsaid continu exercis suggest reliabl method recommend review articl studi cite repres part clinician decisionmak process care affirm temporari deficit muscl sore light advis medic manag muscl sore prescrib clinician
MED-3464~consumpt bing sweet cherri lower circul concentr inflamm marker healthi men women pubm ncbi abstract purpos studi determin effect consum sweet cherri plasma lipid marker inflamm healthi human healthi men women num supplement diet bing sweet cherri num g d num num fast blood sampl start cherri consumpt studi num num num start cherri supplement studi num num num discontinu studi num cherri consumpt cherri consum num circul concentr c reactiv protein crp regul activ normal t cell express secret rant decreas num num num num num num discontinu cherri consumpt num num concentr rant continu decreas num crp differ num pre cherri num post cherri plasma concentr il num solubl receptor intercellular adhes molecul num tissu inhibitor metalloproteinas num chang studi cherri consumpt affect plasma concentr total hdl ldl vldl cholesterol triglycerid subfract hdl ldl vldl particl size number affect fast blood glucos insulin concentr number chemic hematolog variabl result present studi suggest select modulatori effect sweet cherri crp rant anti inflammatori effect benefici manag prevent inflammatori diseas
MED-3465~effect blueberri ingest natur killer cell count oxid stress inflamm prior num run pubm ncbi abstract blueberri rich antioxid anthocyanin exhibit signific health benefit strenous exercis acut generat oxid stress inflammatori state serv on demand model test antioxid anti inflammatori compound purpos studi examin num blueberri day num week num num prior num run num maxim oxygen consumpt counter oxid stress inflamm immun twenty f well train subject recruit random blueberri bb num control con num group blood muscl urin sampl obtain pre exercis immedi postexercis blood urin num postexercis blood examin isoprostan oxid stress cortisol cytokin homocystein leukocyt t cell function natur killer nk lymphocyt cell count inflamm immun system activ ferric reduc abil plasma antioxid capac muscl biopsi examin glycogen nfkb express evalu stress inflamm urin test modif dna num ohdg rna num ohmu marker nucleic acid oxid num treatment num time repeat measur anova statist analysi increas isoprostan num ohmu signific bb plasma il num nk cell count signific greater bb con marker differ studi daili blueberri consumpt num week increas nk cell count acut ingest reduc oxid stress increas anti inflammatori cytokin
MED-3466~influenc tart cherri juic indic recoveri marathon run pubm ncbi abstract investig determin efficaci tart cherri juic aid recoveri reduc muscl damag inflamm oxid stress twenti recreat marathon runner assign consum cherri juic placebo num day day num marathon run marker muscl damag creatin kinas lactat dehydrogenas muscl sore isometr strength inflamm interleukin num il num c reactiv protein crp uric acid total antioxid status tas oxid stress thiobarbitur acid reactiv speci tbar protein carbonyl examin race isometr strength recov signific faster num cherri juic group damag indic signific inflamm reduc cherri juic group il num num crp num uric acid num tas num greater cherri juic placebo group post supplement measur num protein carbonyl tbar lower cherri juic placebo num num cherri juic provid viabl aid recoveri strenuous exercis increas total antioxid capac reduc inflamm lipid peroxid aid recoveri muscl function num john wiley son a
MED-3467~antioxid diet supplement enhanc aerob perform amateur sportsmen pubm ncbi abstract effect antioxid diet supplement blood lactat concentr aerob anaerob threshold adapt train analys fifteen amateur male athlet random assign placebo group antioxidant suppl group num day supplement num mg day num vitamin num mg day num beta caroten num day num day num vitamin antioxid supplement sportsmen perform maxim exercis test cycl ergomet maxim submaxim physiolog paramet assess blood lactat concentr maxim oxygen uptak vo num ax maxim blood lactat concentr maxim workload attain rose signific group num month train end studi maxim blood lactat concentr lower group supplement placebo group percentag vo num ax attain anaerob threshold rose signific group num month train final supplement group higher placebo group antioxid diet supplement induc lower increas blood lactat concentr maxim exercis test improv effici aerob energi obtain
MED-3469~postprandi glycem respons orang juic nondiet cola differ pubm ncbi abstract purpos studi compar effect unsweeten fruit juic regular decaffein soda postprandi serum glucos level individu non insulin depend diabet mellitus niddm liquid ingest separ part mix meal eighteen individu niddm consum test breakfast calcul diabet exchang meal plan system food ident breakfast food fruit exchang carbohydrate equival amount fresh orang slice unsweeten orang juic regular decaffein coke consum breakfast num num serum glucos sampl drawn fast num num hour postprandi differ found postprandi serum glucos respons coke versus orang juic consum breakfast find question appropri unsweeten fruit juic routin meal plan individu niddm
MED-3471~hdl cholesterol rais effect orang juic subject hypercholesterolemia pubm ncbi abstract background orang juice a rich sourc vitamin folat flavonoid hesperidin induc hypocholesterolem respons anim object determin orang juic benefici alter blood lipid subject moder hypercholesterolemia design sampl consist num healthi men num healthi women elev plasma total ldl cholesterol normal plasma triacylglycerol concentr particip incorpor num num cup num ml orang juic sequenti diet dose period num wk num wk washout period plasma lipid folat homocyst ine vitamin complianc marker concentr measur baselin treatment washout period result consumpt num ml num num ml orang juic daili increas hdl cholesterol concentr num num triacylglycerol concentr num num num num num mmol l num folat concentr num num decreas ldl hdl cholesterol ratio num num affect homocyst ine concentr plasma vitamin concentr increas signific dietari period num num num time conclus orang juic num ml d improv blood lipid profil hypercholesterolem subject confirm recommend consum num serv fruit veget daili
MED-3473~orang juic improv lipid profil blood lactat overweight middle ag women subject aerob train pubm ncbi abstract object studi investig consumpt orang juic aerob train affect serum lipid physic characterist overweight middle ag women method experiment group consist num women consum num ml d orang juic num aerob train num time week num month control group consist num women aerob train program consum orang juic result end experi control group lost averag num fat mass num num weight num experiment group lost num fat mass num weight num consumpt orang juic experiment group increas dietari intak vitamin folat num num serum ldl c decreas num num hdl c increas num num experiment group signific chang observ control group group improv anaerob threshold num num blood lactat concentr decreas num experiment group compar num control group suggest experiment group muscl fatigu respons train conclus consumpt num ml d orang juic aerob train overweight women decreas cardiovascular diseas risk reduc ldl c level increas hdl c level associ decreas blood lactat concentr increas anaerob threshold show improv physic perform copyright num elsevi ireland reserv
MED-3474~fruit veget intak relat risk ischem stroke pubm ncbi abstract context studi evalu relationship fruit veget intak cardiovascular diseas object examin associ fruit veget intak ischem stroke design set subject prospect cohort studi includ num women age num num year nurs health studi num year follow up num num men age num num year health profession follow up studi num year follow up num individu free cardiovascular diseas cancer diabet baselin main outcom measur incid ischem stroke quintil fruit veget intak result total num women num men ischem stroke control standard cardiovascular risk factor person highest quintil fruit veget intak median num serv day men num serv day women relat risk rr num num confid interv ci num num compar lowest quintil increment num serv day fruit veget num lower risk ischem stroke rr num num ci num num num test trend crucifer veget rr num increment num serv day num ci num num green leafi veget rr num num ci num num citrus fruit includ juic rr num num ci num num citrus fruit juic rr num num ci num num contribut appar protect effect total fruit veget legum potato lower ischem stroke risk multivari pool rr total stroke num num ci num num increment num serv day conclus data support protect relationship consumpt fruit vegetables particular crucifer green leafi veget citrus fruit juice and ischem stroke risk
MED-3475~effect varieti process storag flavonoid glycosid content composit lettuc endiv pubm ncbi abstract varieti lettuc lactuca sativum varieti endiv cichorium endivia analyz flavonoid composit content total flavonoid content express unit aglycon fresh materi rang num num microg g lettuc num microg g endiv quercetin conjug quercetin num o galactosid quercetin num o glucosid quercetin num o glucuronid quercetin num num o malonyl glucosid quercetin num o rhamnosid luteolin num o glucuronid measur green leaf lettuc addit cyanidin conjug cyanidin num o glucosid cyanidin num num o malonyl glucosid red leaf varieti kaempferol conjug kaempferol num o glucosid kaempferol num o glucuronid kaempferol num num o malonyl glucosid measur endiv varieti presenc ident kaempferol num num o malonyl glucosid endiv shown time shred lettuc leaf exposur light produc signific loss flavonoid moieti green oak leaf num red oak leaf num iceberg num green batavia num lollo biondo num lollo rosso num sampl cos green salad bowl sampl show loss shred endiv produc loss flavonoid moieti escarol num fine frise num coars frise num signific demalon observ quercetin cyanidin glucosid lettuc similar degrad kaempferol analogu found endiv tissu storag head lettuc endiv dark num degre num humid num day result loss total flavonol glycosid rang num identif amount posit substitut natur sugar import understand potenti bioavail biolog activ flavonoid salad
MED-3476~control sugar ascorb acid mixtur flavonoid match navel orang signific increas human postprandi serum antioxidan pubm ncbi abstract fruit veget consumpt reduc risk cardiovascular diseas develop postprandi state import contributor chronic diseas develop orang flavonoid reduc postprandi oxid hypothes mixtur orang flavonoid reduc postprandi oxid singl orang flavonoid orang sugar ascorb acid orang juic consum typic breakfast placebo control crossov trial num male femal particip num treatment num visit carri treatment placebo ascorb acid sugar equival orang juic placebo hesperidin placebo hesperidin luteolin naringenin mixtur found synergist antioxid properti vitro previous work orang juic posit control serum oxygen radic absorb capac orac total plasma phenol tp serum lipoprotein oxid lo measur num hour baselin fast num num hour sampl consumpt placebo mixtur orang juic group signific increas orac lo lag time data tp inconsist orac lo contrari previous studi attribut protect postprandi effect fructos ascorb fruit trial orang phenol compound contribut direct postprandi oxid protect serum inconsist chang serum tp copyright num elsevi reserv
MED-3477~hesperidin contribut vascular protect effect orang juic random crossov studi healthi volunt pubm ncbi abstract background numer human studi shown consist effect polyphenol rich food intermedi marker cardiovascular diseas unknown action specif relat polyphenol object investig effect orang juic major flavonoid hesperidin microvascular reactiv blood pressur cardiovascular risk biomark postprandi chronic intervent studi design twenty four healthi overweight men age num includ random control crossov studi num wk period volunt daili consum num ml orang juic num ml control drink hesperidin cdh num ml control drink placebo cdp measur blood collect perform overnight fast subject num wk treatment period postprandi studi conduct begin experiment period result diastol blood pressur dbp signific lower num wk consumpt orang juic cdh consumpt cdp num microvascular endothelium rel reactiv signific affect measur overnight fast orang juic cdh ingest signific improv postprandi microvascular endotheli reactiv compar cdp num measur peak plasma hesperetin concentr conclus healthi middle ag moder overweight men orang juic decreas dbp regular consum postprandi increas endothelium depend microvascular reactiv studi suggest hesperidin causal link benefici effect orang juic trial regist clinicaltri gov nct num
MED-3478~role hesperetin natur flavonoid analogu apoptosi ht num human colon adenocarcinoma cell line  a compar studi pubm ncbi abstract colon cancer health problem develop countri incid rate increas india hesperetin hn num num trihydroxi num methoxyflavonon hesperetin analogu ha test apoptosi induc abil methyl thiazolyl tetrazolium assay reveal dose duration depend reduct ht num colon adenocarcinoma cellular growth respons hn ha treatment num num hn num ha show num reduct ht num cellular growth acridin orange ethidium bromid stain show apoptot featur cell death induc hn ha rhodamin num stain show signific reduct mitochondri membran potenti induc hn ha hn ha induc dna damag confirm comet tail format lipid peroxid marker tbar protein oxid marker pcc signific elev hn ha treat group enzym antioxid superoxid dismutas sod catalas cat glutathion peroxidas gpx slight decreas activ compar control untreat ht num cell result western blot analysi apoptosi gene reveal increas cytochrom bax cleav caspas num express decreas bcl num express find hn ha induc apoptosi ht num bax depend mitochondri pathway involv oxidant antioxid imbal copyright num elsevi reserv
MED-3479~bioavail oral administ water dispers hesperetin effect peripher vasodilat human subject implic pubm ncbi abstract hesperetin aglycon citrus flavonoid expect exert vasodilat effect vivo develop water dispers hesperetin process micron enhanc bioavail hesperetin studi aim assess effect process bioavail hesperetin estim effici vasodilatation rel function endotheli cell vitro human volunt studi singl dose vivo found water dispers hesperetin absorb rapid maximum plasma concentr max num num time reach max num num mg prepar oral administ human lc ms analys plasma max demonstr hesperetin accumul plasma hesperetin num d glucuronid hp num hesperetin num d glucuronid hp num ga hesperetin sulfat exclus similar hesperetin hp num enhanc nitric oxid releas inhibit nicotinamid adenin dinucleotid phosphate oxidas nadph oxidas activ human umbil vein endotheli cell cultur system indic plasma hesperetin metabolit improv vasodilat vascular system volunt studi women cold sensit show singl dose water dispers hesperetin effect peripher vasodilat result strong suggest rapid accumul higher plasma concentr enabl hesperetin exert potenti vasodilat effect endotheli action plasma metabolit water dispers hesperetin improv health effect dietari hesperetin journal royal societi chemistri num
MED-3480~plant food risk cerebrovascular diseas potenti protect fruit consumpt pubm ncbi abstract studi associ plant food cerebrovascular diseas contradictori result suggest exist effect modifi factor present studi determin consumpt plant food fruit berri veget cereal predict decreas cerebrovascular diseas incid popul low fruit veget high wholegrain intak cohort studi num men women base data finnish mobil clinic health examin survey conduct num particip num year age free cardiovascular diseas baselin data plant food consumpt deriv num year dietari histori interview num year follow up num case cerebrovascular diseas occur lead hospitalis death invers associ found fruit consumpt incid cerebrovascular diseas ischaem stroke intracerebr haemorrhag adjust relat risk rr highest lowest quartil intak cerebrovascular diseas ischaem stroke intracerebr haemorrhag num num ci num num num num ci num num num num ci num num associ primarili due consumpt citrus fruit occur men total consumpt veget cereal cerebrovascular diseas incid consumpt crucifer veget predict reduc risk cerebrovascular diseas rr num num ci num num ischaem stroke rr num num ci num num intracerebr haemorrhag rr num num ci num num conclus consumpt fruit citrus crucifer veget protect cerebrovascular diseas
MED-3481~pancreat lipas inhibitor natur sourc unexplor potenti pubm ncbi abstract preval obes increas alarm rate medic market obes primarili regard disord lipid metabol enzym involv process select target develop antiobes drug recent newer approach treatment obes involv inhibit dietari triglycerid absorpt inhibit pancreat lipas pl major sourc excess calori natur product provid vast pool pl inhibitor possibl develop clinic product articl review extract secondari metabolit plant microbi origin pl inhibitori activ focus drug develop program
MED-3482~hesperidin display relev role nutrigenom effect orang juic blood leukocyt human volunt random control cross ov studi abstract background previous show healthi middle ag moder overweight men orang juic decreas diastol blood pressur signific improv postprandi microvascular endotheli reactiv hesperidin causal link observ benefici effect orang juic object determin effect chronic consumpt orang juic gene express profil leukocyt healthi volunt assess extent hesperidin involv effect orang juic methodology princip find volunt includ random control crossov studi num week period volunt consum daili num ml orang juic num ml control drink hesperidin num ml control drink placebo blood sampl perform num overnight fast subject num week treatment period global gene express profil determin human genom cdna microarray orang juic hesperidin consumpt signific affect leukocyt gene express orang juic consumpt induc express num gene hesperidin intak modul express num gene orang juic hesperidin consumpt group num regul gene common gene implic chemotaxi adhes infiltr lipid transport suggest lower recruit infiltr circul cell vascular wall lower lipid accumul conclus studi show regular consumpt orang juic num week alter leukocyt gene express anti inflammatori anti atherogen profil hesperidin display relev role genom effect beverag trial registr clinicaltri gov nct num
MED-3483~neuroprotect effect citrus flavonoid pubm ncbi abstract recent attent influenc dietari factor health mental well b oxid stress diseas includ neurodegen disord dietari flavonoid exert cardioprotect chemoprevent neuroprotect effect biolog activ flavonoid attribut antioxid anti inflammatori signal properti clear understand mechan action antioxid signal molecul crucial applic flavonoid intervent neurodegener brain food citrus flavonoid exert advers effect low cytotox healthi normal cell main citrus flavonoid travers blood brain barrier promis candid intervent neurodegener constitu brain food review discuss bioactiv multipl neuroprotect mechan antioxid signal properti citrus flavonoid receptor medi neuroprotect action parallel signal pathway explor final induct cellular defens protein oxid stress neurotox hesperetin main widespread citrus flavonoid discuss suggest citrus fruit rich abund sourc hesperetin flavonoid promis develop general food bas neuroprotect brain food
MED-3484~flavonoid cancer prevent review evid pubm ncbi abstract object work review data epidemiolog preclin studi address potenti benefit diet base flavonoid cancer prevent flavonoid subdivid subclass includ flavonol flavon flavanon flavan num ol anthocyanidin isoflavon epidemiolog studi suggest dietari intak flavonoid reduc risk tumor breast colon lung prostat pancrea studi report inconclus harm associ major challeng interpret epidemiolog studi data origin case control studi retrospect acquisit flavonoid intak differ agricultur sociodemograph lifestyl factor contribut heterogen intak flavonoid popul resid unit state europ asia dose time exposur influenc anticanc respons flavonoid rich diet limit number intervent trial flavonoid document cancer prevent effect propos anticanc mechan flavonoid inhibit prolifer inflamm invas metastasi activ apoptosi prospect studi larger sampl size develop biomark flavonoid intak effect mechanist studi ascertain flavonoid rich diet influenc gene regul cancer prevent
MED-3485~phytonutri intak adult unit state relat fruit veget consumpt pubm ncbi abstract background individu consum diet dens fruit veget consum array phytonutri recogn nutrit compon includ vitamin miner fiber grow bodi evid phytonutri play posit role health object purpos research estim usual intak individu phytonutri american consum recommend level fruit veget compar intak adult meet recommend identifi contribut food sourc total phytonutri intak phytonutri examin studi found predomin fruit veget design food consumpt data nation health nutrit examin survey num phytonutri concentr data depart agricultur databas publish literatur estim energy adjust usual intak student test compar energy adjust phytonutri intak subpopul consum recommend amount fruit veget percentag contribut phytonutri food sourc estim adult result energy adjust intak phytonutri ellag acid higher men women meet dietari recommend fruit veget intak compar meet recommend energy adjust intak ellag acid higher women meet meet recommend phytonutri caroten cryptoxanthin lycopen hesperetin ellag acid singl food account num total intak phytonutri conclus energy adjust intak carotenoid flavonoid higher men women diet conform dietari guidanc fruit veget limit number food provid major phytonutri find research provid import refer inform phytonutri contribut diet rich fruit veget
MED-3486~unit state pharmacopeia safeti evalu spirulina pubm ncbi abstract dietari supplement inform expert committe dsi ec unit state pharmacopei convent usp review safeti dietari supplement dietari supplement ingredi purpos determin admit qualiti monograph unit state pharmacopeia nation formulari usp nf unit state food drug administr fda enforc author pursu misbrand action instanc dietari supplement product conform usp standard fail conform recent dsi ec undertook safeti evalu spirulina wide dietari ingredi dsi ec review inform human clinic trial anim studi regulatori pharmacopei sourc analyz num advers event report spirulina assess potenti health concern conclus review dsi ec assign class safeti rate spirulina maxima platensi permit admiss qualiti monograph dietari supplement ingredi usp nf dsi ec continu monitor report safeti dietari supplement dietari supplement ingredi usp dietari supplement monograph develop dsi ec revisit safeti classif spirulina inform dietari ingredi
MED-3487~scienc weight loss supplement compromis conflict interest abstract weight loss supplement power pharmacoact ingredi potenti harm trial determin product safeti effect tend small short durat frequent lack financi conflict interest disclosur factor conspir place consum risk publish research cite advertis cloak product suggest safeti effect proven scienc exampl current weight loss product back potenti conflict low qualiti research includ metabolif num hydroxycut xenadrin lepticor publish research field weight loss supplement conflict interest disclosur regul research find market claim
MED-3488~aloe induc toxic hepat abstract alo wide phytomedicin phytomedicin describ alo herb anti inflammatori anti prolif anti ag effect recent year case aloe induc hepatotox report pharmacokinet toxic poor literatur report case aloe induc toxic hepat num yr old woman num yr old woman num yr old woman admit hospit acut hepat alo prepar month clinic manifest laboratori find histolog find met diagnost criteria rucam scale toxic hepat discontinu oral alo prepar liver enzym return normal level alo consid causat agent hepatotox
MED-3489~herbal supplement ma huang guarana weight loss random double blind trial pubm ncbi abstract object examin overweight human short term safeti efficaci weight loss herbal supplement ma huang guarana ingredi design num week random double blind placebo control studi herbal dietari supplement num mg day ephedrin alkaloid num mg day caffein subject overweight men women bodi mass index num num kg m num measur primari outcom variabl bodi weight chang secondari variabl includ anthropometr metabol cardiovascular result sixty seven subject random placebo num activ ma huang guarana num twenty four subject group complet studi activ treatment produc signific num greater loss weight x   s num num kg fat num num fat num week treatment period placebo num num kg num num fat activ treatment produc greater reduct hip circumfer serum triglycerid level num activ treat subject num num placebo tr control subject withdrew protocol potenti treatment rel effect dri mouth insomnia headach advers symptom report frequent herbal placebo group final evalu visit conclus herbal mixtur ma huang guarana effect promot short term weight fat loss safeti long term requir investig
MED-3490~scienc liquid dietari supplement promot mislead case mangosteen juic abstract liquid dietari supplement repres fast grow market segment includ botanically bas beverag mangosteen acai noni product resembl fruit juic packag pharmacolog activ ingredi human health effect safeti consum product manufactur make extens low qual publish research promot product report analyz science bas market claim wide consum mangosteen liquid dietari supplement compar find research cite review found analyz market claim overst signific find fail disclos sever methodolog weak research cite trend extend relat product similar wide consum pose public health threat mislead consum assum product safeti effect back rigor scientif data
MED-3491~hepatotox due hydroxycut case seri abstract background muscletech hydroxycut iovat health scienc research oakvill ontario popular weight loss supplement recal manufactur num base report hepatotox supplement object character clinic present hydroxycut liver injuri adjud case causal associ hydroxycut design case seri set academ tertiari care hospit fda databas measur assess causal grade sever liver injuri methodolog develop drug induc liver injuri network dilin studi result patient develop liver injuri hydroxycut treat medic center identifi hospit num num patient requir liver transplant case adequ clinic inform obtain fda medwatch databas includ fatal case acut liver failur usual symptom jaundic fatigu nausea vomit abdomin pain patient exhibit hepatocellular pattern injuri adjud causal reveal num case definit num high num probabl num consid conclus hydroxycut implic sever liver injuri lead acut liver failur death weight loss supplement repres class dietari supplement regard capabl caus sever hepat toxic usual identifi liver injuri elucid
MED-3492~effect natur extract hydroxycitr acid hca sx combin hca sx niacin bound chromium gymnema sylvestr extrac pubm ncbi abstract aim efficaci optim dose high bioavail hydroxycitr acid hca sx combin niacin bound chromium nbc standard gymnema sylvestr extract gse weight loss moder obes subject evalu monitor bodi weight bodi mass index bmi appetit lipid profil serum leptin excret urinari fat metabolit hca sx shown reduc appetit inhibit fat synthesi decreas bodi weight stimul central nervous system nbc demonstr abil maintain healthi insulin level gse shown regul weight loss blood sugar level method random double blind placebo control human studi conduct elluru india num week num moder obes subject age num bmi num kg m num subject random divid group group administ hca sx num mg group administ combin hca sx num mg nbc num mg gse num mg group placebo daili equal divid dose num min meal subject receiv num kcal diet day particip supervis walk result end num week bodi weight bmi decreas num group food intak total cholesterol low dens lipoprotein triglycerid serum leptin level signific reduc group high dens lipoprotein level excret urinari fat metabolit increas group margin non signific effect observ paramet group conclus present studi show optim dose hca sx greater degre combin hca sx nbc gse serv effect safe weight loss formula facilit reduct excess bodi weight bmi promot healthi blood lipid level
MED-3493~acut hepatotox ingest morinda citrifolia noni berri juic num year old boy pubm ncbi abstract present case num year old previous healthi boy acut hepatotox noni berri juic consumpt popular noni berri consumpt continu increas heighten awar relat noni berri consumpt acut hepatotox import
MED-3494~reduc fat content ground beef sacrif qualiti review pubm ncbi abstract american health conscious food choic interest reduc dietari fat intak fat replac affect meat flavor ad flavor reduc origin aroma gener substrat fat alter releas aroma compound fat remov meat water general ad replac water bind compound ad prevent ad water cook evapor prevent patti shrinkag fat replac general classifi composit protein bas replac includ whey soy collagen lipid bas substanc soy lecithin function emulsifi maintain fat retain distribut product carbohydrate bas substanc includ flour wheat soy oat starch potato modifi corn starch tapioca gum carrageenan xanthin duplic characterist contribut fat requir combin replac address juici textur firm negat impact flavor publish elsevi
MED-3495~exposur common food addit carrageenan lead reduc sulfatas activ increas sulfat glycosaminoglycan human epitheli cell abstract common food addit carrageenan includ lambda kappa iota form compos galactos disaccharid link alpha num beta num glycosid bond sulfat group disaccharid residu carrageenan close resembl endogen galactos n acetylgalactosamine contain glycosaminoglycan gag chondroitin sulfat cs dermatan sulfat ds keratan sulfat gag beta num beta num glycosid bond contrast unusu alpha num glycosid bond carrageenan sulfatas activ inhibit sulfat carrageenan high sulfat test effect carrageenan exposur sulfatas activ human intestin mammari epitheli cell line found carrageenan exposur signific reduc activ sulfatas includ n acetylgalactosamin num sulfatas galactos num sulfatas iduron sulfatas steroid sulfatas arylsulfatas sulf num heparan sulfamidas consist inhibit sulfatas activ exposur carrageenan gag content increas signific show mark differ disaccharid composit specif cs disaccharid includ increas di sulf disaccharid compon csd num cs e num declin cs a num cs c num specif heparin heparan sulfat disaccharid includ increas num disaccharid increas ns num disaccharid studi result suggest carrageenan inhibit sulfatas activ lead re distribut cellular gag composit increas di sulf cs potenti consequ cell structur function
MED-3496~pro inflammatori nf earli growth respons gene num regul epitheli barrier disrupt food addit carrageenan human intestin epi pubm ncbi abstract wide food addit carrageenan cgn shown induc intestin inflamm ulcer colitis lik symptom neoplasm gut epithelia anim model clinic featur human inflammatori bowel diseas studi effect cgn pro inflammatori transcript factor nf earli growth respons gene num product egr num evalu term human intestin epitheli barrier integr pro inflammatori transcript factor elev cgn nf activ shown involv induct pro inflammatori cytokin interleukin num integr vitro epitheli monolay cgn insult maintain activ pro inflammatori transcript factor nf egr num suppress nf egr num aggrav barrier disrupt cgn reduc gene express tight junction compon zonula occluden num irregular local epitheli monolay copyright num elsevi ireland reserv
MED-3497~evalu food addit contamin pubm ncbi abstract report repres conclus joint fao who expert committe conven evalu safeti food addit view recommend accept daili intak adi prepar specif ident puriti committe evalu risk pose food contamin aim deriv toler intak advis risk manag option purpos public health protect part report general discuss principl govern toxicolog evalu assess dietari exposur food addit contamin summari committee evalu technic toxicolog dietari exposur data food addit aluminium contain food addit benzo tonkinensi glycerol ester gum rosin glycerol ester tall oil rosin glycerol ester wood rosin octenyl succin acid modifi gum arab polydimethyl siloxan ponceau num pullulan pullulanas bacillus deromifican express bacillus licheniformi quinolin yellow sunset yellow fcf food contamin cyanogen glycosid fumonisin specif food addit revis aluminium lake colour matter beta apo num caroten beta apo num caroteno acid ethyl ester beta caroten synthet hydroxypropyl methyl cellulos magnesium silic synthet modifi starch nitrous oxid sodium carboxymethyl cellulos sucros monoest lauric palmit stearic acid annex report tabl summar committee recommend dietari exposur toxicolog evalu food addit contamin consid
MED-3498~dietari acrylamid exposur french popul result french total diet studi pubm ncbi abstract acrylamid heat induc carcinogen compound found food cook thermal process french total diet studi tds acrylamid analys num food sampl collect mainland franc repres popul diet prepar consum highest concentr found potato chips crisp num g kg french fri fri potato num g kg salt biscuit potato chip num g kg exposur general adult child popul assess combin analyt result nation consumpt data acrylamid exposur assess num num g kg bodi weight bw day adult num num g kg bw day children exposur assess lower previous evalu calcul margin exposur base benchmark dose limit defin carcinogen effect remain low young children num num percentil exposur indic health concern advis continu effort order reduc dietari exposur acrylamid copyright num elsevi reserv
MED-3499~carrageenan meat product pubm ncbi abstract carrageenan sulfat linear polysaccharid d galactos num anhydro d galactos extract red seawe food industri gell thicken stabil properti recent meat industri reduc fat product meat complex system muscl tissu connect tissu fat water process numer interact occur compon interact respons function properti meat system meat product carrageenan contribut gel format water retent addit special interest low fat meat product fat reduct lead unaccept tough textur carrageenan incorpor formul improv textur characterist product decreas tough increas juici carrageenan interact milk protein studi extens mechan carrageenan interact meat protein meat compon fulli understood
MED-3500~carrageenan induc cell cycl arrest human intestin epitheli cell vitro pubm ncbi abstract multipl studi anim model shown common food addit carrageenan cgn induc inflamm intestin neoplasia perform studi determin effect cgn exposur human intestin epitheli cell iec tissu cultur test effect low concentr num mg l undegrad high molecular weight cgn concentr cgn anticip exposur human colon cgn averag western diet human colon epitheli cell line ncm num primari human colon epitheli cell expos cgn num found increas cell death reduc cell prolifer cell cycl arrest compar unexpos control cell num cgn exposur percentag cell reenter num num signific decreas percentag cell num phase signific increas increas activ num num num cgn exposur consist cgn induc cell cycl arrest addit data includ dna ladder poli adp ribos polymeras western blot nuclear dna stain activ caspas num num evid increas apoptosi cgn exposur consist cgn induc necrot cell death data document time knowledg mark advers effect low concentr cgn surviv normal human iec suggest cgn exposur role develop human intestin patholog
MED-3501~carrageenan induc interleukin num product distinct bcl num pathway normal human colon epitheli cell pubm ncbi abstract carrageenan high molecular weight sulfat polygalactan improv textur commerci food product increas mark half centuri carrageenan induc inflamm rheumatolog model intestin model coliti perform studi determin direct effect human intestin cell includ normal human intestin epitheli cell colon surgeri normal intestin epitheli cell line ncm num normal rat ileal epitheli cell cell treat high molecular weight lambda carrageenan concentr num mug ml num il num il num promot activ total nuclear nf kappab ikappabalpha phospho ikappabalpha bcl num assess immunohistochemistri western blot elisa cdna microarray increas bcl num nuclear cytoplasm nf kappab il num promot activ il num secret detect carrageenan exposur knockdown bcl num sirna mark reduc increas il num carrageenan exposur ncm num cell result show time exposur human intestin epitheli cell carrageenan trigger distinct inflammatori pathway activ bcl num nf kappab activ upregul il num secret bcl num caspase recruit domain similar found nod num card num genet predisposit crohn diseas studi find repres link genet environment etiolog inflammatori bowel diseas high carrageenan food addit diet find clinic signific
MED-3502~review harm gastrointestin effect carrageenan anim experi abstract articl review associ exposur carrageenan occurr colon ulcer gastrointestin neoplasm anim model intern agenc research cancer num identifi suffici evid carcinogen degrad carrageenan anim regard pose carcinogen risk human carrageenan wide thicken stabil textur varieti process food preval western diet review experiment data pertain carrageenan effect attent occurr ulcer neoplasm associ exposur carrageenan addit review establish sourc mechan product degrad carrageenan undegrad nativ carrageenan data regard carrageenan intak review data demonstr exposur undegrad degrad carrageenan occurr intestin ulcer neoplasm associ attribut contamin undegrad carrageenan compon low molecular weight spontan metabol undegrad carrageenan acid hydrolysi condit normal digest interact intestin bacteria num food drug administr consid restrict dietari carrageenan averag molecular weight num resolut prevail subsequ regul restrict acknowledg carcinogen properti degrad carrageenan anim model cancer promot effect undegrad carrageenan experiment model widespread carrageenan western diet reconsid
MED-3503~nonsteroid anti inflammatori drug primari dysmenorrhoea pubm ncbi abstract background dysmenorrhoea common gynaecolog complaint consist pain cramp accompani menstruat absenc abnorm primari dysmenorrhoea research shown women dysmenorrhoea high level prostaglandin hormon cramp abdomin pain nonsteroid anti inflammatori drug nsaid drug act block prostaglandin product object purpos review compar nonsteroid anti inflammatori drug treatment primari dysmenorrhoea placebo paracetamol evalu effect safeti search strategi search cochran menstrual disord subfertil group trial regist num april num cochran central regist control trial num quarter num medlin num april num embas num week num attempt made identifi trial nation research regist clinic trial regist citat list relev public review articl abstract major scientif meet includ studi search select criteria randomis control comparison nsaid therapi versus placebo versus nsaid versus paracetamol treat primari dysmenorrhoea data collect analysi review independ assess trial qualiti extract data calcul odd ratio dichotom outcom weight differ continu outcom crossov trial data present addit tabl data summaris descript main result women dysmenorrhoea nsaid found signific effect pain relief placebo num num ci num num advers effect signific common num num ci num num nsaid compar paracetamol evid superior individu nsaid regard efficaci safeti evid power detect differ individu comparison base small trial unsuit meta analysi reviewer conclus nsaid effect treatment dysmenorrhoea women awar signific risk advers effect insuffici evid determin individu nsaid safe effect treatment dysmenorrhoea
MED-3504~surgic interrupt pelvic nerv pathway dysmenorrhea systemat review effect pubm ncbi abstract object assess effect surgic interrupt pelvic nerv pathway primari secondari dysmenorrhea data sourc cochran menstrual disord subfertil group trial regist num june num central cochran librari issu num medlin num nov num embas num nov num cinahl num oct num metaregist control trial citat list review articl includ trial contact author includ trial review method inclus criteria random control trial uterosacr nerv ablat presacr neurectomi open laparoscop procedur treatment dysmenorrhea main outcom measur pain relief advers effect review extract data characterist studi qualiti popul intervent outcom independ result random control trial includ systemat review trial open presacr neurectomi trial laparoscop techniqu treatment primari dysmenorrhea laparoscop uterosacr nerv ablat num month compar control treatment num num ci num num comparison laparoscop uterosacr nerv ablat presacr neurectomi primari dysmenorrhea show num month follow up presacr neurectomi effect num num ci num num secondari dysmenorrhea laparoscop surgic treatment endometriosi addit laparoscop uterosacr nerv ablat improv pain relief num num ci num num presacr neurectomi num num ci num num advers event common presacr neurectomi procedur presacr neurectomi num num ci num num conclus evid nerv interrupt manag dysmenorrhea limit methodolog sound suffici power random control trial
MED-3506~repetit rectal pain distent induc rectal hypersensit patient irrit bowel syndrom pubm ncbi abstract background reduc rectal perceptu threshold report patient irrit bowel syndrom ib phenomenon induc comorbid psycholog state evalu rectal pain threshold baselin condit repetit rectal pain distent rrd patient ib function abdomin pain syndrom fap abdomin pain disord healthi control determin rectal hypersensit reliabl marker ib method rectal sensori threshold assess barostat ramp distent num ml min induc threshold pain maximum toler pressur mmhg measur rrd phasic distent num durat separ num interv track method subject complain pain time final ramp distent induc paramet measur normal defin calcul num confid interv control result ib patient show reduc rectal pain threshold maximum toler pressur baselin patient ib threshold reduc rrd load reduc patient fap rrd signific reduc threshold ib group num effect control fap group conclus rectal hypersensit induc rrd reliabl marker ib conditioning induc viscer hypersensit play pathophysiolog role ib
MED-3507~postinfecti function gastrointestin disord pubm ncbi abstract function gastrointestin disord low health rel qualiti life high resourc util postinfecti irrit bowel syndrom pi ib function gastrointestin disord defin acut onset ib symptom individu previous met rome criteria ib immedi acut ill character num fever vomit diarrhea posit bacteri stool cultur pathophysiolog mechan involv pi ib unknown believ transitori inflamm lead subtl perman structur function digest system induc symptom review consid recent evid surround role inflammatori mediat develop hypersensit mediat mechan abdomin pain discomfort acut inflamm clear recent data suggest anatom mast cells nerv fiber suffici induc symptom estim risk develop pi fgid base presenc relat sever risk factor includ prolong durat initi ill toxic infect bacteri strain smoke mucos marker inflamm femal sex depress hypochondriasi advers life event preced num month
MED-3508~gastrointestin infect develop irrit bowel syndrom pubm ncbi abstract purpos review approxim num million person function gastrointestin disord fgds includ irrit bowel syndrom ib ill onset acut bout infecti diarrhea refer postinfecti pi fgd pi ib recent studi identifi pathogenesi natur histori disord recent find group patient acut diarrhea dysenteri passag grossli bloodi stool develop pi ib persist mucos inflamm air trap gut alter intestin motil contribut diseas symptom genet suscept person prognosi postinfecti form ib favor compar peopl idiopath form disord summari full character postdiarrhea form fgds defin mechan diseas earli chronic ill understand common idiopath form diseas identifi specif alter gut pathophysiolog postinfecti fgds classifi poor character group function disord specif gastrointestin disord
MED-3509~editori acut infect chronic disord don t worri it viral gastroenter pubm ncbi abstract postinfecti function gastrointestin disord pi fgid categori general fgid classif bacteri pi fgid document studi meta analysi increas risk confin bacteri gastroenter ge protozoan helminth infect pi fgid issu journal zanini al evid norovirus ge lead develop pi irrit bowel syndrom substanti proport patient
MED-3510~risk benefit assess cisaprid treatment gastrointestin disord pubm ncbi abstract cisaprid substitut benzamid compound stimul motor activ segment gastrointestin tract enhanc releas acetylcholin enter nervous system cisaprid administ oral treatment gastro oesophag reflux diseas function dyspepsia gastroparesi chronic intestin pseudo obstruct syndrom chronic constip gastro oesophag reflux diseas adult children cisaprid symptomat improv mucos heal long term treatment cisaprid effect prevent relaps oesophag cisaprid improv gastric empti rate improv symptom patient gastroparesi origin unlik domperidon metoclopramid long term administr cisaprid result persist enhanc gastric empti cisaprid effect improv symptom patient function dyspepsia compar studi patient function dyspepsia cisaprid effect metoclopramid domperidon cleboprid ranitidin cimetidin cisaprid increas stool frequenc reduc laxat consumpt patient idiopath constip sever case slow transit constip refractori cisaprid clinic studi cisaprid effect treatment chronic intestin pseudo obstruct postop ileus peptic ulcer irrit bowel syndrom clinic studi warrant defin role cisaprid condit dosag cisaprid rang num num time daili num daili cisaprid general toler short long term treatment children cisaprid toler dose num num mg kg num num time daili abstract truncat num word
MED-3511~treatment function dyspepsia red pepper pubm ncbi abstract aim decreas intens dyspept symptom impair viscer nocicept c type fibr capsaicin red pepper powder method studi perform num patient function dyspepsia gastro oesophag reflux diseas irrit bowel syndrom num week washout period num patient receiv meal random double blind manner num g day red pepper powder num week num patient receiv placebo diari sheet patient record day score individu symptom intens subsequ averag week entir treatment durat result symptom score epigastr pain full nausea score red pepper group signific lower placebo group start week treatment decreas reach num end treatment red pepper group whilst placebo score decreas num conclus red pepper effect placebo decreas intens dyspept symptom desensit gastric nocicept c fibr induc content capsaicin repres potenti therapi function dyspepsia
MED-3512~effect red pepper symptom irrit bowel syndrom preliminari studi pubm ncbi abstract background abdomin pain character irrit bowel syndrom ib bloat disord defec relat viscer hypersensit due increas trpv num nocicept nerv fiber activ aim capsaicin red pepper desensit trpv num fibr evalu red pepper oral administr decreas symptom viscer hypersensit ib patient method studi perform num patient ib diagnos rome ii criteria num week washout period num patient plan receiv num pills day num week random doubl blind manner num mg red pepper powder coat dissolv colon num patient placebo patient score day diari abdomin pain bloat intens num point likert scale week symptom score final patient subject evalu treatment effect statist compar group intra group test result patient drop studi num red pepper group abdomin pain num placebo group num patient pill reduc num day abdomin pain onset treatment intra group comparison show patient red pepper abdomin pain bloat score valu week treatment signific improv respect pre treat valu unlik patient placebo final patient subject evalu treatment effect show red pepper group score signific placebo conclus result preliminari studi chronic administr red pepper powder ib patient enteric co pill signific effect placebo decreas intens abdomin pain bloat consid patient effect placebo
MED-3513~alter rectal sensori respons induc balloon distent patient function abdomin pain syndrom abstract background function abdomin pain syndrom fap chronic unexplain abdomin pain similar psychiatr diagnosi somatoform pain disord patient irrit bowel syndrom ib chronic unexplain abdomin pain rectal hypersensit observ major patient report evalu viscer sensori function fap precis aim test hypothesi fap show alter viscer sensat compar healthi control ib present studi determin rectal perceptu threshold intens sensat visual analogu scale vas rectal complianc respons rectal balloon distent barostat fap ib healthi control method ramp distent num ml min induc threshold discomfort pain maximum toler mmhg measur phasic distent num sec durat separ num sec interv num num mmhg random load subject mark vas refer subject intens sensat immedi distent pressure volum relationship determin plot pressur volum ramp distent complianc calcul linear part curv calcul slope curv simpl regress result rectal threshold signific reduc ib fap vas rate intens induc phasic distent discomfort threshold control increas ib signific decreas fap rectal complianc reduc ib fap conclus inconsist viscer sensit lower higher pressur distent key featur understand pathogenesi fap
MED-3514~alter rectal percept biolog marker patient irrit bowel syndrom pubm ncbi abstract background aim lower viscer percept threshold suggest biolog marker irrit bowel syndrom ib current studi sought determin preval alter rectal viscer percept patient ib correl alter percept threshold subject symptom method anorect manometri rectal percept threshold balloon distent determin num patient ib num control subject gastrointestin psycholog symptom assess questionnair percept threshold symptom reassess num month num patient ib result ninety four percent patient show alter rectal percept form lower threshold avers sensat discomfort increas intens sensat alter viscerosomat referr hypersensit found avers sensat respons rapid phasic distent stool threshold threshold respons slow ramp distent normal cluster analysi physiolog paramet identifi ib subgroup predomin pattern symptom longitudin evalu correl percept threshold symptom sever conclus alter rectal percept present patient ib percept threshold correl tempor retrospect symptom sever alter rectal percept repres reliabl biolog marker ib
MED-3515~role nerv block botulinum toxin inject manag cluster headach pubm ncbi abstract cluster headach ch primari headach syndrom classifi trigemin autonom cephalalgia ch treatment involv step acut attack manag transit therapi prevent therapi greater occipit nerv block shown effect altern bridg therapi oral steroid ch botulinum toxin type recent studi prevent treatment patient chronic ch limit success
MED-3516~secret pain sneez induc applic capsaicin nasal mucosa man abstract num topic applic capsaicin human nasal mucosa induc burn sensat sneez dose depend seromuc nasal secret observ capsaicin num microgram potent methacholin num mg produc nasal secret topic histamin num microgram substanc num microgram calcitonin gene rel peptid num microgram induc rhinorrhea num pretreat topic ipratropium bromid system dexchlorpheniramin indomethacin influenc effect induc capsaicin topic pretreat lidocain inhibit pain sensat fail block rhinorrhea desensit effect capsaicin occur num subsequ applic full recoveri observ num day num propos effect capsaicin human nasal mucosa due excit primari affer neuron convey burn pain sensat evok sneez reflex induc nasal secret releas transmitt peripher termin
MED-3517~prevent effect repeat nasal applic capsaicin cluster headach pubm ncbi abstract preliminari studi shown repeat nasal applic capsaicin prevent occurr cluster headach attack present studi design verifi differ efficaci treatment nasal capsaicin depend side applic fifty two patient affect episod form divid num group receiv treatment side attack occur ipsilater side controlater side eighteen patient chronic form altern receiv ipsilater controlater treatment seventi percent episod patient treat ipsilater side show mark amelior improv note patient treat contralater side efficaci ipsilater treatment emphas result obtain chronic patient patient maximum period amelior num day differ effect num treatment contralater ipsilater statist signific episod chronic suffer efficaci repeat nasal applic capsaicin cluster headach congruent previous report therapeut effect capsaicin pain syndrom post herpet neuralgia diabet neuropathi trigemin neuralgia support drug produc select analgesia
MED-3518~melatonin tradit mediterranean diet pubm ncbi abstract compar industri countri lower incid chronic degen disord mediterranean popul emphas recent decad health promot effect aris mediterranean dietari habit attribut larg intak plant foodstuff rich bioactiv phytochem melatonin recent suggest melatonin present edibl plant improv human health virtu biolog activ good bioavail plant melatonin contribut optim physiolog function regul human endogen melatonin involv nutrit therapi reduc risk cancer cardiovascular neurodegen diseas western popul view presenc melatonin mediterranean food beverag add element hypothesi health benefit mediterranean dietari pattern data preliminari incomplet
MED-3519~effect tart cherri juic prunus cerasus melatonin level enhanc sleep qualiti pubm ncbi abstract background tart montmor cherri report high level phytochem includ melatonin molecul critic regul sleep wak cycl human purpos aim investig ascertain ingest tart cherri juic concentr increas urinari melatonin level healthi adult improv sleep qualiti method randomis double blind placebo control crossov design num volunt consum placebo tart cherri juic concentr num day measur sleep qualiti record actigraphi subject sleep questionnair complet sequenti urin sampl num collect urinari num sulfatoxymelatonin major metabolit melatonin determin cosinor analysi determin melatonin circadian rhythm mesor acrophas amplitud addit total urinari melatonin content determin sampl period trial differ determin repeat measur anova result total melatonin content signific elev num cherri juic group whilst differ shown baselin placebo trial signific increas time bed total sleep time sleep effici total num cherri juic supplement differ time melatonin circardian rhythm trend higher mesor amplitud conclus data suggest consumpt tart cherri juic concentr increas exogen melatonin benefici improv sleep durat qualiti healthi men women benefit manag disturb sleep
MED-3520~influenc melatonin cerebr blood flow human pubm ncbi abstract melatonin attribut role number physiolog process distal skin temperatur blood pressur intak melatonin suggest melatonin induc peripher vasodil effect cerebr blood flow unknown examin effect singl puls melatonin cerebr peripher blood flow posit control ten male healthi volunt age num num yr particip double blind random placebo control cross ov studi occas num microg melatonin infus occas salin infus match placebo cerebr blood flow measur phase contrast magnet reson imag peripher blood flow determin distal proxim skin temperatur gradient finger puls volum serum melatonin concentr increas num num pg ml baselin num num pg ml num min num num pg ml num min melatonin administr signific time cerebr blood flow cerebrovascular resist compar placebo melatonin signific increas peripher blood flow measur distal proxim skin temperatur gradient finger puls volum data demonstr melatonin acut regulatori effect cerebr blood flow human
MED-3521~sweet sour cherri phenol protect effect neuron cell pubm ncbi abstract identif phenol cultivar fresh sweet sour cherri protect effect neuron cell compar evalu studi phenol cherri sweet sour cultivar extract analyz total phenol total anthocyanin antineurodegen activ total phenol sweet sour cherri num rang num num num num mg gallic acid equival total anthocyanin sweet sour cherri rang num num num num mg cyanidin num glucosid equival high perform liquid chromatographi hplc analysi reveal anthocyanin cyanidin peonidin deriv preval phenol hydroxycinnam acid consist neochlorogen acid chlorogen acid p coumar acid deriv glycosid quercetin kaempferol isorhamnetin found general sour cherri higher concentr total phenol sweet cherri due higher concentr anthocyanin hydroxycinnam acid posit linear correl num num reveal total anthocyanin measur summat individu peak hplc analysi total anthocyanin measur ph differenti method indic close agreement quantifi method measur anthocyanin content cherri phenol protect neuron cell pc num cell damag oxid stress dose depend manner due anthocyanin result show cherri rich phenol anthocyanin strong antineurodegen activ serv good sourc biofunct phytochem diet
MED-3522~non vertebr melatonin pubm ncbi abstract melatonin detect bacteria eukaryot unicel macroalga plant fungi taxa invertebr precis determin miss organ role melatonin unknown investig speci detail conclus non vertebr melatonin necessarili circadian peak night nocturn maxima frequent found case studi major biosynthet pathway ident vertebr mimick photoperiod respons concentr temperatur decreas studi detail dinoflagel plant involv photoperiod conceiv requir support stimul flower demonstr date particip antioxid protect aerob non vertebr evid contribut physiolog level miss protect stress oxidotoxin or and extens lifespan shown organ dinoflagel lingulodinium ciliat paramecium rotif philodina drosophila melatonin food find implic ecophysiolog human nutrit regard high level medicin plant pharmacolog
MED-3523~consumpt veget alter morn urinari num sulfatoxymelatonin concentr pubm ncbi abstract melatonin veget influenc circulatori melatonin concentr studi examin effect consumpt veget num sulfatoxymelatonin concentr morn urin ninety four healthi women age num recruit citi public health center japan women random alloc intervent group request consum high amount select veget target num g day num day control group avoid veget period first void morn urin collect end intervent period creatinine adjust num sulfatoxymelatonin concentr measur end intervent period daili intak melatonin veget num ng intervent group num ng control group intervent group concentr num sulfatoxymelatonin chang num num confid interv ci num num ng mg creatinin num num ci num num ng mg creatinin intervent period control group concentr num sulfatoxymelatonin chang num num ci num num ng mg creatinin num num ci num num ng mg creatinin intervent period comparison group regard num sulfatoxymelatonin concentr intervent period show signific differ num result increas consumpt veget rais circulatori melatonin concentr
MED-3524~diet promot sleep durat qualiti pubm ncbi abstract sleep eat essenti part life mechan sleep partial clear subject intens research increas evid show sleep influenc dietari choic cross sect epidemiolog studi demonstr sleep consum energy rich food fat refin carbohydr consum fewer portion veget irregular meal pattern narrat review pose opposit question ingest food affect sleep purpos review discuss evid link diet sleep determin eat kind nutrient obtain food consum bedtim matter addit scientif evid tradit sleep promot food milk herbal product briefli review data clinic trial healthi subject addit discuss mechan observ summar find emerg evid confirm link diet sleep food impact avail tryptophan synthesi serotonin melatonin promot sleep clear physiolog connect effect clinic relev studi copyright num elsevi reserv
MED-3525~normat data daili profil urinari num sulfatoxymelatonin healthi subject age num num pubm ncbi abstract hormon melatonin key factor proper function circadian time system cts exogen melatonin shown benefici case cts disturb deficit melatonin defin disord aim studi collect normat data set num melatonin excret healthi human adult live natur environ urin sampl collect num healthi subject num women num men age num sd num rang num consecut period num num num num num num sulfatoxymelatonin amt num concentr analyz duplic ibl hamburg high sensit competit elisa kit twenty four hour amt num total amount rho num num amt num nighttim excret rho num num amt num morn excret rho num num excret num num negat age daytim excret num num intra subject night day ratio vari num num young subject age num num num older individu age num total amount num h amt num rang num num microg amount amt num excret nighttim period rang num num ng h vari num fold individu data show age rel declin melatonin excret healthi subject live natur environ high inter individu variabl excret rate explain normat data set replac strategi
MED-3526~jert valley cherry enrich diet improv nocturn rest increas num sulfatoxymelatonin total antioxid capac urin middle a pubm ncbi abstract tryptophan serotonin melatonin present jert valley cherri particip sleep regul exhibit antioxid properti effect intak jert valley cherri cultivar sleep wak cycl num sulfatoxymelatonin level urinari total antioxid capac middle ag elder particip evalu volunt subject actigraph monitor record display tempor pattern nocturn activ rest num sulfatoxymelatonin total antioxid capac quantifi enzyme link immunosorb assay colorimetr assay kit intak cherri cultivar produc benefici effect actual sleep time total nocturn activ assum sleep immobl signific increas num sulfatoxymelatonin level total antioxid capac urin intak cultivar find suggest intak jert valley cherri exert posit effect sleep potenti nutraceut tool counteract oxid
MED-3527~melatonin prevent treatment jet lag pubm ncbi abstract background jet lag common affect air travel cross time zone result body intern rhythm step day night cycl destin melatonin pineal hormon play central part regul bodili rhythm drug re align world object assess effect oral melatonin dosag regimen allevi jet lag air travel time zone search strategi search cochran control trial regist medlin embas psychlit scienc citat index electron journal aviat space environment medicin sleep hand search citat list relev studi relev trial princip author relev studi unpublish trial report advers event link melatonin randomis trial search systemat side effect drug sed sed annual reaction week medlin advers drug reaction databas uppsala monitor centr umc food drug administr select criteria randomis trial airlin passeng airlin staff militari personnel oral melatonin compar placebo medic outcom measur consist subject rate jet lag relat compon subject wellb daytim tired onset qualiti sleep psycholog function durat return normal indic circadian rhythm data collect analysi ten trial met inclus criteria compar melatonin placebo addit compar hypnot zolpidem trial adequ qualiti contribut assess design fault assess report advers event trial found medlin reaction week umc databas main result ten trial found melatonin close target bedtim destin num midnight decreas jet lag flight cross time zone daili dose melatonin num num similar effect peopl fall asleep faster sleep num num mg dose num effect relat ineffect num slow releas melatonin suggest short liv higher peak concentr melatonin work base review number treat nnt num benefit greater time zone cross westward flight time melatonin dose import wrong time earli day liabl sleepi delay adapt local time incid side effect low case report suggest peopl epilepsi patient warfarin harm melatonin reviewer conclus melatonin remark effect prevent reduc jet lag occasion short term safe recommend adult travel fli time zone easter direct experienc jet lag previous journey travel cross num time zone pharmacolog toxicolog melatonin systemat studi routin pharmaceut qualiti control melatonin product establish effect melatonin peopl epilepsi interact warfarin investig
MED-3528~detect quantif antioxid melatonin montmor balaton tart cherri prunus cerasus pubm ncbi abstract antioxid melatonin recent identifi varieti edibl plant seed high concentr plant anim melatonin believ function free radic scaveng possibl photoperiod studi melatonin detect quantifi fresh frozen balaton montmor tart cherri prunus cerasus high perform liquid chromatographi cherri speci high level melatonin compar melatonin concentr blood mammal montmor cherri num num ng g approxim num time melatonin balaton cherri num num ng g orchard origin time harvest influenc amount melatonin fresh cherri implic current find consum cherri import sourc dietari melatonin melatonin readili absorb oral previous publish data result present show melatonin endogen produc present diet
MED-3530~simultan analysi serotonin melatonin piceid resveratrol fruit liquid chromatographi tandem mass spectrometri pubm ncbi abstract analyt method develop simultan quantif serotonin melatonin tran cis piceid tran cis resveratrol reversed phas high perform liquid chromatographi coupl mass spectrometri hplc ms electrospray ionize esi posit negat ionize mode hplc optim analyt separ achiev mixtur acetonitril water num formic acid mobil phase linear gradient elut mass spectrometri paramet optim reliabl quantif enhanc select sensit select reaction monitor mode srm appli extract direct analysi initi methanol extract compar ethyl acet extract order demonstr applic analyt method serotonin melatonin tran cis piceid tran cis resveratrol num kind common consum fruit quantifi highest serotonin content found plantain orang bell pepper highest melatonin content grape sampl possess higher tran cis piceid tran cis resveratrol content fruit result combin hplc ms detect simpl sampl prepar rapid accur quantif serotonin melatonin tran cis piceid tran cis resveratrol fruit copyright num elsevi reserv
MED-3531~antioxid antiinflammatori activ anthocyanin aglycon cyanidin tart cherri pubm ncbi abstract anthocyanin num cyanidin isol tart cherri exhibit vitro antioxid antiinflammatori activ compar commerci product inhibit lipid peroxid anthocyanin num aglycon cyanidin num num num num mm concentr antioxid activ num cyanidin compar antioxid activ tert butylhydroquinon butyl hydroxytoluen superior vitamin num mm concentr antiinflammatori assay cyanidin gave ic num valu num num mm prostaglandin endoperoxid synthas num prostaglandin endoperoxid synthas num enzym
MED-3532~applic lc lc ms analysi melatonin serotonin edibl plant pubm ncbi abstract melatonin neurohormon produc pineal gland anim serotonin monoamin neurotransmitt precursor melatonin biosynthesi indoleamin recent report widespread occurr edibl plant consum foodstuff melatonin serotonin rais physiolog concentr blood enhanc human health literatur analyt method suitabl determin melatonin serotonin edibl plant limit liquid chromatograph lc techniqu quantif liquid chromatography mass spectrometri lc ms method combin select sensit high precis enabl simultan determin melatonin serotonin work review lc lc ms techniqu determin melatonin serotonin data melatonin serotonin level edibl plant num crown copyright
MED-3533~effect tart cherri juic beverag sleep older adult insomnia pilot studi abstract studi ascertain proprietari tart cherri juic blend cherrypharm geneva ny usa anecdot report sleep enhanc improv subject report insomnia compar placebo beverag pilot studi random double blind crossov design particip receiv treatment placebo num week interven num week washout period sleep continu sleep onset wake sleep onset total sleep time sleep effici assess num week valu daili sleep diari diseas sever insomnia sever index cohort num older adult chronic insomnia healthi tart cherri juic beverag statist signific pre post treat improv sleep variabl compar placebo studi beverag produc signific reduct insomnia sever minut awak sleep onset improv observ sleep latenc total sleep time sleep effici compar placebo effect size moder case neglig result pilot studi suggest cherrypharm tart cherri juic blend modest benefici effect sleep older adult insomnia effect size equal exceed observ studi valerian studi melatonin studi natur product insomnia effect evidence bas treatment insomnia hypnot agent cognitive behavior therapi insomnia
MED-3534~efficaci tart cherri juic blend prevent symptom muscl damag abstract background numer antioxid anti inflammatori agent identifi tart cherri object test efficaci tart cherri juic blend prevent symptom exercis induc muscl damag method randomis placebo control crossov design fourteen male colleg student drank num fl oz cherri juic blend placebo day consecut day bout eccentr elbow flexion contract num num maximum contract perform fourth day supplement isometr elbow flexion strength pain muscl tender relax elbow angl record day eccentr exercis protocol repeat week subject placebo initi cherri juic vice versa opposit arm perform eccentr exercis bout avoid repeat bout protect effect result strength loss pain signific cherri juic trial versus placebo time treatment strength num pain num relax elbow angl time treatment num muscl tender time treatment num trial conclus data show efficaci cherri juic decreas symptom exercis induc muscl damag notabl strength loss averag day eccentr exercis num placebo num cherri juic
MED-3535~cherri health review pubm ncbi abstract cherri sweet cherri nutrit dens food rich anthocyanin quercetin hydroxycinnam potassium fiber vitamin carotenoid melatonin uv concentr degre ripe postharvest storag condit process signific alter amount nutrient bioactiv compon constitu nutrient bioactiv food compon support potenti prevent health benefit cherri intak relat cancer cardiovascular diseas diabet inflammatori diseas alzheimer diseas mechanist cherri exhibit high antioxid activ low glycem respons cox num num enzym inhibit anti carcinogen effect vitro anim experi well design cherri feed studi substanti health benefit human
MED-3536~epidemiolog insomnia learn pubm ncbi abstract epidemiologist publish num studi insomnia base data collect repres community dwel sampl popul survey provid estim preval insomnia definit insomnia symptom insomnia symptom daytim consequ sleep dissatisfact insomnia diagnos definit base insomnia criteria defin dsm iv recogn one third general popul present definit show daytim consequ insomnia account preval num num definit repres num general popul definit precis decision mak diagnosi set preval num insomnia diagnos dsm iv classif definit insomnia higher preval rate women men preval insomnia symptom general increas age rate sleep dissatisfact diagnos variat age numer factor initi maintain insomnia mental disord organ diseas factor frequent studi associ insomnia major depress episod constant report individu insomnia major depress ill longitudin studi shown persist insomnia depress episod futur epidemiolog studi focus natur evolut insomnia epidemiolog genet link insomnia studi
MED-3537~short long sleep durat memori impair older chines guangzhou biobank cohort studi abstract studi object examin associ sleep rel factor memori impair design cross sect studi set community bas studi guangzhou china particip num older chines num women num men age num num year measur result demograph socioeconom data sleep rel factor cognit function collect face to fac interview potenti confound employ occup status smoke alcohol tea physic activ self rat health anthropometri blood pressur fast plasma glucos lipid measur adjust multipl potenti confound invert u shap associ sleep durat delay word recal test dwrt score valid measur memori impair found num num habitu sleep durat show highest score p valu trend num num num num num compar sleep durat num adjust odd ratio memori impair sleep durat num num num num num confid interv num num num num num subject daili nap morn tired insomnia signific lower dwrt score rang num num conclus short long sleep durat import sleep rel factor independ memori impair marker increas risk cognit impair older peopl citat xu jiang cq lam liu jin yl zhu zhang ws cheng kk thoma gn short long sleep durat memori impair older chines guangzhou biobank cohort studi sleep num num num
MED-3538~cumul cost addit wake dose respons effect neurobehavior function sleep physiolog chronic sleep restricti pubm ncbi abstract object inform debat human sleep chronic reduc consequ conduct dose respons chronic sleep restrict experi wake neurobehavior sleep physiolog function monitor compar total sleep depriv design chronic sleep restrict experi involv random sleep dose num num num time bed night maintain num consecut day total sleep depriv experi involv num night sleep num time bed studi involv num baselin pre depriv day num recoveri day set experi conduct standard laboratori condit continu behavior physiolog medic monitor particip total num healthi adult age num particip experi intervent noctum sleep period restrict num num num day num day num num day sleep prohibit result chronic restrict sleep period num num night num consecut day result signific cumul dose depend deficit cognit perform task subject sleepi rate show acut respons sleep restrict small increas subsequ day signific differenti num num condit polysomnograph variabl delta power non rem sleep eeg a putat marker sleep homeostasis  display acut respons sleep restrict neglig num restrict night comparison chronic sleep restrict total sleep depriv show result disproportion larg wake neurobehavior sleep delta power respons relat sleep lost statist model reveal mode sleep depriv laps behavior alert near linear relat cumul durat wake excess num num conclus chronic restrict sleep num night produc cognit perform deficit equival num night total sleep depriv moder sleep restrict impair wake neurobehavior function healthi adult sleepi rate suggest subject larg unawar increas cognit deficit explain impact chronic sleep restrict wake cognit function assum benign physiolog sleep respons chronic restrict mirror wake neurobehavior respons cumul wake excess num predict perform laps experiment condit suggest sleep debt understood result addit wake neurobiolog cost accumul time
MED-3539~effect kiwifruit consumpt sleep qualiti adult sleep problem pubm ncbi abstract numer studi reveal kiwifruit medicin compound antioxid serotonin benefici treatment sleep disord aim studi evalu effect kiwifruit sleep pattern includ sleep onset durat qualiti studi appli free liv self control diet design twenty four subject num male num femal num num year age consum num kiwifruit num hour bedtim night num week chines version pittsburgh sleep qualiti index cpsqi num day sleep diari actigraph sleep act logger watch assess subject object paramet sleep qualiti includ time bed time sleep onset wake time sleep onset time total sleep time self report sleep qualiti sleep onset latenc wake time sleep onset total sleep time sleep effici intervent num week kiwifruit consumpt subject cpsqi score wake time sleep onset sleep onset latenc signific decreas num num num total sleep time sleep effici signific increas num num kiwifruit consumpt improv sleep onset durat effici adult self report sleep disturb investig sleep promot properti kiwifruit warrant
MED-3540~monoaminerg neurotransmiss histori discoveri antidepress num today pubm ncbi abstract num clinic introduct specif antidepress drug iproniazid monoamine oxidas inhibitor treatment tuberculosi imipramin drug tricycl antidepress famili iproniazid imipramin made fundament contribut develop psychiatri social health natur consist authent chang psychiatr care depress patient pure pharmacolog natur agent constitut indispens research tool neurobiolog psychopharmacolog permit thing postul aetiopathogen hypothes depress disord clinic introduct fluoxetin select serotonin reuptak inhibitor late num revolution therapi depress open famili antidepress present work review histor perspect entir process led discoveri drug contribut develop neuroscientif disciplin antidepress rest clinic practic share action mechan involv modul monoaminerg neurotransmiss synapt level futur antidepress therapi revolv search extraneuron non aminerg mechan mechan modul intraneuron biochem pathway
MED-3541~frequent consumpt veget predict lower risk depress older taiwanes result prospect population bas studi pubm ncbi abstract object studi evalu associ consumpt frequenc major food categori risk depress year older taiwanes design prospect cohort studi multistag random sampl logist regress analysi evalu signific longitudin associ intak frequenc major food categori futur num year risk depress control confound factor adjust cognit status set population bas free liv elder subject men women num num year age result regress model control demograph socio econom lifestyl disease health rel variabl cognit status fruit num num ci num num num num num veget num num ci num num num num num protect depress symptom num year regress model adjust cognit status veget num num ci num num num num num protect depress symptom higher consumpt egg close signific regress model num num num num food categori includ meat poultri fish seafood dairi legum grain tea show signific associ conclus result suggest confound factor total rule frequent consumpt veget protect depress symptom elder studi elucid causal role mechan associ
MED-3542~monoamin oxidas inhibitor chees effect pubm ncbi abstract behavior inhibitor monoamin oxidase a mao a consid term possibl effect antidepress give rise hypertens interact dietari tyramin studi punch biopsi sampl human intestin rat intestin sampl show mao a predomin form enzym speci transport studi evert rat intestin prepar tyramin extens metabol transport intestin select inhibit mao a clorgylin result larg increas amount unchang tyramin transport select inhibit mao b l deprenyl selegilin signific effect behavior revers mao a inhibitor signific reduc elimin effect intestin metabol tyramin inhibit competit natur
MED-3543~dietari inhibitor monoamin oxidas pubm ncbi abstract inhibit monoamin oxidas treat depress anxieti inform pharmacokinet flavonoid compon tobacco prompt explor healthi diet smoke activ compound amount suffici partial inhibit monoamin oxidas literatur search identifi dietari monoamin oxidas inhibitor level compound food pharmacokinet absorpt distribut tissu level observ estim daili intak expect tissu concentr compar measur efficaci compound inhibitor monoamin oxidas norharman harman quercetin dietari presenc pharmacokinet tissu level consist signific level reach neuron monoamin oxidas diet smoke num num tetrahydroisoquinolin eugenol num piperoylpiperidin coumarin quercetin equipot norharman monoamin oxidas inhibitor metabolit isorhamnetin inhibit total quercetin highest compound sampl diet bioavail variabl depend sourc healthi diet amount quercetin give suffici amount brain induc monoamin oxidas inhibit small decreas neurotransmitt breakdown
MED-3544~contribut monoamin oxidas mao inhibit tobacco alcohol addict pubm ncbi abstract whole bodi pet scan studi brain tobacco smoker shown decreas monoamin oxidas mao activ revert control level quit smoke observ decreas mao activ smoker due exposur tobacco constitu possess mao inhibit properti inhibit mao activ uniqu featur tobacco smoke subject type ii alcohol report show similar decreas mao activ revers ceas alcohol present review summar data mao inhibit tobacco constitu explain decreas mao activ observ alcohol due concomit tobacco conclud inhibit mao constitu tobacco tobacco smoke enhanc addict induc tobacco smoke
MED-3545~restrict meat fish poultri omnivor improv mood pilot random control trial abstract background omnivor diet high arachidon acid aa compar vegetarian diet research show high intak aa promot brain disturb mood omnivor eat fish regular increas intak eicosapentaeno acid epa docosahexaeno acid dha fat oppos negat effect aa vivo recent cross sect studi omnivor report signific wors mood vegetarian higher intak epa dha studi investig impact restrict meat fish poultri mood find thirty nin omnivor random assign control group consum meat fish poultri daili omn group consum fish num time week avoid meat poultri fish vegetarian group avoid meat fish poultri veg baselin week particip complet food frequenc questionnair profil mood state questionnair depress anxieti stress scale diet intervent veg particip reduc epa dha aa intak fish particip increas epa dha intak mood score unchang omn fish particip mood score veg particip improv signific week conclus restrict meat fish poultri improv domain short term mood state modern omnivor knowledg trial examin impact restrict meat fish poultri mood state omnivor
MED-3546~elev monoamin oxidas level brain explan monoamin imbal major depress pubm ncbi abstract context monoamin theori depress propos monoamin level lower explan monoamin loss occur monoamin oxidas mao a enzym metabol monoamin serotonin norepinephrin dopamin object determin mao a level brain elev untreat depress set tertiari care psychiatr hospit patient seventeen healthi num depress individu major depress disord met entri criteria recruit care general practition psychiatrist studi particip healthi nonsmok depress individu medic free num month main outcom measur harmin label carbon num radioligand select mao a positron emiss tomographi measur mao a dvs specif distribut volum index mao a densiti brain region prefront cortex anterior cingul cortex posterior cingul cortex caudat putamen thalamus anterior tempor cortex midbrain hippocampus parahippocampus result mao a dvs high signific elev brain region assess test num num num mao a dvs elev averag num sds brain major depress conclus sizabl magnitud find absenc compel explan monoamin loss major depress episod led conclus elev mao a densiti primari monoamine low process major depress
MED-3547~monoamin theori depress histor impact biomed research pubm ncbi abstract monoamin theori associ depress reduc brain monoamin level theori achiev broad popular mid num present articl review histor develop monoamin theori subsequ impact biomed research alleg divis west european research compet version theori investig bibliometr subsequ applic monoamin theori nimh collabor program psychobiolog depress cover articl argu impact monoamin theori explain abil research government agenc pharmaceut compani invok theori advanc project agenda
MED-3548~flavonoid ubiquit dietari phenol subclass exert extens vitro anti invas vivo anti metastat activ pubm ncbi abstract cancer metastasi refer spread cancer cell primari neoplasm distant site secondari tumor form major death cancer natur phytochem phenol compound wide demonstr capabl prevent cancer metastasi phenol compound flavonoid larg subclass abund food nutraceut number report demonstr flavonoid effect natur inhibitor cancer invas metastasi increas scientif literatur catechin deriv epigallocatechin num gallat epigallocatechin epicatechin num gallat epicatechin studi compound topic genistein genistin silibinin quercetin anthocyanin wide investig inhibitori activ invasion metastasi flavonoid dietari veget food respons anti invas anti metastat activ tumor includ luteolin apigenin myricetin tangeretin kaempferol glycitein licoricidin daidzein naringenin effect overcom metastat cascad includ cell cel attach tissu barrier degrad migrat invas cell matrix adhes angiogenesi essenti bioactiv compound prevent tumor cell metastas review summar effect flavonoid metastat cascad relat protein vitro anti invas activ flavonoid cancer cell effect flavonoid antiangiogen vivo anti metastat model scientif evid flavonoid ubiquit dietari phenol subclass exert extens vitro anti invas vivo anti metastat activ
MED-3549~fisetin inhibit attribut angiogenesi vitro vivo  impl angioprevent pubm ncbi abstract studi shown fisetin small phytochem molecul antitumor activ antiangiogen activ examin investig antiangiogen efficaci mechan fisetin human umbil vein endotheli cell huvec fisetin num strong inhibit regular serum growth supplement vascular endotheli growth factor vegf induc growth num num surviv num num huvec dose time depend manner fisetin caus cell cycl arrest num strong num moder phase decreas cyclin num increas num level fisetin caus cell death accompani decreas express survivin increas cleav level caspas num num poly adp ribos polymeras increas ratio bax bcl num fisetin inhibit capillary lik tube format matrigel num num migrat num num decreas express endotheli nitric oxid synthas eno vegf huvec decreas express eno vegf induc nitric oxid synthas matrix metalloproteinas num num num du num human cancer cell vivo matrigel plug assay mice show signific decreas size num num vascular hemoglobin content num num plug fisetin tr compar control mice result suggest fisetin inhibit attribut angiogenesi contribut report antitumor effect fisetin warrant investig angioprevent potenti cancer control
MED-3550~tumor angiogenesi target dietari cancer prevent abstract num num number cancer patient diagnos annual expect doubl accompani increas treatment cost num billion decad efficaci strategi cancer prevent vital improv patient qualiti life reduc healthcar cost judah folkman propos antiangiogenesi strategi prevent dormant microtumor progress invas cancer antiangiogen drug advanc malign colorect lung breast kidney liver brain thyroid neuroendocrin multipl myeloma myelodysplast syndrom cost toxic preclud broad cancer prevent potent antiangiogen molecul identifi dietari sourc suggest ration design antiangiogen diet provid safe wide strategi prevent cancer paper present scientif epidemiolog clinic evid support role antiangiogen diet cancer prevent
MED-3551~modul angiogenesi dietari phytoconstitu prevent intervent breast cancer pubm ncbi abstract breast cancer lead cancer rel death women unit state rest world num women develop breast cancer live dietari habit close risk progress breast cancer dietari agent accumul increas import prevent treatment breast cancer manner compound target breast cancer develop progress interfer angiogen pathway angiogenesi intric process involv develop capillari previous exist blood vessel disrupt pathway effect avenu therapeut intervent breast cancer phytochem found diet kill breast cancer cell vitro prevent suppress breast cancer progress preclin anim model review examin dietari phytoconstitu prevent treatment breast cancer modul intric complex process angiogenesi addit potenti benefit challeng futur direct research anti angiogen dietari phytochem prevent intervent breast cancer address copyright num wiley vch verlag gmbh kgaa weinheim
MED-3552~purpl rice oryza sativa extract constitu inhibit vegf induc angiogenesi pubm ncbi abstract studi evalu protect effect purpl rice oryza sativa bran extract pre constitu cyanidin peonidin angiogenesi induc vascular endotheli growth factor vegf effect vegf pre examin vitro tube format assay num day co cultur human umbil vein endotheli cell huvec fibroblast antiangiogen mechan pre evalu vegf induc prolifer migrat huvec and or human retin microvascular endotheli cell hrmec phosphoryl extracellular signal regul kinas erk num pre signific suppress vegf induc tube format prolifer migrat huvec hrmec phosphoryl erk num cyanidin peonidin suppress prolifer migrat induc vegf find pre anthocyanidin suppress vegf induc angiogenesi inhibit prolifer migrat suggest inhibit phosphorylated erk num involv mechan copyright num john wiley son
MED-3553~diet deriv polyphenol inhibit angiogenesi modul interleukin num stat num pathway pubm ncbi abstract epidemiolog studi abund consumpt food plant origin reduc risk develop type cancer chemoprevent effect relat high content food phytochem polyphenol interfer process involv cancer progress includ tumor cell growth surviv angiogenesi addit low intak plant bas food increas bodi mass physic inact recent emerg import lifestyl factor influenc cancer risk lead generat low grad chronic inflammatori condit key process involv tumor progress object current studi investig inhibitori effect polyphenol angiogenesi trigger inflammatori cytokin il num determin mechan action found test polyphenol apigenin luteolin potent angiogenesi inhibitor inhibitori effect inflammatori cytokin il num stat num pathway effect result modul activ extracellular signal regul kinas num signal trigger il num mark reduct prolifer migrat morphogen differenti endotheli cell interest polyphenol modul express il num signal transduc receptor il num secret extracellular matrix degrad enzym mmp num express suppressor cytokin signal soc num protein result provid import inform role diet cancer prevent copyright num elsevi reserv
MED-3554~wholli nutrit multifoc angiostat therapi control dissemin cancer pubm ncbi abstract great deal effort devot develop drug control spread inoper cancer safe inhibit tumor evok angiogenesi grow evid practic nutrit measur potenti slow tumor angiogenesi reason anticip combin measur work distinct complementari imped angiogen process clinic multifoc angiostat therapi mat devis measur includ protocol discuss includ low fat low glycem index vegan diet down regul system igf i activ support angiogenesi supplement omega num rich fish oil shown inhibit endotheli express flk num function crucial receptor vegf suppress tumor product pro angiogen eicosanoid high dos selenium recent shown inhibit tumor product vegf green tea polyphenol suppress endotheli respons vegf fibroblast growth factor high dos glycin recent report angiostat activ reflect inhibit endotheli cell mitosi possibl mediat activ glycine g chlorid channel light evid tumor evok angiogenesi high requir copper copper deplet potenti angiostat measur effici achiev copper chel drug tetrathiomolybd logist difficulti make difficult acquir experiment drug high dos zinc supplement achiev slower deplet body copper pool case mainten therapi maintain adequ level copper deplet provision protocol offer nutrit base mat entail vegan diet supplement intak fish oil selenium green tea polyphenol glycin zinc cox num overexpress cancer camp boost tumor product angiogen factor autogen growth factor adjunct cox num specif nsaid warrant case
MED-3555~phytochem cancer risk review epidemiolog evid pubm ncbi abstract number epidemiolog studi investig associ phytochem cancer risk phytoestrogen carotenoid common studi class phytochem phytosterol isothiocyan chlorophyl investig lesser extent systemat review literatur phytochem cancer risk date articl systemat review num publish epidemiolog studi examin associ phytochem cancer risk studi found null associ individu phytochem cancer risk site addit result past studi larg inconsist observ associ modest magnitud consist protect effect observ higher levels  dietari intak serum plasma urinari metabolites  of caroten renal cell cancer cryptoxanthin lung cancer isothiocyan lung cancer isothiocyan gastrointestin cancer lignan postmenopaus breast cancer flavonoid lung cancer elev risk cancer higher level phytochem observ insuffici pool studi examin associ inconsist find studi limit abil conclud phytochem increas cancer risk addit research support previous identifi associ case studi examin relationship import continu research effort evalu cumul interact effect numer phytochem phytochemical rich food cancer risk
MED-3556~preval hpv infect femal unit state pubm ncbi abstract context human papillomavirus hpv infect estim common sexual transmit infect baselin popul preval data hpv infect unit state widespread avail prophylact hpv vaccin object determin preval hpv femal unit state design set particip nation health nutrit examin survey nhane repres sampl noninstitution civilian popul femal age num num year interview home nhane num examin mobil examin center provid self collect vagin swab specimen swab analyz hpv dna num consensus polymeras chain reaction type specif hybrid demograph sexual behavior inform obtain particip main outcom measur hpv preval polymeras chain reaction result hpv preval num num confid interv ci num num femal age num num year num hpv preval num num ci num num femal age num num year num num ci num num women age num num year num num ci num num women age num num year num num ci num num women age num num year num num ci num num women age num num year num num ci num num women age num num year statist signific trend increas hpv preval year age num num year num gradual declin preval num year num hpv vaccin type num num low risk type num num high risk type detect num femal particip hpv num detect num num ci num num hpv num num num ci num num hpv num num num ci num num hpv num num num ci num num femal particip independ risk factor hpv detect age marit status increas number lifetim recent sex partner conclus hpv common femal unit state data burden preval hpv infect femal greater previous estim highest age num num year preval hpv vaccin type low
MED-3557~vegetarian diet incid cancer low risk popul abstract background cancer lead death dietari factor account num cancer western countri peopl consum individu food combin assess dietari pattern offer valuabl inform determin associ diet cancer risk method examin associ dietari pattern non vegetarian lacto pesco vegan semi vegetarian cancer incid num particip adventist health studi num cancer case identifi match cancer registri cox proport hazard regress analysi perform estim hazard ratio attain age time variabl result num incid cancer case identifi multivari hr cancer risk vegetarian compar non vegetarian statist signific hr num num ci num num gender combin statist signific associ found vegetarian diet cancer gastrointestin tract hr num num ci num num analyz associ specif vegetarian dietari pattern vegan diet show statist signific protect cancer incid hr num num ci num num gender combin female specif cancer hr num num ci num num lacto ovo vegetarian decreas risk cancer gastrointestin system hr num num ci num num conclus vegetarian diet confer protect cancer impact vegan diet confer lower risk female specif cancer compar dietari pattern lacto ovo vegetarian diet confer protect cancer gastrointestin tract
MED-3558~vitamin carotenoid risk persist oncogen human papillomavirus infect pubm ncbi abstract oncogen human papillomavirus hpv infect main etiolog factor cervic neoplasia infect insuffici produc diseas cofactor nutrit factor viral progress neoplasia result previous studi suggest higher dietari consumpt circul level micronutri protect cervic neoplasia studi evalu role vitamin carotenoid hpv persist compar women intermitt persist infect determin hybrid captur ii system oncogen hpv infect assess baselin approxim num num month postbaselin multivari logist regress analysi determin risk persist hpv infect tertil dietari circul micronutri higher level veget consumpt num decreas risk hpv persist adjust odd ratio num num confid interv num num num reduct hpv persist risk observ women highest plasma cis lycopen concentr compar women lowest plasma cis lycopen concentr adjust odd ratio num num confid interv num num data suggest veget consumpt circul cis lycopen protect hpv persist
MED-3559~antioxidant induc ap num transcript complex parallel select suppress human papillomavirus transcript abstract involv redox regulatori pathway express human papillomavirus hpvs hpv type num hpv num immort human keratinocyt treat antioxid pyrrolidine dithiocarbam pdtc pdtc induc elev bind transcript factor ap num cognat recognit site viral regulatori region increas ap num bind indispens effici hpv num transcript viral gene express select suppress level initi transcript electrophoret mobil supershift assay show composit ap num complex predomin consist jun homodim untreat cell alter irrespect enhanc c fos express c jun phosphoryl primarili heterodimer fra num induc pdtc incub addit increas complex format c jun junb fra num junb overexpress negat interfer c jun c fo trans activ ap num respons gene result suggest observ block viral transcript consequ antioxidant induc reconstitut ap num transcript complex express c jun c fo gene famili tight regul cellular differenti defin reorgan central viral transcript factor repres mechan control transcript pathogen hpvs keratinocyt differenti progress cervic cancer
MED-3560~hpv mediat cervic carcinogenesi concept clinic implic pubm ncbi abstract persist infect high risk human papillomavirus hrhpv general accept cervic cancer cervic cancer rare complic hrhpv infect infect transient give rise cervic lesion averag num year persist hrhpv infect ultim consecut premalign stage cin lesion lead overt cervic carcinoma argu hpv induc cervic carcinogenesi multi step natur review data hrhpv mediat vitro transform studi obtain analysi clinic specimen merg cervic cancer progress model model crucial decis maker earli stage infect involv individu suscept hpv type depend genet make up immun surveil determin cin lesion develop alter transcript regul viral num num oncogen result genom instabl distinguish process cell transform product viral infect subsequ import step malign addit epi genet alter subsequ accumul high grad cin lesion result overt malign immort growth condit gradual sensit growth modul influenc mediat cytokin cell cel cell matrix adhes potenti implic hrhpv test biomark deduc model cervic screen clinic manag cin diseas discuss copyright num patholog societi great britain ireland publish john wiley son
MED-3561~sexual transmit diseas model cervic cancer incoher epidemiolog find role misclassif human papillomav pubm ncbi abstract definit cervic neoplasia sexual determin diseas caus type human papillomavirus wide accept recent epidemiolog studi fail identifi correl sexual activ human papillomavirus infect sexual activ shown independ human papillomavirus infect increas cervic cancer risk incoher analyz respect etiolog model cervic neoplasia role misclassif human papillomavirus infect interpret relat assum model small level misclassif distort num presum preval viral infect num associ sexual activ human papillomavirus infect num abil control relat sexual activ cancer human papillomavirus infect field survey presum rate human papillomavirus infect base dna assay filter situ hybrid gross overestim true viral preval moder misclassifi human papillomavirus infect test result effect estim covari adjust data analysi distort relat condit appar incoher recent epidemiolog find constru evid role human papillomavirus etiolog cervic cancer valid sexual transmit diseas model
MED-3562~ct evalu cervic cancer spectrum diseas pubm ncbi abstract invas cervic cancer common gynecolog malign prognosi base stage size histolog grade primari tumor status lymph node assess stage diseas import determin patient benefit surgeri receiv radiat therapi offici clinic stage system intern feder gynecolog obstetr led error num num stage iii iv diseas result unoffici extend stage cross sect imag modal comput tomographi ct ct stage advanc diseas monitor patient recurr primari tumor heterogen hypoattenu relat normal stroma contrast material enhanc scan obliter periureter fat plane soft tissu mass reliabl sign parametri extens num mm separ tumor pelvic muscl vascular encas sign pelvic side wall invas lymphat spread extern intern iliac nodal chain presacr rout paraaort node distant metastas primari recurr diseas involv liver lung bone
MED-3563~high preval oncogen hpv num cervic smear asymptomat women eastern uttar pradesh india population bas studi pubm ncbi abstract develop countri india occurr human papillomavirus hpv cervic cancer asymptomat popul observ high studi hpv preval conduct part countri data eastern region uttar pradesh present studi aim determin status hpv preval associ socio demograph factor popul preval hpv investig total num cervic scrape sampl asymptomat women primer set num consensus region viral genom detect presenc hpv posit sampl genotyp sequenc univari binari logist regress analysi evalu associ socio demograph factor hpv num clinic asymptomat women found infect hpv compris num genotyp hpv posit women num show singl infect num harbour multipl infect hpv num num preval hpv num num hpv num num hpv num num hpv num num signific associ hpv non vegetarian diet num rural residenti area num observ high preval hpv num asymptomat women popul frequenc compar invas cervic cancer highlight urgent therapeut hpv vaccin cover hpv num high risk type provid protect diseas
MED-3567~nonfat bathroom injuri person age num years  unit state num pubm ncbi abstract num approxim num million person age num year sustain nonfat unintent injuri result approxim num billion lifetim medic cost inform injuri occur limit bathroom common believ hazard locat investig assumpt cdc analyz data nation repres sampl emerg depart ed describ incid circumst nonfat injuri bathroom set person age num year unit state report describ result investig found base num case document num nation electron surveil system injuri program neiss aip databas estim num nonfat bathroom injuri treat ed injuri rate increas age injuri num caus fall person older adult awar bathroom activ high risk injuri environment modif reduc risk
MED-3570~human papillomavirus invas cervic cancer worldwid pubm ncbi abstract recent report num cent invas cervic cancer worldwid human papillomavirus hpv underestim due sampl inadequaci integr event affect hpv num gene target polymeras chain reaction pcr base test hpv negat case studi reanalyz hpv serum antibodi hpv dna serolog hpv num vlps num num antibodi perform num num case hpv negat sampl num num case hpv posit origin studi num num hpv negat biopsi reanalyz sandwich procedur outer section seri section histolog review section assay hpv pcr assay target open read frame orf signific differ found serolog hpv num protein case origin hpv pcr negat posit type specif num pcr num high risk hpv type detect hpv dna num cent num origin hpv negat amplifi specimen hpv type detect num num num num num num cent addit case hpv dna posit num and or num consensus pcr histolog analysi num specimen reveal num qualit inadequ num adequ sampl hpv negat pcr test num num inadequ num combin data previous studi exclud inadequ specimen worldwid hpv preval cervic carcinoma num cent presenc hpv virtual cervic cancer impli highest worldwid attribut fraction report specif major human cancer extrem rariti hpv negat cancer reinforc rational hpv test addit cervic cytolog routin cervic screen copyright num john wiley son
MED-3572~ancestr antibiot resist mycobacterium tuberculosi abstract chemotherapeut option treat tuberculosi sever restrict intrins resist mycobacterium tuberculosi major clinic appli antibiot resist partial provid low permeabl uniqu cell envelop describ complementari system coordin resist drug penetr envelop mycobacteria toler divers class antibiot inhibit cytoplasm target system depend whib num gene pathogen mycobacterium share streptomyc phylogenet relat genus sourc divers antibiot tuberculosi whib num induc subinhibitori concentr antibiot erythromycin tetracyclin streptomycin whib num null mutant streptomyc mycobacterium hypersuscept antibiot vitro tuberculosi antibiot sensit monocyt model system addit antibiot whib num induc exposur fatti acid pathogen mycobacterium speci accumul intern encount eukaryot host infect gene express profil analys demonstr whib num transcript determin drug resist activ express regulon includ gene involv ribosom protect antibiot efflux compon whib num system serv attract target identif inhibitor render tuberculosi multidrug resist deriv antibiotic sensit
MED-3577~surveil morbid mortal older adults  unit state num pubm ncbi abstract problem condit twenti centuri growth number older adult person age num year unit state produc unpreced increas number person risk cost age associ chronic diseas health condit injuri report period num descript system report data cdc s nation center health statist nchs report lead death num nation vital statist system major hospit num nation hospit discharg survey nhdsi major chronic condit num nation health interview survey nhis nation vital statist system compil inform death certif file unit state nhds annual probabl sampl discharg nonfeder short stay hospit nhis ongo annual cross sect household survey civilian noninstitution popul addit health car expenditur older adult examin inform obtain publish report health care financ administr hcfa health servic literatur result lead death adult age num year heart diseas num death num popul malign neoplasm num num cerebrovascular diseas num num lead mortal older adult differ race death caus alzheimer diseas frequent white death caus diabet kidney diseas septicemia hypertens frequent black rate hospit length hospit stay increas age hospit heart diseas repres highest proport discharg older adult num discharg rate malign neoplasm stroke pneumonia similar adult age num year heart diseas higher men women rate hospit fractur women exceed rate men arthriti preval chronic condit adult age num year num num adult hypertens num num heart diseas num num num adult age num year compris num popul account num total person health care dollar spent num billion real capita person health car expenditur age group increas averag annual rate num num project futur medic expenditur older adult vari project substanti increas year num hip fractur dementia urinari incontin discuss exampl preval cost health condit older adult differ potenti prevent condit select result substanti medic social cost differ potenti prevent interpret higher preval cost health condit adult age num year highlight import implement prevent health measur popul public health action data morbid mortal health car expenditur older adult provid inform measur effect public health effort reduc modifi risk factor morbid mortal popul
MED-3580~second m effect low glycemic index food eaten dinner improv subsequ breakfast glycem respons pubm ncbi abstract effect glycem index gi carbohydr eaten previous night glycem respons standard test meal eaten subsequ morn breakfast studi separ normal subject ate low high gi test meal nutrient composit dinner consist singl food experi mix meal food differ observ glycem respons low high gi dinner predict gis glycem respons breakfast signific lower morn low gi dinner high gi dinner eat dinner food fiber content gi effect postbreakfast glycemia conclud gi predict differ glycem respons mix dinner meal breakfast carbohydr toler improv low gi food eaten previous
MED-3581~colon ferment indigest carbohydr contribut second m effect pubm ncbi abstract background low postprandi blood glucos low risk metabol diseas meal abil diminish glucos respons carbohydr eaten meal second m effect sme reduc glycemia elicit low glycemic index lgi food consum meal suggest main mechan sme lgi food increas colon ferment presenc fiber resist starch object object studi sme greater ferment high glycemic index hgi lgi carbohydr eaten previous meal design ten healthi volunt ate num breakfast test meal consist spong cake made rapid digest nonferment amylopectin starch cellulos hgi meal amylopectin starch ferment disaccharid lactulos hgi lac meal slowli digest part ferment amylos starch cellulos lgi meal hour subject fed standard lunch num carbohydr blood collect measur glucos insulin nonesterifi fatti acid nefa breath hydrogen measur marker colon ferment postlunch gastric empti measur ultrasonographi result hgi lac lgi meal improv glucos toler lunch case hgi lac meal effect concomit low nefa concentr delay gastric empti conclus ferment carbohydr independ effect food glycem index potenti regul postprandi respons meal reduc nefa competit glucos dispos minor extent affect intestin motil
MED-3582~slow releas dietari carbohydr improv meal toler pubm ncbi abstract breakfast lentil wholem bread ident carbohydr content healthi volunt lentil produc signific num num reduct blood glucos area flatten plasma insulin gastric inhibitori polypeptid respons comparison bread addit lentil breakfast signific flatter blood glucos respons standard bread lunch num num num blood glucos pattern mimick feed bread breakfast slowli num lunch give bread breakfast quarter carbohydr reduc breakfast glucos profil result signific impair blood glucos respons lunch num control num result breath hydrogen studi perform separ group volunt flatten respons lentil due carbohydr malabsorpt slow releas lent carbohydr food lentil form part diet impair carbohydr toler
MED-3583~meal effect puls blood glucos appetit food intak meal pubm ncbi abstract puls low glycem appetite suppress food properti persist consum part meal meal object studi determin effect fixed s puls meal appetit blood glucos bg ad libitum test meal pizza food intak fi test meal male num num num year num num kg num random consum num isocalor meal chickpea lentil yellow split pea macaroni chees control commerci puls provid num kcal consum macaroni tomato sauc fi measur pizza meal num min consumpt isocalor meal bg appetit measur num num min lentil yellow pea chickpea treatment led lower appetit rate num min prepizza meal period fi pizza meal compar macaroni chees num puls treatment lower bg immedi consumpt num min num effect treatment prepizza meal bg auc num immedi pizza meal bg lower chickpea lentil treatment yellow pea treatment num postpizza meal bg auc lower chickpea lentil treatment yellow pea treatment num benefici effect consum puls meal appetit fi meal bg respons meal depend puls type
MED-3584~higher ratio bean white rice lower cardiometabol risk factor costa rican adult abstract background high intak white rice metabol syndrom type num diabet costa rican follow stapl dietari pattern includ white rice bean combin role food cardiometabol risk factor studi object aim determin associ intak white rice bean metabol syndrom compon costa rican adult num diabet design multivariate adjust calcul compon metabol syndrom daili serv white rice bean num num ratio bean white rice metabol syndrom calcul substitut serv bean serv white rice result increas daili serv white rice posit systol blood pressur bp triglycerid fast glucos invers hdl cholesterol p trend num increas serv bean invers diastol bp num signific trend higher hdl cholesterol lower bp triglycerid observ num num num num ratio bean white rice substitut serv bean serv white rice num ci num lower risk metabol syndrom conclus increas ratio bean white rice limit intak white rice substitut bean lower cardiometabol risk factor
MED-3585~spermicid potenc coca cola pepsi cola pubm ncbi abstract inhibitori effect coke caffeine fre coke coke diet coke pepsi cola human sperm motil studi trans membran migrat method decreas sperm motil num control hour previous studi claim mark variat spermicid potenc formul coca cola confirm cola spermicid effect potenc weak compar well known spermicid agent
MED-3586~dietari fat semen qualiti men attend fertil clinic abstract background object studi examin relat dietari fat semen qualiti paramet method data num men complet dietari semen qualiti data analyz fatti acid level sperm semin plasma measur gas chromatographi subgroup men num linear regress determin associ adjust potenti confound result men primarili caucasian num sd age num num year num overweight obes num smoker higher total fat intak negat relat total sperm count concentr men highest total fat intak num confid interv ci num num lower total sperm count num ci num num lower sperm concentr men lowest ptrend num associ driven intak satur fat level satur fatti acid sperm negat relat sperm concentr num satur fat intak unrel sperm level num higher intak omega num polyunsatur fat relat favor sperm morpholog men highest omega num fatti acid num num num higher normal morpholog men lowest ptrend num conclus preliminari cross sect studi high intak satur fat negat relat sperm concentr higher intak omega num fat posit relat sperm morpholog studi larger sampl requir confirm find
MED-3587~question declin sperm densiti revisit analysi num studi publish num abstract num carlsen al report signific global declin sperm densiti num num evid decreas qualiti semen num year br med num num subsequ publish reanalysi studi includ carlsen al swan al sperm densiti declin reanalysi global trend data environ health perspect num num analysi found signific declin sperm densiti unit state europe australia control abstin time age percent men proven fertil specimen collect method declin sperm densiti unit state approxim num year europe australia approxim num year greater averag declin report carlsen al approxim num year found declin sperm densiti non western countri data limit current studi similar method analyz expand set studi ad num english languag studi publish num analyz previous averag declin sperm count virtual unchang report previous carlsen al slope num num slope geograph group similar report earlier north america slope slope found unit state slope num num confid interv ci num num similar declin europ slope num ci num num report previous studi countri show trend slope num ci num num result consist carlsen al previous result suggest report trend depend studi includ carlsen al observ trend previous report num data num
MED-3588~caffein alcohol beverag intak relat ovulatori disord infertil abstract background studi examin caffein alcohol specif beverag affect fertil women studi retrospect collect inform alcohol caffein intak make result suscept bias method num marri women histori infertil num year attempt pregnant diet measur period prospect relat incid ovulatori disord infertil result num incid report ovulatori disord infertil follow up intak alcohol caffein unrel risk ovulatori disord infertil multivariate adjust relat risk rr num confid interv ci trend compar highest lowest categori intak num num num num alcohol num num num num total caffein intak caffein soft drink posit relat ovulatori disord infertil multivariate adjust rr num ci trend compar highest lowest categori caffein soft drink consumpt num num num num similar associ observ noncaffein sugar diet total soft drink conclus find support hypothesi alcohol caffein impair ovul point decreas fertil associ soft drink ovulatori disord infertil attribut caffein sugar content deserv investig
MED-3589~food intak relationship semen qualiti case control studi pubm ncbi abstract object compar dietari habit normosperm oligoasthenoteratosperm patient attend reproduct assist clinic design observ analyt case control studi set privat fertil clinic patient thirti men poor semen qualiti case num normosperm control coupl attend fertil clinic intervent record dietari habit food consumpt food frequenc questionnair adapt meet specif studi object analysi semen paramet hormon level microdelet karyotyp carri main outcom measur frequenc intak food item regist scale categori rang consumpt repeat daili consumpt result control higher intak skim milk shellfish tomato lettuc case consum yogurt meat product potato logist regress model case lower intak lettuc tomato fruit apricot peach signific higher intak dairi meat process product conclus frequent intak lipophil food meat product milk negat affect semen qualiti human fruit veget maintain improv semen qualiti
MED-3590~male reproduct organ risk environment hazard abstract male reproduct disord interest environment point view includ sexual dysfunct infertil cryptorchid hypospadia testicular cancer report suggest declin sperm count increas reproduct disord area time period past num year testicular cancer evid circumstanti cautious interpret male germ line sensit tissu damag effect ioniz radiat radiant heat number toxic occup hazard document risk factor impair male reproduct function includ physic exposur radiant heat ioniz radiat high frequenc electromagnet radiat chemic exposur solvent carbon disulfid ethylen glycol ether pesticid dibromochloropropan ethylendibromid ddt dde heavi metal inorgan lead mercuri work process metal weld improv work condit affluent countri dramat decreas hazard workplac exposur million worker affluent countri risk reproduct toxic data show environment low level exposur biopersist pollut diet pose risk peopl part world toxic evid suggest evalu conclus drawn compound phthalat bisphenol boron present larg number industri consum product entail risk remain establish appli psychosoci stressor mobil phone final data indic vulner fetal testi toxic instanc matern tobacco smoke time male reproduct toxic address form angl includ exposur earli life
MED-3591~perinat exposur low dose dioxin perman impair human semen qualiti abstract background recent decad young men industri area report experienc decreas semen qualiti object examin effect perinat dioxin exposur sperm qualiti reproduct hormon method investig sperm qualiti hormon concentr num son age num year born num num mother expos dioxin accid seveso itali num num comparison age num year born mother expos background dioxin matern dioxin level concept extrapol concentr measur num serum sampl result num breast f son expos mother median serum dioxin concentr low num ppt concept lower sperm concentr num num million ml num total count num num num progress motil num num num total motil count num num million num num breast f comparison num formula f expos num formula f num breast f comparison matern dioxin background num ppt concept sperm rel differ follicle stimul hormon higher breast f expos group breast f comparison num num iu l num formula f expos num num iu l num inhibin lower breast f expos group num breast f comparison num pg ml num formula f expos num pg ml num conclus utero lactat exposur children low dioxin dose perman reduc sperm qualiti
MED-3592~heavi metal commerci fish jersey pubm ncbi abstract level contamin fish interest potenti risk human consum attent focus self caught fish fish eaten american public commerci sourc sampl num type fish shellfish obtain supermarket specialti fish market jersey analyz arsenic cadmium chromium lead manganes mercuri selenium test null hypothesi metal level vari fish type level metal harm fish predat pose health risk human consum signific interspecif differ metal fish type highest level metal signific correl kendal tau metal numer fish yellowfin tuna bluefish flounder correl general low num correl negat manganes lead posit correl tuna bluefish flounder level metal advers effect fish level arsenic lead mercuri selenium fish rang subleth effect sensit predatori bird mammal fish exceed health bas standard greatest risk metal resid fish speci fish highest level metal exceed human health guidanc standard metal risk inform public mercuri present complet pictur potenti harm metal suggest peopl eat smaller quantiti fish accumul mercuri eat divers fish avoid consum unhealthi quantiti heavi metal consum bear mind standard margin safeti
MED-3593~correl lead cadmium mercuri level tissu liver sampl age cattl pubm ncbi abstract aim studi determin accumul select heavi metal pb cd hg meat liver cattl anim divid age group analysi statistical mathemat correl age anim contamin meat research materi determin heavi metal level longissimus back muscl longissimus dorsi sampl tail lobe liver analysi show contamin cd pb depend age anim
MED-3595~heavi metal coupl fecund life studi abstract effect heavi metal environment relev concentr coupl fecund receiv limit studi ubiquit exposur num num coupl num desir pregnanc discontinu contracept recruit complet interview provid blood specimen quantif cadmium g l lead g dl mercuri g l induct coupl plasma mass spectrometri coupl complet daili journal lifestyl intercours menstruat pregnanc test women coupl num month pregnant fecund odd ratio num confid interv cis estim adjust age bodi mass index cotinin serum lipid relat femal male exposur num denot longer time pregnanc adjust model reduc observ femal cadmium num num ci num num male lead num num ci num num concentr joint model coupl exposur male lead concentr signific reduc num num ci num num remain num femal cadmium num num ci num num prospect coupl base cohort longitudin captur time pregnanc suggest cadmium lead reproduct toxic environment relev concentr
MED-3596~physic activ obes eat habit influenc assist reproduct outcom pubm ncbi abstract object determin eat habit physic activ bmi influenc assist reproduct outcom materi method studi analyz num patient undergo intracytoplasm sperm inject cycl patient answer questionnair regress analysi examin relationship lifestyl bmi intracytoplasm sperm inject cycl outcom result influenc lifestyl obes observ number oocyt recov obes reduc normal fertil rate coeffici coef num num increas risk miscarriag num num physic activ posit affect implant coef num num increas chanc pregnanc num num tend decreas risk miscarriag num num addit invers correl found physic activ bmi direct correl found soft drink consumpt bmi conclus eat habit physic activ obes affect clinic outcom assist reproduct
MED-3597~tran fat consumpt aggress abstract background dietari tran fatti acid dtfa primarili synthet compound introduc recent behavior effect dtfa inhibit product omega num fatti acid experiment shown reduc aggress potenti behavior effect dtfa merit investig sought determin dtfa aggression irrit methodolgy prinicp find capit baselin dietari behavior assess exist clinic trial analyz relationship dtfa aggress num broad sampl baselin subject num adult men women brought complet dietari survey baselin visit target analysi subject num num lipid medic ldl cholesterol extrem diabet hiv cancer heart diseas outcom assess advers behavior impact overt aggress scale modified aggress subscal primari behavior endpoint life histori aggress conflict tactic scale self rat impati irrit associ dtfa aggress analyz regress ordin logit unadjust adjust potenti confound sex age educ alcohol smoke addit analys stratifi sex age ethnic examin prospect associ greater dtfa strong signific greater aggress dtfa consist predict assess aggress predictor relationship upheld adjust confound preserv sex age ethnic strata held cross sect prospect conclusions signific studi evid link dtfa behavior irrit aggress confound concern observ studi factor includ strength consist associ biolog gradient tempor biolog plausibl add weight prospect causal connect result relev public polici determin dietari tran fat clinicaltri gov nct num
MED-3598~prospect studi intak trans fatti acid rumin fat partial hydrogen veget oil marin oil mortal cvd pubm ncbi abstract trans fatti acid tfa advers effect blood lipid tfa sourc risk cvd remain unresolv object present studi evalu associ tfa intak partial hydrogen veget oil phvo partial hydrogen fish oil phfo rumin fat rtfa risk death cvd chd cerebrovascular diseas sudden death norwegian counti studi population bas cohort studi num num particip examin time fat intak assess semi quantit ffq total num men women num hazard ratio hr num ci estim cox regress energi tfa compar energi sourc carbohydr unsatur cis fatti acid multivari model follow up num subject die cvd num chd num cerebrovascular diseas num sudden death signific risk compar highest lowest intak categori found tfa phvo chd hr num num ci num num cerebrovascular diseas hr num num ci num num tfa phfo cvd hr num num ci num num cerebrovascular diseas hr num num ci num num rtfa intak cvd hr num num ci num num chd hr num num ci num num sudden death hr num num ci num num women associ rtfa intak signific men interact num present studi support tfa intak irrespect sourc increas cvd risk tfa phvo decreas risk cerebrovascular diseas warrant investig
MED-3599~updat estim tran fat intak popul pubm ncbi abstract dietari intak industrially produc tran fatti acid ip tfa estim popul age num year children age num year teenag boy age num year num nation health nutrit examin survey nhane food consumpt databas market share inform tran fat level base label survey data analyt data packag in stor purchas food fast food mont carlo model estim ip tfa intak intak tran fat estim tran fat level report depart agricultur usda nation nutrient databas standard refer releas num sr num num nhane food consumpt databas cumul intak ip tfa estim num person day g p d popul base estim dietari intak ip tfa decreas signific cite num food drug administr fda final rule establish label requir tran fat num g p d adult intak ip tfa decreas result implement label requir individu dietari habit consum high level ip tfa brand type food product frequent chosen
MED-3601~children guinea pig histor perspect pubm ncbi abstract experiment involv children phenomenon children research subject divers set experi includ trial vaccin sera effort understand normal pediatr anatomi physiolog develop drug procedur concern child particip research develop centuri critic medic research call attent fact children vulner populations  pregn women prison mental ill  hav serv unwit unwil subject medic experi paper earli case children particip includ trial cowpox vaccin human trial rabi vaccin treatment listerian wound antisepsi histori concern children institution children medic research consid develop regul guidelin includ declar helsinki num
MED-3602~effect ginger motion sick gastric slow wav dysrhythmia induc circular vection pubm ncbi abstract ginger long altern medic prevent motion sick mechan action unknown hypothes ginger amelior nausea motion sick prevent develop gastric dysrhythmia elev plasma vasopressin thirteen volunt histori motion sick underw circular vection nausea score num sever electrogastrograph record plasma vasopressin level assess ginger pretreat crossover design double blind random placebo control studi circular vection induc maxim nausea score num num increas tachygastr activ plasma vasopressin pretreat ginger num num mg reduc nausea tachygastria plasma vasopressin ginger prolong latenc nausea onset shorten recoveri time vection cessat intraven vasopressin infus num num u min induc nausea increas bradygastr activ ginger pretreat num mg affect ginger effect reduc nausea tachygastr activ vasopressin releas induc circular vection manner ginger act agent prevent treatment motion sick
MED-3603~richard pearson strong iatrogen plagu disast bilibid prison manila num pubm ncbi abstract novemb num richard pearson strong head philippin biolog laboratori inocul num men  inm manila bilibid prison  with cholera vaccin contamin plagu organ num men die governor gener philippin appoint general committe investig affair senat demand inform episod senat secretari war presid inform develop mainland investig ensu general committe conclud strong neglig lock incub leav visit physician laboratori mix cholera plagu cultur fate day committee charg refer attorney general found strong innoc crimin neglig governor gener exoner strong strong despond bilibid recov develop noteworthi career american tropic medicin retrospect disast bilibid present epitom problem surround prisoner subject author voluntari consent ahead time general committe recogn condemn shortcom urg reform plea govern bilibid episod remain cautionari tale engag clinic research
MED-3604~medic research nuremberg doctor trial nuremberg code review find advisori committe human radiat exp pubm ncbi abstract advisori committe human radiat experi achr establish review alleg abus human subject feder sponsor radiat research charg identifi standard evalu ethic cold war radiat experi central question achr determin role nuremberg code play norm practic medic research base evid achre ethic oral histori project extens archiv research conclud code time promulg effect mainstream medic research engag human subject research clinic investig rais question conduct research involv human medic profess pursu issu num
MED-3606~radioprotect effect zingib officinal rosco ginger past present futur pubm ncbi abstract radiat import modal treat peopl cancer surgic intervent impractic debilit patient effect ioniz radiat compromis side effect result radiation induc damag normal tissu radioprotect compound select protect normal tissu radiat injuri immens addit associ protect normal tissu permit higher dose radiat obtain cancer control cure till date ideal radioprotector synthet compound toxic optim concentr plant common dietari therapeut agent recent focus attent case non tox easili accept human ginger rhizom zingib officinal rosco zingiberacea wide culinari medicin agent preclin studi carri decad shown ginger phytochem dehydrozingeron zingeron possess radioprotect effect laboratori anim cultur cell vitro hydroalcohol extract ginger rhizom administ intraperiton oral rout effect protect gamma radiation induc sick mortal phytochem dehydrogingeron zingeron present ginger shown protect mice radiation induc sick mortal mechanist studi free radic scaveng antioxid affect anti inflammatori anti clastogen effect contribut observ protect addit studi tumor bear mice shown zingeron select protect normal tissu tumoricid effect radiat review time summar result relat radioprotect properti emphas aspect warrant futur research establish activ util radioprotect agent
MED-3607~radioprotect plant product present status futur prospect pubm ncbi abstract develop radioprotect agent subject intens research view potenti radiat environ space explor radiotherapi nuclear war ideal safe synthet radioprotector date search altern sourc includ plant decad ayurveda tradit indian system medicin plant treat free radical medi ailment logic expect plant render protect radiat damag systemat screen approach provid lead identifi potenti candid drug plant sourc mitig radiat injuri articl review promis plant bioactiv principl wide tradit system medicin render signific radioprotect vitro vivo model system plant constitu pharmacolog activ relev amelior radiation medi damag includ antiemet antiinflammatori antioxid cell prolif wound heal haemopoiet stimulatori discuss copyright num john wiley son
MED-3608~oxid stress radiolog staff pubm ncbi abstract excess product reactiv oxygen speci observ acut chronic exposur radiat anim model lead detriment irrevers outcom vital organ aim studi determin oxid stress status radiolog unit worker expos persist low dos radiat method group num radiolog unit employe num sex age match hospit worker expos low dos radiat recruit separ hospit studi expos subject show higher level lipid peroxid num total antioxid capac num thiol group num conclud occup expos individu oxid stress precaut antioxid therapi reason
MED-3609~protect effect zingeron dietari compound radiat induc genet damag apoptosi human lymphocyt pubm ncbi abstract zingeron dietari compound investig abil protect radiat induc genotox apoptosi human lymphocyt grow vitro radiat antagonist potenti zingeron assess alkalin comet cytokinesis block micronucleus apoptosi reactiv oxygen speci inhibit assay treatment lymphocyt zingeron num g ml prior exposur num gamma radiat result signific reduct frequenc micronuclei compar control set cell evalu cytokinesi block micronucleus assay similar treatment lymphocyt zingeron prior radiat exposur show signific decreas dna damag assess comet paramet percent tail dna oliv tail moment treatment zingeron num g ml irradi signific decreas percentag apoptot cell analyz microscop method dna ladder assay similar radiat induc reactiv oxygen speci level signific num inhibit zingeron studi demonstr protect effect zingeron radiat induc dna damag antiapoptot effect human lymphocyt part attribut scaveng radiat induc free radic inhibit radiat induc oxid stress copyright num elsevi reserv
MED-3610~effect melissa officinali oxid status dna damag subject expos long term low dos ioniz radiat pubm ncbi abstract aim studi determin capabl melissa officinali lemon balm infus improv oxid stress status radiolog staff expos persist low dos radiat work studi before aft clinic trial perform num radiolog staff drink lemon balm infus prepar tea bag daili num num ml num day plasma lipid peroxid dna damag catalas superoxid dismutas myeloperoxidas glutathion peroxidas activ measur lemon balm infus lemon balm infus radiolog unit worker result signific improv plasma level catalas superoxid dismutas glutathion peroxidas mark reduct plasma dna damag myeloperoxidas lipid peroxid conclud infus lemon balm mark improv oxid stress condit dna damag radiolog staff dietari supplement radiat protect
MED-3615~evalu chromosom aberr micronuclei sister chromatid exchang hospit worker chronic expos ioniz radiat pubm ncbi abstract cytogenet analysi perform peripher blood lymphocyt hospit worker chronic expos ioniz radiat comparison match non expos individu accumul absorb dose calcul radiat worker rang num num msv endpoint chromosom aberr ca micronuclei mn sister chromatid exchang sce frequenc ca num cell observ expos group signific num higher control group num num similar number sce cell statist higher num expos group num comparison control group num case micronuclei analysi signific num differ group found data cautious interpret increas frequenc mn found radiat worker num mn num cell compar control group num mn num cell increas occur parallel ca sce frequenc differ result explain natur ca mn generat increas frequenc ca sce radiat worker cumul effect low level chronic exposur ioniz radiat relev conduct cytogenet analysi parallel physic dosimetri work place copyright num wiley liss
MED-3617~high dietari antioxid intak decreas chromosom transloc frequenc airlin pilot abstract background dietari antioxid protect dna damag induc endogen exogen sourc includ ioniz radiat ir data ir expos human popul limit object object examin associ frequenc chromosom transloc biomark cumul dna damag intak vitamin carotenoid num male airlin pilot design dietari intak estim self administ semiquantit food frequ questionnair transloc score fluoresc situ hybrid chromosom paint negat binomi regress estim rate ratio num cis adjust potenti confound result signific invers associ observ transloc frequenc intak vitamin caroten cryptoxanthin lutein zeaxanthin food num transloc frequenc intak vitamin caroten lycopen food total vitamin food supplement vitamin multivitamin supplement adjust rate ratio num ci median compar median serv week high vitamin fruit veget citrus fruit green leafi veget num num num num num num num num num strongest invers associ observ median compar median combin intak vitamin caroten cryptoxanthin lutein zeaxanthin food num num num conclus high combin intak vitamin caroten cryptoxanthin lutein zeaxanthin food diet high food sourc protect cumul dna damag ir expos person
MED-3618~dental radiograph updat recommend pubm ncbi abstract background overview nation council radiat protect measur updat recommend radiat protect dentistri num center diseas control prevent publish guidelin infect control dental health car set num food drug administr updat select criteria dental radiograph num report summar recommend present document address addit topic patient select criteria film select convent radiograph collim beam filtrat patient protect equip film holder oper protect film exposur process infect control qualiti assur imag view direct digit radiographi continu educ dental health care worker expos radiograph conclus report discuss implement proper radiograph practic addit guidelin dentist awar compli applic feder state regul clinic implic dentist weigh benefit dental radiograph consequ increas patient exposur radiat implement radiat control procedur
MED-3619~updat biolog effect ioniz radiat relat dose factor radiat hygien pubm ncbi abstract diagnost imag indispens part contemporari medic dental practic decad dramat increas ioniz radiat diagnost imag carcinogen effect high dos exposur diagnost radiat rare cancer don t act dentist select patient wise make radiograph patient specif reason reason expect radiograph offer uniqu inform influenc diagnosi treatment low dos examin made intraor imag fast film digit sensor thyroid collar rectangular collim panoram cephalometr imag digit system rare earth film screen combin cone beam comput tomographi low dos machin restrict field size region interest reduc ma length exposur arc num australian dental associ
MED-3620~dietari factor cancer mortal atomic bomb survivor pubm ncbi abstract dietari factor fruit veget thought reduc risk cancer incid mortal investig effect diet rich fruit veget long term effect radiat exposur risk cancer cohort num atomic bomb survivor hiroshima nagasaki radiat dose estim diet assess num period num year cancer mortal joint effect fruit veget intak radiat exposur risk cancer death examin addit sum effect diet radiat multipl product effect diet radiat model addit model daili intak fruit veget signific reduc risk cancer death num compar intak week radiat exposur num sievert sv increas signific risk cancer death num addit joint effect show lower risk cancer expos num sv diet rich veget num num num fruit num num num multipl model gave similar result cancer risk reduct veget expos person num effect radiat num product effect veget radiat cancer risk reduct fruit num radiat num product effect fruit radiat signific evid reject addit multipl model daili intak fruit veget benefici person expos radiat reduc risk cancer death
MED-3621~dental x ray risk meningioma abstract context ioniz radiat consist identifi potenti modifi risk factor meningioma frequent report primari brain tumor unit state object examin associ dental x ray common artifici sourc ioniz radiat risk intra crani meningioma design set population bas case control studi design particip studi includ num intra crani meningioma case age num year diagnos resid state connecticut massachusett north carolina san francisco bay area houston texa counti num april num num control frequency match age sex geographi main outcom measur associ intra crani meningioma diagnosi self report bitew full mouth panorex dental x ray result lifetim case odd ratio num num confid interv ci num num control report bitew exam age film receiv person report receiv bitew film year greater frequenc elev risk odd ratio num num ci num num num num ci num num num num ci num num num num ci num num age num num num num year increas risk meningioma panorex film young age year greater frequenc person report receiv film age num year num time num ci num num increas risk meningioma associ appreci locat tumor tentorium conclus exposur dental x ray perform past radiat exposur greater current era increas risk intra crani meningioma sourc artifici ioniz radiat consid modifi risk factor benefit patient
MED-3622~dietari clastogen factor children immigr israel region contamin chernobyl accid pubm ncbi abstract author evalu associ dietari histori plasma clastogen factor children immigr israel num num region contamin chernobyl accid author compar questionnair data demograph variabl dietari histori immigr occur health status clastogen factor score num immigr logist regress analysi reveal negat associ clastogen factor score frequenc consumpt fresh veget fruit children num yr age postimmigr period intak egg fish boy num yr age prior immigr posit clastogen factor score consumpt fresh veget fruit afford protect immun system children num yr age
MED-3623~pediatr ct research elev public health concern low dos radiat issu high politic pubm ncbi abstract articl present analysi issu relat low dos radiat focus pediatr comput tomographi ct refer earli studi seldom quot radiat research paper quantifi excess lifetim fatal cancer yield attribut estim num million pediatr abdomin ct scan author highlight import polici document issu joint nation cancer institut societi pediatr radiology  specif conclus small dose ct repres public health concern final articl identifi contenti issu propos polici initi implement result signific reduct futur radiogen cancer chronic injuri author call discuss profession radiolog societi public interest health organ involv stakehold
MED-3624~estim risk radiation induc fatal cancer pediatr ct pubm ncbi abstract object light rapid increas frequenc pediatr ct examin purpos studi assess lifetim cancer mortal risk attribut radiat pediatr ct materi method organ dose function age at diagnosi estim common ct examin estim attribut lifetim cancer mortal risk unit dose organ site appli standard model assum linear extrapol risk intermedi low dose appli basi current standard practic exposur milliampere second assum independ age result larger dose increas lifetim radiat risk children produc sharp increas relat adult estim risk ct estim lifetim cancer mortal risk attribut radiat exposur ct num year old num abdomin num head an order magnitud higher adults although figur repres small increas cancer mortal natrual background rate unit state approxim num abdomin head ct examin annual perform children age num year rough estim num individu ultim die cancer attribut ct radiat conclus risk estim suggest pediatr ct result signific increas lifetim radiat risk adult ct increas dose milliampere second increas lifetim risk unit dose lower milliampere second set children signific loss inform risk benefit balanc strong tilt benefit frequenc pediatr ct examin rapid increas estim quantit lifetim radiat risk children undergo ct neglig stimul activ reduct ct exposur set pediatr patient
MED-3625~inform consent communic risk radiolog nuclear medicin examin escap communic inferno short abstract radiolog nuclear medicin examin confer definit albeit low long term risk cancer patient undergo examin receiv inaccur inform risk picano argu disregard patient autonomi longer accept suggest practic communic risk
MED-3626~justif diagnost medic exposur practic issu report intern atom energi agenc consult abstract object radiat protect patient unit intern atom energi agenc iaea concern effect justif diagnost medic exposur recent publish work report initi iaea consult area gave ground concern signific level inappropri usag case poor level awar dose risk key group involv articl aim address method iaea conven group expert novemb num review practic achiev action lead effect justif result report summaris matter group consid outcom deliber improv communic profess profession hand profession patients publ coupl issu consent imag procedur revisit good evidence bas referr guidelin criteria accept emphasis global adapt dissemin conclus clinic audit regard key tool ensur justif effect transpar account part normal radiolog practic summari justif facilit num awar appropri audit
MED-3627~project cancer risk comput tomograph scan perform unit state num pubm ncbi abstract background comput tomograph ct scan unit state increas num fold num approxim num million scan annual great medic benefit concern potenti radiation rel cancer risk conduct detail estim futur cancer risk current ct scan age sex scan type method risk model base nation research council biolog effect ioniz radiat report organ specif radiat dose deriv nation survey estim age specif cancer risk scan type model combin age sex specif scan frequenc num obtain survey insur claim data estim number radiation rel incid cancer num uncertainti limit ul mont carlo simul result estim approxim num num ul num num futur cancer relat ct scan perform num largest contribut scan abdomen pelvi num num ul num num chest num ul num head num ul num chest ct angiographi num ul num one third project cancer due scan perform age num num year compar num due scan perform age younger num year num femal conclus detail estim highlight area ct scan make larg contribut total cancer risk includ scan type age group high frequenc scan involv high dose risk reduct effort warrant
MED-3628~num marin environ emphasi behaviour biospher pubm ncbi abstract distribut behaviour natural seri alpha emitt polonium num marin environ studi year primarili due enhanc bioaccumul strong affin bind intern tissu import contributor natur radiat dose receiv marin biota human consum seafood result studi span num decad show num po concentr organ vari wide phylogen group tissu speci variat result num po concentr factor rang approxim num num depend organ tissu consid num po num pb ratio marin speci general greater uniti tend increas food chain indic num po preferenti organ compar progenitor num pb effect transfer num po food chain primarili due high degre assimil radionuclid ingest food subsequ strong retent organ case mechan lead appar biomagnif num po higher trophic level pelag speci releas num po num pb packag organ biodetrit particl sink remov radionuclid upper water column biogeochem process coupl scaveng rate radionuclid pair examin proxi estim downward organ carbon flux sea data relat preferenti bioaccumul organ tissu result radiat dose speci process num po transfer recycl food web discuss addit main gap present knowledg propos area futur studi biogeochem behaviour num po tracer oceanograph process highlight review copyright num elsevi reserv
MED-3629~pacif bluefin tuna transport fukushima deriv radionuclid japan california abstract fukushima dai ichi releas radionuclid ocean water caus signific local global concern spread radioact materi report unequivoc evid pacif bluefin tuna thunnus orientali transport fukushima deriv radionuclid entir north pacif ocean measur emit radionuclid california caught tuna found num num num bq kg num elev num num num bq kg num num pacif bluefin tuna sampl august num found num background concentr num bq kg num num pre fukushima bluefin post fukushima yellowfin tuna rule elev radiocesium uptak num california water post fukushima find pacif bluefin tuna rapid transport radionuclid point sourc japan distant ecoregion demonstr import migratori anim transport vector radionuclid larg high migratori marin anim make extens water japan anim transport vector fukushima deriv radionuclid distant region north south pacif ocean result reveal tool trace migrat origin presenc num potenti migrat time num num ratio high migratori marin speci pacif ocean
MED-3630~radioact fallout unit state due fukushima nuclear plant accid pubm ncbi abstract releas radioact atmospher damag fukushima daiichi nuclear power plant start march num num radionuclid releas iodin num cesium isotop num cs num cs transport pacif ocean reach unit state num march num elev level fission product num num num te num cs num cs detect air water milk sampl collect unit state march num april num continu monitor activ period num day spatial variat num sampl locat unit state made character contamin air mass entir period highest detect activ valu rang num bq num num bq num particul num num bq num gaseous num fraction
MED-3631~increas num level human semen fluid mussel ingest pubm ncbi abstract polonium num po radioact concentr determin human semen fluid vasectom non smok volunt num po level rang num num mbq num num num mbq num decreas num num mbq num rang num num mbq num week control diet exclud fish seafood volunt ate singl meal num cook mussel perna perna num po level determin ten day semen fluid sampl collect morn volunt continu control diet maintain sexual abstin period experi num increas num po level observ day mussel consumpt reduct level return baselin day num copyright num elsevi reserv
MED-3632~unexpect mortal increas unit state arriv radioact plume fukushima correl pubm ncbi abstract multipl nuclear meltdown fukushima plant begin march num releas larg amount airborn radioact spread japan nation studi contamin health hazard merit unit state fukushima fallout arriv day earthquak tsunami meltdown sampl radioact precipit air water milk govern show level hundr time normal small number sampl prohibit credibl analysi tempor trend spatial comparison health offici report week death age num citi num num percent nation total death rose num percent num num num week arriv japanes fallout compar num percent increas prior num week number infant death fukushima rose num percent compar previous num percent decreas project figur entir unit state yield num total death num infant death excess expect preliminari data light similar preliminari mortal find month chernobyl fallout arriv num approxim final figur
MED-3633~semen qualiti male idiopath infertil smoker nonsmok ultrastructur studi pubm ncbi abstract retrospect studi aim evalu effect cigarett consumpt semen paramet group men idiopath infertil semen qualiti num group men idiopath infertil smoker num nonsmok num compar convent semen analysi perform sperm morpholog assess transmiss electron microscopi tem tem data elabor mathemat formula base bayesian techniqu furnish fertil index fi percentag sperm apoptosi necrosi immatur valu normal recommend world health organ guidelin control convent semen analysi valu sperm num men proven fertil tem indic infertil smoker nonsmok patient show similar sperm paramet sperm motil tem analysi valu group signific impair compar control smoker patient classifi mild num num cigarettes d moder num num cigarettes day heavi smoker num cigarettes d sperm concentr fi signific num num consid smoker class compar pair smoker class sperm concentr fi heavi smoker signific lower num observ mild smoker nonsmok group semen qualiti male idiopath infertil dramat affect cigarett consumpt heavi smoker show signific lower sperm concentr fi strong reason stop smoke
MED-3634~cigarett smoke radioact lung cancer risk pubm ncbi abstract introduct determin tobacco industry polici action respect radioact polonium num po cigarett smoke assess long term risk lung cancer caus alpha particl deposit lung regular smoker method analysi major tobacco industri intern secret document cigarett radioact made onlin master settlement agreement num result document show industri awar presenc radioact substanc tobacco earli num industri cogniz potenti cancer growth lung regular smoker quantit radiobiolog calcul estim long term num year lung radiat absorpt dose rad ioniz alpha particl emit cigarett smoke calcul lung rad alpha particl match close rad estim industri environment protect agenc industry estim long term lung rad alpha particl num lung cancer death year num regular smoker acid wash discov num high effect remov num po tobacco leav industri avoid concern acid media ioniz nicotin convert poor absorb form brain smoker depriv sought instant nicotin kick sensat conclus evid lung cancer risk caus cigarett smoke radioact compel warrant remov
MED-3635~wet deposit fission product isotop north america fukushima dai ichi incid march num pubm ncbi abstract infrastructur nation atmospher deposit program nadp numer measur radionuclid wet deposit north america made num nadp site fukushima dai ichi nuclear power station incid march num period march num april num wet on precipit sampl collect nadp analyz fission product isotop whole wat filter solid sampl unit state geolog survey gamma spectrometri variabl amount num num cs num cs measur approxim num sampl nadp site distribut wide contigu unit state alaska calcul num num week individu radionuclid deposit flux rang num num becquerel squar meter sampl period wet deposit activ small compar measur activ present soil nadp network respond complex disast provid scientif valid measur compar complementari network north america europ
MED-3636~death polonium num lesson learn murder soviet spi alexand litvinenko pubm ncbi abstract medic respons radiation  wheth result radiolog warfar terrorist deploy improvis radiat dispers weapon polit assassin occup industri accid medic radiat patient remain taught disciplin medic educ aftermath num medic vulner toxic threat categori weapon mass destruct wmd whether cbrne chemic biolog radiolog nuclear explos nbc nuclear biolog chemic acronym  radi taught profession school respond cultur civil prepared organ date health care profession hcp possess fundament knowledg skill identifi diagnos treat radiat victim vulner made obvious aftermath high profil assassin russian agent alexand litvinenko poison polonium num radioact substanc ubiquit radiat sourc transport virtual region nationwid essenti increas prepared communiti rural health care facil urban univers hospit manag radiat injuri effect requir access special equip expertis radiat sick progress requir acut critic long term care ill sourc prepared rest acknowledg threat exist dedic resourc address risk includ enhanc train equip mass individu exposur radiat present uniqu challeng entir respons continuum law enforc respond emerg medic care increas educ practic respond radiolog threat essenti enhanc prepared
MED-3637~antimicrobi trait tea cranberry deriv polyphenol streptococcus mutan abstract num speci bacteria inhabit human oral caviti small fraction attribut caus plaque rel diseas cari streptococcus mutan accept main cariogen agent substanti knowledg specif virul factor render organ pathogen rise interest altern target specif treatment option oppos nonspecif mechan plaqu remov applic broad spectrum antibacteri impact diet oral health undeni direct observ popul consum high quantiti polyphenol rich food beverag popul low cari incid oral health camellia sinensi plant form tea deriv vaccinium macrocarpon american cranberri fruit receiv notabl attent preval human diet uniqu composit polyphenol biolog activ constitu plant demonstr potent enzyme inhibitori properti bactericid key qualiti import develop therapi microorgan develop resist aim review studi investig feasibl tea cranberri select plant deriv potenti basi altern therapeut agent streptococcus mutan evalu current futur clinic relev
MED-3638~suscept helicobact pylori isol antiadhes activ high molecular weight constitu cranberri pubm ncbi abstract sensit larg number antibiotic resist nonresist helicobact pylori isol antiadhes effect high molecular mass nondialys constitu cranberri juic test confluent monolay gastric cell line microtit plate expos bacteri suspens prepar num pylori isol antibiotic tr untreat patient presenc absenc cranberri constitu ureas assay calcul percentag adhes inhibit isol adhes gastric cell inhibit num mg ml nondialys materi relationship antiadhes effect cranberri materi metronidazol resist isol treat untreat patient num num isol num resist nondialys materi metronidazol num resist nondialys materi cross resist nondialys materi metronidazol data suggest combin antibiot cranberri prepar improv pylori erad
MED-3639~differ microbiolog composit saliva dental plaqu subject drink habit pubm ncbi abstract food shown natur compon polyphenol display anti adhes properti streptococcus mutan aetiolog agent respons dental crown cari inhibit glucosyltransferas mutan enzym involv synthesi adher water insolubl glucan sucros studi demonstr vitro action oral plaqu biofilm format desorpt studi evalu activ display vitro food compound affect microbiolog composit saliva dental plaqu subject diet rich food compar result obtain subject diet food consid coffe barley coffe tea wine total num subject recruit studi sampl plaqu saliva collect subject rough one month interv total bacteria total streptococci mutan lactobacilli count determin cultur saliva dental plaqu highest bacteri titr record control popul drink habit subgroup show count rough log lower control differ bacteri count prove statist signific num dental plaqu concern total count signific vari mg plaqu subject belong drink habit subgroup signific decreas num observ subject drink coffe tea barley coffe wine mutan streptococci lactobacilli evalu case log decreas observ plaqu indic determin signific num reduct valu record subject belong specif drink habit subgroup compar control group studi correl consumpt specif food oral health term reduc plaqu deposit lower count odontopathogen
MED-3640~anti microbi therapi dental plaque rel diseas pubm ncbi abstract control dental plaque rel diseas tradit reli non specif remov plaqu mechan knowledg oral diseas mechan increas futur treatment target small group organ singl speci key virul factor produc aim review current status treatment approach mainten oral hygien includ chemic agent increas problem resist synthet antimicrobi encourag search altern natur product plant sourc num prescript over the count prepar potenti natur agent oral prophylaxi consid target approach direct black pig anaerob periodont pigment provid opportun target phototherapi high intens monochromat light studi date demonstr select kill porphyromona gingivali prevotella intermedia biofilm function inhibit approach includ proteas inhibitor explor control periodont replac therapi resid pathogen replac non pathogen bacteriocin produc variant develop respect streptococcus mutan dental cari
MED-3641~inhibitori effect cranberri juic attach oral streptococci biofilm format pubm ncbi abstract cranberri juic inhibit bacteri adhes examin inhibitori effect cranberri juic adhes oral streptococci strain label num thymidin saliva co hydroxyapatit bead s ha bacteri cell momentarili expos cranberri juic adher s ha decreas signific compar control num hydrophob decreas depend concentr cranberri juic evalu inhibitori effect cranberri juic biofilm format micropl system found high molecular mass constitu cranberri juic inhibit biofilm format test streptococci inhibitori activ relat reduct hydrophob present find suggest cranberri juic compon inhibit colon oral streptococci tooth surfac slow develop dental plaqu copyright blackwel munksgaard num
MED-3642~inhibit bacteri adher cranberri juic potenti treatment urinari tract infect pubm ncbi abstract cranberri juic wide treatment prevent urinari tract infect reput give symptomat relief infect attempt account potenti benefit deriv juic focus urin acidif bacteriostasi investig demonstr cranberri juic potent inhibitor bacteri adher total num clinic isol escherichia coli test cranberri juic inhibit adher num cent num cent clinic isol cranberri cocktail mice place normal water suppli period num day urin collect mice inhibit adher coli uroepitheli cell approxim num cent antiadher activ detect human urin fifteen num subject show signific antiadher activ urin num num hour drink num ounc cranberri cocktail conclud report benefit deriv cranberri juic relat abil inhibit bacteri adher
MED-3643~oral consumpt cranberri juic cocktail inhibit molecular scal adhes clinic uropathogen escherichia coli abstract cranberri juic cocktail cjc shown inhibit format biofilm uropathogen escherichia coli order investig anti adhes compon reach urinari tract oral consumpt cjc volunt num oz water cjc urin sampl collect num num num hour consumpt singl dose abil compound urin influenc bacteri adhes test clinic uropathogen coli strain includ p fimbriat strain num cft num bf num num strain express p fimbria exhibit mannose resist hemagglutin num num non fimbri strain hb num control atom forc microscopi afm measur adhes forc silicon nitrid probe bacteria treat urin sampl num hour cjc consumpt bacteria clinic strain treat urin sampl demonstr lower adhes forc treat urin collect cjc consumpt adhes forc continu decreas time cjc consumpt num hour measur period adhes forc bacteria exposur urin collect water consumpt chang hb num show low adhes forc water cjc consumpt chang time afm adhes forc measur consist result hemagglutin assay confirm oral consumpt cjc act adhes uropathogen coli
MED-3644~cranberri prevent urinari tract infect pubm ncbi abstract background cranberri wide decad prevent treatment urinari tract infect uti object assess effect cranberri product prevent uti suscept popul search strategi search medlin embas cochran central regist control trial central cochran librari internet contact compani involv promot distribut cranberri prepar check refer list review articl relev studi date search januari num select criteria randomis control trial rcts quasi rct cranberri product prevent uti popul data collect analysi author independ assess extract inform inform collect method particip intervent outcom uti symptomat asymptomat side effect adher therapi relat risk rr calcul narrat synthesi undertaken qualiti assess cochran criteria main result ten studi num cross ov parallel group includ cranberry cranberry lingonberri juic versus placebo juic water evalu studi cranberri tablet versus placebo studi studi evalu juic tablet cranberri product signific reduc incid uti num month rr num num ci num num compar placebo control cranberri product effect reduc incid uti women recurr uti elder men women peopl requir catheteris studi includ meta analys due methodolog issu lack data report signific result outcom symptomat uti side effect common studi dropouts withdraw studi high author conclus evid cranberri juic decreas number symptomat uti num month period women recurr uti it effect group larg number dropouts withdraw cranberri juic accept long period time clear optimum dosag method administr juic tablet capsul proper design studi relev outcom
MED-3645~cranberri trimethoprim prevent recurr urinari tract infect random control trial older women abstract object compar effect cranberri extract low dos trimethoprim prevent recurr urinari tract infect uti older women patient method hundr thirty seven women antibiotic tr uti previous num month random receiv num mg cranberri extract num mg trimethoprim num month trial registr isrctn num result thirty nin num particip num antibiotic tr uti num cranberri group num trimethoprim group differ proport relat risk num num ci num num num time recurr uti signific group num median time recurr uti num day cranberri group num day trimethoprim group num num num num withdraw studi num num cranberri group num num trimethoprim group num relat risk withdraw cranberri group num num ci num num conclus trimethoprim limit advantag cranberri extract prevent recurr uti older women advers effect find older women recurr uti weigh clinician inher attract cheap natur product cranberri extract carri risk antimicrobi resist super infect clostridium difficil fungi
MED-3646~cranberri antibiot prevent urinari tract infect random double blind noninferior trial premenopaus women pubm ncbi abstract background increas preval uropathogen resist antimicrobi agent stimul interest cranberri prevent recurr urinari tract infect uti method double blind double dummi noninferior trial num premenopaus women recurr uti random num month prophylaxi trimethoprim sulfamethoxazol tmp smx num mg daili cranberri capsul num mg daili primari end point number symptomat uti num month proport patient num symptomat uti median time uti develop antibiot resist indigen escherichia coli result num month number patient num symptomat uti higher cranberri tmp smx group num num num proport patient num symptomat uti higher cranberri tmp smx group num num median time symptomat uti num month cranberri num month tmp smx group num month cranberri group num fecal num asymptomat bacteriuria coli isol tmp smx resist tmp smx group num fecal num asymptomat bacteriuria coli isol tmp smx resist similar found increas resist rate trimethoprim amoxicillin ciprofloxacin coli isol num month tmp smx group discontinu tmp smx resist reach baselin level num month antibiot resist increas cranberri group cranberri tmp smx equal toler conclus premenopaus women tmp smx num mg daili effect cranberri capsul num mg daili prevent recurr uti expens emerg antibiot resist trial registr isrctn org identifi isrctn num
MED-3648~genet evid support fecal perineal urethr hypothesi cystiti caus escherichia coli pubm ncbi abstract purpos fecal perineal urethr hypothesi explain urinari tract infect uti enter bacteria support longitudin studi method serotyp detect urovirul factor fimbria genet techniqu accur character escherichia coli strain exploit materi method total num coli coloni isol urin rectal swab num femal subject acut uncompl cystiti rectal swab num healthi women serotyp examin gene encod urovirul factor coloni hybrid test clonal urin fecal isol coli cystiti subject evalu pulsed field gel electrophoresi pfge result coli strain caus cystiti domin rectal flora num num patient remain num patient similar clone compris num fecal flora carriag coli strain varieti urovirul factor common healthi women pfge demonstr isol share serotyp characterist virul factor urin rectal swab sampl subject ident conclus base precis genet techniqu result support fecal perineal urethr hypothesi indic coli strain resid rectal flora serv reservoir urinari tract infect cystiti
MED-3649~food born origin escherichia coli caus extraintestin infect pubm ncbi abstract human extraintestin escherichia coli infect includ involv antimicrobi resist strain caus member limit number distinct coli lineag term extraintestin pathogen coli expec special abil diseas extraintestin site exit usual reservoir host intestin tract multipl line evid suggest expec strain encount human urinari tract infect sepsi extraintestin infect extens antimicrobial resist strain food anim sourc transmit human food suppli review summar evid food born organ signific extraintestin coli infect human
MED-3651~effect hygien procedur prevent cross contamin chicken carcas domest kitchen pubm ncbi abstract thirteen site num domest kitchen examin salmonella campylobact spp prepar chicken cook applic hygien regim food prepar bacteria wide dissemin hand food contact surfac clean carri deterg hot water prescrib routin signific decreas frequenc contamin surfac hypochlorit addit signific reduct number contamin site observ studi suggest understand promot effect hygien procedur domest kitchen
MED-3652~multidrug resist extraintestin pathogen escherichia coli sequenc type st num anim food pubm ncbi abstract multidrug resist escherichia coli sequenc type num st num recent emerg global distribut extraintestin infect human divers factor investig explan st num rapid success dissemin includ transmiss anim contact consumpt food suggest detect st num number nonhuman speci st num recent identifi clinic infect companion anim poultri host group confirm faecal carrier st num high degre similar shown st num isol human companion anim poultri base resist characterist genom background human companion anim st num isol tend exhibit similar virul genotyp st num isol poultri possess specif virul gene typic absent human companion anim isol includ gene avian pathogen coli number report anim food associ st num isol small role nonhuman host speci emerg dissemin transmiss st num human remain unclear profound public health import emerg st num clonal group limit evid press care studi signific question copyright num elsevi reserv
MED-3653~chicken reservoir extraintestin pathogen escherichia coli human canada abstract previous retail meat chicken reservoir extraintestin pathogen escherichia coli expec caus urinari tract infect uti human rule retail beef pork potenti reservoir test num addit coli isol meat isol beef pork signific chicken genet relat isol human uti test reservoir expec human food anim compar geograph tempor match coli isol num human uti cecal content num slaughter anim found genet similar coli anim abattoir princip chicken expec caus uti human expec transmiss food anim respons human infect chicken probabl reservoir
MED-3654~nutrient profil food creat nutrient rich food index pubm ncbi abstract nutrient profil food scienc rank food base nutrient content fast basi regul nutrit label health claim market advertis children number nutrient profil model develop research scientist regulatori agenc food industri model focus nutrient limit emphas nutrient benefici health combin nutrient profil model tailor specif goal develop process follow science driven rule includ select index nutrient refer amount develop algorithm calcul nutrient densiti valid chosen nutrient profil model healthi diet extrem import nutrient profil valid compar prevail public opinion regulatori agenc act satisfi scientif process algorithm transpar profil model valid respect object measur healthi diet
MED-3655~preval bacteri vaginosi unit state num associ symptom sexual behavior reproduct health pubm ncbi abstract object bacteri vaginosi bv disturb vagin microflora common vagin symptom increas risk acquisit sexual transmit infect hiv advers pregnanc outcom determin preval associ bv repres sampl women reproduct age unit state studi design women age num year particip nation health nutrit examin survey num submit self collect vagin swab gram stain bv determin nugent score defin score num result preval bv num num confid interv num num num million women bv num women bv report vagin symptom preval num non hispan black num mexican american num non hispan white num comparison bv poverti num smoke num increas bodi mass index chi num num trend femal sex partner num multivari model bv remain posit race ethn increas lifetim sex partner chi num num trend increas douch frequenc chi num trend num low educ attain num invers current oral contracept pill num conclus bv common condit num women bv report symptom bv increas risk acquir sexual transmit infect bv contribut racial dispar infect
MED-3656~longitudin studi vagin douch bacteri vaginosi margin structur model analysi abstract etiolog bacteri vaginosi unknown long term therapi prevent frequent recur condit vagin douch report bacteri vaginosi observ studi associ due confound indic confound women douch respons vagin symptom bacteri vaginosi author margin structur model estim causal effect douch bacteri vaginosi risk control confound effect num num nonpregn women num recruit prospect studi visit num public health clinic birmingham alabama routin care particip assess quarter num year bacteri vaginosi base nugent gram stain score num higher thirty two percent particip douch studi interv num douch num studi visit num classifi involv bacteri vaginosi relat risk regular douch compar douch num num confid interv num num find douch confer increas risk disrupt vagin flora absenc larg random trial find provid evid date risk bacteri vaginosi douch
MED-3657~bacteri vaginosi variat dietari indic abstract bacteri vaginosi bv common condit unknown etiolog link advers reproduct obstetr health outcom prior dietari research bv focus specif macro micronutri dietari indic assess relationship bv select dietari indic cohort num nonpregn women age num num birmingham alabama annual intak assess block num ffq glycem index glycem load gl healthi eat index calcul block dietari data system natur nutrient rich nnr score calcul vagin flora evalu nugent gram stain criteria crude adjust determin multinomi logist regress cross sect prospect analys particip predomin african american num age num num sd num unit increas gl posit adjust num num ci num num nnr negat adjust num num ci num num bv compar normal vagin flora prospect analys gl bv progress adjust num num ci num num persist adjust num num ci num num adjust gl nnr greater bv preval gl increas bv persist acquisit result suggest diet composit contribut vagin flora imbal import elucid etiolog bv
MED-3658~triptan serotonin num ht num num agonist migrain detail result method meta analysi num trial pubm ncbi abstract triptan select serotonin num ht num num agonist effect acut migrain drug triptan clinic num oral dose make evidence bas select guidelin triptan trial similar design facilit meta analysi provid evidence bas foundat triptan clinic practic review methodolog issu surround triptan trial pharmaceut compani princip investig company independ trial raw patient data double blind random control clinic trial oral triptan migrain data cross check publish present data calcul summari estim studi import efficaci toler paramet compar direct head to head compar trial num elig clinic trial num publish involv num patient met criteria inclus result num confid interv sumatriptan num mg wide prescrib oral triptan num num num headach respons improv moder sever mild pain num num num pain free improv pain num num sustain pain free pain free num headach recurr rescu medic num post dos num num consist respons treat attack placebo subtract proport patient advers event ae num num central nervous system ae num num chest ae num num num compar data rizatriptan num mg show efficaci consist similar toler eletriptan num mg show efficaci similar consist lower toler almotriptan num mg show similar efficaci num sustain pain fre respons consist toler sumatriptan num mg naratriptan num mg eletriptan num mg show lower efficaci toler zolmitriptan num mg num mg eletriptan num mg rizatriptan num mg show similar result result num trial direct compar triptan show pattern receiv data frovatriptan public data suggest substanti lower efficaci major methodolog issu involv choic primari endpoint consist multipl attack evalu headach recurr placebo subtract proport control across studi differ differ toler safeti addit number methodolog issu specif direct compar trial includ encapsul patient select market dose oral triptan effect toler differ general small clinic relev individu patient rizatriptan num mg eletriptan num mg almotriptan num mg provid highest likelihood consist success sumatriptan featur longest clinic experi widest rang formul triptan contra ind presenc cardiovascular diseas
MED-3659~result patch test lavend oil japan pubm ncbi abstract report annual result patch test lavend oil num year period num num japan finn chamber scanpor tape perform num day close patch test lavend oil num pet upper back patient suspect cosmet contact dermat compar frequenc posit patch test lavend oil year fragranc diagnos contact allergi patch test reaction num day remov posit rate lavend oil num num num num year period num num posit rate lavend oil increas sudden num recent japan trend aromatherapi lavend oil trend place dri lavend flower pillow drawer cabinet room fashion patient show posit reaction lavend oil dri lavend flower confirm dri lavend flower num case num posit case num num num posit case num conclud increas patch test posit rate lavend oil num num due fashion due fragranc cosmet product
MED-3660~lavend essenti oil treatment migrain headach placebo control clinic trial pubm ncbi abstract lavend essenti oil anxiolyt drug mood stabil sedat spasmolyt antihypertens antimicrobi analges agent wound heal acceler studi time efficaci lavend essenti oil inhal treatment migrain placebo control clinic trial method forty seven patient definit diagnosi migrain headach divid case control case inhal lavend essenti oil num min control group liquid paraffin time period patient record headach sever symptom num min interv total num match group key confound factor result reduct headach sever case num num base visual analogu scale score reduct num num control differ control case statist signific num num headach attack case num respond partial lavend control group num num record headach attack respond placebo percentag respond signific higher lavend group placebo group num conclus present studi suggest inhal lavend essenti oil effect safe treatment modal acut manag migrain headach copyright num karger ag basel
MED-3661~introduct migrain ancient treatment function pharmacolog antimigrain therapi pubm ncbi abstract migrain treatment evolv realm supernatur scientif arena controversi migrain primarili vascular neurolog dysfunct irrespect controversi level serotonin num hydroxytryptamin num ht vasoconstrictor central neurotransmitt decreas migrain carotid vasodilat infus num ht abort migrain fact num ht ergotamin dihydroergotamin antimigrain agent invari produc vasoconstrict extern carotid circul decad wit advent sumatriptan generat triptan zolmitriptan rizatriptan naratriptan belong class drug num ht num num num receptor agonist compar sumatriptan second gener triptan higher oral bioavail longer plasma half lif line vascular neurogen theori migrain triptan produc select carotid vasoconstrict num ht num receptor presynapt inhibit trigeminovascular inflammatori respons implic migrain num ht num num ht num receptor select agonist num ht num pnu num num ht num ly num receptor inhibit trigeminovascular system produc vasoconstrict pnu num prove ineffect acut treatment migrain whilst ly num show efficaci dose interact num ht num receptor final triptan effect antimigrain agent produc select cranial vasoconstrict effort made develop effect antimigrain altern act direct blockad vasodil mechan antagonist cgrp receptor antagonist num ht num receptor inhibitor nitric oxid biosynthesi altern lead fewer side effect
MED-3662~biolog activ lavend essenti oil pubm ncbi abstract essenti oil distil member genus lavandula cosmet therapeut centuri common speci angustifolia latifolia stoecha intermedia anecdot inform biolog activ oil substanti scientif clinic evid claim made lavend oil antibacteri antifung carmin smooth muscl relax sedat antidepress effect burn insect bite review detail current state knowledg effect lavend oil psycholog physiolog paramet antimicrobi agent data inconclus controversi scientif clinic data support tradit lavend methodolog oil identif problem sever hamper evalu therapeut signific research lavandula spp issu resolv true pictur biolog activ lavend essenti oil copyright num john wiley son
MED-3663~treatment migrain updat therapi pubm ncbi abstract purpos review review comprehens select latest clinic trial result antimigrain treatment recent find oral calcitonin gene rel peptid antagonist telcagep efficaci acut treatment compar triptan efficaci compar toler superior true num num agonist lasmiditan agent devoid vascular effect triptan drug effici earli nonsteroid anti inflammatori drug analges remain acut treatment meta analys single puls transcrani magnet stimul aura render patient pain fre num sham stimul num studi topiram effect migrain vertigo prevent transform chronic migrain patient high attack frequenc onabotulinumtoxin effect chronic migrain toler therapeut gain placebo modest clinic profil respond remain determin widespread occipit nerv stimul effect intract chronic migrain num respond compar num sham stimul neuromodul techniqu sphenopalatin ganglion stimul promis treatment medic refractori patient larg control trial studi suggest outcom patent foramen oval closur migrain depend anatom function characterist summari drug efficaci side effect profil triptan acut treatment futur brighter disabl chronic migraineur drug neuromodul therapi
MED-3664~random placebo control trial acetaminophen treatment migrain headach pubm ncbi abstract object evalu efficaci safeti acetaminophen num mg treatment episod migrain headach background acetaminophen common treat migrain limit publish clinic trial efficaci result design method ten investig num privat ambulatori primari care site unit state enrol treat num outpati adult num year age migrain headach moder sever intens random placebo control double blind clinic trial num hour durat patient random assign singl dose studi medic acetaminophen num mg num placebo num percentag patient reduct baselin headach pain intens sever moder mild num hour treatment headach pain intens differ baselin num hour primari efficaci measur measur pain relief sever differ baselin migraine associ symptom nausea photophobia phonophobia function disabl percentag patient migraine associ symptom reduc assess result signific num patient treat acetaminophen num mg report mild pain num hour num compar treat placebo num pain intens differ baselin measur num hour signific num greater patient treat acetaminophen num mg num compar treat placebo num signific differ favor acetaminophen num mg placebo observ num hour treatment percentag patient mild pain pain intens differ baselin acetaminophen num mg signific effect placebo num pain reduc num hour clinic import secondari pain relief outcom sever baselin migraine associ symptom nausea photophobia phonophobia function disabl num num hour signific num favor acetaminophen placebo percentag patient symptom num num hour statist signific favor acetaminophen num num comparison advers event specif nausea report frequent placebo group conclus acetaminophen num mg nonprescript drug effect well toler treatment episod moder migrain headach addit acetaminophen general provid benefici effect symptom migrain includ nausea photophobia phonophobia function disabl
MED-3665~sens improv experiment studi evalu aromatherapi massag period rest intens care unit pubm ncbi abstract widespread belief aromatherapi massag intens care environ offer increas qualiti sensori input patient receiv reduc level stress anxieti wealth anecdot evid support claim object studi evalu effect therapi experiment studi num patient admit general intens care unit random alloc receiv massag aromatherapi essenti oil lavend period rest pre post therapi assess includ physiolog stress indic patient evalu anxieti level mood abil cope intens care experi ninety thre patient num complet subject assess statist signific differ physiolog stress indic observ report behaviour patient abil cope intervent patient receiv aromatherapi report signific greater improv mood perceiv level anxieti felt anxious posit immedi therapi effect sustain cumul
MED-3666~prepubert gynecomastia link lavend tea tree oil pubm ncbi abstract case male prepubert gynecomastia classifi idiopath investig gynecomastia prepubert boy healthi normal serum concentr endogen steroid boy gynecomastia coincid topic applic product lavend tea tree oil gynecomastia resolv patient short product oil discontinu studi human cell line oil estrogen antiandrogen activ conclud repeat topic exposur lavend tea tree oil caus prepubert gynecomastia boy num massachusett medic societi
MED-3667~genotox lavend oil linalyl acet linalool human lymphocyt vitro pubm ncbi abstract potenti genotox lavend essenti oil major compon linalool linalyl acet evalu vitro micronucleus test peripher human lymphocyt rang non tox concentr num num g ml linalyl acet increas frequenc micronuclei signific concentration depend manner lavend oil highest concentr test linalool devoid genotox test substanc led increas nucleoplasm bridg nuclear bud frequenc find suggest mutagen activ lavend oil relat presenc linalyl acet profil aneugen agent copyright num wiley liss
MED-3668~effect lavend oil inhal emot state autonom nervous system brain electr activ pubm ncbi abstract object investig effect lavend oil central nervous system autonom nervous system mood respons human inhal materi method twenti healthi volunt particip experi present studi assess autonom paramet blood pressur heart rate respiratori rate skin temperatur determin arous level autonom nervous system addit subject estim mood respons feel pleasant unpleas uncomfort sensual relax refresh order assess subject behavior arous final electroencephalogram eeg record num electrod scalp intern num num system eeg power spectra calcul fast fourier transform fft data analyz compar effect lavend oil physiolog mood state sweet almond oil assess measur pair t test statist procedur result result reveal lavend oil caus signific decreas blood pressur heart rate skin temperatur decreas autonom arous term mood respons subject lavend oil group categor activ fresher relax subject inhal base oil compar base oil lavend oil increas power theta num hz alpha num hz brain activ topograph map show scatter power alpha rang wave bilater tempor central area conclus find provid evid relax effect inhal lavend oil
MED-3669~aromatherapi posit affect mood eeg pattern alert math comput pubm ncbi abstract eeg activ alert mood assess num adult num minut aromatherapi aroma lavend consid relax odor rosemari consid stimul odor particip simpl math comput therapi lavend group show increas beta power suggest increas drowsi depress mood pom report feel relax perform math comput faster accur aromatherapi rosemari group hand show decreas frontal alpha beta power suggest increas alert lower state anxieti score report feel relax alert faster accur complet math comput aromatherapi session
MED-3670~multi cent double blind randomis studi lavend oil prepar silexan comparison lorazepam general anxieti disord pubm ncbi abstract general persist anxieti accompani nervous symptom generalis anxieti disord gad frequent general popul lead benzodiazepin usag substanc induc sedat high potenti drug abus altern anxiolyt properti lavend demonstr pharmacolog studi small scal clinic trial postul lavend posit effect gad control clinic studi perform evalu efficaci silexan oral lavend oil capsul prepar versus benzodiazepin studi efficaci num week intak silexan compar lorazepam investig adult gad primari target variabl chang hamilton anxieti rate scale ham a tot score object measur sever anxieti baselin week num result suggest silexan effect amelior general anxieti compar common benzodiazepin lorazepam ham a tot score decreas similar extent group num num point num silexan group num num point num lorazepam group num num point baselin group activ treatment period ham a subscor somat anxieti ham a subscor psychic anxieti ham a subscor ii decreas similar extent group subscor measur studi sas self rat anxieti scale pswq pw penn state worri questionnair sf num health survey questionnair clinic global impress sever disord cgi item num cgi item num cgi item num result sleep diari demonstr compar posit effect compound conclus result demonstr silexan effect lorazepam adult gad safeti silexan demonstr lavend oil show sedat effect studi potenti drug abus silexan effect toler altern benzodiazepin amelior generalis anxieti copyright num elsevi gmbh reserv
MED-3671~investig role perceiv stress bacteri flora activ salivari cortisol secret mechan susceptibil pubm ncbi abstract studi examin impact academ stress salivari cortisol concentr lactic acid bacteria activ unstimul saliva sampl faecal sampl collect num healthi undergradu student num num year rang num num week period begin semest low stress baselin condit week exam high stress condit student complet seri questionnair measur perceiv level stress gastrointestin symptom nutrit intak signific find faecal lactic acid bacteri level lower high stress condit parallel student rate perceiv level stress greater exam period compar baselin condit find studi provid insight link stress gastrointestin flora activ human
MED-3672~num dahlem confer infect inflamm chronic inflammatori disord psycho neuroimmunolog intestin microbiota clinic observ basic mechan abstract rapid emerg field applic knowledg relationship neural immun system order gain understand human condit slow discuss describ brain microbiota interact bring context clinic relev begin describ establish fact pertain gut brain axi role gut bacteria focus emerg data contribut generat conceptu framework microbiota gut brain axi final section anticip futur direct field
MED-3673~gut inflamm chronic fatigu syndrom abstract chronic fatigu syndrom cfs debilit diseas character unexplain disabl fatigu combin accompani symptom patholog incomplet understood cfs patient complain gut dysfunct fact patient cfs report previous diagnosi irrit bowel syndrom ib common function disord gut experi ibs rel symptom recent evid interact intestin microbiota mucos barrier function immun system shown play role disorder pathogenesi studi examin microecolog gastrointestin gi tract identifi specif microorgan presenc relat diseas cfs role alter intestin microbiota pathogenesi diseas recent suggest mucos barrier dysfunct promot bacteri transloc observ final alter mucos immun system diseas articl discuss interplay factor cfs play signific role gi dysfunct modul activ enter nervous system intrins innerv gut alter intestin microbiota mucos barrier dysfunct aberr intestin immun contribut pathogenesi cfs therapeut effort modifi gut microbiota modul develop and or progress disord administr probiot alter gut microbiota improv mucos barrier function decreas pro inflammatori cytokin potenti posit influenc mood patient emot symptom inflammatori immun signal elev probiot potenti improv gut motil dysfunct cfs patient
MED-3674~gut feel emerg biolog gut brain communic abstract concept gut brain close connect interact play import part gastrointestin function feel state intuit decis make deepli root languag recent neurobiolog insight gut brain crosstalk reveal complex bidirect communic system ensur proper mainten gastrointestin homeostasi digest multipl effect affect motiv higher cognit function includ intuit decis make disturb system implic wide rang disord includ function inflammatori gastrointestin disord obes eat disord
MED-3675~random double blind placebo control pilot studi probiot emot symptom chronic fatigu syndrom abstract chronic fatigu syndrom cfs complex ill unknown etiolog broad rang symptom patient report disturb emot realm frequent anxieti research show patient cfs so cal function somat disord alter intestin microbi flora emerg studi suggest pathogen non pathogen gut bacteria influenc mood rel symptom behavior anim human pilot studi num cfs patient random receiv num billion coloni form unit lactobacillus casei strain shirota lcs placebo daili month patient provid stool sampl complet beck depress beck anxieti inventori intervent found signific rise lactobacillus bifidobacteria lcs signific decreas anxieti symptom probiot control num result lend support presenc gut brain interfac mediat microb resid pass intestin tract
MED-3676~assess psychotropic lik properti probiot formul lactobacillus helveticus num bifidobacterium longum num rat pubm ncbi abstract previous clinic studi probiot formul pf consist lactobacillus helveticus num bifidobacterium longum num pf decreas stress induc gastrointestin discomfort emerg evid role gut microbiota central nervous system function suggest oral intak probiot benefici consequ mood psycholog distress aim present studi investig anxiolytic lik activ pf rat effect anxieti depress stress cope strategi healthi human volunt preclin studi rat daili administ pf num week subsequ test condit defens buri test screen model anti anxieti agent clinic trial volunt particip double blind placebo control randomis parallel group studi pf administ num assess hopkin symptom checklist hscl num hospit anxieti depress scale perceiv stress scale cope checklist ccl num urinari free cortisol ufc daili subchron administr pf signific reduc anxiety lik behaviour rat num num allevi psycholog distress volunt measur hscl num scale global sever index num num somatis num num depress num num anger hostil num num global score num num hads anxieti num num ccl problem solv num num ufc level num num helveticus num longum num combin display anxiolytic lik activ rat benefici psycholog effect healthi human volunt
MED-3677~probiot function mechanist deliveri vehicl neuroact compound microbi endocrinolog design probiot pubm ncbi abstract hypothes abil probiot synthes neuroact compound unifi microbi endocrinology bas mechan explain hitherto incomplet understood action commens microbiota affect host gastrointestin psycholog health ingest probiot enter interact environ encompass microbiolog immunolog neurophysiolog compon util trans disciplinari framework microbi endocrinolog mechan consid appar candid share compon rang neurochem produc probiot includ neurochem receptor bas target immun neuron element intestin extra intestin character product neurochem probiot deliveri vehicl neuroact compound unifi microbi endocrinology bas hypothesi facilit select design probiot clinic highlight larg unrecogn role neurosci understand microb influenc health copyright num wiley period
MED-3678~mood gut feel pubm ncbi abstract evid accumul suggest gut microb microbiota involv neural develop function peripher enter nervous system central brain increas intens current interest role gut bacteria play maintain health host altogeth mass intestin bacteria repres virtual organ num time total genet materi cell human bodi surpris character extraordinarili divers popul begin num microb cultur commens organ live state harmoni symbiosi host disord balanc gut microb thought causal factor chronic medic condit vari obes inflammatori bowel diseas evid limit psychiatr ill rapid coalesc cluster evid point possibl variat composit gut microb normal function nervous system review focus data suggest concept explor increas understand mood disord possibl uncov miss link number co morbid medic diseas
MED-3679~impact meal probiot transit model human upper gastrointestin tract pubm ncbi abstract commerci literatur probiot product suggest meal meal meal meal led confus industri consum object studi examin impact time administr respect mealtim impact buffer capac food surviv probiot microb gastrointestin transit vitro digest system ividi model upper gastrointestin tract examin surviv commerci multi strain probiot protecflor product capsul form microb lactobacilli lactobacillus helveticus num lactobacillus rhamnosus num bifidobacterium longum num saccharomyc cerevisia boulardii enumer transit stomach duoden model show surviv bacteria product meal num minut meal cook oatmeal milk probiot num minut meal surviv high number surviv milk num milk fat oatmeal milk gruel signific appl juic spring water boulardii affect time meal buffer capac meal protein content meal import surviv bacteria fat content conclud ideal non enter coat bacteri probiot product prior meal fat
MED-3680~probiot prevent acut upper respiratori tract infect pubm ncbi abstract background probiot improv person health regul immun function studi show probiot strain prevent respiratori infect evid benefit probiot acut upper respiratori tract infect urti relat potenti advers effect publish object assess effect safeti probiot prevent acut urti search strategi search cochran central regist control trial central cochran librari num issu num includ cochran acut respiratori infect group specialis regist medlin ovid num week num embas num num web scienc includ scienc citat index num num confer proceed citat index num num chines biomed literatur databas includ china biolog medicin databas num num chines medicin popular scienc literatur databas num num master degre dissert beij union medic colleg databas num num select criteria randomis control trial rcts compar probiot placebo prevent acut urti data collect analysi review author independ assess elig qualiti trial extract data main result includ num rcts extract data meta analys num trial involv num particip found probiot placebo measur number particip experienc episod acut urti episod odd ratio num num confid interv ci num num episod num num ci num num rate ratio episod acut urti rate ratio num num ci num num reduc antibiot prescript rate acut urti num num ci num num probiot placebo similar measur durat md episod acut urti md num num ci num num advers event num num ci num num side effect probiot minor gastrointestin symptom common found subgroup high level heterogen conduct pool analys author conclus probiot placebo reduc number particip experienc episod acut urti rate ratio episod acut urti reduc antibiot probiot benefici placebo prevent acut urti result limit data older peopl
MED-3681~system immunity enhanc effect healthi subject dietari consumpt lactic acid bacterium lactobacillus rhamnosus hn num pubm ncbi abstract object determin effect probiot lactic acid bacterium lactobacillus rhamnosus hn num natur cellular immun deliv oral normal low fat milk lfm lactose hydrolyz low fat milk lfm lh design stage pre post intervent trial span week set taipei medic colleg hospit taipei taiwan subject fifty two healthi middle ag elder volunt num male num femal median age num rang num intervent stage num run in diet num num ml reconstitut lfm powder daili num week stage num probiot intervent lfm lfm lh supplement num cfus g rhamnosus hn num case num week stage num wash out lfm num week measur outcom vitro phagocyt capac peripher blood polymorphonuclear pmn leukocyt vitro tumoricid activ natur killer nk leukocyt result immunolog respons unaffect run in diet lfm contrast relat proport pmn cell show phagocyt activ increas num num consumpt hn num lfm lfm lh relat level nk cell tumor kill activ increas num num case level declin cessat remain baselin conclus dietari consumpt rhamnosus hn num base low fat milk lactose hydrolyz low fat milk enhanc system cellular immun respons dietari supplement boost natur immun
MED-3682~matern vagin microflora pregnanc risk asthma hospit antiasthma medic earli childhood pubm ncbi abstract background infant wheez allerg diseas microflora differ healthi infant fetus acquir microorgan birth expos matern vagin microflora conceiv matern vagin microflora influenc establish infant flora consequ develop wheez allerg diseas object sought studi associ composit matern vagin microflora develop wheez asthma childhood method perform population bas cohort studi denmark vagin sampl bacteri analysi obtain pregnanc total num women num invit women complet studi num live infant infant wheez assess hospit asthma num num year age asthma assess num packag antiasthma medic num num year age result matern vagin colon ureaplasma urealyticum pregnanc infant wheez odd ratio num num ci num num asthma year life matern colon staphylococci num num ci num num antibiot pregnanc num num ci num num asthma year life conclus composit matern vagin micro flora wheez asthma offspr num year age
MED-3683~randomis double blind placebo control studi probiot lactobacilli strengthen bodi immun defenc viral inf pubm ncbi abstract background aim studi investig consumpt lactobacillus plantarum heal num dsm num lactobacillus paracasei num dsm num affect natur acquir common cold infect healthi subject method randomis parallel double blind placebo control studi perform investig intak probiot mixtur reduc risk common cold episod number day common cold symptom frequenc sever symptom cellular immun respons common cold infect total num subject supplement daili num cfu coloni form unit probiot num control num num week period result incid acquir common cold episod reduc num control group num probiot group num number day common cold symptom signific num reduc num day control group num day probiot group num week period total symptom score reduc studi period num control group num probiot group reduct pharyng symptom signific num addit prolifer lymphocyt signific counteract probiot group num comparison control group conclus conclus intak probiot strain lactobacillus plantarum heal num dsm num lactobacillus paracasei num dsm num reduc risk acquir common cold infect
MED-3685~caesarean deliveri risk atopi allerg diseas meta analys pubm ncbi abstract background studi deliveri caesarean section c section offspring risk allerg diseas current interest due concern increas c section countri previous studi report inconsist find object investig deliveri c section increas risk atopi allerg diseas review literatur perform meta analysi assess public bias method systemat literatur search medlin num num common allerg outcom includ food allergy food atopi inhal atopi eczema atop dermat allerg rhiniti asthma hospit asthma outcom meta analysi perform summari odd ratio calcul account heterogen study specif relat risk public bias assess funnel plot method result identifi num studi deliveri c section allerg outcom c section increas summari food allergy food atopi num num ci num num studi allerg rhiniti num num ci num num studi asthma num num ci num num num studi hospit asthma num num ci num num studi associ inhal atopi num num ci num num studi eczema atop dermat num num ci num num studi funnel plot associ food allergy food atopi difficult interpret due public bias signific associ allerg outcom num case attribut c section conclus deliveri c section moder risk increas allerg rhiniti asthma hospit asthma food allergy food atopi inhal atopi atop dermat increas c section decad contribut allergi epidem observ period
MED-3686~enhanc immun elder dietari supplement probiot bifidobacterium lacti hn num pubm ncbi abstract background age process lead declin cellular immun elder benefit safe effect intervent restor cellular immun function object determin dietari supplement immunostimul probiot bifidobacterium lacti hn num enhanc aspect cellular immun elder subject design thirti healthi elder volunt age rang num median num particip num stage dietari supplement trial num wk stage num run in subject consum low fat milk num ml daili num wk base diet control stage num intervent consum milk supplement lacti hn num typic dose num num organisms d low dose num num organisms d num wk stage num washout consum low fat milk num wk relat proport leukocyt subset vivo leukocyt phagocyt tumor cell kil activ determin longitudin assay peripher blood sampl result increas proport total helper cd num activ cd num lymphocyt natur killer cell measur subject blood consumpt lacti hn num vivo phagocyt capac mononuclear polymorphonuclear phagocyt tumoricid activ natur killer cell elev lacti hn num consumpt greatest immun found subject poor pretreat immun respons general num dose lacti hn num similar effect conclus lacti hn num effect probiot dietari supplement enhanc aspect cellular immun elder
MED-3687~probiot candid human isol raw fruit veget pubm ncbi abstract studi aim determin probiot potenti larg number autochthon lactic acid bacteria isol fruit veget surviv simul gastric intestin condit show num strain belong speci lactobacillus plantarum maintain high cell densiti select strain affect immune medi caco num cell strain stimul num immune medi peripher blood mononuclear cell pbmc signific num num increas major part cytokin growth factor found chemokin stimul immune medi pro inflammatori activ il num eotaxin ifn signific num stimul strain il num ip num il num mip num stimul il num il num il num strain depend strain increas synthesi cytokin anti inflammatori activ plantarum strain select defin strong adhes strain num bacteria adher caco num cell num adhes strain num bacteria adher caco num cell strain grew acidifi chemic defin medium fructo oligosaccharid fos carbon sourc end product fos ferment found strain inhibit enterohemorrag escherichia coli num bacillus megaterium num isol human sourc result studi show autochthon lactic acid bacteria raw fruit veget function featur consid probiot candid copyright num elsevi reserv
MED-3688~dose respons efficaci proprietari probiot formula lactobacillus acidophilus cl num lactobacillus casei lbc num antibiotic associa pubm ncbi abstract object standard therapi antibiotic associ diarrhea aad clostridium difficile associ diarrhea cdad limit efficaci probiot prophylaxi promis altern reduct aad cdad incid method single cent random double blind placebo control dose rang studi random num adult inpati group probiot capsul day pro num num probiot capsul placebo capsul day pro num num placebo capsul day num probiot capsul num billion live organ lactobacillus acidophilus cl num lactobacillus casei lbc num bio k cl num probiot prophylaxi began num initi antibiot administr continu num day antibiot dose patient addit num day result pro num num lower aad incid pro num num probiot group lower aad incid placebo num patient acquir aad pro num num day pro num num day shorter symptom durat placebo num day similar pro num num lower cdad incid pro num num treatment group lower cdad incid placebo num gastrointestin symptom common treatment group placebo pro num pro num conclus proprietari probiot blend studi toler effect reduc risk aad cdad hospit patient antibiot dose rang effect shown num billion yield superior outcom fewer gastrointestin event compar num billion clinicaltri gov number nct num
MED-3689~standard frozen prepar transplant fecal microbiota recurr clostridium difficil infect pubm ncbi abstract object fecal microbiota transplant fmt histor effect treat recurr clostridium difficil infect cdi refractori standard antibiot therapi procedur rare perform reason limit avail practic includ aesthet concern cost donor screen object studi overcom barrier clinic fmt program method report clinic experi num consecut patient treat fmt recurr cdi incept program univers minnesota time simplifi donor identif screen move patient identifi individu donor standard volunt donor materi prepar shift endoscopi suit standard process laboratori ultim bank frozen process fecal materi readi result standard materi prepar signific simplifi practic aspect fmt loss appar efficaci clear recurr cdi approxim num patient inflammatori bowel diseas fmt equal effect group conclus key step standard donor materi prepar signific simplifi clinic practic fmt recurr cdi patient fail antibiot therapi
MED-3690~probiot prevent treatment diarrhea pubm ncbi abstract purpos review critic apprais evid probiot prevent treatment diarrhea children adult recent find random control trial meta analys suggest probiot effect primari secondari prevent gastroenter treatment select lactobacillus strain modest signific effect primari prevent saccharomyc boulardii effect antibiotic associ clostridium difficil diarrhea evid prevent diarrhea day car center lactobacillus rhamnosus gg reduc diarrheal durat sever evid case childhood rotavirus diarrhea similar weaker evid obtain boulardii strain includ evidence bas recommend gastroenter manag children data lactobacillus strain preliminari probiot efficaci relat earli administr bacteri load mechan antiinfecti action intestin indirect modul innat adapt immun summari probiot gain role adjunct treatment infantil gastroenter rehydr efficaci convinc adult promis antibiotic associ diarrhea evid efficaci limit strain
MED-3691~probiot prebiot infant formula preterm low birth weight infant systemat review abstract background previous review num num preterm infant probiot prebiot breast milk mix feed focus prevent necrot enterocol sepsi diarrhea review assess probiot prebiot led improv growth clinic outcom formula fed preterm infant method cochran methodolog random control trial rcts compar preterm formula probiot prebiot convent preterm formula preterm infant differ md num confid interv ci report continu outcom risk ratio rr num ci dichotom outcom heterogen assess visual inspect forest plot chi num test num test assess inconsist studi num repres substanti heterogen result probiot studi num prebiot studi num includ probiot signific differ weight gain md num num ci num num num studi num maxim enter feed md num num ci num num num studi num number stool day increas signific probiot group md num num ci num num num studi num prebiot galacto oligosaccharid fructo oligosaccharid gos fo yield signific differ weight gain md num num ci num num num studi num gos fo yield signific differ length gain md num num ci num num num studi num signific differ head growth md num num ci num num num studi num age full enter feed md num num ci num num num studi num stool frequenc increas signific prebiot group md num num ci num num num studi num gos fo fos yield higher bifidobacteria count prebiot group md num num ci num num num md num num ci num num num conclus evid state supplement probiot prebiot result improv growth clinic outcom exclus formula fed preterm infant
MED-3692~human gut microbiota relationship health diseas pubm ncbi abstract probiot live microorgan confer health benefit host administ amount num random control human studi conduct probiot result provid strong support probiot clinic prevent treatment gastrointestin tract disord metabol syndrom present review base webinar present develop american gastroenterolog associ aga partnership intern scientif associ probiot prebiot isapp north american branch intern life scienc institut ilsi north america present provid gastroenterologist research fundament current scientif inform influenc gut microbiota human health diseas clinic intervent strategi practic guidelin probiot prebiot num intern life scienc institut
MED-3693~microbiolog evalu commerci probiot product usa num pubm ncbi abstract probiot wide prevent treat diseas commerci product worldwid clear intern local legisl previous studi show test product conform intern guidelin aim studi determin product usa market num correct label term quantiti viabl bacteria identif speci cross contamin speci label disturb found num num product num accord label claim result suggest adequ control probiot product period screen compet organ monitor effect storag product qualiti
MED-3694~recurr clostridium difficil coliti case seri involv num patient treat donor stool administ nasogastr tube pubm ncbi abstract clostridium difficile associ diarrhea coliti emerg major complic system antimicrobi studi medic record num subject receiv donor stool nasogastr tube recurr difficil infect num year period singl institut retrospect review period initi diagnosi difficil coliti stool treatment num subject receiv total num cours antimicrobi rang num cours median num cours num day receipt treatment stool num patient die unrel ill num survivor experienc singl recurr difficil coliti num day follow up advers effect stool treatment observ patient recurr difficil coliti benefit introduct stool healthi donor nasogastr tube
MED-3695~probiot prevent pediatr antibiotic associ diarrhea pubm ncbi abstract background antibiot alter microbi balanc gastrointestin tract probiot prevent antibiotic associ diarrhea aad restor gut microflora antibiot prescrib frequent children aad common popul object assess efficaci advers effect probiot strain dose prevent antibiotic associ diarrhea children assess advers event probiot co administ antibiot children search strategi medlin embas central cinahl ame web scienc incept august num search special regist includ cochran ibd fbd review group ciscom chalmer pedcam research regist trial registri incept num letter author includ trial nutra pharmaceut compani expert field request addit inform ongo unpublish trial confer proceed dissert abstract refer list includ relev articl hand search select criteria random parallel control placebo activ treatment trial compar co administ probiot antibiot prevent diarrhea secondari antibiot children num num year data collect analysi methodolog qualiti assess data extract conduct independ author bcj dichotom data incid diarrhea advers event combin pool relat risk continu data durat diarrhea daili stool frequenc weight differ num confid interv advers event summar risk differ pool result incid diarrhea priori sensit analys includ protocol versus intent treat random versus fix effect methodolog qualiti criterion subgroup analysi conduct probiot strain dose definit antibiotic associ diarrhea antibiot agent main result ten studi met inclus criteria trial includ treatment lactobacilli spp bifidobacterium spp streptococcus spp saccharomyc boulardii combin studi singl strain probiot agent combin probiot strain protocol analysi num trial report incid diarrhea show statist signific result favour probiot active non activ control rr num num ci num num intent treat analysi show non signific result rr num num ci num num ten trial monitor advers event num report advers event author conclus probiot show promis prevent pediatr aad protocol analysi yield treatment effect estim statist clinic signific analysi high qualiti studi estim intent treat analysi statist signific futur studi involv probiot strain dose promis evid lactobacillus gg lactobacillus sporogen saccharomyc boulardii num num billion coloni form units day research date permit determin effect age infant versus older children antibiot durat num day versus num day futur trial benefit valid primari outcom measur antibiotic associ diarrhea sensit chang reflect treatment effect clinician parent children import current data promis prematur routin recommend probiot prevent pediatr aad
MED-3696~alcohol consumpt breast cancer risk women health studi pubm ncbi abstract author assess associ moder alcohol consumpt breast cancer risk women health studi unit state num averag num year follow up num case total breast cancer num invas num situ document num women baselin free cancer cardiovascular diseas provid detail dietari inform includ alcohol consumpt preced num month higher alcohol consumpt modest increas breast cancer risk multivari relat risk num g day alcohol num num confid interv ci num num total breast cancer num num ci num num invas breast cancer increas risk limit estrogen receptor er progesteron receptor pr posit tumor multivari relat risk increment num g day alcohol num num ci num num er pr tumor num case num num ci num num er pr tumor num case num num ci num num er pr tumor num case associ strongest postmenopaus hormon test interact signific find prospect studi suggest moder alcohol consumpt increas breast cancer risk
MED-3697~healthi lifestyl risk breast cancer pubm ncbi abstract background studi analyz effect behavior risk factor common lifestyl pattern risk diseas aim studi assess effect healthi lifestyl index risk breast cancer method population bas case control studi conduct mexico num num thousand incid case num control match case num year age categori region health institut particip studi healthi lifestyl index develop princip compon dietari pattern physic activ alcohol consumpt tobacco smoke condit logist regress model assess associ result healthi lifestyl index defin combin effect moder and or vigorous intens physic activ low consumpt fat process food refin cereal complex sugar avoid tobacco smoke alcohol consumpt result show protect effect pre num num ci num num postmenopaus women num ci num num highest versus lowest index quintil compar conclus healthi lifestyl reduct odd breast cancer primari prevent diseas promot integr manner effect strategi identifi engag women healthi lifestyl impact studi assess healthi lifestyl index relat risk breast cancer num aacr
MED-3698~greater surviv breast cancer physic activ women high vegetable fruit intak obes abstract purpos single vari analys physic activ diet obes surviv breast cancer report investig interact variabl patient method prospect studi perform num women diagnos treat early stag breast cancer num num enrol averag num year postdiagnosi women lost follow up decemb num result univari analysi reduc mortal weak higher vegetable fruit consumpt increas physic activ bodi mass index low weight obes multivari cox model combin consum daili serv vegetables fruit accumul num metabol equival tasks min wk equival walk num minut num d wk signific surviv advantag hazard ratio num num ci num num approxim num reduct risk healthi lifestyl behavior observ obes nonobes women fewer obes women physic activ healthi dietari pattern num num adher healthi lifestyl appar effect obes surviv effect stronger women hormon receptor posit cancer conclus minor breast cancer survivor follow healthi lifestyl includ recommend intak vegetables fruit moder level physic activ strong protect effect observ suggest addit investig effect combin influenc diet physic activ breast cancer surviv
MED-3699~concord world cancer research fund american institut cancer research guidelin cancer prevent relat subsequ risk pubm ncbi abstract background num world cancer research fund wcrf american institut cancer research aicr issu num recommend num special recommend diet physic activ weight manag cancer prevent basi comprehens collect evid object aim investig concord wcrf aicr recommend relat cancer risk european prospect investig cancer nutrit epic studi design present studi includ num epic particip num european countri recruit dietari anthropometr lifestyl inform collect score construct base wcrf aicr recommend weight manag physic activ food drink promot weight gain plant food anim food alcohol drink breastfeed women score rang num men num women higher score greater concord wcrf aicr recommend associ score cancer risk estim multivari cox regress model result concord score signific decreas risk cancer num point increment score risk reduct num ci num total cancer num ci num colorect cancer num ci num stomach cancer signific associ observ cancer breast endometrium lung kidney upper aerodigest tract liver esophagus prostat ovarian pancreat bladder cancer conclus adher wcrf aicr recommend cancer prevent lower risk develop type cancer
MED-3700~red versus white wine nutrit aromatas inhibitor premenopaus women pilot studi abstract background increas risk breast cancer alcohol consumpt controversi red wine increas risk aromatas inhibitor ai prevent convers androgen estrogen occur natur grape grape juic red white wine test red wine nutrit ai premenopaus women method cross ov design num women age sd num year assign num ounc num ml red wine daili white wine num month revers blood collect menstrual cycl measur estradiol num estron num androstenedion total free testosteron sex hormon bind globulin shbg lutein hormon lh follicl stimul hormon fsh result red wine demonstr higher free white wine differ num pg ml num se num lower shbg differ num nmol l num se num num level lower red white wine statist signific lh signific higher red white wine differ num miu ml num se num fsh conclus red wine signific higher free lower shbg level signific higher lh level white wine healthi premenopaus women data suggest red wine nutrit ai explain observ red wine increas breast cancer risk
MED-3701~anti aromatas chemic red wine pubm ncbi abstract estrogen synthes situ play import role breast cancer cell prolifer circul estrogen aromatas enzym convert androgen estrogen express higher level breast cancer tissu surround noncanc tissu promis rout chemoprevent breast cancer suppress situ estrogen format aromatas inhibitor diet high fruit veget reduc incid breast cancer phytochem act aromatas inhibitor previous studi found grape wine potent phytochem inhibit aromatas show red wine effect white wine suppress aromatas activ interest result white wine studi suggest weak induct effect alcohol aromatas activ hand potent effect anti aromatas chemic red wine overcom weak induct effect alcohol wine purif procedur perform red wine separ activ aromatas inhibitor non act compound techniqu includ liquid liquid extract silica gel chromatographi solid phase extract spe column high perform liquid chromatographi activ pinot noir red wine spe num column fraction num acetonitrile wat effect complet pinot noir wine suppress aromatas assay red wine extract analyz transgen mous model aromatas over express mammari tissu gavag red wine extract complet abrog aromatase induc hyperplasia neoplast mammari tissu result suggest red wine red wine extract chemoprevent diet supplement postmenopaus women high risk breast cancer research underway purifi character activ compound red wine respons inhibit aromatas
MED-3702~allergi epidem extend past decad pubm ncbi abstract background increas preval allerg diseas western societi epidem precis turn point epidem antigen respons remain obscur object evalu preval atop diseas chang term detect sensit aeroallergen dietari allergen cross sect comparison subject birth cohort num year method studi group num subject age num num num year repres born num num num num serum total specif ige concentr aeroallergen dietari allergen determin questionnair elicit inform symptom allerg diseas medic result proport subject detect ige antibodi aeroallergen increas consist oldest youngest birth cohort chi num trend num num similar progress sensit dietari allergen proport diagnos asthma differ signific chi num num num birth cohort lowest preval asthma sensit dietari allergen detect born num immedi world war ii conclus preval sensit airborn allergen unlik dietari allergen increas long period time result support concept immun function program extern factor earli life call caution interpret pace allergi epidem made basi short term studi
MED-3703~associ allergi cancer pubm ncbi abstract object provid overview relationship allergi cancer data sourc public select systemat review english languag literatur establish databas medlin ebsco refer materi identifi databas studi select public assess associ asthma hay fever allergy rel diseas cancer includ review result individu type allergi decreas risk cancer compar general popul includ glioma colorect cancer cancer larynx non hodgkin lymphoma cancer esophagus oral cancer pancreat cancer stomach cancer uterin bodi cancer increas risk bladder cancer lymphoma myeloma prostat cancer exist allergi studi involv breast cancer leukemia lung cancer melanoma thyroid cancer shown associ conflict result relat allergi research conclus made relat allergi kaposi sarcoma liver cancer cancer ovari conclus associ allergi cancer site specif research verifi result determin associ exist
MED-3704~pyrogallol activ compound medicin plant emblica officinali regul express pro inflammatori gene bronchial epitheli pubm ncbi abstract relev morbid mortal cystic fibrosi cf patient lung patholog character chronic infect inflamm sustain pseudomona aeruginosa aeruginosa innov pharmacolog approach control excess inflammatori process lung cf patient thought benefici reduc extens airway tissu damag medicin plant so cal tradit asian medicin attract grow interest potenti efficaci safeti due presenc activ compound plant extract understand effect compon import pursu select reproduc applic extract emblica officinali eo test ib num cf bronchial epitheli cell expos aeruginosa laboratori strain pao num eo strong inhibit pao num depend express neutrophil chemokin il num gro alpha gro gamma adhes molecul icam num pro inflammatori cytokin il num pyrogallol compound extract eo inhibit aeruginosa depend express pro inflammatori gene similar eo extract compound purifi eo num hydroxy isoquinolin effect result identifi pyrogallol activ compound respons anti inflammatori effect eo suggest extend investig pre clin studi airway anim model vivo test efficaci safeti molecul cf chronic lung inflammatori diseas
MED-3705~evolut inflammatori diseas abstract associ inflamm modern human diseas obes cardiovascular diseas type num diabet mellitus cancer remain unsolv mysteri current biolog medicin inflamm protect respons noxious stimuli unavoid occur cost normal tissu function fundament tradeoff cost benefit inflammatori respons optim evolutionari time specif environment condit rapid chang human environ due nich construct outpac genet adapt natur select lead increas mismatch modern environ select trait multipl tradeoff affect human physiolog optim modern environ lead increas diseas suscept examin inflammatori respons evolutionari perspect discuss uniqu aspect inflammatori respons evolutionari histori explain associ inflamm modern human diseas
MED-3706~autoimmun diseas predict pubm ncbi abstract autoimmun diseas complex diseas result interact genet environment factor time phase develop autoimmun diseas character detect serum autoantibodi month year onset clinic manifest subsequ diagnosi addit serum antibodi genet suscept factor predict futur develop diseas predict type num diabet accur analysi genet suscept factor first degre relat patient autoantibodi test futur multipl antibodi test combin analysi genet epigenet immunolog anomali fine model precis predict autoimmun diseas prevent measur introduc attempt avoid delay diseas copyright num elsevi reserv
MED-3707~dietari intak agaricus bisporus white button mushroom acceler salivari immunoglobulin secret healthi volunt pubm ncbi abstract object secretori immunoglobulin siga act line adapt humor immun defens mucos surfac lack siga inabl produc antigen specif siga lead increas risk infect dietari intak improv mucos immun acceler siga secret studi investig effect dietari intak agaricus bisporus white button mushroom wbm salivari iga siga secret healthi subject method twenty four healthi volunt random assign normal daili diet control group normal diet wbm subject activ group num num num consum num blanch wbm daili normal diet num wk control group consum normal diet num num num wbm saliva collect commenc studi week num wk saliva flow rate siga concentr osmol determin siga osmol ratio siga secret rate calcul result signific differ pre postdietari mushroom intak indic control group num contrast siga secret rate increas signific week num num num num compar week num num wbm intak group return baselin level week num siga secret rate intervent period greater wbm group control group wbm group signific osmol saliva igg note signific increas siga osmol ratio num confirm postdietari wbm induc siga increas conclus dietari intak bisporus wbm signific acceler siga secret indic potenti health benefit improv mucos immun crown copyright num publish elsevi reserv
MED-3708~asthma epidem ascend pubm ncbi abstract asthma phenotyp heterogen disord multifactori origin affect num million peopl suffer asthma num asthma rel death year treatment asthma improv preval continu increas low middl incom countri ethnic group preval previous low observ spatio tempor variat increas preval asthma depend exposur environment factor recent argument favor involv host suscept stress observ increas asthma preval investig warrant understand mechan asthma increas stagnat copyright num elsevi reserv
MED-3709~immun inflamm allergi gut pubm ncbi abstract gut immun system challeng respond pathogen remain unrespons food antigen commens microflora develop world abil break chronic inflammatori diseas gut commonplac appar absenc overt infect mous man mutat gene control innat immun recognit adapt immun epitheli permeabl gut inflamm suggest perturb homeostasi gut antigen host immun repres critic determin develop gut inflamm allergi
MED-3710~quantit assess infect rate entomophthorac fungus zoophthora anhuiensi green peach aphid myzus persica pubm ncbi abstract two step method develop quantit assess infect rate entomophthorac fungus zoophthora anhuiensi li humber green peach aphid myzus persica sulzer standard time dose mort relationship establish model data bioassay num vari conidi dosag num num conidia mm num anhuiensi num yield estim expect mortal probabl dosag bioassay num conduct simultan expos num day old nymphal coloni shower anhuiensi conidia dosag result exposur num num min subsequ coloni separ immers num chlorothalonil solut num min disinfect surviv conidia host integu num num exposur temperatur treatment num num degre infect rate specif period end exposur immers estim ratio observ mortal expect mortal probabl dosag result show infect persica anhuiensi high rapid differ aphid coloni maintain num num degre immers fungicid solut exposur num hour period exposur crucial success infect fungus infect rate great depend conidi dosag num infect num aphid dosag num conida mm num num num conidia mm num
MED-3711~regulatori t cell abnorm global epidem immuno inflammatori diseas pubm ncbi abstract incid autoimmun allerg inflammatori diseas increas due unidentifi environment factor relat western live condit propos alter gut microbiom act regulatori cell treg respons epidem treg control threshold peripher antigen recognit tonic downregul dendrit cell dc costimul implic maintain tolerogen function dcs model minor perturb treg number function predict lower activ threshold prolifer differenti self react cd num cell low affin undergon negat select thymus failur maintain tolerogen commit dcs expos commens microb allergen result potenti pathogen allerg inflammatori respons epitheli surfac
MED-3712~chemic composit nutrit wide appreci cultiv mushroom inter speci compar studi pubm ncbi abstract report compar chemic composit nutrit consum speci fresh cultiv mushroom agaricus bisporus white brown mushroom pleurotus ostreatus oyster mushroom pleurotus eryngii king oyster mushroom lentinula edod shiitak flammulina velutip golden needl mushroom shiitak reveal highest level macronutri protein highest sugar tocopherol pufa level lowest sfa content white brown mushroom show similar macronutri composit similar valu total sugar mufa pufa total tocopherol oyster king oyster mushroom gave highest mufa content similar content pufa mufa sfa sampl reveal similar moistur ash carbohydr energi valu studi contribut elabor nutrit databas consum fungi speci worldwid comparison report cultiv wild sampl speci chemic composit includ sugar fatti acid tocopherol profil copyright num elsevi reserv
MED-3713~higher frequenc cd num circul lymphocyt allerg rhiniti patient compar healthi donor pubm ncbi abstract background num subset t helper lymphocyt produc proinflammatori cytokin il num serum il num increas allerg patient relat clinic sever recent report cd num high upregul gene num clone il num produc cell cd num cell studi aim compar frequenc peripher cd num cell patient allerg rhiniti ar healthi control relat cd num express symptom sever method forty four patient ar num healthi non allerg subject evalu cd num express evalu cd num cd num cd num cell doubl immunofluoresc stain fluoresc activ cell sorter analysi symptom sever assess visual analogu scale result allerg patient show signific higher frequenc cd num cd num cd num cd num cd num cd num cell healthi non allerg subject num express cd num cell signific relat clinic sever conclus studi evid higher frequenc cd num cell present peripher blood ar patient copyright num karger ag basel
MED-3714~differ antioxid level fresh frozen freeze dri strawberri strawberri jam pubm ncbi abstract present studi conduct determin differ antioxid level fresh frozen freeze dri strawberri strawberri jam hydrophil antioxid activ haa lipophil antioxid activ laa measur abts h hrp decolor method haa laa sum calcul total antioxid activ taa differ haa laa analyz one way analysi varianc dunnett num pairwis comparison taa freeze dri strawberri base consum weight num confid interv ci num num signific higher fresh num ci num num frozen num ci num num jam num ci num num taa base dri weight fresh strawberri num ci num num signific higher freeze dri num ci num num frozen num ci num num jam num ci num num result agre previous studi report strawberri valuabl sourc antioxid consum
MED-3715~oral sex danger carcinogen let closer pubm ncbi abstract introduct question recent arisen popular press associ specif sexual behavior fellatio cunnilingus head neck cancer declin incid head neck cancer past num year shift distribut cancer type oral squamous cell carcinoma oscc younger demograph cancer oscc shown human papillomavirus hpv research suggest shift epidemiolog head neck cancer attribut chang sexual practic specul caught popular press interest contradict exist evid suggest conclus prematur overreach aim intent articl clarifi issu sexual medicin profession give accur up to d inform patient main outcom measur review articl outcom data report review articl measur collect method pubm search hpv oral sex oral cancer oscc result hundr ninety six articl hpv found num articl oral sex num oral cancer num articl oscc identifi relev conclus hpv infect occur common clear num month hpv infect concern monogam coupl rich vari sex life long sexual system remain close immun compromis factor present hpv concern context immun system compromis infect persist factor contribut immun system compromis hpv persist oncogenesi review num intern societi sexual medicin
MED-3716~effect topic appli bioadhes berri gel loss heterozygos indic premalign oral lesion abstract purpos aim studi assess effect topic applic num w w freeze dri black raspberri fbr gel oral intraepitheli neoplasia ien variabl includ histolog diagnos loss heterozygos loh indic microsatellit instabl and or loh tumor suppressor gene chromosom loci higher risk oral ien progress oral squamous cell carcinoma previous laboratori shown fbrs toler possess potent antioxid apoptot differentiation induc properti experiment design particip ien serv intern control treatment lesion photograph lesion tissu hemisect obtain pretreat diagnosi baselin biochem molecular variabl gel dose num appli time daili num week initi num week initi biopsi genom dna isol laser captur basilar suprabasilar surfac epitheli cell pcr amplif primer set target presum tumor suppressor gene loci ink num arf num fhit allel imbal determin sequenc analysi normal particip tissu establish microsatellit marker peak pattern allel size result confirm earlier phase data num particip develop fbr gel toxic result show histolog regress subset patient statist signific reduct loh tumor suppressor gene loci conclus preliminari data suggest evalu berri gel oral ien chemoprevent warrant
MED-3717~oral sex cancer death sexual transmit cancer abstract briefli highlight grow bodi recent evid link unprotect oral sex develop type head neck cancer younger patient tumour increas incid develop sensit method hpv detect confound factor
MED-3718~american cancer societi guidelin nutrit physic activ cancer prevent reduc risk cancer healthi food choic pubm ncbi abstract american cancer societi ac publish nutrit physic activ guidelin serv foundat communic polici communiti strategi ultim affect dietari physic activ pattern american guidelin publish num year develop nation panel expert cancer research prevent epidemiolog public health polici repres current scientif evid relat dietari activ pattern cancer risk ac guidelin includ recommend individu choic diet physic activ pattern choic occur communiti context facilit interfer healthi behavior communiti effort essenti creat social environ promot healthi food choic physic activ committe present key recommend communiti action accompani recommend individu choic reduc cancer risk recommend communiti action recogn support social environ indispens individu level societi genuin opportun choos healthi behavior ac guidelin consist guidelin american heart associ american diabet associ prevent coronari heart diseas diabet general health promot defin depart health human servic num dietari guidelin american
MED-3719~formul vitro in vivo evalu black raspberri extract load plga pla inject millicylindr implant sustain deliveri chemoprevent anthocyanin abstract purpos object studi formul evalu freeze dri black raspberri fbr ethanol extract load poli dl lactic co glycol acid plga poli dl lactic acid pla inject millicylindr implant sustain deliveri chemoprevent fbr anthocyanin cyanidin num sambubiosid cs cyanidin num glucosid cg cyanidin num rutinosid cr method identif quantit cs cg cr perform mass spectroscopi hplc re triacetyl cyclodextrin ta cd inclus complex ic prepar knead method character x ray diffract xrd nuclear magnet reson spectroscopi nmr uv vis spectroscopi re ta cd ic load plga pla implant prepar solvent extrus method vitro vivo control releas studi conduct phosphate buff salin tween num ph num num subcutan administr male sprague dawley rat anthocyanin quantifi hplc num nm result content cs cg cr num num num wt chemic stabil anthocyanin solut determin ph depend degrad rate increas increas ph num num plga pla millicylindr implant load num num wt exhibit high initi burst short releas durat anthocyanin num num num num cg cr releas num num day rapid anthocyanin releas link higher polym water uptak poros high osmolyt compon larg non anthocyanin fraction xrd num nmr uv vis spectroscopi non anthocyanin fraction molecul form ic ta cd decreas hydrophil format ic hydrophob carrier ta cd provid vitro in vivo sustain releas fbr anthocyanin num num num num cg cr releas num num day num wt re ta cd ic pla implant num month owe reduc polym water uptak poros conclus pla inject millicylindr implant load re ta cd ic optim dosag form num month slow continu deliveri chemoprevent fbr anthocyanin
MED-3720~inhibit growth premalign malign human oral cell line extract compon black raspberri pubm ncbi abstract black raspberri rich natur sourc chemoprevent phytochem recent studi shown freeze dri black raspberri inhibit develop oral esophag colon cancer rodent extract black raspberri inhibit benzo pyrene induc cell transform hamster embryo fibroblast molecular mechan activ compon respons black raspberri chemoprevent unclear studi found num major chemoprevent compon black raspberri ferul acid beta sitosterol fraction elut ethanol ro et silica column chromatographi organ extract freeze dri black raspberri inhibit growth premalign malign normal human oral epitheli cell line fraction elut ch num num ethanol dm et ellag acid inhibit growth normal premalign malign human oral cell line investig molecular mechan ferul acid beta sitosterol ro et fraction select inhibit growth premalign malign oral cell flow cytometri western blot cell cycl regulatori protein discern chang cell cycl distribut treatment cell ro et fraction premalign malign cell redistribut num phase cell cycl incub ferul acid beta sitosterol treat premalign malign cell accumul num num num phase ro et fraction reduc level cyclin cell divis cycl gene num cdc num premalign cell cyclin num cyclin num cdc num malign cell line fraction elev level num af num cip num malign cell line ferul acid treatment led increas level cyclin num cdc num cell line num af num cip num induc malign cell line beta sitosterol reduc level cyclin num cdc num increas num af num cip num premalign malign cell line result show time growth inhibitori effect black raspberri premalign malign human oral cell resid specif compon target aberr signal pathway regul cell cycl progress
MED-3721~topic applic bioadhes black raspberri gel modul gene express reduc cyclooxygenas num protein human premalign oral lesion abstract reduc express proapoptot termin differenti gene conjunct increas level proinflammatori angiogenesis induc enzym cyclooxygenas num cox num induc nitric oxid synthas ino correl malign transform oral intraepitheli neoplasia ien studi investig effect num w w freeze dri black raspberri gel oral ien histopatholog gene express profil intraepitheli cox num ino protein microvascular densiti laboratori shown freeze dri black raspberri possess antioxid properti induc keratinocyt apoptosi termin differenti oral ien tissu hemisect provid sampl pretreat diagnos establish baselin biochem molecular variabl treatment remain lesion tissu num gel appli time daili num week began num week initi biopsi rna isol snap frozen ien lesion microarray analys quantit revers transcription pcr valid addit epitheli gene specif quantit revers transcription pcr analys facilit assess target tissu treatment effect surfac epitheli cox num ino protein level microvascular densiti determin imag analysi quantifi immunohistochemistri topic berri gel applic uniform suppress gene rna process growth factor recycl inhibit apoptosi major particip show posttreat decreas epitheli ino cox num protein cox num reduct statist signific data show berri gel applic modul oral ien gene express profil ultim reduc epitheli cox num protein patient subset berri gel applic reduc vascular densiti superfici connect tissu induc gene keratinocyt termin differenti
MED-3722~dietari pattern risk esophag cancer pubm ncbi abstract background role dietari habit esophag cancer risk rare consid term dietari pattern patient method analyz data italian case control studi includ num case squamous cell carcinoma esophagus num hospit control dietari habit evalu food frequenc questionnair posteriori dietari pattern identifi princip compon factor analysi perform num select nutrient odd ratio num confid interv cis obtain multipl logist regress model appli quartil factor score adjust potenti confound variabl result identifi major dietari pattern anim product relat compon vitamin fiber starch rich polyunsatur fatti acid vitamin fat anim product relat compon pattern posit relat esophag cancer num num ci num num highest versus lowest quartil factor score categori vitamin fiber num num ci num num polyunsatur fatti acid vitamin num num ci num num invers relat esophag cancer signific associ observ pattern conclus find suggest diet rich food anim origin poor food vitamin fiber increas esophag cancer risk
MED-3723~dietari pattern risk oesophag cancer population bas case control studi pubm ncbi abstract epidemiolog studi investig associ dietari intak oesophag cancer focus nutrient food group dietari pattern conduct population bas case control studi includ num oesophag adenocarcinoma oac num oesophagogastr junction adenocarcinoma ogjac num oesophag squamous cell carcinoma oscc case frequenc match age sex geograph locat num control data demograph lifestyl dietari factor collect self administ questionnair princip compon analysi deriv dietari pattern meat fat pasta pizza fruit veget uncondit logist regress model estim risk oac ogjac oscc quartil dietari pattern score high score meat and fat pattern increas risk cancer multivariable adjust num num ci num num num oac num num ci num num num ogjac num num ci num num num oscc p trend num num cancer high score pasta and pizza pattern invers oscc risk num num ci num num num trend num num high score fruit and veget pattern borderlin signific decreas risk ogjac num num num ci num num num num num signific decreas risk oscc num num ci num num num trend num num high fat dairi food play domin role associ meat and fat pattern risk oac ogjac investig prospect studi confirm find
MED-3724~synerg sequenc combin curcumin epigallocatechin num gallat cisplatin kill human ovarian cancer cell pubm ncbi abstract drug resist remain on go challeng ovarian cancer chemotherapi object studi determin effect synerg activ sequenc combin cisplatin cis curcumin cur epigallocatechin num gallat egcg human ovarian cancer cell line drug ad binari combin cis combin cur cis combin egcg human ovarian num num cisr cancer cell line sequenc administr num num num num num combin index ci assess combin action drug cis num num synerg addit antagon cellular accumul platinum platinum dna bind level cis combin phytochem determin graphit furnac atom absorpt spectrometri addit cis num cur egcg num combin produc synergist outcom num num cisr cell line cellular accumul platinum platinum dna bind result num combin greater compar valu cis provid explan synergist action sequenc combin cis cur egcg appli human ovarian num num cisr cancer cell line lower concentr shorter time gap addit produc higher cytotox effect
MED-3726~combinatori strategi employ nutraceut cancer develop pubm ncbi abstract cancer lead death worldwid fight cancer import area research medicin possibl contribut increas interest chemoprevent altern approach control cancer cancer prevent nutraceut present fruit veget receiv attent low cost wide safeti margin substanti amount evid human anim cell cultur studi shown cancer chemoprevent effect natur product single ag intervent fail produc expect outcom clinic trial combin nutraceut gain increas popular combin nutraceut mimic real lif situat compet target multipl target virtual toxic review summar result studi report combinatori cancer chemoprevent action nutraceut combin anticanc drug num york academi scienc
MED-3728~strawberri field forev pubm ncbi abstract basi copious preclin data support prevent efficaci small fruit berri grape chen colleagu conduct random noncompar phase ii trial evalu dose strawberri powder num g d num g d month prevent esophag cancer china report issu journal begin page num g d reduc histolog grade dysplast lesion reduc local biomark num g d effect fundament question remain formul strawberri powder activ compon powder actual mechan action standard prepar requir permit widespread strawberri powder predic outcom work good proof of principl highlight import role diet nutrit natur product cancer prevent num aacr
MED-3729~role antioxid cancer therapi pubm ncbi abstract oxid stress key compon link environment toxic multistag carcinogen process reactiv oxygen speci ros generat respons endogen exogen stimuli counterbal ros medi injuri endogen antioxid defens system exist oxid exceed control mechan oxid stress aris chronic cumul oxid stress induc deleteri modif varieti macromolecular compon dna lipid protein primari mechan chemotherapi drug cancer cell format ros free radic radiotherapi base fact ioniz radiat destroy tumor cell radiotherapi induc direct lesion dna biolog molecul eventu affect dna free radic produc oncolog therapi sourc side effect object review provid inform effect antioxid oncolog treatment discuss event efficaci debat arisen antioxid supplement alter efficaci cancer chemotherapi limit evid qualiti sampl size suggest antioxid supplement reduc advers reaction toxic signific reduct toxic allevi dose limit toxic patient complet prescrib chemotherapi regimen turn improv potenti success term tumor respons surviv copyright num elsevi reserv
MED-3730~random phase ii trial lyophil strawberri patient dysplast precancer lesion esophagus pubm ncbi abstract dysplasia histolog precursor esophag squamous cell carcinoma scc previous show dietari freeze dri lyophil strawberri powder inhibit n nitrosomethylbenzylamine induc scc rat esophagus basi observ conduct random noncompar phase ii trial china investig effect dose freeze dri strawberri patient esophag dysplast lesion high risk area esophag cancer random assign num patient identifi endoscopi dysplast esophag premalign lesion receiv freeze dri strawberri powder num g d num patient num g d num patient month powder mix water drunk month assess histolog grade lesion primari endpoint blind fashion dose num g d signific affect histolog measur paramet dose num g d reduc histolog grade dysplast premalign lesion num num num patient dose evalu histolog num strawberri powder toler toxic effect advers event strawberri num g d reduc protein express level induc nitric oxid synthas ino num num cyclooxygenas num cox num num num phospho nuclear factor kappa nf p num pnf b p num num num phospho num ps num num num freeze dri strawberri num g d signific inhibit ki num label index num num present result potenti freeze dri strawberri powder prevent human esophag cancer support clinic test natur agent set num aacr
MED-3731~esophag cancer epidemiolog pathogenesi prevent pubm ncbi abstract esophag cancer high aggress common cancer worldwid past decad incid mortal esophag cancer increas incid mortal cancer decreas esophag squamous cell carcinoma esophag adenocarcinoma differ histolog epidemiolog distribut risk factor dietari defici tobacco mechan carcinogenesi intens research risk factor combin abil identifi precursor lesion squamous dysplasia esophag squamous cell carcinoma barrett esophagus esophag adenocarcinoma pave studi chemoprevent esophag cancer shown promis result
MED-3732~rectal spread tumor success treat step endoscop submucos dissect endoscop mucos resect abstract background endoscop submucos dissect esd advanc techniqu therapeut endoscopi altern endoscop mucos resect emr superfici gastrointestin neoplasm num cm esd direct dissect submucosa larg lesion resect en bloc esd limit resect size increas histolog complet resect rate reduc local recurr techniqu time consum technic demand high complic rate reduc risk complic devic technic advanc propos conflict result esd en bloc resect huge lesion increas complic case present success combin esd emr techniqu huge rectal spread tumor lsts esd circumferenti resect num lesion piecem resect num piec central part tumour patient obtain complet dissect polyp complet histolog evalu absenc complic recurr num month follow conclus treatment rectal lsts combin treatment esd emr resect consid suitabl therapeut option select case altern surgeri techniqu reliabl safe separ confirm result larger trial longer follow requir improv techniqu technic devic
MED-3733~glycem respons sweeten dri raw cranberri human type num diabet pubm ncbi abstract studi assess metabol respons sweeten dri cranberri sdc raw cranberri rc white bread wb human type num diabet develop palat cranberri prepar lower glycem respons improv fruit consumpt glycem control diabet trial type num diabet num receiv wb num num cal num fiber rc num num cal num fiber sdc num num cal num fiber sdc sugar sdc ls num num cal num fiber num polydextros plasma glucos mmol l peak signific num min wb num min rc sdc sdc ls num num num num num num num num wb remain signific elev treatment num min plasma insulin pmol ml peak num min wb sdc num min rc sdc ls num num num num num num plasma insulin sdc ls signific lower num min wb sdc insulin area curv auc valu rc sdc ls signific lower wb sdc phenol content sdc sdc ls determin extract num aceton prior high perform liquid chromatographi hplc electronspray ionization mass spectrometri esi m found rich num caffeoylquin cid quercetin num galactosid quercetin num galactosid proanthocyanidin dimer epicatechin conclus sdc ls favor glycem insulinem respons type num diabet practic applic studi compar phenol content glycem respons cranberri product studi seek expand palat portabl healthi food choic person type num diabet polydextros bulk agent make reduct calor content potenti glycem respons character studi
MED-3734~cranberri cranberri product power vitro vivo vivo sourc antioxid pubm ncbi abstract cranberri product cranberri juic cj consum health reason primarili due effect urinari tract infect investig quantiti free total hydrolysi phenol antioxid cranberri product folin assay order amount total polyphenol cranberri food fresh weight basi dri frozen sauc jelli sauc serv size basi cranberri product order frozen num juic dri num juic sauc jelli sauc high fructos corn syrup hfcs major sourc sugar consumpt glucos fructos potenti mediat oxid stress investig effect consumpt hfcs ascorb cj antioxid cj control num normal individu overnight fast plasma antioxid capac glucos triglycerid ascorb measur num time num consumpt singl num ml serv beverag control hfcs caus slight decreas plasma antioxid capac time point oxid stress spite presenc ascorb cj produc increas plasma antioxid capac signific greater control hfcs time point postprandi triglycerid due fructos beverag respons oxid stress signific correl oxid stress measur antioxid capac cranberri excel sourc high qualiti antioxid examin human supplement studi
MED-3738~comparison health relev flavonoid common consum cranberri product pubm ncbi abstract human health benefit consumpt cranberri product fruit uniqu flavonoid composit includ complex profil anthocyanin proanthocyanidin process techniqu press canning concentr dri number natur compon compromis inactiv due physic separ thermal degrad oxid fresh cranberri compar freeze dri berri individu fruit tissu skin peel fruit product examin includ cranberri juic commerci prepar concentr cranberri sauc commerci homemad sweetened dri cranberri commerci freeze dri result detect loss anthocyanin proanthocyanidin cranberri fruit anthocyanin local skin proanthocyanin higher skin flesh procyanidin num dimer concentr flesh anthocyanin signific higher not from concentr juic reconstitut juic concentr num mg num mg num ml similar proanthocyanidin mark higher not from concentr juic compar juic concentr num mg num mg num ml homemad sauc higher anthocyanin proanthocyanidin num num mg num sauc process berri num num mg num jelled typ num num mg num sweetened dri cranberri low anthocyanin num mg num retain proanthocyanidin num mg num commerci process product signific lower level polyphenol compar fresh home process prepar anthocyanin sensit degrad proanthocyanidin practic applic cranberri juic product increas consum recogn health benefit includ prophylaxi urinari tract infect relev degre commerci home process alter innat level biolog activ flavonoid anthocyanin proanthocyanidin characterist intact fruit num institut food technologist
MED-3742~habitu intak flavonoid subclass incid hypertens adult abstract background dietari flavonoid benefici effect blood pressur intervent set limit inform habitu intak risk hypertens population bas studi object examin associ habitu flavonoid intak incid hypertens prospect studi men women design total num women nurs health studi nhs ii num women nhs num men health profession follow up studi hpfs particip studi total flavonoid subclass intak calcul semiquantit food frequ questionnair collect num updat extend depart agricultur databas result num follow up num case hypertens women num case hypertens men report pool multivariate adjust analys particip highest quintil anthocyanin intak predomin blueberri strawberri num reduct risk hypertens relat risk rr num num ci num num num compar particip lowest quintil anthocyanin intak risk reduct num rr num num ci num num num particip num age num num num particip num age age interact num intak subclass hypertens pool analys individu compound suggest num ci num num num reduct risk highest compar lowest quintil intak flavon apigenin particip num age num ci num num num reduct risk observ flavan num ol catechin highest lowest quintil compar conclus anthocyanin flavon flavan num ol compound contribut prevent hypertens vasodilatori properti result specif structur similar includ b ring hydroxyl methyoxyl pattern
MED-3743~anthocyanin composit wild banana thailand pubm ncbi abstract anthocyanin isol male bract num wild speci banana musa spp enset spp distribut thailand major anthocyanin pigment identifi high perform liquid chromatographi hplc mass spectrometri ms tandem mass spectrometri ms ms delphinidin num rutinosid m z num cyanidin num rutinosid m z num petunidin num rutinosid m z num pelargonidin num rutinosid m z num peonidin num rutinosid m z num malvidin num rutinosid m z num basi type pigment present wild banana divid num group group compris itineran musa sp musa sp acuminata access anthocyanin pigment pelargonidin num rutinosid includ nonmethyl methyl anthocyanin group acuminata subsp truncata malvidin num rutinosid group coccinea cyanidin num rutinosid pelargonidin num rutinosid group acuminata yellow bract glaucum anthocyanin pigment group consist balbisiana velutina laterita superbum nonmethyl anthocyanin delphinidin num rutinosid cyanidin num rutinosid total anthocyanin content analyz bract rang num num mg num bract fresh weight differ type anthocyanin variat amount present wild banana show biochem divers identifi specif group banana clarifi evolut flavonoid metabol banana group
MED-3744~antioxid antiprolif activ common fruit pubm ncbi abstract consumpt fruit veget reduc risk chronic diseas cardiovascular diseas cancer phytochem phenol fruit veget suggest major bioactiv compound health benefit phenol content antioxid activ fruit veget underestim literatur bound phenol includ studi design investig profil total phenol includ solubl free bound form common fruit appli solvent extract base digest solid phas extract method cranberri highest total phenol content appl red grape strawberri pineappl banana peach lemon orang pear grapefruit total antioxid activ measur tosc assay cranberri highest total antioxid activ num num micromol vitamin equiv g fruit appl red grape strawberri peach lemon pear banana orang grapefruit pineappl antiprolifer activ studi vitro hepg num human liver canc cell cranberri show highest inhibitori effect ec num num num mg ml lemon appl strawberri red grape banana grapefruit peach bioactiv index bi dietari cancer prevent propos provid altern biomark futur epidemiolog studi dietari cancer prevent health promot
MED-3745~total cranberri extract versus phytochem constitu antiprolif synergist effect human tumor cell line pubm ncbi abstract cranberri vaccinium macrocarpon ait excel dietari sourc phytochem includ flavonol glycosid anthocyanin proanthocyanidin condens tannin organ phenol acid num sephadex lipophil lh num column chromatographi hplc tandem lc es m total cranberri extract tce analyz quantifi separ fraction enrich sugar organ acid total polyphenol proanthocyanidin anthocyanin num num num num num composit luminesc atp cell viabil assay antiprolif effect tce num microg ml versus fraction evalu human oral kb cal num colon ht num hct num sw num sw num prostat rwpe num rwpe num rv num cancer cell line total polyphenol fraction activ fraction cell line num num inhibit kb cal num oral cancer cell colon cancer cell antiprolif activ fraction greater hct num num ht num num sw num sw num tce fraction show num antiprolif activ prostat cancer cell total polyphenol activ fraction rwpe num rwpe num num num num cranberri sugar num microg ml inhibit prolifer cancer cell line enhanc antiprolif activ total polyphenol compar tce individu phytochem suggest synergist addit antiprolif interact anthocyanin proanthocyanidin flavonol glycosid cranberri extract
MED-3746~anthocyanin bioavail human acut dose cranberri juic pubm ncbi abstract research suggest anthocyanin berri fruit affect varieti physiolog respons includ endotheli function inform pharmacokinet flavonoid human determin pharmacokinet cranberri anthocyanin studi undertaken num particip age num num coronari arteri diseas blood urin sampl collect baselin num num consumpt num ml cranberri juic num juic num mg total polyphenol num mg anthocyanin mark inter individu differ plasma anthocyanin pharmacokinet observ maximum anthocyanin concentr detect num num cranberri anthocyanin bioavail notabl differ maximum concentr area curv num individu particip pattern anthocyanin glucosid observ plasma urin general reflect relat concentr determin juic plasma concentr individu anthocyanin rang num num nmol l total recoveri urinari anthocyanin num num dose deliv data agreement pharmacokinet anthocyanin food suggest cranberri anthocyanin poor absorb rapid remov plasma observ concentr plasma anthocyanin insuffici alter radic load redox potenti adequ affect signal transduct and or gene express
MED-3747~american cranberri vaccinium macrocarpon extract affect human prostat cancer cell growth cell cycl arrest modul express cell pubm ncbi abstract prostat cancer common cancer world preval expect increas appreci decad research understand etiolog progress prevent measur delay stop develop diseas recent interest examin effect extract common harvest crop behaviour progress cancer describ effect cranberri extract wce behaviour du num human prostat cancer cell vitro treatment du num human prostat cancer cell num num ml wce num wce signific decreas cellular viabil du num cell wce decreas proport cell num phase cell cycl increas proport cell num phase cell cycl treatment cell num num ml treatment wce num alter cell cycl cell cycl regulatori protein cell cycl protein wce decreas express cdk num cyclin cyclin num cyclin num cyclin increas express num num ink num prbp num protein express level evid note num ink num prbp num protein express level statist signific find demonstr phytochem extract american cranberri vaccinium macrocarpon affect behaviour human prostat cancer cell vitro support potenti health benefit cranberri
MED-3748~cranberri ripe cancer research pubm ncbi abstract berri recogn function food potenti protect varieti health condit includ cancer cranberri vaccinium macrocarpon product consumpt grown recent year warrant evalu potenti health benefit extract isol constitu cranberri fruit inhibit growth prolifer tumor cell vitro recent data anim studi lend support cranberry reput cancer fighter mechan action cranberri prostat cancer identifi includ induct apoptosi inhibit event link cellular invas migrat articl attempt put perspect cranberry potenti chemoprevent properti determin factor research move forward copyright num societi chemic industri
MED-3749~placebo clinic practic compar attitud belief pattern academ psychiatrist nonpsychiatrist pubm ncbi abstract controversi ethic tenuous placebo central medicin pivot psychosoci therapi scholar research practition larg disagre conceptu placebo profession confound placebo effect placebo respons physician continu prescrib placebo part clinic practic studi aim review attitud belief placebo clinic research compar pattern placebo report academ psychiatrist report physician specialti canadian medic school web bas tool circul onlin survey num canadian medic school special emphasi psychiatri depart university affili teach hospit variat earlier effort num minut num question survey anonym num respond complet onlin survey num psychiatrist analysi reveal psychiatrist prescrib signific subtherapeut dose medic physician specialti num psychiatrist nonpsychiatrist prescrib placebo regular part routin clinic practic compar num nonpsychiatrist num psychiatrist deem placebo clinic benefit addit num psychiatrist agre strong agre placebo therapeut effect relat fewer num practition find pan canadian survey suggest compar physician psychiatrist influenc placebo wield mind bodi maintain favour belief attitud placebo phenomena
MED-3750~bach flower remedi systemat review randomis clinic trial pubm ncbi abstract bach flower remedi continu popular propon make rang medicin claim aim systemat review critic evalu evid claim electron databas search restrict time languag randomis clinic trial flower remedi includ studi locat placebo control placebo control trial fail demonstr efficaci conclud reliabl clinic trial show differ flower remedi placebo
MED-3751~control trial megestrol acet treatment cancer anorexia cachexia pubm ncbi abstract preliminari inform suggest megestrol acet lead appetit stimul nonfluid weight gain patient breast cancer cancer aid pursuant develop random double blind placebo control trial megestrol acet patient cancer associ anorexia cachexia random assign num elig patient receiv num mg megestrol acet day placebo patient assign megestrol acet frequent report improv appetit num food intak num compar patient receiv placebo weight gain num lb baselin num num patient receiv megestrol acet compar num placebo num patient receiv megestrol acet report signific nausea num num num emesi num num num clinic statist signific toxic reaction ascrib megestrol acet mild edema studi convinc demonstr megestrol acet stimul appetit food intak patient anorexia cachexia cancer lead signific weight gain proport patient
MED-3752~questionnair survey placebo abstract object gaug frequenc circumst placebo clinic practic attitud administ design retrospect questionnair set larg hospit communiti clinic jerusalem area particip num physician work hospit inpati outpati depart num head nurs work hospit inpati depart num famili physician work communiti clinic main outcom measur report frequenc circumst attitud placebo result num respond num placebo num confid interv num num user num prescrib placebo month num told patient receiv actual medic num consid placebo diagnost tool num num report found placebo general occasion effect conclus practition question studi continu placebo wise placebo legitim place therapeut wider recognit practic debat implic imper
MED-3753~what placebo analysi random control trial pubm ncbi abstract background regul govern placebo composit composit placebo influenc trial outcom merit report purpos assess investig composit placebo random placebo control trial data sourc num english languag general intern medicin journal high impact factor studi select num review screen titl abstract journal identifi random placebo control trial publish januari num decemb num data extract review independ abstract data introduct method section identifi articl record treatment type pill inject placebo composit state discrep resolv consensus data synthesi studi disclos composit studi placebo disclosur common pill inject treatment num num num limit journal high impact factor repres conclus placebo seldom random control trial pill capsul natur placebo influenc trial outcom placebo formul disclos report placebo control trial
MED-3754~survey placebo general hospit pubm ncbi abstract hundr thirti regist nurs seventi physician particip retrospect studi scrutin placebo effect prescrib pattern staff attitud university bas general hospit set copious experiment literatur devot placebo effect past thirti year medic surgic placebo disregard experiment data num staff placebo hospit knowledg placebo effect respect defici hospit num placebo direct amelior pain author emphasi educ staff perceiv emot social physiolog concomit pain resort pure physicalist approach acknowledg staff conflict ethic placebo signific part educ approach
MED-3755~deceiv patient moral accept daniel sokol argu rare occas benign deceiv patient moral accept devis decis checklist doctor face dilemma
MED-3756~placebo general practic attitud placebo effect pubm ncbi abstract present studi survey dunedin general practition determin deliber placebo treatment condit basic understand placebo effect percept placebo relat colleagu result gps survey deliber placebo treatment circumst clear statist signific tendenc underst relat colleagu clear signific number survey felt placebo treatment imaginari ill result discuss comparison oversea studi regard implic medic train
MED-3757~duti deceiv placebo clinic practic pubm ncbi abstract medic research clinician domin view uneth deceiv patient prescrib placebo opinion formal recent polici issu american medic associ ama chicago il placebo shown safe effect doctor effect prohibit clinic practic argu decept administr placebo subject moral object face form decept clinic practic medic research decept objection ground limit autonomi breach trust ground appli placebo prescrib ethic limit patient reason prefer doctor prescrib placebo ethic respons ama oblig endors promot respons decept placebo clinic practic
MED-3758~systemat review systemat review homeopathi abstract homeopathi remain controversi subject therapeut articl attempt clarifi effect base recent systemat review electron databas search systemat reviews meta analysi subject seventeen articl fulfil inclusion exclus criteria relat re analys landmark meta analysi collect impli posit result meta analysi support critic analysi data eleven independ systemat review locat collect fail provid strong evid favour homeopathi condit respond convinc homeopath treatment placebo control intervent similar homeopath remedi demonstr yield clinic effect convinc placebo conclud clinic evid homeopathi date warrant posit recommend clinic practic
MED-3759~prescrib placebo treatment result nation survey internist rheumatologist abstract object describ attitud behaviour placebo treatment defin treatment benefit deriv posit patient expect physiolog mechan treatment design cross section mail survey set physician clinic practic particip num practis internist rheumatologist unit state main outcom measur investig measur physician report behaviour attitud placebo treatment includ measur recommend placebo treatment ethic judgment practic recommend placebo treatment typic communic patient practic result num physician num respond survey half survey internist rheumatologist report prescrib placebo treatment regular basi num depend question phrase physician num believ practic ethic permiss report salin num sugar pill num placebo treatment larg proport report counter analges num vitamin num placebo treatment past year small notabl proport physician report antibiot num sedat num placebo treatment period physician placebo treatment common describ patient potenti benefici medicin treatment typic condit num rare explicit describ placebo num conclus prescrib placebo treatment common view ethic permiss survey internist rheumatologist vitamin counter analges common treatment physician fulli transpar patient placebo mix motiv recommend treatment
MED-3760~placebo intervent medic practice  a nation questionnair survey danish clinician pubm ncbi abstract author questionnair num random select danish clinician placebo intervent sixty f percent respond general practition num confid interv num report placebo intervent num num placebo intervent ten time year hospital bas doctor privat specialist report placebo intervent frequent num import reason placebo intervent avoid confront patient typic placebo antibiot viral infect approxim num num clinician believ effect placebo intervent object outcom num num found clinic placebo intervent general ethic accept
MED-3761~general practic consult point posit abstract group num patient present general practic symptom abnorm physic sign definit diagnosi made random select consult consult conduct posit manner treatment consult conduct non posit manner call negat consult treatment week consult signific differ patient satisfact posit negat group treat untreat group similar num receiv posit consult compar num receiv negat consult num num treat compar num treat num
MED-3762~moder alcohol consumpt adult life drink pattern breast cancer risk abstract context multipl studi link alcohol consumpt breast cancer risk risk lower level consumpt quantifi addit role drink pattern frequenc drink bing drink consumpt time adult life understood object evalu associ breast cancer alcohol consumpt adult life includ quantiti frequenc age consumpt design set particip prospect observ studi num women enrol nurs health studi num num earli adult updat alcohol assess time main outcom measur relat risk develop invas breast cancer result num case develop num million person year follow up increas alcohol consumpt increas breast cancer risk statist signific level low num num gm day equival num drinks week rr num num ci num num num case num person year control cumul alcohol intak bing drink frequenc drink breast cancer risk alcohol intak earlier adult life independ risk conclus low level alcohol consumpt small increas breast cancer risk consist measur cumul alcohol intak adult life alcohol intak earlier adult life independ risk
MED-3763~singl sip strong alcohol beverag exposur carcinogen concentr acetaldehyd oral caviti pubm ncbi abstract aim studi explor oral exposur carcinogen group num acetaldehyd singl sip strong alcohol beverag high concentr acetaldehyd volunt tast num ml ethanol dilut num vol acetaldehyd num vol calvado num acetaldehyd salivari acetaldehyd ethanol concentr measur gas chromatographi protocol repeat ingest ethanol num g kg bodi weight salivari acetaldehyd concentr signific higher sip calvado sip ethanol num num num mol l num num num mol l num alcohol ingest num min onward signific differ decreas salivari acetaldehyd concentr remain level carcinogen num min system alcohol distribut blood saliva addit effect salivari acetaldehyd sip alcohol beverag carcinogen concentr acetaldehyd produc ethanol oral caviti instant small sip strong alcohol beverag exposur continu num min acetaldehyd present beverag short term effect total acetaldehyd exposur copyright num elsevi reserv
MED-3764~salivari acetaldehyd increas due alcohol contain mouthwash risk factor oral cancer pubm ncbi abstract increas evid suggest acetaldehyd genotox metabolit ethanol mediat carcinogen alcohol beverag ethanol number ready to us mouthwash typic num num vol increas risk oral cancer discuss user mouthwash epidemiolog evid remain inconclus studi investig acetaldehyd level saliva alcohol contain mouthwash ready to us mouthwash mouthrins num rins mouth healthi nonsmok volunt num intend manufactur num ml num sec saliva collect num num num min mouthwash analyz headspac gas chromatographi acetaldehyd content saliva num num microm rang num microm num min num num microm rang num microm num min num num microm rang num microm num min num num microm rang num microm num min content signific endogen level concentr found alcohol beverag consumpt twice daili alcohol contain mouthwash lead system acetaldehyd exposur num microg kg bodyweight day averag correspond lifetim cancer risk num num margin exposur calcul num low public health concern local acetaldehyd content saliva reach concentr dna adduct format sister chromatid exchang vitro concern local carcinogen effect oral caviti remain
MED-3765~molecular mechan alcohol medi carcinogenesi pubm ncbi abstract approxim num cancer worldwid deriv chronic alcohol drink includ upper aerodigest tract liver colorectum breast mechan alcohol associ carcinogenesi complet understood recent research focus acetaldehyd toxic ethanol metabolit cancer caus agent ethanol stimul carcinogenesi inhibit dna methyl interact retinoid metabol alcohol rel carcinogenesi interact factor smoke diet comorbid depend genet suscept
MED-3766~epidemiolog pathophysiolog alcohol breast cancer updat num pubm ncbi abstract aim updat epidemiolog data alcohol breast cancer special emphasi light alcohol consumpt review mechan alcohol mediat mammari carcinogenesi method epidemiolog data novemb num perform literatur search bibliograph databas conduct meta analysi data light alcohol drink relev mechanist studi review novemb num result signific increas order num risk breast cancer present intak alcohol drink day heavi alcohol consumpt defin drinks day increas risk num translat num breast cancer attribut alcohol northern europ north america total approxim num alcohol attribut case breast cancer worldwid num breast cancer europ north america attribut light drink larger preval femal popul compar heavi drink alcohol increas estrogen level estrogen exert carcinogen effect breast tissu er direct mechan includ acetaldehyd oxid stress epigenet due disturb methyl transfer decreas retino acid concentr alter cell cycl conclus women exceed drink day women elev risk breast cancer avoid alcohol consum alcohol occasion
MED-3767~light alcohol drink cancer meta analysi pubm ncbi abstract background convinc evid alcohol consumpt increas risk cancer colorectum breast larynx liver esophagus oral caviti pharynx data deriv studi focus effect moderate high alcohol intak light alcohol drink num drink day patient method evalu associ light drink cancer colorectum breast larynx liver esophagus oral caviti pharynx meta analyt approach search epidemiolog studi pubm isi web scienc embas publish decemb num result includ num articl compris num light drinker num non drink cancer light drink risk oropharyng cancer relat risk rr num num confid interv ci num num esophag squamous cell carcinoma scc rr num num ci num num femal breast cancer rr num num ci num num estim num death oropharyng cancer num esophag scc num breast cancer attribut light drink num worldwid associ found colorectum liver larynx tumor conclus light drink increas risk cancer oral caviti pharynx esophagus femal breast
MED-3768~posit negat health effect alcohol public health implic pubm ncbi abstract paper negat posit effect alcohol health review establish fact high alcohol intak impli increas risk larg number health outcom dementia breast cancer colorect cancer cirrhosi upper digest tract cancer alcohol depend justifi alcohol benefici effect individu regard prevent thrombosi heart public health relev result consid drink limit uk denmark maximum num drink week men num drink week women valid broader public health messag benefici effect alcohol interest western societi small fraction popul drinker good reason
MED-3769~energi densiti nutrient adequaci cost serv provid insight food choic lower mississippi delta pubm ncbi abstract object compar differ food group food cost energi nutrient profil num item cross sect survey num store num counti lower mississippi delta arkansa louisiana mississippi method energi nutrient cost profil food item calcul natur nutrient rich methodolog convert price num edibl portion price serv food group num food group differ compar anova result signific differ exist food group measur energi densiti highest fats oils sweet nutrient densiti highest veget price serv lowest fats oils sweet highest meat conclus implic educ messag focus complet diet role food cost provid specif recommend increas nutrient dens food replac portion meat serv meal cultur accept lower cost nutrient dens food copyright num societi nutrit educ behavior publish elsevi reserv
MED-3770~cost food relat nutrit abstract background comparison cost food relat energi nutrit conduct num depart agricultur usda object object reestablish relat food cost energi nutrient contemporari nutrient composit food price data usda design usda food nutrient databas dietari studi num fndds num center nutrit polici promot food price databas analysi num food key variabl energi densiti kcal g serv size unit price num serv price serv energi cost kcal regress model test associ nutrient unit price num comparison food group test one factor analys varianc relat energi densiti price food group test spearman correl result grain fat food group suppli lowest cost dietari energi energi cost veget higher food group fruit serv size increas water content vari invers energi densiti food highest price serv meat poultri fish lowest price serv fat categori carbohydr sugar fat lower price num protein fiber vitamin miner higher price num adjust energi conclus grain sugar food group cheaper veget fruit calori cheaper fruit serv price differenti explain low cost energy dens food nutrient poor lower educ incom
MED-3771~cell hydrat status healthi children usa preliminari data urin osmol water intak pubm ncbi abstract object hyperosmot stress cell limit aspect cell function metabol health intern data suggest schoolchildren risk hyperosmot stress cell suboptim water intak present studi explor cell hydrat status sampl children usa design cross sect studi describ urin osmol index hyperosmot cell shrinkag water intak conveni sampl los angel la york citi nyc set particip collect urin sampl outpati clinic school weekday morn spring num instruct wake eat drink usual school complet dietari record form describ type amount food beverag consum wake give sampl subject children num year la num nyc num consid healthi school day gave urin sampl result elev urin osmol num mmol kg observ num num particip la nyc multivariable adjust logist regress model elev urin osmol report intak drink water morn la num num ci num num num nyc num num ci num num num num sampl breakfast give urin sampl num drink water conclus research warrant confirm result pursu potenti health implic
MED-3772~hydrat cognit perform pubm ncbi abstract clinic link exist sever dehydr cognit perform rapid sever water loss induc intens exercis and or heat stress initi studi suggest alter short term memori cognit function relat vision recent studi confirm data studi argu water loss respons observ made studi compens water loss fail prevent symptom studi children suggest drink extra water cognit perform data reli small number children older adult age num data strong support relationship mild dehydr cognit function data frail elder dement peopl lack methodolog heterogen studi relationship mild dehydr cognit perform support
MED-3773~mild dehydr impair cognit perform mood men pubm ncbi abstract present studi assess effect mild dehydr cognit perform mood young male total twenty six men age num num sd num num year particip randomis single blind repeated measur trial exercise induc dehydr diuret dd num mg furosemid exercise induc dehydr placebo diuret dn exercis maintain euhydr placebo eu control condit trial includ num min treadmil walk num num km h num grade num num environ comprehens computeris six task cognit test batteri profil mood state questionnair symptom questionnair headach concentr task difficulti administ trial pair test compar dd dn trial result num bodi mass loss num num sd num num volunteer eu trial num num sd num num dehydr degrad specif aspect cognit perform error increas visual vigil num num visual work memori respons latenc slow num num fatigu tension anxieti increas due dehydr rest num num num num fatigu exercis num num plasma osmol increas due dehydr num num rest gastrointestin temperatur alter num num conclus mild dehydr hyperthermia men induc advers vigil work memori increas tension anxieti fatigu
MED-3774~children drink water effect drink water cognit children pubm ncbi abstract dehydr well docu negat effect adult cognit research hydrat cognit perform children investig drink water improv children perform cognit task fifty eight children age num year random alloc group receiv addit water group result show children drank addit water rate signific thirsti comparison group num perform visual attent task letter cancel num spot differ memori task ps num num
MED-3775~effect drink supplementari water school cognit perform children pubm ncbi abstract investig benefici effect drink supplementari water school day cognit perform transitori subject state fatigu vigor num children age num num ear live hot climat south itali sardinia class random divid intervent group receiv water supplement control group dehydr determin urin sampl defin urin osmol greater num osm kg num katz massri agomn toor num chang score morn afternoon hydrat level cognit perform transitori subject state correl line previous observ studi evalu hydrat status school children live countri hot climat bar david urkin kozminski num result show remark proport children state mild voluntari dehydr begin school day num found signific negat correl dehydr auditori number span benefici effect drink supplementari water school short term memori posit correl dehydr perform verbal analog task result discuss light complex neurobiolog mechan involv relationship hydrat status cognit copyright num elsevi reserv
MED-3776~drink num year old children show improv cognit perform baselin test drink pubm ncbi abstract research examin effect water consumpt cognit children examin drink water improv perform baselin test twenty thre num year old children signific interact time test water group water no water improv water group thirst happi rate visual attent visual search visual memori visuomotor perform result condit mild dehydr result exercis intent water depriv heat exposur children cognit perform improv drink water
MED-3778~vegetarian nonvegetarian diet dietari restraint subclin ovulatori disturb prospect num mo studi pubm ncbi abstract ovulatori function prospect assess num mo num vegetarian num nonvegetarian clinic normal menstrual cycl subject num age stabl weight bodi mass index kg m num num current diet num oral contracept quantit analysi basal bodi temperatur record classifi cycl ovulatori short luteal phase num anovulatori subject complet three factor eat questionnair subject complet three factor eat questionnair subscal restraint hunger disinhibit num food record vegetarian lower bmis num num num num num percentag bodi fat num num num num num restraint score num num num num num cycl length similar vegetarian longer luteal phase length num num num num num cycl type differ chi num num num vegetarian fewer anovulatori cycl num num cycl compar restraint score median high restrain women fewer ovulatori cycl num num num num num shorter luteal phase length num num num num num conclud ovulatori disturb restrain eat common vegetarian restraint influenc ovulatori function
MED-3779~vegetarian menstrual cycl disturb associ pubm ncbi abstract question menstrual disturb common vegetarian nonvegetarian women complex disturb cycl clinic amenorrhea oligomenorrhea subclin normal length cycl anovul short defect luteal phase detect requir menstrual cycl monitor prevent recruit bias studi compar vegetarian nonvegetarian vegetarian menstrual disturb volunt studi menstrual disturb vegetarian general mechan contribut menstrual disturb differ vegetarian nonvegetarian includ energi imbal body weight disturb exercis psychosoci cognit factor dietari compon evid mechan review studi compar menstrual function vegetarian nonvegetarian articl result cross sect studi suggest clinic menstrual disturb common vegetarian prospect studi control potenti confound found subclin disturb common weight stabl healthi vegetarian women sampl studi repres vegetarian women result general popul studi draw definit conclus
MED-3780~gut flora metabol phosphatidylcholin promot cardiovascular diseas abstract metabolom studi hold promis discoveri pathway link diseas process cardiovascular diseas cvd repres lead death morbid worldwid metabolom approach generat unbias small molecul metabol profil plasma predict risk cvd metabolit dietari lipid phosphatidylcholin cholin trimethylamin n oxid tmao betain identifi shown predict risk cvd independ larg clinic cohort dietari supplement mice cholin tmao betain promot up regul multipl macrophag scaveng receptor link atherosclerosi supplement cholin tmao promot atherosclerosi studi germ fre mice confirm critic role dietari cholin gut flora tmao product augment macrophag cholesterol accumul foam cell format suppress intestin microflora atherosclerosis pron mice inhibit dietari choline enhanc atherosclerosi genet variat control express flavin monooxygenas fmos enzymat sourc tmao segreg atherosclerosi hyperlipidem mice discoveri relationship gut flora depend metabol dietari phosphatidylcholin cvd pathogenesi opportun develop diagnost test therapeut approach atherosclerot heart diseas
MED-3781~detect increas cholin compound proton nuclear magnet reson spectroscopi subsequ malign transform human prosta pubm ncbi abstract studi panel normal human prostat cell hpcs tumor cell deriv metastas studi num nmr spectroscopi determin malign transform hpcs result elev cholin compound elev cholin signal observ previous clinic studi contribut cho compound elev quantif establish shown hpcs deriv metastas exhibit signific higher phosphocholin glycerophosphocholin level compar normal prostat epitheli stromal cell elev cholin peak observ clinic prostat cancer attribut alter phospholipid metabol simpli increas cell densiti doubl time nonspecif effect androgen depriv androgen receptor posit cell line result signific increas cholin compound chronic androgen depriv lncap cell line decreas cholin compound acut androgen depriv lapc num cell line data strong support proton magnet reson spectroscop imag detect presenc prostat cancer diagnosi detect respons subsequ androgen ablat therapi detect recurr
MED-3782~egg red meat poultri intak risk lethal prostat cancer prostat specif antigen era incid surviv abstract red process meat increas risk advanc prostat cancer data post diagnost diet prostat cancer spars post diagnost intak poultri skin egg increas risk diseas progress prospect examin total unprocess process red meat poultri egg relat risk lethal prostat cancer men cancer baselin develop distant organ metastas die prostat cancer follow up num men num num perform case on surviv analysi examin post diagnost consumpt food risk lethal prostat cancer num men initi diagnos non metastat prostat cancer follow up incid analysi observ num event num person year men consum num egg week num increas risk lethal prostat cancer compar men consum num egg week hr num num confid interv ci num num p trend num case on surviv analysi observ num event num person year suggest statist signific posit associ post diagnost poultri hr num num serv week num num ci num num p trend num post diagnost process red meat hr num num serv week num num ci num num p trend num risk progress local prostat cancer lethal diseas conclus consumpt egg increas risk develop lethal form prostat cancer healthi men
MED-3783~fish odour syndrom abstract fish odour syndrom trimethylaminuria metabol syndrom caus abnorm excret trimethylamin breath urin sweat saliva vagin secret trimethylamin deriv intestin bacteri degrad food rich cholin carnitin oxidis liver odourless trimethylamin n oxid excret urin impair oxid trimethylamin thought fish odour syndrom respons smell rot fish food rich cholin exacerb condit patient varieti psycholog problem recognit condit import dietari adjust reduc excret trimethylamin reduc odour occasion short metronidazol neomycin lactulos suppress product trimethylamin reduc activ gut microflora keyword fish odour syndrom trimethylaminuria
MED-3784~cholin betain intak risk colorect cancer men abstract dietari cholin betain hypothes decreas risk cancer role methyl donor one carbon metabol remain unknown dietari intak cholin betain colorect cancer risk prospect examin associ dietari cholin betain intak risk colorect cancer men health profession follow up studi num men identifi total num incid colorect cancer case num num assess dietari supplement cholin betain intak year valid semi quantit food frequenc questionnair cox proport hazard model estim multivari relat risk rrs num confid interv num cis statist test two sid find statist signific associ cholin intak betain intak risk colorect cancer compar top quintil bottom quintil multivari rrs num ci num num num ptrend num cholin intak num num num ptrend num betain intak similar observ associ colorect cancer risk cholin free cholin glycerophosphocholin phosphocholin phosphatidylcholin sphingomyelin data support cholin betain intak invers colorect cancer risk
MED-3785~one carbon metabol prostat cancer risk prospect investig circul vitamin metabolit pubm ncbi abstract purpos compon one carbon metabol believ influenc cancer develop suggest mechan includ dna methyl dna repair mechan prospect studi investig one carbon metabol relat prostat cancer risk result conflict aim studi comprehens investig compon one carbon metabol relat prostat cancer risk panel circul vitamin relat metabolit select studi materi method analyz plasma concentr betain cholin cystein methionin methylmalon acid mma vitamin num vitamin num num case num control match age recruit date nest population bas northern sweden health diseas cohort relat risk prostat cancer estim condit logist regress result posit associ prostat cancer risk observ cholin vitamin num invers associ observ mma relat risk doubl concentr num num confid interv num ci num num trend num cholin num num ci num num trend num vitamin num num num ci num num trend num mma concentr betain cystein methionin vitamin num prostat cancer risk conclus result larg prospect studi suggest elev plasma concentr cholin vitamin num increas risk prostat cancer find support role one carbon metabol prostat cancer etiolog warrant investig
MED-3786~cholin betaine defin diet clinic research manag trimethylaminuria pubm ncbi abstract articl describ develop seri cholin betaine control diet serv research subject part ongo studi diet requir human diet develop base analysi cholin betain individu food calcul diet compar analys food combin singl sampl day laboratori analys cholin betain whole diet aliquot match estim amount diet calcul analys individu food diet adjust level cholin betain accept research subject consum time period num month articl describ applic diet clinic research methyl group requir human clinic practic counsel client requir choline control diet
MED-3787~num cholin num fdg pet ct assess bone involv patient multipl myeloma abstract background multipl myeloma mm cell neoplasm caus lytic osteopen bone abnorm bodi skelet survey wbss magnet reson mr num fdg pet ct imag techniqu routin evalu bone involv mm patient aim mm bone lesion present low num fdg uptak aim studi assess ad limit num cholin num fdg pet ct patient affect mm method ten patient affect mm underw standard num cholin pet ct num fdg pet ct week result scan compar term number site suvmax lesion result patient num negat concord num cholin num fdg pet ct scan patient num posit num cholin num fdg pet ct scan identifi number site bone lesion remain patient num posit num cholin num fdg pet ct scan exam identifi number lesion cholin show suvmax num fdg show suvmax num num num cholin pet ct scan detect num bone lesion num fdg pet ct scan detect num bone lesion differ signific num conclus preliminari data num cholin pet ct sensit num fdg pet ct detect boni myelomat lesion data confirm larger seri patient num cholin consid function imag associ mri mm bone stage
MED-3788~intestin microbiota metabol l carnitin nutrient red meat promot atherosclerosi abstract intestin microbiota metabol choline phosphatidylcholin produc trimethylamin tma metabol proatherogen speci trimethylamine n oxid tmao demonstr intestin microbiota metabol dietari l carnitin trimethylamin abund red meat produc tmao acceler atherosclerosi omnivor subject shown produc signific tmao vegans vegetarian ingest l carnitin microbiota depend mechan specif bacteri taxa human fece shown associ plasma tmao dietari status plasma l carnitin level subject undergo cardiac evalu num predict increas risk preval cardiovascular diseas cvd incid major advers cardiac event mi stroke death subject concurr high tmao level chronic dietari l carnitin supplement mice signific alter cecal microbi composit mark enhanc synthesi tma tmao increas atherosclerosi suppress intestin microbiota dietari supplement tmao carnitin cholin mice intact intestin microbiota signific reduc revers cholesterol transport vivo intestin microbiota particip well establish link increas red meat consumpt cvd risk
MED-3789~cholin intak risk lethal prostat cancer incid surviv abstract background meat milk egg inconsist risk advanc prostat cancer food sourc cholin nutrient affect prostat cancer progress cell membran function one carbon metabol studi examin dietari cholin risk lethal prostat cancer object object examin dietari cholin choline contain compound betain cholin metabolit increas risk lethal prostat cancer design prospect examin intak nutrient risk lethal prostat cancer num men health profession follow up studi case on surviv analysi examin postdiagnost intak nutrient risk lethal prostat cancer num men initi diagnosi nonmetastat diseas follow up diet assess valid questionnair num time num follow up result incid analysi observ num lethal prostat cancer num person year men highest quintil cholin intak num increas risk lethal prostat cancer hr num num ci num num p trend num case on surviv analysi observ num lethal case num person year postdiagnost cholin intak statist signific risk lethal prostat cancer hr quintil num compar quintil num num ci num num p trend num conclus num men studi popul cholin intak increas risk lethal prostat cancer
MED-3790~intak meat fish poultri egg risk prostat cancer progress abstract background process meat fish shown risk advanc prostat cancer studi examin diet prostat cancer diagnosi risk progress object examin associ postdiagnost consumpt process unprocess red meat fish poultri egg risk prostat cancer recurr progress design conduct prospect studi num men prostat cancer recurr progress num num particip cancer prostat strateg urolog research endeavor averag num result observ num event prostat cancer death metastas elev prostate specif antigen concentr secondari treatment num person year intak process unprocess red meat fish total poultri skinless poultri prostat cancer recurr progress greater consumpt egg poultri skin num fold increas risk comparison extrem quantil egg hazard ratio hr num num ci num num trend num poultri skin hr num num ci num num trend num interact observ prognost risk diagnosi poultri men high prognost risk high poultri intak num fold increas risk recurr progress compar men low intermedi prognost risk low poultri intak interact num conclus result suggest postdiagnost consumpt process unprocess red meat fish skinless poultri prostat cancer recurr progress consumpt egg poultri skin increas risk
MED-3791~recommend prevent chronic diseas applic breast diseas pubm ncbi abstract experiment epidemiolog evid suggest diet dietari fat low num kcal reduc risk breast cancer group women postmenopaus women treat breast cancer premenopaus women cystic breast diseas accompani cyclic mastaligia particip intervent program determin feasibl low fat diet num mo intervent group consum low fat diet premenopaus group serum estrogen level decreas respons fat reduct nutrition educ program research institut restaur school attempt influenc public knowledg behavior import dietari fat reduct
MED-3792~serum prolactin oestradiol level women cyclic mastalgia pubm ncbi abstract basal serum prolactin serum oestradiol num beta concentr measur time menstrual cycl num women sever cyclic mastalgia normal slight fibroadenot breast group num normal women experienc mastalgia serv control basal serum prolactin signific elev patient compar normal normal rang serum oestradiol concentr differ group normal rang signific posit correl oestradiol prolactin found patient normal larger prolactin level patient result point prolactin secretori hypersensit oestradiol patient cyclic mastalgia prolactin consid central factor elicit cyclic mastalgia
MED-3793~global studi women experi premenstru symptom effect daili life pubm ncbi abstract object determin cross cultur effect women experi premenstru symptom impact activ daili life adl studi design cross sect survey sampl total num women age num recruit random sampl approxim num franc germani hungari itali spain uk brazil mexico hong kong pakistan thailand approxim num women japan korea num australian women found internet panel main outcom measur questionnair num premenstru symptom sociodemograph lifestyl variabl adl women knowledg premenstru term result preval symptom abdomin bloat cramp abdomin pain irrit mastalgia joint muscle back pain sever symptom direct proport durat number affect cycl num linear model found symptom preval durat sever age linear quadrat effect pariti current smoke countri premenstru physic mental symptom domain similar negat effect adl impact adl affect educ exercis particip women knowledg term premenstru syndrom pms premenstru dysphor disord pmdd vari symptom intens age educ countri conclus preval premenstru symptom physic great deal similar women experi symptom countri region women knowledg pms term high depend countri live
MED-3794~diet sex hormon bind globulin dysmenorrhea premenstru symptom pubm ncbi abstract object test hypothesi low fat vegetarian diet reduc dysmenorrhea premenstru symptom effect serum sex hormon bind globulin concentr estrogen activ method crossov design num women low fat vegetarian diet menstrual cycl addit cycl customari diet supplement placebo pill dietari intak serum sex hormon bind globulin concentr bodi weight pain durat intens premenstru symptom assess studi phase result standard deviat sd serum sex hormon bind globulin concentr higher diet phase num num nmol l supplement phase num num nmol l num sd bodi weight lower diet num num kg compar supplement phase num num kg num dysmenorrhea durat fell signific baselin num num day diet phase num num day compar chang baselin supplement phase num num day num pain intens fell signific diet phase compar baselin worst second worst third worst day durat premenstru concentr behavior chang water retent symptom reduc signific compar supplement phase conclus low fat vegetarian diet increas serum sex hormon bind globulin concentr reduct bodi weight dysmenorrhea durat intens premenstru symptom durat symptom effect mediat dietari influenc estrogen activ
MED-3795~mastalgia review manag pubm ncbi abstract mastalgia affect two third women time reproduct live benign thefear breast cancer women present evalu mastalgia premenstru syndrom fibrocyst breast diseas psycholog disturb rare breast cancer occasion extramammari condit tietzi syndrom present mastalgia clinic evalu requir assess major women reassur clinic evalu approxim num requir pain reliev therapi mechan breast support low fat high carbohydr diet topic nonsteroid antiinflammatori agent reason first lin treatment hormon agent bromocriptin tamoxifen danazol demonstr efficaci treatment mastalgia side effect limit extens danazol fda approv hormon treatment cyclic form limit advers effect lisurid maleat agent recent studi treatment mastalgia initi data medic encourag sixti percent cyclic mastalgia recur treatment noncycl mastalgia respond poor treatment resolv spontan num case
MED-3796~effect flax seed ingest menstrual cycl pubm ncbi abstract lignan group phytochem shown weak estrogen antiestrogen properti specif lignan enterodiol enterolacton absorb format intestin tract plant precursor abund fiber rich food excret urin evalu effect ingest flax seed powder produc high concentr urinari lignan menstrual cycl num cycl women balanc random cross ov design subject consum usual omnivor low fiber control diet num cycl usual diet supplement flax seed num cycl flax cycl compar control cycl anovulatori cycl occur num control cycl compar num flax seed cycl compar ovulatori control cycl ovulatori flax cycl consist longer luteal phase lp length sem num num num num day num signific differ flax control cycl concentr estradiol estron earli follicular phase midfollicular phase lp flax seed ingest signific effect lp progesteron concentr lp progesterone estradiol ratio signific higher flax cycl midfollicular phase testosteron concentr slight higher flax cycl flax seed ingest effect earli follicular phase concentr dhea prl sex hormone bind globulin data suggest signific specif role lignan relationship diet sex steroid action possibl diet risk breast hormon depend cancer
MED-3797~doubl blind trial prolactin inhibitor bromocriptin pain benign breast diseas pubm ncbi abstract doubl blind crossov trial prolactin inhibitor bromocriptin pain benign breast diseas report twenty nin women cyclic mastalgia num non cycl pain treat bromocriptin num mg daili placebo menstrual cycel assess respons treatment made linear analogu system clinic examin plasma prolactin estim bromocriptin produc signific improv breast symptom signific fall prolactin level cyclic pain group effect non cycl group result suggest bromocriptin offer effect approach manag cyclic breast pain
MED-3798~influenc dietari fat self report menstrual symptom pubm ncbi abstract moo menstrual distress questionnair mmdq complet thirti healthi premenopaus women random set weight maintain diet ratio polyunsatur satur fatti acid p s ratio num p s ratio num baselin interv menstrual cycl group fed high fat diet num energi fat menstrual cycl subject similar interv low fat diet num energi fat signific differ self report menstrual symptom p s group mens premenstru week low fat dietari period signific decreas self report symptom water retent decreas symptom group label arous rest menstrual cycl report
MED-3799~low fat dietari pattern risk benign prolif breast diseas random control dietari modif trial abstract modifi factor includ diet alter breast cancer risk whi dietari modif dm trial test effect intervent risk benign prolif breast diseas condit increas risk consid pathway invas breast cancer whi dm trial random control primari prevent trial conduct num clinic center num num num postmenopaus women age num num year prior breast cancer enrol particip random assign dm intervent group comparison group intervent design reduc total dietari fat intak num total energi intak increas fruit veget intak num servings day intak grain product num servings day result smaller albeit signific practic particip biennial mammogram regular clinic breast exam identifi women report breast biopsi free cancer obtain histolog section subject standard central review follow up averag num year num incid case benign prolif breast diseas ascertain intervent group num comparison group hazard ratio associ dm benign prolif breast diseas num num ci num num risk vari level baselin total vitamin intak vari level baselin variabl result suggest modest reduct fat intak increas fruit veget grain intak alter risk benign prolif breast diseas
MED-3800~mastalgia pubm ncbi abstract object review current manag women breast pain option effect treatment mode health practic includ medic consid manag cyclic noncycl breast pain outcom effect time manag woman breast pain improv qualiti life evid literatur search perform identifi report publish english num juli num medlin cochran databas systemat review valu level evid outlin determin criteria outlin canadian task forc period health examin particip princip author clinic dietitian surgeon oncologist nurs benefit harm cost util inform increas knowledg enabl consist approach reduc number ineffect intervent ensur medic valid comparison made manag protocol literatur clinic guidelin locat formal clinic test place sponsor societi obstetrician gynaecologist canada sogc work guidelin initi team member fill practic guidelin winnipeg region health author breast health centr winnipeg mb recommend num educ reassur integr part manag mastalgia first lin treatment ii num num well fit bra good support consid relief cyclic noncycl mastalgia ii num num chang dose formul schedul consid women hrt hrt discontinu iii num women breast pain advis reduc caffein intak num num vitamin consid treatment mastalgia num num present insuffici evid recommend primros oil epo treatment breast pain ii num num flaxse consid first lin treatment cyclic mastalgia num topic non steroid anti inflammatori gel diclofenac num pluron lethicin organogel consid pain control local treatment mastalgia num tamoxifen num mg daili danazol num mg daili consid first lin treatment ineffect num mastectomi partial mastectomi consid effect treatment mastalgia iii
MED-3801~effect low fat high carbohydr diet symptom cyclic mastopathi pubm ncbi abstract num patient sever persist cyclic mastopathi num year durat randomis control group receiv general dietari advic intervent group taught reduc fat content diet num calori increas complex carbohydr consumpt maintain calor intak group num month food record measur plasma hormon lipid level sever symptom record daili diari patient assess begin end studi physician unawar dietari regimen num month signific reduct intervent group sever premenstru breast tender swell physic examin show reduc breast swell tender nodular num num patient intervent group num num patient control group
MED-3802~fresh aromat herb methylchavicol exhibit pro oxid effect pure methylchavicol human hepatoma cell line hepg num pubm ncbi abstract methylchavicol ch num cv import aromat constitu plant tarragon basil shown carcinogen mechan unclear report carcinogen ch num cv rodent link metabol convers genotox electrophil metabolit generat step bioactiv pathway catalyz cytochrom num enzym sulfotransferas induct carcinogenesi agent generat oxid stress aim present studi determin pure methylchavicol appli human hepatoma cell line hepg num promot oxid stress alter express procarcinogen biomark drug metabol enzym cyp num induc form nitric oxid synthas ino induc express cu zn superoxid dismutas cu zn sod mn sod control redox equilibrium cell ch num cv shown signific induct oxid stress reveal luminol depend chemiluminesc ldcl alter dramat express cyp num ino mn sod indic toxic effect ch num cv mediat nitric oxid depend mechan similar experiment condit extract tarragon chervil basil induc biolog result provid evid generat oxid stress signific event occur ch num cv induc toxic suggest natur extract amount ch num cv tarragon chervil basil elicit toxic compound counteract detriment properti copyright num publish elsevi masson sas
MED-3806~toxicolog nutmeg abus pubm ncbi abstract background unpleas frighten side effect abus nutmeg occasion generat emerg depart referr report young patient first tim experi nutmeg review mechan toxic case report num year old femal ingest num nutmeg num hour period smoke share num joint marijuana facilit ingest nutmeg put num gelatin capsul bizarr behavior visual auditori tactil hallucin develop experienc nausea gag hot cold sensat blur vision numb doubl tripl vision headach drowsi nystagmus muscl weak ataxia present vital sign laboratori test normal receiv num activ charcoal complaint dizzi visual num day admiss unev central nervous system activ nutmeg postul result biotransform chemic compon amphetamine lik compound proven nutmeg compound structur similar substanc central nervous system neuromodulatori activ
MED-3807~artemisia dracunculus tarragon critic review tradit chemic composit pharmacolog safeti pubm ncbi abstract artemisia dracunculus tarragon long histori spice remedi well describ cultivar russian french wide differ ploidi level morpholog chemistri key biolog activ secondari metabolit essenti oil num num coumarin num flavonoid phenolcarbon acid vivo studi rodent russian sourc highlight potenti anti inflammatori hepatoprotect antihyperglycem effect concern toxic effect main constitu estragol num methyleugenol num acut toxic mutagen activ report dose relev human consumpt water extract dracunculus low amount estragol methyleugenol consid pose limit risk stronger focus clinic studi precis taxonom phytochem definit sourc materi essenti futur research effort
MED-3808~risk assess consumpt methylchavicol tarragon genotox potenti vivo vitro pubm ncbi abstract methylchavicol estragol natur flavour substanc present tarragon confirm genotox chemic vitro ud test cultur rat hepatocyt vivo ud test hepatocyt expos rat deep frozen tarragon genotox methylchavicol equival dose level desicc tarragon negat form tarragon test vitro abil decreas signific genotox methylchavicol ad cultur medium concentr num mum deep frozen num mum desicc tarragon decreas attribut antimutagen properti tarragon leav and or adsorpt methylchavicol decreas bioavail desicc tarragon powder genotox vivo ud test administ maximum dose num g kg bw num mg kg bw methylchavicol vivo desicc tarragon show antimutagen properti decreas genotox methylchavicol ad high concentr low exposur level maximum daili tarragon consumpt rapid detoxif excret human no genotoxic effect level methylchavicol oral rout rat tarragon leav high margin exposur exist conclud tarragon consumpt present genotox risk human copyright num elsevi reserv
MED-3809~toxicolog mutagen analysi artemisia dracunculus tarragon extract pubm ncbi abstract mutagen liver toxic herb tarragon artemisia dracunculus evalu singl cell gel comet electrophoresi ten microlitr aliquot peripher venous human blood incub tarragon extract salin mutagen sodium dichrom cell suspens dispers low melt agaros electrophores ethidium bromid result dna migrat trail obtain fluoresc microscopi num magnif grade mutagen index mi cell incub condit vivo liver toxic artemisia dracunculus assess blood mice treat oral extract herb alanin aminotransferas alt aspart aminotransferas ast liver function indic liver morpholog assess hematoxylin eosin stain liver tissu present studi demonstr direct correl tarragon extract dosag major outcom variabl mi serum liver enzym activ liver histopatholog outcom possibl due presenc tarragon methylchavicol genotox compound find provid preliminari guid risk assess tarragon diet therapeut applic copyright num elsevi reserv
MED-3810~christma gingerbread lebkuchen christma cheer  review potenti role mood elev amphetamine lik compound form vivo pubm ncbi abstract typic spice winter includ nutmeg cinnamon clove anis spice group chemic allylbenzen isom propenylbenzen suggest num year ago alexand shulgin substanc act metabol precursor amphetamin biotransform precursor nitrogen contain metabolit review reaction report human pharmacolog toxicolog spice nutmeg explain basi allylbenzen propenylbenzen content specul human expos amphetamin deriv precursor forno format bake cook prepar lebkuchen christma gingerbread respons part uplift mood winter role aromat substanc act simpli odour evok memori winter past spice true pharmacolog effect act aromatherapi remain elucid clinic laboratori studi
MED-3811~cinnamon intak lower fast blood glucos meta analysi pubm ncbi abstract cinnamon dri bark twig cinnamomum spp rich botan sourc polyphenol centuri chines medicin shown affect blood glucos insulin signal cinnamon effect blood glucos subject clinic anim studi issu cinnamon intake effect fast blood glucos fbg peopl type num diabet and or prediabet remain unclear meta analysi clinic studi effect cinnamon intak peopl type num diabet and or prediabet includ clinic trial trial previous meta analys assess cinnamon effect lower fbg clinic studi identifi literatur search pub med biosi num random placebo control trial report data cinnamon and or cinnamon extract fbg comprehens meta analysi biostat englewood nj usa perform identifi data cinnamon cinnamon extract intak random effect model determin standard differ chang num control chang num cinnamon divid pool sd post score cinnamon intak cinnamon cinnamon extract result statist signific lower fbg num num mmol l num num intak cinnamon extract lower fbg num mmol l num num num cinnamon extract and or cinnamon improv fbg peopl type num diabet prediabet
MED-3812~effect short term cinnamon ingest vivo glucos toler pubm ncbi abstract aim spice display insulin potenti activ vitro cinnamon spice phenol extract shown exhibit capabl vivo studi show cinnamon benefici effect glucos homeostasi aim studi investig phenomenon human method lean healthi male volunt age num num year bodi mass index num num kg m num underw oral glucos toler test ogtt supplement num placebo ogtt control num cinnamon ogtt cin num cinnamon num ogtt cin num pre randomized crossov design result cinnamon ingest reduc total plasma glucos respons auc oral glucos ingest num num ogtt cin num ogtt cin num pre num improv insulin sensit assess insulin sensit index measur base matsuda model ogtt cin num ogtt cin num pre num trial compar ogtt control conclus data illustr cinnamon spice supplement import vivo glycaem control insulin sensit human effect sustain num
MED-3813~glucos toler insulin sensit num week daili cinnamon ingest healthi human pubm ncbi abstract cinnamon improv fast glucos human data insulin sensit limit controversi male volunt age num num year bodi mass num num kg bmi num num kg num sem underw num day intervent involv cinnamon placebo supplement num day num placebo supplement continu num day num day period oral glucos toler test ogtt perform day num num num num cinnamon ingest reduc glucos respons ogtt day num num num day num num day num num num day num num cinnamon ingest reduc insulin respons ogtt day num num num day num num improv insulin sensit day num day num num effect lost cessat cinnamon feed cinnamon improv glycaem control insulin sensit effect quick revers
MED-3815~vegetarian diet improv insulin resist oxid stress marker convent diet subject type num diabet abstract aim aim studi compar effect calorie restrict vegetarian convent diabet diet combin exercis insulin resist viscer fat oxid stress marker subject type num diabet method num week random open parallel design seventy four patient type num diabet random assign experiment group num receiv vegetarian diet control group num receiv convent diabet diet diet isocalor calori restrict num kcal day meal studi provid num week diet combin aerob exercis particip examin baselin num week num week primari outcom insulin sensit measur hyperinsulinaem isoglycaem clamp volum viscer subcutan fat measur magnet reson imag oxid stress measur thiobarbitur acid reactiv substanc analys intent treat result forty thre cent particip experiment group num particip control group reduc diabet medic num bodi weight decreas experiment group control group num kg num ci num num num kg num ci num num interact group time num increas insulin sensit signific greater experiment group control group num ci num num num ci num num num reduct viscer subcutan fat greater experiment group control group num num plasma adiponectin increas num leptin decreas num experiment group chang control group vitamin superoxid dismutas reduc glutathion increas experiment group num num num differ group greater addit exercis train insulin sensit enzymat oxid stress marker correl viscer fat conclus calorie restrict vegetarian diet greater capac improv insulin sensit compar convent diabet diet num week greater loss viscer fat improv plasma concentr adipokin oxid stress marker diet respons reduct insulin resist addit exercis train augment improv outcom vegetarian diet
MED-3816~vitro vivo efficaci sulfo carrabios sugar bas cosmet ingredi anti cellulit properti pubm ncbi abstract adult women exhibit cellulit hip buttock thigh extracellular matrix lymphat system disord increas cellulit basic result excess fat storag adipos tissu exert pressur surround skin tissu creat dimpl irregular caffein wide anti cellulit ingredi favour fat break down inhibit phosphodiesteras enzym encourag high intracellular level camp seri studi shown spermin spermidin ubiquit polyamin encourag fat storag slow fat break down adipos tissu shown heparan sulfat glycosaminoglycan strong affin polyamin design cosmet ingredi anti cellulit properti molecular model screen ingredi structur similar heparan sulfat glycosaminoglycan identifi sulfo carrabios potent molecul trap spermin spermidin virtual result confirm tubo sulfo carrabios shown dose depend inactiv spermin spermidin vitro adipocyt cultur sulfo carrabios exhibit signific reduct lipogenesi signific increas lipolysi sulfo carrabios incorpor cosmet formula signific improv observ thigh circumfer result obtain caffein num day combin caffein sulfo carrabios led result signific obtain caffein measur fring project thigh volum signific reduc sulfo carrabios treatment final cellulit assess clinic evalu signific reduc num day num basf beauti care solut ic num societi cosmet scientist soci fran ais de cosm tologi
MED-3817~dietari polyamin intak risk colorect adenomat polyp abstract background putrescin spermidin spermin polyamin requir human cell growth inhibit ornithin decarboxylas odc rate limit enzym polyamin biosynthesi decreas tumor growth develop colorect adenoma databas develop estim dietari polyamin exposur relat exposur health outcom object hypothes high polyamin intak increas risk colorect adenoma allel variat odc g a num modifi associ design polyamin exposur estim subject pool num control arm num random trial colorect adenoma prevent wheat bran fiber low fib diet arm num ursodeoxychol acid placebo arm num baselin food frequ questionnair data subject diagnosi colorect adenoma elig trial result dietari intak polyamin median amount studi popul num increas risk colorect adenoma follow up adjust num num ci num num pool sampl addit younger particip num num ci num num women num num ci num num odc gg genotyp carrier num num ci num num signific increas odd colorect adenoma consum above median polyamin amount conclus studi show role dietari polyamin colorect adenoma risk corrobor find confirm previous unrecogn modifi dietari risk factor colorect adenoma
MED-3818~adiponectin express subcutan adipos tissu reduc women cellulit pubm ncbi abstract background cellulit orang peel typ cottag cheese lik dimpl skin thigh buttock complex multifactori cosmet disord subcutan fat layer superfici skin adiponectin adipocyte deriv hormon produc subcutan fat show import protect anti inflammatori vasodilatori effect hypothes adiponectin express subcutan adipos tissu sat play role pathogenesi cellulit reason reduct express adiponectin humor vasodil sat cellulit area contribut alter microcircul frequent found region method total num lean bodi mass index bmi num kg m num women cellulit num age bmi match women cellulit particip studi real tim revers transcript polymeras chain reaction rt pcr assess adiponectin gene express plasma adiponectin level measur commerci enzym immunoassay kit result adiponectin mrna express sat gluteal region signific lower area cellulit compar num num au versus num num au num plasma adiponectin level differ women num num g ml num num g ml cellulit num conclus adiponectin express signific reduc sat area affect cellulit find provid insight natur cellulit give clue treatment cosmet issu num intern societi dermatolog
MED-3819~postprandi plasma adiponectin decreas glucos high fat meal independ postprandi triacylglycerol pubm ncbi abstract adiponectin discuss regul energi balanc insulin sensit studi associ fast adiponectin paramet metabol syndrom investig postprandi adiponectin releas relat trait metabol syndrom serum adiponectin concentr oral glucos toler test ingest standardis mix fat contain meal num male non diabet subject assess fast postprandi adiponectin decreas adiponectin correl anthropometr metabol paramet subject genotyp adiponectin num g a promot singl nucleotid polymorph adiponectin slight decreas test meal signific decreas attain num num lipid load num glucos load mix meal postprandi adiponectin show stronger correl trait metabol syndrom fast adiponectin postprandi adiponectin hdl num fast adiponectin hdl num postprandi insulin area curv num num fast insulin num num bmi num num waist num num systol blood pressur num num diastol blood pressur num num multivari analysi postprandi tag independ predictor adiponectin signific associ adiponectin nefa tag num g a adiponectin promot polymorph find favour interpret postprandi adiponectin strongest independ associ postprandi tag metabol
MED-3820~meal modul circul interleukin num adiponectin concentr healthi subject patient type num diabet mellitus pubm ncbi abstract background singl high fat meal induc endotheli activ increas serum concentr inflammatori cytokin object compar effect num meal circul concentr interleukin num il num interleukin num il num adiponectin healthi subject patient type num diabet mellitus design thirti patient newli diagnos type num diabet num match nondiabet subject receiv num isoenerget num kcal meal separ num wk interv high fat meal high carbohydr low fib num meal high carbohydr high fib meal refined wheat flour replac whole wheat flour num analyz serum glucos lipid variabl serum il num il num adiponectin concentr baselin num num ingest meal result compar nondiabet subject diabet patient higher fast il num num il num num concentr lower adiponectin concentr num baselin nondiabet diabet subject il num concentr increas adiponectin concentr decreas num baselin concentr consumpt high fat meal consumpt high carbohydr high fib meal serum il num concentr decreas baselin concentr num nondiabet diabet subject adiponectin concentr decreas high carbohydr low fib meal diabet patient il num concentr chang signific consumpt num meal conclus studi evid circul il num adiponectin concentr modul familiar foodstuff human meal modul cytokin involv atherogenesi repres safe strategi amelior atherogenet inflammatori activ diabet patient
MED-3821~develop polyamin databas assess dietari intak abstract reduc concentr polyamin spermin spermidin putrescin bodi pool slow cancer process dietari spermin spermidin putrescin contribut bodi pool polyamin quantifi diet import limit inform polyamin content food diet unit state report describ develop polyamin databas link fred hutchinson cancer center food frequenc questionnair ffq valu spermin spermidin putrescin calcul report serv size nmol serv food databas evalu fresh frozen corn highest level putrescin num nmol serv num nmol serv spermidin num nmol serv num nmol serv green pea soup highest concentr spermin num nmol serv polyamin databas ffq test conveni sampl num averag daili polyamin intak sampl num nmol day putrescin num nmol day spermidin num nmol day spermin orang grapefruit juic contribut greatest amount putrescin num nmol day diet green pea contribut greatest amount spermidin num nmol day ground meat contribut greatest amount spermin num nmol day develop databas link ffq estim polyamin intak contribut investig relat polyamin cancer
MED-3822~cellulit natur aetiopathogenesi pubm ncbi abstract limit number studi cellulit publish intern literatur reach antithet conclus reconcil extrem differ opinion linger year natur disord origin basic aspect histopatholog classif recogn fact term cellul scientif english spread gangren infect subcutan cellular tissu term time time pannicul lipodystrophi edematofibrosclerot pannicul efp liposclerosi lipoedema morpholog pathogenet connot general decad major conflict theori emerg relat ethiopathogenesi cellulit num oedema caus excess hydrophilia intercellular matrix num homeostat alter region microcirculatori level pathogenet theori summar synthet self explanatori denomin efp num peculiar anatom conform subcutan tissu women male morpholog theori updat light recent advanc sophist composit physiopatholog adipos organ act control devic regul systemat equilibrium energi modul food intak metabol tissu substrat multipl glandular secret hormon parahormon
MED-3830~dietari lignan intak relat surviv women breast cancer western york exposur breast cancer web studi abstract dietari lignan intak reduc breast cancer risk previous studi investig lignan intak breast cancer surviv examin associ dietari lignan intak surviv num women primari incid histolog confirm breast cancer identifi num num vital status determin decemb num diet num num month diagnosi assess extens food frequenc questionnair potenti confound assess extens epidemiolog interview abstract clinic data lignan intak calcul publish food composit data hazard ratio hr num confid interv cis dietari lignan intak breast cancer mortal estim cox proport hazard adjust age educ race total energi intak tumor stage bodi mass index num women complet dietari data num die end follow up postmenopaus women highest versus lowest quartil lignan intak statist signific reduct risk mortal hr num num ci num num signific reduc risk breast cancer mortal hr num num ci num num higher intak dri bean hr num num ci num num fruit veget grain weak mortal summari result suggest higher lignan intak improv surviv postmenopaus women breast cancer
MED-3832~phytoestrogen reduc risk breast cancer breast cancer recurr clinician pubm ncbi abstract oestrogen import determin breast cancer risk oestrogen mimick plant compound call phytoestrogen bind oestrogen receptor exert weak oestrogen effect activ epidemiolog studi suggest incid breast cancer lower countri intak phytoestrogen high impli compound reduc breast cancer risk possibl impact surviv isoflavon lignan common phytoestrogen diet articl present find human observ intervent studi relat isoflavon lignan exposur breast cancer risk surviv addit clinic implic find examin light grow dietari supplement market increas number breast cancer patient seek supplement standard treatment hope prevent recurr treat menopaus symptom observ studi suggest protect effect isoflavon breast cancer risk case similar increas lignan consumpt evid inconsist contrast short term intervent studi suggest stimulatori effect breast tissu rais concern advers effect breast cancer patient owe dearth human studi investig effect breast cancer recurr surviv role phytoestrogen remain unclear clear evid exist base guidelin clinic rais patient awar uncertain effect phytoestrogen recommend
MED-3833~reduct ki num benign breast tissu high risk women lignan secoisolariciresinol diglycosid sdg abstract preclin correl studi suggest reduc breast cancer higher lignan intak blood level conduct pilot studi modul risk biomark breast cancer premenopaus women administr plant lignan secoisolariciresinol diglycosid sdg elig criteria includ regular menstrual cycl oral contracept greater num fold increas num year risk baselin ki num num area hyperplasia breast tissu sampl random periareolar fine needl aspir rpfna follicular phase menstrual cycl sdg num mg daili num month repeat rpfna primari endpoint chang ki num secondari endpoint includ chang cytomorpholog mammograph breast densiti serum bioavail estradiol testosteron igf i igfbp num plasma lignan level forty f num elig women complet studi excel complianc median num side effect num grade num median plasma enterolacton increas num fold total lignan num fold thirty six num num evalu subject demonstr decreas ki num median num rang num num num rang num num num wilcoxon sign rank test decreas baselin proport women atyp cytolog num observ base favor risk biomark modul lack advers event initi random trial sdg placebo premenopaus women
MED-3834~dietari lignan intak relat surviv women breast cancer western york exposur breast cancer web studi abstract dietari lignan intak reduc breast cancer risk previous studi investig lignan intak breast cancer surviv examin associ dietari lignan intak surviv num women primari incid histolog confirm breast cancer identifi num num vital status determin decemb num diet num num month diagnosi assess extens food frequenc questionnair potenti confound assess extens epidemiolog interview abstract clinic data lignan intak calcul publish food composit data hazard ratio hr num confid interv cis dietari lignan intak breast cancer mortal estim cox proport hazard adjust age educ race total energi intak tumor stage bodi mass index num women complet dietari data num die end follow up postmenopaus women highest versus lowest quartil lignan intak statist signific reduct risk mortal hr num num ci num num signific reduc risk breast cancer mortal hr num num ci num num higher intak dri bean hr num num ci num num fruit veget grain weak mortal summari result suggest higher lignan intak improv surviv postmenopaus women breast cancer
MED-3836~dietari flaxse alter tumor biolog marker postmenopaus breast cancer pubm ncbi abstract purpos flaxse richest sourc mammalian lignan precursor previous shown reduc growth tumor rat studi examin random double blind placebo control clinic trial effect dietari flaxse tumor biolog marker urinari lignan excret postmenopaus patient newli diagnos breast cancer experiment design patient random daili intak num flaxseed contain muffin num control placebo muffin num time diagnosi definit surgeri tumor tissu analyz rate tumor cell prolifer ki num label index primari end point apoptosi c erbb num express estrogen progesteron receptor level twenty four hour urin sampl analyz lignan num day diet record evalu macronutri calor intak treatment time num num day placebo flaxse group result reduct ki num label index num num c erbb num express num num increas apoptosi num num observ flaxse placebo group signific differ calor macronutri intak group pre posttreat period signific increas urinari lignan excret observ flaxse group num num compar placebo control total intak flaxse correl c erbb num score num num apoptot index num num conclus dietari flaxse potenti reduc tumor growth patient breast cancer
MED-3840~tamoxifen flaxse alter angiogenesi regul normal human breast tissu vivo abstract incid breast cancer increas western world urgent studi mechan sex steroid order develop prevent strategi diet modif breast cancer prevent angiogenesi key tumor progress regul balanc pro anti angiogen factor control extracellular space sampl molecul bioactiv compart aim studi explor tamoxifen anti estrogen treatment breast cancer affect import endogen angiogenesi regul vascular endotheli growth factor vegf angiogenin endostatin normal breast tissu vivo diet supplement flaxse similar effect tamoxifen breast microdialysi situ sampl extracellular protein normal breast tissu women week tamoxifen treatment addit num g day ground flaxse diet control women show signific correl estradiol level vegf angiogenin endostatin vivo verifi vivo breast tissu cultur tamoxifen decreas level vegf angiogenin breast endostatin increas signific flaxse alter vegf angiogenin level similar tamoxifen level endostatin increas signific conclud mechan tamoxifen normal breast tissu includ tip angiogen balanc anti angiogen state flaxse limit effect pro angiogen factor anti angiogen endostatin modifi diet studi diet modif breast cancer prevent warrant
MED-3841~reduct ki num benign breast tissu high risk women lignan secoisolariciresinol diglycosid sdg abstract preclin correl studi suggest reduc breast cancer higher lignan intak blood level conduct pilot studi modul risk biomark breast cancer premenopaus women administr plant lignan secoisolariciresinol diglycosid sdg elig criteria includ regular menstrual cycl oral contracept greater num fold increas num year risk baselin ki num num area hyperplasia breast tissu sampl random periareolar fine needl aspir rpfna follicular phase menstrual cycl sdg num mg daili num month repeat rpfna primari endpoint chang ki num secondari endpoint includ chang cytomorpholog mammograph breast densiti serum bioavail estradiol testosteron igf i igfbp num plasma lignan level forty f num elig women complet studi excel complianc median num side effect num grade num median plasma enterolacton increas num fold total lignan num fold thirty six num num evalu subject demonstr decreas ki num median num rang num num num rang num num num wilcoxon sign rank test decreas baselin proport women atyp cytolog num observ base favor risk biomark modul lack advers event initi random trial sdg placebo premenopaus women
MED-3842~sesam seed rich sourc mammalian lignan precursor flaxse pubm ncbi abstract mammalian lignan enterolacton enterodiol produc microflora colon human anim precursor food suggest potenti anticanc effect studi determin product mammalian lignan precursor food bar num unground flaxse fb sesam seed sb combin fsb num random crossov studi healthi postmenopaus women supplement diet bar num wk separ num wk washout period urinari mammalian lignan excret measur baselin num wk marker mammalian lignan product result show increas treatment num num mumol day num differ treatment lignan excret flaxse similar result studi ground flaxse unidentifi lignan metabolit detect consumpt sb fsb fb demonstr time num precursor unground flaxse sesam seed convert bacteri flora colon mammalian lignan num sesam seed combin flaxse produc mammalian lignan equival obtain flaxse
MED-3843~antiprolif activ lignan breast carcinoma cell line mcf num bt num pubm ncbi abstract purpos phytoestrogen plant deriv non steroid phytochem anticarcinogen potenti major structur class isoflavon lignan aim studi compar effect plant deriv lignan secoisolariciresinol matairesinol human lignan enterodiol enterolacton num estradiol tamoxifen cell prolifer breast carcinoma cell line method influenc lignan num estradiol tamoxifen cell prolifer determin brdu test mcf num bt num cell line result enterodiol enterolacton induc stronger inhibit cell growth mcf num bt num cell secoisolariciresinol matairesinol inhibit effect express bt num mcf num cell conclus human lignan enterodiol enterolacton biolog activ precursor secoisolariciresinol matairesinol defin real drug cancer prevent
MED-3844~antibacteri treatment urinari tract infect contribut risk breast cancer abstract low lignan status report relat elev risk breast cancer lignan status reduc antibacteri medic plausibl hypothes repeat antibiot risk factor breast cancer histori treatment urinari tract infect studi predict breast cancer num finnish women num num year age initi cancer fre follow up num num total num breast cancer case diagnos women report previous present medic urinari tract infect baselin show elev breast cancer risk comparison women age adjust relat risk num num confid interv ci num num associ concentr women num year age relat risk women num num ci num num num num ci num num older women relat risk younger age group num num ci num num num year follow up num num ci num num follow up time longer num year data suggest premenopaus women long term medic urinari tract infect show elev risk futur breast cancer result inconclus hypothesi test studi num cancer researchcampaign
MED-3845~serum enterolacton level mortal outcom women earli breast cancer retrospect cohort studi pubm ncbi abstract previous demonstr high serum enterolacton level reduc incid breast cancer healthi women present studi aim investig similar associ found serum enterolacton level mortal women earli breast cancer level enterolacton cryopreserv serum aliquot obtain num patient oper breast cancer measur time resolv fluoro immunoassay level analyz respect risk mortal surgeri cox proport hazard regress model check prognost featur estim hazard ratio group comparison test interact mortal hazard variabl enterolacton concentr fine gray compet risk proport hazard regress model predict probabl breast cancer rel breast cancer unrel mortal median follow up time num year rang num num num patient die num die due breast cancer rel event associ decreas mortal risk enterolacton level num nmol l found respect all caus breast cancer specif mortal differ mortal hazard statist signific decreas lose signific num year compet risk analysi show breast cancer rel mortal risk remain constant lower patient higher enterolacton level find consist recent literatur provid evid mammalian lignan play import role reduc all caus cancer specif mortal patient oper breast cancer
MED-3846~high perform liquid chromatograph analysi secoisolariciresinol diglucosid hydroxycinnam acid glucosid flaxse alkalin pubm ncbi abstract hplc method develop analysi secoisolariciresinol diglucosid sdg hydroxycinnam acid glucosid mill defat flaxse flour direct extract num naoh num num degre result higher yield obtain hydrolysi alcohol extract intern standard o coumar acid method found easi fast good repeat dri matter basi sampl flaxse vari content sdg num num mg g sdg num num mg g p coumar acid glucosid num num mg g ferul acid glucosid num num mg g
MED-3847~lignan man anim speci pubm ncbi abstract laboratori year phenol compound detect gas chromatographic mass spectrometr analysi urinari steroid extract human anim speci featur mass spectra trimethylsilyl tms ether deriv resembl oestrogen atyp steroid possibl artefact isol procedur discount care studi blank vari extract method present exclus conjug glucuron acid general characterist unknown compound report refer compound num found cyclic pattern excret menstrual cycl adult vervet monkey fig num investig natur distribut compound shown urinari constitu human baboon vervet monkey rat relat compound detect vervet monkey urin report spectroscop chemic studi show origin compound lignan num dibenzylbutan skeleton basic structur unlik previous natur lignan invari plant origin mammalian compound carri phenol hydroxi group meta posit aromat ring
MED-3848~meta analys lignan enterolignan relat breast cancer risk pubm ncbi abstract background epidemiolog studi examin lignan import class phytoestrogen western diet protect breast cancer yield inconsist result object studi conduct meta analys associ lignan breast cancer risk design perform systemat medlin search identifi epidemiolog studi publish num august num calcul pool risk estim res total lignan exposur dietari lignan intak enterolignan exposur blood urin concentr enterolacton menopaus estrogen receptor er status tumor result includ num studi num prospect cohort studi num case control studi meta analys lignan exposur breast cancer risk num num ci num num heterogen num postmenopaus women high lignan intak signific reduc risk breast cancer num studi num num ci num num heterogen num breast cancer risk invers enterolignan exposur num studi num num ci num num blood urin enterolacton concentr associ signific er status subgroup num studi conclus high lignan exposur reduc breast cancer risk postmenopaus women addit work warrant clarifi associ lignan exposur breast cancer risk
MED-3849~role dietari lignan reduct breast cancer risk pubm ncbi abstract lignan larg group fiber associ phenol compound wide distribut edibl plant ingest plant lignan convert intestin microbiota enterolignan enterodiol end enterolacton enl thought major biolog activ lignan suggest low risk breast cancer line administr plant lignan metabol enl enl shown inhibit delay growth experiment mammari cancer mechan anticarcinogen action enl fulli understood intrigu evid enl modul estrogen signal find generat interest lignan compon breast cancer risk reduc function food identif target group benefit pivot import identif valid relev biomark indic lignan enl action breast cancer risk reduct stage diseas import
MED-3850~excret isol structur phenol constitu femal urin pubm ncbi abstract regular occurr peak due unidentifi substanc gas chromatograph trace obtain phenol extract urin human pregnant non pregn femal report biphas excret maxima luteal phase ovulatori cycl high level trimest pregnanc noteworthi suggest substanc biolog signific close similar excretori pattern chemic chromatograph properti phenol steroid suggest initi compound steroid natur similar substanc excret vervet monkey cercopithecus aethiop pygerythrus report excretori pattern detail isol pure compound pool pregnanc urin chemic structur structur determin mass spectrometri ir spectroscopi nmr spectrometri tran num bis num hydroxyphenyl methyl dihydro num num furanon hpmf confirm synthesi
MED-3852~determin urinari lignan phytoestrogen metabolit potenti antiestrogen anticarcinogen urin women habitu pubm ncbi abstract recent group compound diphenol structur lignan isoflavon phytoestrogen detect identifi human urin biolog fluid compound great biolog interest exhibit vitro vivo weak estrogen antiestrogen activ plant lignan shown anticarcinogen antivir antifung interest biolog effect compound found larg amount num time estrogen urin modifi intestin bacteria plant lignan phytoestrogen present fiber rich food grain bean bind low affin estrogen receptor preliminari result suggest induc product sex hormon bind globulin shbg liver influenc sex hormon metabol biolog effect compound lignan enterolacton enl enterodiol end isoflavon phytoestrogen metabolit daidzein da equol eq o desmethylangolensin o dma measur urin gas chromatography mass spectrometri select ion monitor deuter intern standard num group women total number num member dietari group omnivor lactovegetarian macrobiot live boston group helsinki omnivor lactovegetarian measur carri num sampl highest excret abund compound enterolacton found macrobiot group lowest omnivor group total num excret enterolacton num nmol macrobiot num nmol boston lactovegetarian num nmol helsinki lactovegetarian num nmol helsinki omnivor num nmol boston omnivor diphenol approxim pattern earlier studi lowest excret enterolacton num nmol num found group postmenopaus appar healthi breast cancer patient live boston conclud studi elucid role compound cancer diseas evid obtain justifi conclus compound dietari factor afford protect hormone depend cancer vegetarian semivegetarian
MED-3853~serum enterolacton prognosi postmenopaus breast cancer pubm ncbi abstract purpos lignans  plant deriv compound estrogen depend independ anticarcinogen properties  hav postmenopaus breast cancer risk data limit effect surviv dietari lignan metabol enterolignan subsequ absorb bioavail patient method assess prognosi num postmenopaus patient breast cancer age num num year diagnos num num vital status end num ascertain local popul registri death verifi death certif inform recurr secondari tumor verifi clinic record attend physician associ postdiagnost serum enterolacton biomark dietari lignan surviv distant disease fre surviv assess cox proport hazard model stratifi age diagnosi adjust prognost factor result median enterolacton level deceas patient aliv num num nmol l median num year follow up diagnosi num death confirm higher serum enterolacton level signific reduc hazard ratio hrs death hr num nmol l increment num num hr highest quartil num num ci num num distant diseas hr num num nmol l increment num num num ci num num highest quartil highest quartil serum enterolacton signific reduc risk death estrogen receptor neg tumor hr num num ci num num estrogen receptor posit tumor hr num num ci num num heterogen num conclus postmenopaus patient breast cancer high serum enterolacton level surviv
MED-3854~phytoestrogen consumpt associ breast prostat colorect cancer epic norfolk pubm ncbi abstract phytoestrogen polyphenol secondari plant metabolit structur function similar num eta oestradiol protect effect hormone rel cancer food uk small amount phytoestrogen median content num microg num highest content found soya soya contain food highest phytoestrogen content common consum food found bread averag content num microg num main sourc isoflavon uk diet phytoestrogen consumpt case control lower asian countri signific associ phytoestrogen intak breast cancer risk nest case control studi epic norfolk found convers colorect cancer risk invers enterolignan intak women men prostat cancer risk posit enterolignan intak associ non signific adjust dairi intak suggest enterolignan act surrog marker dairi calcium intak num elsevi reserv
MED-3855~estim enterolignan lignan rich food fibr relat surviv postmenopaus breast cancer abstract background lignan oestrogen substanc present food postmenopaus breast cancer risk effect surviv method follow up studi num postmenopaus breast cancer patient diagnos num num vital status death verifi end num hazard ratio hrs num confid interv cis estim enterolignan lignan rich food dietari fibr relat surviv os breast cancer specif surviv bcss assess cox proport hazard model stratifi age diagnosi adjust prognostic confound factor result median follow up time num year num women die num breast cancer high estim enterolacton enterodiol level signific lower mortal highest quintil hr num num ci num num ptrend num hr num num ci num num ptrend num fibr intak signific lower mortal differenti median fibr intak associ estim enterolignan evid low high fibr intak effect modif oestrogen receptor status menopaus hormon therapi conclus postmenopaus breast cancer patient high estim enterolignan surviv
MED-3856~hypothesi antibiot breast cancer pubm ncbi abstract hypothesi antibiot increas cancer risk propos decad ago research suggest increas risk breast cancer women condit requir long term antibiot acn recurr urinary tract infect uti hypothesi verifi biolog mechan clear recent cohort studi finland report increas risk breast canc antibiot uti effect antibiot abil intestin microflora metabolis phytochem edibl plant compound protect cancer propos potenti mechan extend hypothesi propos antibiot breast canc risk effect immun inflammatori factor cytokin lymphocyt prostaglandin matrix metalloproteinas disrupt phytochem oestrogen metabol intestin microflora suggest mechan increas breast canc risk decreas risk depend antibiot classif
MED-3857~enterolacton breast cancer methodolog issu contribut conflict result observ studi pubm ncbi abstract lignan found plant food convert intestin microflora enterolignan structur enterolignan similar estrogen inspir research examin potenti protect associ relat health outcom numer epidemiolog studi measur concentr enterolignan enterolacton blood urin biomark lignan exposur studi relat breast cancer risk case control studi shown decreas breast cancer risk high circul enterolacton concentr result demonstr prospect cohort studi clear purpos review discuss factor contribut contradictori find obtain epidemiolog studi includ age distribut enterolacton measur error heterogen breast cancer subtyp genet factor sourc enterolacton precursor contribut inconclus result conclus robust evid health effect lignan enterolacton effort put methodolog problem includ reduc measur error enterolacton estim identifi factor modifi effect copyright num elsevi reserv
MED-3858~dietari fiber intak risk breast cancer meta analysi prospect cohort studi pubm ncbi abstract background observ preclin studi suggest dietari fiber intak reduc risk breast cancer result inconclus object aim examin associ dietari fiber intak risk breast cancer conduct meta analysi prospect cohort studi design relev studi identifi pubm databas search januari num refer list retriev articl review includ prospect cohort studi report rrs num cis associ dietari fiber intak breast cancer risk fix random effect model calcul summari risk estim result identifi num prospect cohort studi dietari fiber intak risk breast cancer involv num case num particip combin rr breast cancer highest compar lowest dietari fiber intak num num ci num num evid heterogen observ associ dietari fiber intak risk breast cancer signific differ geograph region length follow up menopaus status particip omiss singl studi effect combin risk estim dose respons analysi show num g d increment dietari fiber intak signific num reduct breast cancer risk evid public bias found conclus meta analysi evid signific invers dose respons associ dietari fiber intak breast cancer risk
MED-3860~dietari fiber intak risk breast cancer menopaus estrogen receptor status abstract purpos evalu hypothesi relat breast cancer dietari fiber intak vari type fiber menopaus tumor hormon receptor status method case control studi femal breast cancer conduct connecticut total num incid breast cancer case num age frequency match control includ analysi inform dietari intak collect in person interview semi quantit food frequenc questionnair convert nutrient intak odd ratio num confid interv estim uncondit logist regress result pre menopaus women higher intak solubl fiber highest versus lowest quartil intak signific reduc risk breast cancer num num ci num num ptrend num restrict pre menopaus women er tumor adjust highest quartil intak num num ci num num ptrend num solubl fiber intak post menopaus women reduc risk breast cancer observ solubl insolubl fiber intak er er tumor group conclus result studi show dietari solubl fiber intak signific reduc risk er breast cancer pre menopaus women addit studi larger sampl size confirm result
MED-3862~dietari factor risk breast cancer combin analysi num case control studi pubm ncbi abstract conduct combin analysi origin data evalu consist num case control studi diet breast cancer analysi show consist statist signific posit associ breast cancer risk satur fat intak postmenopaus women relat risk highest lowest quintil num num consist protect effect number marker fruit veget intak demonstr vitamin intak consist statist signific invers associ breast cancer risk relat risk highest lowest quintil num num dietari associ repres causal attribut risk percentag breast cancer prevent dietari modif north american popul estim num postmenopaus women num premenopaus women
MED-3863~sensit skin close physiolog pubm ncbi abstract phenomenon sensit skin recent complaint individu report intens frequent advers sensori effect normal popul cosmet personal car product origin defin minor complaint sensit skin claim major women industri countri half men sensit skin self diagnos typic unaccompani obvious physic sign irrit number individu claim sensit risen steadili number consum product target suppos uncommon group believ dermatologist princess pea phenomenon problem sensit skin larg avoid focuss research year evid document biophys larg sensori symptom disord accumul includ gain improv method identifi subclin sign skin irrit understand aetiolog phenomenon incomplet exist research support biophys origin disord effect method diagnosi intrins extrins contributor exagger neural sensit specif mechan discomfort compliant requir prevent treatment
MED-3864~supplement flaxse oil diminish skin sensit improv skin barrier function condit pubm ncbi abstract background skin sensit common problem western popul correl skin properti skin barrier function hydrat skin physiolog skin properti modul dietari fatti acid fa poly unsatur fa present studi perform evalu effect daili supplement flaxse oil safflowerse oil healthi volunt sensit skin method studi design random double blind num week intervent num femal treatment group num plasma fa profil skin sensit skin hydrat transepiderm water loss tewl skin surfac evalu day num week num week num result supplement flaxse oil led signific decreas sensit nicotin irrit tewl skin rough scale smooth hydrat increas concomit ratio num num fa plasma decreas supplement safflowerse oil signific improv skin rough hydrat observ effect pronounc determin point time flaxse oil plasma num num fa ratio increas conclus data provid evid daili intak flaxse oil modul skin condit copyright num karger ag basel
MED-3865~sensit skin american popul preval clinic data role dermatologist pubm ncbi abstract introduct sensit skin complex dermatolog condit defin abnorm sensori symptom aim epidemiolog survey assess preval sensit skin collect data sensit skin popul method phone survey conduct usa poll institut num sampl drawn repres nation cohort american popul num ear age quota method data demograph characterist environment climat factor skin characterist dermatolog disord cosmet visit dermatologist collect result num subject answer num men num women num declar sensit sensit skin women concern men num num num signific differ relat geograph local age ethnic distribut subject sensit skin dri num mix skin num fair phototyp dermatolog disord higher skin reactiv cosmet environment factor comparison subject state slight sensit sensit skin dermatologist strong influenc subject sensit sensit skin prescript skin care product conclus studi base repres sampl american popul reveal high preval sensit skin usa sensit skin dri skin fair phototyp reactiv climat environment factor cosmet american dermatologist larg involv care condit num intern societi dermatolog
MED-3866~flaxse supplement improv insulin resist obes glucos intoler peopl random crossov design abstract background obes lead increas inflamm insulin resist studi determin antioxid activ flaxse role inflamm insulin resist obes glucos intoler peopl method random crossov design obes glucos intoler peopl consum num ground flaxse num wheat bran daili num week num week washout period plasma inflamm biomark crp tnf il num glucos insulin thiobaribitur acid reactiv substanc tbar measur supplement result flaxse supplement decreas tbar num homa ir num flaxse wheat bran supplement chang plasma inflammatori biomark posit relationship found tbar homa ir num num conclus result studi weak support decreas insulin resist secondari antioxid activ flaxse mechan decreas insulin resist flaxse determin flaxse lignan
MED-3867~high alpha linolen acid flaxse linum usitatissimum nutrit properti human pubm ncbi abstract high alpha linolen acid flaxse linum usitatissimum richest dietari sourc alpha linolen acid good sourc solubl fibr mucilag unstudi human nutrit healthi femal volunt consum num ground raw flaxseed d num week provid num energi intak num num total fat flaxse rais alpha linolen acid long chain num fatti acid plasma erythrocyt lipid rais urinari thiocyan excret num fold flaxse lower serum total cholesterol num low density lipoprotein cholesterol num plasma alpha linolen acid equival num alpha linolen acid d provid raw flaxse flour num g d flaxse oil num g d suggest high bioavail alpha linolen acid ground flaxse test meal num carbohydr flaxse num flaxse mucilag signific decreas postprandi blood glucos respons num malondialdehyd level muffin num flaxse oil flour kg similar wheat flour muffin cyanogen glycosid linamarin linustatin neolinustatin highest extract flaxse mucilag detect bake muffin num flaxseed kg conclud num high alpha linolen acid flaxseed d palat safe nutrit benefici human rais num fatti acid plasma erythrocyt decreas postprandi glucos respons
MED-3868~dietari mill flaxse flaxse oil improv num fatti acid status affect glycem control individu well control type pubm ncbi abstract object determin effect dietari consumpt mill flaxse flaxse oil glycem control num fatti acid status anthropometr adipokin individu type num diabet design thirty four particip random parallel control trial subject particip adult type num diabet age num num year bodi mass index num num kg m num num men num women intervent particip consum select bakeri product flax control group ctl num mill flaxse fxs num g d flaxse oil fxo num g d daili num week fxs fxo group receiv equival amount alpha linolen acid ala num g day measur outcom primari outcom measur fast plasma hemoglobin num glucos insulin phospholipid fatti acid composit secondari outcom measur fast circul leptin adiponectin bodi weight bodi mass index waist circumfer dietari intak assess calcul homeostasi model assess insulin resist quantifi insulin sensit check complet result fxs fxo group increas plasma phospholipid num fatti acid ala eicosapentaeno acid epa decosapentaeno acid dpa docosahexaeno acid fxo group epa dpa plasma phospholipid compar fxs group group similar calor intak ctl group experienc num weight gain compar baselin num flax group constant bodi weight studi period paramet includ glycem control unchang dietari treatment conclus mill fxs fxo intak affect glycem control adult well control type num diabet prevent weight gain flax consumpt warrant investig
MED-3869~open label studi effect flax seed powder linum usitatissimum supplement manag diabet mellitus pubm ncbi abstract diabet mellitus character hyperglycemia aberr metabol carbohydr protein lipid result develop secondari complic extens studi nutrit therapi play pivot role control postpon develop secondari complic function food shown possess hypoglycem hypolipidem properti flax seed fs function food rich omega num fatti acid antioxid low carbohydr exploratori studi fs incorpor recip result reduct glycem index food item observ prompt investig efficaci fs supplement type num diabet num subject assign experiment num control group num basi desir particip studi experiment group diet supplement daili num fs powder period num month control group receiv supplement placebo studi diet drug intak subject remain unalt efficaci supplement fs evalu batteri clinico biochem paramet supplement fs reduc fast blood glucos num glycat hemoglobin num favor reduct total cholesterol num triglycerid num low dens lipoprotein cholesterol num apolipoprotein increas high dens lipoprotein cholesterol num notic observ suggest therapeut potenti fs manag diabet mellitus
MED-3874~flaxse supplement dietari fat restrict reduc prostat cancer prolifer rate men presurgeri abstract background prostat cancer affect one out of six men lifetim dietari factor postul influenc develop progress prostat cancer low fat diet flaxse supplement offer potenti protect strategi method undertook multi sit random control trial test effect low fat and or flaxseed suppl diet biolog prostat biomark prostat cancer patient num schedul num day prostatectomi random assign arm num control usual diet num flaxseed suppl diet num g day num low fat diet num total energi num flaxseed suppl low fat diet blood drawn baselin prior surgeri analyz prostat specif antigen psa sex hormon bind globulin testosteron insulin lik growth factor num bind protein num c reactiv protein total low densiti lipoprotein cholesterol tumor assess prolifer ki num primari endpoint apoptosi result men protocol averag num day prolifer rate signific lower num men assign flaxse arm median ki num posit cells tot nuclei ratio num num flaxseed suppl diet num flaxseed suppl low fat diet num control num low fat diet differ observ arm regard side effect apoptosi serolog endpoint men low fat diet experienc signific decreas serum cholesterol num conclus find suggest flaxse safe biolog alter protect prostat cancer data support low fat diet manag serum cholesterol
MED-3875~effect mammalian lignan growth prostat cancer cell line pubm ncbi abstract background mammalian lignan enterolacton el enterodiol ed shown inhibit breast colon carcinoma date report effect lignan prostat carcinoma investig effect ed el human prostat cancer cell line pc num du num lncap materi method cell treat num v v dmso vehicl num microm el ed genistein posit control num hour cell viabil measur propidium iodid nuclei stain fluorometr assay assay perform triplic result num microm el signific inhibit growth cell line ed inhibit pc num lncap cell el potent growth inhibitor ed potent genistein dose num growth inhibit lncap cell ic num el num microm ic num num microm ed observ ic num genistein num microm conclus ed el suppress growth prostat cancer cell hormonally depend independ mechan
MED-3876~lignan isoflavonoid plasma prostat fluid men sampl portug hong kong unit kingdom pubm ncbi abstract background chines men lower incid prostat cancer compar men europ north america asian consum larg quantiti soya rich sourc isoflavanoid phyto oestrogen high plasma urinari level compound mammalian lignan enterolacton enterodiol group weak plant oestrogen deriv seed cereal grain vegetarian high plasma urinari concentr lignan method concentr lignan isoflavon phyto oestrogen determin gas chromatography mass spectrometri gc ms plasma prostat fluid portugues chines british men consum tradit diet result prostat fluid concentr enterolacton num num ng ml hong kong portug britain high level enterolacton num ng ml observ prostat fluid men portug high concentr equol num ng ml daidzein num ng ml found sampl prostat fluid hong kong higher level daidzein observ prostat fluid hong kong num ng ml compar num num ng ml sampl portug britain level daidzein higher plasma sampl hong kong num ng ml compar portug num ng ml britain num ng ml general plasma concentr enterolacton centr similar num num num ng ml sampl hong kong portug britain conclus higher concentr isoflavanoid phyto oestrogen daidzein equol found plasma prostat fluid men hong kong compar britain portug level lignan enterolacton higher prostat fluid portugues men isoflavanoid lignan interest properti part respons lower incid prostat cancer men asia mediterranean countri isoflavanoid soya present high concentr prostat fluid asian men protect prostat diseas
MED-3877~pilot studi explor effect low fat flaxseed suppl diet prolifer benign prostat epithelium prostate specif antigen pubm ncbi abstract object dietari factor influenc prostat impact prostat growth diseas small number studi suggest flaxseed suppl fat restrict diet thwart prostat cancer growth anim human unknown potenti effect diet benign prostat epithelium method undertook pilot studi explor flaxseed suppl fat restrict diet affect prolifer rate benign epithelium explor effect circul level prostate specif antigen psa total testosteron cholesterol fifteen men schedul undergo repeat prostat biopsi instruct follow low fat num kcal flaxseed suppl num g day diet provid suppli flaxse num month intervent period psa total testosteron cholesterol level determin baselin num month follow up report origin repeat biopsi compar prolifer mib num rate quantifi benign prostat epithelium result statist signific decreas psa num num num num ng ml num cholesterol num num num num mg dl num observ statist signific chang total testosteron num num num num ng dl num month repeat biopsi perform num case psa normal num men underw repeat biopsi prolifer rate benign epithelium decreas signific num num baselin num num num month follow up num conclus pilot data suggest flaxseed suppl fat restrict diet affect biolog prostat biomark random control trial determin flaxse supplement low fat diet combin regimen control prostat growth
MED-3878~effect low fat diet plasma level nf b regul inflammatori cytokin angiogen factor men prostat cancer abstract diet nutrit status dietari supplement postul influenc develop progress prostat cancer angiogenesi inflamm central tumor growth progress effect diet process remain uncertain explor num plasma cytokin angiogen factor caf num men prostat cancer enrol pre op random control phase ii trial arm control usual diet low fat lf diet flaxseed suppl fs diet flaxseed suppl low fat diet durat dietari intervent num num day individu arm largest number signific baselin pre op follow up observ lf arm num caf decreas increas num compar control arm num caf includ pro angiogen factor stromal cel deriv num myeloid factor granulocyte colony stimul factor macrophag colony stimul factor decreas lf arm compar control num num caf chang fs fs lf arm weight loss occur lf arm signific correl vegf decreas num caf chang lf arm regul nuclear factor kappa nf pathway analysi identifi nf regulatori network lf arm fs contain arm result suggest low fat diet flaxse reduc level specif inflammatori cytokin angiogen factor suggest nf pathway mediat
MED-3880~estim public health implement hazard analysi critic control point unit state broiler slaughter pubm ncbi abstract common approach reduc microbi contamin implement hazard analysi critic control point haccp program prevent reduc contamin product pathogen reduct haccp program implement depart agriculture food safeti inspect servic fsis program consist stage implement num num reduc microbi contamin meat poultri product commod regul fsis largest observ reduct salmonella contamin broiler chicken carcass reduct influenc total number salmonellosi case unit state assess studi incorpor inform public health surveil survey poultri slaughter industri model estim number broiler rel salmonellosi case time model estim that follow num reduct proport contamin broiler carcass observ num num approxim num fewer annual salmonellosi case attribut broiler occur num compar num uncertainti bound estim rang approxim num num ill estim ill prevent due modest reduct contamin num num num statist signific analysi relat magnitud chang contamin requir detect human surveil provid
MED-3882~character extended spectrum cephalosporin resist salmonella enterica serovar heidelberg isol food anim retail meat pubm ncbi abstract salmonella enterica common foodborn ill unit state salmonellosi self limit sever infect typic requir antimicrobi treatment ceftriaxon extended spectrum cephalosporin esc common adult children surveil conduct nation antimicrobi resist monitor system narm shown recent increas esc resist salmonella heidelberg isol food anim slaughter retail meat human esc resist salmonella unit state mediat plasmid encod bla cmi lactamas num identifi num esc resist bla cmi posit heidelberg isol human num food anim slaughter num retail meat num spike preval serovar num num anim meat isol isol chicken carcass retail chicken meat screen narm isol presenc bla cmi determin gene plasmid encod examin pulsed field gel electrophoresi pattern assess genet divers isol categor bla cmi plasmid plasmid incompat group plasmid multi locus sequenc type pmlst num bla cmi gene found plasmid encod incompatibility replicon type demonstr num inci num plasmid num confer bla cmi associ resist inca c plasmid carri addit resist gene pmlst inci num bla cmi plasmid show num num sequenc type st num common st bla cmi inci num plasmid heidelberg isol human ten plasmid st profil st num type similar st num work show num increas esc resist salmonella heidelberg caus dissemin bla cmi inci num inca c plasmid varieti genet background result clonal expans
MED-3884~num garrod lectur evolut antimicrobi resist darwinian perspect pubm ncbi abstract microb evolv num billion year arguabl adapt organ earth restrict genet inabl reproduc sexual bacteria acquir addit mechan exchang genet materi horizont mechan bacteria inhabit inhospit environ earth surpris face barrag inim chemic antibiot respond equal opposit forc articl compar contrast evolut antimicrobi resist beta lactam antibiot num year bacteri speci staphylococcus aureus high evolv human pathogen pseudomona aeruginosa opportunist nosocomi pathogen
MED-3885~mechan antimicrobi resist bacteria pubm ncbi abstract treatment bacteri infect increas complic abil bacteria develop resist antimicrobi agent antimicrobi agent categor princip mechan action mechan includ interfer cell wall synthesi beta lactam glycopeptid agent inhibit protein synthesi macrolid tetracyclin interfer nucleic acid synthesi fluoroquinolon rifampin inhibit metabol pathway trimethoprim sulfamethoxazol disrupt bacteri membran structur polymyxin daptomycin bacteria intrins resist num class antimicrobi agent acquir resist de novo mutat acquisit resist gene organ acquir resist gene enabl bacterium produc enzym destroy antibacteri drug express efflux system prevent drug reach intracellular target modifi drug target site produc altern metabol pathway bypass action drug acquisit genet materi antimicrobial suscept bacteria resist strain bacteria occur conjug transform transduct transposon facilit incorpor multipl resist gene host genom plasmid antibacteri agent creat select pressur emerg resist strain num case histories on involv escherichia coli resist third gener cephalosporin focus emerg vancomycin resist staphylococcus aureus detail multidrug resist pseudomona aeruginosa ar review illustr vari resist bacteria develop
MED-3886~mechan antimicrobi resist bacteria pubm ncbi abstract treatment bacteri infect increas complic abil bacteria develop resist antimicrobi agent antimicrobi agent categor princip mechan action mechan includ interfer cell wall synthesi beta lactam glycopeptid agent inhibit protein synthesi macrolid tetracyclin interfer nucleic acid synthesi fluoroquinolon rifampin inhibit metabol pathway trimethoprim sulfamethoxazol disrupt bacteri membran structur polymyxin daptomycin bacteria intrins resist num class antimicrobi agent acquir resist de novo mutat acquisit resist gene organ acquir resist gene enabl bacterium produc enzym destroy antibacteri drug express efflux system prevent drug reach intracellular target modifi drug target site produc altern metabol pathway bypass action drug acquisit genet materi antimicrobial suscept bacteria resist strain bacteria occur conjug transform transduct transposon facilit incorpor multipl resist gene host genom plasmid antibacteri agent creat select pressur emerg resist strain num case histories on involv escherichia coli resist third gener cephalosporin focus emerg vancomycin resist staphylococcus aureus detail multidrug resist pseudomona aeruginosa  ar review illustr vari resist bacteria develop
MED-3887~food anim antimicrobi impact human health abstract summari antimicrobi valuabl therapeut efficaci compromis emerg spread antimicrobi resist provis antibiot food anim encompass wide varieti nontherapeut purpos includ growth promot concern resist emerg spread peopl nontherapeut antimicrobi led conflict practic opinion evid support remov nontherapeut antimicrobi ntas europ base precautionari principl concret scientif evid favor versus unfavor consequ ntas clear stakehold substanti data show elev antibiot resist bacteria anim fed ntas food product resist spread anim human direct contact indirect food chain water air manur sludge fertil soil modern genet techniqu make advanc deciph ecolog impact ntas model effort thwart deficit key knowledg microbi antibiot load stage transmiss chain substanti expand volum evid report animal to human spread resist bacteria includ aris ntas support elimin nta order reduc grow environment load resist gene
MED-3888~salmonella enterica serotyp enteritidi increas incid domest acquir infect pubm ncbi abstract background salmonella enterica estim num million case domest acquir foodborn ill human annual unit state enteritidi se common serotyp public health author regulatori agenc food produc food processor accur inform rate se infect implement evalu evidence bas control polici practic method analyz incid human se infect num foodborn diseas activ surveil network foodnet activ population bas surveil system laboratory confirm infect compar foodnet incid passiv collect data complementari surveil system rate se isol process chicken egg product shell egg routin test compar molecular subtyp pattern se isol human chicken result period num incid human se infect foodnet increas num chang mirror passiv nation surveil data greatest relat increas young children older adult foodnet site southern unit state proport patient se infect report recent intern travel decreas recent year proport chicken se isol increas similar molecular subtyp se common isol human chicken conclus se infect unit state acquir domest sourc problem grow chicken egg major sourc se continu close attent surveil data monitor impact recent regulatori control measur
MED-3889~comparison esbl contamin organ convent retail chicken meat pubm ncbi abstract contamin retail chicken meat extend spectrum beta lactamas esbl produc bacteria contribut increas incid infect bacteria human studi aim compar preval load esbl posit isol organ convent retail chicken meat sampl compar distribut esbl gene strain genotyp co resist num raw chicken breast num convent num organ collect num local store netherland preval esbl produc micro organ num convent num organ sampl num median load esbl produc micro organ num rang num convent num rang num cfu num organ sampl num distribut esbl gene convent sampl organ sampl num versus num ctx m num versus num tem num num versus num num shv num ctx m num shv num tem num exclus found convent sampl co resist rate esbl posit isol convent organ sampl co trimoxazol num ciprofloxacin num tobramycin num tetracyclin num num num num convent meat sampl harbor num mlst type report human num num organ sampl harbor num mlst type report human num st num st num st num conclus major organ chicken meat sampl contamin esbl produc coli esbl gene strain type larg convent meat sampl copyright num elsevi reserv
MED-3890~detect common persist tet carri plasmid chicken waste impact farm soil abstract connect farm gener anim wast dissemin antibiot resist soil microbi communiti mobil genet element remain obscur studi electromagnet induct emi survey broiler chicken farm assist soil sampl chicken waste impact site margin affect site consist emi survey dispar exist site regard soil ph tetracyclin resist tcr level cultur soil bacteria incid preval tet erm gene soil signific differ observ aspect margin affect site site pristin region forest farm oper tet tet tet erm erm erm gene detect waste affect soil year wast remov farm tet tet tet erm gene detect abund tet tet erm measur quantit pcr copi number normal eubacteri num rrna gene copi number tet preval gene tet persist declin num year period mobiliz plasmid carri tet identifi num tcr soil isol plasmid host identifi speci bhargavaea sporosarcina bacillus plasmid mobil mob gene quantifi estim preval soil ratio tet mob shown chang num num num year sampl period
MED-3891~comparison preval antimicrobi resist escherichia coli isol retail meat unit state num num abstract escherichia coli isol recov nation antimicrobi resist monitor system retail meat program examin antimicrobi suscept retail meat sampl num state collect num num consist num chicken breast num ground turkey num ground beef num pork chop sampl analyz total num coli isol recov greatest number sampl contamin organ chicken num turkey num beef num pork num resist common tetracyclin num streptomycin num sulfamethoxazole sulfisoxazol num ampicillin num gentamicin num kanamycin num amoxicillin clavulan acid num cefoxitin num num isol resist trimethoprim ceftriaxon ceftiofur nalidix acid chloramphenicol ciprofloxacin isol suscept amikacin compar beef pork isol poultri meat isol greater percentag resist test drug chloramphenicol pork isol resist half turkey isol num resist multidrug num class compar num chicken num pork num beef isol blacmi gene present ceftriaxon ceftiofur resist isol cmla flo cati gene present num num chloramphenicol resist isol nalidix acid resist isol num gyra mutat num num num parc mutat num num result show coli common present retail meat antimicrobi resist profil differ anim origin isol
MED-3892~applic bayesian techniqu model burden human salmonellosi attribut food commod point process adapt danish model abstract mathemat model estim proport foodborn ill attribut food commod specif point food chain risk manag polici maker formul public health goal priorit intervent document effect mitig aim reduc ill human surveil data laboratory confirm salmonella infect center diseas control prevent salmonella test data depart agricultur food safeti inspect service regulatori program develop point of process foodborn ill attribut model adapt hald salmonella bayesian sourc attribut model key model output includ estim relat proport domest acquir sporad human salmonella infect result contamin raw meat poultri egg product process unit state num num current model estim relat contribut chicken num ground beef num turkey num egg product num intact beef num pork num num salmonella serotyp found food commod point process interpret attribut estim constrain data input adapt model show promis serv basi common approach attribut human salmonellosi food safeti decision mak countri
MED-3893~revers fatigu prolong exercis carbohydr infus ingest pubm ncbi abstract cyclist exercis num maxim num uptak vo num ax fatigu num num min occas num wk trial plasma glucos declin num num num num mm num respiratori exchang ratio fell num num num num num rest num min subject attempt continu exercis num ingest placebo num ingest glucos polym num g kg num glucos infus intraven euglycem clamp placebo ingest restor euglycemia plasma glucos increas num initi approxim num mm rose num approxim num glucos infus carbohydr ingest plasma glucos fell gradual num num mm num num carbohydr ingest maintain num num mm num num glucos infus time fatigu exercis bout signific longer carbohydr ingest num num min num glucos infus num num min num trial compar placebo trial num num min plasma insulin approxim num microu ml vastus laterali muscl glycogen approxim num mmol glucosyl u kg chang glucos infus three fourth total carbohydr oxid exercis bout account euglycem glucos infus rate num num g min abstract truncat num word
MED-3894~sun dri raisin cost effect altern sport jelli bean prolong cycl pubm ncbi abstract purpos studi examin effect natur carbohydr cho sourc form sun dri raisin sdrs sport jelli bean sjbs endur perform train cyclist triathlet ten healthi men num year complet num water on acclimat exercis trial num random exercis trial administ crossov fashion trial consist num minut constant intens glycogen deplet period num km time trial tt experiment trial particip consum isocalor amount sdrs sjbs num minut interv measur includ time complet num km tt power output num km tt blood glucos level respiratori exchang ratio glycogen deplet period rate perceiv exert rpe flow questionnair respons hedon pleasant sensori accept test signific differ endur perform tt time sdrs sjbs num num num num power num num num num rest blood glucos level num num mmol num sdrs num num mmol num sjbs rpe flow experi sdr sjb trial sensori accept score signific higher sdrs compar sjbs num num num num consum sdrs sjbs num minut intens cycl result similar subsequ tt perform equal effect maintain blood glucos level exercis sdrs natur pleasant cost effect cho altern commerci sjbs moder high intens endur exercis
MED-3895~metabol perform effect raisin versus sport gel pre exercis feed cyclist pubm ncbi abstract research suggest pre exercis sourc dietari carbohydr vari glycem index differenti affect metabol endur studi design examin potenti differ metabol cycl perform consumpt moder glycem raisin high glycem commerci sport gel endurance train male num femal num cyclist num num year age complet num trial random order subject fed num carbohydr kilogram bodi weight raisin sport gel num minut prior exercis cycl ergomet num num ax num minut submaxim exercis subject complet num minut perform trial blood collect prior exercis bout num minut exercis determin serum concentr glucos insulin lactat free fatti acid ffas triglycerid beta hydroxybutyr perform num raisin num num kj gel num num kj trial prior exercis serum concentr glucos fuel substrat differ trial insulin higher num gel num num microu ml num raisin trial num num microu ml num num minut exercis insulin decreas num num microu ml num num num microu ml num gel raisin trial ffa concentr increas num num mmol num signific num raisin trial minor differ metabol differ perform detect trial raisin cost effect sourc carbohydr pre exercis feed comparison sport gel short term exercis bout
MED-3896~effect addit daili fruit nut bar diet weight cardiac risk profil overweight adult pubm ncbi abstract background frequenc unhealth snack increas dramat decad fruit nut shown posit health effect studi investig aggreg effect fruit combin nut form snack bar cardiovascular risk factor aim randomis trial investig effect fruit nut snack bar anthropomorph measur lipid panel blood pressur overweight adult method ninety four overweight adult bodi mass index num kg num random assign add fruit nut bar total num kj num kcal ad libitum diet intervent group continu ad libitum diet control group subject underw assess weight primari outcom measur waist circumfer lipid panel blood pressur secondari outcom measur end num week treatment result weight chang baselin snack bar addit compar control num waist circumfer num blood pressur systol num diastol num blood lipid panel total cholesterol num high dens lipoprotein num total cholesterol high dens lipoprotein num triglycerid num low dens lipoprotein num chang baselin compar control conclus daili fruit nut bar total num kj num kcal weight gain role habitu snack nutrient dens satiat food weight time diet qualiti warrant studi satiat snack rich fibr provid weight stabilis num author journal human nutrit dietet num british dietet associ
MED-3897~glycem indic varieti date healthi diabet subject abstract background studi design determin glycem indic common varieti date healthi subject effect postprandi glucos excurs individu type num diabet mellitus method composit analysi carri type date tamer stage weight flesh date equival num carbohydr calcul studi subject thirteen healthi volunt sd age num num year ten particip type num diabet mellitus control lifestyl measur and or metformin hba num sd num num age sd num num year subject test separ day num glucos num occas num equival carbohydr num varieti date occas capillari glucos measur healthi subject num num num num min diabet num num num num min glycem indic determin ratio increment area respons curv date compar glucos statist analys perform mann whitney test repeat measur analysi varianc result glycem indic sem date healthi individu num num num num num num num num num num fara d lulu bo ma an dabba khala valu type num diabet similar num num num num num num num num num num statist signific differ gis control diabet group type date statist signific differ date gis df num num num conclus result show low glycem indic type date includ studi consumpt diabet individu result signific postprandi glucos excurs find point potenti benefit date diabet subject healthi balanc diet trial registr number clinicaltri gov nct num
MED-3900~dri fruit consumpt improv diet qualiti reduc obes adult nation health nutrit examin survey pubm ncbi abstract epidemiolog studi examin potenti associ dri fruit consumpt diet qualiti weight status lack goal studi examin associ dri fruit consumpt nutrient intak diet qualiti anthropometr indic overweight obes secondari analysi dietari anthropometr data collect adult num year particip num num num nation health nutrit examin survey conduct dri fruit consum defin consum amount cup equival fruit day identifi num hour recal diet qualiti measur healthi eat index num covariate adjust ses preval rate odd ratio determin conduct statist test differ dri fruit consum nonconsum percent popul consum dri fruit differ num consum nonconsum adult shortfal nutrient dietari fiber num g d vitamin num retinol activ equival day num mg tocopherol day num mg d num mg d calcium num mg d phosphorus num mg d magnesium num mg d potassium num mg d dri fruit consum improv mypyramid food intak includ lower solid fats alcohol ad sugar intak higher solid fats alcohol ad sugar score num num num num nonconsum total healthi eat index num score signific higher num consum num num nonconsum num num covariate adjust weight num num num num kg bodi mass index num num num num waist circumfer num num num num cm lower num consum nonconsum dri fruit consumpt improv nutrient intak higher diet qualiti score lower bodi weight adipos measur copyright num elsevi reserv
MED-3904~randomis clinic trial dri plum prune psyllium constip pubm ncbi abstract background treatment chronic constip remain challeng num patient dissatisfi current therapi unmet natur safe altern dri plum prune tradit constip efficaci aim assess compar effect dri plum psyllium patient chronic constip method subject enrol num week single blind randomis cross ov studi subject receiv dri plum num fibr num gm day psyllium num fibr num gm day num week crossov trial num week washout period subject maintain daili symptom stool diari assess includ number complet spontan bowel movement week global relief constip stool consist strain toler tast result forti constip subject m f num age num year particip number complet spontan bowel movement week primari outcom measur stool consist score improv signific num dri plum compar psyllium strain global constip symptom differ signific treatment p n dri plum psyllium rate equal palat safe toler conclus dri plum safe palat effect psyllium treatment mild moder constip consid line therapi num blackwel publish
MED-3906~date fruit phoenix dactylifera linn emerg medicin food pubm ncbi abstract date palm oldest tree cultiv man folk lor date fruit ascrib medicin properti consum combin herb fruit date palm serv stapl food million peopl world centuri studi health benefit inadequ recogn healthi food health profession public recent year explos interest numer health benefit date led vitro anim studi identif quantif class phytochem basi document literatur nutrit phytochem composit appar date fruit high nutriti potenti health benefit date sugar pack date varieti low gi diet refut dogma date similar candi regular consumpt develop chronic diseas investig area valid benefici effect mechan action fulli potenti medicin food human world review summar phytochem composit nutrit signific potenti health benefit date fruit consumpt discuss great potenti medicin food number diseas inflict human
MED-3907~glycem indic varieti date healthi diabet subject abstract background studi design determin glycem indic common varieti date healthi subject effect postprandi glucos excurs individu type num diabet mellitus method composit analysi carri type date tamer stage weight flesh date equival num carbohydr calcul studi subject thirteen healthi volunt sd age num num year ten particip type num diabet mellitus control lifestyl measur and or metformin hba num sd num num age sd num num year subject test separ day num glucos num occas num equival carbohydr num varieti date occas capillari glucos measur healthi subject num num num num min diabet num num num num min glycem indic determin ratio increment area respons curv date compar glucos statist analys perform mann whitney test repeat measur analysi varianc result glycem indic sem date healthi individu num num num num num num num num num num fara d lulu bo ma an dabba khala valu type num diabet similar num num num num num num num num num num statist signific differ gis control diabet group type date statist signific differ date gis df num num num conclus result show low glycem indic type date includ studi consumpt diabet individu result signific postprandi glucos excurs find point potenti benefit date diabet subject healthi balanc diet trial registr number clinicaltri gov nct num
MED-3908~daili appl versus dri plum impact cardiovascular diseas risk factor postmenopaus women pubm ncbi abstract background evid suggest consumpt appl bioactiv compon modul lipid metabol reduc product proinflammatori molecul pauciti research human object women experi lower rate cardiovascular diseas menopaus compar men onset menopaus risk cardiovascular diseas increas drastic due ovarian hormon defici conduct num year clinic trial evalu effect dri appl dri plum consumpt reduc cardiovascular diseas risk factor postmenopaus women design one hundr sixti qualifi postmenopaus women recruit greater tallahasse fl area num random assign group dri appl num g day dri plum compar control fast blood sampl collect baselin num num month measur paramet physic activ recal num day dietari recal obtain result dri fruit regimen signific affect particip report total energi intak studi period contrari women consum dri appl lost num kg bodi weight end studi albeit signific dri plum group term cholesterol serum total cholesterol level signific lower dri appl group compar dri plum group num month dri plum consumpt signific reduc serum total cholesterol low dens lipoprotein cholesterol level lower level numer num num num month compar baselin explain lack signific observ group group women consum dri appl signific lower serum level total cholesterol low dens lipoprotein cholesterol num num num month compar baselin serum valu decreas num num num month stay constant within group analysi report daili appl consumpt profound improv atherogen risk ratio signific lipid profil atherogen risk ratio result dri plum consumpt dri fruit lower serum level lipid hydroperoxid c reactiv protein serum c reactiv protein level signific lower dri plum group compar dri appl group num month conclus signific differ dri appl dri plum group alter serum level atherogen cholesterol total cholesterol num month treatment group comparison made consumpt num dri appl medium s appl signific lower atherogen cholesterol level earli num month consumpt dri appl dri plum benefici human health term anti inflammatori antioxid properti copyright num academi nutrit dietet publish elsevi reserv
MED-3910~effect consumpt dri california mission fig lipid concentr abstract background fig rich sourc solubl fiber evalu effect consum dri california mission fig serum lipid hyperlipidem adult method crossov trial men women age num num year elev low dens lipoprotein cholesterol num num mg dl random add dri california mission fig num g day usual diet num week eat usual diet num week cross condit num week num hour dietari recal obtain result low high dens lipoprotein cholesterol triglycerid concentr differ usual figs ad diet bonferroni correct num total cholesterol tend increas fig consumpt num total cholesterol increas particip num random usual figs ad diet num remain unchang subject num start figs ad usual diet num figs ad diet solubl fiber intak num num versus num num g day usual diet num sugar intak increas num num num num kcal figs ad diet num bodi weight chang num conclus daili consumpt fig reduc low dens lipoprotein cholesterol triglycerid concentr signific chang increas sugar intak
MED-3918~herbal infus sourc calcium magnesium iron zinc copper human nutrit pubm ncbi abstract studi materi consist herb chamomil flower mint leav st john wort flower leav sage leav nettl leav sourc produc calcium magnesium iron zinc copper content determin dri herb sampl prepar infus extract rate calcul miner compon determin atom absorpt spectrometri analysi show content individu element herb infus depend type raw materi origin found iron penetr herbal infus lowest degre num num copper highest num num felt averag consumpt herbal infus import calcium magnesium iron zinc copper sourc human nutrit
MED-3919~influenc aspalathus lineari rooibo dihydrochalcon adren steroidogenesi quantif steroid intermedi end pro pubm ncbi abstract steroid hormon output adren gland crucial mainten hormon homeostasi hormon imbal numer clinic condit includ hypertens metabol syndrom cardiovascular diseas insulin resist type num diabet aspalathus lineari rooibo report aid stress rel symptom link metabol diseas wide spectrum bioactiv phenol compound aspalathin uniqu studi inhibitori effect rooibo dihydrochalcon aspalathin nothofagin investig adren steroidogenesi activ cytochrom num hydroxylas num lyas cytochrom num hydroxylas signific inhibit cos num cell order studi effect compound num cell human adren carcinoma cell line uplc ms m method develop detect quantif twenty on steroid metabolit singl chromatograph separ basal forskolin stimul condit total amount steroid produc num cell signific decreas presenc rooibo aspalathin nothofagin stimul condit rooibo decreas total steroid output num fold result signific reduct aldosteron cortisol precursor dehydroepiandrosterone sulf level unchang level androstenedion num num hydroxyandrostenedion num oh a num inhibit num num fold quantif num oh a num show metabolit major product steroidogenesi num cell confirm time steroid metabolit product hydroxyl num human cytochrom num hydroxylas result demonstr rooibo aspalathin nothofagin influenc steroid hormon biosynthesi flux mineralocorticoid glucocorticoid androgen pathway possibl contribut allevi negat effect aris elev glucocorticoid level copyright num elsevi reserv
MED-3920~acut neurocognit effect epigallocatechin gallat egcg pubm ncbi abstract green tea report wide rang benefici health outcom epidemiolog studi attribut flavonoid content investig flavonoid epigallocatechin gallat egcg modul brain activ self report mood double blind placebo control crossov studi particip complet baselin assess cognit cardiovascular function mood rest state electroencephalogram eeg num min administr num mg egcg match placebo egcg administr signific increas alpha beta theta activ reflect eeg activ domin midlin frontal central region specif frontal gyrus medial frontal gyrus comparison placebo egcg treatment increas self rat calm reduc rate stress pattern result suggest particip egcg condit relax attent state consum egcg widespread consumpt green tea purport relaxing refresh properti modul brain function due egcg deserv control human studi copyright num elsevi reserv
MED-3921~consumpt hibiscus sabdariffa aqueous extract impact system antioxid potenti healthi subject pubm ncbi abstract background evalu health benefit attribut hibiscus sabdariffa random open label two way crossov studi undertaken compar impact aqueous sabdariffa extract hse system antioxid potenti aop assay ferric reduc antioxid power frap refer treatment water healthi volunt biokinet variabl area curv auc plasma frap ascorb acid urat pre dos concentr amount excret urin num ae num antioxid assay frap ascorb acid uric acid malondialdehyd biomark oxid stress hippur acid metabolit potenti biomark total polyphenol intak result hse caus signific higher plasma auc frap increas ae num frap ascorb acid hippur acid malondialdehyd excret reduc main hibiscus anthocyanin glucuronid conjug quantifi volunt urin num administ dose conclus aqueous hse investig studi enhanc system aop reduc oxid stress human increas urinari hippur acid excret hse consumpt high biotransform ingest hse polyphenol caus colon microbiota copyright num societi chemic industri
MED-3922~bioavail studi polyphenol enrich extract hibiscus sabdariffa rat antioxid status pubm ncbi abstract aqueous extract hibiscus sabdariffa common folk medicin compound metabolit respons healthi effect identifi major metabolit present rat plasma acut ingest polyphenol enrich hibiscus sabdariffa extract character quantifi order studi bioavail antioxid status plasma sampl measur complementari antioxid techniqu high perform liquid chromatographi coupl time of flight mass spectrometri hplc esi tof m bioavail studi antioxid status measur ferric reduc abil plasma method thiobarbitur acid reactiv substanc assay superoxid dismutas activ assay seventeen polyphenol metabolit detect quantifi eleven compound metabolit phenol acid found plasma modif structur flavonol found quercetin kaempferol glucuronid conjug flavonol glucuronid conjug show longer half lif elimin valu propos contribut observ lipid peroxid inhibitori activ cellular membran contrast phenol acid exert antioxid activ ferric ion reduct superoxid scaveng shorter time propos flavonol conjug form quercetin kaempferol compound respons observ antioxid effect contribut healthi effect sabdariffa polyphenol extract num wiley vch verlag gmbh kgaa weinheim
MED-3923~mechan action sting nettl pubm ncbi abstract object inadvert exposur ubiquit weed urtica dioica call sting nettl produc sting burn sensat skin investig evalu structur effect sting nettl spicul clinic manifest symptom hypothesi investig expos murin skin sting nettl evalu skin electron microscopi hypothes mechan action sting nettl biochem mechan clinic signific treatment acut exposur method fresh post mortem dermi sampl carcass genet modifi hairless mice brush stem leaf sting nettl plant mimick clinic method exposur patient experi set mous skin sampl obtain expos nettl set skin sampl imag scan electron microscopi result skin sampl expos nettl leav uniform occasion striat hair skin surfac nettl spicul skin sampl expos nettl leav show smooth nettl spicul pierc skin surfac spicul retain base empti liquid content conclus mechan action sting nettl dermat biochem mechan impal spicul skin account mechan irrit addit advers chemic effect sting nettl investig treatment modal warrant copyright num wilder medic societi publish elsevi reserv
MED-3924~urtica dioica treatment benign prostat hyperplasia prospect random double blind placebo control crossov studi pubm ncbi abstract purpos determin effect therapi urtica dioica symptomat relief lower urinari tract symptom lut secondari benign prostat hyperplasia bph materi method num month double blind placebo control random partial crossov compar trial urtica dioica placebo num patient conduct patient evalu intern prostat symptom score ipss maximum urinari flow rate qmax postvoid residu urin volum pvr serum prostat specif antigen psa testosteron level prostat size end num month trial unblind reveal patient initi receiv placebo switch urtica dioica group continu medic num month result num patient num complet studi num num urtica dioica group num num placebo group intent to treat analysi end num month trial num num patient urtica dioica group report improv lut compar num num patient placebo group num ipss qmax show greater improv drug placebo ipss num num urtica dioica num num placebo num peak flow rate improv num ml s placebo recipi num ml s treat patient num urtica dioica group pvr decreas initi num num ml num appreci chang placebo group serum psa testosteron level unchang group modest decreas prostat size measur transrect ultrasonographi trus urtica dioica group num cc initi num cc num chang prostat volum end studi placebo num month follow up patient continu therapi favor treatment variabl side effect identifi group conclus present studi urtica dioica benefici effect treatment symptomat bph clinic trial conduct confirm result conclud urtica dioica effect
MED-3925~diet low anim fat rich n hexacosanol fisetin effect reduc symptom parkinson diseas pubm ncbi abstract studi describ food rich fisetin hexacosanol ad strict diet revers symptom parkinson diseas pd patient case report involv outpati care subject dietitian diagnos idiopath pd num age num year histori exposur neurotoxin famili histori pd basic diet start num consist predomin fruit veget num grain extra virgin oliv oil nut seed nonfat milk product tea coffe spice small amount dark chocol num anim fat daili basic diet fail prevent declin due pd num basic diet enhanc good dietari sourc fisetin hexacosanol month patient start enhanc diet rich fisetin hexacosanol clinic signific improv symptom note patient attend neurologist report clinic present cogwheel rigid micrographia bradykinesia dystonia constrict arm swing gait hypomimia retropuls resolv worsen symptom occur diet precis improv tremor seborrhea observ clinic improv persist date knowledg case adjunct diet therapi result signific reduct symptom pd chang type increas amount medic
MED-3926~protein redistribut diet antiparkinsonian respons levodopa pubm ncbi abstract sixteen parkinsonian patient daili fluctuat clinic respons levodopa redistribut protein diet diet virtual protein fre meal unrestrict bedtim redistribut protein diet group patient num num clear signific benefit dietari therapi show definit reduct diurnal motor perform fluctuat addit patient tend show improv constant respons levodopa treatment trial redistribut protein diet simpl reason worthwhil approach pd patient begin experi oscil clinic respons levodopa treatment
MED-3927~caffein treatment parkinson diseas abstract object epidemiolog studi consist link caffein nonselect adenosin antagonist lower risk parkinson diseas pd symptomat effect caffein pd adequ evalu method conduct num week random control trial caffein pd assess effect daytim somnol motor sever nonmotor featur patient pd daytim somnol epworth num caffein num mg daili num week num mg daili num week match placebo primari outcom epworth sleepi scale score secondari outcom includ motor sever sleep marker fatigu depress qualiti life effect caffein analyz bayesian hierarch model adjust studi site baselin score age sex result num patient num random placebo num caffein primari intention to treat analysi caffein result nonsignific reduct epworth sleepi scale score num point num confid interv ci num num somnol improv clinic global impress chang num num num intention to treat signific reduct epworth sleepi scale score per protocol analysi num num num caffein reduc total unifi parkinson diseas rate scale score num point num num object motor compon num point num num modest improv global health measur qualiti life depress sleep qualiti advers event compar caffein placebo group conclus caffein provid equivoc borderlin improv excess somnol pd improv object motor measur potenti motor benefit suggest larger long term trial caffein warrant classif evid studi class evid caffein num mg bid num week signific benefit excess daytim sleepi patient pd
MED-3928~plasma level amino acid correl motor fluctuat parkinson pubm ncbi abstract patient parkinson diseas experienc sever motor fluctuat respons levodopa studi detail relat effect dietari protein motor function levodopa dose patient chang period studi antiparkinsonian drug regular high protein diet result mark elev plasma concentr larg neutral amino acid lnaa compet levodopa transport blood brain barrier elev plasma levodopa level patient elev lnaa level experienc parkinsonian symptom amino acid level drop plasma levodopa level elev patient experienc relief symptom low protein diet lnaa level remain low patient consist dyskinet day plasma levodopa level lower patient consum high protein diet redistribut diet virtual protein free supper unrestrict bedtim toler patient simpl manipul permit near norm daytim motor function
MED-3929~habitu intak dietari flavonoid risk parkinson diseas abstract object prospect examin higher intak total flavonoid subclass flavanon anthocyanin flavan num ol flavonol flavon polym lower risk develop parkinson diseas pd method current analysi includ num men health profession follow up studi num women nurs health studi major sourc flavonoid rich food tea berri fruit appl red wine orange orang juic examin flavonoid intak assess updat food composit databas valid food frequenc questionnair result identifi num particip num men num women develop pd num num year follow up men adjust multipl confound particip highest quintil total flavonoid num lower pd risk lowest quintil hazard ratio hr num num confid interv num num trend num signific relationship observ women trend num pool analys trend num pool analys subclass intak anthocyanin rich dietari sourc berri signific lower pd risk hr compar num extrem intak quintil num anthocyanin num berri trend num conclus find suggest intak flavonoid reduc pd risk men protect effect constitu plant food exclud
MED-3930~intak japanes chines tea reduc risk parkinson diseas pubm ncbi abstract studi address associ intak coffe caffein parkinson diseas pd conduct western countri relationship asian popul perform assess associ intak coffe caffeine contain beverag caffein risk pd japan studi involv num pd case num control subject inform dietari factor obtain self administ diet histori questionnair adjust made sex age region resid educ level pack year smoke bodi mass index dietari glycem index intak cholesterol vitamin caroten vitamin num alcohol iron intak coffe black tea japanes chines tea signific invers risk pd adjust odd ratio comparison highest lowest quartil num num num num confid interv num num num num num num clear invers dose respons relationship total caffein intak pd risk observ confirm intak coffe caffein reduc risk pd studi show signific invers relationship intak japanes chines tea risk pd copyright num elsevi reserv
MED-3931~pilot dietari studi normoprot protein redistribut plant food diet motor perform patient parkinson diseas pubm ncbi abstract plant bas diet provid benefit parkinson diseas pd studi date evalu effect plant food diet manag diseas pilot studi compar effect plant food menu pfd omnivor menu motor perform num pd patient num intervent group pdi num control group pdc num week pdi group show signific reduct mann whitney test unifi parkinson diseas rate scale total score num num num sub scor iii motor perform num num num modifi hoehn yahr stage scale num num num data suggest pfd manag pd patient improv motor perform addit studi order confirm preliminari result
MED-3932~caffein risk parkinson diseas larg cohort men women abstract background caffein consumpt reduc risk parkinson diseas associ strong consist men uncertain women possibl interact hormon replac therapi sought confirm find data parkinson diseas incid cps ii nutrit cohort larg prospect studi men women method conduct prospect studi caffein intak risk pd cancer prevent studi ii nutrit cohort intak coffe sourc caffein assess baselin incid case pd num men num women confirm treat physician medic record review relat risk rr estim proport hazard model adjust age smoke alcohol consumpt result adjust age smoke alcohol intak high caffein consumpt reduc risk pd relat risk compar num num quintil caffein intak num ci num num p trend num men num num ci num num trend num women women associ stronger user hormon replac therapi rr num user rr num p interact num consumpt decaffein coffe pd risk conclus find larg prospect studi men women consist protect effect caffein intak pd incid attenu influenc hormon replac therapi women
MED-3933~clinic pharmacokinet effect diet rich insolubl fiber parkinson diseas pubm ncbi abstract studi effect diet rich insolubl fiber drif motor disabl peripher pharmacokinet oral administ l dopa parkinsonian patient mark constip analyz found effect drif plasma l dopa concentr motor function greatest effect plasma l dopa level found earli num num min oral administr relationship improv constip higher bioavail l dopa drif coadjuv treatment patient parkinson diseas
MED-3935~meet report consensus statement parkinson diseas environ collabor health environ parkinson action network che pan confer num num june num abstract background parkinson diseas pd common neurodegen disord peopl pd famili scientist health care provid general public increas interest identifi environment contributor pd risk method june num multidisciplinari group expert gather sunnyval california usa assess contribut environment factor pd result describ conclus consensus respect environment contributor pd risk conclud summari research conclus pd complex disord multipl pathogen pathway mechan ultim lead pd individu determin pd risk popul pd heterogen rare recogn genet mutat suffici pd account num pd popul incomplet penetr suggest environment factor involv interplay environment factor genet makeup influenc risk develop pd understand risk factor interact studi pd increas understand neurodegen disord
MED-3936~elev serum pesticid level risk parkinson diseas abstract background exposur pesticid report increas risk parkinson diseas pd identif specif pesticid lack studi found elev level organochlorin pesticid postmortem pd brain object determin elev level organochlorin pesticid present serum patient pd design case control studi set academ medic center particip fifti patient pd num control num patient alzheim diseas main outcom measur level num organochlorin pesticid serum sampl result hexachlorocyclohexan hch detect patient pd num compar control num patient alzheim diseas num median level hch higher patient pd compar control patient alzheim diseas mark differ detect control patient pd num organochlorin pesticid final observ signific odd ratio presenc hch serum predict diagnosi pd control odd ratio num num confid interv num num pd alzheim diseas odd ratio num evid appar associ serum hch pd conclus data suggest hch diagnosi pd research warrant potenti role hch etiolog agent case pd
MED-3937~traumat brain injuri illustr literatur experi seri num head injuri asterix comic book pubm ncbi abstract background goal present studi analyz epidemiolog specif risk factor traumat brain injuri tbi asterix illustr comic book illustr literatur tbi predomin injuri pattern method retrospect analysi tbi num asterix comic book perform examin initi neurolog status sign tbi clinic data correl inform trauma mechan sociocultur background victim offend circumst traumata identifi specif risk factor result hundr tbis identifi major person involv adult male major trauma assault num traumata classifi sever num gcs num neurolog deficit sign basal skull fractur identifi half head injuri victim sever initi impair conscious case death perman neurolog deficit found largest group head injur charact constitut roman num gaul caus num tbis helmet worn num victim lost vast major case num num case tbis caus influenc dope agent call magic potion conclus half patient initi sever impair conscious tbi perman deficit found roman nation hypogloss paresi lost helmet ingest magic potion signific correl sever initi impair conscious num
MED-3938~associ polychlorin biphenyl parkinson diseas neuropatholog abstract polychlorin biphenyl pcbs synthet chemic primarili coolant insul electr equip ban decad pcbs continu exist environ long half lif continu presenc item produc ban poor dispos practic epidemiolog experiment studi identifi exposur pcbs potenti risk factor parkinson diseas femal object work examin associ pcb level post mortem human brain tissu diagnosi parkinson diseas degre nigral depigment sought determin associ signific patient stratifi sex post mortem brain sampl control patient diagnos parkinson diseas obtain emori univers brain bank nun studi concentr preval pcb congen extract post mortem brain tissu analyz gas chromatography mass spectrometri pcb congen num num signific elev brain parkinson diseas patient stratifi sex femal parkinson diseas group demonstr signific elev concentr total pcbs specif congen num num compar control pcb concentr male signific control parkinson diseas group separ popul women nun studi clinic sign symptom pd elev concentr total pcb congen num num observ post mortem brain tissu exhibit moder nigral depigment compar subject mild depigment quantit data demonstr associ brain pcb level parkinson disease rel patholog data support epidemiolog laboratori studi report link pcb exposur increas risk parkinson diseas includ greater suscept femal
MED-3939~hospit admiss traumat brain injuri num statist num pubm ncbi excerpt statist present data healthcar cost util project hcup treatment tbi hospit num hospit util cost tbi admiss compar hospit stay injuri addit trend hospit stay tbi differ distribut tbi admiss patient characterist examin final common tbis result hospit admiss coexist condit injuri differ estim note text statist signific num level
MED-3940~lewi patholog sign degener vulner neuron parkinson diseas abstract object determin evid neuron dysfunct demis preced deposit lewi patholog vulner neuron parkinson diseas pd method examin extent nigral dysfunct degener num normal incident lewi bodi diseas ilbd pd case base tyrosin hydroxylas immunoreact neuron densiti relationship marker lewi patholog lp burden substantia nigra sn braak pd stage assess result compar normal subject ilbd case display signific higher percentag th negat cell lower neuron densiti sn earli braak pd stage num num lp deposit nigrostriat system ilbd nigral neuron densiti intermedi normal subject pd case th negat percentag higher ilbd normal pd case neuron densiti neuron dysfunct level remain constant braak pd stage ilbd conclus result suggest signific neurodegener cellular dysfunct preced lp sn challeng pathogen role lp pd assumpt ilbd repres preclin pd
MED-3941~ai euterp oleracea mart polyphenol glycosid aglycon form induc apoptosi hl num leukemia cell pubm ncbi abstract effect ai polyphenol antiprolifer induct apoptosi hl num human leukemia cell investig interact anthocyanin non anthocyanin polyphenol glycosid aglycon form investig determin addit nonaddit respons polyphenol fraction num num microm found reduc cell prolifer num num due caspas num activ apoptosi anthocyanin polyphenol fraction nonaddit contribut cell antiprolifer activ equimolar concentr glycosid form phenol acid flavonoid induc higher magnitud chang cell paramet prolifer apoptosi respect aglycon form opposit trend observ anthocyanin aglycon studi demonstr ai offer rich sourc bioactiv polyphenol confirm import investig food system evalu potenti health benefit individu phytochem compound
MED-3942~effect ai euterp oleracea mart berri prepar metabol paramet healthi overweight popul pilot studi abstract background purpos studi evalu effect ai fruit pulp risk factor metabol disord overweight subject palm euterp oleracea mart nativ south america produc small black purpl fruit edibl fruit recent popular function food due antioxid potenti studi conduct vitro anim potenti health benefit human increas plasma anti oxid capac metabol syndrom condit defin cluster risk factor cardiovascular diseas and or type num diabet preliminari studi reduct reactiv oxygen speci assist normal metabol pathway involv syndrom method open label pilot studi conduct num overweight adult bmi num kg m num num kg m num num ai pulp daili num month studi endpoint includ level fast plasma glucos insulin cholesterol triglycerid exhal breath nitric oxid metabolit eno plasma level high sensit c reactiv protein hs crp respons blood glucos blood pressur eno standard meal determin baselin num day treatment result compar baselin reduct fast glucos insulin level num day treatment num reduct total cholesterol num borderlin signific reduct ldl cholesterol ratio total cholesterol hdl cholesterol num compar baselin treatment ai amelior post prandi increas plasma glucos standard meal measur area curv num effect blood pressur hs crp eno conclus uncontrol pilot studi consumpt ai fruit pulp reduc level select marker metabol diseas risk overweight adult indic studi warrant
MED-3943~absenc pomegran ellagitannin major commerci pomegran extract implic standard qualiti control pubm ncbi abstract health benefit pomegran juic led develop pomegran extract botan dietari supplement pomegran hydrolyz tannin form punicalagin punicalin tannin bas complex oligom account antioxid activ juic content ellag acid standard pomegran extract dietari supplement market supplement adulter ellag acid expens plant sourc undercut method standard compar phytochem content antioxid activ commerci pomegran extract dietari supplement content ellag acid total num supplement form capsul tablet soft gel studi total phenol measur gallic acid equival gae ellag acid equival eae assay punicalagin punicalin ellag acid content determin hplc antioxid capac measur trolox equival antioxid capac teac assay num supplement test num typic pomegran tannin profil hplc num ellag acid predomin chemic minor detect pomegran tannin num detect tannin ellag acid standard pomegran extract supplement base ellag acid content guarante pomegran supplement authent futur research assess health impact substitut ellag acid complex mix phytochem pomegran extract dietari supplement
MED-3944~pain reduct improv rang motion daili consumpt ai euterp oleracea mart pulp fortifi polyphenolic rich fruit berri juic blend abstract dietari intervent involv antioxid interest reduc inflamm improv joint motion alter pain percept evalu effect oral consumpt fruit berri blend pain rang motion rom open label clinic pilot studi involv num studi particip limit rom pain affect daili live particip includ limit age rel osteoarthr studi particip consum num ml monavi activ fruit juic predomin ai pulp euterp oleracea mart fruit concentr daili num week studi particip assess baselin num num num week structur nurs interview pain activ daili live adl questionnair blood sampl rom assess pain score visual analogu scale rom assess dual digit inclinometri recommend american medic associ guidelin consumpt juic result signific pain reduct improv rom measur improv adl serum antioxid status monitor cell bas antioxid protect erythrocyt cap assay improv num week continu improv num week studi particip num inflammatori marker c reactiv protein reduc num week chang reach statist signific lipid peroxid decreas mild num week antioxid status measur cap bioassay show correl improv physic well b pain rom adl signific associ increas antioxid status improv rom pain reduct warrant studi
MED-3945~intern multidimension authent specif ima algorithm detect commerci pomegran juic adulter pubm ncbi abstract pomegran fruit punica granatum intern high valu crop product commerci pomegran juic pj perceiv consum pj due larg part potenti health benefit base signific bodi medic research conduct authent pj establish criteria authent pj intern multidimension authent specif ima algorithm develop exist databas comprehens chemic character num commerci juic sampl num manufactur unit state addit analysi commerci juic sampl obtain unit state data analys pomegran juic fruit includ sampl iran turkey azerbaijan syria india china consid develop protocol univers agreement presenc high constant group anthocyanin punicalagin character polyphenol pj total sugar concentr num degre brix pj characterist sugar includ mannitol num num ml ratio glucos mannitol num glucos fructos num num characterist pj addit sucros present isomeras activ commerci process stabl isotop ratio mass spectrometri num thousand assur ad corn cane sugar ad pj sorbitol present num num ml maltos tartar acid detect presenc amino acid prolin num mg l indic ad grape product malic acid num num ml adulter appl pear grape cherri plum aronia juic adulter method includ addit high concentr aronia blueberri blackberri juic natur grape pigment poor qual juic imit color pomegran juic result abnorm anthocyanin profil adjust astring tast poor qual juic peel extract addit nonpomegran sugar common detect adulter method profil generat analys combin inform exist databas publish literatur integr valid ima pj util detect pj adulter survey commerci pomegran juic num num strict met ima criteria
MED-3946~antioxid capac bioactiv freeze dri amazonian palm berri euterp oleracea mart acai pubm ncbi abstract fruit euterp oleracea common acai demonstr exhibit signific high antioxid capac vitro superoxid peroxyl scaveng health benefit studi antioxid capac freeze dri acai fruit pulp skin powder optiacai evalu assay free radic sourc found activ superoxid superoxid scaveng sod assay highest food report date peroxyl radic measur oxygen radic absorb capac assay fluorescein fluoresc probe oracfl mild activ peroxynitrit hydroxyl radic peroxynitrit avert capac norac hydroxyl radic avert capac horac assay sod acai num units g extrem high scaveng capac num highest fruit veget test date total phenol test comparison total antioxid tao assay antioxid acai differenti slow act fast act compon assay measur inhibit reactiv oxygen speci ros format fresh purifi human neutrophil show antioxid acai enter human cell fulli function form perform oxygen quench function low dose bioactiv relat anti inflamm immun function investig acai found potenti cyclooxygenas cox num cox num inhibitor show weak effect lipopolysaccharid lps induc nitric oxid effect lymphocyt prolifer phagocyt capac
MED-3947~hibiscus anthocyanin rich extract induc apoptot cell death human promyelocyt leukemia cell pubm ncbi abstract hibiscus sabdariffa linn malvacea attract plant believ nativ africa cultiv sudan eastern taiwan anthocyanin exist wide veget fruit report demonstr anthocyanin extract sabdariffa hibiscus anthocyanin group natur pigment exist dri calyx sabdariffa exhibit antioxid activ liver protect studi explor effect human cancer cell result show cancer cell apoptosi hl num cell flow cytometri found treatment num mg ml mark induc apoptosi hl num cell dose time depend manner result reveal increas phosphoryl num c jun cytochrom releas express tbid fas fasl has treat hl num cell sb num num inhibitor pd num mek inhibitor sp num jnk inhibitor wortmannin phosphatidylinositol num kinas pi num inhibitor evalu effect has induc hl num death data show sb num strong potenti inhibit hl num cell apoptosi relat protein express phosphoryl suggest mediat hl num apoptosi num fasl bid pathway result develop chemoprevent agent investig specif mechan
MED-3949~character continu differenti myeloid cell line hl num patient acut promyelocyt leukemia pubm ncbi abstract prelminari communic establish continu human myeloid cell line hl num report detail properti cell line document deriv peripher blood leukocyt patient acut promyelocyt leukemia character light electron microscopi predomin cell type fresh cultur sourc neutrophil promyelocyt promin nuclear cytoplasm asynchroni num cultur cell spontan differenti promyelocyt stage proport termin differenti cell mark enhanc compound stimul differenti mous friend erythroleukemia cell hl num cell lack specif marker lymphoid cell express surfac receptor fc fragment complement num differenti granulocyt exhibit phagocyt activ respons chemotact stimulus commensur proport matur cell characterist transform cell hl num cell form coloni semisolid medium produc subcutan myeloid tumor chloroma nude mice sourc colony stimul activ stimul clone effici soft agar num num fold adapt cultur morpholog phenotyp respons chemic induct differenti essenti unchang num passag cytogenet studi reveal aneuploidi metaphas num chromosom predomin vivo earli cultur passag clone num num chromosom predomin continu passag consist karyotyp abnorm delet chromosom num addit marker resembl d group acrocentr submetacentr marker abnorm e group chromosom dna herpesvirus rna retrovirus isol fresh cultur cell hl num cultur cell line continu sourc human cell studi molecular event myeloid differenti effect physiolog pharmacolog virolog element process
MED-3950~polysaccharid isol fruit induc innat immun respons abstract acai fruit popular nutrit supplement purport enhanc immun system function anecdot claim support limit studi describ immun respons acai polyphenol fraction previous character cell respons polyphenol polysaccharid fraction plant deriv nutrit supplement similar polyphenol polysaccharid fraction found acai fruit hypothes fraction activ cell contrari previous report identifi agonist activ polyphenol fraction acai polysaccharid fraction induc robust cell stimulatori activ human mous bovin pbmc cultur character immun respons acai polysaccharid fraction crude polysaccharid prepar test fraction activ human pbmc cultur largest acai polysaccharid activ vitro activ myeloid cell deliv vivo acai polysaccharid induc myeloid cell recruit il num product result defin innat immun respons induc polysaccharid compon acai implic treatment asthma infecti diseas
MED-3951~rhabdomyolysi mislabel acai berri dietari supplement pubm ncbi abstract introduct case report describ patient develop rhabdomyolysi tempor mislabel acai berri dietari supplement method result author describ num year old man present rhabdomyolysi approxim num week start weight loss dietari supplement medic histori signific hypertens treat amlodipin diagnosi rhabdomyolysi confirm creatin kinas num iu l posit urin myoglobin potenti rule sign symptom patient gradual resolv discharg hospit day num assess naranjo advers drug reaction probabl scale yield score num indic relationship supplement rhabdomyolysi product label promot acai berri addit ingredi acai berri found analysi conclus clinician awar dietari supplement vari uniform unknown contamin
MED-3952~polyphenol ac ai euterp oleracea mart red muscadin grape viti rotundifolia protect human umbil vascular endotheli cell pubm ncbi abstract endotheli anti inflammatori effect ac ai ac red muscadin grape gp polyphenol extens investig hypothes polyphenol ac gp exert compar protect effect human vascular endotheli cell huvec inflammatori stress studi investig microrna relev endotheli function regul ac gp result show ac gp num mg gallic acid equivalent l protect huvec glucose induc oxid stress inflamm glucose induc express interleukin num num down regul ac gp mrna protein level lipopolysaccharid lps num g l induc inflamm ac gp inhibit gene express adhes molecul nf activ similar extent gp effect decreas pecam num icam num protein screen microrna microrna num express found modul ac gp mechan inhibit gene protein express vcam num
MED-3953~evidence bas systemat review acai euterp oleracea natur standard research collabor pubm ncbi abstract evidence bas systemat review acai euterp oleracea natur standard research collabor consolid safeti efficaci data scientif literatur valid reproduc grade rational articl includ written statist analysi clinic trial compil expert opinion folklor preced histori pharmacolog kinetics dynam interact advers effect toxicolog dose
MED-3954~childhood meat eat contribut sex differ risk factor ischaem heart diseas develop popul pubm ncbi abstract background male epidem ischaem heart diseas ihd emerg econom develop previous hypothesis epidem due nutrit driven level pubert sex steroid lead atherogen bodi shape lipid profil boy girl sex specif effect glucos metabol studi test hypothesi examin associ childhood meat eat ihd risk develop chines popul method multivari linear censor regress cross sect studi num chines older num year men women guangzhou biobank cohort studi phase num num assess adjust associ childhood meat eat waist hip ratio whr high dens lipoprotein cholesterol fast plasma glucos result adjust age childhood hunger life cours socioeconom posit current lifestyl childhood daili meat eat compar week meat eat higher whr num num ci num num men women associ fast glucos observ conclus potenti limit studi crude natur exposur modest find result consid preliminari lend support hypothesi male epidem prematur ihd sexual diverg ihd rate occur econom develop nutrit driven childhood elucid development origin non communic chronic diseas attent focus sociohistor context role puberti
MED-3955~serum pbdes age menarch adolesc girl analysi nation health nutrit examin survey num num abstract background polybromin diphenyl ether pbdes wide flame retard num exhibit endocrin disrupt experiment studi tetra hexa bd congen estrogen hepta bd num oh bd num antiestrogen pbdes antiandrogen activ clear pbdes affect human reproduct object analysi design investig potenti endocrin disrupt pbdes age menarch adolesc girl method analyz data sampl num adolesc girl age num num year nation health nutrit examin survey nhane num num estim associ individu total serum bdes bde num num num num lipid adjust age menarch calcul risk ratio rrs num confid interv ci menarch prior age num year relat pbde exposur result median total serum bde concentr num ng g lipid higher serum pbde concentr slight earlier age menarch natur log unit total bdes relat chang num num ci num num year age menarch rr num num ci num num experienc menarch num year age adjust potenti confound conclus data suggest high concentr serum pbdes adolesc younger age menarch
MED-3956~overweight nutrit import lifestyl factor influenc time puberti pubm ncbi abstract earli onset puberti confer advers health consequ modifi factor influenc time puberti public health interest childhood overweight factor earlier onset menarch support prospect evid nonetheless contribut overemphas secular trend younger age menarch univers find recent obes epidem current observ studi suggest notabl associ dietari intak pubert time contribut energi imbal children highest intak veget protein anim protein experi pubert onset num month num month earlier girl high isoflavon intak experi onset breast develop peak height veloc approxim num month effect size order observ potenti neuroact steroid hormon dietari pattern character higher intak veget protein isoflavon lower intak anim protein contribut lower risk breast cancer lower total mortal num intern life scienc institut
MED-3958~intern exposur pollut sexual matur flemish adolesc pubm ncbi abstract flander dens popul industri intens farm sexual matur adolesc age num year studi relat intern exposur pollut serum level pollut sex hormon measur num particip select random sampl adolesc resid studi area data sexual develop obtain medic school examin file self assess questionnair provid inform health medic lifestyl factor boy serum level hexachlorobenzen hcb p  dde polychlorin biphenyl sum marker pcb num num signific posit pubert stage pubic hair genit develop higher level serum hcb blood lead lower higher risk gynecomastia girl signific negat associ detect blood lead pubic hair develop higher exposur pcbs signific delay time menarch environment exposur pollut level present flemish popul measur effect pubert develop understand toxic mode action sensit window exposur explain current find
MED-3959~higher level igf i adren androgen age num year earlier age menarch girl abstract context earlier age menarch rapid infanc weight gain childhood obes role hormon level mediat associ unclear object aim studi identifi childhood hormon level age num yr earli menarch independ bodi size design set subject total num girl prospect unit kingdom birth cohort studi provid blood sampl age num yr rang num num hormon measur longitudin establish age menarch main outcom measur fast plasma level igf i androstenedion dehydroepiandrosteron sulfat dhea leptin insulin igf bind protein num shbg measur age menarch report questionnair categor num num num num yr result earlier menarch greater bodi weight height bodi mass index age num yr p trend num adjust bodi size earlier menarch higher level igf i androstenedion dhea leptin fast insulin lower level igf bind protein num shbg age num yr num adjust bodi mass index height age num yr igf i num androstenedion num dhea num remain earlier menarch conclus associ higher level igf i adren androgen age num yr earlier menarch independ bodi size support function role hormon regul puberti time girl higher level hormon report children exhibit rapid weight gain infanc role development pathway lead earlier sexual matur
MED-3960~dietari microparticl impact toler immun respons gastrointestin tract abstract dietari microparticl non biolog bacterial s particl gastrointestin lumen occur due endogen format calcium phosphat oral exposur exogen microparticl uk num mg num exogen microparticl ingest person day exposur food addit pharmaceutical suppl excipi toothpast constitu ingest exogen microparticl pass gastrointestin tract adsorb surfac ion molecul intestin lumen entropi ionic attract drive interact calcium ion adsorb dietari microparticl provid posit charg surfac attract adsorpt organ molecul lipopolysaccharid peptidoglycan protein antigen diet commens flora major site microparticl entri intestin tissu m cell rich lymphoid aggreg term peyer patch small bowel establish effici transport rout non biolog microparticl unclear hypothesis pathway exist endogen microparticl calcium phosphat immunolog physiolog benefit exogen dietari microparticl titanium dioxid silic hijack rout overview focus microparticl outlin potenti role immun toler gut endogen microparticl immun activ exogen microparticl inflamm gut
MED-3961~lack efficaci reduc microparticl diet multi centr trial patient activ crohn diseas pubm ncbi abstract background aim dietari microparticl bacteria s non biolog found modern western diet implic aetiolog pathogenesi crohn diseas find previous pilot studi aim confirm reduct amount dietari microparticl facilit induct remiss patient activ crohn diseas single blind random multi centr placebo control trial method eighty thre patient activ crohn diseas random alloc num num factori design diet low normal microparticl and or calcium num week patient receiv reduc dose prednisolon num week outcom measur crohn diseas activ index van hee index qualiti life seri object measur inflamm includ erythrocyt sediment rate c reactiv protein intestin permeabl faecal calprotectin num week patient return normal diet num week result dietari manipul provid ad effect corticosteroid treatment outcom measur dietari trial num week follow up num year logist regress crohn diseas activ index base rate remiss num clinic respons num normal versus low microparticl group conclus adequ power care control dietari trial found evid reduc microparticl intak aid remiss activ crohn diseas
MED-3962~biocompat micro nano particl colon part ii pubm ncbi abstract patholog colon tissu investig environment scan electron microscop techniqu verifi presenc inorgan non biodegrad pollut micro nano debri exogen origin debri liver kidney discov num sampl colon tissu affect cancer crohn diseas evalu found case micro nano particl chemistri detect x ray microprob heterogen natur size particl homogen control sampl healthi young cadav analys show absenc debri normal healthi colon mucosa studi reveal presenc particul debri general consid biocompat patholog specimen human colon find suggest link presenc particl patholog case analys
MED-3963~dietari sourc inorgan microparticl intak healthi subject patient crohn diseas pubm ncbi abstract dietari microparticl non biolog bacterial s particl endogen sourc deriv intestin ca phosphat secret exogen sourc titanium dioxid tio num mix silic psil resist degrad accumul human peyer patch macrophag evid exacerb inflamm crohn diseas cd intak differ cd studi aim identifi dietari microparticl sourc intak subject cd patient inact cd match general practice bas control ninety on group complet num food diari intak data dietari fibr sucros compar posit control food pharmaceut toothpast examin microparticl content intak ca exogen microparticl compar group dietari intak signific case control dietari fibr num sd num num sd num g d num sucros num sd num num sd num g d num ca estim median tio num psil intak num num mg individu total num num microparticles individu broad similar capita estim wide variat intak individu signific differ subject cd control exposur microparticl inflamm cd present studi rule excess intak problem nonetheless microparticle contain food identifi low microparticl diet assess cd
MED-3964~diet risk inflammatori bowel diseas pubm ncbi abstract background understand environment factor lead inflammatori bowel diseas prevent occurr diseas relaps aim review current knowledg dietari risk factor inflammatori bowel diseas method pubm medlin cochran librari search studi diet risk inflammatori bowel diseas result establish non diet risk factor includ famili predisposit smoke appendectomi antibiot retrospect case control studi encumb methodolog problem prospect studi european cohort includ middle ag adult suggest diet high protein meat fish higher risk inflammatori bowel diseas intak num polyunsatur fatti acid linol acid confer risk ulcer coliti num polyunsatur fatti acid protect effect found intak dietari fibr sugar macronutri total energi vitamin caroten retinol vitamin risk ulcer coliti prospect data found risk relat intak fruit veget food microparticl titanium dioxid aluminium silic conclus diet high protein anim protein increas risk inflammatori bowel diseas relaps num polyunsatur fatti acid predispos ulcer coliti whilst num polyunsatur fatti acid protect result confirm countri younger subject dietari counsel recommend high risk subject copyright num editric gastroenterologica italiana publish elsevi reserv
MED-3965~efficaci toler low microparticl diet doubl blind random pilot studi crohn diseas pubm ncbi abstract background ultrafin fine particl potent adjuv antigen medi immun respons inflamm suscept individu recent find microparticl accumul phagocyt intestin lymphoid aggreg studi investig reduct diet improv symptom crohn diseas method doubl blind studi num patient activ corticosteroid tr ileal ileo colon crohn diseas random receiv low microparticl diet trial group num control diet num num month crohn diseas activ index cdai corticosteroid requir compar result patient group withdrawn trial group progress decreas cdai entri num num month num num num control group patient remiss cdai num contrast control group return baselin level num num entri num num month num remiss corticosteroid intak reduc trial group reach signific conclus low microparticl diet effect manag ileal crohn diseas explain efficaci element diet similar low microparticl
MED-3966~fine ultrafin particl diet influenc mucos immun respons associ crohn diseas pubm ncbi abstract crohn diseas modern western diseas characteris transmur inflamm gastrointestin tract unknown aetiolog evid suggest result combin genet predisposit environment factor bacterial s microparticl num num microm potent adjuv model antigen medi immun respons increas diseas microparticl tio num aluminosil accumul macrophag human gut associ lymphoid tissu earliest sign lesion crohn diseas observ dietari microparticl endogen exogen origin endogen microparticl domin calcium phosphat hydroxyapatit precipit lumen mid dist gastrointestin tract due secret ca phosphat succus entericus exogen dietari microparticl contamin soil and or dust food addit tio num food colour aluminosil anti cak agent aluminosil occur natur contamin food addit account ingest approxim num particles person mechan role exogen endogen dietari microparticl promot toleragen immun respons gastrointestin mucos phagocytosi discuss double blind randomis pilot studi shown diet low ca exogen microparticl allevi symptom ileal crohn diseas signific num improv crohn diseas activ index multi centr trial mechanist studi cellular level underway
MED-3967~dietari microparticl implic crohn diseas impair macrophag phagocyt activ act adjuv presenc bacteri st pubm ncbi abstract object design western diet regular expos gastrointestin tract gi larg quantiti num day man mad submicron s particl deriv food addit excipi cell accumul gut macrophag influenc aetiolog inflammatori bowel diseas ibd materi investig effect common dietari microparticl function macrophag healthi donor activ crohn diseas cd patient method macrophag incub num microparticl assay cytokin product phagocyt activ result microparticl non stimulatori presenc bacteri antigen lps act adjuv induc potent cytokin respons uptak high concentr microparticl impair macrophag phagocyt capac abil num icrom fluoresc bead conclus dietari microparticl limit effect basic macrophag function abil act adjuv aggrav ongo inflammatori respons bacteri antigen gi tract
MED-3968~origin fate dietari nanoparticl microparticl gastrointestin tract pubm ncbi abstract human evolv oral exposur dietari microparticl nanoparticl normal occurr ever grow exploit nanotechnolog increas exposur qualit quantit unlik situat respir particl gastrointestin intak handl nanoparticl long term interest gut exposur respons dietari microparticl group appli expertis nanoparticl gastrointestin tract aim address current challeng characteris particle host particle cel interact ii origin mechan uptak particl gastrointestin tract peyer patch iii potenti cellular effect nanoparticl generat reactiv oxygen speci inflammasom activ microparticl adjuv activ pro inflammatori signal immun respons copyright num elsevi reserv
MED-3969~titanium dioxid nanoparticl food person care product abstract titanium dioxid common addit food person care consum product peopl enter sewag system subsequ enter environ treat effluent discharg surfac water biosolid appli agricultur land inciner wast landfil solid studi quantifi amount titanium common food product deriv estim human exposur dietari nano tio num discuss impact nanoscal fraction tio num enter environ food highest content tio num includ candi sweet chew gum person care product toothpast select sunscreen num num titanium weight cr mes titanium color white shampoo deodor shave cream lowest level titanium num g mg high consumpt pharmaceut titanium content rang instrument detect limit num ti mg high num ti mg electron microscopi stabil test food grad tio num num suggest approxim num particl num nm dimens readili dispers water fair stabl colloid filtrat water solubil consum product person care product num titanium pass num num pore white paint num ti mg sealant prime coat paint titanium num num ti mg research show white color product titanium prerequisit product class low amount titanium widespread dispos drain eventu wwtps deserv attent mont carlo human exposur analysi tio num food identifi children highest exposur tio num content sweet higher food product typic exposur adult order num mg ti kilogram bodi weight day million ton titanium base white pigment annual test focus food grad tio num num adopt environment health safeti test num lower amount product enter environ catalyst support photocatalyt coat
MED-3970~immun potenti ultrafin dietari particl normal subject patient inflammatori bowel diseas pubm ncbi abstract specif non specif environment factor induct and or exacerb diseas activ patient crohn diseas ulcer coliti factor potenti role ingest ultrafin particl fact base western diet recent data suggest num ultrafin particl ingest person day microparticl consid inert adsorb endogen constitu intestin lumen human intestin lymphoid aggreg base observ determin dietari microparticl titanium dioxid tio num alter intestin cell respons lipopolysaccharid lps colon biopsi specimen num patient ulcer coliti num crohn diseas num healthi control sampl peripher blood mononuclear cell incub control lps num num ng ml tio num num microg ml lps num ng ml adsorb tio num num microg ml case level interleukin num il num produc assay quantit bioassay elisa interest dramat stimul peripher blood mononuclear cell tio num lps conjug valu num fold control minor stimul lps tio num intestin organ cultur increas il num secret challeng tio num num ng ml lps tio num lps conjug produc two to three fold signific increas intestin secret il num data demonstr ultrafin dietari particl immunolog inert import adjunct overcom normal gut cell hyporespons endogen lumin molecul relev patient inflammatori bowel diseas abnorm intestin permeabl copyright num academ press
MED-3971~povidon iodine induc overt hypothyroid patient prolong habitu gargl urinari excret iodin gargl normal su pubm ncbi abstract iodine induc hypothyroid develop patient gargl routin povidon iodin hypothyroid mild resolv spontan cessat gargl report num year old patient overt hypothyroid develop due habitu gargl povidon iodin num year urinari excret iodin estim greater num mg day base valu obtain num normal subject gargl time day num num mg mean   sd discontinu gargl patient euthyroid num month
MED-3972~prevent upper respiratori tract infect gargl random trial pubm ncbi abstract background gargl wash throat common perform japan peopl hygien routin gargl medicin prevent upper respiratori tract infect urti effect establish clinic trial design random control trial carri num winter season analyz num num particip healthi volunt num age num num year intervent particip random assign water gargl povidone iodin gargl usual care control subject gargl group request gargl water dilut povidone iodin time day particip num day main outcom measur primari outcom measur urti incid sever urti symptom incid case evalu outcom assess self administ symptom record analys perform intention to treat basi result total num particip contract urti incid rate urti num episod num person day control subject rate decreas num episod num person day water gargl group num episod num person day povidone iodin gargl group respect incid rate ratio control num num confid interv ci num num num num ci num num cox regress proport hazard model reveal efficaci water gargl hazard ratio num num ci num num urti occur water gargl tend attenu bronchial symptom num conclus simpl water gargl effect prevent urti healthi peopl virtual cost fre modal appreci benefit general popul
MED-3973~gargl oral hygien develop fever childhood popul studi japan abstract background fever common symptom children caus respiratori infect japanes health author long recommend gargl prevent respiratori infect effect children clear method children observ studi enrol num nurseri school fukuoka citi japan children exposur group instruct gargl day endpoint studi incid fever daytim incid sick absenc differ gargl agent endpoint analyz result total num children age num num year observ num day num person day multivari logist regress odd ratio fever onset gargl group signific lower num age stratifi analysi signific lower age num num num num num num year sick absenc num signific gargl group age stratifi analysi signific lower age num num num num num num year subgroup analysi signific lower fever onset observ children gargl green tea num function water num tap water num signific sick absenc conclus gargl effect prevent febril diseas children
MED-3974~econom burden non influenza rel viral respiratori tract infect unit state pubm ncbi abstract background viral respiratori tract infect vrti common ill human high incid econom impact non influenza rel vrti rigor explor object obtain updat incid non influenza rel vrti unit state quantifi health care resourc direct cost product loss indirect cost infect method nationwid telephon survey household num conduct novemb num februari num obtain repres estim self report incid non influenza rel vrti relat treatment pattern direct treatment cost measur includ outpati clinician encount over the count prescript drug infecti complic non influenza rel vrti absente estim infect individu parent infect children extrapol nation health interview survey data result survey respond num report non influenza rel vrti past year respond experienc self report non influenza rel vrti averag num episod annual rate extrapol entir popul approxim num million non influenza rel vrti episod occur year similar treatment pattern report respond extend popul total econom impact non influenza rel vrti approach num billion annual direct cost num billion year indirect cost num billion year conclus larg high attack rate non influenza rel vrti impos greater econom burden clinic condit pend avail effect antivir therapi warrant increas attent paid common expens ill
MED-3975~cost effect gargl prevent upper respiratori tract infect abstract background japan gargl general accept prevent upper respiratori tract infect urti effect gargl prevent urti shown random control trial compar incid urti gargl control group perspect third parti payer gargl domin due fact cost gargl born particip cost effect gargl societ perspect consid studi econom evalu alongsid random control trial perform evalu cost effect gargl prevent urti societ perspect method particip gargl trial num water gargl num control subject involv econom analysi sixty day cumul follow up cost effect measur quality adjust life day qald compar group intention to treat basi increment cost effect ratio icer convert dollar quality adjust life year qali num confid interv num ci probabl gargl cost effect estim bootstrap result num day qald increas num cost num higher gargl group control group icer gargl group num qali num ci num num resembl accept form medic intervent includ urti prevent measur influenza vaccin broad confid interv uncertainti surround result addit one way sensit analysi care evalu requir cost gargl util moder urti major limit studi trial conduct winter time urti preval care appli result season urti preval icer increas due decreas incid conclus studi suggest gargl cost effect prevent strategi urti accept perspect third parti payer societi
MED-3976~respiratori tract ill year life effect dog cat contact pubm ncbi abstract object investig effect dog cat contact frequenc respiratori symptom infect year life method birth cohort studi num children pregnanc onward frequenc respiratori symptom infect inform dog cat contact year life report week diari questionnair age num year children born eastern middl finland septemb num num result multivari analysi children dog home healthier fewer respiratori tract symptom infect children dog contact adjust odd ratio aor num num confid interv ci num num children dog contact home frequent otiti aor num num ci num num tend fewer cours antibiot aor num num ci num num children contact univari analysi week amount contact dog cat averag year amount contact decreas respiratori infecti diseas morbid conclus result suggest dog contact protect effect respiratori tract infect year life find support theori year life anim contact import possibl lead resist infecti respiratori ill childhood
MED-3977~surviv acut coronari syndrom pet theori put test pubm ncbi abstract object aim studi revisit find previous studi report pet ownership improv outcom admiss acut coronari syndrom ac method hundr twenty four patient admit cardiac unit ac complet question pet ownership hospit rate cardiac death readmiss assess num year hospit result pet owner experi death readmiss hospit control key psychosoci medic covari dog cat owner consid separ cat ownership signific increas risk death readmiss conclus independ studi pet ownership baselin cat ownership increas cardiac morbid mortal year admiss acut coronari syndrom find contrari previous report
MED-3978~dog cat ownership lead increas gastroenter young children south australia summari aim studi investig relationship dog cat ownership gastroenter young children diari studi num children age num num year live rural semi rur south australia undertaken data collect pet ownership drink water risk factor gastroenter num household pet dog ownership common cat ownership multivari model gastroenter pet ownership live household dog cat reduc risk gastroenter adj num num ci num num num num num num ci num num num num paper add evid pet major sourc gastroenter home lend support health benefit pet ownership weigh potenti negat consequ dog bite age group
MED-3979~histori respiratori infect num yr children birth cohort pubm ncbi abstract respiratori infect frequent health problem childhood precis inform respiratori ill episod expect normal child studi design creat refer valu frequenc respiratori infect record histori respiratori ill record prospect birth cohort num german children born num track age num yr num children parent record child ill diari answer structur question year age num age studi subject categor infanc num yr pre school age num yr school age num yr cumul number respiratori infect episod age num yr num num episod infanc annual number num num episod pre school age num num episod school age num num episod cumul time episod age num yr num num wk forty f percent infant upper episod incid tertil continu upper tertil school age base twofold standard deviat number num respiratori infect episod year infanc num episod year pre school age num episod year school age regard normal episod refer valu se unwarr concern intervent suspect immunodefici
MED-3980~pet health abstract background pet ownership thought health benefit scientif explor found proper applic repres sampl statist correct methodolog databank small proper statist analys random sampl particip voluntari direct causal evalu incorrect control relev factor note defici studi examin associ pet ownership perceiv health diseas indic account socio demograph background factor health risk factor includ exercis methodology princip find present studi baselin data num year health social support studi hessup studi finnish popul regist centr draw population bas random sampl stratifi gender age group num num num num num num year total num working ag finn respond baselin survey questionnair num year hessup studi num ordin binari logist regress analyz cross sect data pet ownership poor good perceiv health bmi surfac risk factor strong pet ownership conclusions signific pet owner set older found slight higher bmi rest addit research test hypothes involv effect pet ownership health dimens popul group compos kind background characterist
MED-3981~factor acut respiratori ill day care children pubm ncbi abstract aim studi investig relationship child characterist parent environment factor occurr acut respiratori ill ari acut otiti media aom finnish children attend day care centr dccs studi cross sect questionnair num children age num num dccs helsinki finland recurr num diseases i ari present num num y old num num y old recurr aom num num parent atop diseas odd ratio num num mother academ educ num num medium length dcc attend compar short period num num increas furri pet num num older child age num num reduc risk recurr ari recurr ari num num mother academ educ num num medium length dcc attend compar short period num num increas partial breastfeed num month num num older child age num num reduc risk recurr aom parent environment factor signific impact recurr ari aom episod children attend dccs risk factor consid futur studi intend reduc dcc infect
MED-3982~pet ownership risk factor cardiovascular diseas pubm ncbi abstract object test claim pet ownership reduc cardiovascular risk design communiti survey particip num adult age num year num age num year live australian capit territori queanbeyan south wale drawn random australian elector roll num num main outcom measur sociodemograph measur includ pet ownership measur physic health includ bodi mass index bmi alcohol cigarett consumpt level physic activ read diastol systol blood pressur result pet owner non pet owner similar level systol blood pressur pet signific higher diastol blood pressur pet owner higher bmi smoke pet undertook mild physic activ continu signific higher diastol blood pressur control hypertens risk factor conclus studi found evid pet ownership se cardiovascular health benefit pet owner higher diastol blood pressur pet increas health risk link hypertens risk factor indirect pet ownership
MED-3983~molecular epidemiolog rabi virus vietnam num pubm ncbi abstract studi aim determin molecular epidemiolog rabi virus rabv circul vietnam intra vitam sampl saliva cerebrospin fluid collect num patient believ rabi admit hospit northern provinc vietnam brain sampl collect num sick furious rabid dog countri human canin sampl subject revers transcription polymeras chain reaction analysi find show num patient test posit rabv interest num rabi patient histori dog cat bite experi butcher dog cat consum meat rabv detect num num sick dog slaughterhous molecular epidemiolog analysi num rabv strain show virus classifi group rabv classifi group num distribut vietnam sequenc similar strain china thailand malaysia philippin rabv classifi group num found northern provinc vietnam show high sequenc similar strain southern china find suggest recent influx group num rabv vietnam china border incid rabi due circul rabv slaughterhous common due dog bite nation program rabi control prevent vietnam includ monitor health dog meant human consumpt vaccin worker dog slaughterhous monitor research circul rabv dog market determin rabi control spread rabi slaughterhous vietnam
MED-3984~molecular epidemiolog rabi southern peopl republ china abstract recent year number human rabi case peopl republ china increas sever epidem num southern provinc guizhou guangxi hunan analyz high incid human rabi region num num collect num brain specimen appar healthi domest dog meat consumpt restaur num specimen suspect rabid dog num human rabi num provinc partial nucleoprotein gene sequenc obtain rabies posit specimen phylogenet relationship distribut virus determin infer spread rabi virus high incid region long dist movement transprovinci transloc dog caus human rel activ num recent massiv human rabi epidem southern china
MED-3985~vitamin defici treat consum uvb irradi mushroom abstract defici vitamin caus dietari defici and or lack exposur sunlight dark skin individu live northern latitud simpl vitamin defici common treat prescrib vitamin calcium supplement report present patient reject approach research altern treatment option independ opt self treat consum uvb irradi mushroom benefici effect patient plasma biochem marker shown research benefici effect consum uvb irradi mushroom requir
MED-3986~bioavail vitamin uv b irradi button mushroom healthi adult defici serum num hydroxyvitamin random control pubm ncbi abstract background object mushroom vitamin num abund ergosterol convert vitamin num ultraviolet uv irradi object investig bioavail vitamin num vitamin num enhanc mushroom uv b human compar vitamin num supplement subjects method fresh mushroom irradi uv b dose num j cm num increas vitamin num content num num num made experiment soup num week single blind random placebo control trial num young subject serum num hydroxyvitamin num hd num nmol l random assign group mushroom supplement placebo receiv winter num iu num vitamin num experiment soup num iu vitamin num supplement placebo result num week serum num hd signific higher mushroom placebo group num serum num hd concentr mushroom supplement group rose signific similar studi period num nmol l num confid interv num ci num num num nmol l week num ci num num conclus demonstr human bioavail vitamin num vitamin num enhanc button mushroom uv b irradi effect improv vitamin status vitamin num supplement trial regist http   germanctr de drks num
MED-3987~comparison vitamin num vitamin num supplement rais serum num hydroxyvitamin status systemat review meta analysi abstract background lack clariti literatur definit differ effect vitamin num num rais serum num hydroxyvitamin num object object articl report systemat review meta analysi random control trial rcts direct compar effect vitamin num vitamin num serum num concentr human design isi web knowledg januari num juli num databas search electron relev studi adult direct compar vitamin num vitamin num cochran clinic trial registri intern standard random control trial number regist clinicaltri gov search unpublish trial result meta analysi rcts supplement vitamin num signific posit effect rais serum num concentr compar effect vitamin num num frequenc dosag administr compar signific respons vitamin num bolus dose num compar administr vitamin num effect lost daili supplement conclus meta analysi vitamin num efficaci rais serum num concentr vitamin num vitamin num potenti prefer choic supplement addit research requir examin metabol pathway involv oral intramuscular administr vitamin effect age sex ethnic review unabl verifi
MED-3988~vitamin num effect vitamin num maintain circul concentr num hydroxyvitamin abstract context report suggest vitamin num effect vitamin num maintain vitamin status object object determin vitamin num effect vitamin num maintain serum num hydroxyvitamin level increas catabol num hydroxyvitamin num subject design random placebo control double blind studi healthi adult age num num yr receiv placebo num iu vitamin num iu vitamin num num iu vitamin num num iu vitamin num daili num wk end winter result sixti percent healthi adult vitamin defici start studi circul level num hydroxyvitamin sd increas extent group receiv num iu daili vitamin num baselin num num ng ml num wk num num ng ml vitamin num baselin num num ng ml num wk num num ng ml combin num iu vitamin num num iu vitamin num baselin num num ng ml num wk num num ng ml num hydroxyvitamin num level chang group receiv num iu vitamin num daili num iu dose vitamin num vitamin num rais num hydroxyvitamin level vitamin d defici subject num ng ml conclus num iu dose vitamin num daili effect num iu vitamin num maintain serum num hydroxyvitamin level negat influenc serum num hydroxyvitamin num level vitamin num equal effect vitamin num maintain num hydroxyvitamin status
MED-3989~vitamin sterol composit num type mushroom retail supplier unit state pubm ncbi abstract vitamin num ergocalciferol sterol analyz mushroom sampl nationwid unit state updat usda nutrient databas standard refer vitamin num assay hplc num h  vitamin num intern standard sterol gc fid mass spectrometr ms confirm vitamin num low num num num agaricus bisporus white button crimini portabella enoki moder shiitak oyster num num num high morel chanterell maitak num num num uv treat portabella num num num signific variabl composit type ergosterol mg num highest maitak shiitak num num lowest morel enoki num num rang num mg num white button composit num mg num sampl type mushroom ergosta num dienol num dihydroergosterol num num mg num morel ergosta num enol morel brassicasterol num mg num campesterol num num mg num ergosta num dienol ms critic distinguish campesterol ergosta num dienol
MED-3990~vitamin supplement prevent mortal adult pubm ncbi abstract background evid vitamin mortal inconclus object assess benefici harm effect vitamin prevent mortal adult search strategi search cochran librari medlin embas lilac scienc citat index expand confer proceed citat index sci januari num scan bibliographi relev public expert pharmaceut compani addit trial select criteria includ randomis trial compar vitamin dose durat rout administr versus placebo intervent vitamin administ supplement vitamin vitamin num cholecalciferol vitamin num ergocalciferol activ form vitamin num hydroxyvitamin alfacalcidol num dihydroxyvitamin calcitriol data collect analysi author extract data independ random effect fixed effect model meta analys conduct dichotom outcom calcul risk ratio rr account trial event meta analys dichotom data repeat risk differ empir continu correct risk bias consid order minimis risk systemat error trial sequenti analys conduct minimis risk random error main result fifti randomis trial num particip provid data mortal analys trial includ elder women older num year vitamin administ median year half trial low risk bias vitamin decreas mortal rr num num confid interv ci num num num num form vitamin assess separ vitamin num decreas mortal signific rr num num ci num num num num num particip num trial vitamin num alfacalcidol calcitriol trial sequenti analysi support find vitamin num num individu treat prevent addit death vitamin num combin calcium increas risk nephrolithiasi rr num num ci num num num num alfacalcidol calcitriol increas risk hypercalcaemia rr num num ci num num num num data health rel qualiti life health econom inconclus author conclus vitamin form vitamin num decreas mortal predomin elder women institut depend care vitamin num alfacalcidol calcitriol statist signific effect mortal vitamin num combin calcium signific increas nephrolithiasi alfacalcidol calcitriol signific increas hypercalcaemia
MED-3991~ergocalciferol mushroom supplement consum standard meal increas num hydroxyergocalciferol decreas num hydroxycholecalcif pubm ncbi abstract food ergocalciferol cholecalciferol treatment mushroom uv light increas ergocalciferol content provid dietari sourc vitamin evalu impact consum uv treat white button mushroom agaricus bisporus vitamin status healthi adult thirty eight volunt random num treatment consum standard meal num wk control group receiv untreat mushroom provid num g d ergocalciferol num group num num receiv uv treat mushroom provid num num num g d num supplement group receiv purifi ergocalciferol untreat mushroom provid total num g d num serum total num hydroxyvitamin num num hydroxyergocalciferol num num num num num num nmol l baselin sd wk num num increas higher treatment group group num hydroxycholecalciferol num num decreas lower num group group increas num num group num num num num num num num num num num nmol l decreas num num num num num num num num num num nmol l concentr chang group summari ergocalciferol absorb metabol num num affect vitamin status num num decreas proport
MED-4000~coconut oil predict benefici lipid profil pre menopaus women philippin abstract coconut oil common edibl oil countri mix evid effect lipid profil cardiovascular diseas risk examin associ coconut oil consumpt lipid profil cohort num filipino women age num num year particip cebu longitudin health nutrit survey communiti base studi metropolitan cebu citi coconut oil intak measur individu coconut oil intak calcul num hour dietari recal num num gram cholesterol profil measur plasma sampl collect overnight fast lipid valu sampl total cholesterol tc num num mg dl high densiti lipoprotein cholesterol hdl c num num mg dl low densiti lipoprotein cholesterol ldl c num num mg dl triglycerid num num mg dl tc hdl ratio num num linear regress model estim associ coconut oil intak plasma lipid outcom adjust total energi intak age bodi mass index bmi number pregnanc educ menopaus status household asset urban resid dietari coconut oil intak posit hdl c level
MED-4001~open label pilot studi assess efficaci safeti virgin coconut oil reduc viscer adipos abstract introduct open label pilot studi week virgin coconut oil vco investig efficaci weight reduct safeti num obes healthi malay volunt methodolog efficaci assess measur weight anthropometr paramet lipid profil week week vco intak safeti assess compar organ function test week week intak vco pair t test analys differ measur variabl result waist circumfer wc signific reduc reduct num cm num initi measur num wc reduct male num chang lipid profil small reduct creatinin alanin transferas level conclus vco efficaci wc reduct male safe human
MED-4002~effect dietari coconut oil biochem anthropometr profil women present abdomin obes pubm ncbi abstract effect dietari supplement coconut oil biochem anthropometr profil women present waist circumfer wc num cm abdomin obes investig randomis double blind clinic trial involv num women age num year group receiv daili dietari supplement compris num ml soy bean oil group num coconut oil group num num week period subject instruct follow balanc hypocalor diet walk num min day data collect num week num num week num dietari intervent energi intak amount carbohydr ingest group diminish trial consumpt protein fibr increas lipid ingest remain unchang num differ biochem anthropometr characterist group num group present higher level hdl num num num num num lower ldl hdl ratio num num num num num reduct bmi observ group num num group exhibit reduct wc num group present increas num total cholesterol ldl ldl hdl ratio whilst hdl diminish num alter observ group dietet supplement coconut oil dyslipidemia promot reduct abdomin obes
MED-4004~coconut oil enhanc tomato carotenoid tissu accumul compar safflow oil mongolian gerbil merion unguiculatus pubm ncbi abstract evid suggest monounsatur polyunsatur fat facilit greater absorpt carotenoid satur fat comparison consum polyunsatur fat sourc versus satur fat sourc tomato carotenoid bioaccumul examin goal studi determin influenc coconut oil safflow oil tomato carotenoid tissu accumul mongolian gerbil merion unguiculatus fed num fat diet coconut oil feed increas carotenoid concentr compart includ total carotenoid serum num adren glandular phytoen num hepat phytofluen num testicular all trans lycopen num cis lycopen num prostate semin vesicl complex compar safflow oil safflow oil f gerbil greater splenic lycopen concentr num compar coconut oil f gerbil coconut oil feed increas serum cholesterol num decreas hepat cholesterol num compar safflow oil summari coconut oil enhanc tissu uptak tomato carotenoid greater degre safflow oil result due larg proport medium chain fatti acid coconut oil caus shift cholesterol flux favor extrahepat carotenoid tissu deposit
MED-4005~effect fat composit singl high fat meal inflammatori marker healthi young women pubm ncbi abstract aim present studi examin effect singl high fat meal fat qualiti circul inflammatori marker gene express peripher blood mononuclear cell pbmc elucid role fat qualiti postprandi inflamm postprandi studi fourteen healthi femal consum test meal fat qualiti perform test day separ num week fast postprandi blood sampl num num intak analys test meal consist cake enrich coconut fat num energi satur fat num energi linolen acid ala linse oil num energi ala num energi satur fat cod liver oil num energi epa dha num energi ala addit num energi satur fat addit vivo pbmc experi perform healthi subject investig effect epa ala releas gene express inflammatori marker il num mrna level signific increas intak cod liver oil cake num compar fast level signific effect observ intak linse cake contrast effect circul level il num addit ala epa shown elicit effect releas mrna express level inflammatori marker pbmc cultur vivo epa promin pro inflammatori potenti
MED-4006~diet high palmit acid num lauric myrist acid num num oleic acid num alter postprandi fast plasma homoc pubm ncbi abstract background dietari fat type modul plasma lipid profil effect plasma homocystein inflammatori marker unclear object investig effect high protein malaysian diet prepar palm olein coconut oil virgin oliv oil plasma homocystein select marker inflamm cardiovascular diseas cvd healthi adult design randomized crossov intervent num dietari sequenc num wk conduct num healthi subject num test fat palmit acid num rich palm olein po lauric myrist acid num num rich oleic acid num rich virgin oliv oil oo incorpor two third num fat calori high protein malaysian diet result signific differ observ effect num diet plasma total homocystein thci inflammatori marker tnf il num il num il num high sensit c reactiv protein interferon diet prepar po oo compar nonhypercholesterolem effect postprandi total cholesterol diet fast lipid index oo diet signific lower num diet unlik po oo diet diet shown decreas postprandi lipoprotein conclus diet rich satur fatti acid prepar po oo diet high oleic acid alter postprandi fast plasma concentr thci select inflammatori marker trial regist clinicaltri gov nct num
MED-4007~studi ketogen agent ac num mild moder alzheimer diseas random double blind placebo control multicent trial abstract background alzheimer diseas ad character earli region specif declin cerebr glucos metabol keton bodi produc bodi glucos depriv metabol brain oral ketogen compound ac num test subject probabl ad examin ketosi improv cognit perform method daili administr ac num evalu num subject diagnos mild moder ad us bas num day random double blind placebo control parallel group studi subject normal diet continu approv ad medic primari cognit end point chang baselin ad assess scale cognit subscal adas cog global score ad cooper studi clinic global impress chang adcs cgic ac num compar placebo popul group includ intention to treat itt protocol dosag compliant group result stratifi apo num carriag status predefin analysi base epsilon num num variant apolipoprotein gene trial regist clinicaltri gov registri number nct num inform http   clinicaltri gov ct num show nct num result ac num signific elev serum keton bodi hydroxybutyr num hour administr compar placebo popul group signific differ found ac num placebo chang baselin adas cog score day num num point differ num itt num point differ num protocol num point differ num dosag compliant particip carri apo num allel num signific differ found ac num placebo chang baselin adas cog score day num day num itt popul num particip num administ ac num signific num point differ chang baselin adas cog score day num num num point differ day num num compar placebo protocol popul num particip receiv ac num num differ placebo num point day num num num point day num num dosag compliant popul num particip receiv ac num differ placebo num point day num num num num point day num num num signific pharmacolog respons observ serum hydroxybutyr level chang adas cog score num subject day num num advers event occur frequent ac num subject primarili restrict gastrointestin system mild moder sever transient natur conclus ac num rapid elev serum keton bodi ad patient result signific differ adas cog score compar placebo effect notabl apo num subject dosag compliant
MED-4013~periodont diseas brachial arteri endotheli dysfunct system inflamm pubm ncbi abstract object purpos studi determin periodont diseas endotheli dysfunct system inflamm epidemiolog studi suggest sever periodont diseas increas cardiovascular diseas risk mechan remain unknown method result assess flow medi dilat nitroglycerin medi dilat brachial arteri vascular ultrasound num subject advanc periodont diseas num control subject group match age sex patient hypercholesterolemia diabet mellitus hypertens histori cigarett smoke exclud examin serum level c reactiv protein establish high sensit method subject advanc periodont diseas lower flow medi dilat compar control patient num num versus num num num nitroglycerin medi dilat equival group subject advanc periodont exhibit higher serum level high sensit c reactiv protein compar healthi control patient num num versus num num mg l num conclus subject advanc periodont diseas exhibit endotheli dysfunct evid system inflamm possibl place increas risk cardiovascular diseas
MED-4019~one to on dietari intervent undertaken dental set chang dietari behaviour pubm ncbi abstract background dental care set place deliv dietari assess advic part patient manag effect chang dietari behaviour object assess effect one to on dietari intervent age carri dental care set chang dietari behaviour effect intervent subsequ chang oral general health assess search method electron databas search cochran oral health group trial regist num januari num cochran central regist control trial central cochran librari num issu num medlin ovid num num januari num embas ovid num num januari num cinahl ebsco num num januari num psycinfo ovid num num januari num web scienc num num april num undertook electron search key confer proceed iadr orca num num juli num refer list relev articl thesi public dissert abstract onlin num num search author elig trial contact identifi unpublish work select criteria randomis control trial assess effect one to on dietari intervent deliv dental care set data collect analysi abstract screen elig screen data extract decis carri independ duplic review author consensus opinion achiev discuss involv review author main result studi met criteria inclus review multi intervent studi dietari intervent compon wider programm prevent data dietari behaviour chang report singl intervent studi concern dental cari prevent concern general health outcom studi concern dietari chang aim prevent tooth eros includ studi signific chang dietari behaviour found primari outcom variabl author conclus evid one to on dietari intervent dental set chang behaviour evid greater intervent aim chang fruit veget alcohol consumpt aim chang dietari sugar consumpt studi dental practic set greater methodolog rigour design statist analysi report studi
MED-4022~associ chronic periodont vasculogen erectil dysfunct pubm ncbi abstract background erectil dysfunct ed chronic periodont cp share common risk factor report associ ed cp aim studi find associ vasculogen ed cp method total num patient age num num year clinic diagnos ed includ studi sexual health inventori men questionnair subject color penil doppler ultrasound periodont paramet probe depth periodont attach level record patient ed cp select random cardiac color doppler assess integr result select vasculogen patient ed mild to moder vasculogen ed show highest preval preval cp vasculogen patient ed highest sever ed num associ cp vasculogen ed found correl posit show statist signific patient found vascular insuffici conclus hypothes associ exist vasculogen ed cp young male large scal studi confound analysi longitudin follow up warrant
MED-4023~assess influenc vegetarian diet occurr eros abras caviti hard tooth tissu pubm ncbi abstract introduct aim studi determin potenti relat vegetarian diet tooth eros abras material method examin includ num vegetarian number control group clinic research carri order detect presenc abras eros level hygien oral caviti questionnair survey concern dietari hygien habit statist analysi data conduct chi squar test mann whitney test relat vegetarian diet occurr non cari caviti test model logist regress result tooth eros present num vegetarian num control abras num num differ statist insignific distribut similar group vegetarian signific frequent consumpt sour product predomin raw veget fruit tomato observ level oral hygien hygien habit similar group analysi statist regress reveal relat vegetarian diet occurr tooth eros abras discuss result reveal direct influenc vegetarian diet occurr eros abras vegetarian group frequent consumpt sour product common horizont brush method observ slight higher occurr non cari caviti research requir obtain unambigu conclus
MED-4024~dietari factor oral pharyng cancer risk pubm ncbi abstract review data cohort studi approxim num case control studi relat select aspect diet risk oral pharyng cancer fruit veget invers relat risk pool relat risk rr high veget consumpt num cohort studi upper aerodigest tract cancer num num case control studi oral pharyng cancer rrs high fruit consumpt num num beta caroten vitamin select flavonoid invers relat risk difficult disentangl potenti effect fruit veget grain refin grain intak favor relat oral cancer risk result consist refer food beverag nutrient exclud strong relat food oral pharyng cancer risk western countri select aspect diet account num oral pharyng cancer popul attribut risk increas num tobacco alcohol consumpt consid
MED-4025~analysi eros effect dietari substanc medic pubm ncbi abstract excess consumpt acid drink food contribut tooth eros aim present vitro studi twofold num assess eros potenti dietari substanc medic num determin chemic properti impact eros potenti select sixti agent soft drink energi drink sport drink alcohol drink juic fruit miner water yogurt tea coffe salad dress medic eros potenti test agent quantifi surfac hard sh enamel specimen num min sh num sh num min shbaselin num min exposur sh num sh num min sh num min characteris agent chemic properti ph concentr ca pi titrat acid ph num num buffer capac origin ph degre satur pk pi respect hydroxyapatit hap fluorapatit fap determin eros challeng caus statist signific reduct sh agent coffe medic alcohol drink non flavour miner water tea yogurt num num multipl linear regress analysi num variat sh num min num num min immers explain ph concentr ca num num ph variabl highest impact multipl regress bivari correl analys high bivari correl obtain pk pi hap pk pi fap sh
MED-4026~consumpt fruit cariogen pubm ncbi abstract aim aim studi investig risk factor dental cari primari school children method children age num year num resid lithgow non fluorid communiti south wale australia examin cari experi perman dentit inform dental practic diet residenti movement socioeconom status obtain self complet questionnair result cari risk perman teeth social disadvantag diet dietari factor frequenc fruit consumpt higher odd cari experi odd ratio num num confid interv num num conclus exposur high level fruit consumpt suggest increas cari risk longitudin studi requir investig relationship fruit consumpt dental cari num blackwel publish asia pti
MED-4027~dietari behavior knowledg dental eros chines adult abstract object studi dietari behavior knowledg dental eros self report symptom relat dental eros chines adult hong kong method chines adult age num year random select list regist telephon number generat comput telephon survey administ obtain inform demograph characterist dietari habit dental visit knowledg presenc self report symptom relat dental eros result total num particip interview respons rate num sampl error num age num respond num cari num attend dental check up year respond num meal day num num meal day fruit num lemon tea wat num common consum acid food beverag notic teeth respond num experienc chang relat eros num heard dental eros num mix dental eros dental cari conclus hong kong chines adult frequent intak food experienc symptom relat dental eros level awar knowledg dental eros general low regular dental check up dental health educ essenti public understand dental eros damag effect
MED-4028~dietari advic dental practic pubm ncbi abstract paper aim provid dental health profession practic advic pass patient diet dental health sugar import dietari factor contribut dental cari food carri dental health risk non milk extrins sugar potenti damag uk sugar soft drink confectioneri contribut approxim num total intak non milk extrins sugar patient encourag reduc frequenc intak sugari food intak acid food drink contribut dental eros consumpt food limit dietari advic dental patient posit person line dietari recommend general health increas consumpt starchi stapl food bread potato unsweeten cereal veget fruit reduc consumpt sugari fatti food
MED-4029~comparison effect juic fruit veget enamel demineralis situ pubm ncbi abstract compar effect enamel demineralis situ juic fruit veget volunt wore remov mandibular applianc carri pre demineralis human enamel slab consum test food num time day num day test food appl orang grape carrot tomato consum sugar locat intrins juic extrins free sugar raisin num sugar intrins definit studi miner profil enamel slab studi test period transvers microradiographi show demineralis test food irrespect form consumpt signific demineralis observ raisin signific differ found solid juic food conclus sugar present intrins consumpt similar demineralis potenti free sugar consid cariogen copyright num karger ag basel
MED-4030~diet prevent oral cancer strategi clinic practic pubm ncbi abstract background oral health care profession play import role prevent oral cancer perform oral mucos examin detect pre cancer educ patient oral cancer prevent strategi includ dietari approach conclus current evid support diet high fruit veget plant bas food prevent oral cancer dietari supplements includ vitamin minerals hav shown effect substitut diet high fruit veget clinic implic addit discuss tobacco alcohol patient relev betel nut gutka consumpt risk sexual transmiss human papillo mavirus clinician provid dietari advic prevent oral cancer part routin patient educ practic
MED-4031~associ serum ldl cholesterol level periodont patient visit tertiary car hospit pubm ncbi abstract introduct high low dens lipoprotein ldl cholesterol major risk factor cardiovascular diseas recent year evid present periodont infecti inflammatori condit periodontium increas risk cardiovascular diseas elucid associ studi level ldl cholesterol risk marker cardiovascular diseas periodontally diseas group method level serum ldl cholesterol num subject mild sever clinic attach loss equal greater num mm chronic general num teeth affect periodont age num num year measur compar obtain num age num num sex match control group free system ill result serum ldl cholesterol periodont patient found signific higher num compar control clinic attach loss posit correl serum ldl cholesterol num gingiv index num frequenc person patholog valu ldl cholesterol signific higher periodont patient compar control conclus result show high serum ldl cholesterol periodont healthi peopl unclear periodont increas level serum ldl increas ldl risk factor periodont cardiovascular diseas
MED-4032~oral implic vegan diet observ studi pubm ncbi abstract aim aim studi investig oral subject assum vegan diet long time num month diet complet lack meat anim deriv method sampl num subject analyz northern itali age num num year compos num men num women vegan diet minimum num month maximum num year parallel studi sampl control group num subject criteria age sex place origin omnivor diet chosen sampl answer questionnair investig eat habit frequenc eat meal main foodstuff assum oral hygien habit pain symptomatolog teeth general problem oral caviti sampl subject object examin saliva ph measur teeth check deminer enamel white spot cari kavo diagnod attent paid local lesion sound carri detect osseous defect periodont pocket result studi reveal greater incid deminer white spot vegan subject compar omnivor local neck teeth vestibular surfac dental element lower anterior group saliva ph acid omnivor patient rang oral condit group subject observ conclus order research cause effect relationship vegan diet oral caviti effect sampl studi longer period time result re evalu
MED-4033~relationship satur fatti acid periodont diseas pubm ncbi abstract satur fatti acid sfas produc inflammatori respons hyperinflamm recogn key etiolog factor periodont diseas longitudin relationship dietari sfas periodont diseas num japanes individu age num year data year num investig sfa intak assess self administ diet histori questionnair particip classifi quartil sfa intak full mouth periodont status measur clinic attach level cal record baselin follow up examin number teeth loss cal num mm site year calcul periodont diseas event poisson regress analysi conduct dietari sfas primari predictor interest estim influenc periodont diseas event high dietari sfa intak signific greater number periodont diseas event non smok multivari adjust relat risk num confid interv num num num num quartil dietari sfas num num num num num num num num num num find suggest independ associ dietari sfa intak progress periodont diseas older japanes non smok abbrevi satur fatti acid sfa clinic attach level cal toll lik receptor tlr lipopolysaccharid lps self administ diet histori questionnair bdhq decay miss fill teeth dmft clinic attach level cal bodi mass index bmi relat risk rr confid interv ci nuclear factor kappa nf
MED-4034~high fib food reduc periodont diseas progress men age num older veteran affair normat age study dent longitudin st pubm ncbi abstract object determin food good excel sourc fiber reduc periodont diseas progress men design prospect observ studi set greater boston massachusett metropolitan area particip hundr twenty f community dwel men particip depart veteran affair dental longitudin studi measur dental physic examin conduct num num year diet assess food frequenc questionnair ffqs follow up num year rang num year periodont diseas progress tooth defin alveolar bone loss abl advanc num probe pocket depth ppd num mm tooth loss good excel fiber sourc provid num fiber serv multivari proport hazard regress estim hazard ratio hrs num confid interv cis periodont diseas progress tooth loss relat fiber sourc stratifi age younger num versus num older control smoke bodi mass index calculus baselin periodont diseas level cari educ exercis caroten thiamin caffein intak tooth brush result men age num older serv good excel sourc total fiber lower risk abl progress hr num num ci num num tooth loss hr num num ci num num food group fruit good excel sourc fiber lower risk progress abl hr num serv num ci num num ppd hr num num ci num num tooth loss hr num num ci num num signific associ men younger num conclus benefit higher intak high fib food fruit slow periodont diseas progress evid men age num older num copyright author journal compil num american geriatr societi
MED-4035~brush abras soften remineralis dentin situ studi pubm ncbi abstract aim present situ studi evalu effect period intra or remineralis suscept soften dentin toothbrush abras group num human dentin specimen a f recess buccal aspect intra or applianc worn num day num volunt sampl demineralis day extra or acid beverag sprite light ph num num subsequ dentin specimen brush time specimen brush immedi demineralis specimen b e brush intra or applianc worn period mouth specimen num min num min num min num min specimen brush control num day dentin wear measur profilomet valu standard deviat record microm num num num num num num num num num num num num statist signific increas dentin loss group compar control test num intra or period num num min wear signific higher unbrush control conclud protect dentin surfac num min elaps toothbrush eros attack copyright num karger ag basel
MED-4036~diet nutrit prevent dental diseas pubm ncbi abstract oral health relat diet nutrit influenc craniofaci develop oral cancer oral infecti diseas dental diseas impact self esteem qualiti life expens treat object paper review evid associ nutrit diet dental diseas present dietari recommend prevent nutrit affect teeth develop malnutrit exacerb periodont oral infecti diseas signific effect nutrit teeth local action diet mouth develop dental cari enamel eros dental eros increas dietari acid major sourc soft drink improv trend level dental cari develop countri dental cari remain preval increas develop countri undergo nutrit transit convinc evid collect human intervent studi epidemiolog studi anim studi experiment studi associ amount frequenc free sugar intak dental cari ferment carbohydr total blameless epidemiolog studi show consumpt starchi stapl food fresh fruit low level dental cari fluorid reduc cari risk elimin dental cari countri adequ exposur fluorid import countri low intak free sugar increas intak evid show free sugar consumpt num kg yr approxim num energi intak dental cari low countri high consumpt level recommend nation health author decision mak formul country specif community specif goal reduc amount free sugar aim recommend maximum num energi intak addit frequenc consumpt food free sugar limit maximum num time day respons nation author ensur implement feasibl fluorid programm countri
MED-4037~carcinogen potenc polycycl aromat hydrocarbon back door neighbor restaur cook emiss pubm ncbi abstract present studi num polycycl aromat hydrocarbon pah congen measur exhaust stack num type restaur num chines num western num barbequ bbq total pah concentr bbq restaur num num num signific higher chines num num num western num num num restaur total benzo a pyren potenc equival b a p eq concentr highest chines restaur num num num western num num num num bbq type restaur num num num num develop probabilist risk model assess increment lifetim cancer risk ilcr peopl expos carcinogen pah exhaust stack direct affect back door neighbor restaur concern real exposur group exhaust stack outlet restaur ilcr total exposur neighbor inhalation derm contact ingest num num num num num num num num chines western bbq restaur suggest maximum accept exposur time exhaust stack outlet area chines western bbq restaur rang num num num month num base ilcr num num crown copyright num publish elsevi reserv
MED-4038~impact barbecu meat consum pregnanc birth outcom account person prenat exposur airborn polycycl aromat hydrocarbon birth cohort studi poland abstract previous report associ prenat exposur airborn pah lower birth weight birth length head circumfer main goal present analysi assess impact co exposur pah contain barbecu meat consum pregnanc birth outcom birth cohort consist num pregnant women gave birth term num week gestat non smok women singleton pregnanc num year age free chronic diseas diabet hypertens includ studi detail inform diet pregnanc collect interview measur exposur airborn pah carri person air monitor trimest pregnanc effect barbecu meat consumpt birth outcom birthweight length head circumfer birth adjust multipl linear regress model potenti confound factor prenat exposur airborn pah child sex gestat age pariti size mother matern prepregn weight weight gain pregnanc prenat environment tobacco smoke multivari regress model show signific deficit birthweight barbecu meat consumpt pregnanc coeff num num ci num num effect exposur airborn pah magnitud order coeff num num ci num num combin effect sourc exposur amount birth weight deficit num num ci num num regress model perform birth length head circumfer show similar trend estim effect borderlin signific level intak barbecu meat affect durat pregnanc reduc birthweight mediat shorten gestat period conclus studi result provid epidemiolog evid prenat pah exposur diet includ grill meat hazard fetal develop
MED-4040~effect crucifer veget consumpt heterocycl aromat amin metabol man pubm ncbi abstract consumpt cook meat predispos individu colon cancer heterocycl aromat amin ha form cook meat suggest aetiolog agent consumpt crucifer veget thought protect cancer studi effect crucifer veget heterocycl aromat amin metabol man three period dietari intervent studi carri num non smok caucasian male subject consum cook meat meal amount carcinogen high crucifer veget diet num brussel sprout broccoli day maintain period num veget exclud period num num end period subject consum cook meat meal urinari excret ha num amino num dimethylimidazo num quinoxalin meiqx num amino num methyl num phenylimidazo num pyridin phip measur num day period crucifer veget consumpt period num induct hepat cyp num activ appar kinet caffein metabol excret meiqx phip urin end period studi reduc num num compar period num reduct excret due increas amin metabol expect observ increas cyp num activ enzym shown primarili respons oxid activ meiqx phip man period num urinari mutagen increas relat period num num num absenc presenc human liver microsom activ system evid found phip adduct lymphocyt dna potenti biomark activ process num day crucifer veget period num studi kinet caffein metabol return origin valu excret meiqx phip reduc num num urinari mutagen metabol activ elev compar period num prolong respons amin metabol crucifer veget diet shown phip suggest enzym system cyp num involv affect crucifer veget diet
MED-4047~determin total phenol content antioxid activ garlic allium sativum eleph garlic allium ampeloprasum attenu pubm ncbi abstract total phenol content antioxid activ garlic california oregon washington york determin fourier transform infrar ft ir spectroscopi num cm num total phenol content quantifi folin ciocalteu assay fc antioxid activ assay num diphenyl picrylhydrazyl dpph assay trolox equival antioxid capac teac assay ferric reduc antioxid power frap employ refer measur independ partial least squar regress plsr model construct spectra num extract fc dpph teac frap valu num addit extract predict num standard error calibr standard error cross valid num teac num frap num mol trolox g fw dpph num mg gallic acid g fw fc cluster dendrogram analys segreg garlic grown locat hydroxyl phenol function group close correl garlic antioxid activ
MED-4049~intervent human breast cell carcinogenesi chronic induc num amino num methyl num phenylimidazo num b pyridin abstract num breast cancer sporad attribut long term exposur environment carcinogen diet multistep diseas process progress non cancer premalign malign stage chemic carcinogen num amino num methyl num phenylimidazo num b pyridin phip abund heterocycl amin found high temperatur cook meat recogn mammari carcinogen phip mechan action breast cell carcinogenesi clear demonstr time cumul exposur phip physiolog achiev pico nanomolar concentr effect induc progress carcinogenesi human breast epitheli mcf num cell non cancer stage premalign malign stage dose exposure depend manner progress carcinogenesi measur increas acquir cancer associ properti reduc depend growth factor anchorage independ growth acinar conform disrupt prolifer migrat invas tumorigen metastasi increas stem lik cell popul biolog accompani biochem molecular includ upregul h ras gene express extracellular signal regul kinas erk pathway activ nox num express reactiv oxygen speci ros elev increas hif num sp num tumor necrosi factor matrix metalloproteinas mmp num mmp num aldehyd dehydrogenas activ reduc e cadherin ras erk nox ro pathway play import role initi mainten cellular carcinogenesi induc phip biolog biochem molecular target endpoint identifi green tea catechin compon epicatechin num gallat epigallocatechin num gallat non cytotox dose capabl suppress phip induc cellular carcinogenesi tumorigen
MED-4050~green tea consumpt breast cancer risk recurr meta analysi pubm ncbi abstract green tea common consum beverag asia suggest anti inflammatori anti carcinogen properti laboratori studi sought examin associ green tea consumpt risk breast cancer incid recurr epidemiolog evid date conduct systemat search databas perform meta analysi studi breast cancer risk recurr publish num num encompass num case breast cancer summari relat risk rr calcul fix effect model test heterogen combin studi conduct identifi studi breast cancer recurr studi breast cancer incid increas green tea consumpt cup day invers breast cancer recurr pool rr num num ci num num analysi case control studi breast cancer incid suggest invers associ pool rr num num ci num num associ found cohort studi breast cancer incid combin studi breast cancer incid result signific heterogen epidemiolog evid support hypothesi increas green tea consumpt invers risk breast cancer recurr associ green tea consumpt breast cancer incid remain unclear base current evid
MED-4051~protect effect flavonoid food mutagen induc dna damag peripher blood lymphocyt colon cancer patient pubm ncbi abstract food mutagen iq num amino num methylimidazo num f quinolin phip num amino num methyl num phenylimidazo num b pyridin heterocycl amin hca generat heat proteinac food studi investig protect potenti flavonoid quercetin rutin oxid stress induc vitro iq phip lymphocyt healthi individu untreat newli diagnos colon cancer patient comet assay presenc num dna damag result high dose phip num iq num signific reduc num level compar time lower iq num time lower phip dose lymphocyt colon cancer patient greater baselin dna damag healthi individu num higher level damag observ vitro treatment num ear age group male gender confound factor smoke drink and or dietari habit found signific conclus flavonoid reduc oxid stress caus food mutagen vitro lymphocyt healthi individu colon cancer patient dietari supplement flavonoid rich veget fruit prove effect protect oxid stress copyright num elsevi reserv
MED-4053~occurr heterocycl amin cook meat product pubm ncbi abstract heterocycl amin hcas potent mutagen risk factor human cancer produc meat cook high temperatur aim studi determin hca content cook meat product beef chicken pork fish prepar cook method pan fri oven broil oven bake num num prefer meat consum primari hcas sampl phip num amino num methyl num phenylimidazo num b pyridin num num ng g meiqx num amino num dimethylimidazo num f quinoxalin detect num ng g dimeiqx num amino num num trimethyl imidazo num f quinoxalin detect num ng g type content hcas cook meat sampl high depend cook condit total hca content well don meat num time higher medium rar meat fri pork num ng g higher level total hcas fri beef num ng g fri chicken num ng g sampl fri bacon highest total hca content num ng g copyright num elsevi reserv
MED-4055~diallyl sulfid inhibit phip induc dna strand break normal human breast epitheli cell pubm ncbi abstract heterocycl amin hcas form meat product beef chicken pork fish cook high temperatur abund hca found human diet num amino num methyl num phenylimidazo num pyridin phip phip mammari carcinoma femal rat mice increas risk develop colon breast prostat cancer human phip metabol cytochrom num produc n oh phip n oh phip esterifi phase ii enzym form arylnitrenium ion bind dna caus adduct n oh phip reduc cytochrom num reductas produc superoxid anion hydroxyl radic caus dna strand break diallyl sulfid das shown prevent cancer anim model metabol modul hypothes phip produc reactiv oxygen speci caus dna strand break das inhibit format phip induc dna strand break test hypothesi treat normal breast epitheli mcf num cell phip das combin phip das detect lipid peroxid surrog ros lipid peroxid detect peroxidetect kit sigma phip increas product lipid peroxid das decreas phip induc peroxid num determin phip dna strand break mcf num cell cell treat num num num phip num microm das num microm combin phip num microm das num microm dna strand break evalu comet assay phip produc dna strand break dose time depend fashion shown das inhibit phip induc dna strand break inhibit product reactiv oxygen speci propos das prevent phip induc breast cancer
MED-4057~well don meat intak risk breast cancer pubm ncbi abstract background heterocycl amin mutagen form meat cook high temperatur demonstr mammari carcinogen anim conduct nest case control studi num cohort member iowa women health studi evalu potenti role heterocycl amin intak well don meat risk human breast cancer method questionnair mail individu cohort breast cancer diagnos period num num random sampl cancer fre cohort member obtain inform usual intak meat meat prepar practic color photograph show level hamburg beefsteak bacon includ multivari analysi perform data num case subject num control subject complet survey result dose respons relationship found level meat consum breast cancer risk adjust odd ratio well don meat versus rare medium don meat num num confid interv ci num num hamburg num num ci num num beef steak num num ci num num bacon women consum meat consist num time higher risk num ci num num women consum meat rare medium risk breast cancer elev increas intak well don well don meat conclus consumpt well don meat exposur heterocycl amin compound form high temperatur cook play import role risk breast cancer
MED-4058~biomonitor carcinogen heterocycl aromat amin hair valid studi abstract facil method establish measur heterocycl aromat amin haa accumul human hair rodent fur sampl digest base hydrolysi liber haa isol tandem solvent solid phas extract quantif liquid chromatography tandem mass spectrometri tripl stage quadrupol mass spectromet select reaction monitor mode pilot studi num human volunt num amino num methyl num phenylimidazo num b pyridin phip detect hair meat eat level rang num num pg g hair num amino num dimethylimidazo num f quinoxalin meiqx num amino num pyrido num b indol limit quantif loq num pg g hair hair meat eat vegetarian phip detect hair vegetarian level loq num pg g hair indic phip exposur occur primarili meat consumpt level phip hair sampl meat eat vari num num month interv signifi exposur phip accumul hair constant time control feed studi femal num num mice haa drink water num month daili dose concentr rang num num num g kg bodi weight phip detect fur mice dose meiqx detect fur dosag num c kg bodi weight num meiqx kg bodi weight strong posit relationship dosag haa accumul fur dna adduct form liver colon p valu num level haa fur correl level dna adduct adjust dose hair promis long liv biomark assess exposur phip potenti human carcinogen
MED-4059~effect diet serum albumin hemoglobin adduct num amino num methyl num phenylimidazo num b pyridin phip human pubm ncbi abstract num amino num methyl num phenylimidazo num b pyridin phip abund heterocycl amin form meat fish cook model compound class chemic possibl involv human carcinogenesi exposur heterocycl amin import establish role human diseas serum albumin sa globin gb adduct test biomark exposur phip male fischer num rat oral dose num num num num mg kg blood sampl collect num hr treatment phip releas sa gb acid hydrolysi analyz gas chromatography mass spectrometri liquid chromatography tandem mass spectrometri phip sa gb adduct increas linear dose studi num volunt dietari habit exhibit diet major determin format adduct phip sa adduct signific higher meat consum vegetarian num num num num fmol mg sa se num mann whitney test gb adduct pattern quantit lower parallel sa num num meat consum num num vegetarian phip sa adduct smoker non smok result show time phip blood protein adduct present human synthet compound biomark suitabl assess dietari exposur intern phip dose promis tool studi role heterocycl amin etiolog colon cancer diseas copyright num wiley liss
MED-4060~format biochemistri carcinogen heterocycl aromat amin cook meat pubm ncbi abstract heteroycl aromat amin haa class hazard chemic receiv heighten attent risk factor human cancer haa aris cook meat fish poultri haa occur tobacco smoke condens diesel exhaust haa carcinogen induc tumor multipl site rodent number epidemiolog studi report frequent consumpt well don cook meat haa result elev risk colon prostat mammari cancer dna adduct haa detect human tissu demonstr haa induc genet damag concentr compound cook meat general low parts per billion ppb rang recent improv sensit mass spectrometri instrument haa metabolit dna adduct detect trace amount biolog fluid tissu human incorpor haa biomark epidemolog studi clarifi role dietari genotoxic etiolog human cancer
MED-4068~cook meat deriv mammari carcinogen num amino num methyl num phenylimidazo num b pyridin promot invas behaviour breast cancer cell pubm ncbi abstract cook meat deriv genotox carcinogen num amino num methyl num phenylimidazo num b pyridin phip induc cancer colon prostat mammari gland fed rat epidemiolog studi link tumour western diet exposur heterocycl amin phip shown phip potent estrogen propos hormon activ contribut target site carcinogen postul estrogen properti phip influenc metastat potenti vitro assay cell invas base digest migrat reconstitut basement membran model zymographi immunoblot confirm phip medi induct invas phenotyp treatment mammari cancer cell line mcf num num phip induc cell digest migrat reconstitut basement membran respons dose depend observ sub nanomolar concentr phip inhibit antiestrogen ici num phip induc invas phenotyp express cathepsin cyclooxygenas num matrix metalloproteinas activ find emphasis rang potenc biolog activ cook meat product mechanist support tissue specif carcinogen chemic copyright num elsevi ireland reserv
MED-4069~meat fat risk breast cancer case control studi uruguay pubm ncbi abstract examin meat intak modifi breast canc risk case control studi conduct uruguay dietari pattern assess detail case diagnosi symptom occur food frequenc questionnair involv num food item total energi intak calcul nutrient residu calcul regress analysi adjust potenti confound includ famili histori breast cancer menopaus status body mass index total energi total alcohol intak increas risk consumpt total meat intak red meat intak total fat satur fat intak observ strongest effect observ red meat intak num num cl num num consumpt upper quartil control protein fat intak suggest independ effect meat experiment studi shown strong effect heterocycl amin rat mammari carcinogenesi studi perform human epidemiolog biomark heterocycl amin exposur
MED-4070~intak fri meat risk cancer follow up studi finland pubm ncbi abstract suggest mutagen fri meat involv cancer process relationship intak fri meat subsequ risk cancer site studi num finnish men women num year age initi free cancer baselin studi carri num case cancer identifi data linkag finnish cancer registri num year follow up num cancer case diagnos intak fri meat estim dietari histori interview cover total diet particip previous year posit associ fri meat intak risk female hormone rel cancer cancer breast endometrium ovari combin relat risk cancer combin person highest lowest tertil daili intak fri meat adjust age person characterist intak main food group num num confid interv num num pancreat nervous system cancer present non signific suggest associ associ observ respect singl cancer site studi site cancer combin epidemiolog effort ascertain potenti link fried food mutagen cancer risk
MED-4071~detect phip num amino num methyl num phenylimidazo num b pyridin milk healthi women pubm ncbi abstract increas risk breast cancer observ women consum well don meat heterocycl amin mutagen carcinogen pyrolysi product form high temperatur cook meat present studi human milk sampl analyz phip abund dietari heterocycl amin protocol develop mixed mod cation exchang sorbent extract heterocycl amin milk milk sampl acquir healthi canadian women lc ms analysi method isotop dilut quantif level phip determin human milk sampl phip detect num num milk sampl level high num pg ml ppt phip detect milk vegetarian donor detect phip milk ductal mammari epitheli cell direct expos carcinogen suggest heterocycl amin human mammari carcinogen
MED-4072~dietari intak meat meat deriv heterocycl aromat amin correl dna adduct femal breast tissu pubm ncbi abstract aim studi examin associ consumpt meat general meat prepar cook method dietari intak heterocycl aromat amin hca level dna adduct breast tissu women undergo reduct mammoplasti dietari intak meat hca assess questionnair num women undergo reduct mammoplasti dna adduct analysi breast tissu perform num p postlabel analysi spearman rank correl coeffici calcul examin associ meat consumpt dietari hca intak tissu dna adduct level median dna adduct level num interquartil rang num num num nucleotid breast tissu observ median hca intak num ng day interquartil rang num num ng day total hca intak num num consumpt fri meat num num beef num num process meat num num statist signific correl level dna adduct breast tissu detect dna adduct confirm specif hca deriv dna adduct comparison extern standard num p postlabel assay observ strong correl dietari hca intak consumpt fri process meat dna adduct level breast tissu num women detect dna adduct necessarili specif hca hca intak surrog genotox substanc polycycl aromat hydrocarbon meat prepar high temperatur
MED-4073~cook food deriv carcinogen num amino num methyl num phenylimidazo num pyridin potent oestrogen mechanist basi tissue speci pubm ncbi abstract cook meat carcinogen num amino num methyl num phenylimidazo num b pyridin phip induc tumour breast colon prostat rat show addit well establish genotox detect concentr num num phip oestrogen cos num cell transient transfect oestrogen respons report gene phip num num num num mediat transcript oestrogen receptor er alpha er beta inhibit pure er antagonist ici num demonstr requir function er contrast structur relat food deriv carcinogen num amino num dimethylimidazo num f quinoxalin meiqx fail induc report gene transcript addit show hormon respons breast cancer cell line mcf num cell phip induc transcript activ endogen express er examin genotox potenti phip model mammalian cell mutat assay hprt locus demonstr genet toxicolog phip readili detect separ term effect concentr oestrogen activ determin oestrogen phip mediat oestrogen depend respons cell growth examin growth hormon respons cell mcf num cell show phip stimul cell prolifer depend function er ligand blot show phip stimul express progesteron receptor pr a pr b c myc activ mapk signal transduct pathway respons similar produc oestradiol term tempor aspect potenc requir function er dose depend mitogen respons occur concentr phip approxim num num num num equival system human exposur consumpt cook meat phip induc cellular respons encompass alter gene express mitogenesi suggest combin genet toxicolog oestrogen lik promot genom cellular event provid mechan tissue specif tumorigen compound
MED-4075~format mutagen heterocycl aromat amin creatinin urin meat eater vegetarian pubm ncbi abstract liquid chromatographi electrospray ionize mass spectrometri ms tripl quadrupol ms identifi heterocycl aromat amin haa human urin ident num amino num dimethylimidazo num f quinoxalin num meiqx num amino num methyl num phenylimidazo num b pyridin phip confirm product ion spectra constant neutral loss scan mode employ probe analyt urin display transit m h      m h ch num common haa n methylimidazo moieti led detect previous unreport isom num meiqx holland al num chem res toxicol num num report identif haa num amino num methylimidazo num b quinolin iq num isom power anim carcinogen num amino num methylimidazo num f quinolin iq amount iq num measur urin human volunt consum grill beef rang num num ingest dose amount num meiqx phip excret urin averag num ingest dose base treatment urin num degre increas concentr num meiqx phip num fold indic presenc phase ii conjug amount iq num increas num fold iq num detect urin vegetarian base hydrolysi format iq num iq num meiqx phip occur urin incub num degre creatinin num aminobenzaldehyd precursor iq num detect iq num urin meat eater vegetarian suggest haa present nonmeat stapl iq num format occur endogen urinari bladder biolog fluid
MED-4079~program consist phytonutrient rich medic food elimin diet amelior fibromyalgia symptom promot toxic el deto pubm ncbi abstract background effect treatment fibromyalgia fm object assess efficaci ofa lifestyl program consist modifi elimin diet supplement medic food clinic symptom fm assess fibromyalgia impact questionnair fiq fibroquest symptom survey fibroquest medic symptom questionnair msq metallothionein mrna express urinari toxic element excret method women age num year enrol num week pilot trial employ sequenti design initi num week program control particip consum modifi depart agricultur food pyramid diet rice protein powder supplement provid basic macronutri support num week program intervent particip consum modifi elimin diet phytonutrient rich medic food result compar baselin program show trend lower fiq total score msq total score fibroquest total score fiq stiff score fibroquest headach score compar program program result signific decreas num fiqpain score stiff score particip pain toler tender point program program higher metallothionein mrna express observ program increas creatinine adjust mercuri excret suggest increas creatinine adjust arsenic excret note program compar baselin urinari mercury arsen concentr invers fiqand fibroquest score conclus program shown safe efficaci botan deriv medic food treatment program amelior fm symptom
MED-4080~mediterranean diet extend fasting influenc chang intestin microflora immunoglobulin secret clinic outcom patient rheumatoid arthriti fibromyalgia observ studi abstract background alter intestin bacteri flora believ contribut factor chronic inflammatori degen diseas includ rheumat diseas microbiolog fecal cultur analysi increas relationship intestin flora dietari pattern clinic outcom specif diseas clarifi role microbiolog cultur analysi aim evalu patient rheumatoid arthriti ra fibromyalgia fm mediterranean diet num day fast period fecal flora fecal flora clinic outcom method two months period num consecut patient integr medicin hospit depart establish diagnosi ra num fm num includ studi predefin clinic criteria subject choic patient receiv vegetarian mediterranean diet num age num num particip intermitt modifi num day fast therapi num age num num quantit aerob anaerob bacteri flora stool ph concentr secretori immunoglobulin siga analys stool sampl begin end num week hospit stay num month follow up clinic outcom assess das num ra patient diseas sever rate scale fm patient result found signific fecal bacteri count dietari intervent group signific differ found analysi siga stool ph clinic improv end hospit stay tend greater fast non fast patient ra num clinic outcom relat alter intestin flora conclus mediterranean diet fast treatment affect microbiolog assess intestin flora siga level patient ra fm impact dietari intervent human intestin flora role fecal flora rheumat diseas clarifi newer molecular analysi techniqu potenti benefit fast treatment ra fm test randomis trial
MED-4081~potenti dietari link central sensit fibromyalgia past report futur direct pubm ncbi abstract articl review exist literatur fibromyalgia fm diet discuss role diet central sensit fm propos hypothesi food rel contributor central sensit make recommend futur dietari research direct
MED-4084~diet diseas symptom rheumat diseases  result questionnair base survey pubm ncbi abstract experi food intak diet manipul fast regist rheumat patient studi questionnaire bas survey num patient particip compris num patient rheumatoid arthriti num patient juvenil rheumatoid arthriti num patient ankylos spondyl num patient psoriat arthropathi num patient primari fibromyalgia num patient osteoarthr patient rheumatoid arthriti ankylos spondyl psoriat arthropathi report aggrav diseas symptom intak food num patient juvenil rheumatoid arthriti num patient primari fibromyalgia state twenty six percent patient juvenil rheumatoid arthriti num patient rheumatoid arthriti ankylos spondyl primari fibromyalgia previous diet attempt allevi diseas symptom num patient psoriat arthropathi num osteoarthr diet therapi pain stiff report num patient num report reduc joint swell similar benefici effect diet report rheumat diseas group fifteen percent patient rheumatoid arthriti ankylos spondyl fast period pain stiff report num patient group half patient group report reduc number swollen joint
MED-4085~vegan diet allevi fibromyalgia symptom pubm ncbi abstract effect strict low salt uncook vegan diet rich lactobacteria symptom num fibromyalgia patient num month intervent period open non random control studi evalu control num patient continu omnivor diet group differ signific begin studi paramet pain urin sodium result reveal signific improv visual analogu scale pain vas num joint stiff num qualiti sleep num health assess questionnair haq num general health questionnair ghq num rheumatologist questionnair num major patient overweight extent begin studi shift vegan food caus signific reduct bodi mass index bmi num total serum cholesterol show statist signific lower num urin sodium drop num begin valu num indic good diet complianc conclud vegan diet benefici effect fibromyalgia symptom short run
MED-4087~fibromyalgia nutrit pubm ncbi abstract peopl suffer fibromyalgia fm effect treatment good qualiti life maintain normal daili activ hypothes ethiopathophysiolog oxid stress possibl non scientif inform address patient benefit nutrit wide non evidenc strategi aim paper find scientif studi fibromyalgia diseas nutrit status diet food supplement systemat search perform medlin wide rang term nutrit issu search made num articl publish num num target popul peopl suffer fm vegetarian diet benefici effect due increas antioxid intak high preval obes overweight patient weight control effect tool improv symptom nutrit defici clear direct relat diseas food supplement found data studi prove dietari advic patient improv diet maintain normal weight interest investig field nutrit fm reveal relationship
MED-4088~reduc plasma fibrinogen serum peroxid lipid apolipoprotein num week vegetarian diet pubm ncbi abstract influenc num week vegetarian diet fast serum concentr peroxid lipid apolipoprotein plasma fibrinogen studi ten middle ag fibromyalgia fibros patient women men serum peroxid concentr estim thiobarbitur acid react substanc reduc num num num num umol l num plasma fibrinogen num num num num g l num serum total cholesterol fell num num num num mmol l num apolipoprotein num num num num g l num apolipoprotein num num num num g l num high densiti lipoprotein cholesterol concentr decreas num num num num mmol l num atherogen index reflect balanc low high densiti lipoprotein reduc num num num num num num result suggest vegetarian diet fast benefici influenc concentr serum peroxid plasma fibrinogen concentr serum level lipoprotein rel coronari risk factor
MED-4089~antiprolif effect appl peel extract cancer cell pubm ncbi abstract studi shown invers relationship consumpt appl risk cancer peel appl shown possess high concentr antioxid discard studi evalu antiprolif effect appl peel extract ape varieti cancer cell type data demonstr ape obtain organ gala appl impart signific reduct viabil varieti cancer cell line data show signific decreas growth clonogen surviv human prostat carcinoma cwr num nu num du num cell breast carcinoma mcf num mcf num num cell antiprolif effect ape found accompani num num phase arrest prostat breast cancer cell ape treatment result mark concentration depend decreas protein level prolif cell nuclear antigen marker prolifer addit ape treatment result mark increas maspin tumor suppressor protein negat regul cell invas metastasi angiogenesi data suggest ape possess strong antiprolif effect cancer cell appl peel discard diet detail mechanist studi vivo anim model examin antiprolif prevent effect ape cancer
MED-4090~develop ingredi appl peel sourc polyphenol dietari fiber pubm ncbi abstract appl peel wast product dri appl manufactur content phenol compound dietari fiber miner higher appl peel compar edibl part fruit object studi develop ingredi granni smith appl peel pilot scale doubl drum dryer dri technolog control step maxim retent phenol compound dietari fiber consid oper condit dri temperatur time determin import preprocess step grind ppo inhibit addit physical chem characterist miner sugar content technolog function properti water retent capac solubl index dispers analyz simpl econom suitabl pilot scale process produc powder ingredi appl peel by product obtain dri process includ applic ascorb acid num fresh appl peel slurri drum dryer oper condit num degre num rpm num mm drum clearanc ingredi develop consid sourc phenol compound num mg gallic acid equivalent g dri base dietari fiber num dri base formul food practic applic method develop ingredi granni smith appl peel pilot scale doubl drum dryer dri technolog develop method simpl econom feasibl suitabl maxim retent phenol compound dietari fiber present raw matter ingredi formul food
MED-4091~assess antioxid activ vitro method pubm ncbi abstract studi common test measur antioxid activ evalu compar antioxid appli beverag tea juic trolox equival antioxid capac assay teac i iii assay total radical trap antioxid paramet assay trap assay num diphenyl l picrylhydrazyl assay dpph assay n dimethyl p phenylendiamin assay dmpd assay photochemiluminesc assay pcl assay ferric reduc abil plasma assay frap assay antioxid includ gallic acid repres group polyphenol uric acid main antioxid human plasma ascorb acid vitamin wide spread fruit trolox water solubl vitamin analogu method present divid group depend oxidis reagent method organ radic produc teac i iii trap dpph dmpd pcl method work metal ion oxid frap differ test reaction procedur assay delay oxid determin lag phase paramet antioxid activ teac trap pcl determin delay radic generat abil scaveng radic contrast assay teac ii iii dpph dmpd frap analys abil reduc radic cation teac ii iii dpph dmpd ferric ion frap test act radic reduct preform radic determin decreas absorb frap assay measur form ferrous ion increas absorb gallic acid strongest antioxid test dmpd assay contrast uric acid ascorb acid show low activ assay assay determin antioxid activ micromolar rang minut hour assay pcl analys antioxid activ nanomolar rang black currant juic show highest antioxid activ test compar tea appl juic tomato juic differ result vitro assay give idea protect efficaci secondari plant product strong recommend method due differ test system investig
MED-4092~uric acid marker increas cardiovascular risk pubm ncbi abstract relationship uric acid cardiovascular diseas num centuri author report classic associ gout hypertens obes cardiovascular diseas specif genet defect purin metabol increas uric acid general import risk factor atherosclerosi hypertens abdomin obes insulin resist metabol syndrom renal failur studi shown associ increas uric acid concentr oxid stress endotheli dysfunct inflamm subclin atherosclerosi increas risk cardiovascular event increas uric acid level independ marker cardiovascular diseas risk prospect studi show reduct uric acid level prevent cardiovascular event
MED-4093~serum uric acid level independ risk factor all caus cardiovascular ischem stroke mortal chines cohort studi pubm ncbi abstract object associ hyperuricemia cardiovascular event document high risk group undetermin general popul chines studi assess tempor associ serum uric acid level hyperuricemia cardiovascular mortal method prospect cohort studi num men num women age num year conduct data mj health screen center taiwan mortal total cardiovascular diseas cvd ischem stroke congest heart failur hypertens diseas coronari heart diseas compar increas serum uric acid level result total num num event num total death ascrib cvd followup num year hazard ratio hrs hyperuricemia serum uric acid level num mg dl estim cox regress model adjust age sex bodi mass index cholesterol triglycerid diabet hypertens heavi cigarett smoke frequent alcohol consumpt patient hrs num num all caus mortal num num total cvd num num ischem stroke subgroup analysi hrs cardiovascular risk remain signific patient hypertens num num patient diabet num num addit low metabol risk subgroup hrs all caus mortal total cardiovascular morbid num num num num conclus hyperuricemia independ risk factor mortal total cvd ischem stroke taiwanes general popul high risk group potenti low risk group
MED-4094~dietari fiber breast cancer risk systemat review meta analysi prospect studi pubm ncbi abstract background evid case control studi suggest dietari fiber invers relat breast cancer risk unclear support prospect data conduct systemat review meta analysi evid prospect studi method pubm search prospect studi fiber intak breast cancer risk num august num random effect model estim summari relat risk rrs result sixteen prospect studi includ summari rr highest versus lowest intak num num confid interv ci num num num num dietari fiber num num ci num num num num fruit fiber num num ci num num num num veget fiber num num ci num num num num cereal fiber num num ci num num num num solubl fiber num num ci num num num num insolubl fiber summari rr num g day dietari fiber num num ci num num num num heterogen num stratifi analys invers associ observ studi larg rang num g day high level intak num g day conclus meta analysi prospect studi invers associ dietari fiber intak breast cancer risk
MED-4095~mortal western cancer rose dramat african american num centuri dietari anim product blame pubm ncbi abstract statist compil nation cancer institut num num age adjust mortal western cancer breast colon prostat pancrea ovari kidney rose dramat african american phenomenon parallel mark increas incid cancer asia southern europ num centuri conjunct increas intak dietari anim product credibl case made diet rich anim product work complementari up regul serum level insulin free igf i free sex hormon hormon import promot activ western cancer dietari anim product intak black american increas substanti num centuri fact primarili respons concurr mark increas mortal western cancer whole food vegan diet rich fruit veget coupl regular exercis smoke avoid expect remark posit impact african american cancer risk revers increas cancer risk incur num centuri copyright num harcourt publish
MED-4096~statist assess global burden breast cancer pubm ncbi abstract varieti statist quantifi burden occurr outcom cancer general breast cancer specif undertak cancer control program understand statist sourc qualiti import assess current situat alloc resourc control strategi evalu progress core statist cancer incid rate cancer mortal rate provid estim averag risk acquir die diseas num world popul cover registr system produc cancer incid statist mortal data num breast cancer incid mortal vari world region general incid high greater num num develop region world low num num increas develop region rang mortal rate approxim num num favor surviv breast cancer high incid develop region incid breast cancer increas unfavor trend due part increas risk factor decreas childbear breast feed increas exogen hormon exposur detriment dietari lifestyl includ obes physic activ hand mortal decreas high risk countri due combin intensifi earli detect effort introduct mammograph screen result diagnosi small earli stage tumor advanc treatment
MED-4097~green tea breast cancer abstract identif modifi lifestyl factor reduc risk breast cancer research prioriti enorm chemo prevent potenti green tea compel evid anim studi role breast cancer develop human unclear part uncertainti relat small number epidemiolog studi green tea breast cancer result case control studi prospect cohort studi discord addit mechan green tea intak influenc risk breast cancer human remain studi review human studi evalu relationship green tea intak biomark sex steroid hormon mammograph densiti insulin lik growth factor adiponectin believ import breast cancer develop result biomark studi inconclus limit human studi area investig discuss
MED-4098~dietari intak mushroom green tea combin reduc risk breast cancer chines women pubm ncbi abstract investig effect dietari mushroom joint effect mushroom green tea breast cancer case control studi conduct southeast china num incid case num femal patient age num year histolog confirm breast cancer num age match control healthi women random recruit outpati breast clinic inform frequenc quantiti dietari intak mushroom tea consumpt usual diet lifestyl collect face to fac interview valid reliabl questionnair compar nonconsum odd ratio num num ci num num num num num daili intak num fresh mushroom num dri mushroom base multivari logist regress analysi adjust establish potenti confound dose respons relationship signific test trend num invers associ found pre postmenopaus women compar consum mushroom green tea num num num num num num daili high intak fresh dri mushroom combin consum beverag made num dri green tea leav day linear trend statist signific joint effect num conclud higher dietari intak mushroom decreas breast cancer risk pre postmenopaus chines women addit decreas risk breast cancer joint effect mushroom green tea observ research warrant examin effect dietari mushroom mechan joint effect phytochem breast cancer
MED-4099~meta analysi effect glucan intak blood cholesterol glucos level pubm ncbi abstract object meta analysi perform epidemiolog studi assess relat glucan consumpt oat barley blood cholesterol level triglyceride triacylglycerol tgl tag level blood glucos level bgl human addit effect glucan total cholesterol tc bgl translat empir dose respons model method thirti research articl evalu effect exposur level glucan blood cholesterol bgl analyz yield num clinic studi result signific invers relat tc num mmol l num confid interv ci num num low dens lipoprotein num mmol l num ci num num tgl tag num mmol l num ci num num consumpt glucan contrast increas high dens lipoprotein cholesterol note num mmol l num ci num num random effect model analysi show signific chang bgl num mmol l num ci num num high heterogen num num num num studi fixed effect model show signific chang tc low dens lipoprotein bgl show signific high dens lipoprotein tgl tag dose respons model show num g d dose oat barley glucan suffici decreas tc conclus consumpt num g d oat barley glucan suffici decreas blood cholesterol effect bgl inconclus high heterogen requir clinic research studi longer intervent period copyright num elsevi reserv
MED-4100~dead quartet upper bodi obes glucos intoler hypertriglyceridemia hypertens pubm ncbi abstract contribut obes cardiovascular risk adequ appreci failur recogn involv upper bodi predomin bodi weight hypertens diabet hypertriglyceridemia absenc signific obes articl examin evid upper bodi obes induc calor excess presenc androgen mediat problem hyperinsulinemia interrelationship identifi prevent upper bodi obes fail provid therapi control problem aggrav hyperinsulinemia
MED-4101~epidemiolog metabol syndrom usa pubm ncbi abstract metabol syndrom common complex entiti emerg worldwid epidem major public health care concern preval approxim num unit state number definit metabol syndrom center metabol abnorm central obes hypertens decreas high dens lipoprotein elev triglycerid insulin resist unit physiolog factor import metabol syndrom relat high preval rate predict develop diabet cardiovascular diseas nonalcohol fatti liver diseas recogn hepat compon metabol syndrom individu compon diabet elev triglycerid major risk factor develop nonalcohol steatohepat nash sever form nonalcohol fatti liver diseas nash progress cirrhosi hepatocellular carcinoma liver failur common liver transplant project lead liver transplant num weight loss diet bariatr surgeri vitamin recent demonstr effect treatment nash agent prove effect treatment nash effect therapeut strategi earli screen intervent prevent develop insulin resist oxid stress societ level num author journal digest diseas num chines medic associ shanghai branch chines societi gastroenterolog renji hospit affili shanghai jiaotong univers school medicin blackwel publish asia pti
MED-4102~vegetarian dietari pattern lower risk metabol syndrom abstract object studi object compar dietari pattern relationship metabol risk factor mrfs metabol syndrom met research design method cross sect analysi num subject age num year adventist health studi num perform dietari pattern deriv food frequenc questionnair classifi vegetarian num semi vegetarian num nonvegetarian num ancova determin associ dietari pattern mrfs hdl triglycerid glucos blood pressur waist circumfer control relev cofactor logist regress calcul odd ratio met result vegetarian dietari pattern signific lower mrfs hdl trend num factor lower risk met num num ci num num num compar nonvegetarian dietari pattern conclus vegetarian dietari pattern favor profil mrfs lower risk met relationship persist adjust lifestyl demograph factor
MED-4103~pilot studi potassium supplement treatment hypokalem patient rheumatoid arthriti random double blind placeb pubm ncbi abstract patient rheumatoid arthriti ra signific low serum potassium concentr healthi subject assess therapeut efficaci toler oral potassium supplement dissolv grape juic femal hypokalem patient activ ra thirty two hypokalem patient activ ra investig parallel random design addit usual medic control group receiv placebo intervent group receiv num mg chlorid potassium dissolv grape juic num consecut day primari outcom paramet chang pain visual analog scale vas american colleg rheumatolog acr percent respons criteria diseas activ score num das num joint count european leagu rheumat eular moder respons assess age num num year potassium group num num patient met criteria num lower pain intens compar num num placebo group num day num num num patient intervent group achiev moder respons eular criteria percentag patient receiv placebo num num num potassium supplement decreas pain intens perspect articl report trial evalu effect potassium supplement treatment pain hypokalem patient rheumatoid arthriti elev serum cortisol potassium valu treatment group correl negat patient assess pain intens reflect anti pain effect potassium supplement
MED-4104~nutrient intak dietari qualiti particip type num diabet low fat vegan diet convent diabet di pubm ncbi abstract background vegan diet improv diabet manag nutrient profil diet qualiti individu type num diabet adopt vegan diet object assess nutrient intak dietari qualiti particip low fat vegan diet num american diabet associ dietari recommend design num week random control clinic trial examin nutrient intak diet qualiti subjects set particip type num diabet num free liv set research design method particip random assign low fat vegan diet num american diabet associ recommend diet main outcom measur nutrient intak altern healthi eat index ahei score collect baselin num week statist analys perform between group test calcul group pair comparison test calcul within group pearson correl assess relationship ahei score hemoglobin num bodi weight result group report signific decreas energi protein fat cholesterol vitamin selenium sodium intak vegan group signific reduc report intak vitamin num calcium signific increas carbohydr fiber total vitamin activ beta caroten vitamin folat magnesium potassium american diabet associ recommend diet group report signific decreas carbohydr iron report signific increas vegan group signific improv ahei score num american diabet associ recommend diet group num differ ahei score num week group signific num group combin ahei score negat correl hemoglobin num num num weight num num conclus vegan diet increas intak carbohydr fiber micronutri contrast american diabet associ recommend diet vegan group improv ahei score american diabet associ recommend diet group ahei score remain unchang
MED-4106~potassium intak stroke cardiovascular diseas meta analysi prospect studi pubm ncbi abstract object object studi assess relat level habitu potassium intak incid cardiovascular diseas cvd background prospect cohort studi evalu relationship habitu potassium intak incid vascular diseas result consist method perform systemat search prospect studi publish languag restrict num decemb num criteria inclus prospect adult popul studi assess baselin potassium intak assess vascular event outcom follow up num year studi relat risk rrs num confid interv cis extract pool random effect model weight invers varianc heterogen public bias subgroup meta regress analys perform result eleven studi identifi provid num cohort sampl includ num male femal particip follow up num num year num stroke num coronari heart diseas chd event num total cvd event potassium intak assess num dietari recal num food frequenc questionnair num num urinari excret num pool analysi num num mmol day higher potassium intak num lower risk stroke rr num num ci num num num trend lower risk chd total cvd attain statist signific exclus singl cohort base sensit analysi rr num num ci num num num rr num num ci num num num conclus higher dietari potassium intak lower rate stroke reduc risk chd total cvd result support recommend higher consumpt potassium rich food prevent vascular diseas copyright num american colleg cardiolog foundat publish elsevi reserv
MED-4107~sodium potassium intak adult nhane num num abstract background american heart associ aha institut medicin iom depart health human servic agricultur usda dietari guidelin american recommend american limit sodium intak choos food potassium decreas risk hypertens advers health outcom object estim distribut usual daili sodium potassium intak sociodemograph health characterist relat current recommend design num dietari recal data num adult age num particip nhane num num estim sodium potassium intak adjust within individu day to day variat measur error model ses num cis assess jackknif replic weight result num num ci num num adult consum sodium daili recommend aha num mg num num num consum iom toler upper intak level num mg adult recommend dietari guidelin reduc sodium intak num mg d african american age num person hypertens diabet chronic kidney diseas num num num consum num mg d num consum num mg d doubl recommend num adult num men consum num mg k d met recommend potassium conclus recommend sociodemograph health characterist vast major adult consum sodium potassium
MED-4112~insulin lik growth factor i receptor regul cd num protect activ cell apoptosi pubm ncbi abstract co stimulatori signal cd num receptor enhanc surviv cell antigen receptor tcr engag show stimul cd num receptor absenc tcr engag anti cd num cross link antibodi cd num ligand transient increas express insulin lik growth factor i receptor igf ir cell antibodi block signal igf ir decreas surviv cell activ tcr cd num presenc il num num enhanc suscept fas induc apoptosi cd num stimul increas igf ir express jurkat cell exogen ad igf i protect cell fas induc apoptosi conclud cd num mediat enhanc igf ir express activ cell essenti surviv signal independ surviv mediat il num bcl xl
MED-4113~good riddanc thymocyt clonal delet prevent autoimmun pubm ncbi abstract clonal delet arguabl import mechan elimin self react thymocyt t cell repertoir recent work identifi player process thymocyt side molecul newli implic pathway initi t cell receptor signal final result gene transcript thymocyt apoptosi addit proapoptot molecul found death self react thymocyt antigen pres cell side express peripher self antigen regul part autoimmun regul air protein crucial complet elimin autoreact thymocyt import thymic peripher antigen express clonal delet self toler demonstr autoimmun diseas autoimmune polyendocrinopathy candidiasis ectoderm dystrophi type num diabet mellitus
MED-4114~upregul lymphocyt apoptosi strategi prevent treat autoimmun disord role whole food vegan diet fish oil pubm ncbi abstract induc apoptosi autoreact t lymphocyt precursor thymus crucial prevent autoimmun disord igf i prolactin lymphocyt growth factor potenti suppress apoptosi thymocyt encourag autoimmun convers dietari fish oil rich omega num fat upregul apoptosi lymphocyt whole food vegan diet downregul system igf i activ propos diet conjunct fish oil supplement treatment dopamin agonist capabl suppress prolactin secret util treat prevent autoimmun disord predict consist extrem rariti autoimmun disord sub saharan black african long tradit quasi vegan lifestyl recent ecolog studi correl risk iddm multipl sclerosi mortal anim product and or satur fat consumpt evid vegan quasi vegan diet manag rheumatoid arthriti multipl sclerosi possibl sle dopamin agonist bromocryptin exert anti inflammatori effect rodent model autoimmun preliminari evid drug clinic human autoimmun diseas toler num specif agonist cabergolin prove practic therapi moder clinic util supplement fish oil rheumatoid arthriti autoimmun disord document extra thym anti inflammatori effect contribut import clinic util vegan diet bromocryptin fish oil autoimmun favor impact low latitud high altitud autoimmun risk mediat superior vitamin status decreas secret parathyroid hormon theoret ground suspect parathyroid hormon inhibit apoptosi thymocyt androgen up regul thymocyt apoptosi larg respons relat protect autoimmun enjoy men merit evalu manag autoimmun women prove practic prevent autoimmun disord revers establish whole food vegan diet coupl fish oil vitamin supplement repres practic strategi achiev prevent concurr lower risk life threaten western diseas copyright num harcourt publish
MED-4115~rise fall horror autotoxicus forbidden clone pubm ncbi abstract cui associ show healthi individu natur autoantibodi naa specif myeloperoxidas proteinas num glomerular basement membran gbm specif anti neutrophil cytoplasm antibodi anti gbm antibodi pathogen ehrlich propos horror autotoxicus burnet envis elimin forbidden clone naa present healthi individu play benefici homeostat role pathogen autoimmun dysregul natur homeostat autoimmun onset previous absent self recognit
MED-4116~flip side immun surveil immun depend pubm ncbi abstract growth tumor stimul inhibit quantit low level immun reason tumor antigen tumor develop vivo absenc minim immun reaction sens cancer consid autoimmun diseas review base larg work laboratori outlin data show titrat anti tumor immun exhibit phenomenon hormesi dose respons curv non linear low level immun general stimulatori larger quantiti immun reactant inhibit tumor growth evid review suggest immun respons vari qualit quantit progress oncogenesi low level immun reaction aid initi tumor growth larger reaction remiss earli neoplasm neoplasm surviv relat immunolog toler tumor depend part suppressor cell knowledg explain clinic observ relationship tumor type organ distribut metastas
MED-4117~immunolog enhanc breast cancer pubm ncbi abstract breast cancer complex diseas aetiolog multifactori period develop span decad clinic high variabl evalu role immun respons develop control breast cancer complex substanti inform diseas immun respons host defenc reaction serv facilit cancer develop evid varieti sourc includ clinical patholog investig women show correl intens lymphocyt infiltr tumour mass poor prognosi studi breast cancer patient demonstr similar correl delay hypersensit reactiv vitro assay immun reactiv tumour cell membran non specif antigen poor prognosi analys cancer incid chronic immunosuppress kidney transplant recipi develop unexpect low incid breast cancer conclus human studi corrobor observ mous mammari tumour model demonstr immun enhanc breast cell prolifer vitro breast cancer develop vivo potenti mechan effect includ product inflammatori cell infiltr direct indirect modul breast cell growth cytokin peptid steroid hormon enzym involv steroid metabol antibodi growth factor receptor immun facilitatori mechan overcom immune bas therapi appli success breast cancer
MED-4118~recrudesc kaposi sarcoma initi haart manifest immun reconstitut syndrom pubm ncbi abstract object case seri literatur review character clinic prognosi hiv infect patient kaposi sarcoma ks flare immun reconstitut inflammatori syndrom iri heterogen fatal disord immun perturb initi high activ antiretrovir therapi haart medic record num hiv infect patient ks flare virolog immunolog respons haart review singl institut addit num case abstract computer search medic literatur singl institut seri time onset ks flare num week pretreat cd num count num cells mm num hiv viral load num copi millilit flare cd num count num cells mm num hiv viral load num copi millilit similar aggreg result repres literatur fatal report num pulmonari ks num unrel system chemotherapi univers led tumor regress administ num num case instanc haart discontinu onset iris associ ks flare observ earli num week case diagnos num month immunolog virolog respons haart flare necessarili portend poor prognosi patient rapid symptomat ks earli system chemotherapi effect suppress iris associ flare close clinic supervis warrant ks patient initi chang resum haart vigil recommend pulmonari involv
MED-4119~melanoma renal transplant recipi pubm ncbi abstract background document renal transplant recipi increas risk develop skin cancer squamous cell carcinoma extens review literatur increas incid malign melanoma review num patient oxford renal transplant popul develop num melanoma transplant object determin incid characterist melanoma renal transplant recipi method review case note patholog patient develop melanoma oxford renal transplant unit clinic detail record includ date transplant immunosuppress therapi interv transplant melanoma site occurr histori sun exposur type clinician diagnos melanoma histori skin malign outcom histopatholog document prognost factor result ten patient develop num melanoma patient melanoma popul num transplant patient total number transplant year num num incid melanoma popul num num num transplant year approxim num time greater standard rate region found interv transplant melanoma approxim num year median num dermatologist diagnos clinician num case melanoma occur trunk major case num upper limb num patient aliv recurr melanoma patient die result metastat melanoma follow up period melanoma num year patient patient die melanoma num mm breslow thick patient melanoma num mm thick precursor naevus num melanoma precursor dysplast naevus case vertic growth phase tumour infiltr lymphocyt respons absent case nonbrisk patient conclus oxford transplant popul studi melanoma occur approxim num time rate general popul highest rate report literatur patient outcom report previous due detect earli stage renal transplant recipi attend dedic dermatolog clinic oxford contribut earli diagnosi good outcom
MED-4120~sucros activ human tast pathway differ artifici sweeten pubm ncbi abstract anim model suggest sucros activ tast affer differ non calor sweeten inform exist artifici sweeten engag central tast pathway human brain assess sucros sucralos tast pleasant concentr gradient num healthi control women appli num sucros match sucralos function magnet reson imag result num sucros sucralos activ function connect primari tast pathway num tast pleasant predict left insula respons num sucros elicit stronger brain respons anterior insula frontal operculum striatum anterior cingul compar sucralos num sucros sucralos stimul engag dopaminerg midbrain area relat behavior pleasant respons brain respons distinguish calor non calor sweeten conscious mind import implic effect artifici sweeten abil substitut sugar intak
MED-4121~effect covert nutrit dilut spontan food intak obes individu pilot studi pubm ncbi abstract present studi investig feasibl experiment approach studi effect covert nutrit dilut spontan food intak obes individu obes subject studi inpati metabol unit num day time unawar food intak monitor platter method food present encourag ad libitum ingest calor dilut achiev replac sucrose contain product aspartame sweeten analogu normal diet base lin period subject spontan ate suffici convent food maintain slight increas bodi weight covert substitut aspartame sweeten product sucros counterpart result reduct spontan energi intak approxim num aspartam analogu accept convent counterpart equal quantiti consum preliminari result demonstr metabol ward set maintain spontan food intak obes individu level suffici preserv bodi weight arbitrarili decreas level intak num covert calor densiti diet
MED-4124~erythritol sweet antioxid pubm ncbi abstract object hyperglycemia oxid stress onset progress diabet complic strong link reduct oxid stress utmost import long term treatment diabet patient chronic natur diseas call mode antioxid intak sustain easili diet erythritol simpl polyol compound oral toler chemic structur resembl mannitol well known hydroxyl radic ho scaveng method studi antioxid properti erythritol vitro subsequ determin antioxid activ vasoprotect effect streptozotocin diabet rat result erythritol shown excel ho radic scaveng inhibitor num azobi num amidinopropan dihydrochloride induc hemolysi inert superoxid radic high perform liquid chromatograph electron spin reson spectroscopi studi show reaction erythritol hydroxyl radic result format erythros erythrulos abstract carbon bound hydrogen atom streptozotocin diabet rat erythritol display endothelium protect effect accord vitro experi erythros found urin erythritol consum rat conclus erythritol act antioxid vivo protect hyperglycemia induc vascular damag copyright num elsevi reserv
MED-4125~human gut microbiota ferment erythritol pubm ncbi abstract erythritol natur occur polyol gain attent bulk sweeten human nutrit industri produc glucos ferment studi non cariogen rapid absorb small intestin quantit excret urin num enter colon earlier vitro experi show erythritol remain unfer ferment period num order investig fresh human intestin microbiota adapt enzym activ erythritol num ferment carri well standardis vitro condit comparison maltitol lactulos blank faecal inoculum incub ferment pattern establish total gas product hydrogen accumul ph scfa product substrat degrad ferment paramet account erythritol turn complet resist bacteri attack num exclud adapt period vivo condit easili ferment substrat enter colon continu erythritol ferment vivo
MED-4126~formaldehyd aspartam migrain connect pubm ncbi abstract aspartam wide artifici sweeten link pediatr adolesc migrain ingest aspartam broken convert oxid formaldehyd tissu present case seri aspartame associ migrain relat clinic relev posit reaction formaldehyd patch test
MED-4127~aspartame induc fibromyalgia unusu curabl chronic pain pubm ncbi abstract report time unusu musculoskelet advers effect aspartam patient num year old woman suffer widespread pain fatigu num year lead diagnosi fibromyalgia vacat foreign countri suffer pain symptom forgotten aspartam symptom reappear day return reintroduc aspartam daili diet aspartam definit exclud diet result complet regress fibromyalgia symptom num year old man consult num year histori bilater forearm wrist hand cervic pain unsuccess treatment detail question find aspartam year remov aspartam complet regress pain recurr patient chronic pain due ingest aspartam potent flavour agent wide food calorie sav benefit risk ratio diagnosi aspartame induc chronic pain obvious potenti benefit cure disabl chronic diseas spare numer laboratori imag investig avoid potenti harm therapi potenti risk temporarili chang patient diet practition patient suffer fibromyalgia intak aspartam case simpl question lead resolut disabl chronic diseas
MED-4128~valid method detect virul yersinia enterocolitica distribut slaughter pig convent alterna pubm ncbi abstract method literatur detect virul yersinia enterocolitica pig risk factor pig herd contamin determin object studi valid sensit method detect enterocolitica describ distribut bacteria pig slaughter convent altern organ hous system sampl collect tonsil caecum caecal content caecal lymph node num slaughter pig sampl compar sensit laboratori cultur method common literatur polymeras chain reaction primer pair multiplex pcr pcr examin tonsil caecum caecal lymph node group slaughter pig num convent fatten farm num altern hous result multiplex pcr posit num case cultur method prove inferior pcr sensit part studi pcr detect num posit pig altern hous num convent hous num highest rate enterocolitica contamin found tonsil num altern num convent num caecum num lymph node num hous system import factor preval common pathogen pig herd found import differ system studi convent system main risk factor sourc pig pig supplier commerci feed transport slaughter
MED-4129~contamin carcass human pathogen yersinia enterocolitica num num origin pig infect farm pubm ncbi abstract pig consid major reservoir human pathogen yersinia enterocolitica sourc human yersiniosi transmiss rout enterocolitica farm pork unclear transmiss pathogen enterocolitica pig carcass pluck set investig collect sampl num individu ear tag pig farm slaughterhous addit isol strain analyz pulsed field gel electrophoresi isol similar genotyp pathogen enterocolitica num num anim farm slaughterhous carcass show carcass contamin origin strain pig carri fatten period direct contamin carrier pig subsequ pluck set primari contamin rout pluck set cross contamin larger impact pluck set contamin carcass studi within farm preval pathogen enterocolitica vari num num indic specif farm factor affect preval enterocolitica pig associ farm factor high preval pathogen enterocolitica farm studi time correl two level logist regress analys specif farm factor drink nippl absenc coars feed bed slaughter pig access pest anim pig hous high preval pathogen enterocolitica num num
MED-4130~preval yersinia enterocolitica shed bioserotyp distribut ontario finish pig herd num num pubm ncbi abstract investig characterist yersinia enterocolitica infect ontario finish pig herd specif object estim test preval enterocolitica shed finish pig bioserotyp distribut agreement herd level test base sampl pig pool fecal sampl bioserotyp cluster farm enterocolitica posit herd cluster spatial total num fecal sampl collect num farm year num num total herd visit fecal sampl test cultur posit isol biotyp serotyp appar pig level preval enterocolitica num num num num num estim true pig level preval enterocolitica num num num num num herd level preval num num num num num year common bioserotyp num num bioserotyp num num kappa herd level status base pig pool sampl rang num num biotyp num bioserotyp num num num num signific bias discord pair detect indic pig sampl sensit pool sampl declar herd posit farm tend repeat posit bioserotyp posit studi farm cluster spatial suggest lack herd transmiss lack common geograph risk factor copyright num elsevi reserv
MED-4131~annual cost ill quality adjust life year loss unit state due num foodborn pathogen pubm ncbi abstract articl estim annual cost ill quality adjust life year qali loss unit state caus num num major foodborn pathogen report scallan al emerg infect dis num num base incid estim foodborn ill unit state num pathogen account num ill hospit num death due identifi pathogen estim scallan al estim num pathogen num billion rang num billion num billion cost ill loss num qali rang num num qali year rough num loss caus pathogen nontyphoid salmonella enterica num billion num qali campylobact spp num billion num qali listeria monocytogen num billion num qali toxoplasma gondii num billion num qali norovirus num billion num qali companion articl attribut loss estim studi consumpt specif categori food arriv estim pathogen creat diseas outcom tree character symptom sever durat outcom likelihood health state pathogen estim cost ill medic cost product loss valuat prematur mortal pathogen estim qali loss health state pathogen euroqol num scale construct diseas outcom tree outcome specif cost ill euroqol num score greater detail companion articl
MED-4132~rank diseas burden num pathogen food sourc unit state attribut data outbreak investig expert elic pubm ncbi abstract understand relat public health impact major microbiolog hazard food suppli critic risk bas nation food safeti system studi conduct estim health burden num major pathogen num broad categori food rank result num pathogen food combin pathogen examin campylobact clostridium perfringen escherichia coli num num listeria monocytogen norovirus salmonella enterica toxoplasma gondii foodnet pathogen health burden pathogen measur estim cost ill loss quality adjust life year qali acut chronic ill mortal method attribut ill food develop reli outbreak data expert elicit method assum empir data general prefer expert judgment outbreak data attribut evid suggest data consid repres food attribut base evalu outbreak data expert elicit publish scientif literatur outbreak bas attribut estim campylobact toxoplasma cryptosporidium yersinia determin repres expert bas attribut includ pathogen sensit analys conduct assess effect attribut data assumpt rank diseas burden concentr small number pathogen food combin top num pair respons loss num billion num qali num total pair num pathogen poultri pork produc complex food respons num total cost ill loss qali
MED-4133~earli dismiss yersinia enterocolitica infect aetiolog grave diseas evid twin case control studi pubm ncbi abstract background yersinia enterocolitica ye infect long implic pathogenesi grave diseas gd associ ye gd due common genet environment factor affect develop ye infect gd potenti confound minim investig twin pair discord gd aim examin ye infect gd design conduct classic case control studi individu num num gd case control studi twin pair num discord gd method immunoglobulin ig igg antibodi virulence associ yersinia outer membran protein yop measur main outcom measur preval yop iga igg antibodi result subject gd higher preval yop iga num num num ypo igg num num num extern control frequenc chronic ye infect reflect presenc iga igg yop antibodi higher case control num num num similar result found twin pair discord gd case control analysi individu gd increas odd ratio ye infect iga num num ci num num igg num num ci num num co twin analysi twin gd increas ye infect iga num num ci num num igg num num ci num num conclus find associ gd ye case control studi twin pair discord gd support notion ye infect play aetiolog role occurr gd vice versa futur studi examin tempor relationship associ depth
MED-4134~preval pathogen yersinia enterocolitica strain pig unit state abstract yersinia enterocolitica consid import food born pathogen impact pork product process industri unit state bacterium commens swine primari goal studi determin preval pathogen enterocolitica pig unit sate fece sampl sourc total num fecal sampl test presenc swine fecal sampl collect late finish pig num product site num eastern midwestern pork produc state period num week num septemb num num march num preval ail posit enterocolitica determin sampl fluorogen num nucleas pcr assay cultur method preval num num num fecal sampl test pcr culture posit result combin forty on num premis num fecal sampl posit ail sequenc pcr assay contamin rate num num num compar num num num cultur method num pcr posit sampl num cultur negat num culture posit sampl num pcr negat num premis pcr assay reveal signific num higher percentag num num site sampl posit pathogen ail sequenc cultur method num num site higher sensit respect number sampl site identifi posit pcr method compar cultur method detect pathogen enterocolitica demonstr studi result support hypothesi swine reservoir enterocolitica strain potenti pathogen human
MED-4135~behavior yersinia enterocolitica food abstract yersinia enterocolitica ubiquit isol frequent soil water anim varieti food compris biochem heterogen group surviv grow refriger temperatur abil propag refriger temperatur signific food hygien virul strain yersinia invad mammalian cell hela cell tissu cultur chromosom gene inv ail identifi cell invas mammalian pathogen diarrhoea append post infect arthriti occur small proport case common transmiss rout pathogen enterocolitica thought fecal or contamin food direct person to person contact rare occasion pathogen enterocolitica detect veget environment water veget untreat water potenti sourc human yersiniosi isol rate pathogen enterocolitica low due limit sensit detect method identifi transmiss vehicl food item studi extens factor relat epidemiolog enterocolitica sourc transmiss rout predomin genotyp remain obscur low sensit detect method
MED-4136~vital sign incid trend infect pathogen transmit common food  foodborn diseas activ surveil network num pubm ncbi abstract background unit state contamin food approxim num report diseas outbreak estim num million ill num method foodborn diseas activ surveil network foodnet conduct surveil num popul laboratory confirm infect pathogen transmit common food pathogen specif incid estim num num num num hospit num death annual report summar num surveil data describ trend num result total num infect num hospit num death report foodnet site num salmonella infect common infect report num ill num person largest number hospit num death num signific chang incid salmonella infect occur start surveil num shiga toxin produc escherichia coli stec num infect caus num ill num compar num incid infect key pathogen num num lower pathogen specif incid lower campylobact listeria stec num shigella yersinia infect higher vibrio infect compar recent period num num incid num lower stec num shigella infect higher vibrio infect conclus incid stec num infect declin reach num nation health object target num case num success mark declin num incid key foodborn infect demonstr feasibl prevent foodborn ill implic public health practic salmonella infect target declin signific decad data common foodborn infect result estim num million direct medic cost annual prevent measur reduc stec num infect appli broad reduc salmonella infect effect measur farm tabl includ prevent contamin meat slaughter food includ produc process prepar cook meat vigor detect investig outbreak recal contamin food
MED-4137~preval yersinia enterocolitica phase product swine farm pubm ncbi abstract swine identifi primari reservoir pathogen yersinia enterocolitica ye research focus epidemiolog ye farm level object studi describ preval ye product phase swine farm cross sect studi individu pig swine oper sampl presenc ye farm fece oral pharyng swab collect pig product phase gestat farrow suckl nurseri finish pig consid posit sampl test posit sampl cultur cold enrich isol select media plate presumpt isol confirm ye assay presenc ail multiplex pcr num pig sampl num num test posit num ail posit num ye isol farm trend increas preval pig matur num suckl piglet test posit ye num num ail posit nurseri pig test posit num num ail posit finish pig harbor ye interest gestat sow highest preval ye num num ail posit ye detect farrow sow result repres on farm descript ye herd provid initi step design futur studi ye
MED-4138~yersinia enterocolitica review issu relat zoonot pathogen public health challeng pork product chain pubm ncbi abstract yersinia enterocolitica zoonot agent gastrointestin diseas human reactiv arthriti erythema nodosum enteropathogen yersinia etiolog agent yersiniosi acquir consumpt contamin food porcin anim main carrier enterocolitica food safeti measur minim human infect increas interest scientif medic communiti review examin imper inform reservoir preval virul abil pathogen surviv environ investig provid ration measur prevent decreas diseas risk
MED-4139~preval yersinia enterocolitica market weight hog unit state pubm ncbi abstract pig major anim reservoir yersinia enterocolitica strain potenti pathogen human goal studi estim individu anim on farm preval enterocolitica hog base tonsil sampl collect nation anim health monitor system swine num studi ii data data previous publish fecal sampl determin on farm risk factor enterocolitica tonsil swab num fecal sampl num collect num farm locat top num pork produc state ten percent tonsil num num sampl posit irgasan tiracillin chlor itc enrich broth real tim pcr num sampl num num posit subcultur select cefsulodin irgasan novobiocin cin agar tonsil on farm preval base real tim pcr detect ail gene itc enrich broth cultur num num premis sampl preval base subcultur cin agar num num num premis result bacteriolog isol real tim pcr analysi tonsil fece combin estim preval individu anim farm subsequ correl num farm manag practic factor accompani odd ratio identifi final regress model locat central state num vaccin escherichia coli num percentag death due scour num presenc meat bone meal grower finish diet num
MED-4140~factor relat preval pathogen yersinia enterocolitica pig farm pubm ncbi abstract survey num pig num farm conduct determin within farm preval pathogen yersinia enterocolitica questionnair manag condit mail farm univari statist analysi carriag shed outcom conduct random effect logist regress farm cluster factor variabl num num includ respect multivari random effect logist regress model municip water discov protect factor carriag faecal shed pathogen organ product buy feed feed manufactur protect total carriag tonsillar carriag feed manufactur fast pig transport slaughterhous higher level farm health classif snout contact pig risk factor faecal shed conclud differ manag explain preval enterocolitica farm
MED-4141~piglet sourc pathogen yersinia enterocolitica fattening pig farm abstract studi origin spread yersinia enterocolitica pig fecal blood sampl repeat fatten farm piglet found infect breed farm piglet mix infect spread unit eventu pig excret pathogen
MED-4142~human pathogen tetracycline resist bacteria bioaerosol swine confin build nasal flora hog produc pubm ncbi abstract swine confin build eastern canada enclos equip modern product system manag wast bioaerosol swine confin build contamin human pathogen antimicrobi resist bacteria colon expos worker analyz bioaerosol swine confin build nasal flora canadian hog produc evalu colon human pathogen tetracycline resist bacteria cultur non cultur human pathogen tet gene investig bioaerosol num barn nasal passag num hog produc sampl total dna extract calcium algin swab detect pcr campylobact perfringen enterococcus coli enterocolitica teta tetc tetg ribosom protect protein gene airborn cultur perfringen enterococcus coli enterocolitica present bioaerosol num num num num facil aerosol total culturable non cultur campylobact perfringen enterococcus coli enterocolitica detect num num num barn tet gene found isol cultur human pathogen teta tetc tetg ribosom protect protein gene detect bioaerosol num studi build campylobact perfringen enterococcus coli enterocolitica found num num nasal flora worker num worker posit teta tetc tetg gene swine confin build hog produc expos aerosol human pathogen tetracycline resist bacteria contamin nasal flora copyright num elsevi gmbh reserv
MED-4143~yersinia enterocolitica infect diarrheal patient pubm ncbi abstract studi hope provid valuabl clinic inform yersiniosi clinician thousand hundr stool sampl collect outpati diarrhea test cultur method real tim polymeras chain reaction rt pcr total num posit sampl detect rt pcr num cultur method num incid num detect rate rt pcr signific higher cultur method higher incid autumn wint notic identifi spring summ infect sourc focus unboil food num pet num clinic manifest present gastroenter num pseudoappend num extraintestin complic num morbid extraintestin complic adult signific higher children high risk patient adult age num year num children age num year num constitu ratio children versus adult yersiniosi system signific num isol test antimicrobi suscept major suscept third gener cephalosporin aminoglycosid fluoroquinolon trimethoprim sulfamethoxazol small portion suscept first gener cephalosporin penicillin autumn wint month clinician pay attent clinic manifest earli diagnosi treatment suscept antibiot yersiniosi complic target high risk patient
MED-4144~fresh meat process characterist ham muscl finish pig fed ractopamin hydrochlorid pubm ncbi abstract ractopamin hydrochlorid rac consist led advantag carcass cut yield finish pig remain common feed addit finish pig diet effect rac process characterist research report advantag ultim ph lm pig fed rac greater ultim ph observ ham increas ph affect process characterist lead protein interact improv textur properti object experi determin rac f pig yield ham greater ultim ph advantag improv textur properti water retent process ham hundr ham barrow gilt fed rac control diet select base hcw ham fabric num separ piec determin cut yield num muscl evalu ultim ph ham process make cure smoke ham ractopamin increas cut yield ham num insid num num knuckl num express percentag chill side weight ultim ph rectus femori vastus laterali semitendinosus num ph unit greater num bicep femori num ph unit greater num semimembranosus adductor muscl num ph unit greater pig fed num mg kg rac compar control pig cure ham rac f pig heavier stage product differ detect bind strength num protein fat fre valu num rac num kg num control ham num kg num ractopamin increas cut yield total weight cure ham ultim muscl ph ractopamin fed pig achiev desir growth characterist advantag cut yield affect process ham characterist
MED-4145~effect dietari factor metabol modifi qualiti nutrit meat pubm ncbi abstract number technolog increas feed effici lean tissu deposit decreas fat deposit develop effort improv profit anim product general mode action metabol modifi increas muscl deposit simultan reduc fat deposit concern focus increas product effici lean meat yield detriment meat qualiti aim review collat data effect metabol modifi meat qualiti discuss effect data literatur collat subject meta analys conserv technolog result num num num kg increas shear forc similar reduct percept tender born mind magnitud increas similar observ similar increas carcass lean obtain nutrit genet select inher consequ product leaner meat counter metabol factor dietari addit offer potenti improv meat qualiti immuncastr conjunct somatotropin approv agonist anabol implant cla maintain improv meat qualiti
MED-4146~meta analysi effect ractopamin hydrochlorid carcass cutabl primal yield finish pig pubm ncbi abstract object summar previous literatur meta analysi approach effect ractopamin hydrochlorid rac fed dose num num mg kg num harvest carcass cutabl belli qualiti finish pig meta analysi provid opportun determin consensus previous publish literatur ten studi evalu determin cut yield num studi determin belli qualiti review pool dietari rac concentr num mg kg num mg kg num mg kg step up feed program pool feed durat num harvest compar pig fed rac control analyz meta analysi mix procedur sas ractopamin inclus fix effect model individu studi consid random variabl differ rac control pig primal percentag side weight ham num differ detect primal percentag side weight differ detect standard trim primal yield differ num percentag side weight detect boston butt trim loin trim ham translat rac pig carcass cut yield num num num sed num advantag num unit bone lean cut yield num num num sed num advantag num unit compar control pig advantag bone in cutabl result increas boneless primal yield lean cut shoulder loin ham evalu rac pig boneless shoulder boston butt picnic yield advantag num unit num sed num num unit num sed num yield advantag boneless loin canadian back tenderloin sirloin num unit num sed num advantag boneless ham insid knuckl boneless yield calcul summat percentag side weight boneless shoulder boneless loin boneless ham result num unit num num num sed num advantag rac pig compar control pig subprim yield differ num trim belli rac pig num control pig num rac pig num cm num narrow flop distanc num sed num greater iodin valu num sed num compar control pig num cm num
MED-4147~occurr steroid hormon antibiot shallow groundwat impact livestock wast control facil pubm ncbi abstract wastewat impound concentr anim feed oper cafo repres potenti sourc veterinari pharmaceut steroid hormon contamin shallow groundwat studi investig occurr seventeen veterinari pharmaceut thirteen steroid hormon hormon metabolit lagoon adjac groundwat oper swine beef cattl facil site chosen subsurfac geolog previous monitor nitrat ammonia chlorid level shallow ground water strong direct infiltr repres worst case ground water contamin wast water pharmaceut compound detect sampl obtain cattl facil includ sulfamerazin sulfamethazin erythromycin monensin tiamulin sulfathiazol lincomycin ractopamin sulfamethazin sulfathiazol erythromycin tiamulin sulfadimethoxin detect wastewat sampl obtain swine facil steroid hormon detect frequent veterinari pharmaceut studi estron testosteron num androstenedion androsteron detect wastewat impound concentr rang num num g l estron testosteron detect groundwat sampl concentr num g l co occurr veterinari pharmaceut steroid hormon contamin groundwat locat correl pharmaceut occurr lagoon wastewat hydraul downgradi groundwat groundwat livestock wastewat impound suscept contamin veterinari pharmaceut steroid hormon origin wastewat lagoon copyright num elsevi reserv
MED-4148~aggress brain amin concentr domin subordin finish pig fed beta adrenoreceptor agonist ractopamin pubm ncbi abstract farm condit aggress relat format social hierarchi competit resourc major problem injuri social stress carcass loss factor affect regul amount aggress farm system instanc feed beta adrenoreceptor agonist ractopamin rac worthi investig object studi assess effect wide swine feed addit rac effect sex social rank aggress concentr brain amin neurotransmitt essenti control aggress finish pig thirty two barrow num gilt num pigs pen sex fed control diet diet rac paylean elanco anim health greenfield ad num mg kg num wk num mg kg num wk top domin bottom subordin pig num pigs sex pen determin mix num period continu behavior observ pig subject resident intrud test maximum num feed trial measur aggress end wk num amygdala frontal cortex hypothalamus raph nuclei dissect analyz concentr dopamin da serotonin num ht metabolit num dihydroxyphenyl acet acid dopac homovanil acid num hydroxyindoleacet acid num hiaa norepinephrin epinephrin hplc ractopamine f gilt perform attack num test pig subgroup num end resident intrud test num domin control gilt barrow domin subordin rac f gilt perform greatest percentag attack num gilt decreas norepinephrin dopac concentr amygdala frontal cortex fed rac gilt num hiaa concentr greatest da turnov rate amygdala num num ht concentr frontal cortex gilt compar barrow raph nuclei singl site brain num ht synthesi domin gilt num ractopamin affect aggress behavior indirect action central regulatori mechan da system aggress pattern observ test pig gilt link brain monoamin profil defici serotonerg system raph nuclei amygdala frontal cortex enhanc da metabol amygdala brain area vital aggress regul
MED-4149~creation databank content antioxid food product amperometr method pubm ncbi abstract oxid stress excess content reactionari oxygen nitrogen compound roac includ free radic danger diseas prematur age advers effect free radic neutral antioxid order carri antioxid therapi content antioxid food product creat databank content antioxid num food product beverag water solubl antioxid fat solubl antioxid dairi fish product cacao chocol nut determin time amperometr method
MED-4150~pseudo mapl syrup urin diseas due matern prenat ingest fenugreek pubm ncbi abstract fenugreek mapl syrup urin mapl syrup urin diseas msud patient share characterist odour origin common compon sotolon ingest fenugreek mother labour result mapl syrup lik odour newborn infant lead fals suspicion msud
MED-4151~screen bas entertain time all caus mortal cardiovascular event population bas studi ongo mortal hospit event pubm ncbi abstract object aim studi examin independ relationship televis view screen bas entertain screen time all caus mortal clinic confirm cardiovascular diseas cvd event secondari object examin extent metabol bodi mass index high dens lipoprotein total cholesterol inflammatori c reactiv protein marker mediat relationship screen time cvd event background evid suggest prolong sit link cvd risk factor develop physic activ particip studi hard outcom scarc method popul sampl num num men scottish health survey num respond num year num all caus mortal cvd event fatal nonfat combin main exposur interviewer assess screen time num h day num num h day num h day moder vigor intens physic activ result hundr fifteen cvd event num any caus death occur num follow up person year covari age sex ethnic obes smoke social class long stand ill marit status diabet hypertens adjust hazard ratio hr all caus mortal num num confid interv ci num num cvd event num num ci num num particip engag num h day screen time relat num h day adjust physic activ attenu associ slight all caus mortal hr num num ci num num cvd event hr num num ci num num exclus particip cvd event num year follow up previous cancer registr chang result appreci approxim num associ screen time cvd event explain collect c reactiv protein bodi mass index high dens lipoprotein cholesterol conclus recreat sit reflect television screen view time relat rais mortal cvd risk physic activ particip inflammatori metabol risk factor part explain relationship copyright num american colleg cardiolog foundat publish elsevi reserv
MED-4152~sedentari activ lead weight gain sleep pubm ncbi abstract purpos review discuss benefit good night sleep bodi weight stabil recent find experiment studi shown short term partial sleep restrict decreas glucos toler increas sympathet tone elev cortisol concentr decreas satieti hormon leptin increas appetite stimul hormon ghrelin increas hunger appetit short sleep durat increas risk obes recoveri hormon profil facilit appetit control lack sleep lead weight gain obes increas time eat make mainten healthi lifestyl difficult increas fatigu tired sleep lessen one resolv follow exercis regimen summari short sleep durat independ risk factor obes grow preval chronic sleep restrict causal associ reduc sleep obes substanti import public health standpoint futur research determin sleep extens sleep depriv obes individu influenc appetit control and or reduc amount bodi fat
MED-4153~occup sit health risk systemat review pubm ncbi abstract context emerg evid suggest sedentari behavior time spent sit negat health aim studi systemat review evid associ occup sit health risk evid acquisit studi identifi march april num literatur search pubm psycinfo central cinahl embas pedro subsequ related articl search pubm citat search web scienc identifi studi categor health outcom independ review assess methodolog qualiti num item qualiti rate list score rang num point higher score indic qualiti data studi design studi popul measur occup sit health risk analys result extract evid synthesi num paper met inclus criteria num cross sect num case control num prospect examin associ occup sit bmi num cancer num cardiovascular diseas cvd num diabet mellitus dm num mortal num median study qu score num point half cross sect studi show posit associ occup sit bmi prospect studi fail confirm causal relationship case control evid posit associ occup sit cancer general support prospect studi major prospect studi found occup sit higher risk dm mortal conclus limit evid found support posit relationship occup sit health risk heterogen studi design measur find make difficult draw definit conclus time copyright num american journal prevent medicin publish elsevi reserv
MED-4154~associ dietari fat veget antioxid micronutri skin age japanes women pubm ncbi abstract daili diet implic skin age data relationship diet paramet skin condit scarc present studi aim examin associ biophys properti skin women intak fat antioxid micronutri food group sourc nutrient cross sect studi measur hydrat surfac lipid elast skin num japanes women non invas techniqu extent facial wrinkl crow s foot area determin observ daniel scale subject usual diet determin valid ffq control covari includ age smoke status bmi lifetim sun exposur result show higher intak total fat satur fat monounsatur fat signific increas skin elast higher intak green yellow veget signific decreas daniel wrinkl score intak satur fat signific invers daniel wrinkl score addit adjust green yellow veget intak studi accur measur method investig role daili diet skin age
MED-4156~gerson regimen pubm ncbi abstract gerson regimen develop max gerson num promot altern cancer treatment involv consum fresh raw fruit veget juic elimin salt diet supplement potassium vitamin num thyroid hormon pancreat enzym detoxifi liver coffe enema stimul metabol gerson therapi base theori cancer caus alter cell metabol toxic environment substanc process food sodium potassium content emphas increas potassium intak minim sodium consumpt effort correct electrolyt imbal repair tissu detoxifi liver coffe enema believ dilat bile duct excret toxic breakdown product liver colon wall theori substanti scientif research propon claim recoveri rate high num num case review nation cancer institut nci york counti medic societi found evid gerson diet nci sponsor studi gonzalez therapi similar gerson diet show patient inoper pancreat adenocarcinoma underw standard chemotherapi gemcitabin gemzar surviv time longer qualiti life chose enzym treatment includ pancreat enzym nutrit supplement detoxif organ diet
MED-4157~compound bioident menopaus hormon therapi pubm ncbi abstract improv long term health longer indic menopaus hormon therapi evid support fewer advers event younger women combin high effect reinforc short term treatment menopaus symptom menopaus therapi provid commerci product compound creation individu prepar respons health care provider prescript creat medic tailor special individu patient women health initi find coupl increas direct to consum market media promot compound bioident hormon prepar safe effect altern convent menopaus hormon therapi led recent increas popular compound bioident hormon increas question prepar evid lack support superior claim compound bioident hormon convent menopaus hormon therapi claim pose addit risk variabl puriti potenc lack efficaci safeti data committe gynecolog practic american colleg obstetrician gynecologist practic committe american societi reproduct medicin provid overview major issu concern surround compound bioident menopaus hormon therapi provid recommend patient counsel copyright num american societi reproduct medicin publish elsevi reserv
MED-4158~brain volum cognit impair conjug equin estrogen abstract background postmenopaus conjug equin estrogen cee therapi increas risk cognit impair women age num year older smaller region brain volum link phenomena establish method standard magnet reson imag perform num women num num year particip random placebo control clinic trial cee bas therapi women includ report age num num year free dementia mild cognit impair mci origin enrol trial averag num num year conduct num academ medic center associ region brain volum ischem lesion volum develop cognit impair dementia mci contrast treatment group analys covari result fifty thre women develop mci probabl dementia follow up women prescrib cee bas therapi cognit impair smaller hippocamp num total brain volum num qualit associ independ level pretreat cognit function women prescrib placebo relationship evid cognit impair greater ischem lesion volum frontal lobe num num conclus mechan cee bas postmenopaus hormon therapi induc cognit impair increas brain atrophi
MED-4159~conjug equin estrogen incid probabl dementia mild cognit impair postmenopaus women women health initi mem pubm ncbi abstract context women health initi memori studi whim previous found increas risk dementia effect mild cognit impair mci women treat conjug equin estrogen cee medroxyprogesteron acet mpa object determin effect cee cee mpa incid probabl dementia mci older women design set particip random double blind placebo control clinic trial cee estrogen alon trial cee mpa estrogen progestin trial community dwel women age num num year conduct june num juli num estrogen progestin num februari num estrogen alon num num num whi clinic center intervent estrogen alon trial num daili tablet num mg d cee match placebo estrogen progestin trial num daili tablet cee num mg d mpa num mg d match placebo main outcom measur probabl dementia mci result estrogen alon trial num particip diagnos probabl dementia num assign cee num placebo hazard ratio hr num num confid interv ci num num incid rate probabl dementia estrogen alon trial statist similar estrogen progestin trial num num num person year cee mpa placebo num data pool origin whim protocol hr probabl dementia num num ci num num num exclud particip baselin modifi mini ment state examin score screen cut point hr num num ci num num num estrogen alon trial num num ci num num num pool trial estrogen alon trial num particip diagnos mci cee group num placebo group hr num num ci num num combin trial data hr similar num num ci num num estrogen alon trial num particip receiv cee diagnos probabl dementia mci num receiv placebo hr num num ci num num num conclus estrogen therapi reduc dementia mci incid increas risk end point combin pool data estrogen estrogen progestin result increas risk end point hormon therapi prevent dementia cognit declin women num year age older recommend
MED-4160~risk benefit estrogen progestin healthi postmenopaus women princip result women health initi random cont pubm ncbi abstract context decad accumul observ evid balanc risk benefit hormon healthi postmenopaus women remain uncertain object assess major health benefit risk common combin hormon prepar unit state design estrogen progestin compon women health initi random control primari prevent trial plan durat num year num postmenopaus women age num year intact uterus baselin recruit num clinic center num intervent particip receiv conjug equin estrogen num mg d medroxyprogesteron acet num mg d num tablet num placebo num main outcom measur primari outcom coronari heart diseas chd nonfat myocardi infarct chd death invas breast cancer primari advers outcom global index summar balanc risk benefit includ num primari outcom stroke pulmonari embol pe endometri cancer colorect cancer hip fractur death due result num num year follow up data safeti monitor board recommend stop trial estrogen progestin placebo test statist invas breast cancer exceed stop boundari advers effect global index statist support risk exceed benefit report includ data major clinic outcom april num estim hazard ratio hrs nomin num confid interv cis chd num num num num case breast cancer num num num num case stroke num num num num case pe num num num num case colorect cancer num num num num case endometri cancer num num num num case hip fractur num num num num case death due num num num num case hrs nomin num cis composit outcom num num num total cardiovascular diseas arteri venous diseas num num num total cancer num num num combin fractur num num num total mortal num num num global index absolut excess risk num person year attribut estrogen progestin num chd event num stroke num pes num invas breast cancer absolut risk reduct num person year num fewer colorect cancer num fewer hip fractur absolut excess risk event includ global index num num person year conclus health risk exceed benefit combin estrogen progestin averag num year follow up healthi postmenopaus women all caus mortal affect trial risk benefit profil found trial consist requir viabl intervent primari prevent chronic diseas result regimen initi continu primari prevent chd
MED-4161~delus frontotempor lobar degener abstract assess signific natur delus frontotempor lobar degener ftld import young onset dementia promin neuropsychiatr featur remain incomplet characteris case note patient meet diagnost criteria ftld attend tertiari level cognit disord clinic year period retrospect review patient histori delus identifi patient underw detail clinic neuropsycholog evalu brain mri diagnosi confirm patholog case estim preval delus num delus earli promin persist featur phenomenolog divers paranoid somat delus promin behaviour variant ftld frequent clinic subtyp cerebr atrophi bilater predomin right sid case conclud delus clinic issu ftld explor futur work
MED-4162~declin breast cancer whi appar impact hormon therapi pubm ncbi abstract larg number women stop hormon therapi ht estrogen progestin ep formul women health initi trial detect elev risk breast cancer ep user halt juli num recent report substanti signific declin population bas breast cancer incid hormone sensit form num num event link commentari consid evid link mass cessat ht num breast cancer incid declin num quantifi potenti impact cessat burden breast cancer
MED-4163~protein dietari refer intak inadequ vegetarian low amount anim protein consum pubm ncbi abstract object health benefit vegetarian diet well recogn long term adher diet nutrient inadequaci vitamin num calcium iron zinc protein dietari refer intak dris expert panel recommend adjust iron zinc calcium dris vegetarian account decreas bioavail adjust consid protein dri assumpt vegetarian consum num protein anim dairy egg sourc studi examin dietari protein sourc conveni sampl num young adult vegetarian women complet food log num consecut day num weekday num weekend day method daili contribut percentag protein consum cereal legum nuts se fruits veget dairy egg comput protein digest correct amino acid score daili diet calcul result calcul total dietari protein digest score particip num num differ signific num dri refer score num num averag protein digest correct amino acid score sampl num num differ signific num dri refer num analys anim protein account num dietari protein conclus research suggest protein dri vegetarian consum expect amount anim protein num num total protein adjust num num g kg account decreas protein bioavail copyright num elsevi reserv
MED-4164~evid protein requir signific underestim pubm ncbi abstract purpos review review discuss recent evid suggest signific underestim protein requir adult human recent find tradit total protein requir human determin nitrogen balanc recent dietari refer intak recommend population saf intak num num g kg day high qual protein adult human base meta analysi nitrogen balanc studi singl linear regress analysi reanalyz exist nitrogen balanc studi two phas linear regress analysi obtain safe protein requir num num g kg day two phas linear regress analysi consid biolog analysi dose respons curv inher problem nitrogen balanc method develop altern method indic amino acid oxid techniqu determin protein requir population saf requir adult men determin num num g kg day num num higher current dietari refer intak recommend summari indic amino acid oxidation bas requir valu num num protein kg day reanalysi exist nitrogen balanc studi signific higher current recommend urgent reassess recommend protein intak adult human
MED-4165~dietari sourc antioxid effect ergothionein pubm ncbi abstract ergothionein nativ membrane imperm thiol compound specif accumul cell organ cation transport octn num human octn num ergothionein implic etiopathogenesi autoimmun disord evid dietari sourc function role ergothionein human physiolog scarc analyz ergothionein content common food liquid chromatographi tandem mass spectrometri addit assess protect potenc ergothionein oxid stressor octn num express cell comparison main intracellular thiol antioxid glutathion evalu cell viabil mtt reduct assay food ergothionein highest concentr detect specialti mushroom kidney liver black red bean oat bran ergothionein exhibit cell protect copper ii induc toxic potent glutathion indict ergothionein involv intracellular antioxid thiol defens system
MED-4166~concentr antibiot residu vari edibl muscl tissu poultri pubm ncbi abstract antibiot veterinarian produc treat diseas improv anim product feder govern ensur safeti food suppli establish antibiot residu toler edibl anim tissu determin target tissu muscl residu monitor muscl select target tissu feder govern type muscl tissu monitor breast versus thigh specif muscl tissu incorpor residu higher concentr tissu select residu monitor evalu possibl poultri chicken divid group num day age dose enrofloxacin baytril label direct num ppm num day num ppm num day num ppm num day num ppm num day breast thigh muscl tissu collect bird num bird day group dose withdraw period fluoroquinolon concentr determin result higher enrofloxacin concentr breast versus thigh muscl treatment group num data enrofloxacin muscl tissu incorpor antibiot concentr result regulatori agenc determin tissu monitor ensur establish residu safeti toler level exceed
MED-4167~influenc water food consumpt inadvert antibiot intak general popul pubm ncbi abstract antibiot entri water environ grow concern investig perform examin potenti indirect human exposur environment antibiot residu evalu contribut drink water major food consumpt inadvert intak antibiot residu general human popul korea estim daili human intak antibiot sulfamethazin smz sulfamethoxazol smx sulfathiazol stz trimethoprim tmp enrofloxacin efx roxithromycin rtm measur concentr antibiot major metabolit urin general popul korea num addit measur antibiot sourc water drink water tap water sampl survey water consumpt rate studi popul assess contribut dietari factor survey consumpt pattern major food suspect antibiot residu smz sulfamethazine n num acetyl smz n num tmp efx ciprofloxacin cfx rtm detect num num num num num g ml urin sampl estim daili intak major antibiot relat consumpt drink water antibiot frequent detect sourc water num ng l consumpt food correl signific urinari excret antibiot daili intak estim efx cfx consumpt beef pork dairi product smz tmp pork dairi product tmp relat raw fish daili antibiot intak estim exceed accept daili intak level copyright num elsevi reserv
MED-4168~influenc five day vegetarian diet urinari level antibiot phthalat metabolit pilot studi templ stay particip pubm ncbi abstract diet purport exposur environment contamin purpos studi understand influenc dietari chang level exposur environment chemic antibiot phthalat purpos examin extent short term diet influenc inadvert exposur level chemic adult popul recruit particip num five day templ stay program korea collect urin sampl program conduct questionnair survey particip dietari pattern prior particip program particip daili routin buddhist monk maintain vegetarian diet urinari level antibiot major metabolit metabolit major phthalat malondialdehyd mda oxid stress biomark analyz frequenc level detect antibiot phthalat notic decreas program urinari mda level signific lower program particip num versus num mg g creatinin exposur target compound influenc behavior pattern result suggest short term dietari behavior signific decreas inadvert exposur antibiot phthalat reduc oxid stress level copyright num elsevi reserv
MED-4169~pcdd fs dioxin lik pcbs human milk estim infant daili intak review pubm ncbi abstract paper review recent scientif literatur pcdds pcdfs dioxin lik pcbs human milk paper report level contamin human breast milk publish januari num januari num www sciencedirect web site identifi includ aim num studi level pcdds pcdfs pcbs human milk mother geograph area assess infant exposur contamin num studi effect variabl mother age number deliveri dietari smoke habit nutrit infanc environ level contamin breast milk num studi time pattern num identifi data gap copyright num elsevi reserv
MED-4170~breastfe breastfe review impact lactat exposur polychlorin biphenyl pcbs infant pubm ncbi abstract research long debat advers effect exposur polychlorin biphenyl pcbs children versus benefit breastfeed articl author provid overview health effect pcbs children examin level evid risk postnat exposur breastfeed major sourc pcbs environment num human exposur food chain pcb exposur infant predomin breast milk limit evid exist signific toxic mode transmiss breastfeed continu encourag basi evid benefit deriv human milk coupl inconclus proof lactat pcb exposur major detriment effect health develop infant
MED-4171~serum concentr polychlorin biphenyl pcbs hydroxyl pcb metabolit pentachlorophenol pregnanc pubm ncbi abstract studi pregnancy rel serum concentr polychlorin biphenyl pcbs cb num cb num cb num cb num cb num hydroxyl pcb metabolit num oh cb num oh cb num oh cb num pentachlorophenol pcp median serum lipid content increas num fold earli week num late pregnanc week num num median pcb level serum lipid decreas num suggest dilut pcb concentr serum lipid strong posit intra individu correl spearman num num pcbs studi period sampl collect relat narrow time window pregnanc pcb result singl sampl occas assess relat differ bodi burden pregnanc period concentr oh pcb blood serum tend declin pregnanc progress women concentr increas end pregnanc posit intra individu correl num num oh pcb concentr observ trimest correl trimest concentr diverg num num declin pcp concentr observ pregnanc signific correl found concentr sampl period result suggest oh pcb pcp sampl specif time depend time period pregnanc interest differ pattern intra inter individu variabl studi compound due combin factor includ lipid solubl persist compound distribut blood metabol format pregnancy rel bodi composit physiolog process copyright num elsevi reserv
MED-4172~increas pre school children consumpt fruit veget model reward intervent pubm ncbi abstract repeat measur design nurseri set model reward intervent target preschool children consumpt num fruit num veget present num food set compris num fruit num veget num day baselin num subsequ baselin children receiv food set daili snacktim lunchtim consumpt food reward num day fruit intervent phase food set num food set num present altern day reward present snacktim consumpt fruit compon baselin num baselin num intervent target snack consumpt veget compon food set num num final baselin num num month follow conduct intervent produc larg signific increas target fruit veget consumpt smaller signific increas pair opposit categori non target food immedi intervent increas base within categori generalis evid increas generalis strong no reward lunchtim context contrari theori predict respons decrement increas preschool fruit veget consumpt maintain follow month reward withdrawn copyright num elsevi reserv
MED-4173~chronic diseas infant nutrit signific public health pubm ncbi abstract object assess public health signific prematur wean infant breast milk later lif risk chronic ill design review summari recent meta analys studi link prematur wean breast milk later lif chronic diseas risk present estim approxim exposur develop western countri base histor breast feed preval data australia num population attribut proport chronic diseas current pattern artifici feed infanc estim result adjust major confound variabl current research suggest risk chronic diseas num higher breast f compar breast f infanc exposur prematur wean rang num num post world war ii age cohort attribut proport chronic diseas popul estim num num exposur prematur wean conclus breast feed public health signific prevent chronic diseas small consist effect prematur wean breast milk increas later lif chronic diseas risk risk exposur australian popul substanti approxim num current num year old wean breast feed num month age encourag greater durat exclus breast feed potenti avenu reduc futur chronic diseas burden health system cost
MED-4174~perfluorooctanesulfon relat fluorochem human blood countri pubm ncbi abstract perfluorooctanesulfonyl fluorid base compound wide varieti consum product carpet upholsteri textil compound degrad perfluorooctanesulfon pfos persist metabolit accumul tissu human wildlif previous studi report occurr pfos perfluorohexanesulfon pfhxs perfluorooctano pfoa perfluorooctanesulfonamid pfosa human sera collect unit state studi concentr pfos pfhxs pfoa pfosa measur num human blood serum plasma sampl collect unit state colombia brazil belgium itali poland india malaysia korea perfluorochem measur pfos predomin compound found blood concentr pfos highest sampl collect unit state poland num ng ml moder korea belgium malaysia brazil itali colombia num num ng ml lowest india num ng ml pfoa abund perfluorochem blood sampl frequenc occurr compound low age gender rel differ concentr pfos pfoa found serum sampl degre associ concentr perfluorochem vari depend origin sampl result suggest exist sourc vari level composit perfluorochem differ exposur pattern chemic countri addit target fluorochem measur qualit analysi select blood sampl show presenc perfluorochem perfluorodecanesulfon pfds perfluoroheptano acid pfhpa perfluorononano acid pfna perfluorodecano acid pfda perfluorododecano acid pfdoa perfluoroundecano acid pfunda serum sampl concentr approxim num num fold lower concentr pfos studi focus identifi sourc pathway human exposur perfluorochem
MED-4175~perfluorochem meat egg indoor dust china assess sourc pathway human exposur perfluorochem pubm ncbi abstract studi num perfluorochem pfcs measur meat meat product egg indoor dust collect china perfluorooctano acid pfoa perfluorooctan sulfon pfos frequent detect pfcs sampl concentr pfos pfoa foodstuff rang num num ng g fresh wt num num ng g fresh wt concentr pfoa perfluoroheptano acid pfhpa pfos indoor dust num num num ng g dri wt estim daili intak pfos pfoa meat meat product egg edi meat egg rang num num ng d num num ng d valu limit quantit loq assign num num num ng d num num ng d valu loq set num loq edi meat egg pfos pfoa increas increas famili incom estim daili intak pfos pfoa inhal dust edi dust rang num num ng d num num ng d daili intak pfos pfoa consumpt meat meat product egg dust ingest calcul sampl studi compar estim daili intak pfcs report concentr drink water fish seafood china calcul dietari sourc edi dietari account overwhelm proport num pfos num pfoa total daili intak tdi adult analyz foodstuff meat meat product egg major contributor dietari exposur pfos meat primari contributor dietari exposur pfoa
MED-4176~perfluorooctanesulfon relat fluorochem human blood sampl china pubm ncbi abstract perfluorooctanesulfonylfluorid posf base compound manufactur varieti industri applic compound degrad perfluorooctanesulfon pfos regard persist end stag metabolit found accumul tissu human wildlif pfos perfluorohexanesulfon pfhxs perfluorooctano pfoa perfluorooctanesulfonamid pfosa found human sera unit state studi concentr pfhxs perfluorobutanesulfon pfbs pfos perfluorohexano acid pfhxa pfoa perfluorononano acid pfna perfluorodecano acid pfda perfluoroundecano acid pfunda perfluorododecano acid pfdoda pfosa measur num sampl human blood collect citi provinc china includ shenyang liaon beij hebei zhengzhou henan jintan jiangsu wuhan hubei zhoushan zhejiang guiyang guizhou xiamen fujian fuzhou fujian num perfluorin compound pfcs measur pfos predomin compound concentr pfos greatest sampl collect shenyang num ng ml sampl jintan num ng ml pfhxs abund perfluorochem sampl age rel differ concentr pfoa pfos pfosa pfhxs observ gender rel differ found male higher pfos pfhxs femal higher pfunda concentr pfhxs posit correl pfos concentr pfna pfda pfunda posit correl pfoa differ concentr profil percentag composit pfcs sampl citi
MED-4177~variabl pesticid deposit sourc contribut snowpack western nation park abstract fifty six season snowpack sampl collect remot alpin sub arct arctic site western nation park consecut year num num current us pesticid cup dacthal dcpa chlorpyrifo endosulfan hexachlorocyclohexan hch historic us pesticid hup dieldrin hch chlordan hexachlorobenzen hcb common measur site year coeffici variat pesticid concentr num site replic sampl num intra park replic sampl num inter annu replic sampl relat pesticid concentr profil consist year year uniqu individu park indic region sourc effect hup concentr well correl region cropland intens effect temperatur snow air partit consid mass individu cup region locat one day upwind park calcul air mass back trajectori explain distribut cup park percent snowpack pesticid concentr due region transport high num major pesticid park result suggest major pesticid contamin nation park due pesticid north america
MED-4178~chronic dietari risk character pesticid residu rank score method integr agricultur food contamin data pubm ncbi abstract method develop identifi pesticid residu foodstuff inclus nation monitor program prioriti level combin chronic dietari intak indic atmdi base maximum residu level agricultur edi food contamin data num percentil exposur calcul num substanc individu nation consumpt data result show atmdi exceed accept daili intak adi num pesticid upper bound edi adi num substanc seven level risk scale present substanc analyz food franc substanc sought num substanc analyz num pesticid concern level num monitor num prioriti pesticid level num num num substanc sought num pesticid concern level num includ monitor program includ num prioriti pesticid level num order refin exposur assess analyt improv develop lower analyt limit prioriti pesticide commod combin develop nation method appli geograph scale copyright num elsevi reserv
MED-4179~pesticid rain agricultur watersh unit state pubm ncbi abstract rainfal sampl collect num num grow season agricultur local usa maryland indiana nebraska california sampl analyz num insecticid num herbicid fungicid num pesticid degrad data site combin show num num frequent detect pesticid herbicid atrazin num metolachlor num detect site dacthal acetochlor simazin alachlor pendimethalin detect num sampl chlorpyrifo carbaryl diazinon insecticid num frequent detect compound remain pesticid parent compound num detect fewer num sampl num detect frequent detect degrad deethylatrazin oxygen analog oa organophosphorus insecticid chlorpyrifo diazinon malathion num napthol degrad carbaryl deethylatrazin detect num sampl collect maryland indiana nebraska detect california oa chlorpyrifo diazinon detect primarili california degrad acetanilid herbicid rare detect rain indic form atmospher readili volatil soil herbicid account num num total pesticid mass deposit rain california insecticid account num num mass pesticid deposit rainfal estim num total appli agricultur area
MED-4180~half liv serum pcb congen concentr environment expos earli adolesc pubm ncbi abstract aim determin half lif abund pcb congen bodi earli adolesc num environment expos children pcb serum concentr determin age num num ear half lif determin child assum exponenti decreas cohort multipl regress result obtain approach agreement pcb reuptak corrupt half lif estim child congen evalu serum pcb concentr valu fell level detect lod pair exclud pcb half lif exceed arbitrari num ear median half liv year num num num num num num obtain pcb congen num num num num num elimin half lif valu systemat relat pcb serum concentr examin age half lif valu percentag children signific reuptak pcb congen abund serum found signific associ copyright num elsevi reserv
MED-4181~organochlorin pesticid umbil cord blood serum women southern spain adher mediterranean diet pubm ncbi abstract exposur pregnant women organochlorin oc pesticid larg deriv contamin food environment occup domest factor implic investig presenc oc residu umbil cord blood newborn southern spain analyz relationship exposur matern pregnanc variabl includ matern adher mediterranean diet md oc detect num umbil cord blood sampl num mother degre adher md num sd num rang num md priorit consumpt veget fruit meat dairi product oc general lipophil molecul accumul food anim origin consumpt meat fish dairi product dichlorodiphenyldichloroethylen dde umbil cord serum dairi product intak lindan veget consumpt lindan fruit intak endosulfan found signific associ md adher presenc oc residu serum closer adher md offer greater protect oc exposur reduc content meat dairi product copyright num elsevi reserv
MED-4182~polybromin diphenyl ether meat poultri statist design survey show trend level num num pubm ncbi abstract polybromin diphenyl ether pbde bodi burden general popul link consumpt red meat poultri exposur estim meat product major contributor pbde dietari intak establish solid estim pbde concentr domest meat poultri sampl statist design survey meat poultri analyz pbdes survey conduct num num time manufactur penta bd octa bd formul ceas unit state decemb num data provid opportun observ preval concentr trend occur time frame compar pbde level meat poultri industri basi composit sampl averag sum preval pbdes bde num num num num decreas num num ng g lipid num num ng g lipid num meat poultri pbdes measur individu sampl num show beef sampl lowest pbde level hog chicken turkey pbde congen pattern survey resembl penta bd formul bde num num account num num total basi data survey pbde level meat poultri declin manufactur ceas exposur pathway pbdes livestock
MED-4183~flame retard serum pet dog food pubm ncbi abstract previous studi laboratori show pet cat higher serum level flame retard compar human share household environ dog hand expect lower serum level flame retard metabol equip degrad compound hypothes dog similar human respons environment stressor indic human exposur contamin serum sampl food collect num dog analyz pbdes emerg flame retard concentr pbdes dog serum dog food averag num num ng g wet weight ww num num ng g ww dog serum sampl domin tetra hepta bde congen bde num abund congen dog food differ congen pattern analyz term half liv assum food main exposur sourc averag half lif dog serum num num day bromin congen num num day bde num dust consid addit exposur sourc give unreason resid time addit pbdes flame retard includ dechloran decabromodiphenylethan hexabromocyclododecan identifi sampl
MED-4184~high concentr polybromin diphenyleth pbdes breast adipos tissu california women pubm ncbi abstract measur major pbdes pcbs breast adipos tissu california women particip breast cancer studi late num sampl analyz gas chromatographi electron impact ionize tandem mass spectrometri detect congen profil observ bde num bde num bde num bde num bde num pcb num pcb num pcb num pcb num high correl observ chemic class weak correl class point exposur pathway weak negat associ observ pbde congen age pbde data highest report exceed data nation health nutrit examin survey consist high pbdes california data establish baselin pbde bodi burden gaug time result restrict pbde formul copyright num elsevi reserv
MED-4185~relationship urin bisphenol a level declin male sexual function pubm ncbi abstract advers effect bisphenol a bpa male reproduct system observ anim studi examin human popul bpa potenti public health problem wide detect presenc human bodi studi conduct num male worker region high level bpa exposur exist particip provid urin sampl test bpa concentr high perform liquid chromatographi male sexual dysfunct ascertain standard male sexual function inventori male sexual dysfunct measur num domain num indic control potenti confound linear regress increas urin bpa level worsen male sexual function continu scale num indic demonstr negat linear correl increas urin bpa level decreas sexual desir num difficulti erect num lower ejacul strength num lower level satisfact sex life num similar negat correl observ particip expos bpa environment sourc occup exposur bpa estim group stabl smaller sampl size result reveal correl biolog measur urin bpa level declin male sexual function find enhanc understand bpa effect human popul import public health implic widespread human exposur bpa
MED-4186~bisphenol bpa food pubm ncbi abstract bisphenol bpa chemic line metal polycarbon plastic babi bottl rodent bpa earli sexual matur alter behavior effect prostat mammari gland human bpa cardiovascular diseas diabet male sexual dysfunct expos worker food major exposur sourc studi report bpa fresh food food food plastic packag peer review journal measur bpa level num fresh food food sold plastic packag cat dog food plastic packag detect bpa num num sampl includ fresh turkey green bean infant formula ninety thre sampl triplic similar detect level detect level rang num num ng g ww type food packag vari ph bpa level higher food ph num compar acid alkalin food detect level compar found research determin bpa level food larger repres sampl
MED-4187~organochlorin pesticid residu bamboo shoot pubm ncbi abstract background xenobiot organochlorin pesticid ocp major environment problem histor widespread pronounc persist chemic biolog degrad bioaccumul food chain pesticid preval product edibl bamboo shoot export wide china evalu qualiti chines bamboo shoot determin residu content ocp shoot sampl result type ocps hexachlorocyclohexan hch num num trichlor num bis p chlorophenyl ethan ddt pentachloronitrobenzen pcnb were detect bamboo shoot zhejiang provinc china detect rate num num hch ddt pcnb averag residu concentr exceed maximum residu limit pesticid detect food china num kg num term residu concentr pesticid num bamboo shoot sampl classifi safe conclus sampl bamboo shoot ocp num safe consumpt num societi chemic industri
MED-4188~hydro alcohol extract crocus sativus versus fluoxetin treatment mild moder depress double blind random pilot tr pubm ncbi abstract depress disord common clinic practic approxim num adult afflict year saffron world expens spice tradit food addit recent studi therapeut effect saffron depress persian tradit medicin object compar efficaci hydro alcohol extract crocus sativus stigma fluoxetin treatment mild moder depress num week double blind random trial forti adult outpati met diagnost statist manual mental disord fourth edit major depress base structur clinic interview dsm iv mild moder depress particip trial double blind single cent trial random trial patient random assign receiv capsul saffron num mg day bd group num capsul fluoxetin num mg day bd group num num week studi saffron dose found effect similar fluoxetin treatment mild moder depress num num num signific differ group term observ side effect result studi efficaci crocus sativus treatment mild moder depress large scal trial justifi
MED-4192~psycholog neuroendocrinolog effect odor saffron crocus sativus pubm ncbi abstract aim purpos studi clarifi effect saffron odor symptom uniqu women premenstru syndrom pms dysmenorrhea menstrual pain irregular menstruat materi method thirty f women normal sens smell expos saffron odor num min saliva sampl collect measur level cortisol testosteron num estradiol enzym immunoassay state trait anxieti inventori stai administ psycholog test result saffron odor signific decreas level short term stimul num min follicular luteal phase level exposur saffron odor increas follicular luteal phas group stai score decreas follicular luteal phase saffron group conclus present find support exist physiolog psycholog effect saffron odor women result saffron odor exert effect treatment pms dysmenorrhea irregular menstruat report suggest saffron odor effect treat menstrual distress copyright num elsevi gmbh reserv
MED-4193~crocus sativus saffron treatment premenstru syndrom double blind randomis placebo control trial pubm ncbi abstract object aim double blind placebo control trial investig saffron stigma crocus sativus reliev symptom premenstru syndrom pms design double blind randomis placebo control trial set depart gynaecology obstetr psychiatri tehran zanjan univers medic scienc popul women age num year regular menstrual cycl experi pms symptom num month elig studi method women random assign receiv capsul saffron num mg day num mg day morn group capsul placebo day menstrual cycl cycl num num main outcom measur primari outcom measur daili symptom report secondari outcom measur hamilton depress rate scale result trial saffron found effect reliev symptom pms signific differ observ efficaci saffron cycl num num total premenstru daili symptom hamilton depress rate scale conclus result studi efficaci sativus treatment pms toler advers effect profil saffron confirm applic saffron altern treatment pms result deserv investig
MED-4194~antimutagen anticarcinogen survey putat interceptor molecul pubm ncbi abstract review recent public cite number antimutagen molecul survey potenti proven desmutagen interceptor biolog preval synthet molecul small metabolit profici bind react mutagen chemic free radic class block agent soft hard nucleophil vari abil react class electrophil major class direct act mutagen serv line defens mutagen carcinogen interceptor molecul under investig regard spectra activ relev prophylaxi treatment human diseas state
MED-4195~effect chlorophyl chlorophyllin low dos aflatoxin num pharmacokinet human volunt pubm ncbi abstract chlorophyl chla chlorophyllin chl shown previous reduc carcinogen bioavail biomark damag tumorigen trout rat find partial extend human chl reduc excret aflatoxin num afb num dna repair product chines unavoid expos dietari afb num afb num pharmacokinet chla effect examin conduct unblind crossov studi establish afb num pharmacokinet paramet human volunt explor effect chl chla cotreat volunt protocol num fast subject receiv institut review board approv dose num afb num ng num nci capsul num ml water normal eat drink num hour blood cumul urin sampl collect num hour num afb num equival determin acceler mass spectrometri protocol num num similar capsul num mg purifi chla chl protocol repeat thrice volunt studi reveal rapid human afb num uptak plasma num num num max num hour urinari elimin num complet num hour kinet chla chl treatment signific imped afb num absorpt reduc cmax auc plasma urin subject initi result provid afb num pharmacokinet paramet previous unavail human suggest chla chl co consumpt limit bioavail ingest aflatoxin human anim model
MED-4196~molecular pathway cancer chemoprevent dietari phytochem pubm ncbi abstract interest dietari phytochem potenti cancer chemoprevent increas substanti screen dietari compound chemoprevent activ requir systemat wide rang approach encompass complex carcinogenesi present molecular pathway underpin broad biolog process involv carcinogenesi oxid stress inflamm evas apoptosi import biolog mechan carcinogenesi occur subsequ antioxid anti inflammatori pro apoptot activ repres import activ prevent suppress revers develop carcinogenesi ultim mechan action provid basi screen phytochem chemoprevent activ review identifi import molecular process target routin screen dietari phytochem ultim select effect potenti candid cancer chemoprevent
MED-4197~natur compound human diet abil bind mutagen prevent dna mutagen intercal pubm ncbi abstract human diet mutagen carcinogen aromat compound benefici physiolog activ dietari compon plant food phytochem act mutagenesi carcinogenesi inhibitor studi compar bind properti natur compound human diet caffein theophyllin theobromin resveratrol water solubl deriv chlorophyl bind acridin orang mutagen analysi conduct determin substanc effect bind agent prevent chemical induc mutagenesi carcinogenesi data order bind num mutagen complex concentr chlorophyllin resveratrol concentr num fold higher num fold num fold excess xanthin requir bind acridin orang
MED-4198~insect food astronaut gas exchang silkworm fed mulberri lettuc nutrit insect human consumpt pubm ncbi abstract studi silkworm moth bombyx mori larva regard anim protein sourc astronaut bioregen life support system long term deep space explor futur fed mulberri stem lettuc leav instar instar addit kind environment approach utilis ined biomass plant produc anim protein high qualiti likewis appli terrestri provid food peopl live extrem environ and or impoverish agro ecosystem polar region isol militari base ship submarin respir characterist larva develop main physiolog condit eat not eat leav studi nutrient composit silkworm powder sp ground freeze dri silkworm num day num instar larva includ protein fat vitamin miner fatti acid measur intern standard method silkworm respir rate measur larva eat mulberri leav higher similar larva hadn t eaten leav signific differ silkworm fed mulberri leav fed stem lettuc num num instar num amount num exhal silkworm physiolog regim differ num signific differ amount num inhal insect physiolog status num silkworm respir quotient eat regim larger not eat regim sp found rich protein amino acid total num essenti vitamin miner twelv fatti acid detect num kcal generat num gram sp dri weight
MED-4200~differ postprandi inflammatori respons modern tradit meat meal preliminari studi pubm ncbi abstract low grad inflammatori respons metaflamm found chronic diseas propos induc aspect modern lifestyl includ newli introduc food plasma tag inflammatori cytokin c reactiv protein crp tnf alpha il num compar randomis cross ov trial ten healthi subject eat num kangaroo form hybridis beef wagyu separ num week postprandi level num num tag il num tnf alpha signific higher eat wagyu compar kangaroo num tag num num num num il num tnf alpha num num crp signific higher num postprandi wagyu num non signific higher num postprandi num conclud metaflammatori reaction ingest form hybridis beef wagyu indic low grad system immun reaction compar lean game meat kangaroo studi isoenerget intak isol fatti acid compon meat propos
MED-4201~influenc pheasant captiv natur biolog meat human nutrit pubm ncbi abstract life game bird pheasant natur coupl number difficulti season year refer find food breed lay egg rais young flee natur enemi lack protect unfavor climat condit pheasant live captivity  aviari pheasants  do difficulties  they fed regular qualiti feed pheasant protect bad weather natur enemi research aim determin biolog meat pheasant grown settings  in captiv natur highest weight achiev wild pheasant male num num differ test pheasant group statist high signific num differ group relat breast weight tight drumstick weight statist high signific num breast part leg part notifi high num high num differ highest weight breast muscl tight drumstick wild pheasant num num num num wild pheasant lower part lighter skin subcutan fatti tissu breast femal pheasant cultiv higher skin part subcutan fatti tissu tight drumstick relat chemic composit breast muscl establish statist signific differ num num part ca wild pheasant tight drumstick muscl establish statist signific num higher part moistur protein ca statist high signific num lower part fat energet research result qualiti meat pheasant grown natur higher biolog meat pheasant aviari advantag human nutrit
MED-4202~non nutri low grad system inflamm support canari mineshaft view obes chronic diseas pubm ncbi abstract form low grad system inflamm metaflamm link type chronic diseas initi thought causal relat weight gain obes explan link obes diseas lifestyle rel induc inflamm obes identifi common nutrit relat suggest relationship direct indirect obes provid evid non nutrit inflammatori induc provid support earlier suggest obes point direct link diseas suffici explain current epidem chronic diseas ubiquit encompass inflammatori induc modern post industri environ lifestyl eman obes canari mineshaft warn bigger global problem singl pathway modern environment driven diseas num author obes review num intern associ studi obes
MED-4203~evolut dietari antioxid pubm ncbi abstract oxygen vital organ paradox damag key biolog site oxygen threat met antioxid evolv parallel oxygen atmospher plant employ antioxid defend structur reactiv oxygen speci ros oxid produc photosynthesi human bodi expos oxid evolv effect antioxid system infal ros breach defenc oxid damag ensu accumul age varieti patholog plant bas antioxidant rich food tradit form major part human diet plant bas dietari antioxid hypothes import role maintain human health hypothesi logic evolutionari term hypox environ human evolv paper human diet discuss briefli term evolutionari develop strategi antioxid defenc outlin evolut dietari antioxid discuss perspect plant current dietari requir final possibl regard dietari antioxid evolut human health present evolutionari cost benefit analysi present relat lost abil make ascorb acid vitamin retain absolut requir
MED-4205~chemic safeti meat meat product pubm ncbi abstract world war consum behaviour develop countri chang drastic primarili exist demand suffici food period starvat desir higher qualiti aris today peopl safe healthi food high qualiti unit approach compris consist standard sound scienc robust control requir ensur consum health maintain consum confid satisfact chemic analysi food chain downstream track primari product consum upstream trace consum primari product import prerequisit ensur food safeti qualiti frame focus paper chemic safeti meat meat product account inorgan organ residu contamin nitrit meat product incid veterinari drug failur mode effect analysi fmea system assess priorit vulner food chain step decreas elimin vulner
MED-4206~vegetarian diet public health biomark redox connect pubm ncbi abstract vegetarian diet rich antioxid phytochem act antioxid vivo import signal regulatori function act pro oxid modul cellular redox tone oxid redox sensit site review evid health benefit vegetarian diet present perspect epidemiolog biomark evolutionari public health antioxid perspect molecular connect diet health evid role plasma ascorb acid biomark futur diseas risk present basic concept redox bas cell signal present effect antioxid phytochem signal redox tone sulfur switch antioxid respons element explor suffici scientif evid exist public health polici promot plant rich diet health promot wait scienc provid answer action interplay dietari antioxid nonequilibrium system control redox balanc cell signal cell function provid rich ground research advanc understand orthomolecular nutrit provid science bas evid advanc public health age popul
MED-4211~dietari soy fat relat serum insulin lik growth factor num insulin lik growth factor bind protein num level premenopaus jap pubm ncbi abstract circul level insulin lik growth factor num igf num insulin lik growth factor bind protein num igfbp num premenopaus breast cancer risk analyz data cross sect studi num premenopaus japanes women age num yr adequ nutrit status evalu relationship concentr igf num igfbp num serum dietari intak soy fat nutrient diet assess semiquantit food frequenc questionnair signific correl soy product soy isoflavon intak serum igf num igfbp num level control age total energi percent bodi fat educ level total fat intak signific invers correl serum igfbp num level num num correl satur monounsatur fat serum igfbp num borderlin signific num num num num
MED-4212~insulin lik growth factor num bind protein num num year soya intervent premenopaus women pubm ncbi abstract soya food protect develop breast cancer insulin lik growth factor igf num investig link nutrit cancer examin effect soya food circul igf num igf bind protein bp num level num healthi premenopaus women num year randomis nutrit trial intervent group consum daili serv soya food includ tofu soya milk soya nut soya protein powder equival num mg isoflavon num soya protein serv control maintain regular diet serum sampl baselin num num num month collect morn luteal phase analys igf num igfbp num double antibodi elisa appli mix model investig intervent effect predictor serum level repeat measur design adher studi regimen high dropout rate accept randomis result similar igf num igfbp num level group observ signific intervent effect igf num igfbp num molar ratio entir studi period urinari isoflavon excret studi period posit igf num num igf num igfbp num ratio num effect consist time ad soya food diet premenopaus women lower serum level igf num igfbp num greater protein intak soya lead small increas igf num serum level
MED-4216~relationship dietari protein soy isoflavon serum igf num igf bind protein prostat cancer lifestyl trial pubm ncbi abstract high level insulin lik growth factor num igf num increas risk prostat cancer increas level bind protein igfbp protect high intak dietari protein anim soy protein increas igf num soy isoflavon demonstr anti prolif apoptot effect vitro vivo evalu dietari intak total protein soy isoflavon relat igf axi prostat cancer patient make comprehens lifestyl includ low fat vegan diet supplement soy protein num g day year intervent group patient report signific higher intak dietari protein soy isoflavon compar usual car control num igf num increas signific group igfbp num rose experiment group num increas veget protein year increas igfbp num intervent group patient num result suggest dietari protein soy isoflavon context comprehens lifestyl signific alter igf num recent literatur indic high intak protein rich essenti amino acid anim soy protein increas igf num prudent men earli stage prostat cancer exceed dietari protein recommend
MED-4220~effect diet exercis serum insulin igf i igfbp num level growth lncap cell vitro unit state pubm ncbi abstract object accumul evid prostat cancer high level serum igf i studi conduct determin low fat diet exercis de intervent modul igf axi reduc prostat cancer cell growth vitro method fast serum obtain num men age num num year particip num day de program similar age men de program num num year long term insulin igf i igfbp num igfbp num measur elisa serum stimul lncap cell growth vitro result serum igf i level decreas num igfbp num increas num num day de long term group igf i num lower igfbp num num higher relat baselin serum insulin decreas num num day de num lower long term group relat baselin serum igfbp num observ serum stimul lncap cell growth reduc num post num day serum num long term serum relat baselin lncap cell incub post d serum show increas apoptosi necrosi compar baselin conclus low fat diet exercis intervent induc in vivo circul igf axi reduc growth enhanc apoptosis necrosi lncap tumor cell vitro
MED-4222~growth hormon receptor defici major reduct pro ag signal cancer diabet human abstract life span extend mutat growth signal pathway protect age depend dna damag yeast decreas insulin resist cancer mice test effect human monitor num year ecuadorian subject mutat growth hormon receptor gene lead sever growth hormon receptor ghr igf i defici combin inform survey identifi age death subject die period individu ghr defici ghrd exhibit non leth malign case diabet contrast num cancer num diabet preval control explan low incid cancer reveal vitro studi serum ghrd subject reduc dna break increas apoptosi human mammari epitheli cell hmec treat hydrogen peroxid observ reduc insulin concentr num u ml num u ml unaffect relat low homoeostasi model assess insulin resist homa ir index num num unaffect relat ghrd individu indic increas insulin sensit explain absenc diabet subject incub hmec ghrd serum result reduc express ras pka tor up regul sod num promot cellular protect life span extens model organ result provid evid role evolutionarili conserv pathway promot age diseas human identifi candid drug target healthi life span extens
MED-4223~insulin lik growth factor num igf num igf bind protein num igfbp num breast cancer risk pool individu data analysi num prospect studi summari background insulin lik growth factor num igf num stimul mitosi inhibit apoptosi publish result shown associ circul igf num breast canc risk unclear relationship consist modifi igf bind protein num igfbp num menopaus status oestrogen receptor status factor relationship igf num igfbp num breast canc risk factor unclear endogen hormon breast cancer collabor group establish analys pool individu data prospect studi increas precis estim associ endogen hormon breast canc risk method individu data prediagnost igf num igfbp num concentr obtain num prospect studi num countri associ igf num risk factor breast cancer control examin calcul geometr concentr categori factor odd ratio num cis breast cancer increas igf num concentr estim condit logist regress num case num match control stratif studi age baselin date baselin statist test two sid num num consid signific find igf num concentr adjust age posit height age pregnanc invers age menarch year menopaus higher moder overweight women moder alcohol consum women breast cancer women highest versus lowest igf num concentr num num ci num num num num num num associ alter adjust igfbp num vari signific menopaus status blood collect differ igf num concentr highest lowest num num ci num num num num oestrogen receptor posit tumour num num num num num oestrogen receptor neg tumour heterogen num num interpret circul igf num posit breast canc risk associ substanti modifi igfbp num differ mark menopaus status confin oestrogen receptor posit tumour fund cancer research uk
MED-4224~growth factor receptor cancer metastas pubm ncbi abstract metastat primari tumour respons nineti percent cancer death signific advanc understand molecular cellular mechan tumour metastas limit prevent treatment metastat tumour evid aris laboratori clinic studi suggest growth factor receptor implic cancer metastas develop review origin product growth factor receptor stage cancer metastas includ epithelial mesenchym transit cancer cell invas migrat surviv circul seed distant organ metastat tumour angiogenesi function growth factor receptor discuss review present effort made understand challeng aid develop treatment strategi cancer metastas
MED-4225~centenarian escap postpon cancer role igf num inflamm num pubm ncbi abstract background centenarian long live individu escap common age rel diseas effect protect cancer mechan underli protect complex larg unclear aim critic analys literatur order propos unifi hypothesi account cancer protect centenarian method review scientif literatur main player tumourigenesi igf num inflamm num centenarian result centenarian characteris low igf num mediat respons high level anti inflammatori cytokin il num tgf beta condit result protect cancer inflamm igf num pathway converg tumour suppressor num studi genet variant num human longev provid protect cancer mortal conclus data hypothesis mechan well preserv num mediat respons key factor contribut protect cancer centenarian
MED-4226~mechan breast cancer bone metastasi pubm ncbi abstract bone liver lung preferenti metastat target site cancer includ breast prostat lung cancer consequ devast metastasi breast cancer bone metastasi consist step escap primari site colon target site review focus key step includ num invas escap primari tumor site num target migrat bone num specif adhes arrest bone num establish metastasi bone factor involv process provid good target therapi copyright num elsevi ireland reserv
MED-4227~cancer age kinet biolog paramet kinet cancer incid mortal pubm ncbi abstract epidemiolog biolog data strong support exist strict link cancer age spite relev problem numer pitfal epidemiolog investig year ago appar decreas cancer incid age reveal misconcept base lack suffici appreci chang popul size problem solv age specif cancer incid recent stress author advanc age slow rate increas age specif cancer incid demonstr find appar clash major biolog data suggest mechan develop advanc age capabl decreas cancer suscept paper shown slowing down kinet predict cancer incid mathemat model mortal kinet recent propos gerontolog field slow increas rate decreas trend cancer incid age popul compat continu acceler pace loss physiolog capac singl subject advanc age select individu physiolog function
MED-4228~circul insulin lik growth factor igf peptid prostat cancer risk systemat review meta analysi abstract insulin lik growth factor igf i igf ii bind protein igfbp num play key role cell prolifer differenti apoptosi suggest involv carcinogenesi epidemiolog studi show associ igf prostat cancer search publish literatur studi relat level igf igfbp prostat cancer perform random effect meta analysi calcul summari odd ratio number studi prostat cancer case includ meta analysi num num igf i num igf ii num igfbp num num igfbp num num igfbp num num num igf num igfbp num ratio pool odd ratio num confid interv standard deviat increas peptid igf i num num num igf ii num num num igfbp num num num num igfbp num num num num igfbp num num num num igfi igfbp num ratio num num num exposur substanti heterogen num num part explain studi design magnitud associ smaller prospect versus retrospect studi igfbp num invers associ prostat cancer risk retrospect prospect studi weak evid associ igf i igfbp num prostat cancer stronger advanc diseas meta analysi confirm rais circul lgf i posit prostat cancer risk associ igfbp num prostat cancer inconsist evid role igf ii igfbp num igfbp num prostat cancer risk
MED-4230~lifestyl factor benign prostat hyperplasia lower urinari tract symptom pubm ncbi abstract purpos review age genet sex steroid hormon play promin role benign prostat hyperplasia bph lower urinari tract symptom lut recent epidemiolog studi suggest modifi lifestyl factor contribut substanti pathogenesi condit recent find lifestyl metabol factor signific increas risk benign prostat hyperplasia lower urinari tract symptom includ obes diabet meat fat consumpt factor decreas risk includ physic activ moder alcohol intak veget consumpt factor clear risk pattern emerg includ lipid smoke random clinic trial lifestyl alter weight loss exercis diet prevent treatment benign prostat hyperplasia lower urinari tract symptom perform summari lifestyl factor present opportun prevent treatment benign prostat hyperplasia lower urinari tract symptom clinic trial lifestyl modif undertaken promot healthi lifestyl altern context standard benign prostat hyperplasia lower urinari tract symptom treatment algorithm potenti benefici
MED-4231~onion garlic intak odd benign prostat hyperplasia pubm ncbi abstract object analyz relationship onion garlic intak benign prostat hyperplasia bph data multicent case control studi conduct itali method multicent case control studi num patient bph num control admit hospit wide spectrum acut non neoplast condit conduct itali num num inform collect train interview valid reproduc food frequenc questionnair multivari odd ratio num confid interv cis obtain recogn confound factor energi intak result compar nonus multivari highest categori onion garlic intak num num ci num num num num ci num num combin frequent user versus nonus onion garlic num num ci num num invers relationship consist age strata conclus uniqu larg data set european popul show invers associ allium veget consumpt bph
MED-4232~food group risk benign prostat hyperplasia pubm ncbi abstract object evalu role wide rang food risk benign prostat hyperplasia bph conduct case control studi itali num num bph extrem common condit older men risk factor includ dietari remain larg undefin method includ studi num patient younger num year surgic treat bph num control younger num year age admit hospit case wide spectrum acut non neoplast condit valid reproduc food frequenc questionnair includ num food beverag separ section alcohol beverag assess patient dietari habit num year diagnosi hospit admiss multivari odd ratio obtain energi intak major potenti confound factor result signific trend increas risk frequent consumpt found cereal num greatest versus lowest quintil bread num egg num poultri num invers associ observ soup num puls num cook veget num citrus fruit num associ observ milk yogurt product coffe tea pasta rice fish chees row veget potato fruit dessert conclus result studi suggest role dietari habit risk bph diet rich cereal type meat poor veget puls unfavor effect italian popul
MED-4233~pilot studi dietari fat restrict flaxse supplement men prostat cancer surgeri explor effect hormon pubm ncbi abstract object dietari fat fiber affect hormon level influenc cancer progress flaxse rich sourc lignan omega num fatti acid thwart prostat cancer potenti effect flaxse enhanc concomit fat restrict undertook pilot studi explor flaxseed suppl fat restrict diet affect biomark prostat neoplasia method twenty f patient prostat cancer await prostatectomi instruct low fat num kilocalori flaxseed suppl num g day diet baselin follow up level prostate specif antigen testosteron free androgen index total serum cholesterol determin tumor diet treat patient compar histor case match age race prostate specif antigen level diagnosi biopsi gleason sum respect apoptosi termin deoxynucleotidyl transferas tdt  mediat dutp biotin nick end label tunel prolifer mib num result averag durat diet num day rang num num time signific decreas observ total serum cholesterol num num mg dl num num mg dl total testosteron num num ng dl num num ng dl free androgen index num num num num num baselin follow up level prostate specif antigen num num ng ml num num ng ml entir sampl num men gleason sum num num psa valu num num ng ml num num ng ml num prolifer index num num histor control versus num num diet treat patient num distribut apoptot index differ signific num group histor control exhibit tunel categor score num diet treat patient larg exhibit score num prolifer rate apoptosi signific number day diet num num conclus pilot data suggest flaxseed suppl fat restrict diet affect prostat cancer biolog biomark studi determin benefit dietari regimen complementari prevent therapi
MED-4234~dietari pattern supplement risk benign prostat hyperplasia pubm ncbi abstract long appreci healthi lifestyl play critic role cardiovascular health appar true develop benign prostat hyperplasia bph prospect cohort data origin recent publish random trial medic treatment bph prevent prostat cancer invalu grow bodi evid suggest exercis intak specif macronutri micronutri regular diet play benefici role strike magnitud effect similar medic therapi alpha block num alpha reductas inhibitor supplement prostat diseas multibillion dollar busi unit state supplement common prescrib medic therapi countri contrast consumpt micronutri regular diet supplement intak micronutri phytotherapi lack evid support efficaci
MED-4235~transurethr electrovapor prostat benign prostat hyperplasia evalu result urodynam paramet pubm ncbi abstract studi obstruction reliev capabl transurethr electrovapor prostat tvp num symptomat patient benign prostat hyperplasia bph urodynam studi pressure flow analysi perform num month treatment num patient show signific improv subject object obstruct paramet postop irrit symptom patient requir recatheter conclus tvp promis modif perform transurethr resect prostat capabl reliev bladder outflow obstruct
MED-4236~benign prostat hyperplasia primari care pubm ncbi abstract purpos review recent literatur treatment guidelin preval pathophysiolog manag bpo relat bph manag lower urinari tract symptom secondari bph materi method publish literatur current treatment concept review diagnosi treatment option bpo result bph histolog diagnosi contribut medic problem includ enlarg prostat bpo condit treat symptom troublesom risk progress and or cancer suspect effect medic surgic option treat bpo improv patient qualiti life conclus bpo high treatabl manag close collabor patient pharmacolog agent minim invas procedur general prefer invas surgeri patient mild moder symptom treat primari care physician complic case refer urologist evalu manag
MED-4237~epidemiolog survey benign prostat hyperplasia prostat cancer china pubm ncbi abstract object evalu preval benign prostat hyperplasia bph prostat cancer cap mainland china method incid bph cap urolog hospit investig num num provinc num metropolis scatter mainland china chang hospit incid bph cap institut urolog beij medic univers num num review result incid bph cap num num hospit scatter mainland china num num num num num num incid bph cap institut urolog beij univers num num num num num num num num conclus hospit incid bph cap rise rapid china cap common diseas china
MED-4239~low fat diet and or strenuous exercis alter igf axi vivo reduc prostat tumor cell growth vitro pubm ncbi abstract background prostat cancer common solid tumor cancer male rare asian male asian men adopt lifestyl clinic prostat cancer increas great epidemiolog data men regular activ reduc risk prostat cancer method serum obtain group similar ag men control diet exercis exercis stimul lncap cell cultur growth apoptosi tumor cell measur serum sampl measur insulin igf num igfbp num result diet exercis exercis group lower serum insulin igf num higher igfbp num compar control lncap cell growth reduc group compar control major increas apoptosi tumor cell conclus low fat diet and or intens exercis result chang serum hormon growth factor vivo reduc growth induc apoptosi lncap prostat tumor cell vitro copyright num wiley liss
MED-4243~intens lifestyl revers coronari heart diseas pubm ncbi abstract context lifestyl heart trial demonstr intens lifestyl lead regress coronari atherosclerosi num year object determin feasibl patient sustain intens lifestyl total num year effect lifestyl lipid low drug coronari heart diseas design random control trial conduct num num random invit design patient forty eight patient moder sever coronari heart diseas random intens lifestyl chang group usual car control group num complet num year follow up quantit coronari arteriographi set tertiari care univers medic center intervent intens lifestyl num fat food vegetarian diet aerob exercis stress manag train smoke cessat group psychosoci support num year main outcom measur adher intens lifestyl coronari arteri percent diamet stenosi cardiac event result experiment group patient num num patient complet num year follow up made maintain comprehens lifestyl num year control group patient num num patient complet num year follow up made moder experiment group averag percent diamet stenosi baselin decreas num absolut percentag point num year num relat improv num absolut percentag point num year num relat improv contrast averag percent diamet stenosi control group increas num percentag point num year num relat worsen num percentag point num year num relat worsen num group twenty f cardiac event occur num experiment group patient num event num control group patient num year follow up risk ratio event control group num num confid interv num num conclus regress coronari atherosclerosi occur num year num year experiment group contrast control group coronari atherosclerosi continu progress cardiac event occur
MED-4245~effect efficaci intens cardiac rehabilit program num site pubm ncbi abstract purpos purpos studi test efficaci effect intens cardiac rehabilit program improv health outcom multipl site method studi employ nonexperiment prospect time seri design investig cardiovascular diseas num men women num socioeconom divers site particip intens cardiac rehabilit program baselin num week num year pair t test assess differ compar baselin valu num week baselin valu num year valu num week num year result eighty eight percent patient remain enrol program num week num remain enrol program num year patient show statist signific improv num week bodi mass index bmi triglycerid low densiti lipoprotein cholesterol total cholesterol hemoglobin num systol blood pressur diastol blood pressur depress hostil exercis function capac differ remain signific num year addit signific improv num week num year bmi high densiti lipoprotein cholesterol function capac hostil signific recidiv num week num year measur triglycerid depress improv baselin num year remain signific measur hdl unchang num conclus intens cardiac rehabilit program feasibl sustain patient enrol numer subject object improv health outcom demonstr intervent work administ staff multipl clinical commmun site state improv patient num year age older
MED-4246~multicompon intervent reduc bodi weight cardiovascular risk geico corpor site pubm ncbi abstract purpos determin multicompon nutrit intervent program corpor site reduc bodi weight improv cardiovascular risk factor overweight individu design prospect clinic intervent studi subjects set employe govern employe insur compani geico num age num num year bodi mass index num kg m num and or previous diagnosi type num diabet intervent num week intervent includ low fat vegan diet measur bodi weight anthropometr measur blood pressur lipid profil dietari intak analysi multivari analys varianc calcul clinic nutrient measur univari analys varianc determin signific differ group time result intervention group particip experienc greater weight compar control group particip num se num kg num se num kg num greater waist circumfer num se num cm num se num cm num waistratiohip ratio num se num num se num num weight loss num bodi weight frequent observ intervent group num compar control group num chi num num num num num conclus individu volunt num week worksit research studi intervent low fat vegan diet effect reduc bodi weight waist circumfer
MED-4247~lifestyl revers coronari heart diseas lifestyl heart trial pubm ncbi abstract prospect randomis control trial determin comprehens lifestyl affect coronari atherosclerosi num year num patient assign experiment group low fat vegetarian diet stop smoke stress manag train moder exercis num usual car control group num coronari arteri lesion analys quantit coronari angiographi averag percentag diamet stenosi regress num sd num num num experiment group progress num num num num control group lesion greater num stenos analys averag percentag diamet stenosi regress num num num num experiment group progress num num num num control group num experimental group patient averag chang regress comprehens lifestyl bring regress sever coronari atherosclerosi num year lipid low drug
MED-4249~crossov studi diet enrich virgin oliv oil walnut almond effect lipid cardiovascular risk marker pubm ncbi abstract background aim virgin oliv oil voo nut basic compon mediterranean diet heart healthi dietari pattern nut cholesterol lower effect evid unclear voo design studi hypercholesterolem patient assess effect serum lipid intermedi marker cardiovascular risk replac num fat background diet voo walnut almond method result num week run in period healthi diet elig candid random diet sequenc crossov design common background diet enrich voo walnut almond num week outcom serum lipid oxid inflamm marker measur standard method plasma fatti acid determin gas chromatographi assess complianc num particip complet studi num women age num bmi num kg m num ldl cholesterol reduc baselin num num num voo walnut almond diet num friedman test total cholesterol ldl hdl ratio decreas parallel ldl cholesterol decreas greater predict dietari fatti acid cholesterol exchang diet lipid fraction oxid analyt inflammatori biomark observ plasma fatti acid diet sequenc support good complianc conclus result confirm cholesterol lower properti nut enrich diet suggest phenolic rich voo cholesterol lower effect independ fatti acid content deserv studi copyright num elsevi reserv
MED-4250~short term effect snack includ dri prune energi intak satieti normal weight individu pubm ncbi abstract purpos studi test hypothesi preload includ dri prune consum snack meal compar isoenerget equal weigh bread product preload greater short term effect satieti measur subsequ ad libitum meal intak induc greater satieti assess visual analogu scale vas reduc appetit dessert offer short lunch forty f healthi normal weight subject particip randomis within subject crossov studi statist analysi result show subject consum preload includ dri prune consum amount dessert lower total energi intak meal addit subject feel hunger desir motiv eat assess vas lower time point snack meal macronutri content preload similar satiat power prune due high fiber content identifi meal pattern food promot satieti increas energi intak import addit dri prune snack promot satieti provid valuabl nutrient num elsevi reserv
MED-4251~nutraceut supplement weight loss systemat review pubm ncbi abstract obes global public health issu etiolog global epidem multifactori suffer delight find effortless lose weight herbal weight loss pill fit bill author systemat review scientif evid weight loss agent counter food store review start point make inform choic nutraceut agent promot weight loss advic incorpor healthi altern diet
MED-4253~effect cake made soy powder postprandi blood glucos insulin level human subject pubm ncbi abstract investig glycem index gi insulinem index ii cake made soy powder sbc suppress effect sbc postprandi blood glucos insulin carbohydr food breath hydrogen excret simultan investig twenti subject num sbc num cook paddy ric num sbc num cook paddy ric random order within subject repeated measur design blood end expiratori gas collect period ingest gi ii sbc num num num num elev blood glucos cook paddy ric signific suppress addit num sbc insulin secret decreas breath hydrogen excret addit sbc num cook paddy ric signific increas comparison cook paddy ric sbc low gi low ii postprandi insulin secret respons cook paddy ric suppress
MED-4255~resolv coronari arteri diseas epidem plant bas nutrit pubm ncbi abstract world advanc countri easi access plenti high fat food iron rich diet produc atherosclerosi world poorer nation peopl subsist primarili plant bas diet healthier term heart diseas treat coronari heart diseas centuri scientif investig produc device driven risk factor ori strategi patient treat approach experi progress disabl death strategi rear guard defens contrast compel data nutrit studi popul survey intervent studi support effect plant bas diet aggress lipid lower arrest prevent select revers heart diseas essenc offens strategi singl biggest step adopt strategi unit state dietari guidelin support plant bas diet expert committe purg industri polit influenc requir assur scienc basi dietari recommend num chf
MED-4256~systemat review waist to height ratio screen tool predict cardiovascular diseas diabet num num suitabl pubm ncbi abstract systemat review collat seventy eight studi explor waist to height ratio whtr waist circumfer wc bmi predictor diabet cvd publish english num num twenty two prospect analys show whtr wc signific predictor cardiometabol outcom bmi similar signific predictor adjust bmi observ cross sect analys forty four adult thirteen children support predict receiv oper characterist roc analysi reveal area roc auroc valu num num num num num whtr wc bmi boundari valu whtr cover cardiometabol outcom studi fourteen countri includ caucasian asian central american subject num num men num num women whtr wc similar predictor diabet cvd stronger independ bmi make firmer statist comparison meta analysi requir auroc analys whtr global clinic screen tool wc weight boundari num num support simpl public health messag waist circumfer half height
MED-4257~systemat review bodi fat distribut mortal older peopl abstract conduct systemat review investig bodi fat distribut older adult associ morbid mortal search yield num citat level screen num studi select evalu associ bodi fat distribut comorbid num studi mortal analysi select studi analys anthropometr measur bodi mass index bmi waist circumfer waist hip ratio studi direct measur bodi fat lean mass percentag bodi fat studi report inconsist find strongest predictor morbid mortal major studi suggest bmi se predictor morbid mortal elder inabl discern detect age rel bodi fat redistribut addit studi bmi found optim bmi rang lowest mortal elder overweight num kg m num bmi num kg m num mild obes num kg m num bmi num kg m num find suggest current clinic guidelin recommend overweight obes major risk factor increas morbid mortal applic popul central messag review admonish govern establish guidelin specif popul combin bodi fat distribut measur certifi guidelin appli inappropri popul
MED-4258~plant anim protein intak associ overweight obes belgian popul pubm ncbi abstract object present studi assess anim plant protein intak belgian popul examin relationship overweight obes ob subject particip belgian nation food consumpt survey conduct num food consumpt assess non consecut num dietari recal num particip num year age num male num femal provid complet dietari inform anim protein intak num g d contribut total protein intak num g d plant protein intak account num g d meat meat product main contributor total anim protein intak num cereal cereal product contribut plant protein intak num male higher anim plant protein intak femal num num legum soya protein intak low popul num num num num g d male anim protein intak posit bmi num num num num waist circumfer wc num num num num male femal plant protein intak invers bmi male num num num num femal num num num num wc male num num num num femal num num num num conclus plant protein intak lower anim protein intak repres sampl belgian popul decreas age associ anthropometr data plant protein offer protect effect prevent overweight ob belgian popul
MED-4261~meat consumpt prospect weight chang particip epic panacea studi pubm ncbi abstract background meat intak relat weight gain high energi fat content observ studi shown meat consumpt posit weight gain intervent studi shown mix result object object assess associ consumpt total meat red meat poultri process meat weight gain num follow up averag larg european popul particip european prospect investig cancer nutrition phys activ nutrit alcohol cessat smoke eat home obes epic panacea project design total num men num women age num recruit num num num european countri diet assess baselin country specif valid questionnair dietari calibr studi conduct repres subsampl cohort weight height measur baselin self report follow up center associ energi meat kcal d annual weight chang g i assess linear mix model control age sex total energi intak physic activ dietari pattern potenti confound result total meat consumpt posit weight gain men women normal weight overweight subject smoker nonsmok adjust estim energi intak increas meat intak num g d steak approxim num kcal lead num kg higher weight gain num num ci num num kg posit associ observ red meat poultri process meat conclus result suggest decreas meat consumpt improv weight manag
MED-4262~satieti neglect dietari non nutri pubm ncbi abstract satieti inhibit eat end meal influenc number food characterist includ composit structur factor increas understand factor mechan exert effect satieti offer food bas approach weight manag water gas neglect nutrit major compon food contribut volum sensori characterist review previous short term studi evalu effect water gas food satieti show satieti general increas effect subsequ intak appar studi divers term design time food matric preclud definit conclus result solid effect increas satieti liquid gas effect water increas gastric distens main mechan effect pre ingest ingest impact cognit anticipatori sensori respons involv limit evid water effect increas satieti decreas intak drunk meal longer term extrapol suggest increas food volum water gas offer weight manag strategi practic viewpoint effect water gas satieti exploit non nutri manipul perceiv portion size increas energi content
MED-4264~increas time spent thermal comfort zone contribut popul increas obes pubm ncbi abstract domest winter indoor temperatur usa uk develop countri upward trend review examin evid causal link thermal exposur increas obes preval focus acut longer term biolog effect time spent thermal comfort compar mild cold reduc exposur season cold dual effect energi expenditur minim physiolog thermogenesi reduc thermogen capac experiment studi show grade associ acut mild cold human energi expenditur rang temperatur relev indoor heat trend recent studi role brown adipos tissu bat human thermogenesi suggest increas time spent condit thermal comfort lead loss bat reduc thermogen capac pathway link cold exposur adipos direct test human research naturalist experiment set establish effect thermal exposur weight rais possibl public health strategi address obes num author obes review num intern associ studi obes
MED-4265~microbi ecolog human gut microb obes pubm ncbi abstract group benefici bacteria domin human gut bacteroidet firmicut show relat proport bacteroidet decreas obes peopl comparison lean peopl proport increas weight loss type low calori diet find obes microbi compon potenti therapeut implic
MED-4266~high polyphenol low probiot diet weight loss intestin microbiota interact pubm ncbi abstract relat proport bacteroidet firmicut decreas obes peopl imbal gut microbiota generat signal control express gene epitheli intestin cell dairi non dairi probiot increas bodi weight report lactobacillus speci growth gut hand daili intak fruit drink appl pear grapefruit green tea rich polyphenol signific reduc bodi weight obes peopl metabol polyphenol microbiota involv cleavag glycosid linkag glycan product glycosid cleavag surviv intestin microbiota nutrient foundat pivot point firmicut possess disproportion smaller number glycan degrad enzym bacteroidet ii firmicut repress bacteroidet phenol compound antimicrobi properti bacteroidet communiti prevail dietari polyphenol intak ferment phenol compound due glycan degrad enzym mechan dietari polyphenol exert weight lower effect suggest futur studi util clone librari fingerprint techniqu enabl identif composit communiti structur microbiota dot blot hybrid fluoresc situ hybrid analyz abund taxa obes individu supplement polyphenol high bioavail obes individu higher firmicutes bacteroid communiti ratio phenotyp probiot restrict diet propos weight loss hypothesi relev implic plan success dietari regimen and or neutraceutical pharmaceut prepar achiev maintain normal bodi weight obes individu includ polyphenol rich foodstuff and or polyphenol rich syrup includ low amount probiotic rich foodstuff yogurt soy yogurt probiot supplement copyright num elsevi ireland reserv
MED-4267~studi appl blueberri fruit constitu polyphenol reach colon ingest pubm ncbi abstract aim studi determin amount polyphenol reach colon oral intak appl juic blueberri polyphenol fre diet healthi ileostomi volunt consum polyphenol rich cloudi appl juic consum anthocyanin rich blueberri ileostomi effluent collect polyphenol identifi hplc dad hplc esi ms m quantif perform hplc dad oral administ appl polyphenol absorb metabol small intestin num num oral dose recov ileostomi bag maximum excret num higher amount blueberri anthocyanin studi num depend sugar moieti determin ileostomi bag reach colon physiolog circumst structure rel avail consid polyphenol model system studi potenti prevent effect colorect diseas
MED-4269~butyr short chain fatti acid modul immun relev health pubm ncbi abstract purpos review high fib diet shown reduc plasma concentr inflamm marker increas product fermentation deriv short chain fatti acid scfas factor exert posit effect review examin effect scfas immun cell discuss relev effect system inflamm frequent obes recent find scfas shown reduc chemotaxi cell adhes effect depend type concentr scfa spite conflict result butyr anti inflammatori effect mediat signal pathway nuclear factor inhibit histon deacetylas discrep result explain differ cell type prolif differenti status summari scfas show anti inflammatori effect potenc prevent infiltr immun cell bloodstream adipos tissu addit abil inhibit prolifer activ cell prevent adhes antigen pres cell import recent shown obesity associ inflamm antigen depend studi concentr micromolar rang approach physiolog concentr
MED-4271~mechan primari cancer prevent butyr product form gut flora medi ferment dietari fibr pubm ncbi abstract dietari fibr indigest food ingredi reach colon ferment colon bacteria result format short chain fatti acid scfa acet propion butyr scfa butyr recognis potenti act secondari chemoprevent slow growth activ apoptosi colon cancer cell addit scfa act primari prevent activ drug metabolis enzym reduc burden carcinogen decreas number mutat reduc cancer risk activ gsts butyr studi mrna protein enzym activ level real tim rt pcr cdna microarray western blot photometr approach butyr differenti effect colon cell stage cancer develop ht num tumour cell mrna gsta num gstp num gstm num gstt num induc lt num adenoma cell gstm num gstt num mgst num induc gsta num gstt num catalas cat elev primari colon cell colon cell stage carcinogenesi differ post transcript regulatori mechan butyr increas protein level gst isoform total gst enzym activ ht num cell lt num cell gst protein level activ slight reduc butyr increas histon acetyl phosphoryl erk ht num cell inhibit histon deacetylas influenc mapk signal mechan gst activ butyr function consequ activ includ reduct dna damag caus carcinogen hydrogen peroxid num hydroxynonen hne butyrate tr colon cell treatment colon cell supernat vitro ferment inulin increas gst activ decreas hne induc dna damag ht num cell addit anim human studi defin exact role dietari fibr butyr induc gst activ reduc risk colon cancer
MED-4276~propion anti obes satieti enhanc factor pubm ncbi abstract propion produc acet butyr result ferment activ gut microflora dietari fiber long exhibit hypophag effect rumin potenti physiolog role non rumin human remain unnot year view studi point hypophag hypocholesterolem effect propion human act import factor amelior obes lifestyl diseas aris due energi imbal grow startl rate global short chain fatti acid recent ascrib ligand g protein coupl receptor gprs num num propion acet involv regul adipogenesi adipokin releas mediat gprs present review summar evid collect rais possibl propion dietari factor depress appetit combat obes epidem copyright num elsevi reserv
MED-4278~epic oxford lifestyl characterist nutrient intak cohort num meat eat num meat eat uk pubm ncbi abstract object describ lifestyl characterist nutrient intak oxford cohort european prospect investig cancer nutrit epic design cohort men women recruit general practic post includ high proport meat eat dietari anthropometr lifestyl data collect baselin diet group defin set unit kingdom particip total num men women age num num year compris num meat eat num fish eat num lacto ovo vegetarian num vegan result nutrient intak lifestyl factor differ diet group strike differ meat eat vegan fish eat vegetarian intermedi valu fat intak diet group uk dietari refer num total energi intak intak satur fatti acid vegan approxim num energi half intak meat eat num vegan highest intak fibr vitamin num folat vitamin vitamin magnesium iron lowest intak retinol vitamin num vitamin calcium zinc conclus epic oxford cohort includ num meat eat largest studi vegetarian world averag nutrient intak cohort close recommend good health comparison diet group show wide rang intak major nutrient satur fat dietari fibr variat increas abil studi detect associ diet major cancer death
MED-4281~benefici effect l arginin reduc obes potenti mechan import implic human health pubm ncbi abstract past num year grow interest biochemistri nutrit pharmacolog l arginin led extens studi explor nutrit therapeut role treat prevent human metabol disord emerg evid show dietari l arginin supplement reduc adipos genet obes rat diet induc obes rat finish pig obes human subject type num diabet mellitus mechan respons benefici effect l arginin complex ultim involv alter balanc energi intak expenditur favor fat loss reduc growth white adipos tissu recent studi l arginin supplement stimul mitochondri biogenesi brown adipos tissu develop possibl enhanc synthesi cell sign molecul nitric oxid carbon monoxid polyamin cgmp camp increas express gene promot whole bodi oxid energi substrat glucos fatti acid l arginin hold great promis safe cost effect nutrient reduc adipos increas muscl mass improv metabol profil anim human
MED-4284~effect peanut process bodi weight fast plasma lipid pubm ncbi abstract peanut peanut butter common consum snack meal compon ingredi commerci product consumpt reduc cvd risk pose threat posit energi balanc question arisen product form nut butter process properti roast ad flavour compromis posit health effect present studi investig effect peanut form process cvd risk factor fast plasma lipid bodi weight hundr eighteen adult forty seven male seventy on femal age num sd num year bmi num sd num kg m num brazil ghana unit state randomis consum num raw unsalt num roast unsalt num roast salt num honey roast num peanut peanut butter num daili num week peanut form process differenti affect bodi weight fast plasma lipid respons total sampl hdl cholesterol increas signific group level total cholesterol ldl cholesterol tag concentr decreas signific individu classifi elev fast plasma lipid compar normal fast plasma lipid observ suggest process attribut assess trial compromis lipid low effect peanut negat impact bodi weight studi warrant determin effect form process health risk factor
MED-4286~nut healthi bodi weight mainten mechan pubm ncbi abstract nut rich sourc multipl nutrient phytochem health benefit includ reduc cardiovascular diseas risk prompt recommend increas consumpt high fat energi dens associ properti posit energi balanc bodi weight rais question recommend numer epidemiolog clinic studi show nut weight gain mechanist studi larg attribut high satieti low metaboliz energi poor bioaccess lead ineffici energi absorpt properti nut compensatori dietari respons account num energi provid nut limit data suggest routin nut consumpt elev rest energi expenditur thermogen effect feed result dissip portion energi provid addit trial contrast weight loss regimen includ exclud nut improv complianc greater weight loss nut permit nut includ diet moder enhanc palat nutrient qualiti chronic diseas risk reduct compromis weight loss mainten
MED-4287~week overfeed candi peanut increas insulin level bodi weight pubm ncbi abstract object studi effect snack base fast act carbohydr candi fat protein peanut prospect random parallel intervent studi method basal metabol rate bmr cardiovascular risk factor measur hyper aliment addit num kcal kg num kj kg bodi weight candi roast peanut regular calor intak week healthi subject eleven men num women complet random studi result energy intak increas similar group candi num num peanut num num num body weight candi num num kg num num kg num nut num num kg num num kg num waist circumfer increas signific candi group end studi ldl cholesterol candi num num mmol l peanut num num mmol l num apob apoa num ratio candi num num peanut num num num higher candi group peanut group hand bmr increas peanut group candi num num mj num num num mj num num nut num num mj num num num mj num num conclus week snack base peanut negat metabol effect isocalor diet snack base short act carbohydr form candi non obes healthi subject
MED-4288~out of hand nut consumpt improv nutrient intak health risk marker children adult nation health nutr pubm ncbi abstract purpos studi determin associ out of hand nut oohn consumpt nutrient intak diet qualiti preval risk factor cardiovascular diseas metabol syndrom data num hour recal individu age num year num particip num nation health nutrit examin survey popul divid children age num num num adult num year group dichotom oohn consum nonconsum out of hand nut consum defin individu consum oz nut standard error covariate adjust analys varianc determin sampl weight diet qualiti determin healthi eat index num signific set num percent oohn consum increas age num num num num num num num num age num num num num num year num group combin singl group consum age num year subsequ analys consum oohn age group higher intak energi monounsatur polyunsatur fatti acid dietari fiber copper magnesium lower intak carbohydr cholesterol sodium nonconsum diet qualiti higher oohn consum age group children age num num year consum higher preval overweight obes age num num year weight percent overweight lower consum adult consum higher high dens lipoprotein cholesterol red blood cell folat serum folat level lower insulin glycohemoglobin c reactiv protein level nonconsum adult consum num decreas risk hypertens num decreas risk low high dens lipoprotein cholesterol level data suggest oohn consumpt improv nutrient intak diet qualiti adult lower preval num risk factor metabol syndrom consumpt oohn part healthi diet encourag health profession copyright num elsevi reserv
MED-4289~nut consumpt decreas health risk factor cardiovascular diseas metabol syndrom adult nhane num pubm ncbi abstract background recent epidemiolog studi assess effect nut consumpt includ tree nut peanut health risk includ metabol syndrom met object studi compar health risk cardiovascular diseas type num diabet met nut consum nonconsum design adult num year num particip num nation health nutrit examin survey intak num hour recal determin intak nut tre nut consum consum ounc day covariate adjust standard error preval rate determin nut consumpt group result preval nut consum num num num num num year num year older nut consumpt decreas bodi mass index num kg m num num num num kg m num num waist circumfer num num cm num num cm num systol blood pressur num num mmhg num num mmhg num compar nonconsum tree nut consum lower weight num num kg num num kg num nut consum lower percentag risk factor met hypertens num num num num num low high densiti lipoprotein cholesterol hdl c num num num num num tree nut consum lower preval risk factor met abdomin obes num num num num num hypertens num num num num num low hdl c num num num num num high fast glucos num num num num num lower preval met num num num num num conclus nut tre nut consumpt decreas preval select risk factor cardiovascular diseas type num diabet met
MED-4290~cross sect associ nut intak adipos mediterranean popul pubm ncbi abstract background aim nut intak invers relat bodi mass index bmi prospect studi examin dietari determin adipos elder mediterranean popul customarili high nut consumpt method result cross sect studi conduct num subject num women age num year bmi num kg m num high cardiovascular risk recruit predim studi food consumpt evalu valid semi quantit questionnair energi expenditur physic activ minnesota leisur time activ questionnair anthropometr variabl standard measur nut intak decreas quintil bmi waist circumfer p trend num alcohol ingest invers relat bmi p trend num direct waist p trend num meat intak direct waist circumfer p trend num fulli adjust multivari model independ dietari associ bmi intak nut invers num meat meat product direct num waist circumfer independ dietari associ intak nut num veget num invers intak meat meat product direct num regress coeffici predict bmi waist circumfer decreas num kg m num num cm serv num nut result similar men women conclus nut consumpt invers adipos independ lifestyl variabl remain explor residu confound relat healthier lifestyl nut eater part explain result copyright num elsevi reserv
MED-4291~nut consumpt weight gain obes epidemiolog evid pubm ncbi abstract background aim short term trial support ad tree nut peanut usual diet induc weight gain review epidemiolog evid long term nut consumpt bodi weight report result sun seguimiento universidad de navarra cohort method result publish epidemiolog studi num yr follow up locat publish report larg cohort sun nurs health studi num show invers associ frequenc nut consumpt long term weight benefici effect mediterranean diet supplement tree nut waist circumfer report num yr follow up num high risk particip predim prevencion dieta mediterranea trial assess num particip sun cohort borderlin signific trend num invers associ baselin nut consumpt averag year weight gain multivariate adjust num kg yr num confid interv num num num num num kg yr particip consumpt num servings week found num yr follow up conclus consumpt nut higher risk weight gain long term epidemiolog studi clinic trial copyright num elsevi reserv
MED-4292~review evid nut bodi weight pubm ncbi abstract singl dietari lifestyl intervent effect long term weight loss tradit weight loss diet tend low total fat restrict nut consumpt nut import sourc vitamin miner monounsatur polyunsatur fatti acid paper review evid literatur relat nut consumpt bodi weight find show role nut consumpt bodi weight manag vari nut includ part energy control diet found instanc assist weight loss nut ad exist diet control energi intak bodi weight increas lesser extent theoret predict limit evid effect nut consumpt type num diabet evid nut part healthi diet weight gain posit influenc fatti acid profil person diabet review show lack evid support restrict nut consumpt weight manag indic research assess role nut weight manag
MED-4295~phytosterol composit nut seed common consum unit state pubm ncbi abstract phytosterol quantifi nut seed common consum unit state total lipid extract subject acid hydrolysi alkalin saponf free sterol analyz trimethylsilyl deriv capillari gc fid gc ms delta num avenasterol quantifi alkalin saponif direct analysi glucosid sesam seed wheat germ highest total phytosterol content num mg num brazil nut lowest num mg num product typic consum snack food pistachio sunflow kernel richest phytosterol num mg num beta sitosterol delta num avenasterol campesterol predomin campestanol rang num num mg num num mg num beta sitosterol found pumpkin seed kernel total sterol content high num mg num phytosterol concentr greater report exist food composit databas due inclus steryl glycosid repres signific portion total sterol nut seed
MED-4296~effect phytosterol present natur food matric cholesterol metabol ldl cholesterol control feed trial abstract background object extrins phytosterol supplement diet reduc intestin cholesterol absorpt plasma ldl cholesterol effect cholesterol metabol nativ unpurifi form amount achiev diet object investig test hypothesi intrins phytosterol present unmodifi food alter whole bodi cholesterol metabol subjects method twenti num subject complet random crossov feed trial meal provid metabol kitchen subject consum diet num week diet differ phytosterol content phytosterol poor diet num mg phytosterol num kcal phytosterol abund diet num mg num kcal match nutrient content cholesterol absorpt excret determin gas chromatograph mass spectrometri oral administr stabl isotop tracer result phytosterol abund diet result lower cholesterol absorpt num num num confid interv num num num num num num num num higher fecal cholesterol excret num num num num num num mg day num num num relat phytosterol poor diet plasma lathosterol cholesterol ratio rose num num num num num num num g mg num num num ldl cholesterol similar diet conclus intrins phytosterol level present healthi diet biolog activ larg effect bodi cholesterol metabol reflect circul ldl work assess effect phytosterol medi fecal cholesterol excret coronari heart diseas risk human
MED-4298~effect almond consumpt reduct ldl cholesterol discuss potenti mechan futur research direct pubm ncbi abstract diet play semin role prevent treatment cardiovascular diseas consumpt tree nut shown reduc low dens lipoprotein cholesterol ldl c primari target coronari diseas prevent num almond found consist ldl c lower effect healthi individu individu high cholesterol diabet control free liv set almond low satur fatti acid rich unsatur fatti acid fiber phytosterol plant protein cardioprotect nutrient uniqu almond includ tocopherol arginin magnesium copper manganes calcium potassium mechan respons ldl c reduct observ almond consumpt nutrient almond provid biolog activ natur nutrient target primari mechanist rout ldl c reduct includ decreas absorpt cholesterol bile acid increas bile acid cholesterol excret increas ldl c receptor activ nutrient present almond regul enzym involv de novo cholesterol synthesi bile acid product research understand mechan almond reduc cardiovascular diseas risk num intern life scienc institut
MED-4299~evolut human diet link ancestr diet modern function food chronic diseas prevent pubm ncbi abstract evolut human diet past num year paleolith diet current modern pattern intak result profound feed behavior shift occur diet high fruit veget lean meat seafood process food high sodium hydrogen fat low fiber dietari advers affect dietari paramet relat health result increas obes chronic diseas includ cardiovascular diseas cvd diabet cancer intervent trial paleolith dietari pattern shown promis result favor cvd diabet risk factor benefit offset disadvantag paleolith diet low vitamin calcium high fish potenti environment toxin advantag promot food food ingredi ancestr era shown possess health benefit form function food studi investig health benefit function food ingredi includ omega num fatti acid polyphenol fiber plant sterol bioactiv compound prevent reduc incid chronic diseas turn lead health cost save rang num num billion year estim case studi omega num plant sterol exampl public health benefit result promot posit compon paleolith diet function food
MED-4300~cultur histor aspect mediterranean nut emphasi attribut healthi nutrit properti pubm ncbi abstract background aim nut part human diet prehistor time aim present articl describ import histor cultur aspect nut consumpt histori data synthesi discuss histor aspect nut origin mediterranean prehistori egyptian civil spread mediterranean region greek phoenician roman civil reintroduct europ al andalus cultur emphasi healthi nutrit attribut nut histori role global food  th exchang nut continents  and discuss symbol nut human histori context cultur aspect mediterranean region conclus nut fruit earliest food consum human consid import nutrit properti nut past civil drug prevent treat diseas copyright num elsevi reserv
MED-4301~nut consumpt blood lipid level pool analysi num intervent trial pubm ncbi abstract background epidemiolog studi consist nut consumpt reduc risk coronari heart diseas subsequ dietari intervent trial investig effect nut consumpt blood lipid level object studi estim effect nut consumpt blood lipid level examin factor modifi effect method pool individu primari data num nut consumpt trial conduct num countri num men women normolipidemia hypercholesterolemia lipid low medic pool analysi mix linear model assess effect nut consumpt potenti interact result daili consumpt num nut estim reduct achiev total cholesterol concentr num mg dl num chang low dens lipoprotein cholesterol concentr ldl c num mg dl num chang ratio ldl c high dens lipoprotein cholesterol concentr hdl c num num chang ratio total cholesterol concentr hdl c num num chang num convert cholesterol concentr millimol liter multipli num triglycerid level reduc num mg dl num subject blood triglycerid level num mg dl num lower level convert triglycerid level millimol liter multipli num effect nut consumpt dose relat type nut similar effect blood lipid level effect nut consumpt signific modifi ldl c bodi mass index diet type lipid low effect nut consumpt greatest subject high baselin ldl c low bodi mass index consum western diet conclus nut consumpt improv blood lipid level dose rel manner subject higher ldl c lower bmi
MED-4302~cardiovascular effect consumpt black versus english walnut pubm ncbi abstract english walnut shown decreas cardiovascular diseas risk black walnut studi cardioprotect effect purpos studi determin effect english versus black walnut consumpt blood lipid bodi weight fatty acid composit red blood cell rbc membran endotheli function consumpt num english walnut day num day num human particip improv blood lipid effect black walnut depend participant sex addit nut diet result weight gain fatty acid composit rbc membran favor affect walnut consumpt rbc polyunsatur fatti acid increas consumpt type nut eicosapentaeno acid increas signific english walnut consumpt endotheli function num unmed human hypercholesterolemia maintain consumpt english walnut meal high high satur fat consumpt black walnut meal maintain endotheli function result support recommend consumpt num oz english walnut day decreas cardiovascular risk research black walnut consumpt recommend made
MED-4303~oxid stabil shelf lif evalu select culinari oil pubm ncbi abstract healthier oils nam almond oil avocado oil hazelnut oil macadamia nut oil studi rich sourc monounsatur fatti acid oliv oil grape seed oil rice barn oil market recent toast sesam oil walnut oil high level essenti fatti acid order oxid stabil determin rancimat measur induct period temperatur num degre num degre num degre num degre found macadamia oil rice bran oil approxim toast sesam oil avocado oil almond oil hazelnut oil grape seed oil walnut oil high level monounsatur fatti acid oil gave linear relationship num time reciproc induct period total unsatur fatti acid content obtain num num num num num polyunsatur fatti acid oil gave exponenti relationship case rice bran hazelnut oil shelf lif predict extrapol arrhenius plot num factor compar storag time oil produc case oil macadamia nut oil predict shelf liv signific lower storag time walnut oil prone oxid gave num time lower shelf lif best befor storag life
MED-4305~macronutri intak plasma larg neutral amino acid mood weight reduc diet pubm ncbi abstract influenc diet composit mood weight reduc diet studi healthi young women normal weight broad rang macronutri intak achiev diverg dietari instruct composit num kcal day diet adher week global mood week diet signific vegetarian mix diet group time signific correl observ relat carbohydr intak global mood num num ratio plasma tryptophan larg neutral amino acid predictor tryptophan flow brain global mood num num result suggest group differ relat differ carbohydr intak hypothes impair central serotonerg function due reduc tryptophan avail prompt mood deterior situat low carbohydr intak
MED-4306~brain serotonin content physiolog regul plasma neutral amino acid pubm ncbi abstract plasma tryptophan elev inject tryptophan insulin consumpt carbohydr brain tryptophan serotonin rise larger elev plasma tryptophan produc ingest protein contain diet brain tryptophan serotonin chang main determin brain tryptophan serotonin concentr plasma tryptophan ratio amino acid plasma neutral amino acid tyrosin phenylalanin leucin isoleucin valin compet uptak brain
MED-4308~effect nutrient intak premenstru depress pubm ncbi abstract examin occurr coincid depress mood excess carbohydr intak num patient claim suffer sever premenstru syndrom control subject inpati earli follicular late luteal phase menstrual cycl mood assess hamilton depress scale addendum evalu fatigu sociabl appetit carbohydr crave calori nutrient intak measur direct subject premenstru syndrom signific increas calori intak late luteal phase num num num num kcal sem carbohydr intak increas num meal num snack protein intak fail chang intak fat fix constitu test food rose proport calori intak hamilton depress scale addendum score rose num num num num hamilton scale num num num num addendum subject premenstru syndrom luteal phase fail chang control num num num num num num num num consumpt carbohydrate rich protein poor test meal late luteal phase menstrual cycl improv depress tension anger confus sad fatigu alert calm score num patient premenstru syndrom effect meal observ follicular phase control subject phase synthesi brain serotonin involv mood appetit increas carbohydr intak premenstru syndrom subject overconsum carbohydr attempt improv dysphor mood state
MED-4309~hplc analysi serotonin tryptamin tyramin hydroxycinnam acid amid serotonin tyramin food veget pubm ncbi abstract biogen monoamin serotonin tryptamin tyramin function neurotransmitt mitogen factor anim involv flower morphogenesi protect adapt environment plant plant serotonin tyramin conjug form phenol compound thioester linkag synthesi hydroxycinnam acid amid includ p coumaroylserotonin cs feruloylserotonin fs p coumaroyltyramin ct feruloyltyramin ft studi determin amount biogen monoamin cs fs ct ft common consum veget high perform liquid chromatographi serotonin tryptamin tyramin detect veget test serotonin level rang num num microg g dri weight tryptamin level rang num num microg g dri weight tyramin level rang num num microg g dri weight highest serotonin tryptamin content found tomato cherri tomato num num microg g dri weight paprika green pepper higher tyramin content veget num num microg g dri weight level cs fs ct ft rang num num microg g dri weight green onion possess highest level cs num microg g dri weight ft num microg g dri weight ct num microg g dri weight
MED-4312~post epidem eosinophilia myalgia syndrom l tryptophan abstract eosinophilia myalgia syndrom em character subacut onset myalgia peripher eosinophilia chronic neuropathi skin indur epidem em num link l tryptophan consumpt origin singl sourc food drug administr fda ban sale l tryptophan incid em declin rapid case publish fda ban lift num report clinic histopatholog immunogenet featur case l tryptophan associ em evid activ transform growth factor interleukin num signal lesion skin
MED-4313~vegetarian dietari pattern nutrient dens approach weight manag analysi nation health nutrit examin survey pubm ncbi abstract background population bas studi shown vegetarian lower bodi mass index nonvegetarian suggest vegetarian diet plan approach weight manag percept exist vegetarian diet defici nutrient object compar dietari qualiti vegetarian nonvegetarian dieter test hypothesi vegetarian diet compromis nutrient intak manag bodi weight design cross sect analysi nation health nutrit examin survey num dietari anthropometr data diet qualiti determin unit state depart agriculture healthi eat index num particip includ adult age num year older exclud pregnant lactat women num lacto ovo vegetarian diet portray intak particip eat meat poultri fish day survey num weight loss diet portray intak particip consum num kcal estim energi requir num nutrient intak bodi mass index adjust energi sex ethnic analysi varianc vegetarian compar nonvegetarian diet vegetarian diet nonvegetarian nondiet vegetarian nondiet nonvegetarian result intak fiber vitamin thiamin riboflavin folat calcium magnesium iron higher vegetarian nonvegetarian vegetarian intak vitamin vitamin magnesium exceed nonvegetarian num num num num mg num num num num num num num num mg group intak desir healthi eat index score differ vegetarian compar nonvegetarian num num num num num conclus find suggest vegetarian diet nutrient dens consist dietari guidelin recommend weight manag compromis diet qualiti copyright num american dietet associ publish elsevi reserv
MED-4314~nut anti atherogen food pubm ncbi abstract preval cardiovascular diseas lead morbid mortal increas worldwid fact attribut modern lifestyl predomin characterist chang dietari habit reduc physic activ lead metabol disord obes diabet drastic dietari intervent consid order reduc cardiovascular risk nut nutrit compon drawn attent due benefici cardiovascular properti deriv nutrient composit comprehens review potenti general effect nut includ data older larg epidemiolog studi recent signific inform clinic trial topic studi conclud nut play import role part healthi diet order minim cardiovascular risk obtain multipl health benefit copyright num european feder intern medicin publish elsevi reserv
MED-4315~differ metal content heart muscl death ischem heart diseas pubm ncbi abstract group patient die sudden ischem heart diseas uninfarct heart muscl signific lower concentr magnesium iron potassium signific higher concentr calcium heart muscl group normal control group patient die month coronari thrombosi late death group signific lower concentr manganes copper normal group slight decreas magnesium concentr signific signific differ sodium concentr group result discuss relat increas death rate ischem heart diseas area soft drink water dietari defici miner salt
MED-4316~system regul intestin iron absorpt pubm ncbi abstract intestin absorpt essenti trace element iron mobil storag site bodi control system signal reflect tissu iron requir recent advanc liver deriv peptid hepcidin play central role process repress iron releas intestin enterocyt macrophag bodi cell iron requir increas hepcidin level declin iron enter plasma propos level circul diferr transferrin reflect tissu iron level act signal alter hepcidin express liver protein hfe transferrin receptor num hemojuvelin involv mediat signal disrupt molecul decreas hepcidin express patient carri mutat molecul hepcidin develop system iron load hemochromatosi due inabl regul iron absorpt hepcidin respons decreas plasma iron hypoferremia accompani inflamm chronic diseas express stimul pro inflammatori cytokin interleukin num mechan regul hepcidin express act cell control iron releas key area ongo research iubmb life num num
MED-4317~intestin iron absorpt regul dietari system factor pubm ncbi abstract iron essenti trace metal human metabol imbal iron homeostasi preval worldwid detriment effect human health human abil remov excess iron iron homeostasi maintain regul amount iron enter bodi diet iron present human diet number form includ heme meat varieti non hem iron compound heme absorb intact bioavail non hem iron vari great depend dietari composit number dietari compon capabl interact iron regul solubl oxid state interest emerg bodi evid suggest nutrient direct effect express function enterocyt iron transport addit dietari factor bodi iron status major determin iron absorpt role import dietari system factor regul iron absorpt discuss review
MED-4318~low ph cola beverag affect women iron absorpt vegetarian meal pubm ncbi abstract preliminari data literatur iron absorpt meal increas consum low ph beverag cola sugar iron complex alter iron avail random crossov trial conduct compar bioavail nonhem iron vegetarian pizza meal consum num beverag cola diet cola miner water sixteen women serum ferritin concentr num g l recruit complet studi pizza meal nativ iron ad ferric chlorid solut stabl isotop extrins label total iron content meal num mg incorpor iron meal rbc affect type drink num cola num diet cola num water serum ferritin plasma hepcidin correl num num signific predictor iron bioavail combin effect explain num inter individu variat num illustr current lack understand mechan respons fine tun iron absorpt effect low ph drink iron bioavail healthi women effect absorpt fortif iron requir solubil dilut acid reduc iron individu low gastric acid product older peopl individu helicobact pylori infect warrant investig
MED-4319~phytat food signific human food sourc intak process bioavail protect role analysi pubm ncbi abstract articl overview phytic acid food signific human nutrit summaris phytat sourc food discuss problem phytic acid phyt content food tabl data phytic acid intak evalu daili phytic acid intak depend food habit assess degrad phytat gastro intestin passag summaris mechan phytat interact miner trace element gastro intestin chyme pathway inositol phosphat hydrolysi gut present present knowledg phytat absorpt summaris discuss effect phytat miner trace element bioavail report phytat degrad process storag benefici activ dietari phytat effect calcif kidney stone format lower blood glucos lipid report antioxid properti phytic acid potent anticancerogen activ briefli survey develop analysi phytic acid inositol phosphat problem inositol phosphat determin detect discuss standardis phytic acid analysi food argu
MED-4320~higher bioaccess iron zinc food grain presenc garlic onion pubm ncbi abstract bioavail micronutri iron zinc low plant food evolv food bas strategi improv combat widespread defici miner popul depend plant food dietari sulfur contain amino acid report improv miner status experiment anim object examin sulfur compound rich allium spice similar potenti benefici modul miner bioavail context examin influenc exogen ad garlic onion bioaccess iron zinc food grain repres cereal puls studi raw cook condit employ level garlic num num num grain onion num num num grain enhanc effect spice iron bioaccess general evidenc case cereal num num increas puls num num increas raw cook condit spice similar enhanc bioaccess zinc food grain extent increas cereal rang num num puls num num garlic onion evidenc promot influenc bioaccess iron zinc food grain inform potenti applic evolv food bas strategi improv bioavail trace miner contribut human health benefit
MED-4321~dehydroepiandrosteron sulfat postmenopaus women pubm ncbi abstract purpos review level dehydroepiandrosteron dhea declin age era increas supplement life benefit dhea age femal popul controversi goal articl critic review publish studi determin role dhea supplement postmenopaus women recent find daili administr oral dhea achiev serum concentr similar women num observ studi shown lower dhea level increas cardiovascular risk women intervent trial show improv atherosclerosi cardiovascular risk factor lower hdl cholesterol level dhea supplement modest increas bone miner densiti conjunct adjuv therapi improv cognit mild to moder cognit impair affect cognit unimpair women intravagin dhea oral dhea allevi vagin atrophi improv sexual function postmenopaus women summari basi current evid role oral dhea supplement healthi postmenopaus women benefit shown long term studi confirm benefit verifi safeti profil dhea
MED-4322~dhea therapi postmenopaus women move forward lack evid pubm ncbi abstract mark age rel declin serum dehydroepiandrosteron dhea dehydroepiandrosteron sulfat dhea suggest defici steroid causal relat develop seri diseas general age postul consequ low dhea level includ insulin resist obes cardiovascular diseas cancer reduct immun defenc system psychosoci problem depress general deterior sensat well b cognit function clinic spectrum women benefit dhea therapi defin dosag hormon treatment dhea therapi prescrib general anti ag therapi altern treatment women suffer androgen defici syndrom remain uncertain studi lack definit evid biolog mechan presenc studi address emerg issu dhea therapi postmenopaus women encourag critic analysi literatur evidenc current limit incongru
MED-4323~dehydroepiandrosteron age pubm ncbi abstract dehydroepiandrosteron dhea major steroid produc adren zona reticulari contrast cortisol aldosteron secret declin age generat major interest putat role anti ag hormon clear age associ physiolog declin dhea secret repres harm defici dhea exhibit action convers sex steroid addit dhea neurosteroid properti exhibit direct action specif bind site endotheli cell convinc evid benefici effect dhea patient adren insuffici futur research elucid role patient receiv pharmacolog glucocorticoid treatment healthi elder subject current evid randomis control trial justifi dhea major benefici effect report addit potenti advers effect sex steroid depend tumour growth consid copyright num elsevi
MED-4324~egg yolk consumpt carotid plaqu pubm ncbi abstract background increas potenti harm high cholesterol intak specif egg yolk consid insignific assess total plaqu area tpa patient attend canadian vascular prevent clinic determin atherosclerosi burden marker arteri damag relat egg intak provid perspect magnitud effect analys effect smoke pack year method consecut patient attend vascular prevent clinic univers hospit baselin measur tpa duplex ultrasound fill questionnair lifestyl medic includ pack year smoke number egg yolk consum week time number year consum egg yolk year result data num patient sd age num num year num women carotid plaqu area increas linear age age num increas exponenti pack year smoke egg yolk year plaqu area patient consum num egg week num num num mm num versus num num mm num consum num egg week num num adjust age multipl regress egg yolk year remain signific adjust coronari risk factor interpret find suggest regular consumpt egg yolk avoid person risk cardiovascular diseas hypothesi test prospect studi detail inform diet confound exercis waist circumfer copyright num elsevi ireland reserv
MED-4325~kiwifruit improv bowel function patient irrit bowel syndrom constip pubm ncbi abstract irrit bowel syndrom ib common function disord gastrointestin system character abdomin pain diarrhea ibs d constip ibs c altern diarrhea constip ibsc a purpos studi examin impact week kiwifruit intervent bowel function patient diagnos ibs c fifty four patient ibs c num healthi adult particip studi subject particip num week phase studi includ baselin phase num week dietari intervent period num week post intervent phase num week forty on ibs c patient healthi adult consum hayward green actinida deliciosa var kiwifruit day num week thirteen ibs c patient control group placebo capsul day num week colon transit time measur immedi prior intervent period subject complet daili defec record num week intervent week defec frequenc signific increas ibs c group particip consum kiwifruit num colon transit time signific decreas num ibs c group consum kiwi fruit find suggest kiwifruit consumpt num week shorten colon transit time increas defec frequenc improv bowel function adult diagnos ibs c
MED-4327~phosphat restrict diet therapi pubm ncbi abstract hyperphosphatemia hyperparathyroid frequent observ patient endstag renal diseas renal osteodystrophi organ calcif cardiovascular diseas sudden death restrict dietari protein phosphorus benefici slow progress renal failur dietari phosphorus restrict prescrib stage renal failur adult achiev decreas protein intak avoid food rich phosphorus averag num phosphorus intak absorb gut dialysi patient phosphat binder employ phosphorus absorb diet reduc num convent hemodialysi high flux high effici dialyz remov approxim num mmol num mg phosphorus dialysi perform time week num mg phosphorus intak critic posit balanc phosphorus occur correspond protein diet num g day num g kg bodi weight day num kg patient target level num num mg dl calcium num num mg dl phosphorus num mg num dl num calcium phosphorus product num pg ml intact parathyroid hormon
MED-4328~updat human papillomavirus genit wart counsel messag num sexual transmit diseas treatment guidelin pubm ncbi abstract background april num expert sexual transmit diseas stds conven review updat std prevent treatment prepar revis center diseas control prevent cdc std treatment guidelin meet discuss import updat human papillomavirus hpv genit wart cervic cancer screen method key question identifi assist expert panel systemat review literatur conduct search english languag literatur pubm computer databas nation librari medicin evid review inform incorpor num cdc std treatment guidelin result hpv vaccin quadrival hpv vaccin bival hpv vaccin vaccin recommend routin girl age num num year quadrival hpv vaccin boy men age num year patient appli treatment option genit wart sinecatechin num ointment recommend treatment extern genit wart product mixtur activ ingredi catechin green tea final updat counsel guidelin messag hpv genit wart cervic cancer includ conclus manuscript highlight updat num cdc std treatment guidelin hpv genit wart import addit num std treatment guidelin includ inform prophylact hpv vaccin recommend patient appli treatment option genit wart counsel messag patient hpv genit wart cervic cancer screen hpv test
MED-4329~protect effect green tea extract polyphenon egcg human cervic lesion pubm ncbi abstract investig clinic efficaci green tea extract polyphenon poli epigallocatechin num gallat egcg deliv form ointment capsul patient human papilloma virus hpv infect cervic lesion fifty on patient cervic lesion chronic cervic mild dysplasia moder dysplasia sever dysplasia divid group compar num untreat patient control poli ointment appli local num patient week oral deliveri num mg poli egcg capsul oral day num week studi num num patient num poli ointment therapi show respons patient poli ointment poli capsul therapi num show respons patient num poli capsul therapi show respons num patient num egcg capsul therapi show respons num respons rate num note treatment green tea extract compar num respons rate num untreat control num data collect demonstr green tea extract form ointment capsul effect treat cervic lesion suggest green tea extract potenti therapi regimen patient hpv infect cervic lesion
MED-4330~green black tea relat gynecolog cancer abstract scope observ studi evalu relationship green tea intak cancer ovari endometrium awar publish studi green tea intak risk human papillomavirus hpv relat cancer cervix vagina vulva method result critic review publish literatur tea intak risk ovarian endometri cancer conduct meta analys report invers associ green tea intak risk ovarian cancer odd ratio num num confid interv ci num num green tea risk endometri cancer num num ci num num associ black tea ovarian cancer risk num num ci num num posit associ endometri cancer risk num num ci num num summar experiment evid support antivir immunomodulatori activ green tea catechin result random clinic trial demonstr green tea catechin efficaci treatment cervic lesion extern genit wart conclus observ data support protect role green tea risk ovarian endometri cancer observ data evalu green tea reduc risk human papillomavirus rel cancer
MED-4331~black tea signific water mainten normal hydrat human subject result randomis control pubm ncbi abstract belief caffein drink tea advers affect hydrat investig randomis control trial healthi rest male num recruit general popul num abstent caffein alcohol vigor physic activ includ num overnight fast men underw separ test day counter balanc order num washout test beverag provid regular interv num num ml black regular tea num num ml black tea provid num num mg caffein control ident amount boil water tea prepar standardis tea bag includ num ml semi skim milk food num intervent period control subject remain rest beverag offer blood sampl num num num num num urin sampl collect outcom variabl blood cell count na bicarbon total protein urea creatinin osmol blood total volum colour na creatinin osmol urin data twenty on particip includ analysi age num year bmi num num kg m num nineteen men complet condit statist analysi factori anova approach proc mix reveal signific differ tea water blood urin measur conclud black tea amount studi offer similar hydrat properti water
MED-4332~potent antimutagen activ white tea comparison green tea salmonella assay pubm ncbi abstract grow interest potenti health benefit tea includ antimutagen properti varieti white tea repres process form tea shown mark antimutagen activ salmonella assay presenc num activ tea exotica china white tea signific effect premium green tea dragonwel special grade num amino num methylimidazo num f quinolin iq heterocycl amin mutagen num amino num dimethylimidazo num f quinoxalin meiqx num amino num num trimethyl num imidazo num f quinoxalin num dimeiqx num amino num methyl num phenylimidazo num b pyridin phip num amino num methyl num pyrido num b indol trp p num mechan studi perform rat liver num assay methoxyresorufin o demethylas mrod marker enzym cytochrom num activ heterocycl amin salmonella assay direct act mutagen num hydroxyamino num methylimidazo num f quinolin n hydroxy iq white tea low concentr assay inhibit mrod activ attenu mutagen activ n hydroxy iq absenc num major constitu found green tea detect white tea includ high level epigallocatechin num gallat egcg polyphenol major constitu mix produc artifici tea relat level white green tea complet tea exhibit higher antimutagen potenc compar artifici tea result suggest greater inhibitori potenc white versus green tea salmonella assay relat relat level major constitu act synergist minor constitu inhibit mutagen activ scaveng reactiv intermedi
MED-4333~high fat intak lead acut postprandi exposur circul endotoxin type num diabet subject abstract object evalu circul endotoxin high satur fat meal determin effect depend metabol diseas state research design method subject num high fat meal num fat num carbohydr num protein overnight fast nonobes control noc age num num year sd bmi num num kg m num num obes age num num year bmi num num kg m num num impair glucos toler igt age num num year bmi num num kg m num num type num diabet age num num year bmi num num kg m num num blood collect num meal num num analysi result baselin endotoxin signific higher type num diabet igt subject noc subject baselin circul endotoxin level num higher type num diabet subject noc subject num ingest high fat meal led signific rise endotoxin level type num diabet igt obes subject num time period num find show num meal type num diabet subject higher circul endotoxin level num noc subject num conclus studi highlight exposur high fat meal elev circul endotoxin irrespect metabol state earli num meal increas substanti igt type num diabet subject suggest metabol endotoxinemia exacerb high fat intak conclus data suggest compromis metabol state type num diabet continu snack routin cumul promot condit rapid individu greater exposur endotoxin
MED-4335~chocol heart anti inflammatori impact cocoa flavanol pubm ncbi abstract chronic acut inflamm molecular basi atherosclerosi cocoa bas product richest function food base flavanol influenc inflammatori pathway demonstr vitro vivo studi flavanol modifi product pro inflammatori cytokin synthesi eicosanoid activ platelet nitric oxide medi mechan relat pauciti data character vivo implic find albeit studi suggest regular occasion consumpt cocoa rich compound exert benefici effect blood pressur insulin resist vascular damag oxid stress rigor control human studi adequ follow up critic dietari questionnair determin effect flavanol major endpoint cardiovascular health
MED-4336~regular consumpt dark chocol low serum concentr c reactiv protein healthi italian popul pubm ncbi abstract dark chocol high concentr flavonoid antiinflammatori properti evalu associ dark chocol intak serum c reactiv protein crp moli sani project ongo cohort studi men women age num random recruit general popul juli num num subject enrol num subject appar free chronic diseas num subject declar eaten chocol past year age num num num men num subject ate chocol regular form dark chocol num num num men select high sensitivity crp measur immunoturbidimetr method european prospect investig cancer nutrit ffq evalu nutrit intak adjust age sex social status physic activ systol blood pressur bmi waist hip ratio food group total energi intak dark chocol consumpt invers crp num adjust nutrient intak analys show similar result num serum crp concentr geometr num ci univari concentr num num num mg l nonconsum num num num mg l consum num j shape relationship dark chocol consumpt serum crp observ consum num serv num dark chocol num serum crp concentr signific lower nonconsum higher consum find suggest regular consumpt small dose dark chocol reduc inflamm
MED-4337~capac foodstuff induc innat immun activ human monocyt vitro depend food content stimul toll lik pubm ncbi abstract ingest fatti meal transient low grad system inflammatori respons human subject involv activ circul monocyt secret pro inflammatori cytokin clear foodstuff promot inflammatori signal screen forti filter sterilis solubl extract common foodstuff found induc secret tnf il num human monocyt vitro investig differenti inflammatori non inflammatori food extract stimul toll lik receptor tlr num tlr num quantifi human embryon kidney num cell transfect tlr calibr defin bacteri lipopeptid blp lipopolysaccharid lps standard assay reveal food undetect level tlr num tlr num stimul tnf induc food stimul tlr num num ng blp equivalent g tlr num num ng lps equivalent g solubl insolubl fraction tlr stimul present meat product process food minim undetect fresh fruit veget capac food extract induc tnf secret monocyt correl content tlr num num num tlr num stimul num num complet abolish specif inhibit tlr num tlr num lps blp found high resist typic cook time temperatur low ph proteas treatment conclus appar unspoil foodstuff larg quantiti stimul tlr num tlr num regul capac stimul inflammatori signal
MED-4342~anim protein intak risk inflammatori bowel diseas num prospect studi pubm ncbi abstract object diet composit long suspect contribut inflammatori bowel diseas ibd assess assess retrospect studi prone recal bias aim present studi evalu role dietari macronutri etiolog ibd larg prospect cohort method etud pid miologiqu des femm de la mutuell rale de l educ national cohort consist women live franc age num year free major diseas inclus self administ questionnair record dietari habit baselin questionnair diseas occurr lifestyl factor complet num month ibd assess questionnair june num subsequ valid clinic patholog criteria estim associ nutrient food ibd cox proport hazard model adjust energi intak result num particip num person year follow up complet baselin dietari questionnair num year valid num incid ibd case high total protein intak specif anim protein signific increas risk ibd hazard ratio tertil num confid interv num num num trend num num num num trend num total anim protein sourc anim protein high consumpt meat fish egg dairi product ibd risk conclus high protein intak increas risk incid ibd french middle ag women
MED-4345~consumpt polyunsatur fatti acid fish nut risk inflammatori diseas mortal pubm ncbi abstract background num omega num polyunsatur fatti acid pufa fish nut regul inflammatori process respons object investig dietari intak pufa num num omega num linolen acid fish nut num mortal attribut noncardiovascular noncanc inflammatori diseas design analys involv num particip age num baselin dietari data collect semiquantit food frequ questionnair pufa fish nut intak calcul inflammatori diseas mortal confirm australian nation death index result num num subject die inflammatori diseas women highest tertil total num pufa intak compar lowest tertil intak baselin num reduc risk inflammatori diseas mortal trend num associ observ men men women num sd increas energy adjust intak linolen acid invers inflammatori mortal hazard ratio num num ci num num subject tertil nut consumpt num num reduc risk inflammatori diseas mortal compar tertil refer dietari intak long chain num num pufa fish inflammatori diseas mortal conclus report link dietari intak total num pufa risk inflammatori diseas mortal older women data protect role nut fish inflammatori diseas mortal
MED-4346~determin inflammatori marker bi ethn popul abstract background inflamm common pathophysiolog pathway number chronic diseas strong influenc sociodemograph factor lifestyl factor influenc inflammatori respons individu distinct ethnic background studi examin relationship ethnic blood level inflammatori marker sampl non smok church goer method cross sect investig num men women num year num white num black particip biopsy chosoci religion health substudi adventist health studi num contribut socioeconom status educ level difficulti meet expens basic health covari exercis vegetarian type diet bodi mass index presenc inflammatori condit serum level c reactiv protein crp interleukin num il num tumor necrosi factor alpha tnf assess linear regress model level interleukin num il num anti inflammatori marker assess result black show higher level crp il num white control socio demograph health variabl attenu ethnic differ crp il num level remain higher black white num confid interv num num num ethnic differ il num tnf found vegetarian diet lower crp level exercis frequenc higher il num level conclus higher suscept black inflammatori diseas reflect higher il num import assess health dispar black white vegetarian diet exercis counteract effect dispar
MED-4347~legume bas hypocalor diet reduc proinflammatori status improv metabol featur overweight obes subject pubm ncbi abstract background nutrit composit dietari intak produc specif effect metabol variabl inflammatori marker concentr studi assess effect hypocalor diet legume restrict legume bas diet metabol inflammatori accompani weight loss method thirti obes subject num num bmi num num kg m num num year random assign hypocalor treatment num week calorie restrict legume fre diet control c diet calorie restrict legume bas diet l diet prescrib num week cooked serv num lentil chickpea pea bean bodi composit blood pressur bp blood biochem inflammatori marker concentr dietari intak measur baselin nutrit intervent result l diet achiev greater bodi weight loss compar c diet num num num num num total ldl cholesterol level systol bp improv consum l diet num l diet result signific higher reduct c reactiv protein crp complement num num concentr num compar baselin c diet valu interest reduct concentr crp num remain signific higher l diet group adjust weight loss num addit reduct crp concentr posit decreas systol bp total cholesterol concentr specif l diet group independ weight loss num conclus consumpt legum num servings week hypocalor diet result specif reduct proinflammatori marker crp num clinic signific improv metabol featur lipid profil bp overweight obes subject case independ weight loss
MED-4349~anti inflammatori effect plant bas food constitu pubm ncbi abstract inflamm patholog condit number diseas includ cardiovascular diseas cancer chronic inflammatori diseas addit healthi obes subject express marker inflamm blood diet varieti nutrient non nutrit bioactiv constitu modul immunomodulatori inflammatori process epidemiolog data suggest dietari pattern strong affect inflammatori process primarili intak fruit veget wheat invers risk inflamm addit observ studi data human intervent studi suggest anti inflammatori potenti plant food level bioactiv compound occur plant food primarili carotenoid flavonoid modul inflammatori immunolog process conclus convinc evid plant food non nutrit constitu food modul immunolog inflammatori process anti inflammatori activ plant bas diet contribut lower risk cardiovascular diseas cancer high intak veget fruit wheat recommend intern nutrit author wide spectrum bioactiv compound health promot concentr
MED-4350~high antioxid potato acut vivo antioxid sourc hypotens agent human supplement hypertens subject pubm ncbi abstract potato highest daili capita consumpt veget diet pigment potato high concentr antioxid includ phenol acid anthocyanin carotenoid single dos studi microwav potato skin compar amount refin starch cook biscuit normal fast subject repeat sampl blood num period plasma antioxid capac measur ferric reduc antioxid power frap num urin regimen urin antioxid capac due polyphenol measur folin reagent correct nonphenol interfer solid phase polyclar procedur potato caus increas plasma urin antioxid capac refin potato starch caus decreas act pro oxid crossov studi num hypertens subject averag bmi num small microwav purpl potato daili potato num week regimen num week signific effect potato fast plasma glucos lipid hba num signific bodi weight increas diastol blood pressur signific decreas num num mm reduct systol blood pressur decreas num num mm reduct blood pressur drop occur fact num num subject antihypertens drug studi investig effect potato blood pressur purpl potato effect hypotens agent lower risk heart diseas stroke hypertens subject weight gain
MED-4351~human innat immunosenesc consequ immun age abstract past decad explos research focus innat immun wide rang mechan includ phagocytosi intracellular kill activ pro inflammatori antivir cytokin product pattern recognit receptor cell innat immun system initi support adapt immun effect age innat immun respons remain incomplet understood human review advanc studi human immunosenesc divers cell innat immun system includ neutrophil monocyt macrophag nk nkt cell dendrit cell focus consequ respons infect vaccin age
MED-4352~effect dietari protein composit metabol plasma lipoprotein rabbit pubm ncbi abstract concentr composit serum vldl ldl hdl studi rabbit transfer chow diet cholesterol fre semipurifi diet casein isol soy protein week casein diet mark increas ldl cholesterol higher level maintain subsequ num week studi similar mark obtain soy protein diet percent composit particl determin vldl ldl higher proport cholesterol turnov studi fcrs radiolabel vldl ldl reduc casein f anim compar fed soy protein elev ldl level casein f rabbit primarili due reduct receptor medi catabol ldl apo receptor independ remov group similar studi show hypercholesterolemia casein f rabbit compar fed soy protein cholesterol enrich ldl impair receptor depend remov ldl apo
MED-4353~effect dietari protein plasma lipoprotein level normal subject interact dietari cholesterol pubm ncbi abstract compar effect dietari soy protein casein diet low cholesterol num mg d diet enrich cholesterol num mg d examin level cholesterol intak affect respons plasma lipoprotein dietari protein plant anim origin normal men women consum formula diet num calori soy protein casein num fat num carbohydr num crossov studi dietari period num day separ month long interim period self chosen food initi reduct plasma total cholesterol low dens lipoprotein cholesterol ldl c level diet plasma lipid lipoprotein concentr stabil low cholesterol diet concentr major lipoprotein class similar soy casein dietari period cholesterol enrich diet concentr ldl c stabil num lower level soy protein casein diet num concentr high dens lipoprotein cholesterol hdl c num higher num differ ldl c num hdl c num level casein soy protein diet signific greater high low cholesterol intak find level dietari cholesterol determin plant anim dietari protein similar effect plasma ldl c hdl c concentr
MED-4354~scientif technic factor affect set salmonella criteria raw poultri global perspect pubm ncbi abstract concern foodborn salmonellosi led countri introduc microbiolog criteria food product criteria well ground scienc unjustifi obstacl trade raw poultri product import part global food market import export ambigu regulatori confus result salmonella requir impetus conven intern group scientif expert num countri discuss scientif technic issu affect set microbiolog criterion salmonella contamin raw chicken concern group criteria impli toler salmonella suggest complet absenc pathogen notion interpret differ stakehold consid inappropri effect elimin salmonella raw poultri practic method verifi absenc present set food safeti metric involv reduct hazard level term toler absenc microb relat raw poultri avoid defin explain intern agreement risk assess meaning approach toler philosophi metric perform object link human health outcom util food chain defin risk identifi reduc advers effect public health
MED-4355~public knowledg belief diarrheal diseas pubm ncbi abstract sixti percent popul experi acut diarrheal ill year understood public knowledg belief treatment diseas perform telephon survey num tennesse resid knowledg practic diarrheal ill bloodi stool dehydr persist symptom common reason respond seek medic care acut diarrheal diseas self limit overus antimicrobi treatment common peopl believ stool cultur num antibiot num routin diarrhea num respond believ food common sourc diarrhea three fourth believ normal uncook meat bacteria num believ legal sell product result implic medic provid regul public health manag prevent diarrheal diseas
MED-4356~delusion parasitosi neurolog patient pubm ncbi abstract object delusion parasitosi wide rang patient general medic condit report frequenc pathogen mechan neurolog patient paper describ delusion syndrom sampl neurolog patient method review clinic chart hospit patient neuropsychiatri ward neurolog center januari num june num case delusion parasitosi term demograph clinic brain imag featur result total sampl num patient identifi num patient neurolog diseas num patient show delusion parasitosi num neurolog sampl diagnos brain cysticercosi num cerebrovascular diseas num dementia due vitamin num deficit num women late life depress featur signific cognit declin paraesthesia pruritus relat peripher neuropathi pruritus unknown origin possibl hallucinatori conclus delusion parasitosi infrequ sampl hospit neurolog patient femal sex advanc age depress featur cognit declin pruritus paraesthesia peripher central origin contribut delusion parasitosi popul copyright num elsevi reserv
MED-4357~effect extract housefli pupa peptid mixtur chill pork preserv pubm ncbi abstract peptid mixtur housefli pupa broad spectrum antimicrobi activ previous report food preserv studi preserv effect housefli pupa peptid mixtur nisin sodium dehydroacet dha number mesophil aerob bacteria mab total volatil basic nitrogen tvb n ph chill pork compar result show good preserv effect observ num treatment peptid mixtur housefli pupa nisin dha signific differ result housefli peptid mixtur great potenti food preserv result scan electron microscop transmiss electron microscopi suggest primari mechan housefli pupa peptid mixtur bacteri cytoplasm membran lysi pore induc membran practic applic peptid mixtur extract housefli pupa low cost simpl method broad spectrum antimicrobi activ effect chill pork preserv extract housefli peptid mixtur great potenti food preserv
MED-4358~bacteriophag biocontrol anim meat product summari discoveri centuri ago bacteri virus bacteriophag phage prevent treat multitud bacteri infect phage therapi pt addit basi advanc genet biochemistri phage therapi perform human subject unit state europ asia decad discoveri western countri larg abandon pt favour antibiot num recent renaiss pt west attribut part increas preval antibiot resist human anim pathogen stringent control human trial requir unit state europ led greater number domest anim agricultur applic altern pt man trend set continu short term recent approv food drug administr commerci phage treatment human food usa signific mileston grow number success pt trial signific obstacl remain widespread anim food ultim medicin part world review provid overview histori pt west summar key find phage biocontrol studi anim meat product
MED-4359~pictori essay complic swallow fish bone abstract unintent ingest fishbon fb common popul high consumpt seafood instanc ingest fb pass unev gastrointestin gi tract week case fb impact lead complic awar complic import patient present nonspecif symptom unawar ingest fb
MED-4360~ciguatera sexual transmit diseas pubm ncbi abstract ciguatera type food poison consumpt contamin marin fish report case pain ejacul affect male dyspareunia unaffect femal partner ejacul suggest sexual transfer respons agent ciguatoxin ctx immunoassay semen sampl ctx diagnost sensit time test employ preclud detect small quantiti toxin conclud ctx present semen men affect ciguatera toxic capabl produc symptomatolog male femal sexual intercours
MED-4361~dirti money investig hygien status world currenc obtain food outlet pubm ncbi abstract total num banknot obtain food outlet num countri australia burkina faso china ireland netherland zealand nigeria mexico unit kingdom unit state bacteri content enumer presenc bacteria banknot found influenc materi note strong correl number bacteria squar centimet seri indic econom prosper countri strongest correl found index econom freedom indic lower index higher typic bacteri content banknot circul factor influenc number bacteria banknot age banknot materi produc note polymer bas cotton bas banknot screen presenc rang pathogen found pathogen isol enrich mere presenc alarm light intern find recommend current guidelin appli countri regard concurr hygien handl food money univers adopt includ instanc handl food money physic separ employ separ individu carri task instanc advantag handl food glove hand money hand precaut effect implement high recommend food servic personnel practic proper hand wash procedur handl money handl food
MED-4363~barnyard food tabl omnipres hepat virus risk zoonot infect food safeti abstract hepat virus hev import extrem understudi pathogen mechan hev replic pathogenesi poor understood vaccin hev hev classifi famili hepevirida consist recogn major genotyp genotyp num num hev restrict human epidem develop countri genotyp num num hev zoonot respons sporad case worldwid identif character number anim strain hev pig chicken rabbit rat mongoos deer possibl cattl sheep signific broaden host rang divers hev demonstr abil cross speci infect anim strain hev rais public health concern zoonot hev infect pig recogn reservoir hev pig handler increas risk zoonot hev infect sporad case hepat definit link consumpt raw undercook anim meat pig liver sausag deer meat addit larg amount virus excret fece anim manur land applic runoff contamin irrig drink water concomit contamin produc shellfish hev rna swine origin detect swine manur sewag water oyster consumpt contamin shellfish implic sporad case hepat anim strain hev pose zoonot risk food environment safeti concern
MED-4364~occup transmiss hepat virus result supermarket meat slicer pubm ncbi abstract trace risk factor acquir hepat virus hcv hcv infect patient identifi risk work butcher counter supermarket hcv infect patient common ham cut machin frequent bleed hand injuri phylogenet analysi show high percentag nucleotid homolog patient strain num european societi clinic microbiolog infecti diseas claim origin govern work
MED-4365~advers effect concentr green tea extract pubm ncbi abstract myriad health claim made favor consumpt green tea due easi avail greater popular high concentr green tea extract combin attitud more is bett health risk green tea consumpt begun emerg risk possibl liver damag potenti interact prescript drug alter therapeut efficaci chanc harm combin high popular herbal remedi review summar document exampl advers effect green tea human discuss risk copious consumpt high concentr green tea extract studi anim intent minim scientif establish benefit green tea purpos review focus primarili potenti advers effect rais awar rare under appreci risk copyright num wiley vch verlag gmbh kgaa weinheim
MED-4366~market dietari supplement north america emperor nake pubm ncbi abstract background dietari supplement sold north america qualiti evid support efficaci cover wide spectrum base solid scienc vitamin fish oil supplement support evid type supplement common sold includ exot fruit juic goji juic singl herb mixtur herb common claim made support supplement rich antioxid induc detoxif stimul immun system weight loss supplement common sold health food store multilevel market sale promot bulk mail junk mail spam e mail web site larg part market base claim blatant dishonest conclus supplement good support evid exist general cost num num month heavili promot support evid cost num num month major problem unit state weak law urgent stricter regul give advic general public
MED-4369~intervent nausea vomit earli pregnanc abstract background nausea retch vomit common experienc women earli pregnanc physic psycholog effect women experi symptom updat review intervent nausea vomit earli pregnanc previous publish num object assess effect safeti intervent nausea vomit retch earli pregnanc num week gestat search method search cochran pregnanc childbirth group trial regist num num select criteria randomis control trial intervent nausea vomit retch earli pregnanc exclud trial intervent hyperemesi gravidarum cover review exclud quasi randomis trial trial crossov design data collect analysi review author pair review elig trial independ evalu risk bias extract data includ trial main result twenty seven trial num women met inclus criteria trial cover intervent includ acupressur acustimul acupunctur ginger vitamin num antiemet drug identifi studi dietari lifestyl intervent evid effect num acupressur auricular ear acupressur acustimul num point limit acupunctur num tradit show signific benefit women pregnanc ginger product women evid effect limit consist limit evid trial support pharmacolog agent includ vitamin num anti emet drug reliev mild moder nausea vomit inform matern fetal advers outcom psycholog social econom outcom unabl pool find studi outcom due heterogen studi particip intervent comparison group outcom measur report methodolog qualiti includ studi mix author conclus high preval nausea vomit earli pregnanc health profession provid clear guidanc women base systemat review evid lack high qual evid support advic difficulti interpret result studi includ review highlight specif consist justifi outcom approach measur research studi
MED-4370~health food store recommend nausea migrain pregnanc pubm ncbi abstract background pregnant women dietari supplement pregnanc scant inform safeti product consum dietari supplement reli employe health food store provid recommend object evalu recommend made health food store employe phoenix metropolitan area treatment nausea vomit migrain pregnanc method phone call made disguis shopper num health food store greater phoenix area caller pose woman num week pregnant recommend treatment nausea vomit migrain respons recommend record compar current scientif evid obtain search literatur medlin num septemb num supplement method pregnanc contraind result eighty nin percent store offer recommend nausea vomit num provid recommend migrain ginger recommend therapi nausea vomit num respond recommend correct usag fail suppli correct dosag durat total num num recommend nausea vomit migrain product contraind pregnanc conclus light increas dietari supplement women pregnanc personnel health food store make recommend foster concern patient healthcar provid alik dietari supplement contraind pregnanc signific harm mother and or fetus studi address stringent guidelin health food store recommend
MED-4371~emerg issu hiv patient seek advic health food store pubm ncbi abstract object ascertain recommend train educ health food store employe determin communic cost benefit risk natur health product hiv aid communiti method male research assist pose asymptomat hiv posit individu inquir employe retail health food store major canadian citi recommend condit research assist product cost side effect potenti drug interact efficaci inquir employe educ relat complementari altern medicin cam note employe convent medic recommend subject seek physician cam provid advic result total num store includ store employe num offer advic num inquir subject medic num suggest visit physician num suggest visit cam provid total num product num employe recommend variabl product evid cost educ employe vari postgradu educ num undergradu degre num colleg level num cam formal educ cam num conclus heterogen advic natur food product provid employe natur food store general individu limit formal train cam product recommend limit evid support efficaci instanc potenti harm cost find studi support examin regul grow compon health care system
MED-4372~health inform provid retail health food outlet pubm ncbi abstract altern health practic increas popular recent year patient visit specif complementari practition attempt educ trust advic employe local health food store internet thirty two retail health food store survey natur inform provid staff research assist visit store present mother child crohn diseas diagnos seventy two cent num num store employe offer advic nutrit herbal supplement num store recommend made num base recommend sourc inform fourteen num store inform sourc refer book signific impact recommend nutrit supplement favour conclus retail health food store inconsist hypothes varianc type supplement recommend chronic diseas
MED-4373~danger nutrit calcium vitamin shark cartilag nutrit supplement cancer rel hypercalcemia pubm ncbi abstract nutrit supplement general popul cancer patient popular supplement perceiv medic presum safe cancer patient risk hypercalcemia note patient develop symptomat hypercalcemia vitamin calcium shark cartilag supplement report case hypercalcemia cancer patient cleveland clinic foundat nutrit supplement contribut preval sever hypercalcemia
MED-4374~health food store recommend breast cancer patient pubm ncbi abstract context cancer patient widespread grow complementari altern medicin minim attent paid role health food store suppli side phenomenon object gain understand health food store personnel recommend breast cancer patient care design research pose daughter breast cancer patient survey health food store personnel product recommend cancer care set oahu hawaii summer num particip health food store num offer product cancer patient main outcom measur recommend product servic propos mechan action cost result store personnel readili provid inform product recommend shark cartilag frequent suggest mechan action drew tradit heal scientif pseudoscientif rational cost recommend dosag vari multifold store brand conclus retail suppli supplement play import role network author patient breast cancer readili provid advic recommend product reason patient seek health food store remedi develop approach patient educ physician provid key posit assist cancer patient make inform choic health store product
MED-4375~evalu mercuri concentr brand tuna pubm ncbi abstract widespread concern presenc hg fish consum human studi focus determin hg concentr sport fish commerci fish attent direct tuna wide held concentr low present studi amount hg present tuna purchas las vega nevada usa examin brand tempor variat type packag medium impact hg concentr tuna explor signific num brand differ note brand num higher hg concentr bar standard deviat sd num num ppm brand num num num ppm num num num ppm chunk white tuna num num ppm solid white tuna num num ppm signific num higher hg chunk light tuna num num ppm signific tempor variat note packag signific effect hg concentr total num tuna examin environment protect agency epa safeti level human consumpt num ppm num tuna exceed action level establish food drug administr fda num ppm result stricter regul tuna industri ensur safeti sensit popul pregnant women infant children epa refer dose num microg kg bodi weight day hg num ppm num kg child consum meal num chunk white tuna num continu monitor industri effort reduc hg concentr tuna recommend environ copyright num setac
MED-4376~hair mercuri level women reproduct age ontario canada implic fetal safeti fish consumpt pubm ncbi abstract object studi hair mercuri concentr women reproduct age relat fish intak ontario canada studi design group studi num women call motherisk program inform reproduct safeti consum fish pregnanc group japanes resid toronto num consum larger amount fish group canadian women reproduct age num seek advic studi mercuri concentr hair sampl measur induct coupl plasma mass spectrometri seafood consumpt habit record particip base type fish consum consumpt frequenc estim month intak mercuri calcul hair mercuri concentr correl number month seafood serv estim ingest mercuri dose result signific correl fish serv hair mercuri spearman num num amount consum mercuri hair mercuri concentr spearman num num motherisk caller japanes women num canadian women reproduct age hair mercuri num microg g shown recent lowest observ advers effect level larg systemat review perinat studi conclus wide variabl general recommend safe number fish serv suffici protect fetus analysi hair mercuri warrant pregnanc select group women consum num ounc fish week dietari modif decreas bodi burden ensur fetal safeti copyright num publish mosbi
MED-4377~dietari factor incid atrial fibril framingham heart studi abstract background conflict report associ dietari factor incid atrial fibril af object evalu associ consumpt alcohol caffein fiber polyunsatur fatti acid pufa incid af framingham heart studi design particip af num examin age num num women origin offspr cohort complet food frequ questionnair prospect num examin associ dietari exposur af cox proport hazard regress result total num individu develop af num men num women multivari analys signific associ examin dietari exposur af risk hazard ratio hrs increas quartil dietari factor alcohol num num ci num num num num ci num num num num ci num num trend num caffein num num ci num num num num ci num num num num ci num num trend num total fiber num num ci num num num num ci num num num num ci num num trend num num omega num pufa num num ci num num num num ci num num num num ci num num trend num quartil num refer group exploratori analys consumpt num serv dark fish wk num case num individu risk signific af risk compar consumpt num serv dark fish wk hr num num ci num num num conclus consumpt alcohol caffein fiber fish deriv pufa signific af risk observ advers associ consumpt dark fish af merit investig find suggest dietari exposur examin convey limit attribut risk af general popul
MED-4378~dietari intak num num fatti acid risk clinic depress women num prospect follow up studi abstract background associ sourc dietari num omega num num omega num fatti acid risk depress prospect studi object object examin relat num num type clinic depress incid design prospect studi num women nurs health studi num num age free depress symptom baselin inform diet obtain valid food frequ questionnair clinic depress defin report physician diagnos depress regular antidepress medic result num follow up num num incid case depress document intak long chain num fatti acid fish depress risk relat risk rr num g d increment num num ci num num linolen acid ala intak invers depress risk multivari rr num g d increment num num ci num num invers associ ala depress stronger women low linol acid la intak interact num num g d increment ala invers depress la quintil rr num ci num num num num num num num num num fourth quintil conclus result larg longitudin studi support protect effect long chain num fish depress risk data support hypothesi higher ala lower la intak reduc depress risk relat warrant investig
MED-4379~occurr pharmaceut person care product fish result nation pilot studi unit state pubm ncbi abstract pharmaceut person care product increas report varieti biolog matric includ fish tissu screen studi present encompass broad geograph area nation pilot studi initi unit state assess accumul pharmaceut person care product fish sampl effluent domin river receiv direct discharg wastewat treatment facil chicago illinoi dalla texa orlando florida phoenix arizona west chester pennsylvania usa fish collect gila river mexico usa refer condit expect minim impact anthropogen influenc high perform liquid chromatography tandem mass spectrometri analysi pharmaceut reveal presenc norfluoxetin sertralin diphenhydramin diltiazem carbamazepin nanogram per gram concentr fillet composit effluent domin sampl locat addit presenc fluoxetin gemfibrozil confirm liver tissu sertralin detect concentr high num num ng g fillet liver tissu gas chromatography tandem mass spectrometri analysi person care product fillet composit reveal presenc galaxolid tonalid maximum concentr num num ng g trace level triclosan general pharmaceut detect higher concentr greater frequenc liver fillet tissu higher lipid content liver tissu account discrep signific posit correl found accumul pharmaceut concentr lipid content tissu type sampl site contrast accumul person care product galaxolid tonalid signific relat lipid content result suggest detect pharmaceut person care product depend degre wastewat treatment employ
MED-4380~domoic acid human exposur risk review pubm ncbi abstract domoic acid potent neurotoxin natur produc diatom speci genus pseudo nitzschia toxin act glutam agonist excitotox vertebr central nervous system glutam receptor rich organ human exposur domoic acid occur consumpt contamin shellfish accumul toxin filter feed toxigen phytoplankton bloom report human domoic acid poison event occur canada num clinic sign acut toxic gastrointestin distress confus disorient memori loss coma death observ ill amnes shellfish poison asp due effect seafood monitor program document asp case num domoic acid poison signific effect marin wildlif multipl poison event occur marin bird mammal decad domoic acid produc diatom bloom thought increas frequenc world wide pose increas threat wildlif human health concern potenti impact long term low level exposur risk human popul impact repetit low level domoic acid exposur unknown review basic descript mechan action domoic acid synthesi inform pertain domoic acid exposur rout toxin suscept import effect monitor program import investig potenti human health impact long term low level domoic acid exposur risk human popul discuss publish elsevi
MED-4381~amnes shellfish poison pubm ncbi abstract amnes shellfish poison asp caus consumpt shellfish accumul domoic acid neurotoxin produc strain phytoplankton neurotox properti domoic acid result neuron degener necrosi specif region hippocampus outbreak asp occur canada num involv num report case num hospitalis num death consumpt contamin mussel symptom rang gastrointestin disturb neurotox effect hallucin memori loss coma monitor programm place numer countri worldwid closur shellfish harvest area occur domoic acid concentr exceed regulatori limit paper review chemistri sourc metabol toxicolog domoic acid human case report asp discuss mechan toxic
MED-4382~diet vegetarian cataract risk pubm ncbi abstract background age rel cataract major morbid previous studi diet cataract risk focus specif nutrient healthi eat index identifi dietari group vegetarian object investig associ diet cataract risk popul wide rang diet includ high proport vegetarian design cox proport hazard regress studi cataract risk relat baselin dietari lifestyl characterist num self report nondiabet particip age num recruit oxford unit kingdom arm european prospect investig cancer nutrit epic oxford data hospit episod statist england scottish morbid record result strong relat cataract risk diet group progress decreas risk cataract high meat eater low meat eater fish eater particip ate fish meat vegetarian vegan multivari adjust incid rate ratio num cis moder meat eater num meat d low meat eater num meat d fish eater vegetarian vegan compar high meat eater num meat d num num num num num num num num num num num num num num num num heterogen associ cataract risk intak select nutrient food general reflect strong associ diet group conclus vegetarian lower risk cataract meat eater cohort health consci british resid
MED-4383~plasma carotenoid retinol tocopherol level risk ovarian cancer pubm ncbi abstract object investig relat plasma carotenoid retinol tocopherol level ovarian cancer risk korean women design hospital bas case control studi set tertiari medic institut korea popul forty f epitheli ovarian cancer num age match control method preoper plasma concentr beta caroten lycopen zeaxanthin lutein retinol alpha tocopherol gamma tocopherol measur reverse phas gradient high pressur liquid chromatographi main outcom measur odd ratio num confid interv num ci estim tertil evalu effect micronutri endometri cancer risk adjust bodi mass bmi index menopaus pariti oral contracept smoke status alcohol consumpt status result women highest tertil beta caroten num time risk ovarian cancer lowest tertil num num ci num num women highest tertil lycopen num num ci num num zeaxanthin lutein num num ci num num retinol num num ci num num alpha tocopherol num num ci num num gamma tocopherol num num ci num num lower risk ovarian cancer women lowest tertil result consist strata socio epidemiolog factor conclus micronutri specif ss caroten lycopen zeaxanthin lutein retinol alpha tocopherol gamma tocopherol play role reduc risk ovarian cancer
MED-4384~glaucoma risk consumpt fruit veget older women studi osteoporot fractur pubm ncbi abstract purpos explor associ consumpt fruit veget presenc glaucoma design cross sect cohort studi method sampl num women locat multipl center unit state glaucoma specialist diagnos glaucoma eye assess optic nerv head photograph num point suprathreshold screen visual field consumpt fruit veget assess block food frequenc questionnair relationship select fruit veget consumpt glaucoma investig adjust logist regress model result num women num num diagnos glaucoma adjust analysi odd glaucoma risk decreas num odd ratio num num confid interv ci num num women consum serv month green collard kale compar consum fewer serv month num num num ci num num women consum serv week carrot compar consum fewer serv week num num num ci num num women consum serv week dri peach compar consum fewer serv month conclus higher intak fruit veget decreas risk glaucoma studi investig relationship
MED-4385~influenc dietari lutein zeaxanthin visual perform pubm ncbi abstract idea normal constitu diet influenc visual function earli num buzzi identifi yellow macula schulz num specif postul yellow pigment led improv human vision pigment found deriv dietari lutein zeaxanthin oxygen carotenoid xanthophyl wall judd num postul yellow intraocular pigment improv visual perform absorb light scatter glare eye increas visual rang absorb blue light scatter atmospher improv spatial vision enhanc contrast reduc chromat blur articl evid idea review emphasi recent data glare effect
MED-4388~diet qualiti age rel macular degener abstract object examin diet qualiti relat advanc age rel macular degener amd method case control studi identifi num advanc amd patient num unrel control stereoscop color fundus photograph particip predomin non hispan white men women north carolina tennesse num item block food frequenc questionnair gather diet inform diet qualiti measur healthi eat index hei altern healthi eat index ahei result particip highest quartil diet qualiti signific reduc odd amd ahei score num num confid interv num num non signific reduc odd amd hei num num num odd amd num lower highest quartil fish intak compar lowest quartil odd ratio num num num conclus found advanc amd signific relat diet qualiti ahei score instrument assess amd risk due diet potenti improv incorpor specif inform micronutri intak
MED-4389~vegetarian vegan diet treat type num diabet pubm ncbi abstract signific benefit diabet prevent manag observ vegetarian vegan diet articl review observ studi intervent trial diet discuss efficaci nutrit adequaci accept sustain research date demonstr low fat plant bas nutrit approach improv control weight glycemia cardiovascular risk studi shown care plan vegan diet nutriti diet base convent diet guidelin accept compar therapeut regimen current intervent guidelin profession organ offer support approach vegetarian vegan diet present potenti advantag manag type num diabet merit attent individu diabet caregiv
MED-4390~influenc piperin pharmacokinet curcumin anim human volunt pubm ncbi abstract medicin properti curcumin obtain curcuma longa utilis poor bioavail due rapid metabol liver intestin wall studi effect combin piperin inhibitor hepat intestin glucuronid evalu bioavail curcumin rat healthi human volunt curcumin dose num g kg rat moder serum concentr achiev period num concomit administr piperin num mg kg increas serum concentr curcumin short period num post drug time maximum signific increas num elimin half life clearanc signific decreas num bioavail increas num hand human dose num curcumin serum level undetect low concomit administr piperin num mg produc higher concentr num num post drug num num num num num increas bioavail num studi show dosag piperin enhanc serum concentr extent absorpt bioavail curcumin rat human advers effect
MED-4391~lifestyl relat cancer chemoprevent phytonutri pubm ncbi abstract cancer lead death worldwid lot cancer caus agent divid physic carcinogen chemic carcinogen biolog carcinogen carcinogen cancer relat lifestyl diet habit occup radiat infect chemoprevent high prevent cancer relat preterm death avoid cancer concentr diet numer phytochem deriv edibl plant report interfer specif stage carcinogen process mechan shown account anticarcinogen action dietari constitu recent attent focus intracellular signal cascad common molecular target chemoprevent phytochem studi describ lifestyl relat cancer molecular basi cancer prevent phytochem
MED-4392~citrus limonoid analysi bioactiv biomed prospect pubm ncbi abstract limonoid promin group secondari metabolit citrus fruit bitter charact compound group histor compromis qualiti citrus fruit juic detect bitter limonoid citrus understand origin develop method remov citrus juic provid basi citrus limonoid research evalu biolog activ citrus limonoid potenti compound improv human health anticanc cholesterol low antivir agent review chronicl evolut citrus limonoid research defin particip citrus bitter potenti util import contributor improv human health well b
MED-4393~phytonutri intak adult unit state relat fruit veget consumpt pubm ncbi abstract background individu consum diet dens fruit veget consum array phytonutri recogn nutrit compon includ vitamin miner fiber grow bodi evid phytonutri play posit role health object purpos research estim usual intak individu phytonutri american consum recommend level fruit veget compar intak adult meet recommend identifi contribut food sourc total phytonutri intak phytonutri examin studi found predomin fruit veget design food consumpt data nation health nutrit examin survey num phytonutri concentr data depart agricultur databas publish literatur estim energy adjust usual intak student test compar energy adjust phytonutri intak subpopul consum recommend amount fruit veget percentag contribut phytonutri food sourc estim adult result energy adjust intak phytonutri ellag acid higher men women meet dietari recommend fruit veget intak compar meet recommend energy adjust intak ellag acid higher women meet meet recommend phytonutri caroten cryptoxanthin lycopen hesperetin ellag acid singl food account num total intak phytonutri conclus energy adjust intak carotenoid flavonoid higher men women diet conform dietari guidanc fruit veget limit number food provid major phytonutri find research provid import refer inform phytonutri contribut diet rich fruit veget
MED-4394~evid acne promot effect milk insulinotrop dairi product pubm ncbi abstract acn vulgari common skin diseas western civil evolv epidem affect num adolesc acn regard indic diseas exagger insulinotrop western nutrit milk whey protein bas product contribut elev postprandi insulin basal insulin lik growth factor i igf i plasma level evolut principl mammalian milk promot growth support anabol condit neonat nurs period whey protein potent induc glucose depend insulinotrop polypeptid secret enteroendocrin cell concert hydrolyz whey protein deriv essenti amino acid stimul insulin secret pancreat cell increas insulin igf i signal activ phosphoinositid num kinase akt pathway reduc nuclear content transcript factor foxo num key nutrigenom regul acn target gene nuclear foxo num defici link major factor acn pathogenesi androgen receptor transactiv comedogenesi increas sebac lipogenesi follicular inflamm elimin whey protein bas insulinotrop mechan milk import futur challeng nutrit research restrict milk consumpt generat insulinotrop milk enorm impact prevent epidem western diseas obes diabet mellitus cancer neurodegen diseas acn copyright num karger ag basel
MED-4396~milk consumpt acn adolesc girl pubm ncbi abstract remark pauciti evid associ diet acn previous studi suggest associ milk intak teenag acn prospect cohort studi evalu relationship studi num girl age num year num report dietari intak food frequenc questionnair num num presenc sever acn assess questionnair num comput multivari preval ratio pr num percent confid interv acn account age baselin height energi intak multivari prs num ci p valu test trend acn compar highest num serv day lowest num week intak categori num num num num num total milk num num num num milk num num num num low fat milk num num num num skim milk result chang appreci exclud girl report contracept restrict analysi younger num year age baselin found posit associ intak milk acn find support earlier studi suggest metabol effect milk suffici elicit biolog respons consum
MED-4398~high school dietari dairi intak teenag acn pubm ncbi abstract background previous studi suggest associ western diet acn examin data nurs health studi ii retrospect evalu intak dairi food high school physician diagnos sever teenag acn method studi num women complet questionnair high school diet num physician diagnos sever teenag acn num estim preval ratio num confid interv acn histori categori intak result account age age menarch bodi mass index energi intak multivari preval ratio num confid interv test trend acn compar extrem categori intak num num num num total milk num num num num milk num num num num low fat milk num num num num skim milk instant breakfast drink sherbet cottag chees cream chees posit acn conclus found posit associ acn intak total milk skim milk hypothes associ milk presenc hormon bioactiv molecul milk
MED-4399~beta casomorphin num infant type feed level psychomotor develop pubm ncbi abstract casomorphin import year life postnat format activ milk main sourc nutrit biolog activ materi infant studi conduct total num infant num fed breast milk num fed formula cow milk studi substanc immunoreact human irhcm bovin irbcm beta casomorphin num blood plasma natur artifici fed infant irhcm irbcm detect morn feed basal level num feed elev irhcm irbcm level feed detect infant num month life chromatograph character materi irbcm demonstr molecular mass polar synthet bovin beta casomorphin num highest basal irhcm observ breast f infant normal psychomotor develop muscl tone contrast elev basal irbcm found formula f infant show delay psychomotor develop heighten muscl tone formula f infant normal develop rate paramet direct correl basal irbcm data breast feed advantag artifici feed infant develop year life support hypothesi deterior bovin casomorphin elimin risk factor delay psychomotor develop diseas autism
MED-4400~influenc opioid receptor agonist antagonist peptid peripher blood mononuclear cell pbmcs pubm ncbi abstract milk main sourc biologically act peptid function regulatori substanc call food hormon pass gut blood barrier opioid receptor agonist antagonist peptid factor influenc function human organ aim conduct research determin influenc opioid receptor agonist peptid human bovin casomorphin num h bbcm num antagonist peptid casoxin num cxn num prolifer cytokin secret human peripher blood mononuclear cell pbmcs pbmcs prolifer measur brdu test assess dna synthesi activ wst num test assess activ mitochondri dehydrogenas enzym influenc investig peptid secret il num il num il num ifn determin elisa test incub cell peptid caus enzymat activ prove wst num test brdu test observ prolifer pbmcs correl amount bromodeoxyuridin incorpor cellular dna secret il num il num cell influenc agonist detect secret ifn gamma influenc examin substanc obtain result provid inform immunomodulatori effect food deriv opioid peptid clinic signific case allerg diseas newborn copyright num elsevi reserv
MED-4402~relat beta casomorphin apnea sudden infant death syndrom pubm ncbi abstract sudden infant death syndrom sid common death infant pathogenesi complex multifactori aim review summar recent find associ beta casomorphin beta cm apnea sid wide appreci pediatrician scientist beta cm exogen bioactiv peptid deriv casein major protein milk milk product opioid activ mechanist circul peptid infant immatur central nervous system inhibit respiratori center brainstem lead apnea death paper review relationship beta cm sid context passag beta cm gastrointestin tract blood brain barrier bbb permeabl bbb peptid infant character casomorphin system brain
MED-4403~identif chees mite speci inocul mimolett milbenkas chees cryogen scan electron microscopi pubm ncbi abstract sampl mimolett franc milbenkas germani chees tradit ripen mite analyz determin mite speci present sampl scientif literatur review understand mite speci common infest chees morpholog featur possess mite studi understand uniqu characterist requir ensur accur identif identif compil detail key store food mite subclass acari order astigmata delin featur mite view cryogen scan electron microscop determin mimolett chees inocul acarus siro featur studi identifi mite speci includ idiosom length shape seta length arrang leg size placement anus genit solenidia shape milbenkas chees inocul tyrolichus casei oudeman evid view featur identifi siro supracox seta shape knowledg research conduct num chees varieti understand chemic physic microbi occur chees mite import identifi mite speci present chees varieti improv understand role creat distinct characterist set chees copyright num american dairi scienc associ publish elsevi reserv
MED-4404~influenc creatin supplement cognit function vegetarian omnivor pubm ncbi abstract creatin combin form phosphocreatin act reserv high energi phosphat creatin found meat fish anim product level muscl creatin lower vegetarian creatin supplement influenc brain function imag studi measur oxygen hb key role play creatin provis energi influenc supplement cognit function examin contrast effect omnivor vegetarian young adult femal num separ vegetarian random double blind procedur subject consum placebo num creatin supplement num creatin supplement influenc measur verbal fluenci vigil vegetarian consum meat creatin supplement result memori irrespect dietari style supplement creatin decreas variabl respons choic reaction tim task
MED-4405~creatin benefit worth risk pubm ncbi abstract creatin monohydr popular sport supplement maintain level high energi phosphat exercis supplement vari amount consum person paramet bodi mass level train mainten versus load dose numer studi report benefici effect includ increas muscl mass train neural protect negat report made side effect muscl cramp exercis potenti impur present paper introduc posit negat aspect creatin supplement focus toxicolog data creatin metabolit mutagen carcinogen genomeceut effect potenti contamin addit applic creatin area neurolog cardiolog diabet present discuss repres data sport nutrit
MED-4406~longitudin trend gasolin price physic activ cardia studi abstract object investig longitudin associ community level gasolin price physic activ pa method coronari arteri risk develop young adult studi num black white particip age num num baselin num num recruit citi birmingham chicago minneapoli oakland time data num follow up exam num num num num num particip locat num state questionnair data total pa score summar exercis unit eu base intens frequenc num pa categori geograph inform system particip residenti locat link county level inflation adjust gasolin price data collect council communiti econom research random effect longitudin regress model examin associ time vari gasolin price time vari pa control age race gender baselin studi center time vari educ marit status household incom counti cost live counti bus fare census block group poverti urban result hold control variabl constant num cent increas inflation adjust gasolin price signific increas num eu total pa num ci num num conclus rise price gasolin unintend increas leisur pa
MED-4407~addit euterp oleracea cigarett protect effect emphysema mice pubm ncbi abstract chronic inhal cigarett smoke cs induc emphysema damag contribut oxid stress inhal cs ingest ai fruit euterp oleracea anim antioxid anti inflammatori effect studi compar lung damag mice induc chronic num day inhal regular cs smoke cigarett num hydroalcohol extract ai berri stone cs sham smoke expos mice serv control group mice sacrif day num bronchoalveolar lavag perform lung remov histolog biochem analys histopatholog investig show enlarg alveolar space cs mice compar cs control mice increas leukocyt cs group higher increas observ cs group oxid stress evalu antioxid enzym activ mieloperoxidas glutathion num hydroxynonen reduc mice expos cs a versus cs macrophag neutrophil elastas level reduc mice expos cs versus cs presenc ai extract cigarett protect effect emphysema mice reduc oxid inflammatori reaction result rais possibl addit extract normal cigarett reduc harm effect copyright num elsevi reserv
MED-4408~protein oxid emulsifi cook burger patti ad fruit extract influenc colour textur deterior chill storag pubm ncbi abstract influenc protein oxid measur dinitrophenylhydrazin dnph method colour textur chill storag num degre num ay cook burger patti studi extract arbutus berri arbutus unedol au common hawthorn crataegus monogyn cm dog rose rosa canin rc elm leaf blackberri rubus ulmifoliusschott ru prepar ad burger patti num total weight evalu inhibitor protein oxid colour textur negat ad extract posit control ad quercetin num g kg group consid signific increas protein carbonyl chill storag control burger patti reflect intens oxid degrad muscl protein concomit intens loss red increas hard found place burger patti refriger storag fruit extract signific reduc format protein carbonyl inhibit colour textur deterior chill storag mechan protein oxid play major role colour textur chill storag burger patti discuss extract rc suitabl function ingredi process meat enhanc oxid stabil colour textur properti burger patti appar drawback copyright num elsevi reserv
MED-4410~veget fruit reduc risk chronic obstruct pulmonari diseas case control studi japan pubm ncbi abstract object investig relationship veget fruit consumpt risk chronic obstruct pulmonari diseas copd case control studi conduct central japan num method total num refer patient copd diagnos past year num community bas control undertook spirometr measur respiratori function structur questionnair administ face to fac obtain inform demograph lifestyl habitu food consumpt result veget fruit intak case num sd num num sd num g day signific lower num control num sd num num sd num g day substanti reduct copd risk found increas daili total veget intak trend num preval breathless decreas veget consumpt adjust odd ratio num num ci num num highest versus lowest quartil intak effect fruit consumpt signific nutrient veget fruit vitamin signific num estim num reduct copd risk highest level intak conclus studi provid evid invers associ veget consumpt risk copd japanes adult
MED-4411~impact dietari shift higher antioxid food copd randomis trial pubm ncbi abstract chronic obstruct pulmonari diseas copd characteris increas oxid stress dietari factor ampl consumpt food rich antioxid fruit veget benefici effect copd patient associ dietari shift food rich antioxid lung function copd investig num yr prospect studi total num copd patient randomis follow diet base increas consumpt fresh fruit veget intervent group ig free diet control group cg consumpt food antioxid higher ig cg studi period num relationship consumpt food rich antioxid percentag predict forc expiratori volum num assess general linear model repeat measur group time num ig show outcom investig effect confound sex age smoke status comorbid condit exacerb group respons time nonsignific interact found confound group time find suggest dietari shift higher antioxid food intak improv lung function respect dietari intervent consid copd manag
MED-4412~nutrit risk factor develop chronic obstruct pulmonari diseas copd male smoker pubm ncbi abstract background aim aim studi investig nutrit risk factor black tea consumpt invers develop chronic obstruct pulmonari diseas copd male smoker method forti male smoker clinic diagnosi copd group i gi num healthi smoker copd group ii gii includ studi compar dietari habit food intak group adapt arizona food frequenc questionnair affq question form includ list num food item form main food group grain meat altern dairi product vegetables fruit fat num dietari habit data evalu binari logist regress analysi receiv oper characterist roc curv kolmogorov smirnov student mann whitney chi squar test result group compar black tea consumpt gi num gii num num num veget fruit score gi num gii num num num regular breakfast habit gi num patient gii num case num num eat salti gi num patient gii num case num made signific differ roc curv area curv black tea num num ci num num vegetables fruit num num ci num num provid high accuraci distinguish copd group control num conclus high intak black tea vegetables fruit consumpt protect male smoker develop copd
MED-4413~develop valid algorithm establish total antioxid capac databas diet pubm ncbi abstract estim total antioxid intak step investig protect effect antioxid oxid stress medi diseas present studi design develop algorithm estim total antioxid capac tac diet tac individu antioxid num popular antioxidant rich food item diet determin num azino bi num ethylbenzthiazolin num sulphon acid abt assay num diphenyl num picrylhydrazyl dpph assay theoret tac food calcul sum individu antioxid capac compound top num tac food item diet standard serv size blueberri plum green tea strawberri green tea decaffein red wine grape juic black tea cherri grape major contributor tac total phenol content num num flavonoid content num num num food theoret tac posit correl experiment tac num food determin abt assay num num dpph assay num num tac usda databas oxygen radic absorb capac num num num tac databas diet establish valid futur studi tac diet link biomark chronic diseas
MED-4414~fruit veget intak risk acut coronari syndrom pubm ncbi abstract prospect epidemiolog studi report higher fruit veget intak lower risk chd aim present studi examin associ fruit veget consumpt subgroup citrus fruit appl crucifer veget risk acut coronari syndrom ac median follow up num year num incid ac case identifi num men women age num year recruit diet cancer health cohort studi num fruit veget intak estim valid ffq ac incid rate ratio irr estim cox proport hazard model tendenc lower risk ac observ men women higher fruit veget consumpt men found invers associ appl intak irr num g d num num ci num num associ women albeit borderlin signific higher risk women higher fruit juic intak irr num g d num num ci num num present result provid support previous observ invers associ fresh fruit intak appl ac risk
MED-4415~cinnamon health pubm ncbi abstract cinnamon spice tradit herbal medicin centuri vitro anim vivo evid suggest cinnamon anti inflammatori antimicrobi antioxid antitumor cardiovascular cholesterol low immunomodulatori effect vitro studi demonstr cinnamon act insulin mimet potenti insulin activ stimul cellular glucos metabol anim studi demonstr strong hypoglycem properti well control clinic studi fact limit conclus made potenti health benefit cinnamon free liv human cinnamon adjunct treatment type num diabet mellitus promis area research definit recommend made
MED-4416~cinnamon intak lower fast blood glucos meta analysi pubm ncbi abstract cinnamon dri bark twig cinnamomum spp rich botan sourc polyphenol centuri chines medicin shown affect blood glucos insulin signal cinnamon effect blood glucos subject clinic anim studi issu cinnamon intake effect fast blood glucos fbg peopl type num diabet and or prediabet remain unclear meta analysi clinic studi effect cinnamon intak peopl type num diabet and or prediabet includ clinic trial trial previous meta analys assess cinnamon effect lower fbg clinic studi identifi literatur search pub med biosi num random placebo control trial report data cinnamon and or cinnamon extract fbg comprehens meta analysi biostat englewood nj usa perform identifi data cinnamon cinnamon extract intak random effect model determin standard differ chang num control chang num cinnamon divid pool sd post score cinnamon intak cinnamon cinnamon extract result statist signific lower fbg num num mmol l num num intak cinnamon extract lower fbg num mmol l num num num cinnamon extract and or cinnamon improv fbg peopl type num diabet prediabet
MED-4417~glycat haemoglobin blood pressure low effect cinnamon multi ethn type num diabet patient uk random placebo contr pubm ncbi abstract aim determin blood glucos lower effect cinnamon hba num blood pressur lipid profil peopl type num diabet method num type num diabet patient num male num femal age num num treat hypoglycem agent hba num num random assign receiv num cinnamon placebo daili num week result intervent hba num signific decreas num cinnamon group num num compar placebo group num num systol diastol blood pressur sbp dbp signific reduc num num week cinnamon group sbp num num mmhg dbp num num mmhg compar placebo group sbp num num mmhg dbp num num mmhg signific reduct fast plasma glucos fpg waist circumfer bodi mass index bmi observ week num compar baselin cinnamon group signific compar placebo group signific differ serum lipid profil total cholesterol triglycerid hdl ldl cholesterol group conclus intak num cinnamon num week signific reduc hba num sbp dbp poor control type num diabet patient cinnamon supplement consid addit dietari supplement option regul blood glucos blood pressur level convent medic treat type num diabet mellitus num author diabet medicin num diabet uk
MED-4418~toxicolog risk assess coumarin focus human data pubm ncbi abstract coumarin secondari phytochem hepatotox carcinogen properti carcinogen effect genotox mechan consid discount european food safeti author num base evid deriv toler daili intak tdi time num mg kg bodi weight arriv base anim hepatotox data clinic data hepatotox patient treat coumarin medicin drug data reveal subgroup human popul suscept hepatotox effect anim speci investig high suscept unknown mechan discuss human data tdi num mg kg bodi weight deriv confirm european food safeti author nutrit exposur due cassia cinnamon popular spice cooki sweet dish estim exposur coumarin christma season germani telephon survey perform num random select person heavi consum cassia cinnamon reach daili coumarin intak tdi
MED-4419~determin citrullin watermelon rind pubm ncbi abstract watermelon citrullus vulgari schrad natur rich sourc non essenti amino acid citrullin citrullin nitric oxid system human potenti antioxid vasodilat role method gas chromatography mass spectrometri gc ms develop separ citrullin glutam acid co elut analyz high perform liquid chromatographi watermelon analyz gc ms determin citrullin content varieti type flesh color tissu citrullin content rang num num mg g dri weight dwt similar seed seedless type num num mg g dwt red flesh watermelon slight citrullin yellow orang flesh watermelon num num num mg g dwt rind citrullin flesh dri weight basi num num mg g dwt fresh weight fwt basi num num mg g fwt result watermelon rind underutil agricultur wast offer sourc natur citrullin
MED-4421~effect watermelon supplement aortic blood pressur wave reflect individu prehypertens pilot studi pubm ncbi abstract background oral l citrullin effici convert l arginin precursor endotheli nitric oxid synthesi oral l arginin supplement reduc brachial blood pressur bp evalu effect watermelon supplement aortic bp arteri function individu prehypertens method heart rate hr brachial systol bp bsbp brachial puls pressur bpp aortic sbp asbp aortic pp app augment index aix aix adjust hr num beats min aix num amplitud num num systol peak reflect time tr carotid femor puls wave veloc pwv evalu supin posit subject men fiv women age num num year prehypertens num num mm hg subject random assign num week watermelon supplement l citrulline l arginin num num g day placebo num week washout period crossov result signific treatment effect chang watermelon minus placebo baselin num week bpp num num mm hg num asbp num num mm hg num app num num mm hg num aix num num num aix num num num num num mm hg num signific treatment effect num bsbp brachial diastol bp dbp aortic dbp tr num hr carotid femor pwv conclus pilot studi show watermelon supplement improv aortic hemodynam decreas amplitud reflect wave individu prehypertens
MED-4422~oral l citrullin supplement improv erect hard men mild erectil dysfunct pubm ncbi abstract object test efficaci safeti oral l citrullin supplement improv erect hard patient mild erectil dysfunct ed l arginin supplement improv nitric oxide medi vasodil endotheli function oral administr hamper extens presystem metabol contrast l citrullin escap presystem metabol convert l arginin set rational oral l citrullin supplement donor l arginine nitr oxid pathway penil erect method present single blind studi men mild ed erect hard score num receiv placebo num month l citrullin num g d month erect hard score number intercours month treatment satisfact advers event record result total num patient age num num year enter conclud studi advers event improv erect hard score num mild ed num normal erectil function occur num num num men placebo num num men l citrullin num number intercours month increas num num baselin num num end placebo phase num num num end treatment phase num patient report erect hard score improv num num report satisfi conclus effect phosphodiesteras type num enzym inhibitor short term l citrullin supplement prove safe psycholog accept patient role altern treatment mild moder ed patient psycholog fear phosphodiesteras type num enzym inhibitor deserv research copyright num elsevi reserv
MED-4423~collater network concept reassess anatomi spinal cord perfus abstract object prevent paraplegia repair thoracoabdomin aortic aneurysm taaa requir understand anatomi physiolog blood suppli spinal cord recent laboratori studi clinic observ suggest robust collater network exist explain preserv spinal cord perfus segment vessel interrupt anatom studi undertaken method twelv juvenil yorkshir pig underw aortic cannul infus low viscos acryl resin physiolog pressur cure resin digest organ tissu anatomi blood suppli spinal cord studi grossli light electron microscopi result vascular structur num diamet preserv thorac lumbar segment arteri sas give rise anterior spinal arteri asa extens paraspin network feed erector spina iliopsoa muscl asa diamet num num connect multipl point repetit circular epidur arteri diamet num num capac paraspin muscular network num fold capac circular epidur arteri network asa combin extens arteri collater appar intraspin paraspin network network num sas provid direct asa suppli branch conclus asa compon extens paraspin intraspin collater vascular network network anatom explan physiolog resili spinal cord perfus sas sacrif taaa repair
MED-4424~atherosclerosi disc degeneration low back pain  a systemat review pubm ncbi abstract object atherosclerosi obstruct branch arteri abdomin aorta includ pair lumbar arteri middl sacral arteri feed lumbar spine diminish blood flow result back problem aim systemat literatur review assess associ atherosclerosi disc degener dd low back pain lbp data sourc systemat search medline pubm databas origin articl atherosclerosi dd lbp publish octob num search perform medic subject head atherosclerosi cardiovascular risk factor vascular diseas keyword disc degener disc herniat back pain basi mesh tree text search addit refer list studi search manual observ studi investig associ atherosclerosi risk factor lumbar dd lbp select review method data extract studi characterist durat follow up year public find atherosclerosis cardiovascular risk factor dd lbp disc herniat regard form disc degener cardiovascular risk factor regard surrog atherosclerosi epidemiolog studi result hundr seventy nin paper identifi exclus case report letter editori paper relat lumbar spine anim studi num paper includ post mortem studi show associ atheromat lesion aorta dd occlud lumbar arteri life tim lbp clinic studi aortic calcif lbp stenosi lumbar arteri dd lbp epidemiolog studi smoke high serum cholesterol level found consist associ dd lbp conclus aortic atherosclerosi stenosi feed arteri lumbar spine dd lbp cardiovascular risk factor weaker associ appar cohort elder peopl larg studi sampl prospect clinic studi clarifi associ atherosclerosi low back disord
MED-4425~hyperlipidemia sexual function premenopaus women pubm ncbi abstract introduct report studi exist assess relationship sexual function hyperlipidemia women aim studi assess domain sexual function repres sampl sexual activ premenopaus women hyperlipidemia cardiovascular diseas compar age match femal popul hyperlipidemia method enrol studi women meet criteria diagnosi hyperlipidemia low dens lipoprotein ldl cholesterol level num mg dl high dens lipoprotein hdl cholesterol level num mg dl triglycerid level num mg dl lipid paramet assess verifi blood hospit screen phase hundr forty on premenopaus women hyperlipidemia compar num age match premenopaus women hyperlipidemia main outcom measur femal sexual function index fsfi assess key dimens femal sexual function result group match age smoke preval compar women control group women hyperlipidemia reduc global fsfi score num num num num num individu analysi domain show women hyperlipidemia report signific lower arous orgasm lubric satisfact score control women base total fsfi score num women hyperlipidemia score num indic sexual dysfunct compar num women hyperlipidemia num base conserv analysi includ women lower quartil distribut fsfi score num women hyperlipidemia score num compar num women hyperlipidemia num multipl regress analysi identifi age bodi mass index hdl cholesterol triglycerid independ predictor fsfi score conclus women hyperlipidemia signific lower fsfi domain score compar age match women hyperlipidemia hdl cholesterol triglycerid level independ fsfi score
MED-4426~ride shop cart exposur raw meat poultri product preval factor risk factor salmonella pubm ncbi abstract ride shop cart raw meat poultri risk factor salmonella campylobact infect infant describ frequenc factor behavior survey parent children age younger num year foodborn diseas activ surveil network site defin exposur answer seri question packag raw meat poultri child shop cart child cart basket time raw meat poultri num respond num report children visit groceri store past week rode shop cart children num expos raw product children rode basket expos rode seat odd ratio num num confid interv ci num num multivari model ride basket num num ci num num incom num num num ci num num hispan ethnic num num ci num num exposur studi show children expos raw meat poultri product ride shop cart parent separ children raw product place children seat basket cart retail leak proof packag custom placement product plastic bag rack underneath cart hand sanit wipe consum educ
MED-4427~left subclavian arterioesophag fistula induc chicken bone upper gastrointestin hemorrhag unexpect death report case pubm ncbi abstract left subclavian arterioesophag fistula result chicken bone ingest rare occurr author report death num year old thai femal mental retard present hospit sever hematemesi arrest death occur num hour laparotomi due hypovolem shock postmortem examin reveal chicken bone embed middl part esophagus fistula esophagus left subclavian arteri
MED-4428~preval potenti neuropath campylobact jejuni strain commerci broiler chicken product pubm ncbi abstract campylobacteriosi common anteced infect lead develop inflammatori neuropathi includ guillain barr syndrom gbs miller fisher syndrom mfs alter surfac protein genet polymorph confer increas risk poultri common sourc jejuni infect industri countri includ data preval consum poultri product strain jejuni includ hypothes neuropathi studi jejuni isol fresh broiler chicken product purchas groceri store baltimor area los subtyp specif genet polymorph determin pcr dna sequenc observ relat proport los subtyp genet polymorph cstii gene encod bacteri sialyltransferas involv los synthesi jejuni character compar report publish studi patient gbs mfs uncompl enter commerci poultri product carri high preval jejuni strain neuropath sequela relat proport los class poultri isol similar report isol human enter case instanc similar isol patient diagnos neuropath diseas term cstii polymorph similar isol poultri patient gbs mfs copyright num elsevi reserv
MED-4429~cross contamin versus undercook poultri meat egg risk manag pubm ncbi abstract epidemiolog studi show poultri meat egg import sourc consum exposur pathogen salmonella campylobact focus countri reduc level human ill food born pathogen reduct preval contamin poultri meat egg major area focus risk communic consum inform aim chang food prepar behaviour utilis risk manag tool efficaci messag cook poultri meat egg wash hand depend abil chang consum behaviour risk mitig order prioritis messag consum relat contribut exposur pathway final lead ingest pathogen result ill import cross contamin event undercook greatest risk lurk consum kitchen review studi locat pathogen food product perform data intern extern surfac contamin poultri meat salmonella spp campylobact jejuni coli present case egg data intern contamin salmonella contamin egg shell salmonella campylobact discuss result publish risk assess pathogen food commod combin evalu conclus relat risk intern extern contamin poultri meat egg drawn conclus cross contamin event activ cut board chicken meat salad intermedi clean spread pathogen kitchen environ greater import risk undercook poultri meat egg risk manag option discuss background risk communic strategi countri
MED-4430~guillain barr syndrom modern theori etiolog pubm ncbi abstract guillain barr syndrom gbs classic failur immun system life threaten attack critic self compon activ phase diseas short concord latenc primari adapt immun respons trigger gbs includ infect rare vaccin cross react infecti neural epitop demonstr campylobact jejuni motor axon form gbs non protein gangliosid antigen peopl expos gbs trigger rare diseas develop propos gbs illustr compet determin immun system decis mount respons unlucki affect individu co present cross react antigen danger signal activ pattern recognit receptor overcom normal self recognit primari respons initi attack nerv case gbs respons rapid turn attack rare occur suggest activ restor toler specif privileg site attribut nerv declin danger signal trigger wane contribut restor standard immunosuppress effect gbs suggest immun toler restor time therapi initi turn suggest improv gbs outcom protect nerv cell attack normal resumpt toler permit proceed explor aggress immunosuppress approach
MED-4431~mortal baltimor union poultri cohort non malign diseas pubm ncbi abstract background worker poultri plant high exposur varieti transmiss agent present poultri product subject general popul expos agent diseas human reason readili evid high expos group poultri worker report mortal non malign diseas cohort poultri worker method mortal compar general popul comparison group union risk estim standard mortal ratio proport mortal ratio direct standard risk ratio result poultri worker group excess death diabet anterior horn diseas hypertens diseas deficit death intracerebr hemorrhag death zoonot bacteri diseas helminthiasi myasthenia gravi schizophrenia diseas spinal cord diseas esophagus periton non signific elev analys signific race sex subgroup conclus poultri worker excess occurr diseas affect organ system origin widespread infect varieti microorgan result neurolog diseas repres import clue etiolog diseas human small number death involv case limit interpret
MED-4433~cancer mortal poultri slaughtering process plant worker belong union pension fund pubm ncbi abstract background role zoonot biolog agent human cancer occurr studi human common expos virus natur infect cancer food anim poultri constitut part biolog environ virus cancer human object studi cancer mortal largest cohort date num worker poultri slaughter process plant group highest human exposur virus method mortal poultri worker compar general popul estim standard mortal ratio result signific increas risk observ cohort subgroup cancer site cancer buccal caviti pharynx pancrea trachea bronchus lung brain cervix lymphoid leukemia monocyt leukemia tumor hemopoiet lymphat system elev smrs statist signific observ cancer liver nasopharynx myelofibrosi myeloma site observ signific excess studi cancer cervix peni conclus larg studi evid human group high exposur poultri oncogen virus increas risk die cancer occup carcinogen exposur import explain find fume wrap machin find implic public health person general popul expos virus epidemiolog studi demonstr excess specif cancer attribut specif occup exposur adequ control potenti occup non occup carcinogen exposur copyright num elsevi reserv
MED-4436~consumpt meat dairi lymphoma risk european prospect investig cancer nutrit pubm ncbi abstract consumpt meat food anim origin risk factor type cancer result lymphoma inconclus examin associ num particip european prospect investig cancer nutrit median follow up num year num lymphoma num non hodgkin lymphoma nhl num hodgkin lymphoma identifi consumpt red process meat poultri milk dairi product assess dietari questionnair cox proport hazard regress evalu associ consumpt food group lymphoma risk consumpt food anim origin increas risk nhls hl associ specif subgroup nhl entiti note high intak process meat increas risk b cell chronic lymphocyt leukemia bcll relat risk rr num intak num num confid interv ci num num decreas risk follicular lymphoma fl rr num ci num num high intak poultri relat increas risk b cell lymphoma rr num ci num num num intak fl rr num ci num num bcll rr num ci num num continu model conclus consist associ red process meat consumpt lymphoma risk observ found consumpt poultri relat increas risk b cell lymphoma chanc plausibl explan observ associ confirm studi
MED-4437~dioxin pcdd fs pcbs offal occurr dietari exposur pubm ncbi abstract offal wide consum cuisin inform occurr dibenzo p dioxin dibenzofuran pcdd fs polychlorin biphenyl pcbs food spars structur investig kind studi report level contamin common consum offal num lamb ox deer pig liver kidney tongu heart offal product haggi tripe black pud result support literatur observ preferenti accumul contamin liver tissu highest concentr pcdd fs observ liver relat organ num ng who teq kg num lamb liver compar num ng who teq kg num lamb kidney num ng who teq kg num lamb heart offal product general show lower contamin level result process dilut sampl main contribut who teq aros pcdd fs pcbs half lamb liver sampl show pcdd f concentr exceed eu maximum limit num ng kg num fat weight deer liver subject regul general show higher level dietari exposur estim week consumpt num portion lamb ox calf pig liver portion deer liver breach toler daili intak tdi level rest diet includ consumpt portion deer liver week lead tdi exceed crown copyright num publish elsevi reserv
MED-4438~caffeine not stimul pubm ncbi abstract object benefici effect human caffein consumpt deserv clarif method detail literatur review conduct summar result larg bodi scientif evid describ benefici effect human caffein consumpt number physiolog system conclus consumpt moder amount caffein num increas energi avail num increas daili energi expenditur num decreas fatigu num decreas sens effort physic activ num enhanc physic perform num enhanc motor perform num enhanc cognit perform num increas alert wake feel energi num decreas mental fatigu num quicken reaction num increas accuraci reaction num increas abil concentr focus attent num enhanc short term memori num increas abil solv problem requir reason num increas abil make correct decis num enhanc cognit function capabl neuromuscular coordin num healthi non pregn adult safe copyright num elsevi reserv
MED-4439~case fatal caffein poison pubm ncbi abstract caffein natur alkaloid methylxanthin found plant coffe tea symptom sever overdos present hypokalemia hyponatremia ventricular arrhythmia hypertens hypotens respiratori failur seizur rhabdomyolysi ventricular fibril final circulatori collaps num year old woman call ambul ingest num mg caffein arriv ambul patient cardiac arrest immedi total resuscit period num min includ counter shock num mg epinephrin patient stabl transfer hospit patient vf receiv counter shock num mg epinephrin final intraven bolus dose num mg amiodaron initi arteri blood gas show ph num lactat num mmol l potassium level num mmol l blood sampl caffein analysi day hospit admiss patient develop myoclonus respond medic treatment excess intak caffein produc arrhythmia pronounc hypokalemia ensu ventricular fibril case counter shock resist vf give earli load dose amiodaron benefici replac potassium earli epinephrin buffer solut resuscit decreas blood potassium level administr cautious epinephrin replac vasopressor drug vasopressin effect beta receptor
MED-4440~soy food consumpt breast cancer prognosi pubm ncbi abstract background contrari earlier clinic studi suggest soy promot breast tumor growth recent studi show soy contain food advers relat breast cancer prognosi examin data women healthi eat live whel studi effect soy intak breast cancer prognosi method thousand eighty eight breast cancer survivor diagnos num num early stag breast cancer particip whel median num year isoflavon intak measur postdiagnosi food frequenc questionnair women self report outcom event semiannu verifi medic record and or death certif hrs num cis repres associ breast cancer event death soy intak comput adjust studi group covari delay entri cox proport hazard model result isoflavon intak increas risk death decreas trend num women highest level isoflavon intak num mg isoflavon nonsignific num reduct risk death conclus studi epidemiolog studi report advers effect soy food breast cancer prognosi impact studi vari ethnic composit unit state china level type soy consumpt provid epidemiolog evid clinician longer advis soy consumpt women diagnosi breast cancer num aacr
MED-4442~intestin microbiom separ organ insid bodi metabol potenti influenc bioactiv botan pubm ncbi abstract year believ main function larg intestin resorpt water salt facilit dispos wast materi task definit complet activ microbi content larg intestin nowaday clear complex microbi ecosystem intestin consid separ organ bodi metabol capac exceed liver factor num intestin microbiom close involv first pass metabol dietari compound true botan supplement market health applic natur origin structur build block polyphenol high recogn human intestin microbi metabol machineri intens metabol result low circul level origin product consequ final health effect botan relat specif activ metabolit produc bodi relat product origin composit understand metabol process contribut situ exposur crucial proper interpret biolog respons multidisciplinari approach character food phytochem intak metabol potenc gut microbiota measur biomark exposur respons target tissu critic import polyphenol metabol review describ incorpor microbi metabol import variabl evalu final bioactiv botan strong increas relev predict outcom knowledg intestin process offer innov strategi target product develop copyright num elsevi reserv
MED-4443~flaxse potenti sourc food feed fiber pubm ncbi abstract flaxse import oilse crop industri food feed fiber purpos part flaxse plant util commerci direct process stem yield good qualiti fiber high strength durabl seed oil rich omega num digest protein lignan addit richest sourc linolen acid oil lignan flaxse essenti sourc high qualiti protein solubl fiber potenti sourc phenol compound flaxse emerg import function food ingredi rich content linolen acid ala lignan fiber lignan anti carcinogen compound omega num lignan phytoestrogen flaxse focus benefit wide rang health condit possess chemo protect properti anim human paper present review literatur nutrit composit flaxse health benefit disease prevent qualiti util flaxse food feed fiber process flaxse
MED-4445~alcohol intak mortal women invas breast cancer abstract background alcohol intak consist increas breast cancer incid epidemiolog studi relat alcohol surviv breast cancer diagnosi clear method investig alcohol intak surviv num women diagnos invas breast cancer swedish mammographi cohort alcohol consumpt estim food frequenc questionnair cox proport hazard model calcul hazard ratio hrs num confid interv num cis result num num num breast cancer specif death num total death signific associ observ alcohol intak breast cancer specif surviv women consum num day approxim num num drink alcohol adjust hr num ci breast cancer specif death num num num ptrend num compar non drink signific invers associ observ alcohol non breast cancer death consum num num day alcohol num lower risk death compar non drink num ci num num ptrend num conclus find suggest alcohol intak approxim small drink day negat impact breast cancer specif surviv half drink day decreas risk mortal
MED-4446~quantif broad spectrum lignan cereal oilse nut pubm ncbi abstract twenty four plant lignan analyz high perform liquid chromatography tandem mass spectrometri bran extract num cereal speci nut speci oilse speci sesam seed linse eighteen lignan previous unidentifi speci num identifi analyz sampl extract method appli alkalin extract mild acid extract combin alkalin mild acid extract acceler solvent extract extract method great import lignan yield num hydroxymatairesinol previous detect cereal destruct extract method domin lignan wheat tritical oat barley millet corn bran amaranth grain syringaresinol domin cereal lignan wheat rye bran highest lignan content cereal linse sesam seed lignan rich studi speci
MED-4447~lignan content dutch plant food databas includ lariciresinol pinoresinol secoisolariciresinol matairesinol pubm ncbi abstract enterolignan enterodiol enterolacton potenti reduc risk cancer cardiovascular diseas enterolignan form intestin microflora consumpt plant lignan recent secoisolariciresinol matairesinol consid enterolignan precursor precursor identifi lariciresinol pinoresinol high degre convers quantit data content food enterolignan precursor aim studi compil lignan databas includ major enterolignan precursor liquid chromatography tandem mass spectrometri quantifi lariciresinol pinoresinol secoisolariciresinol matairesinol eighty thre solid food twenty six beverag common consum netherland richest sourc lignan flaxse num microg num secoisolariciresinol lignan concentr sesam seed num microg num pinoresinol lariciresinol high grain product import sourc lignan lignan concentr rang num num microg num veget fruit similar concentr contribut lariciresinol pinoresinol brassica veget unexpect high level lignan num microg num pinoresinol lariciresinol lignan level beverag vari num cola num microg num ml red wine num food measur amount lignan case amount lariciresinol pinoresinol larger secoisolariciresinol matairesinol databas larg underestim amount enterolignan precursor food
MED-4448~construct flavonoid databas assess intak population bas sampl women long island york pubm ncbi abstract flavonoid hypothes reduc cancer risk previous epidemiolog studi conduct evalu hypothesi assess flavonoid includ class contribut intak american result underestim intak misclassif mask variabl individu result attenu effect estim associ flavonoid cancer augment flavonoid lignan intak estim develop databas conjunct food frequ questionnair ffq coupl inform deriv literatur depart agricultur databas estim content num flavonoid class lignan num food group item combin estim respons modifi block ffq self complet num population bas sampl women breast cancer long island york num total flavonoid lignan content food item rang num num mg num richest sourc tea cherri grapefruit individu intak estim highest lowest flavan num ol flavanon flavonol lignan isoflavon anthocyanidin flavon class flavonoid lignan exhibit wide rang intak level databas quantifi flavonoid lignan intak observ studi conduct unit state util block ffq
MED-4450~post diagnosi dietari factor surviv invas breast cancer abstract effect diet breast cancer diagnosi surviv prospect examin relat post diagnosi dietari factor breast cancer all caus surviv women histori invas breast cancer diagnos num num age num num year diet breast cancer diagnosi measur num item food frequenc questionnair num women histori breast cancer recurr prior complet questionnair num subsequ die breast cancer num year enrol hazard ratio hr num confid interv ci estim intak macronutri select micronutri food group cox proport hazard regress model adjust factor diagnosi age state resid menopaus status smoke breast cancer stage alcohol histori hormon replac therapi interv diagnosi diet assess follow up energi intak breast cancer treatment bodi mass index physic activ women highest compar lowest quintil intak satur fat tran fat signific higher risk die hr num num ci num num p trend num satur fat hr num num ci num num p trend num tran fat intak associ similar achiev statist signific breast cancer surviv studi suggest lower intak satur tran fat post diagnosi diet improv surviv breast cancer diagnosi
MED-4451~heterocycl amin mutagens carcinogen produc cook meat fish pubm ncbi abstract research lead discoveri seri mutagen carcinogen heterocycl amin hcas inspir idea smoke produc cook food meat fish carcinogen ten kind hcas produc cook heat meat fish isol structur determin previous unregist compound high mutagen salmonella typhimurium presenc num mix mutagen vitro vivo mammalian cell hcas chemic synthes quantiti subject long term anim test hcas fed diet rodent develop cancer organ includ colon breast prostat hca produc hepatoma monkey lesion exhibit alter gene includ apc beta catenin ha ra provid clue induct mechan hcas oxid hydroxyamino deriv cytochrom num convert ester form acetyltransferas sulfotransferas eventu produc dna adduct format n c bond guanin base hca sensit resist strain rodent search respons gene content hcas dish consum ordinari life low suffici explain human cancer coexist mutagens carcinogen autobiot xenobiot type possibl hcas induc genom instabl heighten sensit tumor promot suggest avoid exposur hcas reduct hcas biolog effect high recommend usag microwav oven cook supplement diet soy isoflavon found suppress occurr hca induc breast cancer encourag advic general public reduc carcinogen load impos hcas import contribut cancer prevent
MED-4452~role diet physic activ breast colorect prostat cancer survivorship review literatur abstract background evid role diet physic activ cancer incid document owe increas cancer survivorship understand lifestyl factor cancer diagnosi crucial import purpos review updat literatur review undertaken nation cancer survivorship initi includ observ studi includ wcrf survivorship systemat review method evid initi gather pre defin search cochran librari databas pubm march num februari num comprehens review lifestyl cancer purpos articl studi relat diet physic activ prognost outcom breast colorect prostat cancer exclud search num literatur conduct updat evid result total num record includ review evid observ studi suggest low fat high fibr diet protect cancer recurr progress pauciti rcts substanti support physic activ dose respons outcom synthes find world cancer research fund review rcts investig effect diet physic activ intervent cancer surviv evid suggest mechan benefit diet physic activ pertain bodi weight excess bodi weight risk factor modifi lifestyl implic cancer survivor activ role health care diagnosi includ diet lifestyl make challeng integr lifestyl support standardis model aftercar
MED-4454~bioavail kinet sulforaphan human consumpt cook versus raw broccoli pubm ncbi abstract aim studi determin bioavail kinet suppos anticarcinogen sulforaphan hydrolysi product glucoraphanin raw cook broccoli men consum num crush broccoli raw cook warm meal random free liv open cross ov trial higher amount sulforaphan found blood urin broccoli eaten raw bioavail num versus cook num num absorpt sulforaphan delay cook broccoli consum peak plasma time num versus raw broccoli num num excret half liv compar num num averag raw cook broccoli num studi complet kinet data show consumpt raw broccoli result faster absorpt higher bioavail higher peak plasma amount sulforaphan compar cook broccoli
MED-4455~glucoraphanin num hydroxyglucobrassicin content seed num cultivar broccoli raab kohlrabi radish cauliflow brussel sprout kal pubm ncbi abstract import dietari sulforaphan maintain good health continu gain support health car communiti awar consum addit tradit avenu obtain sulforaphan consumpt crucifer veget consum product ad glucoraphanin natur precursor sulforaphan unit state crucif seed sourc obtain glucoraphanin owe higher concentr glucoraphanin relat eas process seed compar veget part seed common consum crucif analyz glucoraphanin compon negat health implic indole contain glucosinol eruc acid contain lipid glucoraphanin num hydroxyglucobrassicin glucosinol lipid eruc acid quantifi seed num commerci cultivar broccoli num cultivar kohlrabi radish cauliflow brussel sprout kale cabbag num cultivar raab
MED-4456~safeti toler metabol broccoli sprout glucosinol isothiocyan clinic phase studi pubm ncbi abstract broccoli sprout wide consum part world report concern respect toler safeti human formal phase studi safeti toler pharmacokinet justifi sprout vehicl deliveri glucosinol glucoraphanin cognat isothiocyan sulforaphan num isothiocyanato num methylsulfinyl butan clinic trial trial design evalu protect efficaci develop neoplast diseas placebo control double blind random clinic studi sprout extract glucosinol princip glucoraphanin precursor sulforaphan isothiocyan princip sulforaphan conduct healthi volunt in pati clinic research unit subject studi cohort compris treat individu placebo recipi num day acclimat period crucifer fre diet broccoli sprout extract administ oral num interv num day num dose subject monitor period num day treatment dose num micromol glucosinol cohort num micromol glucosinol cohort num micromol isothiocyan cohort cumul excret dithiocarbam fraction dose similar cohort num num num num dose higher consist cohort num num dose thirty two type hematolog chemistri test treatment period indic liver transaminas thyroid thyroid stimul hormon total triiodothyronin num free thyroxin num function examin detail signific consist subject object abnorm event toxic sprout extract ingest observ
MED-4457~sulforaphan induc dna singl strand break cultur human cell pubm ncbi abstract sulforaphan sfr isothiocyan crucifer veget possess growth inhibit apoptosis induc activ cancer cell line recent sfr shown promot mitochondri format reactiv oxygen speci ros human cancer cell line present studi undertaken sfr deriv ros dna damag cultur human cell limphoblastoid jurkat human umbil vein endotheli cell huvec num treatment num microm sfr elicit intracellular ros format assay dihydrorhodamin dhr oxid dna breakag assess fast halo assay fha effect lack cell typ specif observ jurkat huvec differential ph fha analysi damag dna show sfr frank dna singl strand break ssbs dna doubl strand break dsbs found consid treatment time num sfr deriv ros form mitochondri respiratori chain mrc level rotenon myxothiazol mrc complex iii inhibitor abrog ros format ros form jurkat cell pharmacolog deplet respir mitochondria mrc  jurkat format ros causal link induct ssbs experiment condit capabl prevent ros format prevent damag nuclear dna sfr intox cell toxicolog relev ssbs found prevent slight signific attenu sfr cytotox suggest high dos sfr toxic result complex seri event gsh deplet play pivot role conclus present studi identifi mechan contribut sfr toxic dna damag promin mechan cytotox activ establish antineoplast agent exploit therapeut sfr anticanc drug protocol copyright num elsevi reserv
MED-4458~inactiv tautomeras activ macrophag migrat inhibitori factor sulforaphan potenti biomark anti inflammatori intervent abstract background macrophag migrat inhibitori factor mif proinflammatori cytokin keto enol tautomeras activ rise rapid respons inflamm elev chronic diseas isothiocyan sulforaphan broccoli potent inactiv mif tautomeras activ simpl rapid method determin activ tissu bodi fluid valuabl assess sever inflamm efficaci intervent method exist spectrophotometr assay mif base convers methyl l dopachrom methyl num dihydroxyindol num carboxyl loss absorpt num nm lack sensit assay sensit effici mark improv reduc nonenzymat rate lower ph num replac phosphat catalyz reaction bis tri buffer convert microtit plate format result structure pot studi mif tautomeras inactiv isothiocyan show sulforaphan benzyl n hexyl phenethyl isothiocyan potent mif tautomeras readili quantifi human urin concentr ultrafiltr activ compris heat labil sulforaphane inactiv macromolecular fraction mif concentr ultrafiltr ii flow through fraction constant activ filtrat heat stabl insensit sulforaphan administr sulforaphan precursor glucoraphanin human volunt complet abolish urinari tautomeras activ recov hour conclus simpl rapid quantit mif tautomeras assay develop potenti biomark assess inflammatori sever effect intervent impact improv assay measur mif tautomeras activ applic
MED-4459~impact nrf num uvb induc skin inflammation photoprotect photoprotect effect sulforaphan pubm ncbi abstract ultraviolet uv sunlight complet carcinogen burn skin enhanc inflamm drive skin carcinogenesi previous shown sulforaphan sfn inhibit chemic induc skin carcinogenesi nuclear factor erythroid deriv num num nrf num shown broccoli sprout extract high sfn protect uv induc skin carcinogenesi skh num hairless mice recent studi show differ nrf num knockout nrf num ko nrf num wild typ wt balb c mice expos high dose uvb nrf num play critic role anti oxid stress anti inflammatori respons relev assess role nrf num photoprotect uv context role nrf num uvb induc skin inflamm nrf num wt nrf num ko num num mice studi singl dose uvb num mj cm num result skin inflamm wt nrf num ko mice ko mice num num uvb irradi wt mice inflamm return basal level greater extent compar ko mice sfn treatment nrf num wt nrf num ko mice restor number sunburn cell back basal level num uvb irradi addit uvb induc short term inflammatori biomark interleukin num interleukin num increas ko mice uvb induc apoptot cell ko mice signific higher compar wt result show function nrf num confer protect effect uvb induc inflamm sunburn reaction sfn mediat photoprotect effect skin copyright num wiley liss
MED-4460~anti carcinogen effect sulforaphan associ apoptosis induc anti inflammatori properti human cervic cancer cell pubm ncbi abstract background multistep process carcinogenesi character progress disorgan occurr initi promot progress event strategi chemoprevent develop treatment prevent stage carcinogenesi sulforaphan potenti chemoprevent agent possess anti prolif anti inflammatori anti oxid anti canc activ attract extens interest cancer manag method evalu effect sulforaphan combin gemcitabin hela cell cell viabil assay confirm result apoptosi assay analyz effect sulforaphan express bcl num cox num il num rt pcr hela cell result present studi sulforaphan found induc dose depend select cytotox hela cell comparison normal cell point safe cytotox profil addit combin sulforaphan gemcitabin found increas growth inhibit synergist manner hela cell compar individu drug express analysi gene involv apoptosi inflamm reveal signific downregul bcl num cox num il num treatment sulforaphan conclus result suggest sulforaphan exert anticanc activ apoptosi induct anti inflammatori properti evid demonstr synerg sulforaphan gemcitabin enhanc therapeut index prevent and or treatment cervic cancer copyright num elsevi reserv
MED-4461~sulforaphan potenti oxaliplatin induc cell growth inhibit colorect cancer cell induct mode cell death pubm ncbi abstract object studi investig plant deriv isothiocyan sulforaphan sfn enhanc antitumor activ chemotherapeut agent oxaliplatin ox cell cultur model colorect cancer caco num cell cultur standard condit treat increas concentr sfn num and or ox num nm num co incub cell pre treat sfn num cell growth determin brdu incorpor drug interact assess combination index method ci cl num synerg apoptot event character elisa techniqu protein level examin western blot analysi annexin propidium iodid pi stain fac analysi differenti apoptot necrot event sfn ox inhibit cell growth caco num cell dose depend manner effect synergist enhanc cell incub combin agent co treat cell display distinct morpholog occur apoptot process cell surfac exposur phosphatidylserin membran bleb occur cytoplasm histone associ dna fragment observ point simultan activ extrins intrins apoptot pathway increas concentr treatment durat shift apoptot necrot cell death observ conclus data suggest isothiocyan sfn sensit colon cancer cell ox induc cell growth inhibit induct mode cell death
MED-4462~sulforaphan protect human chondrocyt cell death induc stimuli pubm ncbi abstract chondrocyt cell death contribut cartilag degener articular diseas osteoarthr oa sulforaphan sfn natur compound deriv crucifer aliment anti carcinogen recent evid show cytoprotect effect varieti non tumor cell test abil sfn protect chondrocyt cell death vitro treatment grow monolay cultur human num num chondrocyt sfn low micro molecular rang day reduc cell growth affect cell surviv induc apoptosi decreas cell death num num chondrocyt expos stimuli previous report prompt trigger apoptosi cytokin tumor necrosi factor tnf cycloheximid chx polyamin analogu num num diethylnorspermin denspm chx pre treat sfn reduc effector initi caspas activ activ jnk kinas sfn exert cytoprotect action versus num num differ previous stimuli induc cell death produc evid caspas activ sfn pre treat prevent caspas activ three dimension micromass cultur oa chondrocyt stimul growth rel oncogen gro pro apoptot chemokin suppress caspas activ micromass relat inhibit num mapk phosphoryl conclus present work show low micro molecular sfn concentr exert pro surviv anti apoptot action influenc signal pathway varieti experiment condit employ chondrocyt cell line oa chondrocyt treat rang death stimuli copyright num wiley liss
MED-4463~phenethyl isothiocyan sensit human cervic cancer cell apoptosi induc cisplatin abstract naturally occur chemoprevent agent phenethyl isothiocyan peitc deriv primarili watercress shown inhibit cell growth induc apoptosi cancer cell studi examin potenti peitc enhanc cisplatin induc apoptosi cervic cancer cell hela cell expos peitc cisplatin pretreat cell peitc strong enhanc cisplatin induc cytotox peitc activ mitogen activ protein kinas includ jnk erk num synergist induct apoptosi signific attenu mek num inhibitor num jnk num inhibitor suggest erk activ respons synergist effect found nf signal pathway involv synergist effect sulforaphan benzyl isothiocyan member isothiocyan famili sensit hela cell apoptosi induc cisplatin found synergist effect normal cell final demonstr noxa induct apoptosi induc peitc cisplatin studi show peitc sensit cancer cell apoptosi induc cisplatin effect mediat erk activ suggest potenti peitc adjuv cisplatin combin therapeut treatment
MED-4464~cancer stem cell premis promis challeng pubm ncbi abstract decad notion tumor maintain stem cell so cal cancer stem cell creat great excit research communiti review attempt summar concept notion distinguish hard fact belief defin futur challeng field
MED-4465~milk malign role mammari stem cell develop pregnanc breast cancer abstract adult stem cell mammari gland masc high dynam popul cell respons generat gland puberti expans pregnanc recent year signific advanc made understand cell regul development import process human mice understand masc regul import area research suscept target transform breast cancer summar identif masc regul evid serv origin breast cancer focus masc popul explain increas risk develop aggress er pr breast cancer short pregnanc long term decreas risk develop er pr tumor
MED-4466~kale juic improv coronari arteri diseas risk factor hypercholesterolem men pubm ncbi abstract object evalu effect num month kale brassica oleracea acephala juic supplement coronari arteri diseas risk factor hypercholesterolem men method thirty two men hypercholesterolemia num mg dl recruit annual health examin faculti staff univers subject consum num ml kale juic day num week intervent period dietari anthropometr assess perform blood sampl collect evalu biochem profil supplement result serum concentr hdl cholesterol hdl ldl cholesterol ratio signific increas num num num num ldl cholesterol concentr atherogen index signific reduc num num num num affect bodi mass index waist hip circumfer nutrient intak month supplement differ concentr malondialdehyd signific increas glutathion peroxidas activ num accompani signific increas serum selenium level num found respons risk factor kale juic administr depend smoke status conclus regular meal supplement kale juic favor influenc serum lipid profil antioxid system contribut reduc risk coronari arteri diseas male subject hyperlipidemia
MED-4468~effect ascorb acid green tea endogen format n nitrosodimethylamin n nitrosopiperidin human pubm ncbi abstract constitu present human diet inhibit endogen format n nitroso compound noc studi human volunt show inhibit effect intak ascorb acid green tea consumpt nitros n nitrosoprolin test aim present studi evalu effect ascorb acid green tea urinari excret carcinogen n nitrosodimethylamin ndma n nitrosopiperidin npip human twenty f healthi femal volunt consum fish meal rich amin nitrosat precursor combin intak nitrate contain drink water accept daili intak level num consecut day num week nitrat intak diet low nitrat consum protocol effect dose ascorb acid num mg num g day dose green tea num num g day format ndma npip studi nitrat excret urin signific increas control num num num num mg num intak nitrat fish result signific increas urinari excret ndma compar control week num num num num ng num day num num compar num num ng num num excret npip urin relat nitrat intak composit diet intak num mg num ascorb acid day result signific decreas urinari ndma excret day num num day num consumpt cup green tea day num signific decreas excret ndma day num num day num surpris consumpt cup green tea day num signific increas ndma excret day num num day num increas result catalyt effect tea polyphenol nitros unknown mechan result suggest intak ascorb acid moder consumpt green tea reduc endogen ndma format
MED-4469~paleolith modern diets  select pathophysiolog implic pubm ncbi abstract nutrit pattern paleolith human influenc genet evolut time segment defin characterist contemporari human select genom chang begin agricultur genet human remain stone agers  adapt paleolith dietari regimen diet base chiefli wild game fish uncultiv plant food provid abund protein fat profil affluent western nation high fibr carbohydr fruit veget honey cereal refin sugar dairi product high level micronutri phytochem differ contemporari ancestr diet pathophysiolog implic review address phytochem cancer calcium physic exert bone miner densiti bone structur geometri dietari protein potassium renal acid secret urinari calcium loss final sarcopenia adipos insulin receptor insulin resist basi formal recommend awar paleolith nutrit pattern generat testabl hypothes ground evolutionari theori dispel complac accept nutrit tenet
MED-4470~effect vitamin n nitroso compound format carcinogenesi cancer pubm ncbi abstract properti n nitroso compound nnc vitamin briefli author review abil vitamin inhibit nnc format chemic system nitrite preserv meat experiment anim human dietari vitamin produc num num inhibit carcinogenesi experi employ preform carcinogen vitamin revers transform vitro system carcinogen test vitamin review vitamin promot bladder carcinogenesi intak fresh fruit veget vitamin negat correl cancer stomach esophagus larynx mouth cervix gastric esophag cancer evid associ due inhibit vivo nnc format vitamin appar treatment cancer author support recommend fresh fruit veget intak increas lower risk cancer
MED-4471~lung deposit fine ultrafin particl outdoor indoor cook event activ period pubm ncbi abstract indoor activ increas number concentr small particl enhanc dose deliv lung receiv particl dose indoor exceed notic dose ambient air routin in hous activ cook present work intern dose inhal ultrafin fine particl assess mechanist model lung deposit accommod aerosol inhal dynam analysi base size distribut measur num nm indoor outdoor aerosol number concentr typic resid athen greec case examin cook event activ period indoor equival time period outdoor cook event fri bacon egg gas fire occur amount deposit particl deep lung individu indoor exceed num time amount receiv individu time period outdoor fine particl deposit depend level physic exert hygroscop properti inhal aerosol dose found linear depend indoor outdoor concentr cook event activ period practic implic necess determin dose specif region human lung non linear relationship aerosol concentr intern dose make applic dosimetri model import lung dose fine ultrafin particl cook event compar dose indoor activ dose receiv outdoor exposur condit dose express term number surfac deposit particl permit address dosimetri small particl releas indoor sourc repres slight fraction particul matter mass enhanc intern dose result fine ultrafin particl generat cook event dose indoor sourc activ assess result case compar dose calcul measur aerosol outdoor
MED-4472~n nitroso compound diet pubm ncbi abstract n nitroso compound num year ago present food treat sodium nitrit made fish meal hepatotox anim format nitrosodimethylamin ndma time n nitroso compound shown anim experi broad act potent group carcinogen key role nitrit nitrogen oxid form n nitroso compound interact secondari tertiari amino compound led examin worldwid food presenc n nitroso compound found exclus food nitrit expos nitrogen oxid cure meat bacon and cook concentr num microgram kg num found num microgram kg num correspond consumpt num microgram ndma num portion higher concentr ndma lower nitrosamin found japanes smoke cure fish num microgram kg num beer sourc ndma num microgram num report type german beer usual level lower num num microgram num intak heavi beer drinker liter day level nitrosamin declin past decad concurr lower nitrit food greater control exposur malt nitrogen oxid beer make declin n nitroso compound concentr food past decad small amount nitrosamin food nonetheless signific possibility even likelihood that human sensit carcinogen laboratori rodent probabl alkylnitrosamid induc brain tumor rodent present cure meat potenti nitros product spite search limit indirect evid presenc copyright num elsevi scienc
MED-4474~effect dietari factor nitrosoprolin level human urin pubm ncbi abstract effect dietari compon level nitrosoprolin npro excret num period urin examin volunt ingest amount food product ingest nitrite preserv meat num meal includ roll yunnan ham cure pork luncheon meat chines european styl sausag led urinari npro excret level rang num num microgram num consumpt non preserv meat fish product includ chicken herring salmon shrimp ground beef hamburg pork chop beef liver led low npro excret level rang num num microgram num urinari npro level num vegetarian num lacto vegetarian averag num num microgram num chang nitrite preserv meat diet vegetarian diet accompani approxim six fold reduct urinari npro level remain control level num day dietari chang high npro level ingest nitrite preserv meat reduc nitrite trap chemic includ ascorb acid ferul acid caffeic acid phenolic contain mixtur coffe tea effect suppress endogen npro format intak nitrat prolin high urinari npro level ingest preserv meat product due consumpt preform npro understand relat contribut preform endogen form nitrosamin essenti design dietari intervent programm
MED-4475~understand tobacco smoke carcinogen nnk lung tumorigenesi pubm ncbi abstract deleteri effect tumor promot tobacco carcinogen nitrosamin num methylnitrosamino num num pyridyl num butanon nnk nicotine deriv nitrosamin keton undoubt stipul tobacco agent play part develop lung tumor potent effect nnk remain unmatch critic distinguish varieti cofactor involv nnk mediat pathogenesi uniqu pathway success cellular biotransform current review consist identifi strength nnk prospect tumor capabl delin specif cellular factor mediat nnk lung tumor identifi metabol signal pathway larg respons nnk activ tumorigen initi uniqu review summar extens network cofactor cellular mechan promot nnk specif lung tumorigenesi display fuller comprehens overview bring step closer understand fatal consequ nnk discov avenu success break cycl nnk mediat lung carcinogenesi
MED-4476~determin total n nitroso compound precursor frankfurt fresh meat dri salt fish sauc tobacco tobacco smoke pubm ncbi abstract total n nitroso compound noc noc precursor nocp determin extract food tobacco product walter method noc decompos reflux hbr hcl hoac etoac measur chemiluminesc noc determin sulfam acid treatment destroy nitrit nocp determin treatment num mm nitrit sulfam acid analysi hbr gave result num hbr noc method effici nitrosamin nitrosourea standard nitros determin nocp gave high yield readili nitros amin includ num deoxi num fructosylvalin simpl amin dipeptid alkylurea noc nocp result micromol kg product num num frankfurt num num fresh meat num num salt dri fish num num chew tobacco aqueous extract num num nmol cigarett mecn extract cigarett smoke filter pad
MED-4477~determin volatil nitrosamin meat product microwave assist extract dispers liquid liquid microextract coupl ga pubm ncbi abstract microwave assist extract mae dispers liquid liquid microextract dllme coupl gas chromatography mass spectrometri gc ms evalu extract preconcentr volatil nitrosamin meat product paramet affect mae extract solvent dllme includ natur volum extract dispers solvent extract time salt addit centrifug time optim mae method num sampl mass extract num naoh num closed vessel system dllme num ml methanol dispers solvent num carbon tetrachlorid extract solvent rapid inject syring num sampl extract solut previous adjust ph num form cloudi solut phase separ perform centrifug volum num sediment phase analyz gc ms enrich factor provid dllme vari num num n nitrosodiethylamin n nitrosopiperidin matrix effect evalu sampl conclud sampl quantif carri aqueous calibr optim condit detect limit rang num num ngml num npip nmea num num ngg num meat product copyright num elsevi reserv
MED-4479~long term exposur sodium nitrit risk esophag carcinoma cohort studi num year pubm ncbi abstract object studi investig risk esophag carcinoma cohort long term occup exposur sodium nitrit method retrospect cohort studi small wood screw manufactur found num close num product process sodium nitrit solut serv anticorros coolant fluid hundr sixti worker turn mill shop direct exposur sodium nitrit skin mouth airway lack occup protect knowledg studi group num worker workshop direct contact sodium nitrit serv control group incid diagnosi treatment esophag carcinoma malign tumor group end num sodium nitrit exposur time studi group rang num num year averag num year num year follow up num esophag carcinoma num malign tumor num hepat cell carcinoma num lung cancer num breast cancer num leukemia document studi group cancer develop control group risk esophag carcinoma signific increas studi group compar control group relat risk num num confid interv num num chi squar num num long term exposur sodium nitrit mark increas risk esophag carcinoma human bodi num copyright author journal compil num wiley period intern societi diseas esophagus
MED-4480~princip compon analysi dietari lifestyl pattern relat risk subtyp esophag gastric cancer abstract purpos perform pattern analys dietari lifestyl factor relat risk esophag gastric cancer method evalu risk factor esophag adenocarcinoma ea esophag squamous cell carcinoma escc gastric cardia adenocarcinoma gca gastric cancer oga data population bas case control studi conduct connecticut jersey western washington state dietary lifestyl pattern creat princip compon analysi pca impact result score cancer risk estim logist regress result pca identifi pattern meat nitrit fruit veget smoking alcohol legume meat altern gerd bmi fish vitamin risk cancer studi increas rise meat nitrit score risk ea increas increas gerd bmi score risk escc rose increas smoking alcohol score decreas gerd bmi score fruit veget score invers ea escc gca conclus pca provid approach summar extens dietary lifestyl data fewer interpret combin discrimin cancer case control analys suggest meat nitrit intak elev risk cancer studi fruit veget intak reduc risk ea escc gca gerd obes confirm risk factor ea smoking alcohol risk factor escc
MED-4481~dietari fat meat intak risk reflux esophag barrett esophagus esophag adenocarcinoma abstract aim studi investig dietari fat meat intak reflux esophag barrett esophagus esophag adenocarcinoma eac all ireland case control studi dietari intak data collect food frequenc questionnair num patient num patient num eac patient num frequency match control num num uncondit multipl logist regress analysi examin associ dietari variabl diseas risk quartil intak attain odd ratio num confid interv num ci adjust potenti confound patient highest quartil total fat intak higher risk num num ci num num eac num num ci num num higher risk eac report patient highest quartil satur fat intak num num ci num num num num ci num num monounsatur fat intak num num ci num num num num ci num num patient highest quartil fresh red meat intak higher risk eac num num ci num num patient highest categori process meat intak higher risk num num ci num num consist associ fat meat intak studi investig associ dietari fat food sourc fat confirm result
MED-4482~meat consumpt cook practic meat mutagen risk prostat cancer abstract consumpt red meat meat increas prostat cancer risk high temperatur cook method grill barbequ produc heterocycl amin hcas polycycl aromat hydrocarbon pah carcinogen assess associ meat consumpt estim hca pah exposur population bas case control studi prostat cancer newli diagnos case age num num year num advanc case num local case num control dietari intak includ usual meat cook method level odd ratio num confid interv ci calcul multivari logist regress advanc prostat cancer local diseas increas risk higher consumpt hamburg num ci num num process meat num ci num num grill red meat num ci num num red meat num ci num num intermedi intak num amino num methyl num phenylimidazo num b pyridin phip quartil num num num ci num num quartil num num num ci num num higher intak white meat consumpt prostat cancer find provid evid consumpt process meat red meat cook high temperatur increas risk advanc local prostat cancer
MED-4483~n nitroso compound cancer incid european prospect investig cancer nutrit epic norfolk studi pubm ncbi abstract background human expos preform n nitroso compound noc endogen noc noc potenti human carcinogen includ n nitrosodimethylamin ndma evid popul studi inconsist object examin relat dietari noc ndma endogen noc index dietari nitrit cancer incid european prospect investig cancer nutrit epic norfolk unit kingdom studi design prospect studi num men women age num recruit num num baselin diet assess food frequ questionnair result num incid cancer follow up num dietari ndma intak signific increas cancer risk men women hazard ratio hr num num ci num num trend num men hr num num ci num num trend num highest quartil compar lowest quartil age sex adjust analys multivari analys hr num num ci num num hr men num num ci num num trend num continu analyz ndma increas risk gastrointestin cancer hr num num ci num num specif rectal cancer hr num num ci num num num sd increas adjust age sex bodi mass index cigarett smoke status alcohol intak energi intak physic activ educ menopaus status women endogen noc index dietari nitrit signific cancer risk signific interact plasma vitamin concentr dietari ndma intak cancer incid interact num conclus dietari noc ndma higher gastrointestin cancer incid specif rectal cancer plasma vitamin modifi relat ndma exposur cancer risk
MED-4484~salt process meat risk cancer pubm ncbi abstract studi assess associ salt ad tabl process meat risk cancer mail questionnair complet num patient histolog confirm incid cancer stomach colon rectum pancrea lung breast ovari prostat testi kidney bladder brain non hodgkin lymphoma leukaemia num popul control num num measur includ inform socioeconom status lifestyl habit diet num item food frequenc questionnair provid data eat habit num year studi odd ratio num confid interv deriv uncondit logist regress compar ad salt tabl ad salt tabl increas risk stomach lung testicular bladder cancer process meat signific relat risk stomach colon rectum pancrea lung prostat testi kidney bladder cancer leukaemia odd ratio highest quartil rang num num find add evid high consumpt salt process meat play role aetiolog cancer
MED-4485~meat compon meat risk bladder cancer nih aarp diet health studi abstract background meat involv bladder carcinogenesi multipl potenti carcinogen meat rel compound relat cook process includ nitrat nitrit heterocycl amin hcas polycycl aromat hydrocarbon comprehens investig associ meat meat compon bladder cancer method num year follow up num transit cell bladder cancer case identifi num men women complet valid food frequenc questionnair larg prospect nih aarp diet health studi estim intak nitrat nitrit process meat hcas pah cook meat quantit databas measur valu calcul total dietari nitrat nitrit base literatur valu result hazard ratio hr num confid interv ci red meat hr compar quintil num num ci num num p trend num hca num amino num methyl num phenylimidazo num b pyridin phip hr num num ci num num p trend num confer borderlin statist signific increas risk bladder cancer observ posit associ top quintil total dietari nitrit hr num num ci num num p trend num nitrat nitrit intak process meat hr num num ci num num p trend num conclus find provid modest support role total dietari nitrit nitrat nitrit process meat bladder cancer result suggest posit associ red meat phip bladder carcinogenesi
MED-4486~endometri cancer meat consumpt case cohort studi pubm ncbi abstract diet play import role etiolog cancer limit evid regard associ diet risk endometri cancer prospect studi investig meat intak potenti determin endometri cancer risk object studi examin associ endometri cancer risk total meat red meat process meat fish poultri intak conduct case cohort analysi canadian studi diet lifestyl health prospect cohort num adult num women particip recruit num num predomin canadian univers conduct linkag ontario cancer registri year num femal cohort member resid ontario time enrol num yield data cancer incid analyt sampl compris num incid case num subcohort member age stratifi sampl full cohort nonsignific increas risk endometri cancer increas consumpt red meat hazard ratio hr num num confid interv ci num num high low intak trend num process meat hr num num ci num num high low intak trend num meat combin hr num num ci num num high low intak trend num clear pattern note poultri fish result studi base limit number case suggest high meat intak increas risk endometri cancer
MED-4487~red process meat colorect cancer incid meta analysi prospect studi abstract background evid red process meat influenc colorect carcinogenesi judg convinc num world cancer research fund american institut cancer research report ten prospect studi publish result updat evid prospect studi explor non linear associ red process meat colorect cancer risk method find relev prospect studi identifi pubm march num studi relat risk num confid interv ci extract pool random effect model weight invers varianc highest versus lowest intak comparison dose respons meta analys red process meat intak increas colorect cancer risk summari relat risk rr colorect cancer highest versus lowest intak num num ci num num rr num g day increas num num ci num num non linear dose respons meta analys reveal colorect cancer risk increas approxim linear increas intak red process meat approxim num g day curv approach plateau associ similar colon rectal cancer risk analyz separ colorect cancer risk relat intak fresh red meat rr num g day increas num num ci num num process meat rr num g day increas num num ci num num similar result observ colon cancer rectal cancer signific associ observ conclus high intak red process meat signific increas risk colorect colon rectal cancer evid prospect studi support limit red process meat consumpt dietari recommend prevent colorect cancer
MED-4488~epidemilog trend strong suggest exposur etiolog agent pathogenesi sporad alzheimer diseas diabet mellitus pubm ncbi abstract nitrosamin mediat mutagen effect caus dna damag oxid stress lipid peroxid pro inflammatori cytokin activ lead increas cellular degener death pathophysiolog process compris unbuild block age insulin resist diseas includ neurodegener diabet mellitus dm non alcohol steatohepat nash previous studi demonstr experiment exposur streptozotocin nitrosamine rel compound nash diabet mellitus type num num alzheim ad type neurodegener review evid upward spiral trend mortal rate due dm ad parkinson diseas typifi exposur genetic bas diseas model parallel progress increas human exposur nitrat nitrit nitrosamin processed preserv food propos chronic exposur critic role pathogenesi insulin resist diseas pandem potenti solut includ num elimin nitrit food num reduc nitrat level fertil water irrig crop num employ safe effect measur detoxifi food water prior human consumpt futur research effort focus refin abil detect monitor human exposur nitrosamin assess earli evid nitrosamine medi tissu injuri insulin resist
MED-4489~nitrat story  no end sight pubm ncbi abstract demonstr nitrat reduc nitrit human possibl bacteri activ nitrit ubiquit amin lead in vivo synthesi carcinogen nitrosamin averag daili intak nitrat depend amount veget consum nitrat concentr drink water agricultur practic play import part concentr nitrat water veget nitrat plant metabolis amino acid protein nucleic acid store cell vacuol reserv over suppli nitrat relat photosynthesi store nitrat present harvest lead high concentr plant tissu nitrat content plant depend factor plant varieti cultivar kind amount fertilis time harvest environment factor light intens temperatur suggest meet recommend toxicologist dramat reduct nitrat intak human demonstr modern biological organ farm method lead lower leach nitrat lower nitrat content veget synthet fungicid farm method problem reaction metabolit product nitrit high cancerogen multigen nitroso ethylenethiourea exist
MED-4490~survey feed n nitrosodimethylamin ndma domest anim num year period pubm ncbi abstract sodium nitrit formalin preserv fish meal industri norway num num fur farm suffer loss mink due malign liver diseas experiment feed herring meal cow sheep result death anim studi show amin tmao present fish react sodium nitrit preserv nitrogen oxid combust fuel oil process produc toxic agent ndma mink fox consum amount fish meal diet fish meal suffici ndma incid liver failur tumour high long term exposur num mg ndma kg day diet mink cow sheep produc fibro occlus hepat vessel lesion capillari ectasies lik cow similar hemangioma mink mink liver hemangioma develop hemangiosarcoma capillari ectasies lik cow expos ndma repres pre cancer lesion
MED-4491~nutrit composit dry cur ham role healthi diet pubm ncbi abstract dry cur ham tradit product strong presenc market mediterranean area popular european consum enorm econom import meat industri mediterranean area great palat ham larg outweigh aspect relat health wellb increas import factor consum decis potenti role ham context healthi nutrit elucid origin product method dry cur ham induc differ composit object review hand provid analysi compon dry cur ham role healthi diet hand suggest strategi improv nutrit composit num elsevi reserv
MED-4492~meta analysi matern cure meat consumpt pregnanc risk childhood brain tumor pubm ncbi abstract object n nitroso compound noc recogn neural carcinogen anim model suspect human carcinogen meta analysi perform examin associ matern intak cure meat import sourc dietari noc pregnanc risk pediatr brain tumor method data epidemiolog studi pool general variance bas meta analyt method employ confid interv greenland num outcom interest summari relat risk rr reflect risk childhood brain tumor cbt develop matern intak cure meat pregnanc sensit analys perform explain observ statist heterogen result observ studi found met protocol specifi inclus criteria analysi heterogen demonstr lack statist heterogen num indic data statist combin pool data num report data matern cure meat intak type yield rr num num num statist signific result analyz cbt risk type cure meat ingest show hot dog consumpt increas cbt risk num num num similar increas shown frequent ingest sausag num conclus data provid support suspect causal associ ingest noc cure meat pregnanc subsequ cbt offspr limit studi design preclud definit conclus relationship warrant explor addit observ laboratory bas studi copyright num karger ag basel
MED-4493~process meat colorect cancer review epidemiolog experiment evid abstract process meat intak involv etiolog colorect cancer major death affluent countri epidemiolog studi publish date conclud excess risk highest categori process meat eat compris num num compar non eat addit excess risk gram intak higher fresh red meat hypothes base studi carri red meat explain process meat intak link cancer risk test experiment high fat diet promot carcinogenesi insulin resist fecal bile acid ii cook meat high temperatur form carcinogen heterocycl amin polycycl aromat hydrocarbon iii carcinogen n nitroso compound form meat endogen iv heme iron red meat promot carcinogenesi increas cell prolifer mucosa lipoperoxid and or cytotox fecal water nitros increas toxic heme cure product solv puzzl challeng permit reduc cancer load chang process ban process meat
MED-4494~associ process meat unprocess red meat intak incid diabet strong heart famili studi abstract background fifti percent american indian ai develop diabet age num process meat risk diabet ai rural popul high intak process meat meat general refer spam high rate diabet unknown object examin associ usual intak process meat incid diabet ai design prospect cohort studi includ ai particip strong heart famili studi free diabet cardiovascular diseas baselin particip num follow up examin num dietari intak ascertain block food frequ questionnair baselin incid diabet defin basi num american diabet associ criteria general estim equat examin associ dietari intak incid diabet result identifi num incid case diabet comparison upper lower quartil intak process meat higher risk incid diabet num num ci num num adjust potenti confound relat strong spam comparison upper lower quartil num num ci num num intak unprocess red meat incid diabet comparison upper lower quartil num num ci num num conclus consumpt process meat spam unprocess red meat higher risk diabet ai rural popul high risk diabet limit access healthi food
MED-4496~effect fruit veget intak risk coronari heart diseas pubm ncbi abstract background constitu fruit veget reduc risk coronari heart diseas data relationship fruit veget consumpt risk coronari heart diseas spars object evalu associ fruit veget consumpt risk coronari heart diseas design prospect cohort studi set nurs health studi health profession follow up studi particip num women num num year age num year num men num num year num year free diagnos cardiovascular diseas cancer diabet baselin measur main outcom measur incid nonfat myocardi infarct fatal coronari heart diseas num case women num case men diet assess food frequ questionnair result adjust standard cardiovascular risk factor person highest quintil fruit veget intak relat risk coronari heart diseas num num ci num num compar lowest quintil intak num serving d increas intak fruit veget num lower risk coronari heart diseas relat risk num ci num num num test trend green leafi veget relat risk num serving d increas num ci num num vitamin c rich fruit veget relat risk num serving d increas num ci num num contribut appar protect effect total fruit veget intak conclus consumpt fruit veget green leafi veget vitamin c rich fruit veget protect effect coronari heart diseas
MED-4497~case purpl colon pubm ncbi abstract purpl discolor larg bowel autopsi relat beetroot ingest post mortem
MED-4498~trial garlic adjunct therapi multidrug resist pseudomona aeruginosa pneumonia critic ill infant pubm ncbi abstract present case critic ill infant sever multidrug resist pseudomona aeruginosa pneumonia bacteremia treat garlic antibiot vitro demonstr chang resist pattern disc diffus method garlic tr mueller hinton agar knowledg report therapeut garlic critic ill infant literatur
MED-4499~investig antibacteri effect garlic allium sativum concentr garlic deriv organosulfur compound campylobact jejuni fourier transform infrar spectroscopi raman spectroscopi electron microscopi abstract fourier transform infrar ft ir spectroscopi raman spectroscopi studi cell injuri inactiv campylobact jejuni exposur antioxid garlic jejuni treat concentr garlic concentr garlic deriv organosulfur compound growth media salin num num antimicrobi activ diallyl sulfid increas number sulfur atom diallyl sulfid diallyl disulfid diallyl trisulfid ft ir spectroscopi confirm organosulfur compound respons substanti antimicrobi activ garlic greater garlic phenol compound spectral featur protein lipid polysaccharid bacteri cell membran confoc raman microscopi num nm gold particl substrat raman map singl bacterium confirm intracellular uptak sulfur phenol compon scan electron microscopi sem transmiss electron microscopi tem employ verifi cell damag principal compon analysi pca discrimin function analysi dfa soft independ model class analog simca perform result cross valid differenti bacteria base degre cell injuri partial least squar regress plsr employ quantifi predict actual number healthi injur bacteri cell remain treatment plsr base load plot investig verifi cell membran jejuni treat organosulfur compound demonstr bacteri injuri inactiv accur investig complementari infrar raman spectroscopi chemical bas whole organ fingerprint aid chemometr electron microscopi
MED-4501~beeturia biolog fate beetroot pigment pubm ncbi abstract beeturia passag pink red urin ingest beetroot occur num popul common iron defici malabsorpt specif hplc assay betacyanin red beetroot pigment biolog fluid develop studi preval appar polymorph human investig basi rat major peak observ chromatogram extract unpickl beetroot ident uv absorpt spectra lambda max num nm diod array analysi mass spectrometri betacyanin num betanin epim betacyanin num disaccharid betacyanin num popul num normal subject num urinari recoveri oral dose num mg beetroot extract num num betacyanin num num num betacyanin num distribut data skew bimod visual inspect kernel densiti analysi subject produc visibl red urin betacyanin recoveri upper end popul rang studi situ isol perfus rat jejunum liver prepar neglig absorpt pigment num detect metabol biliari secret intact anaesthet rat bolus dose beetroot extract clear betacyanin plasma rate num num sd ml min num num total urinari recoveri pigment amount num dose renal clearanc approach plasma clearanc data suggest beeturia aris defici hepat metabol renal excret betacyanin oral administr beetroot extract rat betacyanin content stomach decreas rapid time intestin bile duct stain visibl red find show instabl betacyanin acid condit suggest variabl biolog fate beetroot pigment determin larg gastric ph empti rate
MED-4502~lifestyl recommend reduc risk kidney stone pubm ncbi abstract kidney stone increas common wealthi industri countri frequent form num idiopath calcium stone diseas eat habit lifestyl direct effect lithogen urinari risk factor pathogenesi condit diet character high intak fluid fruit veget low consumpt salt protein balanc intak calcium fat carbohydr constitut efficaci approach prevent treatment ill correct bodi weight regular exercis reduct stress life event prevent action copyright num elsevi reserv
MED-4504~dietari nitrat supplement reduc num cost walk run placebo control studi pubm ncbi abstract dietari supplement beetroot juic br shown reduc rest blood pressur num cost submaxim exercis increas toler high intens cycl test hypothesi physiolog effect br consequ high num content se presenc potenti bioactiv compound investig blood pressur mitochondri oxid capac max physiolog respons walk moder severe intens run dietari supplement br num deplet br placebo pl control nonsuppl test healthi physic activ male subject assign random double blind crossov design receiv br num l day num mmol num pl num l day num mmol num num day subject complet treadmil exercis test day num num knee extens exercis test estim max num p magnet reson spectroscopi day num supplement period relat pl br elev plasma num concentr num num num num nm num reduc systol blood pressur num num num num mmhg num max pl br num num num num mm s num cost walk num num num num l min pl br num moderate intens run num num num num l min pl br num severe intens run end exercis num uptak num num num num l min pl bl num reduc br time exhaust severe intens run increas num num num num num min pl br num contrast relat control pl supplement alter plasma num concentr blood pressur physiolog respons exercis result posit effect num day br supplement physiolog respons exercis ascrib high num content se
MED-4505~dietari nitrat reduc maxim oxygen consumpt maintain work perform maxim exercis pubm ncbi abstract anion nitrate abund diet ha recent emerg major pool nitric oxid synthase independ product nitrat reduc stepwis vivo nitrit possibl bioactiv nitrogen oxid reduct pathway enhanc low oxygen tension acidosi recent studi show reduct oxygen consumpt submaxim exercis attribut dietari nitrat studi effect dietari nitrat physiolog biochem paramet maxim exercis healthi nonsmok volunt age num num year vo num ax num num l min particip studi random double blind crossov design subject receiv dietari supplement sodium nitrat num mmol kg day placebo nacl num day test dose correspond amount found num nitrate rich veget spinach beetroot maxim exercis test consist increment exercis exhaust combin arm leg crank separ ergomet dietari nitrat reduc vo num ax num num num num l min num reduct vo num ax time exhaust trend increas nitrat supplement num num num num num correl chang time exhaust chang vo num ax num num num moder dietari dose nitrat signific reduc vo num ax maxim exercis larg activ muscl mass reduct occur trend increas time exhaust impli separ mechan involv reduc vo num ax improv energet function work muscl copyright num elsevi reserv
MED-4506~acut dietari nitrat supplement improv cycl time trial perform pubm ncbi abstract purpos dietari nitrat supplement shown reduc num cost submaxim exercis improv high intens exercis toler present unknown enhanc perform simul competit present studi investig effect acut dietari nitrat supplement power output po vo num perform num num km cycl time trial tt method familiar club level competit male cyclist assign random crossov design consum num beetroot juic br num mmol nitrat num nitrate deplet br placebo pl num mmol nitrat num complet num num km tt result br supplement elev plasma nitrit pl num num br num num nm num vo num valu tt signific br pl condit elaps distanc num br signific increas po num km pl num num br num num num num km tt pl num num br num num num br improv num km perform num pl num num br num num min num num km perform num pl num num br num num min num conclus result suggest acut dietari nitrat supplement num br improv cycl economi demonstr higher po vo num enhanc num num km cycl tt perform
MED-4507~increas plasma nitrit dietari nitrat load mark attenu antibacteri mouthwash pubm ncbi abstract recent studi surpris show dietari inorgan nitrat abund veget metabol vivo form nitrit bioactiv nitric oxid reduct blood pressur recent note healthi volunt dietari supplement nitrat effect consist format vasodilatori nitric oxid oral bacteria suggest play role bioactiv nitrat reduc reactiv anion nitrit cross ov design studi healthi volunt examin effect commerci chlorhexidine contain antibacteri mouthwash salivari plasma level nitrit measur oral intak sodium nitrat num g kg dissolv water control situat salivari plasma level nitrat nitrit increas great nitrat load rins mouth antibacteri mouthwash prior nitrat load effect nitrat accumul saliva plasma abolish convers nitrit saliva mark attenu rise plasma nitrit conclud acut increas plasma nitrit nitrat load critic depend nitrat reduct oral caviti commens bacteria remov bacteria antibacteri mouthwash attenu no depend biolog effect dietari nitrat
MED-4508~dietari inorgan nitrat improv mitochondri effici human pubm ncbi abstract nitrat inorgan anion abund veget convert vivo bioactiv nitrogen oxid includ recent demonstr dietari nitrat reduc oxygen cost physic exercis mechan remain unknown double blind crossov trial studi effect dietari intervent inorgan nitrat basal mitochondri function whole bodi oxygen consumpt healthi volunt skelet muscl mitochondria harvest nitrat supplement display improv oxid phosphoryl effici p o ratio decreas state num respir atractylosid respir adenyl improv mitochondri p o ratio correl reduct oxygen cost exercis mechanist nitrat reduc express atp adp translocas protein involv proton conduct conclud dietari nitrat profound effect basal mitochondri function find implic exercis physiolog lifestyle rel disord involv dysfunct mitochondria copyright num elsevi reserv
MED-4509~meta analysi effect soy protein supplement serum lipid pubm ncbi abstract hypercholesterolemia major modifi risk factor cardiovascular diseas studi shown soy protein intak decreas total low dens lipoprotein cholesterol triglycerid increas high dens lipoprotein cholesterol object meta analysi examin effect soy protein supplement serum lipid level adult english languag articl retriev search medlin num februari num bibliographi retriev articl total num random control trial isol soy protein supplement intervent net serum lipid intervent report inform studi design sampl size particip characterist intervent follow up durat treatment outcom independ abstract standard protocol random effect model data studi pool weight invers varianc soy protein supplement signific reduct serum total cholesterol num mg dl num confid interv ci num num low dens lipoprotein cholesterol num mg dl num ci num num triglycerid num mg dl num ci num num signific increas high dens lipoprotein cholesterol num mg dl num ci num num meta regress analys show dose respons relat soy protein isoflavon supplement net serum lipid result soy protein supplement reduc serum lipid adult hypercholesterolemia conclus replac food high satur fat trans satur fat cholesterol soy protein benefici effect coronari risk factor
MED-4510~non soy legum consumpt lower cholesterol level meta analysi random control trial abstract background aim studi evalu effect legum consumpt cholesterol focus soybean non soy legum varieti bean pea seed common consum western countri conduct meta analysi random control trial evalu effect non soy legum consumpt blood lipid method result studi retriev search medlin januari num juli num embas januari num juli num cochran collaboration central regist control clinic trial term medic subject head keyword fabacea soybean isoflavon diet dietari fiber cholesterol hypercholesterolemia triglycerid cardiovascular diseas bibliographi retriev articl search num relev report num random clinic trial select compar non soy legum diet control minimum durat num week report blood lipid intervent control data sampl size particip characterist studi design intervent method durat treatment result independ abstract num investig standard protocol data num trial repres num particip examin random effect model pool net chang total cholesterol treat legum diet compar control num mg dl num confid interv ci num num net chang low densiti lipoprotein cholesterol num mg dl num ci num num conclus result diet rich legum soy decreas total ldl cholesterol
MED-4511~metabol vitamin num status raw vegan diet follow up tablet nutrit yeast probiot supplement pubm ncbi abstract background pure vegetarian diet cobalamin defici due lack dietari intak hypothes popul vegan diet consum raw fruit veget carrot juic dehydr barley grass juic avoid vitamin num defici natur method subject recruit health minist reunion base adher hallelujah diet num year serum cobalamin urinari methylmalon acid mma assay perform follow up sublingu tablet nutrit yeast probiot supplement carri subject abnorm mma result result num subject test subject num num percentil diet num month num subject serum num concentr num pmol l num pg ml num subject num serum num concentr num pmol l num pg ml num subject num abnorm urinari mma concentr equal num microg mg creatinin sublingu cyanocobalamin nutrit yeast probiot supplement signific reduc group mma concentr tablet num yeast num probiot num conclus urinari mma assay effect identifi earli metabol cobalamin defici peopl hallelujah diet raw food vegetarian diet regular monitor urinari mma level consum sublingu cobalamin supplement consum cobalamin food
MED-4512~oral cobalamin remain medicine secret pubm ncbi abstract cross sect survey conduct order describ oral cobalamin geriatrician hematologist general practition explor factor relat studi popul consist geriatrician num hematologist num list canadian medic directori random sampl num general practition respons rate num intramuscular oral cobalamin prescrib num num respond twenti percent report oral intramuscular cobalamin num report oral cobalamin num respond awar rct demonstr efficaci oral cobalamin prior read synopsi studi survey multivari adjust belief oral cobalamin effect certainti carri oral prepar remain independ oral cobalamin oral cobalamin shown efficaci cost effici safe method treat cobalamin defici nonetheless major physician treat condit strategi promot oral cobalamin direct educ physician efficaci provid prescrib inform purchas
MED-4513~diagnost accuraci holotranscobalamin methylmalon acid serum cobalamin indic tissu vitamin status elder pubm ncbi abstract background vitamin defici common elder earli detect clinic import clinic sign symptom limit diagnost accuraci accept refer test method method elder subject num age rang num year investig abil serum cobalamin holotranscobalamin holotc total homocystein thci methylmalon acid mma serum erythrocyt folat hematolog variabl discrimin cobalamin defici defin red blood cell cobalamin num pmol l result serum holotc predictor area roc curv num ci num num num signific num predictor serum cobalamin num num num mma num num num num analyt construct num zone partit posit negat zone deliber indetermin zone boundari valu test result posttest probabl defici num posttest probabl defici num proport indetermin observ holotc cobalamin mma num num holotc indetermin zone defin num pmol l discrimin analysi select erythrocyt folat correct alloc num num observ renal dysfunct compromis diagnost accuraci mma holotc serum cobalamin conclus studi support holotc first lin diagnost procedur vitamin status
MED-4514~low carbohydr diet all caus cause specif mortal cohort studi abstract background data long term associ low carbohydr diet mortal spars object examin associ low carbohydr diet mortal num year follow up women num year men design prospect cohort studi women men num women num men num low carbohydr diet animal bas emphas anim sourc fat protein vegetable bas emphas veget sourc fat protein comput multipl valid food frequenc questionnair assess follow up set nurs health studi health profession follow up studi particip num women age num year baselin num men age num year baselin heart diseas cancer diabet measur investig document num death num cardiovascular num cancer women num death num cardiovascular num cancer men result low carbohydr score modest increas mortal pool analysi hazard ratio hr compar extrem decil num num ci num num p trend num anim low carbohydr score higher all caus mortal pool hr compar extrem decil num num ci num num p trend num cardiovascular mortal hr num num ci num num p trend num cancer mortal hr num num ci num num trend num contrast higher veget low carbohydr score lower all caus hr num num ci num num p trend num cardiovascular mortal hr num num ci num num p trend num limit diet lifestyl characterist assess degre error sensit analys result substanti affect residu confound unmeasur confound addit particip repres sampl popul conclus low carbohydr diet base anim sourc higher all caus mortal men women vegetable bas low carbohydr diet lower all caus cardiovascular diseas mortal rate primari fund sourc nih grant ca num hl num ca num
MED-4515~effect plant bas low carbohydr eco atkin diet bodi weight blood lipid concentr hyperlipidem subject pubm ncbi abstract background low carbohydr high anim protein diet advoc weight loss promot desir reduct low dens lipoprotein cholesterol ldl c concentr effect exchang anim protein fat veget origin test object determin effect weight loss ldl c concentr low carbohydr diet high veget protein gluten soy nut fruit veget cereal veget oil compar high carbohydr diet base low fat dairi grain product method total num overweight hyperlipidem men women consum num low carbohydr num total calori high veget protein num gluten soy nut fruit veget cereal veget oil num plant bas diet num high carbohydr lacto ovo vegetarian diet num carbohydr num protein num fat num week parallel studi design studi food provid num calori requir result num subject num test num control num complet studi weight loss similar diet approxim num kg reduct ldl c concentr total cholesterol hdl c apolipoprotein b apolipoprotein ai ratio greater low carbohydr compar high carbohydr diet num num num num num num reduct systol diastol blood pressur num num num num conclus low carbohydr plant bas diet lipid low advantag high carbohydr low fat weight loss diet improv heart diseas risk factor convent low fat diet anim product
MED-4516~abil high tot antioxid capac diet increas stool weight bowel antioxid status human subject pubm ncbi abstract limit knowledg effect unabsorb dietari antioxid reach larg intestin bowel habit aim present studi investig dietari recommend direct increas diet total antioxid capac tac affect gut function human subject cross ov intervent nineteen subject high tac ht low tac lt diet num week compar energi macronutri total dietari fibr alcohol content end intervent period num stool output record faecal sampl obtain subset subject moistur ph ammonia content lactobacillus bifidobacterium count faecal water antioxid genotox measur num weigh food record assess diet composit ht lt diet intak signific increas intak tac vitamin phenol compound observ ht diet intak higher intak antioxid led increas num stool output num sd num ht num sd num lt higher tac total phenol concentr faecal water signific variat measur paramet observ diet conclus diet select rais intak dietari antioxid increas stool bulk antioxid content faec
MED-4517~fecal weight colon cancer risk dietari intak nonstarch polysaccharid dietari fiber pubm ncbi abstract low fecal weight slow bowel transit time thought bowel cancer risk publish data defin bowel habit communiti exist data stool weight collect num popul num countri defin risk accur relationship stool weight dietari intak nonstarch polysaccharid nsp dietari fiber quantifi num healthi adult undertak care fecal collect median daili stool weight num g day men num g day women num g day num whole gut transit time num hour men num hour women num hour num num women num men pass num stool day data popul world show averag stool weight vari num num g day invers relat colon cancer risk num meta analysi num studi daili fecal weight measur accur num group peopl num control diet nsp content show signific correl fiber intak daili stool weight num stool weight western popul low num g day increas colon cancer risk fecal output increas dietari nsp diet character high nsp intak approxim num g day stool weight num g day reduc risk bowel cancer
MED-4518~antioxid activ human faec pubm ncbi abstract scarcely absorb antioxid reach larg bowel exhibit antioxid activ oppos action reactiv speci bacteri cellular metabol contribut protect oxid damage induc gastrointestin diseas studi carri evalu antioxid activ faec group healthi subject freely select diet associ intak macro micronutri food group fourteen subject record food intak time period num time collect faec pass num total antioxid activ taa mmol num hydroxi num num tetramethylchroman num carboxyl acid trolox kg faecal suspens measur num azinobi num ethylbenzothiazolin num sulfon acid radic cation abt decoloris assay averag taa faec num sd num mmol trolox kg wet faec rang num num total amount antioxid equival excret num deriv multipli taa amount faec pass num num sd num mmol trolox rang num num signific correl averag num intak coffe red wine sum coffe red wine conclus faec healthi subject show detect capac scaveng radic cation suggest antioxid activ occur colon lumen activ part relat dietari habit
MED-4520~assess atherosclerosi role flow medi dilat pubm ncbi abstract evid suggest endotheli dysfunct causal pathway atherogenesi destabil establish plaqu review role flow medi dilat fmd non invas method assess endotheli function discuss technic modif develop analysi softwar signific improv variabl method strict standard protocol enabl reproduc measur achiev export techniqu special laboratori popul studi multicentr set endotheli function assess fmd shown affect cardiovascular risk factor relat structur arteri diseas cardiovascular outcom valid studi pathophysiolog arteri diseas numer studi demonstr respons physiolog pharmacolog intervent flow medi dilat uniqu opportun drug develop programm assess earli rapid respons signal risk benefit complement endpoint structur arteri diseas cardiovascular outcom longer expens
MED-4522~food select base high total antioxid capac improv endotheli function low cardiovascular risk popul pubm ncbi abstract background aim oxid stress advoc major cardiovascular diseas cvd low plasma antioxid concentr endotheli dysfunct step atherosclerosi antioxid content fruit veget explain part protect effect cvd supplement antioxid vitamin fail improv endotheli function reduc cvd risk aim studi investig impact diet rich antioxid endotheli function measur flow medi dilat fmd volunt low cardiovascular risk method result crossov trial num subject num women age num num year receiv randomis order num day high ht num day low lt antioxid diet num week wash out wo diet compar daili portion fruit veget alcohol fibr macronutri intak differ total antioxid capac diet anthropometr blood pressur fast plasma glucos lipid profil hepat enzym circul antioxid concentr high sensit c reactiv protein hs crp fmd assess fmd increas signific ht diet compar lt num fmd valu num higher ht compar lt num adjust age gender diet order tocopherol increas signific num hs crp glutamyltranspeptidas decreas signific num num ht diet compar lt diet conclus short term ht diet improv endotheli function volunt low cardiovascular risk reduc risk cvd copyright num elsevi reserv
MED-4523~lipophil hydrophil antioxid capac common food unit state pubm ncbi abstract lipophil hydrophil antioxid capac determin oxygen radic absorb capac orac fl assay fluorescein fluoresc probe num azobi num amidinopropan dihydrochlorid peroxyl radic generat num kind food includ fruit veget nut dri fruit spice cereal infant food food collect region season market total phenol sampl measur folin ciocalteu reagent hydrophil orac fl valu h orac fl rang num num micromol trolox equival te g food lipophil orac fl valu l orac fl rang num num micromol te g general l orac fl valu num h orac fl valu sampl total antioxid capac calcul combin l orac fl h orac fl differ orac fl valu fruit veget season region larg food analyz detail sampl scheme process method cook peel select food evalu impact process orac fl data demonstr process signific effect orac fl food analyz relationship tp h orac fl show weak correl total hydrophil lipophil antioxid capac intak calcul num num micromol te day basi data usda continu survey food intak individu num
MED-4524~chemistri antioxid capac assay pubm ncbi abstract review summar multifacet aspect antioxid basic kinet model inhibit autoxid analyz chemic principl antioxid capac assay depend reaction involv assay rough classifi type assay base hydrogen atom transfer hat reaction assay base electron transfer major hat bas assay appli competit reaction scheme antioxid substrat compet thermal generat peroxyl radic decomposit azo compound assay includ inhibit induc low dens lipoprotein autoxid oxygen radic absorb capac orac total radic trap antioxid paramet trap crocin bleach assay et bas assay measur capac antioxid reduct oxid color reduc degre color chang correl sample antioxid concentr et bas assay includ total phenol assay folin ciocalteu reagent fcr trolox equival antioxid capac teac ferric ion reduc antioxid power frap total antioxid potenti assay cu ii complex oxid dpph addit assay intend measur sample scaveng capac biolog relev oxid singlet oxygen superoxid anion peroxynitrit hydroxyl radic summar basi analysi suggest total phenol assay fcr quantifi antioxidant reduc capac orac assay quantifi peroxyl radic scaveng capac comprehens studi aspect antioxid valid specif assay addit common accept assay
MED-4525~studi antidiarrho effect dragon blood croton urucurana pubm ncbi abstract red sap obtain slash bark croton urucurana baill euphorbiacea dragon blood screen antidiarrho activ castor oil induc diarrhoea rat cholera toxin induc intestin secret mice small intestin transit mice dragon blood oral dose num mg kg caus mark inhibit diarrhoeal respons castor oil administr intestin fluid accumul promot cholera toxin similar dose red sap signific inhibit small intestin transit found independ opioid mechan result suggest potenti red sap croton urucurana baill control secretori diarrhoea patholog copyright num john wiley son
MED-4526~mutagen antioxid activ croton lechleri sap biolog system pubm ncbi abstract sap croton lechleri muell arg euphorbiacea call dragon blood folk medicin cicatriz anti inflammatori treat cancer research antioxid activ croton lechleri sap evalu yeast saccharomyc cerevisia maiz plantlet treat oxid agent apomorphin hydrogen peroxid mutagen activ sap analyz salmonella microsom assay salmonella typhimurium ta num ta num ta num ta num ta num cell yeast saccharomyc cerevisia result show croton lechleri sap possess signific antioxid activ oxid damag induc apomorphin saccharomyc cerevisia condit studi case hydrogen peroxid antioxid activ sap detect cell stationari phase growth sap protect cell maiz plantlet toxic effect apomorphin sap show mutagen activ strain ta num salmonella typhimurium presenc metabol activ weak mutagen activ strain ta num strain detect base pair substitut frameshift mutat mutagen observ haploid saccharomyc cerevisia strain xv num lys num num locus specif revers hom num frameshift mutat
MED-4527~sangr de grado croton palanostigma induc apoptosi human gastrointestin cancer cell pubm ncbi abstract sangr de grado ethnomedicin red tree sap obtain croton spp treat gastrointestin ulcer cancer promot wound heal evalu potenti role sangr de grado sdg cancer examin effect human cancer cell ag stomach ht num num colon viabil cell treat sdg num microg ml decreas num dose depend manner measur num period cell prolifer num decreas num cell treat sdg num microg ml cell suspens treat sdg num microg ml cell adher sever compromis num cell treat sdg num microg ml underw apoptosi detect nucleus condens dna fragment determin elisa flow cytometri morpholog assess acridin orang effect similar observ taxol num microm signific alter microtubular architectur equal observ stomach colon cancer cell expos sdg num microg ml induct apoptosi microtubul damag ag ht num num cell suggest sangr de grado evalu potenti sourc anti canc agent
MED-4529~lead mercuri arsenic indian manufactur ayurved medicin sold internet abstract context lead mercuri arsenic detect substanti proport indian manufactur tradit ayurved medicin metal present due practic rasa shastra combin herb metal miner gem toxic metal present indian manufactur ayurved medicin unknown object determin preval ayurved medicin internet detect lead mercuri arsenic compar preval toxic metal indian manufactur medicin rasa shastra rasa shastra medicin design search num internet search engin search term ayurveda ayurved medicin identifi num web site offer tradit ayurved herb formula ingredi common ayurveda oral sale num identifi product num ayurved medicin random select purchas august octob num countri manufacturer web site supplier rasa shastra status claim good manufactur practic record metal concentr measur x ray fluoresc spectroscopi main outcom measur preval medicin detect toxic metal entir sampl stratifi countri manufactur rasa shastra status result hundr ninety thre num request medicin receiv analyz preval metal contain product num num confid interv ci num num preval metal us manufactur product num num ci num num compar num num ci num num indian product num rasa shastra compar rasa shastra medicin greater preval metal num num num higher median concentr lead num g g num g g num mercuri num g g num g g num metal contain product num sold web site num claim good manufactur practic metal contain product exceed num standard accept daili intak toxic metal conclus one fifth us manufactur indian manufactur ayurved medicin purchas internet detect lead mercuri arsenic
MED-4531~monitor mercuri arsenic lead tradit asian herbal prepar dutch market estim risk pubm ncbi abstract tradit herbal prepar ayurveda tradit chines medicin tradit tibetan medicin asian tradit medicin system signific amount mercuri arsenic lead deliber incorpor asian tradit herbal prepar therapeut purpos constitu caus intox worldwid aim studi determin mercuri arsenic lead level asian tradit herbal prepar dutch market total num tradit herbal prepar ayurveda tradit chines medicin tradit tibetan medicin sampl num num sampl multi ingredi tradit herbal prepar herb miner label num tradit herbal prepar suggest presenc mercuri arsenic lead element shown induct coupl mass spectrometri icp m num num tradit herbal prepar estim week mercuri arsenic lead intak level calcul tradit herbal prepar analyt determin concentr recommend dose total num tradit herbal prepar num result intak element signific exceed safeti limit num tradit herbal prepar intak estim num tradit herbal prepar signific exceed safeti limit mercuri rang num num mg week num intak estim num tradit herbal prepar signific exceed safeti limit arsenic rang num num mg week num intak estim tradit herbal prepar signific safeti limit lead rang num num mg week num conclud mercuri arsenic lead content tradit herbal prepar ayurveda tradit chines medicin tradit tibetan medicin remain concern requir strict control
MED-4532~cytotox respons breast cancer cell line mcf num num triphala modif antioxid pubm ncbi abstract cytotox effect triphala tpl indian ayurved formul anti canc properti investig human breast cancer cell line differ num status vitro studi show mcf num wild type num sensit tpl num num negat tpl induc loss cell viabil determin mtt assay num incub ic num valu mcf num found approxim num icrog ml num approxim num icrog ml tpl inhibit clonogen growth mcf num cell signific recov pifithrin alpha num inhibitor pifithrin alpha modifi tpl induc cytotox num cell exogen addit antioxid glutathion gsh n acetyl cystein nac inhibit anti prolif abil tpl mcf num num annexin v propidium iodid doubl stain cell treat tpl num reveal tpl induc signific apoptosi cell line dose depend manner magnitud apoptosi signific higher mcf num num cell tpl found induc dose time depend increas intracellular reactiv oxygen speci cell line present result demonstr mcf num num cell exhibit differenti sensit tpl depend num status inhibit anti prolif abil tpl antioxid suggest role tpl induc ros induct apoptosi conclud num status cancer cell form import factor predict respons cancer cell prooxid drug
MED-4533~heavi metal content ayurved herbal medicin product pubm ncbi abstract context lead mercuri arsenic intox ayurved herbal medicin product hmps object determin preval concentr heavi metal ayurved hmps manufactur south asia sold boston area store compar estim daili metal ingest regulatori standard design set systemat search strategi identifi store num mile boston citi hall sold ayurved hmps south asia search onlin yellow page categori market supermarket conveni store busi word india indian citi indian word onlin nation directori indian groceri store south asian communiti busi directori newspap search visit store purchas uniqu ayurved hmps april num octob num main outcom measur concentr microg g lead mercuri arsenic hmp measur x ray fluoresc spectroscopi estim daili metal ingest adult children estim manufactur dosag recommend comparison pharmacopeia environment protect agenc regulatori standard result total num num hmps num confid interv num num heavi metal lead num median concentr num microg g rang num num mercuri num median concentr num microg g rang num num and or arsenic num median concentr num microg g rang num recommend manufactur num result heavi metal intak publish regulatori standard conclus num ayurved hmps produc south asia boston south asian groceri store potenti harm level lead mercuri and or arsenic user ayurved medicin risk heavi metal toxic test ayurved hmps toxic heavi metal mandatori
MED-4534~triphala ayurved formul treat prevent cancer review pubm ncbi abstract background triphala sanskrit tri phala fruit compos medicin fruit phyllanthus emblica emblica officinali gaertn terminalia chebula retz terminalia belerica retz import herbal prepar tradit indian system medicin ayurveda triphala antioxidant rich herbal formul possess divers benefici properti wide prescrib ayurved drug colon cleanser digest diuret laxat cancer major death global studi conduct prevent cancer develop effect nontox therapeut agent experiment studi past decad shown triphala prevent cancer possess antineoplast radioprotect chemoprotect effect conclus review time summar result emphasi publish observ mechan respons benefici effect lacuna exist knowledg bridg discuss
MED-4535~detect toxic heavi metal pesticid residu herbal plant common herbal formul pubm ncbi abstract herbal formul popular world commerci extens medicin properti emphas qualiti assur herbal product includ test heavi metal pesticid residu view guidelin singl herbal drug herbal formul collect local market test heavi metal persist pesticid residu present case examin local sampl herb emblica officinali terminalia chebula terminalia belerica withania somnifera present studi select estim heavi metal arsenic cadmium lead mercuri pesticid residu organochlorin pesticid organophosphorus pesticid pyrethroid analyz sampl singl crude drug heavi metal pesticid residu found detect limit sampl
MED-4536~potenti tradit ayurved formul triphala anticanc drug pubm ncbi abstract cytotox effect aqueous extract triphala ayurved formul investig human breast cancer cell line mcf num transplant mous thymic lymphoma barcl num viabil treat cell found decreas increas concentr triphala hand treatment normal breast epitheli cell mcf num human peripher blood mononuclear cell mous liver spleen cell similar concentr triphala affect cytotox signific drug treatment found induc apoptosi mcf num barcl num cell vitro determin annexin v fluoresc proport apoptot cell found depend triphala concentr mcf num cell treat triphala subject singl cell gel electrophoresi reveal pattern dna damag characterist apoptosi studi triphala treat mcf num barcl num cell show signific increas intracellular reactiv oxygen speci ros concentr depend manner ros increas found insignific mcf num murin spleen liver normal cell vivo direct oral feed triphala mice num mg kg bodi weight transplant barcl num produc signific reduct tumor growth evalu tumor volum measur found apoptosi signific higher excis tumor tissu triphala fed mice compar control suggest involv apoptosi tumor growth reduct result suggest triphala possess abil induc cytotox tumor cell spare normal cell differenti effect triphala normal tumor cell relat abil evok differenti respons intracellular ros generat differenti respons normal tumor cell triphala vitro substanti regress transplant tumor mice fed triphala point potenti anticanc drug clinic treatment
MED-4538~effect amla fruit emblica officinali gaertn blood glucos lipid profil normal subject type num diabet patient pubm ncbi abstract present studi evalu anti hyperglycem lipid low properti emblica officinali gaertn fruit normal diabet human volunt result signific decreas num fast num post prandi blood glucos level num day normal diabet subject receiv num num officinali powder day compar baselin valu signific num decreas observ total cholesterol triglycerid normal diabet volunt day num num num officinali powder day diabet volunt receiv num officinali powder exhibit signific num decreas total lipid day num normal diabet volunt receiv num num officinali powder signific num improv high dens lipoprotein cholesterol lower low dens lipoprotein cholesterol level
MED-4539~natur product sourc drug num year pubm ncbi abstract review updat expand version prior review publish journal num num case approv agent time frame extend includ num year num num diseas worldwid num earliest identifi num approv antitumor drug worldwid continu util secondari subdivis natur product mimic nm join origin primari divis data present util natur product sourc structur necessarili final drug entiti aliv area cancer time frame num date num small molecul num synthet num natur product direct deriv therefrom area influenc natur product structur mark expect prior inform antiinfect area depend natur product structur combinatori chemistri techniqu succeed method optim structur fact optim recent approv agent identifi de novo combinatori compound approv drug num year time frame draw attent reader rapid evolv recognit signific number natur product drugs lead produc microb and or microbi interact host isol area natur product research expand signific
MED-4540~mark variabl monacolin level commerci red yeast rice product buyer bewar pubm ncbi abstract background red yeast rice ryr wide dietari supplement million patient altern therapi hyperlipidemia num activ compound call monacolin inhibit hepat cholesterol synthesi studi suggest formul ryr effect safe lipid lower monacolin level standard market product general publish label evalu monacolin level num commerci ryr formul test citrinin mycotoxin nephrotox anim method formul ryr label num mg capsul activ product analys monacolin citrinin perform august num june num high perform liquid chromatographi mass spectroscopy mass spectroscopi detect laboratori analys ryr product conduct consumerlab white plain york result mark variabl num ryr product total monacolin num num mg capsul monacolin lovastatin num num mg capsul monacolin ka num num mg capsul product elev level citrinin conclus found strike variabl monacolin content num proprietari ryr product presenc citrinin one third formul test ryr potenti altern lipid low agent find suggest improv standard ryr product product label occur physician cautious recommend ryr patient treatment hyperlipidemia primari secondari prevent cardiovascular diseas
MED-4541~compar cardiovascular effect thiazolidinedion systemat review meta analysi observ studi abstract object determin compar effect thiazolidinedion rosiglitazon pioglitazon myocardi infarct congest heart failur mortal patient type num diabet design systemat review meta analysi observ studi data sourc search medlin embas septemb num studi select observ studi direct compar risk cardiovascular outcom rosiglitazon pioglitazon patient type num diabet mellitus includ data extract random effect meta analysi invers varianc method calcul odd ratio cardiovascular outcom thiazolidinedion num statist assess statist heterogen result cardiovascular outcom num observ studi num case control studi num retrospect cohort studi includ num num thiazolidinedion user evalu detail review num citat compar pioglitazon rosiglitazon statist signific increas odd myocardi infarct num studi odd ratio num num confid interv num num num num congest heart failur num num num num num num death num num num num num num number treat harm nnh depend popul risk suggest num excess myocardi infarct num excess case heart failur num excess death num num patient receiv rosiglitazon pioglitazon conclus patient type num diabet rosiglitazon signific higher odd congest heart failur myocardi infarct death relat pioglitazon real world set
MED-4543~antitumour effect phyllanthus emblica induct cancer cell apoptosi inhibit vivo tumour promot vitro invas pubm ncbi abstract phyllanthus emblica linn pe medicin fruit asian tradit medicin system treatment diseas includ cancer present studi test potenti anticanc effect aqueous extract pe num cancer cell line num vitro apoptosi num mous skin tumourigenesi num vitro invas pe extract num microg ml signific inhibit cell growth human cancer cell line num lung hepg num liver hela cervic mda mb num breast sk ov num ovarian sw num colorect extract toxic mrc num normal lung fibroblast apoptosi hela cell observ pe extract caus dna fragment increas activ caspas num caspas num caspas num up regul fas protein indic death receptor medi mechan apoptosi treatment pe extract mous skin result num reduct tumour number volum anim treat dmba tpa num num microg ml pe extract inhibit invas mda mb num cell vitro matrigel invas assay result suggest emblica exhibit anticanc activ select cancer cell warrant studi chemoprevent antiinvas agent copyright num john wiley son
MED-4544~amla emblica officinali gaertn berri treatment prevent cancer pubm ncbi abstract emblica officinali gaertn phyllanthus emblica linn common indian gooseberri amla arguabl import medicin plant indian tradit system medicin ayurveda part plant treat rang diseas import fruit fruit combin plant treat ailment common cold fever diuret laxat liver tonic refriger stomach restor alter antipyret anti inflammatori hair tonic prevent peptic ulcer dyspepsia digest preclin studi shown amla possess antipyret analges antituss antiatherogen adaptogen cardioprotect gastroprotect antianemia antihypercholesterolemia wound heal antidiarrh antiatherosclerot hepatoprotect nephroprotect neuroprotect properti addit experiment studi shown amla phytochem gallic acid ellag acid pyrogallol norsesquiterpenoid corilagin geraniin elaeocarpusin prodelphinidin num num possess antineoplast effect amla report possess radiomodulatori chemomodulatori chemoprevent effect free radic scaveng antioxid anti inflammatori antimutagen immunomodulatori activ properti efficaci treatment prevent cancer review time summar result relat properti emphas aspect warrant futur research establish activ util cancer prevent therapeut drug human
MED-4545~ai palm fruit euterp oleracea mart pulp improv surviv fli high fat diet abstract reduc oxid damag thought effect age intervent ai fruit indigen amazon rich phytochem possess high anti oxid activ anti inflammatori anti canc anti cardiovascular diseas properti potenti anti ag properti organism level evalu effect ai pulp modul lifespan drosophila melanogast found ai supplement num food increas lifespan femal fli fed high fat diet compar non suppl control measur transcript induc ai age rel gene transcript level gene test alter ai increas transcript level num efl small heat shock rel protein detoxif gene gstd num mtna decreas transcript level phosphoenolpyruv carboxykinas pepck key gene involv gluconeogenesi ai increas lifespan oxid stress femal caus sod num rnai suggest ai improv surviv fli fed high fat diet activ stress respons pathway suppress pepck express ai potenti antagon detriment effect fat diet allevi oxid stress age
MED-4546~acut subacut toxic tyramin spermidin spermin putrescin cadaverin rat pubm ncbi abstract acut subacut toxic biogen amines tyramin spermidin spermin putrescin cadaverine wer examin wistar rat tyramin cadaverin low acut oral toxic num mg kg bodi weight putrescin acut oral toxic num mg kg bodi weight spermidin spermin num mg kg bodi weight amin investig caus dose rel decreas blood pressur intraven administr tyramin increas found num wk studi biogen amin administ diet group num male num femal rat tyramin cadaverin level num num num ppm spermin putrescin level num num num ppm spermidin level num num num ppm studi level num num ppm studi spermin toxic high dose level show great number emaci aggress convuls paralysi hind leg growth food intak water intak decreas slight anaemia male plasma clinic chemistri occur relat weight thyroid adren spleen heart increas liver decreas impair kidney function renal histopatholog plasma electrolyt urea occur spermin histopatholog examin reveal decreas glycogen content liver reduct spermatogenesi sever deplet splenic white pulp acut involut thymus moder myocardi degener heart myocardi degener mid dos male advers effect observ top dose group amin decreas bodi weight diminish food intak general slight increas pack cell volum haemoglobin concentr thrombocyt occur cadaverin spermidin decreas plasma creatinin calcium inorgan phosphat observ decreas potassium level cadaverin no observed adverse effect level num ppm num mg kg bodi weight day tyramin cadaverin putrescin num ppm num mg kg bodi weight day spermidin num ppm num mg kg bodi weight day spermin
MED-4547~determin biogen amin korean tradit ferment soybean past doenjang pubm ncbi abstract biogen amin produc bacteri decarboxyl amino acid toxicolog symptom food product twenty thre sampl tradit korean ferment soybean past sampl doenjang analyz order determin content biogen amin amin extract num perchlor acid derivat dansyl chlorid biogen amin separ doenjang sampl high perform liquid chromatographi gradient elut acetonitril ammonium acet detect spectrophotometr uv vi detect num nm ph sampl rang num num strong amino acid decarboxylas activ found acid environ valu biogen amin tryptamin num phenyl ethylamin putrescin cadaverin agmatin histamin tyramin spermidin spermin determin num doenjang sampl found num num num num num num num num num mg find studi enhanc safeti doenjang salt and or ferment food product copyright num elsevi reserv
MED-4548~common household chemic allergi risk pre school age children abstract background risk indoor exposur volatil organ compound voc allerg airway diseas children remain unknown object examin residenti concentr voc emit build materi paint furnitur lifestyl practic risk multipl allerg diseas ige sensit pre school age children sweden method case control investig num case children asthma allergi num healthi control air sampl collect room child slept air sampl analyz level class voc result natural log unit sum propylen glycol glycol ether pges bedroom air equal interquartil rang num num g m num num fold greater likelihood case num ci num num num fold greater likelihood asthma num ci num num num fold greater likelihood rhiniti num ci num num num fold greater likelihood eczema num ci num num account gender secondhand smoke allergi parent wet clean chemic agent construct period build limonen cat dog allergen butyl benzyl phthalat bbzp di num ethylhexyl phthalat dehp analysi restrict case unit concentr num fold greater likelihood ige sensit num ci num num compar non ig sensit case similar associ found class voc conclus propos hypothesi pges indoor air exacerb and or induc multipl allerg symptom asthma rhiniti eczema ige sensit
MED-4550~impact diet serum fatti acid lipid profil polish vegetarian children children allergi pubm ncbi abstract background object vegetarian diet increas trend western world poland frequenc allergi grow effect vegetarian diet allerg diseas concern research aim studi effect vegetarian diet lipid profil serum group polish children poland investig lipid paramet healthi vegetarian children omnivor children diagnos atop diseas subjects method serum lipid profil triglycerid total cholesterol low dens lipoprotein ldl high dens lipoprotein hdl cholesterol fatti acid assess group children healthi vegetarian num children diagnos atop diseas num control group healthi omnivor num diet classif assess questionnair result differ observ serum triglycerid ldl cholesterol satur monounsatur fatti acid level group group polish vegetarian children record high consumpt veget oil rich monounsatur fatti acid sunflow oil linol acid observ higher content linol acid serum group polyunsatur num fatti acid linol acid reveal signific num lower level allergi vegetarian group case eicosapentaeno acid num fatti acid allergi group show higher level compound comparison vegetarian conclus signific higher concentr linol acid vegetarian children comparison allergi group altern path lipid metabol studi group consequ element vegetarian diet promot protect allergi
MED-4551~matern meat fat consumpt pregnanc suspect atop eczema japanes infant age num month osaka matern child pubm ncbi abstract interest increas possibl matern dietari intak pregnanc influenc develop allerg disord children present prospect studi examin associ matern intak select food high fatti acid specif type fatti acid pregnanc risk suspect atop eczema japanes infant age num month subject num mother child pair inform matern dietari intak pregnanc assess valid self administ diet histori questionnair term suspect atop eczema defin outcom base result questionnair complet mother num month postpartum risk suspect atop eczema num num higher matern intak meat pregnanc signific increas risk suspect atop eczema offspr multivari odd ratio highest lowest quartil num num confid interv ci num num trend num posit associ strengthen definit outcom confin definit physician diagnosi atop eczema num multivari extrem quartil num num ci num num trend num materi exposure respons relationship observ matern intak egg dairi product fish total fat satur fatti acid monounsatur fatti acid num polyunsatur fatti acid alpha linolen acid eicosapentaeno acid docosahexaeno acid num polyunsatur fatti acid linol acid arachidon acid cholesterol ratio num num polyunsatur fatti acid consumpt risk suspect atop eczema higher matern meat intak increas risk infantil atop eczema found evid matern intak fish num polyunsatur fatti acid prevent infantil atop eczema num john wiley son a
MED-4553~advanc glycat end product biomark gerontotoxin basi explor methylglyoxal low agent alzheimer diseas pubm ncbi abstract alzheimer diseas ad common dement disord late life trigger event earli stage diseas converg characterist final pathway late stage character inflamm neurodegener review put forward hypothesi advanc glycat end product age precursor includ methylglyox biomark causat agent gerontotoxin characterist disord accumul age normal featur age acceler ad age detect amyloid plaqu neurofibrillari tangl age modif explain neuropatholog biochem featur ad extens protein cross link inflamm oxid stress neuron cell death suggest methylglyox major carbonyl speci respons format age propos promis pharmacolog approach prevent format age lower methylglyox concentr achiev decreas concentr methylglyox precursor d glyceraldehyd num phosphat higher flux pentos phosphat pathway increas methylglyox detoxif glyoxalas system altern methylglyox scaveng type carbonyl scaveng copyright num elsevi reserv
MED-4554~advanc glycat end product food practic guid reduct diet abstract modern diet larg heat process result high level advanc glycat end product age dietari advanc glycat end product dage contribut increas oxid stress inflamm link recent epidem diabet cardiovascular diseas report signific expand dage databas valid dage test methodolog compar cook procedur inhibitori agent dage format introduc practic approach reduc dage consumpt daili life base find dri heat promot dage format num num fold uncook state food categori animal deriv food high fat protein general age rich prone age format cook contrast carbohydrate rich food veget fruit grain milk age cook format dage cook prevent age inhibitori compound aminoguanidin signific reduc cook moist heat shorter cook time cook lower temperatur acid ingredi lemon juic vinegar dage databas valuabl instrument estim dage intak guid food choic reduc dage intak
MED-4555~analysi risk factor abdomin aortic aneurysm cohort num million individu pubm ncbi abstract background abdomin aortic aneurysm aaa diseas insidi condit num chanc death ruptur ultrasound screen reduc mortal advoc limit subset popul risk method data retrospect cohort num million patient complet medic lifestyl questionnair evalu ultrasound imag presenc aaa life line screen num num risk factor aaa identifi multivari logist regress analysi result observ posit associ increas year smoke cigarett smoke negat associ smoke cessat excess weight increas risk exercis consumpt nut veget fruit reduc risk black hispan asian lower risk aaa white nativ american well known risk factor reaffirm includ male gender age famili histori cardiovascular diseas predict score system creat identifi aneurysm effici current criteria includ women nonsmok individu age num year model nation statist risk factor preval estim num million aaa unit state num women nonsmok individu age num year conclus smoke cessat healthi lifestyl lower risk aaa estim half patient aaa diseas elig screen current guidelin creat high yield screen algorithm expand target popul screen includ at risk individu identifi exist screen criteria
MED-4556~toler upper intak level tran fat satur fat cholesterol pubm ncbi abstract toler upper intak level ul set institut medicin iom import part estim percentag popul potenti risk advers effect excess nutrient intak iom set ul tran fat satur fat cholesterol intak level num energi increas ldl cholesterol concentr food compon unavoid ordinari diet purpos analysi present review evalu clinic trial prospect observ data previous consid set ul aim determin current ul model satur fat tran fat cholesterol result analysi confirm limit risk assess model set ul inabl identifi ul food compon cholesterol lack intak threshold increas chronic diseas risk num intern life scienc institut
MED-4559~statin neutral cardiovascular risk unhealthi dietari choic pubm ncbi abstract cardiovascular risk reduct statin prevent cardiovascular diseas cardiovascular risk increas excess dietari intak fat quantifi relat risk direct juxtapos determin increas relat risk num activ neutral oppos chang relat risk activ investig compar increas relat risk cardiovascular diseas total fat tran fat content fast food relat risk decreas provid daili statin consumpt meta analysi statin primari prevent coronari arteri diseas num random control trial includ num patient risk reduct daili consumpt statin pravastatin power risk increas caus daili extra fat intak num oz hamburg quarter pounder chees small milkshak conclus statin therapi neutral cardiovascular risk caus harm diet choic sphere human activ individu choos riski pursuit motorcycl smoke drive advis compel measur minim risk safeti equip filter seatbelt likewis individu eat unhealthili routin access statin establish provid unhealthi food ration modern offset cardiovascular risk fast food outlet offer free condiment supplement meal free statin contain accompani offer cardiovascular benefit opposit effect equal salt sugar high fat condiment substitut systemat lifestyl improv includ healthi diet regular exercis weight loss smoke cessat complimentari statin packet add cost num posit choic panopli negat
MED-4560~prevent arrest coronari atherosclerosi pubm ncbi abstract good news coronari atherosclerosi aw lot plaqu symptom myocardi ischemia occur bad news larg quantiti plaqu symptom occur half unit state eventu quantiti atherosclerosi infrequ hereditari origin atherosclerosi consum fat cholesterol calori consequ elev num mg dl serum total cholesterol level higher number num greater quantiti plaqu deposit arteri serum total cholesterol level prevent rise num mg dl plaqu laid elev level lower num mg dl plaqu form part present vanish fruit vegetarian starch diet rule achiev num mg dl level adult lipid low drug requir patient famili hypercholesterolemia patient atherosclerot event news atherosclerosi prevent hereditari form arrest lower elev serum total ldl cholesterol num mg dl level
MED-4562~intens lipid low therapi patient hospit acut coronari syndrom analysi num hospit num hosp pubm ncbi abstract object studi aim analyz intens lipid low therapi llt discharg broad popul patient hospit acut coronari syndrom ac background earli intens statin therapi ac shown reduc cardiovascular morbid mortal util predictor llt hospit ac patient method gwtg databas analyz acs rel hospit num num llt defin dose statin combin therapi produc num reduct low dens lipoprotein ldl intens llt discharg assess baselin characterist tempor trend llt compar num treatment group result num patient receiv llt num num treat llt regimen total cholesterol ldl triglycerid signific higher llt group ldl num mg dl num receiv llt predictor llt discharg includ llt admiss hyperlipidemia prior coronari arteri diseas increas bodi mass index in hospit percutan coronari intervent tempor improv rate llt num num declin llt note num num attribut sharp reduct ezetimib combin statin increas intens statin monotherapi conclus larg cohort patient admit ac elig patient discharg llt data suggest implement guideline recommend intens statin therapi patient ac publish mosbi
MED-4563~nasal salin irrig symptom chronic rhinosinus pubm ncbi abstract background nasal irrig treatment nose sinus complaint foundat yogic homeopath tradit increas salin irrig douch spray rins adjunct medic manag chronic rhinosinus treatment strategi includ topic salin time day patient effort involv addit benefit difficult discern treatment object evalu effect safeti topic salin manag chronic rhinosinus search strategi search includ cochran ear nose throat disord group trial regist cochran central regist control trial central cochran librari issu num medlin num num embas num num date search novemb num select criteria randomis control trial salin evalu comparison treatment placebo adjunct treatment treatment comparison hyperton versus isoton solut compar data collect analysi trial grade methodolog qualiti cochran approach modif chalmer num symptom score salin versus treatment symptom radiolog score hyperton versus isoton group pool statist analysi narrat overview remain result present main result trial identifi satisfi inclus criteria studi compar topic salin treatment placebo adjunct intranas steroid spray studi compar hyperton solut isoton salin evid salin benefici treatment symptom chronic rhinosinus sole modal treatment evid exist favour salin treatment adjunct superior salin compar reflexolog placebo salin effect intranas steroid evid suggest hyperton solut improv object measur impact symptom clear author conclus salin irrig toler minor side effect common benefici effect salin outweigh drawback major patient topic salin includ treatment adjunct symptom chronic rhinosinus
MED-4564~acut rhinosinus adult pubm ncbi abstract rhinosinus common condit patient seek medic care subtyp rhinosinus includ acut subacut recurr acut chronic acut rhinosinus bacteri viral case acut rhinosinus caus viral infect common cold symptomat treatment analges decongest salin nasal irrig patient present nonsever symptom mild pain temperatur num num narrow spectrum antibiot amoxicillin trimethoprim sulfamethoxazol recommend patient symptom sign acut rhinosinus improv day worsen time limit evid support intranas corticosteroid patient acut rhinosinus radiograph imag recommend evalu uncompl acut rhinosinus comput tomographi sinus routin evalu defin anatom abnorm evalu patient suspect complic acut bacteri rhinosinus rare complic acut bacteri rhinosinus includ orbit intracrani boni involv symptom persist progress maxim medic therapi comput tomographi show evid sinus diseas referr otolaryngologist warrant
MED-4565~clinic signific nasal irrig bottl contamin pubm ncbi abstract objectives hypothesi studi aim assess clinic relev contamin nasal irrig bottl patient recalcitr chronic rhinosinus crs secondari investig identifi presenc bacteri biofilm surfac bottl assess steril method undertaken studi design prospect observ method eleven patient recalcitr crs nasal irrig part treatment regimen examin num week period num week visit cultur sampl irrig bottl middl meatus irrig bottl irrig bottl patient analyz scan electron microscopi sem detect biofilm format final bottl inocul strain staphylococcus aureus clean method bottl cultur immedi clean num hour result num num bottl collect demonstr bacteri growth concurr sinonas bottl infect aureus num patient studi bacteri biofilm demonstr surfac irrig bottl test treatment milton solut num naocl num nacl microwav found effect method steril bottl initi clean num hour conclus patient irrig nose sinus common contamin irrig bottl aureus biofilm form simpl clean method reduc contamin bottl
MED-4566~vitamin largest meal improv absorpt result higher serum level num hydroxyvitamin pubm ncbi abstract patient treat vitamin defici fail achiev adequ serum level num hydroxyvitamin num high dose ergo cholecalciferol object studi determin administr vitamin supplement largest meal day improv absorpt increas serum level num prospect cohort studi ambulatori tertiary car referr center patient cleveland clinic foundat bone clinic treatment vitamin defici respond treatment make studi group subject instruct usual vitamin supplement largest meal day main outcom measur serum num level num num month seventeen patient analyz age sd sex f m ratio num num year num femal num male dose num rang num num iu daili baselin serum num level sd num num ng ml rang num num ng ml serum num level diet modif sd num num ng ml rang num num ng ml num averag serum num level increas num num subgroup analysi base week dose vitamin perform similar trend observ conclud vitamin largest meal improv absorpt result num increas serum level num level achiev similar increas observ wide rang vitamin dose varieti medic condit copyright num american societi bone miner research
MED-4570~vitamin supplement dose serum num hydroxyvitamin rang cancer prevent pubm ncbi abstract background studi intak vitamin rang num num iu d serum num hydroxyvitamin concentr num num ng ml reduc cancer risk community bas studi estim dose respons relationship oral intak vitamin serum num rang num iu d materi method descript studi serum num concentr self report vitamin intak community bas cohort num age num num result serum num rose function self report vitamin supplement ingest curvilinear fashion intak num iu d lower produc num valu lower bound zone potenti toxic num ng ml unsuppl all sourc input estim num iu d supplement dose ensur num popul achiev serum num num ng ml num iu d conclus univers intak num iu vitamin day result vitamin toxic
MED-4573~low vitamin status definit preval consequ correct abstract vitamin obtain cutan product num dehydrocholesterol convert vitamin num cholecalciferol ultraviolet radiat oral intak vitamin num ergocalciferol num individual vitamin status evalu measur circul num hydroxyvitamin num concentr controversi surround definit low vitamin status increas agreement optim circul num level num ng ml definit estim approxim quarter adult unit state low classic low vitamin status skelet consequ osteomalacia ricket recent associ low vitamin status increas risk non skelet morbid recogn associ causal relat low vitamin status remain determin achiev optim vitamin status daili intak num iu vitamin requir risk toxic high amount vitamin intak low substanti between individu variabl exist respons administ vitamin dose monitor num level receiv attent supplement vitamin num prefer vitamin num
MED-4574~preval correl vitamin defici adult pubm ncbi abstract mount evid suggest vitamin defici link chronic diseas includ cardiovascular diseas cancer purpos studi examin preval vitamin defici correl test hypothesi vitamin defici common popul minor group nation health nutrit examin survey num num data analyz vitamin level adult particip num vitamin defici defin serum num hydroxyvitamin concentr num ng ml num nmol l preval rate vitamin defici num highest rate black num hispan num vitamin defici signific common colleg educ obes poor health status hypertens low high dens lipoprotein cholesterol level consum milk daili num multivari analys show non whit race colleg educ obes low high dens lipoprotein cholesterol poor health daili milk consumpt signific independ vitamin defici num summari vitamin defici common popul black hispan vitamin defici link import risk factor lead death unit state import health profession awar connect offer dietari intervent strategi correct vitamin defici minor group copyright num elsevi reserv
MED-4575~vitamin extraskelet health pubm ncbi abstract vitamin defici common nutrit defici common medic condit world major vitamin defici lack appreci bodi requir num num fold higher intak recommend health agenc overwhelm compel scientif epidemiolog data suggest human bodi requir blood level num num ng ml maximum health increas blood level minimum num ng ml requir ingest num iu vitamin day adult general downsid increas child adult vitamin intak copyright num elsevi reserv
MED-4576~impact stage juic process anthocyanin flavonol procyanidin content cranberri pubm ncbi abstract juic common form cranberri consum limit inform polyphenol content berri juic process studi investig effect pretreat grind blanch grind blanch cranberri juic process concentr anthocyanin flavonol procyanidin process flavonol procyanidin retain juic greater extent anthocyanin press result signific loss polyphenol due remov seed skin flavonol aglycon form process result heat treatment dri cranberri pomac result increas extract flavonol procyanidin oligom lower extract polymer procyanidin result cranberri polyphenol stabl process compar berri work determin fate storag juic
MED-4578~effect consumpt pomegran juic carotid intima media thick men women moder risk coronari heart diseas pubm ncbi abstract random double blind parallel trial assess influenc pomegran juic consumpt anterior posterior carotid intima media thick cimt progress rate subject moder risk coronari heart diseas subject men num num year women num num year num major coronari heart diseas risk factor baselin posterior wall cimt num num mm signific stenosi particip consum num ml day pomegran juic num control beverag num num month signific differ cimt progress rate observ pomegran juic control treatment exploratori analys subject advers tertil baselin serum lipid peroxid triglycerid tgs high dens lipoprotein hdl cholesterol tgs hdl cholesterol total cholesterol hdl cholesterol apolipoprotein b num pomegran juic group signific anterior wall and or composit cimt progress versus control subject conclus result suggest subject moder coronari heart diseas risk pomegran juic consumpt signific effect cimt progress rate slow cimt progress subject increas oxid stress disturb tg rich lipoprotein hdl axi
MED-4580~appl juic improv behavior cognit symptom moderate to l stage alzheimer diseas open label pilot studi pubm ncbi abstract preclin studi demonstr appl juic exert multipl benefici effect includ reduct central nervous system oxid damag suppress alzheimer diseas ad hallmark improv cognit perform organ synapt signal initi open label clinic trial num institution individu moderate to sever ad consum num oz glass appl juic daili num month particip demonstr chang dementia rate scale institut caregiv report chang alzheimer diseas cooper studi adc activ daili live adl studi caregiv report approxim num num improv behavior psychot symptom dementia quantifi neuropsychiatr inventori largest anxieti agit delus pilot studi suggest appl juic supplement augment pharmacolog approach attenu declin mood accompani progress ad reduc caregiv burden
MED-4581~fruit veget consumpt cognit declin age women pubm ncbi abstract prospect examin fruit veget intak relat cognit function declin age women particip num biennial questionnair food frequenc questionnair administ num num year num num administ telephon cognit test measur general cognit verbal memori categori fluenci work memori repeat assess year num women num follow up averag dietari intak num cognit assess linear regress obtain multivariable adjust differ perform declin perform intak level fruit cognit cognit declin total veget intak signific declin specif global score combin test women highest quintil crucifer veget declin slower num unit num confid interv num num trend num compar lowest quintil women consum green leafi veget experienc slower declin women consum amount num unit num confid interv num num trend num differ equival observ women num num year age
MED-4582~midlif fruit veget consumpt risk dementia life swedish twin abstract object diet risk dementia alzheimer diseas ad examin associ fruit veget consumpt midlif risk type dementia ad method particip num member swedish twin registri complet diet questionnair approxim num year prior cognit screen full clinic evalu dementia part harmoni studi particip num twin diagnos dementia num twin pair discord dementia num discord ad data analyz logist regress entir sampl general estim equat adjust related twin condit logist regress co twin control design result fully adjust model medium great proport fruit veget diet compar small decreas risk dementia ad effect observ women angina similar non signific odd ratio found co twin control analys conclus find suggest higher fruit veget consumpt reduc risk dementia women angina pectori midlif
MED-4583~cognit perform elder relat intak plant food hordaland health studi pubm ncbi abstract fruit veget nutriti healthi food relat prevent chronic diseas aim studi examin relationship intak plant food cognit perform elder individu cross sect studi thousand thirty on elder subject age num year num women recruit general popul western norway underw extens cognit test complet comprehens ffq cognit test batteri cover domain kendrick object learn test trail make test  part modifi version digit symbol test block design mini ment state examin control oral word associ test valid self report ffq assess habitu food intak subject intak num percentil fruit veget grain product mushroom perform signific cognit test low intak associ strongest cognit combin intak fruit veget mark dose depend relationship num g d dose rel increas intak grain product potato reach plateau num g d level decreas associ linear mushroom individu plant food posit cognit associ carrot crucifer veget citrus fruit high fibr bread pronounc negat cognit associ increas intak white bread elder diet rich plant food perform cognit abil dose depend manner
MED-4585~evalu phenol compound commerci fruit juic fruit drink pubm ncbi abstract total phenol content num commerci fruit juic juic drink select repres popular juic flavor unit kingdom analyz folin ciocalteu assay individu phenol compound identifi quantifi hplc pda m num catechin content degre polymer proanthocyanidin analyz purpl grape juic largest number individu phenol compound highest concentr total phenol main compon flavan num ol anthocyanin hydroxycinnam account num total phenol content contrast white grape juic princip hydroxycinnam lowest total phenol content antioxid activ measur orac frap assay data obtain broad agreement total phenol content view recent find kame project indic long term fruit juic consumpt provid protect alzheimer diseas dai al med num num suggest protect effect enhanc consumpt combin juic rich phenol divers varieti individu phenol compound juic deriv purpl grape grapefruit cranberri appl
MED-4587~identif metabolit human plasma urin consumpt polyphenol rich juic drink pubm ncbi abstract polyphenol rich p r juic drink develop potenti approach increas intak dietari polyphenol analysi beverag hplc pda fluoresc ms detect facilit identification parti identif num flavonoid relat phenol compound main constitu epigallocatechin green tea flavan num ol phloretin num o glucosid gallic acid hesperetin num o rutinosid num o caffeoylquin acid procyanidin trace level flavonol purpl grape juic anthocyanin present healthi human subject num consum num ml p r juic drink plasma urin sampl collect num period hplc ms analysi identifi num metabolit plasma num urin qualit profil glucuronid sulfat methyl metabolit similar detect earlier investig main compon juic drink consum separ feed studi coffe green tea orang juic appl cider
MED-4588~effect flavanol rich cocoa fmri respons cognit task healthi young peopl pubm ncbi abstract flavanol main flavonoid found cocoa chocol abund cocoa research past decad identifi flavanol show divers benefici physiolog antioxid effect context vascular function present studi employ function magnet reson imag base blood oxygen level depend bold contrast explor effect flavanol human brain magnet reson imag measur bold respons cognit task num healthi young subject data present show increas bold signal intens respons cognit task ingest flavanol rich cocoa num day num mg cocoa flavanol aris result alter neuron activ chang vascular respons both  th net effect depend effect domin signific effect evid behavior reaction time switch cost heart rate consumpt moder dose cocoa flavanol pilot studi evalu relationship cerebr blood flow singl acut dose num mg flavanol flavanol rich cocoa show flavanol rich cocoa increas cerebr blood flow gray matter suggest potenti cocoa flavanol treatment vascular impair includ dementia stroke maintain cardiovascular health
MED-4589~flavonoid permeabl situ model blood brain barrier pubm ncbi abstract understand mechan flavonoid neuroprotect complic lack inform abil enter cns studi examin naringenin quercetin permeabl blood brain barrier bbb vitro ecv num num cocultur situ rat model report measur permeabl app flavonoid vitro bbb model consist lipophil flavonoid show measur situ bbb permeabl rate uptak cerebr hemispher num num ml min num num naringenin quercetin quercetin compar colchicin num ml min num num substrat p glycoprotein p gp preadministr p gp inhibitor psc num gf num mg kg bodi wt signific increas colchicin gf num inhibit breast cancer resist protein bcrp affect quercetin naringenin affect influenc efflux transport flavonoid permeabl bbb studi mdck mdr num immort rat brain endotheli cell rbe num colchicin quercetin naringenin show measur accumul distribut volum microl mg protein cell type colchicin increas signific cell line coincub psc num microm gf num microm inhibitor caus increas naringenin contrast gf num coincub signific increas quercetin conclus result demonstr flavonoid travers bbb vivo permeabl flavonoid vivo influenc lipophil interact efflux transport
MED-4590~appl juic prevent oxid stress induc amyloid beta cultur pubm ncbi abstract increas oxid stress contribut declin cognit perform normal age neurodegen condit alzheimer diseas dietari supplement fruit veget high antioxid potenti case compens oxid stress examin appl juic allevi neurotox consequ exposur cultur neuron cell amyloid beta abeta portion neurotox abeta due oxid stress appl juic concentr ajc num degre brix dilut cultur medium sh si num human neuroblastoma cell differenti num day num microm retino acid concurr addit num microm abeta ajc prevent increas generat reactiv oxygen speci ros induc abeta treatment condit ajc prevent abeta induc calcium influx apoptosi result part due increas ros find suggest antioxid potenti appl product prevent abeta induc oxid damag
MED-4591~num gingerol attenu amyloid induc oxid cell death fortifi cellular antioxid defens system pubm ncbi abstract amyloid involv format senil plaqu typic neuropatholog marker alzheimer diseas ad report apoptosi neuron oxid and or nitros stress studi investig neuroprotect effect molecular mechan num gingerol pungent ingredi ginger num induc oxid and or nitros cell death sh si num cell num gingerol pretreat protect num induc cytotox apoptot cell death dna fragment disrupt mitochondri membran potenti elev bax bcl num ratio activ caspas num elucid neuroprotect mechan num gingerol examin num induc oxid and or nitros stress cellular antioxid defens system num gingerol effect suppress num induc intracellular accumul reactiv oxygen and or nitrogen speci restor num deplet endogen antioxid glutathion level num gingerol treatment up regul mrna protein express antioxid enzym glutamylcystein ligas gcl heme oxygenas num ho num rate limit enzym glutathion biosynthesi degrad heme express aforement antioxid enzym mediat activ nf e num relat factor num nrf num result suggest num gingerol exhibit prevent and or therapeut potenti manag ad augment antioxid capac copyright num elsevi reserv
MED-4593~detect quantif methicillin resist staphylococcus aureus mrsa clone retail meat product pubm ncbi abstract aim object studi determin preval methicillin resist staphylococcus aureus mrsa contamin retail meat determin level contamin method result pork pork chop ground pork ground beef chicken leg wing thigh purchas retail outlet canadian provinc test presenc methicillin resist staph aureus qualit quantit method mrsa isol num pork num beef num chicken sampl num low level mrsa typic present num detect threshold quantif num cfu num present quantifi sampl isol classifi canadian epidem mrsa num cmrsa num puls field gel electrophoresi pfge pfge subtyp spa type num num conclus mrsa contamin retail meat uncommon cmrsa num human epidem clone found pig canada lack isol livestock associ st num surpris signific impact studi relev mrsa contamin meat unclear investig requir potenti exposur food handl sourc contamin requir investig result suggest human anim sourc involv
MED-4594~overview livestock associ mrsa agricultur pubm ncbi abstract research veterinari health care practition agricultur produc gather johnston iowa attend eighth annual midwest rural agricultur safeti health forum mrash novemb num focus area plenari talk current research conduct examin methicillin resist staphylococcus aureus mrsa swine farm unit state focus preval mrsa farm swine human worker presenc mrsa air sampl swine barn shower facil presenc methicillin resist methicillin sensit aureus retail meat find begin elucid pictur livestock associ mrsa midwestern unit state
MED-4595~xylitol unusu trigger chronic metabol hyperchlorem acidosi pubm ncbi abstract homeopath globul frequent children first lin treatment globul coat sugar substitut xylitol substitut laxat effect patient show consumpt globul coat xylitol laxat effect weight loss life threaten enter bicarbon loss diarrhea overdos infant
MED-4596~non typhoid salmonellosi emerg problem pubm ncbi abstract major epidemiolog non typhoid salmonellosi occur half num centuri salmonella typhimurium strain resist multipl antibiot emerg spread popul food anim salmonella enteritidi emerg major egg associ pathogen articl review data origin human epidem
MED-4598~misalign percept lifestyl modif knowledg health profession pubm ncbi abstract object present studi aim evalu knowledg practic public sector primary car health profession final year student role nutrit physic activ smoke cessat lifestyl modif manag chronic diseas lifestyl public health car sector design compar cross sect descript quantit studi conduct thirti primari health car facil tertiari institut offer medic and or nurs programm cape town western cape metropol stratifi random sampl base geograph locat select health facil conveni sampl select student tertiari institut valid self administ knowledg test obtain data health profession result differenti lifestyl modif knowledg exist health profession student num achiev desir score num higher major health profession promot theoret concept lifestyl modif experi difficulti provid practic advic patient health profession evalu doctor knowledg lifestyl modif lack time lack patient adher languag barrier main barrier provid lifestyl counsel conclus undergradu curricula medic nurs student includ suffici train lifestyl modif practic advic diet physic activ smoke cessat health profession work primari health car facil updat provid lifestyl modif educ part continu medic educ
MED-4599~nutrit educ medic school latest updat nation survey abstract purpos quantifi number requir hour nutrit educ medic school type cours instruct offer compar result result previous survey method author distribut num accredit medic school matricul student time studi two pag onlin survey devis nutrit medicin project univers north carolina chapel hill august num juli num author contact nutrit educ report nutrit contact hour requir medic student actual hour nutrit educ occur design nutrit clinic rotat result respond num target medic school complet part survey school num requir form nutrit educ num school answer question cours contact hour num requir dedic nutrit num num num school medic student receiv num contact hour nutrit instruct medic school career rang num num hour averag num num hour num num school met minimum num requir hour set nation academi scienc num num num school conclus amount nutrit educ medic student receiv continu inadequ
MED-4600~essenti healthi eat guid abstract solid evid exist offer women fundament strategi healthi eat includ emphas health unsatur fat grain good protein packag fruit veget limit consumpt tran satur fat high refin grain sugari beverag multivitamin folic acid extra vitamin nutrit safeti net diet base principl healthi virtual life stage young adulthood plan pregnanc pregnanc age
MED-4602~manufactur uncertainti protect public health age contest scienc product defens pubm ncbi abstract strategi manufactur uncertainti great success pollut manufactur danger product oppos public health environment regul strategi entail question valid scientif evid regul base approach identifi tobacco industri produc asbesto benzen beryllium chromium diesel exhaust lead plastic hazard product avoid environment occup health regul central debat global warm approach common unusu scienc challeng industri face regul manufactur uncertainti busi numer technic consult firm provid servic call product defens litig support impli usual object activ generat knowledg protect public health protect corpor product alleg toxic properti evid scientif literatur fund effect  th close correl result studi desir study funder report result study  suggest financi interest study sponsor account study find similar interpret data scientist financi conflict light manufactur uncertainti antithet public health principl decis made evid
MED-4603~reduct cardiovascular diseas project modest reduct dietari salt abstract background diet high salt major process food reduc dietari salt import potenti public health target method coronari heart diseas chd polici model quantifi benefit potenti achiev population wid reduct dietari salt num gm day num mg day sodium estim cardiovascular diseas rate cost age sex race subgroup compar salt reduct intervent reduc cardiovascular risk determin cost effect salt reduct compar drug treatment hypertens result reduc salt num gm day project result num num fewer chd case num num fewer stroke num num fewer myocardi infarct num num fewer death annual segment popul benefit black benefit proportion women benefit stroke reduct older adult reduct chd event younger adult lower mortal rate cardiovascular benefit lower salt par benefit reduc tobacco obes cholesterol regulatori intervent design achiev num gm day salt reduct save num num quality adjust life year num num billion healthcar cost annual intervent cost sav modest num gm day reduct achiev gradual decad num num cost effect treat hypertens individu medic conclus modest reduct dietari salt substanti reduc cardiovascular event medic cost public health target
MED-4604~comet assay num mous organ result num food addit pubm ncbi abstract determin genotox num chemic food addit fell categories dy color fixat preserv preserv antioxid fungicid sweeten test group male ddi mice oral addit num xld num limit dose num g kg perform comet assay glandular stomach colon liver kidney urinari bladder lung brain bone marrow num num treatment addit dye genotox amaranth allura red coccin tartrazin erythrosin phloxin rose bengal induc dose rel dna damag glandular stomach colon and or urinari bladder dye induc dna damag gastrointestin organ low dose num num g kg amaranth allura red coccin tartrazin induc dna damag colon close accept daili intak adi antioxid butyl hydroxyanisol bha butyl hydroxytoluen bht fungicid biphenyl sodium o phenylphenol thiabendazol sweeten sodium cyclam saccharin sodium saccharin sucralos induc dna damag gastrointestin organ base result extens assess food addit current warrant
MED-4605~genotox cell transform studi sorbat syrian hamster embryo fibroblast pubm ncbi abstract sorbic acid sodium sorbat potassium sorbat test genotox potenti syrian hamster embryo fibroblast micronucleus assay cell transform test vitro sorbic acid potassium sorbat show activ test system fresh prepar sodium sorbat solut genotox cell transform activ detect sodium sorbat store solut previous heat sonic facilit solubil yield posit respons test system conclud oxid product sodium sorbat possess genotox cell transform properti form condit heat sonic storag
MED-4606~potassium sorbat induc genotox mutagen effect lymphocyt pubm ncbi abstract present studi evalu genotox potenti potassium sorbat ps cultur isol human lymphocyt assess damag caus ps human design vitro experi measur chromosom aberr cas sister chromatid exchang sces micronucleus mn comet assay lymphocyt treat negat control steril distil water posit control mmc cultur lymphocyt num num isol lymphocyt concentr num num num microg ml ps result ps treatment signific increas cas gap num num microg ml concentr sces num num microg ml num num num microg ml num compar vehicl control treatment isol lymphocyt num signific ps induc dna strand break observ concentr ps fail signific affect mn assay contrari ps cell cycl delay note non signific decreas cytokinesis block prolifer index cbpi replic index ri slight decreas observ mitot index mi highest concentr treatment time result ps genotox human peripher blood lymphocyt vitro copyright num elsevi reserv
MED-4607~effect sorbic acid salt chromosom aberr sister chromatid exchang gene mutat cultur chines hamster cell pubm ncbi abstract abil sorbic acid potassium sodium salt induc chromosom aberr sister chromatid exchang sce gene mutat cultur chines hamster num cell examin sodium sorbat caus signific induct chromosom aberr sce induc num thioguanine resist mutat dose depend manner clastogen potenc sodium sorbat found hundredth potent clastogen n methyl n  nitro n nitrosoguanidin induct sce sodium sorbat control level methyl methanesulphon potent induc sce num time control level mutagen potenc sodium sorbat one tenth ethyl methanesulphon potent induc mutat compar equitox level sorbic acid potassium salt induc chromosom aberr highest dose test compound induc num time control level sce compound induc num thioguanine resist mutat cytogenet activ sodium sorbat conclud due effect osmot pressur impur result sodium sorbat genotox agent potenc weak sorbic acid potassium sorbat genotox sodium salt
MED-4608~reduct cardiovascular risk sodium bicarbon miner water moder hypercholesterolem young adult pubm ncbi abstract effect drink sodium bicarbon miner water cardiovascular risk young men women moder cardiovascular risk studi eighteen young volunt total cholesterol level num mmol l diseas particip studi consist num week intervent period subject consum supplement usual diet num l day control low miner water num l day bicarbon miner water num mmol l sodium num mmol l bicarbon num mmol l chlorid determin perform end control water period week num num bicarbon water period bodi weight bodi mass index bmi blood pressur dietari intak total cholesterol low dens lipoprotein ldl cholesterol high dens lipoprotein hdl cholesterol apolipoprotein apo a i apo triacylgycerol glucos insulin adiponectin high sensit c reactiv protein hs crp solubl adhes molecul solubl intercellular adhes molecul sicam solubl vascular adhes molecul svcam sodium chlorid urinari excret urin ph measur dietari intak bodi weight bmi show signific variat systol blood pressur decreas signific num week bicarbon water consumpt signific differ week num num bicarbon water consumpt signific reduct total cholesterol num num ldl cholesterol num num total hdl cholesterol num ldl hdl cholesterol num apo num observ serum triacylglycerol apo a i sicam num svcam num hs crp level chang serum glucos valu tend decreas bicarbon water intervent num insulin level vari sodium bicarbon miner water improv lipid profil moder hypercholesterolem young men women appli dietari intervent reduc cardiovascular risk copyright num elsevi reserv
MED-4609~beriberi analog myocardi infarct pubm ncbi abstract pandem heart attack death plagu world popul past num year pandem induc beriberi caus industri revolut alter nutrit composit rice num simpl work knowledg hand termin beriberi plagu orthodox medicin enchant fals concept diseas caus germ permit million asian die needless beriberi refus eat rice bran drink rice bran tea pandem heart attack death call myocardi infarct mi struck develop nation western world full forc num hypothesi suggest mi pandem rage today caus chang food process occur num oil seed industri introduc food great harm lipid substanc unnatur trans tran isom linol acid human food prior num enter food margarin refin oil block convers natur cis ci linol acid prostaglandin num prevent mi act vasodil minim platelet aggreg harm lacton introduc food increas risk mi decreas fibrinolyt activ blood oil seed industri introduc diet free radic lipid peroxid make myocardium vulner infarct suggest num afflict famili hypercholesterolemia cholesterol concept mi fals today concept num germ caus beriberi suggest work knowledg hand today make death mi rare death beriberi induc heart attack
MED-4612~vegan protein reduc risk cancer obes cardiovascular diseas promot increas glucagon activ pubm ncbi abstract amino acid modul secret insulin glucagon composit dietari protein potenti influenc balanc glucagon insulin activ soy protein vegan protein higher non essenti amino acid animal deriv food protein result preferenti favor glucagon product act hepatocyt glucagon promot insulin inhibit camp depend mechan down regul lipogen enzym cholesterol synthesi up regul hepat ldl receptor product igf i antagonist igfbp num insulin sensit properti vegan diets  high fiber low satur fat  should amplifi effect down regul insulin secret addit low essenti amino acid content vegan diet decreas hepat igf i synthesi diet featur vegan protein expect lower elev serum lipid level promot weight loss decreas circul igf i activ effect imped cancer induct anim studi soy protein lessen neutrophil medi inflammatori damag slow growth matur children fact vegan tend low serum lipid lean physiqu shorter statur puberti decreas risk promin western cancer vegan diet document clinic efficaci rheumatoid arthriti low fat vegan diet protect regard cancer link insulin resistance  nam breast colon cancer  a prostat cancer convers high igf i activ heavi ingest anim product larg respons epidem western cancer wealthi societi increas phytochem intak contribut reduct cancer risk vegan regress coronari stenos document low fat vegan diet coupl exercis train regimen tend mark improv diabet control lower elev blood pressur risk degen disord decreas vegan reduc growth factor activ respons increas risk hemorrhag stroke alter glucagon insulin balanc conceiv supplement intak key non essenti amino acid enabl omnivor enjoy health advantag vegan diet unnecessarili high intak essenti amino acids  eith absolut sens relat total dietari protein  may prove grave risk factor western degen diseas excess fat intak
MED-4613~resolv coronari arteri diseas epidem plant bas nutrit pubm ncbi abstract world advanc countri easi access plenti high fat food iron rich diet produc atherosclerosi world poorer nation peopl subsist primarili plant bas diet healthier term heart diseas treat coronari heart diseas centuri scientif investig produc device driven risk factor ori strategi patient treat approach experi progress disabl death strategi rear guard defens contrast compel data nutrit studi popul survey intervent studi support effect plant bas diet aggress lipid lower arrest prevent select revers heart diseas essenc offens strategi singl biggest step adopt strategi unit state dietari guidelin support plant bas diet expert committe purg industri polit influenc requir assur scienc basi dietari recommend num chf
MED-4615~diet lifestyl etiolog coronari arteri diseas cornel china studi pubm ncbi abstract investig collect analyz mortal data num diseas includ num cancer num counti num villag rural mainland china blood urin food sampl detail dietari data collect num adult villag analyz varieti nutrit viral hormon toxic chemic factor rural china fat intak half unit state fiber intak num time higher anim protein intak low num intak serum total cholesterol num mg dl rural china versus num mg dl adult age num year unit state coronari arteri diseas mortal num fold greater men num fold greater women chines counterpart combin coronari arteri diseas mortal rate gender rural china invers frequenc intak green veget plasma erythrocyt monounsatur fatti acid posit combin index salt intak urinari sodium plasma apolipoprotein apolipoprotein turn posit anim protein intak frequenc meat intak invers plant protein legum light color veget intak rate diseas correl dietari factor evid threshold benefit accru increas proport plant bas food diet
MED-4616~lifestyl revers coronari heart diseas lifestyl heart trial pubm ncbi abstract prospect randomis control trial determin comprehens lifestyl affect coronari atherosclerosi num year num patient assign experiment group low fat vegetarian diet stop smoke stress manag train moder exercis num usual car control group num coronari arteri lesion analys quantit coronari angiographi averag percentag diamet stenosi regress num sd num num num experiment group progress num num num num control group lesion greater num stenos analys averag percentag diamet stenosi regress num num num num experiment group progress num num num num control group num experimental group patient averag chang regress comprehens lifestyl bring regress sever coronari atherosclerosi num year lipid low drug
MED-4617~systemat review incid sudden cardiac death unit state abstract consist current data describ true incid sca and or scd highlight recent sudden cardiac arrest thought leadership allianc scatla tank meet nation expert broad represent key stakehold includ thought leader repres american colleg cardiolog american heart associ heart rhythm societi evalu true magnitud public health problem perform systemat literatur search medlin mesh head death sudden term sudden cardiac death sudden cardiac arrest cardiac arrest cardiac death sudden death arrhythm death studi select criteria includ peer review public primari data estim scd incid web scienc cite refer search evalu impact primari estim medic literatur determin number time primari sourc cite estim annual incid scd vari wide num num num includ studi estim part due data sourc data age rang num num definit scd case ascertain criteria method estimation extrapol sourc case ascertain true incid sca and or scd remain unclear wide rang estim bad date reliabl estim scd incid import improv risk stratif prevent futur effort establish uniform definit sca scd prospect precis captur case sca scd popul
MED-4618~vitro evalu genotox avocado persea americana fruit leaf extract human peripher lymphocyt pubm ncbi abstract persea americana sought nutrit fruit medicin valu plant part chromosom aberr assay undertaken evalu potenti genotox crude extract avocado fruit leav chromosom aberr observ cultur human peripher lymphocyt expos separ increas concentr num methanol extract persea americana fruit leav group expos leaf fruit extract show concentration depend increas chromosom aberr compar control group percentag total aberr metaphas num mg kg num mg kg num mg kg concentr leaf extract found num num num num num num signific higher num control group num num percentag total aberr metaphas num mg kg num mg kg num mg kg concentr fruit extract found num num num num num num signific higher num num num control num num acrocentr associ prematur centromer separ common abnorm observ expos group group expos leaf extract show signific number varieti structur aberr includ break fragment dicentr termin delet minut robertsonian transloc group expos leaf extract show higher frequenc type aberr equal concentr compar group expos fruit extract
MED-4619~select induct apoptosi human oral cancer cell line avocado extract ros medi mechan pubm ncbi abstract avocado high content phytochem potenti chemoprevent activ previous report phytochem extract avocado meat chloroform partit num select induc apoptosi cancer normal human oral epitheli cell line present studi observ treatment human oral cancer cell line high level reactiv oxygen ros num increas ros level twofold threefold induc apoptosi contrast ros level increas num fold apoptosi induc normal cell line lower level basal ros cellular ros level malign cell line reduc n acetyl l cystein nac cell resist num induc apoptosi nac delay induct apoptosi domin negat fadd express malign cell line num increas ros level mitochondri complex electron transport chain induc apoptosi normal human oral epitheli cell line transform hpv num num num express higher basal level ros sensit num data suggest perturb ros level human oral cancer cell line key factor select apoptosi molecular target chemoprevent phytochem
MED-4620~chemoprevent characterist avocado fruit pubm ncbi abstract phytochem recogn play import role cancer prevent fruit veget avocado wide grown consum fruit high nutrient low calori sodium fat studi shown phytochem extract avocado fruit select induc cell cycl arrest inhibit growth induc apoptosi precancer cancer cell line recent studi phytochem extract chloroform avocado fruit target multipl signal pathway increas intracellular reactiv oxygen lead apoptosi review summar report phytochem avocado fruit discuss molecular mechan target studi suggest individu combin phytochem avocado fruit offer advantag dietari strategi cancer prevent
MED-4621~acut sub acut toxicolog assess aqueous seed extract persea americana mill lauracea rat abstract aqueous seed extract persea americana mill lauracea herbalist nigeria manag hypertens part on go scientif evalu extract design present studi assess acut sub acut toxic profil rat experi conduct determin oral median lethal dose ld num gross toxicolog manifest acut basi sub acut experi anim administ num g kg day extract num consecut day anim weight fluid intak record num day period termin kidney heart blood sera obtain weight haematolog biochem marker toxic result show ld num determin maximum dose num g kg sub acut treatment extract affect bodi weight organ to bodi weight ratio signific increas fluid intak num haematolog paramet level alt ast albumin creatinin signific alter concentr total protein signific increas treat group conclus aqueous seed extract americana safe sub acut basi extrem high dose advis
MED-4622~probabilist character health benefit reduc methyl mercuri intak unit state pubm ncbi abstract develop probabilist model character plausibl distribut health econom benefit accru popul reduct methyl mercuri mehg exposur mehg human development neurotoxic increas fatal heart attack risk model paramet reflect current understand relationship mehg intak health risk societ valuat risk expect monetari annual health benefit generat num reduct popul exposur mehg year num million num reduct fatal heart attack remaind iq gain plausibl distribut benefit broad num num percentil estim approxim num million num billion largest sourc uncertainti epidemiolog associ mehg exposur fatal heart attack reflect causal largest sourc uncertainti concern slope relationship matern mehg exposur reduc intellig children relationship exhibit threshold analysi suggest causal relationship mehg exposur fatal heart attack character addit epidemiolog studi formal elicit expert judgment
MED-4625~low dos arachidon acid intak increas erythrocyt plasma arachidon acid young women pubm ncbi abstract arachidon acid ara consid minor contributor diet previous report effect ara supplement composit long chain polyunsatur fatti acid lcpufa blood human extrem limit present studi conduct crossov double blind placebo control studi twenty thre young japanes women consum capsul triacylglycerol enrich num mg ara equival amount egg daili num week blood sampl drawn treatment period composit lcpufa blood lipid fraction measur supplement ara increas composit ara decreas composit num cpufa erythrocyt phospholipid plasma phospholipid esterifi cholesterol triacylglycerol found dietari ara increas ara level lipid fraction blood low dose num elsevi reserv
MED-4626~individu variat intraclass correl arachidon acid eicosapentaeno acid chicken muscl abstract chicken meat reduc concentr arachidon acid aa reduc ratio omega num omega num fatti acid potenti health benefit reduct aa intak dampen prostanoid signal proport omega num omega num fatti acid high diet analys fatti acid determin expens find optim number analys give reliabl result challeng object present studi analys intraclass correl fatti acid meat sampl gram chicken thigh ii studi individu variat concentr rang fatti acid ratio omega num omega num fatti acid concentr fifteen chicken fifteen newli hatch broiler fed wheat bas diet num rapese oil num linse oil week muscl sampl mid locat thigh chicken analys fatti acid composit intraclass correl sampl correl anim num num ratio total omega num total omega num fatti acid aa eicosapentaeno acid epa studi fatti acid ratio sampl gram anim suffici due high individu variat chicken ratio high number anim minimum num requir obtain suffici high power reveal signific effect experiment factor feed regim present experi result meat favor concentr ratio omega num omega num fatti acid aa concentr vari num num num total fatti acid thigh muscl fifteen broiler ratio aa epa concentr rang num num differ bird due genet varianc exploit breed lower aa concentr and or favor aa epa ratio produc meat health benefit
MED-4627~diet inflamm pubm ncbi abstract emerg role chronic inflamm major degen diseas modern societi stimul research influenc nutrit dietari pattern inflammatori indic human studi correl analys habitu dietari intak determin food frequenc questionnair num hour recal system marker inflamm high sensit c reactiv protein hs crp interleukin num il num tumor necrosi factor alpha tnf occasion studi includ nutrit analysi blood compon control intervent evalu effect chang dietari pattern singl food inflammatori marker defin popul studi reveal modest effect dietari composit inflammatori marker free liv adult marker vari unison signific dietari influenc establish glycem index gi load gl fiber fatti acid composit magnesium carotenoid flavonoid tradit mediterranean dietari pattern typic high ratio monounsatur mufa satur sfa fat num num polyunsatur fatti acid pufa suppli abund fruit veget legum grain shown anti inflammatori effect compar typic north american northern european dietari pattern observ intervent studi diet choic diminish chronic inflamm clinic practic
MED-4628~associ dietari arachidon acid measur adipos tissu ulcer coliti pubm ncbi abstract background aim dietari arachidon acid num polyunsatur fatti acid num pufa involv etiolog ulcer coliti uc perform prospect cohort studi determin high level arachidon acid adipos tissu sampl reflect dietari intak uc method analyz data collect num men women epic denmark prospect cohort studi num num adipos tissu biopsi sampl collect gluteal region begin studi cohort monitor subsequ year particip develop uc identifi subcohort num random select particip control concentr arachidon acid measur adipos tissu sampl analysi arachidon acid level divid quartil relat risk rr calcul adjust smoke aspirin nonsteroid anti inflammatori drug level num pufa result total num subject num men develop incid uc median age num year rang num num year highest quartil arachidon acid concentr adipos tissu rr uc num num confid interv ci num num trend num increas arachidon acid num rr observ num ci num num fraction attribut highest level arachidon acid num conclus individu highest relat concentr arachidon acid adipos tissu signific greater risk develop uc dietari modif prevent uc reduc diseas symptom copyright num aga institut publish elsevi reserv
MED-4629~vegetarian diet patient rheumatoid arthriti clinic effect explain psycholog characterist patient pubm ncbi abstract control singl blind clinic trial demonstr recent benefici effect fast vegetarian diet ra present studi compar num patient particip clinic trial num ra patient regard psycholog paramet patient particip clinic trial differ signific ra patient higher intern score lower chanc score multi dimension health locus control scale mhlcs belief effect ordinari medic treatment evalu num cm visual analogu scale lower belief effect altern unconvent form treatment higher patient random vegetarian diet signific differ diet respond diet non respond regard mhlcs score diet respond signific lower belief effect ordinari medic treatment compar diet non respond psycholog distress impos patient chang omnivor diet vegetarian diet monitor clinic trial general health questionnair clinic trial variabl favour vegetarian compar omnivor diet respond diet non respond conclud patient psycholog characterist select clinic trial mhlcs score explain clinic improv influenc patient belief ordinari altern form treatment dietari treatment decreas psycholog distress
MED-4630~arachidonic acid deriv eicosanoid role biolog immunopatholog pubm ncbi abstract arachidon acid aa deriv eicosanoid belong complex famili lipid mediat regul wide varieti physiolog respons patholog process produc cell type distinct enzymat pathway act target cell specif g protein coupl receptor origin recogn capac elicit biolog respons vascular homeostasi protect gastric mucosa platelet aggreg eicosanoid understood regul immunopatholog process rang inflammatori respons chronic tissu remodel cancer asthma rheumatoid arthriti autoimmun disord review major properti eicosanoid expand role biolog medicin
MED-4631~anti inflammatori effect low arachidon acid diet fish oil patient rheumatoid arthriti pubm ncbi abstract background patient rheumatoid arthriti ra improv vegetarian diet supplement fish oil investig effect dietari measur combin inflamm fatti acid composit erythrocyt lipid eicosanoid cytokin biosynthesi patient ra method sixty eight patient definit ra match group num subject group observ num month normal western diet wd anti inflammatori diet aid provid arachidon acid intak num mg day patient group alloc receiv placebo fish oil capsul num mg kg bodi weight num month double blind crossov studi num month washout period treatment clinic examin routin laboratori find evalu month erythrocyt fatti acid eicosanoid cytokin evalu num month experiment period result sixti patient complet studi aid patient wd patient number tender swollen joint decreas num placebo treatment aid patient compar wd patient fish oil led signific reduct number tender num num swollen num num joint num compar baselin level higher enrich eicosapentaeno acid erythrocyt lipid num num lower format leukotrien num num num num dehydro thromboxan num num num prostaglandin metabolit num num num found aid patient fish oil month num experi conclus diet low arachidon acid amelior clinic sign inflamm patient ra augment benefici effect fish oil supplement
MED-4632~effect vegetarian diet plasma lipid platelet level pubm ncbi abstract vegetarian appar diminish risk develop ischem coronari heart diseas secondari dietari effect plasma lipid lipoprotein platelet play role observ aberr function vegetarian measur plasma lipid lipoprotein level platelet function platelet fatti acid level platelet activ prostaglandin ten strict vegetarian vegan num lactovegetarian num age sex match omnivor control strike observ high signific rise platelet linol acid concentr declin platelet arachidon acid concentr vegetarian subgroup compar omnivor control serum thromboxan prostacyclin level result platelet aggreg studi differ group test cholesterol level signific lower vegetarian group compar control plasma high low dens lipoprotein level lower vegan subgroup compar omnivor diet produc platelet fatti acid plasma lipid level contribut decreas risk coronari heart diseas possibl atherosclerosi vegetarian
MED-4633~vegetarian diet healthi mood state cross sect studi seventh day adventist adult abstract background physic health status vegetarian extens report limit research mental health status vegetarian regard mood vegetarian diet exclud fish major dietari sourc eicosapentaeno acid epa docosahexaeno acid dha critic regul brain cell structur function omnivor diet low epa dha link impair mood state observ experiment studi method examin associ mood state polyunsatur fatti acid intak result adher vegetarian omnivor diet cross sect studi num healthi seventh day adventist men women resid southwest particip complet quantit food frequenc questionnair depress anxieti stress scale dass profil mood state pom questionnair result vegetarian veg n num report signific negat emot omnivor omn n num measur total dass pom score num num num num num num num num num num veg report signific lower intak epa num dha num omega num fatti acid arachidon acid aa num report higher intak shorter chain linolen acid num linol acid num omn total dass pom score posit relat intak epa num dha num aa num invers relat intak ala num la num indic particip low intak epa dha aa high intak ala la mood conclus vegetarian diet profil advers affect mood low intak long chain omega num fatti acid
MED-4634~fatti acid profil human saliva indic dietari fat intak pubm ncbi abstract object convent food questionnair precis assess dietari fatti acid purpos studi determin relationship salivari fatti acid profil alimentari habit group attempt develop reliabl determin lipid intak design twenti adult sex mix vegetarian diet studi data fat intak obtain food frequenc questionnair ffq presenc main salivari fatti acid determin gas chromatographi result greater salivari concentr alpha linolen acid num num num found subject num num whilst arachidon acid num num lower num num num differ arachidon acid observ dietari fatti acid intak show signific correl dietari salivari level vegetarian subject conclus result show salivari arachidon acid relev eicosanoid product relat tumourigenesi process cardiovascular diseas influenc dietari fat
MED-4635~global diet health tonga abstract increas flow good peopl idea global contribut increas noncommunic diseas world respons encourag lifestyl educ programm control lifestyle rel diseas key assumpt approach people food prefer link consumpt pattern consumpt pattern transform educ initi investig assumpt polici deriv undertook broad bas survey food rel issu kingdom tonga questionnair data relationship food prefer percept nutrit frequenc consumpt gather tradit import food result show consumpt health compromis import food unrel food prefer percept nutrit suggest diet rel diseas amen intervent base educ campaign recent initi trade liber creation world trade organ tariff import ban serv altern measur control consumpt present signific challeng health policy mak serv econom margin popul suggest popul health concern adequ address awar effect global trade
MED-4637~fibr bowel transit time pubm ncbi abstract num bowel transit time investig vegetarian non vegetarian relat dietari fibr intak presenc diverticular diseas num vegetarian diverticular diseas non vegetarian rapid transit time num subject total dietari fibr intak num g d transit time num num eat transit time exceed num vari num num individu diverticular diseas found faster transit time diseas num colon respond fibre deplet diet hyperact prone diverticular diseas hypoact lead constip
MED-4638~bowel movement constip frequenc risk colorect cancer men netherland cohort studi diet cancer pubm ncbi abstract author investig associ bowel movement constip frequenc colorect cancer crc endpoint men netherland cohort studi diet cancer num explor dietari fiber intak modifi associ num year num num crc case num subcohort member case cohort analys multivari analys show signific increas hazard ratio crc rectal cancer men report bowel movement num time day second highest categori compar day crc hazard ratio hr num num confid interv ci num num trend num rectal cancer hr num num ci num num trend num hazard ratio crc rectal cancer signific decreas lowest men report suffer constip versus crc hr num num ci num num trend num rectal cancer hr num num ci num num trend num trend associ proxim distal colon cancer risk observ interact dietari fiber intak signific studi frequent bowel movement increas risk rectal cancer men constip decreas risk
MED-4639~fecal weight colon cancer risk dietari intak nonstarch polysaccharid dietari fiber pubm ncbi abstract low fecal weight slow bowel transit time thought bowel cancer risk publish data defin bowel habit communiti exist data stool weight collect num popul num countri defin risk accur relationship stool weight dietari intak nonstarch polysaccharid nsp dietari fiber quantifi num healthi adult undertak care fecal collect median daili stool weight num g day men num g day women num g day num whole gut transit time num hour men num hour women num hour num num women num men pass num stool day data popul world show averag stool weight vari num num g day invers relat colon cancer risk num meta analysi num studi daili fecal weight measur accur num group peopl num control diet nsp content show signific correl fiber intak daili stool weight num stool weight western popul low num g day increas colon cancer risk fecal output increas dietari nsp diet character high nsp intak approxim num g day stool weight num g day reduc risk bowel cancer
MED-4640~passclaim  gut health immun pubm ncbi abstract background gut immun system form complex integr structur evolv provid effect digest defenc ingest toxin pathogen bacteria great variat exist consid normal healthi gut immun function whilst measur aspect digest immun difficult interpret benefit individu variat consid normal rang import set standard optim function consum industri concern public health digest tract frequent object function health claim larg market exist gut funct food worldwid aim defin normal function gut immun system describ method measur result defin normal bowel habit transit time identifi role risk factor diseas measur similar defin healthi gut flora term domin genera metabol list vari method determin paramet prove easi provid boundari constitut optim improv gastric empti gut motil nutrient water absorpt function organ liver gallbladd pancrea test function discuss gastrointestin sensat aris gut pleasant unpleas characterist ill defin merg impercept accept unaccept state subject feel import area futur work method develop immun system difficult make quantit judgement defect clinic problem ensur uncommon state innat adapt immun system work synergist compris cellular humor factor adapt system extrem sophist arm immun great redund robust defenc aspect immun function discov regular clear immun function improv measur aspect immun function test defin status function capac immun system human studi limit abil sampl blood secret saliva rememb num lymphocyt circul time limit interpret data recommend assess function capac immun system measur specif cell function vivo measur vivo respons challeng chang antibodi blood respons antigen determin incid sever infect target popul natur occur episod respons attenu pathogen
MED-4641~cytolog abnorm nippl aspir breast fluid women sever constip pubm ncbi abstract relat epitheli dysplasia nippl aspir breast fluid frequenc bowel movement studi num white women signific posit associ dysplasia risk ratio num num confid interv num num women report sever constip fewer bowel movement week women report bowel movement daili women bowel movement daili day increas risk ratio cytolog abnorm breast epithelium sever constip relev studi diet breast diseas intestin flora report metabol bile salt oestrogen secret liver gastrointestin tract a process enhanc sever constip
MED-4642~diet hormon level postmenopaus women breast cancer pubm ncbi abstract role diet breast cancer bc risk unclear fiber reduc bc risk enterohepat circul estrogen examin relationship diet sex hormon postmenopaus women bc thirty on postmenopaus women num omnivor num vegetarian num bc omnivor recruit dietari record num day hormon level num day evalu num occas num yr vegetarian show lower fat fib ratio higher intak total cereal fiber g d bodi weight kg signific lower level plasma estrone sulf estradiol free estradiol free testosteron ring oxygen estrogen signific higher level sex hormone binding globulin bc subject fiber consum slight larger amount omnivor bc subject omnivor signific lower plasma testosteron estrone sulf higher sex hormone binding globulin bc subject differ found urinari num oxygen estrogen num meo num oh num ratio signific lower omnivor bc group ratio posit fat fib ratio conclus testosteron contribut caus alter level catechol estrogen num oxygen estrogen fat fib ratio evalu dietari effect estrogen metabol
MED-4643~dietari habit breast cancer incid seventh day adventist pubm ncbi abstract breast cancer incid monitor cohort num california seventh day adventist women complet detail lifestyl questionnair num num year num histolog confirm primari breast cancer detect num person year follow up age diagnosi num year indic primarili postmenopaus case seri establish risk factor breast cancer show strong relationship risk data age live birth matern histori breast cancer age menopaus educ attain obes signific relat risk increas consumpt high fat anim product increas risk breast cancer consist fashion childhood earli teenag dietari habit vegetarian versus nonvegetarian relat subsequ adult risk develop breast cancer deriv index percent calori anim fat adult year signific relat risk result persist simultan control potenti confound variabl util cox proport hazard regress model
MED-4644~estrogen excret pattern plasma level vegetarian omnivor women pubm ncbi abstract studi num vegetarian num nonvegetarian premenopaus women occas approxim month studi period particip three day dietari record estrogen measur plasma urinari fecal sampl vegetarian consum total fat omnivor num cent total calori compar num cent dietari fiber num day compar num posit correl fecal weight fecal excret estrogen group num vegetarian higher fecal weight increas fecal excret estrogen urinari excret estriol lower vegetarian num plasma level estron estradiol negat correl fecal excret estrogen num vegetarian beta glucuronidas activ fecal bacteria signific reduc num conclud vegetarian women increas fecal output lead increas fecal excret estrogen decreas plasma concentr estrogen
MED-4645~vitamin miner risk prostat cancer case control surveil studi abstract background studi evalu associ vitamin miner supplement risk prostat cancer inconclus result method author examin relat multivitamin singl vitamin miner supplement risk prostat cancer risk num prostat cancer case num match control data hospital bas case control surveil studi conduct unit state odd ratio num confid interv ci risk prostat cancer estim condit logist regress model result multivitamin zinc multivari odd ratio prostat cancer num num num year num num num year num num year trend num men zinc num year multivitamin supplement approxim num fold num num ci num num increas risk prostat cancer vitamin beta caroten folat selenium signific increas risk prostat cancer conclus find long term zinc intak multivitamin singl supplement doubl risk prostat cancer add grow evid unfavor effect zinc prostat cancer carcinogenesi
MED-4646~intak fiber nut adolesc incid prolif benign breast diseas abstract object examin associ adolesc fiber intak prolif bbd marker increas breast cancer risk nurs health studi ii method num women complet high school diet questionnair num prolif bbd case identifi confirm central patholog review num num multivariate adjust cox proport hazard regress estim hazard ratio hrs num confid interv cis result women highest quintil adolesc fiber intak num lower risk prolif bbd multivari hr num ci num num num p trend num women lowest quintil high school intak nut appl relat signific reduc bbd risk women consum num serv nuts week num lower risk multivari hr num ci num num num p trend num women consum num serving month result essenti analysi restrict prospect case num diagnos return high school diet questionnair conclus find support hypothesi dietari intak fiber nut adolesc influenc subsequ risk breast diseas suggest viabl breast cancer prevent
MED-4647~multivitamin risk mortal cancer incid abstract multivitamin miner supplement common unit state efficaci supplement prevent chronic diseas prematur death unclear assess relat multivitamin mortal cancer author prospect examin associ num particip enrol multiethn cohort studi num num hawaii california averag num year follow up num death identifi cox proport hazard model control tobacco potenti confound associ found multivitamin mortal user nonus hazard ratio num num confid interv num num men hazard ratio num num confid interv num num women cardiovascular diseas cancer find vari subgroup ethnic age bodi mass index preexist ill singl vitamin miner supplement hormon replac therapi smoke status evid indic multivitamin risk cancer major site lung colorectum prostat breast conclus clear decreas increas mortal cardiovascular diseas cancer morbid major cancer multivitamin supplement user
MED-4649~structur basi androgen specif oestrogen synthesi human aromatas abstract aromatas cytochrom num enzym vertebr catalys biosynthesi oestrogen androgen num num aromatas inhibitor constitut front lin therapi oestrogen depend breast cancer num three step process step requir num mol num mol nadph coupl redox partner cytochrom num reductas aromatas convert androstenedion testosteron num hydroxytestosteron oestron num oestradiol num num oestriol num num step num methyl hydroxyl step involv aromat steroid a r uniqu aromatas num high substrat select hallmark androgen specif set aromatas structur enzym endoplasm reticulum membran remain unknown decad hinder elucid biochem mechan present crystal structur human placent aromatas natur mammalian full length num num hormon biosynthet pathway crystal unlik activ site microsom num metabol drug xenobiot aromatas androgen specif cleft bind androstenedion molecul snug hydrophob polar residu exquisit complement steroid backbon locat catalyt import residu shed light reaction mechan relat juxtaposit hydrophob amino termin region open catalyt cleft show membran anchor lipophil substrat gain access activ site molecular basi enzym androgen specif uniqu catalyt mechan develop next gener aromatas inhibitor
MED-4650~phytochem breast cancer prevent target aromatas pubm ncbi abstract aromatas cytochrom num enzym cyp num rate limit enzym convers androgen estrogen suppress situ estrogen product aromatas inhibit current treatment strategi hormone respons breast cancer drug inhibit aromatas develop util adjuv therapi breast cancer post menopaus women hormon depend breast cancer natur compound studi extens import biolog effect antioxid anti tumor anti vir effect signific number studi investig aromatas inhibitori properti varieti plant extract phytochem identif natur compound inhibit aromatas chemoprevent standpoint develop aromatas inhibitori drug review discuss food extract common class phytochem investig potenti aromatas inhibitori activ review report aromatas inhibit kinet data structur variat inhibit enhanc interact phytochem aromatas enzym
MED-4651~breast cancer incid rate women longer declin pubm ncbi abstract background public report breast cancer incid rate continu decreas white women declin num num num report exclus examin trend num paper examin breast cancer incid rate non hispan nh white women num num determin decreas breast cancer incid rate persist num addit present breast cancer incid trend nh black hispan women postmenopaus hormon racial ethn group method breast cancer incid rate calcul race ethn age er status data surveil epidemiolog end result seer num registri num num preval postmenopaus hormon calcul nation health interview survey data num num result num num breast cancer incid rate chang signific nh white women age group rate increas num year er breast cancer age num num decreas er breast cancer age num num num num similar breast cancer incid rate chang signific black hispan women hormon continu decreas num num group decreas smaller compar num num conclus sharp declin breast cancer incid rate occur num num nh white women continu num impact studi understand recent breast cancer trend num aacr
MED-4652~ductal carcinoma situ terminolog classif natur histori pubm ncbi abstract ductal carcinoma situ dcis refer breast epitheli cell cancer resid normal place duct lobul set cancer abnorm increas growth epitheli cell accumul great expand duct lobul dcis nonleth type cancer stay normal place dcis import precursor invas breast cancer potenti lethal articl general overview dcis includ histor perspect method classif current perspect futur goal
MED-4653~dietari intak phthalat bodi burden nation repres sampl abstract background phthalat compound wide rang consum product contribut dietari intak phthalat exposur defin object object studi assess contribut food type phthalat exposur phthalat chemic concern high level measur peopl environ demonstr toxic anim studi limit epidemiolog studi previous research limit suggest phthalat contamin food countri method conduct exploratori analysi data collect part num num nation health nutrit examin survey nhane associ dietari intak assess num hr dietari recal rang food type meat poultri fish fruit veget dairi phthalat metabolit measur urin analyz multipl linear regress model result found metabolit di num ethylhexyl phthalat dehp high molecular weight phthalat metabolit consumpt poultri monoethyl phthalat metabolit diethyl phthalat dep veget consumpt specif tomato potato consumpt discuss result combin result previous studi suggest diet import rout intak phthalat research determin sourc food contamin toxic chemic describ level contamin food larg repres sampl
MED-4654~sexual select genit anatomi male primat pubm ncbi abstract correl mate system aspect genit anatomi suggest strong influenc sexual select genit morpholog test general influenc examin primat taxa enhanc sexual select multi mal mate system possess expect spinous penis taxa mate system prosimian anthropoid monkey ape possess penil spine predomin mate system taxa differ taxonom constraint account sexual select appar act penil spine manner aspect genit anatomi spinos greatest multi mal taxa prosimian anthropoid taxa spine stimul reproduct readi synchroni situat sex live communic reproduct state dispers social system stolen extra pair copul problem exist hypothesi idea spine involv scent mark penil spine function penil spinos primat order remain explain
MED-4655~phthalat exposur attention deficit hyperact disord school ag children pubm ncbi abstract background studi examin associ attention deficit hyperact disord adhd phthalat exposur human aim studi investig impact phthalat symptom adhd school ag children method cross sect examin urin phthalat concentr perform score measur adhd symptom neuropsycholog dysfunct regard attent impuls obtain num korean children age num year result mono num ethylheyl phthalat mehp mono num ethyl num oxohexylphthal meop metabolit di num ethylhexylphthal dehp mono n butyl phthalat mnbp metabolit dibutyl phthalat dbp measur urin sampl concentr mehp meop mnbp num microg dl sd num rang num num num microg dl sd num rang num num num microg l sd num rang num num adjust covari teacher r adhd score signific dehp metabolit dbp metabolit found signific relationship urin concentr metabolit dbp number omiss commiss error continu perform test cpt adjust covari conclus present studi show strong posit associ phthalat metabolit urin symptom adhd school ag children
MED-4656~decreas anogenit distanc male infant prenat phthalat exposur abstract prenat phthalat exposur impair testicular function shorten anogenit distanc agd male rodent present data studi examin agd genit measur relat prenat phthalat exposur human standard measur agd obtain num boy num num month age agd signific correl penil volum num num proport boy incomplet testicular descent num num defin anogenit index agi agd divid weight examin agi agd weight mm kg calcul age adjust agi regress analysi examin phthalat monoest metabolit measur prenat urin sampl predictor age adjust agi regress categor analys includ particip prenat urin sampl num urinari concentr phthalat metabolit monoethyl phthalat mep mono n butyl phthalat mbp monobenzyl phthalat mbzp monoisobutyl phthalat mibp invers relat agi adjust age examin p valu regress coeffici rang num num compar boy prenat mbp concentr highest quartil lowest quartil odd ratio shorter expect agi num num confid interv num num odd ratio mep mbzp mibp num num num p valu num defin summari phthalat score quantifi joint exposur phthalat metabolit age adjust agi decreas signific increas phthalat score p valu slope num associ male genit develop phthalat exposur consist phthalate rel syndrom incomplet viril report prenat expos rodent median concentr phthalat metabolit short agi incomplet testicular descent found one quart femal popul unit state base nationwid sampl data support hypothesi prenat phthalat exposur environment level advers affect male reproduct develop human
MED-4658~bioavail natur carotenoid human skin compar blood pubm ncbi abstract skin function structur signific influenc nutrient antioxid protect support layer skin damag irradi effect action free radic lack suitabl method pharmacokinet properti system appli carotenoid transfer skin remain poor understood studi natur kale extract placebo oil oral num healthi volunt num week carotenoid bioaccess evalu non invas reson raman spectroscopi palm forehead skin analysi blood serum standard hplc method blood skin level carotenoid increas signific studi compar blood serum valu increas skin delay depend dermal area carotenoid lycopen measur low extract increas skin compar blood indic natur mixtur extract stabil antioxid network skin supplement end carotenoid decreas faster blood skin delay decreas skin peripher buffer function skin carotenoid copyright num elsevi reserv
MED-4659~facial skin color affect perceiv health human face abstract numer research examin effect skin condit includ textur color percept health age attract human face focus facial color distribut homogen pigment skin qualiti investig role skin color determin percept health face particip manipul skin portion color calibr caucasian face photograph cielab color axe enhanc healthi particip increas skin red provid addit support previous find skin blood color enhanc healthi face particip increas skin yellow light suggest role high carotenoid low melanin color healthi face color prefer resembl red yellow color cue health display speci nonhuman anim
MED-4660~variabl iodin content common commerci edibl seawe pubm ncbi abstract dietari seawe common asia asian restaur establish part popular intern cuisin understand possibl iodine induc thyroid dysfunct collect sampl common dietari seawe commerci sourc unit state harvester provid sampl canada tasmania namibia altogeth num speci seawe analyz iodin content found rang num microg g num nori porphyra tenera num num microg g sampl process kelp granul salt substitut made laminaria digitata explor variat preharvest condit small studi namibian kelp laminaria pallida ecklonia maxima found iodin content lowest sun bleach blade num num microg g highest amount fresh cut juvenil blade num num microg g iodin water solubl cook vapor humid storag condit make averag iodin content prepar food difficult estim asian seawe dish exceed toler upper iodin intak level num microg d
MED-4662~iodine induc neonat hypothyroid secondari matern seawe consumpt common practic asian cultur promot breast milk pubm ncbi abstract mild iodin defici recognis problem australia zealand iodin excess hypothyroid infant highlight case illustr risk excess dietari iodin intak pregnanc breastfeed describ cultur practic consum seawe soup promot breast milk suppli attent recent inadequaci iodin australian diet revers situat overlook feast famin desir num author journal paediatr child health num paediatr child health divis royal australasian colleg physician
MED-4663~hyperthyroid caus excess consumpt sausag pubm ncbi abstract hyperthyroid result excess product thyroid hormon caus grave diseas exogen thyroid hormon lead similar symptom recognit difficult excess intak thyroid hormon admit recognis knowledg exogen hyperthyroid caus thyroid contamin food netherland num year old man present outpati depart intern medicin lab valu reveal hyperthyroid abnorm find physic examin antibodi thyroidstimul hormon tsh receptor detect thyroid scintigraphi num show uptak num silent thyroid diagnos natur await improv thyroid valu thyroglobulin low anamnesi reveal excess daili consumpt sausag thyroid hormon detect sausag patient stop eat remain euthyroid case stipul import anamnesi
MED-4664~iodin toxic soy milk seawe ingest thyroid dysfunct pubm ncbi abstract report seri case thyroid dysfunct adult ingest brand soy milk manufactur kombu seawe case hypothyroid neonat mother drink milk report case neonat hypothyroid link matern ingest seawe made soup product found high level iodin increas awar iodin defici potenti iodin toxic sourc seawe recognis
MED-4665~subgroup reproduct age women unit state risk iodin defici pubm ncbi abstract consum adequ amount iodin pregnanc critic fetal neurolog develop mild defici impair cognit abil import sourc iodin unit state includ dairi product iodiz salt popul tradit consid iodin suffici median urinari iodin concentr uic decreas num num analyz num nhane data urin iodin spot test pregnant num lactat num nonpregn nonlact num women reproduct age num criteria defin iodin suffici median uic num microg l pregnant women num microg l lactat women num microg l nonpregn nonlact women iodin status pregnant women borderlin suffici median uic num microg l num ci num lactat num microg l num ci num nonpregn nonlact num microg l num ci num women iodin suffici dairi product consumpt import contributor iodin status pregnant nonpregn nonlact women consum dairi product risk iodin defici larger sampl confirm find result rais concern iodin status pregnant women women reproduct age consum dairi product iodin level women monitor subgroup risk iodin defici
MED-4666~iodin status thyroid function boston area vegetarian vegan abstract context adequ dietari iodin requir normal thyroid function iodin status thyroid function vegetarian vegan previous studi environment perchlor thiocyan inhibitor thyroid iodin uptak exposur advers affect thyroid function object object studi assess iodin status thyroid function vegetarian consum plant base product egg milk abstain meat poultri fish shellfish vegan avoid anim product affect environment perchlor thiocyan exposur design set cross sect assess urinari iodin perchlor thiocyan concentr serum thyroid function boston area vegetarian vegan subject hundr forty on subject num vegetarian num vegan recruit vegan exclud result median urinari iodin concentr vegan num g liter rang num num g liter lower vegetarian num g liter rang num num g liter num adjust cigarett smoke confirm urinari cotinin level thiocyanate rich food consumpt median urinari thiocyan concentr vegan num g liter rang num g liter higher vegetarian num g liter rang num num g liter num between group differ urinari perchlor concentr num tsh num free num num urinari iodin perchlor thiocyan level tsh num free num num adjust multipl variabl conclus vegetarian iodin suffici vegan risk low iodin intak vegan women child bear age supplement num iodin daili environment perchlor thiocyan exposur thyroid dysfunct group
MED-4667~associ isol staphylococcus aureus week calv milk yield somat cell count clinic mastiti cull pubm ncbi abstract cow isol staphylococcus aureus approxim num week calv milk yield somat cell count scc clinic mastiti cm cull risk remain lactat assess num norwegian dairi herd mix model repeat measur compar milk yield scc surviv analys estim hazard ratio cm cull averag cow isol staph aureus signific higher scc culture neg cow post milk teat disinfect pmtd valu scc num num num num cells ml cow staph aureus isol staph aureus isol num quarter num quarter num quarter iodin pmtd scc num num num num primipar cow test posit staph aureus milk yield curv culture neg cow staph aureus isol num quarter produc num kg num lactat multipar cow isol staph aureus num quarter produc num kg milk num num pariti isol num quarter produc num kg multipar culture neg anim num lactat compar culture neg cow hazard ratio cm cull cow isol staph aureus num quarter num num num num num num decreas scc cm risk culture neg cow iodin pmtd indic iodin pmtd prevent effect healthi cow cow test posit staph aureus num quarter calv iodin pmtd negat effect cm risk scc remain lactat
MED-4668~cretin revisit pubm ncbi abstract endem cretin includ syndrom common neurolog disord brain damag deaf mutism squint spastic paresi leg common syndrom sever hypothyroid growth retard sever mental defect condit due dietari iodin defici prevent correct iodin defici pregnanc endem cretin includ spectrum effect iodin defici popul term iodin defici disord idd includ wide rang lesser degre cognit defect prevent correct iodin defici iodin defici recognis world health organ common prevent brain damag excess num billion risk num countri global unit nation programm prevent achiev num household usag iodis salt year num compar num prior num copyright num elsevi reserv
MED-4669~num week multicent random double blind control trial crocus sativus treatment mild to moder alzheimer diseas pubm ncbi abstract rational increas evid suggest efficaci crocus sativus saffron manag alzheimer diseas ad object purpos present investig assess efficaci sativus treatment patient mild to moder ad method fifty four persian speak adult num year age older live communiti elig particip num week double blind studi parallel group patient ad main efficaci measur chang alzheimer diseas assess scale cognit subscal clinic dementia rate scale sum box score compar baselin advers event ae systemat record particip random assign receiv capsul saffron num mg day num mg day donepezil num mg day num mg day result saffron dose found effect similar donepezil treatment mild to moder ad num week frequenc ae similar saffron extract donepezil group vomit occur signific frequent donepezil group conclus phase ii studi preliminari evid therapeut effect saffron extract treatment patient mild to moder alzheimer diseas trial regist iranian clinic trial registri irct num
MED-4671~saffron treatment patient mild moder alzheimer diseas num week random placebo control trial pubm ncbi abstract herbal medicin treatment behaviour psycholog symptom dementia variabl respons crocus sativus saffron inhibit aggreg deposit amyloid human brain alzheimer diseas ad object goal studi assess efficaci saffron treatment mild moder ad method forty six patient probabl ad screen num week double blind studi parallel group patient mild moder ad psychometr measur includ ad assess scale cognit subscal adas cog clinic dementia rate scale sum box perform monitor global cognit clinic profil patient patient random assign receiv capsul saffron num mg day num mg day group capsul placebo capsul day num week studi result num week saffron produc signific outcom cognit function placebo adas cog num num num num num cdr num num num num num signific differ group term observ advers event conclus double blind placebo control studi suggest short term saffron safe effect mild moder ad larger confirmatori random control trial call copyright num author jcpt num blackwel publish
MED-4672~seropreval cysticercosi orthodox jewish communiti pubm ncbi abstract neurocysticercosi case identifi num orthodox jewish communiti transmiss link tapeworm infect immigr housekeep countri taenia solium endem evalu extent risk local acquir cysticercosi seropreval survey conduct num household communiti cysticercosi antibodi detect num num num person num famili num seroposit person asymptomat intracerebr lesion found num seroposit person underw brain imag seroposit femal sex relat risk rr num num hire domest worker child care duti rr num num employe central america rr num num exposur solium communiti unexpect high widespread employ domest worker endem region high employe turnov contribut exposur risk
MED-4673~misalign percept lifestyl modif knowledg health profession pubm ncbi abstract object present studi aim evalu knowledg practic public sector primary car health profession final year student role nutrit physic activ smoke cessat lifestyl modif manag chronic diseas lifestyl public health car sector design compar cross sect descript quantit studi conduct thirti primari health car facil tertiari institut offer medic and or nurs programm cape town western cape metropol stratifi random sampl base geograph locat select health facil conveni sampl select student tertiari institut valid self administ knowledg test obtain data health profession result differenti lifestyl modif knowledg exist health profession student num achiev desir score num higher major health profession promot theoret concept lifestyl modif experi difficulti provid practic advic patient health profession evalu doctor knowledg lifestyl modif lack time lack patient adher languag barrier main barrier provid lifestyl counsel conclus undergradu curricula medic nurs student includ suffici train lifestyl modif practic advic diet physic activ smoke cessat health profession work primari health car facil updat provid lifestyl modif educ part continu medic educ
MED-4674~nutrit educ medic school latest updat nation survey abstract purpos quantifi number requir hour nutrit educ medic school type cours instruct offer compar result result previous survey method author distribut num accredit medic school matricul student time studi two pag onlin survey devis nutrit medicin project univers north carolina chapel hill august num juli num author contact nutrit educ report nutrit contact hour requir medic student actual hour nutrit educ occur design nutrit clinic rotat result respond num target medic school complet part survey school num requir form nutrit educ num school answer question cours contact hour num requir dedic nutrit num num num school medic student receiv num contact hour nutrit instruct medic school career rang num num hour averag num num hour num num school met minimum num requir hour set nation academi scienc num num num school conclus amount nutrit educ medic student receiv continu inadequ
MED-4676~dietari cholesterol egg yolk patient risk vascular diseas abstract widespread misconcept develop canadian public physician increas believ consumpt dietari cholesterol egg yolk harmless good reason long stand recommend dietari cholesterol limit num mg day singl larg egg yolk approxim num mg cholesterol day worth cholesterol studi show harm consumpt egg healthi peopl outcom due lack power detect clinic relev increas low risk popul studi show particip diabet observ consumpt egg day doubl risk compar egg week diet fast cholesterol postprandi effect cholesterol satur fat oxid stress inflamm misplac focus fast lipid obscur key issu dietari cholesterol increas suscept low dens lipoprotein oxid increas postprandi lipemia potenti advers effect dietari satur fat dietari cholesterol includ egg yolk harm arteri patient risk cardiovascular diseas limit intak cholesterol stop consumpt egg yolk stroke myocardi infarct quit smoke diagnosi lung cancer action late evid present current review suggest widespread percept public health care profession dietari cholesterol benign misplac improv educ correct misconcept sum une id fauss rali se pand au sein du public canadien des decin qui pensent de en la consomm de cholest rol alimentair de jaun uf est inoffens les recommand de longu date qui pr conis de limit le cholest rol alimentair moin de num mg jour repos sur de bonn raison seul gros jaun uf contient environ num mg de cholest rol la portion quotidienn de cholest rol si tude ont montr la consomm uf est pas nuisibl chez les personn en sant ce sultat peut couler de absenc de capacit celer des augment pertinent sur le plan cliniqu au sein une popul faibl risqu de les mes tude ont chez les particip devenus diab tiqu pendant la riod observ la consomm uf par jour doublait leur risqu par rapport la consomm de moin uf par semain le gime ne vise pas viter le cholest rol mai surtout les effet postprandiaux du cholest rol des gras satur du stress oxyd de inflamm le fait de se concentr tort sur les lipid jeun occult troi enjeux le cholest rol alimentair accro la susceptibilit des lipoprot ine faibl densit oxyd accro la lip mie postprandial potentialis les effet secondair des graiss satur es alimentair le cholest rol alimentair compri les jaun uf est nuisibl pour les art res les patient vuln rabl aux maladi cardiovasculair devraient limit leur consomm de cholest rol le fait arr ter de consomm des jaun uf apr accid vasculair bral ou infarctus du myocard apparenterait arr ter de fumer apr diagnost de cancer du poumon est gest cessair mai entrepri tardiv apr les donn es probant pr es dan la pr analys la percept rali du public des professionnel de la sant selon laquell le cholest rol alimentair est mal nin est une id fauss une meilleur inform impos pour la corrig
MED-4677~milk increas mucus product pubm ncbi abstract excess milk consumpt long associ increas respiratori tract mucus product asthma associ explain convent allerg paradigm limit medic evid show causal human colon beta casomorphin num beta cm num exorphin deriv breakdown num milk stimul mucus product gut muc num gland presenc inflamm similar mucus overproduct respiratori tract muc num gland characteris respiratori tract diseas beta cm num blood stream stimul product secret mucus product respiratori gland hypothesi test vitro quantit rt pcr show addit beta cm num incub medium respiratori goblet cell elicit increas muc num mrna identifi beta cm num blood asthmat patient associ necessarili simpli effect person consum num milk beta cm num pass system circul tissu activ inflam prerequisit explain subgroup popul increas respiratori tract mucus product find symptom includ asthma improv dairi elimin diet num elsevi reserv
MED-4678~differenti effect reproduct factor risk pre postmenopaus breast cancer result larg cohort french women abstract aim studi obtain understand role hormon factor breast cancer risk determin effect reproduct event differ age diagnosi analys effect age menarch age full term pregnanc number full term pregnanc number spontan abort risk breast cancer pre postmenopaus onset data num breast cancer case obtain larg sampl num num french women particip num cohort studi result provid evid risk breast cancer increas decreas age menarch increas age pregnanc low pariti effect spontan abort observ effect reproduct factor differ menopaus status age menarch effect premenopaus breast cancer risk decreas risk increas age num year num compar menstrual period num women experienc menarch num rr num num ci num num premenopaus group age full term pregnanc effect pre postmenopaus breast cancer risk signific test show increas risk year increas age num num full term pregnanc age num convey risk num num ci num num num num ci num num pre postmenopaus group protect effect high pariti observ postmenopaus breast cancer risk trend test num point estim num num ci num num num num ci num num num num ci num num num num ci num num full term pregnanc histori spontan abort signific effect risk breast cancer diagnos menopaus result suggest reproduct event complex effect risk breast cancer british journal cancer num num num doi num sj bjc num www bjcancer num cancer research uk
MED-4679~pubert assess method baselin characterist mix longitudin studi girl abstract object object studi describ assess method matur status multisit cohort girl baselin recruit age num num year method method pubert matur stage develop collabor num site girl age num num year recruit num site east harlem york greater cincinnati metropolitan area san francisco bay area california baselin characterist obtain interview caregiv anthropometr measur train examin breast stage num defin onset pubert matur statist evalu agreement master trainer examin logist regress model identifi factor pubert matur linear regress model examin factor height veloc result baselin cohort includ num girl proport girl attain breast stage num vari age race ethn bmi percentil site num year num white num black non hispan num hispan girl attain breast stage num num year num num num attain breast stage num prime determin height veloc pubert status conclus multisit studi substanti agreement pubert stage examin site proport girl breast develop age num num year white girl greater report studi girl born num num year earlier
MED-4680~diet childhood age menarch contemporari cohort british girl pubm ncbi abstract object investig associ dietari intak childhood age menarch indic futur risk diseas contemporari cohort british girl design diet assess ffq num num year age num unweigh food diari num year age menarch categoris num year num month point close median age cohort set bristol south west england subject girl num particip avon longitudin studi parent children result higher energi intak num year posit earli occurr menarch associ remov adjust bodi size total anim protein intak num num year posit age menarch num year num month adjust num sd increas protein num year num num ci num num num higher pufa intak num num year posit earli occurr menarch meat intak num num year strong posit reach menarch num year num month menarch highest lowest categori meat consumpt num year num num ci num num num conclus data suggest higher intak protein meat earli mid childhood lead earlier menarch implic lifetim risk breast cancer osteoporosi
MED-4681~relat isoflavon fiber intak childhood time puberti pubm ncbi abstract background suggest phytoestrogen dietari fiber affect puberti time object examin intak isoflavon fiber healthi white children pubert growth spurt age take off ato puberti time design multivari regress analys perform num donald dortmund nutrit anthropometr longitudin design studi particip num weigh dietari record inform potenti confound baselin num num ato subsampl num urinari isoflavon determin num urin sampl gas chromatography mass spectrometri analysi puberti time examin ato chronolog age pubert stage num breast develop num gonad develop peak height veloc phv menarch voic break result girl diet highest dietari isoflavon tertil experienc tanner stage num breast develop ap num reach phv ap num girl diet lowest isoflavon tertil age num ci num num num num compar num num num trend num age phv num num num compar num num num trend num adjust bodi mass index score fiber intak boy dietari isoflavon pubert marker urinari isoflavon dietari fiber intak pubert marker conclus girl boy higher prepubert isoflavon intak enter puberti age fiber intak sampl healthi white girl boy relev puberti time
MED-4682~calcium absorpt australian osteopen post menopaus women acut compar studi fortifi soymilk cow milk pubm ncbi abstract calcium loss menopaus increas risk osteoporosi age women soymilk consum reduc menopaus symptom nativ form signific calcium cow milk calcium ad fortific absorb effici studi compar calcium absorpt soymilk fortifi proprietari phosphat calcium versus absorpt cow milk preliminari studi compar method label calcium fortific addit soymilk establish fortific label ad soymilk tracer distribut pattern similar shown fortific label ad soymilk provid heat treatment num num min appli method bioavail studi calcium absorpt fortifi soy milk compar cow milk examin randomis single blind acut cross ov design studi num osteopen post menopaus women age sd num num year bodi mass index num num kg m num particip consum num ml test milk label addit fortific num kbq num num mg calcium carrier determin hour fraction calcium absorpt rate alpha singl isotop radiocalcium test hour fraction calcium absorpt fortifi soymilk found compar cow milk alpha num num alpha num num num
MED-4683~serum concentr vitamin num folat british male omnivor vegetarian vegan result cross sect analysi epic oxford cohort studi abstract background object vegan lesser extent vegetarian low averag circul concentr vitamin num relat factor age time diet vitamin num concentr clear object investig differ serum vitamin num folat concentr omnivor vegetarian vegan ascertain vitamin num concentr differ age time diet subjects method cross sect analysi involv num men num omnivor num vegetarian num vegan european prospect investig cancer nutrit oxford cohort result serum vitamin num highest omnivor num ci num pmol l intermedi vegetarian num ci num pmol l lowest vegan num ci num pmol l fifty two percent vegan num vegetarian omnivor classifi vitamin num defici defin serum vitamin num num pmol l signific associ age durat adher vegetarian vegan diet serum vitamin num contrast folat concentr highest vegan intermedi vegetarian lowest omnivor men omnivor categoris folat defici defin serum folat num nmol l conclus vegan lower vitamin num concentr higher folat concentr vegetarian omnivor half vegan categoris vitamin num defici expect higher risk develop clinic symptom relat vitamin num defici
MED-4685~matern neonat vitamin num defici detect expand newborn screening  unit state num pubm ncbi abstract incid neonat vitamin num cobalamin defici matern defici determin survey state newborn screen program thirty two infant nutrit vitamin num defici identifi num num newborn pregnant women assess risk inadequ intake malabsorpt vitamin num copyright num mosbi reserv
MED-4686~propos dietari phytochem index pubm ncbi abstract ampl reason diet rich phytochem provid protect vascular diseas cancer direct antioxid activ modul enzym express hormon activ contribut effect phytochem deriv divers food interact addit possibl synergist total dietari load phytochem import implic health rough quantifi load phytochem index pi propos defin percent dietari calori deriv food rich phytochem calori deriv fruit veget exclud potato legum grain nut seed fruit veget juic soy product wine beer cider food compound therefrom count index partial credit antioxidant rich extra virgin oliv oil ad oil refin sugar refin grain potato product hard liquor anim product regrett chief sourc calori typic western diet exclud pi provid rough approxim quantiti qualiti phytochem nutrit nonetheless aid epidemiologist explor health consequ diet high phytochemical rich plant food clinic nutritionist effort improv phytochem nutrit client
MED-4687~vegetarian diet public health biomark redox connect pubm ncbi abstract vegetarian diet rich antioxid phytochem act antioxid vivo import signal regulatori function act pro oxid modul cellular redox tone oxid redox sensit site review evid health benefit vegetarian diet present perspect epidemiolog biomark evolutionari public health antioxid perspect molecular connect diet health evid role plasma ascorb acid biomark futur diseas risk present basic concept redox bas cell signal present effect antioxid phytochem signal redox tone sulfur switch antioxid respons element explor suffici scientif evid exist public health polici promot plant rich diet health promot wait scienc provid answer action interplay dietari antioxid nonequilibrium system control redox balanc cell signal cell function provid rich ground research advanc understand orthomolecular nutrit provid science bas evid advanc public health age popul
MED-4689~total antioxid content num food beverag spice herb supplement worldwid abstract background plant bas diet protect chronic oxid stress rel diseas dietari plant variabl chemic famili amount antioxid hypothes plant antioxid contribut benefici health effect dietari plant object develop comprehens food databas consist total antioxid content typic food dietari item tradit medicin plant herb spice dietari supplement databas intend wide rang nutrit research vitro cell anim studi clinic trial nutrit epidemiolog studi method procur sampl countri worldwid assay sampl total antioxid content modifi version frap assay result sampl inform countri origin product and or brand regist individu food sampl constitut antioxid food tabl result result demonstr thousand fold differ antioxid content food spice herb supplement includ antioxid rich product studi high berri fruit nut chocol veget product thereof constitut common food beverag high antioxid valu conclus databas knowledg comprehens antioxid food databas publish show plant bas food introduc signific antioxid human diet non plant food larg variat observ compar food sampl studi emphas import comprehens databas combin detail system food registr clinic epidemiolog studi present antioxid databas essenti research tool elucid potenti health effect phytochem antioxid diet
MED-4690~put cancer sleep night neuroendocrine circadian melatonin signal pubm ncbi abstract physiolog pharmacolog blood concentr melatonin inhibit tumorigenesi varieti vivo vitro experiment model neoplasia evid melatonin anticanc effect exert inhibit cell prolifer stimul differenti apoptosi mechan physiolog pharmacolog blood level melatonin inhibit cancer growth vivoi melatonin induc suppress tumor linol acid la uptak metabol import mitogen signal molecul num hydroxyoctadecadieno acid num hode melatonin suppress camp format inhibit tumor uptak la metabol num hode melatonin receptor medi mechan tissue isol rat hepatoma num ctc human breast cancer xenograft postul industri societi light night suppress melatonin product pose risk develop breast cancer cancer support hypothesi light dark suppress nocturn melatonin product stimul la metabol growth rat hepatoma human breast cancer xenograft nocturn dietari supplement melatonin level melatonin rich diet inhibit rat hepatoma growth mechan nocturn melatonin signal organ tumor metabol growth circadian time structur reinforc appropri time melatonin supplement dietari melatonin supplement work concert endogen melatonin signal potenti preventive therapeut strategi optim host canc balanc favor host surviv qualiti life
MED-4691~dietari correl urinari num sulfatoxymelatonin concentr nurs health studi cohort abstract background age lifestyl factor includ higher bodi mass index exposur light night relat lower circul concentr melatonin hormon probabl cancer protect properti melatonin direct deriv essenti amino acid tryptophan relat diet melatonin concentr object object examin cross sect associ nutrient dietari factor food group creatinine adjust morn urinari melatonin num sulfatoxymelatonin amt num concentr design particip num healthi women num independ cohort nurs health studi nhs num nhs ii num comput least squar hormon concentr categori dietari variabl adjust total energi intak age nondietari factor amt num concentr result multivari analys found signific associ intak nutrient includ tryptophan urinari melatonin concentr higher intak meat red meat lower concentr amt num adjust concentr amt num increas quartil red meat intak num num num num ng mg creatinin trend num contrast poultri intak includ turkey fish intak amt num concentr conclus specif nutrient alter concentr melatonin find rais possibl specif food includ red meat affect cancer risk lower melatonin concentr
MED-4692~light night co distribut incid breast lung cancer femal popul israel pubm ncbi abstract recent studi shift work women report excess exposur light night lan risk factor breast cancer studi attempt examin co distribut lan breast cancer incid popul level goal assess coher earlier find popul trend coher hill criteria viewpoint infer causal nighttim satellit imag estim lan level num communiti israel multipl regress analysi perform investig associ lan breast cancer incid rate test specif method lung cancer incid rate women local predict link breast cancer lung cancer adjust variabl popul level ethnic makeup birth rate popul densiti local incom level strong posit associ lan intens breast cancer rate reveal num associ strengthen num statist signific factor filter stepwis regress analysi concurr associ found lan intens lung cancer rate result provid coher previous report case control cohort studi co distribut lan breast cancer popul basi analysi yield estim num higher breast cancer incid highest lan expos communiti compar lowest lan expos communiti
MED-4693~light at night circadian disrupt breast cancer assess exist evid abstract background breast cancer incid increas global larg unknown reason possibl portion breast cancer burden explain introduct increas electr light night suggest num year ago method theori base nocturn light induc disrupt circadian rhythm notabl reduct melatonin synthesi form basi seri predict includ non day shift work increas risk blind women lower risk long sleep durat lower risk communiti nighttim light level co distribut breast cancer incid popul level result accumul epidemiolog evid acceler recent year reflect intern agenc research cancer iarc classif shift work probabl human carcinogen num strong rodent model support light at night lan idea conclus consensus eventu emerg lan increas risk mechan effect import elucid intervent mitig basic understand phototransduct circadian system molecular genet circadian rhythm generat advanc rapid provid develop light technolog home work minim circadian disrupt maintain visual effici aesthet interim strategi reduc potenti circadian disrupt includ extend daili dark period nocturn awaken dark dim red light nighttim necess recommend physician melatonin tablet
MED-4694~total visual blind protect breast cancer pubm ncbi abstract object observ data spars base small studi limit abil control breast cancer risk factor support lower risk breast cancer blind women compar sight women mechan influenc ocular light percept melatonin circadian synchron thought account lower risk method evalu blind women percept light npl lower preval breast cancer compar blind women light percept lp survey cohort num blind women live north america num breast cancer case result multivariate logist regress model control breast cancer risk factor women npl signific lower preval breast cancer women lp odd ratio num num confid interv num num observ differ associ restrict postmenopaus women non shift worker exclud women diagnos breast cancer num num year onset blind blind women npl lower risk breast cancer compar blind women lp research elucid impact lp circadian coordin melatonin product blind factor relat breast cancer risk
MED-4695~electr light cancer you r joke mr steven pubm ncbi abstract night longer dark modern world milki disappear electr light benefit detriment num loss night sky num wast energi num harm anim plant life num increas sever human maladi cancer breast prostat scienc phototransduct circadian system clock gene function evolv rapid rational idea circadian disrupt light night diseas direct evid human rodent model accumul point idea longer fanci logic journey path electr light breast cancer tortuous
MED-4696~modul inflammatori gene natur dietari bioactiv compound pubm ncbi abstract epidemiolog studi shown chronic inflamm predispos individu type cancer cancer aris site infect chronic irrit inflamm convers oncogen chang induc inflammatori microenviron promot develop tumor natur bioactiv compound dietari plant product includ fruit veget grain legum tea wine claim prevent cancer degen diseas chronic acut inflamm modern method cell molecular biolog understand interact natur bioactiv compound basic mechan inflammatori respons molecular pathway cancer rel inflamm unravel natur bioactiv compound exert anti inflammatori activ modul pro inflammatori gene express shown promis chemoprevent activ review summar current knowledg natur bioactiv compound act signal pathway modul inflammatori gene express provid evid substanc cancer chemoprevent action
MED-4697~age mitochondri dna reactiv oxygen speci summari age popul global increas age rel disord develop countri chronic diseas disproportion affect older segment popul contribut disabl diminish qualiti life increas healthcar cost increas life expect reflect success contemporari medicin respond challeng creat achiev includ grow burden chronic ill injuri disabl well develop theoret framework requir understand molecular basi age turn prerequisit develop clinic intervent constitut effici respons challeng age rel health issu review critic analyz experiment evid support refut free radical mitochondri theori age domin field age research half centuri
MED-4698~role mitochondri oxid stress explain longev gender protect effect estrogen pubm ncbi abstract femal live longer male work laboratori shown due up regul longevity associ gene estrogen estrogen bind estrogen receptor subsequ activ mitogen activ protein kinas nuclear factor kappa signal pathway result up regul antioxid enzym estrogen administr undesir effect administ male power femin effect test effect genistein phytoestrogen high nutrit import structur similar estradiol regul express antioxid longevity rel gene oxid level mammari gland tumour cell cultur phytoestrogen mimic protect effect oestradiol signal pathway critic import up regul antioxid gene hormon dietari manipul increas longev discuss
MED-4699~age eat pubm ncbi abstract epidemiolog studi propos extens human lifespan reduct age diseas achiev physic exercis calor restrict consumpt substanc resveratrol selenium flavonoid zinc omega num unsatur fatti acid vitamin ginkgobiloba extract aspirin green tea catechin antioxid general light caffein alcohol consumpt intrigu studi show correl causat effect applic substanc longev hand obes strong menac western societi emerg decad predict obes consid sever problem molecular mechan caus degener organ final death nutrient relat advers consequ health age due high sugar high fat diet excess alcohol consumpt cigarett smoke articl examin interdepend eat age suggest yeast success age model easi tool elucid molecular pathway eat age conserv age pathway yeast easi genet tractabl provid chanc discrimin correl causat effect nutrit age num elsevi reserv
MED-4700~associ manganes superoxid dismutas mnsod val num la polymorph cancer risk meta analysi pubm ncbi abstract grow bodi evid suggest reactiv oxygen speci ros play import role human cancer manganes superoxid dismutas mnsod major antioxid mitochondria catalys dismut superoxid radic form hydrogen peroxid identif well characteris function polymorph val num la mnsod number molecular epidemiolog studi evalu associ val num la cancer risk result remain conflict conclus meta analysi num cancer case num control num publish case control studi show signific main effect mnsod val num la cancer risk found mnsod num la allel increas prostat cancer risk val ala versus val val odd ratio num num confid interv ci num num ala ala versus val val num num ci num num val ala ala ala versus val val num num ci num num addit found mnsod ala num la genotyp contribut increas breast cancer risk premenopaus women low consumpt antioxid ala ala versus val ala val v num num ci num num low vitamin consumpt num num ci num num low vitamin consumpt num num ci num num low carotenoid consumpt result suggest mnsod val num la polymorph contribut cancer develop disturb antioxid balanc
MED-4701~examin antiglycem properti vinegar healthi adult pubm ncbi abstract background vinegar reduc postprandi glycemia ppg healthi adult studi investig vinegar dosag num num time mealtim num meal applic acet acid vinegar neutral salt reduc ppg method random crossov trial conduct adult num trial type num diabet num trial diabet num trial trial protocol standard meal prior test overnight fast num num hour glucos test consumpt bagel juic test meal num trial dextros solut num trial trial ppg compar treatment area under the curv calcul num min meal result teaspoon vinegar num effect reduc ppg effect pronounc vinegar ingest mealtim compar num meal vinegar alter ppg ingest monosaccharid suggest antiglycem action vinegar relat digest carbohydr final sodium acet alter ppg indic acet salt lack antiglycem properti conclus antiglycem properti vinegar evid small amount vinegar ingest meal compos complex carbohydr situat vinegar attenu ppg num compar placebo num karger ag basel
MED-4702~delay gastric empti rate explain improv glycaemia healthi subject starchi meal ad vinegar pubm ncbi abstract object aim studi evalu influenc acet acid administ vinegar postprandi glucos insulin respons potenti involv modifi gastric empti rate studi paracetamol marker design white bread refer meal meal supplement vinegar content starch protein fat meal serv morn over night fast random order capillari blood sampl analysi glucos insulin paracetamol collect postprandi set studi perform depart appli nutrit food chemistri lund univers sweden subject ten healthi volunt women men age num normal bodi mass indic recruit result presenc acet acid vinegar signific reduc postprandi glucos gi num insulin respons ii num starchi meal judg lower paracetamol level test meal vinegar mechan delay gastric empti rate conclus ferment food food product ad organ acid prefer includ diet order reduc glycaemia insulin demand
MED-4703~vinegar supplement lower glucos insulin respons increas satieti bread meal healthi subject pubm ncbi abstract object investig potenti acet acid supplement lower glycaem index gi bread meal evalu dose respons effect postprandi glycaemia insulinaemia satieti subject set num healthi volunt particip test perform appli nutrit food chemistri lund univers sweden intervent level vinegar num num mmol acet acid serv portion white wheat bread num carbohydr breakfast random order overnight fast bread serv vinegar refer meal blood sampl num min analysi glucos insulin satieti measur subject rate scale result signific dose respons relat num min blood glucos serum insulin respons higher acet acid level lower metabol respons rate satieti direct relat acet acid level compar refer meal highest level vinegar signific lower blood glucos respons num num min insulin respons num num min increas satieti score num num min postprandi low intermedi level vinegar lower num min glucos num min insulin respons signific compar refer meal gi ii insulinaem indic calcul num min increment area signific lower found highest amount acet acid valu calcul num min differ refer meal conclus supplement meal base white wheat bread vinegar reduc postprandi respons blood glucos insulin increas subject rate satieti invers dose respons relat level acet acid glucos insulin respons linear dose respons relat acet acid satieti rate result interest potenti ferment pickl product acet acid
MED-4704~lipoid pneumonia present resolv communiti acquir pneumonia case report abstract introduct lipoid pneumonia rare form pneumonia caus inhal aspir fat substanc petroleum jelli miner oil laxat present insidi onset chronic respiratori ill simul interstiti lung diseas rare present acut respiratori ill special exposur fatti substanc acut and or massiv radiolog mimic carcinoma acut chronic pneumonia ard local granuloma diagnosi lp requir demonstr lipid laden macrophag sputum bronchoalveolar lavag fluid fine needl aspir cytology biopsi lung lesion treatment ill poor defin constitut support therapi corticosteroid case present num year indian farmer refer diagnosi resolv communiti acquir pneumonia respiratori examin reveal sign consolid chest radiograph reveal find suggest bilater consolid sputum blood cultur steril treat prolong antibiot signific respons evalu resolv pneumonia fibreopt bronchoscopi bronchoalveolar lavag fluid biopsi lung lesion show lipid laden macrophag diagnosi lipoid pneumonia made patient treat corticosteroid good respons literatur rare entiti discuss conclus lipoid pneumonia rare form pneumonia rare present acut resembl communiti acquir pneumonia requir high degre suspicion diagnosi treatment difficult poor defin prolong corticosteroid effect
MED-4705~human cancer cell antiprolif antioxid activ juglan regia pubm ncbi abstract studi suggest regular consumpt nut walnut benefici effect oxid stress mediat diseas cardiovascular diseas cancer walnut phenol compound thought contribut biolog properti present studi report total phenol content antioxid properti methanol petroleum ether extract obtain walnut juglan regia seed green husk leaf total phenol content determin folin ciocalteu method antioxid activ assess abil quench stabl free radic num diphenyl num picrylhydrazyl dpph inhibit num azobi num amidinopropan dihydrochlorid aaph induc oxid hemolysi human erythrocyt methanol seed extract present highest total phenol content num mg gae g extract dpph scaveng activ ec num num mg ml leaf green husk petroleum ether extract antioxid action lower absent oxid action aaph methanol extract signific protect erythrocyt membran hemolysi time concentration depend manner leaf extract inhibitori effici stronger ic num num mg ml observ green husk seed ic num num num mg ml walnut methanol extract assay antiprolif effect human renal cancer cell line num num colon cancer cell line caco num extract show concentration depend growth inhibit human kidney colon cancer cell num renal cancer cell extract exhibit similar growth inhibit activ ic num valu num num mg ml num renal caco num colon cancer cell walnut leaf extract show higher antiprolif effici ic num valu num num mg ml green husk seed extract result obtain strong walnut tree constitut excel sourc effect natur antioxid chemoprevent agent copyright num elsevi reserv
MED-4706~regular consumpt nut lower risk cardiovascular diseas women type num diabet abstract higher nut consumpt lower risk coronari heart diseas chd event epidemiolog studi studi examin associ intak nut incid cardiovascular diseas cvd cohort women type num diabet primari analysi num women type num diabet complet valid ffq num num num num cvd cancer studi entri major cvd event includ incid myocardi infarct mi revascular stroke num person year follow up num chd event includ mi revascular num incid stroke case frequent nut peanut butter consumpt invers total cvd risk age adjust analys adjust convent cvd risk factor consumpt num servings wk nut peanut butter serv size num num ounc nut num num tablespoon peanut butter signific lower risk cvd relat risk num num ci num num evalu plasma lipid inflammatori biomark observ increas nut consumpt signific favor plasma lipid profil includ lower ldl cholesterol non hdl cholesterol total cholesterol apolipoprotein b num concentr observ signific associ hdl cholesterol inflammatori marker data suggest frequent nut peanut butter consumpt signific lower cvd risk women type num diabet
MED-4707~prospect studi nut consumpt long term weight chang obes risk women abstract background data long term associ nut consumpt weight chang free liv popul spars object object determin relat nut consumpt long term weight chang design particip num women nurs health studi ii age num num cardiovascular diseas diabet cancer prospect evalu dietari intak nut subsequ weight num num result women report eat nut num times wk slight se weight gain num num kg women rare ate nut num num kg trend num comparison total nut consumpt subdivid peanut tree nut result similar weight gain women eat peanut tree nut num times wk result similar normal weight overweight obes particip multivari analys lifestyl dietari factor control found greater nut consumpt num times wk compar never almost slight lower risk obes hazard ratio num num ci num num trend num conclus higher nut consumpt greater bodi weight gain num follow up healthi middle ag women slight lower risk weight gain obes result studi suggest incorpor nut diet lead greater weight gain weight control
MED-4708~long term walnut supplement dietari advic induc favor serum lipid free liv individu pubm ncbi abstract background object walnut shown reduc serum lipid short term well control feed trial inform exist effect sustain walnut consumpt longer durat free liv situat subjects method random crossov design num subject normal moder high plasma total cholesterol initi assign walnut suppl diet habitu control diet num month period switch altern dietari intervent num month period subject attend clinic num month clinic bodi weight measur clinic month num num num blood sampl collect result studi show supplement habitu diet walnut num total daili energi intak equival improv plasma lipid profil benefici effect signific subject high plasma total cholesterol baselin signific serum concentr total cholesterol num triglycerid num signific low dens lipoprotein cholesterol ldl c num found signific chang detect high dens lipoprotein hdl cholesterol ldl hdl ratio conclus includ walnut part habitu diet favor alter plasma lipid profil lipid low effect walnut evid subject higher lipid baselin valu precis peopl greater reduc plasma total ldl c
MED-4709~oliv oil walnut breakfast reduc postprandi inflammatori respons mononuclear cell compar butter breakfast healthi men pubm ncbi abstract background inflamm crucial stage atherosclerosi studi investig effect dietari fat marker inflamm relat diseas postprandi period object evalu chronic effect dietari fat postprandi express proinflammatori gene peripher blood mononuclear cell pbmcs healthi subject design num healthi men diet num week random crossov design western diet num protein num carbohydr cho num fat num satur fatti acid sfa mediterranean diet num protein num cho num fat num monounsatur fatti acid mufa cho rich num diet num protein num cho num fat num polyunsatur fatti acid pufa num fast volunt breakfast fat composit similar consum diets butt breakfast num sfa oliv oil breakfast num mufa walnut breakfast num pufa num alpha linolen acid lna result butter breakfast induc higher increas tumor necrosi factor tnf alpha messeng rna mrna express oliv oil walnut breakfast num pbmcs found higher postprandi respons mrna interleukin il num intak butter oliv oil breakfast walnut breakfast num cell effect fatti breakfast plasma concentr proinflammatori paramet show signific differ p n conclus consumpt butter enrich meal elicit greater postprandi express proinflammatori cytokin mrna pbmcs compar oliv oil walnut breakfast
MED-4710~effect pistachio diet lipid paramet endotheli function inflamm oxid status prospect studi pubm ncbi abstract object recent studi suggest nut favor effect lipid lower aim investig effect antep pistachio pistacia vera blood glucos lipid paramet endotheli function inflamm oxid healthi young men live control environ method mediterranean diet administ normolipidem num healthi young men age num rang num num wk num wk particip continu receiv mediterranean diet pistachio ad num wk replac monounsatur fat content constitut approxim num daili calor intak fast blood sampl brachial endotheli function measur perform baselin diet result compar mediterranean diet pistachio diet decreas glucos num num num low dens lipoprotein num num num total cholesterol num num num triacylglycerol num num num signific high dens lipoprotein num num num non signific total cholesterol high dens lipoprotein low dens lipoprotein high dens lipoprotein ratio decreas signific num pistachio diet signific improv endothelium depend vasodil num num relat increas decreas serum interleukin num total oxid status lipid hydroperoxid malondialdehyd increas superoxid dismutas num signific chang c reactiv protein tumor necrosi factor alpha level conclus trial demonstr pistachio diet improv blood glucos level endotheli function indic inflamm oxid status healthi young men find accord idea nut pistachio nut favor effect lipid lower deserv evalu prospect follow up studi copyright num publish elsevi
MED-4711~licoric licochalcone a induc autophagi lncap prostat cancer cell suppress bcl num express mtor pathway pubm ncbi abstract licoric common chines medicin herb antitumor activ compon licoric root shown induc cell cycl arrest apoptosi cancer cell paper demonstr time licoric glycyrrhiza glabra compon licochalcone a la induc autophagi addit apoptosi human lncap prostat cancer cell exposur cell licoric la result confirm characterist autophagi includ autophag vacuol reveal monodansylcadaverin mdc stain format acid vesicular organell avo autophagosom membran associ microtubule associ protein num light chain num lc num character cleavag lc num punctuat redistribut ultrastructur observ autophag vacuol transmiss electron microscopi autophagi induct accompani down regul bcl num inhibit mammalian target rapamycin mtor pathway summari licoric induc caspase depend autophagy rel cell death lncap cell
MED-4712~goji lycium barbarum chinens phytochemistri pharmacolog safeti perspect tradit recent popular pubm ncbi abstract begin centuri goji berri juic sold health food product western countri prais advertis media well b anti ag remedi popular goji product rapid grown year effici market strategi goji lycium barbarum chinens close speci long tradit medicin food plant east asia china barbarum officin fruit fructus lycii root bark cortex lycii radici speci folk medicin review constitu pharmacolog safeti barbarum chinens part plant investig fruit focus proteoglycan lycium barbarum polysaccharid show antioxid properti interest pharmacolog activ context age relat diseas atherosclerosi diabet root bark compound demonstr hepatoprotect action inhibitori effect rennin angiotensin system support tradit treatment hypertens sign toxic plant case interact warfarin point potenti risk drug interact view pharmacolog data long tradit tradit chines medicin barbarum chinens deserv investig clinic evid rigor procedur qualiti control indispens recommend made goji product copyright georg thiem verlag kg stuttgart york
MED-4713~case kombucha tea toxic pubm ncbi abstract introduct kombucha mushroom tea tout medicin properti present case hyperthermia lactic acidosi acut renal failur num hour kombucha tea ingest case present num year male newli diagnos hiv short breath febril num twelv hour kombucha tea ingest subsequ combat confus requir sedat intub airway control laboratori reveal lactat num mmol l serum creatinin num mg dl discuss kombucha tea black tea ferment yeast bacteria medium case report exist fatal hepat dysfunct lactic acidosi close proxim ingest conclus kombucha tea consid healthi elixir limit evid rais concern pose health risk consumpt tea discourag life threaten lactic acidosi
MED-4714~veget pickl veget negat risk breast cancer pubm ncbi abstract studi investig associ pickl veget consumpt risk breast cancer valid food frequenc questionnair total num patient breast cancer match num healthi control age num yr age distribut recruit nation cancer center south korea adjust nondietari risk factor total veget intak invers risk breast cancer unlik nonpickl veget pickl veget intak proport relat total veget posit risk breast cancer associ profound consist pickl veget intak consid proport relat total veget odd ratio num num confid interv ci num num trend num highest lowest quartil intak absolut consum amount num num ci num num trend num highest lowest quartil intak result suggest amount total veget intak amount type veget pickl nonpickl proport relat total veget signific risk breast cancer
MED-4715~effect date phoenix dactylifera medjool hallawi varieti consumpt healthi subject serum glucos lipid level seru pubm ncbi abstract present pilot studi analyz time vivo effect medjool hallawi date consumpt healthi subject serum glucos lipid oxid stress total phenol concentr hallawi versus medjool date greater num major proport solubl phenol date varieti consist phenol acid ferul acid coumar acid deriv chlorogen caffeic acid deriv unlik medjool date hallawi date signific proport catechin addit varieti quercetin deriv date varieti possess antioxid properti vitro ferric ion reduc antioxid power hallawi versus medjool date higher num ten healthi subject consum period num week num g day medjool hallawi date date consumpt signific affect subject bodi mass index bmi serum total cholesterol cholesterol level vldl ldl hdl fraction import fast serum glucos triacylglycerol level increas consumpt date varieti serum triacylglycerol level signific num decreas num num medjool hallawi date consumpt basal serum oxid status signific num decreas num compar level observ consumpt hallawi medjool date consumpt similar suscept serum aaph induc lipid peroxid decreas num hallawi date consumpt agreement result serum activ hdl associ antioxid enzym paraoxonas num pon num signific increas num hallawi date consumpt conclud date consumpt hallawi varieti healthi subject high sugar content demonstr benefici effect serum triacylglycerol oxid stress worsen serum glucos lipid lipoprotein pattern consid antiatherogen nutrient
MED-4716~fruit date palm food futur pubm ncbi abstract fruit date date palm phoenix dactylifera high percentag carbohydr total sugar num fat num num num salt miner protein num num vitamin high percentag dietari fibr num num flesh date num num oil seed num num oil weight seed num num date fatti acid occur flesh seed rang satur unsatur acid seed num type fatti acid fatti acid occur low concentr flesh unsatur fatti acid includ palmitol oleic linol linolen acid oleic acid content seed vari num num suggest seed date sourc oleic acid num miner date percentag miner dri date vari num num mg num date depend type miner varieti potassium found concentr high num flesh high num seed miner salt found proport includ boron calcium cobalt copper fluorin iron magnesium manganes potassium phosphor sodium zinc addit seed aluminum cadmium chlorid lead sulphur proport date element fluorin protect teeth decay selenium element believ prevent cancer import immun function found date protein date num type amino acid present popular fruit orang appl banana date vitamin includ small amount vitamin vitamin num thiamin num riboflavin nicotin acid niacin vitamin dietari fibr num varieti date shown high num num depend varieti degre ripe date num num pectin import health benefit world product date increas num time num year world popul doubl total world export date increas num num year date consid ideal food provid wide rang essenti nutrient potenti health benefit
MED-4719~tea catechin affin human cannabinoid receptor pubm ncbi abstract health benefit tea catechin count anti inflammatori neuroprotect activ effect regul food intak address cannabimimet bioactiv catechin deriv occur tea leav cellular effector function competit radioligand bind assay recombin human cannabinoid receptor express chem num cho cell identifi epigallocatechin num o gal egcg num microm epigallocatechin egc num microm epicatechin num o gal ecg num microm ligand moder affin type num cannabinoid receptor cb num bind cb num weaker inhibit constant exceed num microm egc ecg epim catechin epicatechin exhibit neglig affin cb num cb num conclud central nervous cannabinoid receptor target select tea catechin signal peripher type receptor play major role vivo
MED-4720~opiat receptor demonstr nervous tissu pubm ncbi abstract tritiat naloxon power opiat antagonist specif bind opiat receptor mammalian brain guinea pig intestin competit opiat receptor opiat antagonist close parallel pharmacolog potenc opiat receptor confin nervous tissu
MED-4721~cannabinoid receptor local brain abstract num cp num radiolabel synthet cannabinoid num time potent vivo delta num tetrahydrocannabinol character local specif cannabinoid receptor brain section potenc seri natur synthet cannabinoid competitor num cp num bind correl close relat potenc biolog assay suggest receptor character vitro assay receptor mediat behavior pharmacolog effect cannabinoid includ human subject experi autoradiographi cannabinoid receptor brain section mammalian speci includ human reveal uniqu conserv distribut bind dens outflow nuclei basal ganglia  th substantia nigra par reticulata globus pallidus  and hippocampus cerebellum general high densiti forebrain cerebellum implic role cannabinoid cognit movement spars densiti lower brainstem area control cardiovascular respiratori function explain high dose delta num tetrahydrocannabinol lethal
MED-4722~dietari protein bone health systemat review meta analysi pubm ncbi abstract background resurg interest controversi relat dietari protein bone health object articl report systemat review meta analysi relat protein bone health healthi human adult design medlin januari num septemb num embas num juli num databas electron search relev studi healthi adult studi calcium excret calcium balanc exclud result cross sect survey pool valu relat protein intak bone miner densiti bmd bone miner content main clinic relev site signific posit protein intak explain num bmd meta analysi random placebo control trial signific posit influenc protein supplement lumbar spine bmd show associ relat risk hip fractur signific effect identifi soy protein milk basic protein lumbar spine bmd conclus small posit effect protein supplement lumbar spine bmd random placebo control trial support posit associ protein intak bone health found cross sect survey result support cohort studi find hip fractur risk effect found small num cis close small benefit protein bone health benefit necessarili translat reduc fractur risk long term
MED-4724~consequ exclus breast feed vegan mother newborn  cas report pubm ncbi abstract report case infant hospit failur thrive megaloblast anemia delay psychomotor develop num month exclus breast f vegan mother investig show vitamin num defici hematocytopenia pervas development disord vitamin vitamin defici infant mother present defici introduct vitamin supplement normal biolog disord infant show weight gain neurolog improv case highlight vegan diet pregnanc exclus breast feed induc nutrit defici newborn clinic consequ detect mother child vitamin defici prevent essenti
MED-4726~impact adopt vegan diet olestra supplement plasma organochlorin concentr result pilot studi pubm ncbi abstract aim studi evalu potenti nutrit approach prevent reduc bodi load organochlorin oc human studi num compar plasma oc concentr vegan omnivor studi num verifi dietari fat substitut olestra prevent increas oc concentr general observ respons weight reduc programm studi num vegan fifteen omnivor recruit concentr twenty six oc beta hexachlorocyclohexan beta hch p  dichlorodiphenyldichloroethan p  dde p  dichlorodiphenyltrichloroethan p  ddt hexachlorobenzen mirex aldrin alpha chlordan gamma chlordan oxychlordan cis nonachlor trans nonachlor polychlorin biphenyl pcb nos num num num num num num num num aroclor num determin studi num concentr twenty six oc measur weight loss num month thirty seven obes men assign treatment standard group num fat diet num fat reduc group num fat diet num fat substitut group num dietari lipid substitut olestra num studi num plasma concentr oc compound aroclor num pcb num pcb num pcb num pcb num signific lower vegan compar omnivor studi num beta hch oc decreas fat substitut group increas group num conclus trend lesser contamin vegan omnivor olestra favour influenc beta hch prevent plasma hyperconcentr oc ongo weight loss
MED-4727~dietari intak organotin compound finland market basket studi pubm ncbi abstract object studi estim intak organ tin compound foodstuff finnish market basket studi conduct collect num market basket supermarket market place citi kuopio eastern finland altogeth num food item bought basket foodstuff mix proport consumpt analys gc ms organ tin compound mono di tributyltin mono di triphenyltin dioctyltin organotin compound detect basket fish basket largest number organotin european food safeti author establish toler daili intak num ng kg num bodi weight sum dibutyltin tributyltin triphenyltin dioctyltin studi daili intak compound num ng kg num bodi weight num origin fish basket exposur num toler daili intak pose neglig risk averag consum consum eat larg quantiti fish contamin area intak higher
MED-4728~environment obesogen organotin endocrin disrupt nuclear receptor signal pubm ncbi abstract decad incid obes metabol syndrom diseas risen dramat global health crisi increas calor intak decreas physic activ believ repres root dramat rise recent find highlight involv environment obesogen xenobiot chemic disrupt normal development homeostat control adipogenesi energi balanc environment estrogen chemic estrogen potenti report perturb adipogen mechan vitro model system class endocrine disrupt chemic scrutini organotin repres class widespread persist organ pollut potent endocrine disrupt properti invertebr vertebr data identifi tributyltin chlorid triphenyltin chlorid nanomolar agonist ligand retinoid receptor rxr alpha rxr beta rxr gamma peroxisom proliferator activ receptor gamma nuclear receptor play pivot role lipid homeostasi adipogenesi environment obesogen hypothesi predict inappropri receptor activ organotin lead direct adipocyt differenti predisposit obes and or sensit expos individu obes relat metabol disord influenc typic high calori high fat western diet link organotin exposur adipocyt differenti obes open import area research potenti environment influenc human health diseas
MED-4729~organohalogen contamin contribut histopatholog liver east greenland polar bear ursus maritimus abstract east greenland polar bear ursus maritimus anthropogen organohalogen compound ohc polychlorin biphenyl dichlorodiphenyltrichloroethan polybromin diphenyl ether contribut renal lesion believ reduc bone miner densiti ohc hepatotox investig liver histolog num subadult num adult femal num adult male east greenland polar bear sampl num num light microscop consist nuclear displac normal central cytoplasm locat parenchym cell mononuclear cell infiltr portal lipid granuloma mild bile duct prolifer accompani fibrosi fat accumul hepatocyt pluripot ito cell lipid accumul ito cell bile duct hyperplasia accompani portal fibrosi correl age sex season summer winter adult femal hepatocyt intracellular fat increas signific concentr sum hexachlorocyclohexan case lipid granuloma hexachlorobenzen adult male base relationship natur chronic inflamm suggest find caus age long term exposur ohc biomark ohc exposur wildlif human knowledg time liver histolog evalu relat ohc concentr mammalian wildlif speci inform import futur polar bear conserv strategi health assess human reli ohc contamin food resourc
MED-4730~simultan quantit multipl class organohalogen compound fish oil direct sampl introduct comprehens two dimension pubm ncbi abstract success optim analyt method gel permeat chromatographi direct sampl introduct comprehens two dimension gas chromatographi time of flight mass spectrometri quantifi multipl group target persist organ pollut halogen natur product hnps simultan fish oil sampl method wider analyt scope tradit approach multipl method cover class compound analysi reveal volatil lighter organ compound polychlorin biphenyl pcbs organochlorin pesticid smaller organohalogen compound present brand pcb free cod liver oil albeit lower level untreat commerci sampl volatil organ compound polybromin diphenyl ether bromin hnps detect similar level cod liver oil suggest commerci molecular distil treatment remov organic inorgan toxic contamin effect lighter organ contamin
MED-4731~effect fish oil supplement serum inflammatori marker interrelationship random control trial healthi middl pubm ncbi abstract background high intak num polyunsatur fatti acid pufa present fish decreas inflamm previous intervent studi fish pufa inflammatori marker healthi individu analyz broad spectrum inflammatori cytokin chemokin cell adhes molecul interrelationship determin effect fish oil supplement num serum inflammatori marker interrelationship healthi middle ag individu method individu num age num year complet random double blind placebo control intervent studi particip receiv num g day fish oil num g day total num pufa num placebo high oleic sunflow oil num num week serum concentr num inflammatori marker determin multiplex immunoassay intervent concentr analyz analysi covari differ pattern inflammatori marker fish oil placebo group analyz princip compon analysi result fish oil supplement signific affect serum concentr cytokin chemokin cell adhes molecul compar placebo trend inflammatori marker increas fish oil supplement pca result mark distinct pattern inflammatori marker fish oil placebo group conclus conclus num week random double blind placebo control intervent trial show num g day num pufa signific affect serum inflammatori respons healthi individu pattern inflammatori marker healthi middle ag popul benefit fish oil anti inflammatori agent
MED-4732~polychlorin biphenyl num induc adipocyt differenti proinflammatori adipokin promot obes atherosclerosi abstract background obes inflammatori condit link cardiovascular diseas expans adipos tissu high preval coplanar polychlorin biphenyl pcbs num num tetrachlorobiphenyl pcb num accumul adipos tissu lipophil increas obes effect pcbs adipocyt obes obesity associ cardiovascular diseas unknown object studi examin vitro vivo effect pcb num adipocyt differenti proinflammatori adipokin adipocyt morpholog bodi weight serum lipid atherosclerosi method pcb num num num num hexachlorobiphenyl pcb num incub num num adipocyt differenti matur adipocyt concentration depend effect pcb num contrast num num tetrachlorodibenzo p dioxin tcdd vivo studi treat num num wild typ wt aryl hydrocarbon receptor ahr mice vehicl pcb num mg kg intraperiton inject examin bodi weight gain separ studi inject apo mice vehicl pcb num num week period examin bodi weight adipocyt size serum lipid atherosclerosi result low concentr pcb num tcdd increas adipocyt differenti glycerol num phosphat dehydrogenas activ express peroxisom prolifer activ receptor higher concentr inhibit adipocyt differenti effect pcb num abolish ahr antagonist naphthoflavon pcb num promot express releas proinflammatori cytokin num num adipocyt administr pcb num increas bodi weight gain wt ahr mice apo mice inject pcb num exhibit greater bodi weight adipocyt hypertrophi serum dyslipidemia augment atherosclerosi conclus find suggest pcb num contribut develop obes obesity associ atherosclerosi
MED-4733~mercuri human hair indic fish consumpt pubm ncbi abstract object mercuri compound extrem toxic handl care inhal absorb skin mucous membran toxic form mercuri organ compound dimethylmercuri methylmercuri fish natur tendenc accumul mercuri methylmercuri produc microbi methyl inorgan mercuri water sediment infiltr food chain accumul fish fish main sourc methylmercuri human food mercuri transfer hair monitor long term exposur mercuri content mercuri hair depend frequenc fish consumpt aim studi compar mercuri content hair children amount fish consumpt increas reduc design total mercuri content hair determin direct method cold vapor ama num analyz total num hair sampl children num year analyz studi local compar neratovic num jesen ky num pragu num czech republ olsztyn poland num sampl accompani questionnair age gender region amalgam fill fish consumpt result find correl content mercuri hair age gender amalgam fill find correl fish consumpt amount mercuri found hair sampl conclus amount mercuri hair increas frequent consumpt freshwat marin fish
MED-4735~dioxin polychlorin biphenyl methyl mercuri omega num polyunsatur fatti acid biomark fish consumpt pubm ncbi abstract background object assess biomark frequenc question measur fish consumpt subjects method particip fishermen substudi number num men num women age num health num substudi num men num women age num particip aim fishermen studi examin health effect fish consumpt high consumpt popul aim health num substudi obtain in depth inform cardiovascular diseas diabet fish consumpt measur valid food frequenc questionnair ffq studi separ frequenc question fishermen substudi dioxin polychlorin biphenyl pcbs methyl mercuri mehg fishermen substudi omega num polyunsatur fatti acid omega num pufa studi analyz fast serum blood sampl result spearman correl coeffici ffq fish consumpt dioxin pcbs mehg omega num pufa num num num num fishermen substudi men num num num num women similar correl coeffici observ ffq fish consumpt serum omega num pufa health num substudi ffq fish consumpt frequenc question fish consumpt fishermen substudi multipl regress model lmg metric import fish consumpt biomark dioxin pcbs men mehg women conclus environment contamin slight fish consumpt biomark omega num pufa baltic sea area separ frequenc question measur fish consumpt equal compar ffq
MED-4736~explor biomark total fish intak pregnant norwegian women pubm ncbi abstract object biomark dietari intak food group establish aim present studi explor selenium se iodin mercuri hg arsenic serv biomark total fish seafood intak addit tradit num fatti acid epa dha design intak fish seafood estim ffq compar intak assess num weigh food diari biomark blood urin set valid studi norwegian mother child cohort studi moba subject hundr nineteen women result total fish seafood intak median num g d calcul moba ffq compar intak calcul food diari median num g d rs num num erythrocyt dha blood hg se arsenic concentr posit correl intak fish seafood associ dha weaken widespread supplement main find consist posit associ intak fish seafood blood arsenic concentr multivari analys blood arsenic blood hg fish seafood intak model arsenic turn indic intak fish seafood total subgroup fish seafood intak conclus dha reflect intak fatti fish num pufa supplement blood arsenic concentr reflect intak lean fish seafood blood arsenic biomark total fish seafood intak
MED-4738~urinari excret total isothiocyan crucifer veget show high dose respons relationship biomark isot pubm ncbi abstract background isothiocyan itc hydrolysi product glucosinol famili biolog activ compound origin crucifer veget itc assum cancer prevent effect evalu potenti health effect reliabl biomark itc exposur aim studi studi investig abil urinari itc excret reflect low high daili intak crucifer veget method design control human crossov studi num subject consum self restrict glucosinolate fre diet num study day basic diet supplement num num mix crucifer veget consum urin collect interv num period ingest crucifer veget total itc crucifer mixtur total itc metabolit urin quantifi cyclocondens product num bezenedithiol high perform liquid chromatographi result total urinari excret itc correl signific dose itc diet high low crucifer content num num fraction urinari itc excret num num num num amount ingest num num crucifer veget conclus result studi urinari excret itc measur cyclocondes reaction precis tool biomark itc exposur popul base studi
MED-4739~hide chemic toxic unborn child pubm ncbi abstract contemporari reproduct age women offspr face unpreced onslaught toxic exposur myriad sourc day to day life public health recommend optim diet nutrit pregnanc incorpor includ safeti foodstuff cultur practic lifestyl issu gestat consumpt contamin seafood remain potenti sourc toxic exposur includ mercuri develop child health care profession respons care women develop children appris risk toxic bioaccumul pregnanc ongo inform emerg import field reproduct toxicolog strategi clinic set facilit nutrit suffici precautionari avoid advers exposur young women
MED-4740~evalu background exposur american dioxin lik compound num num pubm ncbi abstract environment protect agency num dioxin reassess includ character background exposur dioxin lik compound includ estim averag background intak dose averag background bodi burden quantiti deriv data generat mid num studi conduct num gather attempt updat estim generat reassess studi suggest declin averag background dose bodi burden precis quantif declin conclus declin occur made inconsist studi design data sourc treatment non detect generat congen averag concentr averag background intak reassess num pg teq day current data averag background intak num pg teq day averag bodi burden survey mid num num pg teq g lipid weight pg g lwt recent blood concentr data nhane num suggest adult averag num pg g teq lwt teq valu includ num dioxin furan congen num coplanar pcbs generat substitut num dl nd dl sq rt num result provid num analys conduct evalu impact substitut detail examin beef pork data similar design nation statist survey show declin pork statist signific beef concentr remain constant time period
MED-4741~egg consumpt risk cancer multisit case control studi uruguay pubm ncbi abstract background previous studi suggest egg consumpt increas risk colorect cancer cancer evid limit explor associ egg intak cancer risk conduct case control studi num cancer site uruguay num num includ num cancer case num hospit control result multivari model adjust age sex applic resid educ incom interview smoke alcohol intak intak fruit veget grain dairi product fatti food meat energi intak bmi signific increas odd cancer oral caviti pharynx num num ci num num upper aerodigest tract num num ci num num colorectum num num ci num num lung num num ci num num breast num num ci num num prostat num num ci num num bladder num num ci num num cancer site combin num num ci num num high low egg intak conclus found associ higher intak egg increas risk cancer prospect studi associ warrant
MED-4742~evalu real tim polymeras chain reaction pcr assay detect anisaki simplex parasit food born allergen sourc seafo pubm ncbi abstract anisaki simplex recogn import diseas human food born allergen sourc food born parasit recent identifi emerg food safeti risk simplex specif primer prob system base real tim polymeras chain reaction pcr detect assay success optim valid seafood sampl addit dna extract procedur optim detect presenc nematod food sampl assay reliabl specif sensit methodolog detect presenc trace parasit seafood product includ high process sampl result num sequenc cytochrom oxidas ii gene obtain scrutin calcul intra interspecif variabl num num final effici num num assay calcul limit detect num ppm parasit num sampl optim presenc parasit seafood product demonstr enforc necess design good manufactur practic protocol process industri minim presenc parasit food born allergen sourc seafood product
MED-4743~perform evalu sbr treatment nitrogen remov tanneri wastewat pubm ncbi abstract perform sbr treatment nitrogen remov tanneri evalu wide rang wastewat temperatur num num degre pilot scal sbr unit fed plain settl wastewat oper site purpos effect nitrogen remov sustain adjust sludg age num num day concentr profil nitrogen compound select complet sbr cycl steadi state oper wastewat temperatur sludg age evalu model simul system perform interpret term model stoichiometr calcul addit nitrat loss observ aerob period aerat intens reduc factor num
MED-4744~diet qualiti preschool children matern perceptions mispercept genesi studi pubm ncbi abstract object quantifi matern percept qualiti child diet identifi factor mispercept studi design repres sampl num children age num year cross sect studi genesi studi method matern percept qualiti child diet child mother anthropometr characterist characterist socio demograph lifestyl record actual qualiti child diet estim healthi eat index hei score result base hei score num particip poor diet num diet improv num good diet num mother overestim qualiti child diet overestim rate num mother declar choos child food base healthi num report factor play predomin role food choic child num total energi intak intak fruit grain veget meat milk signific higher children mother overestim qualiti diet conclus vast major mother overestim qualiti child diet matern percept qualiti child diet predomin factor determin child food intak health profession make mother awar exist dietari recommend children meet order eat healthi diet
MED-4745~dietari protein intak childhood time puberti pubm ncbi abstract earli puberti onset hormone rel cancer diet childhood influenc pubert time controversi examin associ protein intak earli mid childhood age take off pubert growth spurt ato peak height veloc aphv menarch girl voic break boy data longitudin dortmund nutrit anthropometr longitudin design studi particip provid num weigh dietari record num mo num mo num num num suffici anthropometr measur num num estim ato life cours plot identifi critic period total anim veget protein intak percentag total energi intak pubert time age associ tertil protein intak num num outcom investig multipl linear regress analysi higher total anim protein intak num relat earlier ato highest tertil anim protein intak num ato occur num earlier lowest num ci num num num num num num num num num num num num p trend num adjust sex total energi breast feed birth year patern univers degre similar find aphv p trend num time menarche voic break p trend num convers higher veget protein intak num num relat ato aphv menarche voic break p trend num num result suggest anim veget protein intak mid childhood differenti relat pubert time
MED-4746~fast food hamburg eat pubm ncbi abstract american consum num billion hamburg year presum hamburg compos primarili meat purpos studi assess content num fast food hamburg brand histolog method brand hamburg evalu water content weight microscop recogniz tissu type glial fibrillari acid protein gfap stain evalu brain tissu water content weight rang num num num meat content hamburg rang num num median num cost gram hamburg rang num num median num correl meat content electron microscopi show preserv skelet muscl varieti tissu type skelet muscl observ includ connect tissu num blood vessel num peripher nerv num adipos tissu num plant materi num cartilag num bone num num hamburg intracellular parasit sarcocysti identifi gfap immunostain observ hamburg lipid content oil red o stain grade num moder num burger num mark num burger fast food hamburg compris meat median num approxim half weight made water unexpect tissu type found hamburg includ bone cartilag plant materi brain tissu present sarcocysti parasit discov num hamburg
MED-4747~hormon growth promot agent food produc anim pubm ncbi abstract contrast hormon dope agent sport enhanc perform athlet livestock industri hormon growth promot anabol increas product muscl meat lead intern disput safeti meat origin anim treat anabol consequ total ban eu hormon activ growth promot hormon livestock product contrast legal hormon num eta estradiol testosteron progesteron trenbolon zeranol small solid ear implant hormon feed addit feedlot heifer melengestrol acet swine ractopamin usa regulatori control differ sharpli eu usa eu treatment slaughter anim regulatori offenc control inspect program usa test complianc regulatori maximum residu level edibl product muscl fat liver kidney purpos inspect program ani eu inspect program focus sampl materi suitabl test ban substanc anim farm urin fece hair case slaughter anim favor sampl materi bile blood eye liver rare occas muscl meat sampl case import control monitor program meat sampl butcher shop supermarket result data hormon concentr muscl meat sampl eu market rare obtain case small program ad hoc basi eu data natur hormon meat rarer absenc legal natur level hormon complianc test sampl applic site eu site inject liquid hormon prepar site applic pour prepar hormon concentr observ meat sampl illeg treat anim typic rang microgram kilogram ppb tenth microgram kilogram eu dozen illeg hormon number activ compound expand estrogen androgen progestagen compound thyreostat corticosteroid beta adrenerg compound smart combin overview compound identifi eu black market estim probabl consumpt eu high contamin meat applic site cattl final data present concentr estradiol bovin meat anim treat treat hormon implant data compar recent find estradiol concentr hen egg comparison preliminari conclus hen egg major sourc num lpha num eta estradiol consumer daili normal diet
MED-4748~bodi fat anim protein intak adren androgen secret children pubm ncbi abstract background adrenarch increas adren androgen aa product start childhood unknown nutrit factor modul adrenarch object object examin bodi composit dietari intak aa product children account urinari indic major adrenarche rel steroidogen enzym design androgen glucocorticoid metabolit profil gas chromatography mass spectrometri num urin sampl num healthi prepubert children age num birth characterist growth veloc data num weighed diet record inform associ sum num metabolit reflect daili aa secret nutrit factor fat mass fm fat fre mass ffm nutrient intak glycem index glycem load aa relev estim steroidogen enzym examin stepwis multipl regress model adjust age sex urin volum total energi intak enzym activ estim calcul specif urinari steroid metabolit ratio result nutrition relev predictor fm num explain variat aa secret num num anim protein intak posit aa secret num explain num variat ffm num total protein intak num show posit trend differ daili aa secret lowest highest quartil fm compar lowest highest estim activ major steroidogen enzym conclus bodi fat mass relev influenc prepubert adrenarch androgen status addit anim protein intak make small contribut aa secret children
MED-4749~consequ boar edibl tissu consumpt urinari profil nandrolon metabolit mass spectrometr detect quantif pubm ncbi abstract time field steroid residu human demonstr num norandrosteron num na num lpha hydroxi num lpha estran num num noretiocholanolon num ne num lpha hydroxi num eta estran num excret urin subsequ boar consumpt report male volunt agre consum num tissu edibl part meat liver heart kidney boar individu deliv urin sampl num meal intak deconjug phase ii metabolit purif specif derivatis target metabolit urinari extract analys mass spectrometri identif carri measur obtain gas chromatography high resolut mass spectrometri gc hrms num liquid chromatography tandem mass spectrometri lc ms ms posit electrospray ionis esi quantif realis quadrupol mass filter num na num ne concentr urin reach num num microg l nearbi num hour boar tissu consumpt level return endogen valu num hour steroid exploit confirm exogen administr num nortestosteron num nt num eta hydroxyestr num en num antidop field prove eat tissu non castr male pork num eta nandrolon present induc fals accus abus nandrolon antidop copyright num john wiley son
MED-4750~assess endogen androgen level meat liver testi iranian nativ cross bre male sheep bull gas chromatography mass spe pubm ncbi abstract androgen steroid exist anim tissu trace level signific number interf compound make determin difficult solv problem quantif natur steroid tissu gc ms method develop studi surrog analyt approach develop author previous studi extens sampl prepar procedur success elimin interf compound result cleaner extract accuraci precis sensit select method determin steroid complex matric meat liver testi improv aid method level androgen tissu iranian nativ cross bre bull male sheep determin result obtain present studi androgen profil content ratio precursor metabolit main hormon similar tissu anim total androgen content tissu higher bull tissu male sheep addit anim higher amount androgen found liver comparison meat testi
MED-4751~role femal sex hormon milk pregnant cow develop breast ovarian corpus uteri cancer pubm ncbi abstract continu increas incid hormone rel cancer worldwid great concern estrogen lik substanc environ blame increas role endogen estrogen food wide discuss concern cow milk quantiti estrogen cow milk import rout human exposur estrogen general respons western peopl man drink cow milk num year appar harm milk consum consum num year ago unlik pasture f counterpart num year ago modern dairi cow pregnant continu lactat half pregnanc concentr estrogen blood milk increas correl incid mortal rate environment variabl worldwid countri clue etiolog cancer studi correl incid rate breast ovarian corpus uteri cancer num cancer incid contin food intak num faostat num countri meat close correl breast cancer incid num milk num chees num stepwis multiple regress analysi smra identifi meat factor contribut great incid breast cancer num milk close correl incid ovarian cancer num anim fat num chees num smra reveal milk chees make greatest contribut incid ovarian cancer num milk close correl corpus uteri cancer num chees num smra reveal milk chees make signific contribut incid corpus uteri cancer num conclus increas consumpt animal deriv food advers effect develop hormone depend cancer dietari risk factor concern milk dairi product milk drink today produc pregnant cow estrogen progesteron level mark elev
MED-4752~acn dairi cancer abstract potent link dairi exist hormone respons gland acn breast cancer prostat cancer link epidemiolog dairi intak mechan postul remain accur defin link involv insulin lik growth factor num general stimul synerg steroid hormon present milk igf num absorb milk stimul ingest num lpha reduc compound num lpha pregnanedion num present milk direct precursor dihydrotestosteron act pathway prostat cancer num recent shown capabl induc estrogen receptor breast cancer cell upregul cancer cell sensit estrogen introduct exogen hormon growth factor tissu evolv defens feedback inhibit endogen sourc postul direct stimulatori threat organ system hyperplasia neoplasia
MED-4753~exposur exogen estrogen intak commerci milk produc pregnant cow pubm ncbi abstract background modern genet improv dairi cow continu lactat entir pregnanc recent commerci cow milk larg amount estrogen progesteron regard exposur prepubert children exogen estrogen author concern commerci milk produc pregnant cow purpos present studi examin concentr serum urin sex hormon intak cow milk method subject men prepubert children women men children drank num ml m num cow milk urin sampl collect num milk intak time hour intak men serum sampl obtain num num num num min milk intak women drank num ml cow milk night num day begin day menstruat success menstrual cycl day ovul examin ovul checker result intak cow milk serum estron num progesteron concentr signific increas serum lutein hormon follicle stimul hormon testosteron signific decreas men urin concentr num estradiol estriol pregnanediol signific increas adult children women ovul occur milk intak time ovul similar menstrual cycl conclus present data men children estrogen milk absorb gonadotropin secret suppress decreas testosteron secret sexual matur prepubert children affect ordinari intak cow milk
MED-4755~soybean isoflavon exposur femin effect men critic examin clinic evid pubm ncbi abstract object critic evalu clinic evid anim data relev concern isoflavon exposur form supplement soy food femin effect men design medlin literatur review cross refer publish data result contrast result rodent studi find recent publish metaanalysi subsequ publish studi show isoflavon supplement isoflavone rich soy affect total free testosteron level similar essenti evid identifi clinic studi isoflavon exposur affect circul estrogen level men clinic evid isoflavon effect sperm semen paramet intervent studi identifi longer num month durat final find anim studi suggest isoflavon increas risk erectil dysfunct applic men differ isoflavon metabol rodent human excess high amount isoflavon anim expos conclus intervent data isoflavon exert femin effect men intak level equal higher typic asian male copyright num publish elsevi
MED-4756~consumpt anim product nutrient compon postmenopaus circul steroid hormon concentr pubm ncbi abstract background object nutrit factor influenc circul concentr steroid hormon consist risk breast cancer postmenopaus women aim investig associ consumpt anim product plasma concentr steroid hormon sex hormone bind globulin shbg subjects method cross sect analysi conduct plasma num natur postmenopaus women measur plasma concentr steroid hormon shbg estim dietari intak num item food frequenc questionnair log transform valu hormon concentr regress quartil intak meat dairi product food item fat protein cholesterol nutrient intak result total red fresh red meat consumpt negat shbg level trend num num shbg concentr approxim num num lower women highest quartil compar lowest quartil total red fresh red meat consumpt posit associ observ dairi product consumpt total free estradiol concentr trend num num concentr total free estradiol num num higher women highest quartil dairi product consumpt lowest quartil associ observ consumpt process meat chicken fish egg cholesterol fat protein conclus studi suggest greater consumpt total red fresh red meat dairi product influenc circul concentr shbg estradiol confirm investig requir
MED-4757~comparison sex hormon metabol profil omnivor vegetarian pre post menopaus women pubm ncbi abstract purpos present studi investig sex hormon metabol profil vegetarian compar profil omnivor design present studi cross sect studi sampl pre post menopaus women includ forty on omnivor twenty on vegetarian determin num plasma sex hormon num fast insulin nefa apo a apo b num bmi num dietari profil num dietari record num physic activ num total faecal excret num total urinari excret num vegetarian show higher level sex hormone bind globulin shbg apo a total faecal excret num total fibr intak lower level apo b free oestradiol free testosteron dehydroepiandrosteron sulfat dhea bmi interest control bmi signific differ group persist apo b stepwis regress analysi show total fibr intak explain num variat shbg cohort account greatest sourc uniqu varianc result present studi pre post menopaus vegetarian present higher concentr shbg explain part higher level fibr intak explain part lower risk develop type num diabet
MED-4758~meat process meat obes weight gain occurr diabet adult find adventist health studi pubm ncbi abstract aim examin relat meat intak diabet occurr adult method prospect cohort studi examin relat diet incid diabet record num cohort member age num year adventist mortal studi adventist health studi california usa non diabet baselin num year follow up identifi num incid diabet case result num subject week consum meat num num num ci num num relat meat intak develop diabet num subject consum process meat salt fish frankfurt num num num ci num num develop diabet num long term adher num year interv diet includ week meat intak num increas num num ci num num odd diabet relat long term adher vegetarian diet meat intak analys risk attribut obes and or weight gain  both strong risk factor cohort noteworthi control weight weight chang week meat intak remain import risk factor num num ci num num diabet correct conclus find rais possibl meat intak process meat dietari risk factor diabet num karger ag basel
MED-4759~sex hormone bind globulin shbg estradiol breast cancer pubm ncbi abstract human serum sex hormone bind globulin shbg play import role breast cancer pathophysiolog risk definit regul bioavail fraction circul estradiol summar data report year involv shbg shbg polymorph definit breast cancer risk report direct action shbg breast cancer cell illustr interact cell subsequ initi specif intracellular pathway lead cross talk estradiol activ pathway final inhibit effect estradiol breast cancer cell conclus result uniqu properti regul estrogen free fraction cross talk estradiol pathway inhibit estradiol induc breast cancer cell growth prolifer shbg reduc risk develop neoplasm estrogen exposur num elsevi ireland reserv
MED-4760~microbiom obes obes link gut flora pubm ncbi abstract human gut lush microbi ecosystem num trillion microorgan collect genom microbiom num fold gene entir human genom symbiosi extend genom play role host homeostasi energi extract diet articl summar studi advanc understand microbiom effect metabol obes health metagenom studi demonstr mix gut microbiota protect predispos host obes microbiota transplant studi germ fre murin model show effici energi extract trait obese typ gut flora transmiss propos method microbiom contribut obes includ increas dietari energi harvest promot fat deposit trigger system inflamm futur treatment obes involv modul gut microbiota probiot prebiot
MED-4762~probiot effect cold influenza lik symptom incid durat children pubm ncbi abstract object probiot consumpt effect cold influenza lik symptom incid durat evalu healthi children winter season method double blind placebo control studi num elig children num year age assign random receiv placebo num lactobacillus acidophilus ncfm num acidophilus ncfm combin bifidobacterium animali subsp lacti bi num num children treat daili num month result relat placebo group singl combin probiot reduc fever incid num num num num cough incid num num num num rhinorrhea incid num num num num fever cough rhinorrhea durat decreas signific relat placebo num singl strain num num strain combin num antibiot incid reduc relat placebo num singl strain num num strain combin num subject receiv probiot product signific reduct day absent group child care num singl strain num num strain combin num compar subject receiv placebo treatment conclus daili dietari probiot supplement num month safe effect reduc fever rhinorrhea cough incid durat antibiot prescript incid number miss school day attribut ill children num num year age
MED-4763~obesity associ gut microbiom increas capac energi harvest pubm ncbi abstract worldwid obes epidem stimul effort identifi host environment factor affect energi balanc comparison distal gut microbiota genet obes mice lean litterm obes lean human volunt reveal obes relat abund domin bacteri divis bacteroidet firmicut demonstr metagenom biochem analys affect metabol potenti mous gut microbiota result obes microbiom increas capac harvest energi diet trait transmiss colon germ fre mice obes microbiota result signific greater increas total bodi fat colon lean microbiota result identifi gut microbiota addit contribut factor pathophysiolog obes
MED-4764~gut microbiota composit bodi weight weight gain biochem paramet pregnant women pubm ncbi abstract obes complic pregnanc increas health risk newborn object present studi establish relationship gut microbiota bodi weight weight gain biochem paramet pregnant women fifti pregnant women classifi bmi normal weight num overweight num group gut microbiota composit analys quantit real tim pcr faec biochem paramet plasma num week pregnanc reduc number bifidobacterium bacteroid increas number staphylococcus enterobacteriacea escherichia coli detect overweight compar normal weight pregnant women coli number higher women excess weight gain women normal weight gain pregnanc bifidobacterium akkermansia muciniphila show opposit trend popul increas total bacteria staphylococcus number relat increas plasma cholesterol level increas bacteroid number relat increas hdl cholesterol folic acid level reduc tag level increas bifidobacterium number relat increas folic acid level increas enterobacteriacea coli number relat increas ferritin reduc transferrin bifidobacterium level show opposit trend gut microbiota composit relat bodi weight weight gain metabol biomark pregnanc relev manag health women infant
MED-4765~dietari predictor num year waist circumfer pubm ncbi abstract background previous studi associ macronutri intak develop abdomin obes carri increas health risk shown consist pattern possibl due mix effect aspect food intak object studi investig associ intak num food beverag group subsequ num year differ waist circumfer method studi popul consist num women num men age num num year baselin complet data baselin follow up waist circumfer baselin diet num item food frequenc questionnair bodi mass index select potenti confound smoke status sport activ intak alcohol beverag multipl linear regress analys perform result women num year differ waist circumfer invers relat intak red meat veget fruit butter high fat dairi product intak potato process meat poultri snack food posit men red meat fruit intak invers num year differ waist circumfer snack food intak posit sex differ occur veget high fat dairi product process meat conclus result suggest diet low fruit red meat high snack food larger waist circumfer gain sex women diet low veget butter high fat dairi product high poultri potato process meat determin subsequ gain waist
MED-4766~viral obes fact fiction pubm ncbi abstract aetiolog obes multifactori understand contribut causal factor essenti proper manag obes primarili thought condit brought lifestyl choic recent evid show link obes viral infect numer anim model document increas bodi weight number physiolog includ increas insulin sensit increas glucos uptak decreas leptin secret contribut increas bodi fat adenovirus num infect viral agent increas obes anim includ canin distemp virus rous associ virus num scrapi borna diseas virus smam num adenovirus review attempt determin viral infect obes paper discuss mechan virus produc obes base evid present paper conclud link obes viral infect rule epidemiolog studi establish causal link determin result futur manag prevent obes
MED-4767~associ adenovirus infect human obes pubm ncbi abstract previous report chicken infect avian adenovirus smam num develop uniqu syndrom character excess intra abdomin fat deposit accompani paradox low serum cholesterol triglycerid level previous report avian adenovirus infect human screen serum num human obes bombay india antibodi smam num virus agar gel precipit test agpt method bodyweight serum cholesterol triglycerid level compar smam num posit p agpt smam num negat n agpt group ten subject posit antibodi smam num num subject antibodi p agpt group signific higher bodyweight num bodi mass index num num num kg num num kg m num compar n agpt group num num kg num num kg m num p agpt group signific lower serum cholesterol num triglycerid num valu num mmol l num mmol l compar n agpt group num mmol l num mmol l subject posit smam num antibodi antibodi serum suggest presenc antigen serum sampl inocul chicken embryo macroscop lesion compat smam num infect develop inocul serum n agpt subject produc lesion presenc increas obes antibodi smam num reduc level blood lipid viremia produc typic infect chicken embryo suggest smam num serolog similar human virus involv obes human
MED-4768~infectobes obes infecti origin pubm ncbi abstract rapid increas obes health care cost prompt search approach prevent manag effort facilit understand etiolog obes etiolog factor infect unusu causat factor recent start receiv greater attent decad num adipogen pathogen report includ human nonhuman virus scrapi agent bacteria gut microflora pathogen human obes causat role human obes establish chapter present inform natur host sign symptom pathogenesi adipogen microorgan relev human infectobes extrem signific concept perspect infecti etiolog obes stimul addit research assess contribut hitherto unknown pathogen human obes possibl prevent treat obes infecti origin
MED-4769~effect adenovirus infect adipos chicken pubm ncbi abstract excess fat accumul observ field chicken infect adenovirus present studi verifi experiment condit chicken inocul adenovirus show lesser weight gain excess adipos compar normal control chicken explain variat food consumpt chicken acquir adenovirus natur inocul group show similar adipos serum cholesterol triglycerid level inocul natur infect chicken signific lower compar control group associ adenovirus infect adipos shown time understand complex problem obes
MED-4771~cover extrem slow variabl activ dihydrofol reductas human liver implic high folic acid intak abstract numer clinic trial folic acid prevent cardiovascular diseas stroke cognit declin neural tube defect complet underway function folat perform tetrahydrofol one carbon deriv folic acid synthet oxid form signific found fresh natur food convert tetrahydrofol dihydrofol reductas dhfr increas evid suggest process slow human show sensit assay develop reduct folic acid dhfr gram human liver num obtain organ donor direct surgeri averag num rat liver physiolog ph contrast rat num fold variat dhfr activ human sampl limit abil activ synthet vitam rais issu clinic trial high level folic acid extrem low rate convers folic acid suggest benefit high dose limit satur dhfr individu possess lower averag activ result consist report unmetabol folic acid plasma urin
MED-4772~non anaem pregnant women iron supplement pubm ncbi abstract num iron defici anaemia pregnanc increas risk low birth weight preterm birth num randomis double blind placebo control trial iron supplement pregnant women haemoglobin level num num ml begin num trimest low birth weight matern hypertens num trial women haemoglobin level num num ml supplement iron haemoglobin level num num ml num week gestat num fold increas risk preterm birth num fold increas risk low birth weight num epidemiolog studi show link high matern haemoglobin level low birth weight num practic iron supplement pregnant women haemoglobin level exceed num num ml num num trimest num num ml num trimest
MED-4773~trimest curtail iron absorpt innat suppress teratogen pubm ncbi abstract human pregnanc matern absorpt iron mark curtail trimest murin model iron teratogen analog embryon period iron weak mutagen power oxid catalyst format hydroxyl radic studi determin associ trimest iron supplement miscarriage fet abnorm
MED-4774~caffein pregnanc pubm ncbi abstract caffein frequent ingest pharmacolog activ substanc world found common beverag coffe tea soft drink product cocoa chocol medic wide consumpt level segment popul public scientif communiti express interest potenti caffein produc advers effect human health reproductive ag pregnant women risk subgroup popul requir specif advic moder daili caffein intak articl highlight implic caffein intak pregnanc review latest evidence bas inform subject offer recommend practic advic obstetrician gynecologist prove peripartum care potenti complic pregnanc
MED-4775~green tea consumpt mortal japanes elder peopl prospect shizuoka elder cohort pubm ncbi abstract purpos investig associ green tea consumpt mortal cancer cardiovascular diseas cvd elder peopl method population bas prospect cohort studi total num elder resid age num year random chosen num municip shizuoka japan complet questionnair includ item frequenc green tea consumpt num year decemb num march num num subject analyz estim hazard ratio hrs all caus mortal cancer cvd result num person year num death identifi follow up rate num multivari hrs num confid interv cis cvd mortal compar consum cup day consum cup day num num num num num num num num num total particip men women green tea consumpt invers cancer mortal green tea consumpt colorect cancer mortal invers moder dose respons relationship conclus green tea consumpt reduc mortal cvd studi suggest green tea protect effect colorect cancer
MED-4776~laboratori epidemiolog human intervent studi show tea camellia sinensi prevent obes abstract tea camellia sinensi theacea tea polyphenol studi prevent chronic diseas includ obes obes affect num adult unit state risk factor chronic diseas type ii diabet cardiovascular diseas cancer increas public health concern dietari agent prevent obes tremend benefit laboratori studi demonstr potenti efficaci green black tea prevent obes mechan remain unclear result human intervent studi mix role caffein establish final emerg evid high dose tea polyphenol advers side effect result scientif studi dietari compon includ tea polyphenol translat dietari supplement understand potenti toxic tea polyphenol critic understand potenti prevent obes review critic evalu evid prevent obes tea discuss relev propos mechan light tea polyphenol bioavail review report toxic effect high dose tea polyphenol implic potenti tea prevent obes hope review expos area studi encourag research import public health issu
MED-4777~green tea nature defens malign pubm ncbi abstract current practic introduc phytochem support immun system fight diseas base centuri tradit nutrit support recent advanc domain diet bas therapi green tea constitu import compon strategi prevent cure malign anti carcinogen anti mutagen activ green tea highlight year ago suggest reduc preval cancer provid protect pharmacolog action green tea attribut polyphenol includ epigallocatechin num gallat egcg epicatechin epicatechin num gallat epigallocatechin green tea compon effect mitig cellular damag aris due oxid stress green tea suppos enhanc humor cell medi immun decreas risk cancer advantag treat inflammatori disord cancer chemoprevent properti green tea mediat egcg induc apoptosi promot cell growth arrest alter express cell cycl regulatori protein activ killer caspas suppress nuclear factor kappa b activ regul promot il num depend dna repair stimul cytotox cell activ tumor microenviron block carcinogenesi modul signal transduct pathway involv cell prolifer transform inflamm metastasi review intend highlight chemistri green tea antioxid potenti immunopotenti properti mode action cancer cell line show potenti chemoprevent agent colon skin lung prostat breast cancer
MED-4778~inhibitori effect tea polyphenol local tissu damag induc snake venom pubm ncbi abstract methanol extract fresh tea leav camellia sinensi theacea cs assay potenti inhibit enzym hydrolyt activ naja naja kaouthia lesson elapida calloselasma rhodostoma kuhl viperida venom snake venom enzym respons earli effect envenom local tissu damag inflamm cs extract inhibit phospholipas num proteas hyaluronidas l amino acid oxidas venom vitro neutral inhibit hemorrhag dermonecrot activ venom vivo suggest inhibitori potenti cs extract local tissu damag induc snake venom attribut complex chelat venom protein phenol content extract
MED-4779~tea consumpt risk type num diabet meta analysi cohort studi abstract background tea consumpt extens studi relat diseas epidemiolog studi perform investig associ tea consumpt type num diabet result studi consist object conduct meta analysi studi assess associ tea consumpt risk type num diabet research design method perform systemat literatur search novemb num pubm medlin embas cochran databas systemat review search limit english languag studi studi exclud type num diabet anim studi cohort studi identifi author summari relat risk rrs calcul random effect model result identifi cohort studi includ num particip num incid case type num diabet follow up rang num num year summari adjust rr show tea consumpt reduc type num diabet risk rr num num confid interv ci num num evid result stratifi analys reveal tea consumpt num cup day rr num num ci num num play role prevent type num diabet statist signific associ observ sex follow up durat stratifi tea consumpt type num diabet conclus meta analysi tea consumpt num cup day lower risk type num diabet
MED-4780~associ green tea consumpt tooth loss cross sect result ohsaki cohort num studi pubm ncbi abstract object examin associ green tea consumpt tooth loss method analyz cross sect data ohsaki cohort num studi usabl self administ questionnair green tea consumpt tooth loss return num person num men num women age num num year japan multivari logist regress analysi calcul odd ratio tooth loss num cut off point num num teeth relat categori green tea consumpt result consumpt num cup day green tea signific decreas odd tooth loss associ fit threshold model men multivariate adjust tooth loss cut off point num teeth frequenc green tea consumpt num refer num cup day num num ci num num num cups day num num ci num num num cups day num num ci num num num cups day data women result cut off point num num teeth essenti conclus present find associ green tea consumpt decreas odd tooth loss copyright num elsevi reserv
MED-4782~survey commerci chocol cocoa contain product unit state num comparison flavan num ol content nonfat pubm ncbi abstract survey broad rang chocol cocoa contain product market unit state conduct provid detail analysi flavan num ol monom oligom polym group class compound call procyanidin sampl consist top sel product categori natur cocoa powder unsweeten bake chocol dark chocol semisweet bake chip milk chocol chocol syrup composit sampl character percent fat fat percent nonfat cocoa solid nfcs antioxid level orac total polyphenol epicatechin catechin total monom flavan num ol oligom polym procyanidin gram weight basi epicatechin catechin content product follow decreas order cocoa powder bake chocol dark chocol bake chip milk chocol chocol syrup analysi monom oligom profil product categori show type profil num product high monom decreas level oligom num product level dimer equal greater monom result show strong correl num num epicatechin level nfcs good correl num oligom nfcs weaker correl observ catechin nfcs num num analys show similar high degre correl epicatechin num oligom total polyphenol catechin correl total polyphenol lesser good correl exist calcul percent cacao calcd cacao content proxi percent cacao flavanol measur catechin show lesser degre correl calcd cacao princip compon analysi pca show product group discret class num cocoa powder num bake chocol num dark chocol semisweet chip num milk chocol num syrup pca show factor group close includ antioxid activ total polyphenol flavan num ol measur catechin fat product group separ catechin distribut flavan num ol measur analysi epicatechin catechin ratio indic num fold variat measur product studi cocoa contain product test rang cocoa powder num num mg procyanidin serv num num mg procyanidin serv chocol syrup result discuss respect studi commerci product bioavail flavanol role process amount catechin product
MED-4783~childhood soy intak breast cancer risk asian american women pubm ncbi abstract introduct histor breast cancer incid substanti higher unit state asia asian women migrat unit state breast cancer risk increas generat approach white modifi factor diet respons method population bas case control studi breast cancer women chines japanes filipino descent age num num year live san francisco oakland california los angel california oahu hawaii interview num case num elig num control num adolesc adult diet cultur practic subject mother live unit state num particip interview mother num case num elig num control num daughter childhood exposur seventy thre percent studi particip premenopaus diagnosi result compar highest lowest tertil multivari relat risk num confid interv childhood adolesc adult soy intak num num num trend num num num num trend num num num num trend num invers associ childhood intak note race studi site women born asia unit state adjust measur western attenu associ adolesc adult soy intak affect invers relationship childhood soy intak discuss soy intak childhood adolesc adult life decreas breast cancer risk strongest consist effect childhood intak soy hormon relat early lif exposur influenc breast cancer incid
MED-4785~soy isoflavon risk cancer recurr cohort breast cancer survivor life cancer epidemiolog lace studi abstract purpos soy isoflavon structur similar endogen estrogen affect breast cancer hormonally medi non hormon relat mechan effect soy understood breast cancer survivor increas soy intak post diagnosi attempt improv prognosi examin role soy isoflavon intak risk breast cancer recurr hormon receptor status menopaus status tamoxifen therapi materi method cohort num femal breast cancer survivor diagnos num num prospect num year num breast cancer recurr ascertain isoflavon intak assess mail modifi block supplement soy food frequenc questionnair particip averag num month post diagnosi risk breast cancer recurr measur hazard ratio hr num confid interv ci estim multivari delayed entri cox proport hazard model result suggest trend reduc risk cancer recurr observ increas quintil daidzein glycetin intak compar intak postmenopaus women trend num daidzein num glycetin tamoxifen user num daidzein num glycetin postmenopaus women treat tamoxifen approxim num reduct breast cancer recurr compar highest lowest daidzein intak num microgram day versus num g day hr num num ci num num num conclus soy isoflavon consum level compar asian popul reduc risk cancer recurr women receiv tamoxifen therapi interfer tamoxifen efficaci confirm requir larg prospect studi recommend soy intak issu breast cancer survivor
MED-4786~adolesc adult soy food intak breast cancer risk result shanghai women health studi abstract background soy food rich sourc isoflavon class phytoestrogen antiestrogen anticarcinogen properti object object evalu associ adolesc adult soy food intak breast cancer risk cohort num chines women particip shanghai women health studi design valid food frequ questionnair assess usual dietari intak adulthood adolesc follow up num num incid case breast cancer identifi longitudin analys cox regress result adult soy food consumpt measur soy protein isoflavon intak invers risk premenopaus breast cancer associ high statist signific trend num multivariate adjust relat risk rrs upper intak quintil compar lowest quintil num num ci num num soy protein intak num num ci num num isoflavon intak high intak soy food adolesc reduc risk premenopaus breast cancer rr num num ci num num women consum high amount soy food consist adolesc adulthood substanti reduc risk breast cancer signific associ soy food consumpt found postmenopaus breast cancer conclus larg population bas prospect cohort studi strong evid protect effect soy food intak premenopaus breast cancer
MED-4787~intens time physic activ relat postmenopaus breast cancer risk prospect nih aarp diet health studi abstract background strong evid invers associ physic activ postmenopaus breast cancer risk intens time life physic activ effect lower breast cancer risk method num postmenopaus women prospect nih aarp diet health studi examin relat light moderate to vigor intens physic activ period life histor age num num num year recent past num year postmenopaus breast cancer risk physic activ assess self report baselin num incid breast cancer identifi num year follow up result age adjust multivari cox regress model num hours week moderate to vigor activ past num year num reduc risk postmenopaus breast cancer rr num num ci num num compar inact associ remain statist signific adjust bmi rr num num ci num num moderate to vigor activ period life light intens activ period life relat breast cancer risk associ vari tumor characterist conclus high level recent histor physic activ moderate to vigor intens reduc postmenopaus breast cancer risk precis recal recent physic activ activ distant past explan find
MED-4789~effect aerob exercis mild cognit impair abstract object examin effect aerob exercis cognit biomark alzheim diseas patholog older adult mild cognit impair assess role sex predictor respons design six month random control clinic trial set veteran affair puget sound health care system clinic research unit particip thirty thre adult num women amnest mild cognit impair rang age num num year age num year intervent particip random high intens aerob exercis stretch control group aerob group exercis supervis fit trainer num num heart rate reserv num num min d num d wk num month control group carri supervis stretch activ schedul maintain heart rate num heart rate reserv studi glucometabol treadmil test perform fat distribut assess dual energi x ray absorptiometri baselin month num month num blood collect assay cognit test administ main outcom measur perform measur symbol digit modal verbal fluenci stroop trail task switch stori recal list learn fast plasma level insulin cortisol brain deriv neurotroph factor insulinlik growth factor i amyloid num num result month high intens aerob exercis sex specif effect cognit glucos metabol hypothalamic pituitary adren axi trophic activ compar gain cardiorespiratori fit bodi fat reduct women aerob exercis improv perform multipl test execut function increas glucos dispos metabol clamp reduc fast plasma level insulin cortisol brain deriv neurotroph factor men aerob exercis increas plasma level insulinlik growth factor favor effect trail perform conclus studi support rigor control methodolog potent nonpharma colog intervent improv execut control process older women high risk cognit declin result suggest sex bias cognit respons relat sex bas differ glucometabol hypothalamic pituitary adren axi respons aerob exercis
MED-4790~risk copper toxic contribut cognit declin age popul alzheimer diseas pubm ncbi abstract pleasur honor contribut paper special issu journal american colleg nutrit honor stanley wallach pearl small review advanc hypothesi copper toxic major epidem mild cognit impair alzheimer diseas engulf age popul epidem recent explod num year diseas virtual unknown num year ago involv develop countri copper plumb environ develop poison mind age epidem copper plumb copper multi miner supplement food copper organ copper process liver transport sequest safe manner inorgan copper drink water copper supplement larg bypass liver enter free copper pool blood direct copper potenti toxic penetr blood brain barrier review web anim human data tighten noos hypothesi copper toxic caus epidem alzeimer diseas loss cognit age popul
MED-4791~bovin spongiform encephalopathi aquacultur pubm ncbi abstract dietari consumpt fish wide recommend benefici effect omega num polyunsatur fatti acid risk cardiovascular alzheimer diseas american heart associ recommend eat serv fish week concern consumpt farm fish provid transmiss infecti prion cow bovin spongiform encephalopathi human caus variant creutzfeldt jakob diseas
MED-4792~evalu transmiss bse scrapi gilthead sea bream sparus aurata abstract transmiss spongiform encephalopathi tses group fatal neurodegen disord affect speci key event diseas pathogenesi accumul abnorm conform isoform prpsc host encod cellular prion protein prpc precis mechan prpc prpsc convers understood clear host prpc express prerequisit effect infecti prion propag studi tses mammalian speci tse pathogenesi fish show gilthead sea bream sparus aurata oral challeng brain homogen prepar bse infect cow scrapi infect sheep develop clinic prion diseas brain tse f fish sampl year challeng show sign neurodegener accumul deposit react posit antibodi rais sea bream prp control group fed brain uninfect anim show sign remark deposit develop rapid extens fish inocul bse infect materi challeng scrapie infect brain homogen numer deposit proteinas k resist plaque lik aggreg exhibit congophilia birefring polar light consist amyloid lik compon neurodegener abnorm deposit brain fish challeng prion bse rais concern potenti risk public health fish aquacultur econom import industri provid high protein nutrit human mammalian speci prospect farm fish contamin infecti mammalian prpsc prion diseas develop farm fish alarm requir evalu
MED-4794~community acquir methicillin resist staphylococcus aureus pubm ncbi abstract community associ methicillin resist staphylococcus aureus ca mrsa matter concern worldwid usa analysi emerg spread clear definit base epidemiolog origin discrimin ca mrsa healthcare associ communiti mrsa healthcare associ mrsa ha mrsa role pathogenesi debat capabl panton valentin leukocidin format major ca mrsa isol north america europ ca mrsa isol attribut clonal lineag ha mrsa clonal lineag ha mrsa ca mrsa report st num st num st num st num ca mrsa st num usa num frequent usa report europ ca mrsa st num wide dissemin europ pronounc oxacillin heteroresist phenotyp cefoxitin bas assay advis reliabl detect ca mrsa infect frequent europ usa patient predisposit low social status especi risk
MED-4795~increas incid community associ atyp clostridium difficil diseas children pubm ncbi abstract forty on children varieti gastrointestin complaint diagnos clostridium difficil infect part routin screen num year infect suspect prior screen child respond treatment metronidazol resolut symptom data suggest community associ difficil increas produc atyp diseas lead misdiagnosi
MED-4796~clostridium difficil food  innoc bystand threat pubm ncbi abstract clostridium difficil critic import diseas human hospit individu major factor rais concern potenti pathogen foodborn diseas increas recognit community associ difficil infect recent studi identifi difficil food anim food similar difficil isol anim food human clear difficil common found food anim food region strain import human infect ribotyp num nap num toxinotyp iii ribotyp num toxinotyp present unclear ingest contamin food result colon infect question remain unansw role difficil community associ diarrhoea sourc food contamin infect dose associ ingest contamin food diseas signific role pathogen human diseas potenti emerg import community associ pathogen care evalu sourc exposur includ food requir determin potenti role food difficil infect difficult
MED-4797~vari preval clostridium difficil integr swine oper pubm ncbi abstract object studi compar preval clostridium difficil cd age product group swine vertic integr swine oper texa num compar isol anim human isol result base num cd isol num swine fecal sampl pork trim sampl preval num preval number positive numb test product type cd group p or num highest suckl piglet num num num num lactat sow effluent farrow barn num num nurseri num num pork product num num grower finish num num breed boar sow num isol num posit pcr toxin tcda tcdb gene num isol harbor num base pair delet tcdc gene num isol toxinotyp num isol posit binari toxin gene cdtb isol resist cefoxitin ciprofloxacin imipenem sensit metronidazol piperacillin tazobactam amoxicillin clavulan acid vancomycin major isol resist clindamycin resist intermedi ampicillin sensit tetracyclin chloramphenicol increas num number isol timefram septemb februari compar march august
MED-4798~efficaci clean product difficil abstract object review evid efficaci product environment hand clean rate clostridium difficil diarrhea cdad qualiti evid medlin embas cochran databas systemat review search articl pertin efficaci clean product difficil studi outcom relat rate cdad evid level ii main messag minim incid cdad geriatr rehabilit unit essenti achiev goal increas patient function independ discharg communiti attent environment control difficil spore health care worker patient visitor import secondari prevent strategi conclus chlorine releas agent effect deterg kill spore produc difficil level evid determin chlorine releas agent effect rate cdad hand wash recommend strategi reduc transmiss difficil alcohol gel inactiv difficil spore increas alcohol hand gel higher rate cdad sum objectif examin les preuv indiqu les produit utili pour nettoy environn les main sont efficac pour duir le taux de diarrh due au clostridium difficil ddcd qualit des preuv consult medlin embas la cochran databas systemat review en reten les articl portant sur efficacit des agent de nettoyag contr le difficil ou les tude traitant de question li es aux taux de ddcd les preuv taient de niveau ii princip messag la duction de incid de la ddcd dan les unit de adapt riatriqu est une condit essentiell pour accro tre tat fonctionnel ind pendanc des patient qui retourn dan la communaut pour les interven pour les visiteur des patient le contr le du difficil de ses spore dan environn est primordi comm strat gie de pr vention secondair les agent qui lib rent du chlore sont efficac les tergent pour tuer les spore du difficil il exist pas de preuv de niveau indiqu utilis agent lib rant du chlore influenc les taux de ddcd le lavag des main est la strat gie pr sentement recommand pour duir la transmiss du difficil les gel alcool inactiv pas les spore du difficil toutefoi une utilis accru de gel alcool pas entra augment du taux de ddcd
MED-4799~clostridium difficil retail meat product usa num abstract determin presenc clostridium difficil sampl cook uncook meat product sold tucson arizona forty two percent toxigen difficil strain ribotyp num toxinotyp num num toxinotyp iii nap num nap num relat num find food product play role interspeci difficil transmiss
MED-4800~detect character clostridium difficil retail chicken pubm ncbi abstract aim studi design evalu preval clostridium difficil contamin retail chicken method result chicken leg thigh wing purchas standard method retail outlet ontario canada select cultur qualit quantit detect difficil clostridium difficil isol num num chicken sampl num num thigh num num wing num num leg num isol ribotyp num strain food anim potenti community associ diseas human posit sampl posit enrich cultur conclus clostridium difficil found common retail chicken meat albeit low level signific impact studi studi report difficil chicken meat contamin meat difficil strain implic human infect rais concern food sourc difficil infect relev food contamin complet unclear point food investig sourc infect
MED-4801~methicillin resist staphylococcus aureus mrsa food product anim pubm ncbi abstract recent report methicillin resist staphylococcus aureus mrsa food product anim limit occasion detect dairi cattl mastiti num mrsa clone cc num report colon pig veal calv broiler chicken infect dairi cow aspect preval pig remain unclear livestock colon capac reservoir status requir elucid mrsa cc num detect meat mrsa risk pose unclear worri aspect mrsa cc num capac spread human complic mrsa control measur human healthcar urg research risk factor transmiss rout infect mrsa cc num report carriag investig pathogen potenti requir origin evolut clone remain unknown
MED-4802~methicillin resist staphylococcus aureus mrsa strain st num present midwestern swine swine worker abstract background recent research demonstr swine swine farmer netherland canada colon mrsa studi date investig carriag mrsa swine swine farmer unit state method sampl nare num swine num worker product system iowa illinoi compris approxim num live anim mrsa isol type puls field gel electrophoresi pfge smai eagi restrict enzym multi locus sequenc type mlst pcr determin sccmec type presenc pvl gene result pilot studi mrsa preval swine num num num num worker preval mrsa carriag product system a swine vari age rang num num adult swine num num anim age num num week preval product system a worker num num mrsa isol product system b s swine worker isol examin typeabl pfge smai digest eagi reveal isol clonal relat common human type iowa usa num usa num usa num mlst document isol st num conclus result show colon swine mrsa common swine product system midwestern suggest agricultur anim import reservoir bacterium mrsa strain st num strain document farm studi examin carriag rate addit farm
MED-4803~isol character methicillin resist staphylococcus aureus strain louisiana retail meat abstract investig preval staphylococcus aureus methicillin resist aureus mrsa num retail meat sampl num groceri store baton roug la aureus strain recov num pork sampl num beef sampl mrsa strain isol meat sampl pork sampl beef sampl mrsa isol strain type clone harbor panton valentin leucocidin belong pulsed field gel electrophoresi type usa num belong usa num
MED-4804~effect alcohol bas hand rub remov clostridium difficil spore hand pubm ncbi abstract background alcohol bas hand rub abhr effect decreas transmiss bacteri pathogen alcohol effect clostridium difficil spore examin retent difficil spore hand volunt abhr subsequ transfer spore physic contact method nontoxigen difficil spore spread bare palm num volunt num abhr chlorhexidin soap and wat wash compar plain water rub remov difficil spore palmar cultur perform hand decontamin plate stamp method transfer difficil applic abhr test volunt shake hand uninocul volunt result plain water rub reduc palmar cultur count standard deviat sd num num log num colony form unit cfu cm num set point product compar water wash chlorhexidin soap wash reduc spore count sd num num log num cfu cm num abhr isagel account reduct num num log num cfu cm num num endur reduct num num log num cfu cm num num purel reduct num num log num cfu cm num num statist signific differ reduct achiev abhr endur reduct statist water control rub num abhr handshak transfer num residu difficil spore hand recipi conclus hand wash soap water signific effect remov difficil spore hand volunt abhr residu spore readili transfer handshak abhr
MED-4805~risk factor colibacillosi outbreak cage layer flock pubm ncbi abstract colibacillosi increas signific layer flock studi risk factor outbreak studi aim investig associ risk factor non infecti natur outbreak mortal due colibacillosi flock cage layer hen inform manag biosecur measur hous condit collect num flock suffer diseas num clinic healthi control flock data process multipl logist regress statist analysi demonstr increas distanc nearest poultri farm num km six fold decreas risk outbreak colibacillosi odd ratio num num increas cage volum hen num decreas risk outbreak odd ratio num conclud distanc poultri farm hen densiti cage import risk factor outbreak colibacillosi flock layer hen
MED-4806~medic econom impact extraintestin infect due escherichia coli focus increas import endem problem pubm ncbi abstract escherichia coli best known bacteri speci frequent isol organ clinic specimen underappreci misunderstand exist medic profession lay public alik coli extraintestin pathogen underappreci featur includ wide varieti extraintestin infect coli ii high incid morbid mortal cost divers clinic syndrom iii pathogen potenti group coli strain caus intestin versus extraintestin diseas iv increas antimicrobi resist era health news sensation uncommon infect syndrom pathogen strain coli extraintestin infect increas import endem problem underappreci killer billion health care dollar million work day hundr thousand live lost year extraintestin infect due coli treatment prevent measur improv outcom diminish diseas burden
MED-4807~presenc character shiga toxin produc escherichia coli potenti diarrheagen coli strain retail meat abstract determin presenc shiga toxin produc escherichia coli stec potenti diarrheagen coli strain retail meat num coli isol collect nation antimicrobi resist monitor system narm retail meat program num num screen shiga toxin gene addit num coli isol recov num examin virul gene specif diarrheagen coli strain seventeen isol num ground beef num pork chop posit stx gene includ num posit stx num stx num posit stx num num posit stx num num stec strain belong num serotyp num num num num num num num num num num ont h num ont h num ont h num ont h num ont h num stec isol eae carri enterohemorrhag coli ehec hlya stec isol exhibit toxic effect vero cell dna sequenc analysi show stx num gene stec isol encod mucus activat stx num subtyp num stec isol pulsed field gel electrophoresi pfge yield num distinct restrict pattern num isol num atyp enteropathogen coli epec isol identifi addit num stec isol studi demonstr retail meat ground beef contamin divers stec strain presenc atyp epec strain retail meat concern due potenti human infect
MED-4808~antimicrobial resist extraintestin pathogen escherichia coli retail food pubm ncbi abstract background extraintestin escherichia coli infect special extraintestin pathogen coli expec strain increas antimicrobi resist food suppli dissemin expec antimicrobial resist coli method prospect survey num divers food item num retail market minneapolis st paul area num select cultur disk diffus assay isol character antimicrobial resist coli polymeras chain reaction bas assay serotyp defin expec associ trait perform result coli contamin exhibit preval gradient miscellan food num beef pork num poultri num num coli posit sampl similar preval gradient detect antimicrobi resist num num sampl num expec contamin num num num multivari analysi beef pork poultri natural food store exhibit reduc risk coli contamin antimicrobi resist indirect evid suggest on farm select resist food sourc expec isol pea pod turkey part ground pork veget dip close resembl select human clinic isol antigen genom profil conclus retail food import vehicl community wid dissemin antimicrobial resist coli expec repres newli recogn group medic signific foodborn pathogen
MED-4809~food reservoir escherichia coli caus urinari tract infect abstract close relat strain escherichia coli shown extraintestin infect unrel person studi test food reservoir exist coli isol num sourc time period num num geograph area compar sourc compris prospect collect coli isol women urinari tract infect uti num retail meat num restaurant ready to eat food num coli evalu antimicrobi drug suscept o h serotyp compar num genotyp method identifi num clonal group coli isol num num sourc coli retail chicken num num st num num num st num honeydew melon num num st num indistinguish close relat coli human uti studi strong support role food reservoir foodborn transmiss dissemin coli caus common community acquir uti
MED-4810~bowel function measur individu eat pattern abstract bowel function assess num subject num women men habitu consum omnivor vegetarian vegan diet subject diet intak fibr num num num transit time variabl signific group vegan greater frequenc defec pass softer stool measur bowel function signific correl total dietari fibr dietari fibr increas transit time decreas stool frequenc increas stool softer men produc greater quantiti softer form faec women luteal phase menstrual cycl women excret harder stool signific longer transit time find transit time high correl faecal form bowel function measur practic import
MED-4811~fish induc keriorrhea pubm ncbi abstract deep sea fish store larg amount wax ester bodi buoyanc control frequent caught by catch tuna fish noteworthi includ escolar oilfish accumul indigest wax ester rectum consumpt fish engend discharg leakag rectum orang brownish green oil notic loss water physiolog respons call keriorrhea oili diarrhea oili orang diarrhea orang oili leakag mass media blogger internet outbreak keriorrhea repeat report contin addit symptom includ nausea vomit abdomin cramp diarrhea complain victim due anxieti panic suffer keriorrhea escolar oilfish ban import sale itali japan south korea rapid detect fish imper ensur proper label safeguard public keriorrhea outbreak
MED-4812~meat maladi chang percept epidemiolog hepat pubm ncbi abstract hepat caus hepat virus hev consid zoonosi anthroponosi pig boar deer identifi reservoir flesh entrails  a meat offal  a vehicl hev transmiss shellfish act vehicl dietari gastronom culinari prefer influenc extens hev convey vehicl inactiv ingest host rout infect pave hev enter shed human live anim environ anthroponot transmiss hev primarili environment zoonot transmiss proceed foodborn environment rout
MED-4813~detect character infecti hepat virus commerci pig liver sold local groceri store usa pubm ncbi abstract hepat virus hev zoonot pathogen pig reservoir determin presenc hev rna commerci pig liver sold local groceri store usa num packag commerci pig liver purchas test univers rt pcr assay capabl detect hev genotyp num liver test num posit hev rna sequenc phylogenet analys reveal num isol belong genotyp num anim studi subsequ conduct pig determin pcr posit pig liver infecti virus result show pig inocul pcr posit pig liv homogen infect evidenc detect faecal virus shed viraemia seroconvers data demonstr commerci pig liver sold groceri store contamin hev contamin virus remain infecti rais public health concern food born hev infect
MED-4814~nation mortal rate chronic liver diseas consumpt alcohol pig meat pubm ncbi abstract correl nation pig meat consumpt mortal rate chronic liver diseas cld develop countri report num mechan explain hepat infect spread pig meat aim re examin origin associ recent intern data regress model estim associ nation pig meat consumpt cld mortal adjust confound data cld mortal alcohol consumpt hepat virus hbv hepat virus hcv seropreval num develop countri num obtain databas data nation pig meat beef consumpt obtain databas univari regress show alcohol pig meat consumpt mortal cld beef consumpt hbv hcv seropreval num litr capita increas alcohol consumpt increas mortal cld excess num death num popul num kg higher nation annual averag capita consumpt pork meat increas mortal cld num num death num popul multivari regress show alcohol pig meat consumpt hbv seropreval independ mortal cld hcv seropreval pig meat consumpt remain independ mortal cld develop countri num period work establish mechan
MED-4815~hepat virus load swine organ tissu slaughterhous determin real tim rt pcr pubm ncbi abstract uncommon north america hepat virus hev identifi industri countri patient histori travel hev endem countri presenc ubiquit worldwid swine popul zoonot transmiss swine hev human primat achiev experiment transmiss hev ingest contamin raw undercook meat document canada hev outbreak document hev genotyp num strain identifi sera faecal sampl swine origin object present studi determin viral load hev liver loin bladder hepat lymph node bile tonsil plasma faec sampl num pig slaughter felin calicivirus fcv sampl process control valid rna extract process confirm absenc sampl inhibitor amplif control fcv hev multiplex taqman rt qpcr system hev rna detect num num anim test hev detect lymph node num bladder num liver num bile num faec num tonsil num plasma num sampl infect anim hev posit loin sampl observ viral load num num copies g estim posit liver bile sampl crown copyright num publish elsevi reserv
MED-4816~thermal stabil hepat virus pubm ncbi abstract thermal stabil virul hepat virus hev hepat virus hav compar fecal suspens virus heat temperatur num degre num degre residu infect determin cell cultur system permiss virus hev stabl hav hev surviv intern temperatur rare cook meat
MED-4817~sporad acut fulmin hepat hokkaido japan food born suggest presenc hepat virus pig liver food pubm ncbi abstract ten patient contract sporad acut fulmin hepat num num hokkaido japan num histori consum grill undercook pig liver num week diseas onset test packag raw pig liver sold groceri store food hokkaido presenc hepat virus hev rna rt pcr pig liver specimen num num packag detect hev rna partial sequenc analys reveal swine hev isol belong genotyp iii iv swine hev isol swjl num packag pig liver num ident he ja num isol recov num year old patient hokkaido swine hev isol swjl num swjl num num num ident he ja num isol obtain num year old patient hokkaido result inadequ cook pig liver transmit hev human
MED-4818~pork intak human papillomavirus rel diseas pubm ncbi abstract clinic ecolog evid support associ human papillomavirus hpv relat tumor dietari factor present abstin high intak fri pork num num g day regress urethr condyloma healthi num year old man treat interferon gamma intern correl suggest pork intak posit incid cervic cancer diseas relat hpv pork meat dietari factor pork meat consumpt involv develop hpv relat diseas
MED-4819~mortal malign diseases upd baltimor union poultri cohort pubm ncbi abstract previous studi mortal num num member local union work poultri slaughter process plant expos oncogen virus present poultri report cancer mortal updat year num num num subject work exclus poultri plant mortal poultri worker compar general popul estim proport mortal standard mortal ratio separ race sex group cohort compar general popul excess cancer buccal nasal caviti pharynx base tongu palat unspecifi mouth tonsil oropharynx nasal cavity middl ear accessori sinus esophagus recto sigmoid rectum anus liver intrabiliari system myelofibrosi lymphoid leukemia multipl myeloma observ subgroup entir poultri cohort hypothes oncogen virus present poultri exposur fume candid etiolog role explain excess occurr cancer poultri worker larger studi control confound factor urgent determin signific find
MED-4820~cancer incid british vegetarian abstract background prospect studi examin cancer incid vegetarian method studi num num british men women compris num num meat eater num non meat eater eat fish fish eater num num vegetarian averag follow up num year num incid cancer num meat eater num fish eater num vegetarian relat risk rrs estim cox regress stratifi sex recruit protocol adjust age smoke alcohol bodi mass index physic activ level women pariti oral contracept result signific heterogen cancer risk group cancer site stomach cancer rrs compar meat eater num num ci num num fish eater num num num vegetarian heterogen num ovarian cancer rrs num num num fish eater num num num vegetarian heterogen num bladder cancer rrs num num num fish eater num num num vegetarian heterogen num cancer lymphat haematopoiet tissu rrs num num num fish eater num num num vegetarian heterogen num rrs malign neoplasm num num num fish eater num num num vegetarian heterogen num conclus incid cancer lower fish eater vegetarian meat eater
MED-4821~diet lifestyl acut myeloid leukemia nih aarp cohort abstract relat diet lifestyl acut myeloid leukemia assess cohort num person nih aarp diet health studi num num total num incid case acut myeloid leukemia ascertain multivari cox model util estim hazard ratio num confid interv compar smoker hazard ratio num num confid interv num num num num confid interv num num num num confid interv num num num num confid interv num num smoker smoke num num pack day current smoker smoke num num pack day higher meat intak increas risk acut myeloid leukemia hazard ratio num num confid interv num num quintil trend num clear effect meat cook method level individu drink coffe higher risk acut myeloid leukemia drank quantiti coffe fruit veget intak acut myeloid leukemia larg prospect studi identifi smoke meat intak risk factor acut myeloid leukemia
MED-4822~sweet sweeten beverag risk pancreat cancer larg population bas case control studi abstract object examin associ sweet sweeten unsweeten beverag sugar pancreat cancer risk method conduct population bas case control studi num case num control multivari logist regress model calcul odd ratio num confid interv ci associ sex present result men women combin separ result men greater intak total specif sweet pancreat cancer risk total sweet num num ci num num sweet condiment num num ci num num chocol candi num num ci num num mix candi bar num num ci num num num servings day versus none rar sweet consist risk women sweeten beverag increas pancreat cancer risk contrast low calori soft drink increas risk men low  non calor beverag coffe tea water unassoci risk sugar assess lactos fructos sucros milk sugar lactos pancreat cancer risk num num ci num num compar extrem quartil conclus result provid limit support hypothesi sweet sugar increas pancreat cancer risk
MED-4823~dietari fatti acid pancreat cancer nih aarp diet health studi abstract background previous research relat dietari fat modifi risk factor pancreat cancer inconclus method prospect analyz associ intak fat fat subtyp fat food sourc exocrin pancreat cancer nation institut health aarp diet health studi cohort num num men num num women complet num item food frequenc questionnair num num hazard ratio hrs num confid interv cis calcul cox proport hazard regress model adjust energi intak smoke histori bodi mass index diabet statist test two sid result averag follow up num year num men num women diagnos exocrin pancreat cancer num num case num num person year multivari adjust combin data men women pancreat cancer risk direct relat intak total fat highest lowest quintil num num case num num person year hr num num ci num num ptrend num satur fat num num case num num person year hr num num ci num num ptrend num monounsatur fat num num case num num person year hr num num ci num num ptrend num polyunsatur fat associ strongest satur fat anim food sourc num num case num num person year hr num num ci num num ptrend num specif intak red meat dairi product statist signific increas pancreat cancer risk hr num num conclus larg prospect cohort wide rang intak dietari fat anim origin increas pancreat cancer risk
MED-4824~num chronic pancreat pancreat cancer lifestyle rel diseas pubm ncbi abstract japan number patient chronic pancreat cp pancreat cancer pc increas nationwid survey cp reveal total number patient treat cp japan num estim num num confid interv num num num patient die pc num alcohol pancreat common type pancreat num cigarett smoke independ signific risk factor cp risk pancreat nonpancreat cancer increas cp alcohol consumpt increas risk pc cp smoke import risk factor cp pc increas incid pc close relat increas intak anim fat lifestyl patient cp patient pc environment factor lifestyl combin genet factor increas risk cp pc chang improv lifestyl habit drink smoke nutrit reduc risk cp pc
MED-4825~pancreat cancer review evid causat pubm ncbi abstract pancreat cancer kill num peopl year worldwid poor prognosi aim articl critic review epidemiolog evid exposur increas decreas risk medlin search perform epidemiolog studi review publish april num consist evid posit associ found famili histori cigarett smoke studi document posit associ diabet mellitus chronic pancreat etiolog mechan unclear associ detect result inconsist studi includ posit associ red meat sugar fat bodi mass index gallston helicobact pylori protect effect increas pariti dietari folat aspirin statin evid link alcohol coffe consumpt increas risk pancreat cancer associ exposur clarifi epidemiolog work precis measur risk factor adjust potenti confound dietari studi inform record method food prepar pattern consumpt work import reduc incid fatal diseas
MED-4826~macronutri fatti acid cholesterol pancreat cancer pubm ncbi abstract role diet nutrit pancreat carcinogenesi suggest associ select macronutri fatti acid cholesterol pancreat cancer remain controversi analys data hospital bas case control studi conduct itali num num includ num case num men num women incid pancreat cancer num control num men num women frequency match case sex age studi centr odd ratio num confid interv cis estim multipl logist regress model condit age sex studi centr adjust year interview educ tobacco smoke histori diabet energi intak posit associ found anim protein num highest versus lowest quintil intak num ci num num trend num negat associ observ sugar num num ci num num trend num non signific negat associ emerg veget protein num polyunsatur fatti acid num conclus diet poor anim protein rich sugar deriv fruit benefici effect pancreat cancer risk copyright num elsevi reserv
MED-4827~men low serum cholesterol lower risk high grad prostat cancer placebo arm prostat cancer prevent trial abstract background prospect studi suggest cholesterol low statin drug invers advanc stage possibl high grad prostat cancer studi report men low cholesterol lower risk high grad prostat cancer find investig associ low serum cholesterol prostat cancer risk prostat cancer prevent trial pcpt method conduct cohort studi num men age num year random placebo arm pcpt num num serum cholesterol measur enzymat entri end follow up num prostat cancer case confirm logist regress calcul multivari odd ratio total gleason num num num num num prostat cancer compar low normal num mg dl high borderlin elev cholesterol num mg dl serum cholesterol result men low cholesterol lower risk gleason num prostat cancer num num confid interv ci num num men high cholesterol associ present prostat cancer num num ci num num gleason num diseas num num ci num num gleason num diseas num num ci num num conclus prospect result support men low cholesterol reduc risk high grad prostat cancer contemporari data suggest cholesterol metabol investig etiolog prostat cancer
MED-4828~associ statin associ myopathi skelet muscl damag abstract background patient statin complain muscl pain weak extent muscl pain reflect muscl injuri unknown method obtain biopsi sampl vastus laterali muscl num patient num patient clinic diagnos statin associ myopathi num statin num discontinu statin therapi biopsi minim durat discontinu num week includ num patient statin myopathi num patient statin myopathi classifi muscl injur num muscl fibr biopsi sampl show damag revers transcriptas polymeras chain reaction evalu express level candid gene potenti relat myocyt injuri result muscl injuri observ num num patient myopathi num patient myopathi num patient structur injuri circul level creatin phosphokinas elev num u l num upper limit normal express ryanodin receptor num signific upregul patient biopsi evid structur damag num standard error num interpret persist myopathi patient statin reflect structur muscl damag lack elev level circul creatin phosphokinas rule structur muscl injuri upregul express ryanodin receptor num suggest intracellular calcium leak
MED-4829~statin therapi muscl function fall risk community dwel older adult pubm ncbi abstract background statin therapi myopathi unclear exacerb age rel muscl function declin aim describ differ statin user non us muscl mass muscl function fall risk group community dwel older adult design prospect population bas cohort studi follow up num year method total num older adult num femal standard deviat age num year examin baselin follow up differ percentag appendicular lean mass alm leg strength leg muscl qualiti lmq specif forc fall risk compar statin user non us result num statin user baselin num follow up longitudin analys reveal statin baselin predict increas fall risk score num year num num ci num num trend increas alm num num ci num num statin user time point demonstr decreas leg strength num kg num ci num num lmq num kg kg num ci num num trend increas fall risk num num ci num num compar control final statin user baselin follow up demonstr decreas leg strength num kg num ci num num lmq num kg kg num ci num num compar ceas statin follow up conclus statin exacerb muscl perform declin fall risk age concomit decreas muscl mass effect revers cessat
MED-4830~statin therapi induc ultrastructur damag skelet muscl patient myalgia pubm ncbi abstract muscl pain weak frequent complaint patient receiv num hydroxymethylglutaryl coenzymea hmg coa reductas inhibitor statin patient myalgia creatin kinas level normal margin elev obvious structur defect report patient myalgia investig mechan mediat statin induc skelet muscl damag skelet muscl biopsi statin tr non statin tr patient examin electron microscopi biochem approach present paper report clear evid skelet muscl damag statin tr patient asymptomat degre damag slight characterist pattern includ breakdown t tubular system subsarcolemm ruptur characterist structur abnorm observ statin tr patient reproduc extract cholesterol skelet muscl fibr vitro find support hypothesi statin induc cholesterol lower se contribut myocyt damag suggest specif lipid protein organ skelet muscl cell render vulner copyright num patholog societi great britain ireland publish john wiley son
MED-4831~effect plant bas diet plasma lipid pubm ncbi abstract dyslipidemia primari risk factor cardiovascular diseas peripher vascular diseas stroke current guidelin recommend diet first lin therapi patient elev plasma cholesterol concentr constitut optim dietari regimen remain matter controversi larg prospect trial demonstr popul plant bas diet vegetarian vegan diet lower risk ischem heart diseas mortal investig review publish scientif research determin effect plant bas diet modifi plasma lipid concentr twenty seven random control observ trial includ num type plant bas diet consid intervent test combin diet vegetarian vegan diet combin nut soy and or fiber demonstr greatest effect num plasma low dens lipoprotein cholesterol reduct vegan ovolactovegetarian diet intervent small amount lean meat demonstr dramat reduct total cholesterol low dens lipoprotein level conclus plant bas dietari intervent effect lower plasma cholesterol concentr
MED-4832~effect kiwifruit consumpt serum lipid profil antioxid status hyperlipidem subject pubm ncbi abstract cardiovascular diseas cvd import adult health problem world epidemiolog studi laboratori experi shown fruit veget consumpt protect effect cvd purpos studi investig effect consumpt kiwifruit day lipid profil antioxid marker lipid peroxid hyperlipidem adult men women taiwan forty thre subject hyperlipidemia includ num male num femal particip studi consum kiwifruit day num week anthropometr measur made intervent num num week intervent fast blood sampl analyz total cholesterol triacylglycerol low dens lipoprotein ldl cholesterol high dens lipoprotein cholesterol hdl c addit vitamin vitamin malondialdehyd num hydroxi num nonen concentr lag time ldl oxid determin signific differ baselin num week intervent detect triacylglycerol total cholesterol ldl cholesterol num week consumpt kiwifruit hdl c concentr signific increas ldl cholesterol hdl c ratio total cholesterol hdl c ratio signific decreas vitamin vitamin increas signific addit lag time ldl oxid malondialdehyd num hydroxi num nonen signific chang num num week kiwifruit intervent regular consumpt kiwifruit exert benefici effect antioxid status risk factor cvd hyperlipidem subject
MED-4833~effect strawberri cholesterol low dietari portfolio pubm ncbi abstract effect diet reduc blood lipid oxid damag link complic diabet coronari heart diseas object assess effect ad strawberri sourc antioxid improv antioxid effect cholesterol low diet dietari portfolio end num hyperlipidem subject dietari portfolio consist soy viscous fiber plant sterol nut num year random receiv supplement strawberri num g d num kcal addit oat bran bread num g d num kcal approxim num beta glucan control random num month crossov studi num week washout strawberri supplement result greater reduct oxid damag low dens lipoprotein ldl measur thiobarbitur acid react substanc ldl fraction num end strawberri period reduct ldl cholesterol ratio total high dens lipoprotein cholesterol maintain close num year valu num num num num num similar post oat bran bread valu strawberri improv palat diet conclud strawberri supplement reduc oxid damag ldl maintain reduct blood lipid enhanc diet palat ad fruit improv util diet design lower coronari heart diseas risk
MED-4834~cola intak serum lipid oslo health studi pubm ncbi abstract soft drink major sourc sucros influenc serum lipid concentr examin associ intak frequenc type soft drink concentr serum triglycerid tg high dens lipoprotein hdl low dens lipoprotein ldl cholesterol cross sect oslo health studi total num subject altogeth num particip studi data intak frequenc cola non cola sugar popul sampl consist sex num age group group num year age group num num year age group num num year age sex hdl decreas tg increas signific num increas intak frequenc cola contrast consist associ found report intak non cola soft drink serum lipid found signific differ relat report presenc absenc sugar soft drink multipl linear regress analys cola serum lipid associ prevail num includ num confound sex age group time meal physic activ intak alcohol coffe chees fruit berri fatti fish smoke length educ cholesterol low drug intak non cola self report intak frequenc cola soft drink negat serum hdl posit tg ldl
MED-4835~whole grain ready to eat oat cereal part dietari program weight loss reduc low dens lipoprotein cholesterol adult overw pubm ncbi abstract object weight loss consumpt viscous fiber lower low dens lipoprotein ldl cholesterol level evalu whole grain ready to eat rte oat cereal viscous fiber part dietari program weight loss lower ldl cholesterol level improv cardiovascular diseas risk marker dietari program design random parallel arm control trial subjects set free liv overweight obes adult num bodi mass index num num baselin ldl cholesterol level num num mg dl num num mmol l random num includ main analysi particip complet trial signific protocol violat intervent portion day whole grain rte oat cereal num g day oat b glucan energy match low fib food control part reduc energi approxim num kcal day deficit dietari program encourag limit consumpt food high energi fat portion control regular physic activ main outcom measur fast lipoprotein level waist circumfer tricep skinfold thick bodi weight measur baselin week num num num result ldl cholesterol level reduc signific whole grain rte oat cereal control num num num num num total cholesterol num num num num num non high dens lipoprotein cholesterol num num num num num lower signific whole grain rte oat cereal high dens lipoprotein triglycerid respons differ group weight loss group num num num num kg num waist circumfer decreas num num num num cm num whole grain rte oat cereal larger reduct ldl total non high dens lipoprotein cholesterol level waist circumfer evid earli week num whole grain rte oat cereal group conclus consumpt whole grain rte oat cereal part dietari program weight loss favor effect fast lipid level waist circumfer copyright num american dietet associ publish elsevi reserv
MED-4837~preval type gallston patient cholelithiasi kathmandu medic colleg nepal pubm ncbi abstract background gallston diseas cholelithiasi common digest surgic disord account import part health care expenditur attempt made analys gallston type depend composit aim object main object studi preval type gallston nepal correl clinic find materi method gallston num patient underw cholecystectomi cholelithiasi collect num januari num num num depart patholog kathmandu medic colleg teach hospit detail histori stone analyz chemic enzymat method clinic spectrophotomet result conclus common involv age group cholelithiasi num found num year femal predomin num num cholelithiasi found common non vegetarian vegetarian non vegetarian ratio num mix type stone found common type stone compris num cholesterol stone num brown pigment stone num black pigment stone num
MED-4838~cholesterol gallston diseas pubm ncbi abstract preval num adult europ usa gallston common digest diseas admiss hospit west interplay interprandi postprandi physiolog respons endogen dietari lipid underscor import coordin hepatobiliari gastrointestin function prevent crystallis precipit excess biliari cholesterol identifi metabol transcript pathway drive regul biliari lipid secret major achiev field highlight scientif advanc protein gene regul cholesterol absorpt synthesi catabol biliari lipid secret respect pathogenesi cholesterol gallston diseas discuss physical chem mechan gallston format bile activ role gallbladd intestin discuss gap knowledg pathogenesi gallston format potenti gene target therapi
MED-4839~migrat fish bone present acut onset neck lump pubm ncbi abstract encount num year old woman progress worsen sore throat sharp lump locat left upper neck hour admiss question underw rigid esophagoscopi local hospit suspect fish bone impact gave negat result unusu sign caus arrang comput tomographi scan show foreign bodi penetr left sternocleidomastoid muscl subcutan layer extens emphysema neck extract foreign bodi num cm horizont incis neck general anesthesia patient return normal diet discharg day num hospit morbid rare case migrat foreign bodi present neck lump review literatur case involv subcutan migrat fish bone show develop neck lump week month ingest stabl condit case show neck lump num day ingest acut toxic symptom
MED-4840~homeopathi evid pubm ncbi abstract object evalu evid effect homeopathi data sourc cochran databas systemat review general consid reliabl sourc evid search januari num studi select cochran review term homeopathi titl abstract keyword consid protocol review exclud articl met inclus criteria data extract review examin specif subject matter number clinic trial review total number patient involv author conclus review cover condit cancer attention deficit hyperact disord asthma dementia influenza induct labour data synthesi find review discuss narrat review clinic statist heterogen preclud meta analysi conclus find cochran review studi homeopathi show homeopath medicin effect placebo
MED-4841~humor immun cow milk protein gliadin etiolog recurr aphthous ulcer pubm ncbi abstract object goal studi determin incid serum antibodi gliadin cow milk protein cmp elisa test patient recurr aphthous ulcer rau subject method fifti patient recurr aphthous ulcer fifti healthi peopl includ research level serum iga igg antibodi gliadin iga igg ige cmp determin elisa result level serum antigliadin iga igg antibodi signific higher patient rau comparison control num num level serum anti cmp iga igg ige antibodi signific higher patient rau comparison control num num num general increas humor iga igg immunoreact cmp found num num patient num show increas level iga igg immunoreact cmp time num num patient iga igg ige immunoreact cmp conclus result strong associ high level serum anti cmp iga igg ige antibodi clinic manifest recurr aphthous ulcer
MED-4842~efficaci purslan treatment oral lichen planus pubm ncbi abstract studi evalu effect antioxidant rich purslan treatment oral lichen planus olp total num biopsy proven symptomat olp patient select random double blind placebo control trial subject divid group receiv purslan num placebo num num month assess made baselin num week month num month base visual analog scale vas clinic improv includ lesion type size approxim num purslan patient show partial complet clinic improv num respons placebo group num experienc partial improv num respond num show worsen vas score partial complet respons observ purslane tr patient num num control demonstr partial respons respons worsen symptom signific decreas vas score end studi period num side effect occur group find purslan clinic effect treatment olp lack side effect studi period favor altern treatment olp num john wiley son
MED-4843~laboratori variabl rheumatoid arthriti patient trial fast one year vegetarian diet pubm ncbi abstract previous report signific improv obtain rheumatoid arthriti patient fast vegetarian diet year present studi carri examin extent biochem immunolog variabl chang clinic trial fast vegetarian diet patient randomis vegetarian diet signific decreas platelet count leukocyt count calprotectin total igg igm rheumatoid factor rf num activ product complement compon num num month treatment measur paramet chang signific period group omnivor num num measur variabl favor vegetarian compar omnivor differ signific leukocyt count igm rf complement compon num num laboratori variabl declin vegetarian improv clinic variabl indic substanti reduct inflammatori activ leukocyt count decreas vegetarian irrespect clinic result declin leukocyt count attribut vegetarian diet se reduct diseas activ result present studi accord find clinic trial dietari treatment reduc diseas activ patient rheumatoid arthriti
MED-4844~role meat express rheumatoid arthriti pubm ncbi abstract rheumatoid arthriti ra character inflamm synovi tissu joint number paper relat dietari compon inflamm review addit ecolog approach studi link diet ra multi countri data preval ra femal fifteen countri compar statist compon nation dietari suppli fat meat offal period num year preval data found highest statist associ preval ra num num num countri statist correl meat offal high fat similar correl found tempor indic effect ra european countri num num meat ad nation diet correl higher meat fat hypothes meat offal major factor contribut inflamm ra present short review author examin data associ meat consumpt ra factor fat fe nitrit contribut inflamm
MED-4845~control trial fast one year vegetarian diet rheumatoid arthriti pubm ncbi abstract fast effect treatment rheumatoid arthriti patient relaps reintroduct food effect fast year vegetarian diet assess randomis single blind control trial num patient alloc four week stay health farm initi num day subtot fast put individu adjust gluten fre vegan diet num month food gradual chang lactovegetarian diet remaind studi control group num patient stay week convalesc home ate ordinari diet studi period week health farm diet group show signific improv number tender joint ritchie articular index number swollen joint pain score durat morn stiff grip strength erythrocyt sediment rate c reactiv protein white blood cell count health assess questionnair score control group pain score improv score control group pain score improv signific benefit diet group present year evalu show signific advantag diet group measur indic dietari regimen supplement convent medic treatment rheumatoid arthriti
MED-4846~diverg serum sterol strict uncook vegan diet patient rheumatoid arthriti pubm ncbi abstract effect strict uncook vegan diet serum lipid sterol concentr studi patient rheumatoid arthriti subject random vegan diet group num consum vegan diet num month control group num continu usual omnivor diet serum total ldl cholesterol phospholipid concentr signific decreas vegan diet level serum cholestanol lathosterol decreas serum cholestanol tot cholesterol lathosterol tot cholesterol chang effect vegan diet serum plant sterol diverg concentr campesterol decreas sitosterol increas effect result signific greater sitosterol campesterol vegan diet group control group num sd num num sd num num higher concentr campesterol compar sitosterol normal omnivor subject explain lower absorpt esterif rate sitosterol result suggest strict uncook vegan diet relat absorpt rate sterol and or biliari clearanc
MED-4847~fast vegetarian diet patient rheumatoid arthriti systemat review pubm ncbi abstract clinic experi suggest fast vegetarian diet patient rheumatoid arthriti ra review scientif evid patient frequent dietari advic exclus pharmacolog treatment ra satisfi fast studi ra search medlin check refer relev report result control studi report follow up data month fast quantit pool thirty on report fast studi patient ra found control studi investig effect fast subsequ diet month pool studi show statist clinic signific benefici long term effect evid suggest fast vegetarian diet treatment ra randomis long term studi confirm view methodolog convinc data
MED-4848~vegetarian diet patient rheumatoid arthritis  status year introduct diet pubm ncbi abstract previous report signific improv obtain rheumatoid arthriti patient fast individu adjust vegetarian diet year patient chang diet divid diet respond diet nonrespond clinic trial patient free chang diet medic approxim year attend clinic examin compar chang baselin time studi entri time follow up examin diet respond diet nonrespond control ate omnivor diet variabl favour diet respond pain score durat morn stiff stanford health assess questionnair index number tender joint ritchie articular index number swollen joint esr platelet count correct differ group signific clinic variabl grip strength signific differ group regard laboratori anthropometr variabl time follow up examin diet respond half diet nonrespond diet find group patient rheumatoid arthriti benefit dietari manipul improv sustain two year period
MED-4849~uncook lactobacilli rich vegan food rheumatoid arthriti pubm ncbi abstract test effect uncook vegan diet rich lactobacilli rheumatoid patient random diet control group intervent group experienc subject relief rheumat symptom intervent return omnivor diet aggrav symptom half patient experienc advers effect nausea diarrhoea diet stop experi prematur indic rheumat diseas activ differ statist group posit subject effect experienc patient discern object measur diseas activ health assess questionnair durat morn stiff pain rest pain movement composit index show higher number patient num improv diseas activ measur intervent group stepwis regress analysi decreas diseas activ measur chang diseas activ score das lactobacilli rich chlorophyll rich drink increas fibr intak gold methotrex steroid medic num num num result show uncook vegan diet rich lactobacilli decreas subject symptom rheumatoid arthriti larg amount live lactobacilli consum daili posit effect object measur rheumatoid arthriti
MED-4850~antioxid vegan diet rheumat disord pubm ncbi abstract plant rich natur sourc antioxid addit nutrient intervent cross section studi subject consum uncook vegan diet call live food lf carri clarifi efficaci lf rheumatoid diseas health problem inflamm main concern lf uncook vegan diet consist berri fruit veget root nut germin seed sprout rich sourc carotenoid vitamin subject eat lf show high increas level beta alfa caroten lycopen lutein sera increas vitamin vitamin adjust cholesterol statist signific berri intak num fold compar control intak polyphenol compound quercetin myricetin kaempherol higher omnivor control lf diet rich fibr substrat lignan product urinari excret polyphenol enterodiol enterolacton secoisolaricirecinol increas subject eat lf shift fibromyalg subject lf result decreas joint stiff pain improv self experienc health rheumatoid arthriti patient eat lf diet report similar posit respons object measur support find improv rheumatoid arthriti signific correl day to day fluctuat subject symptom conclus rheumatoid patient subject benefit vegan diet rich antioxid lactobacilli fibr object measur
MED-4851~rheumatoid arthriti treat vegetarian diet pubm ncbi abstract notion dietari factor influenc rheumatoid arthriti ra part folklor diseas scientif support spars control single blind trial test effect fast num consum individu adjust gluten fre vegan diet num mo consum individu adjust lactovegetarian diet num mo patient ra clinic variabl laboratori variabl measur num patient fast vegetarian diet group improv signific compar num patient control group usual omnivor diet studi period year patient complet trial reexamin compar baselin improv measur signific greater vegetarian previous benefit diet diet respond diet nonrespond omnivor benefici effect explain patient psycholog characterist antibodi activ food antigen concentr prostaglandin leukotrien precursor fecal flora differ signific sampl collect time point substanti clinic improv time point minor improv summari result show patient ra benefit fast period vegetarian diet dietari treatment valuabl adjunct ordinari therapeut armamentarium ra
MED-4852~self report food intoler mucos reactiv rectal food protein challeng patient rheumatoid arthriti pubm ncbi abstract object dietari link rheumatoid arthriti ra suspect influenc arthrit symptom diet report primari aim record self experienc advers food reaction patient ra secondari aim relat self experienc advers reaction dairi produc wheat local mucos reactiv observ rectal challeng cow milk protein cm wheat gluten method questionnair self experienc advers reaction food num ra patient rectal challeng cm gluten perform num patient healthi control num num challeng mucos product nitric oxid mucos releas myeloperoxidas mpo eosinophil cation protein ecp measur mucos patch techniqu result twenty seven cent ra patient report food intoler fi food cm meat wheat gluten strong mucos reactiv cm observ num patient moder increas mucos reactiv cm gluten found num num patient relationship found self experienc advers reaction cm gluten mucos reactiv protein conclus perceiv fi report frequent ra patient preval similar report previous general popul mucos reactiv cm gluten minor fraction ra patient relat frequent perceiv intoler protein
MED-4853~effect low fat vegan diet subject rheumatoid arthriti pubm ncbi abstract object demonstr effect low fat vegan diet patient rheumatoid arthriti ra design single blind dietari intervent studi subject studi intervent studi evalu influenc num week low fat approxim num vegan diet num free liv subject ra averag age num num year outcom measur prestudi poststudi assess ra symptomatolog perform rheumatologist blind studi design biochem measur num day diet data collect subject met week diet instruct complianc monitor progress assess result signific num decreas fat num protein num energi num signific increas carbohydr num intak measur ra symptomatolog decreas signific num durat morn stiff num weight decreas signific num num week c reactiv protein decreas num ns num ra factor decreas num ns num erythrocyt sediment rate unchang num conclus studi show patient moderate to sever ra switch low fat vegan diet experi signific reduct ra symptom
MED-4854~plasma phospholipid fatti acid relationship diseas activ rheumatoid arthriti patient treat vegetarian diet pubm ncbi abstract control clinic trial recent shown patient rheumatoid arthriti ra improv fast num improv sustain num month vegan diet num month lactovegetarian diet studi inflammatori process ra reduc manipul dietari fatti acid switch vegetarian diet signific alter intak fatti acid analys fatti acid profil plasma phospholipid fraction relat diseas activ concentr fatti acid num num num num signific reduc num month vegan diet num num concentr increas baselin valu lactovegetarian diet concentr num num signific reduc vegan diet num lactovegetarian diet period num signific differ fatti acid concentr diet respond diet non respond vegan lactovegetarian diet period result fatti acid profil explain clinic improv
MED-4855~hip powder rosa canina rosehip reduc pain osteoarthr patient a meta analysi random control trial pubm ncbi abstract object meta analysi random control trial rcts of hip powder rosa canina rosehip prepar symptomat treatment osteoarthr oa order estim empir efficaci pain reduc compound method rcts systemat search includ explicit state oa patient random rosehip placebo primari outcom reduct pain calcul effect size es defin standard differ smd secondari analysi number respond therapi analyz odd ratio express number treat nnt restrict maximum likelihood reml method appli meta analys mix effect model result studi num patient median trial dur num month all support manufactur hyben vit intern show reduct pain score rosehip powder num patient compar placebo num patient es num num confid interv ci num num num test homogen support efficaci consist trial num num reason assum studi measur effect patient alloc rosehip powder respond therapi compar placebo num num nnt num ci num patient conclus base spars amount data result present meta analysi rosehip powder reduc pain interest nutraceut efficaci safeti evalu independ replic futur large scale long term trial
MED-4856~rose hip herbal remedi patient rheumatoid arthriti randomis control trial pubm ncbi abstract object investig standardis powder made rose hip rosa canina reduc symptom score patient rheumatoid arthriti method double blind placebo control trial patient rheumatoid arthriti ra ara acr criteria randomis treatment capsul rose hip powder num daili match placebo num month outpati clinic berlin copenhagen primari outcom variabl health assess questionnair haq num month secondari outcom includ das num physician global evalu diseas activ raqol sf num concomit pain medic result total num patient num femal age num num year diseas durat num num year haq di rose hip group improv num num placebo group worsen num num adjust num haq patient pain scale signific differ observ group haq patient global scale trend favour rose hip num das num score yield improv rose hip group num num placebo group num num num indic moder clinic relev physician global scale demonstr improv rose hip compar placebo group num raqol sf num physic score improv signific rose hip group compar placebo sf num mental score remain unchang intak pain medic group per protocol analysi confirm result conclus result patient ra benefit addit treatment rose hip powder copyright num elsevi gmbh reserv
MED-4857~benzen infant carrot juic insight format mechan risk assess includ consumpt data donald studi pubm ncbi abstract benzen previous detect heat induc contamin infant carrot juic studi show carrot juic substanc beta caroten phenylalanin terpen act precursor benzen format food process benzen exposur childhood leukaemia cancer studi aim provid quantit risk assess accomplish measur food consumpt data dortmund nutrit anthropometr longitudin design donald studi survey data benzen juic categori calcul exposur infant num num month low averag num num ng kg bw day result margin exposur num exposur judg pose health risk infant carcinogen contamin reduc level low achiev focus set improv steril condit copyright num elsevi reserv
MED-4858~plasma beta caroten suitabl biomark fruit veget intak german subject long term high consumpt fruit pubm ncbi abstract background object beta caroten marker amount fruit veget consum plasma beta caroten concentr subject habitu long term diet character amount food plant origin compar dietari beta caroten intak plasma concentr women habitu diet differ consum amount food plant origin method comparison dietari beta caroten intak plasma beta caroten concentr women adher averag western diet num wholesom nutrit prevent recommend num raw food diet num result dietari beta caroten intak num num num mg day women adher averag western diet wholesom nutrit raw food diet num multivari adjust plasma beta caroten concentr num num num micromol l num compar dietari beta caroten intak result lower multivari adjust plasma beta caroten women adher raw food diet averag western diet compar wholesom nutrit num intak group num mg day amount fruit veget intak predict plasma beta caroten level women consum raw food diet conclus plasma beta caroten concentr differ diet group highest plasma level women adher wholesom nutrit plasma beta caroten concentr reflect beta caroten intak amount fruit veget consum num karger ag basel
MED-4859~jam process storag effect blueberri polyphenol antioxid capac pubm ncbi abstract fresh blueberri process sugar sugar fre jam store num month num num degre jam analyz immedi process num month storag polyphenol content percent polymer color antioxid capac process result loss anthocyanin procyanidin chlorogen acid orac jam type flavonol retain mark loss anthocyanin procyanidin occur num month storag accompani increas polymer color valu chlorogen acid level declin storag flavonol orac chang jam store num degre retain higher level anthocyanin procyanidin orac lower polymer color valu jam store num degre sugar fre jam retain higher level anthocyanin lower polymer color valu sugar jam late storag blueberri jam refriger retain polyphenol antioxid capac
MED-4860~blueberri supplement improv memori older adult abstract preval dementia increas expans older adult popul absenc effect therapi prevent approach essenti address public health problem blueberri polyphenol compound promin anthocyanin antioxid anti inflammatori effect addit anthocyanin increas neuron signal brain center mediat memori function improv glucos dispos benefit expect mitig neurodegener investig effect daili consumpt wild blueberri juic sampl older adult earli memori num week observ improv pair associ learn num word list recal num addit trend suggest reduc depress symptom num lower glucos level num compar memori perform blueberri subject demographically match sampl consum berri placebo beverag companion trial ident design observ compar result pair associ learn find preliminari studi suggest moderate term blueberri supplement confer neurocognit benefit establish basi comprehens human trial studi prevent potenti neuron mechan
MED-4861~fruit veget intak cancer risk european prospect investig cancer nutrit epic pubm ncbi abstract background wide believ cancer prevent high intak fruit veget inconsist result studi conclus establish invers associ fruit veget intak cancer risk method conduct prospect analysi european prospect investig cancer nutrit epic cohort assess relationship intak total fruit total veget total fruit veget combin cancer risk num detail inform dietari habit lifestyl variabl cohort obtain cancer incid mortal data ascertain hazard ratio hrs num confid interv cis estim multivari cox regress model analys conduct cancer tobacco alcohol stratif tobacco smoke alcohol drink result initi num men num women includ studi num men num women identifi cancer median follow up num year crude cancer incid rate num num person year men num num person year women associ reduc cancer risk increas intak total fruit veget combin total veget entir cohort similar num g d increas intak fruit veget combin hr num num ci num num num g d increas intak total veget hr num num ci num num intak fruit show weaker invers associ num g d increas intak total fruit hr num num ci num num reduc risk cancer high veget intak restrict women hr num num ci num num stratif alcohol intak suggest stronger reduct risk heavi drinker confin cancer caus smoke alcohol conclus small invers associ intak total fruit veget cancer risk observ studi small magnitud observ associ caution appli interpret
MED-4862~phenol profil antioxid properti appl skin extract pubm ncbi abstract lipid oxid oxid polyunsatur fatti acid signific issu food industri impact food qualiti health consum appl skin investig sourc natur antioxid phenol compound composit antioxid properti num select appl genotyp evalu lipid stabil abil appl skin extract examin aqueous emuls system methyl linolen total phenol concentr determin high perform liquid chromatographi tandem mass spectrometri methanol extract skin appl genotyp vari num num mg num dw antioxid capac measur folin ciocalteu num num mg gae num dw ferric reduc antioxid power num num te num dw oxygen radic absorb capac num num te num dw percent inhibit oxid methyl linolen num num vari appl genotyp appl skin extract specif crab appl varieti dolgo reveal effect inhibitor oxid polyunsatur fatti acid model system consid potenti sourc natur food antioxid
MED-4863~phenol substanc character chemic cell bas antioxid activ num lentil grown northern unit state pubm ncbi abstract chemic cellular antioxid activ phenol profil num lentil cultivar grown cool northern part unit state investig individu phenol compound includ phenol acid flavan num ol flavon anthocyanin quantit investig hplc cellular antioxid activ caa peroxyl radic scaveng capac prsc evalu fluoresc micropl reader cultivar morton exhibit highest individu flavan num ol catechin epicatechin total flavonoid highest antioxid properti prsc caa lentil test phenol acid benzoic type deriv gallic protocatechu num num trihydroxybenzo p hydroxybenzo acid protocatechualdehyd phenol acid cinnam type chlorogen p coumar m coumar sinap acid detect lentil cultivar flavan num ol catechin epicatechin flavon luteolin detect lentil cultivar phenol compound detect sinap acid predomin phenol acid catechin epicatechin predomin flavonoid result show phenotyp lentil possess variat individu phenol compound chemic cellular antioxid activ caffeic acid catechin epicatechin total flavonoid signific num correl peroxyl radic scaveng assay cellular antioxid assay signific correl chemic antioxid assay orac result studi interest breed program improv lentil function food
MED-4864~compar flavonoid content select herb associ radic scaveng activ antiprolif action num cell pubm ncbi abstract elucid health benefit herbal tea cytotox induc num num num cell herbal extract flavonoid test lactat dehydrogenas releas determin intracellular reactiv oxygen speci generat antioxid activ superoxid radic scaveng assay signific decreas cell viabil observ num cell treat num num mm herbal extract flavonoid includ catechin epigallocatechin gallat prevent ldh releas num num cytotox total catechin content green tea num mg g dri matter signific higher herbal tea num num mg g dm relat concentr num major tea catechin rank egcg egc ec green tea exhibit lowest ic num valu num fresh herb num ml superoxid radic scaveng activ test herbal tea power antioxid activ num radic scaveng black tea dandelion hawthorn rose hip chamomil
MED-4865~evalu cyto genotox activ yerba mate ilex paraguariensi human lymphocyt vitro pubm ncbi abstract antioxid capac well known health benefit yerba mate tea ilex paraguariensi shown possess genotox mutagen activ increas incid type cancer aim studi estim cyto genotox mate tea human peripher lymphocyt vitro found yerba mate extract induc concentration depend statist signific increas level apoptot necrot cell decreas nuclear divis index ndi mate expos lymphocyt reduc transcript rdna activ due stress condit show elev product micronuclei fish techniqu reveal acrocentr signal mate induc micronuclei suggest condit yerba mate extract display aneugen activ caffein abund compound found dri mass mate conduct addit experi caffein show caffein concentr manifest potent cyto genotox effect account part disadvantag effect observ yerba mate extract
MED-4866~evid support vitamin indiscrimin supplement pubm ncbi abstract year prevail concept ldl oxid play central role atherogenesi consequ supplement antioxid vitamin popular major random clinic trial yield disappoint result recent meta analys conclud indiscrimin high dose vitamin supplement result increas mortal conclus rais reason critic refer characterist meta analysi recent studi markov model approach free limit meta analys major find averag quality adjust life year qali vitamin supplement individu num qali num ci num num untreat peopl view support view indiscrimin supplement high dose vitamin recommend general public present communic address recent studi demonstr negat effect vitamin rais mechan respons harm effect vitamin supplement review recent studi conduct specif group patient gain vitamin supplement indic averag indiscrimin supplement high dose vitamin benefici specif popul gain vitamin challeng establish select criteria predict benefit vitamin supplement criteria base assumpt antioxid benefici peopl oxid stress knowledg benefit sick peopl diseas short adopt view vitamin double edg sword consum criteria defin predict benefit high dose supplement vitamin num intern union biochemistri molecular biolog
MED-4867~evalu genotox steviosid steviol vitro vivo mutagen assay pubm ncbi abstract steviosid constitu stevia rebaudiana common non calor sugar substitut japan genet toxic steviosid aglycon steviol examin mutagen test bacteria revers mutat assay forward mutat assay umu test rec assay cultur mammalian cell chromosom aberr test gene mutat assay mice micronucleus test steviosid mutagen assay examin aglycon steviol produc dose rel posit respons mutagen test forward mutat assay salmonella typhimurium tm num chromosom aberr test chines hamster lung fibroblast cell line chl gene mutat assay chl metabol activ system num supernat fraction num liver homogen prepar polychlorin biphenyl phenobarbit num benzoflavone pretr rat requir mutagenesi clastogenesi steviol weak posit umu test typhimurium ta num psk num metabol activ system steviol presenc num activ system negat assay revers mutat assay typhimurium ta num ta num ta num ta num ta num ta num ta num escherichia coli wp num uvra pkm num rec assay bacillus subtili steviol negat mous micronucleus test genotox risk steviol human discuss
MED-4868~stevia stevia rebaudiana bio sweeten review pubm ncbi abstract studi reveal stevia world ancient time purpos sweeten medicin conduct systemat literatur review summar quantifi past current evid stevia search relev paper num databas leav stevia plant function sensori properti superior high pot sweeten stevia major sourc high pot sweeten grow natur food market futur stevia group benefit remark sweeten potenti includ diabet patient interest decreas calor intak children stevia small perenni shrub centuri bio sweeten medicin lower blood sugar white crystallin compound steviosid natur herbal sweeten calori num time sweeter tabl sugar
MED-4869~evalu food addit pubm ncbi abstract report repres conclus joint fao who expert committe conven evalu safeti food addit includ flavour agent view recommend accept daili intak adi prepar specif ident puriti part report general discuss principl govern toxicolog evalu assess intak food addit flavour agent summari committee evalu technic toxicolog intak data food addit asparaginas aspergillus niger express niger calcium lignosulfon num ethyl lauroyl argin paprika extract phospholipas express pichia pastori phytosterol phytostanol ester polydimethylsiloxan steviol glycosid sulfit assess dietari exposur num group relat flavour agent aliphat branched chain satur unsatur alcohol aldehyd acid relat ester aliphat linear alpha beta unsatur aldehyd acid relat alcohol acet ester aliphat secondari alcohol keton relat ester alkoxy substitut allylbenzen present food essenti oil flavour agent ester aliphat acycl primari alcohol aliphat linear satur carboxyl acid furan substitut aliphat hydrocarbon alcohol aldehyd keton carboxyl acid relat ester sulfid disulfid ether miscellan nitrogen contain substanc monocycl bicycl secondari alcohol keton relat ester hydroxi alkoxy substitut benzyl deriv substanc structur relat menthol specif food addit revis canthaxanthin carob bean gum carob bean gum clarifi chlorophyllin copper complex sodium potassium salt fast green fcf guar gum guar gum clarifi iron oxid isomalt monomagnesium phosphat patent blue sunset yellow fcf trisodium diphosph re evalu flavour agent estim intak base anticip poundag data carri num isopropyl num trimethylbutyramid num l monomenthyl glutar num annex report tabl summar committee recommend intak toxicolog evalu food addit consid
MED-4870~detect anatoxin a human anim dietari supplement cyanobacteria pubm ncbi abstract anatoxin a potent neurotoxin produc speci cyanobacteria alkaloid fatal intox expos organ rais concern increas popular food supplement cyanobacteria market alleg health properti anim human consumpt supplement common genera spirulina arthrospira aphanizomenon consumpt repres potenti rout anatoxin a exposur case adequ qualiti control undertaken work dietari supplement cyanobacteria commerci supplier evalu presenc anatoxin a high perform liquid chromatographi fluoresc detect addit presenc previous derivat anatoxin a confirm gas chromatography mass spectrometri total num sampl analys studi result show sampl num anatoxin a concentr rang num num microg num qualiti control cyanobacteri food supplement requir avoid potenti health effect human anim
MED-4871~monosodium glutam allergi menac myth pubm ncbi abstract monosodium glutam msg salt form non essenti amino acid common food addit uniqu flavour enhanc qualiti descript monosodium glutam symptom complex origin num chines restaur syndrom number anecdot report small clinic studi variabl qualiti attribut varieti symptom dietari ingest msg descript msg induc asthma urticaria angio oedema rhiniti prompt suggest msg aetiolog patient present condit review prevent critic review literatur relat role msg so cal chines restaur syndrom elicit asthmat bronchospasm urticaria angio oedema rhiniti concern rais earli report decad research fail demonstr clear consist relationship msg ingest develop condit
MED-4872~safeti potenti interact vitamin vitamin consid drug pubm ncbi abstract object examin advers effect advers event potenti interact vitamin light current preval discuss vitamin consid over the count drug natur health products dietari supplement data sourc perform medline pubm search explor num onlin databas medlin drug digest natur medicin comprehens databas databas univers maryland examin refer list includ studi publish num octob num studi select data extract studi review emphasi random control clinic trial includ articl clinic import inform regard advers event interact data synthesi vitamin north american popul vitamin document advers effect toxic document interact drug vitamin biotin pantothen acid riboflavin thiamin vitamin num vitamin minor revers advers effect fat solubl vitamin advers event water solubl vitamin folic acid niacin signific toxic advers event conclus recommend vitamin folic acid niacin categor over the count medic label vitamin intend children vulner group includ inform toxic dose recommend upper intak limit concurr product vitamin exclud multivitamin supplement food fortific
MED-4873~hypervitaminosi induc intra hepat cholestasis  a rare case report pubm ncbi abstract over the count supplement commonplac today health conscious societi present unusu case intrahepat cholestasi caus vitamin intox patient consum herbalif shake multivitamin tablet brand num year calcul equat recommend daili vitamin consumpt derang liver function test consist cholestat process liver biopsi obtain reveal featur pathognomon vitamin toxic usual fibrosi supplement ceas jaundic alkalin phosphatas complet normal case highlight import health care provid document non prescrib dietari supplement etiolog cholestat liver diseas copyright num elsevi reserv
MED-4874~speci identif vitamin level lutjanid fish implic vitamin poison pubm ncbi abstract outbreak food poison ingest liver larg lutjanid fish investig studi symptom patient primarili includ headach nausea vomit fever vertigo visual disorient includ peel skin speci fish implic incid ete carbunculus famili lutjanida determin direct sequenc analysi pcr restrict fragment length polymorph analysi detect cytochrom gene subsequ specimen carbunculus bodi weight collect level vitamin muscl liver determin high perform liquid chromatographi averag level vitamin carbunculus muscl num num iu g liver num num iu g regress model carbunculus higher bodi weight liver weight higher level vitamin level liver
MED-4875~celiac diseas irrit bowel syndrom man land gluten sensit abstract repertoir gastrointestin gi symptom finit etiolog mechan symptom generat percept divers case unknown review examin clinic experiment evid explor putat relationship gluten sensit gs generat gi symptom explor hypothesi proport patient gs function bowel disord fbd like symptom propos model investig understand induct gi symptom dysfunct gluten fbd organ diseas hypothes absenc fulli develop celiac diseas gluten induc symptom similar fbd discuss hypothesi gs post infecti irrit bowel syndrom ib provid trigger explain part spectrum constitut ib advanc understand role mucos respons lumin factor fbds propos anim model gs human leukocyt antigen hla dq num mice investig mucos pathophysiolog occur onset full blown inflamm gs host understand gluten symptom sensit individu illumin interact host genotyp diet intestin microbiota generat common gi condit
MED-4876~cyanobacteri neurotoxin bmaa al alzheimer diseas pubm ncbi abstract object aim studi screen quantifi neurotox amino acid beta n methylamino l alanin bmaa cohort autopsi specimen alzheimer diseas ad amyotroph sclerosi al huntington diseas hd non neurolog control bmaa produc cyanobacteria found varieti freshwat marin terrestri habitat possibl geograph broad human exposur bmaa suggest discoveri bmaa brain tissu chamorro patient als parkinson dementia complex guam recent ad patient north america observ warrant independ studi bmaa exposur guam ecosystem method postmortem brain specimen neuropatholog confirm case num al num ad num hd patient num age match non neurolog control bmaa quantifi valid fluoresc hplc method previous detect bmaa patient guam tandem mass spectrometr ms analysi carri confirm identif bmaa neurolog specimen result detect quantifi bmaa neuroprotein postmortem brain tissu patient unit state die sporad ad al hd incident detect observ num region analyz control concentr bmaa report previous chamarro al parkinson dementia complex patient demonstr twofold rang diseas region brain area comparison presenc bmaa patient confirm tripl quadrupol liquid chromatography mass spectrometry mass spectrometri conclus occurr bmaa north american al ad patient suggest possibl gene environ interact bmaa trigger neurodegener vulner individu num author journal compil num blackwel munksgaard
MED-4877~increas telomeras activ comprehens lifestyl pilot studi pubm ncbi abstract background telomer protect dna protein complex end linear chromosom promot chromosom stabil telomer short human emerg prognost marker diseas risk progress prematur mortal type cancer includ breast prostat colorect bladder head neck lung renal cell telomer shorten counteract cellular enzym telomeras lifestyl factor promot cancer cardiovascular diseas advers affect telomeras function previous studi address improv nutrit lifestyl increas telomeras activ aim assess num month intens lifestyl increas telomeras activ peripher blood mononuclear cell pbmc method num men biopsy diagnos low risk prostat cancer make comprehens lifestyl primari endpoint telomeras enzymat activ viabl cell measur baselin num month num patient suffici pbmcs longitudin analysi studi regist clinicaltri gov websit number nct num find pbmc telomeras activ express natur logarithm increas num sd num num sd num num raw valu telomeras increas num sd num standard arbitrari unit num sd num standard arbitrari unit increas telomeras activ signific decreas low dens lipoprotein ldl cholesterol num num decreas psycholog distress num num interpret comprehens lifestyl signific increas telomeras activ telomer mainten capac human immune system cell find pilot natur studi report increas telomeras activ signific associ infer causat larger randomis control trial warrant confirm find studi
MED-4878~dietari pattern food group telomer length multi ethn studi atherosclerosi mesa abstract background telomer length reflect biolog age influenc environment factor includ affect inflammatori process object data num white black hispan adult multi ethn studi atherosclerosi studi cross sect associ telomer length dietari pattern food beverag marker inflamm design leukocyt telomer length measur quantit polymeras chain reaction length calcul amount telomer dna divid amount single copi control dna t s ratio intak grain fruit veget low fat dairi nut seed nonfri fish coffe refin grain fri food red meat process meat sugar sweeten soda comput respons num item food frequ questionnair complet baselin score num previous defin empir dietari pattern comput particip result adjust age demograph lifestyl factor intak food beverag process meat intak telomer length num serving d greater intak process meat t s ratio num smaller se num num num categor analysi show particip consum num serv process meat week num smaller t s ratio nonconsum food beverag num dietari pattern telomer length conclus process meat intak show expect invers associ telomer length diet featur show expect associ
MED-4879~estim age human base telomer shorten pubm ncbi abstract estim age dna base telomer shorten determin termin restrict fragment trf length telomer length southern blot analysi peripher human blood blood stain blood stain store room temperatur num month averag trf length show tendenc shorten age formula age estim base correl averag trf length age subject estim age calcul trf length wide depend environment genet factor long dna preserv method feasibl age subject give rough estim age subject forens sampl carri morpholog inform copyright num elsevi scienc ireland
MED-4880~effect very low carbohydr horsemeat beef bas diet restrict feed weight gain feed energi effici ser pubm ncbi abstract background aim benefici harm effect low carbohydr low carb high protein high fat diet atkin diet demonstr determin effect low carb diet restrict feed num ad libitum intak serum level cholesterol triacylglycerol glucos keton bodi insulin rat method experi num num group num adult rat assign high carb diet ain num ad libitum intak restrict feed low carb diet num horsemeat ad libitum intak restrict feed num num factori experi num num group num adult rat assign control ain num low carb diet num beef horsemeat result restrict feed low carb diet reduc num serum triacylglycerol compar ad libitum intak ain num diet experi num dietari effect serum total cholesterol high dens low dens lipid cholesterol inconsist restrict feed increas low dens lipoprotein cholesterol level serum keton bodi level increas low carb diet compar ain num experi num conclus restrict feed low carb diet benefici allevi cardiovascular diseas risk factor effect addit restrict feed pronounc copyright num karger ag basel
MED-4881~improv gell properti lizardfish minc influenc microbi transglutaminas fish fresh pubm ncbi abstract effect microbi transglutaminas mtgase level num num units g sampl properti gel lizardfish saurida undosquami minc set num degre num num degre num min prior heat num degre num min studi break forc deform gel increas increas mtgase amount ad num mtgase level gel prior set num degre num min show higher break forc compar subject prior set num degre num num sodium dodecyl sulfate polyacrylamid gel electrophoret studi reveal myosin heavi chain mhc underw polymer higher extent presenc mtgase set condit microstructur gel ad mtgase finer smaller void compar gel mtgase set temperatur affect properti gel ad mtgase gel properti minc obtain lizardfish store ice time num num mtgase level num units g determin irrespect mtgase addit break forc deform gel decreas storag time lizardfish increas num addit mtgase increas break forc deform result gel produc lizardfish ice storag time fresh mtgase addit direct impact gel properti lizardfish minc
MED-4882~comparison chicken bas formula soy bas formula infant cow milk allergi pubm ncbi abstract object determin chicken bas formula replac soy bas formula infant cow milk allergi subject method thirty eight infant cow milk allergi age num month age random receiv chicken bas formula soy bas formula num day result group soy bas formula num num infant evid intoler continu formula num num infant chicken bas formula group evid clinic intoler num infant fed chicken bas formula success number infant intoler chicken formula signific lower number fed soy bas formula num conclus chicken bas formula effect soy bas formula infant cow milk allergi
MED-4883~flatufonia  or music anus pubm ncbi abstract art music anus review light promin perform anorect physiolog aspect relat specif music perform
MED-4884~investig structur aspect tomato fruit quantit nuclear magnet reson imag pubm ncbi abstract studi magnet reson imag mri appli studi structur aspect tomato fruit main studi perform tomato cv tradiro num electromagnet scanner spin echo imag acquir visual tomato macrostructur air bubbl content tissu evalu exploit suscept effect multipl gradient echo imag microstructur studi measur spin spin num spin lattic num relax time distribut nuclear magnet reson relaxometri macro vision imag chemic analysi complementari independ experiment method order emphas mri result mri imag show air bubbl content vari tissu presenc gas attest macro vision imag quantit imag show num num map obtain mri reflect structur differ tomato tissu made distinguish result cell size chemic composit contribut relax mechan
MED-4885~flaxse supplement dietari fat restrict reduc prostat cancer prolifer rate men presurgeri abstract background prostat cancer affect one out of six men lifetim dietari factor postul influenc develop progress prostat cancer low fat diet flaxse supplement offer potenti protect strategi method undertook multi sit random control trial test effect low fat and or flaxseed suppl diet biolog prostat biomark prostat cancer patient num schedul num day prostatectomi random assign arm num control usual diet num flaxseed suppl diet num g day num low fat diet num total energi num flaxseed suppl low fat diet blood drawn baselin prior surgeri analyz prostat specif antigen psa sex hormon bind globulin testosteron insulin lik growth factor num bind protein num c reactiv protein total low densiti lipoprotein cholesterol tumor assess prolifer ki num primari endpoint apoptosi result men protocol averag num day prolifer rate signific lower num men assign flaxse arm median ki num posit cells tot nuclei ratio num num flaxseed suppl diet num flaxseed suppl low fat diet num control num low fat diet differ observ arm regard side effect apoptosi serolog endpoint men low fat diet experienc signific decreas serum cholesterol num conclus find suggest flaxse safe biolog alter protect prostat cancer data support low fat diet manag serum cholesterol
MED-4886~clinic event prostat cancer lifestyl trial result year follow up pubm ncbi abstract object previous research demonstr patient prostat cancer particip prostat cancer lifestyl trial reduct prostate specif antigen psa level inhibit lncap cell growth fewer prostat cancer rel clinic event end num year compar control aim studi examin clinic event trial num year period method prostat cancer lifestyl trial num year random control clinic trial num patient early stag prostat cancer gleason score num psa num ng ml undergo activ surveil patient experiment arm encourag adopt low fat plant bas diet exercis practic stress manag attend group support session control patient receiv usual care result num year follow up num num control patient num num experiment patient undergon convent prostat cancer treatment radic prostatectomi radiotherapi androgen depriv num differ found group clinic event cardiac death occur treat control patient treat experiment patient psa level num ng ml num treat control patient treat experiment patient psa veloc num ng ml i treatment signific differ found untreat experiment untreat control patient psa chang veloc end num year conclus patient early stag prostat cancer choos activ surveil avoid delay convent treatment num year make diet lifestyl
MED-4887~angina pectori atherosclerot risk factor multisit cardiac lifestyl intervent program pubm ncbi abstract cardiovascular symptom relief major indic revascular procedur examin effect intens lifestyl modif symptom relief investig angina pectori coronari risk factor qualiti life lifestyl behavior patient stabl coronari arteri diseas enrol multisit cardiac lifestyl intervent program ongo health insurance cov lifestyl intervent conduct num site unit state patient coronari arteri diseas nonsmok num men num women age num year make diet num calori fat plant base engag moder exercis num hours week practic stress manag num hour day baselin num patient num women report mild angina num patient num women report limit angina num week num patient angina free addit num move limit mild angina improv angina signific patient mild limit angina baselin gender num signific improv cardiac risk factor qualiti life lifestyl behavior observ patient angina angina free num week show greatest improv exercis capac depress health rel qualiti life num conclus observ improv angina patient make intens lifestyl drastic reduc revascular procedur
MED-4888~prostat gene express men undergo intens nutrit lifestyl intervent abstract epidemiolog prospect studi comprehens lifestyl modifi progress prostat cancer molecular mechan improv diet lifestyl affect prostat microenviron poor understood conduct pilot studi examin prostat gene express uniqu popul men low risk prostat cancer declin surgeri hormon therapi radiat particip intens nutrit lifestyl intervent undergo care surveil tumor progress consist previous studi signific improv weight abdomin obes blood pressur lipid profil observ num surveil low risk patient safe gene express profil obtain num particip pair rna sampl control prostat needl biopsi intervent rna patient num month postintervent biopsi quantit real tim pcr valid array observ select transcript two class pair analysi global gene express signific analysi microarray detect num up regul num down regul transcript intervent pathway analysi identifi signific modul biolog process critic role tumorigenesi includ protein metabol modif intracellular protein traffic protein phosphoryl num intens nutrit lifestyl modul gene express prostat understand prostat molecular respons comprehens lifestyl strengthen effort develop effect prevent treatment larger clinic trial warrant confirm result pilot studi
MED-4890~effect diet exercis intervent growth prostat epitheli cell pubm ncbi abstract epidemiolog studi suggest posit associ nutrient intak hyperinsulinemia risk benign prostat hyperplasi bph studi test hypothesi low fat high fib diet daili exercis lower serum insulin reduc growth serum stimul primari prostat epitheli cell cultur serum sampl obtain overweight men pritikin residenti num week diet exercis intervent men long term follow low fat high fib diet regular exercis lifestyl serum stimul primari prostat epitheli cell cultur growth measur num num apoptosi num num signific differ growth pre num week long term group num growth signific reduc num week num long term num group compar pre data num apoptosi signific group fast insulin reduc num num week group num long term group compar pre data testosteron unchang num week group result studi low fat high fib diet daili exercis lower insulin reduc growth prostat primari epitheli cell suggest lifestyl import factor develop progress bph futur prospect trial address effect lifestyl modif bph symptomatolog progress
MED-4891~epidemiolog sudden cardiac death clinic research implic abstract current annual incid sudden cardiac death rang num num year coincid decreas mortal coronari arteri diseas evid point signific decreas rate sudden cardiac death half twentieth centuri alarm rise preval obes diabet decad millennium worldwid favor trend persist wit resurg coronari arteri diseas heart failur result sudden cardiac death confront share indiscrimin worldwid public health problem increas recognit fact discoveri meaning relev risk stratif prevent methodolog requir care prospect community wid analys access larg archiv dna serum tissu link well phenotyp databas purpos review summar current knowledg sudden cardiac death epidemiolog discuss signific strength community wid evalu sudden cardiac death summar recent observ studi final highlight specif potenti predictor warrant evalu determin sudden cardiac death general popul
MED-4892~egg consumpt risk type num diabet men women abstract object limit inconsist find report relat dietari cholesterol egg consumpt fast glucos previous studi examin associ egg consumpt type num diabet project sought examin relat egg intak risk type num diabet larg prospect cohort research design method prospect studi data complet random trial num men physician health studi num num num women women health studi num num egg consumpt ascertain questionnair cox proport hazard model estim relat risk type num diabet result follow up num year men num year women num men num women develop type num diabet compar egg consumpt multivari adjust hazard ratio type num diabet num num ci num num num num num num num num num num num num num num consumpt num num num num num eggs week men trend num multivari hazard ratio women num num num num num num num num num num num num num num num trend num conclus data suggest high level egg consumpt daili increas risk type num diabet men women confirm find popul warrant
MED-4893~incid heart failur lower whole grain intak greater high fat dairi egg intak atherosclerosi risk communiti aric studi abstract background prospect studi evalu associ food intak risk heart failur hf divers popul object relationship incid hf death hospit intak food categori grain fruits veget fish nut high fat dairi egg red meat investig observ cohort num african american white adult age num num year sampl communiti method baselin num num exam num num dietari intak base respons num item food frequenc questionnair administ baselin intak base averag baselin exam num respons hazard ratio hr num ci hf calcul num daili serv differ food group intak result num year num hf hospit identifi multivari adjust energi intak demograph lifestyl factor preval cardiovascular diseas diabet hypertens hf risk lower greater whole grain intak num num num hf risk higher greater intak egg num num num high fat dairi num num num associ remain signific independ intak food categori hf conclus larg population bas sampl african american white adult whole grain intak lower hf risk intak egg high fat dairi greater hf risk adjust confound
MED-4894~vegan bone miner densiti bodi composit studi buddhist nun pubm ncbi abstract summari cross sect studi show vegan lower dietari calcium protein intak omnivor vegan advers effect bone miner densiti alter bodi composit introduct lifelong vegetarian diet negat effect bone health contenti issu undertook studi examin associ lifelong vegetarian diet bone miner densiti bodi composit group postmenopaus women method hundr mahayana buddhist nun num omnivor women averag age num rang num random sampl monasteri ho chi minh citi invit particip studi religi rule nun eat meat seafood vegan bone miner densiti bmd lumbar spine ls femor neck fn bodi wb measur dxa holog qdr num lean mass fat mass percent fat mass obtain dxa bodi scan dietari calcium protein intak estim valid food frequenc questionnair result signific differ vegan omnivor lsbmd num num num num g cm num sd num fnbmd num num num num g cm num num wbbmd num num num num g cm num num lean mass num num num num kg num fat mass num num num num kg num adjust age preval osteoporosi score num femor neck vegan omnivor num num num median intak dietari calcium lower vegan compar omnivor num num num num mg day num signific correl dietari calcium bmd analysi suggest bodi bmd lumbar spine femor neck bmd posit correl ratio anim protein veget protein conclus result suggest vegan lower intak dietari calcium protein omnivor vegan advers effect bone miner densiti alter bodi composit
MED-4896~acn vulgari diseas western civil pubm ncbi abstract background western societi acn vulgari univers skin diseas afflict num num adolesc popul men women older num year num num degre facial acn clinic facial acn persist middl age num women num men epidemiolog evid suggest acn incid rate lower nonwestern societi report preval acn num nonwestern popul kitavan island papua guinea ach hunter gather paraguay addit analyz element nonwestern environ influenc develop acn observ num kitavan subject examin includ num age num year case acn grade num multipl comedon grade num observ num ach subject examin includ num age num year num day case activ acn grade num observ conclus astonish differ acn incid rate nonwestern fulli modern societi sole attribut genet differ popul result differ environment factor identif factor treatment acn western popul
MED-4897~milk consumpt aggrav factor acn promot chronic diseas western societi pubm ncbi abstract consumpt cow milk cow milk protein result hormon axi insulin growth hormon insulin lik growth factor num igf num human milk consumpt rais igf num serum level perinat period adolesc adulthood puberti physiolog onset increas secret growth hormon igf num serum level increas enhanc milk consumpt igf num potent mitogen bind receptor tissu induc cell prolifer inhibit apoptosi keratinocyt sebocyt androgen synthes adren gonad stimul igf num epidem incid adolesc acn western milk consum societi explain increas insulin igf num stimul sebac gland mediat milk consumpt acn regard model chronic western diseas patholog increas igf num stimul organ thymus bone gland vascular smooth muscl cell neuron subject abnorm increas hormon stimul milk induc chang igf num axi contribut develop fetal macrosomia induct atopi acceler linear growth atherosclerosi carcinogenesi neurodegen diseas observ molecular biolog support epidemiolog data unmask milk consumpt promot chronic diseas western societi
MED-4898~anim food protein calcium prostat cancer risk european prospect investig cancer nutrit abstract examin consumpt anim food protein calcium relat risk prostat cancer num num men european prospect investig cancer nutrit associ examin cox regress stratifi recruit centr adjust height weight educ marit status energi intak averag num year follow up num incid case prostat cancer num localis num advanced stag diseas high intak dairi protein increas risk hazard ratio top versus bottom intak num num confid interv ci num num ptrend num calibr measur error estim num day num increas consumpt dairi protein increas risk prostat cancer num ci num num ptrend num calcium dairi product posit risk calcium food result support hypothesi high intak protein calcium dairi product increas risk prostat cancer
MED-4899~quantit measur endogen estrogen metabolit risk factor develop breast cancer commerci milk product lc ms ms pubm ncbi abstract increas level estrogen metabolit em cancer reproduct system potenti dietari sourc em milk studi absolut quantiti unconjug free unconjug conjug total em measur varieti commerci milk num skim buttermilk result show milk product test level em level unconjug em skim milk substanti lower observ milk num milk buttermilk milk lowest level em buttermilk highest anticip soy milk mammalian em measur method high level catechol estrogen detect milk product support theori milk consumpt sourc em ingest dietari influenc cancer risk
MED-4900~recent advanc berri supplement age rel cognit declin pubm ncbi abstract purpos review summar recent find current concept benefici effect berri consumpt brain function age recent find berryfruit supplement continu demonstr efficaci revers age rel cognit declin anim studi term mechan effect berri central nervous system recent studi demonstr bioavail berri polyphenol anim model studi reveal flavonoid polyphenol berri accumul brain long term consumpt final compel studi reveal berri influenc cell sign cascad vivo cell cultur system studi underscor develop theori berri antioxidant rich food act oxygen radic neutral age central nervous system summari antioxidant rich berri consum diet posit impact learn memori age anim effect cognit thought due direct interact berri polyphenol age neuron reduc impact stress rel cellular signal increas capac neuron maintain proper function age
MED-4901~antioxid status human consumpt blackberri rubus fruticosus juic defat milk pubm ncbi abstract present studi design evalu effect consumpt blackberri juic bj prepar water bjw defat milk bjm plasma antioxid capac enzymat nonenzymat antioxid signific num increas ascorb acid content plasma observ intak bjs observ plasma urat alpha tocopherol level increas plasma antioxid capac orac assay observ consumpt bjw statist signific plasma antioxid capac good posit correl ascorb acid num negat correl urat level num correl observ antioxid capac total cyanidin total ellag acid content observ plasma catalas increas intak bj s chang observ plasma erythrocyt cat glutathion peroxidas activ signific decreas num urinari antioxid capac num num intak bjs observ good correl observ total antioxid capac urat total cyanidin level result suggest associ anthocyanin level cat good correl antioxid capac ascorb acid human plasma intak bjs follow up studi investig antioxid properti health benefit demonstr health benefit polyphenol
MED-4902~addit milk prevent vascular protect effect tea pubm ncbi abstract aim experiment clinic studi tea exert protect cardiovascular diseas question debat addit milk modifi biolog activ tea studi vascular effect tea milk human elucid impact individu milk protein cell cultur experi isol rat aortic ring hplc analysi method result total num healthi femal volunt consum num ml fresh brew black tea black tea num skim milk boil water control flow medi dilat fmd measur high resolut vascular ultrasound num consumpt black tea signific improv fmd human compar water addit milk complet blunt effect tea support find similar experi perform isol rat aortic ring endotheli cell tea induc vasorelax rat aortic ring increas activ endotheli nitric oxid synthas phosphoryl enzym endotheli cell effect complet inhibit addit milk tea kind milk protein casein account inhibit effect milk format complex tea catechin conclus milk counteract favour health effect tea vascular function find awar interpret design studi compris nutrit flavonoid
MED-4903~antioxid activ blueberri fruit impair associ milk pubm ncbi abstract antioxid properti dietari phenol believ reduc vivo affin protein studi assess bioavail phenol vivo plasma antioxid capac consumpt blueberri vaccinium corymbosum milk crossov design num healthi human volunt consum num blueberri num ml water num blueberri num ml milk venous sampl collect baselin num num postconsumpt ingest blueberri increas plasma level reduc chain break potenti num num num num enhanc plasma concentr caffeic ferul acid blueberri milk ingest increas plasma antioxid capac reduct peak plasma concentr caffeic ferul acid num num num num absorpt auc caffeic acid num ingest blueberri associ milk impair vivo antioxid properti blueberri reduc absorpt caffeic acid
MED-4905~supplement black rice pigment fraction improv antioxid anti inflammatori status patient coronari heart diseas pubm ncbi abstract black rice pigment fraction shown anti atherogen activ anim model benefici effect recur human remain unknown aim present studi investig influenc black rice pigment fraction brf supplement select cardiovascular risk factor patient coronari heart diseas chd sixti patient chd age num year recruit affili hospit sun yat sen univers guangzhou china random divid group test group diet supplement num gram brf deriv black rice num month placebo group diet supplement num gram white rice pigment fraction wrf deriv white rice baselin plasma antioxid status level inflammatori biomark measur variabl similar group num month intervent compar wrf supplement brf supplement great enhanc plasma total antioxid capac tac num signific reduc plasma level solubl vascular cell adhes molecul num svcam num num solubl cd num ligand scd num num high sensit c reactiv protein hs crp num test group signific observ plasma total superoxid dismutas t sod activ lipid level carotid arteri intima media thick imt group result suggest brf exert cardioprotect effect patient chd improv plasma antioxid status inhibit inflammatori factor
MED-4906~antiallerg activ pigment rice bran extract cell assay pubm ncbi abstract panel chemic biochem cell assay determin inhibitori effect extract pigment black rice bran vitro allerg reaction ethanol wat num v v extract num pigment bran found effect extract nonpig rice cultivar suppress releas histamin beta hexosaminidas basophil rbl num cell stimul ionophor num immunoglobulin ige antigen complex suppress obtain num stimul rat periton mast cell extent inhibit num marker immun respons accompani influx calcium ion inhibit immun process pigment bran confirm observ modul proinflammatori cytokin gene express cytokin releas reduct tumor necrosi factor tnf alpha interleukin il num eta il num il num mrna express determin revers transcription polymeras chain reaction rt pcr reduct tnf alpha il num eta il num protein releas cultur cell line periton cell confirm enzyme link immunoadsorb assay rice bran lk num num num cultivar effect inhibitor assay rice varieti merit evalu part human diet ascertain potenti protect allerg diseas hay fever asthma
MED-4907~black rice anthocyanin inhibit cancer cell invas repress mmps u pa express pubm ncbi abstract tumor metastasi import cancer death treatment strategi target prevent occurr metastasi anthocyanin natur color belong flavonoid famili wild antioxid properti provid molecular evid anti metastat effect peonidin num glucosid cyanidin num glucosid major anthocyanin extract black rice oryza sativa indica show mark inhibit invas motil skhep num cell effect reduc express matrix metalloproteinas mmp num urokinase typ plasminogen activ u pa peonidin num glucosid cyanidin num glucosid exert inhibitori effect dna bind activ nuclear transloc ap num compound exert inhibitori effect cell invas cancer cell scc num huh num hela final anthocyanin sativa indica oa evidenc inhibit growth skhep num cell vivo
MED-4908~aluminium lead molecular mechan brain toxic pubm ncbi abstract fact aluminium al lead pb toxic metal live organ includ human discov long time ago al pb reach accumul organ human bodi central nervous system target deleteri effect metal select human popul risk al neurotox al propos involv etiolog neurodegen diseas pb widespread environment hazard neurotox effect pb major public health concern spite numer effort accumul evid area research mechan al pb neurotox complet elucid review address involv oxid stress membran biophys alter deregul cell signal impair neurotransmiss key aspect involv al pb neurotox
MED-4909~aluminum bioavail basic sodium aluminum phosphat approv food addit emulsifi agent incorpor chees abstract oral aluminum al bioavail drink water previous estim inform al bioavail food suggest oral al bioavail drink water greater food object test hypothesi oral al bioavail determin rat basic num l  sodium aluminum phosphat basic salp process chees consumpt num gm chees num num basic salp result oral al bioavail num num time maximum serum num concentr tmax num num al bioavail result intermedi previous report result drink water num acidic salp incorpor biscuit num method similar oral bioavail al food water contribut typic human daili al intak num num result suggest food contribut al system circul potenti al bodi burden drink water result support hypothesi drink water disproportion contribut total al absorb gastrointestin tract
MED-4911~environment public health risk arsenic anim feed pubm ncbi abstract arsenic exposur contribut signific burden prevent diseas worldwid specif relat increas risk cancer diabet cardiovascular diseas exposur natur contamin groundwat difficult mitig sourc drink water anthropogen sourc arsenic exposur stem widespread arsenic drug food anim product unit state china countri result residu contamin food product anim rais drug environment contamin dispos wast anim land dispos wast contamin surfac ground water convers anim wast fertil pellet home introduct anim wast inciner increas opportun exposur intent addit anim feed arsenic drug prevent sourc human exposur domest practic drug poultri product subject media attent limit research drug domest swine product rapid grow foreign anim product industri remain larg uncharacter continu expans arsenic drug increas burden global human arsenic exposur risk
MED-4912~inorgan arsenic rice bran product order magnitud higher bulk grain pubm ncbi abstract rice elev arsenic grain crop test date grain brown rice higher arsenic level polish white report rice bran commerci purchas specif mill studi level inorgan arsenic nonthreshold class num carcinogen reach concentr approxim num mg kg dri weight num fold higher concentr found bulk grain pure rice bran health food supplement concern rice bran solubl market superfood supplement malnourish children intern aid program rice bran solubl product test sourc unit state japan found num num mg kg inorgan arsenic manufactur recommend approxim num serv rice bran solubl day equat num num mg intak inorgan arsenic maximum concentr level mcls set arsenic speci food stuff eu water regul set num mg l total inorgan arsenic base assumpt num water day consum num mg arsenic day manufactur recommend rice bran solubl consumpt rate inorgan arsenic intak exceed num mg day rememb rice bran solubl target malnourish children actual risk base mg kg num day num intak
MED-4913~probabilist model exposur dose implic health risk character glycoalkaloid potato pubm ncbi abstract potato sourc glycoalkaloid gas repres primarili alpha solanin alpha chaconin num content gas tuber num mg kg maximum level exceed num mg kg gas hazard human health poison involv gastrointestin ailment neurolog symptom singl intak num mg kg consid critic effect dose ced probabilist model acut chronic usual exposur gas perform czech republ sweden netherland nation databas individu consumpt food data concentr gas tuber num czech swedish result process factor model result conclud potato european market lead acut intak num mg gas kg day upper tail intak distribut num popul countri num mg gas kg raw unpeel tuber ensur num popul exceed ced estim chronic usual intak particip countri num num num mg kg day num upper confid limit remain unclear incid gas poison underreport assumpt worst case extrem sensit person
MED-4914~potato glycoalkaloid true safeti fals sens secur pubm ncbi abstract major agricultur crop cultiv potato consum day million peopl divers cultur background product global import potato tuber toxic glycoalkaloid gas sporad outbreak poison human livestock death articl discuss aspect potato gas includ toxic effect risk factor method detect gas biotechnolog aspect potato breed attempt made answer question vital import potato gas danger human anim extent
MED-4915~human dietari risk assess glycoalkaloid respons potato colorado potato beetl defoli pubm ncbi abstract quantit human dietari risk assess conduct glycoalkaloid concentr measur tuber plant defoli colorado potato beetl undefoli control signific greater product glycoalkaloid defoli plant compar control plant skin tissu tuber dietari risk pose human subgroup consumpt potato estim num num num percentil nation consumpt valu exposur compar toxic threshold num mg kg bodi weight defoli colorado potato beetl increas dietari risk approxim num glycoalkaloid concentr tissu tuber includ undefoli control exceed toxic threshold human subgroup num percentil exposur num percentil
MED-4916~influenc storag household process agaritin content cultiv agaricus mushroom pubm ncbi abstract agaritin n gamma l glutamyl num hydroxymethyl phenylhydrazin identifi quantifi high pressur liquid chromatographi marker occurr phenylhydrazin deriv cultiv agaricus bitorqui garicus hortensi mushroom high level agaritin num mg kg num found fresh harvest bitorqui earli flush sampl supermarket agaritin content num sampl vari num num mg kg num averag num num mg kg num highest amount agaritin found skin cap gill lowest stem signific differ agaritin content mushroom speci studi pronounc reduct agaritin content observ storag mushroom refriger freezer dri mushroom degre reduct depend length condit storag region num reduct agaritin content observ freeze dri depend cook procedur household process cultiv agaricus mushroom reduc agaritin content degre boil extract num agaritin content cook broth num degrad num origin agaritin content mushroom prolong boil prepar sauc reduc content solid mushroom num left num dri bake cultiv mushroom process similar pizza bake reduc agaritin content approxim num fri oil butter deep fri result mark reduct num microwav process cultiv mushroom reduc agaritin content one third origin level exposur agaritin substanti consum process agaricus mushroom compar consum raw mushroom extent agaritin phenylhydrazin deriv occur cultiv mushroom degrad biolog activ compound cook procedur
MED-4917~soy consumpt reduct menopaus symptom pubm ncbi abstract aim review current research effect soy consumpt menopaus symptom method review result recent meta analys individu clinic trial main result recent meta analysi report isoflavon supplement num reduct hot flash increas efficaci baselin number flash isoflavon dose increas review conclud consumpt num mg genistein total isoflavon respons reduct symptom result review support subsequ random control trial conclus consumpt num mg day soy isoflavon num mg genistein reduc hot flash num total reduct includ provid placebo effect greatest benefit realiz isoflavone rich food supplement divid dose subject experi hot flashes day
MED-4918~increas preval mortal undiagnos celiac diseas abstract background aim histor preval long term outcom undiagnos celiac diseas cd unknown investig long term outcom undiagnos cd preval undiagnos cd chang past num year method studi includ num healthi young adult warren air forc base sera collect num num num sex match subject num recent cohort olmst counti minnesota similar year birth num age sampl num air forc cohort sera test tissu transglutaminas abnorm endomysi antibodi surviv measur follow up period num year air forc cohort preval undiagnos cd air forc cohort recent cohort compar result num person air forc cohort num num undiagnos cd cohort num year follow up all caus mortal greater person undiagnos cd seroneg hazard ratio num num ci num num num undiagnos cd found num num person similar age sampl num num person similar year birth rate undiagnos cd num fold num fold greater recent cohort air forc cohort num conclus num year follow up undiagnos cd num fold increas risk death preval undiagnos cd increas dramat unit state past num year
MED-4919~long term health quality of lif consequ mass screen childhood celiac diseas num year follow up studi pubm ncbi abstract object mass screen celiac diseas controversi object studi determin detect childhood celiac diseas mass screen improv long term health status health rel qualiti life method conduct prospect num year follow up studi num children age num num year celiac diseas identifi mass screen gluten fre diet num normal gluten contain diet num follow up includ assess general health status celiac disease associ symptom celiac disease associ serum antibodi health rel qualiti life result ten year mass screen num children adher gluten fre diet health status improv num treat children num earli treatment num prevent gluten depend symptom develop diagnosi num children treatment screen improv health status symptom screen remain symptom fre consum gluten health rel qualiti life children symptom improv signific num year gluten fre diet ten year screen health rel qualiti life children celiac diseas similar refer popul conclus identif mass screen led num year health improv num children deterior generic health rel qualiti life good complianc mass screen research set delay treatment children symptom option posit screen test long term follow up studi assess long term complic untreat nonsymptomat celiac diseas
MED-4920~preval celiac diseas at risk not at risk group unit state larg multicent studi pubm ncbi abstract background celiac diseas cd immune medi enteropath condit trigger genet suscept individu ingest gluten common europ cd thought rare unit state larg epidemiolog studi preval aim studi determin preval cd at risk not at risk group unit state method serum antigliadin antibodi anti endomysi antibodi ema measur ema posit subject human tissu transglutaminas iga antibodi cd associ human leukocyt antigen dq num dq num haplotyp determin intestin biopsi recommend perform ema posit subject total num subject screen num first degre num second degre relat patient biopsy proven cd num symptomat patient gastrointestin symptom disord cd num not at risk individu result at risk group preval cd num first degre relat num second degre relat num symptomat patient preval cd not at risk group num ema posit subject underw intestin biopsi lesion consist cd conclus result suggest cd occur frequent patient gastrointestin symptom second degre relat patient numer common disord absenc gastrointestin symptom preval cd symptomat patient not at risk subject similar report europ celiac diseas common neglect disord general recogn unit state
MED-4921~diagnos mild enteropathi celiac diseas random control clinic studi pubm ncbi abstract background aim diagnost criteria celiac diseas requir small bowel mucos villous atrophi crypt hyperplasia marsh iii mucos damag develop gradual patient evinc clinic symptom histolog endomysi antibodi specif predict forthcom villous atrophi hypothes patient mild enteropathi posit endomysi antibodi benefit gluten fre diet gfd similar patient sever enteropathi method small bowel endoscopi clinic evalu perform num consecut adult posit endomysi antibodi num mild enteropathi marsh i ii random continu gluten contain diet start gfd num year clinic serolog histolog evalu repeat total num particip small bowel mucos lesion compat celiac diseas marsh iii serv diseas control result gluten contain diet group marsh i ii small bowel mucos villous architectur deterior particip symptom abnorm antibodi titer persist contrast gfd group marsh i ii symptom allevi antibodi titer decreas mucos inflamm diminish equal celiac control marsh iii trial complet particip chose continu life long gfd conclus patient endomysi antibodi benefit gfd degre enteropathi diagnost criteria celiac diseas re evalu endomysi antibodi posit atrophi belong spectrum genet gluten intoler warrant dietari treatment
MED-4922~glyconutri sham pubm ncbi abstract disciplin glycobiolog contribut understand human health diseas research publish peer review scientif journal recent legitim discoveri glycobiolog market tool sell plant extract term glyconutri glyconutri industri worldwid sale forc half million peopl sell half billion dollar usd product annual address relationship glyconutri glycobiolog glyconutri claim impact public disciplin
MED-4924~long term caroten retinol lycopen lutein supplement lung cancer risk result vitamin lifestyl vital studi abstract high dos caroten supplement high risk person link increas lung cancer risk clinic trial effect similar general popul unclear author examin associ supplement caroten retinol vitamin lutein lycopen lung cancer risk particip age num num year vitamin lifestyl vital cohort studi washington state num num elig person num complet num page baselin questionnair includ detail question supplement durat frequenc dose previous num year multivitamin individu supplements mixtur incid lung cancer num decemb num identifi linkag surveil epidemiolog end result cancer registri longer durat individu caroten retinol lutein supplement total num year averag dose statist signific elev risk total lung cancer histolog cell type hazard ratio num num confid interv num num individu supplement lutein total lung cancer hazard ratio num num confid interv num num individu caroten small cel lung cancer num year versus evid effect modif gender smoke status long term individu caroten retinol lutein supplement recommend lung cancer prevent smoker
MED-4925~multivitamin risk cancer cardiovascular diseas women health initi cohort abstract context million postmenopaus women multivitamin believ supplement prevent chronic diseas cancer cardiovascular diseas object examin associ multivitamin risk cancer cardiovascular diseas mortal postmenopaus women design set particip num particip women health initi clinic trial num overlap trial hormon therapi dietari modif calcium vitamin observ studi num detail data collect multivitamin baselin follow up time point studi enrol occur num num women median num year clinic trial num year observ studi diseas endpoint collect num outcom measur cancer breast invas colon rectum endometrium kidney bladder stomach ovari lung cardiovascular diseas myocardi infarct stroke venous thrombosi total mortal result num particip multivitamin median num year follow up ct num year os num case breast colorect endometrium kidney bladder stomach lung ovari cancer num cvd event num death report multivariate adjust analys reveal associ multivitamin risk cancer breast hr num num ci num num colorect hr num num ci num num endometri hr num num ci num num lung hr num num ci num num ovari hr num num ci num num cvd mi hr num num ci num num stroke hr num num ci num num vt hr num num ci num num mortal hr num num ci num num conclus median follow up num num year ct os whi cohort provid convinc evid multivitamin influenc risk common cancer cardiovascular diseas total mortal postmenopaus women clinic trial registr clinicaltri gov identifi nct num
MED-4926~role iron neurotox concern elder pubm ncbi abstract purpos review explor role iron physiolog brain healthi adult review increas brain iron deposit common neurodegen diseas affect elder recent find iron play role oxygen transport myelin synthesi neurotransmitt product electron transfer serv crucial cofactor normal central nervous metabol increas level brain iron promot neurotox due free radic format lipid peroxid ultim cellular death advanc neuroimag techniqu patholog studi demonstr increas brain iron age increas iron deposit observ patient constel neurolog diseas includ alzheimer diseas parkinson diseas stroke summari patholog neurolog imag coupl experiment increas understand link iron neurodegener potenti implic disease modifi therapi aim remov excess iron day part armamentarium employ clinician decreas burden neurodegen diseas elder
MED-4928~vitamin beta caroten supplement cancer risk random control trial abstract background observ studi suggest diet high fruit veget rich antioxid prevent cancer develop find random trial associ antioxid cancer risk negat method num women random assign women antioxid cardiovascular studi double blind placebo control num num num factori trial vitamin num mg ascorb acid daili natural sourc vitamin num iu tocopherol day beta caroten num mg day num women free cancer random assign select studi diagnos death cancer specif site confirm hospit report nation death index cox proport hazard regress model assess hazard ratio repres relat risk rrs common cancer antioxid individu combin subgroup analys conduct determin durat modifi associ supplement cancer risk statist test two sid result averag num year treatment num women develop incid invas cancer num women die cancer statist signific effect antioxid total cancer incid compar placebo group rrs num num confid interv ci num num vitamin group num num ci num num vitamin group num num ci num num beta caroten group similar effect antioxid observ cancer mortal compar placebo group rrs num num ci num num vitamin group num num ci num num vitamin group num num ci num num beta caroten group durat combin antioxid effect cancer incid cancer death conclus supplement vitamin vitamin beta caroten offer benefit primari prevent total cancer incid cancer mortal
MED-4929~vitamin prevent cardiovascular diseas men physician health studi ii random trial abstract context basic observ studi suggest vitamin reduc risk cardiovascular diseas cvd long term trial evalu men initi low risk cvd previous trial men examin vitamin prevent cvd object test long term vitamin supplement decreas risk major cardiovascular event men design set particip physician health studi ii phs ii random double blind placebo control factori trial vitamin began num continu schedul complet august num enrol num male physician initi age num year includ num num men preval cvd random intervent individu supplement num iu vitamin day num mg vitamin daili main outcom measur composit endpoint major cardiovascular event nonfat myocardi infarct mi nonfat stroke cvd death result follow up num year num confirm major cardiovascular event compar placebo vitamin effect incid major cardiovascular event activ placebo vitamin group num event num person year hazard ratio hr num num confid interv ci num num num total mi hr num num ci num num num total stroke hr num num ci num num num cardiovascular mortal hr num num ci num num num signific effect vitamin major cardiovascular event activ placebo vitamin group num num event num person year hr num num ci num num num total mi hr num num ci num num num total stroke hr num num ci num num num cardiovascular mortal hr num num ci num num num vitamin hr num num ci num num num vitamin hr num num ci num num num signific effect total mortal vitamin increas risk hemorrhag stroke hr num num ci num num num conclus larg long term trial male physician vitamin supplement reduc risk major cardiovascular event data provid support supplement prevent cvd middle ag older men
MED-4930~potenti liver damag over the count vitamin supplement pubm ncbi abstract grow popular avail over the count otc health product includ vitamin rais concern vitamin toxic report case cirrhosi patient habitu daili ingest otc dietari supplement num microg vitamin mark clinic improv discontinu case highlight potenti liver damag long term intak otc vitamin supplement medic supervis product
MED-4932~aquacultur practic potenti human health risk current knowledg futur prioriti pubm ncbi abstract annual global aquacultur product tripl past num year num aquacultur predict account num total global seafood product weight lack adequ nutrit lead contributor global burden diseas increas food product aquacultur sign product surg aquacultur facil increas reli heavi input formul feed antibiot antifung agrochem review summar current knowledg major chemic biolog emerg agent employ modern aquacultur facil potenti impact public health find review current aquacultur practic lead elev level antibiot residu antibiotic resist bacteria persist organ pollut metal parasit virus aquacultur finfish shellfish specif popul risk exposur contamin includ individu work aquacultur facil popul live facil consum aquacultur food product addit research fulli understand human health risk aquacultur fish versus wild caught fish develop intervent reduc prevent risk order adequ understand address prevent impact local nation global scale research polici maker govern aquacultur industri collabor cooper exchang critic inform develop target polici practic effect enforc
MED-4933~polybromin diphenyl ether pbdes farm wild salmon market northeastern unit state pubm ncbi abstract recent report analysi polychlorin biphenyl pcbs chlorin pesticid farm atlant salmon salmo salar main eastern canada norway wild alaskan chinook salmon oncorhynchus tshawytscha paper extend analysi polybromin diphenyl ether pbdes sampl total pbde concentr farm salmon num num ng g wet weight ww signific wild alaskan chinook sampl num num ng g ww signific differ found region signific intra region variat concentr total pbdes tetra bd num observ salmon canadian farm num congen profil domin bde num penta bd num num pbde concentr canadian sampl lower report year earlier remov skin result reduct pbde concentr farm salmon case pbde concentr higher skin off sampl pbdes correl lipid skin sampl suggest greater accumul retent pbdes muscl lipid skin associ fat skin on sampl modest correl observ concentr pbdes pcbs num num mono ortho pcbs num num pbdes correl non ortho pcbs
MED-4934~atmospher deposit pbdes pesticid pcbs pah western nation park fish concentr consumpt guidelin abstract concentr polybromin diphenyl ether pbdes pesticid polychlorin biphenyl pcbs polycycl aromat hydrocarbon measur num fish num remot lake num western nation parks preserv num num compar human wildlif contamin health threshold sensit median detect limit num pg g wet weight effici num recoveri num ng g reproduc num rsd accur num deviat srm analyt method develop valid analys concentr pcbs hexachlorobenzen hexachlorocyclohexan ddts chlordan western fish compar lower mountain fish recent collect europ canada asia dieldrin pbde concentr higher recent measur mountain fish pacif ocean salmon concentr contamin western fish num num order magnitud calcul recreat fish contamin health threshold contamin concentr exceed subsist fish cancer screen valu num num lake averag contamin concentr fish exceed wildlif contamin health threshold piscivor mammal num lake piscivor bird num lake result atmospher deposit organ contamin accumul high elev fish reach concentr relev human wildlif health
MED-4935~polychlorin naphthalen human adipos tissu york usa pubm ncbi abstract polychlorin naphthalen pcns persist bioaccumul toxic contamin prior studi occurr pcns human adipos tissu usa analyz measur concentr pcns human adipos tissu sampl collect york citi num concentr pcns rang num pg g lipid wt male num pg g lipid wt femal pcn congen num num num num num num num num num num num num num predomin collect account num total pcn concentr concentr pcns human adipos tissu num order magnitud lower previous report concentr polychlorin biphenyl pcbs polybromin diphenyl ether pbdes concentr pcns correl pcb concentr contribut pcns dioxin lik toxic equival teq human adipos tissu estim num polychlorin dibenzo p dioxin dibenzofuran pcdd f teq
MED-4936~algal oil capsul cook salmon nutrit equival sourc docosahexaeno acid pubm ncbi abstract food nutrit profession question supplement sourc nutrient equival deriv natur food sourc compar nutrit avail docosahexaeno acid dha algal oil capsul assay cook salmon num healthi men women age num num year random open label parallel group studi num week studi compar num mg dha day algal oil capsul assay portion cook salmon chang baselin plasma phospholipid erythrocyt dha level analyz dha level compar student test post hoc analys determin bioequival least squar ratio percent chang baselin plasma phospholipid erythrocyt dha level compar dha level increas approxim num plasma phospholipid approxim num erythrocyt group dha level plasma phospholipid erythrocyt similar group measur deliveri dha plasma erythrocyt fish algal oil capsul equival regimen general well toler result algal oil dha capsul cook salmon bioequival provid dha plasma red blood cell algal oil dha capsul repres safe conveni sourc non fish deriv dha
MED-4937~level polybromin diphenyl ether pbdes organochlorin pollut speci antarct fish chionodraco hamatus trematomus pubm ncbi abstract late num scientif studi contamin antarctica demonstr presenc pollut antarct ecosystem persist organ pollut pop transport global area produc releas environ remot area includ antarctica report result obtain accumul polybromin diphenyl ether pbdes mono non ortho polychlorobiphenyl pcbs polychlorodibenzodioxin pcdds polychlorodibenzofuran pcdfs tissu speci antarct fish chionodraco hamatus trematomus bernacchii num num tcdd toxic equival teq calcul evalu potenti risk compound speci general pop level higher tissu bernacchii hamatus highest concentr found liver speci pbde level vari num pg num wet wt hamatus muscl num pg num wet wt bernacchii liver lower level pcbs pcbs main organochlorin compound detect concentr rang num ng num wet wt hamatus muscl num ng num wet wt bernacchii liver teq concentr result higher hamatus bernacchii due pcdds presenc pbdes organochlorin pollut tissu antarct organ confirm global transport distribut
MED-4938~pcbs enhanc collagen express human periton fibroblast abstract object test effect polychlorin biphenyl congen pcb num pcb num pcb num pcb num express adhes marker tgf num vegf type collagen normal human periton adhes fibroblast design cell cultur studi set univers research laboratori patient primari cultur normal periton adhes fibroblast establish patient intervent fibroblast treat pcb num pcb num pcb num pcb num ppm num hour total rna extract treatment subject real tim rt pcr main outcom measur mrna level type collagen vegf tgf num result normal human periton fibroblast express type collagen vegf tgf num exposur normal human fibroblast pcb num pcb num pcb num pcb num affect mrna level actin hous gene normal rna level real tim rt pcr affect cell viabil assess trypan blue exclus pcb treatment compar control result signific chang tgf num vegf mrna level normal periton adhes fibroblast mark contrast type collagen mrna level mark increas respons num hrs exposur pcb treatment num cell type conclus find pcb num pcb num pcb num pcb num increas express type collagen human normal periton adhes fibroblast demonstr involv organochlorin pathogenesi tissu fibrosi implic organochlorin exposur etiolog factor wide varieti previous unlink human ailment character fibrosi
MED-4939~dieldrin induc neurotox relev parkinson diseas pathogenesi pubm ncbi abstract parkinson diseas pd increas recogn neurodegen disord strong environment chemic exposur recent epidemiolog data demonstr environment risk factor play domin role compar genet factor etiopathogenesi idiopath parkinson diseas identif key genet defect alpha synuclein parkin mutat pd underscor import role genet factor diseas understand interplay gene environ pd critic unlock mysteri num year old neurodegen diseas pesticid metal common class environment chemic promot dopaminerg degener organochlorin pesticid dieldrin found human pd postmortem brain tissu suggest pesticid potenti promot nigral cell death dieldrin ban human continu expos pesticid contamin dairi product meat due persist accumul pesticid environ review summar neurotox studi conduct cell cultur anim model dieldrin exposur discuss relev key patholog mechan nigral dopaminerg degener includ oxid stress mitochondri dysfunct protein aggreg apoptosi
MED-4940~num num tetrachlorodibenzo p dioxin matern breast milk newborn head circumfer pubm ncbi abstract dioxin affect infant growth neurodevelop human anim studi examin relationship neonat head circumfer relat fetal brain develop concentr dioxin breast milk indic matern exposur total num milk sampl obtain eighth postpartum day mother japan expos dioxin environ level dioxin num furan isom measur milk sampl hr gc ms system relationship concentr dioxin isom newborn size includ head circumfer investig adjust confound factor concentr num num tetrachlorodibenzo p dioxin tcdd toxic dioxin isom negat correl newborn head circumfer adjust gestat age infant sex pariti confound factor signific relationship concentr dioxin furan isom matern breast milk infant height weight chest circumfer birth fact suggest fetal brain develop influenc matern exposur tcdd environ
MED-4941~dioxin promot inflammation rel develop endometriosi abstract laboratori population bas studi suggest exposur environment toxic trigger develop endometriosi discuss evid modul endometri endocrine immun interfac mechanist link toxic exposur develop diseas capsul summari environment toxic exposur induc inflammatory lik endometri respons promot develop endometriosi
MED-4942~associ polychlorin biphenyl hypertens num nation health nutrit examin survey pubm ncbi abstract associ num polychlorin biphenyl pcbs hypertens investig nation health nutrit examin survey nhane num unweight number particip assess hypertens rang num num depend chemic analyz unadjust logist regress num pcbs hypertens adjust age gender race smoke status bodi mass index exercis total cholesterol famili histori coronari heart diseas num pcbs pcbs num num num num num signific hypertens strongest adjust associ hypertens found dioxin lik pcbs num num pcb num num pg g lipid adjust odd ratio num num ci num num compar pcb num num pg g lipid adjust pcb num num ng g lipid adjust odd ratio num num ci num num compar pcb num num ng g lipid adjust particip elev pcbs odd ratio num num ci num num compar pcbs elev adjust logist regress preval elev pcbs num num million num million person num year non institution popul hypothes associ pcbs hypertens elev pcbs risk factor hypertens clinician result studi limit laboratori method made wide test patient
MED-4943~persist organ pollut fish oil supplement canadian market polychlorin biphenyl organochlorin insecticid pubm ncbi abstract fish seal oil dietari supplement market rich omega num fatti acid frequent consum canadian sampl supplement num collect vancouv canada num num oil supplement analyz polychlorin biphenyl pcbs organochlorin insecticid oc sampl found detect residu highest sigmapcb sigmaddt num num trichloro di num chlorophenyl ethan concentr num ng g num ng g found shark oil sampl lowest level found supplement prepar mix fish oil anchovi mackerel sardin num ng sigmapcb g num ng sigmaddt g sigmapcb concentr oil supplement num num num num num num num ng g unidentifi fish mix fish salmon mix fish salmon salmon veget mix fish shark menhaden num seal num maximum concentr oc general observ seal oil hexachlorin pcb congen domin contributor sigmapcb level sigmaddt greatest contributor organochlorin level intak estim made maximum dosag manufactur label result vari wide due larg differ residu concentr obtain averag sigmapcb sigmaddt intak calcul num num ng d num num ng d
MED-4944~studi fish consumpt sourc methylmercuri fish meal f farm fish anim food pubm ncbi abstract co occurr fish mehg omega num fatti acid wild speci optim choos speci farm finfish shellfish fed fish meal bioconcentr mehg muscl organohalogen pollut pass fat compon dorea num fish meal anim feed human exposur persist bioaccumul toxic substanc food prot num num fish meal feed farm anim offer worst world satur fat organohalogen pollut mehg time address dietari sourc hg deriv anim rais fish meal contribut increas tissu hg concentr
MED-4946~sub clin neurobehavior abnorm low level mercuri exposur fish consumpt pubm ncbi abstract order assess earli neurotox effect low level mercuri absorb fish eat group num adult male subject habitu consum tuna fish num control examin cross sect field studi assess includ neurobehavior test vigil psychomotor function hand tremor measur serum prolactin assess mercuri urin u hg serum prolactin sprl measur expos subject control measur organ compon mercuri blood o hg num expos control u hg signific higher expos subject median num microg g creatinin rang num num control median num microg g creatinin rang num num median valu o hg num microg l tuna fish eater num microg l control group u hg o hg signific correl quantiti fish consum week signific differ sprl found expos num ng ml control num ng ml individu sprl signific correl u hg o hg level neurobehavior perform subject consum tuna fish regular signific wors color word reaction time digit symbol reaction time finger tap speed ft educ level covari multipl stepwis regress analysi o hg concentr signific individu perform test account num varianc test score
MED-4947~hong kong male subfertil link mercuri human hair fish pubm ncbi abstract focus present studi relationship hong kong male subfertil fish consumpt mercuri concentr found hair num hong kong male age num age num year posit correl age signific higher hong kong subject european finnish subject num num ppm mercuri hair num subfertil hong kong male num ppm num signific higher mercuri level found hair collect num fertil hong kong male num ppm subfertil male approx num mercuri hair fertil male similar age num femal subject signific lower level hair mercuri male similar age group male mercuri level num higher femal hair sampl collect num vegetarian live hong kong vegan consum fish shellfish meat num year low level mercuri hair mercuri concentr num ppm
MED-4948~mercuri level fish consumpt practic women child bear age florida panhandl pubm ncbi abstract southeastern unit state coastal area gulf mexico gulf coast florida experi highest level mercuri deposit countri state florida coastal border longest unit state state issu fish consumpt advisori due mercuri multipl fish speci data systemat collect assess mercuri level human popul state assess efficaci consumpt advisori general high rate seafood consumpt coastal popul human popul florida panhandl pensacola fl potenti expos elev level mercuri present studi analyz hair mercuri level women child bear age num year resid pensacola fl num year survey fish consumpt practic cohort evalu awar florida fish consumpt advisori hair mercuri level signific higher women consum fish num day prior sampl num women unawar consumpt advisori num num women report knowledg consumpt advisori pregnant women exhibit lower awar advisori non pregn women data suggest public health intervent educ fish advisori reach major women counti surround pensacola risk consumpt fish high level mercuri
MED-4949~public health econom consequ methyl mercuri toxic develop brain abstract methyl mercuri development neurotoxic exposur result princip consumpt pregnant women seafood contamin mercuri anthropogen num natur num sourc num environment protect agenc epa made steadi progress reduc mercuri emiss anthropogen sourc power plant account num anthropogen emiss epa recent propos slow progress cite high cost pollut abat put perspect cost control emiss american power plant estim econom cost methyl mercuri toxic attribut mercuri plant environment attribut fraction model limit analysi neurodevelopment impact specif loss intellig nation blood mercuri preval data center diseas control prevent found num num children year cord blood mercuri level num g l level loss iq result loss intellig diminish econom product persist entir lifetim children lost product major cost methyl mercuri toxic amount num billion annual rang num num billion cost num total num billion rang num num billion year attribut mercuri emiss american power plant signific toll threaten econom health secur unit state consid debat mercuri pollut control
MED-4950~pubert time controversi usa review causat factor advanc time onset puberti pubm ncbi abstract previous standard diagnosi precoci puberti girl longer usa signific number girl paediatrician offic breast bud num year age time menarch chang past decad earli matur girl obes adolesc adulthood normal late matur girl earli matur white girl heavier onset puberti case african american girl boy race boy girl prematur pubarch hyperinsulinaem normal children girl prematur pubarch develop function ovarian adren hyperandrogen earli menarch preced prepubert hyperinsulinaemia propos pubert onset necessarili tempo puberti influenc hyperinsulinaemia insulin resist hypothesi correct insulin resist preval children previous recogn advanc time onset puberti note countri phenomenon preval countri adopt american lifestyl diet
MED-4951~role environment estrogen deterior male factor fertil pubm ncbi abstract object evalu role environment estrogen polychlorin biphenyl pcbs phthalat ester pes potenti environment hazard deterior semen paramet infertil men obvious etiolog design random control studi set tertiari care referr infertil clinic academ research center patient twenty on infertil men sperm count num million ml and or rapid progress motil num and or num normal form evid obvious etiolog num control men normal semen analys evid concept semen blood sampl obtain part treatment protocol main outcom measur evalu semen paramet ejacul volum sperm count motil morpholog vital osmoregulatori capac sperm chromatin stabil sperm nuclear dna integr result pcbs detect semin plasma infertil men control concentr pes signific higher infertil men compar control ejacul volum sperm count progress motil normal morpholog fertil capac signific lower infertil men compar control highest averag pcb pe concentr found urban fish eater rural fish eater urban vegetarian rural vegetarian total motil sperm count infertil men invers proport xenoestrogen concentr signific lower respect control conclus pcbs pes instrument deterior semen qualiti infertil men obvious etiolog
MED-4952~zinc selenium nutrit status vegetarian pubm ncbi abstract vegetarian diet benefici effect human health well balanc defici nutrient miner aim present studi assess nutrit status zinc selenium vegetarian citi paulo cross sect studi perform inclus criteria age num year gender food pharmaceut supplement thirti vegetarian gender age num year num year vegetarian perform studi bmi num zinc plasma concentr num num microg dl men women erythrocyt concentr num microg ghb gender selenium concentr num num microg l plasma num num microg l erythrocyt men women biochem valu show refer selenium blood level adequ zinc concentr erythrocyt defici studi popul reason vegetarian constant assess receiv nutrit support reduc effect inadequ zinc status
MED-4953~protein intak ovulatori infertil abstract object evalu intak protein anim veget origin ovulatori infertil studi design num marri women histori infertil attempt pregnanc pregnant year period dietari assess relat incid ovulatori infertil result follow up num women report ovulatori infertil multivariate adjust relat risk rr num ci trend ovulatori infertil compar highest lowest quintil anim protein intak num num num num rr num ci trend veget protein intak num num num num consum num total energi intak veget protein anim protein num lower risk ovulatori infertil num conclus replac anim sourc protein veget sourc protein reduc ovulatori infertil risk
MED-4954~semen qualiti fertil male relat mother beef consumpt pregnanc pubm ncbi abstract background long term risk anabol steroid xenobiot beef examin men semen qualiti relat mother self report beef consumpt pregnanc method studi carri citi num num regress analys examin semen paramet num partner pregnant women relat amount beef mother report eat pregnant mother beef consumpt analys relat son histori previous subfertil result sperm concentr invers relat mother beef meal week num son high beef consum num beef meals week sperm concentr num lower num proport men sperm concentr num num ml time higher num versus num num men mother ate beef histori previous subfertil frequent son high beef consum num sperm concentr signific relat mother consumpt meat man consumpt meat conclus data suggest matern beef consumpt possibl xenobiot beef alter man testicular develop utero advers affect reproduct capac
MED-4955~toxoplasma schizophrenia pubm ncbi abstract research infecti agent schizophrenia promin past decad toxoplasma gondii emerg prime candid varieti reason studi report individu schizophrenia compar control higher preval antibodi gondii ii individu adult toxoplasmosi develop psychot symptom similar schizophrenia iii epidemiolog similar toxoplasmosi schizophrenia iv antipsychot drug effect schizophrenia inhibit parasit includ gondii toxoplasma shown induc elev level dopamin experiment infect anim elev dopamin common individu schizophrenia vi studi shown individu schizophrenia compar control greater exposur cat childhood number question remain role toxoplasma aetiolog schizophrenia includ role strain variat time sourc infect role host gene determin diseas suscept establish firm associ toxoplasma aetiolog schizophrenia relat disord repres major breakthrough understand disord lead method treatment prevent
MED-4956~high preval abund atyp genotyp toxoplasma gondii isol lamb destin human consumpt usa pubm ncbi abstract inform presenc viabl toxoplasma gondii tissu lamb worldwid preval gondii determin num lamb num year maryland virginia west virginia usa heart num lamb obtain slaughter hous day kill blood remov heart test antibodi gondii modifi agglutin test mat sera screen num num num num dilut heart select bioassay gondii antibodi mat num higher gondii found num num num lamb heart num seroposit lamb isol viabl gondii bioassay cat mice bioassay cat entir myocardium num chop fed cat cat heart faec recipi cat examin shed gondii oocyst bioassay mice num myocardium digest acid pepsin solut digest inocul mice recipi mice examin gondii infect total num isol gondii obtain num seroposit lamb genotyp num gondii isol num pcr restrict fragment length polymorph marker sag num sag num sag num btub gra num num num num pk num apico reveal num strain num genotyp lamb infect gondii genotyp twenty six num strain belong clonal type ii lineag strain divid group base allel locus apico num strain belong type iii lineag remain num strain divid num atyp genotyp result high parasit preval high genet divers gondii lamb import implic public health in depth genet analysi gondii isol sheep usa
MED-4957~detect sarcocysti parasit retail beef region survey combin histolog genet detect method pubm ncbi abstract sarcocysti spp parasit protist acquir undercook cyst laden meat consum sarcocysti homini cruzi encyst beef homini pathogen human studi histolog method molecular techniqu determin region preval ident sarcocysti spp retail beef num sampl num support amplif parasit rrna pcr num sequenc repres identifi cruzi compar detect method num sampl examin parallel histolog pcr num num sampl posit sampl posit initi histolog section amplifi pcr fifteen pcr posit sampl sarcocyst initi histolog section addit section sampl reveal sarcocyst addit num sampl combin histolog addit section pcr detect num posit specimen num total specimen found evid human pathogen homini confirm cattl pathogen cruzi high preval region sampl pcr assay increas detect sensit sarcocysti spp contribut diagnost precis
MED-4958~biogen amin fish role intox spoilag nitrosamin formation  a review pubm ncbi abstract biogen amin non volatil amin form decarboxyl amino acid biogen amin found fish histamin cadaverin putrescin found signific fish safeti qualiti determin wide report associ histamin scombroid food poison histamin insuffici food toxic putrescin cadaverin suggest potenti histamin toxic respect spoilag hand cadaverin found index initi stage fish decomposit relationship biogen amin sensori evalu trimethylamin spoilag influenc bacteri composit free amino acid content mesophil bacteri count log num cfu g found num mg histamin num fish food drug administr fda maximum histamin level vitro studi shown involv cadaverin putrescin format nitrosamin nitrosopiperidin npip nitrosopyrrolidin npyr addit impur salt high temperatur low ph enhanc nitrosamin format pure sodium chlorid inhibit format understand relationship biogen amin involv format nitrosamin explain mechan scombroid poison assur safeti fish product
MED-4959~public health respons puffer fish tetrodotoxin poison mislabel product pubm ncbi abstract tetrodotoxin neurotoxin occur select speci famili tetraodontida puffer fish paralysi potenti death ingest suffici quantiti num individu develop symptom consist tetrodotoxin poison ingest home cook puffer fish purchas chicago chicago retail california supplier deni sold import puffer fish claim product monkfish genet analysi visual inspect determin ingest fish implic lot retriev supplier belong famili tetraodontida tetrodotoxin detect high level remnant ingest meal fish retriev implic lot investig led voluntari recal monkfish distribut supplier state placement supplier food drug administration import alert speci misbrand case tetrodotoxin poison highlight continu stringent regul puffer fish import food drug administr educ public danger puffer fish consumpt rais awar medic provid diagnosi manag foodborn toxin ingest report public health agenc
MED-4960~fishi sudden fatal hypotens pubm ncbi abstract seafood born ill common recognis sourc morbid report case num year old woman present hospit collaps restaur lunch consist mackerel fish detail food histori clinic exclus diagnos condit scombroid poison patient made complet recoveri antihistamin therapi
MED-4961~haff diseas eat salmon pubm ncbi abstract fish consumpt consid compon heart healthi diet ill eat contamin fish author describ case muscl weak rhabdomyolysi occur eat salmon case rhabdomyolysi muscl weak consumpt fresh water fish rare report unit state frequent report baltic region ill haff diseas etiolog unknown felt toxin palytoxin found marin fish rhabdomyolysi serv model studi suspect toxin respons rhabdomyolysi consumpt fresh water fish case haff diseas suspect contact center diseas control prevent collect uneaten fish laboratori analysi
MED-4962~necrot soft tissu infect primari sepsi caus vibrio vulnificus vibrio cholera non o num pubm ncbi abstract background vibrio speci rare necrot soft tissu infect primari septicemia occur patient hepat diseas diabet adren insuffici immunocompromis condit organ thrive warm seawat present raw oyster shellfish seafood studi examin fulmin clinic characterist vibrio vulnificus vibrio cholera non o num soft tissu infect identifi outcom predictor materi thirti patient necrot fasciiti sepsi caus vibrio speci retrospect review twenty eight patient histori contact seawat raw seafood patient hepat diseas hepat liver cirrhosi patient diabet mellitus patient hepat dysfunct combin diabet mellitus microbiolog laboratori cultur studi confirm vulnificus num patient cholera non o num patient result surgic debrid limb amput initi perform patient necrot soft tissu infect eleven patient num die day admiss num surviv mortal cholera non o num group num higher vulnificus group num signific higher mortal rate note patient initi present systol blood pressur num mm hg leukopenia decreas platelet count combin hepat dysfunct diabet mellitus conclus vibrio necrot soft tissu infect suspect patient clinic find histori contact seawat seafood cholera non o num bacteremia vulnificus patient liver cirrhosi earli fasciotomi culture direct antimicrobi therapi aggress recommend patient hypotens shock leukopenia high band form white blood cell decreas platelet count sever hypoalbuminemia chronic ill hepat dysfunct diabet mellitus
MED-4963~sushi delight parasit risk fishborn foodborn parasit zoonos asia pubm ncbi abstract worldwid popular japanes cuisin tradit japanes fish dish sushi sashimi serv japanes restaur sushi bar suspect caus fishborn parasit zoonos anisakiasi addit array freshwat brackish wat fish wild anim meat import sourc infect zoonot parasit serv sushi sashimi rural area japan fishborn foodborn parasit zoonos endem asian countri relat tradit cook style recent increas number travel area zoonos endem travel infecti diseas specialist unawar risk infect eat exot ethnic dish aim review provid practic background inform repres fishborn foodborn parasit zoonos endem asian countri
MED-4964~microbi qualiti raw aquacultur fish fillet procur internet local retail market pubm ncbi abstract microbi qualiti raw fillet aquacultur catfish salmon tilapia trout evalu total num fillet local internet retail market test valu num log cfu g total aerob mesophil num log cfu g psychrotroph num log probabl number mpn gram coliform differ microbi level kind market type fish signific num internet trout fillet num log higher aerob mesophil trout fillet purchas local escherichia coli detect num num num trout salmon tilapia sampl num log mpn g coli found num catfish averag num log mpn g num fillet listeria spp posit correl preval listeria spp listeria monocytogen observ internet fillet higher preval listeria spp monocytogen fillet purchas local monocytogen present num catfish num num num trout tilapia salmon salmonella coli num found sampl follow up investig catfish oper model reveal gut wast expos eviscer potenti sourc coliform listeria spp
MED-4966~cluster ciguatera fish poisoning  north carolina num pubm ncbi abstract ciguatera fish poison cfp distinct type foodborn diseas result eat predatori ocean fish contamin ciguatoxin num case report worldwid annual condit endem tropic subtrop region pacif basin indian ocean caribbean unit state num num case num person estim occur year ciguatera endem state territori cfp gastrointestin symptom nausea vomit abdomin cramp diarrhea hour eat contamin fish neurolog symptom gastrointestin disturb includ fatigu muscl pain itch tingl characterist revers hot cold sensat report describ cluster case cfp occur north carolina june num patient experienc revers hot cold sensat neurolog symptom symptom persist num month patient patient sexual activ patient complain pain intercours report highlight potenti risk eat contamin ocean fish local state health depart train emerg urgent care physician recognit cfp make awar symptom persist month year
MED-4967~sever diarrhea caus cholera toxin produc vibrio cholera serogroup num infect acquir southeastern unit state pubm ncbi abstract background num num vibrio cholera serogroup num strain possess cholera toxin gene isol num patient sever diarrhea includ num georgia num alabama num south carolina report repres identif cholera num ill unit state cholera num isol water sampl collect pond louisiana num subsequ num cholera isol louisiana num patient diarrhea num num water sampl collect num previous report serogroup num discov serogroup num result num patient infect cholera num adult ill consum seafood num eaten raw oyster trace back gulf coast unit state num isol possess cholera toxin gene suscept num antimicrobi clinic isol num environment water isol pulsed field gel electrophoresi pattern num clinic isol share common pulsed field gel electrophoresi pattern conclus occurr case year concurr identif cholera num water gulf coast state suggest strain surviv long period environ patient exposur histori suggest infect acquir consumpt raw oyster gulf coast clinician public health author vigil occurr toxigen serogroup cholera capabl caus sever diarrhea
MED-4968~cholera type vibriosi stori human pandem oyster half shell pubm ncbi abstract vibrio ubiquit aquat environ common present shellfish seafood small subset strains speci human diseas includ cholera toxin produc strain vibrio cholera respons epidemic pandem cholera thermost direct hemolysin produc strain vibrio parahaemolyticus vibrio vulnificus fulmin sepsi cholera outbreak initi transmiss epidem cholera strain environment reservoir human seafood environment relat food water sourc nonepidem strain cholera strain vibrio speci includ parahaemolyticus vulnificus general acquir eat seafood raw oysters oyst half shell primari clinic manifest infect strain gastroenter wound infect vulnificus septicemia person liver diseas immunocompromis
MED-4969~hand wash frequenc procedur retail food servic pubm ncbi abstract transmiss virus bacteria parasit food improp wash hand major contribut factor spread foodborn ill field observ assess complianc hand wash regul studi includ frequenc method sector food servic industri includ benchmark hand wash num observ period employe num hand wash behavior menu product servic clean conduct num food servic oper total num direct observ oper sector retail food servic industri particip studi assist live elder childcar restaur school valid observ form base num food code guidelin train research research note hand wash hand wash hand wash complianc food code recommend frequenc product servic clean phase rang num restaur num assist live facil procedur complianc rate low propos benchmark number time hand wash occur employe sector food servic phase oper time hour assist live time hour childcar num time hour restaur num time hour school benchmark high restaur employe implement lost product potenti dermat activ manageri control work assign benchmark train guid employe hand wash behavior
MED-4972~detect phip grill chicken entr es popular chain restaur california pubm ncbi abstract heterocycl amin hcas compound form meat cook high temperatur pan fri grill barbequ pose potenti carcinogen risk public unclear level consumpt hcas consid safe effort measur compound includ cook studi laboratori condit measur home cook food analysi commerci cook food minim attempt estim exposur public compound dine home result signific exposur individu survey num locat num popular chain restaur mcdonald burger king chick fil a chili tgi friday outback steakhous applebee california collect entre locat entre analyz num amino num methyl num phenylimidazo num b pyridin phip high perform liquid chromatographi tandem mass spectrometri num sampl phip concentr variabl entre rang num num ng g factor weight entre absolut level phip reach num ng entre potenti strategi reduc exposur includ avoid meat cook method form phip
MED-4973~concentr profil num urinari polycycl aromat hydrocarbon metabolit popul pubm ncbi abstract urinari monohydroxi polycycl aromat hydrocarbon oh pah class pah metabolit biomark assess human exposur pah center diseas control prevention nation health nutrit examin survey nhane oh pah establish refer rang concentr popul set benchmark futur epidemiolog biomonitor studi year num num oh pah metabolit measur urin specimen num nhane particip percentag sampl detect level rang num metabolit naphthalen fluoren phenanthren pyren num metabolit parent compound higher molecular weight chrysen benzo c phenanthren benz a anthracen geometr num hydroxypyren num pyr the common biomark pah exposure  wa num ng l urin num ng g creatinin children age num general higher level adolesc age num adult age num older model adjust least squar geometr num pyr num num ng l children adolesc age num adult age num year older log transform concentr major detect oh pah signific correl correl coeffici num pyr metabolit rang num num support num pyr surrog repres pah exposur
MED-4974~polycycl aromat hydrocarbon pah coffe brew sampl analyt method gc ms profil level sourc pubm ncbi abstract roast crucial step product coffe enabl develop color aroma flavor essenti character coffe qualiti time roast lead format desir compound polycycl aromat hydrocarbon pah paper report method pah determin coffe brew base saponif liquid liquid extract small volum hexan exclus process purif analyz extract gas chromatographi mass spectrometr detector singl ion monitor mode sim total concentr num compound investig express sum concentr sigmapah coffe brew vari num num microg l carcinogen pah express b a peq rang num num microg l result coffe contribut insignific quantiti daili human intak carcinogen pah valu calcul isomer ratio confirm pah identifi coffe sampl origin high temperatur process
MED-4975~serum polycycl aromat hydrocarbon children asthma correl environment dietari factor pubm ncbi abstract background children low incom famili subject high exposur polycycl aromat hydrocarbon pah lead respiratori disord studi aim establish method assess total pah exposur asthmat non asthmat children low incom famili estim serum pah concentr children estim relat import environment pathway pah exposur materi method total num asthmat num non asthmat saudi children num year includ particip cross sect studi particip answer general questionnair dietari question serum pah measur hplc uv detect result serum naphthalen pyren signific elev asthmat children p valu num num serum acenaphthylen fluorin num benzanthracen hand signific higher non asthmat p valu num num num signific correl presenc smoker famili serum concentr carbazol pyren num benzanthracen benzacephenanthrylen num num num num p valu num num num num signific correl elicit daili meat intak serum level acenaphthylen benzopyren num benzanthracen num num num p valu num num conclus children serum pah signific correl meat intak presenc smoker home public health awar enhanc educ parent precaut home prevent indoor smoke reduc intak grill smoke meat children decreas exposur carcinogen pah
MED-4976~airborn mutagen produc fri beef pork soy bas food pubm ncbi abstract airborn cook by product fri beef hamburg pork bacon strip soybean bas food tempeh burger collect extract test mutagen chemic analys fume generat fri pork beef mutagen num num revertants g food cook mutagen detect fume fri tempeh burger bacon fri well don non char state time mutagen microsuspens ames salmonella test ta num num hamburg num time mutagen tempeh burger food sampl cook well don non char state bacon strip num fold mass num ng g beef heterocycl amin hca detect fri tempeh burger num amino num methyl num phenylimidazo num b pyridin phip abund hca num amino num dimethylimidazo num f quinoxalin meiqx num amino num num trimethylimidazo num f quinoxalin dimeiqx num amino num pyrido num b indol alpha detect food sampl fri num degre present collect airborn product total amount hcas smoke condens num ng g fri bacon num ng g fri beef num ng g fri soy bas food studi cook potenti expos high level airborn mutagen carcinogen long term sampl insid restaur kitchen warrant order assess potenti risk prolong exposur
MED-4977~dietari epidemiolog essenti tremor meat consumpt meat cook practic abstract background aim harman num methyl num pyrido num indol tremor produc neurotoxin blood harman concentr elev essenti tremor patient unclear reason potenti mechan includ increas dietari harman intak well cook meat genetic metabol factor test hypothesi meat consumpt level meat higher case control method detail data collect lawrenc livermor nation laboratori meat questionnair result total current meat consumpt greater men num num num num g day num women versus num num num num g day num adjust logist regress analysi male higher total current meat consumpt num num num addit g day meat odd increas num male case higher odd highest lowest quartil total current meat consumpt adjust num num meat level similar case control conclus studi evid dietari differ male case male control etiolog ramif result warrant addit investig copyright num karger ag basel
MED-4978~biomonitor urinari metabolit num amino num methyl num phenylimidazo num b pyridin phip human consumpt cook chicken pubm ncbi abstract human risk assess exposur num amino num methyl num phenylimidazo num b pyridin phip diet improv conduct biomonitor studi compar metabol human rodent eleven volunt ingest meal cook chicken num oh phip phip amount num num microg kg urin collect num larg number phip metabolit treatment urin sampl hydrazin hydrat hydrolyt enzym reduc substanc num oh phip phip num oh phip biomark detoxif biomark activ eleven volunt elimin larg amount num oh phip urin major account presenc num oh phip fri chicken show phip small extent num metabolis num oh phip larger fraction phip exposur num recov phip largest fraction num recov num oh phip suggest phip human larg extent metabolis reactiv substanc rat num dose phip elimin num oh phip suggest human cancer risk exposur phip higher risk estim base extrapol rodent bioassay
MED-4980~detect fecal residu poultri carcass laser induc fluoresc imag pubm ncbi abstract feasibl fluoresc imag techniqu detect dilut fecal matter part digest tract includ colon ceca small intestin duodenum poultri carcass investig challeng fluoresc imag inspect agricultur materi low fluoresc yield fluoresc mask ambient light laser induc fluoresc imag system lifi develop group acquisit fluoresc feces contamin poultri carcass ambient light fluoresc emiss imag num nm captur num nm laser excit imag process algorithm includ threshold imag eros identifi fecal spot dilut num weight doubl distil water fece spot carcass dilut num dilut detect num accuraci fece type detect accuraci fecal matter dilut num num result demonstr good potenti lifi detect dilut poultri fecal matter harbor pathogen poultri carcass
MED-4981~one year studi variat carotenoid antioxid substanc live human skin influenc dietari supplement stress factor pubm ncbi abstract variat level carotenoid antioxid substanc beta caroten lycopen human skin ten healthi volunt measur reson raman spectroscopi vivo experi num month inform lifestyl volunt dietari supplement stress factor obtain daili complet questionnair result show individu variat level carotenoid antioxid substanc skin volunt strong correl specif lifestyl intak dietari supplement rich carotenoid influenc stress factor carotenoid rich nutrit base larg amount fruit veget increas measur carotenoid level skin stress factor fatigu ill smoke alcohol consumpt gave rise decreas carotenoid level skin decreas occur quick day subsequ increas num day summer autumn month increas level carotenoid skin measur volunt averag season increas carotenoid content skin determin num fold
MED-4983~meat intak mortal prospect studi half million peopl abstract context high intak red process meat increas risk mortal object determin relat red white process meat intak risk total cause specif mortal design set particip nih aarp diet health studi cohort half million peopl age num year baselin meat intak estim food frequenc questionnair administ baselin cox proport hazard regress estim hazard ratio hrs num confid interv cis quintil meat intak covari includ model age educ marit status famili histori cancer yes no cancer mortal race bodi mass index num level smoke histori physic activ energi intak alcohol intak vitamin supplement fruit consumpt veget consumpt menopaus hormon therapi women main outcom measur total mortal death due cancer cvd accid result num male death num femal death num year follow up men women highest versus lowest quintil red hr num num ci num num hr num num ci num num process meat intak hr num num ci num num hr num num num num elev risk mortal cause specif mortal men women elev risk cancer mortal red hr num num ci num num hr num num ci num num process meat hr num num ci num num hr num num ci num num cvd risk elev men women highest quintil red hr num num ci num num hr num num ci num num process meat hr num num ci num num hr num num ci num num compar highest lowest quintil white meat intak invers associ total mortal cancer mortal death men women conclus red process meat intak modest increas total mortal cancer mortal cvd mortal
MED-4984~vegetarian vegan diet type num diabet manag pubm ncbi abstract vegetarian vegan diet offer signific benefit diabet manag observ studi individu vegetarian diet half develop diabet compar non vegetarian clinic trial individu type num diabet low fat vegan diet improv glycem control greater extent convent diabet diet effect primarili attribut greater weight loss evid suggest reduc intak satur fat high glycemic index food increas intak dietari fiber veget protein reduc intramyocellular lipid concentr decreas iron store mediat influenc plant bas diet glycemia vegetarian vegan diet improv plasma lipid concentr shown revers atherosclerosi progress clinic studi report accept vegetarian vegan diet compar therapeut regimen present literatur vegetarian vegan diet present potenti advantag manag type num diabet
MED-4985~low fat vegan diet convent diabet diet treatment type num diabet random control num wk clinic trial abstract background low fat vegetarian vegan diet weight loss increas insulin sensit improv cardiovascular health object compar effect low fat vegan diet convent diabet diet recommend glycemia weight plasma lipid design free liv individu type num diabet random assign low fat vegan diet num diet num american diabet associ guidelin convent num num wk glycat hemoglobin hb num plasma lipid assess week num num num num weight measur week num num result weight loss signific diet group signific group num kg vegan group num kg convent diet group num relat signific hb num num num hb num baselin num wk valu num num vegan convent diet num hb num baselin medic adjust num num vegan convent diet num analys alter lipid low medic total cholesterol decreas num num mg dl vegan convent diet group num ldl cholesterol decreas num num mg dl vegan convent group num conclus diet sustain reduct weight plasma lipid concentr analysi control medic low fat vegan diet improv glycemia plasma lipid convent diabet diet recommend observ differ provid clinic benefit macro microvascular complic diabet remain establish trial regist clinicaltri gov nct num
MED-4987~safeti rosiglitazon treatment type num diabet pubm ncbi abstract background cardiovascular diseas lead mortal adult type num diabet thiazolidinedion includ rosiglitazon approv treatment type num diabet basi abil lower blood sugar surrog marker cardiovascular diseas object ascertain cardiovascular skelet hematolog safeti profil rosiglitazon method synthesi evid recent trial systemat review meta analysi regulatori document clinic trial registri manufactur conclus rosiglitazon increas risk heart failur myocardi infarct fractur women type num diabet
MED-4988~type vegetarian diet bodi weight preval type num diabet abstract object assess preval type num diabet peopl type vegetarian diet compar nonvegetarian research design method studi popul compris num men num women particip adventist health studi num conduct num num collect self report demograph anthropometr medic histori lifestyl data seventh day adventist church member north america type vegetarian diet categor base food frequ questionnair calcul odd ratio num cis multivariate adjust logist regress result bmi lowest vegan num kg m num increment higher lacto ovo vegetarian num kg m num pesco vegetarian num kg m num semi vegetarian num kg m num nonvegetarian num kg m num preval type num diabet increas num vegan num nonvegetarian preval intermedi particip consum lacto ovo num pesco num semi vegetarian num diet adjust age sex ethnic educ incom physic activ televis watch sleep habit alcohol bmi vegan num num ci num num lacto ovo vegetarian num num num pesco vegetarian num num num semi vegetarian num num num lower risk type num diabet nonvegetarian conclus num unit bmi differ vegan nonvegetarian substanti potenti vegetarian protect obes increas conform vegetarian diet protect risk type num diabet lifestyl characterist bmi account pesco semi vegetarian diet afford intermedi protect
MED-4989~effect high nutrient densiti diet long term weight loss retrospect chart review pubm ncbi abstract background high nutrient densiti hnd vegetable bas diet offer dietari model extrem low satur fat refin carbohydr emphas liber intak fresh fruit veget bean nut conduct retrospect chart review patient famili practic offic seek nutrit counsel weight loss patient prescrib hnd diet extend counsel session famili physician method conveni sampl num patient seek dietari counsel weight loss famili practic physician num year period includ chart review person identifi data record initi counsel session averag num hour length patient provid sampl hnd daili meal plan recip verbal written inform rational diet data record patient chart num month interv num year follow up includ weight blood pressur total cholesterol high dens lipoprotein hdl cholesterol low dens lipoprotein ldl cholesterol triglycerid cholesterol hdl ratio non parametr statist test friedman rank order exact test k relat sampl conduct follow up survey adher medic complet num patient result num patient return follow up num year weight loss num lbs num num patient return num year weight loss num lbs num cholesterol fell num point ldl num point triglycerid num point cardiac risk ratio drop num num systol diastol blood pressur high signific follow up time interv num signific correl adher degre weight loss num conclus weight loss sustain patient return follow up substanti report good adher recommend patient lost follow up favor lipid profil blood pressur note hnd diet potenti provid sustain signific long term weight loss provid substanti lower cardiac risk patient motiv provid extend one on on counsel follow up visit develop tool aid patient retent area studi clinic trial long term follow up test therapeut potenti examin adher follow up issu relat dietari approach hnd diet demonstr group health favor effect lose weight appropri motiv patient
MED-4990~type vegetarian diet bodi weight preval type num diabet abstract object assess preval type num diabet peopl type vegetarian diet compar nonvegetarian research design method studi popul compris num men num women particip adventist health studi num conduct num num collect self report demograph anthropometr medic histori lifestyl data seventh day adventist church member north america type vegetarian diet categor base food frequ questionnair calcul odd ratio num cis multivariate adjust logist regress result bmi lowest vegan num kg m num increment higher lacto ovo vegetarian num kg m num pesco vegetarian num kg m num semi vegetarian num kg m num nonvegetarian num kg m num preval type num diabet increas num vegan num nonvegetarian preval intermedi particip consum lacto ovo num pesco num semi vegetarian num diet adjust age sex ethnic educ incom physic activ televis watch sleep habit alcohol bmi vegan num num ci num num lacto ovo vegetarian num num num pesco vegetarian num num num semi vegetarian num num num lower risk type num diabet nonvegetarian conclus num unit bmi differ vegan nonvegetarian substanti potenti vegetarian protect obes increas conform vegetarian diet protect risk type num diabet lifestyl characterist bmi account pesco semi vegetarian diet afford intermedi protect
MED-4991~bean consumpt greater nutrient intak reduc systol blood pressur lower bodi weight smaller waist circumfer pubm ncbi abstract background epidemiolog studi shown posit find legum consumpt measur cardiovascular diseas obes observ trial examin bean separ food variabl determin associ health paramet object determin associ consum bean nutrient intak physiolog paramet nation health examin survey nhane num method data nhane num secondari analysi complet reliabl num hour dietari recal group bean consum identifi num determin nutrient intak physiolog valu bean consum non consum squar standard error anova calcul sampl weight adjust age gender ethnic energi result relat non consum bean consum higher intak dietari fiber potassium magnesium iron copper p s num consum bean lower bodi weight num smaller waist size num relat non consum addit consum bean num reduc risk increas waist size num num reduc risk obes num bake bean consumpt lower systol blood pressur conclus bean consum nutrient intak level bodi weight waist circumfer lower systol blood pressur comparison non consum data support benefit bean consumpt improv nutrient intak health paramet
MED-4992~determin bisphenol bisphenol residu peel tomato reversed phas liquid chromatographi pubm ncbi abstract bisphenol bpa bisphenol bpb concentr determin peel tomato brand bought italian supermarket tomato sampl analyz packag coat epoxyphenol lacquer low badg enamel solid phase extract spe perform num strata cartridg step florisil cartridg detect quantit perform revers phase high perform liquid chromatographi rp hplc method uv fluoresc detect fd total num test tomato sampl bpa detect num sampl num bpb detect num sampl num bpa bpb simultan present num analyz sampl level bpa found studi lower european union migrat limit num mg kg food unabl produc daili intak exceed limit num mg kg bodi weight establish european food safeti author
MED-4993~effect low salt diet flow medi dilat human pubm ncbi abstract background effect salt reduct vascular function assess brachial arteri flow medi dilat fmd unknown object aim compar effect low salt ls num mmol na d diet usual salt num mmol na d diet fmd design random crossov design num overweight obes normotens men women ls diet diet num wk diet similar potassium satur fat content design ensur weight stabil intervent fmd puls wave veloc augment index blood pressur measur result fmd signific greater num ls diet num num diet num num systol blood pressur signific num lower ls diet num num mm hg diet num num mm hg num sodium excret signific lower num ls diet num num mmol diet num num mmol correl chang fmd chang num sodium excret chang blood pressur signific augment index puls wave veloc observ conclus salt reduct improv endothelium depend vasodil normotens subject independ measur rest clinic blood pressur find suggest addit cardioprotect effect salt reduct blood pressur reduct trial regist australian zealand clinic trial registri uniqu identifi anzctr num http   www anzctr org au trial view aspx id num
MED-4994~benefit cardioprotect properti alcohol consumption  health freak couch potato pubm ncbi abstract background cardioprotect properti moder alcohol consumpt compar abstin heavi drink wide report benefit experienc equal moder drinker aim examin associ averag alcohol intak week incid fatal non fat myocardi infarct num year follow up num men women preval diseas general popul test level cardioprotect differ subject health behaviour healthi moder healthi unhealthi entri studi method longitudin british civil service bas cohort studi baselin num result signific benefit moder drink compar abstin heavi drink found poor health behaviour exercis poor diet smoker addit benefit alcohol found healthiest behaviour profil num hour vigor exercis week daili fruit veget consumpt non smok conclus cardioprotect benefit moder drink appli equal drinker variabl emphasis public health messag
MED-4995~salicyl acid san aspirin anim man persist fast biosynthesi benzoic acid abstract salicyl acid sa central defens mechan plant princip metabolit aspirin occur natur man higher level sa urinari metabolit salicylur acid su vegetarian overlap level patient low dos aspirin regimen sa wide distribut anim blood fast major colorect surgeri disappear sa plasma patient total proctocolectomi num benzoic acid load ingest volunt led num num median num label urinari salicylur acid contribut benzoic acid salt turnov circul sa requir assess sa partial endogen compound lead reassess role human anim pathophysiolog
MED-4996~cover calor restrict improv memori elder human abstract anim studi suggest diet low calori rich unsatur fatti acid ufa benefici cognit function age test prospect intervent design effect induc human fifti healthi normal overweight elder subject num femal age num year bodi mass index num kg m num stratifi num group calor restrict num reduct ii relat increas intak ufa num increas unchang total fat iii control num month intervent memori perform assess standard condit found signific increas verbal memori score calor restrict increas num num correl decreas fast plasma level insulin high sensit c reactiv protein pronounc subject adher diet valu num valu num level brain deriv neurotroph factor remain unchang signific memori observ num group intervent trial demonstr benefici effect calor restrict memori perform healthi elder subject mechan improv includ higher synapt plastic stimul neurofacilitatori pathway brain improv insulin sensit reduc inflammatori activ studi generat prevent strategi maintain cognit function age
MED-4998~curcumin exert antidifferenti effect ampkalpha ppar gamma num num adipocyt antiproliferatori effect ampkalpha cox num pubm ncbi abstract curcumin report potenti prevent obes cancer downstream target regul amp activ protein kinas ampk inhibit adipocyt differenti cancer cell prolifer curcumin investig activ ampk curcumin crucial inhibit differenti growth adipocyt cancer cell stimul ampk curcumin result down regul ppar peroxisom proliferator activ receptor gamma num num adipocyt decreas cox num mcf num cell applic synthet ampk activ support evid ampk act upstream signal ppar gamma num num adipocyt cancer cell ampk found act regul erk num num cox num regul ampk downstream target ppar gamma mapkinas cox num curcumin import control adipocyt cancer cell
MED-4999~curcumin demethoxycurcumin bisdemethoxycurcumin differenti inhibit cancer cell invas down regul mmps upa pubm ncbi abstract curcumin cur compon turmer curcuma longa report exhibit antimetastat activ mechan remain unclear curcuminoid present turmer demethoxycurcumin dmc bisdemethoxycurcumin bdmc investig exhibit antimetastat activ extent curcumin regul matrix metalloproteinas mmps urokinas plasminogen activ upa play import role cancer cell invas cleavag extracellular matrix ecm line compar examin influenc cur dmc bdmc express upa mmp num mmp num membran type num mmp mt num mmp tissu inhibitor metalloproteinas timp num vitro invas human fibrosarcoma cell result differenti potenc inhibit cancer cell invas bdmc dmc cur cell migrat affect zymographi analysi exhibit curcumin dmc bdmc signific decreas upa active mmp num mmp num pro mmp num secret cell dose depend manner bdmc dmc show higher potenc curcumin suppress activ mmp num level correl inhibit mt num mmp timp num protein level involv pro mmp num activ import bdmc dmc num microm reduc mt num mmp timp num protein express curcumin slight reduc mt num mmp timp num addit form curcuminoid signific inhibit collagenas mmp num mmp num upa activ summari data demonstr dmc bdmc show higher antimetastasi potenc curcumin differenti down regul ecm degrad enzym
MED-5000~effect cinnamon turmer urinari oxal excret plasma lipid plasma glucos healthi subject pubm ncbi abstract background high oxal intak result consum supplement dose cinnamon turmer increas risk hyperoxaluria signific risk factor urolithiasi object studi assess urinari oxal excret supplement dose cinnamon turmer fast plasma glucos cholesterol triacylglycerol concentr design eleven healthi subject age num particip num wk random assign crossov studi involv ingest supplement dose cinnamon turmer num wk period provid num mg oxalate d oxal load test entail ingest num mg dose oxal test spice perform num wk experiment period studi onset water control treatment fast plasma glucos lipid concentr assess time point result compar cinnamon control treatment turmer ingest led signific higher urinari oxal excret oxal load test signific fast plasma glucos lipid conjunct num wk period cinnamon turmer supplement conclus percentag oxal water solubl differ mark cinnamon num turmer num primari greater urinari oxal excretion oxal absorpt turmer consumpt supplement dose turmer cinnamon signific increas urinari oxal level increas risk kidney stone format suscept individu
MED-5001~curcumin lead compound hormone independ multidrug resist breast cancer pubm ncbi abstract examin evid phytochem curcumin overcom resist hormon cytotox agent breast cancer present observ mcf num multidrug resist mdr variant mcf num breast cancer cell line contrast mcf num mcf num lack aromatas estrogen receptor alpha eralpha overexpress multidrug transport abcb num product gene implic cell prolifer surviv c iap num naip survivin cox num cytotox cell death induct assay found antitumor activ curcumin substanti mcf num mcf num elabor diketon system curcumin analogu benzyloxim isoxazol pyrazol heterocycl show remark increas antitumor potenc parent mdr mcf num cell curcumin potent isoxazol analogu produc earli reduct amount relev gene transcript divers relat bcl num bcl x mcf num inhibitori apoptosi protein cox num mcf num cell line compound exhibit remark properti modifi molecular activ distinct characterist parent mdr cell discuss curcumin num exert antitumor effect breast cancer er depend er independ mechan num act drug transporter medi mdr revers agent structur curcumin repres basi develop effect anticanc agent hormone independ mdr breast cancer
MED-5002~high tofu intak wors memori elder indonesian men women pubm ncbi abstract background aim cell cultur studi suggest phytoestrogen abund soy product temp tofu protect cognit declin paradox honolulu asia age studi report increas risk cognit impair dementia marker high tofu soybean curd intak method cross sect studi carri num rural site borobudur sumedang num urban site jakarta javanes sundanes elder num num year age memori measur word learn test sensit dementia soy consumpt assess food frequenc questionnair item result high tofu consumpt wors memori beta num num num ci num num high temp consumpt ferment soybean product independ relat memori beta num num num ci num num particip num year age fruit consumpt independ posit associ analys control age sex educ site intak food conclus result tofu consumpt risk factor low memori function tie honolulu asia age studi data unclear negat associ attribut potenti toxin phytoestrogen level estrogen receptor phytoestrogen exert effect found increas dementia risk women num year age temp high level phytoestrogen due ferment exhibit high folat level exert protect effect futur studi valid find investig potenti mechan copyright num karger ag basel
MED-5003~genistein inhibit differenti primari human adipocyt pubm ncbi abstract genistein major soy isoflavon report exhibit antiadipogen proapoptot potenti vivo vitro phytoestrogen high affin estrogen receptor beta studi determin effect genistein adipogenesi estrogen receptor er alpha beta express differenti primari human preadipocyt genistein inhibit lipid accumul dose depend manner concentr num microm higher num microm genistein inhibit lipid accumul complet low concentr genistein num microm increas cell viabil higher concentr num num microm decreas num num num num num num oil red stain confirm effect lipid accumul inhibit lipid accumul inhibit glycerol num phosphat dehydrogenas activ down regul express adipocyte specif gene includ peroxisom proliferator activ receptor gamma ccaat enhanc bind protein alpha glycerol num phosphat dehydrogenas adipocyt fatti acid bind protein fatti acid synthas sterol regulatori element bind protein num perilipin leptin lipoprotein lipas hormone sensit lipas effect genistein differenti period down regul eralpha erbeta express studi add elucid molecular pathway involv inhibit adipogenesi phytoestrogen
MED-5004~weight gain num year num meat eat fish eat vegetarian vegan men women epic oxford pubm ncbi abstract background cross sect studi shown vegetarian vegan leaner omnivor longitudin data weight gain group spars object investig weight bodi mass index bmi num year period meat eat fish eat vegetarian vegan men women uk design self report anthropometr dietari lifestyl data collect baselin num follow up num median durat follow up num year subject total num men women particip oxford arm european prospect investig cancer nutrit age num year baselin result annual weight gain num sd num men num sd num women differ meat eat fish eat vegetarian vegan age adjust bmi follow up similar baselin multivariable adjust weight gain smaller vegan num men num women num sex fish eat num women num compar meat eat men women chang diet step direct meat eat fish eat vegetarian vegan show smallest annual weight gain num ci num num ci num conclus num year follow up annual weight gain health consci cohort uk approxim num small differ weight gain observ meat eat fish eat vegetarian vegan lowest weight gain follow up chang diet fewer anim food
MED-5005~increas preval constip pre school children attribut under consumpt plant food community bas studi pubm ncbi abstract aim evalu consumpt food rich dietari fibr relat preval constip pre school children method total num children age num year random select kindergarten hong kong constip confirm rome criteria children normal bowel habit serv non constip control consumpt veget fruit whole grain cereal fluid determin num day food record result total num children report constip median dietari fibr intak constip children signific lower non constip children num g d inter quartil rang iqr num num g d num g d iqr num num g d num num refer dietari fibr intak constip children signific lower intak vitamin num folat num magnesium num fruit intak total plant food intak signific lower constip non constip children num g d iqr num num g d num g d iqr num num g d num num g d iqr num num g d num g d iqr num num g d num total fluid intak differ group milk intak constip children margin higher non constip children num conclus insuffici dietari fibr intak common hong kong pre school children constip children signific lower intak dietari fibr micronutri includ vitamin folat magnesium non constip counterpart attribut under consumpt plant food milk intak margin higher constip children public educ parent develop healthi dietari habit bowel habit earli life order prevent childhood constip
MED-5006~american overweight obes estim progress cost obes epidem pubm ncbi abstract project futur preval bmi distribut base nation survey data nation health nutrit examin studi collect num num futur obesity rel health car cost adult estim project preval census popul project publish nation estim capita excess health car cost obesity overweight object illustr potenti burden obes preval health car cost obes overweight unit state occur current trend continu overweight obes preval increas steadili popul group notabl differ group annual increas rate increas percentag point obes overweight adult faster children num num num women men num num trend continu num num adult overweight obes num obes black women num mexican american men num affect num american adult overweight obes black women reach state num children preval overweight bmi num percentil num doubl num total health car cost attribut obesity overweight doubl decad num num billion dollar num account num total health car cost continu move healthi peopl num object time dramat effect develop implement correct programs polici avoid inevit health societ consequ impli project
MED-5007~plasma adiponectin concentr bodi composit plant bas dietari factor femal twin pubm ncbi abstract circul adiponectin emerg import link obes type num diabet cardiovascular diseas cvd spectrum lifestyl factor modul adiponectin concentr remain elucid women conduct cross sect studi num femal twin pair twinsuk adult twin registri co twin design examin dietari bodi composit influenc adiponectin conduct match within pair analys elimin confound multivari adjust within twin pair signific influenc adiponectin log transform percent chang sd dietary bodi composit variabl observ nonstarch polysaccharid num num ci num num num magnesium intak num num ci num num num trend associ fruit veget f v intak num num ci num num num modest posit associ explain confound lifestyl factor share twin signific relationship adiponectin num deriv dietari pattern f v diet tradit english carbohydr protein tran fat alcohol intak observ strong invers associ adiponectin observ bmi num num ci num num total num num ci num num num central fat mass num num ci num num num relationship signific twin analyz individu characterist contrast within twin pair suggest direct effect observ modest associ dietari factor adiponectin femal twin independ adipos report strong invers associ bodi composit data reinforc import weight mainten increas consumpt diet rich plant bas food prevent cvd type num diabet
MED-5008~bariatr surgeri pediatrics  i time pubm ncbi abstract view increas preval obes world morbid obes occur earlier age adolesc main approach conserv includ chang lifestyl impli feed habit physic activ weapon deal pandem obes solv larg number case admit bariatr surgeri contempl special case approach devis bariatr surgeon complic short long term high potenti sever case approach potenti put patient back normal metabol situat signific weight loss discuss main surgic approach morbid obes comment pros con
MED-5009~symptomat efficaci avocado soybean unsaponifi asu osteoarthr oa patient meta analysi random control trial pubm ncbi abstract object evalu efficaci prepar avocado soybean unsaponifi asus osteoarthr oa patient meta analysi random control trial rcts method rcts systemat search includ explicit state hip and or knee oa patient random asu placebo co primari outcom reduct pain lequesn index lead effect size es calcul standard differ secondari analysi number respond therapi analyz odd ratio restrict maximum likelihood method appli meta analys mix effect model result trials  al support manufacturer  wer includ num oa patient hip num knee num oa alloc num mg asu num placebo num averag trial durat num month rang num month base heterogen result combin pain reduct favor asu num num es num num confid interv num num num appli lequesn index favor asu num num es num num num num secondarili number respond asu compar placebo num num correspond number treat num patient conclus base evid patient recommend give asu chanc num month meta analysi data support chanc success patient knee oa hip oa
MED-5010~chemoprevent characterist avocado fruit pubm ncbi abstract phytochem recogn play import role cancer prevent fruit veget avocado wide grown consum fruit high nutrient low calori sodium fat studi shown phytochem extract avocado fruit select induc cell cycl arrest inhibit growth induc apoptosi precancer cancer cell line recent studi phytochem extract chloroform avocado fruit target multipl signal pathway increas intracellular reactiv oxygen lead apoptosi review summar report phytochem avocado fruit discuss molecular mechan target studi suggest individu combin phytochem avocado fruit offer advantag dietari strategi cancer prevent
MED-5011~effect av num natur sugar avocado malassezia furfur invas express hbd num cytokin human keratinocyt pubm ncbi abstract av num patent blend sugar avocado induc human beta defensin num product normal human keratinocyt studi analys effect av num growth invas malassezia furfur dimorph lipid depend yeast part normal human cutan commens flora abil modul express proinflammatori immunomodulatori cytokin normal human keratinocyt investig microbiolog assay demonstr sugar induc aggreg yeast cell inhibit invas furfur affect growth real tim pcr analysi demonstr av num modul hbd num respons treat keratinocyt reach maximum num treatment induc recoveri satisfactori proinflammatori respons human keratinocyt av num induc aggreg yeast cell inhibit penetr keratinocyt sugar prepar cosmet pharmacolog drug inhibit colon skin pathogen strain furfur
MED-5012~cholesterol low effect coconut flake human moder rais serum cholesterol pubm ncbi abstract studi investig effect coconut flake serum cholesterol level human moder rais serum cholesterol num subject serum total cholesterol subject differ rang num num mg dl studi conduct double blind random crossov design num week period consist num week experiment period experiment period separ num week washout period test food corn flake control food oat bran flake refer food corn flake num num dietari fiber coconut flake made coconut flour product result show signific percent reduct serum total low dens lipoprotein ldl cholesterol mg dl test food corn flake oat bran flake num num num num num coconut flake num num num num num coconut flake num num num num serum triglycerid signific reduc test food corn flake num num oat bran flake num num num coconut flake num num num coconut flake num num num subject consid serum triglycerid reduct serum triglycerid num mg dl conclus num num coconut flake reduc serum total ldl cholesterol serum triglycerid human moder rais serum cholesterol level coconut flour good sourc solubl insolubl dietari fiber type fiber signific role reduct lipid biomark knowledg studi conduct show relationship dietari fiber coconut by product lipid biomark result studi serv good basi develop coconut flakes flour function food justifi increas product coconut coconut by product
MED-5013~impair endotheli function  a mechan atherosclerosi high fat meal intak pubm ncbi abstract introduct endotheli dysfunct occur patient coronari arteri diseas flow medi dilat brachial arteri doppler ultrasound non invas techniqu assess endotheli function object studi method evalu pathophysiolog high fat hf intak endotheli function local popul popular local dish nasi lemak sourc high satur fat content coconut milk chosen repres local high fat meal lhf addit effect western high fat whf mcdonald meal low fat lf meal control endotheli function studi materi method studi popul consist num healthi male non smok age num num year normal bodi mass index normal fast sugar lipid profil nitric oxid depend flow medi dilat nitric oxid independ gtn dilat assess doppler flow brachial arteri num hour meal separ occas num experienc sonograph blind type meal result baselin brachial arteri size baselin vessel flow increas flow cuff deflat similar arteri studi respons reactiv hyperaemia cuff deflat endothelium depend dilat signific meal mark decreas endothelium depend dilat whf meal compar lf meal num num num num num mark decreas endothelium depend dilat lhf meal compar lf meal num num num num num compar hf meal chang endothelium depend dilat signific num num num gtn induc dilat signific lf whf lhf num num num num num num num conclus result suggest local popul impair endotheli function mechan pathophysiolog atherosclerosi hf intak affect lipid level effect observ lhf whf meal intak techniqu studi endotheli function non invas screen tool studi hf diet choic inform educ influenc dietari choic atherosclerosi
MED-5014~dietari intak risk coronari heart diseas coconut consum minangkabau west sumatra indonesia pubm ncbi abstract nutrit non nutrit pathway recognis develop occurr cardiovascular diseas popul high intak satur fat elev serum cholesterol concentr increas coronari heart diseas chd mortal studi report hyperlipidaemia heart diseas common popul consum coconut sourc satur fat case control studi conduct minangkabau high coconut consum examin differ food pattern risk coronari heart diseas chd coronari case gender age match appar healthi counterpart serv control elig subject chd identifi co oper particip hospit locat padang bukittinggi west sumatra indonesia total num elig case num men num women case group num subject num men num women control group recruit inform intak individu food dish preced num month obtain semi quantit food frequenc questionnair case group signific higher intak meat egg sugar tea coffe fruit lower intak soy product rice cereal compar control coconut consumpt flesh milk case control case signific higher intak protein cholesterol lower intak carbohydr similar intak satur unsatur fatti acid case control consumpt total fat satur fat includ coconut predictor chd food cultur intak anim food total protein dietari cholesterol plant deriv carbohydr predictor chd
MED-5015~intraven coconut water pubm ncbi abstract medic resourc routin intraven hydrat resuscit critic ill patient limit remot region world face shortag physician improvis resourc simpli report success coconut water short term intraven hydrat fluid solomon island patient laboratori analysi local coconut review previous document intraven coconut
MED-5016~effect dietari coconut oil butter safflow oil plasma lipid lipoprotein lathosterol level pubm ncbi abstract object aim present studi determin plasma level lathosterol lipid lipoprotein apolipoprotein diet rich butter coconut fat safflow oil design studi consist sequenti week period diet rich butter coconut fat safflow oil measur made baselin week num diet period subject forty on healthi pacif island polynesian live zealand particip trial intervent subject suppli food rich test fat detail dietari advic reinforc regular result plasma lathosterol concentr num ratio plasma lathosterol cholesterol num low densiti lipoprotein ldl cholesterol num apob num level signific diet signific lower coconut safflow oil diet compar butter diet plasma total cholesterol hdl cholesterol apoa level signific num diet signific buffer coconut diet conclus data suggest cholesterol synthesi lower diet rich coconut fat safflow oil compar diet rich butter lower product rate apob contain lipoprotein
MED-5017~associ betel nut chew chronic kidney diseas men pubm ncbi abstract background betel nut metabol syndrom obes associ betel nut chew risk chronic kidney diseas ckd unknown present studi conduct determin associ betel nut chew ckd men method retrospect review health check record num men hospital bas cross sect screen programm num num ckd defin estim glomerular filtrat rate num ml min num num calcul modif diet renal diseas formula risk factor ckd includ diabet hypertens bmi smoke alcohol consumpt age consid result total num num men found ckd num num particip report histori betel nut preval num ckd betel nut user signific higher num particip betel nut num multivari logist regress analysi adjust age hypertens diabet hyperlipidaemia betel nut independ ckd num adjust odd ratio betel nut num num ci num num conclus betel nut ckd men associ betel nut ckd independ age bmi smoke alcohol consumpt hypertens diabet hyperlipidaemia
MED-5018~american academi pediatr recommend effect earli nutrit intervent develop atop diseas abstract purpos review articl review aap statement earli nutrit intervent develop atop diseas infant children recent find recent find suggest restrict matern diet pregnanc lactat play major role develop allerg diseas high risk infant exclus breastfeed num month prevent delay atop dermat cow milk allergi wheez earli life evid supplement breastfeed hydrolyz formula protect atop diseas atop dermat risk infant final evid delay introduct complimentari food num num month age protect effect allergi insuffici data dietari intervent num num month age protect effect develop atop diseas summari high risk infant evid exclus breastfeed num month delay complimentari food num num month prevent develop allergi evid supplement hydrolyz formula high risk infant delay prevent allerg diseas convinc evid matern manipul diet pregnanc lactat soy product infant dietari restrict num num month effect develop atop diseas
MED-5019~cancer chemoprevent potenti appl appl juic appl compon pubm ncbi abstract appl malus sp rosacea rich sourc nutrient non nutri compon high level polyphenol phytochem main structur class appl constitu includ hydroxycinnam acid dihydrochalcon flavonol quercetin glycosid catechin oligomer procyanidin triterpenoid appl peel anthocyanin red appl line evid suggest appl appl product possess wide rang biolog activ contribut health benefici effect cardiovascular diseas asthma pulmonari dysfunct diabet obes cancer review boyer liu nutr num present review summar current knowledg potenti cancer prevent effect appl appl juic appl extract joint design appl product appl extract compon oligomer procyanidin shown influenc multipl mechan relev cancer prevent vitro studi includ antimutagen activ modul carcinogen metabol antioxid activ anti inflammatori mechan modul signal transduct pathway antiprolif apoptosis induc activ mechan epigenet event innat immun appl product shown prevent skin mammari colon carcinogenesi anim model epidemiolog observ regular consumpt appl day reduc risk lung colon cancer
MED-5020~phytochem appl peel isol structur elucid antiprolif antioxid activ pubm ncbi abstract bioactivity guid fraction red delici appl peel determin chemic ident bioactiv constitu show potent antiprolif antioxid activ twenty nin compound includ triterpenoid flavonoid organ acid plant sterol isol gradient solvent fraction diaion hp num silica gel od column prepar hplc chemic structur identifi hr ms num num nmr antiprolif activ isol pure compound hepg num human liver cancer cell mcf num human breast cancer cell evalu basi yield isol flavonoid compound num major flavonoid appl peel quercetin num o beta d glucopyranosid compound num num quercetin num o beta d galactopyranosid compound num num trace amount quercetin compound num num catechin compound num epicatechin compound num quercetin num o alpha l arabinofuranosid compound num compound isol quercetin num quercetin num o beta d glucopyranosid num show potent antiprolif activ hepg num mcf num cell ec num valu num num num num microm hepg num cell num num num num microm mcf num cell flavonoid num phenol compound num num show potent antioxid activ caffeic acid num quercetin num quercetin num o beta d arabinofuranosid num show higher antioxid activ ec num valu num microm test flavonoid phenol compound high antioxid activ compar ascorb acid respons antioxid activ appl result show appl peel phytochem potent antioxid antiprolif activ
MED-5021~mechan star fruit induc acut renal failur pubm ncbi abstract previous discov star fruit induc oligur acut renal failur investig mechan star fruit associ acut oxal nephropathi nephrotox effect star fruit examin cellular experi anim model evalu renal function patholog kidney tissu apoptot effect termin deoxynucleotidyl transferas nick end label tunel assay group rat control group cg fed tap water num star fruit group sg fed star fruit juic natur num oxal num oxal group oxg fed num num num num oxal solut effect star fruit juic oxal mdck cell analyz flow cytometri found creatinin clearanc signific lower sg num oxg num oxg dose depend apoptot effect evid tunel assay flow cytometri analysi treat mdck cell show dose time depend effect find suggest star fruit juic produc acut renal injuri obstruct effect calcium oxal crystal induc apoptosi renal epitheli cell caus level oxal fruit
MED-5022~sever lactic acidosi juic mangosteen fruit garcinia mangostana pubm ncbi abstract tropic mangosteen fruit long prize southeast asia tradit heal properti mangosteen fruit juic unit state market purport health benefit describ case sever lactic acidosi mangosteen juic dietari supplement
MED-5023~green algal infect human pubm ncbi abstract infect unicellular green alga human case report num year old woman develop persist infect heal oper wound dorsum foot contamin river water cano wound debrid num month histolog infect tissu mix suppur granulomat inflamm endosporul round oval microorgan rang num micron diamet organ multipl strong period acid schiff gomori methenamine silv gridley fungus posit granul cytoplasm organ tissu stain fluoresc antibodi conjug specif pathogen prototheca speci organ electron microscopi reveal membran cytoplasm profil consid remnant degener chloroplast find consist presenc green algal infect
MED-5024~dissemin chlorellosi dog pubm ncbi abstract adult dog ataxia lingual mass previous diagnos protothecosi euthan postmortem examin lingual mass region lung hilar lymph node liver mesenter sublumbar lymph node spinal mening pronounc green discolor histolog pyogranulomat inflamm algal organ found tongu spinal mening hilar mesenter lymph node liver lung alga cell wall posit period acid schiff cytoplasm granul ultrastructur alga well defin cell wall stack grana thylakoid membran dens bodi typic starch granul organ identifi chlorella green alga base result histochemist electron microscop examin author knowledg report dissemin chlorella infect report companion anim
MED-5025~detect hepatotox microcystin num kind cyanobacteria spirulina food product china pubm ncbi abstract gel filtrat chromatographi ultra filtr solid phas extract silica gel clean up evalu abil remov microcystin select extract cyanobacteria spirulina sampl reversed phas octadecylsilyl od cartridg subsequ analysi liquid chromatographi coupl tandem mass spectrometri lc ms ms reversed phas od cartridge silica gel combin effect optim wash elut condit num wash num methanol water wash num methanol water elut reversed phas od cartridg num methanol water elut silica gel cartridg presenc microcystin num kind cyanobacteria spirulina health food sampl obtain retail outlet china detect lc ms ms num sampl num microcystin rang num num ng num num num ng num signific lower microcystin present blue green alga product previous report mc rr molecul arginin num sampl predomin microcystin mc lr leucin num mc yr tyros num potenti health risk chronic exposur microcystin contamin cyanobacteria spirulina health food toxin concentr low method present propos detect microcystin present commerci cyanobacteria spirulina sampl
MED-5026~fruit veget fish consumpt heart rate variabl veteran administr normat age studi abstract background higher intak fruit veget dark fish prevent sudden cardiac death arrhythmia exact mechan fulli understood object examin high consumpt fruit veget dark fish benefici heart rate variabl hrv design hrv variabl measur num older men num total observ novemb num june num normat age studi community bas longitudin studi age dietari intak evalu self administ semiquantit food frequ questionnair categor quartil result control potenti confound intak green leafi veget posit normal high frequ power invers normal low frequ power trend num signific associ retain adjust healthi lifestyl factor physic activ multivitamin signific associ hrv measur intak fruit veget vitamin carotenoid tuna dark meat fish num omega num fatti acid effect modif intak noncitrus fruit obes total veget crucifer veget cigarett smoke warrant investig conclus find suggest higher intak green leafi veget reduc risk cardiovascular diseas favor cardiac autonom function
MED-5027~diet risk ischem heart diseas india pubm ncbi abstract background ischem heart diseas ihd lead death india dietari reduc risk studi address associ diet ihd risk india object goal address associ diet ihd risk indian delhi northern india bangalor southern india design collect data num case acut myocardi infarct num control match basi age sex hospit part hospital bas case control studi num hospit long term dietari intak assess food frequ questionnair develop delhi bangalor condit logist regress control match factor predictor risk result observ signific dose depend invers associ veget intak ihd risk invers associ stronger green leafi veget multivari analysi person consum median num servings wk num lower relat risk rr num num ci num num trend num consum num servings wk control dietari covari alter associ cereal intak lower risk mustard oil rich alpha linolen acid lower risk sunflow oil cook rr num num ci num num fri rr num num ci num num conclus diet rich veget mustard oil contribut lower risk ihd indian
MED-5028~food group renal cell carcinoma result case control studi pubm ncbi abstract background role diet renal cell carcinoma risk inconclus studi integr approach assess role food group food item renal cell carcinoma risk design case control studi conduct num subjects set incid case num identifi hospit record florida cancer registri popul control num frequenc match age num year sex race identifi random digit dial eat habit assess num item block food frequenc questionnair statist analys odd ratio num confid interv cis test trend calcul logist regress control age sex race incom bodi mass index pack year smoke result decreas renal cell carcinoma risk observ total sampl men veget consumpt subject num num ci num num men num num ci num num fruit consumpt tomato consumpt decreas renal cell carcinoma risk total popul men subject num num ci num num men num num ci num num increas risk renal cell carcinoma observ subject women increas consumpt red meat subject num num ci num num women num num ci num num white bread consumpt increas renal cell carcinoma risk women num num ci num num total dairi consumpt num num ci num num conclus protect role veget increas risk renal cell carcinoma meat consumpt support protect role fruit find includ increas risk renal cell carcinoma white bread white potato consumpt decreas risk renal cell carcinoma tomato consumpt
MED-5029~control head lice coconut deriv emuls shampoo pubm ncbi abstract object evalu coconut deriv emuls cde shampoo head lice infest children design school trial pupil treat day num num check day num num famili trial product appli parent time num week cosmet shampoo check day num day num set uk school bristol western super mar famili northern somerset main outcom measur number children free infest treatment result school trial percentag cure day num num permethrin num num cde num famili trial famili member treat cure rate num num shampoo subsequ cosmet shampoo num num children re infest num week conclus cde shampoo effect method control head lice treatment cosmet shampoo aid reduct re infest
MED-5030~associ sleep durat mortal cardiovascular diseas japanes men women jacc studi abstract studi object examin sex specif associ sleep durat mortal cardiovascular diseas design cohort studi set community bas studi particip total num subject num men num women age num num year num num num intervent n a measur result median follow up num year num death men women num num stroke num num coronari heart diseas num num cardiovascular diseas num num cancer num num num compar sleep durat num hour sleep durat num hour increas mortal coronari heart diseas women noncardiovascular disease noncanc sex respect multivari hazard ratio num num num coronari heart diseas women num num num num num num noncardiovascular disease noncanc num num num num num num men women long sleep durat num hour longer num num fold increas mortal total ischem stroke total cardiovascular diseas noncardiovascular disease noncanc men women compar num hour sleep sex associ sleep durat cancer mortal sex conclus short long sleep durat increas mortal cardiovascular diseas noncardiovascular disease noncanc sex yield u shap relationship total mortal nadir num hour sleep citat ikehara iso date kikuchi watanab wada inaba tamakoshi associ sleep durat mortal cardiovascular diseas japanes men women jacc studi sleep num num num num
MED-5031~sleep habit suscept common cold abstract background sleep qualiti thought import predictor immun turn suscept common cold articl examin sleep durat effici week preced viral exposur cold suscept method particip num healthi men women volunt age num num num consecut day report sleep durat sleep effici percent time bed asleep previous night felt rest averag score sleep variabl calcul num day baselin subsequ particip administ nasal drop rhinovirus quarantin monitor day day exposur develop clinic cold infect presenc object sign ill result grade associ averag sleep durat num hour sleep num time ci num num num develop cold num hour associ sleep effici grade num effici num time ci num num num develop cold effici num relat explain differ pre challeng virus specif antibodi demograph season year bodi mass socioeconom status psycholog variabl health practic percent day feel rest cold conclus poorer sleep effici shorter sleep durat week preced exposur rhinovirus lower resist ill
MED-5032~process meat risk childhood leukemia california usa pubm ncbi abstract relat intak food item thought precursor inhibitor n nitroso compound noc risk leukemia investig case control studi children birth age num year los angel counti california unit state case ascertain population bas tumor registri num num control drawn friend random digit dial interview obtain num case num control food item princip interest breakfast meat bacon sausag ham luncheon meat salami pastrami lunch meat corn beef bologna hot dog orang orang juic grapefruit grapefruit juic intak appl appl juic regular charcoal broil meat milk coffe coke cola drink usual consumpt frequenc determin parent child risk adjust risk factor persist signific associ children intak hot dog odd ratio num num percent confid interv ci num num num hot dog month trend num father intak hot dog num ci num num highest intak categori trend num evid fruit intak provid protect result compat experiment anim literatur hypothesi human noc intak leukemia risk potenti bias data studi hypothesi focus comprehens epidemiolog studi warrant
MED-5033~cancer prevent diseas requir major lifestyl abstract year num million american num million peopl worldwid expect diagnos cancer diseas common believ prevent num num cancer case attribut genet defect remain num num root environ lifestyl lifestyl factor includ cigarett smoke diet fri food red meat alcohol sun exposur environment pollut infect stress obes physic inact evid cancer rel death num num due tobacco num num link diet num num due infect remain percentag due factor radiat stress physic activ environment pollut cancer prevent requir smoke cessat increas ingest fruit veget moder alcohol calor restrict exercis avoid direct exposur sunlight minim meat consumpt grain vaccin regular check up review present evid inflamm link agents factor cancer agent prevent addit provid evid cancer prevent diseas requir major lifestyl
MED-5034~cure broil meat consumpt relat childhood cancer denver colorado unit state pubm ncbi abstract associ cure broil meat consumpt mother pregnanc child examin relat childhood cancer meat group ham bacon sausag hot dog hamburg bologna pastrami corn beef salami lunch meat charcoal broil food assess exposur num cancer case includ num acut lymphocyt leukemia num brain tumor num control select random digit dial denver colorado unit state standard metropolitan statist area compar adjust confound matern hot dog consumpt time week childhood brain tumor odd ratio num num percent confid interv ci num num children eat hamburg time week risk num ci num num eat hot dog time week brain tumor num ci num num children combin vitamin eat meat strong brain cancer vitamin meat consumpt produc result link hot dog brain tumor replic earlier studi appar synerg vitamin meat consumpt suggest advers effect dietari nitrit nitrosamin
MED-5035~meat fish consumpt cancer canada pubm ncbi abstract studi examin associ meat fish intak risk cancer mail questionnair complet num incid histolog confirm case cancer stomach colon rectum pancrea lung breast ovari prostat testi kidney bladder brain non hodgkin lymphoma nhl leukemia num popul control num num num canadian provinc measur includ inform socioeconom status lifestyl habit diet num item food frequenc questionnair provid data eat habit num yr data collect odd ratio num confid interv deriv uncondit logist regress total meat process meat direct relat risk stomach colon rectum pancrea lung breast postmenopaus prostat testi kidney bladder leukemia red meat signific colon lung men bladder cancer relat observ cancer ovari brain nhl consist excess risk emerg fish poultri invers relat risk number cancer site find add evid meat specif red process meat play unfavor role risk cancer fish poultri favor diet indic
MED-5036~meta analysi long term mobil phone associ brain tumour pubm ncbi abstract evalu long term mobil phone risk brain tumour case control studi publish issu identifi ten studi glioma meta analysi yield num num ci num num latenc period num year gave num num ci num num base studi ipsilater side tumour num num ci num num studi contralater increas risk signific num num ci num num meta analysi studi acoust neuroma gave num num ci num num increas num num ci num num num year latenc period studi ipsilater gave num num ci num num contra later num num ci num num num year latenc period group studi studi gave result meningioma yield num num ci num num num year latenc period num num ci num num calcul studi increas num num ci num num ipsilater num num ci num num contralater studi conclud meta analysi gave consist pattern associ mobil phone ipsilater glioma acoust neuroma num year latenc period
MED-5037~extract carob ceratonia siliqua chemoprevent potenti relat oxid stress drug metabol human colon cell pubm ncbi abstract phenol ingredi aqueous carob extract character consist gallic acid ga order assess chemoprevent mechan carob cacao substitut effect express gene relat stress respons drug metabol studi human colon cell line transform state lt num ht num stress rel gene catalas cat superoxid dismutas sod num induc carob extract ga lt num adenoma ht num carcinoma cell protein product enzym activ elev pretreat carob extract ga num reduc dna damag cell challeng hydrogen peroxid num num conclus carob extract major phenol ingredi ga modul gene express protect colon adenoma cell genotox impact num num upregul stress respons gene relat function consequ
MED-5038~chocol lifestyl health pubm ncbi abstract interest biolog activ cocoa polyphenol increas steadili fact high polyphenol content cocoa coupl widespread presenc food item render food interest nutrit pharmacolog viewpoint paper summar find develop effect cocoa chocol consumpt human health present intern confer chocol lifestyl health milan itali march num effect cocoa chocol consumpt human health
MED-5039~cocoa cardiovascular health pubm ncbi abstract epidemiolog data demonstr regular dietari intak plant deriv food beverag reduc risk coronari heart diseas stroke ingredi cocoa import mediat recent research demonstr benefici effect cocoa blood pressur insulin resist vascular platelet function debat rang potenti mechan cocoa exert benefit cardiovascular health propos includ activ nitric oxid antioxid antiinflammatori effect review summar data cardiovascular effect cocoa outlin potenti mechan involv respons cocoa highlight potenti clinic implic consumpt
MED-5040~acut dark chocol cocoa ingest endotheli function random control crossov trial pubm ncbi abstract background studi suggest cardioprotect benefit dark chocol cocoa object studi examin acut effect solid dark chocol liquid cocoa intak endotheli function blood pressur overweight adult design random placebo control single blind crossov trial num healthi adult age num bodi mass index kg m num phase num subject random assign consum solid dark chocol bar num cocoa powder cocoa fre placebo bar num cocoa powder phase num subject random assign consum sugar fre cocoa num cocoa powder sugar cocoa num cocoa powder placebo num cocoa powder result solid dark chocol liquid cocoa ingest improv endotheli function measur flow medi dilat compar placebo dark chocol num num compar num num num sugar fre sugar cocoa num num num num compar num num num blood pressur decreas ingest dark chocol sugar fre cocoa compar placebo dark chocol systol num num mm hg compar num num mm hg num diastol num num mm hg compar num num mm hg num sugar fre cocoa systol num num mm hg compar num num mm hg num diastol num num mm hg compar num num mm hg num endotheli function improv signific sugar fre regular cocoa num num compar num num num conclus acut ingest solid dark chocol liquid cocoa improv endotheli function lower blood pressur overweight adult sugar content attenu effect sugar fre prepar augment
MED-5041~flavanol intak influenc mortal nitric oxide depend process ischem heart diseas stroke diabet mellitus cancer panama abstract substanti data suggest flavonoid rich food prevent cardiovascular diseas cancer cocoa richest sourc flavonoid current process reduc content substanti kuna live san blas drink flavanol rich cocoa main beverag contribut num mg day flavonoid rich diet popul diagnosi death certif compar cause specif death rate year num num mainland san blas island kuna live hypothesi high flavanoid intak consequ nitric oxid system activ import result reduct frequenc ischem heart diseas stroke diabet mellitus cancer nitric oxid sensit process num death mainland panama num death san blas mainland panama anticip cardiovascular diseas lead death num num age adjust death num cancer num num contrast rate cvd cancer island dwel kuna lower num num num num similar death due diabet mellitus common mainland num num san blas num num compar lower risk kuna san blas common morbid mortal world possibl reflect high flavanol intak sustain nitric oxid synthesi activ risk factor observ studi provid definit evid
MED-5042~flavanol kuna cocoa consumpt nitric oxid abstract kuna indian resid archipelago caribbean coast panama low blood pressur level live longer panamanian reduc frequenc myocardi infarct stroke diabet mellitus cancer death certif outstand featur diet includ high intak flavanol rich cocoa flavonoid cocoa activ nitric oxid synthesi healthi human possibl high flavanol intak protect kuna high blood pressur ischem heart diseas stroke diabet mellitus cancer suffici intrigu suffici import larg random control clinic trial pursu
MED-5043~hibiscus sabdariffa extract inhibit mutagen microsuspens assay prolifer hela cell pubm ncbi abstract hibiscus sabdariffa refresh beverag tradit medicin object studi determin vitro effect phenol compound present aqueous ethyl acet chloroform extract sabdariffa mutagen num nitropyren num np antiprolif effect extract inhibit cell prolifer dna fragment test transform human hela cell hot aqueous extract hae num num mg protocatechu acid pca gram lyophil dri extract statist cold aqueous chloroform extract ethyl acet extract produc amount pca sabdariffa extract inhibit mutagen num np dose respons manner inhibit rate hela cell hae dose depend hae induc dna fragment result suggest sabdariffa extract antimutagen activ num np decreas prolifer hela cell due phenol acid composit
MED-5044~anti genotox effect ocimum sanctum extract cyproteron acet induc genotox damag cultur mammalian cell pubm ncbi abstract anti genotox effect ocimum sanctum extract studi genotox effect induc synthet progestin cyproteron acet human lymphocyt chromosom aberr mitot index sister chromatid exchang replic index paramet num microm cyproteron acet treat sanctum infus dosag num num num num num num num num num g ml cultur medium clear dose depend decreas genotox damag cyproteron acet observ suggest modul role plant infus result present studi suggest plant infus se genotox potenti modul genotox cyproteron acet human lymphocyt vitro
MED-5045~suppress effect select food phytochem cd num express nci n num gastric carcinoma cell abstract helicobact pylori pylori widespread human pathogen play major role chronic gastriti gastric cancer cd num gastric epitheli cell recent identifi adhes molecul ureas pylori studi found cd num high express constitut manner nci n num human gastric carcinoma cell protein mrna level compar hs num int fetal gastric cell subsequ cell bas elisa rapid screen suppress agent cd num express establish nci n num cell treat separ num food phytochem num num num subject assay result citrus coumarin bergamottin promis compound lc num ic num greater num luteolin num nobiletin num quercetin num find suggest cd num suppress uniqu candid prevent pylori adhes subsequ infect reason action mechan
MED-5046~common tea formul modul vitro digest recoveri green tea catechin pubm ncbi abstract epidemiolog evid suggest role tea catechin reduct chronic diseas risk stabil catechin digest condit poor understood object studi character effect common food addit digest recoveri tea catechin green tea water extract formul beverag provid num num num mg num ml epicatechin ec epigallocatechin egc epigallocatechin gal egcg epicatechin gal ecg common commerci beverag addit citric acid ca bht edta ascorb acid aa milk bovin soy rice citrus juic orang grapefruit lemon lime formul finish tea beverag increment dosag sampl subject vitro digest simul gastric small intestin condit pre post digest catechin profil assess hplc catechin stabil green tea poor num total catechin remain post digest egc egcg sensit doubl equal num recoveri tea formul num bovin soy rice milk increas total catechin recoveri signific num num includ num mg aa num ml tea beverag signific num increas catechin recoveri egc egcg ec ecg num num num juic prepar result highest recoveri formul egc num egcg num ec num ecg num data provid evid tea consumpt practic formul factor impact catechin digest recoveri result divers physiolog profil
MED-5047~associ concentr green tea blood glucos level abstract object examin habitu green tea consumpt blood glucos level biomark glucos metabol conduct cross sect studi num male volunt num num year resid shizuoka prefectur japan biochem data measur conduct questionnair survey health lifestyl nutrit frequenc consumpt concentr num num green tea men consum num concentr green tea show lower valu fast blood glucos fructosamin consum num concentr fast blood glucos level found signific green tea concentr num num green tea consumpt frequenc show signific differ level blood glucos fructosamin hemoglobin num conclus find suggest consumpt green tea high concentr potenti reduc blood glucos level
MED-5048~effect green tea epigallocatechin gallat ethanol induc toxic hepg num cell pubm ncbi abstract continu report support hepatoprotect effect green tea ethanol intox remain controversi activ compound molecular mechan issu address present studi cultur hepg num cell expos lethal dose ethanol gamma glutamyl transferas ggt chosen marker ethanol toxic wide clinic cell treat ethanol concentr dose depend increas ggt activ cultur media loss cell viabil pretreat cell green tea extract attenu signific green tea constitu epigallocatechin gallat egcg attenu ethanol cytotox effect l theanin caffein effect ethanol cytotox attenu alcohol dehydrogenas inhibitor num methyl pyrazol ggt inhibitor acivicin thiol modul s adenosyl l methionin n acetyl l cystein glutathion egcg fail prevent intracellular glutathion loss caus ethanol strong ggt inhibitor cytoprotect effect green tea attribut inhibit ggt activ egcg studi suggest ggt inhibitor includ egcg provid strategi attenu ethanol induc liver damag
MED-5049~associ soy green tea camellia sinensi diminish hypercholesterolemia increas total plasma antioxid potenti dysli pubm ncbi abstract object evalu hypolipem antioxid effect soy green tea and or associ dyslipidem subject method hundr dyslipidem individu alloc group soy group ingest num soy kinako daili green tea group ingest num green tea num ml water day group ingest num soy num green tea daili control group hypocholesterolem diet evalu perform baselin num num plasma level total cholesterol high dens lipoprotein triacylglycerol evalu autom method low dens lipoprotein ldl cholesterol calcul friedewald equat ldl isol ultracentrifug total plasma antioxid capac plasma level total lipid hydroperoxid link ldl evalu chemiluminesc result express median valu num num percentil num level signific result signific differ occur ldl high dens lipoprotein cholesterol triacylglycerol level group statist signific differ total cholesterol occur soy green tea group num num intervent statist signific differ occur plasma level lipid hydroperoxid link ldl group studi group soy and or green tea present increas total plasma antioxid potenti conclus soy green tea combin increas total antioxid potenti hypercholesterolem patient combin decreas total cholesterol level
MED-5050~l theanin natur constitu tea effect mental state pubm ncbi abstract tea wide consum beverag world water tea rich sourc flavonoid antioxid tea uniqu amino acid l theanin modul aspect brain function human evid human electroencephalograph eeg studi show direct effect brain juneja al trend food scienc tech num num l theanin signific increas activ alpha frequenc band relax mind induc drowsi effect establish higher dose typic found cup black tea approxim num aim current research establish effect realist dietari level eeg measur healthi young particip baselin num num num minut ingest num l theanin num placebo num particip rest eye close eeg record greater increas alpha activ time l theanin condit relat placebo num studi replic effect particip engag passiv activ data l theanin realist dietari level signific effect general state mental alert arous alpha activ play import role critic aspect attent research focuss understand effect l theanin attent process
MED-5052~green tea literatur review clinic evid pubm ncbi abstract object habitu green tea consumpt long health benefit includ chemoprevent cardiovascular protect non systemat literatur review present clinic evid date method literatur review peer review articl observ intervent studi conduct includ green tea extract purifi polyphenol epigallocatechin num gallat egcg electron databas search includ pubm num cochran librari issu num result observ studi inconclus benefit habitu consumpt green tea prevent cancer trend prevent breast prostat cancer intervent studi demonstr reduct relaps surgic resect colorect adenoma increas surviv rate epitheli ovarian cancer observ studi green tea provid protect hypertens reduc risk stroke intervent studi provid biochem physiolog evid conclus clinic evid inconclus habitu green tea consumpt provid level chemoprevent prostat breast cancer green tea attenu risk factor associ develop atherosclerosi reduc incid cardiovascular event stoke
MED-5053~artifici sweeten consumpt urinari tract tumor cordoba argentina pubm ncbi abstract object determin role habitu common artifici sweeten develop urinari tract tumor utt argentina method case control studi num patient histolog confirm utt transit varieti num control acut non neoplast non urinari tract diseas admit hospit rdoba argentina num num subject interview exposur suspect risk factor utt result fifty on utt patient num num control num risk utt signific increas long term num year user compar none a user num ci long term consum num num num short term user num num num adjust age gender bmi social status year tobacco conclus regular num year posit utt
MED-5054~potenti toxic artifici sweeten pubm ncbi abstract discoveri safeti artifici sweeten controversi artifici sweeten provid sweet sugar calori public health attent turn revers obes epidem unit state individu age choos product choic benefici toler sugar diet diabet scientist disagre relationship sweeten lymphoma leukemia cancer bladder brain chronic fatigu syndrom parkinson diseas alzheimer diseas multipl sclerosi autism system lupus recent substanc receiv increas attent due effect glucos regul occup health nurs accur time inform counsel individu substanc articl overview type artifici sweeten sweeten histori chemic structur biolog fate physiolog effect publish anim human studi current standard regul
MED-5055~critic review genet toxic steviol steviol glycosid pubm ncbi abstract extract leav stevia plant stevia rebaudiana bertoni sweeten food beverag south america japan china compon respons sweet properti plant glycosid steviol primari steviosid ent num hydroxykaur num en num oic acid num time sweeter sucros rebaudiosid steviosid steviol subject extens genet test major find show evid genotox activ steviosid aglycon steviol shown react direct dna demonstr genotox damag assay relev human risk mutagen activ steviol deriv exhibit strain tm num reproduc bacteria normal dna repair process singl posit vivo studi measur single strand dna break wistar rat tissu steviosid confirm experi mice measur process direct dna damag steviosid steviol induc clastogen effect extrem high dose level vivo applic weight of evid approach assess genet toxicolog databas conclud substanc pose risk genet damag human consumpt
MED-5056~total antioxid content altern refin sugar pubm ncbi abstract background oxid damag implic etiolog cancer cardiovascular diseas degen disord recent nutrit research focus antioxid potenti food current dietari recommend increas intak antioxidant rich food supplement specif nutrient altern refin sugar includ raw cane sugar plant saps syrup mapl syrup agav nectar molass honey fruit sugar date sugar unrefin sweeten hypothes higher level antioxid similar contrast refin grain product object compar total antioxid content natur sweeten altern refin sugar design ferric reduc abil plasma frap assay estim total antioxid capac major brand num type sweeten refin white sugar corn syrup sampl retail outlet unit state result substanti differ total antioxid content sweeten found refin sugar corn syrup agav nectar minim antioxid activ num mmol frap num raw cane sugar higher frap num mmol num dark blackstrap molass highest frap num num mmol num mapl syrup brown sugar honey show intermedi antioxid capac num num mmol frap num base averag intak num g day refin sugar antioxid activ measur typic diet substitut altern sweeten increas antioxid intak averag num mmol day similar amount found serv berri nut conclus readili altern refin sugar offer potenti benefit antioxid activ
MED-5057~effect high fructos syrup pubm ncbi abstract high fructos corn syrup hfcs increas common food ingredi num year concern hfcs consumpt increas risk obes advers health outcom compar calor sweeten common type hfcs hfcs num hfcs num similar composit sucros tabl sugar consist rough equal amount fructos glucos primari differ monosaccharid exist free solut hfcs disaccharid form sucros disaccharid sucros easili cleav small intestin free fructos glucos absorb sucros hfcs advantag food manufactur free monosaccharid hfcs provid flavor enhanc stabil fresh textur color pourabl consist food comparison sucros composit hfcs sucros similar absorpt bodi hfcs contribut obes condit sucros studi evalu potenti differenti effect sweeten relat health condit obes develop long period time improv nutrient databas analyz food consumpt epidemiolog studi strong design experiment studi includ mechan action relationship fructos dose respons present time insuffici evid ban restrict hfcs fructose contain sweeten food suppli requir warn label product hfcs dietari advic limit consumpt ad calor sweeten includ hfcs warrant
MED-5058~sucros behavior problem pubm ncbi abstract mechan sucros influenc behavior review food intoler dozen food advers reaction demonstr reaction sucros frequent food mechan hypoglycemia evid tendenc develop low blood glucos level higher clinic hypoglycem irrit violenc sucros predomin swing blood glucos level role sucros intak micro nutri status consid studi found micro nutri supplement decreas anti soci behavior micro nutri intak close total energi sucros intak typic amount sucros diet lead micro nutri defici fact meta analysi design studi examin impact sucros behavior children produc evid advers influenc
MED-5059~evalu food addit seventy first report joint fao who expert committe food addit pubm ncbi abstract report repres conclus joint fao who expert committe conven evalu safeti food addit view recommend accept daili intak adi prepar specif ident puriti part report general discuss principl govern toxicolog evalu assess intak food addit summari committee evalu technic toxicolog intak data food addit branch glycosyltransferas rhodothermus obamensi express bacillus subtili cassia gum cyclam acid salt dietari exposur assess cyclotetraglucos cyclotetraglucos syrup ferrous ammonium phosphat glycerol ester gum rosin glycerol ester tall oil rosin lycopen sourc lycopen extract tomato miner oil low medium viscos class ii class iii octenyl succin acid modifi gum arab sodium hydrogen sulfat sucros oligoest type type ii specif food addit revis diacetyltartar acid fatti acid ester glycerol ethyl lauroyl argin glycerol ester wood rosin nisin prepar nitrous oxid pectin starch sodium octenyl succin tannic acid titanium dioxid triethyl citrat annex report tabl summar committee recommend intak toxicolog evalu food addit consid
MED-5060~domest farm anim exposur risk non hodgkin lymphoma population bas studi san francisco bay area abstract object assess associ anim exposur non hodgkin lymphoma nhl method exposur data collect num case num control in person interview population bas case control studi nhl san francisco bay area odd ratio num confid interv cis adjust potenti confound result pet owner reduc risk nhl num ci num num diffus large cel immunoblast large cel dlcl or num ci num num compar pet dog and or cat reduc risk nhl num ci num num dlcl num ci num num longer durat cat ownership p trend num dog ownership p trend num dog and or cat ownership p trend num invers risk nhl ownership pet cat dog reduc risk nhl num ci num num dlcl num ci num num exposur cattl num year increas risk nhl num ci num num exposur pig nhl num ci num num dlcl num ci num num conclus associ anim exposur nhl warrant investig pool analys
MED-5061~human antibodi reactiv bovin leukemia virus pubm ncbi abstract bovin leukemia virus blv oncogen retrovirus common infect cattl cell leukosi num infect cattl blv infect cell present market beef dairi product decad discoveri blv num studi agar gel immunodiffus complement fixat assay fail find antibodi blv human sera led prevail opinion exposur human blv and or potenti infect signific virus public health hazard reexamin issu sensit immunolog techniqu today immunoblot test sera num human antibodi isotyp igg num igm iga igg num blv capsid antigen num detect antibodi isotyp reactiv blv num human sera test specif reactiv strong suggest competit studi rule cross react antibodi chronic human virus result suggest antibodi reactiv blv capsid antigen serv biomark exposur blv exposur widespread result necessarili human infect blv antibodi respons heat denatur blv antigen consum food suggest studi area import
MED-5062~food addit hyperact behaviour num year old num year old children communiti randomis double blind placebo control pubm ncbi abstract background undertook randomis double blind placebo control crossov trial test intak artifici food colour addit afca affect childhood behaviour method num year old num num year old children includ studi challeng drink sodium benzoat afca mix placebo mix main outcom measur global hyperact aggreg gha base aggreg z score observ behaviour rate teacher parent num year old children computeris test attent clinic trial regist current control trial registr number isrctn num analysi protocol find num year old children num num year old children complet studi reason unrel childhood behaviour mix signific advers effect compar placebo gha num year old children effect size num num ci num num num mix versus placebo result persist analysi restrict num year old children consum num juic miss data num num num num num year old children show signific advers effect mix num num num num mix num num num num analysi restrict children consum num drink miss data interpret artifici colour sodium benzoat preserv diet result increas hyperact num year old num year old children general popul
MED-5063~food addit hyperact evid support trial period elimin colour preserv diet
MED-5064~consumpt brussel sprout protect peripher human lymphocyt num amino num methyl num phenylimidazo num b pyridin phip oxid pubm ncbi abstract find cancer protect effect brussel sprout epidemiolog studi due protect dna damag intervent trial conduct impact veget consumpt dna stabl monitor lymphocyt comet assay consumpt sprout num g p d num reduct dna migr num induc heterocycl aromat amin num amino num methyl num phenyl imidazo num b pyridin phip observ effect num amino num methyl num pyrido num b  indol trp p num effect protect due inhibit sulfotransferas num play key role activ phip addit decreas endogen format oxid base observ dna damag caus hydrogen peroxid signific num lower intervent effect explain induct antioxid enzym glutathion peroxidas superoxid dismutas vitro experi sprout compound act direct scaveng reactiv oxygen speci serum vitamin level increas num sprout consumpt correl prevent dna damag individu alter vitamin level studi show time sprout consumpt lead inhibit sulfotransferas human protect phip oxid dna damag
MED-5065~anthocyanin rich grape extract block breast cell dna damag pubm ncbi abstract anthocyanin belong flavonoid famili phytochem receiv attent agent potenti prevent chronic diseas cardiovascular diseas cancer present studi anthocyanin rich extract concord grape refer concord grape extract cge anthocyanin delphinidin evalu capac inhibit dna adduct format due environment carcinogen benzo a pyren bp mcf num cell noncancer immort human breast epitheli cell line cge num num microg ml delphinidin num microm concentr signific inhibit bp dna adduct format signific increas activ phase ii detoxif enzym glutathion s transferas nad h quinon reductas num addit grape compon suppress reactiv oxygen speci ros format induc antioxid respons element depend transcript data suggest cge compon grape anthocyanin breast cancer chemoprevent potenti due part capac block carcinogen dna adduct format modul activ carcinogen metabol enzym suppress ros noncancer human breast cell
MED-5066~influenc diet high veget fruit fiber low fat prognosi treatment breast cancer abstract context evid lack dietari pattern high veget fruit fiber low total fat influenc breast cancer recurr surviv object assess major increas veget fruit fiber intak decreas dietari fat intak reduc risk recurr primari breast cancer all caus mortal women previous treat earli stage breast cancer design set particip multi institut random control trial dietari chang num women previous treat earli stage breast cancer num num year diagnosi women enrol num num june num intervent intervent group num random assign receiv telephon counsel program supplement cook class newslett promot daili target num veget serv num oz veget juic num fruit serv num fiber num num energi intak fat comparison group num provid print materi describ num a day dietari guidelin main outcom measur invas breast cancer event recurr primari death result compar dietari pattern baselin conserv imput analysi show intervent group achiev maintain statist signific differ comparison group num year serv veget num fruit num fiber num energi intak fat num plasma carotenoid concentr valid fruit veget intak studi women group receiv similar clinic care num year follow up num women intervent group num num comparison group num experienc invas breast cancer event adjust hazard ratio num num confid interv num num num num intervent group women num num comparison group women num die adjust hazard ratio num num confid interv num num num signific interact observ diet group baselin demograph characterist origin tumor baselin dietari pattern breast cancer treatment conclus survivor earli stage breast cancer adopt diet high veget fruit fiber low fat reduc addit breast cancer event mortal num year follow up period trial registr clinicaltri gov identifi nct num
MED-5069~bean berri teamwork plant chemic protect optim human health pubm ncbi abstract consum world fruit veget prevent treat chronic human diseas peopl don t fulli singl compon plant deriv food complex mixtur interact natur chemic produc power health protect effect natur compon accumul simultan plant provid multifacet defens strategi plant human consum order investig strength natur chemic cooper highly pig flavonoid rich function food lab reli analysi fruit continu reliabl plant cell cultur product system accumul anthocyanin proanthocyanidin high concentr success round gentl rapid large volum fraction link bioassay complex simpl mixtur semi purifi compound strategi addit interact synergi relat compound health mainten sort interest phytochem interact class compound intensifi efficaci flavonoid rich fruit multipl necessarili discret human diseas condit includ cvd cancer metabol syndrom
MED-5070~berri extract exert antiprolif effect cervic colon cancer cell grown vitro pubm ncbi abstract polyphenol rich berri extract screen antiprolif effect human cervic cancer hela cell grown microtit plate rowan berri raspberri lingonberri cloudberri arctic brambl strawberri extract effect blueberri sea buckthorn pomegran extract effect effect extract strawberri arctic brambl cloudberri lingonberri gave ec num valu rang num microg ml phenol extract effect human colon cancer caco num cell general sensit low concentr convers sensit higher concentr strawberri cloudberri arctic brambl raspberri extract share common polyphenol constitu ellagitannin shown effect antiprolif agent compon effect lingonberri extract lingonberri extract fraction anthocyanin rich tannin rich fraction chromatographi sephadex lh num anthocyanin rich fraction effect origin extract antiprolif activ retain tannin rich fraction polyphenol composit lingonberri extract assess liquid chromatography mass spectrometri similar previous report tannin rich fraction compos procyanidin linkag type antiprolif activ lingonberri caus predomin procyanidin
MED-5071~identif anthocyanin liver eye brain blueberry f pig pubm ncbi abstract dietari intervent anthocyanin confer benefit brain function includ vision research date anim limit capac absorb anthocyanin compar type flavonoid pig suitabl model human digest absorpt examin deposit anthocyanin tissu includ liver eye brain tissu pig fed diet supplement num num num w w blueberri vaccinium corymbosum jersey num week prior euthanasia pig fast num anthocyanin detect plasma urin fast anim intact anthocyanin detect tissu sought lc ms ms result present relat concentr num intact anthocyanin liver eye cortex cerebellum result suggest anthocyanin accumul tissu includ tissu blood brain barrier
MED-5072~lycopene rich treatment modifi noneosinophil airway inflamm asthma proof concept pubm ncbi abstract antioxidant rich diet reduc asthma preval direct evid alter intak antioxidant rich food affect asthma lack object investig asthma airway inflamm result low antioxid diet subsequ lycopene rich treatment asthmat adult num consum low antioxid diet num day commenc random cross ov trial involv num num day treatment arm placebo tomato extract num mg lycopene day tomato juic num mg lycopene day consumpt low antioxid diet plasma carotenoid concentr decreas asthma control score worsen fev num fvc decreas sputum neutrophil increas treatment tomato juic extract reduc airway neutrophil influx treatment tomato extract reduc sputum neutrophil elastas activ conclus dietari antioxid consumpt modifi clinic asthma outcom chang dietari antioxid intak contribut rise asthma preval lycopene rich supplement investig therapeut intervent
MED-5073~polyphenol antioxid properti almond skin influenc industri process pubm ncbi abstract almond prunus dulcis mil webb skin propos sourc bioactiv polyphenol articl phenol composit antioxid activ almond skin obtain process blanch freeze dri blanch dri roast studi total num phenol compound flavan num ol num num total phenol compound identifi flavonol glycosid num num hydroxybenzo acid aldehyd num num flavonol aglycon num num flavanon glycosid num num flavanon aglycon num num hydroxycinnam acid num num dihydroflavonol aglycon num num determin skin num varieti almond total content phenol compound identifi signific num higher num fold roast sampl blanch almond freeze dri industri dri oven dri blanch almond skin produc increas num fold content phenol compound result statist signific num sampl antioxid activ orac valu higher roast sampl num num mmol trolox g sampl subject blanch dri num num mmol trolox g blanch freeze dri sampl num num mmol trolox g roast suitabl type industri process almond obtain almond skin extract greatest antioxid capac
MED-5074~effect microwav cook condit bioactiv compound present broccoli infloresc pubm ncbi abstract cook domest process method great impact food nutrient brassica brassicacea crucifera veget consum cook cook affect health promot compound specif glucosinol phenol compund miner vitamin studi microwav cook process present controversi result literatur due condit employ time power ad water aim work studi influenc condit microwav cook human bioactiv compound broccoli result show general decreas level studi compound miner nutrient stabl cook condit vitamin show greatest loss degrad leach loss phenol compound glucosinol due leach water general longest microwav cook time higher volum cook water avoid minim loss nutrient
MED-5075~effect meal composit cook durat fate sulforaphan consumpt broccoli healthi human subject pubm ncbi abstract isothiocyan sulforaphan implic cancer protect effect brassica veget broccoli consum sulforaphan releas hydrolysi glucoraphanin plant myrosinas and or colon microbiota influenc meal composit broccoli cook durat isothiocyan uptak investig design experi volunt num offer meal beef num light cook broccoli microwav num min fulli cook broccoli microwav num min broccoli seed extract receiv num mustard pre form allyl isothiocyan aitc meal urinari output allyl ama sulforaphan sfma mercaptur acid biomark product aitc sulforaphan measur num meal consumpt estim yield sulforaphan vivo num fold higher consumpt light cook broccoli fulli cook broccoli absorpt aitc mustard num fold higher consumpt meat contain meal compar meat contain altern meal matrix signific influenc hydrolysi glucoraphanin excret sfma broccoli isothiocyan interact meal matrix greater extent ingest pre form product hydrolysi glucosinol vivo main influenc product isothiocyan vivo brassica veget cook effect meal matrix
MED-5076~effect cook method nutrit physicochem characterist select veget pubm ncbi abstract object present studi evalu effect common cook practic boil steam fri phytochem content polyphenol carotenoid glucosinol ascorb acid total antioxid capac tac measur analyt assay trolox equival antioxid capac teac total radical trap antioxid paramet trap ferric reduc antioxid power frap physicochem paramet veget carrot courgett broccoli water cook treatment preserv antioxid compound carotenoid veget analyz ascorb acid carrot courgett steam veget maintain textur qualiti boil boil veget show limit discolor fri veget show lowest degre soften antioxid compound retain increas teac frap trap valu observ cook veget matrix soften increas extract compound partial convert antioxid chemic speci find defi notion process veget offer lower nutrit qualiti suggest veget cook method prefer preserv nutrit physicochem qualiti
MED-5077~chemic microbi physic evalu commerci bottl water greater houston area texa pubm ncbi abstract due increas demand consumpt bottl water unit state grow concern qualiti product retail outlet sell local import bottl water consum bottl num brand bottl water random collect local groceri store greater houston area num brand num design spring water num purifi and or fortifi tap water num carbon water num distil water chemic microbi physic properti sampl evalu includ ph conduct bacteria count anion concentr trace metal concentr heavi metal volatil organ concentr determin sampl induct coupl plasma mass spectrometri icpm element analysi gas chromatographi electron captur detector gcecd gas chromatographi mass spectrometri gcms analysi volatil organ ion chromatographi ic select ion electrod analysi anion bacteri identif perform biolog softwar biolog hayward ca usa result obtain compar guidelin drink water recommend intern bottl water associ ibwa unit state food drug administr fda unit state environment protect agenc epa world health organ drink water standard major analyz chemic respect drink water standard maximum admiss concentr mac volatil organ chemic found detect limit num brand bottl water sampl analyz found contamin bacteria
MED-5078~mutagen antimutagen effect methanol extract unfer ferment black soybean pubm ncbi abstract studi solid ferment steam black soybean gras general recogn safe filamentious fungi includ aspergillus awamori aspergillus oryza bcrc num aspergillus soja bcrc num rhizopus azygosporus bcrc num rhizopus sp num perform mutagen antimutagen methanol extract unfer ferment steam black soybean num nitroquinoline n oxid num nqo direct mutagen benzo a pyren b a p indirect mutagen salmonella typhimurium ta num ta num examin methanol extract unfer ferment steam black soybean show mutagen activ test strain dose test extract inhibit mutagenesi num nqo b a p typhimurium ta num ta num ferment fungi enhanc antimutagen effect black soybean antimutagen effect ferment black soybean extract vari starter organ mutagen test strain typhimurium examin general extract awamori fer black soybean exhibit highest antimutagen effect strain ta num inhibitori effect num mg awamori fer black soybean extract plate mutagen effect num nqo b a p num num rate extract unfer num num strain num inhibit rate num num ferment bean extract num num unfer bean extract test extract prepar black soybean awamori temperatur num num degre time num day reveal general extract prepar bean ferment num degre num day exhibit greatest inhibit mutagen effect num nqo b a p
MED-5079~pinto bean consumpt reduc biomark heart diseas risk pubm ncbi abstract object determin effect daili intak num cup pinto bean black ey pea carrot placebo risk factor coronari heart diseas chd diabet mellitus dm free liv mild insulin resist adult num week period method random crossov num block design sixteen particip num men num women receiv treatment eight week two week washout fast blood sampl collect begin end period analyz total cholesterol tc low densiti lipoprotein cholesterol ldl c high densiti lipoprotein cholesterol triacylglycerol high sensit c reactiv protein insulin glucos hemoglobin num result signific treatment by tim effect impact serum tc num ldl num week pair t test pinto bean respons effect num num chang serum tc pinto bean black ey pea placebo num num num num num num mg dl num chang serum ldl c pinto bean black ey pea placebo num num num num num mg dl order num pinto bean differ signific placebo num signific differ blood concentr num treatment period conclus pinto bean intak encourag lower serum tc ldl c reduc risk chd
MED-5080~phytochem black bean seed coat isol structur elucid antiprolif antioxid activ pubm ncbi abstract bioactivity guid fraction black bean phaseolus vulgari seed coat determin chemic ident bioactiv constitu show potent antiprolif antioxid activ twenty four compound includ num triterpenoid num flavonoid num phytochem isol gradient solvent fraction silica gel od column semiprepar prepar hplc chemic structur identifi ms nmr x ray diffract analysi antiprolif activ isol compound caco num human colon cancer cell hepg num human liver cancer cell mcf num human breast cancer cell evalu compound isol compound num num num num num num show potent inhibitori activ prolifer hepg num cell ec num valu num num num num num num num num num num num num num num num num num num num num num num microm compound num num num num num num num num show potent antiprolif activ caco num cell growth ec num valu num num num num num num num num num num num num num num num num num num num num num num num num num num num num microm compound num num num num show potent antiprolif activ mcf num cell growth dose depend manner ec num valu num num num num num num num num num num num num num num microm flavonoid compound num show potent antioxid activ result show phytochem extract black bean seed coat potent antioxid antiprolif activ
MED-5081~raisin addit walk distinct effect plasma lipid inflammatori cytokin abstract background raisin signific sourc dietari fiber polyphenol reduc cardiovascular diseas cvd risk affect lipoprotein metabol inflamm walk repres low intens exercis intervent reduc cvd risk purpos studi determin effect consum raisin increas step walk combin intervent blood pressur plasma lipid glucos insulin inflammatori cytokin result thirty four men postmenopaus women match weight gender random assign consum num cup raisins d raisin increas amount step walked d walk combin intervent raisin walk subject complet num wk run in period num wk intervent systol blood pressur reduc subject num plasma total cholesterol decreas num subject num explain num reduct plasma ldl cholesterol ldl c num plasma triglycerid tg concentr decreas num walk num group effect plasma tnf decreas num ng l num ng l raisin num time group time effect subject reduct plasma sicam num num conclus research show simpl lifestyl modif ad raisin diet increas step walk distinct benefici effect cvd risk
MED-5082~anti canc properti phenol appl wast colon carcinogenesi vitro pubm ncbi abstract colorect cancer common cancer western countri world health organis identifi diet critic risk factor develop progress diseas protect role high level fruit veget consumpt studi shown appl phenol compound potent anti oxid human benefici properti appl phenol cancer ht num ht num caco num cell line vitro model examin effect appl phenol num num appl extract key stage colorect carcinogenesi dna damag comet assay colon barrier function ter assay cell cycl progress dna content assay invas matrigel assay result crude extract appl phenol protect dna damag improv barrier function inhibit invas num anti invas effect extract enhanc twenty four hour pretreat cell num shown crude appl extract wast rich phenol compound benefici influenc key stage carcinogenesi colon cell vitro
MED-5083~systemat screen total antioxid dietari plant pubm ncbi abstract predomin plant bas diet reduc risk develop chronic diseas assum antioxid contribut protect result intervent trial singl antioxid administ supplement consist support benefit dietari plant hundr antioxid total concentr electron don antioxid reduct individu item data identif benefici dietari plant assess systemat total antioxid varieti dietari plant worldwid includ fruit berri veget cereal nut puls analyz sampl dietari plant geograph region world total antioxid assess reduct fe num fe num frap assay occur rapid reduct half react reduct potenti fe num fe num valu express concentr electron don antioxid result demonstr num fold differ total antioxid dietari plant plant antioxid includ member famili rosacea dog rose sour cherri blackberri strawberri raspberri empetracea crowberri ericacea blueberri grossulariacea black currant juglandacea walnut asteracea sunflow seed punicacea pomegran zingiberacea ginger norwegian diet fruit berri cereal contribut num num num total intak plant antioxid veget contribut num systemat analysi present facilit research nutrit role combin effect antioxid dietari plant
MED-5084~culinari medicin herb import sourc dietari antioxid pubm ncbi abstract assess contribut culinari medicin herb total intak dietari antioxid result demonstr num fold differ antioxid concentr herb dri culinari herb test oregano sage peppermint garden thyme lemon balm clove allspic cinnamon chines medicin herb cinnamomi cortex scutellaria radix high concentr antioxid num mmol num normal diet intak herb contribut signific total intak plant antioxid sourc dietari antioxid food group fruit berri cereal veget addit herbal drug stronger neo minophagen glycyrrhizin prepar intraven inject treatment chronic hepat boost total antioxid intak tempt specul effect due herb mediat antioxid activ
MED-5085~factor domin adhes nacl potato chip pubm ncbi abstract studi adhes factor examin time fri coat surfac oil content chip temperatur oil composit nacl size nacl shape electrostat coat surfac oil content potato chip high low produc oil soybean oliv corn peanut coconut fri chip coat immedi num num mo nacl crystal num particl size num num num num microm coat electrostat nonelectrostat adhes cubic dendrit flake crystal examin chip coat temperatur chip high surfac oil highest adhes salt make surfac oil content import factor decreas chip temperatur decreas surfac oil adhes increas time fri coat reduc adhes low surfac oil chip affect high surfac oil chip chang oil composit affect adhes increas salt size decreas adhes salt size greater effect chip lower surfac oil content signific differ cubic crystal gave adhes flake crystal dendrit crystal high low surfac oil chip electrostat coat chang adhes small size crystal decreas adhes larg salt surfac oil content chip electrostat coat improv adhes small salt size affect adhes larg crystal
MED-5086~prospect studi dietari acrylamid intak risk endometri ovarian breast cancer pubm ncbi abstract background acrylamid probabl human carcinogen detect heat treat carbohydrate rich food num epidemiolog studi shown relationship cancer aim investig associ acrylamid intak endometri ovarian breast cancer risk method netherland cohort studi diet cancer includ num women age num year baselin num random subcohort num women select case cohort analysi approach analysi acrylamid intak subcohort member case assess food frequenc questionnair base chemic analysi relev dutch food subgroup analys never smok elimin influenc smoke import sourc acrylamid result num year follow up num num case endometri ovarian breast cancer document compar lowest quintil acrylamid intak intak num mug day multivariable adjust hazard rate ratio hr endometri ovarian breast cancer highest quintil intak num mug day num num confid interv num ci num num trend num num num ci num num trend num num num ci num num trend num never smok hrs num num ci num num trend num num num ci num num trend num num num ci num num trend num conclus observ increas risk postmenopaus endometri ovarian cancer increas dietari acrylamid intak never smok risk breast cancer acrylamid intak
MED-5087~acrylamid exposur incid breast cancer postmenopaus women danish diet cancer health studi pubm ncbi abstract acrylamid probabl human carcinogen form food high temperatur process epidemiolog studi shown associ human cancer risk dietari exposur acrylamid purpos studi conduct nest case control studi prospect cohort studi associ breast cancer exposur acrylamid biomark n termin hemoglobin adduct level acrylamid genotox metabolit glycidamid red blood cell analyz lc ms ms biomark exposur num breast cancer case num control cohort postmenopaus women adduct level acrylamid glycidamid similar case control smoker higher level approxim num time nonsmok associ acrylamide hemoglobin level breast cancer risk unadjust adjust potenti confound hrt durat pariti bmi alcohol intak educ adjust smoke behavior posit associ acrylamide hemoglobin level estrogen receptor posit breast cancer estim incid rate ratio num ci num num num num fold increas acrylamide hemoglobin level weak associ glycidamid hemoglobin level incid estrogen receptor posit breast cancer found associ disappear acrylamid glycidamid hemoglobin level mutual adjust num wiley liss
MED-5088~mitig strategi reduc acrylamid format fri potato product pubm ncbi abstract potato product high amount acrylamid exceed concentr num mg l strategi acrylamid reduct potato product work approach reduc acrylamid format review mind applic strategi acrylamid format main criteria maintain organolept nutrit qualiti final product
MED-5089~dietari acrylamid intak risk renal cell bladder prostat cancer pubm ncbi abstract background acrylamid probabl human carcinogen recent detect heat treat carbohydrate rich food epidemiolog studi relat cancer larg negat object aim prospect examin associ dietari acrylamid intak renal cell bladder prostat cancer design netherland cohort studi diet cancer includ num men women age num baselin num random subcohort num particip select case cohort analysi approach cox proport hazard analysi acrylamid intak assess food frequ questionnair baselin base chemic analysi relev dutch food result num follow up num num case renal cell bladder prostat cancer analysi compar lowest quintil acrylamid intak intak num microg d multivariable adjust hazard rate renal cell bladder prostat cancer highest quintil intak num microg d num num ci num num trend num num num ci num num trend num num num ci num num trend num invers nonsignific trend advanc prostat cancer smoker conclus found indic posit associ dietari acrylamid renal cell cancer risk posit associ bladder prostat cancer risk
MED-5090~associ meat consumpt preval degen arthriti soft tissu disord adventist health studi califor pubm ncbi abstract object examin associ preval degen arthriti soft tissu disord consumpt meat food particip adventist health studi method uncondit logist regress analysi examin cross sect associ adjust effect age smoke alcohol consumpt bodi mass index sex hormon pariti result preval degen arthriti soft tissu disord num percent women higher preval men preval increas great age smoke higher bodi mass index contracept pill current hormon replac therapi higher preval disord multivari analysi multivari or compar consumpt meat num week num week refer meat num num ci num num num num num women num num ci num num num num num men dairi fat fruit consumpt weak increas risk protect associ nut salad consumpt conclus greater meat consumpt higher preval degen arthriti soft tissu disord male femal subject popul hormon replac therapi women
MED-5091~essenti num fatti acid pregnant women earli visual acuiti matur term infant pubm ncbi abstract background docosahexaeno acid dha import neural develop dha intak low pregnant women impair infant develop uncertain object sought determin dha defici occur pregnant women contribut poor infant develop design biochem cutoff dietari intak development score indic dha defici defin infant develop distribut individual potenti develop unknown random intervent establish distribut development score infant women dha intak consid requir compar develop infant mother consum usual diet dha num mg d num placebo num consum women num wk gestat deliveri determin matern red blood cell ethanolamin phosphoglycerid fatti acid dietari intak num num wk gestat infant visual acuiti num age result approach identifi dha defici biochem function marker defici unknown multivari analys infant visual acuiti relat sex beta num se num odd ratio num matern dha intervent beta num se num odd ratio num infant girl placebo dha intervent group visual acuiti averag num matern red blood cell ethanolamin phosphoglycerid docosatetraeno acid invers relat visual acuiti boy rho num num girl rho num num conclus studi suggest pregnant women studi popul dha defici
MED-5092~visual acuiti cognit outcom num year age double blind random trial long chain polyunsatur fatti acid suppl pubm ncbi abstract background larg bodi data effect long chain polyunsatur fatti acid supplement infant formula visual cognit matur infanc longterm visual cognit outcom data random trial scarc aim evalu docosahexaeno acid dha arachidon acid ara supplement infant formula visual cognit outcom num year age method fifty two num healthi term infant enrol single cent double blind random clinic trial dha ara supplement infant formula follow up num year age addit num breast f infant serv gold standard outcom measur visual acuiti wechsler preschool primari scale intelligence  revis result num year control formula group poorer visual acuiti breast f group dha dha ara suppl group differ signific breast f group control formula dha suppl group verbal iq score poorer breast f group conclus dha ara supplement infant formula support visual acuiti iq matur similar breast f infant
MED-5093~matern consumpt docosahexaeno acid contain function food pregnanc benefit infant perform problem solv pubm ncbi abstract background studi report docosahexaeno acid dha num num supplement pregnanc infant cognit function dha supplement pregnanc infant problem solv year investig object test hypothesi infant born women consum dha contain function food pregnanc demonstr problem solv abil recognit memori infant born women consum placebo pregnanc design double blind placebo control random trial pregnant women consum dha contain function food placebo gestat week num deliveri studi group receiv dha contain cereal bas bar num mg dha num kcal bar averag consumpt num bars wk num cereal bas placebo bar num infant plan test fagan test infant intellig administ infant age num mo problem solv trial includ support step search step procedur score basi infant perform step entir problem intent score total intent solut score generat basi cumul perform infant num trial result treatment signific effect perform problem solv task total intent score num total intent solut num number intent solut cloth num cover num step signific differ group measur fagan test infant intellig conclus data point benefit problem solv recognit memori age num mo infant mother consum dha contain function food pregnanc
MED-5094~record human infect tapeworm diphyllobothrium nihonkaiens north america pubm ncbi abstract tapeworm diphyllobothrium nihonkaiens cestoda diphyllobothriidea origin japan report man north america time speci identif base sequenc ribosom partial num rrna mitochondri partial cytochrom oxidas subunit gene proglottid expel czech tourist ate raw pacif sockey salmon oncorhynchus nerka british columbia canada
MED-5095~bioequival docosahexaeno acid algal oil capsul dha fortifi food pubm ncbi abstract docosahexaeno acid dha long chain omega num fatti acid import eye brain develop ongo visual cognit cardiovascular health unlik fish sourc oil bioavail dha vegetarian sourc algal oil formal assess assess bioequival dha oil capsul algal strain versus bioavail algal dha fortifi food num day random placebo control parallel group studi compar bioavail algal dha oil capsul dhasco t dhasco dose num num mg dha day num group algal dha fortifi food num bioequival base plasma phospholipid erythrocyt dha level effect arachidon acid ara docosapentaeno acid n num dpan num eicosapentaeno acid epa determin dhasco t dhasco capsul produc equival dha level plasma phospholipid erythrocyt dha respons dose depend linear dose rang plasma phospholipid dha increas num num num num fatti acid num num mg dose snack bar fortifi dhasco oil deliv equival amount dha dha dose basi advers event monitor reveal excel safeti toler profil algal oil capsul supplement algal oil fortifi food repres bioequival safe sourc dha
MED-5096~low num long chain polyunsatur fatti acid status austrian vegetarian vegan pubm ncbi abstract background aim object studi collect data dietari fat intak omnivor vegetarian vegan semi omnivor impact num num fatti acid long term marker sphingolipid phosphatidylcholin pc phosphatidylserin ps phosphatidylethanolamin pe calcul sphingo phospholipid spl erythrocyt method present observ studi includ num austrian adult volunt gender num omnivor num vegetarian num vegan num semi omnivor inform anthropometri measur bodi weight height obtain amount composit ingest fat calcul num hour recal fatti acid pattern phospholipid assess gas chromatographi result unbalanc num num ratio limit dietari sourc eicosapentaeno acid epa docosahexaeno acid dha vegan vegetarian led reduct num num num num num num total num fatti acid spl pc ps pe compar omnivor semi omnivor total content polyunsatur fatti acid monounsatur fatti acid satur fatti acid remain unchang conclus vegetarian diet averag num num ratio num promot biochem num tissu declin ensur physic mental neurolog health vegetarian reduc num num ratio addit intak direct sourc epa dha age gender num karger ag basel
MED-5097~fish consumpt methylmercuri child neurodevelop abstract purpos review summar recent evid associ earli life exposur mercuri matern fish consumpt pregnanc thimeros vaccin dental amalgam child neurodevelop recent find recent public built previous evid demonstr mild detriment neurocognit effect prenat methylmercuri exposur matern fish consumpt pregnanc studi examin effect prenat fish consumpt methylmercuri suggest benefit prenat fish consumpt consumpt fish high mercuri avoid futur studi incorpor inform methylmercuri docosahexaeno acid fish refin recommend optim outcom mother children addit recent studi support safeti vaccin thimeros dental amalgam repair dental cari children summari exposur mercuri harm child develop intervent intend reduc exposur low level mercuri earli life care evalu potenti attend harm result behavior reduc docosahexaeno acid exposur lower seafood intak reduc uptak childhood vaccin suboptim dental care
MED-5098~risk benefit analysi french high fish consumpt qali approach pubm ncbi abstract health risk nutrit benefit food assess separ toxicologist recommend limit consumpt fish methylmercuri nutritionist recommend eat oili fish omega num common evalu imper provid coher recommend order evalu risk benefit relat fish consumpt common metric base quality adjust life year qali method impact theoret chang medium num pufa intak high intak studi term cardiovascular system chd mortal stroke mortal morbid fetal neuron develop iq loss gain applic consid sensit analysi model impact chang dose respons relationship cardiovascular diseas num pufa intak result show increas fish consumpt benefici impact health confid interv estim negat lower bound increas fish consumpt negat impact due mehg contamin limit qali approach identifi concern determin dose respons relationship concern econom origin approach individu prefer final benefici aspect risk element studi benefici risk compon integr model
MED-5099~nutrient methyl mercuri exposur consum fish pubm ncbi abstract controversi risk benefit consum fish fish consumpt nutrient essenti brain growth develop fish methyl mercuri mehg neurotoxic toxic effect mehg damag brain develop prenat exposur greatest concern present level prenat exposur risk child neurodevelop balanc reward risk fish consumpt present dilemma consum regulatori author review nutrient fish import brain develop current evid risk mehg exposur level achiev consum fish review find larg prospect cohort studi popul consum fish daili seychell child develop studi mehg content fish consum seychell similar ocean fish industri countri repres sentinel popul risk fish consumpt seychell evalu children num age show consist pattern advers associ prenat mehg exposur recent studi seychell focus nutrient fish influenc child develop includ long chain polyunsatur fatti acid iodin iron cholin preliminari find studi suggest benefici influenc nutrient fish counter advers effect mehg develop nervous system
MED-5100~public health guidanc cardiovascular benefit risk relat fish consumpt abstract histor concern fish consumpt address risk contamin methylmercuri mehg pcbs recent public health concern widen appreci specif benefit fish consumpt aris polyunsatur fatti acid pufa fish oil fish vari level pufa mehg address health outcom opposit direct occur fish great care exercis provid public health guidanc mozaffarian rimm recent articl jama num num num made strong case benefici effect pufa reduc risk coronari heart diseas time broad discount increas risk coronari heart diseas pose mehg fish state adult benefit fish intak exceed potenti risk conclus base inaccur insuffici critic analysi literatur literatur re examin light conclus public health option consid
MED-5101~nutrient contamin tradeoff exchang meat poultri seafood dietari protein pubm ncbi abstract make food choic consum face dilemma reconcil differ health benefit exposur potenti toxin analys estim intak exposur outcom young children women child bear age show seafood chicken beef approxim equival protein vari key nutrient import level contamin increas varieti choic meat poultri seafood consum amount consist current dietari guidelin advisori contribut meet nutrit reduc exposur singl type contamin
MED-5102~simul impact fish base shift popul num fatti acid intak exposur dioxin dioxin lik compound pubm ncbi abstract due favour health effect lc num pufa marin product recognis food group special import human diet seafood suscept contamin lipophil organ pollut object studi evalu intak level pcdds pcdfs dioxin lik pcbs probabilist mont carlo procedur relat recommend lc num pufa belgian feder health council recommend scenario develop differ lc num pufa intak num num scenario total exposur dioxin dioxin lik substanc num lc num pufa scenario rang num pg teq kg bw day num percentil num pg teq kgbw day num percentil num pg teq kgbw day num percentil num lc num pufa scenario num num percentil expos num num num pg teq kgbw day recommend lc num pufa intak base fish consumpt extra sourc major studi popul exceed propos health base guidanc valu dioxin dioxin lik substanc
MED-5104~bromin flame retard food pubm ncbi abstract recent began studi bromin flame retard level matric includ human milk food paper review food studi studi ten thirteen polybromin diphenyl ether pbde congen measur includ bde num women milk sampl contamin pbdes num num ng g lipid order magnitud higher level report european studi highest report worldwid compar market basket studi meat fish dairi product food studi meat fish studi show higher level pbdes report fish high contamin median num pg g meat median num pg g dairi product median num pg g unlik european countri fish predomin dietari intak pbdes meat fish dairi product broil decreas amount pbdes serv measur level hexabromocyclododecan hbcd bromin flame retard human milk level lower pbdes num num ng g similar european level unlik pbdes level higher european level
MED-5105~dioxin dibenzofuran dioxin lik pcbs dde fast food num pubm ncbi abstract food dairi product meat fish primari sourc environment exposur dioxin general popul data exist dioxin level popular wide consum fast food data present previous publish pilot studi limit measur level dioxin dibenzofuran type fast food studi add previous paper present data addit dioxin dibenzofuran close relat dioxin lik polychlorin biphenyl pcbs persist metabolit ddt num dichloro num bis p chlorophenyl ethylen dde type popular fast food includ mcdonald big mac hamburg pizza hut person pan pizza suprem kentucki fri chicken kfc piec origin recip mix dark white meat luncheon packag agen daz chocolate chocol chip ice cream dioxin dibenzofuran dioxin toxic equival teq rang num num teq pg g wet weight big mac num num pizza num num kfc num num teq pg g ice cream daili teq consumpt kilogram bodi weight kg bw assum averag num kg adult num kg child serv fast food rang num num pg kg adult children valu num num pg kg total measur pcdd fs big mac person pan pizza kfc agen daz ice cream vari num num pg g measur dde level fast food rang num num pg g total mono ortho pcb level rang num pg g num teq pg g kfc di ortho pcbs num pg g num teq pg g pizza sampl total pcb valu sampl rang num pg g num teq pg g chicken sampl
MED-5106~milk consumpt acn teenag boy abstract object sought examin associ dietari dairi intak teenag acn boy method prospect cohort studi studi num boy member prospect cohort studi youth lifestyl factor report dietari intak num food frequenc questionnair num num teenag acn num comput multivari preval ratio num confid interv acn result adjust age baselin height energi intak multivari preval ratio num confid interv test trend acn compar highest num servings d lowest num wk intak categori num num num num num total milk num num num num num milk num num num num low fat num milk num num num num skim milk limit member cohort respond questionnair acn assess self report boy symptom part disord exclud adjust steroid lifestyl factor affect occurr acn conclus found posit associ intak skim milk acn find suggest skim milk hormon constitu factor influenc endogen hormon suffici quantiti biolog effect consum
MED-5107~diet acn pubm ncbi abstract acn caus action dihydrotestosteron deriv endogen exogen precursor act synergist insulin lik growth factor num sourc interact discuss mechan action recommend dietari limit ingest product hormon propos
MED-5108~effect heat inactiv mycobacterium avium subsp paratuberculosi raw milk contamin natur infect fece abstract effect high temperatur short hold time htst pasteur homogen respect inactiv mycobacterium avium subsp paratuberculosi evalu quantit detail determin inactiv kinet high concentr fece cow clinic symptom johne diseas contamin raw milk order realist mimic incid close final avium subsp paratuberculosi concentr vari num num num cell ml raw milk heat treatment includ industri htst simul pilot scale num time temperatur combin includ num num hold resid time num num num hold time num num num num stringent condit viabl avium subsp paratuberculosi cell recov result num num fold reduct depend origin inoculum concentr inactiv kinet model num quantit data point yield ea num j mol lnk num num num num num homogen signific affect inactiv conclus drawn htst pasteur condit equal num num result more than sevenfold reduct avium subsp paratuberculosi
MED-5109~microbi sensori ripen prato chees made milk level somat cell pubm ncbi abstract object research evalu effect num level raw milk somat cell count scc composit prato chees microbiolog sensori prato chees ripen group dairi cow select obtain low scc num cells ml high scc num cells ml milk manufactur num vat chees pasteur milk evalu ph total solid fat total protein lactos standard plate count coliform num degre salmonella spp chees composit evalu num manufactur lactic acid bacteria psychrotroph bacteria yeast mold count carri num num num storag salmonella spp listeria monocytogen coagulase posit staphylococcus count carri num num storag num num factori design num replic perform sensori evalu chees low high scc milk carri accept num point hedon scale num num num storag somat cell level affect total protein salt moistur content chees ph moistur content higher clot time longer chees high scc milk chees present absenc salmonella spp monocytogen coagulase posit staphylococcus count num num cfu g storag time lactic acid bacteria count decreas signific storag time chees low high scc milk faster rate chees high scc milk chees high scc milk present lower psychrotroph bacteria count higher yeast mold count chees low scc milk chees low scc milk show accept consum lower accept chees high scc milk textur flavor defect caus higher proteolysi chees
MED-5110~appli morpholog techniqu evalu hotdog hotdog eat pubm ncbi abstract american consum billion hotdog year result billion dollar retail sale packag label typic list type meat primari ingredi purpos studi assess meat water content hotdog brand determin packag label accur brand hotdog evalu water content weight varieti routin techniqu surgic patholog includ routin light microscopi hematoxylin eosin stain section special stain immunohistochemistri electron microscopi assess meat content recogniz compon packag label top list ingredi num brand meat list ingredi water num type meat num water compris num num median num total weight meat content determin microscop cross sect analysi rang num num median num cost hotdog num num rough correl meat content varieti tissu observ skelet muscl includ bone num collagen num blood vessel num plant materi num peripher nerv num adipos num cartilag num skin num glial fibrillari acid protein immunostain observ hotdog lipid content oil red stain grade moder num hotdog mark num hotdog electron microscopi show recogniz skelet muscl evid degen conclus hotdog ingredi label mislead brand num water weight amount meat skelet muscl brand compris num cross sect surfac area expens brand general meat hotdog tissu type bone cartilag relat skelet muscl brain tissu present
MED-5111~dietari factor breast cancer risk case control studi popul southern franc pubm ncbi abstract case control studi examin food group relat breast cancer num num case num control match age area resid interview diet measur valid food frequenc questionnair adjust odd ratio comput level dietari intak identifi method classic spline method num method found associ total fruit veget consumpt breast cancer result num method show nonsignific decreas associ cook veget intak legum fish consumpt spline method show associ classic method show signific associ relat lowest consumpt raw veget dairi product breast cancer risk adjust raw veget consumpt num num g day num g day num num confid interv ci num num adjust dairi consumpt num num g day num g day num num ci num num result consist compar classic method spline method show signific associ cereal meat oliv oil cereal oliv oil invers breast cancer risk breast cancer risk increas num addit num g day meat consumpt studi methodolog techniqu confirm dietari threshold respons breast cancer risk approach consist analyz dietari pattern dietari food
MED-5112~legum soy food intak incid type num diabet shanghai women health studi abstract background postul diet high legum benefici prevent type num diabet mellitus type num dm data link type num dm risk legum intak limit object object studi examin associ legum soy food consumpt self report type num dm design studi conduct population bas prospect cohort middle ag chines women num women histori type num dm cancer cardiovascular diseas studi recruit averag num particip complet in person interview collect inform diabet risk factor includ dietari intak physic activ adulthood anthropometr measur dietari intak assess valid food frequ questionnair baselin survey follow up survey administ num num studi recruit result observ invers associ quintil total legum intak num mutual exclus legum group peanut soybean legum type num dm incid multivariate adjust relat risk type num dm upper quintil compar lower quintil num num ci num num total legum num num ci num num soybean associ soy product soy milk soy protein consumpt protein deriv soy bean product type num dm signific conclus consumpt legum soybean invers risk type num dm
MED-5113~effect soy bas compar tradit low calori diet weight loss lipid level overweight adult pubm ncbi abstract object studi investig effect soy bas low calori diet weight control bodi composit blood lipid profil compar tradit low calori diet method thirti obes adult bodi mass index num kg m num random group soy bas low calori group consum soy protein protein sourc tradit low calori group consum two third anim protein rest plant protein num kcal d diet num wk diet record everyday studi food intak analyz studi anthropometr data acquir week biochem data num wk experi compar result bodi weight bodi mass index bodi fat percentag waist circumfer signific decreas group num decreas bodi fat percentag soy group num num confid interv num num greater tradit group num num confid interv num num serum total cholesterol concentr low dens lipoprotein cholesterol concentr liver function paramet decreas soy bas group signific measur tradit group num signific chang serum triacylglycerol level serum high dens lipoprotein cholesterol level fast glucos level found soy tradit group conclus soy bas low calori diet signific decreas serum total cholesterol low dens lipoprotein cholesterol concentr greater effect reduc bodi fat percentag tradit low calori diet soy bas diet health benefit reduc weight blood lipid
MED-5114~epidemiolog soy exposur breast cancer risk abstract earli studi publish soy breast cancer design test effect soy assess soy intak crude potenti confound consid analysi review focus studi complet assess dietari soy exposur target popul potenti confound statist analysi studi data meta analysi num cohort num case control studi conduct high soy consum asian show signific trend decreas risk increas soy food intak compar lowest level soy food intak num mg isoflavon day risk intermedi num num confid interv ci num num modest num mg isoflavon day intak lowest num num ci num num high intak num mg isoflavon day contrast soy intak unrel breast cancer risk studi conduct num low soy consum western popul averag highest lowest soy isoflavon intak level num num mg day evid date base larg case control studi suggest soy food intak amount consum asian popul protect effect breast cancer
MED-5115~genistein genotox critic vitro exposur dose pubm ncbi abstract potenti health benefit soy deriv phytoestrogen includ report util anticarcinogen cardioprotect hormon replac altern menopaus increas popular dietari phytoestrogen supplement vegetarian vegan diet adolesc adult concern potenti detriment genotox effect persist varieti genotox effect phytoestrogen report vitro concentr effect occur higher physiolog relev dose achiev dietari pharmacolog intak soy food supplement review focus vitro studi abund soy phytoestrogen genistein critic examin dose crucial determin cellular effect level dietari genistein uptak bioavail defin vitro concentr genistein num microm non physiolog high dose contrast previous literatur often cit genotox effect genistein includ apoptosi cell growth inhibit topoisomeras inhibit obvious recent cellular epigenet microarray studi begin deciph genistein effect occur dietarili relev low concentr toxicolog accept principl dose defin poison appli toxic invok distinguish genotox versus potenti benefici vitro effect natur dietari product genistein
MED-5116~dietari flavonoid intak breast cancer surviv women long island pubm ncbi abstract background laboratori research grow number epidemiolog studi provid evid reduc risk breast cancer dietari intak class flavonoid effect flavonoid surviv population bas cohort breast cancer patient investig dietari flavonoid intak diagnosi subsequ surviv method women age num num year newli diagnos primari invas breast cancer august num juli num particip population bas case control studi num vital status decemb num case control interview conduct short diagnosi respond complet ffq assess dietari intak previous num month all caus mortal num death breast cancer specif mortal num death determin nation death index result reduc hazard ratio age energy adjust hazard ratio num confid interv all caus mortal observ premenopaus postmenopaus women highest quintil intak compar lowest flavon num num num isoflavon num num num anthocyanidin num num num signific trend risk observ result similar breast cancer specif mortal conclus mortal reduc associ high level dietari flavon isoflavon postmenopaus breast cancer patient larger studi confirm find
MED-5117~plasma isoflavon level subsequ risk breast cancer japanes women nest case control studi japan public health center pubm ncbi abstract purpos larg variat consumpt asian countri suitabl set studi effect high dos isoflavon intak breast cancer risk prospect studi asia assess blood urin level biomark isoflavon intak patient method total num women age num num year japan public health center bas prospect studi respond baselin questionnair provid blood num num observ decemb num num year follow up num patient newli diagnos breast cancer identifi match control patient select cohort isoflavon level assess plasma level food frequenc questionnair odd ratio breast cancer isoflavon level estim condit logist regress model result found statist signific invers associ plasma genistein risk breast cancer associ plasma daidzein adjust odd ratio highest versus lowest quartil plasma level num genistein num ci num num trend num num daidzein num ci num num trend num median plasma genistein valu control group num ng ml lowest num ng ml highest quartil group dietari intak isoflavon nonsignific invers associ observ genistein daidzein conclus nest case control studi found invers associ plasma genistein risk breast cancer japan
MED-5118~effect type soy milk dairi milk plasma lipid hypercholesterolem adult random trial pubm ncbi abstract object compar effect commerci soy milk made soy bean soy protein isol low fat dairi milk plasma lipid insulin glucos respons design random clinic trial cross ov design subject particip num year age num pre studi ldl cholesterol ldl c concentr num mg dl lipid lower medic framingham risk score num intervent particip requir consum suffici milk provid num protein d sourc protocol includ num week treatment phase separ wash out period num week result ldl c concentr end phase sd num num num num num mg dl bean soy milk soy protein isol milk dairi milk num soy milk num soy milk dairi milk signific differ type milk observ hdl cholesterol triacylglycerol insulin glucos conclus num dose daili soy protein soy milk led modest num lower ldl c relat dairi milk adult elev ldl c effect differ type soy milk soy milk signific affect lipid variabl insulin glucos
MED-5120~l theanin intervent enhanc human gammadeltat lymphocyt function pubm ncbi abstract human gammadeltat lymphocyt subset cell line defens microb tumor gammadeltat cell prime nitrogen contain bisphosphon short chain alkylamin prime gammadeltat cell enhanc capac prolifer secret cytokin vivo exposur wide varieti microb tumor cell largest dietari sourc alkylamin l theanin amino acid uniqu tea beverag catabol ethylamin supplement subject capsul l theanin catechin recent shown decreas incid cold flu symptom enhanc gammadeltat cell function
MED-5121~antiprolif apoptot effect chamomil extract human cancer cell pubm ncbi abstract chamomil matricaria chamomilla popular herb valu centuri tradit medicin treat human ailment anticanc activ unknown evalu anticanc properti aqueous methanol extract chamomil human cancer cell line exposur chamomil extract caus minim growth inhibitori respons normal cell signific decreas cell viabil observ human cancer cell line chamomil exposur result differenti apoptosi cancer cell normal cell similar dose hplc analysi chamomil extract confirm apigenin num o glucosid major constitu chamomil minor glycosid compon observ apigenin glucosid inhibit cancer cell growth lesser extent parent aglycon apigenin vivo experi suggest deconjug glycosid occur vivo produc aglycon small intestin studi repres report demonstr anticanc effect chamomil investig mechan action chamomil warrant evalu potenti herbal remedi manag cancer patient
MED-5122~high level carcinogen polycycl aromat hydrocarbon mate drink pubm ncbi abstract background drink mate cancer esophagus oropharynx larynx lung kidney bladder conduct studi determin drink mate lead substanti exposur polycycl aromat hydrocarbon pah includ carcinogen benzo a pyren method concentr num individu pah measur dri leav commerci brand yerba mate infus made hot num degre cold num degre water measur gas chromatography mass spectrometri deuter pah surrog infus made ad water leav remov result infus num min ad water remain leav process repeat num time infus temperatur result total concentr num pah brand yerba mate rang num num ng g dri leav benzo a pyren concentr rang num num ng g dri leav mate infus prepar hot water brand num num num ng total measur pah num num num ng benzo a pyren content releas num infus similar result obtain hot cold infus conclus high concentr carcinogen pah found yerba mate leav hot cold mate infus result support hypothesi carcinogen mate relat pah content
MED-5123~tea coffe case studi evid dietari advic pubm ncbi abstract present paper explor level evid requir justifi give dietari advic public import practic differ develop public health nutrit guidelin guidelin clinic practic gold standard evid clinic practic guidelin meta analysi number randomis control trial unrealist uneth evalu public health nutrit intervent epidemiolog studi make bulk evid nutrit guidelin tea coffe interest case studi relat issu common consum beverag worldwid dietari advic evid relationship coffe tea consumpt diseas discuss studi predomin epidemiolog anim vitro studi coffe tea safe beverag tea healthier option role prevent cancer cvd evid relationship strong public continu drink tea coffe continu nutritionist make recommend argu advic data wait complet data sever consequ public health
MED-5124~egg consumpt cardiovascular diseas mortal physician health studi abstract background reduct dietari cholesterol recommend prevent cardiovascular diseas cvd egg import sourc cholesterol nutrient limit inconsist data effect egg consumpt risk cvd mortal object examin associ egg consumpt risk cvd mortal design prospect cohort studi num particip physician health studi egg consumpt assess simpl abbrevi food questionnair cox regress estim relat risk result averag follow num year total num myocardi infarct mi num incid stroke num death occur cohort egg consumpt incid mi stroke multivari cox regress contrast adjust hazard ratio num ci mortal num refer num num num num num num num num num num num num egg consumpt num num num num week trend num associ stronger diabet subject num fold increas risk death compar highest lowest categori egg consumpt non diabet subject hr num num num interact num conclus data suggest infrequ egg consumpt influenc risk cvd confer modest increas risk total mortal male physician addit egg consumpt posit relat mortal relat stronger diabet subject select popul
MED-5125~whole grain consumpt reduc risk noncardiovascular noncanc death attribut inflammatori diseas iowa wom pubm ncbi abstract background recent shown oxid stress infect inflamm predomin pathophysiolog factor major diseas object investig associ whole grain intak death attribut noncardiovascular noncanc inflammatori diseas design postmenopaus women num age num baselin num num exclus cardiovascular diseas cancer diabet coliti liver cirrhosi baselin num particip remain num die num proport hazard regress model adjust age smoke adipos educ physic activ dietari factor result inflammation rel death invers whole grain intak compar hazard ratio women rare ate whole grain food hazard ratio num num ci num num consum num servings wk num num num num num servings wk num num num num num servings wk num num num num servings wk trend num previous report invers associ whole grain intak total coronari heart diseas mortal persist num follow up conclus reduct inflammatori mortal habitu whole grain intak larger previous report coronari heart diseas diabet varieti phytochem found grain direct indirect inhibit oxid stress oxid stress inevit consequ inflamm suggest oxid stress reduct constitu grain mechan protect effect
MED-5126~pathogen detect test control fresh broccoli sprout abstract background recent increas interest consum green veget sprout temper fact fresh sprout case vehicl food born ill grown proper condit sanit handl food product agricultur commod sprout grown accord criteria propos sprout industri develop regulatori agenc adher sprouter green sprout produc low risk contamin occur guidelin method year program microbi hold and releas test conduct concert strict seed facil clean procedur num broccoli sprout grower evalu microbi contamin test perform num drum sprout equival num million consum packag fresh green sprout result num num num sprout sampl gave initi posit test escherichia coli num num salmonella spp re test num drum test posit composit test pool num drum pathogen test equal sensit singl drum test conclus test and re test protocol grower minim crop destruct pool drum test reduc test cost repres substanti portion cost sprout grow test and hold scheme batch contamin sprout found prior packag ship event isol safe sprout enter food suppli
MED-5127~sulforaphan mobil cellular defens protect skin damag uv radiat abstract uv radiat uvr complet carcinogen elicit constel patholog event includ direct dna damag generat reactiv oxid peroxid lipid damag cellular compon initi inflamm suppress immun respons recent dramat increas incid nonmelanoma skin cancer larg attribut higher exposur age popul uvr develop cellular strategi intrins protect skin deleteri effect uvr imper show erythema result uvr comprehens noninvas biomark assess uvr damag precis easili quantifi human skin topic applic sulforaphane rich extract num day old broccoli sprout up regul phase num enzym mous human skin protect uvr induc inflamm edema mice reduc suscept erythema aris narrow band num nm uvr human human subject male femal num num year age reduct erythema dose uvr num num mj cm num num mj cm num increment num rang num num num protect carcinogen human catalyt long
MED-5128~low vitamin num status risk cognit declin older adult pubm ncbi abstract background elev total homocystein thci concentr cognit impair unclear low vitamin num folat status respons cognit declin object examin associ cognit declin vitamin num folat status longitudin cohort studi perform num num oxford unit kingdom design cognit function assess mini ment state examin num occas num relat serum concentr vitamin num holotranscobalamin holotc thci methylmalon acid mma folat linear mix model num particip provid blood num result cognit function declin abrupt younger age particip remain intact age multivari regress analys adjust establish risk factor concentr holotc marker reduc vitamin num status thci mma predict cognit declin folat doubl holotc concentr num num pmol l num slower rate cognit declin num num doubl thci num num micromol l mma num num micromol l num rapid cognit declin num num num num adjust vitamin marker simultan associ cognit declin holotc mma remain signific conclus low vitamin num status rapid cognit declin random trial requir determin relev vitamin num supplement prevent dementia
MED-5129~modern societi prospect low vitamin num intak pubm ncbi abstract background vitamin num defici occur individu dietari pattern exclud anim food patient unabl absorb vitamin num food materi method clinic serv high incom popul live southern israel hypothes tendenc decreas level vitamin num popul caus premedit decreas consumpt anim product analyz num medic histori patient undergo blood test vitamin num level reason result level vitamin num num patient num num pg ml conclus result media inform dissemin relationship meat cholesterol cardiovascular diseas consumpt meat beef decreas life style segment popul high socioeconom level hand exist poverti main factor decreas consumpt anim product decreas level vitamin num general popul consequ increas patholog due vitamin num defici lieu develop order prevent health problem vitamin num fortif consid discuss num karger ag basel
MED-5130~schizophrenia lik psychot episod precipit cobalamin defici pubm ncbi abstract cobalamin defici wide present hematolog neuropsychiatr manifest psychiatr symptom predomin manifest describ young singl male vegetarian develop cobalamin induc psychot episod preced neurolog manifest hematolog symptom recov short antipsychot oral cobalamin supplement remain asymptomat function independ num year follow up
MED-5131~vitamin num sourc bioavail pubm ncbi abstract usual dietari sourc vitamin num anim food meat milk egg fish shellfish intrins factor medi intestin absorpt system estim satur num num microg meal physiolog condit vitamin num bioavail signific decreas increas intak vitamin num meal bioavail vitamin num healthi human fish meat sheep meat chicken meat averag num num num num vitamin num egg poor absorb num relat anim food product dietari refer intak unit state japan assum num dietari vitamin num absorb healthi adult normal gastro intestin function plant food dri green purpl laver nori substanti amount vitamin num edibl alga trace vitamin num edibl blue green alga cyanobacteria human supplement predomin pseudovitamin num inact human edibl cyanobacteria suitabl vitamin num sourc vegan fortifi breakfast cereal valuabl sourc vitamin num vegan elder peopl product vitamin num enrich veget devis
MED-5132~role vitamin num depress disorder  a case report pubm ncbi abstract vitamin num defici anemia psychiatr manifest preced hematolog symptom varieti symptom spars data role vitamin num depress report case vitamin num defici present recurr episod depress
MED-5133~floppi babi macrocyt anemia vegan mother pubm ncbi abstract report case num month old girl present acut anemia general muscular hypotonia failur thrive laboratori evalu reveal cobalamin defici due vegan diet mother clinic triad acquir floppi babi syndrom megaloblast anemia failur thrive pathognom infantil cobalamin defici neurolog abnorm irrevers delay myelin mri normal cobalamin level matern serum absenc anemia exclud subclin defici cobalamin defici suspect pregnant women vegan diet urinari methylmalon acid excret plasma homocystein level determin cobalamin substitut start earli stage avoid potenti irrevers damag fetus
MED-5134~complementari feed commentari espghan committe nutrit pubm ncbi abstract posit paper complementari feed summar evid health effect complementari food focus healthi infant europ review current knowledg practic formul conclus exclus full breast feed num month desir goal complementari feed solid food liquid breast milk infant formula follow on formula introduc num week num week convinc scientif evid avoid delay introduct potenti allergen food fish egg reduc allergi infant consid increas risk develop allergi consid increas risk complementari feed period num iron requir breast f infant met complementari food provid suffici bioavail iron cow milk poor sourc iron main drink num month small volum ad complementari food prudent avoid earli num month late num month introduct gluten introduc gluten gradual infant breast f reduc risk celiac diseas type num diabet mellitus wheat allergi infant young children receiv vegetarian diet receiv suffici amount approxim num ml breast milk formula dairi product infant young children fed vegan diet
MED-5135~west syndrom infant vitamin num defici absenc macrocyt anaemia pubm ncbi abstract vitamin num defici infant produc haematolog neurolog deficit includ macrocyt anaemia neurodevelopment delay regress irrit weak hypotonia ataxia apathi tremor seizur diagnosi vitamin num defici difficult typic macrocyt anaemia absent report case num month old femal diagnos west syndrom vitamin num defici macrocyt anaemia caus nutrit inadequaci mother patient motor skill cognit develop normal num month began exhibit seri sudden flexion head trunk arm leg exclus breast f receiv vitamin supplement result electroencephalographi eeg modifi hypsarrhythmia patient diagnos west syndrom synthet adrenocorticotrop hormon administ spasm resolv patient remain apath sit assist eeg result general slow activ diagnos vitamin num defici parenter treatment vitamin num initi symptom resolv eeg complet normal num month exhibit age appropri development neurolog profil knowledg report west syndrom present symptom vitamin num defici
MED-5136~mortal random trial antioxid supplement primari secondari prevent systemat review meta analysi pubm ncbi abstract context antioxid supplement prevent diseas object assess effect antioxid supplement mortal random primari secondari prevent trial data sourc trial select search electron databas bibliographi publish octob num random trial involv adult compar beta caroten vitamin vitamin ascorb acid vitamin selenium singl combin placebo intervent includ analysi random blind follow up consid marker bias includ trial effect antioxid supplement all caus mortal analyz random effect meta analys report relat risk rr num confid interv cis meta regress assess effect covari trial data extract includ num random trial num particip num public data synthesi low high bia risk trial antioxid supplement pool signific effect mortal rr num num ci num num multivari meta regress analys show low bia risk trial rr num num ci num correct num selenium rr num num ci num num signific mortal num low bia trial num particip antioxid supplement signific increas mortal rr num num ci num num low bia risk trial exclus selenium trial beta caroten rr num num ci num num vitamin rr num num ci num num vitamin rr num num ci num num singl combin signific increas mortal vitamin selenium signific effect mortal conclus treatment beta caroten vitamin vitamin increas mortal potenti role vitamin selenium mortal studi
MED-5137~black pepper pungent principle piperin review divers physiolog effect pubm ncbi abstract black pepper piper nigrum wide spice valu distinct bite qualiti attribut alkaloid piperin black pepper human dietari varieti purpos medicin preserv perfumeri physiolog effect black pepper extract major activ principl piperin report recent decad dietari piperin favor stimul digest enzym pancrea enhanc digest capac signific reduc gastrointestin food transit time piperin demonstr vitro studi protect oxid damag inhibit quench free radic reactiv oxygen speci black pepper piperin treatment evidenc lower lipid peroxid vivo benefici influenc cellular thiol status antioxid molecul antioxid enzym number experiment situat oxid stress far reach attribut piperin inhibitori influenc enzymat drug biotransform reaction liver strong inhibit hepat intestin aryl hydrocarbon hydroxylas udp glucuronyl transferas piperin document enhanc bioavail number therapeut drug phytochem properti piperine bioavail enhanc properti part attribut increas absorpt result effect ultrastructur intestin brush border initi controversi report safeti food addit evid question studi establish safeti black pepper activ principl piperin anim studi piperin non genotox fact found possess anti mutagen anti tumor influenc
MED-5138~consensus meet monosodium glutam updat pubm ncbi abstract object updat hohenheim consensus monosodium glutam num summari evalu recent knowledg respect physiolog safeti monosodium glutam design expert rang relev disciplin receiv consid seri question relat aspect topic set univers hohenheim stuttgart germani method expert met discuss question arriv consensus conclus total intak glutam food european countri general stabl rang num num g day free ca num protein bound ca num ad flavor ca num l glutam glu sourc energi fuel enterocyt maximum intak num correct mg kg bodi weight regard safe general glutam salt monosodium l glutam food addit regard harmless popul unphysiolog high dose glu trespass fetal circul research work effect high dose bolus suppli presenc impair blood brain barrier function situat decreas appetit elder person palat improv low dose monosodium l glutam
MED-5139~aspartam bioassay find portend human cancer hazard pubm ncbi abstract food drug administr fda reevalu posit aspartam safe condit anim bioassay result predict human cancer risk recent anim studi confirm potenti aspartam risk human aspartam produc packag china domest global distribut japan franc unit state major produc studi long term advers occup health effect aspartam worker conduct fda sponsor prospect epidemiolog studi aspartam worker
MED-5140~effect meat consumpt bodi odor attract pubm ncbi abstract axillari bodi odor individu specif potenti rich sourc inform produc odor individu part result genet individu influenc ecolog factor eat habit main sourc odor variabl dietari compon shape bodi odor test effect red meat consumpt bodi odor attract balanc within subject experiment design seventeen male odor donor meat nonmeat diet num week wear axillari pad collect bodi odor final num diet fresh odor sampl assess pleasant attract masculin intens num women hormon contracept repeat procedur month odor donor opposit diet result repeat measur analysi varianc show odor donor nonmeat diet judg signific attract pleasant intens suggest red meat consumpt negat impact perceiv bodi odor hedon
MED-5141~iq childhood vegetarian adulthood num british cohort studi abstract object examin relat iq childhood vegetarian adulthood design prospect cohort studi iq assess test mental abil age num year vegetarian self report age num year set great britain particip num men women age num year particip num british cohort studi nation birth cohort main outcom measur self report vegetarian type diet result num num particip vegetarian num num admit eat fish chicken vegetarian femal higher social class childhood attain higher academ vocat qualif socioeconom advantag reflect incom higher iq age num year increas likelihood vegetarian age num odd ratio standard deviat increas childhood iq score num num confid interv num num iq remain statist signific predictor vegetarian adult adjust social class childhood academ vocat qualif sex num num num exclus vegetarian ate fish chicken effect strength associ conclus higher score iq childhood increas likelihood vegetarian adult
MED-5142~irrevers subacut sclerot combin degener spinal cord vegan subject pubm ncbi abstract object describ case irrevers subacut sclerot combin degener spinal cord western vegan subject method num y old man member vegan cult num develop weak paraplegia hyper reflexia distal symmetr muscular hypotrophi impair superfici sensat hand feet loss deep sensat lower limb neurogen bladder bowel magnet reson imag cervic dorsal spine disclos abnorm increas signal intens num weight section posterior column subacut sclerot combin degener spinal cord diagnos treatment cobalamin start result rehabilit treatment patient develop spastic hypertonia mild improv paresthesia month vitamin num plasma level hematolog analysi normal year spastic paraplegia present patient unabl walk improv magnet reson imag conclus irrevers subacut sclerot combin degener spinal cord rare effect strict vegetarian diet
MED-5143~methanol extract seawe gloiopelti furcata induc num arrest inhibit cyclooxygenas num activ human hepatocarcinoma hepg num cell pubm ncbi abstract previous report methanol extract gloiopelti furcata megf kind edibl seawe inhibit growth human cancer cell line present studi effect megf growth human hepatocarcinoma hepg num cell effect cyclooxygenas cox express investig megf mark reduc viabil hepg num cell induc num arrest cell cycl concentr depend manner effect down regul cyclin up regul cyclin depend kinas cdk inhibitor num waf num cip num dephosphoryl cdc num found megf decreas level cox num mrna protein express signific level cox num correl decreas prostaglandin num pge num synthesi find megf therapeut potenti hepatoma cancer patient
MED-5144~arsenic seaweed  form concentr dietari exposur pubm ncbi abstract studi measur content total inorgan form arsenic seawe retail sale consumpt provid data dietari exposur estim support advic consum total num sampl cover varieti seawe collect retail outlet london internet sampl purchas dri product varieti soak advis prior consumpt recommend method prepar individu sampl total inorgan arsenic analys prepar arsenic remain water soak measur arsenic detect sampl total arsenic concentr rang num num mg kg inorgan arsenic liver cancer found sampl hijiki seawe analys concentr rang num mg kg type seawe found num mg kg inorgan arsenic limit detect method consumpt hijiki seawe signific increas dietari exposur inorgan arsenic uk food standard agenc fsa issu advic consum avoid eat
MED-5145~compar fractur risk vegetarian nonvegetarian epic oxford pubm ncbi abstract object compar fractur rate diet group meat eater fish eater vegetarian vegan oxford cohort european prospect investig cancer nutrit epic oxford design prospect cohort studi self report fractur risk follow up set unit kingdom subject total num men num women age num year includ num meat eater num fish eater num vegetarian num vegan recruit postal method general practic surgeri method cox regress result averag num year follow up num men num women report fractur compar meat eater fractur incid rate ratio men women combin adjust sex age non dietari factor num num ci num num fish eater num num num vegetarian num num num vegan adjust dietari energi calcium intak incid rate ratio vegan compar meat eater num num num subject consum num mg day calcium incid rate ratio num num num fish eater num num num vegetarian num num num vegan conclus popul fractur risk similar meat eater fish eater vegetarian higher fractur risk vegan consequ lower calcium intak adequ calcium intak essenti bone health irrespect dietari prefer sponsorship epic oxford studi support medic research council cancer research uk
MED-5146~plasma ldl hdl cholesterol oxid ldl concentr alter normo hypercholesterolem human intak leve pubm ncbi abstract cocoa powder rich polyphenol catechin procyanidin shown varieti subject model inhibit oxid ldl atherogenesi studi evalu plasma ldl cholesterol oxid ldl concentr intak level cocoa powder num num num g d normocholesterolem mild hypercholesterolem human compar double blind studi examin num subject ingest cocoa powder low polyphenol compound placebo cocoa group num level cocoa powder high polyphenol compound num num num g d low middl high cocoa group num wk test powder consum beverag addit hot water day blood sampl collect baselin num wk intak test beverag measur plasma lipid plasma oxid ldl concentr decreas low middl high cocoa group compar baselin stratifi analysi perform num subject ldl cholesterol concentr num mmol l baselin subject plasma ldl cholesterol oxid ldl apo concentr decreas plasma hdl cholesterol concentr increas relat baselin low middl high cocoa group result suggest polyphenol substanc deriv cocoa powder contribut reduct ldl cholesterol elev hdl cholesterol suppress oxid ldl
MED-5147~immun effect cocoa procyanidin oligom peripher blood mononuclear cell pubm ncbi abstract work relationship nutrit immun respons studi focus adapt respons increas recognit import innat immun host protect initi cytokin network studi examin effect select cocoa flavanol procyanidin innat respons vitro peripher blood mono nuclear cell pbmcs purifi monocyt cd num cd num cell isol healthi volunt cultur presenc cocoa flavanol fraction differ degre flavanol polymer short chain flavanol fraction scff monom pentam long chain flavanol fraction lcff hexam decam parallel investig high purifi flavanol monom procyanidin dimer isol cell challeng lipopolysaccharid lps quantit activ cd num cd num express analysi secret tumor necrosi factor tnf alpha interleukin il num eta il num il num granulocyt macrophag colony stimul factor gm csf chain length flavanol fraction signific effect cytokin releas unstimul lps stimul pbmcs strike increas lps induc synthesi il num eta il num il num tnf alpha presenc lcff lcff scff absenc lps stimul product gm csf addit lcff scff increas express cell marker cd num cd num uniqu differenti respons mononuclear cell popul studi conclud oligom potent stimul innat immun system earli event adapt immun
MED-5148~effect low habitu cocoa intak blood pressur bioactiv nitric oxid random control trial pubm ncbi abstract context regular intak cocoa contain food link lower cardiovascular mortal observ studi short term intervent num week high dose cocoa improv endotheli function reduc blood pressur bp due action cocoa polyphenol clinic effect low habitu cocoa intak bp bp lower mechan unclear object determin effect low dose polyphenol rich dark chocol bp design set particip random control investigator blind parallel group trial involv num adult age num num year num women num men untreat upper rang prehypertens stage num hypertens concomit risk factor trial conduct primari care clinic germani januari num decemb num intervent particip random assign receiv num week num num kcal day dark chocol num mg polyphenol match polyphenol fre white chocol main outcom measur primari outcom measur chang bp num week secondari outcom measur plasma marker vasodil nitric oxid s nitrosoglutathion oxid stress num isoprostan bioavail cocoa polyphenol result baselin num week dark chocol intak reduc sd systol bp num num mm hg num diastol bp num num mm hg num bodi weight plasma level lipid glucos num isoprostan hypertens preval declin num num bp decreas accompani sustain increas s nitrosoglutathion num num nmol l num dark chocol dose result cocoa phenol plasma white chocol intak caus bp plasma biomark conclus data small sampl healthi individu above optim bp inclus small amount polyphenol rich dark chocol part usual diet effici reduc bp improv format vasodil nitric oxid trial registr clinicaltri gov identifi nct num
MED-5149~continu intak polyphenol compound cocoa powder reduc ldl oxid suscept benefici effect plasma hdl c pubm ncbi abstract background cocoa powder rich polyphenol catechin procyanidin shown model inhibit ldl oxid atherogenesi object examin long term intak cocoa powder alter plasma lipid profil normocholesterolem mild hypercholesterolem human subject design twenty f subject random assign ingest num sugar d control group num cocoa powder num sugar d cocoa group num wk blood sampl collect studi num wk intak test drink plasma lipid ldl oxid suscept urinari oxid stress marker measur result num wk measur num prolong baselin level lag time ldl oxid cocoa group prolong cocoa group signific greater reduct measur control group num signific greater increas plasma hdl cholesterol num observ cocoa group control group num negat correl observ plasma concentr hdl cholesterol oxid ldl num wk num reduct dityrosin baselin concentr cocoa group reduct cocoa group signific greater reduct control group num conclus increas hdl cholesterol concentr contribut suppress ldl oxid polyphenol substanc deriv cocoa powder contribut elev hdl cholesterol
MED-5150~sustain increas flow medi dilat daili intak high flavanol cocoa drink num week pubm ncbi abstract single dos ingest flavanol rich cocoa acut revers endotheli dysfunct investig time endotheli function daili consumpt high flavanol cocoa determin flow medi dilat fmd acut num hour single dos ingest chronic administr num day studi popul repres individu smoking rel endotheli dysfunct addit fmd plasma nitrit nitrat measur daili consumpt flavanol rich cocoa drink num num mg flavanols d num day num result continu fmd increas baselin overnight fast flavanol ingest sustain fmd augment num hour ingest fast fmd respons increas num num day num num num num num num num num day num num fmd return num num washout week cocoa fre diet day num increas observ circul nitrit circul nitrat parallel observ fmd augment acut single dos consumpt cocoa drink num num mg flavanol led dose depend increas fmd nitrit maxim fmd num hour consumpt dose achiev half maxim fmd respons num mg num general appli biomark oxid stress plasma mda teac antioxid status plasma ascorb urat remain unaffect cocoa flavanol ingest daili consumpt flavanol rich cocoa potenti revers endotheli dysfunct sustain dose depend manner
MED-5151~emerg role flavonoid rich cocoa chocol cardiovascular health diseas pubm ncbi abstract cocoa chocol recent found rich plant deriv sourc antioxid flavonoid benefici cardiovascular properti favor physiolog effect includ antioxid activ vasodil blood pressur reduct inhibit platelet activ decreas inflamm increas evid experiment clinic studi cocoa deriv product chocol suggest import role high flavanol contain food heart vascular protect
MED-5152~age vascular respons flavanol rich cocoa pubm ncbi abstract object strong evid secur age power predictor cardiovascular risk endotheli dysfunct specif treatment test hypothesi vascular respons flavanol rich cocoa increas advanc age previous shown flavanol rich cocoa induc peripher vasodil improv endotheli function nitric oxid depend mechan method studi blood pressur peripher arteri respons day cocoa num young num year num older num healthi subject result nitric oxid synthas nos inhibitor omega nitro l arginine methyl est l name induc signific pressor respons cocoa administr older subject systol blood pressur sbp rose num num mmhg diastol blood pressur dbp num num mmhg num num sbp signific higher older subject num flow medi vasodil measur tonometri finger enhanc flavanol rich cocoa group signific num final basal puls wave amplitud pwa similar pattern day flavanol rich cocoa caus rise pwa group peak vasodil acut cocoa intak final day group show signific rise pwa respons older subject robust num l name signific revers dilat group conclus flavanol rich cocoa enhanc measur endotheli function greater degre older younger healthi subject data suggest no depend vascular effect flavanol rich cocoa greater older peopl endotheli function disturb
MED-5153~acut effect high fat meal enrich walnut oliv oil postprandi endotheli function pubm ncbi abstract object sought investig addit walnut oliv oil fatti meal differenti effect postprandi vasoact lipoprotein marker oxid endotheli activ plasma asymmetr dimethylarginin adma background compar mediterranean diet walnut diet shown improv endotheli function hypercholesterolem patient hypothes walnut revers postprandi endotheli dysfunct consumpt fatti meal method random crossov design num healthi subject num patient hypercholesterolemia num high fat meal sequenc num oliv oil num walnut ad test meal num fat num satur fatti acid consumpt meal separ num week venipunctur ultrasound measur brachial arteri endotheli function perform fast num test meal result studi group flow medi dilat fmd wors oliv oil meal walnut meal num time period interact fast postprandi triglycerid concentr correl invers fmd num num flow independ dilat plasma adma concentr unchang concentr oxid low dens lipoprotein decreas num meal plasma concentr solubl inflammatori cytokin adhes molecul decreas num independ meal type e selectin decreas num walnut meal conclus ad walnut high fat meal acut improv fmd independ oxid inflamm adma walnut oliv oil preserv protect phenotyp endotheli cell
MED-5154~whole grain intak bodi mass index colleg student pubm ncbi abstract object measur whole grain intak colleg student determin associ bodi mass index bmi design cross sect conveni sampl colleg student enrol introductori nutrit set larg state univers particip num colleg student age num main outcom measur intak grain refin grain calori fiber food record bmi determin height weight measur analysi analysi varianc linear contrast particip group bmi categori num result averag intak cereal grain num serv day whole grain intak account averag num serv day whole grain intak signific higher normal weight student overweight obes student base bmi conclus implic low intak grain popul colleg student intervent aim increas whole grain intak recommend minimum num serv day colleg student concern bodi weight motiv increas intak whole grain food intak grain influenc avail food item campus dine hall locat colleg campus
MED-5155~effect daili supplement soy protein bodi composit insulin secret postmenopaus women abstract object determin supplement soy protein improv bodi composit bodi fat distribut glucos insulin metabol non diabet postmenopaus women compar isocalor casein placebo design random double blind placebo control num month trial set clinic research center patient num postmenopaus women intervent ct scan num num dual energi x ray absorptiometri dxa hyperglycem clamp main outcom measur total fat total abdomin fat viscer fat subcutan abdomin fat insulin secret result weight dxa chang group num num kg placebo num num kg soy num total subcutan abdomin fat increas placebo compar soy group differ group total abdomin fat num num cm num placebo num num cm num soy num subcutan abdomin fat num num cm num placebo num num cm num soy num insulin secret viscer fat total bodi fat lean mass differ group isoflavon level increas soy group conclus daili supplement soy protein prevent increas subcutan total abdomin fat observ isocalor casein placebo postmenopaus women
MED-5156~overview antibacteri antitoxin antivir antifung activ tea flavonoid tea pubm ncbi abstract tea leav produc organ compound involv defens plant invad pathogen includ insect bacteria fungi virus metabolit includ polyphenol compound so cal catechin methyl xanthin alkaloid caffein theobromin theophyllin postharvest inactiv phenol oxidas green tea leav prevent oxid catechin postharvest enzyme catalyz oxid ferment catechin tea leav result format theaflavin polymer thearubigin substanc impart black color black tea black part ferment oolong tea class phenol compound exist develop understand role polyphenol tea compound food medic microbiolog overview survey interpret present knowledg activ tea flavonoid tea foodborn pathogen bacteria virul protein toxin produc bacteria virul bacteriophag pathogen virus fungi cover synergist mechanist bioavail aspect antimicrobi effect research suggest categori find fundament interest practic implic nutrit food safeti anim human health
MED-5157~herbal innocu ten case sever hepatotox dietari supplement herbalif product pubm ncbi abstract background aim herbal agent popular perceiv safe suppos natur report num case toxic hepat implic herbalif product method determin preval outcom hepatotox due herbalif product questionnair public swiss hospit report case subject causal assess ciom criteria result twelv case toxic hepat implic herbalif prepar num retriev num suffici document permit causal analysi median age patient num year rang num latenc onset num month num num liver biopsi num show hepat necrosi mark lymphocytic eosinophil infiltr cholestasi patient patient fulmin liver failur success transplant explant show giant cell hepat sinusoid obstruct syndrom observ case patient liver biopsi present hepatocellular num mix num liver injuri causal assess advers drug reaction classifi probabl case conclus present case seri toxic hepat implic herbalif product liver toxic sever detail declar compon pro act role regulatori agenc desir
MED-5158~associ consumpt herbalif nutrit supplement acut hepatotox pubm ncbi abstract background aim nutrit supplement frequent consid harmless indiscrimin unlabel ingredi lead signific advers reaction method num identif index case acut hepat herbalif intak led ministri health investig isra hospit twelv patient acut idiopath liver injuri associ consumpt herbalif product investig result eleven patient femal age num num patient stage primari biliari cirrhosi hepat acut liver injuri diagnos num num month initi herbalif consumpt liver biopsi demonstr activ hepat portal inflamm rich eosinophil ductular reaction parenchym inflamm peri centr accentu patient develop sub fulmin fulmin episod hepat failur hepat resolv eleven patient patient succumb complic liver transplant patient resum consumpt herbalif product normal liver enzym result bout hepat conclus associ intak herbalif product acut hepat identifi israel call prospect evalu herbalif product hepatotox caution exercis consum individu suffer liver diseas
MED-5159~cannabi risk lung cancer case control studi abstract aim determin risk lung cancer cannabi smoke method case control studi lung cancer adult num year age conduct district health board zealand case identifi zealand cancer registri hospit databas control random select elector roll frequenc match case num year age group district health board interview administ questionnair assess risk factor includ cannabi relat risk lung cancer cannabi smoke estim logist regress result num case lung cancer num control risk lung cancer increas num ci num num joint year cannabi smoke adjust confound variabl includ cigarett smoke num ci num num pack year cigarett smoke adjust confound variabl includ cannabi smoke highest tertil cannabi increas risk lung cancer rr num num ci num num adjust confound variabl includ cigarett smoke conclus long term cannabi increas risk lung cancer young adult
MED-5160~antioxid antimutagen antitumor effect pine needl pinus densiflora pubm ncbi abstract pine needl pinus densiflora siebold zuccarini long tradit health promot medicin food korea investig potenti anticanc effect antioxid antimutagen antitumor activ assess vitro and or vivo pine needl ethanol extract pne signific inhibit fe num induc lipid peroxid scaveng num diphenyl num picrylhydrazyl radic vitro pne mark inhibit mutagen num anthramin num nitrofluoren sodium azid salmonella typhimurium ta num ta num ame test pne exposur effect inhibit growth cancer cell mcf num snu num hl num compar normal cell hdf num num dimethylthiazol num yl num diphenyltetrazolium bromid assay vivo antitumor studi freeze dri pine needl powder supplement num wt wt diet fed mice inocul sarcoma num cell rat treat mammari carcinogen num dimethylbenz a anthracen dmba num mg kg bodi weight tumorigenesi suppress pine needl supplement model system blood urea nitrogen aspart aminotransferas level signific lower pine needle suppl rat dmba induc mammari tumor model result demonstr pine needl exhibit strong antioxid antimutagen antiprolif effect cancer cell antitumor effect vivo point potenti cancer prevent
MED-5161~dietari intak flavonol flavon coronari heart diseas women pubm ncbi abstract dietari flavonol flavon subgroup flavonoid suggest decreas risk coronari heart diseas chd author prospect evalu intak flavonol flavon relat risk nonfat myocardi infarct fatal chd nurs health studi assess dietari inform study num num food frequenc questionnair comput cumul averag intak flavonol flavon cox proport hazard regress time vari variabl analysi num year follow up num author document num nonfat myocardi infarct num chd death num women observ associ flavonol flavon intak risk nonfat myocardi infarct fatal chd weak risk reduct chd death found women higher intak kaempferol individu flavonol found primarili broccoli tea women highest quintil kaempferol intak relat lowest multivari relat risk num num confid interv num num trend num lower risk kaempferol intak attribut broccoli consumpt prospect data support invers associ flavonol flavon intak chd risk
MED-5162~antimutagen effect broccoli flower head ame salmonella revers mutat assay pubm ncbi abstract studi perform investig antimutagen effect broccoli flower head ame salmonella revers mutat assay broccoli flower head high edibl part plant analys antimutagen effect isol phytomolecul crude ethanol extract broccoli flower head test suppress mutagen effect induc chemic mutagen strain ta num ta num ta num studi tester strain challeng respect mutagen challeng ethanol extract broccoli flower head concentr num num mg plate plate incub num revert coloni count crude extract prove promutagen ethanol extract broccoli flower head num mg plate suppress mutagen effect induc posit mutagen tester strain studi crude extract broccoli flower head cytotox maximum concentr test num mg plate conclus ethanol extract broccoli num mg plate suggest divers antimutagen potenti mutagen chemic employ studi num john wiley son
MED-5163~hepat induc noni juic morinda citrifolia rare hepatotox tip iceberg pubm ncbi abstract num year old femal patient present communiti hospit mild elev serum transaminas bilirubin level multipl sclerosi treat interferon beta num num week exclus viral hepat due hepat a e interferon beta num withdrawn suspicion drug induc hepat week admit communiti hospit sever icterus transaminas bilirubin level high elev begin impair liver synthesi express reduc prothrombin time confin depart occur fulmin hepat suspicion begin acut liver failur evid hepat due potenti hepatotox virus alcohol hepat budd chiari syndrom hemochromatosi wilson diseas serum high titer liver kidney microsom type num autoantibodi serum gamma globulin level normal rang fine needl aspir biopsi liver rule autoimmun hepat show sign drug induc toxic interview admit general immun system stimul drink noni juic polynesian herbal remedi made tropic fruit morinda citrifolia past num week cessat noni juic ingest transaminas level normal quick normal rang num month copyright num karger ag basel
MED-5164~dietari putrescin num diaminobutan influenc recoveri turkey poult challeng mix coccidi infect pubm ncbi abstract exogen dietari putrescin num diaminobutan increas growth rate neonat anim includ calv chick piglet nutrit stress turkey poult high mortal rate due poor initi feed behavior inadequ develop intestin tract conduct experi determin effect dietari putrescin supplement growth perform role dietari putrescin prevent recoveri coccidi challeng total num d old turkey poult fed corn soybean meal bas starter diet supplement num control num num num num purifi putrescin num birds pen num pens diet num age half bird infect approxim num sporul oocyst experi num fecal sampl gather num num postinfect total collect ten control num infect bird fed diet sampl num num postinfect induc infect produc signific depress growth feed intak detriment morpholog small intestin poult absenc mortal weight gain protein content jejunum morphometr indic duodenum jejunum ileum greater challeng poult fed num num putrescin control conclud dietari putrescin supplement benefici poult growth mucos develop small intestin recoveri subclin coccidiosi
MED-5165~watermelon consumpt increas plasma arginin concentr adult pubm ncbi abstract object watermelon rich sourc citrullin amino acid metabol arginin condit essenti amino acid human arginin nitrogen substrat synthesi nitric oxid play essenti role cardiovascular immun function detail studi conduct evalu plasma arginin respons human long term feed citrullin natur plant sourc studi investig watermelon juic consumpt increas fast concentr plasma arginin ornithin citrullin healthi adult human method subject num treatment consum control diet num control num num watermelon juic day num wk crossov design treatment provid num num citrullin day treatment period preced washout period num num wk result compar baselin fast plasma arginin concentr increas num num wk lower dos watermelon treatment arginin ornithin concentr increas num num num wk higher dos watermelon treatment fast citrullin concentr increas relat control remain stabl studi conclus increas fast plasma concentr arginin ornithin stabl concentr plasma citrullin respons watermelon juic consumpt citrullin plant origin effect convert arginin result demonstr plasma concentr arginin increas intak citrullin watermelon
MED-5166~cranberri blueberri evid protect effect cancer vascular diseas pubm ncbi abstract grow evid tissu cultur anim clinic model suggest flavonoid rich fruit north american cranberri blueberri vaccinium spp potenti abil limit develop sever cancer vascular diseas includ atherosclerosi ischem stroke neurodegen diseas age fruit varieti phytochem contribut protect effect includ flavonoid anthocyanin flavonol proanthocyanidin substitut cinnam acid stilben triterpenoid ursol acid ester cranberri blueberri constitu act mechan counteract oxid stress decreas inflamm modul macromolecular interact express gene diseas process evid suggest potenti role dietari cranberri blueberri prevent cancer vascular diseas justifi research determin bioavail metabol berri phytonutri influenc activ vivo
MED-5167~endocrin disruptor hypospadia role genistein fungicid vinclozolin pubm ncbi abstract object phytoestrogen plant estrogen genistein present soy product interest utero exposur genistein hypospadia mous model matern consumpt soy preval human popul compound interest fungicid vinclozolin hypospadia mous rat occur concurr genistein diet residu expos food studi unit kingdom found relationship matern organ vegetarian diet hypospadia frequenc women consum nonorgan vegetarian diet greater percentag son hypospadia nonorgan diet includ residu pesticid vinclozolin sought assess interact realist daili exposur genistein vinclozolin effect incid hypospadia method pregnant mice fed soy fre diet oral gavag gestat day num num num mg kg day genistein num mg kg day vinclozolin genistein vinclozolin dose num microl corn oil control receiv corn oil vehicl male fetus examin gestat day num hypospadia macroscop histolog result identifi hypospadia corn oil group incid hypospadia num genistein num vinclozolin num genistein vinclozolin conclus find support idea exposur compound gestat contribut develop hypospadia
MED-5168~matern vegetarian diet pregnanc hypospadia alspac studi team avon longitudin studi pregnanc childhood pubm ncbi abstract object investig role matern diet vegetarian consumpt phytoestrogen origin hypospadia report increas preval subject method detail inform obtain prospect mother includ previous obstetr histori lifestyl dietari practic structur self complet questionnair pregnanc previous recogn associ environment parent factor examin focus hypothes hormon link multivari logist regress identifi independ associ result num boy born mother part avon longitudin studi pregnanc childhood num hypospadia case identifi signific differ proport hypospadia case mother smoke consum alcohol aspect previous reproduct histori includ number previous pregnanc number miscarriag contracept pill time concept age menarch signific differ detect aspect matern diet vegetarian iron supplement half pregnanc mother vegetarian pregnanc adjust odd ratio num num confid interv ci num num give birth boy hypospadia compar omnivor supplement diet iron omnivor supplement diet iron adjust num num ci num num statist signific associ hypospadia influenza num month pregnanc adjust num num ci num num conclus vegetarian greater exposur phytoestrogen omnivor result support possibl phytoestrogen deleteri effect develop male reproduct system
MED-5169~reduct faecal coliform coliform heterotroph plate count bacteria household kitchen bathroom disinfect hypochlori pubm ncbi abstract fourteen site divid household kitchen bathroom monitor week basi number faecal coliform total coliform heterotroph plate count bacteria num week compris control period hypochlorit clean product introduc household num week strict clean regimen hypochlorit product implement num week kitchen heavili contamin bathroom toilet seat contamin site highest concentr class bacteria found site moist environ and or frequent touch includ sponge dishcloth kitchen sink drain area bath sink drain area kitchen faucet handl implement clean regimen common household hypochlorit product result signific reduct class bacteria site household site
MED-5170~microbiolog qualiti sushi sushi bar retail pubm ncbi abstract sushi tradit japanes food consist rice raw fish fish consid healthi food anim product consumpt raw muscl incur potenti health risk ingest pathogen bacteria parasit studi num sushi sampl analyz microbiolog status preval pathogen bacteria comparison made frozen sushi supermarket fresh sushi sushi bar aerob mesophil bacteria count differ sushi sourc num log cfu g frozen sushi num log cfu g fresh sushi preval escherichia coli staphylococcus aureus higher fresh sampl salmonella found num sushi sampl listeria monocytogen found num sampl result microbiolog qualiti industri process sushi higher fresh prepar sushi qualiti fresh prepar sushi strong depend skill habit prepar cook vari
MED-5171~incid enterohemorrhag escherichia coli escherichia coli num salmonella listeria monocytogen retail fresh ground beef sprout pubm ncbi abstract object studi determin preval enterohemorrhag escherichia coli ehec coli num salmonella listeria monocytogen retail food sampl seattl wash total num sampl ground beef num sampl mushroom num sampl sprout num sampl collect num month period analyz presenc pathogen pcr assay cultur confirm determin presenc absenc organ num ground beef sampl analyz num num posit ehec num num posit coli num salmonella present num num num ground beef sampl num ground beef sampl analyz num num posit monocytogen ehec found num num num sprout sampl num num yield coli num num total sprout sampl num num posit salmonella posit monocytogen num mushroom sampl num num posit ehec num sampl posit coli num salmonella detect num num mushroom sampl monocytogen found num num sampl
MED-5172~effect spirulina allerg rhiniti pubm ncbi abstract preval allerg rhiniti increas global due affect qualiti life larg group peopl world allerg rhiniti remain inadequ control present medic continu medic therapi make individu anxious side effect drug altern strategi effect spirulina tinospora cordifolia butterbur investig recent allerg rhiniti investig spirulina repres blue green alga produc commerci dietari supplement modul immun function amelior varieti diseas doubl blind placebo control studi evalu effect toler spirulina treat patient allerg rhiniti spirulina consumpt signific improv symptom physic find compar placebo num includ nasal discharg sneez nasal congest itch spirulina clinic effect allerg rhiniti compar placebo studi perform order clarifi mechan effect
MED-5173~acut rhabdomyolysi caus spirulina arthrospira platensi pubm ncbi abstract rhabdomyolysi potenti life threaten disord occur primari diseas complic broad spectrum diseas report case acut rhabdomyolysi ingest spirulina arthrospira platensi planton blue green alga dietari supplement
MED-5175~nutrit lifestyl relat bowel movement frequenc cross sect studi num men women epic oxford pubm ncbi abstract object investig relationship nutrit lifestyl factor bowel movement frequenc design cross sect analysi data prospect studi number bowel movement calcul relat rang factor addit individu categoris frequenc bowel movement fewer num week daili versus num week daili odd ratio calcul logist regress model result factor adjust factor set european prospect investig cancer nutrit oxford cohort epic oxford uk particip total num men women age num year recruit thirti cent subject vegetarian vegan result women fewer bowel movement averag men daili bowel movement bowel movement frequenc higher vegetarian num men num women vegan num men num women compar particip ate meat num men num women signific posit associ bowel movement frequenc bodi mass index bmi intak dietari fibr non alcohol fluid men women vigor exercis posit bowel movement frequenc women result men clear alcohol intak posit bowel movement frequenc men women conclus vegetarian vegan strong higher frequenc bowel movement high intak dietari fibr fluid high bmi increas frequenc bowel movement
MED-5176~effect dietari flaxse lignan extract symptom benign prostat hyperplasia pubm ncbi abstract flaxse lignan extract num secoisolariciresinol diglucosid sdg evalu abil allevi lower urinari tract symptom lut num subject benign prostat hyperplasia bph random double blind placebo control clinic trial repeat measur conduct num month period treatment dosag num placebo num num mg day sdg num month treatment num num subject complet studi num num mg day sdg group intern prostat symptom score ipss decreas num num num num num num se num num num compar baselin qualiti life score qol score improv num num num num num num se num num compar placebo num num num compar baselin number subject lut grade chang moderate sever mild increas num num num compar baselin maximum urinari flow insignific increas num num num num num num ml second se statist signific reach postvoid urin volum decreas insignific num num num num num num ml se statist signific reach plasma concentr secoisolariciresinol seco enterodiol ed enterolacton el signific rais supplement observ decreas ipss qol score correl concentr plasma total lignan seco ed el conclus dietari flaxse lignan extract appreci improv lut bph subject therapeut efficaci compar common intervent agent alpha num adrenoceptor blocker num lpha reductas inhibitor
MED-5177~pilot evalu flaxse manag hot flash pubm ncbi abstract object studi evalu phase num pilot studi toler effect num week flaxse therapi hot flash score women receiv estrogen therapi elig includ num hot flash week num month baselin week particip studi medic document characterist hot flash crush flaxse administ num daili particip provid week toxic report health rel qualiti life inform primari end point chang hot flash score prospect report daili hot flash diari thirti women enrol june num novemb num decreas hot flash score flaxse therapi num median decreas num reduct daili hot flash frequenc num median reduct num num hot flash num fourteen num particip num experienc mild moder abdomin distent particip num experienc mild diarrhea experienc flatul num withdrew toxic studi suggest dietari therapi decreas hot flash activ women estrogen therapi reduct greater expect placebo
MED-5178~dietari flaxse lignan extract lower plasma cholesterol glucos concentr hypercholesterolaem subject pubm ncbi abstract lignan deriv flaxse phyto oestrogen increas studi health benefit num week randomis double blind placebo control studi conduct fifty f hypercholesterolaem subject treatment num placebo num num mg d dietari secoisolariciresinol diglucosid sdg flaxse extract determin effect plasma lipid fast glucos level signific treatment effect achiev num num decreas total cholesterol tc ldl cholesterol ldl c glucos concentr percentag decreas baselin week num num num mg sdg group decreas tc ldl c concentr rang num num num compar placebo num mg sdg group signific differ baselin observ decreas tc ldl c substanti effect lower concentr fast plasma glucos note num mg sdg group week num num subject baselin glucos concentr num mmol l lower num num num num compar placebo plasma concentr secoisolariciresinol seco enterodiol ed enterolacton signific rais group supplement flaxse lignan observ cholesterol low valu correl concentr plasma seco ed num num num num conclus dietari flaxse lignan extract decreas plasma cholesterol glucos concentr dose depend manner
MED-5179~dietari supplement flaxse oil lower blood pressur dyslipidaem patient pubm ncbi abstract object alpha linolen acid ala natur precursor cardioprotect long chain num fatti acid data benefici effect ala cardiovascular diseas cvd respons cvd risk factor increas ala intak character purpos present studi examin effect increas ala intak blood pressur man design set subject intervent prospect two group parallel arm design examin effect num week dietari supplement flaxse oil rich ala num g day blood pressur middle ag dyslipidaem men num diet control group supplement safflow oil equival num fatti acid num g day linol acid la num arteri blood pressur measur begin end dietari intervent period result supplement ala result signific lower systol diastol blood pressur level compar la num num analysi varianc anova repeat measur conclus observ hypotens effect ala constitut mechan account part appar cardioprotect effect num fatti acid
MED-5181~diet high fruit low meat reduc risk colorect adenoma pubm ncbi abstract recent evid suggest dietari pattern specif dietari compon predictor colorect adenoma cancer cluster analysi aim assess associ dietari pattern colorect adenoma adjust total energi consumpt prior creat cluster affect relat data case control studi num individu undergo colonoscopi util case num num adenoma colonoscopi control num adenoma dietari data obtain ffq daili intak num food group calcul valu transform z score particip cluster energi adjust base consumpt num kcal num kj associ dietari pattern colorect adenoma energi adjust prior creat dietari cluster cluster form by product energi consumpt adjust energi consumpt num distinct cluster emerg num high fruit low meat cluster num high vegetable moder meat cluster num high meat cluster adjust potenti confound high vegetable moder meat cluster odd ratio num num ci num num high meat cluster num num ci num num signific increas odd adenoma compar high fruit low meat cluster high fruit low meat diet protect colorect adenoma compar dietari pattern increas veget meat consumpt
MED-5182~dietari fibr risk breast cancer uk women cohort studi pubm ncbi abstract background report relationship dietari fibr intak breast cancer inconsist previous cohort studi limit narrow rang intak method women develop invas breast cancer num post menopaus num pre menopaus num person year follow up uk women cohort studi ukwc studi cohort num subject wide rang exposur dietari fibr intak total fibr lowest quintil num g day num g day top quintil fibr breast cancer relationship explor cox regress model adjust measur error effect fibr adjust confound examin pre post menopaus women separ result pre menopaus post menopaus women statist signific invers relationship found total fibr intak risk breast cancer trend num top quintil fibr intak hazard ratio num num confid interv ci num num compar lowest quintil pre menopaus fibr cereal invers risk breast cancer trend num fibr fruit borderlin invers relationship trend num model includ dietari folat strengthen signific invers relationship total fibr pre menopaus breast cancer conclus find suggest pre menopaus women total fibr protect breast cancer fibr cereal possibl fruit
MED-5183~diet risk ovarian cancer california teacher studi cohort abstract dietari phytochem compound includ isoflavon isothiocyan inhibit cancer develop examin prospect epidemiolog studi ovarian cancer author investig associ consumpt nutrient ovarian cancer risk prospect cohort studi num elig women california teacher studi cohort complet baselin dietari assess num num women develop invas borderlin ovarian cancer decemb num multivari cox proport hazard regress age timescal estim relat risk num confid interv statist test side intak isoflavon lower risk ovarian cancer compar risk women consum num mg total isoflavon day relat risk ovarian cancer consumpt num mg day num num confid interv num num intak isothiocyan food high isothiocyan ovarian cancer risk intak macronutri antioxid vitamin micronutri dietari consumpt isoflavon decreas ovarian cancer risk dietari factor play major role ovarian cancer develop
MED-5184~dietari lignan intak risk breast cancer tumor estrogen receptor status pubm ncbi abstract examin associ dietari lignan intak estrogen receptor negat er er posit er breast cancer risk breast cancer case control studi premenopaus women reduc risk er breast cancer highest compar lowest quartil lignan intak suggest observ negat associ lignan breast cancer limit er tumor
MED-5185~food intak risk squamous cell carcinoma skin communiti nambour skin cancer cohort studi pubm ncbi abstract evid dietari factor modifi risk squamous cell carcinoma scc skin associ food intak scc evalu prospect examin associ food intak scc incid num random select adult live australian sub trop communiti measurement error correct estim intak num food group defin valid food frequenc questionnair num associ scc risk assess poisson negat binomi regress person affect tumour count base incid histolog confirm tumour occur num num multivari adjust food group signific scc risk stratifi analysi particip past histori skin cancer show decreas risk scc tumour high intak green leafi veget rr num num ci num num trend num increas risk high intak unmodifi dairi product rr num num ci num num trend num food intak scc risk person past histori skin cancer find suggest consumpt green leafi veget prevent develop subsequ sccs skin peopl previous skin cancer consumpt unmodifi dairi product milk chees yoghurt increas scc risk suscept person copyright num wiley liss
MED-5186~nutrit factor relat endometri cancer report population bas case control studi shanghai china abstract evalu role dietari nutrient etiolog endometri cancer population bas case control studi num newli diagnos endometri cancer case num age frequency match control inform usual dietari habit collect in person interview valid quantit food frequenc questionnair logist regress analysi conduct evalu associ nutrient endometri cancer risk energi densiti method nutrient intak num kilocalori intak higher energi intak increas risk attribut anim sourc energi high proport energi protein fat odd ratio compar highest versus lowest quintil intak elev intak anim protein odd ratio num num confidenti interv num num fat num num num num reduc plant sourc nutrient num num num num protein num num num num fat analysi show satur monounsatur fat intak elev risk polyunsatur fat intak unrel risk dietari retinol caroten vitamin vitamin fiber vitamin supplement invers risk signific associ observ dietari vitamin num vitamin num find suggest associ dietari macronutri endometri cancer risk depend sourc intak anim origin nutrient relat higher risk intak plant origin nutrient relat lower risk dietari fiber retinol caroten vitamin vitamin vitamin supplement decreas risk endometri cancer
MED-5188~meat intak bladder cancer risk num prospect cohort studi pubm ncbi abstract background nitrosamin bladder carcinogen precursor found meat item concentr compound high bacon num cohort studi num case subject examin relat meat intak bladder cancer studi examin relat meat type bladder cancer object aim examin associ specif meat item bladder cancer num larg prospect studi design analyz data num cohort num follow up num incid bladder cancer case detail data meat obtain multipl food frequ questionnair administ time multivari relat risk rrs num cis estim cox proport hazard model control potenti confound includ detail smoke histori result men women high intak bacon num servings wk elev risk bladder cancer compar ate bacon multivari rr num num ci num num associ statist signific trend num associ bacon stronger statist signific remov individu great chang red meat men bacon women intak num baselin multivari rr num num ci num num trend num posit associ detect intak chicken skin chicken skin meat includ process meat hot dog hamburg conclus num cohort combin frequent consumpt bacon elev risk bladder cancer studi data specif meat item confirm find
MED-5189~adolesc milk fat galactos consumpt testicular germ cell cancer pubm ncbi abstract recent case control studi suggest dairi product consumpt import risk factor testicular cancer examin associ consumpt dairi product milk milk fat galactos testicular cancer population bas case control studi includ num case num control respons proport num num dietari histori assess food frequenc question index person mother includ diet num year interview diet age num year condit logist regress calcul odd ratio estim relat risk rr num confid interv num ci control social status height rr testicular cancer num num ci num num addit num serv milk month num ml adolesc elev risk due increas risk seminoma rr num num ci num num addit num milk serv month rr seminoma num num ci num num addit num milk fat month num num ci num num addit num galactos month adolesc result suggest milk fat and or galactos explain associ milk dairi product consumpt seminomat testicular cancer
MED-5190~dietari mutagen exposur risk pancreat cancer abstract investig associ dietari exposur food mutagen risk pancreat cancer conduct hospital bas case control studi univers texa anderson cancer center june num num atot num case num noncanc control frequenc match race sex age num year dietari exposur inform collect person interview meat prepar questionnair signific greater portion case control show prefer well don pork bacon grill chicken pan fri chicken hamburg steak case higher daili intak food mutagen mutagen activ revert gram daili meat intak control daili intak num amino num num trimethylimidazo num f quinoxalin dimeiqx benzo pyren bap mutagen activ signific predictor pancreat cancer num num num adjust confound signific trend elev cancer risk increas dimeiqx intak observ quintil analysi ptrend num ahigh intak dietari mutagen top quintil num fold increas risk pancreat cancer famili histori cancer famili histori cancer aposs synergist effect dietari mutagen exposur smoke observ individu highest level exposur top num phip bap pinteract num num data support hypothesi dietari mutagen exposur interact factor contribut develop pancreat cancer
MED-5191~anim food intak cook method relat endometri cancer risk shanghai abstract evalu anim food intak cook method relat endometri cancer risk population bas case control studi shanghai china valid food frequenc questionnair collect usual dietari habit num case num control age num num year num num statist analys base uncondit logist regress model adjust potenti confound high intak meat fish increas risk endometri cancer adjust odd ratio highest lowest quartil group num num confid interv num num num num num elev risk observ type meat fish intak intak egg milk relat risk cook method level meat fish risk modifi associ meat fish consumpt studi suggest anim food consumpt play import role aetiolog endometri cancer cook method minim influenc risk chines women
MED-5192~prospect studi dietari calcium dairi product prostat cancer risk finland pubm ncbi abstract high dietari intak calcium dairi product hypothes enhanc prostat cancer risk prospect data associ inconsist examin dietari intak calcium dairi product relat risk prostat cancer alpha tocopherol beta caroten atbc cancer prevent studi cohort num male smoker age num year studi entri dietari intak assess baselin valid num item food questionnair cox proport hazard regress adjust suspect risk factor prostat cancer num year follow up ascertain num incid case prostat cancer high versus low intak dietari calcium mark increas prostat cancer risk multivari relat risk rr prostat cancer num mg day compar num mg day calcium intak num num confid interv ci num num trend num total dairi intak posit risk prostat cancer multivari rr prostat cancer compar extrem quintil intak num num ci num num trend num associ total dairi intak remain adjust calcium trend num find similar stage grade prostat cancer result larg prospect studi suggest intak calcium relat compon dairi food increas prostat cancer risk
MED-5193~plasma erythrocyt biomark dairi fat intak risk ischem heart diseas pubm ncbi abstract background relat dairi product intak risk ischem heart diseas ihd remain controversi object aim explor biomark dairi fat intak plasma erythrocyt assess hypothesi higher concentr biomark greater risk ihd women design num particip nurs health studi provid blood sampl num num incid case ihd ascertain baselin num case match num control age smoke fast status date blood draw result control correl coeffici averag dairi fat intak num num tran num num content num num plasma num num erythrocyt multivari analys control age smoke risk factor ihd women higher plasma concentr num signific higher risk ihd multivariate adjust relat risk num ci lowest highest tertil num concentr plasma num refer num num num num num num trend num associ biomark signific conclus plasma erythrocyt content num tran num num biomark dairi fat intak data suggest high intak dairi fat greater risk ihd
MED-5194~childhood dairi intak adult cancer risk num follow up boyd orr cohort pubm ncbi abstract background dairi consumpt affect biolog pathway carcinogenesi evid link cancer risk dairi consumpt adulthood increas associ childhood dairi consumpt studi adequ object investig dairi consumpt childhood cancer incid mortal adulthood design num num num children live england scotland particip studi famili food consumpt assess num household food inventori nation health servic central regist ascertain cancer registr death num num num trace cohort member capita household intak estim dairi product calcium proxi individu intak result follow up period num cancer registr cancer death occur high childhood total dairi intak near tripl odd colorect cancer multivari odd ratio num num ci num num num side trend num compar low intak independ meat fruit veget intak socioeconom indic milk intak show similar associ colorect cancer risk high milk intak weak invers prostat cancer risk trend num childhood dairi intak breast stomach cancer risk posit associ lung cancer risk confound smoke behavior adulthood conclus famili diet rich dairi product childhood greater risk colorect cancer adulthood confirm biolog mechan
MED-5195~meat consumpt risk breast cancer uk women cohort studi abstract perform surviv analysi assess effect meat consumpt meat type risk breast cancer uk women cohort studi num num cohort num num women recruit age num num year wide rang dietari intak assess num item food frequenc questionnair hazard ratio hrs estim cox regress adjust confound high consumpt total meat compar premenopaus breast cancer hr num num ci num num high non process meat intak compar hr num num ci num num larger effect size found postmenopaus women meat type signific associ total process red meat consumpt process meat show strongest hr num num ci num num high consumpt compar women pre postmenopaus consum meat highest risk breast cancer
MED-5196~dairi product risk parkinson diseas abstract author prospect investig associ dairi intak risk parkinson diseas num men num women cancer prevent studi ii nutrit cohort american cancer societi total num men num women parkinson diseas identifi follow up num num dairi consumpt posit risk parkinson diseas compar lowest intak quintil relat risk rrs quintil num num num num num num num percent confid interv ci num num trend num higher risk dairi consum found men women associ women non linear meta analysi prospect studi confirm moder elev risk parkinson diseas individu high dairi consumpt rrs extrem intak categori num num percent ci num num men women combin num men num percent ci num num num women num percent ci num num data suggest dairi consumpt increas risk parkinson diseas men studi examin find explor mechan
MED-5197~cook meat risk breast cancer  lifetim versus recent dietari intak pubm ncbi abstract background polycycl aromat hydrocarbon pah heterocycl amin hcas carcinogen form surfac well don meat cook high temperatur method estim breast cancer risk relat intak cook meat population bas case control studi num case num control conduct long island ny num num lifetim intak grill barbecu smoke meat deriv interviewer administ questionnair data dietari intak pah hca deriv self administ modifi block food frequenc questionnair intak num year refer date uncondit logist regress estim adjust odd ratio num confid interv cis result modest increas risk observ postmenopaus premenopaus women consum grill barbecu smoke meat life num ci num num highest lowest tertil intak postmenopaus women low fruit veget intak high lifetim intak grill barbecu smoke meat higher num ci num num associ observ food frequenc questionnaire deriv intak measur pah hcas benzo alpha pyren meat postmenopaus women tumor posit estrogen receptor progesteron receptor num ci num num conclus result support accumul evid consumpt meat cook method promot carcinogen format increas risk postmenopaus breast cancer
MED-5198~african american colon cancer nativ african pubm ncbi abstract incid colorect cancer crc dramat higher african american aa nativ african nas num num num num slight higher caucasian american cas explor differ explain interact diet colon bacteri flora compar random select sampl healthi num num y old aa num nas num cas num diet measur num recal colon metabol breath hydrogen methan respons oral lactulos fecal sampl cultur num alpha dehydroxyl bacteria lactobacillus plantarum colonoscop mucos biopsi measur prolifer rate comparison nas aa consum num protein num num num num g d fat num num num num g d meat satur fat cholesterol consum num calcium vitamin vitamin fiber intak breath hydrogen higher num methan lower aa fecal coloni count num alpha dehydroxyl bacteria higher lactobacilli lower colon crypt cell prolifer rate dramat higher aa num num num num label num conclus higher crc risk mucos prolifer rate aa nas higher dietari intak anim product higher colon popul potenti toxic hydrogen secondari bile salt produc bacteria support hypothesi crc risk determin interact extern dietari intern bacteri environ
MED-5199~amount fate egg protein escap assimil small intestin human pubm ncbi abstract studi attempt evalu protein assimil human hitherto reli ileostomi subject intub techniqu avail stabl isotope label protein determin amount fate dietari protein escap digest absorpt small intestin healthi volunt noninvas tracer techniqu ten healthi volunt studi ingest cook test meal consist num num num num h label egg protein ingest raw meal amount num num num cook raw test meal escap digest absorpt small intestin signific higher percentag malabsorb raw egg protein recov urin ferment metabolit result num confirm substanti amount easili digest protein escap assimil healthi volunt num support hypothesi metabol fate protein colon affect amount protein made
MED-5200~shift convent diet uncook vegan diet revers alter fecal hydrolyt activ human pubm ncbi abstract studi effect fecal hydrolyt activ adopt uncook extrem vegan diet readopt convent diet eighteen subject random divid test control group test group subject adopt uncook extrem vegan diet num mo resum convent diet month control consum convent diet studi phenol p cresol concentr serum daili output urin fecal enzym activ measur activ fecal ureas signific decreas num cholylglycin hydrolas num beta glucuronidas num beta glucosidas num num wk begin vegan diet level remain period consum diet phenol p cresol concentr serum daili output urin signific declin fecal enzym activ return normal valu num wk resum convent diet concentr phenol p cresol serum daili output urin return normal num mo consum convent diet observ control group studi result suggest uncook extrem vegan diet decreas bacteri enzym toxic product implic colon cancer risk
MED-5201~product colon microbiota mediat effect diet colon cancer risk pubm ncbi abstract estim colon cancer attribut dietari hypothes diet influenc health colon mucosa interact microbiota milieu interior regul mucos prolifer cancer risk valid compar colon content healthi num num y old peopl popul high low risk specif low risk nativ african cancer incid num num num high risk african american risk num num num caucasian american risk num num num american typic consum high anim protein fat diet african consum stapl diet maiz meal rich resist starch low anim product overnight fast rapid colon evacu perform num polyethylen glycol total colon evacu analyz scfa vitamin nitrogen miner total scfa butyr signific higher nativ african american group colon folat biotin content measur lactobacillus rhamnos lactobacillus plantarum atcc num bioassay exceed normal daili dietari intak compar african calcium iron content signific higher caucasian american zinc content signific higher african american nitrogen content differ num group conclus result support hypothesi microbiota mediat effect diet colon cancer risk generat butyr folat biotin molecul play key role regul epitheli prolifer
MED-5202~synthesi stabil studi major metabolit hydroxybutyr acid summari hydroxybutano acid ghb date rap drug render victim unconsci defenceless intox difficult detect forens scientist due rapid metabol endogen level ghb recent discov major metabolit num ghb num potenti extend analyt detect window ghb intox disclos synthet procedur base koenig knorr glucuronid approach ghb glucuronid num deuterium label analogu num high puriti suitabl analyt chemistri addit assess stabil ghb glucuronid num mimick natur ph rang urin import develop analyt method nmr show ghb glucuronid num high stabl aqueous hydrolysi ph rang observ urin elev temperatur abstract
MED-5203~diet cell growth modul ammonia pubm ncbi abstract fiber digest endogen enzym ferment microb princip larg intestin ferment energi microb synthes protein ammonia releas enzym urea nitrogen substanc ingesta intestin secret fibber ferment yield fatti acid lower concentr free ammonia lower ph fiber increas bulk water intestin content shorten transit time decreas concentr toxic substanc contact intestin mucosa process decreas durat intens exposur intestin mucosa free ammonia form nitrogen toxic readili absorb cell concentr found lower bowel usual western diet ammonia destroy cell alter nucleic acid synthesi increas intestin mucos cell mass increas virus infect favor growth cancer cell noncancer cell tissu cultur increas virus infect ammonia bowel increas protein intak increas attribut ammonia epidemiolog evid compar popul maintain low intak unrefin carbohydr consum high intak protein fat refin carbohydr implic ammonia carcinogenesi diseas process
MED-5204~relev protein ferment gut health pubm ncbi abstract general accept carbohydr ferment result benefici effect host generat short chain fatti acid protein ferment consid detriment host health protein ferment occur distal colon carbohydr deplet result product potenti toxic metabolit ammonia amin phenol sulfid effect metabolit establish vitro studi addit import bowel diseas colorect cancer crc ulcer coliti distal colon primari site protein ferment final epidemiolog studi reveal diet rich meat preval crc case western societi import meat intak increas ferment protein induc increas intak fat heme heterocycl amin play role develop crc indic relationship gut health protein ferment investig review exist evid potenti toxic protein ferment vitro anim human studi summar copyright num wiley vch verlag gmbh kgaa weinheim
MED-5205~meat rel compound colorect cancer risk anatom subsit abstract meat involv etiolog colorect cancer associ meat rel compound examin elucid mechan population bas case control studi particip num case num healthi control complet food frequenc questionnair meat specif modul multivari logist regress examin associ meat variabl colorect cancer polytom logist regress subsite specif analys signific posit associ observ meat rel compound num amino num num trimethylimidazo num f quinoxalin dimeiqx colorect distal colon rectal tumor num amino num dimethylimidazo num f quinoxalin meiqx colorect colon cancer tumor nitrites nitr proxim colon cancer num amino num methyl num phenylimidazo num b pyridin phip rectal cancer benzo a pyren rectal cancer p trend num analys meat type cook method prefer posit associ red process meat proxim colon cancer pan fri red meat colorect cancer found p trend num invers associ observ unprocess poultri colorect colon proxim colon rectal tumor grilled barbequ poultri proxim colon cancer well done char poultri colorect colon proxim colon tumor p trend num hcas pah nitrit nitrat involv colorect cancer etiolog examin unexpect invers associ poultri colorect cancer warrant
MED-5206~udp glucuronosyltransferas famili detoxifi enzym pubm ncbi abstract glucuronid import process metabol xenobiot endogen substanc lead enhanc excret compound bodi multigen famili encod number udp glucuronosyltransferas enzym catalys rout metabol recent advanc biochem molecular biolog approach review thoma teph brian burchel insight function structur udp glucuronosyltransferas protein surpris similar capabl conjug remark number chemic
MED-5207~fecal bacteri beta glucuronidas control diet pubm ncbi abstract effect mix western high meat diet nonmeat diet intestin bacteri beta glucuronidas activ studi human volunt enzym signific higher stool subject high meat diet compar nonmeat regimen intestin flora subject high meat diet hydrolyz glucuronid conjug individu nonmeat diet turn rais amount substanc carcinogen colon lumen
MED-5208~rariti colon cancer african low anim product consumpt fiber pubm ncbi abstract object investig rariti colon cancer black african preval num num account dietari factor consid reduc risk differ colon bacteri ferment method sampl adult black south african popul drawn rural urban region food consumpt assess home visit food frequenc questionnair computer analysi num dietari recal blood sampl colon ferment measur breath num ch num respons tradit meal num lactulos cancer risk estim measur epitheli prolifer indic ki num brdu rectal mucos biopsi result evalu comparison measur high risk white south african preval num num result epitheli prolifer signific lower rural urban black white diet black subgroup character low anim product high boil maize m content white consum fresh anim product chees wheat product black consum rda quantiti fiber num rda vitamin num num folic acid num calcium num white consum anim protein num rda fat num fast food induc breath methan product time higher black conclus low preval colon cancer black african explain dietari protect factor fiber calcium vitamin folic acid influenc absenc aggress factor excess anim protein fat differ colon bacteri ferment
MED-5209~fried potato diet vitamin defici autist child pubm ncbi abstract num year old boy autism develop dri eye xerophthalmia serum vitamin undetect dietari histori reveal mark alter intak consist fri potato rice ball num year fri potato vitamin autism multifacet development disord infrequ accompani abnorm eat practic author knowledg children autism develop dietari vitamin defici consum excess fri potato attent vitamin defici essenti fri potato consum exclus
MED-5210~preval xerophthalmia malnourish children rural ethiopia pubm ncbi abstract assess preval eye diseas malnourish children rural ethiopian health center evalu correl xerophthalmia grade malnutrit retrospect cross sect survey institution bas cross sect prospect studi perform bushulo health center rural south ethiopia includ children age num month num year receiv care malnourish june num juli num num data collect involv combin interview caretak ocular examin pediatr ophthalmologist anthropometr measur hundr seventy thre children averag age examin num num year treat malnutrit num femal num male hundr forty nin patient moder malnutrit num num sever malnutrit num eye diseas diagnosed  trachoma num blephar num xerophthalmia num sever malnourish children suffer xerophthalmia moder malnourish children num compar anthropometr measur diagnosi xerophthalmia weight percentil show signific num xerophthalmia common global pediatr blind high correl sever malnutrit continu effort improv nutrit outcom patient
MED-5211~whole bodi hydrat import dri eye pubm ncbi abstract purpos identifi whole bodi hydrat play import role dri eye de hypothes individu classifi de higher plasma osmol posm indic suboptim hydrat compar classifi non d method hospital bas observ cross sect design assess de hydrat perform admiss num particip num male num femal sd age num num year assess de includ tear osmolar tosm num item dri eye questionnair deq num rate eye dryness visual analogu scale vas noninvas tear film breakup time nitbut hydrat assess perform measur posm freezing point depress osmometri result posm higher de control con indic suboptim hydrat num mosm l tosm cutoff de posm num mosm kg versus con num cohen effect size num conserv tosm classif de tosm num con num mosm l posm num mosm kg versus con num num posm higher de con composit de assess includ tosm deq num num num tosm nitbut num num vas deq num num num conclus publish data show individu classifi de higher posm indic suboptim hydrat compar non d find whole bodi hydrat import de
MED-5212~surgic punctal occlus high heat energi releas cauteri devic sever dri eye recurr punctal plug extrus pubm ncbi abstract purpos report rate recan efficaci punctal occlus surgeri high heat energy releas cauteri devic patient sever dri eye diseas recurr punctal plug extrus design prospect intervent case seri method seventi puncta num eye num dri eye patient underw punctal occlus thermal cauteri patient histori recurr punctal plug extrus high heat energy releas thermal cauteri devic optemp ii alcon japan punctal occlus surgeri symptom score best correct visual acuiti fluorescein stain score rose bengal stain score tear film break up time schirmer test valu compar num month surgeri rate punctal recan examin result month surgic cauter symptom score decreas num num num num num logarithm minim angl resolut best correct visual acuiti improv num num num num num fluorescein stain score rose bengal stain score tear film break up time schirmer test improv signific surgeri num num puncta recan thermal cauter num conclus punctal occlus high heat energy releas cauteri devic low recan rate improv ocular surfac wet visual acuiti copyright num elsevi reserv
MED-5213~dri eye diseas treatment systemat review publish trial critic apprais therapeut strategi pubm ncbi abstract dri eye diseas ded treatment area increas complex emerg treatment agent recent year evalu efficaci agent limit heterogen outcom definit small number compar studi provid systemat review clinic trial cts relat ded treatment critic apprais ct public databas ct report obtain databas review public free access electron databas ct registr data evalu base endpoint symptom schirmer test ocular surfac stain score recruit patient type efficaci drug design site perform studi forty nin cts evalu involv num patient receiv ded treatment heterogen studi design prevent meta analysi yield meaning result descript analysi studi conduct frequent categori drug ded studi artifici tear anti inflammatori drug secretagogu num studi complet registr databas clinic trial num num publish num regist cts relat ded num perform usa pharmaceut industri sponsor num identif effect ded treatment strategi hinder lack accept set definit criteria evalu diseas sever copyright num elsevi reserv
MED-5214~epidemiolog dri eye diseas report epidemiolog subcommitte intern dri eye workshop num pubm ncbi abstract report epidemiolog subcommitte num dri eye workshop summar current knowledg epidemiolog dri eye diseas provid preval incid data popul stress expand epidemiolog studi addit geograph region incorpor multipl race ethnic futur studi build consensus dri eye diagnost criteria epidemiolog studi recommend made characterist dri eye questionnair suitabl epidemiolog studi random control clinic trial risk factor dri eye morbid diseas identifi impact dri eye diseas qualiti life visual function outlin suggest made prospect research lead improv eye general public health
MED-5215~review complic lacrim occlus punctal canalicular plug pubm ncbi abstract punctal canalicular plug wide temporari perman occlus lacrim puncta dri eye design materi market efficaci improv dri eye symptom wide proven gamut complic devic subject general review numer case seri literatur devic review aim examin track record varieti plug review manag complic propos strategi prevent complic treatment
MED-5216~preval vitamin defici south asia outcom remedi abstract vitamin defici vad recogn public health issu develop countri econom constraint sociocultur limit insuffici dietari intak poor absorpt lead deplet vitamin store bodi regard potenti determin preval vad south asian develop countri vad exacerb lack educ poor sanit absenc legisl enforc exist food law week monitor surveil system recent estim confirm higher morbid mortal rate children pregnant non pregn women childbear age xerophthalmia lead prevent childhood blind earliest manifest night blind bitot spot blind keratomalacia ocular manifest vad children addit vitamin consum normal diet general improv vitamin status supplement fortif dietari diversif approach solv problem south asian countri desir extent poor government support supervis vitamin supplement year extens review extant literatur carri data section identifi computer bibliograph search pubm web scienc googl scholar abstract full text articl examin relev articl select screen inclus review conclus high preval vad south asian develop countri lead increas morbid mortal infant children pregnant women stern effort address issu public health signific local intern level lower middle incom countri south asia
MED-5217~tear fluid osmolar potenti marker hydrat status pubm ncbi abstract suggest tear fluid isoton plasma plasma osmol osm accept albeit invas hydrat marker aim determin tear fluid osmolar osm assess portabl noninvas rapid collect measur devic track hydrat purpos studi aim compar osm wide noninvas marker urin specif graviti usg osm hypertonic hypovolemia method random order num healthi volunt exercis heat occas fluid restrict fr num num bodi mass loss bml overnight fluid restrict num day occas fluid intak fi volunt rehydr num num osm assess tearlab osmolar system result osm usg increas progress dehydr fr num osm increas signific fr num num num num mosm num num bml remain elev overnight num num mosm num num osm osm decreas exercis fi return preexercis valu morn rehydr restor osm usg osm preexercis valu correl osm osm num usg osm num conclus osm increas dehydr track alter osm compar util usg measur osm tearlab osmolar system offer sport medicin practition clinician research investig practic rapid hydrat assess techniqu
MED-5218~influenc diet tear function pubm ncbi abstract effect diet tear function illustr malnutrition induc xerophthalmia dietari habit nourish north american societi implic tear dysfunct review ocular literatur suggest suffici dietari protein vitamin num potassium zinc normal tear function excess dietari fat salt cholesterol alcohol protein sucros suggest tear dysfunct unequivoc link establish diet remiss dri eye state nourish popul
MED-5219~antiag approach treatment dri eye pubm ncbi abstract dri eye common eye disord affect million peopl ocular irrit discomfort decreas function vision caus dramat deterior qualiti life treatment num agonist cyclosporin eye drop develop level patient satisfact obtain fundament treatment develop therapi recov lacrim function normal status recent progress understand age laid foundat intervent age process dri eye acceler age approach prevent treatment dri eye interfer age process scientif communiti global consensus calori restrict extend life span kind anim establish intervent age import hypothesi believ involv age free radic theori theori age process manag control level calori reactiv oxygen speci review num import age theori calori restrict free radic age examin discuss appli theori prevent treatment dri eye
MED-5220~econom burden dri eye diseas unit state decis tree analysi pubm ncbi abstract purpos aim studi estim direct indirect annual cost manag dri eye diseas ded unit state societ payer perspect method decis analyt model develop estim annual cost manag cohort patient dri eye differ sever symptom treatment direct cost includ ocular lubric cyclosporin punctal plug physician visit nutrit supplement indirect cost measur product loss absente presente model popul data obtain survey complet dri eye suffer recruit onlin databas sensit analys employ evalu impact paramet estim cost cost convert num dollar result survey data collect num respond ded analysi averag annual cost manag patient dri eye num variat num num payer perspect adjust preval ded nationwid burden ded healthcar system num billion societ perspect averag cost manag ded estim num patient num billion societi conclus ded pose substanti econom burden payer societi find provid valuabl inform health plan employ budget estim
MED-5221~keratomalacia pubm ncbi abstract xerophthalmia keratomalacia public health problem great magnitud multipl vitamin protein defici author report case num year old commune member subject bizarr protein vitamin defici diet month ultim produc nyctalopia xerophthalmia keratomalacia bilater corneal perfor therapi remain comatos expir short admiss ocular patholog includ bilater corneal melt prolaps intraocular content conjunctiv epidermid goblet cell atrophi thin outer nuclear layer retina note ocular find pure avitaminosi produc experimentalyy includ epitheli atrophi keratin
MED-5222~pharmaceut herbal product contribut dri eye pubm ncbi abstract background symptomat dryness eye common blepharoplasti complic author review medic herbal product potenti complic method medlin pubm databas search year num num search term includ dri eye syndrom kerat sicca keratoconjunct sicca ocular side effect herbal supplement herbal dri eye dri eye risk factor etiolog dri eye drug side effect drug dri eye dietari supplement ocular toxic tear film refer herbal product review elig medic report search addit articl manual search conduct base citat publish literatur result num articl found relat dri eye syndrom risk factor num exclud discuss medic herbal product risk factor dri eye syndrom thirty six articl examin pathophysiolog risk factor dri eye includ book review inform associ medic herbal product dri eye agent categor base mechan action usag medic list includ antihistamin decongest antidepress anticonvuls antipsychot antiparkinson drug beta block hormon replac therapi main herbal product contribut dri eye niacin echinacea kava strong associ anticholinerg alkaloid dri eye conclus studi identifi medic herbal product consid patient undergo blepharoplasti complain symptom dryness eye
MED-5223~post lasik tear dysfunct dysesthesia abstract symptom tear dysfunct laser situ keratomileusi lasik occur patient resolv vast major dri eye complaint lead patient discomfort dissatisfact lasik symptom uniform diseas singl entiti post lasik tear dysfunct syndrom dri eye term describ spectrum diseas encompass transient persist post op neurotroph diseas tear instabl true aqueous tear defici neuropath pain state neural cornea neuropath ocular surfac discomfort play separ synergist role develop symptom patient case earli post op dri eye symptom resolv manag includ optim ocular surfac health surgeri sever symptom symptom persist num month rare respond satisfactorili tradit treatment modal requir aggress manag review cover current theori post lasik dri eye diseas pathophysiolog risk factor manag option diseas spectrum post lasik tear dysfunct neuropath pain
MED-5224~safeti efficaci cyclosporin treatment chronic dri eye abstract dry ey syndrom des multifactori diseas affect million individu worldwid factor includ age hormon status genet sex immun status innerv status nutrit pathogen environment stress alter cellular molecular structur function compon ocular surfac system result imbal increas suscept desicc epitheli damag lead vicious circl inflamm amplifi sustain damag chronic deregul system lubric agent steroid treatment option diseas elucid chemic complex cyclosporin increas treatment option unit state food drug administr fda approv prescript drug treatment dri eye safeti efficaci cyclosporin shown numer studi
MED-5225~vegetarian diet improv insulin resist oxid stress marker convent diet subject type num diabet abstract aim aim studi compar effect calorie restrict vegetarian convent diabet diet combin exercis insulin resist viscer fat oxid stress marker subject type num diabet method num week random open parallel design seventy four patient type num diabet random assign experiment group num receiv vegetarian diet control group num receiv convent diabet diet diet isocalor calori restrict num kcal day meal studi provid num week diet combin aerob exercis particip examin baselin num week num week primari outcom insulin sensit measur hyperinsulinaem isoglycaem clamp volum viscer subcutan fat measur magnet reson imag oxid stress measur thiobarbitur acid reactiv substanc analys intent treat result forty thre cent particip experiment group num particip control group reduc diabet medic num bodi weight decreas experiment group control group num kg num ci num num num kg num ci num num interact group time num increas insulin sensit signific greater experiment group control group num ci num num num ci num num num reduct viscer subcutan fat greater experiment group control group num num plasma adiponectin increas num leptin decreas num experiment group chang control group vitamin superoxid dismutas reduc glutathion increas experiment group num num num differ group greater addit exercis train insulin sensit enzymat oxid stress marker correl viscer fat conclus calorie restrict vegetarian diet greater capac improv insulin sensit compar convent diabet diet num week greater loss viscer fat improv plasma concentr adipokin oxid stress marker diet respons reduct insulin resist addit exercis train augment improv outcom vegetarian diet
MED-5226~effect diet excret estrogen pre postmenopaus women pubm ncbi abstract fecal urinari plasma estrogen plasma androgen studi healthi pre postmenopaus vegetarian omnivor women dietari histori subject reveal omnivor consum higher percentag total protein fat anim sourc total num hr fecal excret measur dri weight higher vegetarian preliminari result vegetarian women excret num num time estrogen fece omnivor omnivor num higher plasma level unconjug estron estradiol vegetarian estriol num glucuronid compound form reabsorpt free estriol intestin found lower concentr urin vegetarian data suggest vegetarian greater amount biliari estrogen escap reabsorpt excret fece differ estrogen metabol explain lower incid breast cancer vegetarian women
MED-5228~phytochem impact adipos tissu inflamm diabet pubm ncbi abstract type num diabet mellitus inflammatori diseas mechan underli diseas incomplet understood place adipos tissu obes subject concurr preval obes caus western diet excess energi intak lack exercis escal believ causat chronic inflammatori state adipos tissu overnutrit overload energi induc adipocyt secret chemokin activ attract immun cell adipos tissu inflammation medi food ingredi satur fatti acid believ direct initi inflammatori cascad addit hypoxia adipos tissu direct consequ obes effect gene express adipocyt surround cell fat tissu obes subject play central role inflammatori respons contrast revisit diet world natur food product beverag curat effect human health natur compound spice curcumin capsaicin gingerol secondari plant metabolit catechin resveratrol genistein quercetin report provid improv health status consum regard diabet investig anti inflammatori effect review give overview phytochem role interfer inflammatori cascad adipos tissu potenti fight inflammatori diseas diabet investig vivo copyright num elsevi reserv
MED-5229~meat consumpt risk factor type num diabet abstract diseas risk factor identifi epidemiolog studi serv import public health tool clinician identifi individu benefit aggress screen risk modif procedur policymak priorit intervent program encourag at risk individu modifi behavior improv health factor base primarili evid cross sect prospect studi lend random trial risk factor modifi eat habit subject chang individu action broader polici initi meat consumpt frequent investig variabl diabet risk diabet risk factor articl evalu evid support meat consumpt clinic risk factor type num diabet base studi evalu risk meat consumpt categor dietari characterist meat consumpt versus meat consumpt scalar variabl gradat meat consumpt part broader dietari pattern
MED-5230~dietari fiber weight gain cardiovascular diseas risk factor young adult pubm ncbi abstract context dietari composit affect insulin secret high insulin level turn increas risk cardiovascular diseas cvd object examin role fiber consumpt associ insulin level weight gain cvd risk factor compar major dietari compon design set coronari arteri risk develop young adult cardia studi multicent population bas cohort studi chang cvd risk factor num year num num birmingham ala chicago iii minneapoli minn oakland calif particip total num healthi black white adult num num year age enrol main outcom measur bodi weight insulin level cvd risk factor year num adjust baselin valu result adjust potenti confound factor dietari fiber show linear associ lowest highest quintil intak bodi weight white num num lb num num kg num black num num lb num num kg num waist to hip ratio white num num num black num num num fast insulin adjust bodi mass index white num num pmol l num num microu ml num black num num pmol l num num microu ml num num hour postglucos insulin adjust bodi mass index white num num pmol l num num microu ml num black num num pmol l num num microu ml num fiber blood pressur level triglycerid high dens lipoprotein cholesterol low dens lipoprotein cholesterol fibrinogen associ substanti attenu adjust fast insulin level comparison fiber intak fat carbohydr protein inconsist weak associ cvd risk factor conclus fiber consumpt predict insulin level weight gain cvd risk factor strong total satur fat consumpt high fib diet protect obes cvd lower insulin level
MED-5231~plant bas food sourc lipotrop human nutrit survey vivo studi pubm ncbi abstract increas consumpt plant product lower chronic diseas preval attribut great divers healthi phytochem present food investig physiolog effect antioxid anti carcinogen hypolipidem hypoglycem properti studi human compound earli shown lipotrop anim capac hasten remov fat liver and or reduc hepat lipid synthesi deposit increas phospholipid synthesi transmethyl pathway triglyceride rich lipoprotein export liver enhanc fatti acid oxid and or up regul gene involv lipogen fatti acid oxid enzym synthesi main plant lipotrop cholin betain myo inositol methionin carnitin magnesium niacin pantothen folat indirect support lipotrop effect exhaust review rat studi investig phytochem effect hepat lipid metabol suggest fatti acid acet acid melatonin phytic acid fiber compound oligofructos resist starch phenol acid flavonoid lignan stilben curcumin saponin coumarin plant extract solid food lipotrop remain confirm human intervent studi practic non exist supplement materi articl publisher onlin edit critic review food scienc nutrit view free supplement file
MED-5232~reactiv oxygen speci causal role multipl form insulin resist pubm ncbi abstract insulin resist cardin featur type num diabet characterist wide rang clinic experiment set insulin resist occur context insult trigger insulin resist act common mechan suggest distinct cellular pathway report genom analysi cellular model insulin resist induc treatment cytokin tumour necrosi factor alpha glucocorticoid dexamethason gene express analysi suggest reactiv oxygen speci ros level increas model confirm measur cellular redox state ros previous propos involv insulin resist evid causal role scant test hypothesi cell cultur treatment design alter ros level includ small molecul transgen amelior insulin resist vari degre treatment test obes insulin resist mice shown improv insulin sensit glucos homeostasi find suggest increas ros level import trigger insulin resist numer set
MED-5233~fatti acid induc inflamm insulin resist skelet muscl liver pubm ncbi abstract plasma free fatti acid ffa level elev obes ffa caus insulin resist muscl liver endotheli cell contribut develop type num diabet mellitus num hypertens dyslipidemia nonalcohol fatti liver diseas nafld mechan ffa induc insulin resist involv intramyocellular intrahepatocellular accumul triglycerid diacylglycerol activ serine threonin kinas reduct tyrosin phosphoryl insulin receptor substrat ir num impair irs phosphatidylinositol num kinas pathway insulin signal ffa produc low grad inflamm skelet muscl liver activ nuclear factor kappab result releas proinflammatori proatherogen cytokin elev ffa level due obes high fat feed insulin resist skelet muscl liver contribut develop num produc low grad inflamm contribut develop atherosclerot vascular diseas nafld
MED-5234~inflammatori mediat induc dietari glycotoxin major risk factor diabet angiopathi abstract diet major environment sourc proinflammatori age heat gener advanc glycat end product impact human remain unclear explor effect equival diet regular high age h age num fold lower age l age content inflammatori mediat num diabet subject num num week crossov num num week studi num week h age serum age increas num num l age decreas num num mononuclear cell tumor necrosi factor actin mrna ratio num num h age num num l age num serum vascular adhes molecul num num num num num ng ml num h age num week peripher blood mononuclear cell tumor necrosi factor rose num num declin num signific l age diet c reactiv protein increas num h age decreas num l age num vascular adhes molecul num declin num l age num increas num h age serum age increas num h age num reduc num l age num age low densiti lipoprotein increas num h age reduc num l age diet num diabet environment dietari age promot inflammatori mediat lead tissu injuri restrict dietari age suppress effect
MED-5235~meat consumpt diabet complic pubm ncbi abstract prospect studi report risk type num diabet num elev meat consum process meat consum elev risk coronari heart diseas chd stroke meat consum report overview evid meat consumpt risk diabet type num diabet num num macro microvascular complic review num perform meta analysi includ public octob num num studi report increas risk meat consum high intak satur fatti acid nitrat nitrit num chd stroke evid strongest num total meat pool relat risk rr num num num ci num num unprocess red meat num num ci num num poultri num num ci num num num process meat pool rr num num ci num num strongest associ num observ process red meat similar observ made chd stroke recent meta analysi show moder elev risk meat consum process fresh meat microvascular complic diabet prospect data suggest elev risk deriv find hyperglycemia hypertens result discuss light typic nutrient compound present meat  that satur tran fatti acid dietari cholesterol protein amino acid heme iron sodium nitrit nitrosamin advanc glycat end product light find diet moder low red meat unprocess lean prepar moder temperatur choic public health point view
MED-5236~associ dietari meat consumpt incid type num diabet epic interact studi pubm ncbi abstract aims hypothesi diet rich meat report contribut risk type num diabet present studi aim investig associ meat consumpt incid type num diabet epic interact studi larg prospect case cohort studi nest european prospect investig cancer nutrit epic studi method num year follow up num incid case type num diabet identifi num adult european countri centre stratifi random subsampl num individu select order perform case cohort design prentice weight cox regress analys estim hr num ci incid diabet meat consumpt result multivari analys show signific posit associ incid type num diabet increas consumpt total meat num increment hr num num ci num num red meat hr num num ci num num process meat hr num num ci num num borderlin posit associ meat iron intak effect modif sex class bmi observ men result analys confirm women associ total red meat persist attenu associ poultri consumpt emerg hr num num ci num num associ evid obes particip conclusions interpret prospect studi confirm posit associ high consumpt total red meat incid type num diabet larg cohort european adult
MED-5237~mtor growth signal integr cancer diabet age prefac eukaryot target rapamycin tor signal pathway coupl energi nutrient abund execut cell growth divis owe abil tor protein kinas simultan sens energi nutrient stress metazoan growth factor mammalian tor complex num num mtorc num mtorc num exert action regul import kinas num akt year signific advanc understand regul function mtor reveal critic involv onset progress diabet cancer age
MED-5238~persist organ pollut diabet review epidemiolog evid pubm ncbi abstract preval diabet obes increas rapid decad develop develop countri intuit appeal suggest lifestyl risk factor decreas physic activ adopt poor diet explain increas evid support poor impetus wide tradit lifestyl biomed risk factor risk factor aris environ industri revolut introduct chemic environ environment pollut grow interest key class environment pollut persist organ pollut pop potenti role develop diabet review summaris apprais current epidemiolog evid relat pop diabet highlight gap flaw evid copyright num elsevi masson sas reserv
MED-5239~leucin signal pathogenesi type num diabet obes abstract epidemiolog evid point increas dairi meat consumpt stapl western diet major risk factor develop type num diabet num paper present concept comprehens review leucine medi cell signal explain pathogenesi num obes leucine induc over stimul mammalian target rapamycin complex num mtorc num mtorc num pivot nutrient sensit kinas promot growth cell prolifer respons glucos energi growth factor amino acid dairi protein meat stimul insulin insulin lik growth factor num signal provid high amount leucin primari independ stimul mtorc num activ downstream target mtorc num kinas num induc insulin resist phosphoryl insulin receptor substrat num increas metabol burden cell leucine medi mtorc num num signal play import role adipogenesi increas risk obesity medi insulin resist high consumpt leucine rich protein explain exagger mtorc num depend insulin secret increas cell growth cell prolifer promot earli onset replic cell senesc subsequ cell apoptosi disturb cell mass regul increas cell prolifer apoptosi insulin resist hallmark num hyperactiv mtorc num contrast anti diabet drug metformin antagon leucine medi mtorc num signal plant deriv polyphenol flavonoid identifi natur inhibitor mtorc num exert anti diabet anti obes effect bariatr surgeri obes reduc increas plasma level leucin branched chain amino acid attenu leucine medi mtorc num signal defin upper limit daili intak leucine rich anim dairi protein offer great chanc prevent num obes epidem diseas civil increas mtorc num signal cancer neurodegen diseas frequent num
MED-5240~oral absorb reactiv glycat product glycotoxin environment risk factor diabet nephropathi abstract endogen advanc glycat endproduct age includ chemic crosslink speci glycotoxin contribut vascular renal complic diabet mellitus dm renal excret catabol product endogen age impair patient diabet nondiabet kidney diseas kd aim studi examin oral absorpt renal clearanc kinet food age dm kd circul diet deriv age activ glycotoxin thirty eight diabet dm kd healthi subject nl receiv singl meal egg white num protein cook age diet fructos num cl diet serum urin sampl collect num hr monitor age immunoreact elisa age specif crosslink reactiv base complex format num label fibronectin age diet cl diet produc distinct elev serum age level direct proport amount ingest num num area curv serum num ingest age correl direct sever kd renal excret dietari age incomplet num amount absorb dm correl invers degre albuminuria direct creatinin clearanc num num reduc num dm renal failur post age m serum exhibit increas age crosslink activ time baselin serum age time negat control inhibit aminoguanidin conclus renal excret oral absorb age mark suppress diabet nephropathi patient ii daili influx dietari age includ glycotoxin constitut ad chronic risk renal vascular injuri dm iii dietari restrict age food intak great reduc burden age diabet patient possibl improv prognosi
MED-5241~coffe tea risk hip fractur meta analysi pubm ncbi abstract present meta analysi show clear associ coffe consumpt risk hip fractur nonlinear associ tea consumpt risk hip fractur compar tea consumpt drink num cup tea daili lower risk hip fractur introduct prospect cohort case control studi suggest coffe tea consumpt risk hip fractur result inconsist conduct meta analysi assess associ coffe tea consumpt risk hip fractur method perform systemat search medlin embas ovid februari num limit languag public year relat risk rrs num confid interv ci deriv random effect model analys conduct categor dose respons heterogen public bias subgroup analys result studi base num individu num case hip fractur num studi includ cohort case control studi pool rrs hip fractur highest lowest categori coffe tea consumpt num num ci num num num num ci num num dose respons analysi found evid nonlinear associ tea consumpt risk hip fractur nonlinear num compar tea consumpt num cup tea day reduc risk hip fractur num num ci num num num cups day num num ci num num num cups day num num ci num num num cups day conclus found signific associ coffe consumpt risk hip fractur nonlinear associ emerg tea consumpt risk hip fractur individu drink num cup tea day exhibit lower risk hip fractur drank tea associ num daili cup tea hip fractur risk investig
MED-5242~caffein intak associ urinari incontin unit state men result nation health nutrit examin survey pubm ncbi abstract purpos epidemiolog studi women reveal associ caffein intak urinari incontin evid men limit evalu associ caffein intak urinari incontin unit state men materi method data male nhane nation health nutrit examin survey num num particip urinari incontin defin standard questionnair incontin sever index score num greater categor moder sever structur dietari recal determin caffein consumpt mg day water intak gm day total dietari moistur gm day stepwis multivari logist regress model assess associ caffein intak num num percentil moder sever urinari incontin control potenti confound urinari incontin risk factor prostat condit men age num year older result num men num num num year older complet data men preval urinari incontin num moder sever urinari incontin num caffein intak num mg day caffein intak upper num percentil num mg daili num percentil num mg day signific moder sever urinari incontin num num num num num num num num addit adjust prostat condit effect size associ caffein intak moder sever urinari incontin remain conclus caffein consumpt equival approxim num cup coffe daili num mg signific moder sever urinari incontin unit state men find support studi caffein modif men urinari incontin copyright num american urolog associ educ research publish elsevi reserv
MED-5243~coffe consumpt risk fractur systemat review dose respons meta analysi pubm ncbi abstract purpos data associ coffe consumpt risk fractur inconclus perform comprehens literatur review meta analysi quantifi associ method identifi potenti relev articl search medlin embas cochran librari web scienc scopus cinahl februari num keyword coffe caffein drink beverag exposur factor keyword fractur outcom factor determin relat risk rr confid interv ci highest lowest level coffe consumpt dose respons analysi perform assess risk fractur base level coffe consumpt result includ num particip num fractur case num cohort num case control studi estim rr fractur highest level coffe consumpt num num ci num num num num women num num ci num num num num men dose respons analysi pool rrs fractur women consum num num cup coffe day num num ci num num num num ci num num conclus meta analysi suggest daili consumpt coffe increas risk fractur women contrast decreas risk men futur well design studi perform confirm find copyright num elsevi reserv
MED-5244~effect habitu coffe consumpt cardiometabol diseas cardiovascular health all caus mortal pubm ncbi abstract coffe water wide consum beverag unit state princip sourc caffein intak adult biolog effect coffe substanti limit action caffein coffe complex beverag hundr biolog activ compound health effect chronic coffe intak wide rang cardiovascular cv standpoint coffe consumpt reduc risk type num diabet mellitus hypertens condit cv risk obes depress advers affect lipid profil depend beverag prepar grow bodi data suggest habitu coffe consumpt neutral benefici risk varieti advers cv outcom includ coronari heart diseas congest heart failur arrhythmia stroke larg epidemiolog studi suggest regular coffe drinker reduc risk mortal cv all caus potenti benefit includ protect neurodegen diseas improv asthma control lower risk select gastrointestin diseas daili intak num num cup coffe safe neutral benefici effect studi health outcom data coffee health effect base observ data random control studi associ prove causat addit advantag regular coffe consumpt weigh potenti risk relat high caffein content includ anxieti insomnia tremul palpit bone loss possibl increas risk fractur copyright num american colleg cardiolog foundat publish elsevi reserv
MED-5245~effect decaffein coffe tea gastro oesophag reflux pubm ncbi abstract background coffe tea believ gastro oesophag reflux effect beverag major compon caffein quantifi aim studi evalu gastro oesophag reflux induc coffe tea decaffein process compar water water contain caffein method three hour ambulatori ph metri perform num healthi volunt receiv num ml regular coffe decaffein coffe tap water num ii normal tea decaffein tea tap water coffe adapt normal tea caffein concentr num iii caffeine fre caffeine contain water num standard breakfast result regular coffe induc signific num gastro oesophag reflux compar tap water normal tea decaffein coffe signific num diminish gastro oesophag reflux decaffein tea addit caffein water effect coffe adapt normal tea caffein concentr signific num increas gastro oesophag reflux conclus coffe contrast tea increas gastro oesophag reflux effect pronounc decaffein caffein respons gastro oesophag reflux attribut compon coffe
MED-5246~effect caffein intraocular pressur systemat review meta analysi pubm ncbi abstract background caffein wide consum effect intraocular pressur iop report conflict data aim meta analysi quantit summar effect caffein iop normal individu patient glaucoma ocular hypertens oht method comprehens literatur search perform cochran collabor methodolog identifi pertin random control trial rcts cochran central regist control trial central pubm embas systemat review meta analysi perform iop num hour num num caffein ingest main outcom measur result rcts parallel design crossover design evalu num particip fulfil inclus criteria risk bias studi uncertain particip num normal individu num patient glaucoma oht normal individu iop measur num num num post intervent affect ingest caffein weight differ wmd num confid interv num ci measur point num num num num num num num num num patient glaucoma oht iop increas measur point wmd num ci num num num num num num num num num public bias detect begg egger test conclus evid show caffein effect iop group individu normal individu iop chang ingest caffein patient glaucoma oht iop increas signific high qual rcts warrant confirm mechan phenomenon clinic signific explor
MED-5247~caffein consumpt risk primari open angl glaucoma prospect cohort studi abstract purpos investig caffein transient increas intraocular pressur iop risk primari open angl glaucoma poag method num women num num men num num num year poag report receiv eye examin inform caffein consumpt potenti confound poag diagnos repeat updat valid follow up questionnair confirm num incid poag case medic record review cohort specif pool analys cohort conduct calcul multivari rate ratio rr result compar daili intak num mg pool multivari rrs num num confid interv ci num num consum num num mg num num ci num num num num mg day num num ci num num num num mg num num ci num num num mg trend num consum num cup caffein coffe daili rr num num ci num num trend num tea caffein cola intak risk greater caffein intak advers poag report famili histori glaucoma relat poag elev iop trend num p interact num conclus caffein intak increas risk poag secondari analys caffein elev risk high tens poag famili histori glaucoma due chanc warrant studi
MED-5248~atrial fibril chocol intak abus chronic salbutamol inhal abus pubm ncbi abstract substanc substrat atrial fibril frequent recogn chocol deriv roast seed plant theobroma cacao compon methylxanthin alkaloid theobromin caffein caffein methylxanthin primari biolog effect competit antagon adenosin receptor normal consumpt caffein risk atrial fibril flutter sympathomimet effect due circul catecholamin cardiac manifest caffein overdos toxic produc tachyarrhythmia supraventricular tachycardia atrial fibril ventricular tachycardia ventricular fibril common dose inhal nebul salbutamol induc acut myocardi ischaemia arrhythmia heart rate variabl patient coronari arteri diseas clinic stabl asthma chronic obstruct pulmonari diseas two week salbutamol treatment shift cardiovascular autonom regul level character greater sympathet respons slight beta num receptor toler present case atrial fibril chocol intak abus num year old italian woman chronic salbutamol inhal abus case focus attent chocol intak abus chronic salbutamol abus substrat atrial fibril copyright num elsevi ireland reserv
MED-5249~coffe consumpt benefit risk pubm ncbi abstract coffe lead worldwid beverag water trade exceed num billion worldwid controversi benefit risk exist reliabl evid support health promot potenti research argu associ coffe consumpt cardiovascular complic cancer insurg health promot properti coffe attribut rich phytochemistri includ caffein chlorogen acid caffeic acid hydroxyhydroquinon hhq research investig epidemiolog studi meta analys coffe consumpt reveal invers correl diabet mellitus cancer line parkinson alzheimer diseas amelior oxid stress abil induc mrna protein express mediat nrf num pathway stimul caffein metabolit proper cognit function coffe lipid fraction cafestol kahweol act safeguard malign cell modul detoxifi enzym hand higher level rais serum cholesterol pose threat coronari health myocardi cerebr infarct insomnia cardiovascular complic caffein affect adenosin receptor withdraw accompani muscl fatigu alli problem addict coffe array evid show pregnant women postmenopaus problem avoid excess consumpt coffe interfer oral contracept postmenopaus hormon review articl attempt dissemin general inform health claim risk factor coffe consumpt scientist alli stakehold reader taylor franci group llc
MED-5250~meta analysi prospect studi coffe consumpt mortal cancer cardiovascular diseas pubm ncbi abstract prospect studi consid relat coffe consumpt mortal studi underpow detect associ includ death obtain quantit estim combin publish data prospect studi relat coffe mortal cancer cardiovascular diseas cvd coronary ischem heart diseas chd ihd stroke bibliographi search updat januari num carri pubm embas identifi prospect observ studi provid quantit estim mortal cancer cvd chd ihd stroke relat coffe consumpt systemat review meta analysi conduct estim relat risk rr num confid interv ci random effect model pool rrs mortal study specif highest versus low num cup day coffe drink categori num num ci num num base num studi num num ci num num num smoke adjust studi combin rrs cvd mortal num num ci num num num smoke adjust studi highest versus low drink num num ci num num num studi increment num cup day compar low drink rrs highest consumpt coffe num num ci num num num smoke adjust studi chd ihd num num ci num num num studi stroke num num ci num num num studi cancer meta analysi quantit evid coffe intak invers relat cvd mortal
MED-5251~heavi coffe drink epilepsi pubm ncbi abstract dietari habit rare seizur frequenc patient epilepsi report case man partial symptomat epilepsi daili habit heavi coffe drink increas seizur frequenc patient wit dramat decreas frequenc seizur stop coffe ingest caffein global stimul reduct intak treatment epilepsi
MED-5252~caffein increas risk atrial fibril systemat review meta analysi observ studi pubm ncbi abstract background atrial fibril af preval sustain arrhythmia risk factor establish caffein exposur increas risk af heterogen data exist literatur object evalu associ chronic exposur caffein af design systemat review meta analysi observ studi data sourc pubm central isi web knowledg lilac decemb num review refer retriev articl comprehens search studi select review independ search studi retriev characterist data estim data synthesi random effect meta analysi perform pool estim express num ci heterogen assess num test subgroup analys conduct caffein dose sourc coffe result observ studi evalu num individu includ cohort case control studi caffein exposur increas risk af num num ci num num num num pool result high qual studi show num odd reduct af risk lower heterogen num num ci num num num num low dos caffein exposur show num num ci num num num num signific differ dosag strata caffein exposur base sole coffe consumpt influenc af risk conclus caffein exposur increas af risk low dos caffein protect effect
MED-5253~tea consumpt didn modifi risk fractur dose respons meta analysi observ studi abstract background fractur import healthi damag econom loss nowaday conclus observ studi tea consumpt fractur risk inconsist object meta analysi determin effect tea drink risk fractur method comprehens literatur search conduct pubm embas refer list relev articl observ studi report estim associ tea drink incid fractur includ meta analysi conduct stata softwar result total num studi involv num individu examin associ tea consumpt risk fractur includ meta analysi odd risk num confid interv cis pool random effect model pool num observ studi tea consumpt risk fractur num num ci num num subgroup analys signific associ detect cohort studi num num num ci num num case control studi num num num ci num num signific associ detect dose respons meta analysi conclus tea consumpt risk fractur large sampl well design studi requir confirm exist conclus virtual slide virtual slide articl found http   www diagnosticpatholog diagnomx eu v num
MED-5254~caffein urinari incontin women abstract introduct hypothesi goal studi character associ caffein consumpt sever urinari incontin ui women hypothes moder high caffein intak ui women control factor ui method women particip num num num num nation health nutrit examin survey nhane cross sect nation repres survey incontin sever index ui categor moderate sever type ui includ stress urg mix food diari complet averag water gm day total dietari moistur gm day caffein mg day intak calcul quartil step wis logist regress model construct adjust sociodemograph chronic diseas bodi mass index self rat health depress alcohol dietari water moistur reproduct factor result num non pregn women age num year complet ui dietari data ui preval ui num num moderate sever ui stress ui common ui type num women consum caffein intak num mg day adjust multipl factor caffein highest quartil num mg day ui preval odd ratio por num num ci num num moderate sever ui por num num ci num num type ui stress urgenc mix caffein intak conclus caffein intak num mg day ui moderate sever ui women
MED-5255~caffein intak atrial fibril incid dose respons meta analysi prospect cohort studi pubm ncbi abstract background associ habitu caffein intak incid atrial fibril af unknown conduct meta analysi investig associ chronic exposur caffein risk af evalu potenti dose respons relat method search pubm embas cochran librari novemb num refer relev retriev articl prospect cohort studi includ relat risk rr hazard ratio num confid interv cis af coffee caffein intak result prospect cohort studi num particip includ primari meta analysi caffein exposur weak reduc risk af rr num num ci num num num num num subgroup analys pool result studi adjust potenti confound show num reduct low dose rr num num ci num num num num num num num high dose rr num num ci num num num num num num caffein consumpt af risk invers relat found habitu caffein intak af risk trend num nonlinear num dose respons meta analysi incid af decreas num rr num num ci num num num mg d increment habitu caffein intak conclus caffein consumpt contribut af habitu caffein consumpt reduc af risk copyright num canadian cardiovascular societi publish elsevi reserv
MED-5256~associ coffe consumpt gastric ulcer duoden ulcer reflux esophag non eros reflux diseas cross sect studi num healthi subject japan abstract due caffeine induc gastric acid secret negat effect coffe upper gastrointestin diseas precari accept inadequ epidemiolog evid aim evalu effect coffe consumpt major acid rel diseas gastric ulcer gu duoden ulcer du reflux esophag non eros reflux diseas nerd base large scal multivari analysi num healthi adult gu du diagnos endoscopi nerd diagnos symptom heartburn regurgit esophag eros associ coffe consumpt disord evalu age gender bodi mass index bmi helicobact pylori hp infect status pepsinogen i ii ratio smoke alcohol perform meta analysi random effect model redefin relationship coffe intak peptic ulcer diseas elig num studi subject compris num coffe drinker num non coffe drinker univari analysi age bmi pepsinogen i ii ratio smoke alcohol show signific associ coffe consumpt multipl logist regress analysi posit correl factor signific hp infect current smoke bmi pepsinogen i ii ratio gu hp infect pepsinogen i ii ratio current smoke du hp non infect male bmi pepsinogen i ii ratio smoke age alcohol younger age smoke femal nerd meta analys detect associ coffe consumpt gu du conclus signific relationship coffe consumpt major acid rel upper gastrointestin disord
MED-5257~tea consumpt cardiovascular diseas risk pubm ncbi abstract background present analysi conduct respons inconsist epidemiolog studi relat consumpt tea cardiovascular diseas object undertook literatur review consist strength associ tea cardiovascular diseas basi publish observ studi meta analys address tea tea flavonoid cardiovascular diseas risk design perform search num databas meta analys compar studi subsum perform addit search subsequ studi determin conclus consist result epidemiolog studi conduct summar num meta analys tea consumpt flavonoid consumpt cardiovascular diseas subset stroke heterogen effect outcom includ cardiovascular diseas case stroke consist dose respons associ tea consumpt incid mortal note rrs num num ci num num flavonoid num num ci num num tea high low intak compar addit num cups d estim conclus strength evid support hypothesi tea consumpt lower risk stroke
MED-5258~associ coffe drink total cause specif mortal abstract background coffe wide consum beverag associ coffe consumpt risk death remain unclear method examin associ coffe drink subsequ total cause specif mortal num men num women nation institut health aarp diet health studi num num year age baselin particip cancer heart diseas stroke exclud coffe consumpt assess baselin result num num person year follow up num num total num men num women die age adjust model risk death increas coffe drinker coffe drinker smoke adjust tobacco smok status potenti confound signific invers associ coffe consumpt mortal adjust hazard ratio death men drank coffe compar num num confid interv ci num num drink num cup day num num ci num num num cup num num ci num num num num cup num num ci num num num num cup num num ci num num num cup coffe day num trend respect hazard ratio women num num ci num num num num ci num num num num ci num num num num ci num num num num ci num num num trend invers associ observ death due heart diseas respiratori diseas stroke injuri accid diabet infect death due cancer result similar subgroup includ person smoke person report good excel health baselin conclus larg prospect studi coffe consumpt invers total cause specif mortal causal associ find determin data fund intramur research program nation institut health nation cancer institut divis cancer epidemiolog genet
MED-5259~associ coffe consumpt all caus cardiovascular diseas mortal abstract object evalu associ coffe consumpt mortal cardiovascular diseas cvd patient method data aerob center longitudin studi acl repres total num particip contribut num person year follow up time includ baselin data collect in person interview base standard questionnair medic examin includ fast blood chemistri analysi anthropometri blood pressur electrocardiographi maxim grade exercis test februari num decemb num cox regress analysi quantifi associ coffe consumpt all caus cause specif mortal result num year median follow up period num death occur num due cvd multivari analys coffe intak posit all caus mortal men men drank num cup coffe week higher all caus mortal hazard ratio hr num num confid interv ci num num stratif base age younger num year men women show statist signific associ high coffe consumpt num cups week all caus mortal adjust potenti confound fit level hr num num ci num num men hr num num ci num num women conclus larg cohort posit associ coffe consumpt all caus mortal observ men men women num year age base find suggest younger peopl avoid heavi coffe consumpt averag num cups day find assess futur studi popul
MED-5260~phenol content virgin oliv oil improv ischem reactiv hyperemia hypercholesterolem patient pubm ncbi abstract object goal studi evalu effect phenol content virgin oliv oil endotheli reactiv background endothelial depend vasodilat impair postprandi state oxid stress play key role develop method twenty on hypercholesterolem volunt receiv breakfast random sequenti crossov design arm receiv oliv oil phenol acid content reduc num num ppm ischem reactiv hyperemia irh measur laser doppl procedur baselin num num oil intak postprandi plasma concentr lipid fraction lipoperoxid lpo num epi prostaglandin f num lpha nitrates nitrit obtain baselin num fat meal result intak polyphenol rich breakfast improv endotheli function greater increas concentr num lower increas lpo num num epi prostaglandin f num lpha num induc low polyphenol fat meal posit correl found exist enhanc endotheli function hour num num negat correl found irh lpo num num num epi prostaglandin f num lpha level num num conclus meal high phenol virgin oliv oil improv ischem reactiv hyperemia postprandi state phenomenon mediat reduct oxid stress increas nitric oxid metabolit
MED-5261~differenti effect isoenerget meal rich satur monounsatur fat endotheli function subject type num diabet abstract object examin acut effect consumpt monounsatur mufa satur fatti acid safa endotheli function subject type num diabet research design method total num particip examin consumpt isocalor meal rich mufa rich safa form extra virgin oliv oil butter endotheli function assess determin flow medi dilat fmd result fmd chang signific mufa rich meal declin safa rich meal fmd experi express increment area curv increas mufa rich meal num num decreas safa rich meal num num num num num conclus consumpt safa rich meal harm endothelium mufa rich meal impair endotheli function subject type num diabet
MED-5262~effect mediterranean styl diet endotheli dysfunct marker vascular inflamm metabol syndrom random trial pubm ncbi abstract context metabol syndrom identifi target dietari therapi reduc risk cardiovascular diseas role diet etiolog metabol syndrom poor understood object assess effect mediterranean styl diet endotheli function vascular inflammatori marker patient metabol syndrom design set patient random single blind trial conduct june num januari num univers hospit itali num patient num men num women metabol syndrom defin adult treatment panel iii intervent patient intervent group num instruct follow mediterranean styl diet receiv detail advic increas daili consumpt grain fruit veget nut oliv oil patient control group num prudent diet carbohydr num num protein num num total fat num main outcom measur nutrient intak endotheli function score measur blood pressur platelet aggreg respons l arginin lipid glucos paramet insulin sensit circul level high sensit c reactiv protein hs crp interleukin num il num il num num il num result num year patient mediterranean styl diet consum food rich monounsatur fat polyunsatur fat fiber lower ratio omega num omega num fatti acid total fruit veget nut intak num g d grain intak num g d oliv oil consumpt num g d signific higher intervent group num level physic activ increas group approxim num differ group num sd bodi weight decreas patient intervent group num num kg control group num num kg num compar patient consum control diet patient consum intervent diet signific reduc serum concentr hs crp num il num num il num num il num num decreas insulin resist num endotheli function score improv intervent group sd chang num num num remain stabl control group num num num num year follow up num patient intervent group featur metabol syndrom compar num patient control group num conclus mediterranean styl diet effect reduc preval metabol syndrom cardiovascular risk
MED-5263~postprandi anti inflammatori antioxid effect extra virgin oliv oil pubm ncbi abstract high postprandi serum lipid concentr increas oxid stress turn increas risk atherosclerosi epidemiolog studi correl lower incid cardiovascular diseas adher mediterranean diet aim studi evalu inflammatori txb num ltb num oxid stress marker urinari hydrogen peroxid level serum antioxid capac addit classic lipid paramet fat rich meal administ num normolipem healthi subject latin squar design subject divid group receiv kind oil extra virgin oliv oil evoo oliv oil oo corn oil num potato num week washout period treatment blood sampl drawn baselin num num meal signific decreas inflammatori marker txb num ltb num num num evoo oo consumpt concomit increas serum antioxid capac record data reinforc notion mediterranean diet reduc incid coronari heart diseas partial due protect role phenol compon includ extra virgin oliv oil
MED-5265~effect dietari antioxid postprandi endotheli dysfunct induc high fat meal healthi subject pubm ncbi abstract background person current dietari guidelin lower risk mortal coronari heart diseas object object compar short term effect high fat meal high carbohydr meal dietari antioxid vasomotor antiplatelet hemostat function endothelium healthi subject design observer blind random crossov studi num men num women healthi subject num meal random order num wk interv high fat meal num kcal isoenerget high carbohydr meal high fat meal dietari antioxid veget num kcal endotheli function assess hemodynam rheolog respons l arginine  th natur precursor nitric oxide  wer evalu num meal result unlik high carbohydr meal high fat meal increas plasma concentr triacylglycerol num meal activ hemostasi high carbohydr meal modifi blood pressur platelet aggreg decreas respons l arginin load num num mm hg num num high fat meal decreas blood pressur respons l arginin reduc num num mm hg platelet aggreg show paradox increas num num num compar high carbohydr meal high fat meal antioxid partial restor vascular respons l arginin conclus compar high carbohydr meal high fat meal modifi endotheli function atherogenet profil partial prevent dietari antioxid
MED-5266~flow medi brachial arteri vasoact lower desir cholesterol level healthi middle ag men pubm ncbi abstract current nation cholesterol educ program guidelin desir total low dens lipoprotein cholesterol level num num mg dl healthi individu multipl coronari risk factor determin extent level affect vascular function assess flow medi endothelium depend brachial arteri vasoact noninvas cholesterol lower simvastatin num mg day num healthi middle ag men cholesterol level meet current recommend flow medi brachial arteri vasoact measur num mhz ultrasound express percent diamet chang baselin hyperem condit num minut num minut blood pressur cuff arteri occlus flow medi vasoact rose num num baselin num num num num num num num cholesterol fell num num num num num num num mg dl num num week cholesterol low therapi vasoact cholesterol return baselin level num week simvastatin discontinu vasoact found correl invers cholesterol level num num data suggest flow medi brachial arteri vasoact respond rapid cholesterol level endotheli function improv lower cholesterol level recommend current guidelin
MED-5267~mediterranean low fat diet improv endotheli function hypercholesterolem men pubm ncbi abstract background regulatori function endothelium alter hypercholesterolemia subsequ endotheli dysfunct play central role develop atherosclerosi object determin endotheli function hypercholesterolem patient affect replac satur fat enrich diet low fat low satur fat diet nation cholesterol educ program stage num ncep num diet diet rich monounsatur fat common mediterranean countri design intervent dietari studi baselin phase random crossov dietari period set hospit universitario reina sof rdoba spain patient num hypercholesterolem men intervent patient diet high satur fat assign crossov design ncep num diet mediterranean diet dietari period num day measur plasma p selectin level lipid concentr endotheli function result compar satur fat diet flow medi dilat increas mediterranean diet ncep num diet addit level plasma cholesterol low dens lipoprotein cholesterol apolipoprotein p selectin decreas ncep num mediterranean diet conclus hypercholesterolem men diet low fat satur fat diet rich monounsatur fat improv endotheli function
MED-5268~oliv oil intak chd european prospect investig cancer nutrit spanish cohort pubm ncbi abstract oliv oil cardioprotect properti epidemiolog data show oliv oil consumpt reduc incid chd event limit studi associ oliv oil chd european prospect investig cancer nutrit epic spanish cohort studi analysi includ num num particip num male free chd event baselin recruit epic spain centr num num num baselin dietari lifestyl inform collect interview administ questionnair cox proport regress model assess relationship valid incid chd event oliv oil intak energy adjust quartil num g d num kj num kcal increment adjust potenti confound num num year follow up num male chd event record oliv oil intak negat chd risk exclud dietari mis report hazard ratio hr num num ci num num num num g d num kj num kcal hr num num ci num num num upper lower quartil invers associ oliv oil intak num g d num kj num kcal chd pronounc smoker num reduc chd risk num num never low alcohol drinker num reduc chd risk num num virgin oliv oil consum num reduc chd risk num num conclus oliv oil consumpt relat reduc risk incid chd event emphasis conserv tradit culinari oliv oil mediterranean diet reduc chd burden
MED-5269~oliv soybean palm oil intak similar acut detriment effect endotheli function healthi young subject pubm ncbi abstract background aim num calor intak colombian popul veget oil consumpt ingest deep fri food recent report unsatur fatti acid rich oil benefici effect endotheli function deep fri process alter chemic composit veget oil produc advers effect endotheli function object evalu acut effect ingest larg amount oliv soybean palm oil fresh deep fri level glucos lipid profil endotheli function method result ten healthi young volunt includ studi perform baselin evalu cardiovascular risk factor draw fast blood sampl subject expos random assign potato soup meal num ml veget oil oliv soybean palm fresh deep fri level num num fri flow medi vasodil fmd perform fast condit num intak oil rich meal blood sampl stage lipid profil plasma glucos determin meal result similar acut endotheli impair fmd decreas num confid interv ci num num num postprandi increas triglycerid num ci num num num independ type oil ingest num deep fri level num correl found endotheli impair postprandi triglycerid increment num num conclus differ found acut advers effect ingest veget oil endotheli function veget oil fresh deep fri produc increas triglycerid plasma level healthi subject
MED-5270~diabet mediterranean diet benefici effect oleic acid insulin sensit adipocyt glucos transport endothelium dependen pubm ncbi abstract abnorm endotheli function increas cardiovascular risk diabet patient examin effect oleic acid rich diet insulin resist endothelium depend vasoreact type num diabet eleven type num diabet patient chang usual linoleic acid rich diet treat num month oleic acid rich diet insulin medi glucos transport measur isol adipocyt fatti acid composit adipocyt membran determin gas liquid chromatographi flow medi endothelium depend independ vasodilat measur superfici femor arteri end dietari period signific increas oleic acid decreas linol acid oleic acid rich diet num diabet control diet small signific decreas fast glucose insulin oleic acid rich diet insulin stimul num ng ml glucos transport signific greater oleic acid rich diet num num num num nmol num cell num min num endothelium depend flow medi vasodilat fmd signific greater oleic acid rich diet num num num num num signific correl adipocyt membran oleic linol acid insulin medi glucos transport num relationship insulin stimul glucos transport chang endothelium depend fmd signific posit correl adipocyt membran oleic linol acid endothelium depend fmd num num chang polyunsatur monounsatur diet type num diabet reduc insulin resist restor endothelium depend vasodilat suggest explan anti atherogen benefit mediterranean typ diet
MED-5271~postprandi effect compon mediterranean diet endotheli function pubm ncbi abstract object studi investig postprandi effect compon mediterranean diet endotheli function atherogen factor background mediterranean diet oliv oil pasta fruit veget fish wine unexpect low rate cardiovascular event lyon diet heart studi found mediterranean diet substitut omega num fatty acid enrich canola oil tradit consum omega num fatty acid rich oliv oil reduc cardiovascular event method fed num healthi normolipidem subject meal num kcal num fat meal fat sourc oliv oil canola oil salmon oliv oil meal antioxid vitamin food balsam vinegar salad measur serum lipoprotein glucos brachial arteri flow medi vasodil fmd index endotheli function num meal result meal signific rais serum triglycerid chang lipoprotein glucos num postprandi oliv oil meal reduc fmd num num num num num num invers correl observ postprandi serum triglycerid fmd num num remain meal signific reduc fmd conclus term postprandi effect endotheli function benefici compon mediterranean lyon diet heart studi diet antioxidant rich food includ veget fruit deriv vinegar omega num rich fish canola oil
MED-5272~chronic effect high fat diet enrich virgin oliv oil low fat diet enrich alpha linolen acid postprandi endotheli pubm ncbi abstract tradit cardiovascular risk factor endotheli dysfunct vascular endothelium play key role local vascular tone regul modul dietari fat propos determin chronic effect diet fat composit postprandi endotheli function inflammatori biomark twenti healthi men num week diet randomis cross ov design western diet rich satur fat num sfa num mufa num alpha linolen acid ala fraction energi mediterranean diet rich mufa num sfa num mufa num ala low fat diet enrich ala num sfa num mufa num ala end dietari period subject underw postprandi studi plasma concentr lipid paramet solubl intercellular cell adhes molecul num solubl vascular cell adhes molecul num svcam num nitrat nitrit nox endotheli function studi laser doppler examin num num num endothelium depend vasodilatori respons greater num ingest mufa rich diet sfa ala low fat diet num num postprandi plasma svcam num level lower mufa meal ala low fat diet num bioavail nox higher mufa diet sfa ala low fat diet num found differ paramet measur chronic ingest mediterranean diet avoid postprandi deterior endotheli function westernis diet healthi individu
MED-5273~differenti anti inflammatori effect phenol compound extra virgin oliv oil identifi human blood cultur pubm ncbi abstract object oliv oil rich mediterranean diet protect cardiovascular diseas involv inflammatori process studi investig effect phenol compound found extra virgin oliv oil inflammatori mediat product human mononuclear cell method dilut human blood cultur stimul lipopolysaccharid presenc phenol vanil p coumar syring homovanil caffeic acid kaempferol oleuropein glycosid tyrosol concentr num num num num concentr inflammatori cytokin tumor necrosi factor alpha interleukin num eta interleukin num inflammatori eicosanoid prostaglandin num measur enzyme link immunosorb assay result oleuropein glycosid caffeic acid decreas concentr interleukin num eta concentr num num oleuropein glycosid inhibit interleukin num eta product num caffeic acid inhibit product num kaempferol decreas concentr prostaglandin num concentr num num kaempferol inhibit prostaglandin num product num effect concentr interleukin num tumor necrosi factor alpha effect phenol compound conclus phenol compound deriv extra virgin oliv oil decreas inflammatori mediat product human blood cultur contribut antiatherogen properti ascrib extra virgin oliv oil
MED-5274~oliv oil polyphenol decreas blood pressur improv endotheli function young women mild hypertens pubm ncbi abstract background oliv oil polyphenol cardiovascular health benefit studi aim examin influenc polyphenol rich oliv oil blood pressur bp endotheli function num young women high norm bp stage num essenti hypertens method conduct double blind random crossov dietary intervent studi run in period num month baselin valu diet polyphenol rich oliv oil num mg day polyphenol fre oliv oil dietari period num month num week washout diet systol diastol bp serum plasma biomark endotheli function oxid stress inflamm ischemia induc hyperemia forearm measur result compar baselin valu polyphenol rich oliv oil diet led signific num decreas num mm hg systol num mm hg diastol bp similar find found serum asymmetr dimethylarginin adma num num mol l num oxid low dens lipoprotein ox ldl num num g l num plasma c reactiv protein crp num num mg l num polyphenol rich oliv oil diet elicit increas plasma nitrites nitr num num mol l num hyperem area ischemia num num perfus unit pu sec num conclus conclud consumpt diet polyphenol rich oliv oil decreas bp improv endotheli function young women high norm bp stage num essenti hypertens
MED-5275~absenc postprandi surg coronari blood flow distal signific stenosi mechan postprandi angina pubm ncbi abstract object studi design investig mechan postprandi angina background postprandi angina recogn centuri mechan controversi wide accept mechan involv increas myocardi oxygen demand food intak recent redistribut coronari blood flow cbf suggest mechan method twenti young healthi volunt control num patient signific stenosi left anterior descend lad left main coronari arteri enrol studi coronari blood flow evalu distal lad transthorac doppler echocardiographi num num num min food intak cbf curv time veloc integr diastol flow dtvi product dtvi heart rate hr measur patient measur repeat success coronari intervent result healthi volunt control dtvi dtvi hr increas food intak peak num min presenc postprandi surg cbf fast valu peak valu num min signific dtvi num num cm s num num cm s num dtvi hr num num cm min num num num num contrast control postprandi increas doubl product hr blood pressur dtvi dtvi hr patient group decreas food intak nadir num min fast valu nadir valu num min signific dtvi num num cm s num num cm s num dtvi hr num num num num cm min num num num num cm min num patient cbf pattern resum normal pattern postprandi surg cbf success coronari intervent conclus result studi suggest steal phenomenon play role mechan postprandi angina
MED-5276~num num influenc high fat meal compar olestra meal coronari arteri endotheli dysfunct rubidium rb num positron em pubm ncbi abstract background cellular lead coronari arteri endotheli dysfunct ed preced plaqu format clinic event unstabl angina acut coronari syndrom common consequ ed coronari arteri ed character rb num pe perfus abnorm rest improv stress risk factor modif studi cholesterol low trial coronari arteri ed demonstr revers studi correl low fat diet modif improv coronari arteri diseas purpos studi evalu myocardi perfus meal low versus high tg content influenc post prandial serum tg method random doubl blind placebo control cross design investig num patient num ed num normal perfus rb num pet myocardi blood flow rest adenosin stress pet imag serum triglycerid obtain olestra oa meal num tg num olestra high fat meal num tg meal match carbohydr protein cholesterol content result myocardi perfus uci cc increas num num oa meal compar high fat meal patient ed patient combin serum tg increas signific num non oa group median chang baselin num mg dl compar num mg dl oa group num hour meal conclus singl olestra meal signific diminish post prandial serum tg level improv myocardi perfus patient endotheli diseas
MED-5277~effect fat carbohydr consumpt endotheli function pubm ncbi abstract consumpt meal high monounsatur fat acut impair endotheli function compar carbohydrate rich meal diverg respons endotheli function import modul vascular function health diseas
MED-5278~brachial arteri ultrasound noninvas tool assess triglyceride rich lipoprotein pubm ncbi abstract recent year endotheli dysfunct identifi earli featur atherosclerosi endotheli function measur noninvas brachial arteri ultrasound varieti factor atherosclerosi impair endotheli function factor lipoprotein form low dens lipoprotein postprandi chylomicron remnant fast triglyceride rich particl free fatti acid high fat diet advers effect endotheli function intervent improv endotheli function time reduc cardiovascular event measur endotheli function eventu serv index determin individual risk coronari arteri diseas
MED-5279~impair endotheli function high fat meal patient coronari arteri diseas pubm ncbi abstract object determin effect postprandi lipid endotheli function patient coronari arteri diseas cad high fat meal method studi num cad patient num control particip normocholesterolem flow medi vasodilat brachial arteri evalu high resolut ultrasound techniqu singl high fat meal num calori num fat result postprandi serum triglycerid level increas signific num flow medi vasodilat impair signific num num num num num num subject increment num serum triglycerid level correl posit decrement postprandi flow medi vasodilat num num postprandi triglycerid level signific higher cad patient control particip flow medi vasodilat signific impair cad patient num num num num num control particip num num num num num high fat meal impair flow medi dilat sever cad patient num control particip num num conclus postprandi endothelium depend vasodilat singl high fat meal sever impair normocholesterolem cad patient control particip disord postprandi metabol triglyceride rich lipoprotein play atherogen role induc endotheli dysfunct
MED-5280~transient triglyceridemia decreas vascular reactiv young healthi men risk factor coronari heart diseas pubm ncbi abstract background hypertriglyceridemia accept risk factor coronari heart diseas mechan increas risk understood present studi undertaken investig effect triglyceridemia endotheli function impair endotheli function consid marker atherogenesi method result flow nitroglycerin induc dilat brachial arteri investig noninvas high resolut ultrasound techniqu young healthi men risk factor coronari heart diseas transient triglyceridemia induc infus triglycerid emuls intralipid rais free fatti acid concentr twofold triglycerid level fourfold flow induc vasodilat decreas num num num num num nitroglycerin induc vasodilat decreas num num num num num num hour infus intralipid conclus transient triglyceridemia decreas vascular reactiv endothelium depend endothelium independ mechan
MED-5281~vascular endothelium human diseas abstract alter endotheli cell vasculatur play central role pathogenesi broad spectrum dread human diseas endotheli cell key function particip mainten patent function capillari endothelium direct involv peripher vascular diseas stroke heart diseas diabet insulin resist chronic kidney failur tumor growth metastasi venous thrombosi sever viral infecti diseas dysfunct vascular endothelium hallmark human diseas review main endotheli abnorm found human diseas cancer diabet mellitus atherosclerosi viral infect address
MED-5282~postprandi angina pectori clinic angiograph correl pubm ncbi abstract object studi design determin sever coronari arteri diseas patient postprandi angina pectori background postprandi angina manifest coronari arteri diseas clinic practic publish syndrom anatom correl method questionnair num patient chest pain object evid ischemia thirty f patient num identifi postprandi angina group num patient group nonpostprandi angina serv control group coronari angiographi perform patient result analyz result postprandi angina observ predomin men num num num high incid rest angina num group num group num high incid left main num num num three vessel num num num coronari arteri diseas eject fraction lower patient num num num postprandi angina occur rest exert common dinner conclus postprandi angina marker sever coronari arteri diseas consid indic coronari angiographi
MED-5283~chocolate cocoa human health review pubm ncbi abstract chocolate cocoa good tast propos health effect centuri earlier chocol criticis fat content consumpt sin remedi acn cari obes high blood pressur coronari arteri diseas diabet physician tend warn patient potenti health hazard consum larg amount chocol recent discoveri biolog activ phenol compound cocoa chang percept stimul research effect age oxid stress blood pressur regul atherosclerosi today chocol laud tremend antioxid potenti studi contradictori result concern methodolog issu made hard health profession public understand evid chocolate effect health purpos review interpret research decad benefit risk chocol consumpt
MED-5284~habitu chocol consumpt increas bodi weight dose respons manner abstract object habitu chocol intak recent found lower bodi weight cross sect epidemiolog studi object assess cross sect result hold rigor prospect analysi method data atherosclerosi risk communiti cohort usual dietari intak assess questionnair baselin num num year particip report usual chocol intak frequenc eat num oz num serv bodi weight height measur visit miss data replac multipl imput linear mixed effect model evalu cross sect prospect associ chocol intak adipos result data num num particip visit frequent chocol consumpt signific greater prospect weight gain time dose respons manner instanc compar particip ate chocol serv month ate num num time month week experienc increas bodi mass index kg m num num num ci num num num num num six year studi period cross sect analys frequenc chocol consumpt invers bodi weight invers associ attenu exclud particip preexist obesity rel ill compar particip ill higher bmi report frequent chocol intak lower calor intak diet richer fruit veget tend make dietari ill conclus prospect analysi found chocol habit long term weight gain dose respons manner cross sect find chocol intak lower bodi weight appli particip preexist ill
MED-5285~cocoa blood pressur cardiovascular health pubm ncbi abstract high blood pressur import risk factor cardiovascular diseas cardiovascular event worldwid clinic epidemiolog studi suggest cocoa rich product reduc risk cardiovascular diseas cocoa high content polyphenol flavanol flavanol exert favor effect endothelium deriv vasodil stimul nitric oxide synthas increas avail l arginin decreas degrad cocoa benefici effect protect oxid stress alter decreas platelet aggreg decreas lipid oxid insulin resist effect decreas blood pressur favor trend reduct cardiovascular event stroke previous meta analys shown cocoa rich food reduc blood pressur long term trial investig effect cocoa product determin blood pressur reduc chronic basi daili ingest cocoa long term trial investig effect cocoa clinic outcom assess cocoa effect cardiovascular event num mmhg systol blood pressur reduct estim decreas risk cardiovascular all caus mortal paper summar find cocoa effect blood pressur cardiovascular health focus putat mechan action nutraceut viewpoint
MED-5286~dark chocol obes paradox culprit weight gain pubm ncbi abstract obes remain major public health challeng preval dramat increas diet exercis typic recommend prevent manag obes result conflict polyphenol class phytochem shown reduc risk factor diabet type ii cardiovascular diseas recent suggest complementari agent manag obes mechan decreas fat absorpt and or fat synthesi dark chocol high sourc polyphenol flavanol receiv attent role modul obes potenti effect fat carbohydr metabol satieti outcom investig anim model obes cell cultur human observ clinic studi research undertaken date shown promis result implic cocoa dark chocol modul obes bodi weight mechan includ decreas express gene involv fatti acid synthesi reduc digest absorpt fat carbohydr increas satieti copyright num john wiley son
MED-5287~candi consumpt bodi weight measur risk factor cardiovascular diseas metabol syndrom adult nhane pubm ncbi abstract limit research examin relationship candi consumpt adult diet health purpos studi determin total chocol sugar candi consumpt effect energi satur fatti acid ad sugar intak weight risk factor cardiovascular diseas metabol syndrom met diet qualiti adult num year older num particip num nation health nutrit examin survey twenty four hour dietari recal determin intak covariate adjust se preval rate determin candi consumpt group odd ratio determin likelihood cardiovascular risk factor met total num num num adult consum total chocol sugar candi daili capita intak total chocol sugar candi num num num num num num intak consum num num num num num num energi num num num num kj num satur fatti acid num num num num num ad sugar num num num num num intak higher candi consum nonconsum bodi mass index num num num num kg m num num waist circumfer num num num num cm num c reactiv protein num num num num mg dl num level lower candi consum nonconsum candi consum num decreas risk elev diastol blood pressur num chocol consum num decreas risk lower high dens lipoprotein cholesterol num num reduc risk met num result suggest current level candi consumpt health risk copyright num elsevi reserv
MED-5288~background music genr modul flavor pleasant impress food stimuli pubm ncbi abstract studi aim determin background music genr alter food percept accept determin effect background music vari function type food emot versus non emot food sourc music perform singl versus multipl perform music piec edit genr classic jazz hip hop rock singl multipl perform consumpt emot milk chocol non emot food bell pepper music stimuli particip rate sensori percept impress food stimuli particip food stimuli signific listen jazz stimulus hip hop stimulus influenc background music impress present emot food non emot food addit flavor pleasant impress food stimuli differ music genr arrang singl perform multipl perform conclus find demonstr music genr alter flavor pleasant impress food stimuli influenc music genr food accept vari function type serv food sourc music perform publish elsevi
MED-5289~low higher dos dark chocol blood pressur cardiovascular high risk patient pubm ncbi abstract background dark chocol blood pressure low properti conduct prospect random open label blind end point design trial studi potenti dose depend presum antihypertens effect dark chocol direct compar low higher dose dark chocol num month method enrol total num patient prehypertension stag num hypertens establish cardiovascular end organ damag diabet mellitus patient random assign receiv num num g day flavanol rich dark chocol num month differ num blood pressur group defin primari outcom measur result signific reduct ambulatori num blood pressur observ baselin follow up group num g day num mm hg num confid interv num num num g day num mm hg num confid interv num num signific differ blood pressur group higher dos group slight increas bodi weight note num kg num confid interv num num conclus find consist hypothesi dark chocol reduct blood pressur bp due lack control group confound result interpret caution
MED-5290~dietari salt reduct lower blood pressur iii  analysi data trial salt reduct abstract object determin reduct blood pressur achiev trial dietari salt reduct quantit consist estim deriv blood pressur sodium intak popul estim impact reduc dietari salt mortal stroke ischaem heart diseas design analysi result num crossov trial num randomis control trial dietari salt reduct main outcom measur comparison observ reduct systol blood pressur trial predict valu calcul popul analysi result num trial salt reduct week observ reduct blood pressur predict differ observ predict reduct greatest trial shortest durat num trial week longer predict reduct individu trial close match wide rang observ reduct appli age group peopl high normal level blood pressur peopl age num year reduct daili sodium intak num mmol num salt attain moder dietari salt reduct week lower systol blood pressur averag num mm hg num mm hg high blood pressur num mm hg diastol blood pressur lower half estim reduct salt intak western popul reduc incid stroke num ischaem heart diseas num correct conclus result trial support estim observ data accompani paper effect univers moder dietari salt reduct mortal stroke ischaem heart diseas substantial  larg achiev fulli implement recommend polici treat high blood pressur drug reduct amount salt ad process food lower blood pressur prevent num correct death year britain disabl
MED-5291~dietari salt intak hypertens abstract past centuri salt subject intens scientif research relat blood pressur elev cardiovascular mortal moder reduct dietari salt intak general effect measur reduc blood pressur recent academ societi lay media disput benefit salt restrict point inconsist outcom note observ studi reduct dietari salt current intak num g day recommend level num g day major benefici effect cardiovascular health major healthcar cost save world world health organ strong recommend reduc dietari salt intak top prioriti action tackl global non communic diseas crisi urg member nation action reduc popul wide dietari salt intak decreas number death hypertens cardiovascular diseas stroke scientist advoc possibl increas risk cvd morbid mortal extrem low salt intak futur research inform optim sodium reduct strategi intak target general popul continu build consensus greatest benefit salt reduct cvd prevent dietari salt intak reduct strategi remain top public health agenda
MED-5292~blood pressur sodium intak sodium relat hormon yanomamo indian no salt cultur pubm ncbi abstract yanomamo indian unaccultur tribe inhabit tropic equatori rain forest northern brazil southern venezuela salt diet group present unusu opportun studi hormon regul sodium metabol cultur life long extrem restrict dietari sodium parallel observ blood pressur blood pressur increas decad constrast civil popul systemat increas subsequ year life twenty four hour urin collect adult male indian excret sodium averag num minus num sd meq simultan plasma renin activ elev compar civil subject period num meq sodium diet similar excret rate aldosteron equal accultur subject low sodium diet find suggest hormon adjust life long low sodium intak similar achiev acut sodium restrict civil man parenthet elev level aldosteron renin norm man human evolut suggest valu observ civil control depress excess salt intak contemporari diet
MED-5293~compar risk assess burden diseas injuri attribut num risk factor risk factor cluster num region num num systemat analysi global burden diseas studi num summari background quantif diseas burden caus risk inform prevent provid account health loss provid disease by diseas analysi complet revis global diseas burden caus risk factor compar risk assess num previous analysi assess burden attribut risk factor time method estim death disability adjust life year dali sum year live disabl yld year life lost yll attribut independ effect num risk factor cluster risk factor num region num num estim exposur distribut year region sex age group relat risk unit exposur systemat review synthesis publish unpublish data estim estim cause specif death dali global burden diseas studi num calcul burden attribut risk factor exposur compar theoretical minimum risk exposur incorpor uncertainti diseas burden relat risk exposur estim attribut burden find num lead risk factor global diseas burden high blood pressur num num uncertainti interv num num num num global dali tobacco smoke includ second hand smoke num num num num num alcohol num num num num num num lead risk childhood underweight num num num num num household air pollut solid fuel hap num num num num num tobacco smoke includ second hand smoke num num num num num dietari risk factor physic inact collect account num num ui num num num num global dali num promin dietari risk diet low fruit high sodium risk primarili affect childhood communic diseas includ unimprov water sanit childhood micronutri defici fell rank num num unimprov water sanit account num num num num num global dali num sub saharan africa childhood underweight hap non exclus discontinu breastfeed lead risk num hap lead risk south asia lead risk factor eastern europ latin america southern sub saharan africa num alcohol asia north africa middl east central europ high blood pressur declin tobacco smoke includ second hand smoke remain lead risk high incom north america western europ high body mass index increas global lead risk australasia southern latin america rank high high incom region north africa middl east oceania interpret worldwid contribut risk factor diseas burden chang substanti shift risk communic diseas children non communic diseas adult relat age popul decreas mortal children younger num year cause of death composit risk factor exposur evid led magnitud key risk includ unimprov water sanit vitamin zinc defici ambient particul matter pollut extent epidemiolog shift occur lead risk vari great region sub saharan africa lead risk poverti affect children fund bill melinda gate foundat
MED-5294~lipid profil yanomamo indian brazil pubm ncbi abstract determin serum lipid level correl world isol popul num adult yanomamo indian amazonian rain forest examin measur bodi weight height estim age casual blood sampl obtain estim age rang num num year men averag num women num year serum total cholesterol low men num mg dl women num mg dl compar western sampl triglycerid num num mg dl respectively  wer lower men slight higher women men women yanomamo women signific higher total cholesterol num bodi mass index bmi num men hdl cholesterol num ldl cholesterol num higher women multivari regress analysi estim age independ relat cholesterol sex bmi borderlin signific low serum lipid level isol popul appar attribut larg vegetarian diet low fat cholesterol high fiber concomit high physic activ low bmi
MED-5295~dietari salt influenc postprandi plasma sodium concentr systol blood pressur pubm ncbi abstract plasma sodium concentr direct effect blood pressur addit effect extracellular volum regul endothelium mechan elev blood pressur habitu increas salt intak unclear effect salt singl meal plasma sodium concentr blood pressur resolv compar effect soup num salt amount similar singl meal plasma sodium concentr blood pressur num normotens volunt random crossov design plasma sodium concentr signific increas num num mmol l salt compar unsalt soup blood pressur increas volunt ingest soup ad salt signific posit correl plasma sodium concentr systol blood pressur num mmol l increas plasma sodium num mm hg increas systol blood pressur linear regress plasma sodium concentr occur time meal salt consum potenti mechan blood pressur salt intak effect plasma sodium concentr
MED-5296~yanomami indian intersalt studi pubm ncbi abstract object studi distribut interrelationship constitut biochem variabl blood pressur bp popul yanomami indian compar find popul method yanomami indian part intersalt studi compris num male femal age num num year belong num popul num countri africa america asia europ num center requir accru num individu num particip age group variabl analyz age sex arteri bp urinari sodium potassium excret num hour urin bodi mass index alcohol ingest result find yanomami popul low urinari sodium excret num mmol num systol diastol bp level num mmhg num mmhg case hypertens obes knowledg alcohol beverag bp level elev age urinari sodium excret relat posit urinari potassium excret relat negat systol bp correl maintain control age bodi mass index conclus posit relat salt intak blood pressur detect analysi set divers popul particip intersalt studi includ popul yanomami indian qualit observ lifestyl provid addit inform
MED-5297~double blind randomis crossov trial moder sodium restrict essenti hypertens pubm ncbi abstract nineteen unselect patient mild moder essenti hypertens averag supin blood pressur month observ treatment num mm hg advis add salt food avoid sodium laden food num week sodium restrict patient enter num week double blind randomis crossov studi slow sodium ciba versus slow sodium placebo supin blood pressur num mm hg num lower fourth week placebo fourth week slow sodium num urinari sodium excret fourth week slow sodium num num mmol num fourth week placebo num mmol num mmol num num differ potassium excret result suggest moder sodium restrict achiev ad salt avoid sodium laden food part manag essenti hypertens
MED-5298~eat salt pubm ncbi abstract high blood pressur major cardiovascular risk factor overwhelm evid high salt consumpt major increas blood pressur link high salt consumpt risk stroke left ventricular hypertrophi renal diseas obes renal stone stomach cancer reduc salt consumpt lead decreas blood pressur incid cardiovascular diseas deleteri effect reduc salt consumpt cost effect organ state govern issu recommend suitabl amount salt consumpt franc object salt consumpt num day men num g day women children num consum salt manufactur product develop countri reduct salt consumpt requir particip food industri tool consum inform educ salt consumpt decreas franc recent year effort continu copyright num elsevi masson sas reserv
MED-5299~prevent death unit state compar risk assess dietari lifestyl metabol risk factor abstract background knowledg number death caus risk factor health polici prioriti set aim estim mortal effect num modifi dietari lifestyl metabol risk factor unit state consist compar method high blood glucos low dens lipoprotein ldl cholesterol blood pressur overweight obes high dietari tran fatti acid salt low dietari polyunsatur fatti acid omega num fatti acid seafood fruit veget physic inact alcohol tobacco smoke method find data risk factor exposur popul nation repres health survey disease specif mortal statist nation center health statist obtain etiolog effect risk factor disease specif mortal age systemat review meta analys epidemiolog studi adjust major potenti confound ii regress dilut bias estim number disease specif death attribut non optim level risk factor exposur age sex num tobacco smoke high blood pressur respons estim num num confid interv ci num num num num num death account death adult overweight obes num num num physic inact num num num respons num num death high dietari salt num num num low dietari omega num fatti acid num num num high dietari tran fatti acid num num num dietari risk largest mortal effect num num num death ischem heart diseas ischem stroke diabet avert current alcohol outweigh num num num death cardiovascular diseas cancer liver cirrhosi pancreat alcohol disord road traffic injuri violenc conclus smoke high blood pressur effect intervent respons largest number death dietari lifestyl metabol risk factor chronic diseas substanti number death articl editor summari editor summari number modifi factor respons prematur prevent death overweight obes shorten life expect half long term tobacco smoker western popul die prematur diseas direct relat smoke modifi risk factor fall main group lifestyl risk factor includ tobacco smoke physic inact excess alcohol small amount alcohol prevent diabet type heart diseas stroke dietari risk factor high salt intak low intak fruit veget final metabol risk factor shorten life expect increas person chanc develop cardiovascular diseas heart problem stroke diabet metabol risk factor includ high blood pressur blood cholesterol overweight obes studi reduc prevent death chang modifi risk factor introduc public health polici program regul reduc exposur risk factor import death caus risk factor develop polici program aim improv nation health previous studi provid inform number prematur death caus modifi risk factor problem studi consist compar method estim number death attribut risk factor rare consid effect dietari metabol risk factor studi research estim number death due num modifi dietari lifestyl metabol risk factor unit state popul method call compar risk assess approach estim number death prevent current distribut risk factor exposur chang hypothet optim distribut research find research extract data exposur num select risk factor nation health survey obtain inform death differ diseas num nation center health statist previous publish studi estim risk factor increas risk death diseas research mathemat formula estim number death caus risk factor num million death num estim half million tobacco smoke num high blood pressur risk factor account num num death adult overweight obes physic inact respons num num death dietari factor examin high dietari salt intak largest effect respons num death adult final alcohol prevent num death ischem heart diseas ischem stroke diabet research estim caus num death type cardiovascular diseas medic condit road traffic accid violenc find find smoke high blood pressur respons largest number prevent death modifi risk factor death accuraci estim obtain studi affect qualiti data find suggest target hand risk factor great reduc prematur mortal find appli countri risk factor respons prevent death vari countri import effect individual level population wid intervent reduc people exposur risk factor respons prevent death research suggest combin regul price educ potenti reduc exposur resid risk factor shorten live addit inform access web site onlin version summari http   dx doi org num journal pmed num
MED-5300~salt volum prevent hypertens pubm ncbi abstract evid support thesi hypertens prevent elimin salt diet base princip sourc num epidemiolog studi unaccultur peopl show preval hypertens invers correl degre salt intak num hemodynam studi suggest develop chronic experiment hypertens homeostat respons maintain increas extracellular fluid volum ecf num evid ecf salt eater expand comparison no salt eater num investig hypertens patient receiv diet great restrict salt continu diuret therapi correl fall blood pressur reduct ecf mechan essenti hypertens obscur evid good conclus reduct salt diet num g day result prevent essenti hypertens disappear major public health problem
MED-5301~reduct cardiovascular diseas project modest reduct dietari salt abstract background diet high salt major process food reduc dietari salt import potenti public health target method coronari heart diseas chd polici model quantifi benefit potenti achiev population wid reduct dietari salt num gm day num mg day sodium estim cardiovascular diseas rate cost age sex race subgroup compar salt reduct intervent reduc cardiovascular risk determin cost effect salt reduct compar drug treatment hypertens result reduc salt num gm day project result num num fewer chd case num num fewer stroke num num fewer myocardi infarct num num fewer death annual segment popul benefit black benefit proportion women benefit stroke reduct older adult reduct chd event younger adult lower mortal rate cardiovascular benefit lower salt par benefit reduc tobacco obes cholesterol regulatori intervent design achiev num gm day salt reduct save num num quality adjust life year num num billion healthcar cost annual intervent cost sav modest num gm day reduct achiev gradual decad num num cost effect treat hypertens individu medic conclus modest reduct dietari salt substanti reduc cardiovascular event medic cost public health target
MED-5302~increas burden hypertens nigeria dietari salt reduct strategi chang trend pubm ncbi abstract develop countri face dual challeng communic non communic diseas num death cardiovascular diseas occur low middle incom countri hypertens rank highest attribut mortal develop develop countri preval hypertens rise rapid nigeria num decad ago num recent time review explor salt reduct diet population wid level reduc burden hypertens nigeria evid strategi explor method goal achiev countri investig recommend accomplish nigerian context consid suggest salt reduct effect implement population wid basi impact morbid mortal larg provis drain safe water num centuri royal societi public health num
MED-5303~state health num burden diseas injuri risk factor pubm ncbi abstract import understand major health problem unit state chang time critic inform nation health polici object measur burden diseas injuri lead risk factor unit state num num compar measur num countri organis econom co oper develop oecd countri design systemat analysi descript epidemiolog num diseas injuri num sequela diseas injuri num risk factor cluster risk factor num num num countri develop global burden diseas num studi describ health status unit state compar health outcom num oecd countri year life lost due prematur mortal ylls comput multipli number death age refer life expect age year live disabl ylds calcul multipli preval base systemat review disabl weight base population bas survey sequela disabl studi refer short long term loss health disability adjust life year dali estim sum ylds ylls death dali relat risk factor base systemat review meta analys exposur data relat risk risk outcom pair healthi life expect hale summar popul health account length life level ill health experienc age result life expect sex combin increas num year num num year num period hale increas num year num year diseas injuri largest number ylls num ischem heart diseas lung cancer stroke chronic obstruct pulmonari diseas road injuri age standard yll rate increas alzheim diseas drug disord chronic kidney diseas kidney cancer fall diseas largest number ylds num low back pain major depress disord musculoskelet disord neck pain anxieti disord popul age ylds compris larger share dali ylls lead risk factor relat dali dietari risk tobacco smoke high bodi mass index high blood pressur high fast plasma glucos physic inact alcohol num oecd countri num num rank age standard death rate chang num num age standard yll rate num num age standard yld rate num num life expect birth num num hale num num conclus relev num num unit state made substanti progress improv health life expect birth hale increas all caus death rate age decreas age specif rate year live disabl remain stabl morbid chronic disabl account half health burden improv popul health unit state pace advanc popul health wealthi nation
MED-5304~regul brown adipos tissu develop white fat reduct l arginin pubm ncbi abstract purpos review brown adipos tissu bat present human play import role oxid fatti acid glucos purpos review highlight import role l arginin regul bat growth develop reduc obes mammal recent find dietari supplement l arginin reduc white adipos tissu genet diet induc obes rat obes pregnant sheep obes human type ii diabet l arginin treatment enhanc bat growth fetus postnat anim molecular cellular level l arginin stimul express peroxisom proliferator activ receptor coactiv num master regul mitochondri biogenesi nitric oxid synthas heme oxygenas adenosin monophosphate activ protein kinas bodi level l arginin increas blood flow insulin sensit tissu adipos tissu lipolysi catabol glucos fatti acid inhibit fatti acid synthesi amelior oxid stress improv metabol profil summari l arginin increas mammalian bat growth develop mechan involv gene express nitric oxid signal protein synthesi enhanc oxid energi substrat reduc white fat accret bodi l arginin hold great promis prevent treat obes human
MED-5305~effect spice food metabol rate pubm ncbi abstract time lavoisi ingest food anim man produc increas oxygen consumpt increas metabol rate origin call specif dynam action sda wide refer thermic effect te food diet induc thermogenesi dit rothwel stock num earli work thermic effect confin type amount food notabl macronutrients  protein fat carbohydr shown minor constitu diet caffein methylxanthin zahorska markrewicz num jung al num tea coffe profound effect metabol rate consumpt alcohol shown increas metabol rate rosenberg durnin num work paper report effect minor constitu food spice metabol rate spice food steadili increas time inform exist effect metabol rate estim approxim num spice diet today communic report effect chilli red pepper capsicum annuum mustard brassica juncea
MED-5307~anatom locat human brown adipos tissu abstract review inform present hypothes anatomi brown adipos tissu bat locat human anatom distribut confer surviv protect critic organ hypothermia adapt thermogenesi ultim locat function import therapeut strategi prevent treat obes type num diabet case success intervent signific effect bat function subject live thermoneutr environ view divers locat potenti differ respons bat depot bat shown subtl previous overlook function regulatori control mechan
MED-5310~acut effect capsaicin energi expenditur fat oxid negat energi balanc abstract background addit capsaicin cap diet shown increas energi expenditur capsaicin interest target anti obes therapi aim investig num effect cap energi expenditur substrat oxid blood pressur num negat energi balanc method subject underw num session respir chamber measur energi expenditur substrat oxid blood pressur receiv num num daili energi requir condit num cap num control num cap num control cap dose num mg num red chili pepper num scovill heat unit shu meal result induc negat energi balanc num effect num negat energi balanc due adapt mechan diet induc thermogenesi dit rest energi expenditur ree num cap differ dit ree num control num control tend lower num control num num sleep metabol rate smr num cap differ smr num cap smr num control lower num cap num fat oxid num cap higher num control num num control differ num control respiratori quotient rq decreas num cap num num control num compar num control blood pressur differ condit conclus effect num negat energi balanc consumpt num mg capsaicin meal support negat energi balanc counteract unfavor negat energi balanc effect decreas compon energi expenditur consumpt num mg capsaicin meal promot fat oxid negat energi balanc increas blood pressur signific trial registr nederland trial regist registr number ntr num
MED-5311~dinitrophenol obes earli twentieth centuri regulatori dilemma pubm ncbi abstract earli num industri chemic dinitrophenol found widespread favor weight loss drug due princip work mauric tainter clinic pharmacologist stanford univers compound therapeut index razor thin thousand peopl suffer irrevers harm mainstream physician realiz dinitrophenol risk outweigh benefit abandon passag food drug cosmet act num feder regul abil stop patent medicin men sell dinitrophenol american lure promis drug safe melt one fat
MED-5312~capsinoid relat food ingredi activ brown fat thermogenesi reduc bodi fat human pubm ncbi abstract purpos review capsaicin nonpung analog capsinoid food ingredi increas energi expenditur decreas bodi fat articl review role brown adipos tissu bat thermogen effect compound human propos possibl antiobes food ingredi recent find singl oral ingest capsinoid increas energi expenditur human individu metabol activ bat indic capsinoid activ bat increas energi expenditur find gave ration explan discrep result effect capsinoid previous studi human bat larg compos induc beig adipocyt typic brown adipocyt gene express pattern similar beig cell isol murin white fat depot fact preadipocyt isol supraclavicular fat deposit bat detect capabl differenti brown lik adipocyt vitro provid evid induc brown adipogenesi adult human summari human bat induc prolong ingest capsinoid recruit activ bat increas energi expenditur decreas bodi fat addit capsinoid numer food ingredi expect activ bat prevent obes daili life
MED-5313~uptak supraclavicular area fat usa fat descript num fdg pet ct pubm ncbi abstract supraclavicular region common site lymph node metastas common report type nonmalign num f fdg uptak pet imag supraclavicular region muscl uptak purport due muscl contract tens patient num f fdg uptak phase pet ct offer uniqu opportun correl pet find ct anatomi supraclavicular region method imag num consecut clinic whole bodi studi num patient num f fdg pet ct scanner ct attenu correct ordered subset expect maxim osem reconstruct retrospect review supraclavicular region evalu presenc abnorm uptak pet imag ct find assess distinct pattern abnorm num f fdg uptak note pattern uptak local supraclavicular area fat usa fat lymph node muscl uptak ct pattern uptak local muscl ct pattern uptak local lymph node soft tissu mass ct result forty nin patient num num femal num male age num num age rang num show abnorm num f fdg uptak supraclavicular region twenti patient num muscl uptak group num num definit abnorm lymph node group num patient num usa fat group foci low hounsfield unit ct foci present num ge attenuation correct imag obtain non attenuation correct imag uptak usa fat typic bilater symmetr intens multifoc linear locat fat pet ct age signific group versus num group intens standard uptak lean suv maximum standard uptak lean suv max differenti pattern num standard uptak valu suv max num suv num signific lower group num group num conclus so cal muscl uptak supraclavicular region caus signific proport case unrel process call usa fat find num f fdg uptak tissu low hounsfield fat densiti find reflect nonpatholog process hypothes foci brown fat intens supraclavicular uptak recogn misinterpret malign metastat process muscl uptak
MED-5314~implic brown adipos tissu human abstract discuss role brown adipos tissu energi homeostasi assess potenti target bodi weight manag high number mitochondria presenc uncoupl protein num brown fat adipocyt term energi ineffici adenosin num triphosph atp product energi effici heat product energi ineffici atp product high energi substrat oxid brown adipos tissu generat heat bodi temperatur regul thermogen properti play role bodi weight regul debat recent discoveri brown adipos tissu human adult understand brown adipos tissu develop encourag quest altern treat obes obes individu brown adipos tissu mass act lean counterpart review discuss physiolog relev brown adipos tissu thermogenesi potenti bodi weight control human
MED-5315~measur human brown adipos tissu volum activ anatom mri function mri abstract exist brown adipos tissu bat human previous assess vivo sequenti num fdg pet ct imag develop mri protocol detect bat mass base bat properti higher water to fat ratio white adipos tissu wat show signal contrast obtain water satur water satur higher bat wat fast spin echo imag num weight imag water to fat ratio higher bat contrast water fat imag dixon method mri measur volum locat bat similar pet ct result subject addit demonstr cold challeng num led signific fmri bold signal increas bat
MED-5316~num dinitrophenol dnp weight loss agent signific acut toxic risk death abstract num dinitrophenol dnp report rapid loss weight unaccept high rate signific advers effect dnp sold internet number weight loss slim aid uncoupl oxid phosphoryl classic symptom complex toxic phenol bas product dnp combin hyperthermia tachycardia diaphoresi tachypnoea eventu lead death fatal relat exposur dnp report turn twentieth centuri date num publish death medic literatur attribut dnp review describ pattern pathophysiolog dnp toxic summaris previous fatal exposur dnp
MED-5317~identif import brown adipos tissu adult human abstract background obes result imbal energi intak expenditur rodent newborn human brown adipos tissu regul energi expenditur thermogenesi mediat express uncoupl protein num ucp num brown adipos tissu consid physiolog relev adult human method analyz num consecut num fluorodeoxyglucos num fdg positron emiss tomograph comput tomograph pet ct scan perform diagnost reason num patient presenc substanti depot putat brown adipos tissu depot defin collect tissu num mm diamet densiti adipos tissu ct maxim standard uptak valu num fdg num millilit indic high metabol activ clinic index record compar date match control immunostain ucp num perform biopsi specimen neck supraclavicular region patient undergo surgeri result substanti depot brown adipos tissu identifi pet ct region extend anterior neck thorax tissu region ucp num immunoposit multilocular adipocyt indic brown adipos tissu posit scan num num women num num num men num female mal ratio greater num num women greater mass brown adipos tissu higher num fdg uptak activ probabl detect brown adipos tissu invers correl year age num outdoor temperatur time scan num beta block num older patient body mass index num conclus defin region function activ brown adipos tissu present adult human frequent women men quantifi noninvas num fdg pet ct import amount brown adipos tissu invers correl body mass index older peopl suggest potenti role brown adipos tissu adult human metabol
MED-5318~brown adipos tissu whole bodi energi expenditur thermogenesi healthi adult men pubm ncbi abstract brown adipos tissu bat identifi num f fluorodeoxyglucos fdg positron emiss tomographi pet adult human thirteen healthi male volunt age num year underw fdg pet num cold exposur num light cloth intermitt put leg ice block expos cold num num subject show mark fdg uptak adipos tissu supraclavicular paraspin region bat posit group remain show detect uptak bat neg group bmi bodi fat content similar group warm condit num energi expenditur bat posit group estim indirect calorimetri num num kcal day compar bat neg group num num kcal day cold exposur energi expenditur increas mark num num num slight num num kcal day num bat posit negat group posit correl num found cold induc rise energi expenditur bat activ quantifi fdg uptak cold exposur skin temperatur supraclavicular region close bat deposit drop num bat posit group drop mark num num bat neg group skin temperatur drop region bat deposit similar group result suggest bat involv cold induc increas whole bodi energi expenditur control bodi temperatur adipos adult human
MED-5319~nonpung capsaicin analog capsinoid increas energi expenditur activ brown adipos tissu human pubm ncbi abstract background capsinoids nonpung capsaicin analogs ar activ brown adipos tissu bat thermogenesi whole bodi energi expenditur ee small rodent bat activ assess f fluorodeoxyglucose positron emiss tomographi fdg pet human object aim current studi examin acut effect capsinoid ingest ee analyz relat bat activ human design eighteen healthi men age num underw fdg pet num cold exposur num wear light cloth whole bodi ee skin temperatur oral ingest capsinoid num mg measur num warm condit num single blind random placebo control crossov design result expos cold num subject show mark fdg uptak adipos tissu supraclavicular paraspin region bat posit group remain num subject bat neg group show detect uptak warm condit num sem rest ee num num kj d bat posit group num num kj d bat neg group ns ee increas num num kj h num bat posit group num num kj h bat neg group oral ingest capsinoid num placebo ingest produc signific chang group capsinoid placebo chang skin temperatur region includ region close bat deposit conclus capsinoid ingest increas ee activ bat human trial regist http   www umin ac jp ctr umin num
MED-5320~usa fat preval relat ambient outdoor temperature evalu num fdg pet ct pubm ncbi abstract increas num f fdg activ fatti tissu previous report pet ct previous activ uptak supraclavicular area fat usa fat specul uptak exist metabol activ brown adipos tissu bat tissu expect vari metabol activ depend ambient temperatur purpos studi evalu frequenc usa fat relationship outdoor temperatur method juli num june num num consecut whole bodi scan obtain pet ct scanner num f fdg clinic patient pet imag review presenc usa fat result usa fat observ num scan obtain num patient num femal num male incid usa fat highest num januari march temperatur low signific lower num rest year conclus incid usa fat increas cooler period year find suggest stimul cold temperatur increas frequenc usa fat occur support bat etiolog activ
MED-5321~recruit brown adipos tissu antiobes agent human abstract brown adipos tissu bat burn fat produc heat bodi expos cold play role energi metabol fluorodeoxyglucose positron emiss tomographi comput tomographi previous report bat decreas age acceler age rel accumul bodi fat human recruit bat effect bodi fat reduct studi examin effect repeat stimul cold capsinoid nonpung capsaicin analog healthi human subject low bat activ acut cold exposur num num hour increas energi expenditur ee cold induc increment ee cit strong correl bat activ independ age fat fre mass daili num hour cold exposur num num week result parallel increas bat activ cit concomit decreas bodi fat mass bat activ bodi fat mass negat correl similar daili ingest capsinoid num week increas cit result demonstr human bat recruit individu decreas bat activ contribut bodi fat reduct
MED-5322~character bacteria clostridia bacteroid faec vegetarian qpcr pcr dgge fingerprint pubm ncbi abstract background aim studi aim investig quantit qualit bacteria bacteroid bifidobacterium clostridium cluster iv faecal microbiota vegetarian diet method bacteri abund measur faecal sampl num vegetarian num omnivor quantit pcr divers assess pcr dgge fingerprint princip compon analysi pca shannon divers index result vegetarian num higher abund bacteri dna omnivor tendenc clostridium cluster iv num num num num higher abund bacteroid num num num num signific due high interindividu variat pca suggest group bacteria member clostridium cluster iv band signific frequent omnivor vegetarian num num identifi faecalibacterium sp num similar uncultur gut bacteriumdq num conclus vegetarian diet affect intestin microbiota decreas amount chang divers clostridium cluster iv remain determin shift affect host metabol diseas risk copyright num karger ag basel
MED-5323~endocrine disrupt chemic obes develop human review pubm ncbi abstract studi review literatur relat exposur chemic endocrine disrupt abil obes human studi general exposur endocrine disrupt chemic increas bodi size human result depend type chemic exposur level time exposur gender studi investig dichlorodiphenyldichloroethylen dde found exposur increas bodi size result studi investig polychlorin biphenyl pcb exposur depend dose time gender hexachlorobenzen polybromin biphenyl beta hexachlorocyclohexan oxychlordan phthalat likewis general increas bodi size studi investig polychlorin dibenzodioxin polychlorin dibenzofuran found associ weight gain increas waist circumfer associ studi investig relat bisphenol found associ studi investig prenat exposur exposur utero perman physiolog predispos weight gain studi find suggest endocrin disruptor play role develop obes epidem addit common perceiv putat contributor num author obes review num intern associ studi obes
MED-5324~effect high fat meal pulmonari function healthi subject pubm ncbi abstract obes import health consequ includ elev risk heart diseas diabet cancer high fat diet contribut obes effect high fat diet pulmonari function dramat increas preval respiratori ailment asthma purpos studi determin high fat meal hfm increas airway inflamm decreas pulmonari function healthi subject pulmonari function test pft forc expiratori volum num forc vital capac forc expiratori flow num vital capac exhal nitric oxid eno airway inflamm perform num healthi num men num women inact subject age num num year pre num post hfm num fat num kg bodi weight num num fat total cholesterol triglycerid c reactiv protein crp system inflamm determin venous blood sampl pre post hfm bodi composit measur dual energi x ray absorptiometri hfm signific increas total cholesterol num num triglycerid num num eno increas num due hfm num num pre num num post num num ppb eno triglycerid signific relat baselin post hfm num num increas eno pft crp chang num hfm result demonstr hfm lead signific increas total cholesterol triglycerid increas exhal suggest high fat diet contribut chronic inflammatori diseas airway lung
MED-5325~vegetarian diet blood pressur white subject result adventist health studi num ah num abstract object previous work studi vegetarian found lower blood pressur bp reason includ lower bmi higher intak level fruit veget seek extend evid geograph divers popul vegan lacto ovo vegetarian omnivor design data analys calibr sub studi adventist health studi num ah num cohort attend clinic provid valid ffq criteria establish vegan lacto ovo vegetarian partial vegetarian omnivor dietari pattern set clinic conduct church usa canada dietari data gather mail questionnair subject hundr white subject repres ah num cohort result covariate adjust regress analys demonstr vegan vegetarian lower systol diastol bp mmhg omnivor adventist num num num num num num num num find lacto ovo vegetarian num num num num num num num num similar vegetarian vegan antihypertens medic defin hypertens systol bp num mmhg diastol bp num mmhg antihypertens medic odd ratio hypertens compar omnivor num num ci num num num num ci num num num num num ci num num num vegan lacto ovo vegetarian partial vegetarian effect reduc adjust bmi conclus conclud larg studi vegetarian vegan divers characterist stabl diet lower systol diastol bp hypertens omnivor part due lower bodi mass
MED-5326~red meat colon cancer vegetarian make meat safer pubm ncbi abstract effect meat consumpt cancer risk controversi issu recent meta analys show high consum cure meat red meat increas risk colorect cancer increas signific modest num current wcrf aicr recommend eat num week red meat avoid process meat studi show beef meat cure pork meat promot colon carcinogenesi rat major promot meat heme iron n nitros fat peroxid dietari addit suppress toxic effect heme iron instanc promot colon carcinogenesi rat cook nitrite tr oxid high hem cure meat suppress dietari calcium tocopherol studi volunt support protect effect human addit studi provid accept prevent colorect cancer copyright num elsevi reserv
MED-5327~associ dietari pattern mental health earli adolesc pubm ncbi abstract object investig associ dietari pattern mental health earli adolesc method western australian pregnanc cohort rain studi prospect studi num pregnanc recruit num num year age num num child behaviour checklist cbcl assess behaviour characteris mental health status higher score repres poorer behaviour dietari pattern western healthi identifi factor analysi food group intak estim num item food frequenc questionnair relationship dietari pattern food group intak behaviour examin general linear model adjust potenti confound factor age num total energi intak bodi mass index physic activ screen famili structur incom function gender matern educ pregnanc result higher total num num ci num num intern withdrawn depress num num ci num num extern delinquent aggress num num ci num num cbcl score signific western dietari pattern increas intak takeaway food confectionari red meat improv behaviour score signific higher intak leafi green veget fresh fruit compon healthi pattern conclus find implic western dietari pattern poorer behaviour outcom adolesc behaviour outcom higher intak fresh fruit leafi green veget
MED-5328~vegetarian diet incid diabet adventist health studi num abstract aim evalu relationship diet incid diabet non black black particip adventist health studi num method result particip num men num women num black canada free diabet provid demograph anthropometr lifestyl dietari data particip group vegan lacto ovo vegetarian pesco vegetarian semi vegetarian non vegetarian refer group follow up questionnair year elicit inform develop diabet case diabet develop num vegan num lacto ovo vegetarian num pesco vegetarian num semi vegetarian num non vegetarian black increas risk compar non black odd ratio num num confid interv ci num num multipl logist regress analysi control age gender educ incom televis watch physic activ sleep alcohol smoke bmi vegan num num ci num num lacto ovo vegetarian num num ci num num semi vegetarian num num ci num num lower risk diabet non vegetarian non black vegan lacto ovo semi vegetarian diet protect diabet num num ci num num num num ci num num num num ci num num black vegan lacto ovo vegetarian diet protect num num ci num num num num ci num num associ strengthen bmi remov analys conclus vegetarian diet vegan lacto ovo semi substanti independ reduct diabet incid black dimens protect vegetarian diet great excess risk black ethnic
MED-5329~rapid reduct serum cholesterol blood pressur twelve day low fat strict vegetarian diet pubm ncbi abstract object studi conduct demonstr effect strict vegetarian low fat diet cardiac risk factor modif method hundr men women particip intens num day live in program studi program focus dietari modif moder exercis stress manag hospital bas health cent result short time period cardiac risk factor improv averag reduct total serum cholesterol num num blood pressur num num weight loss num kg men num kg women serum triglycerid increas subgroup femal age num year serum cholesterol num mmol l femal num num year baselin serum cholesterol num num mmol l high dens lipoprotein cholesterol measur num subject decreas num conclus strict low fat vegetarian diet free anim product combin lifestyl includ exercis weight loss effect lower serum cholesterol blood pressur
MED-5330~effect singl high fat meal endotheli function healthi subject pubm ncbi abstract well establish relat serum cholesterol coronari arteri diseas risk individu nation variat associ suggest factor involv atherogenesi high fat diet triglyceride rich lipoprotein suggest atherogen assess direct effect postprandi triglyceride rich lipoprotein endotheli function earli factor atherogenesi num healthi normocholesterolem volunteers  wer studi num hour singl isocalor high low fat meal num calori num num fat endotheli function form flow medi vasoact assess brachial arteri num mhz ultrasound percent arteri diamet chang num minut num minut upper arm arteri occlus serum lipoprotein glucos determin eat num num hour postprandi serum triglycerid increas num num mg dl preprandi num num mg dl num hour high fat meal num flow depend vasoact decreas num num preprandi num num num num num num num hour high fat meal num compar low fat meal data lipoprotein flow medi vasoact observ low fat meal fast low dens lipoprotein cholesterol correl invers num num preprandi flow medi vasoact triglycerid level chang postprandi flow medi vasoact num num hour correl chang num hour serum triglycerid num num result demonstr singl high fat meal transient impair endotheli function find identifi potenti process high fat diet atherogen independ induc cholesterol
MED-5331~influenc public nutrit non communic diseas prevent communiti intervent nation programme  experi finland pubm ncbi abstract global health transit underway burden non communic diseas ncds increas rapid develop world result lifestyl addit tobacco physic activ major place diet contribut great grow epidem ncd huge global public health challeng influenc trend diet nutrit effect global ncd prevent health transit place rapid finland world war ii mortal cardiovascular diseas cvd high north karelia project launch num community bas nation programm influenc diet lifestyl crucial prevent cvd intervent strong theori base employ comprehens strategi broad communiti organis strong particip peopl key element evalu shown diet fat consumpt chang led major reduct popul serum cholesterol blood pressur level shown ischaem heart diseas mortal working ag popul declin num north karelia num countri num num finland industrialis countri north karelia rural low socio econom level social problem num num project base low cost intervent activ people particip communiti organis play key role comprehens intervent communiti eventu support nation activities  from expert guidelin media activ industri collabor polici similar principl nutrit intervent programm develop countri tailor local condit paper discuss experi north karelia project light less industrialis countri make general recommend
MED-5332~quantif butyryl coa acet coa transferas gene reveal butyr product capac individu diet age pubm ncbi abstract gastrointestin microbiota produc short chain fatti acid butyr affect colon health immun function epigenet regul assess effect nutrit age product butyr butyryl coa acet coa transferas gene popul shift clostridium cluster lv xlva main butyr produc analys faecal sampl young healthi omnivor num num year vegetarian num num year elder num num year omnivor evalu diet lifestyl assess questionnaire bas interview elder signific fewer copi butyryl coa acet coa transferas gene young omnivor num vegetarian show highest number copi num thermal denatur butyryl coa acet coa transferas gene variant melt curv relat roseburia eubacterium rectal spp signific variabl vegetarian elder clostridium cluster xiva abund vegetarian num omnivor num elder group gastrointestin microbiota elder character decreas butyr product capac reflect increas risk degen diseas result suggest butyryl coa acet coa transferas gene valuabl marker gastrointestin microbiota function num feder european microbiolog societi publish blackwel publish reserv
MED-5333~vegetarian diet affect gene oxid metabol collagen synthesi pubm ncbi abstract background aim vegetarian diet prevent seri diseas influenc balanc carbohydr fat metabol collagen synthesi studi compar express pattern relev gene oral mucosa omnivor vegetarian method quantit revers transcriptas polymeras chain reaction appli analysi mrna level carnitin transport octn num hepat cpt num nonhepat cpt num isoform carnitin palmitoyltransferas collagen ccol num oral mucosa result compar volunt tradit eat habit carbohydr consumpt signific higher num vegetarian signific stimul cpt num num octn num lower collagen synthesi num conclus find provid insight associ chang fat metabol reduc collagen synthesi vegetarian play role age process copyright num karger ag basel
MED-5334~protein sourc tryptophan efficaci treatment social anxieti disord pilot studi pubm ncbi abstract recent intact protein rich tryptophan altern pharmaceutical grad tryptophan protein larg neutral amino acid lnaa compet transport site blood brain barrier recent evid deoil gourd seed rich sourc tryptophan approxim num mg g protein combin glucos carbohydr reduc serum level compet lnaa clinic effect similar pharmaceutical grad tryptophan achiev object subject measur anxieti suffer social phobia social anxieti disord employ measur anxieti respons stimulus part double blind placebo control crossov studi wash out period num week studi session subject random assign start protein sourc tryptophan deoil gourd seed combin carbohydr ii carbohydr week initi session subject return follow up session receiv opposit treatment receiv session num subject began studi complet num week protocol protein sourc tryptophan carbohydr carbohydr result signific improv object measur anxieti protein sourc tryptophan combin high glycem carbohydr potenti anxiolyt suffer social phobia
MED-5335~vegan diet reduc risk parkinson diseas pubm ncbi abstract recent case control studi conclud diet high anim fat cholesterol substanti increas risk parkinson diseas pd contrast fat plant origin increas risk report age adjust preval rate pd tend uniform europ america sub saharan black african rural chines japanes group diet tend vegan quasi vegan enjoy substanti lower rate current pd preval african american white environment factor respons low pd risk black african aggreg find suggest vegan diet notabl protect respect pd offer insight satur fat compound anim fat anim protein integr impact compon anim product mediat risk anim fat consumpt calor restrict recent shown protect central dopaminerg neuron mice neurotoxin part induct heat shock protein conceiv protect afford vegan diet reflect similar mechan possibl vegan diet therapeut benefici pd slow loss surviv dopaminerg neuron retard progress syndrom merit examin vegan diet pd patient promot vascular health aid blood brain barrier transport l dopa copyright num harcourt publish
MED-5337~intens lifestyl affect progress prostat cancer pubm ncbi abstract purpos men prostat cancer advis make diet lifestyl impact document evalu effect comprehens lifestyl prostat specif antigen psa treatment trend serum stimul lncap cell growth men earli biopsi proven prostat cancer num year materi method patient recruit limit men chosen undergo convent treatment provid unusu opportun nonintervent random control group avoid confound effect intervent radiat surgeri androgen depriv therapi total num volunt serum psa num num ng ml cancer gleason score num random assign experiment group make comprehens lifestyl usual care control group result experiment group patient num control patient underw convent treatment due increas psa and or progress diseas magnet reson imag psa decreas num experiment group increas num control group num growth lncap prostat cancer cell american type cultur collect manassa virginia inhibit num time serum experiment control group num num num serum psa lncap cell growth signific degre chang diet lifestyl conclus intens lifestyl affect progress earli low grade prostat cancer men studi longer term followup warrant
MED-5338~origin articl vegetarian compar meat dietari protein sourc phosphorus homeostasi chronic kidney diseas summari background object patient advanc chronic kidney diseas ckd posit phosphorus balanc phosphorus level maintain normal rang phosphaturia induc increas fibroblast growth factor num fgf num parathyroid hormon pth rational recommend restrict dietari phosphat intak num mg d protein sourc phosphat import design set particip measur conduct crossov trial patient estim gfr num ml min direct compar vegetarian meat diet equival nutrient prepar clinic research staff num hour num day diet period subject hospit research center urin blood frequent monitor result result num week vegetarian diet led lower serum phosphorus level decreas fgf num level inpati stay demonstr similar diurnal variat blood phosphorus calcium pth urin fraction excret phosphorus signific differ vegetarian meat diet final num hour fraction excret phosphorus high correl num hour fast urin collect vegetarian diet meat diet conclus summari studi demonstr sourc protein signific effect phosphorus homeostasi patient ckd dietari counsel patient ckd includ inform amount phosphat sourc protein phosphat deriv
MED-5339~escherichia coli urinari tract infect zoonosi proof direct link product anim meat pubm ncbi abstract recent suggest escherichia coli caus urinari tract infect uti meat anim purpos investig clonal link exist coli anim meat uti patient twenty two geograph tempor match num coli uti patient community dwel human broiler chicken meat pork broiler chicken previous identifi exhibit virul genotyp microarray detect approxim num gene investig clonal related pfge isol select test vivo virul mous model ascend uti uti community dwel human strain close clonal relat meat strain human deriv strain clonal interrel isol origin virul uti model posit urin bladder kidney cultur isol gene profil yield similar bacteri count urin bladder kidney studi show clonal link coli meat human provid solid evid uti zoonosi close relationship community dwel human uti isol point sourc spread contamin meat
MED-5340~renal function paramet thai vegan compar non vegan pubm ncbi abstract asia vegetarian well establish eat behavior adopt vegan diet lead lessen health risk factor vegetarian notabl effect hematolog system effect nephrolog system clarifi pattern renal function paramet studi num thai vegan compar num non vegetarian studi paramet found urin protein signific num vegan control vegan signific lower urin protein level
MED-5341~effect low fat high fib diet exercis program breast cancer risk factor vivo tumor cell growth apoptosi vitro pubm ncbi abstract present studi investig effect diet exercis intervent breast cancer bca risk factor includ estrogen obes insulin insulin lik growth factor i igf i overweight obes postmenopaus women addit subject pre postintervent serum vitro serum stimul growth apoptosi estrogen receptor posit bca cell line studi women low fat num kcal high fib num num kcal day diet attend daili exercis class num wk serum estradiol reduc women hormon treatment ht num ht num serum insulin igf i signific reduc women igf bind protein num increas signific vitro growth bca cell line reduc num mcf num cell num zr num cell num num cell apoptosi increas num zr num cell num mcf num cell num num cell num result show very low fat high fib diet combin daili exercis result major reduct risk factor bca subject remain overweight obes vivo serum slow growth induc apoptosi serum stimul bca cell line vitro
MED-5342~vegetarian diet healthi mood state cross sect studi seventh day adventist adult abstract background physic health status vegetarian extens report limit research mental health status vegetarian regard mood vegetarian diet exclud fish major dietari sourc eicosapentaeno acid epa docosahexaeno acid dha critic regul brain cell structur function omnivor diet low epa dha link impair mood state observ experiment studi method examin associ mood state polyunsatur fatti acid intak result adher vegetarian omnivor diet cross sect studi num healthi seventh day adventist men women resid southwest particip complet quantit food frequenc questionnair depress anxieti stress scale dass profil mood state pom questionnair result vegetarian veg n num report signific negat emot omnivor omn n num measur total dass pom score num num num num num num num num num num veg report signific lower intak epa num dha num omega num fatti acid arachidon acid aa num report higher intak shorter chain linolen acid num linol acid num omn total dass pom score posit relat intak epa num dha num aa num invers relat intak ala num la num indic particip low intak epa dha aa high intak ala la mood conclus vegetarian diet profil advers affect mood low intak long chain omega num fatti acid
MED-5343~manag medic mistak ideolog insular account internists in train pubm ncbi abstract end graduat medic train novic internist collect housestaff initi experi patient deleteri consequ wit colleagu event occur housestaff engag social psycholog process util varieti cope mechan in group practic manag mishap major mechan util housestaff defin defend mishap frequent occur denial discount distanc denial consist compon negat concept error defin practic medicin art gray area repress actual mistak forget redefinit mistak non mistak discount includ defens extern blame mistak due circumst control includ blame bureaucrat system medicin blame superior subordin intern medicin blame diseas blame patient longer deni discount mistak magnitud util distanc techniqu withstand share elabor repertoir denial discount distanc found profound doubt guilt remain housestaff troublesom feel easili automat resolv interspers defens fundament question culpabl respons vacil blame case close termin formal train point neglect medic sociolog literatur num year graduat program work attend vulner ambigu accompani manag mistak maladapt aspect collect acquir defens mechan system account graduat medic specialti train found variabl time contradictori process housestaff ultim sole arbit mistak adjud housestaff feel judg decis patient progress train intern account cohorts  th depart medicin teach faculti peers  ar discount vari degre develop strong ideolog justifi jealous guard autonomi abstract truncat num word
MED-5344~risk factor myocardi infarct women men insight interheart studi pubm ncbi abstract aim coronari heart diseas chd lead death men women global women develop chd num year men reason unclear purpos report determin differ risk factor distribut exist women men age categori explain women develop acut mi men method result interheart global case control studi includ num particip num countri num women median age acut mi higher women men num num year num modifi risk factor mi women men hypertens num num num num num num diabet num num num num num num physic activ num num num num num num moder alcohol num num num num num num strong mi women men associ abnorm lipid current smoke abdomin obes high risk diet psychosoci stress factor mi similar women men risk factor associ general stronger younger individu compar older women men popul attribut risk par risk factor exceed num similar women men num num men signific suffer mi prior num year age women adjust level risk factor sex differ probabl mi case occur age num year reduc num conclus women experi acut mi averag num year men modifi risk factor signific acut mi men women explain greater num par differ age mi larg explain higher risk factor level younger age men compar women
MED-5345~year err human learn pubm ncbi abstract year ago institut medicin iom call nation effort make health care safe progress slow iom report chang convers focus chang system stimul broad array stakehold engag patient safeti motiv hospit adopt safe practic pace chang acceler implement electron health record diffus safe practic team train full disclosur patient injuri direct hospit achiev high level safeti pay perform provid addit incent improv magnitud envis iom requir nation commit strict ambiti quantit well track nation goal agenc healthcar research qualiti bring stakehold includ payer agre set explicit ambiti goal patient safeti reach num
MED-5346~resid duty hour restrictions who protect aoa critic issu pubm ncbi abstract advoc nasca teach program nurtur profession effac interest core practic medicin profess evid date suggest work hour restrict base sole clock defin time limit discourag promot profession behavior desir tomorrow physician notwithstand issu relat duti hour fit duti competency bas system medic educ desir current environ medic educ absenc evid suggest duty hour limit reduc medic error enhanc patient safeti evolv competency bas system resid educ misguid overzeal focus limit work hour exert unintend consequ erod etho profession patient expect physician
MED-5347~effect health care provid work hour sleep depriv safeti perform pubm ncbi abstract background increas interest impact resident physician nurs work hour patient safeti evid demonstr work schedul profound effect provid sleep perform safeti patient nurs work shift greater num hour signific increas risk experienc decreas vigil job suffer occup injuri make medic error physicians in train work tradit num hour on cal shift great increas risk experienc occup sharp injuri motor vehicl crash drive home work make fatal medic error compar work num hour shift on cal resid attent failur work overnight commit num medic error report make num fatigue rel medic error lead patient death conclus weight evid strong suggest extended dur work shift signific increas fatigu impair perform safeti standpoint provid patient hour routin work health care provid unit state unsaf reduc unaccept high rate prevent fatigue rel medic error injuri health care worker unit state establish enforc safe work hour limit
MED-5348~rye lignan human health pubm ncbi abstract rye bran high content dietari fibr plant lignan bioactiv compound so cal dietari fibr complex blood concentr lignan enterolacton biomark intak lignan rich plant food present evid studi human subject warrant conclus rye grain orphyto oestrogen protect cancer studi point direct especi relat cancer upper digest tract number prospect epidemiolog studi shown protect effect wholegrain cereal myocardi infarct protect effect diabet ischaem stroke brain infarct demonstr reason assum protect effect factor dietari fibr complex
MED-5349~rye bread consumpt earli life reduc risk advanc prostat cancer abstract object determin consumpt whole grain rye bread oatmeal whole wheat bread period life risk prostat cancer pca method num num num men age num year report dietari habit ages reykjavik cohort studi dietari habit assess earli mid current life valid food frequenc questionnair ffq linkag cancer mortal regist retriev inform pca diagnosi mortal num regress model estim odd ratio hazard ratio hrs pca grain consumpt adjust confound factor includ fish fish liver oil meat milk intak result num men num diagnos pca follow up num advanc diseas stage num die pca daili rye bread consumpt adolesc daili decreas risk pca diagnosi num num confid interv ci num num advanc pca num num ci num num high intak oatmeal adolesc num num time week signific risk pca diagnosi num num ci num num advanc pca num num ci num num mid late life consumpt rye bread oatmeal whole wheat bread pca risk conclus result suggest rye bread consumpt adolesc reduc risk pca advanc diseas
MED-5350~randomis control short term intervent pilot studi rye bran bread prostat cancer pubm ncbi abstract short term effect rye bran bread intak prostat cancer investig ten men conserv treat prostat cancer randomis daili supplement num rye bran bread men num wheat bread control similar fibr content week blood sampl ultrasound guid core biopsi prostat urin sampl rye group signific increas plasma enterolacton apoptot index increas signific num sd num num sd num num measur tunel index case rye group case control group signific decreas weight group small observ plasma concentr prostat specif antigen psa circul sex hormon excret oestrogen insulin lik growth factor igf i endotheli fibrinolyt system high intak rye bran bread suggest increas apoptosi prostat tumour
MED-5351~serum enterolacton risk breast cancer case control studi eastern finland pubm ncbi abstract phytoestrogen link risk breast cancer main phytoestrogen finnish diet lignan enterolacton quantit import circul lignan purpos studi examin associ serum enterolacton risk breast cancer finnish women subject particip kuopio breast cancer studi analysi concern num breast cancer case num premenopaus num postmenopaus enter studi diagnosi num community bas control complet valid food frequenc questionnair refer previous num month gave serum sampl examin measur serum enterolacton perform time resolv fluoroimmunoassay statist analys logist regress method serum enterolacton concentr num nmol l case num nmol l control num serum enterolacton concentr lowest quintil num nmol l num nmol l highest odd ratio highest quintil enterolacton valu adjust risk factor breast cancer num num confid interv num num trend num invers associ serum enterolacton risk breast cancer premenopaus postmenopaus women high enterolacton level higher consumpt rye product tea higher intak dietari fiber vitamin compar low serum enterolacton valu serum enterolacton level signific invers risk breast cancer
MED-5352~intak grain product risk breast cancer hormon receptor status histolog postmenopaus women pubm ncbi abstract clear relationship grain product risk breast cancer establish larg prospect cohort studi investig associ intak grain product risk breast cancer tumour receptor status oestrogen receptor er progesteron receptor pr tumour histolog ductal lobular investig associ differ hormon replac therapi hrt studi includ num postmenopaus women particip danish diet cancer health cohort studi num follow up time num year num breast cancer case diagnos associ intak grain product breast cancer rate analys cox regress model higher intak grain product lower risk breast cancer increment intak total grain product num day adjust incid rate ratio num confid interv num num num intak rye bread oatmeal grain bread breast cancer risk associ observ intak total specif grain product risk develop er er pr pr combin er pr status ductal lobular breast cancer interact intak grain product hrt risk breast cancer conclus intak grain product risk breast cancer cohort danish postmenopaus women copyright num wiley liss
MED-5353~cancer risk second gener immigr sweden pubm ncbi abstract nationwid swedish family canc databas analyz cancer risk sweden born descend immigr european north american countri studi includ close num num year old descend immigr father mother calcul standard incid ratio sir num confid interv cis num cancer site nativ swede refer cancer margin swedish incid offspr immigr origin decreas sir observ breast cancer norwegian descend melanoma descend hungarian father ovarian bladder cancer descend finnish mother consist differ cancer incid swede indigen popul cervic cancer increas daughter danish men thyroid cancer non hodgkin lymphoma excess offspr parent yugoslav asian descent result agre high incid rate parent compar swede non hodgkin lymphoma explan relat immun malfunct comparison result second gener immigr suggest num decad life import set pattern cancer develop subsequ life birth sweden set swedish pattern cancer incid irrespect nation descent enter sweden num late influenc environment imprint program cancer destini copyright num wiley liss
MED-5354~lignan human health pubm ncbi abstract review focus role human health consumpt lignan rich food plant lignan human food convert intestin microflora upper part larg bowel enterolacton enterodiol call mammalian enterolignan protect role compound chronic western diseas discuss evid suggest fiber lignan rich whole grain cereal bean berri nut seed main protect food factor addit diet intestin microflora smoke antibiot obes affect circul lignan level bodi lignan rich diet benefici consum life experiment evid anim shown clear anticarcinogen effect flaxse pure lignan type cancer epidemiolog result controversi part determin plasma enterolacton countri sourc lignan play role factor food particip protect effect result promis work area medicin
MED-5355~intak whole grain product risk prostat cancer men danish diet cancer health cohort studi pubm ncbi abstract object high intak whole grain product protect prostat cancer evid limit inconclus aim present studi investig relationship intak whole grain product risk prostat cancer larg prospect cohort method total num men age num year particip diet cancer health cohort studi provid inform diet potenti prostat cancer risk factor median follow up num year identifi num prostat cancer case associ whole grain product intak prostat cancer incid analyz cox regress model result associ total intak whole grain product prostat cancer risk adjust incid rate ratio num day num num confid interv num num intak specif whole grain product whole grain rye bread whole grain bread oatmeal risk prostat cancer risk estim differ stage grade diseas conclus result prospect studi suggest higher intak total specif whole grain product risk prostat cancer popul danish middle ag men
MED-5356~rye grain bran intak compar refin wheat decreas urinari c peptid plasma insulin prostat specif antigen men pubm ncbi abstract rye grain bran intak shown benefici effect prostat cancer progress anim model includ lower tumor rate smaller tumor volum reduc prostat specif antigen psa concentr human pilot studi show increas apoptosi consumpt rye bran bread studi investig effect high intak rye grain bran prostat cancer progress assess psa concentr men diagnos prostat cancer seventeen particip provid num rye grain bran product rp refin wheat product ad cellulos wp num daili energi intak random control crossov design blood sampl fast men num num wk treatment num urin sampl collect intervent period treatment plasma total psa concentr lower treatment rp compar wp treatment effect num num addit fast plasma insulin num urinari c peptid excret lower treatment rp compar wp num num daili excret num lignan higher rp treatment wp treatment num conclud grain bran rye result signific lower plasma psa compar cellulose suppl refin wheat diet patient prostat cancer effect relat inhibit prostat cancer progress caus decreas exposur insulin plasma insulin urinari c peptid excret
MED-5357~rye intak decreas risk human breast cancer abstract background rye fibr bioactiv compound cereal bread product fibr compound fibr complex provid protect breast cancer bc object review evid theoret background role rye compon prevent bc design short review base great extent work scientist nordic countri result mechan fibr complex reduc bc risk present fibr effect ferment increas esterif bile acid reduc toxic free bile acid involv product butyr potenti anticanc effect includ bc fibr reduc enterohepat circul oestrogen lead lower plasma oestrogen concentr fibr complex bioactiv compound lignan alkylresorcinol antioxid potenti anticarcinogen addit vitamin miner phytic acid rye provid protect bc conclus rye product made wholegrain rye flour contribut reduc bc risk
MED-5358~plasma urinari alkylresorcinol metabolit potenti biomark breast cancer risk finnish women pilot studi pubm ncbi abstract alkylresorcinol ar shown good biomark consumpt rye whole grain wheat product man aim pilot studi investig ar metabolit potenti biomark breast cancer bc risk finnish women intak cereal fiber compon propos reduc risk effect enterohepat circul estrogen cross sect observ pilot studi total num omnivor num vegetarian num bc women num mo oper investig num occas num mo dietari intak num day record plasma urinari ar metabolit num dihydroxybenzo acid dhba num num dihydroxyphenyl num propano acid dhppa plasma urinari enterolacton measur group compar nonparametr test observ plasma dhba num num plasma dhppa num num urinari dhba num num urinari dhppa num num cereal fiber intak num num signific lower bc group compar vegetarian omnivor group base measur ar metabolit urin plasma whole grain rye wheat cereal fiber intak low bc subject urinari plasma ar metabolit potenti biomark bc risk women approach facilit studi associ rye whole grain wheat cereal fiber intak diseas find confirm larger subject popul
MED-5359~milk intak earli life risk advanc prostat cancer abstract author investig early lif resid area iceland mark distinct differ milk intak risk prostat cancer population bas cohort num men born num num linkag cancer mortal regist men prostat cancer diagnosi mortal studi entri wave num num num num num subgroup num particip report milk intak earli mid current life follow up period num year num men diagnos prostat cancer includ num advanc diseas stage num higher prostat cancer death compar early lif resid capit area rural resid num year life margin increas risk advanc prostat cancer hazard ratio num num confid interv ci num num men born num hazard ratio num num ci num num daili milk consumpt adolesc daili midlif num fold risk advanc prostat cancer num ci num num data suggest frequent milk intak adolesc increas risk advanc prostat cancer
MED-5360~fruit veget antioxid intak lower older adult depress abstract studi shown associ depress antioxid level oxid stress general includ intak antioxid antioxidant rich fruit veget present studi examin cross sect associ clinically diagnos depress intak antioxid fruit veget cohort older adult antioxid fruit veget intak assess num elder particip num depress num depress block num food frequenc questionnair administ num num particip age num year vitamin lutein cryptoxanthin intak signific lower depress individu comparison particip num addit fruit veget consumpt primari determin antioxid intak lower depress individu multivari model control age sex educ vascular comorbid score bodi mass index total dietari fat alcohol vitamin cryptoxanthin fruit veget remain signific antioxid dietari supplement depress antioxid fruit veget intak lower individu late lif depress comparison particip associ partial explain elev risk cardiovascular diseas older depress individu addit find point import antioxid food sourc dietari supplement
MED-5361~double blind random control clinic trial compar eicosapentaeno acid versus docosahexaeno acid depress pubm ncbi abstract object compar num omega num num prepar enrich eicosapentaeno acid epa versus docosahexaeno acid dha monotherapi major depress disord mdd num site placebo control random double blind clinic trial method num adult num femal sd age num num year dsm iv mdd baselin num item hamilton depress rate scale hdrs num score num random equal num june num num week double blind treatment oral epa enrich num mg d dha enrich num num mg d placebo result num subject complet studi modifi intent to treat mitt analysi num subject num postbaselin visit num femal sd age num num year employ mixed model repeat measur mmrm num group demonstr statist signific improv hdrs num primari outcom measur num item quick inventori depress symptomatology self report qids sr num clinic global improvement sever scale cgi num num prepar separ placebo num respons remiss rate rang num num num treatment signific differ group subject receiv epa enrich num discontinu due worsen depress num subject receiv placebo discontinu due unspecifi negat reaction pill conclus epa enrich dha enrich num superior placebo treatment mdd trial registr clinicaltri gov identifi nct num copyright num physician postgradu press
MED-5362~systemat review meta analysi dietari pattern depress community dwel adult pubm ncbi abstract background studi singl nutrient depress produc inconsist result fail complex interact nutrient increas number studi recent year investig associ dietari pattern depress object studi aim systemat review current literatur conduct meta analys studi address associ dietari pattern depress design electron databas search articl publish august num examin associ total diet depress adult studi consid methodolog rigor includ independ review complet studi select qualiti rate data extract effect size elig studi pool random effect model summari find present studi meta analyz result total num studi identifi result num observ studi pool dietari pattern identifi healthi diet pattern signific reduc odd depress num num ci num num num statist signific associ observ western diet depress num num ci num num num studi precis estim effect conclus result suggest high intak fruit veget fish grain reduc depress risk high qual random control trial cohort studi confirm find specif tempor sequenc associ
MED-5363~dietari pattern depress symptom japanes men women pubm ncbi abstract object studi report associ depress state specif nutrient food studi examin associ dietari pattern adult investig associ major dietari pattern depress symptom japanes method subject num municip employe num men num women age num year particip health survey time period checkup depress symptom assess center epidemiolog studi depress ces d scale dietari pattern deriv princip compon analysi consumpt num food beverag item assess valid diet histori questionnair logist regress analysi estim odd ratio depress symptom ces d num adjust potenti confound variabl result identifi dietari pattern healthi japanes dietari pattern character high intak veget fruit mushroom soy product fewer depress symptom multivariate adjust odd ratio num confid interv depress symptom lowest highest tertil healthi japanes dietari pattern score num refer num num num num num num trend num dietari pattern appreci depress symptom conclus find suggest healthi japanes dietari pattern relat decreas preval depress status
MED-5364~long chain num fatti acid intak fish consumpt suicid cohort japanes men women  th japan public health center bas jphc pubm ncbi abstract object eicosapentaeno acid epa docosahexaeno acid dha implic protect suicid uncertain higher intak epa dha fish major sourc nutrient lower suicid risk japanes fish consumpt suicid rate high studi prospect examin relat fish epa dha intak suicid japanes men women method subject num men num women age num year particip jphc studi complet food frequenc questionnair num death decemb num cox proport hazard regress model estim hazard ratio hr num confid interv ci suicid quintil intak result total num num death suicid record num num person year follow up men women higher intak fish epa dha lower risk suicid multivari hrs num ci suicid death highest versus lowest quintil fish consumpt num num num num num num men women signific increas risk suicid death observ women low intak fish hrs num ci num percentil versus middl quintil num num num conclus result support protect role higher intak fish epa dha suicid japanes men women copyright num elsevi reserv
MED-5365~antioxid antidepress fact fiction pubm ncbi abstract depress medic condit complex biolog pattern aetiolog involv genet epigenet factor environment stressor recent evid suggest oxid stress process play relev role pathogen mechan major psychiatr disord includ depress reactiv oxygen nitrogen speci shown modul level activ noradrenalin norepinephrin serotonin dopamin glutam princip neurotransmitt involv neurobiolog depress major depress lower concentr endogen antioxid compound vitamin zinc coenzym num enzym glutathion peroxidas impair total antioxid status observ introduc potenti target develop therapeut intervent base antioxid compound present review focus role oxid stress process pathogenesi depress therapeut potenti antioxid compound co adjuv treatment convent antidepress discuss instanc n acetyl cystein shown signific benefit depress symptom random placebo control trial addit curcumin yellow pigment curri shown strong interfer neuron redox homeostasi cns possess antidepress activ anim model depress abil inhibit monoamin oxidas urgent develop toler effect treatment depress disord antioxid treatment promis deserv studi
MED-5366~associ mediterranean dietari pattern incid depress seguimiento universidad de navarra univers navarra fol pubm ncbi abstract context adher mediterranean dietari pattern mdp thought reduc inflammatori vascular metabol process involv risk clinic depress object assess associ adher mdp incid clinic depress design prospect studi valid num item food frequenc questionnair assess adher mdp mdp score posit weight consumpt veget fruit nut cereal legum fish monounsatur saturated fatty acid ratio moder alcohol consumpt meat meat product whole fat dairi negat weight set dynam cohort univers graduat seguimiento universidad de navarra univers navarra follow up sun project particip total num initi healthi spanish particip sun project particip studi recruit began decemb num ongo main outcom measur particip classifi incid depress free depress antidepress medic baselin report physician mad diagnosi clinic depress and or antidepress medic follow up result median follow up num year num case depress identifi multipl adjust hazard ratio num confid interv depress num upper success categori adher mdp categori lowest adher refer num num num num num num num num num num num num trend num invers dose respons relationship found fruit nut monounsatur saturated fatty acid ratio legum conclus result suggest potenti protect role mdp regard prevent depress disord addit longitudin studi trial confirm find
MED-5367~relationship plasma carotenoid depress symptom older person abstract object examin cross sect longitudin relationship plasma carotenoid depress symptom six year follow up older person method materi research part inchianti studi prospect population bas studi older person tuscani itali sampl analysi includ num women men age num year older plasma total carotenoid assess baselin depress symptom assess baselin num num year follow up center epidemiolog studies depress scale ces d depress mood defin ces d num result baselin higher total carotenoid level lower probabl depress mood num num ci num num num adjust sociodemograph health inflamm exclus particip baselin depress mood antidepress higher total carotenoid level lower risk incid depress mood num num ci num num num num year follow up adjust confound baselin ces d inflammatori marker interleukin num receptor antagonist partial mediat associ discuss low plasma concentr carotenoid depress symptom predict develop depress symptom older person understand mechan associ reveal potenti target prevent treatment
MED-5368~suicid mortal relat dietari intak num num polyunsatur fatti acid fish equivoc find num larg cohort studi abstract intak num num polyunsatur fatti acid pufa implic pathogenesi depress sought estim associ intak fish num num pufa suicid mortal long term follow up prospect cohort studi biennial questionnair administ num men enrol health profession follow up studi num num num women enrol nurs health studi num num num women enrol nurs health studi ii num num dietari fish num num pufa intak assess num year valid food frequ questionnair suicid mortal ascertain blind physician review death certif hospit patholog report adjust relat risk suicid mortal estim multivari cox proport hazard model pool cohort random effect meta analysi pool multivari relat risk suicid person highest quartil intak num num pufa relat lowest quartil rang num num num pufa ptrend num num num num num pufa ptrend num num find evid intak num pufa fish lower risk complet suicid
MED-5369~suicid mortal european union pubm ncbi abstract background estim million complet suicid year worldwid respons increas concern suicid europ eurosav european review suicid violenc epidemiolog studi undertaken examin recent trend epidemiolog suicid self inflict injuri mortal european union eu method suicid self inflict injuri mortal data num eu countri year num obtain world health organis european statist offic european commiss eurostat nation statist agenc data obtain group death classifi undetermin violenc age standard mortal rate calcul examin trend time result finland highest suicid rate greec lowest latest year num age standard suicid rate tend lowest mediterranean countri signific downward linear time trend suicid mortal observ countri rate vari mark countri ireland spain display signific upward linear trend suicid mortal portug highest rate undetermin death num num greec lowest num num countri includ ireland spain show signific downward trend death due undetermin belgium germani show borderlin signific upward linear trend death due undetermin conclus suicid rate countri decreas valid data uncertain misclassif contribut geograph tempor variat suicid rate eu countri explain phenomenon detail research compar suicide record procedur practic eu requir absenc adequ eu wide data suicid epidemiolog effect prevent distress phenomenon remain elus
MED-5370~long chain omega num fatti acid intak fish consumpt mental disord sun cohort studi pubm ncbi abstract background long chain omega num fatti acid num pufa intak fish consumpt suggest protect factor neuropsychiatr disord scarciti larg cohort studi assess associ aim studi assess associ num pufa intak fish consumpt mental disord method prospect cohort studi perform num particip num pufa intak fish consumpt ascertain valid semi quantit food frequenc questionnair outcom num year follow up num incid mental disord depress anxieti stress num incid depress num incid anxieti logist regress model general addit model fit assess relationship num pufa intak fish consumpt incid outcom odd ratio num confid interv ci calcul result num case depress num case anxieti num case stress observ num year follow up num ci mental disord success quintil energy adjust num pufa intak num refer num num num num num num num num num num num num subject moder consumpt fish fourth quintil consumpt median quintil num num g day relat risk reduct higher num conclus potenti benefit num pufa intak total mental disord suggest linear trend appar
MED-5371~omega num fatti acid treatment depress systemat review meta analysi abstract conduct meta analysi random placebo control trial omega num fatti acid treatment major depress disord order determin efficaci examin sourc heterogen trial pubm num num search random placebo control trial omega num fatti acid major depress disord primari outcom measur standard differ clinic measur depress sever stratifi meta analysi examin effect trial durat trial methodolog qualiti baselin depress sever diagnost indic dose eicosapentaeno acid epa docosahexaeno acid dha omega num prepar omega num fatti acid monotherapi augment num random placebo control trial examin efficaci omega num fatti acid involv num particip meta analysi demonstr signific benefit omega num fatti acid treatment compar placebo smd num num ci num num meta analysi demonstr signific heterogen public bias evid omega num benefit remov adjust public bias trim and fil method smd num num ci num num secondari analys suggest trend increas efficaci omega num fatti acid trial lower methodolog qualiti trial shorter durat trial util complet intention to treat analysi trial studi particip greater baselin depress sever current publish trial suggest small non signific benefit omega num fatti acid major depress treatment efficaci observ publish literatur attribut public bias
